Citrus Sinensis ID: 015480

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400------
Protein Sequence
MSVIFGLIVIIVVFYIIRYFWEKLNRTETETRNAASANKPEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYLDLIKMTRLKSLESSDGLNSSNQSRWYKETTPIMAKHDTQ
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHcccccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHcccccccEEEEEEcccccEEEEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHccccEEEEccccccccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHcccccccccccccccHHHHHccccccccccccccccccccEEEcccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccEcHHHHHHHHHccHHHccccccccEEccccccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHEEEcccccEEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHccccEEEcccccHHHEEccEEEHHHHcHccHHHEcccccccccccEEEEccccccHHHHHcccEEEccccHEHHHEEEEEEEccccccccccccccccHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHHccccHHHHHHHcccccccccccccccEEEEcccccccccccccccccccccccEccccccccccccc
Coil and Loop (DISEMBL)
MSVIFGLIVIIVVFYIIRYFWEKLNRTETEtrnaasankpeeDVVEVIWEAGQTMERFLQEIGrekpvrftslqlnnftsnystrlgfggfgevykgqfpngVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMengsldgylfgKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIhydikpenvlldanfspkvadfglaklcdrnkthvtisgykgtpgysapeflsgnypithkcdvysFGMVLFEIVGRRRNAIVGAtesldwfpkhvWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWcvqdspedrppMSAVIKMLEGVvevlpppkpfryldliKMTRLkslessdglnssnqsrwykettpimakhdtq
Flexible Loop (DISEMBL)
MSVIFGLIVIIVVFYIIRYFWEKLNRTETetrnaasankpeedvVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVtisgykgtpgYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGatesldwfpkhVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWcvqdspedrPPMSAVIKMLEGVVEVLPPPKPFRYLDLIKMTRLKslessdglnssnqsrwykettpimakhdtq
Low Complexity Region (SEG)
MSvifgliviivvfyiiRYFWEKLNRTETETRNAASANKPEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYLDLIKMTRLKSLESSDGLNSSNQSRWYKETTPIMAKHDTQ
Disordered region (IsUnstruct)
**VIFGLIVIIVVFYIIRYFWEKLN******************VVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQ**********AVIKMLEGVVEVLPPPKPFRYLDLIKMTR********************************
Disordered Region (DISOPRED)
MSVIFGLIVIIVVFYIIRYFWEKLNRTETE*******NKPEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNR*****AEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRN******ESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRY****************************************
Disordered Region (DISEMBL)
MSVIFGLIVIIVVFYIIRYFWEKLNRTE************EEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYLDLIKMTRLKSL**********QSRWYKETTPIMAKHDTQ
Disordered Region (DISPRO)
MSVIFGLIVIIVVFYIIRYFWEKLNRT*************************************EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYLDLIK***********************************
Transmembrane Helix (TMHMM)
iHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSVIFGLIVIIVVFYIIRYFWEKLNRTETETRNAASANKPEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYLDLIKMTRLKSLESSDGLNSSNQSRWYKETTPIMAKHDTQ
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	406	2.2.26 [Sep-21-2011]
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.830	0.410	0.415	3e-69
O64477	828	G-type lectin S-receptor-	no	no	0.714	0.350	0.483	8e-69
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.825	0.384	0.399	2e-68
Q9XID3	829	G-type lectin S-receptor-	no	no	0.741	0.363	0.458	9e-68
Q9FID5	806	Probable receptor-like pr	no	no	0.761	0.383	0.428	1e-67
Q9FID6	813	Probable receptor-like pr	no	no	0.783	0.391	0.400	1e-65
Q3ECH2	892	Probable receptor-like pr	no	no	0.780	0.355	0.382	2e-64
Q39203	797	G-type lectin S-receptor-	no	no	0.689	0.351	0.459	4e-62
C0LGH3	1033	Probable LRR receptor-lik	no	no	0.709	0.278	0.440	2e-58
C0LGH2	1032	Probable LRR receptor-lik	no	no	0.709	0.279	0.430	2e-57

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  262 bits (670), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 146/351 (41%), Positives = 217/351 (61%), Gaps = 14/351 (3%)

Query: 46  EVIWEAGQTM---ERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNG 102
           ++I EA Q     + FL+ +    P+RF    L + T+N+S +LG GGFG VY+G  P+G
Sbjct: 457 KMILEAPQESSEEDNFLENL-SGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDG 515

Query: 103 VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL 162
            ++AVK L   +G+  +++F AEV  IG  +H++LVRL GFC +     L YE++  GSL
Sbjct: 516 SRLAVKKL-EGIGQ-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSL 573

Query: 163 DGYLFGKKRA---IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK 219
           + ++F KK     ++W+    IA+GTAKGL YLHE+C  RI+H DIKPEN+LLD NF+ K
Sbjct: 574 ERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAK 633

Query: 220 VADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           V+DFGLAKL  R ++HV  +  +GT GY APE+++ NY I+ K DVYS+GMVL E++G R
Sbjct: 634 VSDFGLAKLMTREQSHV-FTTMRGTRGYLAPEWIT-NYAISEKSDVYSYGMVLLELIGGR 691

Query: 280 RNAIVGATESLDWFPKHVWEEYEKCELGAMILG--CGIEEKDKEKAKRLCMVALWCVQDS 337
           +N     T     FP   +++ E+ +L  ++ G    ++  D E+ +R    ALWC+Q+ 
Sbjct: 692 KNYDPSETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTD-ERVQRAMKTALWCIQED 750

Query: 338 PEDRPPMSAVIKMLEGVVEVLPPPKPFRYLDLIKMTRLKSLESSDGLNSSN 388
            + RP MS V++MLEGV  V+ PP        +  +  KS+    G  +S+
Sbjct: 751 MQTRPSMSKVVQMLEGVFPVVQPPSSSTMGSRLYSSFFKSISEDGGATTSS 801

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  261 bits (666), Expect = 8e-69,   Method: Compositional matrix adjust.
 Identities = 145/300 (48%), Positives = 189/300 (63%), Gaps = 10/300 (3%)

Query: 70  FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTI 129
           F+  +L N T N+S +LG GGFG V+KG  P+   IAVK L   + +  E+QF  EV TI
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRL-EGISQ-GEKQFRTEVVTI 540

Query: 130 GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF----GKKRAIEWEKLHEIAIGT 185
           G   H+NLVRL GFC +     LVY+YM NGSLD +LF     +K  + W+   +IA+GT
Sbjct: 541 GTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGT 600

Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
           A+GL YLH+EC+  IIH DIKPEN+LLD+ F PKVADFGLAKL  R+ + V ++  +GT 
Sbjct: 601 ARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRV-LTTMRGTR 659

Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCE 305
           GY APE++SG   IT K DVYS+GM+LFE+V  RRN      E + +FP        K  
Sbjct: 660 GYLAPEWISG-VAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDG 718

Query: 306 LGAMILGCGIEEK--DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKP 363
               ++   +E    D E+  R C VA WC+QD    RP MS V+++LEGV+EV PPP P
Sbjct: 719 DIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  259 bits (663), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 153/383 (39%), Positives = 215/383 (56%), Gaps = 48/383 (12%)

Query: 1   MSVIFGLIVIIVVFYIIRYFWEKLNRTETETRNAASANKPEEDVVEVIWEAGQTMERFLQ 60
           + ++ G++V++ +  ++ Y+   L+R  T  R A ++                       
Sbjct: 476 IPIVVGMLVLVALLGMLLYY--NLDRKRTLKRAAKNS----------------------- 510

Query: 61  EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEE 120
            I  + PV FT   L N T+N+S  LG GGFG VYKG       +AVK L+R L    E 
Sbjct: 511 LILCDSPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSH-GER 569

Query: 121 QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA---IEWEK 177
           +F+ EV TIG  +H+NLVRL G+C +     LVYEYM NGSLD ++F  ++    ++W  
Sbjct: 570 EFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRT 629

Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
             EIA+ TA+G+ Y HE+C+ RIIH DIKPEN+LLD NF PKV+DFGLAK+  R  +HV 
Sbjct: 630 RFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHV- 688

Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHV 297
           ++  +GT GY APE++S N PIT K DVYS+GM+L EIVG RRN  +       ++P   
Sbjct: 689 VTMIRGTRGYLAPEWVS-NRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWA 747

Query: 298 WEEYEKCELGAMILGCGIEEKDK--------EKAKRLCMVALWCVQDSPEDRPPMSAVIK 349
           ++E           G  ++  DK        E+  +   VA WC+QD    RP M  V+K
Sbjct: 748 YKELTN--------GTSLKAVDKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVK 799

Query: 350 MLEGVV-EVLPPPKPFRYLDLIK 371
           +LEG   E+  PP P   L+LI+
Sbjct: 800 LLEGTSDEINLPPMPQTILELIE 822

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  257 bits (657), Expect = 9e-68,   Method: Compositional matrix adjust.
 Identities = 142/310 (45%), Positives = 184/310 (59%), Gaps = 9/310 (2%)

Query: 59  LQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIA 118
           L E     PV+FT  +L   T ++  +LG GGFG VY+G   N   +AVK L        
Sbjct: 463 LLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGI--EQG 520

Query: 119 EEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA--IEWE 176
           E+QF  EV TI  T+H+NLVRL GFC       LVYE+M NGSLD +LF    A  + WE
Sbjct: 521 EKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWE 580

Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
               IA+GTAKG+ YLHEEC+  I+H DIKPEN+L+D NF+ KV+DFGLAKL +      
Sbjct: 581 YRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRY 640

Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKH 296
            +S  +GT GY APE+L+ N PIT K DVYS+GMVL E+V  +RN  V    +   F   
Sbjct: 641 NMSSVRGTRGYLAPEWLA-NLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIW 699

Query: 297 VWEEYEKCELGAMILGCGIEEK---DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG 353
            +EE+EK    A IL   + E    D E+  R+   + WC+Q+ P  RP M  V++MLEG
Sbjct: 700 AYEEFEKGNTKA-ILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEG 758

Query: 354 VVEVLPPPKP 363
           + E+  P  P
Sbjct: 759 ITEIKNPLCP 768

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1

 Score =  257 bits (657), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 137/320 (42%), Positives = 203/320 (63%), Gaps = 11/320 (3%)

Query: 70  FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTI 129
           +T  +L   T ++S  +G GGFG VY G   NG K+AVKVL    G  + E F+ EV ++
Sbjct: 488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKG--SAEDFINEVASM 545

Query: 130 GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAI-EWEKLHEIAIGTAKG 188
            +T H+N+V L GFC +    A+VYE++ENGSLD ++   K    +   L+ IA+G A+G
Sbjct: 546 SQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNKSLTQDVTTLYGIALGIARG 605

Query: 189 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYS 248
           L YLH  C+ RI+H+DIKP+N+LLD N  PKV+DFGLAKLC++ ++ +++   +GT GY 
Sbjct: 606 LEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYI 665

Query: 249 APEFLSGNYP-ITHKCDVYSFGMVLFEIVGRRRNAIVGATESL---DWFPKHVWEEYEKC 304
           APE  S  Y  ++HK DVYSFGM++ +++G R   IV   +S     +FP  ++++ E  
Sbjct: 666 APEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDG 725

Query: 305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP-PPKP 363
           E    I G  I +++KE AK++ +V LWC+Q  P DRP M+ V++M+EG ++ L  PPKP
Sbjct: 726 E-QTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPKP 784

Query: 364 FRYLDLIKMTRLKSLESSDG 383
             ++    +T   SL  SDG
Sbjct: 785 SMHISTEVITESSSL--SDG 802

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1

 Score =  250 bits (639), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 131/327 (40%), Positives = 204/327 (62%), Gaps = 9/327 (2%)

Query: 74  QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 133
           +L   T ++S  +G GGFG VY+G   NG  +AVKVL    G    + F+ EV ++ +T 
Sbjct: 490 ELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGN--GDDFINEVTSMSQTS 547

Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYL 192
           H+N+V L GFC++    A++ E++E+GSLD ++   K        L+ IA+G A+GL YL
Sbjct: 548 HVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFISRNKSLTPNVTTLYGIALGIARGLEYL 607

Query: 193 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF 252
           H  C+ RI+H+DIKP+N+LLD NF PKVADFGLAKLC++ ++ +++   +GT GY APE 
Sbjct: 608 HYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGYIAPEV 667

Query: 253 LSGNY-PITHKCDVYSFGMVLFEIVGRRRNA-IVGATESLDWFPKHVWEEYEKCELGAMI 310
           +S  Y  I+HK DVYS+GM++ +++G R          S  +FP  ++++ E  +    I
Sbjct: 668 VSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLENGD-QTWI 726

Query: 311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP-PPKPFRYLDL 369
           +G  I E+D +  K++ +V+LWC++  P DRPPM+ V++M+EG ++ L  PPKP R++  
Sbjct: 727 IGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALELPPKPSRHIST 786

Query: 370 IKMTRLKSLESSDGLNSSNQSRWYKET 396
             +    SL  SDG  +  Q++    T
Sbjct: 787 ELVLESSSL--SDGQEAEKQTQTLDST 811

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2

 Score =  246 bits (628), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 128/335 (38%), Positives = 211/335 (62%), Gaps = 18/335 (5%)

Query: 45  VEVIWEAGQTMERFLQEIGREKPVR-FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGV 103
           V++  +   + E  LQ++    P++ +T  ++   T +++  +G GGFG VY G   +  
Sbjct: 520 VQIFRKRKTSDEVRLQKLKALIPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSS 579

Query: 104 KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLD 163
            +AVKVL  + G   E+ F+ EV ++ +T H+N+V L GFC +    A++YE++ NGSLD
Sbjct: 580 MVAVKVLKDSKGTDGED-FINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLD 638

Query: 164 GYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD 222
            ++  K    ++ + L+ IA+G A+GL YLH  C+ RI+H+DIKP+NVLLD N  PKV+D
Sbjct: 639 KFISDKSSVNLDLKTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSD 698

Query: 223 FGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRN 281
           FGLAKLC++ ++ +++   +GT GY APE +S  Y  ++HK DVYS+GM++ E++G R+ 
Sbjct: 699 FGLAKLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKK 758

Query: 282 AIVGATESLD----WFPKHVWEEYEKCEL--------GAMILGCGIEEKDKEKAKRLCMV 329
                    D    +FP+ ++++ EK  +        G +I   GI  +++E A+++ +V
Sbjct: 759 ERFDQNSRSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIEN-GISSEEEEIARKMTLV 817

Query: 330 ALWCVQDSPEDRPPMSAVIKMLEGVVEVLP-PPKP 363
            LWC+Q SP DRPPM+ V++M+EG ++ L  PP+P
Sbjct: 818 GLWCIQSSPSDRPPMNKVVEMMEGSLDALEVPPRP 852

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  238 bits (608), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 135/294 (45%), Positives = 181/294 (61%), Gaps = 14/294 (4%)

Query: 70  FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVK-IAVKVLNRNLGRIAEEQFMAEVGT 128
           F+  +L + T+ +S ++G GGFG V+KG  P     +AVK L R      E +F AEV T
Sbjct: 451 FSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGS--GESEFRAEVCT 508

Query: 129 IGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAK 187
           IG   H+NLVRL GFC +     LVY+YM  GSL  YL     + + WE    IA+GTAK
Sbjct: 509 IGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWETRFRIALGTAK 568

Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
           G+ YLHE C+  IIH DIKPEN+LLD++++ KV+DFGLAKL  R+ + V ++  +GT GY
Sbjct: 569 GIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRV-LATMRGTWGY 627

Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGA-------TESLDW-FPKHVWE 299
            APE++SG  PIT K DVYSFGM L E++G RRN IV +       TE   W FP     
Sbjct: 628 VAPEWISG-LPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAR 686

Query: 300 EYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG 353
           E  +  + +++      E + E+  R+  VA+WC+QD+ E RP M  V+KMLEG
Sbjct: 687 EIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2

 Score =  226 bits (577), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 130/295 (44%), Positives = 181/295 (61%), Gaps = 7/295 (2%)

Query: 66  KPVRFTSLQLNNFTSNY--STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFM 123
           KP  FT  +L + T ++  S +LG GGFG VYKG+  +G ++AVK+L+    R  + QF+
Sbjct: 677 KPYTFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVG-SRQGKGQFV 735

Query: 124 AEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIA 182
           AE+  I    H NLV+LYG C++     LVYEY+ NGSLD  LFG+K   ++W   +EI 
Sbjct: 736 AEIVAISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKTLHLDWSTRYEIC 795

Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK 242
           +G A+GLVYLHEE + RI+H D+K  N+LLD+   PKV+DFGLAKL D  KTH++ +   
Sbjct: 796 LGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHIS-TRVA 854

Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE 302
           GT GY APE+    + +T K DVY+FG+V  E+V  R N+     +   +  +  W  +E
Sbjct: 855 GTIGYLAPEYAMRGH-LTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHE 913

Query: 303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV 357
           K     +I    + E + E+ KR+  +AL C Q S   RPPMS V+ ML G VEV
Sbjct: 914 KGREVELI-DHQLTEFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEV 967

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2

 Score =  223 bits (569), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 127/295 (43%), Positives = 177/295 (60%), Gaps = 7/295 (2%)

Query: 66  KPVRFTSLQLNNFTSNY--STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFM 123
           KP  FT  +L + T ++  S +LG GGFG VYKG   +G  +AVK+L+    R  + QF+
Sbjct: 678 KPYIFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVG-SRQGKGQFV 736

Query: 124 AEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIA 182
           AE+  I    H NLV+LYG C +     LVYEY+ NGSLD  LFG K   ++W   +EI 
Sbjct: 737 AEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKTLHLDWSTRYEIC 796

Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK 242
           +G A+GLVYLHEE   RI+H D+K  N+LLD+   P+++DFGLAKL D  KTH++ +   
Sbjct: 797 LGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHIS-TRVA 855

Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE 302
           GT GY APE+    + +T K DVY+FG+V  E+V  R N+     E   +  +  W  +E
Sbjct: 856 GTIGYLAPEYAMRGH-LTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHE 914

Query: 303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV 357
           K      ++   + + + E+AKR+  +AL C Q S   RPPMS V+ ML G VE+
Sbjct: 915 KSR-DIELIDDKLTDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEI 968

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	406
296081766	543	unnamed protein product [Vitis vinifera]	0.918	0.686	0.708	1e-157
225429784	361	PREDICTED: G-type lectin S-receptor-like	0.864	0.972	0.734	1e-157
359476316	361	PREDICTED: G-type lectin S-receptor-like	0.866	0.975	0.736	1e-157
449437068	436	PREDICTED: G-type lectin S-receptor-like	0.990	0.922	0.642	1e-149
449532913	358	PREDICTED: G-type lectin S-receptor-like	0.864	0.980	0.698	1e-147
449437352	452	PREDICTED: G-type lectin S-receptor-like	0.906	0.814	0.627	1e-141
449437350	363	PREDICTED: G-type lectin S-receptor-like	0.866	0.969	0.665	1e-140
449528245	486	PREDICTED: G-type lectin S-receptor-like	0.908	0.759	0.623	1e-139
449437348	452	PREDICTED: probable receptor-like protei	0.884	0.794	0.595	1e-127
225454761	491	PREDICTED: G-type lectin S-receptor-like	0.766	0.633	0.640	1e-116

>gi|296081766|emb|CBI20771.3| unnamed protein product [Vitis vinifera]

 Score =  562 bits (1448), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 268/378 (70%), Positives = 306/378 (80%), Gaps = 5/378 (1%)

Query: 34  AASANKPEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGE 93
           A  A KP    ++       TMERF QEI +EKPVRFT+ QL +FT+NYST LG GGFG 
Sbjct: 38  ARKARKPIVKELQAREVDAPTMERFFQEIAKEKPVRFTAQQLCSFTANYSTTLGSGGFGV 97

Query: 94  VYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV 153
           VYKGQF NGVKIAVKVLNR+  R A EQFMAEVGTIGRTYH+NLVRLYGFCHDQ M+ALV
Sbjct: 98  VYKGQFLNGVKIAVKVLNRSPDRQAGEQFMAEVGTIGRTYHMNLVRLYGFCHDQFMSALV 157

Query: 154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD 213
           YEY+ENGSLD YLF + R IEWEKLH IA+GTAKG+ YLHEEC QRIIHYDIKP NVLLD
Sbjct: 158 YEYLENGSLDKYLFSEAREIEWEKLHHIAVGTAKGIAYLHEECVQRIIHYDIKPGNVLLD 217

Query: 214 ANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
           ANF PKVADFGLAKLC+R+ TH+T+SGY+GTPGYSAPEFL  N+PITHKCDVYSFGM+LF
Sbjct: 218 ANFFPKVADFGLAKLCNRDNTHLTVSGYRGTPGYSAPEFLLKNHPITHKCDVYSFGMLLF 277

Query: 274 EIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWC 333
           EIVGRRRNA +G+ ES+DWFPKHVWEEYEK +L AM + CGIEEKD+EKA+R+ MVALWC
Sbjct: 278 EIVGRRRNAKIGSNESMDWFPKHVWEEYEKGDLAAMTVACGIEEKDREKAERMSMVALWC 337

Query: 334 VQDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYL-----DLIKMTRLKSLESSDGLNSSN 388
           VQDSP+ RP MSAV+KMLEG VEV+PPPKPF YL     ++++        SS   +   
Sbjct: 338 VQDSPDSRPLMSAVVKMLEGGVEVMPPPKPFHYLYSVGINVLQQANETGTSSSYATSKET 397

Query: 389 QSRWYKETTPIMAKHDTQ 406
            S WYKETTPIMAK++ Q
Sbjct: 398 NSIWYKETTPIMAKYEIQ 415

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225429784|ref|XP_002282725.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Vitis vinifera]

 Score =  560 bits (1444), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 263/358 (73%), Positives = 301/358 (84%), Gaps = 7/358 (1%)

Query: 55  MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL 114
           ME+F QE+ REKPVRFT+ QL +FT NY+T LG GGFG VYKGQFPNGVKIAVKVLNR+ 
Sbjct: 1   MEKFFQELAREKPVRFTAQQLCSFTDNYTTTLGSGGFGMVYKGQFPNGVKIAVKVLNRSP 60

Query: 115 GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 174
            R AEEQFMAEVGTIGRTYHINLVRLYGFC+DQ M+ALVYEY+ENGSLD YLF + + +E
Sbjct: 61  DRQAEEQFMAEVGTIGRTYHINLVRLYGFCYDQFMSALVYEYLENGSLDKYLFSEAQEVE 120

Query: 175 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT 234
           WEKLH IA+GTAKG+ YLHEEC +RIIHYDIKP N+LLDANF PKVADFGLAKLC+R+ T
Sbjct: 121 WEKLHHIAVGTAKGIAYLHEECVERIIHYDIKPGNILLDANFFPKVADFGLAKLCNRDGT 180

Query: 235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP 294
           H+T+SGY+GTPGYSAPEFL  N+PITHKCDVYSFGM+LFEIVGRRRNA VG+ ES+DWFP
Sbjct: 181 HLTVSGYRGTPGYSAPEFLLKNHPITHKCDVYSFGMLLFEIVGRRRNAKVGSNESMDWFP 240

Query: 295 KHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV 354
           KH WEEYEK +L AM + CGIEEKD+EKA+R+ MVALWCVQDSP+ RPPMSAV+KMLEG 
Sbjct: 241 KHTWEEYEKGDLAAMTVACGIEEKDREKAERMSMVALWCVQDSPDSRPPMSAVVKMLEGG 300

Query: 355 VEVLPPPKPFRYLDLIKMTRLKSLESSDGLNSS------NQSRWYKETTPIMAKHDTQ 406
           VEV+PPPKPF YL  + M   +    + G NSS        S WYKETTPIMAK++ Q
Sbjct: 301 VEVMPPPKPFHYLYSVGMNVFQQANET-GTNSSYATSEETSSIWYKETTPIMAKYEIQ 357

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359476316|ref|XP_003631817.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Vitis vinifera]

 Score =  559 bits (1441), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 263/357 (73%), Positives = 299/357 (83%), Gaps = 5/357 (1%)

Query: 55  MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL 114
           MERF QEI +EKPVRFT+ QL +FT+NYST LG GGFG VYKGQF NGVKIAVKVLNR+ 
Sbjct: 1   MERFFQEIAKEKPVRFTAQQLCSFTANYSTTLGSGGFGVVYKGQFLNGVKIAVKVLNRSP 60

Query: 115 GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 174
            R A EQFMAEVGTIGRTYH+NLVRLYGFCHDQ M+ALVYEY+ENGSLD YLF + R IE
Sbjct: 61  DRQAGEQFMAEVGTIGRTYHMNLVRLYGFCHDQFMSALVYEYLENGSLDKYLFSEAREIE 120

Query: 175 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT 234
           WEKLH IA+GTAKG+ YLHEEC QRIIHYDIKP NVLLDANF PKVADFGLAKLC+R+ T
Sbjct: 121 WEKLHHIAVGTAKGIAYLHEECVQRIIHYDIKPGNVLLDANFFPKVADFGLAKLCNRDNT 180

Query: 235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP 294
           H+T+SGY+GTPGYSAPEFL  N+PITHKCDVYSFGM+LFEIVGRRRNA +G+ ES+DWFP
Sbjct: 181 HLTVSGYRGTPGYSAPEFLLKNHPITHKCDVYSFGMLLFEIVGRRRNAKIGSNESMDWFP 240

Query: 295 KHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV 354
           KHVWEEYEK +L AM + CGIEEKD+EKA+R+ MVALWCVQDSP+ RP MSAV+KMLEG 
Sbjct: 241 KHVWEEYEKGDLAAMTVACGIEEKDREKAERMSMVALWCVQDSPDSRPLMSAVVKMLEGG 300

Query: 355 VEVLPPPKPFRYL-----DLIKMTRLKSLESSDGLNSSNQSRWYKETTPIMAKHDTQ 406
           VEV+PPPKPF YL     ++++        SS   +    S WYKETTPIMAK++ Q
Sbjct: 301 VEVMPPPKPFHYLYSVGINVLQQANETGTSSSYATSKETNSIWYKETTPIMAKYEIQ 357

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449437068|ref|XP_004136314.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Cucumis sativus]

 Score =  535 bits (1379), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 262/408 (64%), Positives = 312/408 (76%), Gaps = 6/408 (1%)

Query: 3   VIFGLIVIIVVFYIIRYFWEKLNRTETETRNAASANKPEEDVVEVIWEAGQ-TMERFLQE 61
           VIF +I  I   +  R   + + R       +A+ N      V  IWE  Q TME+F++E
Sbjct: 27  VIFAVIGAISCCFA-RKVRQGIVRELQTVVASATPNLTHSPNVVQIWEIDQPTMEKFIRE 85

Query: 62  IGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ 121
           +  E+PVR T  QL  FTSNYST LG GGFG VYKGQFPNGVKIAVKVL RN  R AEEQ
Sbjct: 86  MAEERPVRLTPQQLYCFTSNYSTPLGSGGFGSVYKGQFPNGVKIAVKVLKRNADRQAEEQ 145

Query: 122 FMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI 181
           FMAEVGTIGRTYHINLVRLYGFC+DQ+M ALV+EYMENGSLD YLFGK + I+W KLH++
Sbjct: 146 FMAEVGTIGRTYHINLVRLYGFCYDQYMGALVFEYMENGSLDKYLFGKNQDIDWRKLHDV 205

Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY 241
           AIGTAKGL YLHEECQQRIIHYDIKP N+LLDANFSPKV DFGLAKLC+R+ TH++++GY
Sbjct: 206 AIGTAKGLAYLHEECQQRIIHYDIKPANILLDANFSPKVGDFGLAKLCNRDITHMSLTGY 265

Query: 242 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEY 301
           +GTPGYSAPEFL  NYPITHKCDVYSFGMVLFEIVGR+RNA V  + + DW P+HVW+ Y
Sbjct: 266 RGTPGYSAPEFLFFNYPITHKCDVYSFGMVLFEIVGRKRNAGVTDSGNPDWLPQHVWDNY 325

Query: 302 EKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPP 361
           EK +L  + L CGIEE +KE+A R+C VALWCVQDSP++RPPMS V++MLEG VE++PPP
Sbjct: 326 EKGKLEELTLMCGIEEDNKERANRMCEVALWCVQDSPDNRPPMSTVVRMLEGGVEIMPPP 385

Query: 362 KPFRYLDLIKMTRLKSLESSDGLNSSNQ---SRWYKETTPIMAKHDTQ 406
           KPF YL        +   +S   ++SN+   S WYK+ TPIM K++ Q
Sbjct: 386 KPFLYLQSTAKRNAQQTSNSSDYSTSNEESGSVWYKD-TPIMKKYEIQ 432

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449532913|ref|XP_004173422.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Cucumis sativus]

 Score =  528 bits (1359), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 248/355 (69%), Positives = 292/355 (82%), Gaps = 4/355 (1%)

Query: 55  MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL 114
           ME+F++E+  E+PVRFT  QL  FTSNYST LG GGFG VYKGQFPNGVKIAVKVL RN 
Sbjct: 1   MEKFIREMAEERPVRFTPQQLYCFTSNYSTPLGSGGFGSVYKGQFPNGVKIAVKVLKRNA 60

Query: 115 GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 174
            R AEEQFMAEVGTIGRTYHINLVRLYGFC+DQ+M ALV+EYMENGSLD YLFGK + I+
Sbjct: 61  DRQAEEQFMAEVGTIGRTYHINLVRLYGFCYDQYMGALVFEYMENGSLDKYLFGKNQDID 120

Query: 175 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT 234
           W KLH++AIGTAKGL YLHEECQQRIIHYDIKP N+LLDANFSPKV DFGLAKLC+R+ T
Sbjct: 121 WRKLHDVAIGTAKGLAYLHEECQQRIIHYDIKPANILLDANFSPKVGDFGLAKLCNRDIT 180

Query: 235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP 294
           H++++GY+GTPGYSAPEFL  NYPITHKCDVYSFGMVLFEIVGR+RNA V  + + DW P
Sbjct: 181 HMSLTGYRGTPGYSAPEFLFFNYPITHKCDVYSFGMVLFEIVGRKRNAGVTDSGNPDWLP 240

Query: 295 KHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV 354
           +HVW+ YEK +L  + L CGIEE +KE+A R+C VALWCVQDSP++RPPMS V++MLEG 
Sbjct: 241 QHVWDNYEKGKLEELTLMCGIEEDNKERANRMCEVALWCVQDSPDNRPPMSTVVRMLEGG 300

Query: 355 VEVLPPPKPFRYLDLIKMTRLKSLESSDGLNSSNQ---SRWYKETTPIMAKHDTQ 406
           VE++PPPKPF YL        +   +S   ++SN+   S WYK+ TPIM K++ Q
Sbjct: 301 VEIMPPPKPFLYLQSTAKRNAQQTSNSSDYSTSNEESGSVWYKD-TPIMKKYEIQ 354

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449437352|ref|XP_004136456.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Cucumis sativus]

 Score =  508 bits (1307), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 236/376 (62%), Positives = 295/376 (78%), Gaps = 8/376 (2%)

Query: 37  ANKPEEDVVEVIWEA-GQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVY 95
           A++P  + V  +WE    TME+F+QE+ +EKP+RFT+ QL  FT NYST LG G F  VY
Sbjct: 71  AHQPMHNNVIQVWEIDAPTMEKFIQELAKEKPIRFTAQQLYIFTRNYSTILGAGAFSTVY 130

Query: 96  KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE 155
           KG+FPNGVKIAVKVLNRN  + AE+QFMAEVGTIG+TYH +LVRLYGFC+DQ+M ALV+E
Sbjct: 131 KGEFPNGVKIAVKVLNRNSDKQAEQQFMAEVGTIGKTYHRHLVRLYGFCYDQYMGALVFE 190

Query: 156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN 215
           YMENGSLD YLFGK + ++W KLH++AIGTAKGL YLHEECQ+RIIHYDIKP N+LLDAN
Sbjct: 191 YMENGSLDKYLFGKNQDVDWGKLHDVAIGTAKGLTYLHEECQERIIHYDIKPANILLDAN 250

Query: 216 FSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
           FSPKV DFGLAKLC R++TH++++GY+GTPGYSAPEF   NYPITHKCDVYSFGM+LFEI
Sbjct: 251 FSPKVCDFGLAKLCHRDRTHISLTGYRGTPGYSAPEFFLNNYPITHKCDVYSFGMLLFEI 310

Query: 276 VGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQ 335
           VGR++NA V  + +LDWFP+HVW++Y+K EL  +   CGIEEKDKE   R+C VALWC+Q
Sbjct: 311 VGRKKNATVTPSGNLDWFPRHVWDKYKKRELEEISQICGIEEKDKESVSRMCKVALWCIQ 370

Query: 336 DSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYLDLI-------KMTRLKSLESSDGLNSSN 388
           DSP++RPPMS V+KMLEG VE++ P  PF++ +          + +  S  +    +   
Sbjct: 371 DSPDERPPMSVVVKMLEGDVEIMAPSNPFKFSNPTPVGNNKPNLLQSSSSSNYSTSSEEI 430

Query: 389 QSRWYKETTPIMAKHD 404
            S WYK+ TPIM K++
Sbjct: 431 HSSWYKKATPIMKKYE 446

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449437350|ref|XP_004136455.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Cucumis sativus]

 Score =  504 bits (1299), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 239/359 (66%), Positives = 286/359 (79%), Gaps = 7/359 (1%)

Query: 55  MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL 114
           ME+F ++I  EKPVRFT+ QL  FTSNYSTRLG GGFGEVYKG+FPNGV IAVKVL R  
Sbjct: 1   MEKFFRKIAEEKPVRFTADQLYTFTSNYSTRLGSGGFGEVYKGKFPNGVNIAVKVLKRGS 60

Query: 115 GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 174
            + AEEQFMAEVG+I RTYHINLVRLYGFC+D  M+ALV+EY+ NGSLD YLFGK++ IE
Sbjct: 61  DKRAEEQFMAEVGSICRTYHINLVRLYGFCYDHFMSALVFEYLVNGSLDKYLFGKRKEIE 120

Query: 175 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT 234
           W KLH+IAIGTAKGL YLHEECQQRIIHYDIKP N+LLDANFSPKV DFGLAKLC+R+ T
Sbjct: 121 WRKLHDIAIGTAKGLAYLHEECQQRIIHYDIKPANILLDANFSPKVGDFGLAKLCNRDST 180

Query: 235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP 294
           H++ SGY+GTPGYSAPEFL  NYP+THKCDVYSFGMVLFEI+GR+ NA    + + DWFP
Sbjct: 181 HISFSGYRGTPGYSAPEFLLVNYPLTHKCDVYSFGMVLFEIIGRKSNAGTTVSGNPDWFP 240

Query: 295 KHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV 354
           +HVW+ YE  +L  +I+GCGI E+D+E A R C VALWCVQDSP+ RP MS V++MLEG 
Sbjct: 241 QHVWDAYENGKLEELIIGCGIGEEDREMASRACEVALWCVQDSPDGRPTMSVVVRMLEGG 300

Query: 355 VEVLPPPKPFRYLDLIKM-------TRLKSLESSDGLNSSNQSRWYKETTPIMAKHDTQ 406
           VE++PP KPF+YL+ I+         +  S  S    +  + S+WYK+TT IM K++ Q
Sbjct: 301 VEIMPPAKPFQYLNPIRTGNSSTSSQQTGSNSSGSSTSRDSNSQWYKKTTTIMRKYEIQ 359

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449528245|ref|XP_004171116.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like, partial [Cucumis sativus]

 Score =  502 bits (1293), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 235/377 (62%), Positives = 293/377 (77%), Gaps = 8/377 (2%)

Query: 37  ANKPEEDVVEVIWEA-GQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVY 95
           A++P  + V  +WE    TME+F+QE+ +EKP+RFT+ QL  FT NYST LG G F  VY
Sbjct: 71  AHQPMHNNVIQVWEIDAPTMEKFIQELAKEKPMRFTAQQLYIFTRNYSTILGAGAFSTVY 130

Query: 96  KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE 155
           KG+FPNGVKIAVKVLNRN  + AE+QFMAEVGTIG+TYH +LVRLYGFC+DQ+M ALV+E
Sbjct: 131 KGEFPNGVKIAVKVLNRNSDKQAEQQFMAEVGTIGKTYHRHLVRLYGFCYDQYMGALVFE 190

Query: 156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN 215
           YMENGSLD YLFGK + ++W KLH++AIGTAKGL YLHEECQ+RIIHYDIKP N+LLDAN
Sbjct: 191 YMENGSLDKYLFGKNQDVDWGKLHDVAIGTAKGLTYLHEECQERIIHYDIKPANILLDAN 250

Query: 216 FSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
           FSPKV DFGLAKLC R++TH++++G +GTPGYSAPEF   NYPITHKCDVYSFGM+LFEI
Sbjct: 251 FSPKVCDFGLAKLCHRDRTHISLTGCRGTPGYSAPEFFLNNYPITHKCDVYSFGMLLFEI 310

Query: 276 VGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQ 335
           VGR++NA V  + +LDWFP+HVW++Y+K EL  +   CGIEEKDKE   R+C VALWC+Q
Sbjct: 311 VGRKKNATVTPSGNLDWFPRHVWDKYKKRELEEISQICGIEEKDKESVSRMCKVALWCIQ 370

Query: 336 DSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYLDLI-------KMTRLKSLESSDGLNSSN 388
           DSP++RPPMS V+KMLEG VE++ P  PF++ +          + +  S  +    +   
Sbjct: 371 DSPDERPPMSVVVKMLEGDVEIMAPSNPFKFSNPTPVGNNKPNLLQSSSSSNYSTSSEEI 430

Query: 389 QSRWYKETTPIMAKHDT 405
            S WYK+ TPIM K  +
Sbjct: 431 HSSWYKKATPIMKKMSS 447

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449437348|ref|XP_004136454.1| PREDICTED: probable receptor-like protein kinase At5g39020-like [Cucumis sativus]

 Score =  461 bits (1187), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 219/368 (59%), Positives = 276/368 (75%), Gaps = 9/368 (2%)

Query: 4   IFGLIVIIVVFYIIRYFWEKLNRTETETRNAASANKPEEDVVEVIWEA-GQTMERFLQEI 62
           + GL+++I +      F +KL           S   P E     IW      ME+ L+ I
Sbjct: 46  VVGLLILIAIAIFSYKFAKKLVPGVVREWRNTSTPAPAE-----IWGVDAPKMEKILRGI 100

Query: 63  GREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQF 122
             E P+RFT+LQLN FTSNYSTRLG GGFG+VYKGQFPNG+KIAVK+L +N  + AE QF
Sbjct: 101 AEESPIRFTALQLNAFTSNYSTRLGSGGFGDVYKGQFPNGLKIAVKILKKNSNKKAENQF 160

Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEI 181
           MAE+ TIGRT H NL+RLYGFC+D+ M+ALV E+MENGSLD +L+GK K  ++WEKL EI
Sbjct: 161 MAEIETIGRTRHRNLLRLYGFCYDETMSALVLEFMENGSLDRFLYGKTKNELDWEKLLEI 220

Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY 241
           AIGT +G+ Y+HEEC+++IIHYDIKP N+LLD NFSPK+ DFGLA LC+++ TH +++ Y
Sbjct: 221 AIGTGRGIAYMHEECERKIIHYDIKPANILLDENFSPKIGDFGLANLCNKDNTHDSLTEY 280

Query: 242 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEY 301
           +GTPGYSAPE L  N+P+T+KCDVYSFGMVLFE+VGRR+NA V    S+DWFP  VWE +
Sbjct: 281 RGTPGYSAPELLRFNFPVTYKCDVYSFGMVLFEMVGRRKNAAVSPLGSIDWFPIQVWERF 340

Query: 302 EKCELGAMILGCGIEEKDKEKAK--RLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP 359
           EK EL  M     +EE  + K K  R+C+VALWCVQDSPEDRPPMSAV++MLEG VE++P
Sbjct: 341 EKGELVNMSGDYDVEEDGERKMKVDRMCVVALWCVQDSPEDRPPMSAVVRMLEGSVEIMP 400

Query: 360 PPKPFRYL 367
           PPKPF+Y+
Sbjct: 401 PPKPFQYM 408

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225454761|ref|XP_002272528.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Vitis vinifera]

 Score =  424 bits (1089), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 201/314 (64%), Positives = 241/314 (76%), Gaps = 3/314 (0%)

Query: 54  TMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRN 113
           TME FL E+ REKP RF+  QL  FTS++S  LG GGFG VYKG+FPNG+ +AVKV+N N
Sbjct: 135 TMEIFLSEMEREKPTRFSPQQLARFTSDFSMVLGSGGFGVVYKGEFPNGLPVAVKVINSN 194

Query: 114 LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAI 173
             +   EQFMAEV +IGRTYHINLVRLYGFC D  M ALVYEY+ENGSLD  LFG+ +A 
Sbjct: 195 SEKKVAEQFMAEVASIGRTYHINLVRLYGFCFDPTMRALVYEYVENGSLDRLLFGENKAT 254

Query: 174 --EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 231
             +W K  EIA+GTAKG+ YLHEEC+QRIIHYDIKP NVLLDA FSPK+ADFGLAKLC+R
Sbjct: 255 NDQWGKFEEIAVGTAKGIAYLHEECRQRIIHYDIKPANVLLDAVFSPKLADFGLAKLCNR 314

Query: 232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD 291
           + T V ++G++GTPGY+APE L   YP+T KCDVYSFGM+LFE+VGRRRN     +E+  
Sbjct: 315 DSTQVPVTGFRGTPGYAAPE-LWKPYPVTCKCDVYSFGMLLFEMVGRRRNHDASLSETRQ 373

Query: 292 WFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML 351
           W P+  WE +EK EL  M+  CGI+E + EKA R+CMVA+WCVQ  PE RP M  V+KML
Sbjct: 374 WLPRWTWEMFEKNELPEMLSLCGIKETNIEKAGRMCMVAMWCVQYLPEARPTMGKVVKML 433

Query: 352 EGVVEVLPPPKPFR 365
           EG  E+ PPP PF+
Sbjct: 434 EGETEIPPPPYPFQ 447

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	406
TAIR|locus:2176737	665	PR5K "PR5-like receptor kinase	0.795	0.485	0.413	2.7e-68
TAIR|locus:2020583	799	AT1G70250 [Arabidopsis thalian	0.800	0.406	0.412	4.4e-68
TAIR|locus:2116525	821	SD2-5 "S-domain-2 5" [Arabidop	0.847	0.419	0.407	1.2e-67
TAIR|locus:2019688	674	AT1G66930 [Arabidopsis thalian	0.729	0.439	0.432	8.2e-67
TAIR|locus:2141862	853	AT4G18250 [Arabidopsis thalian	0.798	0.379	0.412	2.2e-66
TAIR|locus:2059103	828	AT2G19130 [Arabidopsis thalian	0.793	0.388	0.451	7.4e-66
TAIR|locus:2204480	666	AT1G66910 [Arabidopsis thalian	0.724	0.441	0.427	1.2e-65
TAIR|locus:2177152	806	AT5G39030 [Arabidopsis thalian	0.761	0.383	0.431	3.2e-65
TAIR|locus:2026155	829	AT1G34300 [Arabidopsis thalian	0.738	0.361	0.459	1.1e-64
TAIR|locus:2176717	638	AT5G38260 [Arabidopsis thalian	0.770	0.490	0.406	1.8e-64

TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 693 (249.0 bits), Expect = 2.7e-68, P = 2.7e-68
 Identities = 139/336 (41%), Positives = 221/336 (65%)

Query:    69 RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVG 127
             R++  ++   T++++  LG GGFG VYKG+  + G  +AVK+L  + G    E+F+ EV 
Sbjct:   320 RYSYTRVKKMTNSFAHVLGKGGFGTVYKGKLADSGRDVAVKILKVSEGN--GEEFINEVA 377

Query:   128 TIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTA 186
             ++ RT H+N+V L GFC++++  A++YE+M NGSLD Y+       +EWE+L+++A+G +
Sbjct:   378 SMSRTSHVNIVSLLGFCYEKNKRAIIYEFMPNGSLDKYISANMSTKMEWERLYDVAVGIS 437

Query:   187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG 246
             +GL YLH  C  RI+H+DIKP+N+L+D N  PK++DFGLAKLC   ++ +++   +GT G
Sbjct:   438 RGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNKESIISMLHMRGTFG 497

Query:   247 YSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIV---GATESLDWFPKHVWEEYE 302
             Y APE  S N+  ++HK DVYS+GMV+ E++G +    V   G+     +FP+ V++++E
Sbjct:   498 YIAPEMFSKNFGAVSHKSDVYSYGMVVLEMIGAKNIEKVEYSGSNNGSMYFPEWVYKDFE 557

Query:   303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP-PP 361
             K E+   I G  I +++++ AK+L +VALWC+Q +P DRPPM  VI+MLEG +E L  PP
Sbjct:   558 KGEI-TRIFGDSITDEEEKIAKKLVLVALWCIQMNPSDRPPMIKVIEMLEGNLEALQVPP 616

Query:   362 KPFRYLDLIKMTRLKSLESSDGLNSS-NQSRWYKET 396
              P  +    + T   +LE SD  ++  N S + + T
Sbjct:   617 NPLLFSP--EETVPDTLEDSDDTSTFFNPSHFERGT 650

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)]

 Score = 691 (248.3 bits), Expect = 4.4e-68, P = 4.4e-68
 Identities = 139/337 (41%), Positives = 215/337 (63%)

Query:    69 RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVK-IAVKVLNRNLGRIAEEQFMAEVG 127
             RF+ +Q+   T ++   LG GGFG VYKG+ P+G + +AVK+L  +      E F+ E+ 
Sbjct:   448 RFSYVQVKKMTKSFENVLGKGGFGTVYKGKLPDGSRDVAVKILKES--NEDGEDFINEIA 505

Query:   128 TIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTA 186
             ++ RT H N+V L GFC++    A++YE M NGSLD ++     A +EW+ L+ IA+G +
Sbjct:   506 SMSRTSHANIVSLLGFCYEGRKKAIIYELMPNGSLDKFISKNMSAKMEWKTLYNIAVGVS 565

Query:   187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG 246
              GL YLH  C  RI+H+DIKP+N+L+D +  PK++DFGLAKLC  N++ +++   +GT G
Sbjct:   566 HGLEYLHSHCVSRIVHFDIKPQNILIDGDLCPKISDFGLAKLCKNNESIISMLHARGTIG 625

Query:   247 YSAPEFLSGNYP-ITHKCDVYSFGMVLFEIVGRR---RNAIVGATESLDWFPKHVWEEYE 302
             Y APE  S N+  ++HK DVYS+GMV+ E++G R   R    G++ +  +FP  ++++ E
Sbjct:   626 YIAPEVFSQNFGGVSHKSDVYSYGMVVLEMIGARNIGRAQNAGSSNTSMYFPDWIYKDLE 685

Query:   303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP-PP 361
             K E+ + +     EE+D++  K++ +V LWC+Q +P DRPPMS V++MLEG +E L  PP
Sbjct:   686 KGEIMSFLADQITEEEDEKIVKKMVLVGLWCIQTNPYDRPPMSKVVEMLEGSLEALQIPP 745

Query:   362 KPFRYLDLIK--MTRLKSL-ESSDGLNSSNQSRWYKE 395
             KP   L  I   +T  + + E+S  L  S  + +Y E
Sbjct:   746 KPLLCLPAITAPITVDEDIQETSSFLKPSQDTSYYSE 782

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 687 (246.9 bits), Expect = 1.2e-67, P = 1.2e-67
 Identities = 145/356 (40%), Positives = 221/356 (62%)

Query:    38 NKPEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKG 97
             +K ++ ++E   E+ +  + FL+ +    P+RF    L + T+N+S +LG GGFG VY+G
Sbjct:   453 HKRKKMILEAPQESSEE-DNFLENLSG-MPIRFAYKDLQSATNNFSVKLGQGGFGSVYEG 510

Query:    98 QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM 157
               P+G ++AVK L   +G+  +++F AEV  IG  +H++LVRL GFC +     L YE++
Sbjct:   511 TLPDGSRLAVKKLE-GIGQ-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFL 568

Query:   158 ENGSLDGYLFGKKRA---IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA 214
               GSL+ ++F KK     ++W+    IA+GTAKGL YLHE+C  RI+H DIKPEN+LLD 
Sbjct:   569 SKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDD 628

Query:   215 NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 274
             NF+ KV+DFGLAKL  R ++HV  +  +GT GY APE+++ NY I+ K DVYS+GMVL E
Sbjct:   629 NFNAKVSDFGLAKLMTREQSHV-FTTMRGTRGYLAPEWIT-NYAISEKSDVYSYGMVLLE 686

Query:   275 IVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC--GIEEKDKEKAKRLCMVALW 332
             ++G R+N     T     FP   +++ E+ +L  ++ G    ++  D E+ +R    ALW
Sbjct:   687 LIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTD-ERVQRAMKTALW 745

Query:   333 CVQDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYLDLIKMTRLKSLESSDGLNSSN 388
             C+Q+  + RP MS V++MLEGV  V+ PP        +  +  KS+    G  +S+
Sbjct:   746 CIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSSTMGSRLYSSFFKSISEDGGATTSS 801

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)]

 Score = 679 (244.1 bits), Expect = 8.2e-67, P = 8.2e-67
 Identities = 132/305 (43%), Positives = 208/305 (68%)

Query:    67 PVR-FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAE 125
             P++ +T  Q+   T +++  +G GGFG VY+G   +G  +AVKVL  + G  +E+ F+ E
Sbjct:   332 PLKHYTYAQVKRMTKSFAEVVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNSED-FINE 390

Query:   126 VGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAI-EWEKLHEIAIG 184
             V ++ +T H+N+V L GFC +    A++YE++ENGSLD ++  K   I +   L+ IA+G
Sbjct:   391 VSSMSQTSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDKFISEKTSVILDLTALYGIALG 450

Query:   185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
              A+GL YLH  C+ RI+H+DIKP+NVLLD N SPKV+DFGLAKLC++ ++ +++   +GT
Sbjct:   451 VARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSLMDTRGT 510

Query:   245 PGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIVG---ATESLDWFPKHVWEE 300
              GY APE +S  Y  ++HK DVYS+GM++FE++G R+    G   A  S  +FP+ ++++
Sbjct:   511 IGYIAPEMISRVYGSVSHKSDVYSYGMLVFEMIGARKKERFGQNSANGSSMYFPEWIYKD 570

Query:   301 YEKCELGAMI-LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP 359
              EK + G +  +  GI  +++E AK++ +V LWC+Q SP DRPPM+ V++M+EG ++ L 
Sbjct:   571 LEKADNGDLEHIEIGISSEEEEIAKKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALE 630

Query:   360 -PPKP 363
              PP+P
Sbjct:   631 VPPRP 635

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)]

 Score = 675 (242.7 bits), Expect = 2.2e-66, P = 2.2e-66
 Identities = 140/339 (41%), Positives = 219/339 (64%)

Query:    69 RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN--GVKIAVKVLNRNLGRIAEEQFMAEV 126
             R++  ++   T+++   +G GGFG VYKG+ P+  G  IA+K+L  + G    E+F+ E+
Sbjct:   508 RYSFEKVKKMTNSFDHVIGKGGFGTVYKGKLPDASGRDIALKILKESKGN--GEEFINEL 565

Query:   127 GTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGT 185
              ++ R  H+N+V L+GFC++    A++YE+M NGSLD ++       IEW+ L+ IA+G 
Sbjct:   566 VSMSRASHVNIVSLFGFCYEGSQRAIIYEFMPNGSLDKFISENMSTKIEWKTLYNIAVGV 625

Query:   186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
             A+GL YLH  C  +I+H+DIKP+N+L+D +  PK++DFGLAKLC + ++ +++   +GT 
Sbjct:   626 ARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKISDFGLAKLCKKKESIISMLDARGTV 685

Query:   246 GYSAPEFLSGNYP-ITHKCDVYSFGMVLFEIVG--RRRNAIVGATE-SLDWFPKHVWEEY 301
             GY APE  S NY  ++HK DVYS+GMV+ E++G  +R      AT+ S  +FP  V+E+ 
Sbjct:   686 GYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGATKREEVETSATDKSSMYFPDWVYEDL 745

Query:   302 EKCELGAMILGCGIEEKDKEK-AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV-VEVLP 359
             E+ E   ++    IEE+++EK  KR+ +V LWC+Q +P DRPPM  V++MLEG  +E L 
Sbjct:   746 ERKETMRLLEDHIIEEEEEEKIVKRMTLVGLWCIQTNPSDRPPMRKVVEMLEGSRLEALQ 805

Query:   360 -PPKPFRYLDLIKMTRLKSLESSDGLNS-SNQSRWYKET 396
              PPKP   L+L  +T  ++ E S   +  S QS   ++T
Sbjct:   806 VPPKPL--LNLHVVTDWETSEDSQQTSRLSTQSLLERKT 842

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)]

 Score = 670 (240.9 bits), Expect = 7.4e-66, P = 7.4e-66
 Identities = 152/337 (45%), Positives = 205/337 (60%)

Query:    70 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTI 129
             F+  +L N T N+S +LG GGFG V+KG  P+   IAVK L   + +  E+QF  EV TI
Sbjct:   483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLE-GISQ-GEKQFRTEVVTI 540

Query:   130 GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF----GKKRAIEWEKLHEIAIGT 185
             G   H+NLVRL GFC +     LVY+YM NGSLD +LF     +K  + W+   +IA+GT
Sbjct:   541 GTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGT 600

Query:   186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
             A+GL YLH+EC+  IIH DIKPEN+LLD+ F PKVADFGLAKL  R+ + V ++  +GT 
Sbjct:   601 ARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRV-LTTMRGTR 659

Query:   246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCE 305
             GY APE++SG   IT K DVYS+GM+LFE+V  RRN      E + +FP   W      +
Sbjct:   660 GYLAPEWISG-VAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPS--WAATILTK 716

Query:   306 LGAM--ILGCGIEEK--DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPP 361
              G +  ++   +E    D E+  R C VA WC+QD    RP MS V+++LEGV+EV PPP
Sbjct:   717 DGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPP 776

Query:   362 KPFRYLDLIKMTR-LKSLESSDGLNSSNQSRWYKETT 397
              P     L+     +     S   +S N S+ +K ++
Sbjct:   777 FPRSIQALVVSDEDVVFFTESSSSSSHNSSQNHKHSS 813

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)]

 Score = 668 (240.2 bits), Expect = 1.2e-65, P = 1.2e-65
 Identities = 130/304 (42%), Positives = 203/304 (66%)

Query:    67 PVR-FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAE 125
             P++ ++  Q+ + T +++  +G GGFG VY+G   +G  +AVKVL  + G    E F+ E
Sbjct:   334 PLKHYSYAQVTSITKSFAEVIGKGGFGTVYRGTLYDGRSVAVKVLKESQGN--GEDFINE 391

Query:   126 VGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIG 184
             V ++ +T H+N+V L GFC + +  A++YE+MENGSLD ++  KK + ++W +L+ IA+G
Sbjct:   392 VASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFISSKKSSTMDWRELYGIALG 451

Query:   185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
              A+GL YLH  C+ RI+H+DIKP+NVLLD N SPKV+DFGLAKLC+R ++ +++   +GT
Sbjct:   452 VARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCERKESILSLMDTRGT 511

Query:   245 PGYSAPEFLSGNYP-ITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLD--WFPKHVWEE 300
              GY APE  S  Y  ++HK DVYS+GM++ +I+G R + +    T S    +FP+ ++ +
Sbjct:   512 IGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGARNKTSTEDTTSSTSSMYFPEWIYRD 571

Query:   301 YEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP- 359
              EK   G  I    I  ++ E AK++ +V LWC+Q  P DRP M+ V++M+EG ++ L  
Sbjct:   572 LEKAHNGKSI-ETAISNEEDEIAKKMTLVGLWCIQPWPLDRPAMNRVVEMMEGNLDALEV 630

Query:   360 PPKP 363
             PP+P
Sbjct:   631 PPRP 634

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)]

 Score = 664 (238.8 bits), Expect = 3.2e-65, P = 3.2e-65
 Identities = 138/320 (43%), Positives = 206/320 (64%)

Query:    70 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTI 129
             +T  +L   T ++S  +G GGFG VY G   NG K+AVKVL ++L   AE+ F+ EV ++
Sbjct:   488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVL-KDLKGSAED-FINEVASM 545

Query:   130 GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE-WEKLHEIAIGTAKG 188
              +T H+N+V L GFC +    A+VYE++ENGSLD ++   K   +    L+ IA+G A+G
Sbjct:   546 SQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNKSLTQDVTTLYGIALGIARG 605

Query:   189 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYS 248
             L YLH  C+ RI+H+DIKP+N+LLD N  PKV+DFGLAKLC++ ++ +++   +GT GY 
Sbjct:   606 LEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYI 665

Query:   249 APEFLSGNYP-ITHKCDVYSFGMVLFEIVGRRRNAIVGATESL---DWFPKHVWEEYEKC 304
             APE  S  Y  ++HK DVYSFGM++ +++G R   IV   +S     +FP  ++++ E  
Sbjct:   666 APEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDG 725

Query:   305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP-PPKP 363
             E    I G  I +++KE AK++ +V LWC+Q  P DRP M+ V++M+EG ++ L  PPKP
Sbjct:   726 EQ-TWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPKP 784

Query:   364 FRYLDLIKMTRLKSLESSDG 383
               ++    +T   SL  SDG
Sbjct:   785 SMHISTEVITESSSL--SDG 802

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)]

 Score = 659 (237.0 bits), Expect = 1.1e-64, P = 1.1e-64
 Identities = 143/311 (45%), Positives = 187/311 (60%)

Query:    59 LQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIA 118
             L E     PV+FT  +L   T ++  +LG GGFG VY+G   N   +AVK L   + +  
Sbjct:   463 LLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLE-GIEQ-G 520

Query:   119 EEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA--IEWE 176
             E+QF  EV TI  T+H+NLVRL GFC       LVYE+M NGSLD +LF    A  + WE
Sbjct:   521 EKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWE 580

Query:   177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
                 IA+GTAKG+ YLHEEC+  I+H DIKPEN+L+D NF+ KV+DFGLAKL +      
Sbjct:   581 YRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRY 640

Query:   237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKH 296
              +S  +GT GY APE+L+ N PIT K DVYS+GMVL E+V  +RN  V    +   F   
Sbjct:   641 NMSSVRGTRGYLAPEWLA-NLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIW 699

Query:   297 VWEEYEKCELGAMILGCGIEEK---DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG 353
              +EE+EK    A IL   + E    D E+  R+   + WC+Q+ P  RP M  V++MLEG
Sbjct:   700 AYEEFEKGNTKA-ILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEG 758

Query:   354 VVEVLPP--PK 362
             + E+  P  PK
Sbjct:   759 ITEIKNPLCPK 769

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)]

 Score = 657 (236.3 bits), Expect = 1.8e-64, P = 1.8e-64
 Identities = 131/322 (40%), Positives = 205/322 (63%)

Query:    69 RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT 128
             +++  ++   T  +S  LG GGFG VY G   +G K+AVK+L ++     E+ F+ EV +
Sbjct:   310 QYSYAEVRKITKLFSHTLGKGGFGTVYGGNLCDGRKVAVKIL-KDFKSNGED-FINEVAS 367

Query:   129 IGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAK 187
             + +T H+N+V L GFC++    A+VYE++ENGSLD +L  KK   ++   L+ IA+G A+
Sbjct:   368 MSQTSHVNIVSLLGFCYEGSKRAIVYEFLENGSLDQFLSEKKSLNLDVSTLYRIALGVAR 427

Query:   188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
             GL YLH  C+ RI+H+DIKP+N+LLD  F PKV+DFGLAKLC++ ++ +++   +GT GY
Sbjct:   428 GLDYLHHGCKTRIVHFDIKPQNILLDDTFCPKVSDFGLAKLCEKRESILSLLDARGTIGY 487

Query:   248 SAPEFLSGNYP-ITHKCDVYSFGMVLFEIVGRRRNAI---VGATESLDWFPKHVWEEYEK 303
              APE  SG Y  ++HK DVYS+GM++ E++G +   I     +  S  +FP  +++  E 
Sbjct:   488 IAPEVFSGMYGRVSHKSDVYSYGMLVLEMIGAKNKEIEETAASNSSSAYFPDWIYKNLEN 547

Query:   304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP-PPK 362
              E      G  I  +DKE AK++ +V LWC+Q SP +RPPM+ +++M+EG ++VL  PPK
Sbjct:   548 GE-DTWKFGDEISREDKEVAKKMTLVGLWCIQPSPLNRPPMNRIVEMMEGSLDVLEVPPK 606

Query:   363 PFRYLDLIKMTRLKSLESSDGL 384
             P  +     + +L S    + +
Sbjct:   607 PSIHYSAEPLPQLSSFSEENSI 628

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	406
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-53
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-46
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-45
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-40
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-40
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-32
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-31
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-31
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-30
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-28
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-26
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-25
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-25
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-24
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-24
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-23
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-21
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-21
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-19
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-18
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-18
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-16
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-15
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-14
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-11
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-10
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-07
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-06
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-06
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-06
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	9e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  176 bits (448), Expect = 2e-53
 Identities = 72/192 (37%), Positives = 109/192 (56%), Gaps = 7/192 (3%)

Query: 86  LGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG GGFG VY  +    G K+A+K++ +       E+ + E+  + +  H N+V+LYG  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
            D++   LV EY E GSL   L   +  +  +++  I +   +GL YLH      IIH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117

Query: 205 IKPENVLLDA-NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKC 263
           +KPEN+LLD+ N   K+ADFGL+KL   +K+   +    GTP Y APE L G    + K 
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 264 DVYSFGMVLFEI 275
           D++S G++L+E+
Sbjct: 176 DIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  160 bits (408), Expect = 8e-47
 Identities = 79/275 (28%), Positives = 121/275 (44%), Gaps = 33/275 (12%)

Query: 86  LGFGGFGEVYKGQ-----FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FGEVYKG+         V++AVK L  +      E+F+ E   + +  H N+V+L
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C ++    +V EYME G L  YL   +  +    L   A+  A+G+ YL     +  
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES---KNF 123

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG---YKGTPGYSAPE-FLSGN 256
           IH D+   N L+  N   K++DFGL++    +  +    G    +    + APE    G 
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPESLKEGK 179

Query: 257 YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE 316
           +  T K DV+SFG++L+EI         G         + V E  +          C   
Sbjct: 180 F--TSKSDVWSFGVLLWEIFTL------GEQPYPGMSNEEVLEYLKNGYRLPQPPNC--- 228

Query: 317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML 351
                    L  + L C  + PEDRP  S ++++L
Sbjct: 229 ------PPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  159 bits (405), Expect = 2e-46
 Identities = 75/197 (38%), Positives = 108/197 (54%), Gaps = 8/197 (4%)

Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           +LG G FG VYK +    G  +AVK+L  R+     ++    E+  + R  H N+VRL  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
              D+    LV EY E G L  YL  +   +  ++  +IA+   +GL YLH      IIH
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHS---NGIIH 121

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+KPEN+LLD N   K+ADFGLAK   ++ + +T   + GTP Y APE L G      K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT--TFVGTPWYMAPEVLLGGNGYGPK 179

Query: 263 CDVYSFGMVLFEIVGRR 279
            DV+S G++L+E++  +
Sbjct: 180 VDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  157 bits (399), Expect = 2e-45
 Identities = 78/276 (28%), Positives = 119/276 (43%), Gaps = 34/276 (12%)

Query: 86  LGFGGFGEVYKGQ-----FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FGEVYKG          V++AVK L  +      E+F+ E   + +  H N+V+L
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
            G C ++    +V EYM  G L  YL   + + +    L   A+  A+G+ YL     + 
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KN 123

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG---YKGTPGYSAPE-FLSG 255
            IH D+   N L+  N   K++DFGL++    +  +    G    +    + APE    G
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPESLKEG 179

Query: 256 NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI 315
            +  T K DV+SFG++L+EI         G           V E          +     
Sbjct: 180 KF--TSKSDVWSFGVLLWEIFTL------GEEPYPGMSNAEVLE---------YLKKGYR 222

Query: 316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML 351
             K       L  + L C  + PEDRP  S ++++L
Sbjct: 223 LPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  150 bits (382), Expect = 5e-43
 Identities = 68/192 (35%), Positives = 99/192 (51%), Gaps = 9/192 (4%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G FG+VY  +    G  +A+KV+ +   +   E+ + E+  + +  H N+VRLY   
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
            D+    LV EY E G L   L  + R  E E            L YLH    + I+H D
Sbjct: 67  EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-ARFYLRQILSALEYLH---SKGIVHRD 122

Query: 205 IKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCD 264
           +KPEN+LLD +   K+ADFGLA+  D  +   T   + GTP Y APE L G        D
Sbjct: 123 LKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPEYMAPEVLLGK-GYGKAVD 178

Query: 265 VYSFGMVLFEIV 276
           ++S G++L+E++
Sbjct: 179 IWSLGVILYELL 190

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  144 bits (366), Expect = 1e-40
 Identities = 65/195 (33%), Positives = 95/195 (48%), Gaps = 9/195 (4%)

Query: 86  LGFGGFGEVYKG-----QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FGEVYKG           K+AVK L         E+F+ E   + +  H N+VRL
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       +V EYM  G L  +L      +  + L ++A+  AKG+ YL     +  
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES---KNF 123

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H D+   N L+  N   K++DFGL++    +  +    G K    + APE L  +   T
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK-DGKFT 182

Query: 261 HKCDVYSFGMVLFEI 275
            K DV+SFG++L+EI
Sbjct: 183 SKSDVWSFGVLLWEI 197

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  144 bits (365), Expect = 1e-40
 Identities = 88/285 (30%), Positives = 124/285 (43%), Gaps = 43/285 (15%)

Query: 86  LGFGGFGEVYKGQF----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           LG G FGEVYKG+         ++AVK L  +      + F+ E   + +  H N+VRL 
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 142 GFCHDQHMTALVYEYMENGSLDGYL--------FGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           G C ++    LV EYME G L  YL          +K  +  + L   AI  AKG+ YL 
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYS----- 248
               ++ +H D+   N L+  +   K++DFGL++    +         K T G       
Sbjct: 123 S---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD-----YYRKKTGGKLPIRWM 174

Query: 249 APE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG 307
           APE    G +  T K DV+SFG++L+EI         GAT       + V E   K    
Sbjct: 175 APESLKDGIF--TSKSDVWSFGVLLWEIFTL------GATPYPGLSNEEVLEYLRKGYRL 226

Query: 308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
                C  E         L  + L C Q  PEDRP  S +++ LE
Sbjct: 227 PKPEYCPDE---------LYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  121 bits (305), Expect = 7e-32
 Identities = 76/218 (34%), Positives = 115/218 (52%), Gaps = 23/218 (10%)

Query: 61  EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEE 120
           EI RE      SL+L         +LG G FGEV+ G +    K+AVK L    G ++ E
Sbjct: 2   EIPRE------SLKLER-------KLGAGQFGEVWMGTWNGTTKVAVKTLKP--GTMSPE 46

Query: 121 QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL-FGKKRAIEWEKLH 179
            F+ E   + +  H  LV+LY  C ++    +V EYM  GSL  +L  G+ + +   +L 
Sbjct: 47  AFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLV 106

Query: 180 EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS 239
           ++A   A+G+ YL     +  IH D+   N+L+  N   K+ADFGLA+L + ++ +    
Sbjct: 107 DMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTARE 162

Query: 240 GYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 276
           G K    ++APE    G + I  K DV+SFG++L EIV
Sbjct: 163 GAKFPIKWTAPEAANYGRFTI--KSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  119 bits (301), Expect = 3e-31
 Identities = 73/231 (31%), Positives = 99/231 (42%), Gaps = 43/231 (18%)

Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMA---EVGTIGRTYHINLVRLY 141
           LG G FG VY       G  +AVK +   L   +EE+  A   E+  +    H N+VR Y
Sbjct: 8   LGRGSFGSVYLALDKDTGELMAVKSVE--LSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 142 GFCHD-QHMTALVY-EYMENGSLDGYL--FGKKRAIEWEKLHEIAIGT-----AKGLVYL 192
           G   D +  T  ++ EY+  GSL   L  FGK        L E  I        +GL YL
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK--------LPEPVIRKYTRQILEGLAYL 117

Query: 193 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF 252
           H      I+H DIK  N+L+D++   K+ADFG AK     +T       +GTP + APE 
Sbjct: 118 HS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 253 LSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK 303
           + G        D++S G  + E+          AT       K  W E   
Sbjct: 175 IRGE-EYGRAADIWSLGCTVIEM----------ATG------KPPWSELGN 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  119 bits (299), Expect = 3e-31
 Identities = 73/271 (26%), Positives = 127/271 (46%), Gaps = 24/271 (8%)

Query: 82  YSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
               +G G FG V+ G +    K+A+K +    G ++EE F+ E   + +  H  LV+LY
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE--GAMSEEDFIEEAQVMMKLSHPKLVQLY 65

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G C ++    LV+E+ME+G L  YL  ++     E L  + +   +G+ YL       +I
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS-GNYPIT 260
           H D+   N L+  N   KV+DFG+ +    +  + + +G K    +S+PE  S   Y  +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPEVFSFSKY--S 179

Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++++E+    +      + S         E  E    G  +       K +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNS---------EVVETINAGFRLY------KPR 224

Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKML 351
             ++ +  +   C ++ PEDRP  S ++  L
Sbjct: 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  119 bits (299), Expect = 7e-31
 Identities = 71/213 (33%), Positives = 106/213 (49%), Gaps = 12/213 (5%)

Query: 86  LGFGGFGEVYKGQF-PNG--VKI--AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G  VKI  A+KVL       A ++ + E   +    H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C    +  L+ + M  G L  Y+   K  I  + L    +  AKG+ YL E   +R+
Sbjct: 75  LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRL 130

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H D+   NVL+      K+ DFGLAKL D ++      G K    + A E +  +   T
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL-HRIYT 189

Query: 261 HKCDVYSFGMVLFEIV--GRRRNAIVGATESLD 291
           HK DV+S+G+ ++E++  G +    + A E  D
Sbjct: 190 HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD 222

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  117 bits (295), Expect = 2e-30
 Identities = 62/193 (32%), Positives = 97/193 (50%), Gaps = 9/193 (4%)

Query: 84  TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
             LG G  G VYK +  P G   A+K ++ +      +Q + E+ T+       +V+ YG
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             + +   ++V EYM+ GSL   L  K   I    L  IA    KGL YLH   ++ IIH
Sbjct: 67  AFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIH 123

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITH 261
            DIKP N+L+++    K+ADFG++K+ +        + + GT  Y +PE     +Y   +
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLENTLD-QCNT-FVGTVTYMSPERIQGESYS--Y 179

Query: 262 KCDVYSFGMVLFE 274
             D++S G+ L E
Sbjct: 180 AADIWSLGLTLLE 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 2e-30
 Identities = 66/191 (34%), Positives = 96/191 (50%), Gaps = 13/191 (6%)

Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           +G G FG+V  G +  G K+AVK L  +    A + F+AE   +    H NLV+L G   
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
             +   +V EYM  GSL  YL  + RA I   +    A+   +G+ YL E   +  +H D
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRD 127

Query: 205 IKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCD 264
           +   NVL+  +   KV+DFGLAK     +        K    ++APE L      + K D
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREK-KFSTKSD 181

Query: 265 VYSFGMVLFEI 275
           V+SFG++L+EI
Sbjct: 182 VWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  118 bits (296), Expect = 8e-30
 Identities = 93/320 (29%), Positives = 137/320 (42%), Gaps = 25/320 (7%)

Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYH-INLVRLYG 142
           LG G FGEVY  +  +   +A+KVL + L       E+F+ E+  +    H  N+V+LY 
Sbjct: 8   LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 143 FCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           F  D+    LV EY++ GSL+  L   G+K  +   +   I       L YLH    + I
Sbjct: 66  FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGI 122

Query: 201 IHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNKTHVTI----SGYKGTPGYSAPEFLSG 255
           IH DIKPEN+LLD +    K+ DFGLAKL     +  +I    S   GTPGY APE L G
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Query: 256 NY--PITHKCDVYSFGMVLFEIV-GRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG 312
                 +   D++S G+ L+E++ G         + +     K + E         +   
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP- 241

Query: 313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVVEVLPPPKPFRYLDLI 370
               E   + A  L       +   P++R   S+ +   +L  +             D  
Sbjct: 242 -SNPELISKAASDLLKK---LLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297

Query: 371 KMTRLKSLESSDGLNSSNQS 390
              RL    S + L SS  S
Sbjct: 298 APLRLSLPPSLEALISSLNS 317

Length = 384

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 2e-29
 Identities = 71/199 (35%), Positives = 104/199 (52%), Gaps = 20/199 (10%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV++G + N   +AVK L    G +  + F+AE   + +  H  L++LY  C
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKP--GTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
             +    +V E M+ GSL  YL G   RA++  +L ++A   A G+ YL     Q  IH 
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHR 127

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG------YSAPEFLSGNY 257
           D+   NVL+  N   KVADFGLA++   +        Y+   G      ++APE    N 
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDI-------YEAREGAKFPIKWTAPEAALYN- 179

Query: 258 PITHKCDVYSFGMVLFEIV 276
             + K DV+SFG++L EIV
Sbjct: 180 RFSIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  113 bits (285), Expect = 8e-29
 Identities = 78/294 (26%), Positives = 129/294 (43%), Gaps = 37/294 (12%)

Query: 82  YSTRLGFGGFGEVYKGQFPN-----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +  +LG G FG+V   ++       G ++AVK LN +        F  E+  +    H N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 137 LVRLYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G C      +  L+ EY+ +GSL  YL   +  I  ++L   +    KG+ YL  
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG-YSAPEFL 253
              QR IH D+   N+L+++    K++DFGLAK+   +K +  +     +P  + APE L
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184

Query: 254 SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC 313
                 +   DV+SFG+ L+E+      +     E L                G MI+  
Sbjct: 185 R-TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL---------RMIGIAQGQMIV-T 233

Query: 314 GIEEKDKEKAKRL-----C-------MVALWCVQDSPEDRPPMSAVIKMLEGVV 355
            + E  KE  +RL     C       M   W  +  P+DRP  + +I +++ + 
Sbjct: 234 RLLELLKE-GERLPRPPSCPDEVYDLMKLCW--EAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  111 bits (280), Expect = 2e-28
 Identities = 68/197 (34%), Positives = 108/197 (54%), Gaps = 12/197 (6%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV++G + N V++A+K+L  +     ++ F  EV  + R  H +L+ L+  C
Sbjct: 13  KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD-FQKEVQALKRLRHKHLISLFAVC 71

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                  ++ E ME GSL  +L   + + +    L ++A   A+G+ YL E   Q  IH 
Sbjct: 72  SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHR 128

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLS-GNYPITH 261
           D+   N+L+  +   KVADFGLA+L    K  V +S  K  P  ++APE  S G +  + 
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLI---KEDVYLSSDKKIPYKWTAPEAASHGTF--ST 183

Query: 262 KCDVYSFGMVLFEIVGR 278
           K DV+SFG++L+E+   
Sbjct: 184 KSDVWSFGILLYEMFTY 200

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  110 bits (278), Expect = 4e-28
 Identities = 62/194 (31%), Positives = 99/194 (51%), Gaps = 15/194 (7%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG- 142
           ++G GGFGEVYK +    G ++A+KV+        +E+ + E+  + +  H N+V+ YG 
Sbjct: 7   KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE-KKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 143 -FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
               D+    +V E+   GSL   L    + +   ++  +     KGL YLH      II
Sbjct: 66  YLKKDELW--IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGII 120

Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H DIK  N+LL ++   K+ DFGL+  L D    +  +    GTP + APE ++G  P  
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV----GTPYWMAPEVINGK-PYD 175

Query: 261 HKCDVYSFGMVLFE 274
           +K D++S G+   E
Sbjct: 176 YKADIWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 1e-27
 Identities = 62/193 (32%), Positives = 102/193 (52%), Gaps = 13/193 (6%)

Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           LG G FG V+ G++   + +A+K++    G ++E+ F+ E   + +  H NLV+LYG C 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIRE--GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 205
            Q    +V EYM NG L  YL  +K  +  E L ++     + + YL        IH D+
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126

Query: 206 KPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
              N L+  +   KV+DFGLA+  L D+   + +  G K    ++ PE F    +  + K
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYSRF--SSK 181

Query: 263 CDVYSFGMVLFEI 275
            DV+SFG++++E+
Sbjct: 182 SDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 1e-26
 Identities = 62/195 (31%), Positives = 100/195 (51%), Gaps = 10/195 (5%)

Query: 86  LGFGGFGEVYKG--QFPNG--VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FGEV +G  + P    + +A+K L           F+ E   +G+  H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         ++ EYMENGSLD +L          +L  +  G A G+ YL E      +
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YV 128

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI-T 260
           H D+   N+L+++N   KV+DFGL++  + ++   T  G K    ++APE ++  Y   T
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA--YRKFT 186

Query: 261 HKCDVYSFGMVLFEI 275
              DV+SFG+V++E+
Sbjct: 187 SASDVWSFGIVMWEV 201

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 63/194 (32%), Positives = 104/194 (53%), Gaps = 10/194 (5%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF 143
           ++G G FG+VYKG      ++AVK     L    + +F+ E   I + Y H N+V+L G 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQE-AEILKQYDHPNIVKLIGV 60

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
           C  +    +V E +  GSL  +L  KK  +  +KL ++++  A G+ YL  +     IH 
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLS-GNYPITH 261
           D+   N L+  N   K++DFG+++  +     V+  G K  P  ++APE L+ G Y  T 
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVS-DGLKQIPIKWTAPEALNYGRY--TS 174

Query: 262 KCDVYSFGMVLFEI 275
           + DV+S+G++L+E 
Sbjct: 175 ESDVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  105 bits (264), Expect = 5e-26
 Identities = 68/198 (34%), Positives = 104/198 (52%), Gaps = 15/198 (7%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G  G V K    P G  +AVK +   +    ++Q + E+  + +     +V  YG  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
           ++    ++  EYM+ GSLD  L   +  I    L +IA+   KGL YLHE  + +IIH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRD 126

Query: 205 IKPENVLLDANFSPKVADFGLA-KLCDR-NKTHVTISGYKGTPGYSAPEFLSGN-YPITH 261
           +KP N+L+++    K+ DFG++ +L +   KT V      GT  Y APE + GN Y +  
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV------GTSSYMAPERIQGNDYSV-- 178

Query: 262 KCDVYSFGMVLFEI-VGR 278
           K D++S G+ L E+  GR
Sbjct: 179 KSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 6e-26
 Identities = 64/199 (32%), Positives = 94/199 (47%), Gaps = 25/199 (12%)

Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHINLVRLY 141
           +G G FG VYKG     G  +A+K ++    +I EE     M E+  +    H N+V+  
Sbjct: 8   IGRGAFGVVYKGLNLETGDFVAIKQISLE--KIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTA---KGLVYLHEEC 196
           G         ++ EY ENGSL   +  KK    +    E  +A+      +GL YLHE  
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQII--KK----FGPFPESLVAVYVYQVLQGLAYLHE-- 117

Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
            Q +IH DIK  N+L   +   K+ADFG+A KL   N      +   GTP + APE +  
Sbjct: 118 -QGVIHRDIKAANILTTKDGVVKLADFGVATKL---NDVSKDDASVVGTPYWMAPEVIEM 173

Query: 256 NYPITHKCDVYSFGMVLFE 274
           +   +   D++S G  + E
Sbjct: 174 S-GASTASDIWSLGCTVIE 191

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  104 bits (261), Expect = 9e-26
 Identities = 72/196 (36%), Positives = 111/196 (56%), Gaps = 15/196 (7%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV+ G +    K+A+K L +  G ++ E F+AE   + +  H  LVRLY   
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQ--GSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 145 HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++    ++  I
Sbjct: 71  -TQEPIYIITEYMENGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGMAFIE---RKNYI 124

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS-GNYPIT 260
           H D++  N+L+      K+ADFGLA+L + N+ +    G K    ++APE ++ G + I 
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTI- 182

Query: 261 HKCDVYSFGMVLFEIV 276
            K DV+SFG++L EIV
Sbjct: 183 -KSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  104 bits (262), Expect = 1e-25
 Identities = 70/211 (33%), Positives = 93/211 (44%), Gaps = 34/211 (16%)

Query: 85  RLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           RLG G  G V K +  N   I A+K +  +     ++Q + E+          +V+ YG 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 144 CHDQH--MTALVYEYMENGSLDGYL--FGKKRAIEWEK-LHEIAIGTAKGLVYLHEECQQ 198
             D+      +  EY E GSLD       K+     EK L +IA    KGL YLH    +
Sbjct: 68  FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---R 124

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG---------YKGTPGYSA 249
           +IIH DIKP N+LL           G  KLCD       +SG         + GT  Y A
Sbjct: 125 KIIHRDIKPSNILLTRK--------GQVKLCD-----FGVSGELVNSLAGTFTGTSFYMA 171

Query: 250 PEFLSG-NYPITHKCDVYSFGMVLFEIVGRR 279
           PE + G  Y IT   DV+S G+ L E+   R
Sbjct: 172 PERIQGKPYSIT--SDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  102 bits (255), Expect = 5e-25
 Identities = 84/270 (31%), Positives = 132/270 (48%), Gaps = 26/270 (9%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV+ G +    K+AVK L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKP--GTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 145 HDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++ +  +V EYM  GSL  +L  G+ RA++   L ++A   A G+ Y+    +   IH 
Sbjct: 71  SEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D++  N+L+      K+ADFGLA+L + N+ +    G K    ++APE  L G + I  K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI--K 183

Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV+SFG++L E+V + R    G         + V E+ E+         C I   +   
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVERGYRMPCPQDCPISLHE--- 234

Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
                 + L C +  PE+RP    +   LE
Sbjct: 235 ------LMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  100 bits (250), Expect = 3e-24
 Identities = 66/194 (34%), Positives = 108/194 (55%), Gaps = 10/194 (5%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV+ G + N  K+AVK L    G ++ + F+ E   +    H  LVRLY   
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
             +    ++ EYM  GSL  +L   +   +   KL + +   A+G+ Y+    ++  IH 
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 127

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS-GNYPITHK 262
           D++  NVL+  +   K+ADFGLA++ + N+ +    G K    ++APE ++ G++ I  K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTI--K 184

Query: 263 CDVYSFGMVLFEIV 276
            DV+SFG++L+EIV
Sbjct: 185 SDVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 99.5 bits (249), Expect = 5e-24
 Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 25/201 (12%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG- 142
           +G G FG+VY  +   +G    +K ++  N+     E  + EV  + +  H N+++ Y  
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG-----TAKGLVYLHEECQ 197
           F     +  +V EY + G L   +  KK+  E +   E  I          L YLH    
Sbjct: 68  FEEKGKL-CIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWFVQLCLALKYLHS--- 121

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKL----CDRNKTHVTISGYKGTPGYSAPEFL 253
           ++I+H DIKP+N+ L +N   K+ DFG++K+     D  KT V      GTP Y +PE  
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV------GTPYYLSPELC 175

Query: 254 SGNYPITHKCDVYSFGMVLFE 274
             N P  +K D++S G VL+E
Sbjct: 176 Q-NKPYNYKSDIWSLGCVLYE 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 98.7 bits (247), Expect = 9e-24
 Identities = 71/204 (34%), Positives = 98/204 (48%), Gaps = 25/204 (12%)

Query: 86  LGFGGFGEVYKGQFPN-GVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRL-Y 141
           LG G FG+V   +  + G   A+KVL   + + R   E  + E   + R  H  +V+L Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 142 GFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
            F   +    LV EY   G L  +L     F ++RA  +    EI +     L YLH   
Sbjct: 61  AF-QTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFY--AAEIVLA----LEYLHS-- 111

Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSG 255
              II+ D+KPEN+LLDA+   K+ DFGLAK L        T     GTP Y APE L G
Sbjct: 112 -LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC---GTPEYLAPEVLLG 167

Query: 256 NYPITHKCDVYSFGMVLFE-IVGR 278
                   D +S G++L+E + G+
Sbjct: 168 K-GYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 98.0 bits (244), Expect = 2e-23
 Identities = 76/267 (28%), Positives = 128/267 (47%), Gaps = 24/267 (8%)

Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           LG G FG V+ G++   +K+A+K +N   G ++EE F+ E   + +  H  LV+LYG C 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 205
            Q    +V E+MENG L  YL  ++  +  + L  +     +G+ YL    +   IH D+
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDL 126

Query: 206 KPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHKCD 264
              N L+ +    KV+DFG+ +    +  + + SG K    +S PE F    Y  + K D
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKY--SSKSD 183

Query: 265 VYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAK 324
           V+SFG++++E+           TE      K  +E+    E+  MI       + K  + 
Sbjct: 184 VWSFGVLMWEVF----------TEG-----KMPFEKKSNYEVVEMISRGFRLYRPKLASM 228

Query: 325 RLCMVALWCVQDSPEDRPPMSAVIKML 351
            +  V   C  + PE RP  + +++ +
Sbjct: 229 TVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 97.8 bits (244), Expect = 3e-23
 Identities = 65/208 (31%), Positives = 95/208 (45%), Gaps = 25/208 (12%)

Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLN------RNLGRIAEEQFMAEVGTIGRTYHINLV 138
           +G G FG+VY       G  +AVK +       + +  IA+E     +  +    H NLV
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADE-----MKVLELLKHPNLV 62

Query: 139 RLYGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK-LHEIAIGTAKGLVYLHEEC 196
           + YG   H + +  +  EY   G+L+  L   +  I  E  +    +   +GL YLH   
Sbjct: 63  KYYGVEVHREKVY-IFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHS-- 117

Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT--HVTISGYKGTPGYSAPEFLS 254
              I+H DIKP N+ LD N   K+ DFG A     N T     +    GTP Y APE ++
Sbjct: 118 -HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 255 GNYPITH--KCDVYSFGMVLFEIV-GRR 279
           G     H    D++S G V+ E+  G+R
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 97.0 bits (241), Expect = 5e-23
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 9/196 (4%)

Query: 86  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FGEV++G         V +A+K L         + F++E   +G+  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         ++ EYMENG+LD YL          +L  +  G A G+ YL +      +
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYV 129

Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFGL++ L D  +   T SG K    ++APE ++     T
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFT 188

Query: 261 HKCDVYSFGMVLFEIV 276
              DV+SFG+V++E++
Sbjct: 189 SASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 96.7 bits (241), Expect = 6e-23
 Identities = 74/281 (26%), Positives = 120/281 (42%), Gaps = 41/281 (14%)

Query: 85  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           +LG G FG V +G++    G  + +AVK L  +      + F+ E   +    H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 141 YGFCHDQHMTALVYEYMENGSL-DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           YG      +  +V E    GSL D              L + A+  A G+ YL     +R
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNYP 258
            IH D+   N+LL ++   K+ DFGL +   +N+ H  +  +   P  + APE L     
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR-TRT 176

Query: 259 ITHKCDVYSFGMVLFEI--------VGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI 310
            +H  DV+ FG+ L+E+         G   + I+          K + +E E+       
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL----------KKIDKEGERL------ 220

Query: 311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML 351
                 E+ +   + +  V L C   +P DRP  +A+ + L
Sbjct: 221 ------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 95.9 bits (238), Expect = 1e-22
 Identities = 74/270 (27%), Positives = 130/270 (48%), Gaps = 26/270 (9%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV+   +    K+AVK +    G ++ E F+AE   +    H  LV+L+   
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
             + +  ++ E+M  GSL  +L   +       KL + +   A+G+ ++    Q+  IH 
Sbjct: 71  TKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 126

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PITHK 262
           D++  N+L+ A+   K+ADFGLA++ + N+ +    G K    ++APE +  N+   T K
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFGSFTIK 183

Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV+SFG++L EIV   R    G +           E     E G  +       + +  
Sbjct: 184 SDVWSFGILLMEIVTYGRIPYPGMSNP---------EVIRALERGYRM------PRPENC 228

Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            + L  + + C ++ PE+RP    +  +L+
Sbjct: 229 PEELYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 94.8 bits (236), Expect = 5e-22
 Identities = 69/291 (23%), Positives = 121/291 (41%), Gaps = 48/291 (16%)

Query: 86  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FG+V+ G+  +         +AVK L       A + F  E   +    H N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFG-------------KKRAIEWEKLHEIAIGTA 186
            YG C +     +V+EYME+G L+ +L                   +   +L +IA+  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKG 243
            G+VYL     Q  +H D+   N L+  +   K+ DFG+++     D  +    + G+  
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR----VGGHTM 185

Query: 244 TP-GYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEY 301
            P  +  PE  +   +  T + DV+SFG+VL+EI                 + K  W   
Sbjct: 186 LPIRWMPPESIMYRKF--TTESDVWSFGVVLWEIFT---------------YGKQPWYGL 228

Query: 302 EKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
              E+   I    + ++ +     +  + L C +  P+ R  +  + + L+
Sbjct: 229 SNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 93.8 bits (233), Expect = 9e-22
 Identities = 83/274 (30%), Positives = 128/274 (46%), Gaps = 32/274 (11%)

Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    R  +    L  +A   +  + YL    ++  IH
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L     T+   +G K    ++APE L+ N   + K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIK 185

Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFP----KHVWEEYEKCELGAMILGCGIEEK 318
            DV++FG++L+EI          AT  +  +P      V+E  EK        GC     
Sbjct: 186 SDVWAFGVLLWEI----------ATYGMSPYPGIDLSQVYELLEKGYRMERPEGC----- 230

Query: 319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
              K   L M A W  Q +P DRP  + + +  E
Sbjct: 231 -PPKVYEL-MRACW--QWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 93.4 bits (232), Expect = 9e-22
 Identities = 61/190 (32%), Positives = 100/190 (52%), Gaps = 7/190 (3%)

Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           LG G FG V  G++     +A+K++    G ++E++F+ E   + +  H  LV+LYG C 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 205
            Q    +V EYM NG L  YL    +  +  +L E+     +G+ YL  E +Q  IH D+
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL--ESKQ-FIHRDL 126

Query: 206 KPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDV 265
              N L+D     KV+DFGL++    +  + +  G K    +S PE L      + K DV
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLL-YSKFSSKSDV 184

Query: 266 YSFGMVLFEI 275
           ++FG++++E+
Sbjct: 185 WAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 43/221 (19%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR------TYHINLV 138
           +G G F  V   +      + A+K+L++   ++ +E+ +  V  I +        H  ++
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYV-KIEKEVLTRLNGHPGII 65

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK-----LHEIAIGTAKGLVYLH 193
           +LY    D+     V EY  NG L  Y+  +K     EK       EI +     L YLH
Sbjct: 66  KLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLA----LEYLH 119

Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG------------- 240
               + IIH D+KPEN+LLD +   K+ DFG AK+ D N +  +  G             
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 241 -----YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
                + GT  Y +PE L+   P     D+++ G ++++++
Sbjct: 177 RRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQML 216

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 93.2 bits (231), Expect = 1e-21
 Identities = 66/198 (33%), Positives = 109/198 (55%), Gaps = 11/198 (5%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 145 HDQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H 
Sbjct: 71  SEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D++  N+L+  N   KVADFGLA+L + N+ +    G K    ++APE  L G + I  K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI--K 183

Query: 263 CDVYSFGMVLFEIVGRRR 280
            DV+SFG++L E+  + R
Sbjct: 184 SDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 92.8 bits (230), Expect = 2e-21
 Identities = 81/270 (30%), Positives = 132/270 (48%), Gaps = 26/270 (9%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV+ G +    K+A+K L    G +  E F+ E   + +  H  LV LY   
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKP--GTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70

Query: 145 HDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++ +  +V E+M  GSL  +L  G  + ++  +L ++A   A G+ Y+    +   IH 
Sbjct: 71  SEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D++  N+L+  N   K+ADFGLA+L + N+ +    G K    ++APE  L G + I  K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI--K 183

Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV+SFG++L E+V + R    G         + V E+ E+        GC    +   +
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVN------REVLEQVERGYRMPCPQGC---PESLHE 234

Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
             +LC    W  +  P++RP    +   LE
Sbjct: 235 LMKLC----W--KKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 22/205 (10%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAV-KVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
            +G G FG V K +  +  KI V K ++  N+    ++Q ++EV  +    H N+VR Y 
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 143 FCHD--QHMTALVYEYMENGSLDGYLFGKKRA----IEWEKLHEIAIGTAKGLVYLH--E 194
              D       +V EY E G L   L  K +     IE E +  I       L   H   
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN----KTHVTISGYKGTPGYSAP 250
           +    ++H D+KP N+ LDAN + K+ DFGLAK+   +    KT+V      GTP Y +P
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV------GTPYYMSP 179

Query: 251 EFLSGNYPITHKCDVYSFGMVLFEI 275
           E L+       K D++S G +++E+
Sbjct: 180 EQLNHM-SYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 17/198 (8%)

Query: 84  TRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
            ++G G  GEVYK      G ++A+K +   L +  +E  + E+  +    H N+V  Y 
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMR--LRKQNKELIINEILIMKDCKHPNIVDYYD 82

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
                    +V EYM+ GSL   +      +   ++  +     +GL YLH    Q +IH
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIH 139

Query: 203 YDIKPENVLLDANFSPKVADFGLA----KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
            DIK +N+LL  + S K+ADFG A    K   +  + V      GTP + APE +     
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV------GTPYWMAPEVIKRK-D 192

Query: 259 ITHKCDVYSFGMVLFEIV 276
              K D++S G++  E+ 
Sbjct: 193 YGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 93.6 bits (232), Expect = 2e-21
 Identities = 66/196 (33%), Positives = 103/196 (52%), Gaps = 10/196 (5%)

Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K+LN   G  A  +FM E   +    H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C    +  LV + M +G L  Y+   K  I  + L    +  AKG++YL E   +R+
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRL 130

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H D+   NVL+ +    K+ DFGLA+L + ++      G K    + A E +      T
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFT 189

Query: 261 HKCDVYSFGMVLFEIV 276
           H+ DV+S+G+ ++E++
Sbjct: 190 HQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 91.4 bits (227), Expect = 5e-21
 Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 13/195 (6%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           LG G +G VYK +   +    A+K ++  ++ +   E  + E+  +    H N++     
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 144 CHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
             D +   +V EY   G L   +     K++ I  +++  I I   +GL  LHE   Q+I
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKI 124

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H D+K  N+LL AN   K+ D G++K+  +N     I    GTP Y APE   G  P +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVWKGR-PYS 179

Query: 261 HKCDVYSFGMVLFEI 275
           +K D++S G +L+E+
Sbjct: 180 YKSDIWSLGCLLYEM 194

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 90.8 bits (225), Expect = 6e-21
 Identities = 60/191 (31%), Positives = 103/191 (53%), Gaps = 9/191 (4%)

Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           LG G FGEV+KG   +   +AVK    +L +  + +F++E   + +  H N+V+L G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 205
            +    +V E +  G    +L  KK  ++ ++L + A+  A G+ YL     +  IH D+
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDL 119

Query: 206 KPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLS-GNYPITHKC 263
              N L+  N   K++DFG+++  D      + SG K  P  ++APE L+ G Y  + + 
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGI--YSSSGLKQIPIKWTAPEALNYGRY--SSES 175

Query: 264 DVYSFGMVLFE 274
           DV+S+G++L+E
Sbjct: 176 DVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 91.0 bits (226), Expect = 9e-21
 Identities = 83/291 (28%), Positives = 124/291 (42%), Gaps = 52/291 (17%)

Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FGEVY+G +         +++AVK L  +     E  F+ E   + +  H N+VR
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYL------FGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           L G   ++    ++ E M  G L  +L        +  ++  + L   A   AKG  YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 194 EECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRN----KTHVTISGYKGTP 245
           E      IH DI   N LL     P    K+ADFG+A+   R     K    +   K  P
Sbjct: 134 E---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMP 189

Query: 246 GYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC 304
               PE FL G +  T K DV+SFG++L+EI             SL + P      Y   
Sbjct: 190 ----PEAFLDGIF--TSKTDVWSFGVLLWEIF------------SLGYMP------YPGR 225

Query: 305 ---ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
              E+   + G G  +  K     +  +   C Q +PEDRP  + +++ ++
Sbjct: 226 TNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.9 bits (223), Expect = 2e-20
 Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 11/198 (5%)

Query: 86  LGFGGFGEVYKGQF-PNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FGEV +G+    G +   +A+K L           F++E   +G+  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         ++ E+MENG+LD +L          +L  +  G A G+ YL E      +
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYV 128

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS---GYKGTPGYSAPEFLSGNYP 258
           H D+   N+L+++N   KV+DFGL++  + + +  T +   G K    ++APE ++    
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-K 187

Query: 259 ITHKCDVYSFGMVLFEIV 276
            T   DV+S+G+V++E++
Sbjct: 188 FTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 88.9 bits (221), Expect = 3e-20
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 23/203 (11%)

Query: 85  RLGFGGFGEVYKG--QFPNG--VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
            LG G FG V KG     +G  V++AVK L +      +++F+ E   + +  H  +VRL
Sbjct: 2   ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C  + +  LV E    G L  YL  K+R I    L E+A   A G+ YL     +  
Sbjct: 62  IGVCKGEPLM-LVMELAPLGPLLKYLK-KRREIPVSDLKELAHQVAMGMAYLES---KHF 116

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG------YSAPEFLS 254
           +H D+   NVLL      K++DFG+++       +     Y+ T        + APE   
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-----YRATTAGRWPLKWYAPE--C 169

Query: 255 GNYPI-THKCDVYSFGMVLFEIV 276
            NY   + K DV+S+G+ L+E  
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 89.0 bits (221), Expect = 4e-20
 Identities = 71/268 (26%), Positives = 112/268 (41%), Gaps = 39/268 (14%)

Query: 86  LGFGGFGEVYKG-QFPNGVKIAVK----VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY+G    +G   AVK      +   G+ A +Q   E+  + +  H N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G   ++    +  E +  GSL   L  K  +     +         GL YLH+   +  
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLHD---RNT 123

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H DIK  N+L+D N   K+ADFG+AK   +         +KG+P + APE ++      
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM--ILGCG---- 314
              D++S G  + E+          AT       K  W + E   + A+  I        
Sbjct: 181 LAADIWSLGCTVLEM----------ATG------KPPWSQLE--GVAAVFKIGRSKELPP 222

Query: 315 IEEKDKEKAKRLCMVALWCVQDSPEDRP 342
           I +   ++AK   +    C+Q  P  RP
Sbjct: 223 IPDHLSDEAKDFILK---CLQRDPSLRP 247

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 89.0 bits (221), Expect = 5e-20
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 21/204 (10%)

Query: 86  LGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHINLVRLY 141
           LG G FG+VYK Q    G+  A K++       +EE+   FM E+  +    H N+V LY
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLY 68

Query: 142 -GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
             + ++  +  L+ E+ + G+LD  +   +R +   ++  +     + L +LH     ++
Sbjct: 69  EAYFYENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKV 124

Query: 201 IHYDIKPENVLLDANFSPKVADFGL-AKLCDRNKTHVTISGYKGTPGYSAPEFL----SG 255
           IH D+K  N+LL  +   K+ADFG+ AK     +   T   + GTP + APE +      
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACETFK 181

Query: 256 NYPITHKCDVYSFGMVLFEIVGRR 279
           + P  +K D++S G+ L E+    
Sbjct: 182 DNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 88.7 bits (220), Expect = 5e-20
 Identities = 77/282 (27%), Positives = 119/282 (42%), Gaps = 38/282 (13%)

Query: 86  LGFGGFGEVYKGQFPNGVK--IAVK---VLNRNLGRIAEEQ------FMAEVGTIGRT-Y 133
           LG G FG VYK +  N  +  +A+K   V N   G+   E+       ++EV  I     
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFG----KKRAIEWEKLHEIAIGTAKGL 189
           H N+VR Y    +     +V + +E   L G  F     KK+    E++  I +     L
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPL-GEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
            YLH+E  +RI+H D+ P N++L  +    + DFGLAK         ++    GT  YS 
Sbjct: 127 RYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV---GTILYSC 181

Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM 309
           PE +  N P   K DV++FG +L+++          +T  L    K V   YE       
Sbjct: 182 PEIVK-NEPYGEKADVWAFGCILYQMC--TLQPPFYSTNMLSLATKIVEAVYEPL----- 233

Query: 310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML 351
                    +   ++ +  V   C+    E RP +  V  M+
Sbjct: 234 --------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 91.8 bits (228), Expect = 7e-20
 Identities = 77/274 (28%), Positives = 125/274 (45%), Gaps = 31/274 (11%)

Query: 89  GGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ 147
           G  G  YKG+   NG++  VK +N ++  I      +E+  +G+  H N+V+L G C  +
Sbjct: 701 GKKGASYKGKSIKNGMQFVVKEIN-DVNSIPS----SEIADMGKLQHPNIVKLIGLCRSE 755

Query: 148 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 207
               L++EY+E  +L   L    R + WE+  +IAIG AK L +LH  C   ++  ++ P
Sbjct: 756 KGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811

Query: 208 ENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 267
           E +++D    P +       LC   K  +       +  Y APE       IT K D+Y 
Sbjct: 812 EKIIIDGKDEPHLRLSLPGLLCTDTKCFI-------SSAYVAPE-TRETKDITEKSDIYG 863

Query: 268 FGMVLFEIVGRR--RNAIVGATESLDWFPKHVWEEYEKCEL----GAMILG-CGIEEKDK 320
           FG++L E++  +   +A  G   S+  + ++    Y  C L       I G   + + + 
Sbjct: 864 FGLILIELLTGKSPADAEFGVHGSIVEWARYC---YSDCHLDMWIDPSIRGDVSVNQNEI 920

Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV 354
            +   L   AL C    P  RP  + V+K LE  
Sbjct: 921 VEVMNL---ALHCTATDPTARPCANDVLKTLESA 951

Length = 968

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 87.8 bits (218), Expect = 9e-20
 Identities = 60/201 (29%), Positives = 88/201 (43%), Gaps = 20/201 (9%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G    VY     PN  K+A+K ++    + + ++   EV  + +  H N+V+ Y   
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQQR 199
                  LV  Y+  GSL   +   K +     L E  I T      KGL YLH      
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIM---KSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNG 122

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKL-----CDRNKTHVTISGYKGTPGYSAPEFLS 254
            IH DIK  N+LL  + S K+ADFG++           K   T     GTP + APE + 
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV---GTPCWMAPEVME 179

Query: 255 GNYPITHKCDVYSFGMVLFEI 275
             +    K D++SFG+   E+
Sbjct: 180 QVHGYDFKADIWSFGITAIEL 200

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 87.6 bits (217), Expect = 1e-19
 Identities = 82/284 (28%), Positives = 119/284 (41%), Gaps = 48/284 (16%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLN--RNLGRIAE---EQFMAEVGTIGRTYHINLVR 139
           LG G F   Y+ +    G  +AVK +   RN     E   E    E+  + R  H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 140 LYG-FCHDQHMTALVYEYMENGSLDGYL--FGK-KRAIEWEKLHEIAIGTAKGLVYLHEE 195
           + G  C D H    V E+M  GS+   L  +G  K A+      ++     +GL YLHE 
Sbjct: 68  MLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLHE- 121

Query: 196 CQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISG-----YKGTPGYSA 249
              +IIH D+K  N+L+D+     ++ADFG A    R     T +G       GT  + A
Sbjct: 122 --NQIIHRDVKGANLLIDSTGQRLRIADFGAAA---RLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM 309
           PE L G       CDV+S G V+ E+          AT    W  +            A+
Sbjct: 177 PEVLRGE-QYGRSCDVWSVGCVIIEM----------ATAKPPWNAEKHSNHL------AL 219

Query: 310 I--LGCGIEEKDKEKAKR--LCMVALWCVQDSPEDRPPMSAVIK 349
           I  +          +     L  V L C++  PEDRPP   ++K
Sbjct: 220 IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 87.5 bits (218), Expect = 2e-19
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 32/209 (15%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRI--AEEQF----MAEVGTIGRTYHINL 137
           +LG G +G VYK +    G  +A+K +     R+   EE      + E+  +    H N+
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKI-----RLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
           V+L    H +    LV+EY +   L  YL  +   +    +  I     +GL Y H    
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---S 116

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNKTHVTISGYKGTPGYSAPEFLS 254
            RI+H D+KP+N+L++ +   K+ADFGLA+      R  TH  +     T  Y APE L 
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-----TLWYRAPEILL 171

Query: 255 G----NYPITHKCDVYSFGMVLFEIVGRR 279
           G    +  +    D++S G +  E++  +
Sbjct: 172 GSKHYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.1 bits (213), Expect = 4e-19
 Identities = 75/282 (26%), Positives = 129/282 (45%), Gaps = 38/282 (13%)

Query: 86  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G+        + +A+K L           F++E   +G+  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI--GTAKGLVYLHEECQQR 199
           G         +V EYMENGSLD +L  +K   ++  +  + +  G A G+ YL +     
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKYLSD---MG 126

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
            +H D+   N+L+++N   KV+DFGL++ L D  +   T  G K    ++APE ++    
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-K 185

Query: 259 ITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK 318
            T   DV+S+G+V++E+              + +  +  WE   +  + A      IEE 
Sbjct: 186 FTSASDVWSYGIVMWEV--------------MSYGERPYWEMSNQDVIKA------IEEG 225

Query: 319 DKEKAKRLCMVALW-----CVQDSPEDRPPMSAVIKMLEGVV 355
            +  A   C  AL      C Q    +RP    ++ +L+ ++
Sbjct: 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 86.4 bits (214), Expect = 4e-19
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 21/206 (10%)

Query: 82  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +  +LG G FG V   ++       G  +AVK L  +        F  E+  +    H N
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDN 66

Query: 137 LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G C+   +    LV EY+  GSL  YL   +  ++  KL   A    KG+ YL  
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYS-----A 249
              +R +H D+   N+L+++    K+ DFGL K+  ++K +  +      PG S     A
Sbjct: 127 ---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR----EPGESPIFWYA 179

Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEI 275
           PE L+ +   +   DV+SFG+VL+E+
Sbjct: 180 PESLTES-KFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 86.2 bits (214), Expect = 4e-19
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 27/210 (12%)

Query: 86  LGFGGFGEVYKG---QFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGR--TYHINL 137
           LG G FG VY+G       G    ++A+K +N N       +F+ E   +     +H+  
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV-- 71

Query: 138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------RAIEWEKLHEIAIGTAKG 188
           VRL G       T +V E M  G L  YL  ++              +K  ++A   A G
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 189 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT-P-G 246
           + YL     ++ +H D+   N ++  + + K+ DFG+ +  D  +T     G KG  P  
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRKGGKGLLPVR 186

Query: 247 YSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
           + APE L      T K DV+SFG+VL+E+ 
Sbjct: 187 WMAPESLKDGV-FTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 85.8 bits (213), Expect = 5e-19
 Identities = 60/196 (30%), Positives = 89/196 (45%), Gaps = 20/196 (10%)

Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G +G VYK      G  +A+KV+      +  ++ + E+  + +     +V+ YG  
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPVE-EDL--QEIIKEISILKQCDSPYIVKYYGSY 67

Query: 145 HDQHMTALVYEYMENGS-LDGYLFGKKRAIEWEKLHEIAI---GTAKGLVYLHEECQQRI 200
                  +V EY   GS  D      K   E     EIA     T KGL YLH     + 
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIMKITNKTLTE----EEIAAILYQTLKGLEYLH---SNKK 120

Query: 201 IHYDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           IH DIK  N+LL+     K+ADFG++ +L D      T+    GTP + APE +      
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI---GTPFWMAPEVIQEI-GY 176

Query: 260 THKCDVYSFGMVLFEI 275
            +K D++S G+   E+
Sbjct: 177 NNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.5 bits (212), Expect = 9e-19
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 14/200 (7%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  R       +  + E+  +    H N+++L  
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +    LV+E+M+   L   +  ++R +    +        +GL + H      I+H
Sbjct: 66  VFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILH 121

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCD---RNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KPEN+L++     K+ADFGLA+      R  TH     Y  T  Y APE L G+   
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH-----YVVTRWYRAPELLLGDKGY 176

Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E++ RR
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 14/201 (6%)

Query: 86  LGFGGFGEVYKGQF-PN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG+V    + P     G  +AVK L R  G+     +  E+  +   YH N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 141 YGFCHDQ--HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            G C +Q      L+ EY+  GSL  YL   K  +   +L   A    +G+ YLH    Q
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYLH---SQ 126

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFLSGNY 257
             IH D+   NVLLD +   K+ DFGLAK       +  +     +P +  A E L    
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK-EN 185

Query: 258 PITHKCDVYSFGMVLFEIVGR 278
             ++  DV+SFG+ L+E++  
Sbjct: 186 KFSYASDVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 63/209 (30%), Positives = 90/209 (43%), Gaps = 43/209 (20%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLN-----RNLGRIAEE-QFMAEVGTIGRTYHINL 137
            +G G FGEVYK         +A+KV++       +  I +E QF+++     R+ +I  
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC----RSPYI-- 61

Query: 138 VRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVY 191
            + YG F     +  ++ EY   GS    L       +  KL E  I         GL Y
Sbjct: 62  TKYYGSFLKGSKL-WIIMEYCGGGSCLDLL-------KPGKLDETYIAFILREVLLGLEY 113

Query: 192 LHEECQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNKTHVTISGYKGTPGY 247
           LHE   +  IH DIK  N+LL      K+ADFG    L     +  T V      GTP +
Sbjct: 114 LHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV------GTPFW 164

Query: 248 SAPEFLS-GNYPITHKCDVYSFGMVLFEI 275
            APE +    Y    K D++S G+   E+
Sbjct: 165 MAPEVIKQSGY--DEKADIWSLGITAIEL 191

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 84.5 bits (210), Expect = 2e-18
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 16/198 (8%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYG 142
           +LG G FG VY  +    G  +A+K + +      E   + EV ++ +   H N+V+L  
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
              +      V+EYME          K +      +  I     +GL ++H   +    H
Sbjct: 66  VFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFH 122

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL--SGNY--P 258
            D+KPEN+L+      K+ADFGLA+       +     Y  T  Y APE L  S +Y  P
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD---YVSTRWYRAPEILLRSTSYSSP 179

Query: 259 ITHKCDVYSFGMVLFEIV 276
           +    D+++ G ++ E+ 
Sbjct: 180 V----DIWALGCIMAELY 193

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 32/273 (11%)

Query: 82  YSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           Y   LG G  G VYK       +I AVKV+  ++    ++Q M+E+  + +     ++  
Sbjct: 5   YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG    ++  ++  E+M+ GSLD Y     R I    L  IA+   KGL YL      +I
Sbjct: 65  YGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYL---WSLKI 116

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H D+KP N+L++     K+ DFG++        +     Y GT  Y APE +SG     
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPERISGEQYGI 172

Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK-- 318
           H  DV+S G+   E+             +L  FP    ++ +   +   +L C ++E   
Sbjct: 173 HS-DVWSLGISFMEL-------------ALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP 218

Query: 319 ---DKEKAKRLCMVALWCVQDSPEDRPPMSAVI 348
                + +++       C++  P++RP    ++
Sbjct: 219 VLPVGQFSEKFVHFITQCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 23/206 (11%)

Query: 86  LGFGGFGEVYKGQF----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRL 140
           +G G FG VY G         +  AVK LNR       EQF+ E G I + + H N++ L
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKE-GIIMKDFSHPNVLSL 61

Query: 141 YGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
            G C     + LV   YM++G L  ++  +      + L    +  AKG+ YL     ++
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKK 118

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAK-LCDR------NKTHVTISGYKGTPGYSAPEF 252
            +H D+   N +LD +F+ KVADFGLA+ + D+      N T       K    + A E 
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGA-----KLPVKWMALES 173

Query: 253 LSGNYPITHKCDVYSFGMVLFEIVGR 278
           L      T K DV+SFG++L+E++ R
Sbjct: 174 LQ-TQKFTTKSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 83.8 bits (207), Expect = 3e-18
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 30/213 (14%)

Query: 86  LGFGGFGEVYKGQFPN-------GVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHIN 136
           LG G FGEVY+G   +        +++AVK L +  G   +E+  F+ E   +    H N
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK--GATDQEKKEFLKEAHLMSNFNHPN 60

Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA------IEWEKLHEIAIGTAKGLV 190
           +V+L G C       ++ E ME G L  YL   +        +  ++L +I +  AKG V
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 191 YLHEECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
           YL    Q   IH D+   N L+     DA+   K+ DFGLA+   ++  +    G    P
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD-YYRKEGEGLLP 176

Query: 246 -GYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 276
             + APE  L G +  T + DV+SFG++++EI+
Sbjct: 177 VRWMAPESLLDGKF--TTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 83.5 bits (206), Expect = 3e-18
 Identities = 58/196 (29%), Positives = 104/196 (53%), Gaps = 23/196 (11%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
            +G G FG V +G++  G K+AVK +  +   +  + F+ E   + + +H NLVRL G  
Sbjct: 13  IIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
               +  +V E M  G+L  +L  + RA +   +L + ++  A+G+ YL     ++++H 
Sbjct: 69  LHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124

Query: 204 DIKPENVLLDANFSPKVADFGLAKL----CDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           D+   N+L+  +   KV+DFGLA++     D +K  V          ++APE L      
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK---------WTAPEALKHK-KF 174

Query: 260 THKCDVYSFGMVLFEI 275
           + K DV+S+G++L+E+
Sbjct: 175 SSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 83.5 bits (206), Expect = 3e-18
 Identities = 61/196 (31%), Positives = 100/196 (51%), Gaps = 13/196 (6%)

Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY-GF 143
           LG G FG+VYK Q    GV  A KV++        E +M E+  +    H N+V+L   F
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++ ++  L+ E+   G++D  +   +R +   ++  +   T + L YLHE    +IIH 
Sbjct: 72  YYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHR 127

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL----SGNYPI 259
           D+K  N+L   +   K+ADFG++      +T      + GTP + APE +    S + P 
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185

Query: 260 THKCDVYSFGMVLFEI 275
            +K DV+S G+ L E+
Sbjct: 186 DYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 61/194 (31%), Positives = 97/194 (50%), Gaps = 11/194 (5%)

Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G FG V+K  +  +    A+K ++   + R   E+ + E   + +     ++R Y 
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
              D+    +V EY ENG L   L   + R +  +++    I    GL +LH    ++I+
Sbjct: 67  SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKIL 123

Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H DIK  N+ LDA  + K+ D G+AK L D      TI    GTP Y +PE L  + P  
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV---GTPYYLSPE-LCEDKPYN 179

Query: 261 HKCDVYSFGMVLFE 274
            K DV++ G+VL+E
Sbjct: 180 EKSDVWALGVVLYE 193

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 5e-18
 Identities = 60/198 (30%), Positives = 91/198 (45%), Gaps = 19/198 (9%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           R+G G +G+VYK +    G  +A+KV+    G    E    E+  +    H N+V  +G 
Sbjct: 10  RIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
              +    +V EY   GSL       +  +   ++  +   T KGL YLH   +   IH 
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHR 125

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK---GTPGYSAPEFLS----GN 256
           DIK  N+LL  +   K+ADFG++          TI+  K   GTP + APE  +    G 
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTA-----TIAKRKSFIGTPYWMAPEVAAVERKGG 180

Query: 257 YPITHKCDVYSFGMVLFE 274
           Y    KCD+++ G+   E
Sbjct: 181 Y--DGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 82.7 bits (205), Expect = 6e-18
 Identities = 67/241 (27%), Positives = 99/241 (41%), Gaps = 51/241 (21%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG GGFG V   +        A+K + +   +    +E   +E   +    H  +V+LY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI---GTAK--------GLVY 191
              D+    ++ EY   G L            W  L +  +    TA+           Y
Sbjct: 61  TFKDKKYIYMLMEYCLGGEL------------WTILRDRGLFDEYTARFYIACVVLAFEY 108

Query: 192 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAP 250
           LH    + II+ D+KPEN+LLD+N   K+ DFG AK L    KT        GTP Y AP
Sbjct: 109 LHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC----GTPEYVAP 161

Query: 251 EFLSGN-YPITHKCDVYSFGMVLFEI-VGR------------RRNAIVGATESLDWFPKH 296
           E +    Y      D +S G++L+E+  GR              N I+     L+ FP +
Sbjct: 162 EIILNKGY--DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE-FPNY 218

Query: 297 V 297
           +
Sbjct: 219 I 219

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 83.1 bits (205), Expect = 6e-18
 Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 12/197 (6%)

Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG V+KG + P G    + +A+K +    GR   ++    +  +G   H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C    +  LV +    GSL  ++   + +++ ++L    +  AKG+ YL E    R+
Sbjct: 75  LGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRM 130

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H ++   N+LL ++   ++ADFG+A L   +      S +K    + A E  L G Y  
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY-- 188

Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 189 THQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 79/284 (27%), Positives = 136/284 (47%), Gaps = 34/284 (11%)

Query: 84  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 11  SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             +     ++  E+M+ GSLD  L  K   I  + L +++I   KGL YL E  + +I+H
Sbjct: 71  AFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMH 127

Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 181

Query: 262 KCDVYSFGMVLFEI-VGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE--EK 318
           + D++S G+ L E+ +GR               P    +E E      ++ GC +E    
Sbjct: 182 QSDIWSMGLSLVEMAIGRYP------------IPPPDAKELE------LMFGCPVEGDPA 223

Query: 319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPK 362
           + E + R            P+ RPPM A+ ++L+ +V   PPPK
Sbjct: 224 ESETSPRPRPPGRPLSSYGPDSRPPM-AIFELLDYIVNE-PPPK 265

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 26/205 (12%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           R+G G  G VYK    P G   A+KV+  N       Q   E+  +    H N+V+    
Sbjct: 81  RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK---- 136

Query: 144 CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           CHD         ++ E+M+ GSL+G     ++      L ++A     G+ YLH   ++ 
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF-----LADVARQILSGIAYLH---RRH 188

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS----- 254
           I+H DIKP N+L+++  + K+ADFG++++    +T    +   GT  Y +PE ++     
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNSSVGTIAYMSPERINTDLNH 246

Query: 255 GNYPITHKCDVYSFGMVLFEI-VGR 278
           G Y   +  D++S G+ + E  +GR
Sbjct: 247 GAYD-GYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 81.1 bits (200), Expect = 2e-17
 Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 9/207 (4%)

Query: 74  QLNNFTSNYSTRLGFGGFGEVYKG--QFPNG--VKIAVKVLNRNLGRIAEEQFMAEVGTI 129
           +L+N +      LG G FGE+ +G  + P+   + +A+  L           F+AE  T+
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60

Query: 130 GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGL 189
           G+  H N+VRL G     +   +V EYM NG+LD +L   +  +   +L  +  G A G+
Sbjct: 61  GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGM 120

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
            YL E      +H  +    VL++++   K++ F   +  D+++   T    K    ++A
Sbjct: 121 KYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE-DKSEAIYTTMSGKSPVLWAA 176

Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE +  ++  +   DV+SFG+V++E++
Sbjct: 177 PEAIQYHH-FSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 56/195 (28%), Positives = 98/195 (50%), Gaps = 9/195 (4%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +  VYKG+    G  +A+K ++ +         + E+  +    H N+VRL+  
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 144 CHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
            H ++   LV+EYM+   L  Y+   G + A++   +        KG+ + HE    R++
Sbjct: 67  IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVL 122

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H D+KP+N+L++     K+ADFGLA+         T S    T  Y AP+ L G+   + 
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYST 180

Query: 262 KCDVYSFGMVLFEIV 276
             D++S G ++ E++
Sbjct: 181 SIDIWSVGCIMAEMI 195

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 25/204 (12%)

Query: 89  GGFGEVY---KGQFPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRL-YG 142
           G +G V+   K     G   A+KV+ +   + +   +Q + E   + +     +V+L Y 
Sbjct: 4   GAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS 61

Query: 143 FCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           F   +++  LV EY+  G L   L   G   +++ +            L YLH      I
Sbjct: 62  FQGKKNLY-LVMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLH---SNGI 114

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKL------CDRNKTHVTISGYKGTPGYSAPEFLS 254
           IH D+KP+N+L+D+N   K+ DFGL+K+       + N          GTP Y APE + 
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 255 GNYPITHKCDVYSFGMVLFE-IVG 277
           G    +   D +S G +L+E +VG
Sbjct: 175 GQ-GHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 80.1 bits (197), Expect = 4e-17
 Identities = 55/193 (28%), Positives = 100/193 (51%), Gaps = 9/193 (4%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           R+G G FGEV+ G+   +   +AVK     L    + +F+ E   + +  H N+VRL G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
           C  +    +V E ++ G    +L  +   ++ ++L ++    A G+ YL  +     IH 
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHR 118

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLS-GNYPITH 261
           D+   N L+      K++DFG+++  + +  + +  G K  P  ++APE L+ G Y  + 
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRY--SS 175

Query: 262 KCDVYSFGMVLFE 274
           + DV+SFG++L+E
Sbjct: 176 ESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 62/198 (31%), Positives = 105/198 (53%), Gaps = 12/198 (6%)

Query: 84  TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           + LG G  G V K Q  P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 11  SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             +     ++  E+M+ GSLD  L   KR  E E L +++I   +GL YL E+ Q  I+H
Sbjct: 71  AFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSIAVLRGLAYLREKHQ--IMH 127

Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 181

Query: 262 KCDVYSFGMVLFEI-VGR 278
           + D++S G+ L E+ +GR
Sbjct: 182 QSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 80.0 bits (197), Expect = 5e-17
 Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 22/203 (10%)

Query: 86  LGFGGFGEVYKGQFPNGVKIAVK--VLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRL 140
           LG G +G VY G    G  IAVK   L+ +    AE+++     EV  +    H+N+V+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            G C D +  ++  E++  GS+   L  FG      + K  +  +    G+ YLH  C  
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL---DGVAYLHNNC-- 122

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS----GYKGTPGYSAPEFL- 253
            ++H DIK  NV+L  N   K+ DFG A+       H T S       GTP + APE + 
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Query: 254 -SGNYPITHKCDVYSFGMVLFEI 275
            SG      K D++S G  +FE+
Sbjct: 182 ESGY---GRKSDIWSIGCTVFEM 201

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 80.1 bits (197), Expect = 7e-17
 Identities = 77/263 (29%), Positives = 120/263 (45%), Gaps = 27/263 (10%)

Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P+G    + +A+KVL  N    A ++ + E   +       + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       LV + M  G L  Y+   K  I  + L    +  AKG+ YL E    R+
Sbjct: 75  LGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRL 130

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H D+   NVL+ +    K+ DFGLA+L D ++T     G K    + A E +  +   T
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL-HRRFT 189

Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP-KHVWEEYEKCELGAMILGCGIEEKD 319
           H+ DV+S+G+ ++E++        GA +  D  P + + +  EK E       C I+   
Sbjct: 190 HQSDVWSYGVTVWELM------TFGA-KPYDGIPAREIPDLLEKGERLPQPPICTID--- 239

Query: 320 KEKAKRLCMVALWCVQDSPEDRP 342
                 + M+ + C     E RP
Sbjct: 240 ------VYMIMVKCWMIDSECRP 256

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 79.8 bits (197), Expect = 8e-17
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 22/200 (11%)

Query: 86  LGFGGFGEVYKGQF--PNGVKI--AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FG+VY+G +  P   KI  AVK           E+F+ E   + +  H ++V+L 
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G   +  +  +V E    G L  YL   K +++   L   +   +  L YL     +R +
Sbjct: 74  GVITENPVW-IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFV 129

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG-----YSAPEFLSGN 256
           H DI   NVL+ +    K+ DFGL++  +        S YK + G     + APE  S N
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDE------SYYKASKGKLPIKWMAPE--SIN 181

Query: 257 Y-PITHKCDVYSFGMVLFEI 275
           +   T   DV+ FG+ ++EI
Sbjct: 182 FRRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 32/209 (15%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY--HINLVRLYG 142
           +G G +G+VYK +    G  +A+K+++       EE+   E   + R Y  H N+   YG
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE--EEEIKEEYNIL-RKYSNHPNIATFYG 70

Query: 143 F--------CHDQHMTALVYEYMENGS---LDGYLFGKKRAIEWEKLHEIAIGTAKGLVY 191
                      DQ    LV E    GS   L   L  K + ++ E +  I   T +GL Y
Sbjct: 71  AFIKKNPPGNDDQ--LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 192 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN--KTHVTISGYKGTPGYSA 249
           LHE    ++IH DIK +N+LL  N   K+ DFG++   D    + +  I    GTP + A
Sbjct: 129 LHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI----GTPYWMA 181

Query: 250 PEFLSGN----YPITHKCDVYSFGMVLFE 274
           PE ++ +         + DV+S G+   E
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)

Query: 83  STRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMA-EVGT---IGRTYHINL 137
              +G G +G VYK +  N  +  A+K +   L           E+     +    H N+
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 138 VRLYGFCHDQHMT-----ALVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGLVY 191
           VRL   CH           LV+E+++   L  YL    K  +  E + ++     +G+ +
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122

Query: 192 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK--THVTISGYKGTPGYSA 249
           LH     RI+H D+KP+N+L+ ++   K+ADFGLA++       T V +     T  Y A
Sbjct: 123 LH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-----TLWYRA 174

Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           PE L  +   T   D++S G +  E+  RR
Sbjct: 175 PEVLLQSSYAT-PVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 41/219 (18%)

Query: 86  LGFGGFGEVYKGQF--PNGVK----IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FG+VYKG+   PN       +A+K L  N     +++F  E   +    H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF---------------GKKRAIEWEKLHEIAIG 184
           L G C  +  T +++EY+ +G L  +L                  K +++      IAI 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
            A G+ YL        +H D+   N L+    + K++DFGL++        +  + Y   
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD-------IYSADYYRV 182

Query: 245 PGYS-------APE-FLSGNYPITHKCDVYSFGMVLFEI 275
              S        PE  L G +  T + D++SFG+VL+EI
Sbjct: 183 QSKSLLPVRWMPPEAILYGKF--TTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 15/192 (7%)

Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-FC 144
           +G G FG+V  G +  G K+AVK +  +      + F+AE   + +  H NLV+L G   
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++    +V EYM  GSL  YL  + R+ +  + L + ++   + + YL        +H 
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHR 126

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKC 263
           D+   NVL+  +   KV+DFGL K     +   T    K    ++APE L      + K 
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR-EKKFSTKS 180

Query: 264 DVYSFGMVLFEI 275
           DV+SFG++L+EI
Sbjct: 181 DVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 50/226 (22%)

Query: 85  RLGFGGFGEVYKGQF------PNGVKIAVKVL-----NRNLGRIAEEQFMAEVGTIGRTY 133
            LG G FG+V K +            +AVK+L      ++L  +  E  M  +  IG+  
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE--MEMMKMIGK-- 74

Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---------------L 178
           H N++ L G C  +    +V EY  +G+L  +L  ++   E+                 L
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 179 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTH 235
              A   A+G+ +L     ++ IH D+   NVL+  +   K+ADFGLA+     D  +  
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR-- 189

Query: 236 VTISGYKGTPG-----YSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
                 K T G     + APE L      TH+ DV+SFG++L+EI 
Sbjct: 190 ------KTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 31/202 (15%)

Query: 86  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-F 143
           LG G  G V K    P G  +A KV++        +Q + E+  +       +V  YG F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++ ++  +  E+M+ GSLD  ++ K   I  E L +IA+   +GL YL+     RI+H 
Sbjct: 73  LNENNIC-MCMEFMDCGSLDR-IYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHR 128

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG---------YKGTPGYSAPEFL- 253
           DIKP N+L+++    K+ DFG             +SG         + GT  Y +PE + 
Sbjct: 129 DIKPSNILVNSRGQIKLCDFG-------------VSGELINSIADTFVGTSTYMSPERIQ 175

Query: 254 SGNYPITHKCDVYSFGMVLFEI 275
            G Y  T K DV+S G+ + E+
Sbjct: 176 GGKY--TVKSDVWSLGISIIEL 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 18/200 (9%)

Query: 87  GFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL- 140
           G G FG+V   Q        A+K +N+   +  E+      + E   +    H  LV L 
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNK--QKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y F  +++M  LV + +  G L  Y   +K     E++          L YLH    + I
Sbjct: 67  YSFQDEENMY-LVVDLLLGGDLR-YHLSQKVKFSEEQVKFWICEIVLALEYLHS---KGI 121

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKP+N+LLD      + DF +A     +    + S   GTPGY APE L      +
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLCRQG-YS 177

Query: 261 HKCDVYSFGMVLFE-IVGRR 279
              D +S G+  +E + G+R
Sbjct: 178 VAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 87/270 (32%), Positives = 120/270 (44%), Gaps = 44/270 (16%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRL-Y 141
           LG GGFGEV   Q     K+ A K L+  R   R  E+  + E   + +     +V L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 142 GFCHDQHMTALVYEYMENGSLDGYL-------FGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
            F   +    LV   M  G L  ++       F + RAI +    +I  G    L +LH+
Sbjct: 61  AF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA--QIICG----LEHLHQ 113

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFL 253
               RI++ D+KPENVLLD + + +++D GLA +L    K      G  GTPGY APE L
Sbjct: 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK----GRAGTPGYMAPEVL 166

Query: 254 SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC 313
            G        D ++ G  L+E++  R             F +   E+ EK EL    L  
Sbjct: 167 QGEV-YDFSVDWFALGCTLYEMIAGRSP-----------FRQRK-EKVEKEELKRRTLEM 213

Query: 314 GIEEKDK--EKAKRLCMVALWCVQDSPEDR 341
            +E  DK   +AK LC   L   Q  PE R
Sbjct: 214 AVEYPDKFSPEAKDLCEALL---QKDPEKR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 78.3 bits (193), Expect = 4e-16
 Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 23/205 (11%)

Query: 84  TRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVR 139
             +G G FG VY  +       +A+K ++ + G+ + E++   + EV  + +  H N + 
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQQLRHPNTIE 79

Query: 140 LYGFCHDQHMTA-LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            Y  C+ +  TA LV EY   GS    L   K+ ++  ++  I  G  +GL YLH   + 
Sbjct: 80  -YKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL----S 254
             IH DIK  N+LL    + K+ADFG A L     + V      GTP + APE +     
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDE 188

Query: 255 GNYPITHKCDVYSFGMVLFEIVGRR 279
           G Y    K DV+S G+   E+  R+
Sbjct: 189 GQY--DGKVDVWSLGITCIELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 14/200 (7%)

Query: 86  LGFGGFGEV----YKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG+V    Y  +  N G ++AVK L    G         E+  +   YH N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 141 YGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            G C +       L+ E++ +GSL  YL   K  I  ++  + A+   KG+ YL     +
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPE-FLSGN 256
           + +H D+   NVL+++    K+ DFGL K  + +K + T+     +P +  APE  +   
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188

Query: 257 YPITHKCDVYSFGMVLFEIV 276
           + I    DV+SFG+ L+E++
Sbjct: 189 FYIA--SDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 77.6 bits (191), Expect = 5e-16
 Identities = 71/203 (34%), Positives = 99/203 (48%), Gaps = 18/203 (8%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRL-Y 141
           LG GGFGEV   Q    G   A K LN  R   R   E  M E   + + +   +V L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK---GLVYLHEECQQ 198
            F   +    LV   M  G L  +++                 TA+   GL +LH   Q+
Sbjct: 61  AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QR 116

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLA-KLCD-RNKTHVTISGYKGTPGYSAPEFLSGN 256
           RII+ D+KPENVLLD + + +++D GLA +L D ++KT     GY GTPG+ APE L G 
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT----KGYAGTPGFMAPELLQGE 172

Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D ++ G+ L+E++  R
Sbjct: 173 -EYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 77.6 bits (192), Expect = 5e-16
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 39/213 (18%)

Query: 86  LGFGGFGEVYKGQFPN-GVKIAVKV------------LNRNLGRIAEEQFMAEVGTIGRT 132
           LG G +  VYK +    G  +A+K             +N    R  E + + E+      
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR--EIKLLQEL------ 59

Query: 133 YHINLVRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH--EIAIGTAKGL 189
            H N++ L   F H  ++  LV+E+ME   L+  +  K ++I           + T +GL
Sbjct: 60  KHPNIIGLLDVFGHKSNIN-LVFEFME-TDLEKVI--KDKSIVLTPADIKSYMLMTLRGL 115

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNKTHVTISGYKGTPG 246
            YLH      I+H D+KP N+L+ ++   K+ADFGLA+     +R  TH  +     T  
Sbjct: 116 EYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-----TRW 167

Query: 247 YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           Y APE L G        D++S G +  E++ R 
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 77.5 bits (191), Expect = 6e-16
 Identities = 69/229 (30%), Positives = 110/229 (48%), Gaps = 39/229 (17%)

Query: 137 LVRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
           +V  YG F  D  ++  + E+M+ GSLD  L  K   I    L +I+I   +GL YL E+
Sbjct: 61  IVGFYGAFYSDGEISICM-EHMDGGSLDQVL-KKAGRIPENILGKISIAVLRGLTYLREK 118

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLS 254
            +  I+H D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L 
Sbjct: 119 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQ 171

Query: 255 GNYPITHKCDVYSFGMVLFEI-VGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC 313
           G +  T + D++S G+ L E+ +GR              +P  +     K EL AM    
Sbjct: 172 GTH-YTVQSDIWSLGLSLVEMAIGR--------------YP--IPPPDAK-ELEAMF--- 210

Query: 314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPK 362
           G    + E  +    V+       P D P   A+ ++L+ +V   PPPK
Sbjct: 211 GRPVSEGEAKESHRPVS-----GHPPDSPRPMAIFELLDYIVNE-PPPK 253

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 77.3 bits (190), Expect = 6e-16
 Identities = 71/299 (23%), Positives = 125/299 (41%), Gaps = 50/299 (16%)

Query: 84  TRLGFGGFGEVYKGQ------FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL 137
             LG G FG+V K              +AVK+L  N         ++E   + +  H ++
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK-----------------------RAIE 174
           ++LYG C       L+ EY + GSL  +L   +                       RA+ 
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 175 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT 234
              L   A   ++G+ YL E    +++H D+   NVL+      K++DFGL++      +
Sbjct: 126 MGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP 294
           +V  S  +    + A E L  ++  T + DV+SFG++L+EIV       +G        P
Sbjct: 183 YVKRSKGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIV------TLGGNPYPGIAP 235

Query: 295 KHVWEEYEKCELGAMILGCGIE-EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
           + ++           +L  G   E+ +  ++ +  + L C +  P+ RP  + + K LE
Sbjct: 236 ERLFN----------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.3 bits (190), Expect = 9e-16
 Identities = 61/197 (30%), Positives = 95/197 (48%), Gaps = 12/197 (6%)

Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL E   +R+
Sbjct: 75  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRL 130

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL   ++      G K    + A E  L   Y  
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY-- 188

Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 189 THQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 20/210 (9%)

Query: 75  LNNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLN--RNLGRIAEEQFMAEVGTIGR 131
           L NF      ++G G F  VYK     +G  +A+K +     +   A +  + E+  + +
Sbjct: 1   LGNFK--IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQ 58

Query: 132 TYHINLVRLYGFCHDQHMTALVYEYMENGSLD---GYLFGKKRAIEWEKLHEIAIGTAKG 188
             H N+++      + +   +V E  + G L     +   +KR I    + +  +     
Sbjct: 59  LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 189 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK--GTPG 246
           L ++H    +RI+H DIKP NV + A    K+ D GL     R  +  T + +   GTP 
Sbjct: 119 LEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLG----RFFSSKTTAAHSLVGTPY 171

Query: 247 YSAPEFLSGN-YPITHKCDVYSFGMVLFEI 275
           Y +PE +  N Y    K D++S G +L+E+
Sbjct: 172 YMSPERIHENGY--NFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 59/197 (29%), Positives = 87/197 (44%), Gaps = 17/197 (8%)

Query: 85  RLGFGGFGEVYK-GQFPNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           R+G G  G V+K      G  +A+K V  R L      Q + E+  +    H  +V+L  
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 143 -FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
            F H      LV EYM    L   L  ++R +   ++        KG+ Y+H      I+
Sbjct: 67  VFPHGSGF-VLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIM 121

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCD----RNKTHVTISGYKGTPGYSAPEFLSGNY 257
           H D+KP N+L+ A+   K+ADFGLA+L      R  +H        T  Y APE L G  
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-----ATRWYRAPELLYGAR 176

Query: 258 PITHKCDVYSFGMVLFE 274
                 D+++ G +  E
Sbjct: 177 KYDPGVDLWAVGCIFAE 193

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 67/227 (29%), Positives = 96/227 (42%), Gaps = 47/227 (20%)

Query: 84  TRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHIN--- 136
             +G G FGEV+  +  +  ++ A+KVL ++   I   Q     AE     R    +   
Sbjct: 7   KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSD-MIKRNQIAHVRAE-----RDILADADS 60

Query: 137 --LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             +V+LY    D+    LV EYM  G L   L  K    E           A+ ++ L  
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE----ETARFYIAELVLALDS 116

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-----------------LCDRNKTHVT 237
             +   IH DIKP+N+L+DA+   K+ADFGL K                 L  R+   V 
Sbjct: 117 VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 238 ISGYK----------GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 274
              +K          GTP Y APE L G      +CD +S G++L+E
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 62/203 (30%), Positives = 84/203 (41%), Gaps = 37/203 (18%)

Query: 89  GGFGEVYKGQ-FPNGVKIAVKVL--------NRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           G FG VY  +    G   A+KVL        N+     AE   M     + +     + +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM-----MIQGESPYVAK 61

Query: 140 LYGFCHDQHMTALVYEYMENGSLD------GYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           LY     +    LV EY+  G         G L       +W K  +       G+  LH
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGL-----PEDWAK--QYIAEVVLGVEDLH 114

Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
              Q+ IIH DIKPEN+L+D     K+ DFGL++    NK  V      GTP Y APE +
Sbjct: 115 ---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETI 165

Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
            G        D +S G V+FE +
Sbjct: 166 LGV-GDDKMSDWWSLGCVIFEFL 187

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 15/197 (7%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG- 142
           LG G FG+VYK +    G   A KV+  ++   +  E +M E+  +    H  +V+L G 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYMVEIEILATCNHPYIVKLLGA 77

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           F  D  +  ++ E+   G++D  +    R +   ++  I     + L YLH     +IIH
Sbjct: 78  FYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIH 133

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL----SGNYP 258
            D+K  NVLL  +   K+ADFG++      KT      + GTP + APE +      + P
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191

Query: 259 ITHKCDVYSFGMVLFEI 275
             +K D++S G+ L E+
Sbjct: 192 YDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 68/228 (29%), Positives = 102/228 (44%), Gaps = 43/228 (18%)

Query: 81  NYSTRLGFGGFGEVY------------KGQFPNGVK-----IAVKVLNRNLGRIAEEQFM 123
           N+  +LG G FGEV+            K    N        +AVKVL  +    A E F+
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 124 AEVGTIGRTYHINLVRLYGFC-HDQHMTALVYEYMENGSLDGYL----------FGKKRA 172
            EV  + R    N+ RL G C  D  +  ++ EYMENG L+ +L              ++
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPL-CMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126

Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           + +  L  +A   A G+ YL        +H D+   N L+  N++ K+ADFG+     RN
Sbjct: 127 LSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGM----SRN 179

Query: 233 ---KTHVTISGYKGTP-GYSAPE-FLSGNYPITHKCDVYSFGMVLFEI 275
                +  + G    P  + A E  L G +  T K DV++FG+ L+EI
Sbjct: 180 LYSSDYYRVQGRAPLPIRWMAWESVLLGKF--TTKSDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 23/199 (11%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIA----EEQFMAEVGTIGRTYHINLVRL 140
           LG G FG V   +   +G   A+K+L++   +I      E  + E   +    H  LV L
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKA--KIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKR-AIEWEKLH--EIAIGTAKGLVYLHEECQ 197
           YG   D     LV EY+  G L  +L    R      + +  ++ +     L YLH    
Sbjct: 67  YGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----LEYLHSL-- 120

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY 257
             I++ D+KPEN+LLD++   K+ DFG AK     +T+ T+    GTP Y APE +  + 
Sbjct: 121 -DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTY-TLC---GTPEYLAPEIIL-SK 173

Query: 258 PITHKCDVYSFGMVLFEIV 276
                 D ++ G++++E++
Sbjct: 174 GYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 74/295 (25%), Positives = 127/295 (43%), Gaps = 41/295 (13%)

Query: 86  LGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FG+V+  +  N       + +AVK L ++    A + F  E   +    H ++V+
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF-----------GKKRAIEWE----KLHEIAIG 184
            YG C D     +V+EYM++G L+ +L            G+ R  + E    ++  IA  
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
            A G+VYL     Q  +H D+   N L+ AN   K+ DFG+++    +  +  + G+   
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYRVGGHTML 187

Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC 304
           P    P         T + DV+SFG++L+EI                 + K  W +    
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---------------YGKQPWFQLSNT 232

Query: 305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP 359
           E+   I    + E+ +   K +  + L C Q  P+ R  +  + K+L  + +  P
Sbjct: 233 EVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 77/291 (26%), Positives = 130/291 (44%), Gaps = 43/291 (14%)

Query: 86  LGFGGFGEVYKGQFP-NGVKI--AVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLY 141
           +G G FG+V +     +G+K+  A+K+L           F  E+  + +  +H N++ L 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 142 GFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRAIEWEKLHEIAIGTA 186
           G C ++    +  EY   G+L  +L                G    +  ++L + A   A
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG 246
            G+ YL E   ++ IH D+   NVL+  N + K+ADFGL++     + +V  +  +    
Sbjct: 130 TGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLPVR 183

Query: 247 YSAPEFLSGNYPI-THKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCE 305
           + A E L  NY + T K DV+SFG++L+EIV        G T +         E YEK  
Sbjct: 184 WMAIESL--NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---------ELYEKLP 232

Query: 306 LGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
            G  +      EK +     +  +   C +D P +RPP + +   L  ++E
Sbjct: 233 QGYRM------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 69/235 (29%), Positives = 105/235 (44%), Gaps = 49/235 (20%)

Query: 82  YSTRLGFGGFGEVY-----------KGQFPNGVK------IAVKVLNRNLGRIAEEQFMA 124
           +  +LG G FGEV+             QFP  V+      +AVK+L  +  + A   F+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 125 EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF----------------- 167
           EV  + R    N++RL G C D+    ++ EYMENG L+ +L                  
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 168 -GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 226
                AI +  L  +A+  A G+ YL        +H D+   N L+  N + K+ADFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 227 KLCDRN---KTHVTISGYKGTP-GYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 276
               RN     +  I G    P  + A E  L G +  T   DV++FG+ L+EI+
Sbjct: 186 ----RNLYAGDYYRIQGRAVLPIRWMAWECILMGKF--TTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 24/203 (11%)

Query: 86  LGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH-INLVRLYGF 143
           +G G FG V K      G  +AVK +   +    +++ + ++  + R+     +V+ YG 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 144 CHDQHMTALVYEYMENGSLDG-----YLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
              +    +  E M+  SLD      Y   K    E E L +IA+ T K L YL EE   
Sbjct: 72  LFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPE-EILGKIAVATVKALNYLKEEL-- 127

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLA-KLCDR-NKTHVTISGYKGTPGYSAPEFLSGN 256
           +IIH D+KP N+LLD N + K+ DFG++ +L D   KT        G   Y APE +  +
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA-----GCRPYMAPERIDPS 182

Query: 257 ----YPITHKCDVYSFGMVLFEI 275
               Y +  + DV+S G+ L+E+
Sbjct: 183 ARDGYDV--RSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.0 bits (181), Expect = 7e-15
 Identities = 73/292 (25%), Positives = 131/292 (44%), Gaps = 45/292 (15%)

Query: 86  LGFGGFGEVYKGQFP-NGVKI--AVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLY 141
           +G G FG+V K +   +G+++  A+K +     +     F  E+  + +  +H N++ L 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE----------------KLHEIAIGT 185
           G C  +    L  EY  +G+L  +L  K R +E +                +L   A   
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
           A+G+ YL +   ++ IH D+   N+L+  N+  K+ADFGL++     + +V  +  +   
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 175

Query: 246 GYSAPEFLSGNYPI-THKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC 304
            + A E L  NY + T   DV+S+G++L+EIV        G T +         E YEK 
Sbjct: 176 RWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------ELYEKL 224

Query: 305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
             G  +      EK       +  +   C ++ P +RP  + ++  L  ++E
Sbjct: 225 PQGYRL------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 74.2 bits (182), Expect = 8e-15
 Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 44/224 (19%)

Query: 85  RLGFGGFGEV----------YKGQFPNG-----VKIAVKVLNRNLGRIAEEQFMAEVGTI 129
           +LG G FGEV          + G+         V +AVK+L  ++ + A   F+ E+  +
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 130 GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE-------------WE 176
            R  + N++RL G C       ++ EYMENG L+ +L   +R IE               
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL--SQREIESTFTHANNIPSVSIA 129

Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN---K 233
            L  +A+  A G+ YL        +H D+   N L+  +++ K+ADFG++    RN    
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMS----RNLYSG 182

Query: 234 THVTISGYKGTP-GYSAPE-FLSGNYPITHKCDVYSFGMVLFEI 275
            +  I G    P  + A E  L G +  T   DV++FG+ L+E+
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKF--TTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 74.1 bits (182), Expect = 8e-15
 Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 16/199 (8%)

Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G +G VYK    P GV +A+K +   L      Q + E+  + +     +V  YG  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEW---EKLHEIAIGTAKGLVYLHEECQQRII 201
             +    +  EYM+ GSLD  L+    A E    + L  I     KGL +L EE    II
Sbjct: 69  FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI-- 259
           H D+KP NVL++ N   K+ DFG++     +     I    G   Y APE +    P   
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERIKSGGPNQN 181

Query: 260 ---THKCDVYSFGMVLFEI 275
              T + DV+S G+ + E+
Sbjct: 182 PTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 73.8 bits (182), Expect = 9e-15
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 18/199 (9%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYG 142
           ++G G F EV K Q    G   A+K + ++   + +   + E+  + R + H N++RL  
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 143 FCHDQHM--TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
              D+     ALV+E M+  +L   + G+KR +  +++        K L ++H   +  I
Sbjct: 66  VLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGI 121

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFL--SGNY 257
            H DIKPEN+L+  +   K+ADFG  + +  +      IS    T  Y APE L   G Y
Sbjct: 122 FHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTEYIS----TRWYRAPECLLTDGYY 176

Query: 258 PITHKCDVYSFGMVLFEIV 276
               K D+++ G V FEI+
Sbjct: 177 --GPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 64/194 (32%), Positives = 92/194 (47%), Gaps = 13/194 (6%)

Query: 85  RLGFGGFGEVYKGQFPNGVK--IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           R+G G FGEVYKG   N  K  +A+K+++        E    E+  + +     + R YG
Sbjct: 11  RIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
                    ++ EY+  GS    L  K   +E   +  I     KGL YLH E   R IH
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE---RKIH 124

Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            DIK  NVLL      K+ADFG+A +L D   T +  + + GTP + APE +  +     
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVIKQS-AYDF 180

Query: 262 KCDVYSFGMVLFEI 275
           K D++S G+   E+
Sbjct: 181 KADIWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 34/209 (16%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTY-----HINLVR 139
           LG G FG+V   +     ++ AVKVL +++  I ++  +    T  R       H  L +
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDV--ILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 140 LYGFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYL 192
           L      Q    L  V EY+  G L  ++     F + RA  +    EI +G    L +L
Sbjct: 61  L--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAA--EIVLG----LQFL 112

Query: 193 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYSAP 250
           HE   + II+ D+K +NVLLD+    K+ADFG+ K  +     T    S + GTP Y AP
Sbjct: 113 HE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT----STFCGTPDYIAP 165

Query: 251 EFLSGNYPITHKCDVYSFGMVLFE-IVGR 278
           E LS   P     D ++ G++L+E + G+
Sbjct: 166 EILSYQ-PYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 34/208 (16%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH-INLVRLYGF 143
           LG G +G V K +  P G  +AVK +   +    +++ + ++    R+      V  YG 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 144 CHDQHMTALVYEYMENGSLDGY---LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
              +    +  E M+  SLD +   ++ K   I  + L +IA+   K L YLH   +  +
Sbjct: 69  LFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSV 125

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY----------KGTPGYSAP 250
           IH D+KP NVL++ N   K+ DFG             ISGY           G   Y AP
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFG-------------ISGYLVDSVAKTIDAGCKPYMAP 172

Query: 251 EFLSGNYPITH---KCDVYSFGMVLFEI 275
           E ++          K DV+S G+ + E+
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 11/194 (5%)

Query: 86  LGFGGFGEVYKGQF---PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G FG V KG +      + +A+KVL     +   ++ M E   + +  +  +VR+ G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
            C  + +  LV E    G L+ +L GKK  I    + E+    + G+ YL     +  +H
Sbjct: 63  VCEAEALM-LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVH 118

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI-SGYKGTPGYSAPEFLSGNY-PIT 260
            D+   NVLL      K++DFGL+K    + ++    S  K    + APE +  N+   +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI--NFRKFS 176

Query: 261 HKCDVYSFGMVLFE 274
            + DV+S+G+ ++E
Sbjct: 177 SRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 79/311 (25%), Positives = 138/311 (44%), Gaps = 53/311 (17%)

Query: 70  FTSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKI--AVKVLNRNLGRIAEEQFMAEV 126
           +  L+ N+    +   +G G FG+V K +   +G+++  A+K +     +     F  E+
Sbjct: 1   YPVLEWNDI--KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 58

Query: 127 GTIGRT-YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT 185
             + +  +H N++ L G C  +    L  EY  +G+L  +L  K R +E +    IA  T
Sbjct: 59  EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANST 117

Query: 186 A----------------KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 229
           A                +G+ YL    Q++ IH D+   N+L+  N+  K+ADFGL++  
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-- 172

Query: 230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPI-THKCDVYSFGMVLFEIVGRRRNAIVGATE 288
              + +V  +  +    + A E L  NY + T   DV+S+G++L+EIV        G T 
Sbjct: 173 -GQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 229

Query: 289 SLDWFPKHVWEEYEKCELGAMI---LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMS 345
           +         E YEK   G  +   L C  E  D  +          C ++ P +RP  +
Sbjct: 230 A---------ELYEKLPQGYRLEKPLNCDDEVYDLMRQ---------CWREKPYERPSFA 271

Query: 346 AVIKMLEGVVE 356
            ++  L  ++E
Sbjct: 272 QILVSLNRMLE 282

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 15/206 (7%)

Query: 86  LGFGGFGEVYKG-QFPNGVKIAVK---VLNRNLGRIAEEQ------FMAEVGTIGRTYHI 135
           +G G +G VY       G  +AVK   +     GR    Q        +E+ T+    H+
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 136 NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
           N+V+  GF   +   ++  EY+  GS+ G         E + +        +GL YLH  
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRFFTEQVLEGLAYLH-- 125

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
             + I+H D+K +N+L+DA+   K++DFG++K  D    +      +G+  + APE +  
Sbjct: 126 -SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184

Query: 256 NYP-ITHKCDVYSFGMVLFEIVGRRR 280
                + K D++S G V+ E+   RR
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 17/198 (8%)

Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVL-----NRNLGRIAEEQFMAEVGTIGRTYHINLV 138
            +G G +G V K +    G  +A+K       + ++ + A    + EV  + +  H N+V
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA----LREVKVLRQLRHENIV 63

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            L      +    LV+EY+E   L+  L      +  + +        + + Y H     
Sbjct: 64  NLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNY 257
            IIH DIKPEN+L+  +   K+ DFG A+ L  R  + +T   Y  T  Y APE L G+ 
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT--DYVATRWYRAPELLVGDT 177

Query: 258 PITHKCDVYSFGMVLFEI 275
                 DV++ G ++ E+
Sbjct: 178 NYGKPVDVWAIGCIMAEL 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 11/196 (5%)

Query: 84  TRLGFGGFGEVYKG--QFPNGVK-IAVKVL-NRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
             LG G FG V KG  +     K +AVK+L N N     +++ + E   + +  +  +VR
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           + G C  +    LV E  E G L+ +L  K + +  + + E+    + G+ YL E     
Sbjct: 61  MIGICEAESWM-LVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLEE---TN 115

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNYP 258
            +H D+   NVLL      K++DFGL+K    ++ +     +   P  + APE ++  Y 
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN-YYK 174

Query: 259 ITHKCDVYSFGMVLFE 274
            + K DV+SFG++++E
Sbjct: 175 FSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 39/225 (17%)

Query: 82  YSTRLGFGGFGEVY-------------------KGQFPNGVKIAVKVLNRNLGRIAEEQF 122
           +  +LG G FGEV+                    G  P  V +AVK+L  +  + A   F
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQP--VLVAVKMLREDANKNARNDF 66

Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL----------FGKKRA 172
           + E+  + R    N++RL   C       ++ EYMENG L+ +L                
Sbjct: 67  LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126

Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           I +  L  +A   A G+ YL        +H D+   N L+  N++ K+ADFG+++     
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183

Query: 233 KTHVTISGYKGTP--GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
             +  I G    P    S    L G +  T   DV++FG+ L+EI
Sbjct: 184 D-YYRIQGRAVLPIRWMSWESILLGKF--TTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 71.5 bits (175), Expect = 5e-14
 Identities = 64/199 (32%), Positives = 98/199 (49%), Gaps = 13/199 (6%)

Query: 86  LGFGGFGEVYKGQFPN-GVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRL-Y 141
           LG GGFGEV   Q  N G   A K L+  R   +  E+  + E   + +     +V L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            F    H+  LV   M  G L  +++   +R +E E++   +     G+++LH      I
Sbjct: 61  AFESKTHL-CLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDI 116

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           ++ D+KPENVLLD   + +++D GLA      K   TI+   GT GY APE L    P +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILK-EEPYS 172

Query: 261 HKCDVYSFGMVLFEIVGRR 279
           +  D ++ G  ++E+V  R
Sbjct: 173 YPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 71.4 bits (175), Expect = 6e-14
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)

Query: 86  LGFGGFGEVYKGQF--PNGV--KIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG V +GQ    +G   K+AVK +          E+F++E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 141 YGFCHDQH------MTALVYEYMENGSLDGYLFGKKRA-----IEWEKLHEIAIGTAKGL 189
            G C +           ++  +M++G L  +L   +       +  + L +  +  A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
            YL     +  IH D+   N +L  + +  VADFGL+K       +      K    + A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            E L+     T K DV++FG+ ++EI  R
Sbjct: 184 IESLADRV-YTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 71.3 bits (175), Expect = 6e-14
 Identities = 70/289 (24%), Positives = 115/289 (39%), Gaps = 45/289 (15%)

Query: 84  TRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL 137
           T LG G FGEV+  +     +      + VK L +      + +F  E+    +  H N+
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKL------HEIAIGT--AKGL 189
           VRL G C +     ++ EY + G L  +L   K   E  K        ++A+ T  A G+
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK------LCDRNKTHVTISGYKG 243
            +L      R +H D+   N L+ +    KV+   L+K              + +     
Sbjct: 131 DHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR---- 183

Query: 244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK 303
              + APE +  +   + K DV+SFG++++E+              L  F     EE   
Sbjct: 184 ---WLAPEAVQED-DFSTKSDVWSFGVLMWEVF---------TQGELP-FYGLSDEEVLN 229

Query: 304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
             L A  L   + E    +  +L M   W V  +P+DRP  S ++  L 
Sbjct: 230 -RLQAGKLELPVPEGCPSRLYKL-MTRCWAV--NPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 70.8 bits (173), Expect = 7e-14
 Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 24/201 (11%)

Query: 86  LGFGGFGEVY--KGQFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYG 142
           +G G FG++Y  K +  +     +K ++     + E E    EV  + +  H N+V  + 
Sbjct: 8   IGEGSFGKIYLAKAKSDSE-HCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 143 FCHDQHMTALVYEYMENGSL-------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
              +     +V EY + G L        G LF + + + W    +I++G    L ++H+ 
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG----LKHIHD- 119

Query: 196 CQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS 254
             ++I+H DIK +N+ L  N    K+ DFG+A+    N +        GTP Y +PE + 
Sbjct: 120 --RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLSPE-IC 174

Query: 255 GNYPITHKCDVYSFGMVLFEI 275
            N P  +K D++S G VL+E+
Sbjct: 175 QNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.6 bits (173), Expect = 7e-14
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 29/206 (14%)

Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLN--RNLGRIAEE--QFMAEVGTIGRTYHINLVRL 140
           LG G FG VY       G ++AVK +    +     +E      E+  +    H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYL--FGK-----KRAIEWEKLHEIAIGTAKGLVYLH 193
           YG   D    ++  EYM  GS+   L  +G       R    + L         G+ YLH
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE--------GVEYLH 121

Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEF 252
                 I+H DIK  N+L D+  + K+ DFG +K      +  T +    GTP + +PE 
Sbjct: 122 S---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178

Query: 253 LSGNYPITH--KCDVYSFGMVLFEIV 276
           +SG     +  K DV+S G  + E++
Sbjct: 179 ISGE---GYGRKADVWSVGCTVVEML 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.8 bits (174), Expect = 8e-14
 Identities = 48/154 (31%), Positives = 79/154 (51%), Gaps = 21/154 (13%)

Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKG 188
           H N+VRL    H ++   LV+E++ +  L  Y+      G    +    L+++     +G
Sbjct: 57  HPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QG 111

Query: 189 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTP 245
           + Y H     R++H D+KP+N+L+D   + K+ADFGLA+   +  R  TH  +     T 
Sbjct: 112 IAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-----TL 163

Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            Y APE L G+   +   D++S G +  E+V RR
Sbjct: 164 WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 70.3 bits (172), Expect = 9e-14
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 13/200 (6%)

Query: 86  LGFGGFGEVY--KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY-G 142
           +G G FG V+  + +    + I  ++    + +        E   +    H N++  Y  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           F  D+ +  +V EY   G+L  Y+  +  ++  E    I     + L+ LH    + I+H
Sbjct: 68  FLEDKAL-MIVMEYAPGGTLAEYIQKRCNSLLDED--TILHFFVQILLALHHVHTKLILH 124

Query: 203 YDIKPENVLLDAN-FSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
            D+K +N+LLD +    K+ DFG++K L  ++K +  +    GTP Y +PE   G  P  
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV----GTPCYISPELCEGK-PYN 179

Query: 261 HKCDVYSFGMVLFEIVGRRR 280
            K D+++ G VL+E+   +R
Sbjct: 180 QKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 39/213 (18%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHINL 137
           ++G G +G VYK +    G  +A+K +     R+  E        + E+  +    H N+
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKI-----RLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK--------GL 189
           V+L    H ++   LV+E++ +  L       K+ ++   L  I +   K        GL
Sbjct: 62  VKLLDVIHTENKLYLVFEFL-HQDL-------KKFMDASPLSGIPLPLIKSYLFQLLQGL 113

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPG 246
            + H     R++H D+KP+N+L++   + K+ADFGLA+   +  R  TH  +     T  
Sbjct: 114 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLW 165

Query: 247 YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           Y APE L G    +   D++S G +  E+V RR
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 17/198 (8%)

Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQ---FMA--EVGTIGRTYHINLV 138
           +LG G +  VYKG+   NG  +A+KV+     R+ EE+   F A  E   +    H N+V
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVI-----RLQEEEGTPFTAIREASLLKGLKHANIV 66

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            L+   H +    LV+EY+    L  Y+      +  E +        +GL Y+H   Q+
Sbjct: 67  LLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QR 122

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
            I+H D+KP+N+L+      K+ADFGLA+   ++    T S    T  Y  P+ L G+  
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 259 ITHKCDVYSFGMVLFEIV 276
            +   D++  G +  E++
Sbjct: 181 YSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 30/204 (14%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAE---VGTIGRTYHINLVR 139
           LG G FG+V   ++   G   A+K L +   + R   E  M E     T     H  LV 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 140 LYG-FCHDQHMTALVYEYMENGSLDGYL----FGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           L+  F  + H+   V EY   G L  ++    F + RA+ +      A     GL YLHE
Sbjct: 67  LFACFQTEDHV-CFVMEYAAGGDLMMHIHTDVFSEPRAVFY------AACVVLGLQYLHE 119

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYSAPEF 252
               +I++ D+K +N+LLD     K+ADFGL K  +   ++T    S + GTP + APE 
Sbjct: 120 ---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT----STFCGTPEFLAPEV 172

Query: 253 LSG-NYPITHKCDVYSFGMVLFEI 275
           L+  +Y  T   D +  G++++E+
Sbjct: 173 LTETSY--TRAVDWWGLGVLIYEM 194

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 25/201 (12%)

Query: 102 GVKIAVKVLNRNLGRIAEE--QFMAEVGTIGRTYHINLVRLY--GFCHDQHMTALVYEYM 157
           G ++A+K+L  +      +  +F  E     R YH N+V L   G      + A V+EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYV 61

Query: 158 ENGSLDGYLF--GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL--- 212
              +L   L   G   A E  +L    +     L   H    Q I+H D+KP+N+++   
Sbjct: 62  PGRTLREVLAADGALPAGETGRL---MLQVLDALACAHN---QGIVHRDLKPQNIMVSQT 115

Query: 213 DANFSPKVADFGLAKLC----DRNKTHVTISG-YKGTPGYSAPEFLSGNYPITHKCDVYS 267
                 KV DFG+  L     D +   +T +    GTP Y APE L G  P+T   D+Y+
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGE-PVTPNSDLYA 174

Query: 268 FGMVLFE-IVGRRRNAIVGAT 287
           +G++  E + G+R   + GA+
Sbjct: 175 WGLIFLECLTGQR--VVQGAS 193

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 36/97 (37%), Positives = 56/97 (57%), Gaps = 12/97 (12%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD----RNKTHVTISGYK 242
           +GL YLH      I+H DIKP N+L+++N   K+ DFGLA++ +    ++ T   ++ Y 
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169

Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
               Y APE L G+   T   D++S G +  E++GRR
Sbjct: 170 ----YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 40/293 (13%)

Query: 86  LGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FG+V+  +  N       + +AVK L ++    A + F  E   +    H ++V+
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWE----------KLHEIAIGTAK 187
            YG C +     +V+EYM++G L+ +L   G    +  E          ++  IA   A 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT-HVTISGYKGTPG 246
           G+VYL     Q  +H D+   N L+  N   K+ DFG+++  D   T +  + G+   P 
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVGGHTMLPI 186

Query: 247 YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCEL 306
              P         T + DV+S G+VL+EI                 + K  W +    E+
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT---------------YGKQPWYQLSNNEV 231

Query: 307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP 359
              I    + ++ +   K +  + L C Q  P  R  +  +  +L+ + +  P
Sbjct: 232 IECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 57/197 (28%), Positives = 89/197 (45%), Gaps = 15/197 (7%)

Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEE--QFMA--EVGTIGRTYHINLVR 139
           +LG G +  VYKG    NG  +A+KV++       EE   F A  E   +    H N+V 
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMK----TEEGVPFTAIREASLLKGLKHANIVL 67

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L+   H +     V+EYM    L  Y+      +    +        +GL Y+H    Q 
Sbjct: 68  LHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQH 123

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I+H D+KP+N+L+      K+ADFGLA+   ++    T S    T  Y  P+ L G    
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181

Query: 260 THKCDVYSFGMVLFEIV 276
           +   D++  G +  E++
Sbjct: 182 SSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 68.4 bits (167), Expect = 4e-13
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 18/204 (8%)

Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           +G G FG+V  G+  +G    ++ VK L  +     + +F+ E        H NL++  G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRA----IEWEKLHEIAIGTAKGLVYLHEECQQ 198
            C +     LV E+   G L GYL   ++A     +   L  +A   A GL++LH   + 
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLS--- 254
             IH D+   N LL A+ + K+ D+GL+    +   +VT       P  + APE +    
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT-PDQLWVPLRWIAPELVDEVH 178

Query: 255 GNYPI---THKCDVYSFGMVLFEI 275
           GN  +   T + +V+S G+ ++E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 68.7 bits (168), Expect = 5e-13
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 40/214 (18%)

Query: 85  RLGFGGFGEVYKGQ--FPNGVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHIN 136
           ++G G +G VYK +    N   IA+K +     R+ +E        + E+  +    H N
Sbjct: 9   KIGEGTYGVVYKARDRVTNET-IALKKI-----RLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 137 LVRLYGFCHDQHMTALVYEYME-------NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGL 189
           +VRL    H +    LV+EY++       + S D   F K   +    L++I     +G+
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPD---FAKNPRLIKTYLYQIL----RGI 115

Query: 190 VYLHEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAK---LCDRNKTHVTISGYKGTP 245
            Y H     R++H D+KP+N+L+D    + K+ADFGLA+   +  R  TH  +     T 
Sbjct: 116 AYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-----TL 167

Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            Y APE L G+   +   D++S G +  E+V ++
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 15/200 (7%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-----FMAEVGTIGRTYHINLVR 139
           +LG G +  VYKG+     K+   ++     R+  E+      + EV  +    H N+V 
Sbjct: 13  KLGEGTYATVYKGR----SKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L+   H +    LV+EY++   L  YL     +I    +        +GL Y H   +++
Sbjct: 69  LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRK 124

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           ++H D+KP+N+L++     K+ADFGLA+   ++    T S    T  Y  P+ L G+   
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPDILLGSTDY 182

Query: 260 THKCDVYSFGMVLFEIVGRR 279
           + + D++  G + +E+   R
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 68.3 bits (167), Expect = 7e-13
 Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 12/198 (6%)

Query: 86  LGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLV 138
           LG G FG+V +       +    +K+AVK+L         E  M+E+  +     H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQ 197
            L G C       ++ EY   G L  +L  K+ + +  E L   +   AKG+ +L     
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---AS 159

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY 257
           +  IH D+   NVLL      K+ DFGLA+    +  +V     +    + APE +    
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219

Query: 258 PITHKCDVYSFGMVLFEI 275
             T + DV+S+G++L+EI
Sbjct: 220 -YTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 68.6 bits (167), Expect = 7e-13
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 27/205 (13%)

Query: 86  LGFGGFGEVYKGQFPNGVK----IAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLV 138
           +G G FG VY   F   V+    +A+K ++ + G+ + E++   + EV  + R  H N +
Sbjct: 33  IGHGSFGAVY---FARDVRTNEVVAIKKMSYS-GKQSNEKWQDIIKEVKFLQRIKHPNSI 88

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
              G    +H   LV EY   GS    L   K+ ++  ++  I  G  +GL YLH     
Sbjct: 89  EYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SH 144

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL----S 254
            +IH DIK  N+LL      K+ADFG A +     + V      GTP + APE +     
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVILAMDE 198

Query: 255 GNYPITHKCDVYSFGMVLFEIVGRR 279
           G Y    K DV+S G+   E+  R+
Sbjct: 199 GQY--DGKVDVWSLGITCIELAERK 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 44/287 (15%)

Query: 86  LGFGGFGEVYKGQFPNG---VKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLY 141
           LG G FG V +GQ       +K+AVK +   +   +E E F++E   +    H N++RL 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 142 GFCHDQHMT------ALVYEYMENGSLDGYLFGKKRA-----IEWEKLHEIAIGTAKGLV 190
           G C     +       ++  +M++G L  +L   +       +  + L +     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 191 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAP 250
           YL     +  IH D+   N +L+ N +  VADFGL+K       +      K    + A 
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 251 EFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI 310
           E L+ +   T K DV+SFG+ ++EI  R +    G   S         E Y+    G   
Sbjct: 184 ESLA-DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---------EIYDYLRQG--- 230

Query: 311 LGCGIEEKDKEKAKRLCMVALW-----CVQDSPEDRPPMSAVIKMLE 352
                   ++ K    C+  L+     C   +P+DRP    +   LE
Sbjct: 231 --------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 67.8 bits (165), Expect = 8e-13
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 23/210 (10%)

Query: 83  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 11  SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70

Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 187
           +VRL G       T ++ E M  G L  YL   +  +E          +K+ ++A   A 
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG--TP 245
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG    
Sbjct: 131 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 185

Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 186 RWMSPESLKDGVFTTYS-DVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 21/202 (10%)

Query: 86  LGFGGFGEVY--KGQFPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLY 141
           +G G FG VY       N V +AVK ++ +  +  E  +  + EV  + +  H N +   
Sbjct: 29  IGHGSFGAVYFATNSHTNEV-VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G    +H   LV EY   GS    L   K+ ++  ++  I  G  +GL YLH      +I
Sbjct: 88  GCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MI 143

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL----SGNY 257
           H DIK  N+LL      K+ADFG A       + V      GTP + APE +     G Y
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAMDEGQY 197

Query: 258 PITHKCDVYSFGMVLFEIVGRR 279
               K DV+S G+   E+  R+
Sbjct: 198 --DGKVDVWSLGITCIELAERK 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 67.9 bits (166), Expect = 9e-13
 Identities = 57/190 (30%), Positives = 94/190 (49%), Gaps = 39/190 (20%)

Query: 102 GVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTA----LVYE 155
           G ++AVK ++ R   R   E    EV  I R Y H N+V +Y      ++      +V E
Sbjct: 44  GRQVAVKKMDLRKQQR--RELLFNEV-VIMRDYQHPNIVEMY----SSYLVGDELWVVME 96

Query: 156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQQRIIHYDIKPENV 210
           ++E G+L          +   +++E  I T      K L +LH    Q +IH DIK +++
Sbjct: 97  FLEGGAL-------TDIVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSI 146

Query: 211 LLDANFSPKVADFG----LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVY 266
           LL ++   K++DFG    ++K   R K+ V      GTP + APE +S   P   + D++
Sbjct: 147 LLTSDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPEVIS-RLPYGTEVDIW 199

Query: 267 SFGMVLFEIV 276
           S G+++ E+V
Sbjct: 200 SLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 7/196 (3%)

Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +  V+KG+       +A+K +       A    + EV  +    H N+V L+  
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            H +    LV+EY+++  L  YL      +    +        +GL Y H+   ++I+H 
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHR 127

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKC 263
           D+KP+N+L++     K+ADFGLA+   ++    T S    T  Y  P+ L G+   +   
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185

Query: 264 DVYSFGMVLFEIVGRR 279
           D++  G +L+E+   R
Sbjct: 186 DMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 11/195 (5%)

Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI---NLVRLY 141
           +G G +G VY+G   P G  +A+K++N +           EV  + +       N+ + Y
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         ++ EY E GS+   +  K   I  + +  I       L Y+H   +  +I
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYISVIIREVLVALKYIH---KVGVI 123

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DIK  N+L+    + K+ DFG+A L   N+     S + GTP + APE ++       
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181

Query: 262 KCDVYSFGMVLFEIV 276
           K D++S G+ ++E+ 
Sbjct: 182 KADIWSLGITIYEMA 196

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 63/273 (23%), Positives = 109/273 (39%), Gaps = 33/273 (12%)

Query: 86  LGFGGFGE--VYKGQFPNGVKIAVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHINLVRL 140
           LG G FGE  +Y+    + + +  +V   NL R++E++    + E+  +    H N++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEV---NLTRLSEKERRDALNEIVILSLLQHPNIIAY 64

Query: 141 YGFCHDQHMTALVYEYMENGSL-DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           Y    D +   +  EY   G+L D  +  K +  E E +          + Y+H+     
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---G 121

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG-NYP 258
           I+H DIK  N+ L      K+ DFG++K+     +        GTP Y +PE   G  Y 
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA--ETVVGTPYYMSPELCQGVKY- 178

Query: 259 ITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK 318
              K D+++ G VL+E++  +R                 ++      L   I+       
Sbjct: 179 -NFKSDIWALGCVLYELLTLKR----------------TFDATNPLNLVVKIVQGNYTPV 221

Query: 319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML 351
               +  L  +    +Q  PE RP    V+   
Sbjct: 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 26/207 (12%)

Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHINL 137
           ++G G +G VYKG+    G  +A+K +     R+  E+       + E+  +    H N+
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKI-----RLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 138 VRLYGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
           V L      +    L++E++    L  YL    K + ++ E +        +G+++ H  
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH-- 118

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEF 252
             +R++H D+KP+N+L+D     K+ADFGLA+   +  R  TH  +     T  Y APE 
Sbjct: 119 -SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-----TLWYRAPEV 172

Query: 253 LSGNYPITHKCDVYSFGMVLFEIVGRR 279
           L G+   +   D++S G +  E+  ++
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 23/199 (11%)

Query: 85  RLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G FGEV+KG      K+ A+K+++        E    E+  + +     + + YG 
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 144 CHDQHMTALVYEYMENGS-LDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQ 197
                   ++ EY+  GS LD         +E   L E  I T      KGL YLH E  
Sbjct: 71  YLKDTKLWIIMEYLGGGSALD--------LLEPGPLDETQIATILREILKGLDYLHSE-- 120

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
            + IH DIK  NVLL  +   K+ADFG+A +L D   T +  + + GTP + APE +  +
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVIKQS 176

Query: 257 YPITHKCDVYSFGMVLFEI 275
                K D++S G+   E+
Sbjct: 177 -AYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 68/225 (30%), Positives = 101/225 (44%), Gaps = 50/225 (22%)

Query: 86  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 131
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 82

Query: 132 TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 176
             H N++ L G C       ++ EY   G+L  YL  ++                 + ++
Sbjct: 83  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA    R+  H 
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHH- 192

Query: 237 TISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            I  YK T        + APE L      TH+ DV+SFG++L+EI
Sbjct: 193 -IDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 61/195 (31%), Positives = 91/195 (46%), Gaps = 11/195 (5%)

Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTY-HINLVRLY 141
           +G G FG+V   +   +G   AVKVL +   L +  +   MAE   + +   H  LV L+
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
                      V +Y+  G L  +L  ++  +E  +    A   A  + YLH      II
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE-PRARFYAAEVASAIGYLH---SLNII 118

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           + D+KPEN+LLD+     + DFGL K  +  +   T S + GTP Y APE L    P   
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKE-PYDR 175

Query: 262 KCDVYSFGMVLFEIV 276
             D +  G VL+E++
Sbjct: 176 TVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 70/225 (31%), Positives = 103/225 (45%), Gaps = 50/225 (22%)

Query: 86  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 132
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 79

Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA---------- 182
            H N++ L G C       ++ EY   G+L  YL  + R    E  ++IA          
Sbjct: 80  -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDIARVPDEQMTFK 137

Query: 183 ------IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
                    A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  D N    
Sbjct: 138 DLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVN---- 188

Query: 237 TISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            I  YK T        + APE L  +   TH+ DV+SFG++++EI
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 63/197 (31%), Positives = 93/197 (47%), Gaps = 15/197 (7%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTY-HINLVRLY 141
           +G G FG+V   +     K  AVKVL +   L +  ++  MAE   + +   H  LV L+
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE-KLHEIAIGTAKGLVYLHEECQQRI 200
                      V +Y+  G L  +L  ++   E   + +   I +A G  YLH      I
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS---LNI 117

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKL-CDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I+ D+KPEN+LLD+     + DFGL K   + +KT  T   + GTP Y APE L    P 
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST---FCGTPEYLAPEVLRKQ-PY 173

Query: 260 THKCDVYSFGMVLFEIV 276
               D +  G VL+E++
Sbjct: 174 DRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 39/225 (17%)

Query: 82  YSTRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI 135
           Y   +G G FG V++ + P  +       +AVK+L        +  F  E   +    H 
Sbjct: 9   YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68

Query: 136 NLVRLYGFCHDQHMTALVYEYMENGSLDGYL---------------------FGKKRAIE 174
           N+V+L G C       L++EYM  G L+ +L                           + 
Sbjct: 69  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128

Query: 175 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDR 231
             +   IA   A G+ YL E   ++ +H D+   N L+  N   K+ADFGL++     D 
Sbjct: 129 CTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185

Query: 232 NKTHVTISGYKGTP-GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            K     S     P  +  PE +  N   T + DV+++G+VL+EI
Sbjct: 186 YK----ASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 48/142 (33%), Positives = 70/142 (49%), Gaps = 10/142 (7%)

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
            Y F  D+    LV EY   G L   L  +      E + +  +  A+ ++ +H   Q  
Sbjct: 67  QYAF-QDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYL--AELVLAIHSVHQMG 122

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL---SGN 256
            +H DIKPENVL+D     K+ADFG A     NK  V      GTP Y APE L   +G+
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPEVLTTMNGD 181

Query: 257 YPITH--KCDVYSFGMVLFEIV 276
              T+  +CD +S G++ +E++
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMI 203

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 66.1 bits (161), Expect = 4e-12
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 40/285 (14%)

Query: 86  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 138
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 72

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 189
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG--TPGY 247
            YL+    ++ +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG     +
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 187

Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG 307
            APE L      T   D++SFG+VL+EI         G +           E+  K    
Sbjct: 188 MAPESLKDGVFTTSS-DMWSFGVVLWEITSLAEQPYQGLSN----------EQVLK---- 232

Query: 308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
             ++  G  ++     +R+  +   C Q +P+ RP    ++ +L+
Sbjct: 233 -FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 22/204 (10%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYGF 143
           +G G +G+VYKG+    G   A+KV++  +    EE+   E+  + + ++H N+   YG 
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 144 C-------HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEE 195
                   HD  +  LV E+   GS+   +   K  A++ + +  I     +GL +LH  
Sbjct: 82  FIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH-- 138

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS- 254
              ++IH DIK +NVLL  N   K+ DFG++   DR  T    + + GTP + APE ++ 
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIAC 195

Query: 255 ---GNYPITHKCDVYSFGMVLFEI 275
               +    ++ D++S G+   E+
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 23/199 (11%)

Query: 85  RLGFGGFGEVYKGQFPNGVK--IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           R+G G FGEV+KG   N  +  +A+K+++        E    E+  + +     + + YG
Sbjct: 11  RIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQ 197
                    ++ EY+  GS    L    RA  ++   E  I T      KGL YLH E  
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLL----RAGPFD---EFQIATMLKEILKGLDYLHSE-- 120

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
            + IH DIK  NVLL      K+ADFG+A +L D   T +  + + GTP + APE +  +
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVIQQS 176

Query: 257 YPITHKCDVYSFGMVLFEI 275
                K D++S G+   E+
Sbjct: 177 -AYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 24/201 (11%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGR----IAEEQFMAEVGTIGRTYHINLVR 139
           R+G G +G+VYK +    G   AVK++    G     I +E FM     +    H N+V 
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFM-----VKECKHCNIVA 70

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
            +G    +    +  EY   GSL   ++     +   ++  +   T +GL YLH + +  
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGK-- 127

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK---GTPGYSAPEF--LS 254
            +H DIK  N+LL  N   K+ADFG+A      K   TI+  K   GTP + APE   + 
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAA-----KITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 255 GNYPITHKCDVYSFGMVLFEI 275
            N      CD+++ G+   E+
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 17/196 (8%)

Query: 86  LGFGGFGEVYKGQFPNGVK-IAVKVLN-RNLGRIAEEQFM-AEVGTIGRTYHINLVRLYG 142
           +G G FG V+  +        A+KV+    + R+ +EQ +  E   +    H  ++RL+ 
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA-IGTAKGLVYLHEECQQRII 201
             HDQ    ++ EY+  G L  YL    R      L   + I  A  L YLH    + I+
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA--LEYLH---SKEIV 123

Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           + D+KPEN+LLD     K+ DFG AK L DR  T        GTP Y APE +  +    
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC------GTPEYLAPEVI-QSKGHN 176

Query: 261 HKCDVYSFGMVLFEIV 276
              D ++ G++++E++
Sbjct: 177 KAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.1 bits (161), Expect = 5e-12
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 48/224 (21%)

Query: 86  LGFGGFGEVYKG-------QFPN-GVKIAVKVL-----NRNLGRIAEEQFMAEVGTIGRT 132
           LG G FG+V +          P+  V +AVK+L     +++L  +  E  + ++  IG+ 
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKL--IGK- 76

Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK-----RAIEWEKLHE------- 180
            H N++ L G C  +    ++ EY   G+L  +L  ++        +  K+ E       
Sbjct: 77  -HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 181 ---IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
               A   A+G+ YL     +R IH D+   NVL+  +   K+ADFGLA+       H  
Sbjct: 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLAR-----GVH-D 186

Query: 238 ISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
           I  YK T        + APE L  +   TH+ DV+SFG++++EI
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALF-DRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 27/211 (12%)

Query: 86  LGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FG+V+  +  N       + +AVK L +     A + F  E   +    H ++VR
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTVLQHQHIVR 71

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF-----------GKKRA---IEWEKLHEIAIGT 185
            YG C +     +V+EYM +G L+ +L            G+  A   +   ++  IA   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT-HVTISGYKGT 244
           A G+VYL        +H D+   N L+      K+ DFG+++  D   T +  + G    
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRTML 186

Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
           P    P         T + D++SFG+VL+EI
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 65.5 bits (160), Expect = 8e-12
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 5/94 (5%)

Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT--ISGYKGTP 245
           GL Y+H      ++H D+KP N+L++A+   K+ DFGLA+    N       ++ Y  T 
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            Y APE +      T   DV+S G +L E++GR+
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 67/224 (29%), Positives = 103/224 (45%), Gaps = 48/224 (21%)

Query: 86  LGFGGFGEVY--------KGQFPNGVKIAVKVL-----NRNLGRIAEEQFMAEVGTIGRT 132
           LG G FG+V         K +    V +AVK+L     +++L  +  E  M ++  IG+ 
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKM--IGK- 76

Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 177
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 77  -HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
           L   A   A+G+ YL     Q+ IH D+   NVL+  +   K+ADFGLA+       H  
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DVH-N 186

Query: 238 ISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
           I  YK T        + APE L  +   TH+ DV+SFG++L+EI
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 64.9 bits (158), Expect = 8e-12
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 20/220 (9%)

Query: 86  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRL 140
           LG G FG V + Q      +  K+AVK+L  ++   ++ E+F+ E   +    H N+++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 141 YGFCHDQH------MTALVYEYMENGSLDGYLFGKKRA-----IEWEKLHEIAIGTAKGL 189
            G            +  ++  +M++G L  +L   +       +  + L    I  A G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
            YL     +  IH D+   N +L+ N +  VADFGL+K       +      K    + A
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183

Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES 289
            E L+ N   TH  DV++FG+ ++EI+ R +    G   S
Sbjct: 184 LESLADNVYTTHS-DVWAFGVTMWEIMTRGQTPYAGVENS 222

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 65.0 bits (159), Expect = 9e-12
 Identities = 63/229 (27%), Positives = 96/229 (41%), Gaps = 39/229 (17%)

Query: 79  TSNY--STRLGFGGFGEVYKG-QFPNGVKIAVK-VLNRNLGRIAEEQF----MAEVGTIG 130
             +Y    +LG G FGEVYK  Q   G  +A+K +L  N     ++ F    + E+  + 
Sbjct: 7   LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN----EKDGFPITALREIKILK 62

Query: 131 RTYHINLVRLYGFCHDQHMTA--------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
           +  H N+V L     ++   +        +V  YM++  L G L      +   ++    
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYM 121

Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK 242
           +   +G+ YLHE     I+H DIK  N+L+D     K+ADFGLA+  D    +       
Sbjct: 122 LQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN---PKGG 175

Query: 243 GTPG------------YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           G  G            Y  PE L G    T   D++  G V  E+  RR
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 20/203 (9%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYGF 143
           +G G +G+VYKG+    G   A+KV++  +    EE+   E+  + + ++H N+   YG 
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 144 CHDQHMTA------LVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEEC 196
              ++         LV E+   GS+   +   K   ++ E +  I     +GL +LH   
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 128

Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS-- 254
           Q ++IH DIK +NVLL  N   K+ DFG++   DR  T    + + GTP + APE ++  
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIACD 186

Query: 255 GNYPITH--KCDVYSFGMVLFEI 275
            N   T+  K D++S G+   E+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 18/217 (8%)

Query: 65  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNG--VKIAVKVLNRN--LGRIAEE 120
           ++P R   ++  +F  N+   LG G FG V    + N     +A+K   ++  + +   +
Sbjct: 19  KEPKRKNKMKYEDF--NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD 76

Query: 121 QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE 180
              +E   +    H   V LYG   D+    LV E++  G    +L   KR       ++
Sbjct: 77  HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP-----ND 131

Query: 181 IAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS 239
           +    A  +V + E  Q   I++ D+KPEN+LLD +   K+ DFG AK+ D  +T+    
Sbjct: 132 VGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-TRTYTLC- 189

Query: 240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
              GTP Y APE L  N       D ++ G+ ++EI+
Sbjct: 190 ---GTPEYIAPEILL-NVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 63/196 (32%), Positives = 89/196 (45%), Gaps = 13/196 (6%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTY-HINLVRLY 141
           +G G FG+V   +     K  AVKVL +   L +  E+  M+E   + +   H  LV L+
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
                      V +Y+  G L  Y   ++R     +    A   A  L YLH      I+
Sbjct: 63  FSFQTADKLYFVLDYINGGEL-FYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIV 118

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH-VTISGYKGTPGYSAPEFLSGNYPIT 260
           + D+KPEN+LLD+     + DFG   LC  N  H  T S + GTP Y APE L    P  
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFG---LCKENIEHNGTTSTFCGTPEYLAPEVLHKQ-PYD 174

Query: 261 HKCDVYSFGMVLFEIV 276
              D +  G VL+E++
Sbjct: 175 RTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 64.1 bits (156), Expect = 1e-11
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 18/204 (8%)

Query: 86  LGFGGFGEVYKGQFPNGVKIA---VKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           +G G FG+V  G+   G+  A   VK L  +     +  F+ EV       H N+++  G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAI----EWEKLHEIAIGTAKGLVYLHEECQQ 198
            C +     LV E+   G L  YL   +  +    + + L  +A   A GL++LH   Q 
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNY 257
             IH D+   N  L A+ S K+ D+GLA L    + +         P  + APE +    
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 258 P------ITHKCDVYSFGMVLFEI 275
                   T K +++S G+ ++E+
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 79/266 (29%), Positives = 111/266 (41%), Gaps = 53/266 (19%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVL--NRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG GGFGEV   Q    G   A K L   R   R  E   + E   + +     +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 143 FCHDQHMTALVYEYMENGSLDGYL-------FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
               +    LV   M  G L  ++       F + RA+ +      A     GL  LH+E
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY------AAEICCGLEDLHQE 121

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV----TISGYKGTPGYSAPE 251
              RI++ D+KPEN+LLD +   +++D GLA        HV    TI G  GT GY APE
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLA-------VHVPEGQTIKGRVGTVGYMAPE 171

Query: 252 FLSGNYPITHKCDVYSFGMVLFEIVG------RRRNAIVGATESLDWFPKHVWEEYEKCE 305
            +  N   T   D ++ G +L+E++       +R+  I    E ++   K V EEY    
Sbjct: 172 VVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEVQEEY---- 224

Query: 306 LGAMILGCGIEEKDKEKAKRLCMVAL 331
                      EK    A+ LC + L
Sbjct: 225 ----------SEKFSPDARSLCKMLL 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 64.5 bits (158), Expect = 1e-11
 Identities = 51/171 (29%), Positives = 72/171 (42%), Gaps = 36/171 (21%)

Query: 134 HINLVRLYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK---- 187
           H N+VRL      +   +  +V+EYM++  L G L             +      K    
Sbjct: 57  HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLD--------SPEVKFTESQIKCYMK 107

Query: 188 ----GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVT---IS 239
               GL YLH      I+H DIK  N+L++ +   K+ADFGLA     RN    T   I 
Sbjct: 108 QLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI- 163

Query: 240 GYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATE 288
               T  Y  PE L G   Y    + D++S G +L E+    +    G+TE
Sbjct: 164 ----TLWYRPPELLLGATRY--GPEVDMWSVGCILAELF-LGKPIFQGSTE 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 21/202 (10%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRLY 141
           +G G FG VY  +   N   +A+K ++ + G+ + E++   + EV  + +  H N ++  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G    +H   LV EY   GS    L   K+ ++  ++  +  G  +GL YLH      +I
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMI 137

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL----SGNY 257
           H D+K  N+LL      K+ DFG A +       V      GTP + APE +     G Y
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDEGQY 191

Query: 258 PITHKCDVYSFGMVLFEIVGRR 279
               K DV+S G+   E+  R+
Sbjct: 192 --DGKVDVWSLGITCIELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 35/221 (15%)

Query: 86  LGFGGFGEVYKGQFPN-GVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYG 142
           +G GG GEVY    P    ++A+K +  +L    + +++F+ E        H  +V +Y 
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKL-HEIAIGTAKG--LVYLHEECQ-- 197
            C D         Y+E  +L   L   K   + E L  E+A  T+ G  L   H+ C   
Sbjct: 70  ICSDGDPVYYTMPYIEGYTLKSLL---KSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126

Query: 198 -----QRIIHYDIKPENVLLDANFSPKV-ADFGLAKLC----------DRNKTHV----- 236
                + ++H D+KP+N+LL   F   V  D+G A             D ++ ++     
Sbjct: 127 EYVHSKGVLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185

Query: 237 TISG-YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
           TI G   GTP Y APE L G  P +   D+Y+ G++L++++
Sbjct: 186 TIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 63.8 bits (155), Expect = 1e-11
 Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 43/213 (20%)

Query: 85  RLGFGGFGEVY-----KGQFPNGVK----IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI 135
           RLG G FG VY     K      +K    I V  LN N       Q   E   + +  H 
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPN----ETVQANQEAQLLSKLDHP 62

Query: 136 NLVRLYGFCHDQHMTALVYEYMENGSLD---------GYLFGKKRAIEWEKLHEIAIGTA 186
            +V+ +    ++    ++ EY E   LD         G    + +  EW       I   
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW------FIQLL 116

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL----CDRNKTHVTISGYK 242
            G+ Y+H   Q+RI+H D+K +N+ L  N   K+ DFG+++L    CD   T      + 
Sbjct: 117 LGVHYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT------FT 166

Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
           GTP Y +PE L  +     K D++S G +L+E+
Sbjct: 167 GTPYYMSPEALK-HQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 13/219 (5%)

Query: 65  EKPVR-FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEE 120
           EK VR    LQ+     +    +G G FGEV   +  +  K+ A+K+L++   + R    
Sbjct: 29  EKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSA 88

Query: 121 QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE 180
            F  E   +       +V+L+    D     +V EYM  G L   +       +W K + 
Sbjct: 89  FFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFY- 147

Query: 181 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG 240
               TA+ ++ L       +IH D+KP+N+LLD +   K+ADFG     D     V    
Sbjct: 148 ----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDT 202

Query: 241 YKGTPGYSAPEFLS---GNYPITHKCDVYSFGMVLFEIV 276
             GTP Y +PE L    G+     +CD +S G+ LFE++
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 34/208 (16%)

Query: 84  TRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEE--QFMAEVGTIGRTYHINLVRL 140
           T++G GG+G+V+  +  +  +I A+K + ++L     E    + E   +  T    LV+L
Sbjct: 7   TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66

Query: 141 -YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE----- 194
            Y F  D+++  L  EY+  G     L           L E     A+   Y+ E     
Sbjct: 67  LYAFQDDEYLY-LAMEYVPGGDFRTLLNNLG------VLSE---DHAR--FYMAEMFEAV 114

Query: 195 -ECQQR-IIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPE 251
               +   IH D+KPEN L+DA+   K+ DFGL+K +     + V      G+P Y APE
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV------GSPDYMAPE 168

Query: 252 FLSG-NYPITHKCDVYSFGMVLFE-IVG 277
            L G  Y      D +S G +L+E + G
Sbjct: 169 VLRGKGY--DFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 29/204 (14%)

Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQ---FMA--EVGTIGRTYHINLV 138
           +LG G +  VYKG+    G  +A+K +     R+  E+   F A  E   +    H N+V
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEI-----RLEHEEGAPFTAIREASLLKDLKHANIV 66

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT---AKGLVYLHEE 195
            L+   H +    LV+EY++   L  Y+      +    +H + +      +GL Y H  
Sbjct: 67  TLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGL---SMHNVRLFLFQLLRGLAYCH-- 120

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK---THVTISGYKGTPGYSAPEF 252
            Q+R++H D+KP+N+L+      K+ADFGLA    R K   +  T S    T  Y  P+ 
Sbjct: 121 -QRRVLHRDLKPQNLLISERGELKLADFGLA----RAKSVPSK-TYSNEVVTLWYRPPDV 174

Query: 253 LSGNYPITHKCDVYSFGMVLFEIV 276
           L G+   +   D++  G + +E+ 
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMA 198

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 5/95 (5%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT--ISGYKGT 244
           +GL Y+H      +IH D+KP N+L++ +   ++ DFG+A+    + T     ++ Y  T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
             Y APE L      T   D++S G +  E++GRR
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 66/209 (31%), Positives = 95/209 (45%), Gaps = 31/209 (14%)

Query: 86  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLVRLYG- 142
           +G G +G+VYK     +G   AVK+L+       +E+  AE   +     H N+V+ YG 
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGM 87

Query: 143 FCHDQHMTA----LVYEYMENGS----LDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           F     +      LV E    GS    + G L   +R  E   +  I  G   GL +LH 
Sbjct: 88  FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE-AMISYILYGALLGLQHLH- 145

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGL-AKLCD---RNKTHVTISGYKGTPGYSAP 250
               RIIH D+K  N+LL      K+ DFG+ A+L     R  T V      GTP + AP
Sbjct: 146 --NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV------GTPFWMAP 197

Query: 251 EFLSG----NYPITHKCDVYSFGMVLFEI 275
           E ++     +Y    +CDV+S G+   E+
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 51/200 (25%), Positives = 93/200 (46%), Gaps = 15/200 (7%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-----FMAEVGTIGRTYHINLVR 139
           +LG G +  V+KG+     K+   ++     R+  E+      + EV  +    H N+V 
Sbjct: 13  KLGEGTYATVFKGR----SKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L+   H      LV+EY++   L  Y+      +    +        +GL Y H   +++
Sbjct: 69  LHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRK 124

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           ++H D+KP+N+L++     K+ADFGLA+   ++    T S    T  Y  P+ L G+   
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182

Query: 260 THKCDVYSFGMVLFEIVGRR 279
           + + D++  G + FE+   R
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 42/137 (30%), Positives = 69/137 (50%), Gaps = 11/137 (8%)

Query: 149 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE 208
           M ALV +Y   G L   +  + +     + HE  +   + L+ +H    + +IH DIK  
Sbjct: 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172

Query: 209 NVLLDANFSPKVADFGLAKLCDRNKTHVTISG-----YKGTPGYSAPEFLSGNYPITHKC 263
           N+LL +N   K+ DFG +K+        T+S      + GTP Y APE      P + K 
Sbjct: 173 NILLCSNGLVKLGDFGFSKM-----YAATVSDDVGRTFCGTPYYVAPEIWR-RKPYSKKA 226

Query: 264 DVYSFGMVLFEIVGRRR 280
           D++S G++L+E++  +R
Sbjct: 227 DMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 59/202 (29%), Positives = 89/202 (44%), Gaps = 25/202 (12%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G +G VY  +     V+IA+K +     R  +     E+       H N+V+  G  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHSYLKHRNIVQYLGSD 74

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWE--KLHEIAIG-----TAKGLVYLHEECQ 197
            +     +  E +  GSL   L  K     W   K +E  I        +GL YLH+   
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSK-----WGPLKDNEQTIIFYTKQILEGLKYLHD--- 126

Query: 198 QRIIHYDIKPENVLLDANFSP--KVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLS 254
            +I+H DIK +NVL++  +S   K++DFG +K L   N    T   + GT  Y APE + 
Sbjct: 127 NQIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTET---FTGTLQYMAPEVID 182

Query: 255 -GNYPITHKCDVYSFGMVLFEI 275
            G        D++S G  + E+
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEM 204

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 17/199 (8%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI-NLVRLYGF 143
           +G G  G+VYK +F   G  +AVK + R   +   ++ + ++  + +++    +V+ YG+
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                   +  E M    LD  L   +  I  + L ++ +   K L YL E+    +IH 
Sbjct: 83  FITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHR 139

Query: 204 DIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLS-----GNY 257
           D+KP N+LLDA+ + K+ DFG++ +L D +K     +   G   Y APE +        Y
Sbjct: 140 DVKPSNILLDASGNVKLCDFGISGRLVD-SKAK---TRSAGCAAYMAPERIDPPDPNPKY 195

Query: 258 PITHKCDVYSFGMVLFEIV 276
            I  + DV+S G+ L E+ 
Sbjct: 196 DI--RADVWSLGISLVELA 212

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 65/272 (23%), Positives = 118/272 (43%), Gaps = 25/272 (9%)

Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           ++G G F EVY+     +GV +A+K +     +   A    + E+  + +  H N+++ Y
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68

Query: 142 GFCHDQHMTALVYEYMENGSLDGYL--FGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
               + +   +V E  + G L   +  F K KR I  + + +  +     L ++H    +
Sbjct: 69  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SR 125

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
           R++H DIKP NV + A    K+ D GL +      T        GTP Y +PE +  N  
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN-G 182

Query: 259 ITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK 318
              K D++S G +L+E+    ++   G   +L    K +    E+C+   +         
Sbjct: 183 YNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKI----EQCDYPPL--------P 229

Query: 319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM 350
               ++ L  +   C+   PE RP ++ V  +
Sbjct: 230 SDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 63.7 bits (156), Expect = 4e-11
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 12/98 (12%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTP 245
           +GL YLH      +IH D+KP N+L+++N   K+ DFGLA+ +         ++ Y  T 
Sbjct: 114 RGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170

Query: 246 GYSAPEFL--SGNY--PITHKCDVYSFGMVLFEIVGRR 279
            Y APE L  S  Y   I    D++S G +  E++ R+
Sbjct: 171 WYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 22/199 (11%)

Query: 86  LGFGGFGEVYKGQFPNG-VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY-GF 143
           +G G FG     Q  N   K A+K +       A E    E   + +  H N+V     F
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 144 CHDQHMTALVYEYMENGSL-------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
             D H+  +V EY + G L        G LF +   ++W       +    G+ ++HE  
Sbjct: 68  EADGHLY-IVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHE-- 118

Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
            +R++H DIK +N+ L  N   K+ DFG A+L      +     Y GTP Y  PE    N
Sbjct: 119 -KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWE-N 174

Query: 257 YPITHKCDVYSFGMVLFEI 275
            P  +K D++S G +L+E+
Sbjct: 175 MPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 24/217 (11%)

Query: 86  LGFGGFGEVYKGQFPN-GVKIAVKVL----NRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           +G G +G VYK + P+ G  +A+K +    N +   ++  + +A +  +    H N+VRL
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 141 YGFCH----DQHM-TALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHE 194
              C     D+     LV+E+++   L  YL       +  E + ++     +GL +LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL--CDRNKTHVTISGYKGTPGYSAPEF 252
            C   I+H D+KPEN+L+ +    K+ADFGLA++  C    T V +     T  Y APE 
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV-----TLWYRAPEV 178

Query: 253 LSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES 289
           L  +   T   D++S G +  E+  RR+    G +E+
Sbjct: 179 LLQSTYAT-PVDMWSVGCIFAEMF-RRKPLFCGNSEA 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 62.9 bits (153), Expect = 5e-11
 Identities = 66/232 (28%), Positives = 105/232 (45%), Gaps = 21/232 (9%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE--EQFMAEVGTIG-RTYHINLVRLY 141
           LG G FG+V   +     +  A+K L +++    +  E  M E   +     H  L  L+
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 142 -GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
             F   +H+   V EY+  G L  ++    R  +  +    A     GL +LH   ++ I
Sbjct: 63  CTFQTKEHLF-FVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KKGI 117

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           I+ D+K +NVLLD +   K+ADFG+ K     +     S + GTP Y APE L G     
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPEILKGQ-KYN 174

Query: 261 HKCDVYSFGMVLFE-IVGRRRNAIVGATESLD-------WFPKHVWEEYEKC 304
              D +SFG++L+E ++G+         E  D        FP+ + +E + C
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDC 226

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 18/198 (9%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIA----VKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           ++G G +G V+K +     +I     V++ + + G       + E+  +    H N+VRL
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG--VPSSALREICLLKELKHKNIVRL 64

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y   H      LV+EY +   L  Y       I+ E +        KGL + H      +
Sbjct: 65  YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNV 120

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG---TPGYSAPEFLSGNY 257
           +H D+KP+N+L++ N   K+ADFGLA+        + +  Y     T  Y  P+ L G  
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLAR-----AFGIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 258 PITHKCDVYSFGMVLFEI 275
             +   D++S G +  E+
Sbjct: 176 LYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 16/199 (8%)

Query: 84  TRLGFGGFGEVYKGQF-PNGVKIAVKVL-----NRNLGRIAEEQFMAEVGTIGRTYHINL 137
           +++G G +G V+K +    G  +A+K       +  + +IA    + E+  + +  H NL
Sbjct: 7   SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA----LREIRMLKQLKHPNL 62

Query: 138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
           V L      +    LV+EY ++  L+  L    R +    + +I   T + + + H   +
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDHTVLN-ELEKNPRGVPEHLIKKIIWQTLQAVNFCH---K 118

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY 257
              IH D+KPEN+L+      K+ DFG A++        T   Y  T  Y APE L G+ 
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT--DYVATRWYRAPELLVGDT 176

Query: 258 PITHKCDVYSFGMVLFEIV 276
                 DV++ G V  E++
Sbjct: 177 QYGPPVDVWAIGCVFAELL 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 25/202 (12%)

Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTY-HINLVRLY 141
           LG G FG+V+  +        A+K L +++  + +  E  M E   +   + H  L  LY
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 142 GFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
                +     V EY+  G L  ++     F   RA  +    EI  G    L +LH   
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAA--EIICG----LQFLH--- 113

Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYSAPEFLS 254
            + I++ D+K +N+LLD +   K+ADFG+ K  +    KT      + GTP Y APE L 
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT----CTFCGTPDYIAPEILL 169

Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
           G        D +SFG++L+E++
Sbjct: 170 GQ-KYNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 22/201 (10%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE-------EQFMAEVGTIGRTYHINL 137
           +G GGFGEVY  +  +  K+ A+K L++   ++ +       E+ M  + + G    I +
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI-V 60

Query: 138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
              Y F H       + + M  G L  Y   +      +++   A     GL ++H    
Sbjct: 61  CMTYAF-HTPDKLCFILDLMNGGDLH-YHLSQHGVFSEKEMRFYATEIILGLEHMH---N 115

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCD--RNKTHVTISGYKGTPGYSAPEFLSG 255
           + +++ D+KP N+LLD +   +++D GLA  CD  + K H ++    GT GY APE L  
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV----GTHGYMAPEVLQK 169

Query: 256 NYPITHKCDVYSFGMVLFEIV 276
                   D +S G +LF+++
Sbjct: 170 GTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 23/204 (11%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTI--GRTYHINLVRL 140
           +G G FGEV   +  +  +I A+K+LN+   L R     F  E   +  G    I  +  
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH- 67

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           Y F  + ++  LV +Y   G L   L  F  +   +  + +      A+ ++ +H   Q 
Sbjct: 68  YAFQDENYLY-LVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVLAIHSIHQL 121

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS---- 254
             +H DIKP+NVLLD N   ++ADFG     +++ T V  S   GTP Y +PE L     
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMED 180

Query: 255 --GNYPITHKCDVYSFGMVLFEIV 276
             G Y    +CD +S G+ ++E++
Sbjct: 181 GMGKY--GPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 30/204 (14%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLY-G 142
           +G G +GEV   +   +G +  +K LN RN  R   +    E   + +  H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 143 FCHDQHMTALVYEYMENGSL-------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
           +  +  +  +V  + E G L        G L  + + +EW       +  A  L YLHE+
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQYLHEK 121

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKL----CDRNKTHVTISGYKGTPGYSAPE 251
               I+H D+K +NV L      KV D G+A++    CD   T +      GTP Y +PE
Sbjct: 122 ---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI------GTPYYMSPE 172

Query: 252 FLSGNYPITHKCDVYSFGMVLFEI 275
             S N P  +K DV++ G  ++E+
Sbjct: 173 LFS-NKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 9/95 (9%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG 246
           +GL Y+H      ++H D+KP N+LL+AN   K+ DFGLA+    ++    ++ Y  T  
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRW 173

Query: 247 YSAPEFL--SGNYPITHKCDVYSFGMVLFEIVGRR 279
           Y APE L     Y  T   DV+S G +  E++GR+
Sbjct: 174 YRAPELLLNCSEY--TTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 14/198 (7%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVR-L 140
           ++G G F EVY+     +   +A+K +     +   A +  + E+  + +  H N+++ L
Sbjct: 9   KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68

Query: 141 YGFCHDQHMTALVYEYMENGSLDG---YLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
             F  D  +  +V E  + G L     Y   +KR I    + +  +     + ++H    
Sbjct: 69  DSFIEDNELN-IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---S 124

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY 257
           +R++H DIKP NV + A    K+ D GL +      T        GTP Y +PE +  N 
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN- 181

Query: 258 PITHKCDVYSFGMVLFEI 275
               K D++S G +L+E+
Sbjct: 182 GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 52/160 (32%), Positives = 84/160 (52%), Gaps = 10/160 (6%)

Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H  LV L+     +     V EY+  G L  ++  ++R +  E     +   +  L YLH
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNYLH 113

Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
           E   + II+ D+K +NVLLD+    K+ D+G+ K   R     T S + GTP Y APE L
Sbjct: 114 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEIL 168

Query: 254 SG-NYPITHKCDVYSFGMVLFEIV-GRRRNAIVGATESLD 291
            G +Y  +   D ++ G+++FE++ GR    IVG++++ D
Sbjct: 169 RGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPD 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 30/204 (14%)

Query: 86  LGFGGFGEVYKGQFPN-GVKIAVKVL-----NRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           +G G +G V K +    G  +A+K       ++ + +IA    M E+  + +  H NLV 
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIA----MREIRMLKQLRHENLVN 64

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L      +    LV+E++++  LD  L      ++  ++ +      +G+ + H      
Sbjct: 65  LIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCH---SHN 120

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG-------YKGTPGYSAPEF 252
           IIH DIKPEN+L+  +   K+ DFG A+         T++        Y  T  Y APE 
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFAR---------TLAAPGEVYTDYVATRWYRAPEL 171

Query: 253 LSGNYPITHKCDVYSFGMVLFEIV 276
           L G+       D+++ G ++ E++
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEML 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 22/205 (10%)

Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVL--------NRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +G G FG VY G    +G  +AVK +        +++  R   +    E+  +    H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G   D     +  EY+  GS+   L  +G   A E   +        KGL YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLH- 123

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG----YKGTPGYSAP 250
              + IIH DIK  N+L+D     K++DFG++K  + N      +G     +G+  + AP
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 251 EFLSGNYPITHKCDVYSFGMVLFEI 275
           E +      T K D++S G ++ E+
Sbjct: 182 EVVKQTS-YTRKADIWSLGCLVVEM 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 59/195 (30%), Positives = 92/195 (47%), Gaps = 11/195 (5%)

Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTY-HINLVRLY 141
           +G G FG+V   +   +G   AVKVL +   L R  ++  MAE   + +   H  LV L+
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
                      V +++  G L  +L  ++R+    +    A   A  L YLH      I+
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHL-QRERSFPEPRARFYAAEIASALGYLH---SINIV 118

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           + D+KPEN+LLD+     + DFGL K  +      T + + GTP Y APE +    P  +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQ-PYDN 175

Query: 262 KCDVYSFGMVLFEIV 276
             D +  G VL+E++
Sbjct: 176 TVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 77/261 (29%), Positives = 108/261 (41%), Gaps = 43/261 (16%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVL--NRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG GGFGEV   Q    G   A K L   R   R  E   + E   + +     +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 143 FCHDQHMTALVYEYMENGSLDGYL-------FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
               +    LV   M  G L  ++       F ++RA+ +    EI  G    L  LH E
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA--EITCG----LEDLHRE 121

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
              RI++ D+KPEN+LLD     +++D GLA      +   TI G  GT GY APE +  
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVK- 174

Query: 256 NYPITHKCDVYSFGMVLFEIVG-----RRRNAIVGATESLDWFPKHVWEEYEKCELGAMI 310
           N   T   D +  G +++E++      R+R   V   E ++   K   EEY         
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVERRVKEDQEEY--------- 224

Query: 311 LGCGIEEKDKEKAKRLCMVAL 331
                 EK  E A+ +C   L
Sbjct: 225 -----SEKFSEAARSICRQLL 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRL- 140
           LG G FG+V   +     K  A+K+L + +  IA+++    + E   +  T H  L  L 
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEV-IIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y F         V EY   G L  +L  ++R    ++           L YLH      +
Sbjct: 62  YSF-QTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALGYLHS---CDV 116

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
           ++ D+K EN++LD +   K+ DFGL K  + D          + GTP Y APE L  N  
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM----KTFCGTPEYLAPEVLEDN-D 171

Query: 259 ITHKCDVYSFGMVLFEIV-GR 278
                D +  G+V++E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 8/96 (8%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV-TISGYKGTP 245
           +GL Y+H      ++H D+KP N+LL+ N   K+ DFGLA++ D    H   ++ Y  T 
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 246 GYSAPEFL--SGNYPITHKCDVYSFGMVLFEIVGRR 279
            Y APE +  S  Y  T   D++S G +L E++  R
Sbjct: 174 WYRAPEIMLNSKGY--TKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 35/96 (36%), Positives = 55/96 (57%), Gaps = 6/96 (6%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDR--NKTHVTISGYKG 243
           K L Y+H      +IH D+KP N+LL+++   K+ADFGLA+ L +   N  +  ++ Y  
Sbjct: 118 KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           T  Y APE L G+   T   D++S G +L E++  +
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 20/202 (9%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHINL 137
           R+G G +G VY+ +   +G  +A+K +     R+  E+       + E+  +    H N+
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKV-----RMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 138 VRLYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
           V L      +H+ +  LV EY E   L   L          ++  + +   +GL YLHE 
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
               IIH D+K  N+LL      K+ADFGLA+        +T      T  Y APE L G
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLLG 182

Query: 256 NYPITHKCDVYSFGMVLFEIVG 277
               T   D+++ G +L E++ 
Sbjct: 183 CTTYTTAIDMWAVGCILAELLA 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 18/215 (8%)

Query: 71  TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNR-NLGRIAEEQFMAEVGT 128
           T L++     +    +G G FGEV   +  +  ++ A+K+L++  + + ++  F  E   
Sbjct: 36  TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 129 IGRTYHIN---LVRL-YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG 184
           I    H N   +V+L Y F  D+++  +V EYM  G L   +       +W + +   + 
Sbjct: 96  I--MAHANSEWIVQLHYAFQDDKYLY-MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVV 152

Query: 185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
            A  L  +H       IH D+KP+N+LLD +   K+ADFG     D N   V      GT
Sbjct: 153 LA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGT 206

Query: 245 PGYSAPEFL---SGNYPITHKCDVYSFGMVLFEIV 276
           P Y +PE L    G+     +CD +S G+ L+E++
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 60.2 bits (146), Expect = 4e-10
 Identities = 38/98 (38%), Positives = 56/98 (57%), Gaps = 12/98 (12%)

Query: 180 EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH-VTI 238
           EIAIG    L +LH    + II+ D+K +NV+LDA    K+ADFG   +C  N     T 
Sbjct: 109 EIAIG----LFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFG---MCKENIFGGKTT 158

Query: 239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
             + GTP Y APE ++   P     D ++FG++L+E++
Sbjct: 159 RTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 61/197 (30%), Positives = 95/197 (48%), Gaps = 15/197 (7%)

Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTY-HINLVRLY 141
           LG G FG+V   +    G   AVK L +++  I +  E  M E   +   + +  L  LY
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
                +     V E++  G L  ++  K R  +  +    A     GL +LH    + II
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLH---SKGII 118

Query: 202 HYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           + D+K +NV+LD +   K+ADFG+ K  +   N+     S + GTP Y APE L G    
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA----STFCGTPDYIAPEILQG-LKY 173

Query: 260 THKCDVYSFGMVLFEIV 276
           T   D +SFG++L+E++
Sbjct: 174 TFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 50/181 (27%), Positives = 92/181 (50%), Gaps = 19/181 (10%)

Query: 101 NGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN 159
            G ++AVK ++ R   R   E    EV  +   +H N+V +Y          +V E++E 
Sbjct: 46  TGKQVAVKKMDLRKQQR--RELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103

Query: 160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK 219
           G+L   +   +  +  E++  + +   + L YLH    Q +IH DIK +++LL ++   K
Sbjct: 104 GALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIK 158

Query: 220 VADFG----LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
           ++DFG    ++K   + K+ V      GTP + APE +S   P   + D++S G+++ E+
Sbjct: 159 LSDFGFCAQVSKEVPKRKSLV------GTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEM 211

Query: 276 V 276
           +
Sbjct: 212 I 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 22/201 (10%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE-------EQFMAEVGTIGRTYHINL 137
           +G GGFGEVY  +  +  K+ A+K L++   ++ +       E+ M  + + G    I +
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI-V 60

Query: 138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
              Y F H     + + + M  G L  Y   +       ++   A     GL ++H    
Sbjct: 61  CMSYAF-HTPDKLSFILDLMNGGDLH-YHLSQHGVFSEAEMRFYAAEIILGLEHMH---N 115

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCD--RNKTHVTISGYKGTPGYSAPEFLSG 255
           + +++ D+KP N+LLD +   +++D GLA  CD  + K H ++    GT GY APE L  
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV----GTHGYMAPEVLQK 169

Query: 256 NYPITHKCDVYSFGMVLFEIV 276
                   D +S G +LF+++
Sbjct: 170 GVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 26/203 (12%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEE--QFMAEVGTIGRTYHIN---LVR 139
           +G G FG+VY+ +  +  +I A+KVL++      +E    + E   + RT       +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 140 L-YGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           L + F  D  +  LV +YM  G L  +L     F + RA  +  + E+ +     L +LH
Sbjct: 61  LKFSFQTDSDLY-LVTDYMSGGELFWHLQKEGRFSEDRAKFY--IAELVLA----LEHLH 113

Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL-CDRNKTHVTISGYKGTPGYSAPEF 252
           +     I++ D+KPEN+LLDA     + DFGL+K     NKT  T   + GT  Y APE 
Sbjct: 114 K---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT---FCGTTEYLAPEV 167

Query: 253 LSGNYPITHKCDVYSFGMVLFEI 275
           L      T   D +S G+++FE+
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 20/203 (9%)

Query: 86  LGFGGFGEVY----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY--HIN--- 136
           LG G +G+V+     G    G   A+KVL +    I ++   AE     R     +    
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKK--ATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 137 -LVRL-YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
            LV L Y F  D  +  L+ +Y+  G L  +L+ ++         E+ +  A+ ++ L  
Sbjct: 66  FLVTLHYAFQTDTKLH-LILDYVNGGELFTHLYQREHF----TESEVRVYIAEIVLALDH 120

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS 254
             Q  II+ DIK EN+LLD+     + DFGL+K     +     S + GT  Y APE + 
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIR 179

Query: 255 GNYPITHKC-DVYSFGMVLFEIV 276
           G      K  D +S G++ FE++
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 54/182 (29%), Positives = 94/182 (51%), Gaps = 21/182 (11%)

Query: 101 NGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYME 158
           +G ++AVK+++ R   R   E    EV  I R Y H N+V +Y          ++ E+++
Sbjct: 45  SGRQVAVKMMDLRKQQR--RELLFNEV-VIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101

Query: 159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP 218
            G+L   +  + R  E E++  +     + L YLH    Q +IH DIK +++LL  +   
Sbjct: 102 GGALTD-IVSQTRLNE-EQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRV 156

Query: 219 KVADFG----LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 274
           K++DFG    ++K   + K+ V      GTP + APE +S   P   + D++S G+++ E
Sbjct: 157 KLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVIS-RTPYGTEVDIWSLGIMVIE 209

Query: 275 IV 276
           +V
Sbjct: 210 MV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 12/197 (6%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           +G G FGEV   +  +  K+ A+K+L++   + R     F  E   +       +V+L+ 
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
              D     +V EYM  G L   +       +W + +     TA+ ++ L        IH
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIH 165

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS---GNYPI 259
            D+KP+N+LLD +   K+ADFG     ++    V      GTP Y +PE L    G+   
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYY 224

Query: 260 THKCDVYSFGMVLFEIV 276
             +CD +S G+ L+E++
Sbjct: 225 GRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 47/142 (33%), Positives = 76/142 (53%), Gaps = 10/142 (7%)

Query: 152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVL 211
            V E++  G L  +   ++R +  E     +   +  L +LHE   + II+ D+K +NVL
Sbjct: 73  FVIEFVSGGDL-MFHMQRQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVL 128

Query: 212 LDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG-NYPITHKCDVYSFGM 270
           LDA    K+ D+G+ K   R     T S + GTP Y APE L G +Y  +   D ++ G+
Sbjct: 129 LDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPEILRGEDYGFS--VDWWALGV 184

Query: 271 VLFEIV-GRRRNAIVGATESLD 291
           ++FE++ GR    IVG +++ D
Sbjct: 185 LMFEMMAGRSPFDIVGMSDNPD 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 7/90 (7%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG 246
           +GL YLH    QRIIH D+K EN+ ++      + D G A+            G  GT  
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLAGTVE 221

Query: 247 YSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            +APE L+ +     K D++S G+VLFE++
Sbjct: 222 TNAPEVLARD-KYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 13/199 (6%)

Query: 86  LGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTIGRTYHINLVRL-Y 141
           LG G FG+V    +   G   A+K+L + +    +E    + E   +  + H  L  L Y
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 142 GF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            F  HD+     V EY   G L  +L  ++R    ++           L YLH E  + +
Sbjct: 63  SFQTHDR--LCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALDYLHSE--KNV 117

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           ++ D+K EN++LD +   K+ DFGL K  +  K   T+  + GTP Y APE L  N    
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDN-DYG 174

Query: 261 HKCDVYSFGMVLFEIVGRR 279
              D +  G+V++E++  R
Sbjct: 175 RAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 20/199 (10%)

Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRL 140
           R+G G +G+VYK +  N G   A+KV+    G    E F     E+  +    H N+V  
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEPG----EDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           +G    +    +  E+   GSL   ++     +   ++  ++  T +GL YLH + +   
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGK--- 127

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS----GN 256
           +H DIK  N+LL  N   K+ADFG++       T      + GTP + APE  +    G 
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 257 YPITHKCDVYSFGMVLFEI 275
           Y     CD+++ G+   E+
Sbjct: 186 Y--NQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 28/210 (13%)

Query: 86  LGFGGFGEVYKGQ-FPNG--------VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +G G +G+V+K +   NG        V++        L  I E   +  + T     H N
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPN 65

Query: 137 LVRLYGFC------HDQHMTALVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGL 189
           +VRL+  C       +  +T LV+E+++   L  YL    +  +  E + ++     +GL
Sbjct: 66  VVRLFDVCTVSRTDRETKLT-LVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
            +LH     R++H D+KP+N+L+ ++   K+ADFGLA++       + ++    T  Y A
Sbjct: 124 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRA 177

Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           PE L  +   T   D++S G +  E+  R+
Sbjct: 178 PEVLLQSSYAT-PVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 77/271 (28%), Positives = 112/271 (41%), Gaps = 63/271 (23%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG GGFGEV   Q    G   A K L +   RI + +        G    +N  R+    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKK--RIKKRK--------GEAMALNEKRILEKV 57

Query: 145 HDQHMTALVYEY------------MENGSLDGYL-------FGKKRAIEWEKLHEIAIGT 185
           + + + +L Y Y            M  G L  ++       F ++RAI +      A   
Sbjct: 58  NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY------AAEL 111

Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
             GL  L  E   RI++ D+KPEN+LLD     +++D GLA      +   T+ G  GT 
Sbjct: 112 CCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTV 165

Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-----RRRNAIVGATESLDWFPKHVWEE 300
           GY APE ++ N   T   D +  G +++E++      R+R   V   E +D   K   EE
Sbjct: 166 GYMAPEVIN-NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEVDRRVKEDQEE 223

Query: 301 YEKCELGAMILGCGIEEKDKEKAKRLCMVAL 331
           Y               EK  E AK +C + L
Sbjct: 224 Y--------------SEKFSEDAKSICRMLL 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 35/211 (16%)

Query: 86  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLVRLYGF 143
           +G G +G+V+K     NG K AVK+L+  +  I EE   AE   +   + H N+V+ YG 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEE-IEAEYNILKALSDHPNVVKFYGM 83

Query: 144 CHDQHMTA-----LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIG-----TAKGLVYL 192
            + + +       LV E    GS+   + G  KR    E++ E  I         GL +L
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG---ERMEEPIIAYILHEALMGLQHL 140

Query: 193 HEECQQRIIHYDIKPENVLLDANFSPKVADFGL-AKLCD---RNKTHVTISGYKGTPGYS 248
           H     + IH D+K  N+LL      K+ DFG+ A+L     R  T V      GTP + 
Sbjct: 141 HV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV------GTPFWM 191

Query: 249 APEFLSGNYPI----THKCDVYSFGMVLFEI 275
           APE ++    +      +CDV+S G+   E+
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 19/158 (12%)

Query: 125 EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL-------DGYLFGKKRAIEWEK 177
           EV  +    H N+V+      +     +V +Y E G L        G LF + + ++W  
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW-- 106

Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
                +     L ++H+   ++I+H DIK +N+ L  + + K+ DFG+A++   N T   
Sbjct: 107 ----FVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVEL 157

Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
                GTP Y +PE    N P  +K D+++ G VL+E+
Sbjct: 158 ARTCIGTPYYLSPEICE-NRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 19/181 (10%)

Query: 101 NGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN 159
           +G  +AVK ++ R   R   E    EV  +    H N+V +Y          +V E++E 
Sbjct: 44  SGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101

Query: 160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK 219
           G+L   +   +  +  E++  + +   K L  LH    Q +IH DIK +++LL  +   K
Sbjct: 102 GALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVK 156

Query: 220 VADFG----LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
           ++DFG    ++K   R K+ V      GTP + APE +S   P   + D++S G+++ E+
Sbjct: 157 LSDFGFCAQVSKEVPRRKSLV------GTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEM 209

Query: 276 V 276
           V
Sbjct: 210 V 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 16/200 (8%)

Query: 86  LGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRL- 140
           LG G FG+V    +   G   A+K+L + +  IA+++    + E   +  T H  L  L 
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEV-IIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 141 YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           Y F  HD+     V EY   G L  +L  ++R    E+           L YLH    + 
Sbjct: 62  YAFQTHDR--LCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH---SRD 115

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           +++ DIK EN++LD +   K+ DFGL K    +    T+  + GTP Y APE L  N   
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN-DY 172

Query: 260 THKCDVYSFGMVLFEIVGRR 279
               D +  G+V++E++  R
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 70/210 (33%), Positives = 102/210 (48%), Gaps = 38/210 (18%)

Query: 86  LGFGGFGEVY---KGQFPNGVKI-AVKVLN-----RNLGRIAEEQFMAEVGTIGRTYHIN 136
           LG GG+G+V+   K    +  KI A+KVL      RN    A  +  AE   +    H  
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNILEAVKHPF 61

Query: 137 LVRL-YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK-----LHEIAIGTAKGLV 190
           +V L Y F     +  L+ EY+  G L  +L  ++  I  E      L EI++     L 
Sbjct: 62  IVDLIYAFQTGGKLY-LILEYLSGGELFMHL--EREGIFMEDTACFYLSEISLA----LE 114

Query: 191 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYS 248
           +LH   QQ II+ D+KPEN+LLDA    K+ DFGL K  + +   TH     + GT  Y 
Sbjct: 115 HLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT----FCGTIEYM 167

Query: 249 APEFL--SGNYPITHKCDVYSFGMVLFEIV 276
           APE L  SG+       D +S G ++++++
Sbjct: 168 APEILMRSGH---GKAVDWWSLGALMYDML 194

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 37/230 (16%)

Query: 60  QEIGR---EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL- 114
           +E+ +   E P R+TSL           ++G G +G V        G K+A+K L+R   
Sbjct: 4   EEVNKTVWELPERYTSL----------KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ 53

Query: 115 GRIAEEQFMAEVGTIGRTYHINLVRLYGF------CHDQHMTALVYEYMEN--GSLDGYL 166
             I  ++   E+  +    H N++ L           +     LV  YM+     + G+ 
Sbjct: 54  SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP 113

Query: 167 FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 226
             +      +K+  +      GL Y+H      IIH D+KP N+ ++ +   K+ DFGLA
Sbjct: 114 LSE------DKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA 164

Query: 227 KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
           +  D   T     GY  T  Y APE +          D++S G ++ E++
Sbjct: 165 RHADAEMT-----GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 66/232 (28%), Positives = 97/232 (41%), Gaps = 48/232 (20%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHINLVRLY 141
           +G G FGEV   Q  +   I A+K L R    + +EQ     AE   +    +  +V+LY
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
               D++   L+ EY+  G +   L  K    E E    IA  T   +  +H   +   I
Sbjct: 68  YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIH---KLGYI 123

Query: 202 HYDIKPENVLLDANFSPKVADFGLAK--------LCDRNKTHVTISGYK----------- 242
           H DIKP+N+LLDA    K++DFGL             R  +H   S +            
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183

Query: 243 -----------------GTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 276
                            GTP Y APE FL   Y    +CD +S G++++E++
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY--NKECDWWSLGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)

Query: 86  LGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRLY 141
           LG G FG+V    +  +G   A+K+L + +  IA+++    + E   +  T H  L  L 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEV-IIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
                +     V EY+  G L  +L  ++R    ++           L YLH     +I+
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGAEIVSALDYLH---SGKIV 117

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           + D+K EN++LD +   K+ DFGL K  +      T+  + GTP Y APE L  N     
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDN-DYGR 174

Query: 262 KCDVYSFGMVLFEIVGRR 279
             D +  G+V++E++  R
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 42/129 (32%), Positives = 70/129 (54%), Gaps = 13/129 (10%)

Query: 152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEI--AIGTAKGLVYLHEECQQRIIHYDIKPEN 209
            V EY+  G L   ++  ++   +++ H +  A   A GL +LH    + II+ D+K +N
Sbjct: 78  FVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDN 131

Query: 210 VLLDANFSPKVADFGLAKLCDRNK-THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSF 268
           V+LD+    K+ADFG   +C  N    VT   + GTP Y APE ++   P     D ++F
Sbjct: 132 VMLDSEGHIKIADFG---MCKENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAF 187

Query: 269 GMVLFEIVG 277
           G++L+E++ 
Sbjct: 188 GVLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 47/144 (32%), Positives = 73/144 (50%), Gaps = 9/144 (6%)

Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
           LV L+          LV EY+  G L  ++  ++R +  E     A      L +LHE  
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIALNFLHE-- 114

Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG- 255
            + II+ D+K +NVLLDA+   K+ D+G+ K  +      T S + GTP Y APE L G 
Sbjct: 115 -RGIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGE 171

Query: 256 NYPITHKCDVYSFGMVLFEIVGRR 279
            Y  +   D ++ G+++FE++  R
Sbjct: 172 EYGFS--VDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           +G G FGEV   +  N  K+ A+K+LN+   L R     F  E   +    +  +  L+ 
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68

Query: 143 FCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
              D++   LV +Y   G L   L  F  +   +  + +      A+ ++ +    Q   
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVIAIDSVHQLHY 123

Query: 201 IHYDIKPENVLLDANFSPKVADFG-LAKLCDRNKTHVTISGYKGTPGYSAPEFLS----G 255
           +H DIKP+N+L+D N   ++ADFG   KL +      +++   GTP Y +PE L     G
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEDG 181

Query: 256 NYPITHKCDVYSFGMVLFEIV 276
                 +CD +S G+ ++E++
Sbjct: 182 KGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 27/216 (12%)

Query: 82  YSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHIN 136
           +   LG   FG++YKG  +  G+  A  V  + L  I   Q    F  E   +   +H N
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK----------------KRAIEWEKLHE 180
           +V L G    +    +++EY+  G L  +L  +                K +++      
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 181 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG 240
           IAI  A G+ YL        +H D+   N+L+      K++D GL++       +     
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 241 YKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEI 275
                 +  PE  + G +  +   D++SFG+VL+EI
Sbjct: 186 SLLPIRWMPPEAIMYGKF--SSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 40/216 (18%)

Query: 83  STRLGFGGFGEVYKGQFP-NGVKIAVK-VLNRNLGRIAEEQF----MAEVGTIGRTYHIN 136
             ++G G FGEV+K +       +A+K VL  N     +E F    + E+  +    H N
Sbjct: 17  LAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN----EKEGFPITALREIKILQLLKHEN 72

Query: 137 LVRLYGFCH--------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKG 188
           +V L   C          +    LV+E+ E+  L G L  K       ++ ++      G
Sbjct: 73  VVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNG 131

Query: 189 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA------KLCDRNKTHVTISGYK 242
           L Y+H   + +I+H D+K  N+L+  +   K+ADFGLA      K    N+     +   
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR----YTNRV 184

Query: 243 GTPGYSAPEFLSG--NY--PITHKCDVYSFGMVLFE 274
            T  Y  PE L G  +Y  PI    D++  G ++ E
Sbjct: 185 VTLWYRPPELLLGERDYGPPI----DMWGAGCIMAE 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 41/131 (31%), Positives = 71/131 (54%), Gaps = 17/131 (12%)

Query: 152 LVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIK 206
            V EY+  G L  ++     F + +A+ +    EI++G    L +LH    + II+ D+K
Sbjct: 78  FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAA--EISVG----LFFLHR---RGIIYRDLK 128

Query: 207 PENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVY 266
            +NV+LD+    K+ADFG+ K  +     VT   + GTP Y APE ++   P     D +
Sbjct: 129 LDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWW 185

Query: 267 SFGMVLFEIVG 277
           ++G++L+E++ 
Sbjct: 186 AYGVLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 59/201 (29%), Positives = 89/201 (44%), Gaps = 23/201 (11%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGR--------IAEEQFMAEVGTIGRTYHIN 136
           LG GGFGEV   Q    G   A K L +   +        + E+Q + +V +    + +N
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS---QFVVN 64

Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEE 195
           L   Y     +    LV   M  G L  +++       E E+    A     GL  LH E
Sbjct: 65  LAYAY---ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
                ++ D+KPEN+LLD     +++D GLA      +   +I G  GT GY APE L+ 
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLN- 174

Query: 256 NYPITHKCDVYSFGMVLFEIV 276
           N   T   D +  G +++E++
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 8/90 (8%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG 246
           +GL Y+H      ++H D+KP N+L++ N   K+ DFGLA++ D   T     GY  T  
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT-----GYVSTRY 170

Query: 247 YSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
           Y APE +        + D++S G +  E++
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 25/208 (12%)

Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVL--NRNLGRIAEE--QFMAEVGTIGRTYHINLVRL 140
           LG G FG VY       G ++AVK +  +      ++E      E+  +    H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 141 YGFCHD--QHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
           YG   D  +   ++  E+M  GS+   L  +G   A+      +      +G+ YLH   
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLH--- 123

Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG-----YKGTPGYSAPE 251
              I+H DIK  N+L D+  + K+ DFG +K   R +T + +SG       GTP + +PE
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASK---RLQT-ICLSGTGMKSVTGTPYWMSPE 179

Query: 252 FLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            +SG      K D++S G  + E++  +
Sbjct: 180 VISGE-GYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 48/152 (31%), Positives = 76/152 (50%), Gaps = 25/152 (16%)

Query: 89  GGFGEVYKGQFPNGVKI-AVKV------LNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           G FG+VY G+  N  K+ AVKV      +N+N+      Q  AE   +  +    +V LY
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNM----VHQVQAERDALALSKSPFIVHLY 70

Query: 142 GFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
                 +   LV EY+  G +   L     F ++ A+++  + E+A+     L YLH   
Sbjct: 71  YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY--ISEVALA----LDYLH--- 121

Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKL 228
           +  IIH D+KP+N+L+      K+ DFGL+K+
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 34/234 (14%)

Query: 58  FLQEIGR---EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLNRN 113
           + QE+ +   E P R+ +L          + +G G +G V        G+++AVK L+R 
Sbjct: 4   YRQELNKTIWEVPERYQNL----------SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 53

Query: 114 LGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK--K 170
              I   ++   E+  +    H N++ L     D    A   E   +  L  +L G    
Sbjct: 54  FQSIIHAKRTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLN 109

Query: 171 RAIEWEKLHE-----IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 225
             ++ +KL +     +     +GL Y+H      IIH D+KP N+ ++ +   K+ DFGL
Sbjct: 110 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 166

Query: 226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           A+  D   T     GY  T  Y APE +          D++S G ++ E++  R
Sbjct: 167 ARHTDDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 7/94 (7%)

Query: 185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL--CDRNKTHVTISGYK 242
           TA+ L  L    +  +I+ D+KPEN+LLD      + DFGL KL   D +KT+     + 
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT----FC 154

Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
           GTP Y APE L G +  T   D ++ G++L+E++
Sbjct: 155 GTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEML 187

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 4/100 (4%)

Query: 181 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG 240
           I     + L YLH    + IIH D+K EN+ LD   +  + DFG A   D +       G
Sbjct: 190 IQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246

Query: 241 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR 280
           + GT   ++PE L+ + P   K D++S G+VLFE+  +  
Sbjct: 247 WSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNV 285

Length = 392

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 12/95 (12%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG 246
           +GL Y+H      IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT-----GYVATRW 180

Query: 247 YSAPE--FLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           Y APE      +Y      D++S G ++ E++  +
Sbjct: 181 YRAPEIMLNWMHY--NQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 42/211 (19%)

Query: 86  LGFGGFGEVY---KGQFPN-GVKIAVKVLNRNLGRI-------AEEQFMAEVGTIGRTYH 134
           LG G FG+V+   K   P+ G   A+KVL +   ++        E   +AEV       H
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN------H 57

Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK-----LHEIAIGTAKGL 189
             +V+L+     +    L+ +++  G L   L   K  +  E+     L E+A+     L
Sbjct: 58  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAELALA----L 111

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGY 247
            +LH      II+ D+KPEN+LLD     K+ DFGL+K  +    K +     + GT  Y
Sbjct: 112 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY----SFCGTVEY 164

Query: 248 SAPEFLS--GNYPITHKCDVYSFGMVLFEIV 276
            APE ++  G+   T   D +SFG+++FE++
Sbjct: 165 MAPEVVNRRGH---TQSADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 49/218 (22%)

Query: 86  LGFGGFGEVYKGQF-PNG----------VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH 134
           LG G F  +YKG                V + +KVL  +  R +   F      + +  H
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-HRDSLA-FFETASLMSQLSH 60

Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
            +LV+LYG C       +V EY++ G LD +L  +K  +      ++A   A  L YL +
Sbjct: 61  KHLVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYS------ 248
              ++++H ++  +N+L+ A +          KL D              PG        
Sbjct: 120 ---KKLVHGNVCGKNILV-ARYGLNEGYVPFIKLSD--------------PGIPITVLSR 161

Query: 249 ----------APEFLSGNYP-ITHKCDVYSFGMVLFEI 275
                     APE +      +T   D +SFG  L EI
Sbjct: 162 EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.5 bits (131), Expect = 3e-08
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 15/197 (7%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAE--VGTIGRTYHINLVRL 140
           LG G FG+V   +     ++ AVKVL ++  L     E  M E  + ++ R  H  L +L
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-HPFLTQL 61

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y           V E++  G L  +   K R  +  +    A      L++LH+   + I
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARARFYAAEITSALMFLHD---KGI 117

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN-YPI 259
           I+ D+K +NVLLD     K+ADFG+ K    N    T S + GTP Y APE L    Y  
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGP 175

Query: 260 THKCDVYSFGMVLFEIV 276
           +   D ++ G++L+E++
Sbjct: 176 S--VDWWAMGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 23/203 (11%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAE--VGTIGRTYHINLVRL 140
           +G G FGEV   +  N  ++ A+K+LN+   L R     F  E  V   G    I  +  
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH- 67

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           Y F  + ++  LV +Y   G L   L  F  +   +  + +      A+ ++ +    Q 
Sbjct: 68  YAFQDENNLY-LVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVLAIDSVHQL 121

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL----- 253
             +H DIKP+NVLLD N   ++ADFG       + T V  +   GTP Y +PE L     
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMED 180

Query: 254 -SGNYPITHKCDVYSFGMVLFEI 275
             G Y    +CD +S G+ ++E+
Sbjct: 181 GKGRY--GPECDWWSLGVCMYEM 201

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 47/230 (20%)

Query: 86  LGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHINLVRLY 141
           +G G FGEV   Q  + G   A+K+L R    + +EQ     AE   +     + +V+++
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKIL-RKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
               D+    L+ E++  G +   L  K    E E    IA  T   +  +H   Q   I
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH---QLGFI 123

Query: 202 HYDIKPENVLLDANFSPKVADFGL----------------------------------AK 227
           H DIKP+N+LLD+    K++DFGL                                  A+
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183

Query: 228 LCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 276
              RN+  +  S   GTP Y APE F+   Y     CD +S G++++E++
Sbjct: 184 TWKRNRRQLAFSTV-GTPDYIAPEVFMQTGY--NKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 46/147 (31%), Positives = 70/147 (47%), Gaps = 17/147 (11%)

Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H ++++L G       T L+    +   L  YL  K+     + L  I     + + YLH
Sbjct: 142 HPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDIL-AIERSVLRAIQYLH 199

Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC-----DRNKTHVTISGYKGTPGYS 248
           E    RIIH DIK EN+ ++      + DFG A  C     + NK +    G+ GT   +
Sbjct: 200 E---NRIIHRDIKAENIFINHPGDVCLGDFGAA--CFPVDINANKYY----GWAGTIATN 250

Query: 249 APEFLSGNYPITHKCDVYSFGMVLFEI 275
           APE L+ + P     D++S G+VLFE+
Sbjct: 251 APELLARD-PYGPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 53.8 bits (129), Expect = 6e-08
 Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 32/230 (13%)

Query: 58  FLQEIGR---EKPVRFTSLQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRN 113
           + QE+ +   E P R+  L+          ++G G +G V        G K+A+K L R 
Sbjct: 2   YRQEVNKTIWEVPDRYRDLK----------QVGSGAYGTVCSALDRRTGAKVAIKKLYRP 51

Query: 114 L-GRIAEEQFMAEVGTIGRTYHINLVRLYG-FCHDQHMTA-----LVYEYMENGSLDGYL 166
               +  ++   E+  +    H N++ L   F  D  +       LV  +M  G+  G L
Sbjct: 52  FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKL 109

Query: 167 FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 226
              ++  E +++  +     KGL Y+H      IIH D+KP N+ ++ +   K+ DFGLA
Sbjct: 110 MKHEKLSE-DRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 165

Query: 227 KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
           +  D   T     GY  T  Y APE +      T   D++S G ++ E++
Sbjct: 166 RQTDSEMT-----GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 28/203 (13%)

Query: 86  LGFGGFGEV----YKGQFPNGVKIAVKVL-NRNLGRIAEEQ-FMAEVGTIGRTYHINLVR 139
           LG G FG V    +KG    G   A+K L  R + ++ + Q    E   +    H  +V 
Sbjct: 26  LGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           +     D++    + E++  G L  +L    R   +  K +   +  A    YLH    +
Sbjct: 83  MMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA--FEYLHS---K 137

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNY 257
            II+ D+KPEN+LLD     KV DFG AK + DR  T        GTP Y APE +    
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC------GTPEYLAPEVIQSK- 190

Query: 258 PITH--KCDVYSFGMVLFE-IVG 277
              H    D ++ G++L+E I G
Sbjct: 191 --GHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 52.7 bits (126), Expect = 9e-08
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 25/208 (12%)

Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLG--RIAEE--QFMAEVGTIGRTYHINLVRL 140
           LG G FGEVY       G ++AVK +  +      ++E      E+  +    H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 141 YGFC---HDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
           YG C    ++   ++  EYM  GS+   L  +G   A+             +G+ YLH  
Sbjct: 70  YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLH-- 123

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAK----LCDRNKTHVTISGYKGTPGYSAPE 251
               I+H DIK  N+L D+  + K+ DFG +K    +C    +   I    GTP + +PE
Sbjct: 124 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC---MSGTGIKSVTGTPYWMSPE 179

Query: 252 FLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            +SG      K DV+S    + E++  +
Sbjct: 180 VISGE-GYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 64/229 (27%), Positives = 95/229 (41%), Gaps = 45/229 (19%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHINLVRLY 141
           +G G FGEV   Q  +   I A+K+L R    + +EQ     AE   +       +V+++
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKIL-RKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
               D+    L+ E++  G +   L  K    E      IA  T   +  +H   Q   I
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH---QLGFI 123

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCD--------RNKTHVTISGYK----------- 242
           H DIKP+N+LLDA    K++DFGL             RN TH   S +            
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183

Query: 243 --------------GTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 276
                         GTP Y APE F+   Y     CD +S G++++E++
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVFMQTGY--NKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 33/84 (39%), Positives = 46/84 (54%), Gaps = 4/84 (4%)

Query: 191 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAP 250
           Y+H E    IIH DIK ENVL++      + DFG A     + +     G  GT   +AP
Sbjct: 275 YIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331

Query: 251 EFLSGNYPITHKCDVYSFGMVLFE 274
           E L+G+ P T   D++S G+V+FE
Sbjct: 332 EVLAGD-PYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 17/150 (11%)

Query: 86  LGFGGFGEVYKGQF---PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY----HINLV 138
           +G G FG+V   +        ++ VK L  N     + +F+ +    G  Y    H N++
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQ----GDPYRILQHPNIL 58

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEE 195
           +  G C +     LV+EY E G L  YL      +R  +   L  +A   A G+ ++H  
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH-- 116

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGL 225
            +   +H D+   N  L ++ + KV D+G+
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 35/215 (16%)

Query: 86  LGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHINLV 138
           +G G +G+VYK +  + G  +A+K +     R+  E+       + E+  + +  H N+V
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKV-----RLDNEKEGFPITAIREIKILRQLNHRNIV 69

Query: 139 RLY----------GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKG 188
            L            F  D+    LV+EYM++  L G L         + +        +G
Sbjct: 70  NLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEG 128

Query: 189 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD----RNKTHVTISGYKGT 244
           L Y H   ++  +H DIK  N+LL+     K+ADFGLA+L +    R  T+  I     T
Sbjct: 129 LNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-----T 180

Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
             Y  PE L G        DV+S G +L E+  ++
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 41/125 (32%), Positives = 62/125 (49%), Gaps = 8/125 (6%)

Query: 152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVL 211
           LV+EY+E   L+  L      +  EK+        K + + H   +  I+H DIKPEN+L
Sbjct: 77  LVFEYVEKNMLE-LLEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLL 132

Query: 212 LDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGM 270
           +  N   K+ DFG A+ L + +  + T   Y  T  Y +PE L G  P     D++S G 
Sbjct: 133 ISHNDVLKLCDFGFARNLSEGSNANYT--EYVATRWYRSPELLLGA-PYGKAVDMWSVGC 189

Query: 271 VLFEI 275
           +L E+
Sbjct: 190 ILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 20/164 (12%)

Query: 125 EVGTIGRTYHINLVRLYGFCHD--QHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHE 180
           E+  +    H  +V+ YG   D  +    +  EYM  GS+   L  +G   A+      +
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRK 110

Query: 181 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG 240
                 +G+ YLH      I+H DIK  N+L D+  + K+ DFG +K   R +T + +SG
Sbjct: 111 YTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASK---RLQT-ICMSG 163

Query: 241 -----YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
                  GTP + +PE +SG      K DV+S G  + E++  +
Sbjct: 164 TGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 54/233 (23%), Positives = 84/233 (36%), Gaps = 40/233 (17%)

Query: 69  RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRN---LGRIAEEQFMA 124
           R+   Q           LG G +G+V K      G  +A+K +           + Q + 
Sbjct: 9   RYI--QKGAH-------LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVG 59

Query: 125 EVG---TIGRT-------YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 174
             G   T  R         H N++ L     +     LV + M    L   +  K R  E
Sbjct: 60  MCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTE 118

Query: 175 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT 234
            +    I +    GL  LH   +   +H D+ P N+ +++    K+ADFGLA+       
Sbjct: 119 SQV-KCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPY 174

Query: 235 HVTISGYKG------------TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
             T+S  +             T  Y APE L G        D++S G +  E+
Sbjct: 175 SDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227

Length = 335

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 21/200 (10%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--------GRIAEEQFMAEVGTIGRTYHIN 136
           LG G FG+V   +     ++ A+KVL +++          + E++ +A         H  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK-----HPF 57

Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
           L  L+     +     V EY+  G L  +   + R  +  +    A      L++LH   
Sbjct: 58  LTALHCCFQTKDRLFFVMEYVNGGDL-MFQIQRSRKFDEPRSRFYAAEVTLALMFLH--- 113

Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
           +  +I+ D+K +N+LLDA    K+ADFG+ K  +     VT + + GTP Y APE L   
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQ-E 170

Query: 257 YPITHKCDVYSFGMVLFEIV 276
                  D ++ G++++E++
Sbjct: 171 LEYGPSVDWWALGVLMYEMM 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 48/217 (22%)

Query: 86  LGFGGFGEVYKG---------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           LG G F +++KG         +  +  ++ +KVL+++  R   E F      + +  H +
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGEL-HKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKH 60

Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE--WEKLHEIAIGTAKGLVYLHE 194
           LV  YG C     + +V EY++ GSLD YL   K  I   W KL E+A   A  L +L +
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW-KL-EVAKQLAWALHFLED 118

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYS------ 248
              + + H ++  +NVLL      K  +    KL D              PG S      
Sbjct: 119 ---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD--------------PGISITVLPK 161

Query: 249 ----------APEFLSGNYPITHKCDVYSFGMVLFEI 275
                      PE +     ++   D +SFG  L+EI
Sbjct: 162 EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEI 198

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 50.6 bits (122), Expect = 4e-07
 Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 26/150 (17%)

Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSL-DGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 192
           + N ++LY          L+ +Y+++G L D  L  K+  +   ++ +I     + L  L
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD--LLKKEGKLSEAEVKKIIRQLVEALNDL 125

Query: 193 HEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAKLCDRNKTHV-TISGYKGTPGYSAP 250
           H   +  IIH DIK ENVL D A     + D+GL K        + T S Y GT  Y +P
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-------IIGTPSCYDGTLDYFSP 175

Query: 251 EFLSGNYPITHKCDVYSF-----GMVLFEI 275
           E + G     H  D  SF     G++ +E+
Sbjct: 176 EKIKG-----HNYD-VSFDWWAVGVLTYEL 199

Length = 267

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 8/90 (8%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG 246
           +GL Y+H      IIH D+KP NV ++ +   ++ DFGLA+  D   T     GY  T  
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT-----GYVATRW 180

Query: 247 YSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
           Y APE +          D++S G ++ E++
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 24/205 (11%)

Query: 86  LGFGGFGEVY----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY--HIN--- 136
           LG G +G+V+         +G   A+KVL +    I ++    E     R    HI    
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKK--ATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 137 -LVRL-YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
            LV L Y F  D  +  L+ +Y+  G L  +L  ++R  E     E+ I + + ++ L  
Sbjct: 66  FLVTLHYAFQTDTKL-HLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVLALEH 120

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYSAPEF 252
             +  II+ DIK EN+LLD+N    + DFGL+K    D  +   +     GT  Y AP+ 
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC---GTIEYMAPDI 177

Query: 253 LSGNYPITHKC-DVYSFGMVLFEIV 276
           + G      K  D +S G++++E++
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 51.1 bits (123), Expect = 4e-07
 Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 22/101 (21%)

Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLC--------DRNKTH 235
           G+ YLH      ++H D+KP N+L+          K+ D GLA+L         D +   
Sbjct: 120 GVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176

Query: 236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
           VTI        Y APE L G    T   D+++ G +  E++
Sbjct: 177 VTI-------WYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 47/201 (23%), Positives = 84/201 (41%), Gaps = 17/201 (8%)

Query: 89  GGFGEVYKG-----QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           G FG ++ G     +     ++ VK +  +   I     + E   +    H N++ +   
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 144 CHDQHMTALV-YEYMENGSLDGYL-------FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
           C +      V Y YM  G+L  +L           +A+  ++L  +AI  A G+ YLH  
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-- 134

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
            ++ +IH DI   N ++D     K+ D  L++       H           + A E L  
Sbjct: 135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193

Query: 256 NYPITHKCDVYSFGMVLFEIV 276
               +   DV+SFG++L+E++
Sbjct: 194 KE-YSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 41/231 (17%)

Query: 74  QLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVG 127
           ++N  T  +   LG   FG+VYKG             +A+K L         E+F  E  
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60

Query: 128 TIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK---------------KRA 172
              R  H N+V L G    +   ++++ Y  +  L  +L  +               K  
Sbjct: 61  MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120

Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           +E      I    A G+ +L       ++H D+   NVL+    + K++D GL +     
Sbjct: 121 LEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR----- 172

Query: 233 KTHVTISGYKGTPGYS-------APE-FLSGNYPITHKCDVYSFGMVLFEI 275
              V  + Y    G S       +PE  + G + I    D++S+G+VL+E+
Sbjct: 173 --EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSI--DSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 31/217 (14%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQF----MAEVGTIGRTYH-INLV 138
           ++G G +G+VYK +    G  +A+K   +    + EE      + E+  +      I +V
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIYIV 64

Query: 139 RLYGFCHDQH-----MTALVYEYMEN---GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLV 190
           RL    H +         LV+EY+++     +D    G  R +  + +        KG+ 
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 191 YLHEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAKLCDRNKTHVTISGYKG---TPG 246
           + H   +  ++H D+KP+N+L+D      K+AD GL     R  + + +  Y     T  
Sbjct: 125 HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLG----RAFS-IPVKSYTHEIVTLW 176

Query: 247 YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAI 283
           Y APE L G+   +   D++S G +  E+   R+  +
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMS--RKQPL 211

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 50.5 bits (120), Expect = 6e-07
 Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 20/198 (10%)

Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G  G VY       G ++A+K +N    +  +E  + E+  +    + N+V     
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL-- 82

Query: 144 CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
             D ++      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 83  --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLH---SNQ 135

Query: 200 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
           +IH DIK +N+LL  + S K+ DFG  A++        T+    GTP + APE ++    
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVT-RKA 191

Query: 259 ITHKCDVYSFGMVLFEIV 276
              K D++S G++  E+V
Sbjct: 192 YGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 9/94 (9%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI--SGYKGT 244
           + L Y+H      + H D+KP+N+L +A+   K+ DFGLA++   N T   I  + Y  T
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVAT 169

Query: 245 PGYSAPEFLSGNY--PITHKCDVYSFGMVLFEIV 276
             Y APE L G++    T   D++S G +  E++
Sbjct: 170 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVL 202

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 20/198 (10%)

Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G  G VY       G ++A+K +N    +  +E  + E+  +    H N+V     
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYL-- 82

Query: 144 CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
             D ++      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 83  --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 135

Query: 200 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
           +IH DIK +N+LL  + S K+ DFG  A++        T+    GTP + APE ++    
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVT-RKA 191

Query: 259 ITHKCDVYSFGMVLFEIV 276
              K D++S G++  E+V
Sbjct: 192 YGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 5/159 (3%)

Query: 124 AEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE--KLHEI 181
           +E+  +    H  +V+ +          L+ EY   G L+  +  K+R  E    + +E+
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRLKEHLPFQEYEV 171

Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY 241
            +   + ++ L E   ++++H D+K  N+ L      K+ DFG +K    + +    S +
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231

Query: 242 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR 280
            GTP Y APE L      + K D++S G++L+E++   R
Sbjct: 232 CGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 47/197 (23%), Positives = 88/197 (44%), Gaps = 32/197 (16%)

Query: 94  VYKGQFPNGVKIAVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF----CHDQ 147
           +YKG F N  ++ ++   +     ++  +    E+  + R    N++++YGF      D 
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 148 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 207
              +L+ EY   G L   L  K++ + ++   ++AI   KGL  L++        Y  KP
Sbjct: 95  PRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYK--------YTNKP 145

Query: 208 ------ENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK--GTPGYSAPEFLSGNY-P 258
                  + L+  N+  K+   GL K+       ++   +K      Y + + L+  +  
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKI-------LSSPPFKNVNFMVYFSYKMLNDIFSE 198

Query: 259 ITHKCDVYSFGMVLFEI 275
            T K D+YS G+VL+EI
Sbjct: 199 YTIKDDIYSLGVVLWEI 215

Length = 283

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 58/247 (23%), Positives = 96/247 (38%), Gaps = 66/247 (26%)

Query: 86  LGFGGFGEVY----KGQFPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G  G V+    KG    G   A+KVL++   + R   ++ + E   +    H  L  
Sbjct: 9   LGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPT 65

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK--------GLVY 191
           LY     +    LV +Y   G L        R ++ +    ++   A+         L Y
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELF-------RLLQRQPGKCLSEEVARFYAAEVLLALEY 118

Query: 192 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG----- 246
           LH      I++ D+KPEN+LL  +    ++DF L+K  D     V+ +  KG+       
Sbjct: 119 LH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 247 ----------------------YSAPEFLSGNYPITH--KCDVYSFGMVLFEIV------ 276
                                 Y APE +SG+    H    D ++ G++L+E++      
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGD---GHGSAVDWWTLGILLYEMLYGTTPF 232

Query: 277 -GRRRNA 282
            G  R+ 
Sbjct: 233 KGSNRDE 239

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 62/247 (25%), Positives = 92/247 (37%), Gaps = 68/247 (27%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVK------VLNRN-LGRI-AEEQFMAEVGTIGRTYHIN 136
           +G G FGEV   +  +   + A+K      VL RN    + AE   +AE           
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW------ 62

Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT-AKGLVYLHEE 195
           +V+LY    D+     V +Y+  G +   L   +  I  E L    I      +  +H  
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI--RLGIFEEDLARFYIAELTCAIESVH-- 118

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLA----------------------------- 226
            +   IH DIKP+N+L+D +   K+ DFGL                              
Sbjct: 119 -KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 227 ------------KLCDRNKTHVTISGYKGTPGYSAPEFL--SGNYPITHKCDVYSFGMVL 272
                       +   R           GTP Y APE L  +G    T  CD +S G++L
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY---TQLCDWWSVGVIL 234

Query: 273 FE-IVGR 278
           +E +VG+
Sbjct: 235 YEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 48.0 bits (115), Expect = 4e-06
 Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 9/94 (9%)

Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG--TP 245
           G+ +LH      I+H D+K  N+LL+     K+ DFGLA+         T    +   T 
Sbjct: 118 GVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT----QLVVTL 170

Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            Y APE L G    +   D++S G +  E++ ++
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 47.8 bits (113), Expect = 5e-06
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 20/198 (10%)

Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G  G V+       G ++A+K +N    +  +E  + E+  +    + N+V     
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKKELIINEILVMKELKNPNIVNFL-- 82

Query: 144 CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
             D  +      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 83  --DSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLH---ANQ 135

Query: 200 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
           +IH DIK +NVLL  + S K+ DFG  A++        T+    GTP + APE ++    
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVT-RKA 191

Query: 259 ITHKCDVYSFGMVLFEIV 276
              K D++S G++  E+V
Sbjct: 192 YGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 33/108 (30%), Positives = 58/108 (53%), Gaps = 9/108 (8%)

Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      T+  ++ Y  T  Y
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYY 188

Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPK 295
            APE + G        D++S G ++ E+V  + + I   T+ +D + K
Sbjct: 189 RAPEVILG-MGYKENVDIWSVGCIMGELV--KGSVIFQGTDHIDQWNK 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 17/201 (8%)

Query: 86  LGFGGFGEVY---KGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTY--HIN--- 136
           LG G +G+V+   K    +  K+ A+KVL +    + ++    E     R    H+    
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQK--AALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 137 -LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
            LV L+     +    L+ +Y+  G +  +L+ +    E     E+   + + ++ L   
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE----DEVRFYSGEIILALEHL 121

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
            +  I++ DIK EN+LLD+     + DFGL+K     +   T S + GT  Y APE + G
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRG 180

Query: 256 NYPITHKCDVYSFGMVLFEIV 276
                   D +S G+++FE++
Sbjct: 181 KGGHGKAVDWWSLGILIFELL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 47.4 bits (112), Expect = 6e-06
 Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 18/197 (9%)

Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G  G VY       G ++A++ +N    +  +E  + E+  +    + N+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL-- 83

Query: 144 CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
             D ++      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 84  --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           +IH DIK +N+LL  + S K+ DFG        ++    S   GTP + APE ++     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVT-RKAY 193

Query: 260 THKCDVYSFGMVLFEIV 276
             K D++S G++  E++
Sbjct: 194 GPKVDIWSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 62/240 (25%), Positives = 91/240 (37%), Gaps = 55/240 (22%)

Query: 86  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G FGEV    +       A+K L +   L R       AE   +    +  +V+LY 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
              D+     V +Y+  G +   L   +  +  E L    I  A+  + +    +   IH
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLI--RMEVFPEVLARFYI--AELTLAIESVHKMGFIH 124

Query: 203 YDIKPENVLLDANFSPKVADFGL-----------------------------------AK 227
            DIKP+N+L+D +   K+ DFGL                                    +
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR 184

Query: 228 LCDRNKT--------HVTISGYK--GTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 276
             DR KT        H     +   GTP Y APE  L   Y  T  CD +S G++LFE++
Sbjct: 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY--TQLCDWWSVGVILFEML 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 47.1 bits (112), Expect = 9e-06
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 15/97 (15%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNKTHVTISGYKG-- 243
           +GL Y+H      ++H D+KP NV ++  +   K+ DFGLA++ D + +H    GY    
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH---KGYLSEG 178

Query: 244 --TPGYSAPEFL--SGNYPITHKCDVYSFGMVLFEIV 276
             T  Y +P  L    NY  T   D+++ G +  E++
Sbjct: 179 LVTKWYRSPRLLLSPNNY--TKAIDMWAAGCIFAEML 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 7/89 (7%)

Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      T   ++ Y  T  Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 183

Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            APE + G        D++S G ++ E++
Sbjct: 184 RAPEVILG-MGYKENVDIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 34/108 (31%), Positives = 52/108 (48%), Gaps = 23/108 (21%)

Query: 185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK-- 242
           T   L YLH      I+H D+KP+N+L+ +    K+ DFGL+K+   + T     G+   
Sbjct: 110 TVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 243 -----------GTPGYSAPE-FLSGNY--PITHKCDVYSFGMVLFEIV 276
                      GTP Y APE  L   Y  P+    D ++ G++L+E +
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPV----DWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 42/177 (23%), Positives = 81/177 (45%), Gaps = 23/177 (12%)

Query: 112 RNLGRIAEEQFMAEVGTIGRTYHINLVRL--------YGFCHDQHMTALVYEYMENGSLD 163
           +   R A  Q   E+  +GR  H N++++          +   Q     +Y +M + + D
Sbjct: 201 KAGSRAAI-QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD 259

Query: 164 GYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF 223
                K R +  +    I       + Y+H+   +++IH DIK EN+ L+ +    + DF
Sbjct: 260 W----KDRPLLKQT-RAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDF 311

Query: 224 GLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLFEIVGR 278
           G A   ++ +      G+ GT   ++PE L+G+    IT   D++S G++L +++  
Sbjct: 312 GTAMPFEKEREAFDY-GWVGTVATNSPEILAGDGYCEIT---DIWSCGLILLDMLSH 364

Length = 501

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 36/216 (16%)

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           GF  ++ ++ +  E  E    D Y    K+ +  E L   +   AKG+ +L     ++ I
Sbjct: 151 GFVEEKSLSDV--EEEEAEQEDLY----KKVLTLEDLICYSFQVAKGMEFL---ASRKCI 201

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H D+   N+LL  N   K+ DFGLA+   ++  +V     +    + APE +      T 
Sbjct: 202 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTI 260

Query: 262 KCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPK-HVWEEYEKCELGAMILGCGIEEKDK 320
           + DV+SFG++L+EI        +GA+     +P   + EE+  C          ++E  +
Sbjct: 261 QSDVWSFGVLLWEIFS------LGASP----YPGVKIDEEF--C--------RRLKEGTR 300

Query: 321 EKA-----KRLCMVALWCVQDSPEDRPPMSAVIKML 351
            +A       +    L C    P  RP  S +++ L
Sbjct: 301 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 68/255 (26%), Positives = 97/255 (38%), Gaps = 89/255 (34%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN-------LGRI-AEEQFMAEVGTIGRTYHIN 136
           +G G FGEV   Q  +  KI A+K L ++       L  + AE   +AE  +        
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW------ 62

Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE-----------IAIGT 185
           +V LY    D     L+ E++  G L   L      I+++   E           +AI  
Sbjct: 63  VVSLYYSFQDAQYLYLIMEFLPGGDLMTML------IKYDTFSEDVTRFYMAECVLAIEA 116

Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA----KLCD----------- 230
              L +         IH DIKP+N+L+D     K++DFGL+    K  D           
Sbjct: 117 VHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167

Query: 231 --------RNKTHV-----------TISGYK-----------GTPGYSAPE-FLSGNYPI 259
                   RN   V            I+ +K           GTP Y APE FL   Y  
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-- 225

Query: 260 THKCDVYSFGMVLFE 274
             +CD +S G ++FE
Sbjct: 226 GQECDWWSLGAIMFE 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 48/168 (28%), Positives = 83/168 (49%), Gaps = 22/168 (13%)

Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
           A+G+ +L     ++ IH D+   N+LL  N   K+ DFGLA+   ++  +V     +   
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240

Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPK-HVWEEYEKC 304
            + APE +      T + DV+SFG++L+EI        +GA+     +P   + EE+  C
Sbjct: 241 KWMAPESIFDKV-YTTQSDVWSFGVLLWEIFS------LGASP----YPGVQINEEF--C 287

Query: 305 ELGAMILGCGIEEKDKEKAK-RLCMVALWCVQDSPEDRPPMSAVIKML 351
           +     L  G   +  E A   +  + L C Q  P++RP  SA++++L
Sbjct: 288 QR----LKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 45.5 bits (107), Expect = 3e-05
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 7/89 (7%)

Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      T   ++ Y  T  Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 184

Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            APE + G        D++S G ++ E+V
Sbjct: 185 RAPEVILG-MGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 59/240 (24%), Positives = 85/240 (35%), Gaps = 55/240 (22%)

Query: 86  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G FGEV    +       A+K L +   L R       AE   +    +  +VRLY 
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
              D+     V +Y+  G +   L   +  I  E L    I  A+    +    +   IH
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLI--RMGIFPEDLARFYI--AELTCAVESVHKMGFIH 124

Query: 203 YDIKPENVLLDANFSPKVADFG-------------------------------------- 224
            DIKP+N+L+D +   K+ DFG                                      
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCR 184

Query: 225 -------LAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 276
                  L +   R           GTP Y APE  L   Y  T  CD +S G++L+E++
Sbjct: 185 CGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY--TQLCDWWSVGVILYEML 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 7/91 (7%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
           + L Y+H    + I H D+KP+N+L+D N  + K+ DFG AK     +  V+   Y  + 
Sbjct: 181 RALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS---YICSR 234

Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            Y APE + G    T   D++S G ++ E++
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 39/145 (26%), Positives = 59/145 (40%), Gaps = 18/145 (12%)

Query: 136 NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
           N+V L+ +   +    LV ++ E G L  ++  K   I  E +   A      L  LH E
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-SKFLNIPEECVKRWAAEMVVALDALHRE 104

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNKTHVTISGYKGTPGYSAPE 251
               I+  D+ P N+LLD     ++  F     +   CD                Y APE
Sbjct: 105 ---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM---------YCAPE 152

Query: 252 FLSGNYPITHKCDVYSFGMVLFEIV 276
            + G    T  CD +S G +LFE++
Sbjct: 153 -VGGISEETEACDWWSLGAILFELL 176

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.5 bits (105), Expect = 6e-05
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 4/90 (4%)

Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
           A+G+ +L     ++ IH D+   N+LL  N   K+ DFGLA+   ++  +V     +   
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239

Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            + APE +      T + DV+SFG++L+EI
Sbjct: 240 KWMAPESIFDKV-YTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 44.3 bits (104), Expect = 7e-05
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 7/89 (7%)

Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      T   ++ Y  T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 191

Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            APE + G        D++S G ++ E++
Sbjct: 192 RAPEVILG-MGYKENVDIWSVGCIMGEMI 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 43.9 bits (103), Expect = 8e-05
 Identities = 49/205 (23%), Positives = 84/205 (40%), Gaps = 15/205 (7%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-- 142
           ++G G +G VYK +  +G       L +  G         E+  +    H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY-----LHEECQ 197
             H      L+++Y E+       F +      +K  ++  G  K L+Y     +H    
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYLHA 126

Query: 198 QRIIHYDIKPENVLLDANFSP-----KVADFGLAKLCDRN-KTHVTISGYKGTPGYSAPE 251
             ++H D+KP N+L+     P     K+AD G A+L +   K    +     T  Y APE
Sbjct: 127 NWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 252 FLSGNYPITHKCDVYSFGMVLFEIV 276
            L G    T   D+++ G +  E++
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.8 bits (103), Expect = 9e-05
 Identities = 56/223 (25%), Positives = 88/223 (39%), Gaps = 41/223 (18%)

Query: 86  LGFGGFGEVYKGQFPNGVKI----AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G GGFG VY+ Q  +   I      K+ N        E  + E       Y I+ + L+
Sbjct: 20  IGCGGFGCVYETQCASDHCINNQAVAKIENLE-----NETIVMETLVYNNIYDIDKIALW 74

Query: 142 GFCHD-QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE-------------------I 181
              H+  H+   + +Y   GS         R I  EKL E                   I
Sbjct: 75  KNIHNIDHLG--IPKYYGCGSFK-RCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNI 131

Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG- 240
                  L Y+HE     I H DIKPEN+++D N    + D+G+A     +  H+  S  
Sbjct: 132 MKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188

Query: 241 ----YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
               ++GT  Y+  +  +G   +T + D+ S G  + +  G +
Sbjct: 189 QKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIK 230

Length = 294

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 35/105 (33%), Positives = 56/105 (53%), Gaps = 6/105 (5%)

Query: 172 AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 231
           A++ E L   +   AKG+ +L     +  IH D+   N+LL      K+ DFGLA+   R
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI-R 265

Query: 232 NKTHVTISGYKGTP-GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
           N ++  + G    P  + APE +  N   T + DV+S+G++L+EI
Sbjct: 266 NDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 43.2 bits (101), Expect = 2e-04
 Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 46/227 (20%)

Query: 85  RLGFGGFGEVY--KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G FGEV+  K +          +  R L    + Q + EV  +    H N+VR   
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79

Query: 143 -FCH--DQHMTALVYEYMENGSLDG------YLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
            F +  +Q +  L+ E+ + G L         +FGK   IE   + +I       L Y H
Sbjct: 80  RFLNKANQKLYILM-EFCDAGDLSRNIQKCYKMFGK---IEEHAIVDITRQLLHALAYCH 135

Query: 194 E----ECQQRIIHYDIKPENVLL---------------DANFSP--KVADFGLAK-LCDR 231
                   +R++H D+KP+N+ L               + N  P  K+ DFGL+K +   
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE 195

Query: 232 NKTHVTISGYKGTPGYSAPEFL---SGNYPITHKCDVYSFGMVLFEI 275
           +  H  +    GTP Y +PE L   + +Y    K D+++ G +++E+
Sbjct: 196 SMAHSCV----GTPYYWSPELLLHETKSY--DDKSDMWALGCIIYEL 236

Length = 1021

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 48/205 (23%), Positives = 83/205 (40%), Gaps = 15/205 (7%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-- 142
           ++G G +G VYK +  +G       L +  G         E+  +    H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY-----LHEECQ 197
             H      L+++Y E+       F +      +K  ++     K L+Y     +H    
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 198 QRIIHYDIKPENVLLDANFSP-----KVADFGLAKLCDRN-KTHVTISGYKGTPGYSAPE 251
             ++H D+KP N+L+     P     K+AD G A+L +   K    +     T  Y APE
Sbjct: 127 NWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 252 FLSGNYPITHKCDVYSFGMVLFEIV 276
            L G    T   D+++ G +  E++
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 47/182 (25%), Positives = 81/182 (44%), Gaps = 21/182 (11%)

Query: 103 VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL 162
           +++ +KVL+ +   IA   F      + +  HI+L  ++G C       +V E++E+G L
Sbjct: 45  LRVVLKVLDPSHRDIAL-AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103

Query: 163 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD 222
           D  L  +K  +       +A   A  L YL +   + ++H ++  +N+LL        A 
Sbjct: 104 DVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILL--------AR 152

Query: 223 FGLA-------KLCDRNKTHVTISGYKGTP--GYSAPEFLSGNYPITHKCDVYSFGMVLF 273
            GLA       KL D   +   +S  +      + APE + G   ++   D +SFG  L 
Sbjct: 153 LGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLL 212

Query: 274 EI 275
           EI
Sbjct: 213 EI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 4/90 (4%)

Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
           A+G+ +L     +  +H D+   NVLL      K+ DFGLA+    +  +V+        
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303

Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            + APE +  N   T   DV+S+G++L+EI
Sbjct: 304 KWMAPESIFDNL-YTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 19/205 (9%)

Query: 79  TSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
           T  Y+  L +    E     +   +K+ +KVL+ +  R     F      + +  H ++V
Sbjct: 9   TQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-HRDISLAFFETASMMRQVSHKHIV 67

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            LYG C       +V E++E G LD ++  K   +      ++A   A  L YL +   +
Sbjct: 68  LLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---K 124

Query: 199 RIIHYDIKPENVLL-----DANFSP--KVADFGLA-KLCDRNKTHVTISGYKGTPGYSAP 250
            ++H ++  +N+LL     D    P  K++D G+   +  R +    I        + AP
Sbjct: 125 DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP-------WIAP 177

Query: 251 EFLSGNYPITHKCDVYSFGMVLFEI 275
           E +  +  ++   D +SFG  L+EI
Sbjct: 178 ECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 6/91 (6%)

Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
           A+G+ +L     +  IH D+   NVLL      K+ DFGLA+    +  +V     +   
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278

Query: 246 GYSAPE-FLSGNYPITHKCDVYSFGMVLFEI 275
            + APE      Y  T + DV+S+G++L+EI
Sbjct: 279 KWMAPESIFDCVY--TVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 6/91 (6%)

Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
           A G+ +L     +  +H D+   NVL+      K+ DFGLA+   R+  +++  G    P
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS-KGSTFLP 304

Query: 246 -GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
             + APE +  N   T   DV+SFG++L+EI
Sbjct: 305 LKWMAPESIFNNL-YTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	406
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.98
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
PRK10345	210	hypothetical protein; Provisional	99.84
smart00090	237	RIO RIO-like kinase.	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.8
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.62
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.56
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
KOG1243	690	consensus Protein kinase [General function predict	99.47
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.42
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.38
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.38
KOG3087	229	consensus Serine/threonine protein kinase [General	99.37
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.37
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.18
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.17
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.12
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.06
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.0
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.99
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.95
COG4248	637	Uncharacterized protein with protein kinase and he	98.94
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.88
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.79
PRK09902	216	hypothetical protein; Provisional	98.79
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.76
PF01636	239	APH: Phosphotransferase enzyme family This family	98.56
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.56
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.49
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.48
PLN02876	822	acyl-CoA dehydrogenase	98.47
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.46
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.26
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.26
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.21
PRK10593	297	hypothetical protein; Provisional	98.2
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.19
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.17
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.04
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.98
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.91
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.88
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.79
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.72
PRK05231	319	homoserine kinase; Provisional	97.69
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.65
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.54
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.49
PLN02756	418	S-methyl-5-thioribose kinase	97.29
KOG2270	520	consensus Serine/threonine protein kinase involved	97.19
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.17
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.14
PLN02236	344	choline kinase	97.13
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.87
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.83
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.8
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.76
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.73
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.6
PRK12396	409	5-methylribose kinase; Reviewed	96.42
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.31
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.25
PRK11768	325	serine/threonine protein kinase; Provisional	96.23
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.22
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.9
COG2334	331	Putative homoserine kinase type II (protein kinase	95.87
PRK06148	1013	hypothetical protein; Provisional	95.85
PTZ00384	383	choline kinase; Provisional	95.42

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-55  Score=409.95  Aligned_cols=287  Identities=41%  Similarity=0.661  Sum_probs=242.6

Q ss_pred             CceeeChHHHhhhhhccc--ccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEE
Q 015480           66 KPVRFTSLQLNNFTSNYS--TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF  143 (406)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~--~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~  143 (406)
                      ....|+..++..+|.+|.  ++||+|+||.||+|...+|..||||++....... ..+|..|++++.+++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            445689999999999998  7999999999999999999999999887654332 5569999999999999999999999


Q ss_pred             EecCC-eeEEEEEeccCCChhhHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEe
Q 015480          144 CHDQH-MTALVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVA  221 (406)
Q Consensus       144 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (406)
                      |.+.+ ..+|||||+++|+|.++|+.... .++|.++.+|+.++|+||+|||..+...|+||||||+|||||+++++||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99998 59999999999999999987666 89999999999999999999999877789999999999999999999999


Q ss_pred             ccccccccCC-CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHH
Q 015480          222 DFGLAKLCDR-NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEE  300 (406)
Q Consensus       222 DfGl~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  300 (406)
                      |||+|+.... ...... .. .||.+|+|||++... ..+.++||||||++|+||+||+++.+.........+..+.+..
T Consensus       220 DFGLa~~~~~~~~~~~~-~~-~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~  296 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVST-TV-MGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL  296 (361)
T ss_pred             CccCcccCCccccceee-ec-CCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence            9999965543 222111 11 799999999999875 7899999999999999999999888765533333356666667


Q ss_pred             HhhhhcchhhccCCC-CcchH-HHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          301 YEKCELGAMILGCGI-EEKDK-EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       301 ~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      +.+..+...++.... ..... .....+..++.+|++.+|.+||+|.+|++.|+.+..
T Consensus       297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            777667777666543 33332 677889999999999999999999999999966643

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-52  Score=390.63  Aligned_cols=262  Identities=32%  Similarity=0.485  Sum_probs=217.2

Q ss_pred             hhcccccccccceeEEEEEEeCCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCC-eeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-MTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~  156 (406)
                      ...+.+.||+|+||+||+|.|.....||||++.... .....+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            334456699999999999999544449999998542 2223678999999999999999999999999987 79999999


Q ss_pred             ccCCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCC-eeecCCCCCcEEEcCCC-CceEeccccccccCCCC
Q 015480          157 MENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIHYDIKPENVLLDANF-SPKVADFGLAKLCDRNK  233 (406)
Q Consensus       157 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-i~H~dlk~~Nill~~~~-~~kl~DfGl~~~~~~~~  233 (406)
                      +++|+|.++++. .+..+++..++.++.|||+||.|||+   .+ ||||||||+|||++.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            999999999977 47899999999999999999999999   77 99999999999999998 99999999998665432


Q ss_pred             ceEEecCCCCCCCccCccccCC-CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          234 THVTISGYKGTPGYSAPEFLSG-NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                        ...+...||+.|||||++.+ ...++.++||||||+++|||+||+.||......               .........
T Consensus       199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---------------~~~~~v~~~  261 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---------------QVASAVVVG  261 (362)
T ss_pred             --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---------------HHHHHHHhc
Confidence              22344679999999999994 247999999999999999999999998643321               001112223


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCC
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPP  360 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~  360 (406)
                      ...+..+..++..+..++.+||+.||..||++.+++..|+.+......
T Consensus       262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            344555566889999999999999999999999999999988664443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-52  Score=370.92  Aligned_cols=250  Identities=28%  Similarity=0.426  Sum_probs=213.6

Q ss_pred             cccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC-eeEEEEEecc
Q 015480           81 NYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-MTALVYEYME  158 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~  158 (406)
                      .....||+|..|+||++.++ +++.+|+|++..+......+++.+|+++++..+||+||.+||.|..+. ..+|+||||+
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD  161 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD  161 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence            44567999999999999774 688999999987777778899999999999999999999999999988 5999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      +|+|++++. ..+.+++..+.+|+.++++||.|||.  .++|+||||||+||||+..|.+||||||.+..+.+.    ..
T Consensus       162 gGSLd~~~k-~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a  234 (364)
T KOG0581|consen  162 GGSLDDILK-RVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA  234 (364)
T ss_pred             CCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence            999999984 44779999999999999999999995  389999999999999999999999999999877654    23


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ..+.||..|||||.+.+. .|+.++||||||+.++|+.+|+-|+.........++.           +...+.....+..
T Consensus       235 ~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~-----------Ll~~Iv~~ppP~l  302 (364)
T KOG0581|consen  235 NTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE-----------LLCAIVDEPPPRL  302 (364)
T ss_pred             ccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH-----------HHHHHhcCCCCCC
Confidence            568899999999999998 8999999999999999999999988654222222221           1122223333445


Q ss_pred             hHH-HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          319 DKE-KAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       319 ~~~-~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      +.. +++++++++..||++||.+||++.++++
T Consensus       303 P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  303 PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            554 8999999999999999999999999987

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-51  Score=384.35  Aligned_cols=248  Identities=27%  Similarity=0.408  Sum_probs=214.9

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      .+|...+.||+|||+.||.++. .+|+.||+|++.+..  .....+.+.+|+++.+.|+|||||+++++|++.++.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4566678899999999999977 789999999998642  3456788999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      |+|+.++|..++. .++.+++..+..++.||+.||.|||+   .+|+|||||..|+||+++.++||+|||||..+..+..
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            9999999999884 78899999999999999999999999   9999999999999999999999999999998875533


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                      ..  ...+|||.|.|||++... .++..+||||+||+||-||.|++||...          .+.+.+...+...      
T Consensus       174 rk--~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk----------~vkety~~Ik~~~------  234 (592)
T KOG0575|consen  174 RK--KTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETK----------TVKETYNKIKLNE------  234 (592)
T ss_pred             cc--ceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccc----------hHHHHHHHHHhcC------
Confidence            22  247899999999999976 8999999999999999999999999543          2233333333222      


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       ...+...+.+..+|+..+|+.||.+|||+++|+.
T Consensus       235 -Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  235 -YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             2334467788999999999999999999999998

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-52  Score=387.08  Aligned_cols=263  Identities=29%  Similarity=0.469  Sum_probs=222.3

Q ss_pred             hHHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           72 SLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        72 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      ..++......+.+.||+|-||+||.|.++....||+|.++..  ....++|.+|+++|++|+|+|||+++|+|..++.++
T Consensus       200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy  277 (468)
T KOG0197|consen  200 PWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY  277 (468)
T ss_pred             CeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence            345555666778899999999999999977779999999864  345678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          152 LVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ||||||+.|+|.+||.. .+..+...+.+.++.|||+|++||++   +++|||||.++||||++++.+||+||||++...
T Consensus       278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccC
Confidence            99999999999999975 56789999999999999999999999   999999999999999999999999999999554


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      .+... ...+..-+..|.|||.+... .++.+||||||||+||||+|-.....               ..+...+....+
T Consensus       355 d~~Y~-~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py---------------~~msn~ev~~~l  417 (468)
T KOG0197|consen  355 DDEYT-ASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPY---------------PGMSNEEVLELL  417 (468)
T ss_pred             CCcee-ecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCC---------------CCCCHHHHHHHH
Confidence            44333 23445567799999999987 79999999999999999998543221               112223333444


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      ..+.+-+.+..||.++.++|..||+.+|++|||++.+...|+++..
T Consensus       418 e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  418 ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            4555567778899999999999999999999999999999988754

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-50  Score=363.58  Aligned_cols=255  Identities=27%  Similarity=0.345  Sum_probs=206.7

Q ss_pred             hhhhhcccccccccceeEEEEEE-eCCCcEEEEEEeccccchh------hHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRI------AEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      .+..|-+.+.||+|+||.|-+|. -++|+.||||++.+.....      ......+|+++|++|+|||||+++++|...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            34455667899999999999994 4679999999998542211      2234579999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC---CCceEecccc
Q 015480          149 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFGL  225 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~DfGl  225 (406)
                      ..||||||++||+|.+.+ -.++.+.+.....+++|++.|+.|||+   .||+||||||+|||+..+   ..+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~v-v~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKV-VANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHH-HhccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence            999999999999999999 445677888889999999999999999   999999999999999766   6799999999


Q ss_pred             ccccCCCCceEEecCCCCCCCccCccccCCCC--CCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhh
Q 015480          226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK  303 (406)
Q Consensus       226 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  303 (406)
                      |+....   ...+...+||+.|.|||++.+..  .+..++|+||+||+||-+++|.+||....++.      ...+....
T Consensus       326 AK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------sl~eQI~~  396 (475)
T KOG0615|consen  326 AKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------SLKEQILK  396 (475)
T ss_pred             hhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc------cHHHHHhc
Confidence            997763   33456789999999999997652  23458899999999999999999996543331      11222222


Q ss_pred             hhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      +...      ..+......+.+..+++.+||..||++|||++|+++
T Consensus       397 G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  397 GRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             Cccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            2111      113445678899999999999999999999999987

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=359.18  Aligned_cols=248  Identities=26%  Similarity=0.415  Sum_probs=198.9

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      .|.+.++||.|+||+||+|++ .+|..||||.+.+.. .....+.+..|+.+|+.++|||||.+++++.+++..||||||
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy   90 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY   90 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence            355677899999999999976 458999999998653 556678889999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC------CCceEeccccccccC
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN------FSPKVADFGLAKLCD  230 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~------~~~kl~DfGl~~~~~  230 (406)
                      |.||+|.+|++ ..+.+++.++..++.|+|.||++||+   ++|+||||||.||||+..      -.+||+|||+|+.+.
T Consensus        91 C~gGDLs~yi~-~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   91 CNGGDLSDYIR-RRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             CCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999994 55589999999999999999999999   999999999999999764      458999999999887


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      ....   ....+|++-|||||++... .|+.|+|+||+|+|+|+|++|+.||.......+.       -.+..       
T Consensus       167 ~~~~---a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~-------~~~~k-------  228 (429)
T KOG0595|consen  167 PGSM---AETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELL-------LYIKK-------  228 (429)
T ss_pred             chhH---HHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHH-------HHHhc-------
Confidence            5433   2457899999999999877 7999999999999999999999998643322110       00000       


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVI  348 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl  348 (406)
                      ....++..+...+..+.+++...++.+|.+|-++.+-.
T Consensus       229 ~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  229 GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             cccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence            11112233334444555666667777777776665543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-51  Score=349.60  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=207.2

Q ss_pred             hcccccccccceeEEEEE-EeCCCcEEEEEEecc-ccchhhHHHHHHHHHHhhccCcCccccEEE-EEecCC-eeEEEEE
Q 015480           80 SNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYG-FCHDQH-MTALVYE  155 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~-~~~~g~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~-~~~lv~e  155 (406)
                      |.+.++||.|+||+||++ ...+|..+|.|.+.- .......++...|+.+|++|+|||||++++ .+.++. .++||||
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE  100 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME  100 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence            455678999999999999 457899999998873 334556788999999999999999999998 444444 4899999


Q ss_pred             eccCCChhhHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHHhcCC-CeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          156 YMENGSLDGYLF---GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       156 ~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      ||.+|+|...+.   +.++.+++.++++++.|++.||..+|+...+ -++||||||.||+|+.+|.+||+||||++.+..
T Consensus       101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s  180 (375)
T KOG0591|consen  101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS  180 (375)
T ss_pred             hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence            999999999884   3467899999999999999999999984422 389999999999999999999999999998876


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ..+..  ...+|||.||+||.+.+. +|+.+|||||+||++|||+.-++||....          ..+.      ...+.
T Consensus       181 ~~tfA--~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n----------~~~L------~~KI~  241 (375)
T KOG0591|consen  181 KTTFA--HSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDN----------LLSL------CKKIE  241 (375)
T ss_pred             hhHHH--HhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCccccc----------HHHH------HHHHH
Confidence            65432  457899999999999988 89999999999999999999999985441          1111      11122


Q ss_pred             cCCCCcch-HHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 015480          312 GCGIEEKD-KEKAKRLCMVALWCVQDSPEDRPPMSAVIKML  351 (406)
Q Consensus       312 ~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  351 (406)
                      .+..+..+ ..++..+..|+..|+..||..||+...++..+
T Consensus       242 qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  242 QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            33334455 67899999999999999999999855444443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.5e-50  Score=392.29  Aligned_cols=263  Identities=24%  Similarity=0.393  Sum_probs=224.1

Q ss_pred             hhhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      .....+.+.||+|+||+||+|+..      +...||||.++.........+|.+|++++..++|||||+++|+|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            334466788999999999999753      34679999999887777889999999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC
Q 015480          151 ALVYEYMENGSLDGYLFGK-------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  217 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  217 (406)
                      ++|+|||..|+|.+||...             ..+++..+.+.|+.|||.|+.||-+   +.+|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence            9999999999999999421             1238899999999999999999999   99999999999999999999


Q ss_pred             ceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhH
Q 015480          218 PKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKH  296 (406)
Q Consensus       218 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  296 (406)
                      |||+||||++.....+......+..-+.+|||||.|... .++.+||||||||+|||+++ |+.|+              
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy--------------  706 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPY--------------  706 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcc--------------
Confidence            999999999987766554433333456799999999988 79999999999999999997 44443              


Q ss_pred             HHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCC
Q 015480          297 VWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP  359 (406)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~  359 (406)
                        ....+.+..+.+..+.+-+.+.++|.+++.||..||+.+|++||++.||...|+......+
T Consensus       707 --~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  707 --YGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             --cccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence              3334444555566666678889999999999999999999999999999999998765543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-49  Score=351.65  Aligned_cols=243  Identities=25%  Similarity=0.319  Sum_probs=203.0

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ...+.+.+.||+|+||+||.++. .+++.+|+|++++...  .......+.|..+|..++||.||+++..|++.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            34456788999999999999955 5699999999986532  23457789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      +||+.||.|...| ++.+.+++..+.-++.+|+.||.|||+   +||+||||||+|||||.+|+++|+||||++......
T Consensus       104 ld~~~GGeLf~hL-~~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  104 LDYLNGGELFYHL-QREGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EeccCCccHHHHH-HhcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            9999999999998 566789999999999999999999999   999999999999999999999999999998544332


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      ..  ...++||+.|||||++.+. .++..+|+||||+++|||++|.+||......          +..+      .+...
T Consensus       180 ~~--t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~----------~~~~------~I~~~  240 (357)
T KOG0598|consen  180 DA--TRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----------KMYD------KILKG  240 (357)
T ss_pred             Cc--cccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHH----------HHHH------HHhcC
Confidence            22  2458999999999999988 8999999999999999999999998643221          1111      11122


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCC
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRP  342 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  342 (406)
                      .....+.-.+.+..+++...|..||.+|.
T Consensus       241 k~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  241 KLPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             cCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            22333444677899999999999999996

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.4e-48  Score=338.91  Aligned_cols=264  Identities=22%  Similarity=0.286  Sum_probs=206.2

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |+-..++|+|+||.||+++++ +|+.||||.+..... ....+-.++|+++|+++.|+|+|.++.+|.....++||+|||
T Consensus         4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~   83 (396)
T KOG0593|consen    4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC   83 (396)
T ss_pred             HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence            344567999999999999875 499999999975433 445566789999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      +. ++.+-|......++...+.++++|++.|+.|+|+   ++++||||||+||||+.+|.+||||||+|+.+.....  .
T Consensus        84 dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--~  157 (396)
T KOG0593|consen   84 DH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--N  157 (396)
T ss_pred             ch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCcc--h
Confidence            88 5555565677789999999999999999999999   9999999999999999999999999999998774322  2


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhH--------HHHHHhhhh----
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKH--------VWEEYEKCE----  305 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~----  305 (406)
                      .+.++.|.+|.|||.+.+...|...+||||+||++.||++|.+.|-..+.-..-+....        -.+......    
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence            35678899999999999987999999999999999999999987643332111111110        011111111    


Q ss_pred             --cchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          306 --LGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       306 --~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        +...-.....+......+.-+.+++..||+.||++|++.++++.
T Consensus       238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence              11111111222223445667899999999999999999999886

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-47  Score=347.09  Aligned_cols=254  Identities=27%  Similarity=0.364  Sum_probs=204.2

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC--eeEEEEEe
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH--MTALVYEY  156 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~  156 (406)
                      +...+.||+|+||.||++... +|+..|||......... .+.+.+|+.+|++++|||||+++|......  .+++.|||
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            455678999999999999764 49999999987653222 677899999999999999999999854444  68999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC-CCCceEeccccccccCCCCc-
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNKT-  234 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~DfGl~~~~~~~~~-  234 (406)
                      +++|+|.+++......+++..+..++.||++||.|||+   +|++||||||+|||++. ++.+||+|||++........ 
T Consensus        98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            99999999996655589999999999999999999999   99999999999999999 79999999999987664111 


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                      ........||+.|||||++.......+++|||||||++.||+||++||...    ....     +.     +........
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~-----~~-----~~~ig~~~~  240 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEA-----EA-----LLLIGREDS  240 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchH-----HH-----HHHHhccCC
Confidence            122234789999999999985323446999999999999999999988532    0000     00     011111222


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML  351 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  351 (406)
                      .+..+...+.+..+++..|+..||.+|||+.++++..
T Consensus       241 ~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  241 LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            3456667888999999999999999999999999844

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-49  Score=376.72  Aligned_cols=266  Identities=26%  Similarity=0.425  Sum_probs=227.1

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      .++......+.+.||.|.||+||+|+++-    ...||||.++....+.+..+|+.|+.+|.++.||||+++.|+.....
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~  703 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK  703 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence            34445555667889999999999998742    45799999998888889999999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          149 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      ...||+|||++|+|+.||..+++.+++.++..++++||.|+.||-+   .++|||||.++|||++.+..+|++||||++.
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceee
Confidence            9999999999999999999899999999999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCCC-ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhc
Q 015480          229 CDRNK-THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCEL  306 (406)
Q Consensus       229 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (406)
                      +..+. ......+.+-+.+|.|||.+..+ .++.++||||||++|||.++ |.+|+.       ++-...+.+       
T Consensus       781 ledd~~~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYW-------dmSNQdVIk-------  845 (996)
T KOG0196|consen  781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYW-------DMSNQDVIK-------  845 (996)
T ss_pred             cccCCCccccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCccc-------ccchHHHHH-------
Confidence            76544 33334455567799999999988 79999999999999999775 555542       222222222       


Q ss_pred             chhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                        .+..+-..+.+++++..|.+|+..||++|-.+||.+.+|+..|++++...
T Consensus       846 --aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  846 --AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             --HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence              23333445678899999999999999999999999999999999987543

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=361.79  Aligned_cols=276  Identities=30%  Similarity=0.389  Sum_probs=223.1

Q ss_pred             CCceeeChHHHhhhhhcccccccccceeEEEEEEeCC--C---cEEEEEEecc--ccchhhHHHHHHHHHHhhccCcCcc
Q 015480           65 EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN--G---VKIAVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINL  137 (406)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~--g---~~vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni  137 (406)
                      ..|+....+++...+..+.++||+|+||+||+|++..  +   ..||||..+.  .........|++|+++|++++||||
T Consensus       144 ~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NV  223 (474)
T KOG0194|consen  144 KRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNV  223 (474)
T ss_pred             cccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCE
Confidence            3455566788888888888999999999999997633  3   2389999884  3456677899999999999999999


Q ss_pred             ccEEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC
Q 015480          138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  217 (406)
Q Consensus       138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  217 (406)
                      |++||++.....+++|||+|.||+|.++|......++..+...++++.|+||+|||+   ++++||||.++|+|++.++.
T Consensus       224 Vr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~  300 (474)
T KOG0194|consen  224 VRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGV  300 (474)
T ss_pred             EEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCe
Confidence            999999999999999999999999999997777789999999999999999999999   99999999999999999999


Q ss_pred             ceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhH
Q 015480          218 PKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKH  296 (406)
Q Consensus       218 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  296 (406)
                      +||+||||++......  .......-+.+|+|||.+... .+++++|||||||++||+++ |..|+...       ....
T Consensus       301 vKISDFGLs~~~~~~~--~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~-------~~~~  370 (474)
T KOG0194|consen  301 VKISDFGLSRAGSQYV--MKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGM-------KNYE  370 (474)
T ss_pred             EEeCccccccCCccee--eccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCC-------CHHH
Confidence            9999999997654111  111122456799999999987 89999999999999999997 56554221       1111


Q ss_pred             HHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCCC
Q 015480          297 VWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPP  361 (406)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~p  361 (406)
                      +.....        ........+...+..+..++.+||..+|++||+|.++.+.|+.+.....++
T Consensus       371 v~~kI~--------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  371 VKAKIV--------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             HHHHHH--------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence            111110        112222334467788999999999999999999999999999987665543

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-47  Score=384.79  Aligned_cols=265  Identities=28%  Similarity=0.423  Sum_probs=221.2

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeCC--Cc----EEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecC
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFPN--GV----KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ  147 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~--g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  147 (406)
                      ++......+.+.||+|+||.||.|.+.+  |.    .||||.+++..+.....+|.+|..+|++++|||||+++|+|.+.
T Consensus       688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            3445566777889999999999997633  43    48999999887778889999999999999999999999999999


Q ss_pred             CeeEEEEEeccCCChhhHhhcC------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEe
Q 015480          148 HMTALVYEYMENGSLDGYLFGK------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVA  221 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (406)
                      ...+|++|||++|+|..||...      ...++...++.++.|||+|+.||++   +++|||||.++|+||+....+||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEc
Confidence            9999999999999999999766      5679999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhccc-ccccCCCcccccchhHHHHH
Q 015480          222 DFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR-NAIVGATESLDWFPKHVWEE  300 (406)
Q Consensus       222 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~  300 (406)
                      |||||+...............-+.+|||||.+... .++.++|||||||++||++|... |+..                
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY~~----------------  907 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPYPS----------------  907 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCCCC----------------
Confidence            99999966554443332222345699999999876 79999999999999999998553 3321                


Q ss_pred             HhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          301 YEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                      ..+.++......+++.+.+..|+..++++|..||+.+|++||++..|++.+..+....
T Consensus       908 ~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  908 RSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             cchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            1112222223333456777889999999999999999999999999999998886544

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-48  Score=355.64  Aligned_cols=268  Identities=22%  Similarity=0.307  Sum_probs=213.2

Q ss_pred             HhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCC-eeE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQH-MTA  151 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~  151 (406)
                      ....+|...++||.|+||.||+|+. .+|..||||.+++......+-.=.+|+..|++++ ||||+++.+++.+.+ .++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            3456788889999999999999964 5699999999988765544444578999999999 999999999999888 999


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +|||||+. +|.+++..+++.+++..+..|++||++||+|+|.   +|+.|||+||+|||+..+..+||+|||+|+....
T Consensus        87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc
Confidence            99999966 9999998889999999999999999999999999   9999999999999999888999999999997765


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHH-----HHHHhhhh-
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHV-----WEEYEKCE-  305 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-----~~~~~~~~-  305 (406)
                      ...   .+.++.|.+|.|||++.....|+.+.|+|++|||++|+.+-++.|-....-..-|....+     ++.+..+. 
T Consensus       163 kpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  163 KPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             CCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            443   345788999999999887778999999999999999999988766322211111100000     01111110 


Q ss_pred             c---chh----hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          306 L---GAM----ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       306 ~---~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      +   ..+    .....+.......+.++.+++..|++.||.+|||+.+.++
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            0   000    1111222333457889999999999999999999999998

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=9.6e-47  Score=357.76  Aligned_cols=263  Identities=24%  Similarity=0.393  Sum_probs=206.5

Q ss_pred             HhhhhhcccccccccceeEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecC
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQ  147 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  147 (406)
                      +...+|.+.++||+|+||.||+|.+      .++..||+|++...........+.+|+.++..+ +||||++++++|...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            4445678889999999999999964      235689999998654444556799999999999 899999999988764


Q ss_pred             -CeeEEEEEeccCCChhhHhhcCC--------------------------------------------------------
Q 015480          148 -HMTALVYEYMENGSLDGYLFGKK--------------------------------------------------------  170 (406)
Q Consensus       148 -~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------  170 (406)
                       ...++||||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             46789999999999999985321                                                        


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCC
Q 015480          171 -----RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP  245 (406)
Q Consensus       171 -----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~  245 (406)
                           ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++...............++.
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                 347888999999999999999999   999999999999999999999999999998654332222223345678


Q ss_pred             CccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHH
Q 015480          246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAK  324 (406)
Q Consensus       246 ~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (406)
                      .|+|||++.+. .++.++|||||||++|||++ |..||......      ..........         .....+...+.
T Consensus       241 ~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~  304 (338)
T cd05102         241 KWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------EEFCQRLKDG---------TRMRAPENATP  304 (338)
T ss_pred             cccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHHhcC---------CCCCCCCCCCH
Confidence            89999999876 78999999999999999997 88887532211      0111111111         11112234567


Q ss_pred             HHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          325 RLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       325 ~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      .+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            79999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-47  Score=349.82  Aligned_cols=263  Identities=23%  Similarity=0.296  Sum_probs=209.2

Q ss_pred             hhhcccccccccceeEEEEEE-eCCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecC--CeeEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTALV  153 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~-~~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  153 (406)
                      ..|.-.++||+|+||.||+|+ ..+|+.||+|.++-+. ......-..+|+.+|++|+||||+++.+...+.  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            344556789999999999995 5679999999998543 334456678999999999999999999998876  689999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      +|||+. +|..++....-.+++.++..++.|++.||.|||+   +|++|||||.+|||||.+|.+||+|||||+++....
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            999988 9999997777889999999999999999999999   999999999999999999999999999999887654


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc---------chhHHHHHHhhh
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW---------FPKHVWEEYEKC  304 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~---------~~~~~~~~~~~~  304 (406)
                      ... .++.+-|.+|.|||.+.+...|+.+.|+||.||||.||+.|++.+-.. .+..+.         -....|.   ..
T Consensus       273 ~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~-tEveQl~kIfklcGSP~e~~W~---~~  347 (560)
T KOG0600|consen  273 SAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR-TEVEQLHKIFKLCGSPTEDYWP---VS  347 (560)
T ss_pred             Ccc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc-cHHHHHHHHHHHhCCCChhccc---cc
Confidence            332 566778999999999999989999999999999999999999765322 110000         0000111   11


Q ss_pred             hcchhh-------ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          305 ELGAMI-------LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       305 ~~~~~~-------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .+....       ....+.+.....+....+|+..+|..||.+|.|+.++++
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            111100       111122333455677889999999999999999999987

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-47  Score=357.16  Aligned_cols=269  Identities=25%  Similarity=0.424  Sum_probs=216.8

Q ss_pred             ChHHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccc-cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCe
Q 015480           71 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM  149 (406)
Q Consensus        71 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  149 (406)
                      ..+++......+..+||+|+||+||+|+|. | .||||+++-. ......+.|+.|+.++++-+|.||+-+.|+|.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            345555555667789999999999999983 4 6999999854 234467899999999999999999999999998877


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                       .||+.+|+|.+|+.+++..+..+...+.+.|+.|||+|+.|||+   ++|||||||..||++.++++|||+||||+...
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeee
Confidence             99999999999999998888999999999999999999999999   99999999999999999999999999999643


Q ss_pred             CCCCceEEecCCCCCCCccCccccCC--CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ..-..........|...|||||+++-  ..+|++.+||||||+++|||++|..|+.....+..-|....       +.  
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGr-------G~--  609 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGR-------GY--  609 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecc-------cc--
Confidence            22111122233457789999999863  23689999999999999999999999874333322221100       00  


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                         ...........+++++.+|+..||..++++||.+.+|+..|+.+...
T Consensus       610 ---l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  610 ---LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             ---cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence               00111223356788999999999999999999999999999888654

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=349.47  Aligned_cols=251  Identities=24%  Similarity=0.338  Sum_probs=207.0

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  152 (406)
                      ...|.|.+.||+|+|++|++|+. .+++.||||++.+..-  +...+-+..|-++|.+| .||.|++++-.|+|+..+|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            35567889999999999999954 5699999999986421  12224467788999999 79999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |+||+++|+|.+++ .+.+.+++.....++.+|+.||+|||+   .|||||||||+|||||.|+++||+|||.|+.+...
T Consensus       152 vLe~A~nGdll~~i-~K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLI-KKYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEEecCCCcHHHHH-HHhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            99999999999999 455789999999999999999999999   99999999999999999999999999999876532


Q ss_pred             Cce---------EE--ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHH
Q 015480          233 KTH---------VT--ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEY  301 (406)
Q Consensus       233 ~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  301 (406)
                      ...         ..  ...++||..|.+||++... ..++.+|+|+||||+|+|+.|.+||.....       ...++..
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-------yliFqkI  299 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANE-------YLIFQKI  299 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccH-------HHHHHHH
Confidence            211         11  1458999999999999987 789999999999999999999999954422       1111211


Q ss_pred             hhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          302 EKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      -...          -..+...++.+.+|+.+.|..||.+|++.++|.+
T Consensus       300 ~~l~----------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  300 QALD----------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHhc----------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            1111          2334455578899999999999999999999887

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=333.99  Aligned_cols=265  Identities=24%  Similarity=0.301  Sum_probs=212.6

Q ss_pred             HhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ++...|.+...||.|..++||+|.. +.++.||||++.-+.+....+.+.+|+..|+.++||||++++..|..+..+|+|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            4556677888999999999999954 678999999999776666778999999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          154 YEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |.||.+|++.+++.. ....+++..+..|+.++++||.|||.   +|.||||||+.||||+++|.+||+|||.+..+...
T Consensus       103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            999999999999954 34569999999999999999999999   99999999999999999999999999998655433


Q ss_pred             Cce--EEecCCCCCCCccCcccc-CCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          233 KTH--VTISGYKGTPGYSAPEFL-SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       233 ~~~--~~~~~~~gt~~y~aPE~~-~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ...  .....+.||+.|||||++ ..-.+|+.|+||||||++..||.+|..||....+-      +.......+. ....
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~-pp~~  252 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQND-PPTL  252 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCC-CCCc
Confidence            222  122567899999999994 44457999999999999999999999998543211      0000111000 0000


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .....-.+........+.+++..||+.||.+|||+.++++
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0001111233456678999999999999999999999887

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-45  Score=345.85  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=207.1

Q ss_pred             hhhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc----chhhHHHHHHHHHHhhccC-cCccccEEEEEecCCe
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL----GRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHM  149 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  149 (406)
                      ....|.+.+.||+|+||+|+.|.. .+|+.||+|++.+..    .....+.+.+|+.+++.++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            344567788999999999999955 568999999877641    1123456778999999999 9999999999999999


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC-CCceEeccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKL  228 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~DfGl~~~  228 (406)
                      .++|||||.||+|.+++.. .+++.+..+..++.|+++|++|||+   +||+||||||+|||++.+ +++||+|||++..
T Consensus        95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999966 7889999999999999999999999   999999999999999999 9999999999987


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCCCC-CCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ..  .........+||+.|+|||++.+.. ....++||||+||+||.|++|..||+.....          .........
T Consensus       171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~----------~l~~ki~~~  238 (370)
T KOG0583|consen  171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP----------NLYRKIRKG  238 (370)
T ss_pred             cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH----------HHHHHHhcC
Confidence            74  1222345689999999999999875 4468999999999999999999999762211          111111111


Q ss_pred             hhhccCCCCcchHHH-HHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 AMILGCGIEEKDKEK-AKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .       -..+... +.++..++.+||..||.+|+++.+|+.
T Consensus       239 ~-------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  239 E-------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             C-------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            0       1122222 788999999999999999999999994

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-46  Score=348.04  Aligned_cols=247  Identities=24%  Similarity=0.335  Sum_probs=207.0

Q ss_pred             hcccccccccceeEEEEE-EeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      |.-..+||+|+.|.||.+ +..+++.||||++... .....+-+..|+.+|+..+|+|||++++.|...+.+|+||||++
T Consensus       275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~-~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~  353 (550)
T KOG0578|consen  275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR-KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME  353 (550)
T ss_pred             hcchhhhccccccceeeeeeccCCceEEEEEEEec-cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence            344568999999999999 4567899999999764 22345678899999999999999999999998899999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      ||+|.+.+  ....+++.++..|++++++||+|||.   +||+|||||.+|||++.+|.+||+|||++..+.......  
T Consensus       354 ggsLTDvV--t~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR--  426 (550)
T KOG0578|consen  354 GGSLTDVV--TKTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR--  426 (550)
T ss_pred             CCchhhhh--hcccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc--
Confidence            99999988  44459999999999999999999999   999999999999999999999999999998877655432  


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ..-+||+.|||||++... .|.++.||||||++++||+-|.+||..+.+-...+      -...        ........
T Consensus       427 ~TmVGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly------LIa~--------ng~P~lk~  491 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIAT--------NGTPKLKN  491 (550)
T ss_pred             ccccCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHHHH------HHhh--------cCCCCcCC
Confidence            346799999999999877 89999999999999999999999986532211000      0000        11112234


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       319 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      +...+..+.+++.+||+.|+.+||++.|+|+
T Consensus       492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  492 PEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            5667889999999999999999999999998

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2e-45  Score=314.02  Aligned_cols=264  Identities=22%  Similarity=0.312  Sum_probs=208.6

Q ss_pred             hhcccccccccceeEEEEEE-eCCCcEEEEEEeccc-cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~-~~~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      +|...++||+|.||.||+|+ ..+|+.||||.++.. ..........+|++.|+.++|+||+.++++|-..+...||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            45556789999999999995 567999999999853 2223346688999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      ++. +|...+..+...++..++..++.++++||+|||+   +.|+||||||.|+|++++|.+||+|||+++.+.......
T Consensus        83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence            976 9999998888899999999999999999999999   999999999999999999999999999999887665443


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc---------chhHHHHHHhh----
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW---------FPKHVWEEYEK----  303 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~---------~~~~~~~~~~~----  303 (406)
                      .  ..+-|.+|.|||.+.|...|+..+|+||.|||+.||+-|.+-| .+..+..+.         -....|..+..    
T Consensus       159 ~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f-pG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  159 T--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF-PGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             c--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC-CCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            3  2367889999999999889999999999999999999887544 333321110         00001111110    


Q ss_pred             hhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      .++.... ...........+..+.+|+..|+..||.+|+++.|+++.
T Consensus       236 ~~~~~~P-~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  236 VKIQQFP-KPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHhcCC-CCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            0111000 111122334566778999999999999999999999873

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.4e-45  Score=341.49  Aligned_cols=256  Identities=25%  Similarity=0.315  Sum_probs=202.9

Q ss_pred             HhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      +.-..|...+.||+|+||.||+|+- .+|..+|+|++++..  ...+.+..+.|-.+|....+|.||+++..|++.+.+|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            3445566778999999999999954 569999999998642  3345577899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      |||||++||++..+| .+...+++..+..++.+++.|+..+|.   .|++||||||+|+|||..|++||+||||+.-...
T Consensus       218 LiMEylPGGD~mTLL-~~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLL-MRKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEEecCCccHHHHH-HhcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            999999999999999 466789999999999999999999999   9999999999999999999999999999853211


Q ss_pred             C-----------------------Cce----EE------------------ecCCCCCCCccCccccCCCCCCCccccee
Q 015480          232 N-----------------------KTH----VT------------------ISGYKGTPGYSAPEFLSGNYPITHKCDVY  266 (406)
Q Consensus       232 ~-----------------------~~~----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Dvw  266 (406)
                      .                       ...    ..                  ....+|||.|||||++.+. +|+..+|+|
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-gY~~~cDwW  372 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-GYGKECDWW  372 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-CCCccccHH
Confidence            0                       000    00                  0124699999999999998 799999999


Q ss_pred             ecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCC---
Q 015480          267 SFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPP---  343 (406)
Q Consensus       267 slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---  343 (406)
                      |||||+||||.|.+||....+.          +.+.+.........   -+.....+.+..+||.+|+. ||.+|.-   
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~----------~T~rkI~nwr~~l~---fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G  438 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQ----------ETYRKIVNWRETLK---FPEEVDLSDEAKDLITRLLC-DPENRLGSKG  438 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHH----------HHHHHHHHHhhhcc---CCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence            9999999999999999655432          22221111111011   11122344889999999999 9999975   


Q ss_pred             hHHHHH
Q 015480          344 MSAVIK  349 (406)
Q Consensus       344 ~~~vl~  349 (406)
                      ++||-+
T Consensus       439 ~~EIK~  444 (550)
T KOG0605|consen  439 AEEIKK  444 (550)
T ss_pred             HHHHhc
Confidence            556554

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.7e-45  Score=334.50  Aligned_cols=259  Identities=25%  Similarity=0.366  Sum_probs=208.8

Q ss_pred             HhhhhhcccccccccceeEEEEEEeC----CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      ++...+.+.+.||+|+||.||+|.+.    .+..||+|.++..........+.+|+.++.+++||||+++++++..+...
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            34566788899999999999999753    36789999998765545557799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ++||||+++|+|.+++......+++..++.++.|++.||+|||+   .+++||||||+||+++.++.++++|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999999997666689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ..... ......++..|+|||.+.+. .++.++|||||||++||+++ |..||......       ...+...       
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-------~~~~~~~-------  222 (266)
T cd05064         159 SEAIY-TTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------DVIKAVE-------  222 (266)
T ss_pred             ccchh-cccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHH-------
Confidence            22111 11123456789999998876 78999999999999999775 88887532211       0111111       


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                        .......+..++..+.+++..||+.+|.+||++.+|++.|.++
T Consensus       223 --~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         223 --DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              1111223345677899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9.8e-45  Score=338.91  Aligned_cols=264  Identities=26%  Similarity=0.346  Sum_probs=202.9

Q ss_pred             hhhhcccccccccceeEEEEEEeCC-----------------CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCcccc
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPN-----------------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR  139 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  139 (406)
                      ...|.+.++||+|+||.||+|.+.+                 +..||+|++...........|.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3456778899999999999997532                 34699999986544455678999999999999999999


Q ss_pred             EEEEEecCCeeEEEEEeccCCChhhHhhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCee
Q 015480          140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKK------------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRII  201 (406)
Q Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~  201 (406)
                      +++++.+.+..++||||+++|+|.+++....                  ..+++..+..++.|++.||.|||+   .+++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence            9999999999999999999999999884321                  247888999999999999999999   9999


Q ss_pred             ecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhc--c
Q 015480          202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR--R  279 (406)
Q Consensus       202 H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg--~  279 (406)
                      ||||||+|||++.++.+||+|||+++...............++..|+|||++.+. .++.++||||||+++|||+++  .
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHccCC
Confidence            9999999999999999999999999866544333223344567899999998776 689999999999999999874  3


Q ss_pred             cccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          280 RNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       280 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                      .|+......       .........  ............+..++..+.+++.+||+.||.+|||+.+|.+.|++
T Consensus       240 ~p~~~~~~~-------~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         240 QPYGELTDE-------QVIENAGEF--FRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCcCCHH-------HHHHHHHHH--hhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            444321110       011110000  00000000011223456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5e-45  Score=350.26  Aligned_cols=261  Identities=24%  Similarity=0.366  Sum_probs=205.1

Q ss_pred             HhhhhhcccccccccceeEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecC
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQ  147 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  147 (406)
                      +....+.+.+.||+|+||+||+|++      .++..||||+++........+.+.+|+.++..+ +||||++++++|.+.
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            3344677789999999999999963      246689999997654444557789999999999 899999999999999


Q ss_pred             CeeEEEEEeccCCChhhHhhcCC---------------------------------------------------------
Q 015480          148 HMTALVYEYMENGSLDGYLFGKK---------------------------------------------------------  170 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  170 (406)
                      ...++|||||++|+|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            99999999999999999885321                                                         


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          171 -----------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       171 -----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                                       ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                             247888999999999999999999   999999999999999999999999999998665433


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      .........++..|+|||.+.+. .++.++|||||||++|||++ |..||......      ..........        
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~--------  333 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYKMIKEG--------  333 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHHHHHhC--------
Confidence            22222234456789999999876 78999999999999999998 77776432111      0111111111        


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                       .....+...+.++.+++.+||+.||++||++.+|++.|++.
T Consensus       334 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         334 -YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence             01111223456799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=7.2e-45  Score=348.89  Aligned_cols=263  Identities=23%  Similarity=0.359  Sum_probs=207.3

Q ss_pred             HHhhhhhcccccccccceeEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEec
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHD  146 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  146 (406)
                      .+....+.+.+.||+|+||.||+|.+      .++..||+|+++..........+.+|+++++.+ +|+||++++++|.+
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            44556678889999999999999864      234579999998654444557789999999999 89999999999999


Q ss_pred             CCeeEEEEEeccCCChhhHhhcCC--------------------------------------------------------
Q 015480          147 QHMTALVYEYMENGSLDGYLFGKK--------------------------------------------------------  170 (406)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------  170 (406)
                      ....++||||+++|+|.+++....                                                        
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            999999999999999999884321                                                        


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          171 -------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       171 -------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                                   ..+++..+.+++.|++.||+|||+   ++++||||||+|||+++++.+||+|||+++..........
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                         247888999999999999999999   9999999999999999999999999999986544332222


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                      .....++..|+|||++.+. .++.++|||||||++|||++ |+.||.......      .........         ...
T Consensus       271 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~---------~~~  334 (374)
T cd05106         271 KGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRG---------YQM  334 (374)
T ss_pred             ccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHcc---------cCc
Confidence            2233456789999998776 78999999999999999997 888875322110      001111110         001


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      ..+...+.++.+++.+||+.||++|||+.+|++.|+++.
T Consensus       335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            111223578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-46  Score=339.83  Aligned_cols=247  Identities=24%  Similarity=0.339  Sum_probs=209.5

Q ss_pred             hcccccccccceeEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      |+-.+.||+|+||.||+|. ..+++.||+|++.-+..+...+++.+|+.++++++++||.++|+.+..+..++++||||.
T Consensus        15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~   94 (467)
T KOG0201|consen   15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG   94 (467)
T ss_pred             cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence            3334679999999999995 467899999999977777778899999999999999999999999999999999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      ||++.+.+ .....+.+..+.-++.+++.||.|||.   ++.+|||||+.|||+..+|.+||+|||++..........  
T Consensus        95 gGsv~~lL-~~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--  168 (467)
T KOG0201|consen   95 GGSVLDLL-KSGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--  168 (467)
T ss_pred             Ccchhhhh-ccCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc--
Confidence            99999999 445556888899999999999999999   999999999999999999999999999998766543332  


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ..++||+.|||||++.+. .|+.++||||||++.+||.+|.+|+..-.+....+                .+-....+..
T Consensus       169 ~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf----------------lIpk~~PP~L  231 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF----------------LIPKSAPPRL  231 (467)
T ss_pred             ccccccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE----------------eccCCCCCcc
Confidence            568999999999999966 89999999999999999999999985443321111                1111112233


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       319 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...+++.+.+++..||.+||+.||++.++++
T Consensus       232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            3467788999999999999999999999887

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-45  Score=331.24  Aligned_cols=300  Identities=25%  Similarity=0.366  Sum_probs=223.4

Q ss_pred             HHhchhhHHHHHHh---cCCCceeeChHHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHH
Q 015480           49 WEAGQTMERFLQEI---GREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAE  125 (406)
Q Consensus        49 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e  125 (406)
                      ...+.++.+++...   +.+...++........+..+.+.||+|.||+||+|+| .|+.||||++..    ..+..+.+|
T Consensus       179 ~~~~stl~Dll~~~~tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s----rdE~SWfrE  253 (513)
T KOG2052|consen  179 LAGDSTLKDLLDDLETSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS----RDERSWFRE  253 (513)
T ss_pred             ccCCccHHHHHHhhccCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecc----cchhhhhhH
Confidence            34455666666443   5556666666777778888899999999999999999 689999999975    356788999


Q ss_pred             HHHhhc--cCcCccccEEEEEecC----CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHh----
Q 015480          126 VGTIGR--TYHINLVRLYGFCHDQ----HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE----  195 (406)
Q Consensus       126 ~~~l~~--l~h~niv~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----  195 (406)
                      .++...  |+|+||+.+++.-..+    .+++||++|.+.|||.|||  ++..++.+..++++..+|.||++||..    
T Consensus       254 tEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL--~r~tv~~~~ml~LalS~AsGLaHLH~eI~GT  331 (513)
T KOG2052|consen  254 TEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYL--NRNTVTTEGMLKLALSIASGLAHLHMEIVGT  331 (513)
T ss_pred             HHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHH--hhccCCHHHHHHHHHHHhhhHHHHHHHHhcC
Confidence            999875  5899999999876433    3788999999999999999  447899999999999999999999974    


Q ss_pred             -cCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce--EEecCCCCCCCccCccccCCCCC-----CCcccceee
Q 015480          196 -CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH--VTISGYKGTPGYSAPEFLSGNYP-----ITHKCDVYS  267 (406)
Q Consensus       196 -~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~Dvws  267 (406)
                       .++.|+|||||+.|||+..+|.+.|+|+|||.........  ...+..+||.+|||||++....+     .-..+||||
T Consensus       332 qgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYa  411 (513)
T KOG2052|consen  332 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYA  411 (513)
T ss_pred             CCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHH
Confidence             3678999999999999999999999999999876654332  33456789999999999976432     124689999


Q ss_pred             cchhHHHHhhccccccc---CCCcccccchhHH-HHHHhhhhcchhhccCCCC--cchHHHHHHHHHHHHHhcccCCCCC
Q 015480          268 FGMVLFEIVGRRRNAIV---GATESLDWFPKHV-WEEYEKCELGAMILGCGIE--EKDKEKAKRLCMVALWCVQDSPEDR  341 (406)
Q Consensus       268 lG~il~elltg~~p~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~R  341 (406)
                      ||.++||+..+..--..   ...+..++.+..+ .+++.+.--.+.+. ..++  -...+....+.++++.||..||.-|
T Consensus       412 fgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~R-P~ipnrW~s~~~l~~m~klMkeCW~~Np~aR  490 (513)
T KOG2052|consen  412 FGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLR-PNIPNRWKSDPALRVMAKLMKECWYANPAAR  490 (513)
T ss_pred             HHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccC-CCCCcccccCHHHHHHHHHHHHhhcCCchhh
Confidence            99999999743311000   0011111111111 12222211111111 1111  2234677889999999999999999


Q ss_pred             CChHHHHHHhhcccc
Q 015480          342 PPMSAVIKMLEGVVE  356 (406)
Q Consensus       342 Ps~~~vl~~L~~~~~  356 (406)
                      -|+--|-+.|.++..
T Consensus       491 ltALriKKtl~~l~~  505 (513)
T KOG2052|consen  491 LTALRIKKTLAKLSN  505 (513)
T ss_pred             hHHHHHHHHHHHHhc
Confidence            999999999988864

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-45  Score=314.77  Aligned_cols=235  Identities=27%  Similarity=0.313  Sum_probs=200.5

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      +++.+.||.|+||.|.+++.+ +|..+|+|++.+..  .-.+.++...|..+|+.+.||+++++++.|.+...++|||||
T Consensus        46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey  125 (355)
T KOG0616|consen   46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY  125 (355)
T ss_pred             hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence            455778999999999999764 58899999998642  233557788899999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      ++||.|..++ ++.+++++..+.-++.||+.||+|||+   .+|++|||||+|||||.+|.+||+|||+|+......   
T Consensus       126 v~GGElFS~L-rk~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT---  198 (355)
T KOG0616|consen  126 VPGGELFSYL-RKSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT---  198 (355)
T ss_pred             cCCccHHHHH-HhcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCcE---
Confidence            9999999999 566789999999999999999999999   999999999999999999999999999998776542   


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                        ...+||+.|+|||++..+ ++..++|+|||||++|||+.|.+||....+       ....+..-.++          -
T Consensus       199 --~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~KI~~~~----------v  258 (355)
T KOG0616|consen  199 --WTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYEKILEGK----------V  258 (355)
T ss_pred             --EEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHHHHHhCc----------c
Confidence              236799999999999988 899999999999999999999999965533       11222222222          2


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCC
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDR  341 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~R  341 (406)
                      ..+...+..+.+|+...|+.|-.+|
T Consensus       259 ~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            3445566789999999999999999

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3e-45  Score=334.39  Aligned_cols=250  Identities=33%  Similarity=0.525  Sum_probs=197.7

Q ss_pred             ccccccccceeEEEEEEeC-----CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           82 YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        82 ~~~~ig~G~~g~V~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      ..+.||.|+||.||+|.+.     .+..|+||.+.........+.|.+|++.+++++||||++++|++......++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4567999999999999875     36789999997654555678999999999999999999999999988889999999


Q ss_pred             ccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          157 MENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       157 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +++|+|.+++... ...+++.++..|+.|+++||+|||+   .+++|+||+++||+++.++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            9999999999766 6789999999999999999999999   89999999999999999999999999999877433333


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                      .......+...|+|||.+... .++.++||||||+++|||++ |+.|+.....       ....+....         ..
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~-~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-------~~~~~~~~~---------~~  222 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDG-EYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-------EEIIEKLKQ---------GQ  222 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHS-EESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-------HHHHHHHHT---------TE
T ss_pred             ccccccccccccccccccccc-ccccccccccccccccccccccccccccccc-------ccccccccc---------cc
Confidence            333445577899999999876 58999999999999999999 5666532211       111111111         11


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML  351 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  351 (406)
                      ....+..++..+.+++..||+.||.+||++.++++.|
T Consensus       223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1223345677899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1e-44  Score=337.83  Aligned_cols=245  Identities=25%  Similarity=0.374  Sum_probs=207.2

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccc-cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |...+.||+|+||.||||+- .+++.||+|.+.+. ..+.....+.+|+++++.++||||+.++++|+...+.++|+|||
T Consensus         4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a   83 (808)
T KOG0597|consen    4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA   83 (808)
T ss_pred             hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence            45567899999999999954 46899999999753 33445677999999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      .| +|..++ ..++.+.++.+..+++|++.||.|||+   .+|.|||+||.|||++.+|.+|+||||+|+....+  ...
T Consensus        84 ~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t~v  156 (808)
T KOG0597|consen   84 VG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--TSV  156 (808)
T ss_pred             hh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC--cee
Confidence            77 999999 567789999999999999999999999   99999999999999999999999999999976653  333


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      .+..+||+-|||||...+. .|+..+|.||+|||+||+.+|++||...          .+.+...      .+.... ..
T Consensus       157 ltsikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~----------si~~Lv~------~I~~d~-v~  218 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYAR----------SITQLVK------SILKDP-VK  218 (808)
T ss_pred             eeeccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHH----------HHHHHHH------HHhcCC-CC
Confidence            4668899999999999977 8999999999999999999999998422          1111111      111111 12


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .+.+.+..+..++...|.+||..|.+-.+++.
T Consensus       219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            33477788999999999999999999999876

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-45  Score=341.07  Aligned_cols=240  Identities=25%  Similarity=0.404  Sum_probs=205.1

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCChh
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLD  163 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  163 (406)
                      +-||+|+.|.||+|++. ++.||||.++.-        -..+++-|++|+||||+.|.|+|.....+|||||||..|-|.
T Consensus       130 eWlGSGaQGAVF~Grl~-netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH-NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhccCcccceeeeecc-CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            45999999999999994 678999977642        124788899999999999999999999999999999999999


Q ss_pred             hHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCC
Q 015480          164 GYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG  243 (406)
Q Consensus       164 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~g  243 (406)
                      ..| +.+..++......|..+||.|+.|||.   +.|||||||.-||||..+..+||+|||.++......+..   .++|
T Consensus       201 ~VL-ka~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkM---SFaG  273 (904)
T KOG4721|consen  201 EVL-KAGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKM---SFAG  273 (904)
T ss_pred             HHH-hccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhh---hhhh
Confidence            999 566789999999999999999999999   999999999999999999999999999998776554443   4889


Q ss_pred             CCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHH
Q 015480          244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKA  323 (406)
Q Consensus       244 t~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (406)
                      |..|||||++++. +.++|+|||||||+|||||||..|+.........|-.               -........+..++
T Consensus       274 TVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV---------------GsNsL~LpvPstcP  337 (904)
T KOG4721|consen  274 TVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV---------------GSNSLHLPVPSTCP  337 (904)
T ss_pred             hHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEEec---------------cCCcccccCcccCc
Confidence            9999999999988 8999999999999999999999998654433222210               01111234566788


Q ss_pred             HHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          324 KRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       324 ~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      +.+.-|+++||+..|.+||++.+|+..|+-..
T Consensus       338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             hHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            99999999999999999999999999998654

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-45  Score=341.43  Aligned_cols=262  Identities=24%  Similarity=0.369  Sum_probs=223.1

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeC---CC--cEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecC
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFP---NG--VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ  147 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~---~g--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  147 (406)
                      .++........++||.|-||.||+|.+.   .|  -.||||.++.+......+.|+.|.-+|++++||||++++|+|.+.
T Consensus       384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~  463 (974)
T KOG4257|consen  384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ  463 (974)
T ss_pred             ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence            3444455566788999999999999753   23  358999999877767789999999999999999999999999875


Q ss_pred             CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          148 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                       ..|||||.++-|.|..||..+...++..++..+++||+.+|+|||+   ..++||||..+|||+.....+||+|||+++
T Consensus       464 -P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  464 -PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             -ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhh
Confidence             5689999999999999999888999999999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhc
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCEL  306 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (406)
                      ..+....... +...-+..|||||.+..+ .++.++|||.|||.+||+++ |.+||..                ..+...
T Consensus       540 ~~ed~~yYka-S~~kLPIKWmaPESINfR-rFTtASDVWMFgVCmWEIl~lGvkPfqg----------------vkNsDV  601 (974)
T KOG4257|consen  540 YLEDDAYYKA-SRGKLPIKWMAPESINFR-RFTTASDVWMFGVCMWEILSLGVKPFQG----------------VKNSDV  601 (974)
T ss_pred             hccccchhhc-cccccceeecCccccchh-cccchhhHHHHHHHHHHHHHhcCCcccc----------------ccccce
Confidence            8876654433 234456789999999887 89999999999999999874 7777632                222333


Q ss_pred             chhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      ...+..+.+.+.+..|+..|+.|+.+||..+|.+||.+.++...|.++..
T Consensus       602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            33445566678889999999999999999999999999999998887654

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6e-44  Score=327.08  Aligned_cols=257  Identities=28%  Similarity=0.435  Sum_probs=209.3

Q ss_pred             hhhcccccccccceeEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ..+.+.+.||+|+||.||+|.+..    ...||+|.++..........|..|+.++.+++||||+++++++.+....+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            456778899999999999997742    4579999988665555667899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+++++|.+++......+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            99999999999997666689999999999999999999999   999999999999999999999999999998775332


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      .........++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....       ........         .
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~---------~  223 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSN-------QDVIKAVE---------D  223 (266)
T ss_pred             cceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCH-------HHHHHHHH---------c
Confidence            22222234456789999998876 78999999999999999997 8877643211       11111111         1


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      ....+.+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       224 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         224 GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111122234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.7e-44  Score=330.72  Aligned_cols=248  Identities=19%  Similarity=0.252  Sum_probs=199.9

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEec----CCeeEEEEEec
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHD----QHMTALVYEYM  157 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  157 (406)
                      ..||+|++|.||+|.+ +|+.||||+++....  ....+.+.+|+.+|.+++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            4699999999999998 788999999975422  1224678899999999999999999999876    34678999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++|+|.+++. ....+++.....++.|++.||.|||+  ..+++||||||+|||+++++.+||+|||+++......    
T Consensus       105 ~~g~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----  177 (283)
T PHA02988        105 TRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----  177 (283)
T ss_pred             CCCcHHHHHh-hCCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence            9999999994 44678999999999999999999997  2488899999999999999999999999997654322    


Q ss_pred             ecCCCCCCCccCccccCCC-CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          238 ISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                       ....|+..|+|||++.+. ..++.++|||||||++|||++|..||......       .......        ......
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------~~~~~i~--------~~~~~~  241 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------EIYDLII--------NKNNSL  241 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHH--------hcCCCC
Confidence             124578899999998752 26899999999999999999999998643211       1111110        011111


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      ..+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            222346778999999999999999999999999998764

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.1e-44  Score=329.98  Aligned_cols=256  Identities=25%  Similarity=0.428  Sum_probs=207.4

Q ss_pred             hhcccccccccceeEEEEEEeCC------CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      .+.+.+.||+|+||.||+|....      ...||+|.+...........+.+|+.++..++||||+++++++.+....++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            45677889999999999997532      257999999865554556779999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC
Q 015480          153 VYEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  217 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  217 (406)
                      +|||+++++|.+++....               ..+++..+..++.|++.||.|||+   .+++|+||||+||++++++.
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence            999999999999985321               458889999999999999999999   99999999999999999999


Q ss_pred             ceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhH
Q 015480          218 PKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKH  296 (406)
Q Consensus       218 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  296 (406)
                      ++|+|||++................+++.|+|||.+.+. .++.++|||||||++|||++ |..||.....       ..
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~-------~~  234 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-------QE  234 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence            999999999765433322222344567899999998776 68999999999999999998 8888753221       11


Q ss_pred             HHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          297 VWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      ....         +........+..++.++.+|+.+||+.||.+||++.+|++.|+.+
T Consensus       235 ~~~~---------i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         235 VIEM---------IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHH---------HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            1111         111222233456778999999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-44  Score=341.13  Aligned_cols=251  Identities=26%  Similarity=0.359  Sum_probs=212.9

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccc--cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      +.+.+-||.|+.|.|-+|++ .+|+.+|||++.+.  ........+.+|+-+|+.+.|||++.+|+++.+..++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            34567799999999999965 67999999999764  2333446688999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +++|-|.+++ ..++++.+..+..++.||+.|+.|||.   .+|+||||||+|+|||.++++||+|||+|..-.....  
T Consensus        94 v~gGELFdyl-v~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl--  167 (786)
T KOG0588|consen   94 VPGGELFDYL-VRKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL--  167 (786)
T ss_pred             cCCchhHHHH-HhhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCcc--
Confidence            9999999999 456788899999999999999999999   9999999999999999999999999999975443332  


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                       ..+.||++.|.+||++.+..+...++||||.|||||.||+|+.||+.+.-       .........+          .-
T Consensus       168 -LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-------r~LLlKV~~G----------~f  229 (786)
T KOG0588|consen  168 -LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-------RVLLLKVQRG----------VF  229 (786)
T ss_pred             -ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-------HHHHHHHHcC----------cc
Confidence             34578999999999999998889999999999999999999999974321       1222222222          23


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcc
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGV  354 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~  354 (406)
                      +.+...+.++++|+.+|+..||+.|.|+++|++  +|.+.
T Consensus       230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~  269 (786)
T KOG0588|consen  230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY  269 (786)
T ss_pred             cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence            455778889999999999999999999999998  44443

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.9e-43  Score=332.92  Aligned_cols=242  Identities=23%  Similarity=0.295  Sum_probs=196.6

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCC
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      +.||+|+||.||+++. .+|+.||+|+++...  .......+..|+.++..++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3599999999999965 568999999997542  2233456788999999999999999999999999999999999999


Q ss_pred             ChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecC
Q 015480          161 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG  240 (406)
Q Consensus       161 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~  240 (406)
                      +|.+++. ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........  ...
T Consensus        81 ~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~  154 (323)
T cd05571          81 ELFFHLS-RERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKT  154 (323)
T ss_pred             cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc--ccc
Confidence            9999884 45678999999999999999999999   99999999999999999999999999998753322111  223


Q ss_pred             CCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchH
Q 015480          241 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK  320 (406)
Q Consensus       241 ~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (406)
                      ..||+.|+|||++.+. .++.++|||||||++|||++|..||......       .........          ....+.
T Consensus       155 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~~~~~----------~~~~p~  216 (323)
T cd05571         155 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILME----------EIRFPR  216 (323)
T ss_pred             eecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHH-------HHHHHHHcC----------CCCCCC
Confidence            5689999999999876 7899999999999999999999998532211       001111000          012223


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          321 EKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       321 ~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                      ..+.++.+++.+||+.||++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            4567899999999999999999     7888876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.1e-44  Score=344.64  Aligned_cols=264  Identities=23%  Similarity=0.345  Sum_probs=208.5

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEe
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCH  145 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~  145 (406)
                      .+.....+.+.++||+|+||.||+|.+.      .+..||||++.........+.+.+|++++.++. ||||++++++|.
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            3344556677889999999999999752      234799999986555555678999999999996 999999999999


Q ss_pred             cCCeeEEEEEeccCCChhhHhhcCC-------------------------------------------------------
Q 015480          146 DQHMTALVYEYMENGSLDGYLFGKK-------------------------------------------------------  170 (406)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  170 (406)
                      +....+||||||++|+|.+++....                                                       
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            9999999999999999998885321                                                       


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcE
Q 015480          171 ----------------------------------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV  210 (406)
Q Consensus       171 ----------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Ni  210 (406)
                                                              ..+++..+..++.|+++||.|||+   .+++||||||+||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Ni  268 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhE
Confidence                                                    247888899999999999999999   9999999999999


Q ss_pred             EEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcc
Q 015480          211 LLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATES  289 (406)
Q Consensus       211 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~  289 (406)
                      |++.++.+||+|||+++...............++..|+|||.+.+. .++.++|||||||++|||++ |..|+...... 
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-  346 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-  346 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchh-
Confidence            9999999999999999865433322222334567889999998876 68999999999999999997 87777432111 


Q ss_pred             cccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          290 LDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                           .........         ......+...+..+.+++.+||+.||++||++.+|.+.|+.+.
T Consensus       347 -----~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         347 -----STFYNKIKS---------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             -----HHHHHHHhc---------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence                 001111111         1111223456678999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.8e-44  Score=335.04  Aligned_cols=260  Identities=25%  Similarity=0.350  Sum_probs=207.6

Q ss_pred             hhhhhcccccccccceeEEEEEEeC-CCc----EEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFP-NGV----KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      ....|...+.||+|+||.||+|.+. +|.    .||+|++.........+.+..|+.+++.++||||++++|+|... ..
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            3455677889999999999999753 343    38999987654445567899999999999999999999999875 46


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ++++||+++|+|.+++......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEcccccccccc
Confidence            79999999999999997766779999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ............++..|+|||.+.+. .++.++||||||+++|||++ |..|+......       .......       
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-------~~~~~~~-------  225 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EISSILE-------  225 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHh-------
Confidence            44433333334456789999999876 78999999999999999997 88887432110       0011111       


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                        .......+..++..+.+++..||+.+|.+||++.+++..|..+..
T Consensus       226 --~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         226 --KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             --CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence              111111223345678999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.4e-43  Score=322.81  Aligned_cols=252  Identities=27%  Similarity=0.443  Sum_probs=203.4

Q ss_pred             hhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      ..+.+.+.||+|+||.||++.+.++..+|+|.+...  ......+..|+.+++.++||||+++++++.+....++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            346677889999999999999888889999988753  234567899999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++|+|.+++......+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||+++........ .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~  157 (256)
T cd05114          82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-S  157 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-c
Confidence            9999999996655678999999999999999999999   99999999999999999999999999999765433222 1


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                      .....++..|+|||.+.+. .++.++||||||+++|||++ |+.||......       .........         ...
T Consensus       158 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-------~~~~~i~~~---------~~~  220 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-------EVVEMISRG---------FRL  220 (256)
T ss_pred             cCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCC---------CCC
Confidence            1233456689999998876 68999999999999999999 88777433211       011111111         001


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                      ..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            112223567899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.6e-43  Score=327.71  Aligned_cols=250  Identities=24%  Similarity=0.311  Sum_probs=200.2

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      |...+.||+|+||+||+|.. .+|+.||+|.+.....  ......+.+|+.++.+++|+||+++++++.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            45678899999999999965 5799999999875321  12334678899999999999999999999999999999999


Q ss_pred             ccCCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          157 MENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       157 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +++|+|.+++.. ....+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++........ 
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  157 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-  157 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence            999999888753 34468999999999999999999999   9999999999999999999999999999976543221 


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        .....||..|+|||++.+. .++.++|||||||++|||++|+.||........       .+.....     . ....
T Consensus       158 --~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-------~~~~~~~-----~-~~~~  221 (285)
T cd05631         158 --VRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-------REEVDRR-----V-KEDQ  221 (285)
T ss_pred             --ecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-------HHHHHHH-----h-hccc
Confidence              2345789999999999876 789999999999999999999999864322110       0111100     0 0011


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPP-----MSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  349 (406)
                      ...+...+..+.+|+.+||+.||.+||+     ++++++
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            1223345678999999999999999997     677776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.2e-44  Score=330.91  Aligned_cols=265  Identities=22%  Similarity=0.289  Sum_probs=200.9

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|.+.++||+|+||+||+|.. .++..||+|+++..........+.+|+.++++++||||+++++++.+....++||||+
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL   85 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence            366778999999999999965 4689999999875433334456789999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++ +|.+++......+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||+++.......  .
T Consensus        86 ~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~  159 (288)
T cd07871          86 DS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--T  159 (288)
T ss_pred             Cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--c
Confidence            75 9999886666678999999999999999999999   9999999999999999999999999999975443221  1


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc--------chhHHHHHHhh-hhcch
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW--------FPKHVWEEYEK-CELGA  308 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~-~~~~~  308 (406)
                      .....+++.|+|||++.+...++.++||||+||++|||++|+.||..........        .....|..... .....
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            2335678999999998765578999999999999999999999985432211000        00000110000 00000


Q ss_pred             hhccCCCC----cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 MILGCGIE----EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ........    ......+.++.+++.+||+.||.+|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000000    001123467889999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.1e-43  Score=320.78  Aligned_cols=249  Identities=24%  Similarity=0.365  Sum_probs=199.3

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCCh
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  162 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  162 (406)
                      +.||+|+||.||+|.+ .+|+.||+|.+...........+.+|++++++++||||+++++++.+....++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            3699999999999976 468999999987654445567899999999999999999999999999999999999999999


Q ss_pred             hhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCC
Q 015480          163 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK  242 (406)
Q Consensus       163 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~  242 (406)
                      .+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            99996656678999999999999999999999   999999999999999999999999999987544221111111122


Q ss_pred             CCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHH
Q 015480          243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKE  321 (406)
Q Consensus       243 gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (406)
                      ++..|+|||.+.+. .++.++||||||+++|||++ |..|+......       .......         .......+..
T Consensus       158 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~---------~~~~~~~~~~  220 (252)
T cd05084         158 IPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIE---------QGVRLPCPEL  220 (252)
T ss_pred             CceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHH---------cCCCCCCccc
Confidence            34579999998876 68999999999999999997 77766432110       0001110         1111122334


Q ss_pred             HHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          322 KAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       322 ~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                      .+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            5678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.9e-43  Score=326.16  Aligned_cols=256  Identities=26%  Similarity=0.397  Sum_probs=206.3

Q ss_pred             hhhcccccccccceeEEEEEEeCC------CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      .+|.+.+.||+|+||.||+|.+.+      +..||+|.++........+.+.+|++++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            456677889999999999997633      47899999986544445678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCc
Q 015480          152 LVYEYMENGSLDGYLFGK-------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP  218 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  218 (406)
                      +||||+++++|.+++...             ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence            999999999999998533             2357889999999999999999999   999999999999999999999


Q ss_pred             eEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHH
Q 015480          219 KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHV  297 (406)
Q Consensus       219 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  297 (406)
                      ||+|||++................++..|+|||.+.+. .++.++|||||||++|||++ |..||.......       .
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------~  233 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------V  233 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------H
Confidence            99999999765433222222233457789999999876 78999999999999999998 888875332210       1


Q ss_pred             HHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          298 WEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                      .....         .......+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus       234 ~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         234 IECIT---------QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHH---------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            11111         111122233466789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.6e-43  Score=330.98  Aligned_cols=242  Identities=25%  Similarity=0.315  Sum_probs=195.9

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCC
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      +.||+|+||.||++.. .+|..||+|++....  .......+..|+.++..++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3699999999999975 468999999997542  2233456788999999999999999999999999999999999999


Q ss_pred             ChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecC
Q 015480          161 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG  240 (406)
Q Consensus       161 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~  240 (406)
                      +|..++. ....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++........  ....
T Consensus        81 ~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~  154 (323)
T cd05595          81 ELFFHLS-RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT  154 (323)
T ss_pred             cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cccc
Confidence            9998884 44578999999999999999999999   9999999999999999999999999999875432221  1234


Q ss_pred             CCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchH
Q 015480          241 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK  320 (406)
Q Consensus       241 ~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (406)
                      ..||+.|+|||++.+. .++.++|||||||++|||++|+.||......       ..........          ...+.
T Consensus       155 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~~~~~~----------~~~p~  216 (323)
T cd05595         155 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEE----------IRFPR  216 (323)
T ss_pred             ccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCC----------CCCCC
Confidence            5689999999999876 7899999999999999999999998533211       0011111000          11223


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          321 EKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       321 ~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                      ..+..+.+++.+||+.||.+||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            4567889999999999999998     7888876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.4e-43  Score=326.66  Aligned_cols=263  Identities=24%  Similarity=0.368  Sum_probs=209.2

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEe
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCH  145 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  145 (406)
                      +++....|++.+.||+|+||.||++.+.      +...+|+|.+...........+.+|++++.++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            3455566777889999999999999763      23679999988654444556788999999999 7999999999999


Q ss_pred             cCCeeEEEEEeccCCChhhHhhc---------------CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcE
Q 015480          146 DQHMTALVYEYMENGSLDGYLFG---------------KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV  210 (406)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~---------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Ni  210 (406)
                      .+...+++|||+++|+|.+++..               ....+++..+..++.|++.||.|||+   .+++||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeE
Confidence            99999999999999999999853               23568999999999999999999999   9999999999999


Q ss_pred             EEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcc
Q 015480          211 LLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATES  289 (406)
Q Consensus       211 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~  289 (406)
                      +++.++.+||+|||+++...............++..|+|||.+.+. .++.++|||||||++|||++ |..|+.....  
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~--  240 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--  240 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCH--
Confidence            9999999999999999876543332222333456789999998776 78999999999999999997 7777632211  


Q ss_pred             cccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          290 LDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                           ........         .......+...+..+.+++.+||+.||.+|||+.++++.|++++
T Consensus       241 -----~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 -----EELFKLLK---------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -----HHHHHHHH---------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                 00111111         11111223345678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.1e-43  Score=330.81  Aligned_cols=244  Identities=23%  Similarity=0.259  Sum_probs=198.7

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||.||+|++. +|+.||+|++....  .....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus        19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   98 (329)
T PTZ00263         19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE   98 (329)
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence            4567788999999999999764 58999999997532  12234678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++|+|.+++. ....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++........ 
T Consensus        99 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-  173 (329)
T PTZ00263         99 FVVGGELFTHLR-KAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF-  173 (329)
T ss_pred             CCCCChHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc-
Confidence            999999999984 44578899999999999999999999   9999999999999999999999999999986543321 


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                          ...||+.|+|||++.+. .++.++|||||||++|||++|..||.....       ....+......          
T Consensus       174 ----~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~~~----------  231 (329)
T PTZ00263        174 ----TLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYEKILAGR----------  231 (329)
T ss_pred             ----eecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCC----------
Confidence                24689999999999877 689999999999999999999999853221       11111111110          


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPP-----MSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  349 (406)
                      ...+...+..+.+++.+||+.||.+||+     ++++++
T Consensus       232 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        232 LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            1112234567899999999999999997     577764

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.6e-43  Score=326.20  Aligned_cols=258  Identities=24%  Similarity=0.363  Sum_probs=203.3

Q ss_pred             hhhhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCe
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM  149 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  149 (406)
                      ...+|.+.+.||+|+||.||+|.+.      ++..||+|++...........+.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4556788899999999999998652      3567999998754343455678999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceE
Q 015480          150 TALVYEYMENGSLDGYLFGKK---------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV  220 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl  220 (406)
                      .++||||+++++|.+++....         ..+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999985322         246788999999999999999999   99999999999999999999999


Q ss_pred             eccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHH
Q 015480          221 ADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWE  299 (406)
Q Consensus       221 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  299 (406)
                      +|||+++...............++..|+|||.+.+. .++.++|||||||++|||++ |..|+.....       .....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-------~~~~~  232 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQVLR  232 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHH
Confidence            999999765443332222223457789999998876 68999999999999999999 5666632211       01111


Q ss_pred             HHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          300 EYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                      ..         ........+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus       233 ~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         233 FV---------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HH---------HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            11         1111112223456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.6e-43  Score=324.27  Aligned_cols=258  Identities=24%  Similarity=0.324  Sum_probs=202.7

Q ss_pred             hhcccccccccceeEEEEEEeC-CCc----EEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGV----KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      .+.+.+.||+|+||+||+|.+. +|+    .+++|.+...........+..|+..++.++||||+++++++.. ...+++
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i   86 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV   86 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence            4566788999999999999763 454    4778887654333445678888889999999999999998864 456789


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      +||+++|+|.+++......+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++......
T Consensus        87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            99999999999997667789999999999999999999999   999999999999999999999999999998654333


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      .........++..|+|||.+.+. .++.++||||||+++|||++ |..|+......       ...+....         
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~---------  226 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEK---------  226 (279)
T ss_pred             cccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHC---------
Confidence            32223345577899999998876 68999999999999999998 88877432211       00111111         


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                      ......+..++..+.+++.+||..||++|||+.++++.|..+...
T Consensus       227 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         227 GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            111111222445688899999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.3e-43  Score=332.86  Aligned_cols=262  Identities=25%  Similarity=0.387  Sum_probs=205.1

Q ss_pred             hhhhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEec-C
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHD-Q  147 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~  147 (406)
                      ...+|.+.+.||+|+||.||+|...      +++.||+|+++........+.+..|+.++.++ +|+||++++++|.. +
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3456778899999999999999532      35789999997544444456788999999999 79999999998865 4


Q ss_pred             CeeEEEEEeccCCChhhHhhcCC---------------------------------------------------------
Q 015480          148 HMTALVYEYMENGSLDGYLFGKK---------------------------------------------------------  170 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  170 (406)
                      ...+++|||+++++|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            57789999999999999884321                                                         


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCc
Q 015480          171 ---RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY  247 (406)
Q Consensus       171 ---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y  247 (406)
                         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.++|+|||++................++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence               267899999999999999999999   99999999999999999999999999999866443322222334567789


Q ss_pred             cCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHH
Q 015480          248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRL  326 (406)
Q Consensus       248 ~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (406)
                      +|||++.+. .++.++|||||||++|||++ |..||......      ..........         .....+...+.++
T Consensus       242 ~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~  305 (337)
T cd05054         242 MAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQID------EEFCRRLKEG---------TRMRAPEYATPEI  305 (337)
T ss_pred             cCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCcc------HHHHHHHhcc---------CCCCCCccCCHHH
Confidence            999999876 78999999999999999998 88887432111      0011111111         1111223445779


Q ss_pred             HHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          327 CMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       327 ~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      .+++.+||+.+|++||++.++++.|+.+..
T Consensus       306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-43  Score=330.79  Aligned_cols=253  Identities=22%  Similarity=0.288  Sum_probs=203.1

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||.||+|.+. +|+.||+|++.....  ......+..|+.++..++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            3567789999999999999765 589999999975421  1234568899999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++|+|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++.....    
T Consensus        82 ~~~g~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----  153 (333)
T cd05600          82 YVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----  153 (333)
T ss_pred             CCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence            999999999994 44578999999999999999999999   9999999999999999999999999999975543    


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                       ......||+.|+|||++.+. .++.++|||||||++|||++|..||......       .........  .........
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~--~~~~~~~~~  222 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-------ETWENLKYW--KETLQRPVY  222 (333)
T ss_pred             -ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHH-------HHHHHHHhc--cccccCCCC
Confidence             12345689999999999877 7899999999999999999999998543211       111111110  000111111


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      .......+.++.+++.+||..+|.+||++.++++.
T Consensus       223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            11112456789999999999999999999999973

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=324.09  Aligned_cols=255  Identities=23%  Similarity=0.296  Sum_probs=200.3

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-------------chhhHHHHHHHHHHhhccCcCccccEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-------------GRIAEEQFMAEVGTIGRTYHINLVRLYGF  143 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~niv~~~~~  143 (406)
                      ++|.+.+.||+|.||.|-+|.. .+++.||||++.+..             .....+...+|+.+|++++|||||+++.+
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            3456678899999999999965 569999999997531             11123578999999999999999999999


Q ss_pred             EecC--CeeEEEEEeccCCChhhHhhcCCCC-CCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceE
Q 015480          144 CHDQ--HMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV  220 (406)
Q Consensus       144 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl  220 (406)
                      ..+.  +.+|||+|||..|.+...  ...++ +++.++++++.+++.||+|||.   +||+||||||+|+||+++|++||
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEe
Confidence            9774  688999999999887542  24455 9999999999999999999999   99999999999999999999999


Q ss_pred             eccccccccCCC---CceEEecCCCCCCCccCccccCC---CCCCCcccceeecchhHHHHhhcccccccCCCcccccch
Q 015480          221 ADFGLAKLCDRN---KTHVTISGYKGTPGYSAPEFLSG---NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP  294 (406)
Q Consensus       221 ~DfGl~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~  294 (406)
                      +|||.+......   ..........||+.|+|||...+   ....+.+.||||+||+||.|+.|+.||..+         
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~---------  322 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD---------  322 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc---------
Confidence            999999766221   11112334689999999998876   334577899999999999999999998543         


Q ss_pred             hHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          295 KHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                       ...+.+++....     ...-+...+....+.+|+.++|.+||..|.+..+|....-
T Consensus       323 -~~~~l~~KIvn~-----pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  323 -FELELFDKIVND-----PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             -hHHHHHHHHhcC-----cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence             222333222211     1111222356778999999999999999999999887553

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.2e-43  Score=328.50  Aligned_cols=264  Identities=23%  Similarity=0.266  Sum_probs=199.8

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      ..|.+.+.||+|+||+||+|+.. +|+.||+|++...........+.+|+.+++.++||||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            35677889999999999999764 68999999997543333445678899999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +. ++|.+++......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++........  
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  158 (303)
T cd07869          85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--  158 (303)
T ss_pred             CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--
Confidence            95 58888886666778999999999999999999999   9999999999999999999999999999875432221  


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhh---h------hcc
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK---C------ELG  307 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~------~~~  307 (406)
                      ......|++.|+|||++.+...++.++|||||||++|||++|..||....... .... ........   .      ...
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ-DQLE-RIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHH-HHHHHhCCCChhhccchhhcc
Confidence            12345688999999998766568899999999999999999999986422110 0000 00000000   0      000


Q ss_pred             hhhc---cCCCCcch------HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 AMIL---GCGIEEKD------KEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~~~~---~~~~~~~~------~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....   ........      ...+..+.+++..||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000   00000000      012356889999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.7e-42  Score=327.02  Aligned_cols=242  Identities=24%  Similarity=0.312  Sum_probs=196.4

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCC
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      +.||+|+||.||++.. .+|+.||+|++....  .......+.+|+.+++.++||||+++++++.+++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999965 468999999997542  2234467888999999999999999999999999999999999999


Q ss_pred             ChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecC
Q 015480          161 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG  240 (406)
Q Consensus       161 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~  240 (406)
                      +|.+++. ....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.......  ....
T Consensus        81 ~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~  154 (328)
T cd05593          81 ELFFHLS-RERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKT  154 (328)
T ss_pred             CHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cccc
Confidence            9998884 44578999999999999999999999   9999999999999999999999999999875432221  1234


Q ss_pred             CCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchH
Q 015480          241 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK  320 (406)
Q Consensus       241 ~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (406)
                      ..||+.|+|||++.+. .++.++|||||||++|||++|+.||......       ......         ... ....+.
T Consensus       155 ~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------~~~~~~---------~~~-~~~~p~  216 (328)
T cd05593         155 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELI---------LME-DIKFPR  216 (328)
T ss_pred             ccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHH-------HHHHHh---------ccC-CccCCC
Confidence            5789999999999876 7899999999999999999999998532211       000100         000 012223


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          321 EKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       321 ~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                      ..+..+.+++.+||+.||.+||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            4567789999999999999997     8888876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.4e-43  Score=331.59  Aligned_cols=266  Identities=24%  Similarity=0.355  Sum_probs=204.2

Q ss_pred             hhhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ....|...+.||+|+||.||+++.. +|..||+|++...........+.+|++++++++||||+++++++.+++..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            3456677889999999999999764 688999999986544455678999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+++|+|.+++. ....+++..+..++.|++.||.|||+  ..+++||||||+|||++.++.+||+|||++....... 
T Consensus        83 e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          83 EHMDGGSLDQVLK-EAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             ecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            9999999999984 34568999999999999999999998  2469999999999999999999999999987553321 


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc-cchhHH----------------
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD-WFPKHV----------------  297 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-~~~~~~----------------  297 (406)
                         .....|+..|+|||++.+. .++.++|||||||++|||++|+.||......... .+....                
T Consensus       159 ---~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         159 ---ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             ---cccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence               2335689999999999876 7899999999999999999999998532211000 000000                


Q ss_pred             -------------HHHHhhhhcchhhccCCCCc-chHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          298 -------------WEEYEKCELGAMILGCGIEE-KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       298 -------------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                                   ............+....... .....+.++.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~  300 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN  300 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                         00000000000000000011 11235678999999999999999999999987

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.1e-43  Score=325.30  Aligned_cols=255  Identities=22%  Similarity=0.334  Sum_probs=203.7

Q ss_pred             hhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      .+.+.+.||+|+||.||+|.+.      ++..||+|+++........+.+..|+.++..++||||+++++++.+....++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4566778999999999999753      2578999999865444455778999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC
Q 015480          153 VYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  217 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  217 (406)
                      ++||+.+++|.+++...               ...+++..+..++.|++.||+|||+   ++++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence            99999999999998421               2357888999999999999999999   99999999999999999999


Q ss_pred             ceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhH
Q 015480          218 PKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKH  296 (406)
Q Consensus       218 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  296 (406)
                      +||+|||+++...............+++.|+|||.+.+. .++.++|||||||++|||++ |..|+.....       ..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~  234 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QD  234 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence            999999998865443332223344567899999998766 68999999999999999998 6666532211       11


Q ss_pred             HHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          297 VWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                      ..+...         .......+..++..+.+++..||+.+|.+||++++|+..|+.
T Consensus       235 ~~~~i~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         235 VIEMIR---------NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHH---------cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            111111         111222334567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-44  Score=332.62  Aligned_cols=264  Identities=25%  Similarity=0.373  Sum_probs=217.4

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      +......+.++||+|-||+|.++....+..||||.++.........+|.+|+++|.+++||||+.++|+|..++.+++|+
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            33344567789999999999999987789999999998877777899999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCC-CCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          155 EYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      ||+++|+|.+|+..+..+ +.-....+|+.||+.|++||.+   .+++||||.++|+|++.++++||+|||+++.+....
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCC
Confidence            999999999999665433 3556778899999999999999   999999999999999999999999999999777666


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHh--hcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV--GRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ell--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ........+-+.+|||||.+... .++.++|||+||+++||++  +..+|+..-..+       .+.     .+...+..
T Consensus       692 yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-------~vv-----en~~~~~~  758 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-------QVV-----ENAGEFFR  758 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-------HHH-----HhhhhhcC
Confidence            55554556667899999988776 7999999999999999976  455555321111       111     11112222


Q ss_pred             c---CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          312 G---CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       312 ~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      .   ..+...+.-++..+++++.+||+.+-.+||+++++...|.+.
T Consensus       759 ~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  759 DQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            2   123455677889999999999999999999999999988654

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.6e-43  Score=318.91  Aligned_cols=252  Identities=25%  Similarity=0.434  Sum_probs=203.4

Q ss_pred             hhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      ..+.+.+.||+|+||.||+|++.++..+|+|.+....  ...+.+.+|+.++.+++||||+++++++.+....++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            3467788899999999999988777789999987532  33567899999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++|+|.+++......+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++........ .
T Consensus        82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~  157 (256)
T cd05113          82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-S  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-e
Confidence            9999999996655578999999999999999999999   99999999999999999999999999998765433221 1


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                      .....++..|+|||.+.+. .++.++||||||+++|||++ |..|+......       .........         ...
T Consensus       158 ~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~---------~~~  220 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-------ETVEKVSQG---------LRL  220 (256)
T ss_pred             cCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHhcC---------CCC
Confidence            2233456789999999876 68899999999999999998 88776432211       111111111         011


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                      ..+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            112234678999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-43  Score=328.79  Aligned_cols=241  Identities=21%  Similarity=0.266  Sum_probs=193.6

Q ss_pred             ccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCCh
Q 015480           86 LGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  162 (406)
Q Consensus        86 ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  162 (406)
                      ||+|+||.||+|... +++.||+|++....  .......+..|+.++.+++||||+++++++.+....++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999764 58899999987532  223446788899999999999999999999999999999999999999


Q ss_pred             hhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCC
Q 015480          163 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK  242 (406)
Q Consensus       163 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~  242 (406)
                      .+++.. ...+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++.......  ......
T Consensus        81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~  154 (312)
T cd05585          81 FHHLQR-EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFC  154 (312)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccccc
Confidence            999843 4578999999999999999999999   9999999999999999999999999999975432221  123456


Q ss_pred             CCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHH
Q 015480          243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK  322 (406)
Q Consensus       243 gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (406)
                      ||+.|+|||++.+. .++.++|||||||++|||++|..||......       ........         . ....+...
T Consensus       155 gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~-------~~~~~~~~---------~-~~~~~~~~  216 (312)
T cd05585         155 GTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-------EMYRKILQ---------E-PLRFPDGF  216 (312)
T ss_pred             CCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHH-------HHHHHHHc---------C-CCCCCCcC
Confidence            89999999999876 7899999999999999999999998532211       00111100         0 01223345


Q ss_pred             HHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          323 AKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       323 ~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      +..+.+++.+||+.||.+||++..+.+.
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~  244 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEI  244 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence            6788999999999999999865444333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.1e-43  Score=319.40  Aligned_cols=255  Identities=28%  Similarity=0.443  Sum_probs=206.2

Q ss_pred             hhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      ...+.+.++||+|+||.||+|...++..||+|.+...  ....+.+.+|+.+++.++|+||+++++++.+....+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            3456778899999999999998878889999998753  23457889999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          157 MENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       157 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +++++|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            9999999998543 4568999999999999999999999   99999999999999999999999999999865433221


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                       ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||......       .........         .
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~---------~  221 (261)
T cd05072         160 -AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-------DVMSALQRG---------Y  221 (261)
T ss_pred             -ccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-------HHHHHHHcC---------C
Confidence             12233456789999998776 68899999999999999998 88877432111       111111110         0


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      ..+.....+..+.+++.+||+.+|++||+++++.+.|+++
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         222 RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            1112223567799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.6e-43  Score=322.74  Aligned_cols=255  Identities=23%  Similarity=0.376  Sum_probs=203.2

Q ss_pred             hhcccccccccceeEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      .+.+.+.||+|+||.||+|.+     .++..||+|.+...........+.+|+++++.++||||+++++++......++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   85 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML   85 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence            356678899999999999974     246789999998654444556788999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC
Q 015480          154 YEYMENGSLDGYLFGK----------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  217 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  217 (406)
                      |||+++++|.+++...                ...+++.++..++.|++.||+|||+   ++++||||||+|||+++++.
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCc
Confidence            9999999999998422                2347889999999999999999999   99999999999999999999


Q ss_pred             ceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhH
Q 015480          218 PKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKH  296 (406)
Q Consensus       218 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  296 (406)
                      +||+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |..||.....       ..
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------~~  234 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------QE  234 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence            999999999866443322222334567789999998766 68999999999999999998 7777642211       11


Q ss_pred             HHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          297 VWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                      ..+....         ......+..++..+.+++.+||+.||++||++.+|++.|..
T Consensus       235 ~~~~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 VIEMVRK---------RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHc---------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1111111         11112233456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-43  Score=319.13  Aligned_cols=257  Identities=32%  Similarity=0.452  Sum_probs=206.3

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      +...++++.+.||+|++|.||+|.+.+++.||+|.++...  ...+.+.+|+.++++++||||+++++++......+++|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            3445677889999999999999988778889999987532  24567899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          155 EYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       155 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      ||+++++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            999999999999543 3578999999999999999999999   999999999999999999999999999998765322


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      .. ...+...+..|+|||.+.+. .++.++||||||+++|||++ |+.|+.....       ..........        
T Consensus       158 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~--------  220 (261)
T cd05068         158 YE-AREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-------AEVLQQVDQG--------  220 (261)
T ss_pred             cc-ccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcC--------
Confidence            11 11122334579999998876 78999999999999999999 8877743211       1111111110        


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                       .....+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       221 -~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         221 -YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence             01112234567899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.7e-43  Score=324.00  Aligned_cols=260  Identities=24%  Similarity=0.386  Sum_probs=206.6

Q ss_pred             hhhhcccccccccceeEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      ...+.+.+.||+|+||+||++..      .++..+|+|.+... .......+.+|+.++.+++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            34566778899999999999964      23456899988754 234456799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcCC------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCc
Q 015480          151 ALVYEYMENGSLDGYLFGKK------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP  218 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  218 (406)
                      ++||||+++++|.+++....            ..+++.++..++.|++.||+|||+   .+++||||||+||++++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence            99999999999999985322            358999999999999999999999   999999999999999999999


Q ss_pred             eEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHH
Q 015480          219 KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHV  297 (406)
Q Consensus       219 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  297 (406)
                      ||+|||++................++..|+|||.+.+. .++.++|||||||++|+|++ |..||......       ..
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------~~  231 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------EV  231 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HH
Confidence            99999999866443332222334457789999999876 78999999999999999998 78776432211       11


Q ss_pred             HHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          298 WEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                      .......         .....+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       232 ~~~i~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         232 IECITQG---------RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHHHHcC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            1111111         11112223456799999999999999999999999999988644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-42  Score=321.22  Aligned_cols=259  Identities=27%  Similarity=0.384  Sum_probs=207.1

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCc----EEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGV----KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      ...+.+.+.||+|+||+||+|.+ .+|.    .||+|++...........+..|+.++..++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            44567778999999999999975 3454    48999987655555667889999999999999999999999764 467


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +++||+++|+|.+++......+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            9999999999999997666789999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      ...........++..|+|||.+.+. .++.++|||||||++|||++ |..|+......       .......        
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~--------  225 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-------EIPDLLE--------  225 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHH--------
Confidence            4333222334456789999998776 68999999999999999998 77776432211       0011111        


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                       .......+...+..+.+++..||+.||++||++.++++.|+.+..
T Consensus       226 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         226 -KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             -CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence             111112233456789999999999999999999999999987743

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-42  Score=321.22  Aligned_cols=269  Identities=23%  Similarity=0.354  Sum_probs=207.1

Q ss_pred             hhhhcccccccccceeEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecC--Ce
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HM  149 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~  149 (406)
                      +..|...+.||+|+||.||++++     .++..||+|.++..........+.+|+.+++.++|||++++++++.+.  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            34566778899999999999974     357889999998654445567899999999999999999999998775  56


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+++++|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||+++..
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            889999999999999996555678999999999999999999999   99999999999999999999999999999866


Q ss_pred             CCCCceE-EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc----chhHHHHHHhhh
Q 015480          230 DRNKTHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW----FPKHVWEEYEKC  304 (406)
Q Consensus       230 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~----~~~~~~~~~~~~  304 (406)
                      ....... ......++..|+|||.+.+. .++.++||||||+++|||++++.|...........    .........   
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  235 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL---  235 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH---
Confidence            5433221 12234567789999998876 68999999999999999999876543211100000    000000000   


Q ss_pred             hcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                        ............+..++..+.+++.+||+.||++||++.++++.|+.+
T Consensus       236 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         236 --VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             --HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence              000111111122234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.6e-44  Score=320.63  Aligned_cols=249  Identities=21%  Similarity=0.393  Sum_probs=210.1

Q ss_pred             hhhhcccccccccceeEEEEEE-eCCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ..+|.+.+.||+|.||+|-++. ...|+.||||.++++.  .+...-.+.+|+++|+.|+||||+.+|.+|.+.+.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            4567778889999999999995 4789999999998753  334456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||..+|.|.+|+ ..++.+++..+..++.||.+|+.|+|.   ++++|||||.+|||+|+|+++||+||||+..+....
T Consensus       132 MEYaS~GeLYDYi-Ser~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  132 MEYASGGELYDYI-SERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEecCCccHHHHH-HHhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            9999999999999 567789999999999999999999998   999999999999999999999999999998776554


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      .   ...++|++-|.+||++.+...-.+.+|-||||++||-|+.|..||+.....       ........+...      
T Consensus       208 f---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~GaYr------  271 (668)
T KOG0611|consen  208 F---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGAYR------  271 (668)
T ss_pred             H---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhccccc------
Confidence            3   356899999999999999977789999999999999999999998643221       111111222111      


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                           ..+.+....-|+.+||-.||++|.|+.+|...
T Consensus       272 -----EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  272 -----EPETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             -----CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                 12234456779999999999999999999873

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-43  Score=328.81  Aligned_cols=244  Identities=23%  Similarity=0.243  Sum_probs=198.8

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||.||+|... +|+.||+|++....  .....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            3567788999999999999764 68999999986432  12244668899999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++|+|.+++. ..+.+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||++.......  
T Consensus        82 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--  155 (291)
T cd05612          82 YVPGGELFSYLR-NSGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--  155 (291)
T ss_pred             CCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence            999999999984 44578999999999999999999999   999999999999999999999999999997654322  


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                         ....|++.|+|||++.+. .++.++|||||||++|||++|+.||.....       ....+......          
T Consensus       156 ---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~----------  214 (291)
T cd05612         156 ---WTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNP-------FGIYEKILAGK----------  214 (291)
T ss_pred             ---ccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC----------
Confidence               224689999999999876 689999999999999999999999854321       11111111110          


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPP-----MSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  349 (406)
                      ...+...+..+.+++.+||+.||.+||+     ++++++
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         215 LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            1122334667899999999999999995     777765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.5e-42  Score=316.34  Aligned_cols=249  Identities=25%  Similarity=0.361  Sum_probs=200.0

Q ss_pred             cccccceeEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCC
Q 015480           85 RLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  161 (406)
                      .||+|+||.||+|.+.   ++..||+|++.........+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999653   3567999999866544556779999999999999999999999864 46789999999999


Q ss_pred             hhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE-EecC
Q 015480          162 LDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV-TISG  240 (406)
Q Consensus       162 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~  240 (406)
                      |.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......... ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            999997667789999999999999999999999   999999999999999999999999999997654332211 1222


Q ss_pred             CCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          241 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       241 ~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ..++..|+|||.+.+. .++.++||||||+++|||++ |..||......       ......         ........+
T Consensus       158 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~---------~~~~~~~~~  220 (257)
T cd05115         158 GKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------EVMSFI---------EQGKRLDCP  220 (257)
T ss_pred             CCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHH---------HCCCCCCCC
Confidence            3346789999998766 68999999999999999996 88887533211       011111         111112233


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      ..++.++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            45578899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.6e-42  Score=327.82  Aligned_cols=253  Identities=23%  Similarity=0.254  Sum_probs=201.8

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||+||++.. .+|+.||+|+++....  ......+..|+.++..++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            356778999999999999965 4689999999985422  2344668889999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++|+|.+++......+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++.........
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            999999999997666789999999999999999999999   99999999999999999999999999999866543322


Q ss_pred             EEecCCCCCCCccCccccCC-----CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          236 VTISGYKGTPGYSAPEFLSG-----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                       ......||+.|+|||++..     ...++.++|||||||++|||++|..||.......       ........  ....
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~--~~~~  228 (330)
T cd05601         159 -NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-------TYNNIMNF--QRFL  228 (330)
T ss_pred             -eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-------HHHHHHcC--CCcc
Confidence             2233568999999999863     2357889999999999999999999985432210       01111000  0000


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                         . .......+..+.+++..||+ +|.+||++.++++
T Consensus       229 ---~-~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         229 ---K-FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ---C-CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence               0 01112356778999999998 9999999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-42  Score=331.95  Aligned_cols=247  Identities=25%  Similarity=0.377  Sum_probs=196.0

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      +...++||+|+||+||+|.+ .+|+.||||++...........+.+|+++++.++|+||+++++++.+.+..++||||++
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  155 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD  155 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence            34567899999999999976 46899999999765444556789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      +|+|.+.     ....+..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++.........  .
T Consensus       156 ~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~  225 (353)
T PLN00034        156 GGSLEGT-----HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--C  225 (353)
T ss_pred             CCccccc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc--c
Confidence            9998653     245677888999999999999999   99999999999999999999999999999865432211  2


Q ss_pred             cCCCCCCCccCccccCCC----CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          239 SGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                      ....||..|+|||++...    ...+.++|||||||++|||++|+.||......  .+..     .....      ....
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~-----~~~~~------~~~~  292 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWAS-----LMCAI------CMSQ  292 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHH-----HHHHH------hccC
Confidence            235689999999987432    23456899999999999999999998633221  1100     00000      0011


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ........+.++.+++.+||+.||++||++.++++
T Consensus       293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            12233456678999999999999999999999988

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.5e-42  Score=322.19  Aligned_cols=258  Identities=26%  Similarity=0.406  Sum_probs=206.6

Q ss_pred             hhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      .+.+.+.||+|+||.||+|+..      ++..+++|.+.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            3556788999999999999642      35568999886542 2344678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC
Q 015480          153 VYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  217 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  217 (406)
                      ||||+++++|.+++...               ...+++..++.++.|++.||+|||+   ++++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence            99999999999998532               2348999999999999999999999   99999999999999999999


Q ss_pred             ceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhH
Q 015480          218 PKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKH  296 (406)
Q Consensus       218 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  296 (406)
                      ++|+|||++................++..|+|||.+.+. .++.++||||||+++|||++ |..|+......       .
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~  233 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------E  233 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------H
Confidence            999999999765443322222334567889999998876 68999999999999999998 88887433211       1


Q ss_pred             HHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          297 VWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                      ..+...         ...........+..+.+++.+||+.+|.+||++.+|++.|+++...
T Consensus       234 ~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         234 VIECIT---------QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHHHh---------CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            111111         1111222334567899999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=336.89  Aligned_cols=245  Identities=26%  Similarity=0.315  Sum_probs=203.0

Q ss_pred             HhhhhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccC-cCccccEEEEEecCCee
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMT  150 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  150 (406)
                      +.-..+.+.+.||+|+||+|+++..+ +++.+|||++++..  .....+..+.|-+++...+ ||.+++++.+|+..+++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34455677899999999999999764 58899999999763  3445677888988888775 99999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      |+||||+.||++..+  .....+++..+.-++..|+.||+|||+   ++|||||||.+|||||.+|++||+||||++..-
T Consensus       445 ~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccC
Confidence            999999999995433  466789999999999999999999999   999999999999999999999999999998554


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      ....  ..+.++||+.|||||++.+. .|+.++|+|||||+|||||.|..||..+..+..       .+..        +
T Consensus       520 ~~g~--~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-------FdsI--------~  581 (694)
T KOG0694|consen  520 GQGD--RTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-------FDSI--------V  581 (694)
T ss_pred             CCCC--ccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHH--------h
Confidence            2222  34579999999999999988 899999999999999999999999965433211       1111        1


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCCh
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPM  344 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  344 (406)
                      .+.  ...+...+.+...++.++|..||++|.-+
T Consensus       582 ~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  582 NDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             cCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            110  23455678889999999999999999866

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1e-42  Score=323.09  Aligned_cols=257  Identities=27%  Similarity=0.400  Sum_probs=204.8

Q ss_pred             hcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      +.+.+.||+|+||.||+|...      ....+++|.+...........+.+|+.+++.++||||+++++.+..++..+++
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI   81 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence            456678999999999999752      23578999987655445567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcE
Q 015480          154 YEYMENGSLDGYLFGK-----------------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV  210 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Ni  210 (406)
                      +||+.+++|.+++...                       ...+++.+++.++.|++.||+|||+   .+++||||||+||
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ni  158 (290)
T cd05045          82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNV  158 (290)
T ss_pred             EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheE
Confidence            9999999999987431                       1357899999999999999999999   9999999999999


Q ss_pred             EEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcc
Q 015480          211 LLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATES  289 (406)
Q Consensus       211 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~  289 (406)
                      |+++++.+||+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |..||....   
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~---  234 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---  234 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence            9999999999999999765433322222334567789999998766 68999999999999999998 887774321   


Q ss_pred             cccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          290 LDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                          +...++.....         .....+...+..+.+++.+||+.+|.+||++.++++.|+++..
T Consensus       235 ----~~~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         235 ----PERLFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             ----HHHHHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                11112211111         0111223455789999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-43  Score=320.08  Aligned_cols=269  Identities=29%  Similarity=0.406  Sum_probs=207.5

Q ss_pred             cccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhc--cCcCccccEEEEEecCC----eeEEEE
Q 015480           81 NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR--TYHINLVRLYGFCHDQH----MTALVY  154 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~  154 (406)
                      ++.++||+|+||.||+|++ +++.||||++..    ...+.|..|-++.+.  +.|+||+++++.-....    .++||+
T Consensus       213 ~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhHHHhhcCccceeehhhc-cCceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            4456799999999999999 458999999975    466778888888775  57999999999875544    889999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHh------cCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE------CQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~------~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      +|.+.|+|.+||  +...++|....+|+..+++||+|||+.      .+++|+|||||.+||||..|+++.|+|||||..
T Consensus       288 ~fh~kGsL~dyL--~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  288 EFHPKGSLCDYL--KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             eeccCCcHHHHH--HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence            999999999999  566899999999999999999999974      367899999999999999999999999999998


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCCCCCCC-----cccceeecchhHHHHhhcccccccCCCc-ccccchhHHHHHHh
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT-----HKCDVYSFGMVLFEIVGRRRNAIVGATE-SLDWFPKHVWEEYE  302 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DvwslG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~  302 (406)
                      +.........-+.+||.+|||||++.+..++.     .+.||||+|.+||||+++..-...+..+ ....+...+-+.-.
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            87665555555688999999999998765554     4689999999999999987655432222 11111111111111


Q ss_pred             hhhcchhhc-cCCCCcch-----HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          303 KCELGAMIL-GCGIEEKD-----KEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       303 ~~~~~~~~~-~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      -.++...+. ...++..+     ......+.+.+..||..||+.|.|+.=+-+++..+..
T Consensus       446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence            111222221 22222222     2456779999999999999999999999998877753

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.6e-43  Score=330.21  Aligned_cols=246  Identities=23%  Similarity=0.262  Sum_probs=199.4

Q ss_pred             hhhhcccccccccceeEEEEEEeCC--CcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPN--GVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~--g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      -..|.+.+.||+|+||.||+|.+.+  +..||+|++....  .....+.+..|+.++..++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3456778899999999999997543  3689999986532  22344678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ||||+++|+|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++......
T Consensus       109 v~Ey~~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLR-RNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999984 44578999999999999999999999   99999999999999999999999999999765432


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      .     ....||+.|+|||++.+. .++.++|||||||++|||++|..||......       ..........       
T Consensus       185 ~-----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~-------  244 (340)
T PTZ00426        185 T-----YTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGI-------  244 (340)
T ss_pred             c-----ceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCC-------
Confidence            2     235689999999999876 6899999999999999999999998543211       1111111110       


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                         ...+...+..+.+++.+||+.||.+|+     +++++++
T Consensus       245 ---~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        245 ---IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence               111223456688999999999999995     8888876

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.1e-42  Score=328.96  Aligned_cols=267  Identities=24%  Similarity=0.349  Sum_probs=203.7

Q ss_pred             HhhhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      +....|++.++||+|+||.||++.+. +|..+|+|.+...........+.+|++++.+++||||++++++|.+++..++|
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            34566788899999999999999764 58889999987654445567799999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+++|+|.+++. ....+++..+..++.|++.||.|||+  ..+++||||||+|||++.++.+||+|||++.......
T Consensus        82 ~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          82 MEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             EecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            99999999999984 34568899999999999999999997  2479999999999999999999999999987553221


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccch-------------------
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP-------------------  294 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-------------------  294 (406)
                          .....|+..|+|||++.+. .++.++|||||||++|||++|+.||............                   
T Consensus       159 ----~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         159 ----ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             ----cccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence                1235689999999999876 6899999999999999999999988533211000000                   


Q ss_pred             -hHHHHHHh--------hhhcchhhccCCCCcc-hHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          295 -KHVWEEYE--------KCELGAMILGCGIEEK-DKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       295 -~~~~~~~~--------~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       ........        .......+.....+.. ....+.++.+++.+||+.||++|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence             00000000        0000000000000110 1124567899999999999999999999976

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-43  Score=317.27  Aligned_cols=251  Identities=27%  Similarity=0.449  Sum_probs=202.1

Q ss_pred             hhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      .+.+.+.||+|+||.||+|.+.++..+|+|.+....  .....+.+|++++++++||||+++++++.+....++||||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            356778899999999999988777889999986532  234578899999999999999999999999999999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      +++|.+++......+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++........ ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~  158 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SS  158 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc-cc
Confidence            999999996656688999999999999999999999   99999999999999999999999999999765432211 11


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      ....++..|+|||.+.+. .++.++||||||+++|||++ |..||......       ........         .....
T Consensus       159 ~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~---------~~~~~  221 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-------EVVESVSA---------GYRLY  221 (256)
T ss_pred             CCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-------HHHHHHHc---------CCcCC
Confidence            222345689999998876 68999999999999999998 77777432111       01111110         01112


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                      .+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            22346778999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4e-43  Score=345.03  Aligned_cols=264  Identities=23%  Similarity=0.300  Sum_probs=210.7

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeCCC-cEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEE-EEec---
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNG-VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYG-FCHD---  146 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~-~~~~---  146 (406)
                      +++...+..+.+.|.+|||+.||+|....+ ..||+|++... .+...+.+++|+++|++|. |+|||.+++ ....   
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~  110 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS  110 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence            455666677788999999999999987665 99999999876 6677889999999999997 999999999 3321   


Q ss_pred             ---CCeeEEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEec
Q 015480          147 ---QHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD  222 (406)
Q Consensus       147 ---~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (406)
                         .-+.+|+||||.||.|-++++.+ ...|++.++++|++|+++|+++||. ++.+|||||||.+||||+.+|..||||
T Consensus       111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCc
Confidence               13567999999999999999633 3459999999999999999999998 346799999999999999999999999


Q ss_pred             cccccccCCCCc-eEEe------cCCCCCCCccCccccC--CCCCCCcccceeecchhHHHHhhcccccccCCCcccccc
Q 015480          223 FGLAKLCDRNKT-HVTI------SGYKGTPGYSAPEFLS--GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWF  293 (406)
Q Consensus       223 fGl~~~~~~~~~-~~~~------~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~  293 (406)
                      ||.+.-...... ....      -...-|+.|+|||++.  .+...++|+|||+|||+||-|+....||+..+.-..   
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI---  266 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI---  266 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE---
Confidence            999863322211 0000      0123589999999864  344799999999999999999999999976533211   


Q ss_pred             hhHHHHHHhhhhcchhhccCCC-CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          294 PKHVWEEYEKCELGAMILGCGI-EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                                       ..+.. -+....++..+.+||..||+.||.+||++.+|+..+-++....
T Consensus       267 -----------------lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  267 -----------------LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             -----------------EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                             11111 1222678999999999999999999999999999988876543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.6e-43  Score=309.88  Aligned_cols=263  Identities=20%  Similarity=0.223  Sum_probs=201.9

Q ss_pred             cccccccccceeEEEEEEe-CCCcEEEEEEeccccch-hhHHHHHHHHHHhhccCcCccccEEEEEec--CCeeEEEEEe
Q 015480           81 NYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGR-IAEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMTALVYEY  156 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~  156 (406)
                      ...++|++|+||.||+|++ ++++.||+|+++.+... .-.-...+|+.+|.+.+|||||.+-.+...  -+..||||||
T Consensus        79 e~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~  158 (419)
T KOG0663|consen   79 EKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY  158 (419)
T ss_pred             HHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence            3456899999999999976 46899999999865321 122456899999999999999999988754  3578999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      |+. +|..++....+++...++..+..|+++|++|||.   ..|+|||||++|+|++..|.+||+|||+|+.+.....  
T Consensus       159 ~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k--  232 (419)
T KOG0663|consen  159 VEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK--  232 (419)
T ss_pred             HHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCcc--
Confidence            987 9999998778899999999999999999999999   9999999999999999999999999999998876632  


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc--------cchhHHHHHHhhhhcch
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD--------WFPKHVWEEYEKCELGA  308 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~  308 (406)
                      .++..+-|.+|.|||.+.+...|+.+.|+||+|||+.||+++++.|........-        .-....|..+..-....
T Consensus       233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k  312 (419)
T KOG0663|consen  233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK  312 (419)
T ss_pred             cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence            2345667999999999999989999999999999999999998776433221100        00011111111111110


Q ss_pred             hhccCC------CCcchH-HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 MILGCG------IEEKDK-EKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~~~~~~------~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ......      ...+.. ..+..-.+|+..+|..||.+|.|+.+.++
T Consensus       313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            000000      000111 14467789999999999999999999887

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.5e-42  Score=320.13  Aligned_cols=262  Identities=22%  Similarity=0.307  Sum_probs=210.1

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCC-----CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec-CC
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPN-----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-QH  148 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~  148 (406)
                      +...+|.+.+.||+|+||.||+|.+.+     +..|++|.+...........+.+|+.++..++||||+++++++.+ +.
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            345567788899999999999998755     788999998866555667788999999999999999999998766 56


Q ss_pred             eeEEEEEeccCCChhhHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEe
Q 015480          149 MTALVYEYMENGSLDGYLFGKK-------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVA  221 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (406)
                      ..+++++|+++++|.+++....       ..+++.++..++.|++.||+|||+   .+++|+||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEEC
Confidence            7889999999999999985422       468999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHH
Q 015480          222 DFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEE  300 (406)
Q Consensus       222 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  300 (406)
                      |||+++...............++..|+|||++.+. .++.++||||||+++||+++ |+.|+......       .....
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~  231 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-------EMAAY  231 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-------HHHHH
Confidence            99999865443333222334567789999999876 68999999999999999998 88887532211       11111


Q ss_pred             HhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          301 YEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      ....         ........++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       232 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         232 LKDG---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHcC---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1110         0111223346789999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.9e-43  Score=344.48  Aligned_cols=249  Identities=17%  Similarity=0.229  Sum_probs=201.1

Q ss_pred             hcccccccccceeEEEEEEe-CC-CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |.+.+.||+|+||.||+|.. .+ ++.||+|.+... .......+..|+.+++.++||||+++++++.+.+..+|||||+
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            67788999999999999954 34 678899877543 2234456788999999999999999999999999999999999


Q ss_pred             cCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          158 ENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       158 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ++|+|.+++..   ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++........
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999988743   34568999999999999999999999   9999999999999999999999999999986654332


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                      ........||+.|+|||++.+. .++.++|||||||++|||++|+.||......       .......         ...
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-------~~~~~~~---------~~~  287 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQR-------EIMQQVL---------YGK  287 (478)
T ss_pred             cccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHH---------hCC
Confidence            2223446799999999999876 7899999999999999999999998532110       0111111         111


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....+...+..+.+++..||+.||++||++.+++.
T Consensus       288 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        288 YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            12223345678999999999999999999999864

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.6e-42  Score=317.86  Aligned_cols=258  Identities=27%  Similarity=0.454  Sum_probs=206.8

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CC---cEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NG---VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      ...++..+.||+|+||.||+|... ++   ..+|+|.+.........+.+..|++++.+++|||++++++++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            345667789999999999999764 23   37999998765444556789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ||||+++++|.+++......+++.++..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            999999999999997666789999999999999999999999   99999999999999999999999999999766433


Q ss_pred             CceE-EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          233 KTHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       233 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      .... .......+..|+|||.+.+. .++.++|||||||++|||++ |..|+......       .......        
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-------~~~~~i~--------  224 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-------EVMKAIN--------  224 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHh--------
Confidence            2211 11122335579999998876 68999999999999999997 88887432210       1111111        


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                       ...........+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       225 -~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         225 -DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             1111122234567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.1e-43  Score=323.98  Aligned_cols=265  Identities=21%  Similarity=0.238  Sum_probs=199.6

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      +|.+.+.||+|+||+||+|++. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            4667888999999999999774 58899999987542 223456788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      ++++.+..+. .....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++......... 
T Consensus        82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  156 (287)
T cd07848          82 VEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-  156 (287)
T ss_pred             CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-
Confidence            9987776544 445679999999999999999999999   99999999999999999999999999999865432211 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc--------cchhHHHHHHh-hhhcc
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD--------WFPKHVWEEYE-KCELG  307 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~-~~~~~  307 (406)
                      ......|+..|+|||++.+. .++.++|||||||++|||++|+.||.........        ..+...+.... .....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             cccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            12335689999999999876 6899999999999999999999988543211100        00000000000 00000


Q ss_pred             hhhccC--CCC----cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 AMILGC--GIE----EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~~~~~~--~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ......  ...    ......+..+.+++.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000  000    001124677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.3e-42  Score=327.14  Aligned_cols=269  Identities=25%  Similarity=0.375  Sum_probs=211.2

Q ss_pred             hHHHhhhhhcccccccccceeEEEEEEeC--------CCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEE
Q 015480           72 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP--------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYG  142 (406)
Q Consensus        72 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~  142 (406)
                      .+++...+|.+.+.||+|+||.||++...        .+..||+|.+...........+.+|++++.++ +||||+++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            34566667888999999999999999642        12368999988654445567899999999999 7999999999


Q ss_pred             EEecCCeeEEEEEeccCCChhhHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCC
Q 015480          143 FCHDQHMTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP  207 (406)
Q Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~  207 (406)
                      ++.+....+++|||+++|+|.+++...               ...+++.++..++.|++.||.|||+   .+++||||||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp  162 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAA  162 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeecccccc
Confidence            999999999999999999999998532               2357889999999999999999999   9999999999


Q ss_pred             CcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCC
Q 015480          208 ENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGA  286 (406)
Q Consensus       208 ~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~  286 (406)
                      +||+++.++.+||+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |..||....
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~  241 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  241 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999999765443222222223345689999999876 68999999999999999998 666663221


Q ss_pred             CcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCC
Q 015480          287 TESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPP  360 (406)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~  360 (406)
                      .       ........         .......+...+..+.+++.+||+.+|.+||++.++++.|+.+......
T Consensus       242 ~-------~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~  299 (334)
T cd05100         242 V-------EELFKLLK---------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST  299 (334)
T ss_pred             H-------HHHHHHHH---------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence            1       00111111         1111122334567899999999999999999999999999998765543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-42  Score=324.85  Aligned_cols=264  Identities=24%  Similarity=0.380  Sum_probs=209.0

Q ss_pred             HHhhhhhcccccccccceeEEEEEEe--------CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEE
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQF--------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFC  144 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  144 (406)
                      ++....+.+.+.||+|+||.||+|++        .++..||+|.+...........+.+|+.++..+ +||||+++++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            45566677889999999999999964        124579999987654445567899999999999 799999999999


Q ss_pred             ecCCeeEEEEEeccCCChhhHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCc
Q 015480          145 HDQHMTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN  209 (406)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~N  209 (406)
                      ......++||||+++|+|.+++...               ...+++.++..++.|+++||+|||+   .+++||||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccce
Confidence            9999999999999999999998542               2357888999999999999999999   999999999999


Q ss_pred             EEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCc
Q 015480          210 VLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATE  288 (406)
Q Consensus       210 ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~  288 (406)
                      |++++++.+||+|||+++...............++..|+|||++.+. .++.++||||||+++|||++ |..|+..... 
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-  245 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-  245 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCH-
Confidence            99999999999999999866543332222334467789999999876 68999999999999999998 6666532110 


Q ss_pred             ccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          289 SLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                            ....+...         .......+..++..+.+++.+||+.+|.+|||+.++++.|+++...
T Consensus       246 ------~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         246 ------EELFKLLK---------EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             ------HHHHHHHH---------cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                  11111111         1111122334567899999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.2e-42  Score=320.39  Aligned_cols=255  Identities=29%  Similarity=0.405  Sum_probs=202.1

Q ss_pred             hhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      ..+.+.+.||+|+||.||+|.+.      .+..||+|.............+..|+.+++.++|+||+++++++.+....+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            44667789999999999999764      357899998876544555677999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCC------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC---CceEec
Q 015480          152 LVYEYMENGSLDGYLFGKK------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVAD  222 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~D  222 (406)
                      +||||+++++|.+++....      ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++   .+||+|
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEecc
Confidence            9999999999999985432      258999999999999999999999   9999999999999998765   599999


Q ss_pred             cccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHH
Q 015480          223 FGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEY  301 (406)
Q Consensus       223 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  301 (406)
                      ||+++................+..|+|||++.+. .++.++|||||||++|||++ |..||......       ..... 
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-------~~~~~-  233 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-------EVMEF-  233 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH-
Confidence            9999866433222221222345689999999876 68999999999999999997 88777432211       00111 


Q ss_pred             hhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          302 EKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                              +........+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       234 --------~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 --------VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             --------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                    1111112223445678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.6e-42  Score=328.05  Aligned_cols=252  Identities=21%  Similarity=0.232  Sum_probs=198.8

Q ss_pred             hcccccccccceeEEEEEEe----CCCcEEEEEEecccc---chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeE
Q 015480           80 SNYSTRLGFGGFGEVYKGQF----PNGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~----~~g~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  151 (406)
                      |.+.+.||+|+||.||+++.    .+|+.||+|++.+..   .....+.+..|+.++..+ +||||+++++++.++...+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            56678899999999999965    358899999987532   122345678899999999 4999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +||||+++|+|.+++. .+..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++....
T Consensus        82 lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          82 LILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            9999999999999984 34568999999999999999999999   9999999999999999999999999999976533


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ..... .....||..|+|||++.+...++.++|||||||++|||++|..||.........   .........        
T Consensus       158 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~--------  225 (332)
T cd05614         158 EEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILK--------  225 (332)
T ss_pred             cCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhc--------
Confidence            22211 123568999999999987646789999999999999999999998643221110   011111100        


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                        .....+...+..+.+++.+||+.||++||     +++++++
T Consensus       226 --~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 --CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence              00122234567789999999999999999     6677775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.2e-42  Score=334.90  Aligned_cols=264  Identities=23%  Similarity=0.355  Sum_probs=207.0

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEe
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCH  145 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~  145 (406)
                      +++....+.+.++||+|+||.||+|.+.      .+..||+|+++........+.+..|++++.++. ||||++++++|.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4555556677789999999999999753      346899999986544444567899999999997 999999999999


Q ss_pred             cCCeeEEEEEeccCCChhhHhhcCC-------------------------------------------------------
Q 015480          146 DQHMTALVYEYMENGSLDGYLFGKK-------------------------------------------------------  170 (406)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  170 (406)
                      .....++||||+++|+|.++++...                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999985321                                                       


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCC
Q 015480          171 ------------------------------------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE  208 (406)
Q Consensus       171 ------------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~  208 (406)
                                                                ..+++..+..++.|++.||.|||+   .+++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcc
Confidence                                                      236778889999999999999998   99999999999


Q ss_pred             cEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCC
Q 015480          209 NVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGAT  287 (406)
Q Consensus       209 Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~  287 (406)
                      |||+++++.+||+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999865432222122234567889999999876 68999999999999999998 7777643211


Q ss_pred             cccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          288 ESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      .      .........         ......+...+.++.+++..||+.+|.+||++.+|++.|+.++
T Consensus       348 ~------~~~~~~~~~---------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 N------EQFYNAIKR---------GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             h------HHHHHHHHc---------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            0      000111111         1111122335678999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-42  Score=316.83  Aligned_cols=255  Identities=29%  Similarity=0.429  Sum_probs=204.6

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ...+.+.+.||+|+||.||+|.+. +++.||+|.+..+  ......+.+|++++..++||||+++++++..+...+++||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            344667788999999999999764 5889999998754  2345678999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          156 YMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       156 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      |+++++|.+++... ...+++..+..++.|+++||+|||+   .+++||||||+||++++++.+||+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999998543 4568999999999999999999999   9999999999999999999999999999976644322


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      . ......++..|+|||.+.+. .++.++|||||||++|||++ |..|+......       ..+.....         .
T Consensus       160 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~---------~  221 (263)
T cd05052         160 T-AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEK---------G  221 (263)
T ss_pred             e-ccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHC---------C
Confidence            1 11223346689999998876 78999999999999999998 77776432111       11111111         0


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      .....+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus       222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            11122334567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-42  Score=320.28  Aligned_cols=272  Identities=25%  Similarity=0.379  Sum_probs=202.8

Q ss_pred             hhhcccccccccceeEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec--CCee
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMT  150 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  150 (406)
                      ..+.+.+.||+|+||.||++..     .++..||+|.+... .....+.+.+|++++.+++||||+++++++..  ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            3566778899999999999974     35889999998754 23445678999999999999999999998754  3467


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++....
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            89999999999999996666679999999999999999999999   999999999999999999999999999998664


Q ss_pred             CCCceEEe-cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          231 RNKTHVTI-SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       231 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ........ ....++..|+|||.+.+. .++.++||||||+++|||++|..++.......................+...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            43322111 122344569999998876 6899999999999999999987654322111000000000000000000011


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      .............+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            111111122334567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.9e-42  Score=321.85  Aligned_cols=263  Identities=23%  Similarity=0.346  Sum_probs=208.3

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEe
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCH  145 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  145 (406)
                      ..+....+.+.+.||+|+||.||++..      ..+..||+|+++........+.+.+|+.+++++ +||||+++++++.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            345556678889999999999999964      135579999987654444557899999999999 7999999999999


Q ss_pred             cCCeeEEEEEeccCCChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccc
Q 015480          146 DQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  224 (406)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfG  224 (406)
                      ..+..+++|||+++|+|.+++.... ..+++.++..++.|++.||+|||+   .+++|+||||+|||++.++.++|+|||
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCc
Confidence            9999999999999999999996433 348999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhh
Q 015480          225 LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEK  303 (406)
Q Consensus       225 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  303 (406)
                      ++................++..|+|||.+.+. .++.++|||||||++|||++ |..|+......      ........ 
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------~~~~~~~~-  258 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------SKFYKLIK-  258 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------HHHHHHHH-
Confidence            99865443322222334567889999998876 68999999999999999998 88876432211      00001111 


Q ss_pred             hhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                              .......+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus       259 --------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 --------EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --------cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                    0001111223456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.4e-42  Score=324.36  Aligned_cols=242  Identities=24%  Similarity=0.258  Sum_probs=194.5

Q ss_pred             ccccccceeEEEEEEe----CCCcEEEEEEecccc---chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           84 TRLGFGGFGEVYKGQF----PNGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~----~~g~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      +.||+|+||.||+++.    .+|+.||+|++....   .......+..|+.++..++||||+++++++.+++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999965    357899999997532   122335678899999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +++++|.+++. ....+.+..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++........ 
T Consensus        82 ~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  156 (323)
T cd05584          82 LSGGELFMHLE-REGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV-  156 (323)
T ss_pred             CCCchHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc-
Confidence            99999999884 44568888999999999999999999   99999999999999999999999999998754322211 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                       .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......       .........          ..
T Consensus       157 -~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~~~~~~~----------~~  217 (323)
T cd05584         157 -THTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTIDKILKG----------KL  217 (323)
T ss_pred             -ccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcC----------CC
Confidence             1235689999999999876 6889999999999999999999998543211       011111111          01


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                      ..+...+..+.+++.+||+.||++||     ++.++++
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            12233456789999999999999999     7888776

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-42  Score=321.12  Aligned_cols=264  Identities=23%  Similarity=0.337  Sum_probs=201.3

Q ss_pred             hhhhhcccccccccceeEEEEEEeCC---------------CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccE
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFPN---------------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL  140 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  140 (406)
                      ...+|.+.++||+|+||.||++....               ...||+|.++..........+.+|++++.+++|||++++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            34567788899999999999986532               235899999865554556789999999999999999999


Q ss_pred             EEEEecCCeeEEEEEeccCCChhhHhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCc
Q 015480          141 YGFCHDQHMTALVYEYMENGSLDGYLFGKK-----------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN  209 (406)
Q Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~N  209 (406)
                      ++++......++||||+++++|.+++....           ..+++..+..++.|++.||+|||+   .+++|+||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence            999999999999999999999999984321           246889999999999999999999   999999999999


Q ss_pred             EEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhc--ccccccCCC
Q 015480          210 VLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR--RRNAIVGAT  287 (406)
Q Consensus       210 ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg--~~p~~~~~~  287 (406)
                      |++++++.+||+|||++................++..|+|||.+.+. .++.++||||||+++|+|+++  ..||.....
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            99999999999999999765433322222233457789999998876 689999999999999999984  444432111


Q ss_pred             cccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          288 ESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                      .       ........  .............+...+..+.+++.+||+.||++|||+++|++.|.
T Consensus       239 ~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 E-------QVIENTGE--FFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             H-------HHHHHHHH--hhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1       00000000  00000000001112234578999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-42  Score=319.37  Aligned_cols=259  Identities=25%  Similarity=0.360  Sum_probs=205.9

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCC------CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      +....+.+.+.||+|+||.||+|...+      +..||+|.+...........+.+|+.++..++||||+++++++.+..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            344566778899999999999997632      46899999876544455567889999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCce
Q 015480          149 MTALVYEYMENGSLDGYLFGK---------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK  219 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k  219 (406)
                      ..++||||+++|+|.+++...         ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEE
Confidence            999999999999999998532         2347889999999999999999999   9999999999999999999999


Q ss_pred             EeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHH
Q 015480          220 VADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVW  298 (406)
Q Consensus       220 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  298 (406)
                      |+|||+++...............++..|+|||.+.+. .++.++|||||||++|||++ |..|+......       ...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~~~  231 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-------EVL  231 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHH-------HHH
Confidence            9999999765443322222334567899999998766 68999999999999999998 77776422111       111


Q ss_pred             HHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          299 EEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                      +...         .......+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       232 ~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         232 KFVI---------DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHHh---------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            1111         111122233347789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-43  Score=328.32  Aligned_cols=250  Identities=24%  Similarity=0.338  Sum_probs=212.1

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccc-cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCe-eEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM-TALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e  155 (406)
                      .|...+++|+|+||.++.++.+ ++..|++|.+.-. ..........+|+.++++++|||||.+.+.|.+++. .+|||+
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~   84 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME   84 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence            4566788999999999999653 5778999988743 233445578899999999999999999999999888 999999


Q ss_pred             eccCCChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          156 YMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+||+|.+.+...+ ..+.++.+..++.|++.|+.|||+   ..|+|||||+.||+++.++.+||+|||+|+.......
T Consensus        85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            999999999996554 778999999999999999999998   9999999999999999999999999999998876652


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                      .  .....||+.||.||.+.+. +|..|+|||||||++|||++-+++|.......                +...+....
T Consensus       162 ~--a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~----------------Li~ki~~~~  222 (426)
T KOG0589|consen  162 L--ASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE----------------LILKINRGL  222 (426)
T ss_pred             h--hheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccchHH----------------HHHHHhhcc
Confidence            2  2347799999999999987 89999999999999999999998885432211                111122233


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      ..+.+..++.++..++..|++.+|..||++.+++..
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            466778899999999999999999999999999984

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-42  Score=317.50  Aligned_cols=254  Identities=29%  Similarity=0.456  Sum_probs=206.9

Q ss_pred             hhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      ..|.+.++||.|+||.||+|.+.++..+|+|++.... ......+..|+.+++.++||||+++++++.+....++||||+
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            3466778899999999999998889999999987642 234567889999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          158 ENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       158 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      ++++|.+++... ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++......... 
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-  160 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-  160 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence            999999999643 4568999999999999999999999   99999999999999999999999999999765432221 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                       .....++..|+|||.+.+. .++.++||||||+++|+|++ |..|+.....       ........         ....
T Consensus       161 -~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~---------~~~~  222 (261)
T cd05148         161 -SSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-------HEVYDQIT---------AGYR  222 (261)
T ss_pred             -ccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHH---------hCCc
Confidence             1234467789999998776 78999999999999999998 7777743221       00111111         1111


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      ...+..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            223345567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.9e-42  Score=316.09  Aligned_cols=257  Identities=26%  Similarity=0.440  Sum_probs=206.2

Q ss_pred             hhhcccccccccceeEEEEEEeC-C---CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-N---GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      .++.+.+.||+|+||.||+|.+. +   +..+|+|.++..........+..|+.++.+++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            45677889999999999999753 2   3379999987654445567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+++++|.+++......+++.++..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            99999999999997666778999999999999999999999   999999999999999999999999999998665432


Q ss_pred             ceE-EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          234 THV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       234 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ... ......++..|+|||.+.+. .++.++|+||||+++||+++ |..||......       ........        
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-------~~~~~~~~--------  224 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-------DVIKAIEE--------  224 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-------HHHHHHhC--------
Confidence            221 11223345689999999876 68999999999999999886 88887432211       01111111        


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                       ..........+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       225 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 -GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence             001112234567789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1e-42  Score=325.68  Aligned_cols=263  Identities=24%  Similarity=0.369  Sum_probs=207.1

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeC--------CCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEE
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFP--------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFC  144 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  144 (406)
                      ++....|.+.+.||+|+||.||++...        ++..+|+|.+...........+..|++++..+ +||||+++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            444566788899999999999999652        23579999998654444556788999999999 799999999999


Q ss_pred             ecCCeeEEEEEeccCCChhhHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCc
Q 015480          145 HDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN  209 (406)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~N  209 (406)
                      .+....++||||+++|+|.+++....               ..+++.++..++.|++.||+|||+   .+++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHh
Confidence            99999999999999999999995432               358899999999999999999999   999999999999


Q ss_pred             EEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCc
Q 015480          210 VLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATE  288 (406)
Q Consensus       210 ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~  288 (406)
                      |+++.++.+||+|||++................++..|+|||.+.+. .++.++|||||||++|||++ |..|+..... 
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-  248 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-  248 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-
Confidence            99999999999999998755432221111223345689999998876 68999999999999999998 7666632111 


Q ss_pred             ccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          289 SLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                            ........         .......+...+..+.+++.+||+.+|.+||++.+|++.|+.+.+
T Consensus       249 ------~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         249 ------EELFKLLK---------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             ------HHHHHHHH---------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence                  00111111         111122333456789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.3e-42  Score=312.44  Aligned_cols=248  Identities=27%  Similarity=0.399  Sum_probs=200.7

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCChh
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLD  163 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  163 (406)
                      +.||+|+||.||+|...++..+|+|.++..........+.+|+++++.++||||+++++++.+....++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36999999999999888889999999886655555667899999999999999999999999999999999999999999


Q ss_pred             hHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCC
Q 015480          164 GYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG  243 (406)
Q Consensus       164 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~g  243 (406)
                      +++......+++..+..++.|++.+|.|||+   .+++|+||||+||+++.++.+||+|||++.......... .....+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc-CCCCCC
Confidence            9986666678999999999999999999999   999999999999999999999999999987543222111 112234


Q ss_pred             CCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHH
Q 015480          244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK  322 (406)
Q Consensus       244 t~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (406)
                      +..|+|||++.+. .++.++||||||+++|++++ |..||......       .........         .....+...
T Consensus       157 ~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~---------~~~~~~~~~  219 (250)
T cd05085         157 PIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKG---------YRMSCPQKC  219 (250)
T ss_pred             cccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcC---------CCCCCCCCC
Confidence            5679999998766 68999999999999999998 88777422111       011111110         011122335


Q ss_pred             HHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       323 ~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                      +..+.+++.+||+.+|++||++.++++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.6e-42  Score=326.81  Aligned_cols=245  Identities=26%  Similarity=0.340  Sum_probs=192.9

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHh---hccCcCccccEEEEEecCCeeEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTI---GRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      |.+.+.||+|+||.||+|.+ .+|+.||||+++...  .....+.+..|.+++   +.++||||+++++++.+....++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            34567899999999999976 468999999997542  122335566666554   567899999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+++|+|..++.  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            99999999998873  4579999999999999999999999   999999999999999999999999999987433222


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      .  ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||......       ..........        
T Consensus       156 ~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~~--------  217 (324)
T cd05589         156 D--RTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-------EVFDSIVNDE--------  217 (324)
T ss_pred             C--cccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC--------
Confidence            1  12346789999999999876 7899999999999999999999998543211       0111111100        


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                        ...+...+..+.+++.+||+.||.+||     ++.++++
T Consensus       218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 --VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence              112234567789999999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-42  Score=331.27  Aligned_cols=253  Identities=21%  Similarity=0.251  Sum_probs=195.1

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||+||++.. .+|+.||||++....  .......+.+|++++.+++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            356678999999999999965 568999999986532  22334678889999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++|+|.+++. ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        82 ~~~gg~L~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          82 FLPGGDLMTMLI-KYDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             CCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            999999999984 44678999999999999999999999   99999999999999999999999999998633210000


Q ss_pred             ---------------------------------------------EEecCCCCCCCccCccccCCCCCCCcccceeecch
Q 015480          236 ---------------------------------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGM  270 (406)
Q Consensus       236 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~  270 (406)
                                                                   .......||+.|+|||++.+. .++.++|||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGv  236 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGA  236 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecch
Confidence                                                         000124689999999999876 7899999999999


Q ss_pred             hHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCC---CChHHH
Q 015480          271 VLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDR---PPMSAV  347 (406)
Q Consensus       271 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~~v  347 (406)
                      ++|||++|..||......       .........  .   ..... ......+.++.+++.+|+. +|.+|   +++.++
T Consensus       237 il~elltG~~Pf~~~~~~-------~~~~~i~~~--~---~~~~~-p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~  302 (377)
T cd05629         237 IMFECLIGWPPFCSENSH-------ETYRKIINW--R---ETLYF-PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI  302 (377)
T ss_pred             hhhhhhcCCCCCCCCCHH-------HHHHHHHcc--C---CccCC-CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence            999999999998543211       001111000  0   00000 1112345678999999997 67765   589888


Q ss_pred             HHH
Q 015480          348 IKM  350 (406)
Q Consensus       348 l~~  350 (406)
                      +..
T Consensus       303 l~h  305 (377)
T cd05629         303 KSH  305 (377)
T ss_pred             hcC
Confidence            873

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.7e-42  Score=316.59  Aligned_cols=256  Identities=26%  Similarity=0.437  Sum_probs=204.5

Q ss_pred             hhcccccccccceeEEEEEEeCC-C---cEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFPN-G---VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      .+.+.+.||+|+||.||+|.+.. |   ..||+|++...........|..|+.++++++||||+++++++.++...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            45678899999999999997643 3   3699999986544555678999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+++++|.+++......+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            9999999999997666779999999999999999999999   9999999999999999999999999999876543322


Q ss_pred             eEEecC---CCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          235 HVTISG---YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       235 ~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      ......   ...+..|+|||.+.+. .++.++|||||||++|||++ |..||......       ...+....       
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-------~~~~~i~~-------  226 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------DVINAIEQ-------  226 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHc-------
Confidence            111111   1124579999998876 78999999999999999886 88887432211       11111110       


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                        ......+..++..+.+++.+||+.+|++||++.+|+..|+.+
T Consensus       227 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 --DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              000112234567789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.6e-42  Score=319.18  Aligned_cols=268  Identities=26%  Similarity=0.357  Sum_probs=202.8

Q ss_pred             cccccccccceeEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecC--CeeEEE
Q 015480           81 NYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTALV  153 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  153 (406)
                      .+.+.||+|+||+||++.+     .++..||+|+++..........+.+|+++++.++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            6678899999999988643     357889999998654434567788999999999999999999988653  467899


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+++++|.+++..  ..+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||++.......
T Consensus        87 ~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          87 MEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             ecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            999999999999843  459999999999999999999999   999999999999999999999999999998664332


Q ss_pred             ceEE-ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          234 THVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       234 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      .... .....++..|+|||.+.+. .++.++||||||+++|||++|..|+.............. ...............
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  239 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPK-QGQMTVVRLIELLER  239 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccc-ccccchhhhhhhhhc
Confidence            2111 1223456679999998766 689999999999999999999988754322110000000 000000001111111


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      ......+...+..+.+++..||+.+|++|||+++|++.|+.+.
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1111223445678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4e-42  Score=313.41  Aligned_cols=248  Identities=25%  Similarity=0.375  Sum_probs=197.6

Q ss_pred             cccccceeEEEEEEe---CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCC
Q 015480           85 RLGFGGFGEVYKGQF---PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~---~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      .||+|+||.||+|.+   .++..+|+|+++.... ....+.+..|+.+++.+.||||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            599999999999965   3578899999875432 2345778999999999999999999998864 4668999999999


Q ss_pred             ChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE-ec
Q 015480          161 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-IS  239 (406)
Q Consensus       161 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~-~~  239 (406)
                      +|.+++. ....+++..+..++.|++.||+|||+   ++++||||||+||+++.++.+||+|||++........... ..
T Consensus        81 ~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQ-KNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999984 34578999999999999999999999   9999999999999999999999999999986654432211 12


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ...++..|+|||.+... .++.++|||||||++|||++ |..||......       .......         .......
T Consensus       157 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~i~---------~~~~~~~  219 (257)
T cd05116         157 HGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-------EVTQMIE---------SGERMEC  219 (257)
T ss_pred             CCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHH---------CCCCCCC
Confidence            23446789999998765 68899999999999999998 88887532111       1111111         1111223


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       319 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      +...+.++.+++.+||+.||++||++++|.+.|++.
T Consensus       220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            334667899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.9e-42  Score=319.73  Aligned_cols=261  Identities=23%  Similarity=0.376  Sum_probs=204.4

Q ss_pred             HhhhhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      +...+|.+.+.||+|+||.||+|...      .+..||+|.+...........+.+|+.+++.++||||+++++++.+..
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            44567788899999999999999653      245799999875544344567889999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCce
Q 015480          149 MTALVYEYMENGSLDGYLFGK---------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK  219 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k  219 (406)
                      ..++||||+++|+|.+++...         ...+++..+..++.|++.||.|||+   ++++||||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence            999999999999999999532         1345778899999999999999999   9999999999999999999999


Q ss_pred             EeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHH
Q 015480          220 VADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVW  298 (406)
Q Consensus       220 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  298 (406)
                      |+|||+++...............++..|+|||.+.+. .++.++|||||||++|||++ |..|+.....           
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----------  227 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----------  227 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----------
Confidence            9999999765433222222223456789999998876 68999999999999999998 5666632111           


Q ss_pred             HHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          299 EEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      +...     ...........+...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus       228 ~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         228 EQVL-----KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHH-----HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            0000     011111111222334578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.9e-42  Score=324.08  Aligned_cols=249  Identities=22%  Similarity=0.282  Sum_probs=195.0

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|+||.||++++ .+++.||+|++++..  .......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3699999999999976 468899999998642  122345678899999888 699999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |+|.+++. ..+.+++..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++........  ...
T Consensus        81 g~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (329)
T cd05588          81 GDLMFHMQ-RQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTS  154 (329)
T ss_pred             CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--ccc
Confidence            99998884 44679999999999999999999999   9999999999999999999999999999874322111  123


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcc--cccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES--LDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      ...||+.|+|||++.+. .++.++|||||||++|||++|+.||.......  .........+.....          ...
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~~  223 (329)
T cd05588         155 TFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK----------QIR  223 (329)
T ss_pred             cccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC----------CCC
Confidence            45789999999999876 78999999999999999999999996432211  000111111111110          011


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCC------hHHHHH
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPP------MSAVIK  349 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs------~~~vl~  349 (406)
                      .+...+..+.+++.+||+.||.+||+      +.++++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            22345677899999999999999998      556654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.9e-42  Score=324.30  Aligned_cols=239  Identities=24%  Similarity=0.250  Sum_probs=192.9

Q ss_pred             ccccccceeEEEEEEe----CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           84 TRLGFGGFGEVYKGQF----PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~----~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      +.||+|+||.||+++.    .+|+.||+|++..... ......+..|++++.+++||||+++++++.++...++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4699999999999964    3588999999975422 2234567789999999999999999999999999999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      +|+|.+++. ....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.........  .
T Consensus        82 ~~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--~  155 (318)
T cd05582          82 GGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--A  155 (318)
T ss_pred             CCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc--e
Confidence            999999984 44578999999999999999999999   99999999999999999999999999999765433221  2


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ....|++.|+|||.+.+. .++.++|||||||++|||++|+.||......       .........         . ...
T Consensus       156 ~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~-------~~~~~i~~~---------~-~~~  217 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-------ETMTMILKA---------K-LGM  217 (318)
T ss_pred             ecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHH-------HHHHHHHcC---------C-CCC
Confidence            245689999999999876 6899999999999999999999998533211       001111000         0 112


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCChHH
Q 015480          319 DKEKAKRLCMVALWCVQDSPEDRPPMSA  346 (406)
Q Consensus       319 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~  346 (406)
                      +...+..+.+++.+||+.||.+||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            2345677899999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-43  Score=296.81  Aligned_cols=246  Identities=26%  Similarity=0.365  Sum_probs=206.2

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .+++.+.||+|-||.||.|+. +++..||+|++.+..  ......++.+|+++-+.|+||||+++|++|.+....||++|
T Consensus        23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE  102 (281)
T KOG0580|consen   23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE  102 (281)
T ss_pred             hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence            346788999999999999965 568899999998642  22344779999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          156 YMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       156 ~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      |..+|.|...|.. ....+++.....+..|+|.||.|+|.   ++++||||||+|+|++.++..||+|||.+.....+. 
T Consensus       103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k-  178 (281)
T KOG0580|consen  103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK-  178 (281)
T ss_pred             ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCCCC-
Confidence            9999999999953 45679999999999999999999999   999999999999999999999999999997554222 


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                         ....+||..|++||+..+. .++..+|+|++|++.||++.|.+||.....+          +.+......+      
T Consensus       179 ---R~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------etYkrI~k~~------  238 (281)
T KOG0580|consen  179 ---RKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------ETYKRIRKVD------  238 (281)
T ss_pred             ---ceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhH----------HHHHHHHHcc------
Confidence               1246799999999999988 8999999999999999999999999644311          1121111111      


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       ...+...+....+++.+|+..+|.+|.+..|+++
T Consensus       239 -~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  239 -LKFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             -ccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence             1233566778999999999999999999999886

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.3e-42  Score=328.94  Aligned_cols=259  Identities=22%  Similarity=0.228  Sum_probs=196.1

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ...|.+.+.||+|+||.||++.. .+++.||+|....       ..+.+|++++++++||||+++++++..+...++|+|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            35678889999999999999965 5689999996532       346789999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      ++. ++|..++. ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++........ 
T Consensus       164 ~~~-~~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-  237 (391)
T PHA03212        164 RYK-TDLYCYLA-AKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-  237 (391)
T ss_pred             cCC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence            995 68888884 34578999999999999999999999   9999999999999999999999999999975432211 


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccch----hHHH-------------
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP----KHVW-------------  298 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~----~~~~-------------  298 (406)
                      .......||+.|+|||++.+. .++.++|||||||++|||++|..|+............    ....             
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             cccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            112345799999999999876 7899999999999999999999876532211000000    0000             


Q ss_pred             --HHHhh---hhcchhhc-cCCCC--cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          299 --EEYEK---CELGAMIL-GCGIE--EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       299 --~~~~~---~~~~~~~~-~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        .....   ........ .....  ......+.++.+++.+||+.||.+|||+.++++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence              00000   00000000 00000  111245678999999999999999999999996

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.6e-42  Score=317.78  Aligned_cols=256  Identities=23%  Similarity=0.354  Sum_probs=202.7

Q ss_pred             hhhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      ..++.+.++||+|+||.||++...      ++..+|+|.+... .......+.+|+++++.++|+||+++++++.+....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            345567889999999999999632      3567899988754 334567899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC
Q 015480          151 ALVYEYMENGSLDGYLFGKK--------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF  216 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~  216 (406)
                      +++|||+++++|.+++....              ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCC
Confidence            99999999999999985432              358899999999999999999999   9999999999999999999


Q ss_pred             CceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchh
Q 015480          217 SPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPK  295 (406)
Q Consensus       217 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~  295 (406)
                      .+||+|||++................+++.|+|||.+.+. .++.++|||||||++|||++ |.+||.......      
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------  232 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------  232 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------
Confidence            9999999999755433222222233456789999998876 68999999999999999998 787764322110      


Q ss_pred             HHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          296 HVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                       .....         ........+..++..+.+++.+||+.||.+||++.+|++.|+.
T Consensus       233 -~~~~~---------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         233 -AIECI---------TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             -HHHHH---------HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence             00111         1111112223456779999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.3e-42  Score=315.67  Aligned_cols=254  Identities=26%  Similarity=0.364  Sum_probs=197.3

Q ss_pred             cccccccccceeEEEEEEeCC-Cc--EEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecC------Cee
Q 015480           81 NYSTRLGFGGFGEVYKGQFPN-GV--KIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------HMT  150 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~~~-g~--~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~  150 (406)
                      .+.+.||+|+||.||+|.+.+ +.  .+|+|.++... .....+.+..|+.+++.++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            356789999999999998754 33  58999887542 233457789999999999999999999987432      246


Q ss_pred             EEEEEeccCCChhhHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccc
Q 015480          151 ALVYEYMENGSLDGYLFG-----KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  225 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl  225 (406)
                      +++|||+++|+|.+++..     ....+++..+..++.|++.||+|||+   ++++||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence            899999999999988732     23458999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhh
Q 015480          226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKC  304 (406)
Q Consensus       226 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (406)
                      +................+++.|+|||.+.+. .++.++||||||+++|||++ |..||.....       ....+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~  230 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------SEIYDYLRQG  230 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcC
Confidence            9866543322222223467789999999876 78999999999999999999 6777643211       1111111111


Q ss_pred             hcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                               .........+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       231 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         231 ---------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                     11122234566799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3e-42  Score=327.45  Aligned_cols=263  Identities=24%  Similarity=0.373  Sum_probs=203.0

Q ss_pred             HhhhhhcccccccccceeEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecC
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQ  147 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  147 (406)
                      +...+|.+.+.||+|+||.||+|.+      .+++.||||+++..........+.+|+.++.++ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            3455678899999999999999963      347889999998654444456788999999999 689999999988654


Q ss_pred             -CeeEEEEEeccCCChhhHhhcCC--------------------------------------------------------
Q 015480          148 -HMTALVYEYMENGSLDGYLFGKK--------------------------------------------------------  170 (406)
Q Consensus       148 -~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------  170 (406)
                       ...+++|||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             56789999999999999985321                                                        


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecC
Q 015480          171 ----------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG  240 (406)
Q Consensus       171 ----------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~  240 (406)
                                ..+++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++..............
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                      246788899999999999999999   9999999999999999999999999999976543322222223


Q ss_pred             CCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          241 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       241 ~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ..++..|+|||.+.+. .++.++||||||+++|||++ |..|+......      ..........         .....+
T Consensus       241 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~---------~~~~~~  304 (343)
T cd05103         241 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEG---------TRMRAP  304 (343)
T ss_pred             CCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHHHhcc---------CCCCCC
Confidence            3456789999998776 78999999999999999997 77776432111      0011111111         111111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      ...+..+.+++..||+.||++||++.+|++.|+.+..
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            2234678999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8e-42  Score=322.57  Aligned_cols=244  Identities=23%  Similarity=0.291  Sum_probs=191.6

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|+||+||+|.. .+++.||+|++.+..  .......+..|+.++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            3699999999999976 458899999997642  222345677888888776 799999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |+|..++. ....+++..+..++.|++.||+|||+   ++++||||||+||+++.++.+||+|||+++........  ..
T Consensus        81 ~~L~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~--~~  154 (329)
T cd05618          81 GDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TS  154 (329)
T ss_pred             CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc--cc
Confidence            99998884 44578999999999999999999999   99999999999999999999999999999754322211  23


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc--cchhHHHHHHhhhhcchhhccCCCCc
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD--WFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      ...||..|+|||++.+. .++.++|||||||++|||++|+.||.........  .......+.....          ...
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----------~~~  223 (329)
T cd05618         155 TFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----------QIR  223 (329)
T ss_pred             cccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC----------CCC
Confidence            45689999999999876 7899999999999999999999998532221111  0111111111110          112


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCCh
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPM  344 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~  344 (406)
                      .+...+..+.+++.+||+.||++||++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            233456778999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-43  Score=312.03  Aligned_cols=274  Identities=21%  Similarity=0.266  Sum_probs=210.5

Q ss_pred             cccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEec-----CCeeEEEEE
Q 015480           83 STRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-----QHMTALVYE  155 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e  155 (406)
                      .+.||+|+||.|+.+.. .+|+.||||.+.... .....++..+|+.+|+.++|+||+.+++++..     -...|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            56799999999999965 579999999987432 33456788999999999999999999999865     356799999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +| +.+|...+ +.+..++...+..+++|+++||.|+|+   .+++||||||+|+|++.+..+||+|||+|+........
T Consensus       107 lM-etDL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~  181 (359)
T KOG0660|consen  107 LM-ETDLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED  181 (359)
T ss_pred             HH-hhHHHHHH-HcCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence            99 45999888 455569999999999999999999999   99999999999999999999999999999988654344


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc--------ccchhHHHHHHhhhhcc
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL--------DWFPKHVWEEYEKCELG  307 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~  307 (406)
                      ..++.++.|.+|.|||++.....|+...||||.|||+.||++|++.|.....-..        ..-..............
T Consensus       182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar  261 (359)
T KOG0660|consen  182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR  261 (359)
T ss_pred             cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence            4557788999999999988777899999999999999999999987743321100        00011111111111111


Q ss_pred             hhhcc-CCC-----CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--HhhccccCCCCC
Q 015480          308 AMILG-CGI-----EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVVEVLPPP  361 (406)
Q Consensus       308 ~~~~~-~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~~~~~~p  361 (406)
                      ..+.. ...     .....+......+|+.+||..||.+|+|++|.++  .|...-.....|
T Consensus       262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence            11111 111     1222356678899999999999999999999988  555554444333

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.9e-42  Score=329.14  Aligned_cols=253  Identities=22%  Similarity=0.275  Sum_probs=194.9

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||+||+++. .+|+.||+|++....  .......+.+|++++..++||||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            356778999999999999975 458999999987532  12234568899999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC--
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK--  233 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~--  233 (406)
                      |+++|+|.+++. ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.......  
T Consensus        82 ~~~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          82 YIPGGDMMSLLI-RLGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             CCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            999999999984 34568899999999999999999999   999999999999999999999999999975321000  


Q ss_pred             ---------------------------------------ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHH
Q 015480          234 ---------------------------------------THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE  274 (406)
Q Consensus       234 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~e  274 (406)
                                                             .........||+.|+|||++.+. .++.++|||||||++||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye  236 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYE  236 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccceeee
Confidence                                                   00001234699999999999876 78999999999999999


Q ss_pred             HhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCC---ChHHHHHH
Q 015480          275 IVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRP---PMSAVIKM  350 (406)
Q Consensus       275 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~~vl~~  350 (406)
                      |++|+.||.......       .........  .   ... .......+..+.+++.+|+ .+|.+|+   ++.++++.
T Consensus       237 ll~G~~Pf~~~~~~~-------~~~~i~~~~--~---~~~-~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         237 MLVGQPPFLADTPAE-------TQLKVINWE--T---TLH-IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhhCCCCCCCCCHHH-------HHHHHhccC--c---ccc-CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999986433210       000000000  0   000 0111234566778888876 5999999   88888873

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.3e-41  Score=318.84  Aligned_cols=238  Identities=27%  Similarity=0.315  Sum_probs=187.9

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHH-HhhccCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVG-TIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|+||+||+|.. .+|+.||+|++.....  ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            3699999999999976 4689999999975321  122344555554 56789999999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |+|..++. ....+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++........  ...
T Consensus        81 g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (323)
T cd05575          81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTS  154 (323)
T ss_pred             CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccc
Confidence            99999884 45578999999999999999999999   9999999999999999999999999999875322211  123


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ...||+.|+|||++.+. .++.++|||||||++|||++|..||......       .........         . ....
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~---------~-~~~~  216 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-------EMYDNILNK---------P-LRLK  216 (323)
T ss_pred             cccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHH-------HHHHHHHcC---------C-CCCC
Confidence            45689999999999876 7899999999999999999999998542211       011111100         0 1112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCChH
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPMS  345 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~~  345 (406)
                      ...+..+.+++.+||+.||.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            23467799999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=329.89  Aligned_cols=253  Identities=28%  Similarity=0.354  Sum_probs=202.4

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      +|.+.+.||+|+||+||+|... +|+.||+|+++...  .......+..|+.++..++||||+++++++.++...++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            4667789999999999999764 68999999997532  12344678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC--
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK--  233 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~--  233 (406)
                      |+++++|.+++... ..+++..+..++.|++.||+|||+   .|++||||||+|||++.++.+||+|||++.......  
T Consensus        82 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          82 YMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            99999999999544 679999999999999999999999   999999999999999999999999999997654332  


Q ss_pred             -------------------------ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCc
Q 015480          234 -------------------------THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATE  288 (406)
Q Consensus       234 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~  288 (406)
                                               .........||+.|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                     00112335689999999999887 7899999999999999999999998643211


Q ss_pred             ccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCC-hHHHHHH
Q 015480          289 SLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPP-MSAVIKM  350 (406)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~~vl~~  350 (406)
                             ........     .......+ .....+..+.+++.+|+. ||.+||+ +.++++.
T Consensus       237 -------~~~~~i~~-----~~~~~~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 -------ETYNKIIN-----WKESLRFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             -------HHHHHHhc-----cCCcccCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence                   01111111     00000011 111256789999999997 9999999 9999873

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.2e-42  Score=329.85  Aligned_cols=252  Identities=21%  Similarity=0.256  Sum_probs=194.9

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      |.+.+.||+|+||+||+|.. .+++.||+|++....  .......+.+|+.++..++||||+++++++.+....++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~   82 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence            55678899999999999965 568999999997532  223456789999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc--
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT--  234 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~--  234 (406)
                      +++|+|.+++. ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++........  
T Consensus        83 ~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          83 IPGGDMMSLLI-RMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             CCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            99999999984 34568899999999999999999999   9999999999999999999999999999754311000  


Q ss_pred             -------------------------------------------eEEecCCCCCCCccCccccCCCCCCCcccceeecchh
Q 015480          235 -------------------------------------------HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMV  271 (406)
Q Consensus       235 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~i  271 (406)
                                                                 ........||+.|+|||++.+. .++.++|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~i  237 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVI  237 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccceeehhhH
Confidence                                                       0001234699999999999876 68999999999999


Q ss_pred             HHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHH--hcccCCCCCCChHHHHH
Q 015480          272 LFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALW--CVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       272 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPs~~~vl~  349 (406)
                      +|||++|..||........       ......  ..   .... .......+.++.+++.+  |+..+|..||++.++++
T Consensus       238 l~elltG~~Pf~~~~~~~~-------~~~i~~--~~---~~~~-~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTET-------QLKVIN--WE---NTLH-IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHH-------HHHHHc--cc---cccC-CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            9999999999864322100       000000  00   0000 01112345677888877  55667777999999988

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.6e-42  Score=313.52  Aligned_cols=256  Identities=30%  Similarity=0.474  Sum_probs=206.3

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ++...+|++.++||+|+||.||+|...+++.||+|.+....  .....+.+|+.++++++|+|++++++++.+ ...+++
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYII   78 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcEEE
Confidence            34567788899999999999999998889999999987543  345678999999999999999999998754 568999


Q ss_pred             EEeccCCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          154 YEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |||+++++|.+++.. ....+++.++..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            999999999999854 34578999999999999999999998   99999999999999999999999999999766532


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ... ......++..|+|||.+.+. .++.++||||||+++|||++ |+.||......       ........        
T Consensus       156 ~~~-~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~--------  218 (260)
T cd05067         156 EYT-AREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-------EVIQNLER--------  218 (260)
T ss_pred             Ccc-cccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChH-------HHHHHHHc--------
Confidence            221 11233466789999998776 68899999999999999998 88887532211       11111111        


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                       ......+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus       219 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         219 -GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence             11112223345789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-42  Score=309.93  Aligned_cols=265  Identities=22%  Similarity=0.288  Sum_probs=200.5

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCc-cccEEEEEecCC------ee
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHIN-LVRLYGFCHDQH------MT  150 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------~~  150 (406)
                      |...++||+|+||+||+|+. .+|+.||+|.++-... +.......+|+.+++.++|+| |+++++++...+      .+
T Consensus        13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l   92 (323)
T KOG0594|consen   13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL   92 (323)
T ss_pred             HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence            44456799999999999965 5689999999986533 334456789999999999999 999999998877      88


Q ss_pred             EEEEEeccCCChhhHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          151 ALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ++|+||++. +|.+++....   ..++...+..+++|++.||+|||+   ++|+||||||.||||+++|.+||+|||+|+
T Consensus        93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHH
Confidence            999999965 9999996544   467888999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccch--------hHHHH
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP--------KHVWE  299 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~--------~~~~~  299 (406)
                      ...-+..  ..+...+|.+|.|||++.+...|+...||||+|||+.||+++++.|..+.........        ...|+
T Consensus       169 a~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  169 AFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             HhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence            6553322  2345678999999999999888999999999999999999988776443321100000        00011


Q ss_pred             HHhhhhcchhhccC-----CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          300 EYEKCELGAMILGC-----GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       300 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      ..............     ..............+++.+||+.+|.+|.|++.++..
T Consensus       247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11100000000000     0001111122478899999999999999999999884

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.3e-42  Score=319.27  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=203.2

Q ss_pred             hhhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      ...+.+.+.||+|+||.||+|...      ++..||+|++...........+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            345677789999999999999753      46789999998654444567799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCc
Q 015480          151 ALVYEYMENGSLDGYLFGKK---------------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN  209 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~N  209 (406)
                      +++|||+++|+|.+++....                     ..+++..++.++.|++.||.|||+   .+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence            99999999999999985321                     247888999999999999999999   999999999999


Q ss_pred             EEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCc
Q 015480          210 VLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATE  288 (406)
Q Consensus       210 ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~  288 (406)
                      |++++++.++|+|||++.................+..|+|||.+.+. .++.++|||||||++|||++ |..|+......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999998765433222222223456689999998776 68999999999999999997 76666322110


Q ss_pred             ccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          289 SLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                             ........         ......+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus       240 -------~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 -------EVIYYVRD---------GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -------HHHHHHhc---------CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                   11111111         11112223456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1e-41  Score=317.14  Aligned_cols=263  Identities=27%  Similarity=0.356  Sum_probs=204.3

Q ss_pred             hhhcccccccccceeEEEEEEeCC-----------------CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPN-----------------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL  140 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  140 (406)
                      ..|.+.+.||+|+||.||+|...+                 +..||+|.+.........+.+.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            456778899999999999997532                 245899999876555566789999999999999999999


Q ss_pred             EEEEecCCeeEEEEEeccCCChhhHhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcE
Q 015480          141 YGFCHDQHMTALVYEYMENGSLDGYLFGKK----------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV  210 (406)
Q Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Ni  210 (406)
                      ++++.++...+++|||+++++|.+++....          ..+++..+..++.|++.||+|||+   .+++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence            999999999999999999999999985432          268999999999999999999999   9999999999999


Q ss_pred             EEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh--cccccccCCCc
Q 015480          211 LLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG--RRRNAIVGATE  288 (406)
Q Consensus       211 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~  288 (406)
                      +++.++.++|+|||+++...............++..|+|||.+.+. .++.++|||||||++|||++  |..|+..... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            9999999999999999765443332223344567789999998876 68999999999999999998  5555532211 


Q ss_pred             ccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          289 SLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                            ...+......  ............+...+.++.+++.+||+.||.+|||+.+|++.|+.
T Consensus       240 ------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 ------QQVIENAGHF--FRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             ------HHHHHHHHhc--cccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence                  1111111100  00000000111223455789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.8e-42  Score=325.26  Aligned_cols=243  Identities=23%  Similarity=0.302  Sum_probs=195.1

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCC
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      +.||+|+||.||++.. .+|+.||+|++....  .......+..|++++..++||||+++++++.+....++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3599999999999965 568999999997542  2233456788999999999999999999999999999999999999


Q ss_pred             ChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecC
Q 015480          161 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG  240 (406)
Q Consensus       161 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~  240 (406)
                      +|..++. ....+++..+..++.|++.||+|||+  ..+++||||||+|||++.++.+||+|||+++........  ...
T Consensus        81 ~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~  155 (325)
T cd05594          81 ELFFHLS-RERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKT  155 (325)
T ss_pred             cHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--ccc
Confidence            9998884 44578999999999999999999996  269999999999999999999999999998754322211  223


Q ss_pred             CCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchH
Q 015480          241 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK  320 (406)
Q Consensus       241 ~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (406)
                      ..||+.|+|||++.+. .++.++|||||||++|||++|..||......       .........          ....+.
T Consensus       156 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~~~~~i~~~----------~~~~p~  217 (325)
T cd05594         156 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILME----------EIRFPR  217 (325)
T ss_pred             ccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHH-------HHHHHHhcC----------CCCCCC
Confidence            5689999999999876 7899999999999999999999998533211       001111000          011223


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          321 EKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       321 ~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                      ..+.++.+++.+||+.||++|+     ++.++++
T Consensus       218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            3567789999999999999996     8999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-42  Score=314.29  Aligned_cols=254  Identities=24%  Similarity=0.398  Sum_probs=199.7

Q ss_pred             cccccccccceeEEEEEEeCC----CcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCe------
Q 015480           81 NYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM------  149 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~~~----g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------  149 (406)
                      .+.+.||+|+||.||+|....    +..||+|.++... .......+.+|+..++.++||||+++++++.+...      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            456789999999999997632    3679999987542 23345678999999999999999999999866554      


Q ss_pred             eEEEEEeccCCChhhHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccc
Q 015480          150 TALVYEYMENGSLDGYLFG-----KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  224 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfG  224 (406)
                      .++++||+++|+|..++..     ....+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence            7899999999999988843     23468999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhh
Q 015480          225 LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEK  303 (406)
Q Consensus       225 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  303 (406)
                      +++...............++..|+|||.+.+. .++.++|||||||++|||++ |..|+......       ...+... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-------~~~~~~~-  229 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-------EIYDYLR-  229 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHH-
Confidence            99866543322222223456789999998766 78999999999999999999 77776432110       0111111 


Q ss_pred             hhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                              .......+...+..+.+++.+||+.||++||++.++++.|+++
T Consensus       230 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 --------HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             --------cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    1111223345667899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-42  Score=311.48  Aligned_cols=249  Identities=33%  Similarity=0.490  Sum_probs=205.3

Q ss_pred             ccccccceeEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|+||.||+|....    +..|++|.+...........+.+|++.+..++|+|++++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999997643    7889999998754444567899999999999999999999999999999999999999


Q ss_pred             CChhhHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          160 GSLDGYLFGK--------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       160 g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      ++|.+++...        ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999654        4789999999999999999999999   9999999999999999999999999999987655


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      ...........++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....       ....+....       
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~-------  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------EEVLEYLRK-------  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHc-------
Confidence            4322223345678899999998876 78999999999999999999 5777754311       111111111       


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                        ......+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       223 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 --GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              1112233445788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.2e-41  Score=316.95  Aligned_cols=263  Identities=24%  Similarity=0.339  Sum_probs=201.4

Q ss_pred             hhhcccccccccceeEEEEEEeC-----------------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-----------------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL  140 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  140 (406)
                      .+|.+.++||+|+||+||++.+.                 ++..||+|++...........+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            45677889999999999998542                 2346899999865444556789999999999999999999


Q ss_pred             EEEEecCCeeEEEEEeccCCChhhHhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcE
Q 015480          141 YGFCHDQHMTALVYEYMENGSLDGYLFGKK----------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV  210 (406)
Q Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Ni  210 (406)
                      ++++.+.+..++||||+++++|.+++....          ..+++.++..++.|++.||+|||+   .+++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence            999999999999999999999999985322          247788999999999999999999   9999999999999


Q ss_pred             EEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh--cccccccCCCc
Q 015480          211 LLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG--RRRNAIVGATE  288 (406)
Q Consensus       211 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~  288 (406)
                      +++.++.++|+|||++................++..|+|||...+. .++.++|||||||++|||++  |..|+......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999865443322222223446789999987766 68999999999999999998  55665422111


Q ss_pred             ccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          289 SLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                      .  .. ....+.....      ........+..++..+.+++.+||+.||.+||++.+|++.|++
T Consensus       241 ~--~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 Q--VI-ENTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H--HH-HHHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            0  00 0000000000      0000111223355789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.8e-42  Score=341.34  Aligned_cols=254  Identities=24%  Similarity=0.325  Sum_probs=203.5

Q ss_pred             hhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccc-cchhhHHHHHHHHHHhhccCcCccccEEEEEecCC-----
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-----  148 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  148 (406)
                      ...+|.+.+.||+|+||+||+|+. .+|+.||||++... ........+.+|+..+..++|+|++++++.+....     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            345778889999999999999965 56999999998753 23344567889999999999999999988775432     


Q ss_pred             ---eeEEEEEeccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEec
Q 015480          149 ---MTALVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD  222 (406)
Q Consensus       149 ---~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (406)
                         ..++||||+++|+|.+++..   ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEe
Confidence               36799999999999999853   24578999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHh
Q 015480          223 FGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE  302 (406)
Q Consensus       223 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  302 (406)
                      ||+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||......       ...... 
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-------~~~~~~-  257 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENME-------EVMHKT-  257 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHH-
Confidence            9999866543222223346799999999999876 7899999999999999999999998532110       011111 


Q ss_pred             hhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                              ........+...+.++.+++..||+.||.+||++.++++
T Consensus       258 --------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        258 --------LAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             --------hcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence                    111122233456678999999999999999999999986

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.1e-42  Score=321.49  Aligned_cols=262  Identities=25%  Similarity=0.383  Sum_probs=205.5

Q ss_pred             HhhhhhcccccccccceeEEEEEEeC--------CCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEe
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFP--------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCH  145 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  145 (406)
                      +...++.+.+.||+|+||.||+++..        .+..+|+|.++..........+..|+.++.++ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            34456677889999999999999642        24578999988654445567789999999999 5999999999999


Q ss_pred             cCCeeEEEEEeccCCChhhHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcE
Q 015480          146 DQHMTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV  210 (406)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Ni  210 (406)
                      +....+++|||+++|+|.+++...               ...+++.++..++.|++.||.|||+   .|++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeE
Confidence            999999999999999999998542               2358899999999999999999999   9999999999999


Q ss_pred             EEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcc
Q 015480          211 LLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATES  289 (406)
Q Consensus       211 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~  289 (406)
                      +++.++.+||+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |..||.....  
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--  242 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--  242 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCH--
Confidence            9999999999999999765432221111222345689999998876 78999999999999999998 7766632111  


Q ss_pred             cccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          290 LDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                           ....+....         ......+..++..+.+++.+||+.+|++||++.++++.|.++..
T Consensus       243 -----~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         243 -----EELFKLLRE---------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             -----HHHHHHHHc---------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                 111111111         11112233456678999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.6e-42  Score=312.69  Aligned_cols=253  Identities=29%  Similarity=0.412  Sum_probs=195.8

Q ss_pred             ccccccceeEEEEEEeC----CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEe-cCCeeEEEEEecc
Q 015480           84 TRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH-DQHMTALVYEYME  158 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~  158 (406)
                      +.||+|+||.||+|.+.    ++..||+|.+.........+.+.+|+.+++.++||||+++++++. .+...+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36999999999999753    245799999865434445678889999999999999999999875 4556889999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE--
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV--  236 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~--  236 (406)
                      +|+|.+++.......++..+..++.|++.||.|||+   .+++||||||+|||+++++.+||+|||+++.........  
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            999999996656667888899999999999999999   999999999999999999999999999997554322111  


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                      ......++..|+|||.+.+. .++.++||||||+++|||++|..|+......      ......         +......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~---------~~~~~~~  221 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVY---------LLQGRRL  221 (262)
T ss_pred             ccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH---------HhcCCCC
Confidence            11233467789999998776 7899999999999999999965443221110      000011         1111111


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      ..+...+..+.+++..||+.+|++||++.+|++.|+++.
T Consensus       222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            122234567999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-42  Score=327.16  Aligned_cols=265  Identities=19%  Similarity=0.248  Sum_probs=195.1

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecC-----CeeEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-----HMTAL  152 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l  152 (406)
                      |.+.+.||+|+||.||+|.. .+|+.||||.+..... ......+.+|+++++.++||||+++++++...     ...++
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            56778899999999999975 4689999999874322 22345688999999999999999999988543     24799


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ||||+. ++|.+++. ....+++..+..++.|+++||.|||+   .+++||||||+|||++.++.+||+|||+++.....
T Consensus        82 v~e~~~-~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          82 VFELME-SDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             EEecCC-CCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            999995 68988884 44568999999999999999999999   99999999999999999999999999999754322


Q ss_pred             Cc-eEEecCCCCCCCccCccccCCC-CCCCcccceeecchhHHHHhhcccccccCCCccc-c-------cchhHHHHHHh
Q 015480          233 KT-HVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL-D-------WFPKHVWEEYE  302 (406)
Q Consensus       233 ~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~-------~~~~~~~~~~~  302 (406)
                      .. ........||..|+|||++.+. ..++.++|||||||++|||++|+.||........ .       ...........
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            21 1122345789999999998652 3688999999999999999999998854321100 0       00000001110


Q ss_pred             hhhcchh---hccC---CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          303 KCELGAM---ILGC---GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       303 ~~~~~~~---~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .......   +...   .........+..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0000000   0000   000111123567889999999999999999999997

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.3e-42  Score=312.62  Aligned_cols=255  Identities=29%  Similarity=0.436  Sum_probs=203.3

Q ss_pred             hhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      ..+|.+.++||+|+||.||+|.+.++..||+|.++...  ...+.+.+|++++..++||||+++++++.+ ...++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            45678889999999999999988777789999997532  234678999999999999999999998754 557899999


Q ss_pred             ccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          157 MENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       157 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +++|+|.+++... ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999999999643 3468999999999999999999999   99999999999999999999999999999765433221


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                      . .....++..|+|||...+. .++.++||||||+++|||++ |..||......       .......         ...
T Consensus       159 ~-~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~~~~~---------~~~  220 (262)
T cd05071         159 A-RQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVE---------RGY  220 (262)
T ss_pred             c-ccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHHHHHh---------cCC
Confidence            1 1233467789999998766 68999999999999999999 66666432111       1111110         011


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      ........+..+.+++.+|++.||++||++.++++.|+...
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            11223456778999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-42  Score=314.84  Aligned_cols=259  Identities=27%  Similarity=0.384  Sum_probs=207.8

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCc----EEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGV----KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      ...+.+.+.||+|+||.||+|.+. +|.    .+|+|.+...........+.+|+.++..++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            345677789999999999999763 343    5899998766554556788999999999999999999999987 7889


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            9999999999999997766779999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      ...........++..|+|||.+... .++.++|+||||+++||+++ |..||......       .......        
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~--------  225 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-------EIPDLLE--------  225 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHh--------
Confidence            4333222233346789999998765 68999999999999999998 88887532211       1111111        


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                       .......+..++..+.+++.+||..||.+||++.++++.|+++..
T Consensus       226 -~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         226 -KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             -CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence             111112222345678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.1e-41  Score=310.71  Aligned_cols=254  Identities=25%  Similarity=0.329  Sum_probs=193.4

Q ss_pred             ccccccceeEEEEEEeCC---CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCC
Q 015480           84 TRLGFGGFGEVYKGQFPN---GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~---g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      +.||+|+||.||+|.+.+   +..+|+|.++..........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            359999999999997643   46799999876544445567889999999999999999999999999999999999999


Q ss_pred             ChhhHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          161 SLDGYLFGK----KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       161 ~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +|.+++...    ....++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            999998542    2346778888999999999999999   999999999999999999999999999997544333222


Q ss_pred             EecCCCCCCCccCccccCCC------CCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          237 TISGYKGTPGYSAPEFLSGN------YPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ......++..|+|||++.+.      ..++.++||||||+++|||++ |..||.......       ........    .
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~----~  226 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-------VLTYTVRE----Q  226 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHhhc----c
Confidence            22334578889999988642      135789999999999999996 988884322110       00000000    0


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                      ......+......+..+.+++..|| .+|++|||+++|+..|+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         227 QLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            0000111111234566888999999 68999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5e-42  Score=323.05  Aligned_cols=242  Identities=23%  Similarity=0.300  Sum_probs=193.4

Q ss_pred             ccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|+||.||+|+.. +|+.||+|++....  .......+..|.+++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999764 58899999997542  223345677888888866 799999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |+|..++. ....+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++.........  ..
T Consensus        81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--~~  154 (321)
T cd05591          81 GDLMFQIQ-RSRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TT  154 (321)
T ss_pred             CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc--cc
Confidence            99998884 44578999999999999999999999   99999999999999999999999999998754322221  23


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ...||+.|+|||++.+. .++.++|||||||++|||++|+.||......       ..........          ...+
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-------~~~~~i~~~~----------~~~p  216 (321)
T cd05591         155 TFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNED-------DLFESILHDD----------VLYP  216 (321)
T ss_pred             ccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC----------CCCC
Confidence            45689999999999876 7899999999999999999999998643211       1111111110          1112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCC-------ChHHHHH
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRP-------PMSAVIK  349 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RP-------s~~~vl~  349 (406)
                      ...+.++.+++..||+.||++||       ++.++++
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            23456789999999999999999       6777765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.3e-42  Score=312.17  Aligned_cols=254  Identities=31%  Similarity=0.445  Sum_probs=202.7

Q ss_pred             hhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ....+.+.++||+|+||.||+|...++..+|+|.+....  ...+.+.+|+.++++++|+|++++++++.+ ...+++||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC--CCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEE
Confidence            344677788999999999999988888889999987642  234679999999999999999999998854 56789999


Q ss_pred             eccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          156 YMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       156 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      |+++++|.+++... ...+++.++..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999998643 3568999999999999999999999   9999999999999999999999999999976543322


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      .. .....++..|+|||.+.+. .++.++||||||+++|||++ |..||......       .......         ..
T Consensus       158 ~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~---------~~  219 (260)
T cd05070         158 TA-RQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-------EVLEQVE---------RG  219 (260)
T ss_pred             cc-ccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHH---------cC
Confidence            11 1223456789999998766 68999999999999999999 77777432110       0111111         11


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                      .....+...+..+.+++.+||..+|++|||+.++.+.|+.
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1112233456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.8e-42  Score=322.34  Aligned_cols=237  Identities=26%  Similarity=0.313  Sum_probs=190.6

Q ss_pred             ccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|+||+||+|+.. +++.||+|++.+..  .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999764 58899999997542  223445677888888876 699999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |+|.+++. ....+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||++.........  ..
T Consensus        81 g~L~~~i~-~~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~--~~  154 (320)
T cd05590          81 GDLMFHIQ-KSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TS  154 (320)
T ss_pred             chHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc--cc
Confidence            99998884 44578999999999999999999999   99999999999999999999999999998754322211  23


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ...||+.|+|||++.+. .++.++|||||||++|||++|+.||......       ...+......          ...+
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~----------~~~~  216 (320)
T cd05590         155 TFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAILNDE----------VVYP  216 (320)
T ss_pred             ccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHhcCC----------CCCC
Confidence            45689999999999876 7899999999999999999999998543211       1111111110          1112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCh
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPM  344 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~  344 (406)
                      ...+.++.+++.+||+.||.+||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            2356778999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=310.11  Aligned_cols=250  Identities=27%  Similarity=0.407  Sum_probs=198.7

Q ss_pred             ccccccceeEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      ++||+|+||.||+|.+..    +..+|+|.+..+......+.+..|+.+++.+.||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            469999999999996522    368999999865444456789999999999999999999998764 457899999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE-e
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-I  238 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~-~  238 (406)
                      |+|.+++... ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.......... .
T Consensus        80 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            9999999543 478999999999999999999999   9999999999999999999999999999986644332211 1


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      ....++..|+|||.+.+. .++.++||||||+++|||++ |..||......       ........         .....
T Consensus       156 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-------~~~~~~~~---------~~~~~  218 (257)
T cd05060         156 TAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-------EVIAMLES---------GERLP  218 (257)
T ss_pred             cCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHc---------CCcCC
Confidence            122345689999998776 68999999999999999998 88887432211       11111111         11112


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      .+...+..+.+++.+||+.+|.+||++.++++.|+++.
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            33345678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2e-41  Score=318.08  Aligned_cols=241  Identities=26%  Similarity=0.310  Sum_probs=191.7

Q ss_pred             ccccccceeEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHhhc-cCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGR-TYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|+||.||+|++. +|+.||+|+++....  ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999764 588999999976421  2234556778888775 4899999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |+|..++. ....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~i~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (316)
T cd05620          81 GDLMFHIQ-DKGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAS  154 (316)
T ss_pred             CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--cee
Confidence            99999884 34578999999999999999999999   9999999999999999999999999999874322211  123


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ...||..|+|||++.+. .++.++|||||||++|||++|..||......       ...+.....          ....+
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~~~~----------~~~~~  216 (316)
T cd05620         155 TFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESIRVD----------TPHYP  216 (316)
T ss_pred             ccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhC----------CCCCC
Confidence            46689999999999877 7899999999999999999999998543211       111111100          11122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCChH-HHH
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPMS-AVI  348 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~~-~vl  348 (406)
                      ...+.++.+++.+||+.||.+||++. +++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            23456789999999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-41  Score=314.50  Aligned_cols=272  Identities=25%  Similarity=0.371  Sum_probs=208.0

Q ss_pred             hhhcccccccccceeEEEEEEeC-----CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec--CCee
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMT  150 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  150 (406)
                      ..+.+.+.||+|+||.||+|.+.     ++..||+|++...........|.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            34566788999999999999753     3788999999865443356789999999999999999999999877  5678


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      +++|||+++++|.+++......+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            99999999999999997666679999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCceEE-ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          231 RNKTHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       231 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ....... .....++..|+|||.+.+. .++.++||||||+++|||++|..|+.........+........ ........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  238 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM-IVTRLLEL  238 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccc-cHHHHHHH
Confidence            3322211 1123455679999998776 7899999999999999999999887543222111000000000 00000001


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      +........+..++.++.+++.+||+.+|++||++.+|+++|+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111111122334557899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.9e-42  Score=321.24  Aligned_cols=242  Identities=24%  Similarity=0.310  Sum_probs=191.0

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhc-cCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGR-TYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|+||+||+|.+ .+++.||+|+++...  .....+.+..|..++.. .+||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999976 458899999997542  12233455667777765 4799999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |+|..++. ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++........  ...
T Consensus        81 g~L~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~~~  154 (316)
T cd05592          81 GDLMFHIQ-SSGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KAS  154 (316)
T ss_pred             CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--ccc
Confidence            99999884 34578999999999999999999999   9999999999999999999999999999975433221  123


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ...||+.|+|||++.+. .++.++|||||||++|||++|..||......       ........          .....+
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~----------~~~~~~  216 (316)
T cd05592         155 TFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDED-------ELFDSILN----------DRPHFP  216 (316)
T ss_pred             cccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHc----------CCCCCC
Confidence            45689999999999876 6899999999999999999999998533211       01111100          111223


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCChH-HHHH
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPMS-AVIK  349 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~~-~vl~  349 (406)
                      ...+.++.+++.+||+.||.+||++. ++++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            34567789999999999999999876 4443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.7e-42  Score=320.52  Aligned_cols=265  Identities=21%  Similarity=0.283  Sum_probs=201.4

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      +|...+.||+|+||+||+|... +++.||+|.++..........+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   86 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL   86 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence            4666788999999999999764 588899999875543344456788999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++ +|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.........  
T Consensus        87 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  160 (309)
T cd07872          87 DK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--  160 (309)
T ss_pred             CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc--
Confidence            75 8888886666678999999999999999999999   99999999999999999999999999999754332221  


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc--------chhHHHHHHhhhh-cch
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW--------FPKHVWEEYEKCE-LGA  308 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~-~~~  308 (406)
                      .....++..|+|||.+.+...++.++|||||||++|||++|+.||..........        .....|....... ...
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            1234578899999998765568999999999999999999999985433211000        0000111110000 000


Q ss_pred             hhccCCC----CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 MILGCGI----EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .......    .......+.++.+++.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000000    0111234567899999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-41  Score=308.25  Aligned_cols=250  Identities=26%  Similarity=0.399  Sum_probs=201.0

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCChh
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLD  163 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  163 (406)
                      ++||+|+||.||++.+.+++.||+|.+...........+..|++++++++||||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999876699999999876544445678999999999999999999999999999999999999999999


Q ss_pred             hHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCC
Q 015480          164 GYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG  243 (406)
Q Consensus       164 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~g  243 (406)
                      +++......+++..+..++.+++.+|+|||+   .+++||||+|+||+++.++.++|+|||++................+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            9996666678999999999999999999999   9999999999999999999999999999976543222111112234


Q ss_pred             CCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHH
Q 015480          244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK  322 (406)
Q Consensus       244 t~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (406)
                      +..|+|||.+.+. .++.++|+||||+++|||++ |..|+......       ........         ......+...
T Consensus       158 ~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-------~~~~~~~~---------~~~~~~~~~~  220 (251)
T cd05041         158 PIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-------QTRERIES---------GYRMPAPQLC  220 (251)
T ss_pred             eeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHH-------HHHHHHhc---------CCCCCCCccC
Confidence            5679999998776 68999999999999999999 66666332211       00111110         0011122345


Q ss_pred             HHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       323 ~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                      +..+.+++.+||+.+|++||++.++++.|+.
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            6789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-42  Score=327.46  Aligned_cols=252  Identities=22%  Similarity=0.275  Sum_probs=196.8

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||+||+|+. .+|+.||||++....  .......+.+|+.++..++||||+++++++.++...++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            356678899999999999976 468999999997531  12334567889999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++|+|.+++.. ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.........
T Consensus        82 ~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          82 YLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            9999999999853 4579999999999999999999999   99999999999999999999999999998754321100


Q ss_pred             E------------------------------------EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcc
Q 015480          236 V------------------------------------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR  279 (406)
Q Consensus       236 ~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~  279 (406)
                      .                                    ......||+.|+|||++.+. .++.++|||||||++|||++|.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcCC
Confidence            0                                    01124689999999998876 7899999999999999999999


Q ss_pred             cccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCC---hHHHHH
Q 015480          280 RNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPP---MSAVIK  349 (406)
Q Consensus       280 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~~vl~  349 (406)
                      .||......       .........  ..   .... ......+..+.+++.+|+. +|.+|++   +.++++
T Consensus       237 ~Pf~~~~~~-------~~~~~i~~~--~~---~~~~-~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         237 PPFCSDNPQ-------ETYRKIINW--KE---TLQF-PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCHH-------HHHHHHHcC--CC---ccCC-CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            998543211       000000000  00   0000 1111345678899999996 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.4e-42  Score=318.42  Aligned_cols=257  Identities=26%  Similarity=0.415  Sum_probs=201.4

Q ss_pred             hhcccccccccceeEEEEEEeCC-Cc--EEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFPN-GV--KIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      .|.+.+.||+|+||.||+|...+ |.  .+++|.++........+.+.+|+.++.++ +||||+++++++.+....++++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~   82 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI   82 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence            35677889999999999997643 33  47888887543444557789999999999 7999999999999999999999


Q ss_pred             EeccCCChhhHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCce
Q 015480          155 EYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK  219 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k  219 (406)
                      ||+++++|.+++....               ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+|
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEE
Confidence            9999999999985321               358899999999999999999999   9999999999999999999999


Q ss_pred             EeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHH
Q 015480          220 VADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVW  298 (406)
Q Consensus       220 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  298 (406)
                      |+|||++......   ........+..|+|||.+.+. .++.++|||||||++|||++ |..||......       ...
T Consensus       160 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-------~~~  228 (297)
T cd05089         160 IADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-------ELY  228 (297)
T ss_pred             ECCcCCCccccce---eccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHH
Confidence            9999998643211   111112235579999998776 68999999999999999997 88887432211       111


Q ss_pred             HHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          299 EEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                      +....         ......+..++..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus       229 ~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         229 EKLPQ---------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HHHhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11111         1111122345677999999999999999999999999998886544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=8.6e-42  Score=327.21  Aligned_cols=257  Identities=23%  Similarity=0.256  Sum_probs=201.9

Q ss_pred             HHhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      .+....|.+.+.||+|+||.||+++. .+|+.||+|++....  .......+..|+.+++.++||||+++++++.++...
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            34455677889999999999999976 468899999997431  122335578899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ++||||+++|+|.+++..  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus       119 ~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            999999999999998843  458888999999999999999999   999999999999999999999999999997654


Q ss_pred             CCCceEEecCCCCCCCccCccccCCC---CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGN---YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      .... .......||+.|+|||++.+.   ..++.++|||||||++|||++|..||......       ..........  
T Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~--  263 (370)
T cd05596         194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMDHK--  263 (370)
T ss_pred             CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------HHHHHHHcCC--
Confidence            3321 112345799999999998653   24788999999999999999999998643211       0111111100  


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCC--CCChHHHHH
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPED--RPPMSAVIK  349 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~vl~  349 (406)
                         .... .......+..+.+++..||+.+|.+  ||+++++++
T Consensus       264 ---~~~~-~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         264 ---NSLT-FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             ---CcCC-CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence               0000 0111235678999999999999987  999999977

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.9e-41  Score=319.82  Aligned_cols=245  Identities=23%  Similarity=0.264  Sum_probs=192.9

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|+||+||+|+. .+++.||+|++.....  ....+.+..|..++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3699999999999976 4578999999986422  22345678899999888 599999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |+|..++. ....+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||++.........  ..
T Consensus        81 ~~L~~~~~-~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~~  154 (327)
T cd05617          81 GDLMFHMQ-RQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TS  154 (327)
T ss_pred             CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc--ee
Confidence            99998884 44579999999999999999999999   99999999999999999999999999998753222111  23


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ...||+.|+|||++.+. .++.++|||||||++|||++|..||.....................         .. ...+
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~-~~~p  223 (327)
T cd05617         155 TFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---------KP-IRIP  223 (327)
T ss_pred             cccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---------CC-CCCC
Confidence            45689999999999876 7899999999999999999999999643222111111111111111         11 1123


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCChH
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPMS  345 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~~  345 (406)
                      ...+..+.+++.+||+.||.+|+++.
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            34557789999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-43  Score=331.69  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=210.9

Q ss_pred             hhhcccccccccceeEEEEEEeCC--Cc--EEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPN--GV--KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~--g~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ....+.++||+|+||.|++|.|..  |.  .||||+++.+.-.....+|++|+.+|.+|+|||++++||+..+ ....||
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            344556789999999999998743  43  5799999976554577899999999999999999999999988 667899


Q ss_pred             EEeccCCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          154 YEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ||+++.|+|.+.|+. ....+-...+..++.|||.|++||.+   +++|||||..+|+||.....+||+||||.+.+..+
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            999999999999976 56778899999999999999999999   99999999999999999999999999999988766


Q ss_pred             CceEEecC-CCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          233 KTHVTISG-YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       233 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      .....+.. ..-...|+|||.+... .++.++|||+|||++|||+|+..-         .|...      ....+...++
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEe---------PW~G~------~g~qIL~~iD  329 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEE---------PWVGC------RGIQILKNID  329 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCC---------CCCCC------CHHHHHHhcc
Confidence            65554443 4456789999999987 799999999999999999986531         22221      1222333344


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ++.....+..|++.++++++.||..+|++||++..|.+
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            55556778889999999999999999999999999974

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=315.19  Aligned_cols=250  Identities=26%  Similarity=0.304  Sum_probs=199.8

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      |+..+.||+|+||+||++.. .+++.||+|.+.....  ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            56678899999999999976 4689999999875321  12235678899999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          157 MENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       157 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +++|+|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-  157 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence            9999999888543 4568999999999999999999999   9999999999999999999999999999976543222 


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        .....|+..|+|||++.+. .++.++|||||||++|||++|..||.......       ..+....     .+.. ..
T Consensus       158 --~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-------~~~~~~~-----~~~~-~~  221 (285)
T cd05605         158 --IRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-------KREEVER-----RVKE-DQ  221 (285)
T ss_pred             --cccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhh-------HHHHHHH-----Hhhh-cc
Confidence              1235689999999999876 78999999999999999999999986432110       0111110     0011 11


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                      ...+...+..+.+++..||+.||.+||     +++++++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            222344677899999999999999999     7778765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.8e-41  Score=319.73  Aligned_cols=242  Identities=24%  Similarity=0.301  Sum_probs=189.8

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHH-HhhccCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVG-TIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|+||+||+|+. .+|+.||+|++....  .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3699999999999965 468999999997542  1223345556655 46778999999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |+|..++. ....+++..+..++.|++.||+|||+   .|++||||||+|||++.++.+||+|||++........  ...
T Consensus        81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (325)
T cd05604          81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTT  154 (325)
T ss_pred             CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Ccc
Confidence            99998884 45678999999999999999999999   9999999999999999999999999999875332211  123


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ...||+.|+|||++.+. .++.++|||||||++|||++|..||......       .........   .       ....
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~~~~~---~-------~~~~  216 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------EMYDNILHK---P-------LVLR  216 (325)
T ss_pred             cccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHH-------HHHHHHHcC---C-------ccCC
Confidence            45689999999999876 7899999999999999999999998543211       011111110   0       0111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...+..+.+++..|++.+|.+||++.+.++
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence            234567889999999999999998864333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-41  Score=311.33  Aligned_cols=248  Identities=24%  Similarity=0.401  Sum_probs=195.1

Q ss_pred             cccccceeEEEEEEeCC-Cc--EEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEEEeccCC
Q 015480           85 RLGFGGFGEVYKGQFPN-GV--KIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      .||+|+||.||+|.+.+ |.  .+++|.++........+.+..|++++.++ +||||+++++++......+++|||+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            59999999999997743 43  46888887544445567889999999999 7999999999999999999999999999


Q ss_pred             ChhhHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccc
Q 015480          161 SLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  225 (406)
Q Consensus       161 ~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl  225 (406)
                      +|.+++....               ..+++.++..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999985322               257899999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhh
Q 015480          226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKC  304 (406)
Q Consensus       226 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (406)
                      +.......   .......+..|+|||++.+. .++.++||||||+++|||++ |..||......       ........ 
T Consensus       159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~~~~~~~~-  226 (270)
T cd05047         159 SRGQEVYV---KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYEKLPQ-  226 (270)
T ss_pred             ccccchhh---hccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHH-------HHHHHHhC-
Confidence            85322111   11112345679999998766 68999999999999999997 88887432111       01111111 


Q ss_pred             hcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                              ......+...+..+.+++.+||+.||.+|||+.+++..|+.+.
T Consensus       227 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         227 --------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             --------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                    0011122234567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-41  Score=307.06  Aligned_cols=262  Identities=22%  Similarity=0.271  Sum_probs=207.6

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeCC-CcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~-g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      .+.-..+++.++||+|.-|+||+++..+ +..+|+|++.+..-  .....+...|-+||+.++||.++.+|+.|+.+...
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS  152 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence            3344445667889999999999998754 58999999987532  22335677899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          151 ALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      |++||||+||+|..+++. ..+.+++..+.-++.+++-||+|||.   .|||+|||||+||||.++|++.|+||.|+..+
T Consensus       153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            999999999999999864 46789999999999999999999999   99999999999999999999999999997532


Q ss_pred             CC---------------------------------CCc---------------------eEEecCCCCCCCccCccccCC
Q 015480          230 DR---------------------------------NKT---------------------HVTISGYKGTPGYSAPEFLSG  255 (406)
Q Consensus       230 ~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~  255 (406)
                      ..                                 ...                     ......++||-.|+|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            11                                 000                     011234679999999999999


Q ss_pred             CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcc
Q 015480          256 NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQ  335 (406)
Q Consensus       256 ~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  335 (406)
                      . ..+.++|+|+|||++|||+.|..||.......          ...+     .+.....-....+.+..+.+||.+.|.
T Consensus       310 ~-GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~----------Tl~N-----Iv~~~l~Fp~~~~vs~~akDLIr~LLv  373 (459)
T KOG0610|consen  310 E-GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE----------TLRN-----IVGQPLKFPEEPEVSSAAKDLIRKLLV  373 (459)
T ss_pred             C-CCCchhhHHHHHHHHHHHHhCCCCcCCCCchh----------hHHH-----HhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence            8 89999999999999999999999996544321          1111     111111111122667889999999999


Q ss_pred             cCCCCCCC----hHHHHH--Hhhcc
Q 015480          336 DSPEDRPP----MSAVIK--MLEGV  354 (406)
Q Consensus       336 ~dP~~RPs----~~~vl~--~L~~~  354 (406)
                      +||.+|..    +.||-+  .++.+
T Consensus       374 KdP~kRlg~~rGA~eIK~HpFF~gV  398 (459)
T KOG0610|consen  374 KDPSKRLGSKRGAAEIKRHPFFEGV  398 (459)
T ss_pred             cChhhhhccccchHHhhcCccccCC
Confidence            99999998    777765  44443

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1e-41  Score=318.28  Aligned_cols=255  Identities=24%  Similarity=0.399  Sum_probs=199.5

Q ss_pred             hhcccccccccceeEEEEEEeC-CCc--EEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGV--KIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      .+.+.+.||+|+||.||+|.+. +|.  .+|+|.+...........+.+|++++.++ +||||+++++++.++...++||
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~   87 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI   87 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence            4566788999999999999763 454  45777776544444567889999999999 8999999999999999999999


Q ss_pred             EeccCCChhhHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCce
Q 015480          155 EYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK  219 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k  219 (406)
                      ||+++++|.+++....               ..+++.++..++.|++.||+|||+   .+++||||||+|||++.++.+|
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~k  164 (303)
T cd05088          88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAK  164 (303)
T ss_pred             EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEE
Confidence            9999999999985332               357899999999999999999999   9999999999999999999999


Q ss_pred             EeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHH
Q 015480          220 VADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVW  298 (406)
Q Consensus       220 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  298 (406)
                      |+|||++.......   ......++..|+|||.+.+. .++.++|||||||++|||++ |..||......       ...
T Consensus       165 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~  233 (303)
T cd05088         165 IADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELY  233 (303)
T ss_pred             eCccccCcccchhh---hcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChH-------HHH
Confidence            99999986322111   11112346689999998766 68899999999999999998 88887432111       001


Q ss_pred             HHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          299 EEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      +...         .......+...+..+.+++.+||+.+|++||++++++..|+.+..
T Consensus       234 ~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         234 EKLP---------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             HHHh---------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1110         000111222345678999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.6e-41  Score=313.53  Aligned_cols=245  Identities=27%  Similarity=0.360  Sum_probs=194.7

Q ss_pred             ccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCCh
Q 015480           86 LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  162 (406)
Q Consensus        86 ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  162 (406)
                      ||+|+||+||++.. .+|+.||+|.+.....  ....+.+..|+++++.++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999965 4689999999875322  12235678899999999999999999999999999999999999999


Q ss_pred             hhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          163 DGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       163 ~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      ..++..   ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.........  ..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence            887743   34578999999999999999999999   99999999999999999999999999999765433221  23


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ...||+.|+|||.+.+. .++.++|||||||++|||++|+.||........       .......     ..... ...+
T Consensus       156 ~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-------~~~~~~~-----~~~~~-~~~~  221 (280)
T cd05608         156 GYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-------NKELKQR-----ILNDS-VTYP  221 (280)
T ss_pred             ccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-------HHHHHHh-----hcccC-CCCc
Confidence            45689999999999877 789999999999999999999999854322110       0000000     00110 1223


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                      ...+..+.+++..||+.||++||     +++++++
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            34667899999999999999999     5666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.5e-41  Score=318.32  Aligned_cols=238  Identities=26%  Similarity=0.324  Sum_probs=187.6

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHH-HhhccCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVG-TIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|+||.||+|+. .+|+.||+|++.+...  ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999976 4689999999875321  122344555554 57889999999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |+|...+. ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (321)
T cd05603          81 GELFFHLQ-RERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTS  154 (321)
T ss_pred             CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--ccc
Confidence            99988884 45678889999999999999999999   9999999999999999999999999999875322221  123


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ...||+.|+|||++.+. .++.++|||||||++|||++|..||......       ...+...         ... ...+
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~---------~~~-~~~~  216 (321)
T cd05603         155 TFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-------QMYDNIL---------HKP-LQLP  216 (321)
T ss_pred             cccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHH-------HHHHHHh---------cCC-CCCC
Confidence            45689999999999876 6899999999999999999999998543210       0011110         000 1122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCChH
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPMS  345 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~~  345 (406)
                      ...+..+.+++.+||+.||.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            34456789999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.7e-41  Score=327.00  Aligned_cols=251  Identities=23%  Similarity=0.272  Sum_probs=193.0

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      |...++||+|+||+||+|.. .+++.||+|++....  .......+.+|++++++++||||+++++.+.++...++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~   82 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY   82 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence            56678899999999999965 568899999997532  123446788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc--
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT--  234 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~--  234 (406)
                      |++|+|.+++.. ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++........  
T Consensus        83 ~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          83 IPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            999999999843 4568899999999999999999999   9999999999999999999999999999753210000  


Q ss_pred             -------------------------------------------eEEecCCCCCCCccCccccCCCCCCCcccceeecchh
Q 015480          235 -------------------------------------------HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMV  271 (406)
Q Consensus       235 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~i  271 (406)
                                                                 ........||+.|+|||++.+. .++.++|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvi  237 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVI  237 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeeeEEechHH
Confidence                                                       0001234689999999999876 78999999999999


Q ss_pred             HHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCC---hHHHH
Q 015480          272 LFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPP---MSAVI  348 (406)
Q Consensus       272 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~~vl  348 (406)
                      +|||++|+.||......          +.....  ........ .......+.++.+++.+|+ .+|.+|++   +++++
T Consensus       238 l~elltG~~Pf~~~~~~----------~~~~~i--~~~~~~~~-~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  303 (382)
T cd05625         238 LYEMLVGQPPFLAQTPL----------ETQMKV--INWQTSLH-IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK  303 (382)
T ss_pred             HHHHHhCCCCCCCCCHH----------HHHHHH--HccCCCcC-CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence            99999999998543211          000000  00000000 1111234566777777765 59999997   77776


Q ss_pred             H
Q 015480          349 K  349 (406)
Q Consensus       349 ~  349 (406)
                      +
T Consensus       304 ~  304 (382)
T cd05625         304 A  304 (382)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.9e-41  Score=312.43  Aligned_cols=247  Identities=27%  Similarity=0.344  Sum_probs=194.4

Q ss_pred             ccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCCh
Q 015480           86 LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  162 (406)
Q Consensus        86 ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  162 (406)
                      ||+|+||+||+++. .+|+.||+|++.....  ......+..|++++.+++||||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999976 4589999999874321  12234566799999999999999999999999999999999999999


Q ss_pred             hhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCC
Q 015480          163 DGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY  241 (406)
Q Consensus       163 ~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~  241 (406)
                      .+++.. ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++........   ....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eecc
Confidence            988754 33468999999999999999999999   9999999999999999999999999999976543322   1235


Q ss_pred             CCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHH
Q 015480          242 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKE  321 (406)
Q Consensus       242 ~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (406)
                      .|+..|+|||++.+. .++.++|||||||++|||++|..||........       .........     ..........
T Consensus       155 ~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-------~~~~~~~~~-----~~~~~~~~~~  221 (277)
T cd05607         155 AGTNGYMAPEILKEE-PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-------KEELKRRTL-----EDEVKFEHQN  221 (277)
T ss_pred             CCCCCccCHHHHccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-------HHHHHHHhh-----cccccccccc
Confidence            689999999999877 589999999999999999999999853221100       011111100     1111111224


Q ss_pred             HHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 015480          322 KAKRLCMVALWCVQDSPEDRPPMSAVIKML  351 (406)
Q Consensus       322 ~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  351 (406)
                      .+.++.+++..||+.||.+||++.++++.+
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            567799999999999999999997766433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.3e-41  Score=315.61  Aligned_cols=261  Identities=24%  Similarity=0.363  Sum_probs=191.7

Q ss_pred             hhcccccccccceeEEEEEEe-C-CCcEEEEEEeccccc-hhhHHHHHHHHHHhhcc---CcCccccEEEEEe-----cC
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-P-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRT---YHINLVRLYGFCH-----DQ  147 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~~  147 (406)
                      +|.+.+.||+|+||+||+|+. . +|..||+|+++.... ......+.+|+.++..+   +||||+++++++.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            466778899999999999976 3 468899999875322 22234566777776655   6999999999985     34


Q ss_pred             CeeEEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccc
Q 015480          148 HMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  226 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~  226 (406)
                      ...++||||+. ++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            56889999996 5898888543 4568999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHH-------H
Q 015480          227 KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVW-------E  299 (406)
Q Consensus       227 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-------~  299 (406)
                      .......   ......||+.|+|||.+.+. .++.++|||||||++|||++|.+||........  ......       .
T Consensus       158 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~--~~~i~~~~~~~~~~  231 (290)
T cd07862         158 RIYSFQM---ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPGEE  231 (290)
T ss_pred             EeccCCc---ccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHHhCCCChh
Confidence            7654331   12345689999999999776 789999999999999999999998864322100  000000       0


Q ss_pred             HHhh-hhcchhhccC----CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          300 EYEK-CELGAMILGC----GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       300 ~~~~-~~~~~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .+.. ..........    .........+..+.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0000 0000000000    000111234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.9e-41  Score=309.75  Aligned_cols=254  Identities=24%  Similarity=0.333  Sum_probs=191.1

Q ss_pred             ccccccceeEEEEEEeCC---CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCC
Q 015480           84 TRLGFGGFGEVYKGQFPN---GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~---g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      +.||+|+||.||+|...+   ...+++|.+...........+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            359999999999996543   35688888765544445567889999999999999999999999999999999999999


Q ss_pred             ChhhHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          161 SLDGYLFGKK----RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       161 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +|.+++....    ...++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999995432    235678889999999999999999   999999999999999999999999999987543332222


Q ss_pred             EecCCCCCCCccCccccCC------CCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          237 TISGYKGTPGYSAPEFLSG------NYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ......++..|+|||++..      ...++.++|||||||++|||++ |..|+......      ..........     
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~-----  226 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQ-----  226 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhcc-----
Confidence            2233446778999998743      2256889999999999999999 66665322110      0000000000     


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                      ......+......+..+.+++..|| .||++|||+++|++.|.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         227 DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            0011111223345677888999998 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.7e-41  Score=311.47  Aligned_cols=258  Identities=23%  Similarity=0.319  Sum_probs=205.6

Q ss_pred             hhhhhcccccccccceeEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      ...++.+.+.||+|+||.||+|.+.+    ...||+|...........+.+.+|+.++++++||||+++++++.+. ..+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~   82 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVW   82 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcE
Confidence            34556778899999999999997643    2468999987655445667899999999999999999999998764 568


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +||||+++|+|.+++......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999996656678999999999999999999999   9999999999999999999999999999976654


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      ..... .....++..|+|||.+... .++.++||||||+++|||++ |..||.......       ........      
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~------  224 (270)
T cd05056         160 ESYYK-ASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-------VIGRIENG------  224 (270)
T ss_pred             cccee-cCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHcC------
Confidence            42221 1223345689999998766 68999999999999999986 888874332110       01111110      


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                         .....+..++..+.+++.+|+..+|.+|||+.++++.|+++.
T Consensus       225 ---~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         225 ---ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             ---CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               111222345678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.1e-41  Score=321.06  Aligned_cols=241  Identities=24%  Similarity=0.294  Sum_probs=192.6

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCc-CccccEEEEEecCCeeEEEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYH-INLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  155 (406)
                      |.+.+.||+|+||.||+|+.. +++.||+|++....  .....+.+..|..++..+.| ++|+++++++.+.+..++|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            567788999999999999764 57899999997542  22344678889999999976 468889999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++|+|.+++. ....+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||++.........
T Consensus        82 ~~~~g~L~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          82 YVNGGDLMYHIQ-QVGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             CCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence            999999999884 44568999999999999999999999   99999999999999999999999999998743222211


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......       .........          .
T Consensus       158 --~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~~~----------~  217 (324)
T cd05587         158 --TRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------ELFQSIMEH----------N  217 (324)
T ss_pred             --eeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcC----------C
Confidence              2235689999999999876 6899999999999999999999998543211       111111110          0


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCCh
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPM  344 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  344 (406)
                      ...+...+..+.+++.+||+.||.+|++.
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            11223456778999999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.2e-41  Score=308.27  Aligned_cols=256  Identities=21%  Similarity=0.378  Sum_probs=205.6

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccc--cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||.||+|+. .+|+.||||.+...  ........+..|+++++.++||||+++++++.+.+..++++|
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            356678899999999999976 46899999987642  233445678999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          156 YMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       156 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |+++++|.+++..   ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999988842   34568899999999999999999999   99999999999999999999999999998765433


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ...  .....|+..|+|||.+.+. .++.++|+||||+++|||++|+.|+.........     ......         .
T Consensus       160 ~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~-----~~~~~~---------~  222 (267)
T cd08228         160 TTA--AHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS-----LCQKIE---------Q  222 (267)
T ss_pred             hHH--HhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHH-----HHHHHh---------c
Confidence            221  1234688899999998876 6889999999999999999999997543221100     001111         1


Q ss_pred             CCCC-cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          313 CGIE-EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       313 ~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      .... ......+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus       223 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            1111 12234567899999999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.3e-41  Score=308.89  Aligned_cols=253  Identities=29%  Similarity=0.433  Sum_probs=201.6

Q ss_pred             hhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      ..++.+.+.||+|+||.||+|.+..+..+|+|.+....  ...+.+.+|+++++.++|||++++++++.. ...+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF   81 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence            34567778899999999999988777789999887532  345678899999999999999999998854 567899999


Q ss_pred             ccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          157 MENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       157 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999999999643 3458999999999999999999999   99999999999999999999999999999765433221


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                       ......++..|+|||.+.+. .++.++||||||+++|||++ |..|+......       ........         ..
T Consensus       159 -~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~---------~~  220 (260)
T cd05069         159 -ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-------EVLEQVER---------GY  220 (260)
T ss_pred             -ccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHc---------CC
Confidence             11223456789999998766 68999999999999999999 77776432111       11111111         01


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                      ....+...+..+.+++.+||+.||.+||++++|++.|++
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            112233556789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=308.50  Aligned_cols=250  Identities=30%  Similarity=0.436  Sum_probs=203.8

Q ss_pred             hhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      ...+.+.+.||+|+||.||+|.. .|+.||+|.+.....  ..+++.+|+.++..++|+||+++++++.+....++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            34567788999999999999987 478999999986533  467899999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          157 MENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       157 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++....... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            99999999995443 379999999999999999999999   9999999999999999999999999999976532221 


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                          ...++..|+|||.+... .++.++||||||+++|||++ |..|+.....       ....+....         ..
T Consensus       158 ----~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~---------~~  216 (256)
T cd05039         158 ----SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVVPHVEK---------GY  216 (256)
T ss_pred             ----cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHhc---------CC
Confidence                23346689999998766 68899999999999999997 8877643211       111111111         11


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      ....+...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         217 RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            1122234567899999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.4e-41  Score=307.12  Aligned_cols=249  Identities=29%  Similarity=0.433  Sum_probs=199.9

Q ss_pred             ccccccceeEEEEEEeCC--C--cEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQFPN--G--VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|++|.||+|.+.+  +  ..||+|.+.........+.+..|+.++++++||||+++++++.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            469999999999997643  3  36899999876444556789999999999999999999999988 888999999999


Q ss_pred             CChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE-E
Q 015480          160 GSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV-T  237 (406)
Q Consensus       160 g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~-~  237 (406)
                      ++|.+++.... ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++.......... .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999996544 578999999999999999999999   999999999999999999999999999998765432221 1


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                      .....++..|+|||.+.+. .++.++|||||||++|||++ |..|+......       ........        .....
T Consensus       157 ~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~--------~~~~~  220 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------QILKKIDK--------EGERL  220 (257)
T ss_pred             ccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHh--------cCCcC
Confidence            1234577899999998876 68999999999999999998 98887432111       01111110        00111


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                      ..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            122345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.6e-41  Score=306.78  Aligned_cols=257  Identities=23%  Similarity=0.384  Sum_probs=207.4

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccc--cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||.||+|... +|+.||+|.++..  ........+.+|++++++++|+|++++++++.+.+..++|||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            4677889999999999999775 7999999988632  223345778999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          156 YMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       156 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |+++++|.+++..   ....+++.++..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            9999999998843   34568999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ...  .....++..|+|||.+.+. .++.++||||||+++|+|++|+.|+........     ...+...         .
T Consensus       160 ~~~--~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~---------~  222 (267)
T cd08224         160 TTA--AHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----SLCKKIE---------K  222 (267)
T ss_pred             Ccc--cceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHH-----HHHhhhh---------c
Confidence            221  1234578899999998876 689999999999999999999998754321100     0011111         1


Q ss_pred             CCCCcch-HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          313 CGIEEKD-KEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       313 ~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      +.....+ ...+..+.+++.+||..+|++||++.+|++.|+.+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            1111222 256678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.5e-41  Score=306.70  Aligned_cols=249  Identities=25%  Similarity=0.378  Sum_probs=204.2

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccc-cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |.+.+.||+|+||.||+|.. .+|+.|++|.+... ........+.+|+++++.++|||++++++++.+....++||||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            45678899999999999976 46899999998643 23445678899999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          158 ENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       158 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      ++++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......... 
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-  157 (256)
T cd08529          82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-  157 (256)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch-
Confidence            999999999654 5678999999999999999999999   99999999999999999999999999998866543221 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                       .....|++.|+|||++.+. .++.++|+||||+++|+|++|+.||......       .....         ......+
T Consensus       158 -~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~---------~~~~~~~  219 (256)
T cd08529         158 -ANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQG-------ALILK---------IIRGVFP  219 (256)
T ss_pred             -hhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH---------HHcCCCC
Confidence             1234578899999999877 6889999999999999999999998543211       00011         1111122


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      ......+..+.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            3333567789999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.8e-41  Score=324.67  Aligned_cols=258  Identities=23%  Similarity=0.268  Sum_probs=200.3

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      .+....|.+.+.||+|+||.||+++.. +++.||+|++.+..  .......+..|+.+++.++||||+++++++.++...
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            444567788899999999999999764 58899999986421  222345678899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ++||||+++|+|.+++..  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus       119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            999999999999999843  358889999999999999999999   999999999999999999999999999998664


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCC---CCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNY---PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      .... .......||+.|+|||++.+..   .++.++|||||||++|||++|..||......       ..........  
T Consensus       194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------~~~~~i~~~~--  263 (370)
T cd05621         194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------GTYSKIMDHK--  263 (370)
T ss_pred             cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC--
Confidence            3322 1223467999999999987542   3788999999999999999999998543211       0011111000  


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCC--CCChHHHHHH
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPED--RPPMSAVIKM  350 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~vl~~  350 (406)
                         .... .+.....+..+.+++..|+..++..  |+++.++++.
T Consensus       264 ---~~~~-~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         264 ---NSLN-FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ---cccC-CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence               0000 0111245677889999999865543  8899998883

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.9e-41  Score=307.22  Aligned_cols=249  Identities=22%  Similarity=0.301  Sum_probs=202.7

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      |.+.+.||+|+||.||+++.. ++..+|+|.++........+.+..|+.+++.++||||+++++.+.++...+++|||++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD   81 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence            456788999999999999764 6889999998754444556788899999999999999999999999999999999999


Q ss_pred             CCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          159 NGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       159 ~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      +++|.+++.. ....+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||++.........  
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--  156 (255)
T cd08219          82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--  156 (255)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc--
Confidence            9999998854 34568999999999999999999999   99999999999999999999999999999765433221  


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      .....|+..|+|||++.+. .++.++|+||||+++|+|++|..||......       ......         .......
T Consensus       157 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~~~~~~---------~~~~~~~  219 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWK-------NLILKV---------CQGSYKP  219 (255)
T ss_pred             cccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHH-------HHHHHH---------hcCCCCC
Confidence            1235688899999998876 6899999999999999999999998532110       000010         0111122


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      .+...+..+.+++.+||+.||++||++.+++..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            233456678999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.7e-41  Score=318.93  Aligned_cols=242  Identities=26%  Similarity=0.314  Sum_probs=194.0

Q ss_pred             ccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|+||+||+|.+. +++.||+|++++..  .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999764 58899999998542  122345677888888877 699999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |+|..++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++........  ..
T Consensus        81 ~~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~  154 (318)
T cd05570          81 GDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TS  154 (318)
T ss_pred             CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--cc
Confidence            99998884 34579999999999999999999999   99999999999999999999999999998753222211  12


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ...|+..|+|||++.+. .++.++|||||||++|+|++|+.||......       .........          ....+
T Consensus       155 ~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-------~~~~~i~~~----------~~~~~  216 (318)
T cd05570         155 TFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDED-------ELFQSILED----------EVRYP  216 (318)
T ss_pred             ceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-------HHHHHHHcC----------CCCCC
Confidence            34689999999999876 7899999999999999999999998533211       111111110          01122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCh-----HHHHH
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPM-----SAVIK  349 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~-----~~vl~  349 (406)
                      ...+..+.+++.+||+.||.+||++     .++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            3456789999999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2e-41  Score=324.25  Aligned_cols=254  Identities=21%  Similarity=0.293  Sum_probs=193.4

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||+||++.. .+|+.||+|+++...  .......+..|+.++..++||||+++++.+.+....++|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            356678899999999999965 458999999997532  12234568889999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++|+|.+++. ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        82 ~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          82 FLPGGDMMTLLM-KKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             CCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            999999999984 34679999999999999999999999   99999999999999999999999999998754321100


Q ss_pred             ---------------------------------EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhccccc
Q 015480          236 ---------------------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNA  282 (406)
Q Consensus       236 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~  282 (406)
                                                       ......+||+.|+|||++.+. .++.++|||||||++|||++|..||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                             001235799999999999876 7899999999999999999999998


Q ss_pred             ccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcc--cCCCCCCChHHHHHH
Q 015480          283 IVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQ--DSPEDRPPMSAVIKM  350 (406)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~dP~~RPs~~~vl~~  350 (406)
                      ......       .......... ....    .+. ....+.++.+++.+++.  .++..||++++|++.
T Consensus       237 ~~~~~~-------~~~~~i~~~~-~~~~----~p~-~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         237 CSETPQ-------ETYKKVMNWK-ETLI----FPP-EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCHH-------HHHHHHHcCc-Cccc----CCC-cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            543211       1111111100 0000    011 11234566777776443  344456899999873

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.7e-41  Score=318.55  Aligned_cols=242  Identities=24%  Similarity=0.314  Sum_probs=191.7

Q ss_pred             ccccccceeEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHhhc-cCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGR-TYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|+||+||+|.+. +++.||+|+++....  ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999764 578999999976421  2234556778888876 4899999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |+|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++.........  ..
T Consensus        81 g~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~  154 (316)
T cd05619          81 GDLMFHIQ-SCHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TC  154 (316)
T ss_pred             CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc--ee
Confidence            99999984 34578999999999999999999999   99999999999999999999999999998753222111  12


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ...||..|+|||++.+. .++.++|||||||++|||++|..||......       .........   .       ...+
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~---~-------~~~~  216 (316)
T cd05619         155 TFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQSIRMD---N-------PCYP  216 (316)
T ss_pred             eecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhC---C-------CCCC
Confidence            35689999999999876 6899999999999999999999998543211       111111100   0       1122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCChH-HHHH
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPMS-AVIK  349 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~~-~vl~  349 (406)
                      ...+..+.+++.+||+.||++||++. ++.+
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            23456789999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=322.87  Aligned_cols=245  Identities=25%  Similarity=0.347  Sum_probs=205.8

Q ss_pred             cccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCChh
Q 015480           85 RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLD  163 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  163 (406)
                      .||+|.||+||-|++. +...+|||-+....+ ...+-+..|+.+-++|+|.|||+++|.+.+++++-|.||.++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            5999999999999764 466789999875432 34566889999999999999999999999999999999999999999


Q ss_pred             hHhhcCCCCC--CHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC-CCCceEeccccccccCCCCceEEecC
Q 015480          164 GYLFGKKRAI--EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNKTHVTISG  240 (406)
Q Consensus       164 ~~l~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~DfGl~~~~~~~~~~~~~~~  240 (406)
                      +++..+-+++  .+.++..+..||++||.|||.   ..|+|||||-+||||+. .|.+||+|||-++.+..-...  ...
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~--TET  735 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC--TET  735 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCcc--ccc
Confidence            9998888888  788999999999999999999   99999999999999974 689999999999876544332  245


Q ss_pred             CCCCCCccCccccCCC-CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          241 YKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       241 ~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      +.||..|||||++..+ .+|..++|||||||++.||.||++||..-+.+.         ..+....     .-..-++.+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---------AAMFkVG-----myKvHP~iP  801 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---------AAMFKVG-----MYKVHPPIP  801 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---------Hhhhhhc-----ceecCCCCc
Confidence            7799999999999743 479999999999999999999999996433321         1111111     112235677


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .+.+.+...++.+|+.+||.+||++.+++.
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            889999999999999999999999999987

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.7e-41  Score=319.63  Aligned_cols=241  Identities=24%  Similarity=0.309  Sum_probs=192.7

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      |++.+.||+|+||.||+|... +++.||+|++.+...  ......+..|..++..+ +|++|+++++++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            566788999999999999764 578999999975421  22334567788888777 58999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++|+|.+++. ....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++........ 
T Consensus        82 ~~~~g~L~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~-  156 (323)
T cd05616          82 YVNGGDLMYQIQ-QVGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-  156 (323)
T ss_pred             CCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-
Confidence            999999998884 34568999999999999999999999   9999999999999999999999999999975432221 


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                       ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......       .........         . 
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-------~~~~~i~~~---------~-  217 (323)
T cd05616         157 -TTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIMEH---------N-  217 (323)
T ss_pred             -ccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhC---------C-
Confidence             12345689999999999876 7899999999999999999999998543211       111111111         0 


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCCh
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPM  344 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  344 (406)
                      ...+...+.++.+++.+||+.||.+|++.
T Consensus       218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            11223456788999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.3e-41  Score=307.12  Aligned_cols=255  Identities=27%  Similarity=0.440  Sum_probs=204.3

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      +...++.+.++||+|+||.||++.+.++..+|+|.+...  ......+.+|+.+++.++|+||+++++++.+ ...+++|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            345567888999999999999998877888999988753  2345678999999999999999999999887 6789999


Q ss_pred             EeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          155 EYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       155 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      ||+++++|.+++... ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999543 4568899999999999999999999   999999999999999999999999999997654322


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      .. ......++..|+|||.+... .++.++|+|||||++|++++ |..||......       ........         
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~---------  218 (260)
T cd05073         157 YT-AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------EVIRALER---------  218 (260)
T ss_pred             cc-cccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhC---------
Confidence            21 11223456789999999876 68999999999999999998 78777432111       01111111         


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                      ..........+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       219 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         219 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            11112223456779999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.9e-41  Score=316.58  Aligned_cols=257  Identities=28%  Similarity=0.427  Sum_probs=202.0

Q ss_pred             hhcccccccccceeEEEEEEeC-CCc----EEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGV----KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      .+...+.||+|+||.||+|.+. +|.    .||+|.+...........+.+|+.+++.++||||+++++++... ..+++
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v   86 (303)
T cd05110           8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV   86 (303)
T ss_pred             hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence            3455678999999999999753 444    57899887654444456788999999999999999999998764 46799


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      +||+++|+|.+++......+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++......
T Consensus        87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE  163 (303)
T ss_pred             ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCcc
Confidence            99999999999997666678999999999999999999999   999999999999999999999999999998665433


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      .........++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....       .........         
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~---------  226 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------REIPDLLEK---------  226 (303)
T ss_pred             cccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHC---------
Confidence            22222334457789999998876 78999999999999999997 7777743211       000111111         


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      ......+..++..+.+++..||..+|++||++.++++.|+.+..
T Consensus       227 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         227 GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            11111122345678999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.4e-41  Score=310.20  Aligned_cols=249  Identities=27%  Similarity=0.436  Sum_probs=197.5

Q ss_pred             cccccceeEEEEEEeCC-------CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           85 RLGFGGFGEVYKGQFPN-------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .||+|+||.||+|++.+       +..+|+|.+...........+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            59999999999997642       25799998876543345677899999999999999999999999999999999999


Q ss_pred             cCCChhhHhhc------CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC-----CceEeccccc
Q 015480          158 ENGSLDGYLFG------KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-----SPKVADFGLA  226 (406)
Q Consensus       158 ~~g~L~~~l~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-----~~kl~DfGl~  226 (406)
                      ++++|.+++..      ....+++.++..++.|++.||+|||+   .+++|+||||+||+++.++     .++|+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            99999999853      22447899999999999999999999   9999999999999999887     8999999999


Q ss_pred             cccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhh
Q 015480          227 KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCE  305 (406)
Q Consensus       227 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (406)
                      ................++..|+|||.+.+. .++.++||||||+++|||++ |..||......       ......    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-------~~~~~~----  226 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-------EVLQHV----  226 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHH-------HHHHHH----
Confidence            765433222222223456789999999876 68999999999999999998 88877422110       000110    


Q ss_pred             cchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          306 LGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                           ........+...+..+.+++.+||+.+|.+||++++|++.|++
T Consensus       227 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         227 -----TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -----hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                 0111112234456789999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.2e-41  Score=319.21  Aligned_cols=243  Identities=26%  Similarity=0.287  Sum_probs=189.6

Q ss_pred             ccccccceeEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHH-HhhccCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVG-TIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|+||+||+|... +++.||+|++.....  ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999764 578899999975321  122234444444 56788999999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |+|.+++. ....+.+..+..++.|++.||+|||+   .|++||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~  154 (325)
T cd05602          81 GELFYHLQ-RERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTS  154 (325)
T ss_pred             CcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccc
Confidence            99999884 34568888999999999999999999   9999999999999999999999999999975432221  123


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ...||+.|+|||++.+. .++.++|||||||++|||++|..||......       .........         . ....
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~---------~-~~~~  216 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNK---------P-LQLK  216 (325)
T ss_pred             cccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHH-------HHHHHHHhC---------C-cCCC
Confidence            45689999999999876 7899999999999999999999998532211       011111110         0 1112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      ...+..+.+++.+||+.||.+||++.+.+..
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            2456778999999999999999998754443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7.7e-41  Score=306.51  Aligned_cols=258  Identities=23%  Similarity=0.375  Sum_probs=206.1

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccc--cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||.||+|.. .+|..+|||.+...  ........+.+|+.+++.++||||+++++++.+++..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            355677899999999999975 57899999987642  122345678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          156 YMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       156 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |+++++|.+++..   ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999998842   34568999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ...  .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..|+..........     ......        .
T Consensus       160 ~~~--~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~--------~  223 (267)
T cd08229         160 TTA--AHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-----CKKIEQ--------C  223 (267)
T ss_pred             Ccc--cccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHH-----hhhhhc--------C
Confidence            221  1234688899999999876 68899999999999999999999875332211000     000000        0


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      ..........+..+.+++.+||+.||++|||+.+|++.++++.
T Consensus       224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            0011112346678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3e-41  Score=307.39  Aligned_cols=248  Identities=27%  Similarity=0.397  Sum_probs=198.3

Q ss_pred             hhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEe-cCCeeEEEEEe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH-DQHMTALVYEY  156 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~  156 (406)
                      ..+.+.+.||+|+||.||++.. .|..||+|.++..   ...+.+.+|+.++++++|+|++++++++. ++...+++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            4567778999999999999987 4788999998753   23467899999999999999999999764 55678999999


Q ss_pred             ccCCChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          157 MENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       157 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +++++|.+++.... ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  157 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-  157 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccCC-
Confidence            99999999986543 358999999999999999999999   9999999999999999999999999999875433221 


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                          ...++..|+|||++.+. .++.++|||||||++|||++ |+.|+......       ........         ..
T Consensus       158 ----~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~-------~~~~~~~~---------~~  216 (256)
T cd05082         158 ----TGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRVEK---------GY  216 (256)
T ss_pred             ----CCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHhc---------CC
Confidence                23345689999998876 68999999999999999997 88776422110       00111110         01


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      .......++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            1122234567899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.1e-41  Score=307.14  Aligned_cols=250  Identities=28%  Similarity=0.489  Sum_probs=201.4

Q ss_pred             hhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      .+++.+.||+|+||.||++.+.++..+|+|.+....  .....+.+|++++++++|||++++++++......++||||++
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            456778899999999999988778899999987532  234678999999999999999999999999999999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      +++|.+++......+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++......... ..
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~  158 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-cc
Confidence            999999997666678999999999999999999999   99999999999999999999999999998755432211 11


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      ....++..|+|||.+.+. .++.++||||||+++|||++ |..|+......       ...+.....         ....
T Consensus       159 ~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~---------~~~~  221 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------EVVETINAG---------FRLY  221 (256)
T ss_pred             CCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-------HHHHHHhCC---------CCCC
Confidence            223356789999998876 68899999999999999998 88777432211       111111110         0011


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML  351 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  351 (406)
                      .+...+..+.+++.+||+.+|++||++.++++.|
T Consensus       222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            1122457799999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=8.4e-41  Score=308.47  Aligned_cols=250  Identities=26%  Similarity=0.375  Sum_probs=198.1

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      +.+.+.||+|+||.||+|.. .+++.||+|++..+........+.+|++++.+++||||+++++++......++||||++
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   82 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD   82 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence            45677899999999999965 56899999998765444455679999999999999999999999999999999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      +++|..+.     .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.......    .
T Consensus        83 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~  150 (279)
T cd06619          83 GGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----A  150 (279)
T ss_pred             CCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----c
Confidence            99996543     46788899999999999999999   999999999999999999999999999997554321    2


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ....|+..|+|||.+.+. .++.++||||||+++|+|++|+.||......................        ......
T Consensus       151 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~  221 (279)
T cd06619         151 KTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--------DPPVLP  221 (279)
T ss_pred             cCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc--------CCCCCC
Confidence            335689999999999876 68999999999999999999999986432221111111111111000        000111


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       319 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      ....+.++.+++.+||+.+|.+||+++++++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            12345678999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-41  Score=308.46  Aligned_cols=256  Identities=31%  Similarity=0.485  Sum_probs=205.3

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      +....+.+.+.||+|+||.||+|.+.++..||+|.+....  .....+.+|+.++++++|+||+++++++.+....++||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            3445667788999999999999988788899999987532  34567899999999999999999999999989999999


Q ss_pred             EeccCCChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          155 EYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      ||+++++|.+++.... ..+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999996543 578999999999999999999999   999999999999999999999999999997654321


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ... .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.....       .........         
T Consensus       158 ~~~-~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-------~~~~~~~~~---------  219 (261)
T cd05034         158 YTA-REGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-------REVLEQVER---------  219 (261)
T ss_pred             hhh-hhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHc---------
Confidence            111 1122345689999998876 68999999999999999998 8887743211       111111110         


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                      ......+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         220 GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            00111222336789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.8e-40  Score=312.40  Aligned_cols=255  Identities=21%  Similarity=0.223  Sum_probs=197.3

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||+||+++.. +++.||+|++.+..  .......+..|..++..++|+||+++++++.+.+..++|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            4567789999999999999764 58899999987521  22234557889999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++|+|.+++......+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++.........
T Consensus        82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            999999999997656788999999999999999999999   99999999999999999999999999999765443322


Q ss_pred             EEecCCCCCCCccCccccCCC----CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          236 VTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                       ......||+.|+|||++.+.    ..++.++|||||||++|||++|+.||......       ..........     .
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~-----~  225 (331)
T cd05624         159 -QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHE-----E  225 (331)
T ss_pred             -eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------HHHHHHHcCC-----C
Confidence             12335689999999988642    25788999999999999999999998533211       0011110000     0


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCC--CCChHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPED--RPPMSAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~vl~  349 (406)
                      ....+......+.++.+++.+|+..++.+  |++++++++
T Consensus       226 ~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         226 RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            00112222335678899999999865544  457887775

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.9e-41  Score=307.85  Aligned_cols=241  Identities=22%  Similarity=0.335  Sum_probs=189.2

Q ss_pred             ccccccceeEEEEEEeCC-------------CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           84 TRLGFGGFGEVYKGQFPN-------------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      +.||+|+||.||+|.+..             ...|++|++.... ......+..|+.++..++||||+++++++.++...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            369999999999997532             2358899876542 23445788899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC-------ceEecc
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS-------PKVADF  223 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-------~kl~Df  223 (406)
                      ++||||+++|+|..++......+++..+..++.|+++||+|||+   .+++||||||+|||++.++.       ++++||
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            99999999999999986666779999999999999999999999   99999999999999987664       899999


Q ss_pred             ccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHh-hcccccccCCCcccccchhHHHHHHh
Q 015480          224 GLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV-GRRRNAIVGATESLDWFPKHVWEEYE  302 (406)
Q Consensus       224 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~  302 (406)
                      |++......      ....++..|+|||.+.....++.++|||||||++|||+ +|..|+.......        .....
T Consensus       157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~~~~~  222 (262)
T cd05077         157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--------KERFY  222 (262)
T ss_pred             CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--------HHHHH
Confidence            998654322      22457889999998875447899999999999999998 4666653211100        00000


Q ss_pred             hhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                      ...          ..........+.+++.+||+.||.+||++.+|++.|+
T Consensus       223 ~~~----------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 EGQ----------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             hcC----------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            000          0011123467899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=291.23  Aligned_cols=264  Identities=23%  Similarity=0.286  Sum_probs=208.0

Q ss_pred             HHHhhhhhcccccccccceeEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec-----
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-----  146 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----  146 (406)
                      ..+++.+|.+.++||+|||+.||+++ ..++..||+|++.-.. ....+..++|++..++++|||+++++++...     
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            34678889999999999999999996 4678999999987543 3566788999999999999999999988743     


Q ss_pred             CCeeEEEEEeccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecc
Q 015480          147 QHMTALVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF  223 (406)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (406)
                      ....||+++|...|+|.+.+..   ++..+++.+++.|+.++++||++||+.. .+++||||||.|||+.+.+.++|.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence            3458999999999999999853   3457999999999999999999999822 34999999999999999999999999


Q ss_pred             ccccccCCCCce-------EEecCCCCCCCccCccccCCC--CCCCcccceeecchhHHHHhhcccccccCCC--ccccc
Q 015480          224 GLAKLCDRNKTH-------VTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVLFEIVGRRRNAIVGAT--ESLDW  292 (406)
Q Consensus       224 Gl~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~--~~~~~  292 (406)
                      |.+....-.-..       ..-.....|..|.|||.+.-+  ...++++|||||||+||.|+.|..||+...+  ++...
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL  253 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL  253 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence            998744311000       001123468899999987532  2578999999999999999999999864322  11111


Q ss_pred             chhHHHHHHhhhhcchhhccC--CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          293 FPKHVWEEYEKCELGAMILGC--GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                                      .+...  ..+.. ..++..+.+++++|++.||.+||++.+++..++.+.
T Consensus       254 ----------------Av~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  254 ----------------AVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----------------eeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                            11111  11112 237888999999999999999999999999998764

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.7e-41  Score=315.23  Aligned_cols=265  Identities=22%  Similarity=0.276  Sum_probs=201.0

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      +|.+.+.||+|+||.||+|... +++.||+|.+...........+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~   86 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   86 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence            3566788999999999999764 588999999875433344556788999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      + ++|.+++......+++..+..++.|+++||+|||+   .+++|+||||+||+++.++.+||+|||++.........  
T Consensus        87 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--  160 (301)
T cd07873          87 D-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--  160 (301)
T ss_pred             c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--
Confidence            7 58999886666778999999999999999999999   99999999999999999999999999999754332211  


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc--------cchhHHHHHHhhh-hcch
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD--------WFPKHVWEEYEKC-ELGA  308 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~-~~~~  308 (406)
                      .....+++.|+|||.+.+...++.++|||||||++|||++|++||.........        ......|...... ....
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence            123456889999999876656889999999999999999999998543221000        0000011111000 0000


Q ss_pred             hhccCCC----CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 MILGCGI----EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .......    .......+..+.+++.+||+.||.+|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000000    0111234567899999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=325.35  Aligned_cols=263  Identities=27%  Similarity=0.415  Sum_probs=217.3

Q ss_pred             ChHHHhhhhhcccccccccceeEEEEEEeCC-CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCe
Q 015480           71 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM  149 (406)
Q Consensus        71 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  149 (406)
                      ..++++.-.+.+.++||-|.||+||.|.|+. .-.||||.++.+.  ...+.|+.|..+|+.+.|||+|+++|+|..+..
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            5678888888889999999999999998865 5679999998753  456889999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      +|||+|||..|+|.+||... +..++.-.+++++.||+.|+.||..   +++|||||.++|+|+.++..+|++||||+++
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            99999999999999999654 4557778889999999999999998   9999999999999999999999999999998


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      +..+.... ..+..-+..|.|||.+... .++.++|||+|||+|||+.|-......+..      ...++..        
T Consensus       415 MtgDTYTA-HAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSqVY~L--------  478 (1157)
T KOG4278|consen  415 MTGDTYTA-HAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYGL--------  478 (1157)
T ss_pred             hcCCceec-ccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHHHH--------
Confidence            87654332 2334446689999999877 799999999999999999985432211111      1111222        


Q ss_pred             hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                       +..+-.-+.+..|++.+++|+..||+.+|.+||++.|+.+.++.+.
T Consensus       479 -LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  479 -LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             -HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence             2222223455678899999999999999999999999999888764

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-41  Score=316.83  Aligned_cols=242  Identities=24%  Similarity=0.260  Sum_probs=187.6

Q ss_pred             ccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhcc---CcCccccEEEEEecCCeeEEEEEeccC
Q 015480           86 LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRT---YHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        86 ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      ||+|+||+||+|+. .+|+.||+|++.....  ......+..|..++...   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999976 4589999999864321  12233455666666654   699999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |+|.+++. ....+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||++.........  ..
T Consensus        81 g~L~~~l~-~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~~  154 (330)
T cd05586          81 GELFWHLQ-KEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TN  154 (330)
T ss_pred             ChHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--cc
Confidence            99998884 45678999999999999999999999   99999999999999999999999999998753322211  23


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ...||..|+|||++.+...++.++|||||||++|||++|..||......       ..........         .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~---------~~~~~  218 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-------QMYRNIAFGK---------VRFPK  218 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-------HHHHHHHcCC---------CCCCC
Confidence            4568999999999876646899999999999999999999998542211       1111111110         00111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCC----hHHHHH
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPP----MSAVIK  349 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs----~~~vl~  349 (406)
                      ...+..+.+++.+||+.||.+||+    +.++++
T Consensus       219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            124567889999999999999984    555555

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.9e-41  Score=310.72  Aligned_cols=240  Identities=23%  Similarity=0.342  Sum_probs=188.4

Q ss_pred             cccccceeEEEEEEeCC-------------------------CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCcccc
Q 015480           85 RLGFGGFGEVYKGQFPN-------------------------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR  139 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  139 (406)
                      +||+|+||.||+|.+..                         ...|++|++.... ......+..|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence            69999999999996421                         1358899887542 233467888999999999999999


Q ss_pred             EEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC---
Q 015480          140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---  216 (406)
Q Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---  216 (406)
                      +++++.+....++||||+++|+|..++......+++..+..++.|+++||+|||+   ++++||||||+|||++.++   
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence            9999999999999999999999999986666788999999999999999999999   9999999999999997654   


Q ss_pred             ----CceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHh-hcccccccCCCcccc
Q 015480          217 ----SPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV-GRRRNAIVGATESLD  291 (406)
Q Consensus       217 ----~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ell-tg~~p~~~~~~~~~~  291 (406)
                          .+|++|||++......      ....++..|+|||.+.+...++.++||||||+++|||+ +|..|+........ 
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-  230 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-  230 (274)
T ss_pred             CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence                3799999988643221      12346788999998876546899999999999999985 67777743322110 


Q ss_pred             cchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          292 WFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                            ......        .   ...+......+.+++.+||+.+|++|||+.+|++.|+
T Consensus       231 ------~~~~~~--------~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ------ERFYEK--------K---HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ------HHHHHh--------c---cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                  000000        0   0011112356899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-40  Score=312.53  Aligned_cols=256  Identities=20%  Similarity=0.204  Sum_probs=196.8

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||+||+++.. +++.||+|++.+..  .......+..|..++..++|+||+++++++.++...++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            4667889999999999999764 58999999997421  22234568889999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++|+|.+++......+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||++.........
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            999999999996656789999999999999999999999   99999999999999999999999999998765433221


Q ss_pred             EEecCCCCCCCccCccccCC----CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          236 VTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      . .....||+.|+|||++..    ...++.++|||||||++|||++|+.||......       .........     ..
T Consensus       159 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-------~~~~~i~~~-----~~  225 (331)
T cd05597         159 Q-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNH-----KE  225 (331)
T ss_pred             c-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-------HHHHHHHcC-----CC
Confidence            1 122458999999999863    235788999999999999999999998533211       000110000     00


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCC--CCCCChHHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSP--EDRPPMSAVIKM  350 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP--~~RPs~~~vl~~  350 (406)
                      ....+......+..+.+++.+|+..++  ..||++.++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         226 HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            001112222356778888888775533  347899888874

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.5e-42  Score=308.41  Aligned_cols=258  Identities=23%  Similarity=0.279  Sum_probs=194.2

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC-----eeEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-----MTALV  153 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  153 (406)
                      +.-.+++|.|+||.||+|.. .+++.||||..-.+..-.     -+|+.+|+.+.|||||++.-+|....     ...+|
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            34457899999999999976 457899999887543322     36999999999999999998885432     34589


Q ss_pred             EEeccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC-CCceEecccccccc
Q 015480          154 YEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLC  229 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~DfGl~~~~  229 (406)
                      |||++. +|...++.   .+..++.-.+.-+.+|+++||.|||+   .+|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999987 99888853   36778888899999999999999999   999999999999999976 89999999999987


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc-----chhHHHHHHhhh
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW-----FPKHVWEEYEKC  304 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-----~~~~~~~~~~~~  304 (406)
                      ........   +..|..|.|||.+.+...|+.+.||||.||++.||+-|++.|........-.     +.....+.....
T Consensus       177 ~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  177 VKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             ccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            66554432   3457899999999998899999999999999999999998775433211100     000000111100


Q ss_pred             -------hcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          305 -------ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       305 -------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                             +...........-.....+.++.+++.++|..+|.+|.++.+++.
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                   000010011111133456788999999999999999999999886

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.8e-41  Score=314.82  Aligned_cols=197  Identities=22%  Similarity=0.324  Sum_probs=161.8

Q ss_pred             cccccccceeEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec--CCeeEEEEEec
Q 015480           83 STRLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMTALVYEYM  157 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~  157 (406)
                      .++||+|+||+||+|...   +++.||+|.+....   ....+.+|+.++++++||||+++++++.+  +...+++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            467999999999999754   46789999987532   23457789999999999999999999854  45688999999


Q ss_pred             cCCChhhHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEE----cCCCCceEecccc
Q 015480          158 ENGSLDGYLFGK--------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL----DANFSPKVADFGL  225 (406)
Q Consensus       158 ~~g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~DfGl  225 (406)
                      .+ +|.+++...        ...+++..+..++.|++.||+|||+   .+++||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            64 888776321        2358899999999999999999999   999999999999999    4567899999999


Q ss_pred             ccccCCCCc-eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCC
Q 015480          226 AKLCDRNKT-HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGA  286 (406)
Q Consensus       226 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~  286 (406)
                      ++....... ........||+.|+|||++.+...++.++||||+||++|||++|++||....
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            986643321 1223346789999999999876568999999999999999999999986443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8e-41  Score=320.52  Aligned_cols=260  Identities=21%  Similarity=0.256  Sum_probs=200.6

Q ss_pred             hHHHhhhhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           72 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        72 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      ...+....|.+.+.||+|+||.||++... +++.||+|++....  .......+..|+.++..++||||+++++++.++.
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34455577888899999999999999764 58899999986421  2223456788999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          149 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      ..++||||+++|+|.+++..  ..++...+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            99999999999999999843  458888999999999999999999   9999999999999999999999999999986


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCCCC---CCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhh
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSGNY---PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCE  305 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (406)
                      ....... ......||+.|+|||++.+..   .++.++|||||||++|||++|..||......       ......... 
T Consensus       192 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~-  262 (371)
T cd05622         192 MNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMNH-  262 (371)
T ss_pred             cCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-------HHHHHHHcC-
Confidence            5433221 123467999999999987542   3788999999999999999999998643211       001111100 


Q ss_pred             cchhhccCCCCcchHHHHHHHHHHHHHhcccCCCC--CCChHHHHHH
Q 015480          306 LGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPED--RPPMSAVIKM  350 (406)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~vl~~  350 (406)
                          ...... ......+..+.+++..||..++.+  ||++.++++.
T Consensus       263 ----~~~~~~-~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         263 ----KNSLTF-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             ----CCcccC-CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                000000 112345677899999999844433  7788888874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-40  Score=325.02  Aligned_cols=262  Identities=20%  Similarity=0.253  Sum_probs=197.6

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ...|.+.+.||+|+||.||++.+. .++.||||....       ..+.+|++++++++|+||+++++++......++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            445777889999999999999764 478899996432       235689999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      ++. ++|.+++......+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            995 68988886656689999999999999999999999   99999999999999999999999999999865433222


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCc-ccccchhHHHHHHhhhhcc--hh---
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATE-SLDWFPKHVWEEYEKCELG--AM---  309 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~--~~---  309 (406)
                      .......||..|+|||++.+. .++.++|||||||++|||++|..++...... ...................  ..   
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            222345699999999999877 7899999999999999999988765433221 1111111111111110000  00   


Q ss_pred             ----------------hcc-CCCCc--chHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          310 ----------------ILG-CGIEE--KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       310 ----------------~~~-~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                                      ... .....  ........+.+|+.+||+.||.+|||+.|+++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                            000 00000  001223468899999999999999999999873

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.5e-40  Score=303.50  Aligned_cols=253  Identities=23%  Similarity=0.337  Sum_probs=188.3

Q ss_pred             cccccceeEEEEEEeCCC---cEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCC
Q 015480           85 RLGFGGFGEVYKGQFPNG---VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~~~g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  161 (406)
                      .||+|+||+||+|...++   ..+++|.+.........+.+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999965443   34567776654444456789999999999999999999999999999999999999999


Q ss_pred             hhhHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          162 LDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       162 L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      |.+++...   .....+..+..++.|++.||+|||+   .+++||||||+|||++.++.++|+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999543   2346677888999999999999999   99999999999999999999999999998643222111112


Q ss_pred             cCCCCCCCccCccccCCC------CCCCcccceeecchhHHHHhhc-ccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          239 SGYKGTPGYSAPEFLSGN------YPITHKCDVYSFGMVLFEIVGR-RRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~------~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ....++..|+|||++...      ..++.++||||||+++|||+++ ..|+.....       .................
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~~~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REVLNHVIKDQQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhhcccccCC
Confidence            345678899999987531      2357899999999999999975 445532111       01111111111111111


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                          +.........+.+++..|| .+|++||++++|++.|.
T Consensus       232 ----~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 ----PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ----CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence                1112235567888999999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=304.39  Aligned_cols=252  Identities=23%  Similarity=0.291  Sum_probs=200.6

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc----hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG----RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      .|...+.||+|++|.||+|.. .+|+.||+|.+.....    ......+.+|++++++++||||+++++++.++...++|
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            356678899999999999965 4689999999864321    12235688899999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      +||+++++|.+++. ....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        83 ~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          83 MEYMPGGSVKDQLK-AYGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEECCCCcHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence            99999999999884 34568899999999999999999999   999999999999999999999999999987554321


Q ss_pred             ceE-EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          234 THV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       234 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ... ......|+..|+|||.+.+. .++.++||||||+++|||++|+.||......          .....     ....
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------~~~~~-----~~~~  222 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----------AAIFK-----IATQ  222 (263)
T ss_pred             cccccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchH----------HHHHH-----Hhcc
Confidence            111 11234578899999999877 6899999999999999999999987532111          00000     0011


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      ......+...+..+.+++.+||..+|.+|||+.++++.
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            11122334566789999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.4e-40  Score=311.25  Aligned_cols=256  Identities=19%  Similarity=0.206  Sum_probs=197.6

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.++||+|+||+||++... +++.||+|++.+..  .......+..|+.++..++|+||+++++++.+....++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            4567789999999999999764 47889999986421  12233457889999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++|+|.+++......+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++.........
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            999999999997656789999999999999999999999   99999999999999999999999999998754332221


Q ss_pred             EEecCCCCCCCccCccccCC----CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          236 VTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                       ......||+.|+|||++..    ...++.++|||||||++|||++|+.||......      . ........     ..
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~-~~~~i~~~-----~~  225 (332)
T cd05623         159 -QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------E-TYGKIMNH-----KE  225 (332)
T ss_pred             -eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------H-HHHHHhCC-----Cc
Confidence             1234569999999998862    235788999999999999999999998543211      0 00111000     00


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCC--CCChHHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPED--RPPMSAVIKM  350 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~vl~~  350 (406)
                      ....+......+..+.+++.+|+..++..  |+++.++++.
T Consensus       226 ~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         226 RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            01112222345677889999988654443  6889888774

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.8e-41  Score=331.59  Aligned_cols=263  Identities=19%  Similarity=0.262  Sum_probs=193.2

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecC--------C
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--------H  148 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~  148 (406)
                      ..|.+.+.||+|+||.||+|.. .+++.||||.+....     ....+|+.+++.++||||+++++++...        .
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            4577889999999999999976 468999999886532     2235799999999999999999886432        2


Q ss_pred             eeEEEEEeccCCChhhHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC-CceEeccc
Q 015480          149 MTALVYEYMENGSLDGYLF---GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFG  224 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~DfG  224 (406)
                      .+++||||+++ +|.+++.   .....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46799999975 7776663   245679999999999999999999999   9999999999999999665 69999999


Q ss_pred             cccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHH-------
Q 015480          225 LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHV-------  297 (406)
Q Consensus       225 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-------  297 (406)
                      +++........   ....||+.|+|||++.+...++.++|||||||++|||++|.+||........  +....       
T Consensus       217 la~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~~~~~p~  291 (440)
T PTZ00036        217 SAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQVLGTPT  291 (440)
T ss_pred             cchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCC
Confidence            99865433221   2356899999999987765789999999999999999999999854322100  00000       


Q ss_pred             HHHHhh--hhcchhhccCCC-----CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcc
Q 015480          298 WEEYEK--CELGAMILGCGI-----EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGV  354 (406)
Q Consensus       298 ~~~~~~--~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~  354 (406)
                      .+....  ............     ...+...+.++.+|+.+||+.||.+|||+.++++  .+..+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence            000000  000000000000     0011224568999999999999999999999986  45444

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.7e-41  Score=322.83  Aligned_cols=263  Identities=21%  Similarity=0.308  Sum_probs=197.2

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCC-----eeEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-----MTAL  152 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l  152 (406)
                      +...+.||+|+||.||++.. .+|+.||+|.+.... .......+.+|+++++.++||||+++++++....     ..++
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            35567899999999999975 568999999986532 2234467889999999999999999999998776     7899


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ||||+. ++|.+++ .....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.....
T Consensus        82 v~e~~~-~~l~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          82 VTELMQ-SDLHKII-VSPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             Eeeccc-cCHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            999996 5788777 345679999999999999999999999   99999999999999999999999999999765433


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc-cc-------hhHHHHHHhhh
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD-WF-------PKHVWEEYEKC  304 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-~~-------~~~~~~~~~~~  304 (406)
                      ... ......++..|+|||.+.+...++.++|||||||++|||++|+.||......... ..       ....+......
T Consensus       157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         157 ESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             ccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            221 1233567889999999987656899999999999999999999998543211000 00       00000000000


Q ss_pred             hcchhhccCC-CC-------cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          305 ELGAMILGCG-IE-------EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       305 ~~~~~~~~~~-~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       ....+.... ..       ......+.++.+++.+||+.||.+|||+.++++
T Consensus       236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         236 -ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             -HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence             000000000 00       111223567899999999999999999999987

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9.8e-41  Score=305.87  Aligned_cols=255  Identities=23%  Similarity=0.318  Sum_probs=199.5

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      ..|.+.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.++.+++||||+++++++......++||||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            3567788999999999999976 5688999999875422 2345678899999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +++++|.+++. ....+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......... 
T Consensus        88 ~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~-  162 (267)
T cd06646          88 CGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK-  162 (267)
T ss_pred             CCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccccc-
Confidence            99999999884 34578999999999999999999999   99999999999999999999999999999765432211 


Q ss_pred             EecCCCCCCCccCccccCC--CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          237 TISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                       .....|+..|+|||.+..  ...++.++|||||||++|||++|+.|+..........       ......     ....
T Consensus       163 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~-----~~~~  229 (267)
T cd06646         163 -RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSN-----FQPP  229 (267)
T ss_pred             -cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCC-----CCCC
Confidence             123468889999998742  2247889999999999999999998874322110000       000000     0000


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML  351 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  351 (406)
                      ........+..+.+++.+||+.+|++||+++++++.|
T Consensus       230 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0111223467899999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-41  Score=311.90  Aligned_cols=253  Identities=24%  Similarity=0.370  Sum_probs=217.3

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccc-cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      .|++.+-||+|.|..|-++++ -+|+.||||++.+. .......++.+|++-|+.++|||||++|.+......+|||+|+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            466777899999999999954 68999999999864 3445567899999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc-CCCCceEeccccccccCCCCce
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      -.+|+|.+|+.+....+.+..+.+++.||+.|+.|+|.   ..++||||||+||.+- .-|-+||+|||++..+..... 
T Consensus        99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k-  174 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK-  174 (864)
T ss_pred             cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcch-
Confidence            99999999999999999999999999999999999999   9999999999998875 568899999999987765443 


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        .+..+|+..|-|||++.+..+..+++||||||||||-|++|++||....                +.+...++.++. 
T Consensus       175 --L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN----------------DSETLTmImDCK-  235 (864)
T KOG4717|consen  175 --LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN----------------DSETLTMIMDCK-  235 (864)
T ss_pred             --hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc----------------chhhhhhhhccc-
Confidence              3568899999999999998777889999999999999999999984321                222233444444 


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcc
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGV  354 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~  354 (406)
                      ...+...+.++.+||..||..||++|.+.++|+.  +|+.+
T Consensus       236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence            3466788999999999999999999999999987  55544

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5e-41  Score=316.37  Aligned_cols=242  Identities=23%  Similarity=0.301  Sum_probs=193.0

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      +++.+.||+|+||+||+|.. .+|+.||+|++.+..  .....+.+..|..++..+. |++|+++++++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            56778999999999999975 468999999997542  1223456778888888875 6788899999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++|+|.+++. ....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++....... 
T Consensus        82 y~~~g~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-  156 (323)
T cd05615          82 YVNGGDLMYHIQ-QVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-  156 (323)
T ss_pred             CCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence            999999999884 44579999999999999999999999   9999999999999999999999999999875432221 


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                       ......||+.|+|||++.+. .++.++|||||||++|||++|..||......       ..........          
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~~~~----------  217 (323)
T cd05615         157 -TTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-------ELFQSIMEHN----------  217 (323)
T ss_pred             -cccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC----------
Confidence             12345689999999999876 7899999999999999999999998543211       1111111110          


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMS  345 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  345 (406)
                      ...+...+..+.+++.+||+.+|.+|++..
T Consensus       218 ~~~p~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         218 VSYPKSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence            112234556789999999999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.6e-40  Score=352.50  Aligned_cols=258  Identities=27%  Similarity=0.443  Sum_probs=197.4

Q ss_pred             cccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           81 NYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      ...+.||+|+||.||+|.. .+|..||||.+.....     ....|++.+++++|||||+++|+|.+....++||||+++
T Consensus       693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~  767 (968)
T PLN00113        693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG  767 (968)
T ss_pred             CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence            4456799999999999976 5789999999864321     123468889999999999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |+|.++++    .++|..+..++.|+++||+|||..+..+++||||||+||+++.++.+++. ||........      .
T Consensus       768 g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~  836 (968)
T PLN00113        768 KNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------T  836 (968)
T ss_pred             CcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------C
Confidence            99999994    38999999999999999999995444899999999999999999888875 6655432211      1


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC--CCc
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG--IEE  317 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  317 (406)
                      ...||..|+|||++.+. .++.++|||||||++|||++|+.|+......... ...+..............+...  ...
T Consensus       837 ~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (968)
T PLN00113        837 KCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGS-IVEWARYCYSDCHLDMWIDPSIRGDVS  914 (968)
T ss_pred             CccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCc-HHHHHHHhcCccchhheeCccccCCCC
Confidence            23578999999999876 7899999999999999999999998543222111 1111111111111111111111  112


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      .......++.+++.+||+.||++||+|.+|++.|+++..
T Consensus       915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            334566788999999999999999999999999998754

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=313.52  Aligned_cols=251  Identities=25%  Similarity=0.317  Sum_probs=209.2

Q ss_pred             hhhhcccccccccceeEEEEEEeCC-CcEEEEEEeccccch--hhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGR--IAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~-g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  152 (406)
                      ...|.+.+.||+|.||.||++..+. |+.+|+|++.+....  ...+.+.+|+.+|+++. |||||.++++|.+....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            3456777899999999999997654 999999999865332  24478999999999998 9999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC----CCCceEeccccccc
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA----NFSPKVADFGLAKL  228 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~----~~~~kl~DfGl~~~  228 (406)
                      |||+|.||.|.+.+...  .+++..+..++.|++.+++|||+   .|++||||||+|+|+..    ++.+|++|||++..
T Consensus       114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            99999999999999555  39999999999999999999999   99999999999999953    35799999999998


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      ....   ......+||+.|+|||++... .++..+||||+|+++|.|++|.+||.........       .....++.  
T Consensus       189 ~~~~---~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-------~~i~~~~~--  255 (382)
T KOG0032|consen  189 IKPG---ERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-------LAILRGDF--  255 (382)
T ss_pred             ccCC---ceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-------HHHHcCCC--
Confidence            7762   234567899999999999876 7999999999999999999999999655432110       11111111  


Q ss_pred             hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                          .-..+.....+..+.+++..|+..||..|+++.++++
T Consensus       256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence                0112344566888999999999999999999999999

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-40  Score=311.51  Aligned_cols=263  Identities=25%  Similarity=0.358  Sum_probs=200.7

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|.+.+.||+|+||.||++.+ .+|..+|+|.+...........+.+|++++.+++||||+++++++.+++..++||||+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            356778899999999999976 4688899999876544445567889999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++++|.+++.. ...+++..+..++.|+++||.|||+  ..+++|+||||+|||++.++.+||+|||++.......    
T Consensus        82 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----  154 (308)
T cd06615          82 DGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----  154 (308)
T ss_pred             CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence            99999999953 4678999999999999999999997  2589999999999999999999999999986543221    


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc-cchhHHHHHHh--------------
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD-WFPKHVWEEYE--------------  302 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~--------------  302 (406)
                      .....|+..|+|||.+.+. .++.++|+||||+++|+|++|+.|+......... ..... .....              
T Consensus       155 ~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRP-VSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             cccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCc-cccccccCCcccccCCCCC
Confidence            1345688999999998776 6889999999999999999999987533211100 00000 00000              


Q ss_pred             ------hhhcchhhccCCCCcc-hHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          303 ------KCELGAMILGCGIEEK-DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       303 ------~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                            .............+.. ....+.++.+++.+||+.||++||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0000000000000000 11245679999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.2e-41  Score=306.72  Aligned_cols=254  Identities=32%  Similarity=0.513  Sum_probs=198.4

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhH-HHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |.+.+.||+|+||+||+++.. +++.||+|++......... ....+|+.++.+++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456788999999999999764 4678999999865332222 33456999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++++|.+++. ....+++..+..++.|+++||.+||+   .+++|+||||+||+++.++.++|+|||.+......  ...
T Consensus        81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NEN  154 (260)
T ss_dssp             TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSE
T ss_pred             cccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--ccc
Confidence            9999999995 56678999999999999999999999   99999999999999999999999999999764221  122


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      .....++..|+|||++......+.++||||+|+++|+|++|..|+........       ................   .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~---~  224 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-------LEIIEKILKRPLPSSS---Q  224 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-------HHHHHHHHHTHHHHHT---T
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhh-------hhhhhhcccccccccc---c
Confidence            34567899999999988333789999999999999999999988864311000       0001000000000000   0


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ........+.+++..||+.||++||++.++++
T Consensus       225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00111278999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1e-40  Score=339.85  Aligned_cols=261  Identities=22%  Similarity=0.338  Sum_probs=203.4

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      +|.+.++||+|+||.||+|.+. +|+.||+|+++.+..  ....+++.+|++++++++||||+++++++.+++..++|||
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME   82 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP   82 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence            4667789999999999999764 589999999975432  2345679999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcC----------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccc
Q 015480          156 YMENGSLDGYLFGK----------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  225 (406)
Q Consensus       156 ~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl  225 (406)
                      |++||+|.+++...          ....++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||+
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCc
Confidence            99999999988431          1345677889999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCce----------------EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcc
Q 015480          226 AKLCDRNKTH----------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES  289 (406)
Q Consensus       226 ~~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~  289 (406)
                      +.........                .......||+.|+|||.+.+. .++.++|||||||++|||++|..||.......
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9865211100                001124699999999999877 78999999999999999999999985422111


Q ss_pred             cccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCC-ChHHHHHHhhccccC
Q 015480          290 LDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRP-PMSAVIKMLEGVVEV  357 (406)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~~vl~~L~~~~~~  357 (406)
                      ..      ..    ...    ............+..+.+++.+||+.||++|| +++++++.|+.....
T Consensus       239 i~------~~----~~i----~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 IS------YR----DVI----LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hh------hh----hhc----cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            00      00    000    00000011134567789999999999999996 677788888777554

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-40  Score=303.07  Aligned_cols=250  Identities=32%  Similarity=0.503  Sum_probs=201.2

Q ss_pred             cccccccccceeEEEEEEeCC-----CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           81 NYSTRLGFGGFGEVYKGQFPN-----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .+.+.||.|+||.||++.+.+     +..||+|++...........+..|+..+..++|+||+++++++.+....+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            356789999999999997743     388999999865444466789999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCC-CCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          156 YMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      |+++++|.+++...... +++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++........
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            99999999999654444 9999999999999999999999   9999999999999999999999999999986654422


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      ... ....++..|+|||.+.+. .++.++||||||+++++|++ |..|+.....       ....+....         .
T Consensus       159 ~~~-~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~~~~~~~~---------~  220 (258)
T smart00219      159 YKK-KGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EEVLEYLKK---------G  220 (258)
T ss_pred             ccc-ccCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhc---------C
Confidence            211 123367899999998665 78999999999999999998 6666543111       111111111         1


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML  351 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  351 (406)
                      .....+...+..+.+++.+||..||++|||+.++++.|
T Consensus       221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      221 YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            11222333677899999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-40  Score=306.89  Aligned_cols=262  Identities=25%  Similarity=0.349  Sum_probs=205.3

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ...|.+.+.||+|+||+||++.. .+|+.||+|++...........+.+|++++..++||||+++++++.+....++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            44566778899999999999976 46889999998765444556789999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++++|.+++. ..+.+++..+..++.+++.||.|||+  ..+++||||+|+||+++.++.++|+|||++.......  
T Consensus        84 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--  158 (284)
T cd06620          84 FMDCGSLDRIYK-KGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--  158 (284)
T ss_pred             cCCCCCHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence            999999999884 34578999999999999999999996  2589999999999999999999999999986543221  


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc-cchhHHHHHHhhhhcchhhccCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD-WFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                        .....|+..|+|||++.+. .++.++|||||||++|+|++|..||......... .......+...     .......
T Consensus       159 --~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  230 (284)
T cd06620         159 --ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ-----QIVQEPP  230 (284)
T ss_pred             --cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH-----HHhhccC
Confidence              1235689999999998766 7899999999999999999999998644322110 00000001000     0111101


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML  351 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  351 (406)
                      ........+..+.+++.+||+.||++||++.++++..
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            1111123567899999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=7.8e-41  Score=308.32  Aligned_cols=246  Identities=26%  Similarity=0.341  Sum_probs=200.4

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      |...+.||+|+||.||+|.+ .+|+.||+|.+.........+.+..|+.+++.++||||+++++++..+...++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            44556799999999999965 45889999998755444456788999999999999999999999999999999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      +++|.+++.  ...+++..+..++.|+++|+.|||+   .+++|+||+|+||++++++.++|+|||++.........  .
T Consensus        86 ~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~  158 (277)
T cd06642          86 GGSALDLLK--PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--R  158 (277)
T ss_pred             CCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcchh--h
Confidence            999999883  3568999999999999999999999   99999999999999999999999999999765432211  1


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ....|+..|+|||.+.+. .++.++||||||+++|||++|..|+........       ...         .........
T Consensus       159 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~---------~~~~~~~~~  221 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-------LFL---------IPKNSPPTL  221 (277)
T ss_pred             hcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-------Hhh---------hhcCCCCCC
Confidence            234578899999999876 789999999999999999999988753221100       000         011111222


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       319 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....+..+.+++.+||+.+|++||++.++++
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            2345677999999999999999999999998

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-43  Score=294.84  Aligned_cols=250  Identities=22%  Similarity=0.354  Sum_probs=202.7

Q ss_pred             hhcccccccccceeEEEEE-EeCCCcEEEEEEeccc-cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~-~~~~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      .|++.+.||+|.|+.||++ +-.+|+.+|+|++..+ ......+.+.+|+++-+.|+||||+++.+.+.+....|||+|+
T Consensus        12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~   91 (355)
T KOG0033|consen   12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL   91 (355)
T ss_pred             hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence            3455667999999999999 5577999999998743 3334668899999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC---CCCceEeccccccccCCCC
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~DfGl~~~~~~~~  233 (406)
                      |.|++|..-+- .+.-+++..+..++.||+++|.|+|.   .+|+|||+||+|+++..   ..-+||+|||++...... 
T Consensus        92 m~G~dl~~eIV-~R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g-  166 (355)
T KOG0033|consen   92 VTGGELFEDIV-AREFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG-  166 (355)
T ss_pred             ccchHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCCc-
Confidence            99999976552 33567888899999999999999999   99999999999999954   346999999999877722 


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                        ....++.|||.|||||++... +++..+|||+.|||||-|+.|.+||....+.       ..++....+...   .+ 
T Consensus       167 --~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rlye~I~~g~yd---~~-  232 (355)
T KOG0033|consen  167 --EAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYEQIKAGAYD---YP-  232 (355)
T ss_pred             --cccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------HHHHHHhccccC---CC-
Confidence              223568899999999999987 8999999999999999999999999653322       112222221111   11 


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        .....+.+++..+|+.+||..||++|.|+.|.++
T Consensus       233 --~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  233 --SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             --CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence              1233456778999999999999999999998775

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-40  Score=317.90  Aligned_cols=194  Identities=25%  Similarity=0.362  Sum_probs=166.3

Q ss_pred             HhhhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      +....|.+.+.||+|+||.||+|... +++.||+|+....       ....|+.++++++||||+++++++.+....++|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            44456788899999999999999764 5788999975542       234689999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+. ++|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus       136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence            99995 58888886667789999999999999999999999   999999999999999999999999999997543221


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccc
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAI  283 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~  283 (406)
                      .   .....||..|+|||++.+. .++.++|||||||++|||+++..++.
T Consensus       212 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        212 A---FLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             c---cccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccc
Confidence            1   1235689999999999876 78999999999999999998766553

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.8e-40  Score=304.56  Aligned_cols=250  Identities=25%  Similarity=0.360  Sum_probs=198.6

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      |++.+.||+|+||.||+|... ++..+++|.+... .....+.+.+|+++++.++|||++++++++......++|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            455677999999999999764 5788899988654 23345678899999999999999999999999999999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      +++|..++......+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++........  ..
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~  160 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RR  160 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc--cc
Confidence            999999886666789999999999999999999999   9999999999999999999999999999875433221  12


Q ss_pred             cCCCCCCCccCccccCC----CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          239 SGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                      ....++..|+|||++..    ...++.++|||||||++|||++|++|+......       .........       ...
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~-------~~~  226 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKS-------EPP  226 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-------HHHHHHhhc-------CCC
Confidence            33568899999998742    225778999999999999999999887432210       000000000       000


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....+...+..+.+++.+||+.||.+||++.++++
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         227 TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            01122345678999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.6e-40  Score=307.51  Aligned_cols=250  Identities=26%  Similarity=0.303  Sum_probs=197.8

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      |...+.||+|+||+||++.. .+++.||+|.+.....  ......+..|+.++.+++|+|++.+++.+.+++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            45567899999999999965 4689999999875322  12235677899999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          157 MENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       157 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........ 
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence            9999999988543 3468999999999999999999999   9999999999999999999999999999875543221 


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        .....|+..|+|||++.+. .++.++||||||+++|+|++|..||........    ..........         ..
T Consensus       158 --~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~----~~~~~~~~~~---------~~  221 (285)
T cd05630         158 --IKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVERLVKE---------VQ  221 (285)
T ss_pred             --ccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccch----HHHHHhhhhh---------hh
Confidence              1234689999999999876 689999999999999999999999864322110    0000000000         00


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPP-----MSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  349 (406)
                      .......+..+.+++..||+.||.+|||     +.++++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            1112334567899999999999999999     778776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.6e-41  Score=306.07  Aligned_cols=242  Identities=25%  Similarity=0.348  Sum_probs=190.0

Q ss_pred             ccccccceeEEEEEEeCC--------CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           84 TRLGFGGFGEVYKGQFPN--------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      +.||+|+||.||+|....        ...||+|.+... .....+.+..|+.++..+.|||++++++++..+...++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            369999999999996532        234888887643 22345678899999999999999999999999889999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC--------ceEecccccc
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS--------PKVADFGLAK  227 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--------~kl~DfGl~~  227 (406)
                      |+++|+|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.        ++++|||++.
T Consensus        80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999997666678999999999999999999999   99999999999999987765        5899999886


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      .....      ....++..|+|||++.+...++.++||||||+++|||++|..++.......       .......    
T Consensus       157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-------~~~~~~~----  219 (258)
T cd05078         157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-------KKLQFYE----  219 (258)
T ss_pred             ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-------HHHHHHH----
Confidence            44322      224578899999999875467999999999999999999964332211110       0000000    


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                          .  ....+......+.+++.+||+.||++|||++++++.|+
T Consensus       220 ----~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 ----D--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ----c--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                0  01112223467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.5e-40  Score=306.23  Aligned_cols=250  Identities=25%  Similarity=0.303  Sum_probs=196.7

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      |...+.||+|+||+||+|.+ .+|+.||+|.+.....  ......+.+|++++..++|+|++.+++++.+++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            44567899999999999966 4689999999875422  12234578899999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          157 MENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       157 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+||++++++.++|+|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  157 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-  157 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence            9999999888543 3469999999999999999999999   9999999999999999999999999999975433221 


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        .....|+..|+|||.+.+. .++.++|+||||+++|||++|..||........       .+....     ..... .
T Consensus       158 --~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-------~~~~~~-----~~~~~-~  221 (285)
T cd05632         158 --IRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-------REEVDR-----RVLET-E  221 (285)
T ss_pred             --ccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHH-----hhhcc-c
Confidence              1235689999999999876 789999999999999999999999854321100       001100     00000 0


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPP-----MSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  349 (406)
                      .......+..+.+++..||+.||++||+     +.+++.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            1122334567899999999999999999     556555

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-42  Score=332.02  Aligned_cols=254  Identities=28%  Similarity=0.391  Sum_probs=219.3

Q ss_pred             cccccccceeEEEEEEe-CCC----cEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           83 STRLGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~-~~g----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .++||+|+||+||+|.| +.|    -+||||++...........+..|+-+|..++|||+++++|+|.... +-||++|+
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            46799999999999965 444    4689999988777677789999999999999999999999998876 77999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      +.|+|.++++.++..+-....+.|.+|||+||.|||.   +.++||||.++||||..-..+||.|||+++....+.....
T Consensus       780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~  856 (1177)
T KOG1025|consen  780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS  856 (1177)
T ss_pred             ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence            9999999998889999999999999999999999998   9999999999999999999999999999998887776666


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                      ....+-.+.|||-|.+... .++.++|||||||++||++| |..|++.-                ...++...+..+.+.
T Consensus       857 ~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi----------------~~~eI~dlle~geRL  919 (1177)
T KOG1025|consen  857 APGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGI----------------PAEEIPDLLEKGERL  919 (1177)
T ss_pred             ccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCC----------------CHHHhhHHHhccccC
Confidence            5666667799999999887 89999999999999999886 66665322                122344444555556


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                      ..+..++-++..++.+||..|+..||+++++...+.+....
T Consensus       920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            77788899999999999999999999999999988776543

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1e-40  Score=319.02  Aligned_cols=251  Identities=22%  Similarity=0.290  Sum_probs=193.5

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      |++.+.||+|+||+||++.. .+|+.||+|+++...  .......+..|+.++..++||||+++++.+.+....++||||
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~   82 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF   82 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            56678899999999999976 468999999997532  223446788899999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce-
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH-  235 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~-  235 (406)
                      +++|+|.+++. ....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++......... 
T Consensus        83 ~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          83 LPGGDMMTLLM-KKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             CCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            99999999984 44678999999999999999999999   99999999999999999999999999998744321100 


Q ss_pred             --------------------------------EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccc
Q 015480          236 --------------------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAI  283 (406)
Q Consensus       236 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~  283 (406)
                                                      .......||+.|+|||++.+. .++.++|||||||++|||++|..||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecccCCCCCC
Confidence                                            001134699999999999876 78999999999999999999999985


Q ss_pred             cCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCC---hHHHHH
Q 015480          284 VGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPP---MSAVIK  349 (406)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~~vl~  349 (406)
                      .....       .........  ....   ..+ .....+.++.+++.+|+ .||.+|++   +.++++
T Consensus       238 ~~~~~-------~~~~~i~~~--~~~~---~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         238 SETPQ-------ETYRKVMNW--KETL---VFP-PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCHH-------HHHHHHHcC--CCce---ecC-CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            43221       011111100  0000   000 01124567888888876 49999996   556555

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.9e-40  Score=311.77  Aligned_cols=259  Identities=20%  Similarity=0.287  Sum_probs=188.2

Q ss_pred             ccccccceeEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec--CCeeEEEEEecc
Q 015480           84 TRLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMTALVYEYME  158 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  158 (406)
                      .+||+|+||+||+|+..   ++..||+|.+....   ....+.+|+.+++.++||||+++++++..  +...++||||+.
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            57999999999999764   35789999987532   23457889999999999999999999853  567889999996


Q ss_pred             CCChhhHhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEE----cCCCCceEeccccc
Q 015480          159 NGSLDGYLFG--------KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL----DANFSPKVADFGLA  226 (406)
Q Consensus       159 ~g~L~~~l~~--------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~DfGl~  226 (406)
                      + +|.+++..        ....+++..+..++.|++.||.|||+   .+++||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 77777631        12358899999999999999999999   999999999999999    56779999999999


Q ss_pred             cccCCCCce-EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccc---hh-------
Q 015480          227 KLCDRNKTH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWF---PK-------  295 (406)
Q Consensus       227 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~---~~-------  295 (406)
                      +........ .......||+.|+|||++.+...++.++|||||||++|||++|.+||...........   ..       
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            866543221 1223456899999999987754689999999999999999999999864432211000   00       


Q ss_pred             -------HHHHHHhhhh----cchhhccCC---------CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          296 -------HVWEEYEKCE----LGAMILGCG---------IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       296 -------~~~~~~~~~~----~~~~~~~~~---------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                             ..|+......    .........         ...........+.+++.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence                   0011100000    000000000         00001112355888999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.3e-40  Score=303.40  Aligned_cols=248  Identities=24%  Similarity=0.325  Sum_probs=203.2

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|+..+.||+|+||.||+|.+. ++..||+|++...........+..|+.+++.++||||+++++++.++...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            3455678999999999999764 588999999876544455678999999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++++|.+++.  ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.........  
T Consensus        85 ~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--  157 (277)
T cd06640          85 GGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--  157 (277)
T ss_pred             CCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc--
Confidence            9999999884  3468899999999999999999999   99999999999999999999999999999765433211  


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      .....++..|+|||.+.+. ..+.++|+||||+++|||++|..|+........       .         ........+.
T Consensus       158 ~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~---------~~~~~~~~~~  220 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------L---------FLIPKNNPPT  220 (277)
T ss_pred             cccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-------h---------hhhhcCCCCC
Confidence            1234578899999998876 689999999999999999999998753321100       0         0011111233


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      .....+..+.+++.+||+.+|++||++.+++..
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            445677889999999999999999999999774

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.1e-40  Score=300.60  Aligned_cols=250  Identities=22%  Similarity=0.288  Sum_probs=203.7

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |++.+.||.|+||.||.++. .+++.+++|.+.... .......+.+|++++++++|+||+++++++.+....+++|||+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            56778999999999999965 568899999886432 3345567889999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          158 ENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       158 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      ++++|.+++... ...+++.++..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++........  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--  156 (256)
T cd08221          82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--  156 (256)
T ss_pred             CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--
Confidence            999999999554 4578999999999999999999999   9999999999999999999999999999976644332  


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                      ......|+..|+|||.+.+. ..+.++||||||+++|||++|..|+......          +.....      ......
T Consensus       157 ~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----------~~~~~~------~~~~~~  219 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPL----------NLVVKI------VQGNYT  219 (256)
T ss_pred             cccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHH----------HHHHHH------HcCCCC
Confidence            12345689999999998876 6889999999999999999999887532211          111110      011112


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML  351 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  351 (406)
                      ......+..+.+++.+||+.+|.+||++.++++.+
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            22345567899999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-40  Score=321.10  Aligned_cols=264  Identities=21%  Similarity=0.248  Sum_probs=200.2

Q ss_pred             HhhhhhcccccccccceeEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      +...+|.+.+.||+|+||.||++...   .+..||+|.+...      ....+|++++++++||||+++++++......+
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            34456888899999999999999642   3678999988653      23467999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      ++||++. ++|.+++ .....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.++|+|||++.....
T Consensus       163 lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        163 MVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             EEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            9999995 5888888 455689999999999999999999999   9999999999999999999999999999976654


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhh-------
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC-------  304 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------  304 (406)
                      ...........||+.|+|||++.+. .++.++|||||||++|||++|+.||......................       
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~  316 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN  316 (392)
T ss_pred             ccccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence            4333333356799999999999876 78999999999999999999999986543221100000000000000       


Q ss_pred             -------hcchhhc--cC--CCCcc--hHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          305 -------ELGAMIL--GC--GIEEK--DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       305 -------~~~~~~~--~~--~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                             .......  ..  ..+..  ....+..+.+++.+||..||++||++.+++..
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                   0000000  00  00000  01234678899999999999999999999884

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.8e-40  Score=300.71  Aligned_cols=249  Identities=23%  Similarity=0.327  Sum_probs=203.3

Q ss_pred             hhhcccccccccceeEEEEEEeCC-CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      ..|.+.+.||+|+||.||+|.+.+ +..+++|.+....   ..+.+.+|+++++.++||||+++++++.+....++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            356677889999999999998754 8899999987542   267899999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +++++|.+++......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......... 
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~-  155 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK-  155 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCccc-
Confidence            99999999997667789999999999999999999999   99999999999999999999999999999866543221 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                       .....++..|+|||.+.+. .++.++||||||+++|+|++|+.|+........       ......       ......
T Consensus       156 -~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-------~~~~~~-------~~~~~~  219 (256)
T cd06612         156 -RNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-------IFMIPN-------KPPPTL  219 (256)
T ss_pred             -cccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-------hhhhcc-------CCCCCC
Confidence             1234478899999998876 789999999999999999999998753221100       000000       000011


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..+...+..+.+++.+||+.||++|||+.++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            123345678999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.3e-40  Score=306.34  Aligned_cols=264  Identities=20%  Similarity=0.263  Sum_probs=197.7

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |.+.+.||+|++|.||+|... +|..||+|.++.... ......+.+|+.++..++||||+++++++.++...++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            456788999999999999764 689999999864322 223467888999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          158 ENGSLDGYLFGK--KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       158 ~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      + ++|.+++...  ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++........ 
T Consensus        82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  156 (285)
T cd07861          82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-  156 (285)
T ss_pred             C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence            7 5888887432  3678999999999999999999999   9999999999999999999999999999975543221 


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc--------chhHHHHHHhhhhcc
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW--------FPKHVWEEYEKCELG  307 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~  307 (406)
                       ......+++.|+|||.+.+...++.++||||||+++|+|++|+.|+.........+        .....|.........
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence             11234568899999998766567899999999999999999999886432210000        000000000000000


Q ss_pred             h----hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 A----MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .    ..............+.++.+++.+||+.||++|||+.+|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0    00000001111235677889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.5e-40  Score=302.83  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=200.3

Q ss_pred             hcccccccccceeEEEEEEeCCCcEEEEEEeccccc-----hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG-----RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      |...+.||+|+||+||+|...+|+.+|+|.+.....     ......+.+|+++++.++|+||+++++++.+....++++
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            456678999999999999887899999998864321     223356889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC-
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK-  233 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~-  233 (406)
                      ||+++++|.+++. ....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++....... 
T Consensus        82 e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          82 EFVPGGSISSILN-RFGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL  157 (265)
T ss_pred             ecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence            9999999999994 33568899999999999999999999   999999999999999999999999999987543211 


Q ss_pred             ---ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          234 ---THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       234 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                         .........|+..|+|||.+.+. .++.++||||||+++|+|++|..||......          ........    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------~~~~~~~~----  222 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRL----------AAMFYIGA----  222 (265)
T ss_pred             cccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChH----------HHHHHhhh----
Confidence               11112335688999999999876 6889999999999999999999998532111          00000000    


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .....+..+...+..+.+++.+||+.+|.+||++.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         223 HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            001112233456778999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.1e-40  Score=304.29  Aligned_cols=252  Identities=25%  Similarity=0.386  Sum_probs=201.5

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|++.+.||+|+||.||++.+. +|..||+|.+...........+.+|+.++.+++||||+++++.+......++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            3566788999999999999774 689999999876544444578899999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          158 ENGSLDGYLFGK--KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       158 ~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      ++++|..++...  ...+++..+..++.|++.||.|||+  ..+++|+||||+||+++.++.+||+|||++........ 
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  158 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA-  158 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-
Confidence            999999988543  3478999999999999999999996  25999999999999999999999999999875532221 


Q ss_pred             EEecCCCCCCCccCccccCCCC-----CCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          236 VTISGYKGTPGYSAPEFLSGNY-----PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                         ....++..|+|||.+.+..     .++.++|+|||||++|+|++|..||.......       .......      .
T Consensus       159 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-------~~~~~~~------~  222 (286)
T cd06622         159 ---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-------IFAQLSA------I  222 (286)
T ss_pred             ---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-------HHHHHHH------H
Confidence               2345788999999885431     35889999999999999999999985322110       0111100      1


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ........+...+..+.+++.+||+.+|++||++.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         223 VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            111122334457788999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.5e-40  Score=314.57  Aligned_cols=259  Identities=22%  Similarity=0.290  Sum_probs=193.4

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCC------e
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH------M  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  149 (406)
                      ..|...+.||+|+||.||++.. .+|..||+|++.... .......+.+|+.+++.++||||+++++++....      .
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            4567788999999999999976 458999999987532 2234567889999999999999999999986543      4


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+++ +|.+.+.   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876         101 VYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             eEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence            6899999975 6666552   347889999999999999999999   99999999999999999999999999999754


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccc---------hhHHHHH
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWF---------PKHVWEE  300 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~---------~~~~~~~  300 (406)
                      ....   ......||..|+|||++.+. .++.++|||||||++|+|++|+.||....... .+.         .......
T Consensus       174 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         174 CTNF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             ccCc---cCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHHHH
Confidence            3322   12345689999999999876 78999999999999999999999986432110 000         0000000


Q ss_pred             Hhhhhcchhhcc-C-----------------CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          301 YEKCELGAMILG-C-----------------GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       301 ~~~~~~~~~~~~-~-----------------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ... ........ .                 .........+..+.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         249 LQP-TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHH-HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            000 00000000 0                 000111123567899999999999999999999988

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-40  Score=303.54  Aligned_cols=247  Identities=24%  Similarity=0.310  Sum_probs=201.9

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      +|.+.+.||.|+||.||+|... +|+.||+|.+...........+.+|+.+++.++|+|++++++++.++...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            3566778999999999999764 689999999876543445567889999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++++|.+++...  .+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||+++.......  .
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~  154 (274)
T cd06609          82 GGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--K  154 (274)
T ss_pred             CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--c
Confidence            999999998433  88999999999999999999999   9999999999999999999999999999987654321  1


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      .....++..|+|||.+.+. .++.++||||||+++|+|++|..|+......       ........         ...+.
T Consensus       155 ~~~~~~~~~y~~PE~~~~~-~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-------~~~~~~~~---------~~~~~  217 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPM-------RVLFLIPK---------NNPPS  217 (274)
T ss_pred             cccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccCchH-------HHHHHhhh---------cCCCC
Confidence            2335678899999999877 5899999999999999999999998533211       00000000         01111


Q ss_pred             chHH-HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          318 KDKE-KAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       318 ~~~~-~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .... .+..+.+++.+||..+|++||++.++++
T Consensus       218 ~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1112 5677999999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=307.29  Aligned_cols=265  Identities=23%  Similarity=0.328  Sum_probs=196.8

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|.+.+.||+|++|.||+|... +|+.||+|.+...........+.+|++++++++||||+++++++.+....++||||+
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL   85 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence            4566788999999999999764 689999999875433333355778999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      .+ +|.+++......+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++........  
T Consensus        86 ~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--  159 (291)
T cd07844          86 DT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--  159 (291)
T ss_pred             CC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc--
Confidence            75 9999886666688999999999999999999999   99999999999999999999999999998754322111  


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc---------chhHHHHHHhhh-hcc
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW---------FPKHVWEEYEKC-ELG  307 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~---------~~~~~~~~~~~~-~~~  307 (406)
                      .....++..|+|||.+.+...++.++||||||+++|+|++|..||..........         .....+...... ...
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK  239 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence            1223467899999998765468899999999999999999999885332110000         000000000000 000


Q ss_pred             hhhc----cCCCCcchHH--HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 AMIL----GCGIEEKDKE--KAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~~~~----~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....    ..........  ....+.+++.+||+.+|.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0000    0000000001  1267789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.5e-40  Score=300.03  Aligned_cols=246  Identities=27%  Similarity=0.439  Sum_probs=197.1

Q ss_pred             hhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      ..|.+.+.||+|+||.||++.. +++.||+|.++..   .....+.+|+.++..++|||++++++++..+. .+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECC
Confidence            3466788999999999999976 6788999998753   23467889999999999999999999987654 68999999


Q ss_pred             cCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          158 ENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       158 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      ++++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......   
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            999999999644 3468999999999999999999999   999999999999999999999999999987543221   


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        .....+..|+|||.+.+. .++.++|+||||+++|||++ |..||......       ........         ...
T Consensus       155 --~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~---------~~~  215 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-------EVKECVEK---------GYR  215 (254)
T ss_pred             --CCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-------HHHHHHhC---------CCC
Confidence              123345689999998766 68999999999999999997 88777432211       01111111         111


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                      .......+..+.+++.+||+.+|.+||+++++++.|++
T Consensus       216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            11223456788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=9.7e-41  Score=308.71  Aligned_cols=264  Identities=22%  Similarity=0.281  Sum_probs=198.9

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |.+.+.||+|+||.||+|.+ .+|+.||+|.++... .......+.+|++++++++||||+++++++.+....++|+||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            56678899999999999976 468999999987432 2223356788999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      + ++|.+++......+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++.........  
T Consensus        82 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--  155 (284)
T cd07839          82 D-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--  155 (284)
T ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--
Confidence            7 48888876656779999999999999999999999   99999999999999999999999999999755432211  


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc---------chhHHHHHHhhhhcch
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW---------FPKHVWEEYEKCELGA  308 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~---------~~~~~~~~~~~~~~~~  308 (406)
                      .....++..|+|||.+.+...++.++|||||||++|||++|..|+..+.......         .....+..........
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            1234578899999998776567899999999999999999998865433211000         0000000000000000


Q ss_pred             hh-c---cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 MI-L---GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~~-~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .. .   ...........+.++.+++.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00 0   00000111235678899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.6e-41  Score=288.83  Aligned_cols=244  Identities=23%  Similarity=0.345  Sum_probs=201.5

Q ss_pred             cccccccceeEEEEEEe-CCCcEEEEEEecccc----c---hhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEE
Q 015480           83 STRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL----G---RIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~----~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  153 (406)
                      .+.||.|..+.|.++.. .+|..+|+|++.-..    .   ....+.-.+|+.+|+++ .||||+++.+++..+...++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            45699999999999854 568899999886321    1   12235567899999998 599999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      +|.|+.|.|.|+| ...-.+++....+|+.|+.+|++|||.   .+|+||||||+|||+|++.++||+|||++..+....
T Consensus       102 Fdl~prGELFDyL-ts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge  177 (411)
T KOG0599|consen  102 FDLMPRGELFDYL-TSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE  177 (411)
T ss_pred             hhhcccchHHHHh-hhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccCCch
Confidence            9999999999999 556689999999999999999999999   999999999999999999999999999998776554


Q ss_pred             ceEEecCCCCCCCccCccccC-----CCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          234 THVTISGYKGTPGYSAPEFLS-----GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      .   ....+||++|+|||.+.     +..+|+..+|+|++|||+|-|+.|.+||....+                .-+..
T Consensus       178 k---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----------------mlMLR  238 (411)
T KOG0599|consen  178 K---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----------------MLMLR  238 (411)
T ss_pred             h---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH----------------HHHHH
Confidence            3   34578999999999874     345789999999999999999999999842211                11112


Q ss_pred             hhccCC---CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 MILGCG---IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ++..+.   .++...+.+....+|+.+||+.||.+|.|++|++.
T Consensus       239 ~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  239 MIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            222222   23445678889999999999999999999999987

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.1e-40  Score=303.92  Aligned_cols=252  Identities=24%  Similarity=0.341  Sum_probs=200.2

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      ..|.+.++||+|+||.||+|+.. ++..|++|++... .....+.+..|+.+++.++|||++++++++..+...++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            45677888999999999999764 5899999998754 234457788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +++++|..++......+++..+..++.|++.+|+|||+   .+++||||||+||+++.++.+||+|||++......... 
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~-  166 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR-  166 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccccc-
Confidence            99999998886666789999999999999999999999   99999999999999999999999999998654322111 


Q ss_pred             EecCCCCCCCccCccccCC----CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          237 TISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                       .....++..|+|||.+.+    ...++.++|||||||++|||++|..|+......       .........       .
T Consensus       167 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~-------~  231 (292)
T cd06644         167 -RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKS-------E  231 (292)
T ss_pred             -cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-------HHHHHHhcC-------C
Confidence             123457889999998853    224688999999999999999999887432110       000000000       0


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ......+...+..+.+++.+||+.||++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         232 PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0001122345667899999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.5e-40  Score=306.55  Aligned_cols=259  Identities=24%  Similarity=0.361  Sum_probs=190.2

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccch-hhHHHHHHHHHHhhcc---CcCccccEEEEEec-----CCe
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR-IAEEQFMAEVGTIGRT---YHINLVRLYGFCHD-----QHM  149 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~~  149 (406)
                      |.+.+.||+|+||+||+|... +|+.||+|.++..... .....+.+|+.++..+   +||||+++++++.+     ...
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            566788999999999999664 6899999998753221 1223456677766655   69999999999864     345


Q ss_pred             eEEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      .+++|||+.+ +|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence            7899999975 888888543 3458999999999999999999999   9999999999999999999999999999976


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHH--------H
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWE--------E  300 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~  300 (406)
                      ......   .....||..|+|||++.+. .++.++|||||||++|||++|.+||........  ... ...        .
T Consensus       158 ~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~-~~~~~~~~~~~~  230 (288)
T cd07863         158 YSCQMA---LTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGK-IFDLIGLPPEDD  230 (288)
T ss_pred             ccCccc---CCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHH-HHHHhCCCChhh
Confidence            543221   1234678999999999876 689999999999999999999988753321100  000 000        0


Q ss_pred             Hhh-hhcchhhcc----CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          301 YEK-CELGAMILG----CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       301 ~~~-~~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      +.. .........    ..........+..+.+++.+||+.||++|||+.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000 000000000    0001111234567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-41  Score=314.65  Aligned_cols=241  Identities=27%  Similarity=0.374  Sum_probs=198.0

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCC
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      +.||.|+||.||.+++ .+.+.||||.+.-.-  +...-.++..|+..|.+++|||++.+-|+|..+...|||||||- |
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence            4599999999999965 678899999986331  22233678999999999999999999999999999999999995 5


Q ss_pred             ChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecC
Q 015480          161 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG  240 (406)
Q Consensus       161 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~  240 (406)
                      +-.|++...++++-+-.+..|+.+.+.||+|||+   .+.||||||+.|||+++.|.|||+|||.+......      +.
T Consensus       111 SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA------ns  181 (948)
T KOG0577|consen  111 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA------NS  181 (948)
T ss_pred             cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch------hc
Confidence            8899998788899999999999999999999999   99999999999999999999999999999765543      45


Q ss_pred             CCCCCCccCccccCC--CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          241 YKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       241 ~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ++|||.|||||++..  ...|+-++||||||++..||.-+++|......          ....-     .........-.
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----------MSALY-----HIAQNesPtLq  246 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----------MSALY-----HIAQNESPTLQ  246 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----------HHHHH-----HHHhcCCCCCC
Confidence            889999999998752  34689999999999999999999988642211          11100     00001111122


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       319 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..+.+..+..++..||++-|.+|||.+++++
T Consensus       247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            4677889999999999999999999998765

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.2e-40  Score=306.39  Aligned_cols=249  Identities=20%  Similarity=0.298  Sum_probs=200.8

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      .+|...+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.+.|||++++++.+.+....++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            3566778899999999999975 5689999999875433 2356788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +++++|.+++.  ...+++.++..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++......... 
T Consensus        99 ~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-  172 (296)
T cd06654          99 LAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  172 (296)
T ss_pred             cCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence            99999999984  3468999999999999999999999   99999999999999999999999999998754432211 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                       .....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||........      ......        ......
T Consensus       173 -~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~--------~~~~~~  236 (296)
T cd06654         173 -RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIAT--------NGTPEL  236 (296)
T ss_pred             -cCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhc--------CCCCCC
Confidence             1234688899999998876 678999999999999999999999854322100      000000        000011


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..+...+..+.+++.+||..+|++||++.++++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            123345677899999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4e-40  Score=302.57  Aligned_cols=250  Identities=25%  Similarity=0.353  Sum_probs=195.3

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecC------Ce
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQ------HM  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~~  149 (406)
                      ..|.+.+.||+|+||+||+|.. .+++.||+|++....  .....+..|+.++.++ +||||+++++++...      ..
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            3456677899999999999976 458899999987532  3446788999999998 699999999998653      46


Q ss_pred             eEEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      .+++|||+++++|.+++... ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++..
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            78999999999999998653 4568999999999999999999999   9999999999999999999999999999976


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCC----CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhh
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC  304 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (406)
                      .......  .....|+..|+|||++.+    ...++.++|||||||++|||++|..|+.......       ....... 
T Consensus       161 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-------~~~~~~~-  230 (272)
T cd06637         161 LDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIPR-  230 (272)
T ss_pred             ccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-------HHHHHhc-
Confidence            5432211  233568899999999853    2257889999999999999999999885322110       0000000 


Q ss_pred             hcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                             ...........+..+.+++.+||+.||.+|||+.++++
T Consensus       231 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 -------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                   00011112234567899999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.6e-40  Score=301.34  Aligned_cols=249  Identities=24%  Similarity=0.301  Sum_probs=198.8

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccch--------hhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGR--------IAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      +.+.+.||+|+||.||+|.. .+++.||+|.+......        ...+.+.+|+.++++++||||+++++++.+....
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            45677899999999999965 45889999988643211        1235688899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      +++|||+++++|.+++.. ...+++..+..++.|++.||+|||+   .+++||||+|+||++++++.++|+|||+++...
T Consensus        82 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          82 NIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             EEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            999999999999999943 4678899999999999999999999   999999999999999999999999999998665


Q ss_pred             CCCce----EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhc
Q 015480          231 RNKTH----VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCEL  306 (406)
Q Consensus       231 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (406)
                      .....    .......|+..|+|||.+.+. .++.++|+||||+++|+|++|..||......          ......  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------~~~~~~--  224 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----------QAIFKI--  224 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHH----------HHHHHH--
Confidence            32111    111234578899999998876 6889999999999999999999998532110          010000  


Q ss_pred             chhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                          ........+...+..+.+++.+||+.||.+||++.++++
T Consensus       225 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 ----GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ----hccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                001112333456678999999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.4e-40  Score=300.99  Aligned_cols=252  Identities=21%  Similarity=0.324  Sum_probs=197.3

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|.+.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.++..++||||+++++++.+.+..++||||+
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            456677899999999999965 4689999999875422 23456788999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++++|.+++. ..+.+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++........  .
T Consensus        89 ~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~  162 (267)
T cd06645          89 GGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--K  162 (267)
T ss_pred             CCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--c
Confidence            9999999884 44578999999999999999999999   9999999999999999999999999999875543221  1


Q ss_pred             ecCCCCCCCccCccccC--CCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          238 ISGYKGTPGYSAPEFLS--GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                      .....|+..|+|||.+.  ....++.++|+|||||++|+|++|..|+........      ... .......    ... 
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~-~~~~~~~----~~~-  230 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFL-MTKSNFQ----PPK-  230 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHh-hhccCCC----CCc-
Confidence            23456899999999874  222578899999999999999999988753322110      000 0000000    000 


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .......+..+.+++.+||+.+|++||++++|++
T Consensus       231 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         231 LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0111134567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.2e-40  Score=299.45  Aligned_cols=239  Identities=23%  Similarity=0.360  Sum_probs=188.5

Q ss_pred             ccccccceeEEEEEEeCCCc-----------EEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           84 TRLGFGGFGEVYKGQFPNGV-----------KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      +.||+|+||.||+|.+.+..           .+++|.+.....  ....+.+|+.+++.++||||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            36999999999999775432           578887765422  26788999999999999999999999988 77899


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC-------CceEecccc
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-------SPKVADFGL  225 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-------~~kl~DfGl  225 (406)
                      ||||+++|+|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++       .+||+|||+
T Consensus        78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999996655578999999999999999999999   9999999999999999888       799999999


Q ss_pred             ccccCCCCceEEecCCCCCCCccCccccCCC-CCCCcccceeecchhHHHHhhc-ccccccCCCcccccchhHHHHHHhh
Q 015480          226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGR-RRNAIVGATESLDWFPKHVWEEYEK  303 (406)
Q Consensus       226 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~  303 (406)
                      +......      ....++..|+|||++.+. ..++.++||||||+++|||++| ..|+......  .+     ...+..
T Consensus       155 a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~-----~~~~~~  221 (259)
T cd05037         155 PITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EK-----ERFYQD  221 (259)
T ss_pred             ccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hH-----HHHHhc
Confidence            9765431      123467789999998765 3678999999999999999995 5554332111  00     000000


Q ss_pred             hhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                              ...   .+......+.+++.+||..+|.+||++.++++.|+
T Consensus       222 --------~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 --------QHR---LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             --------CCC---CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                    000   00111267899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=296.87  Aligned_cols=253  Identities=24%  Similarity=0.345  Sum_probs=202.2

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|.+.+.||+|+||.||+|.. .+++.+++|++..... ...+.+.+|+.++++++||||+++++++.+....+++|||+
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            466778899999999999976 4578899999875433 24577899999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++++|.+++......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++.........  
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--  157 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK--  157 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhhc--
Confidence            9999999986665789999999999999999999999   99999999999999999999999999999765432211  


Q ss_pred             ecCCCCCCCccCccccCCC--CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          238 ISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                      .....++..|+|||.+.+.  ..++.++|+||||+++|||++|..|+.......      . .........     ....
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~------~-~~~~~~~~~-----~~~~  225 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR------A-LFLISKSNF-----PPPK  225 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH------H-HHHHHhccC-----CCcc
Confidence            1235678899999988643  257889999999999999999999875322110      0 000000000     0111


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .......+..+.+++.+||+.+|.+|||+.+|+.
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1223456678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=9.4e-40  Score=299.60  Aligned_cols=248  Identities=22%  Similarity=0.296  Sum_probs=196.2

Q ss_pred             ccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCC
Q 015480           82 YSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        82 ~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      ....||+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..++|+||++++
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   90 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG   90 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence            345799999999999975 457889999887542 234567899999999999999999999999999999999999999


Q ss_pred             ChhhHhhcCCCCC--CHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC-CCCceEeccccccccCCCCceEE
Q 015480          161 SLDGYLFGKKRAI--EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       161 ~L~~~l~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      +|.+++......+  ++..+..++.|++.||+|||+   .+++||||||+||+++. ++.++|+|||++.........  
T Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~--  165 (268)
T cd06624          91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--  165 (268)
T ss_pred             CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc--
Confidence            9999996554555  888899999999999999999   99999999999999976 679999999998755432221  


Q ss_pred             ecCCCCCCCccCccccCCC-CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          238 ISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                      .....|+..|+|||.+.+. ..++.++||||||+++|+|++|..|+.........     .+..         .......
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-----~~~~---------~~~~~~~  231 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-----MFKV---------GMFKIHP  231 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-----Hhhh---------hhhccCC
Confidence            1234578899999998653 24788999999999999999999987532211000     0000         0001112


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..+...+.++.+++.+||+.+|.+|||+.+++.
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         232 EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            233456678999999999999999999999886

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-42  Score=297.41  Aligned_cols=247  Identities=23%  Similarity=0.326  Sum_probs=207.0

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      +++..+||+|+||.||++.+ ..|+.+|||.+.-+   ...+.+..|+.+|.++..|++|++||.+.....+|+|||||.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            45677899999999999954 57999999988753   467789999999999999999999999999899999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      .|++.+.+..+++++++..+..++.+.++||+|||.   ..-+|||||+.|||++.+|.+||+|||.+-.+...-  ...
T Consensus       112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKR  186 (502)
T KOG0574|consen  112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKR  186 (502)
T ss_pred             CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH--Hhh
Confidence            999999998899999999999999999999999999   778999999999999999999999999997554322  223


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      +...||+.|||||++..- .|+.++||||||++..||..|++|+..-.+-..-+.              -.......-..
T Consensus       187 NTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM--------------IPT~PPPTF~K  251 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM--------------IPTKPPPTFKK  251 (502)
T ss_pred             CccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEe--------------ccCCCCCCCCC
Confidence            456799999999999865 799999999999999999999998754322111000              00011112234


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       319 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      +...+.++.++++.||-++|++|.|+.++++
T Consensus       252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            5678899999999999999999999988876

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.8e-40  Score=304.83  Aligned_cols=262  Identities=21%  Similarity=0.268  Sum_probs=198.8

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccc----hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG----RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      |.+.+.||+|+||.||+|... +|+.||+|.++....    ......+..|+++++.++|+||+++++++.+....++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            566778999999999999764 689999999975432    123456778999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+ +++|.+++......+++..+..++.|+++||+|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            999 889999996544479999999999999999999999   9999999999999999999999999999986654322


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHH-------HHHhh-hhc
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVW-------EEYEK-CEL  306 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~-~~~  306 (406)
                      .  .....++..|+|||.+.+...++.++|||||||++|||++|.+++.......  .......       ..+.. ...
T Consensus       158 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         158 K--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             c--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhhcccc
Confidence            1  1223467889999998765567899999999999999999976664322110  0000000       00000 000


Q ss_pred             chhhc-----cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          307 GAMIL-----GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       307 ~~~~~-----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .....     ...........+..+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            00000     00001112334678999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6e-40  Score=301.99  Aligned_cols=256  Identities=23%  Similarity=0.344  Sum_probs=200.2

Q ss_pred             hhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      ..+...+.||+|+||+||+|+.+      +...|++|.+...........+.+|++++.+++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            34556778999999999999763      246799998876444335578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecc
Q 015480          152 LVYEYMENGSLDGYLFGKK--------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF  223 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (406)
                      +||||+++|+|.+++....        ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999995432        268999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHh
Q 015480          224 GLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYE  302 (406)
Q Consensus       224 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  302 (406)
                      |++........ .......++..|+|||.+.+. ..+.++||||||+++|+|++ |..||.....       ........
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~~~  232 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNRLQ  232 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHHHH
Confidence            99875432211 112234467789999998766 67899999999999999998 6666632111       01111111


Q ss_pred             hhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                      .....        .......+..+.+++.+||+.+|.+||++.++++.|.+
T Consensus       233 ~~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         233 AGKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             cCCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            11100        01122455789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=9.9e-40  Score=297.36  Aligned_cols=248  Identities=23%  Similarity=0.336  Sum_probs=199.3

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEec-CCeeEEEEEe
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-QHMTALVYEY  156 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  156 (406)
                      |.+.+.||+|++|.||++... +++.||+|.+.... .....+.+..|++++++++|+|++++++.+.. +...+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            567789999999999999764 57899999986432 23345678899999999999999999998764 4467899999


Q ss_pred             ccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          157 MENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       157 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +++++|.+++... ...+++.++..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.........
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM  158 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence            9999999998653 4568999999999999999999999   99999999999999999999999999999766433221


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.|+......      .. .....         .+..
T Consensus       159 --~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~-~~~~~---------~~~~  219 (257)
T cd08223         159 --ASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SL-VYRII---------EGKL  219 (257)
T ss_pred             --cccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HH-HHHHH---------hcCC
Confidence              2235688999999998876 7889999999999999999999887532110      00 00111         1111


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...+...+..+.+++.+||+.||.+||++.++++
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            2233456778999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.4e-40  Score=309.10  Aligned_cols=265  Identities=17%  Similarity=0.185  Sum_probs=194.5

Q ss_pred             cccccccc--ceeEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           82 YSTRLGFG--GFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        82 ~~~~ig~G--~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      +.++||+|  +||+||++.. .+|+.||+|++..... ......+..|+++++.++||||+++++++.+++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45679999  7899999965 5789999999975432 233456778999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          158 ENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       158 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      ++|+|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.++++||+............
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999998543 3468999999999999999999999   999999999999999999999999998754332111100


Q ss_pred             -----EecCCCCCCCccCccccCCC-CCCCcccceeecchhHHHHhhcccccccCCCcccc------cch------hHHH
Q 015480          237 -----TISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD------WFP------KHVW  298 (406)
Q Consensus       237 -----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~------~~~------~~~~  298 (406)
                           ......++..|+|||++.+. ..++.++|||||||++|||++|..||.........      ..+      ....
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 01123467789999998753 25889999999999999999999998532211000      000      0000


Q ss_pred             HHHhh--------hhcchh---------hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          299 EEYEK--------CELGAM---------ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       299 ~~~~~--------~~~~~~---------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      +....        ......         .............+..+.+++.+||+.||++|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            00000        000000         0000001122345678999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-40  Score=313.42  Aligned_cols=261  Identities=21%  Similarity=0.249  Sum_probs=193.2

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecC------Ce
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------HM  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  149 (406)
                      .+|...+.||+|+||+||+|.. .+++.||||.+..... ......+.+|+.++++++||||+++++++...      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            3456678899999999999965 5688999999875422 22345678899999999999999999988543      35


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .+++++++ +++|.+++  ....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...
T Consensus        95 ~~~~~~~~-~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          95 VYLVTNLM-GADLNNIV--KCQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             EEEEeecC-CCCHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceec
Confidence            68999998 77998877  34569999999999999999999999   99999999999999999999999999999865


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc--------cchhHHHHHH
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD--------WFPKHVWEEY  301 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~~  301 (406)
                      ...     .....||..|+|||++.+...++.++|||||||++|+|++|..||.........        ..........
T Consensus       169 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         169 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             CCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            432     234568999999999887557899999999999999999999988532210000        0000000000


Q ss_pred             hhhhcchhhcc-CCCC-----cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          302 EKCELGAMILG-CGIE-----EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       302 ~~~~~~~~~~~-~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ........... ....     .........+.+++.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000000000 0000     000112345789999999999999999999997

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.9e-40  Score=300.47  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=196.5

Q ss_pred             cccccccccceeEEEEEEeC----CCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCC------e
Q 015480           81 NYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH------M  149 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~~----~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  149 (406)
                      .+.+.||+|+||.||+|.+.    +|+.||||++..+. .....+++.+|+.+++.++||||+++++++....      .
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            45678999999999999653    46889999987543 2334567889999999999999999999886532      3


Q ss_pred             eEEEEEeccCCChhhHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccc
Q 015480          150 TALVYEYMENGSLDGYLFG-----KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  224 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfG  224 (406)
                      .+++++|+.+|+|.+++..     ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence            4789999999999888732     12357889999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhh
Q 015480          225 LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEK  303 (406)
Q Consensus       225 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  303 (406)
                      +++...............++..|++||.+.+. .++.++||||||+++|||++ |.+|+......       ........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~  230 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-------EIYNYLIK  230 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-------HHHHHHHc
Confidence            99866443322222234456789999998876 68899999999999999999 77766422110       01111111


Q ss_pred             hhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      .         .........+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       231 ~---------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 G---------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             C---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0         00111223457899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.9e-40  Score=304.20  Aligned_cols=265  Identities=21%  Similarity=0.312  Sum_probs=199.4

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      .|++.+.||+|+||.||+|... +|+.||+|++..... ....+.+.+|+.++++++|||++++++++.+....++||||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            4567788999999999999775 589999999864322 22345688999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +++++|..++ .....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++......... 
T Consensus        82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-  156 (286)
T cd07847          82 CDHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-  156 (286)
T ss_pred             cCccHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCccc-
Confidence            9998888776 344568999999999999999999999   99999999999999999999999999999866543221 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhH--------HHHHHhhhhcc-
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKH--------VWEEYEKCELG-  307 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~-  307 (406)
                       .....++..|+|||.+.+...++.++||||||+++|||++|..||..............        ........... 
T Consensus       157 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         157 -YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             -ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence             12345788999999987654678999999999999999999998853322110000000        00000000000 


Q ss_pred             hhhccCC-----CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 AMILGCG-----IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .......     ........+..+.+++.+||+.+|++||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000000     00011234677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.4e-40  Score=297.43  Aligned_cols=248  Identities=21%  Similarity=0.347  Sum_probs=201.6

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccc-cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |.+.+.||+|+||++|++.. .+|+.||+|.+... ........+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            56778999999999999965 46899999998643 22334567899999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          158 ENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       158 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      ++++|.+++... ...+++.++..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......... 
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-  157 (256)
T cd08218          82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL-  157 (256)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-
Confidence            999999988543 3468899999999999999999999   99999999999999999999999999999765433221 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                       .....|+..|+|||.+.+. ..+.++|+||||+++++|++|..|+......          +....      .......
T Consensus       158 -~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----------~~~~~------~~~~~~~  219 (256)
T cd08218         158 -ARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMK----------NLVLK------IIRGSYP  219 (256)
T ss_pred             -hhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHH----------HHHHH------HhcCCCC
Confidence             1234578899999998876 6889999999999999999999987543211          00000      0111122


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..+...+..+.+++.+||+.+|++||++.+|++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            233456778999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-40  Score=302.30  Aligned_cols=251  Identities=25%  Similarity=0.400  Sum_probs=201.2

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|.+.+.||.|+||.||+|.+ .++..||+|++... .....+.+..|++++++++||||+++++++.++...++||||+
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            466678899999999999976 46899999998754 2344567899999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++++|.+++......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.........  
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--  159 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK--  159 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccccc--
Confidence            9999999986666789999999999999999999999   99999999999999999999999999998755432221  


Q ss_pred             ecCCCCCCCccCccccCC----CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          238 ISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      .....++..|+|||.+..    ...++.++|+||||+++|||++|..|+......       ..........       .
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~-------~  225 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-------RVLLKILKSE-------P  225 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-------HHHHHHhcCC-------C
Confidence            123458889999998752    224678999999999999999999987532211       0001111100       0


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .....+...+..+.+++..||+.+|.+||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            011122345677899999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.2e-40  Score=306.65  Aligned_cols=265  Identities=23%  Similarity=0.319  Sum_probs=199.6

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccch-hhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR-IAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      +|++.++||+|+||.||+|.+. +|+.||+|++...... ...+.+.+|+++++.++||||+++++++.++...++||||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            4567789999999999999775 5899999998654222 2456788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +++++|..+.. ....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++......... 
T Consensus        82 ~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-  156 (286)
T cd07846          82 VDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-  156 (286)
T ss_pred             CCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc-
Confidence            99988887763 34458999999999999999999999   99999999999999999999999999999765443221 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc--------cchhHHHHHHhhhhcc-
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD--------WFPKHVWEEYEKCELG-  307 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~-  307 (406)
                       .....++..|+|||.+.+...++.++||||||+++|||++|++|+.........        .+.............. 
T Consensus       157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         157 -YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             -cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence             233557889999999876546788999999999999999999887533211000        0000000000000000 


Q ss_pred             hhhccCC-----CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 AMILGCG-----IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .......     ........+..+.+++.+||+.+|.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0000000     00011234677999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-40  Score=301.14  Aligned_cols=247  Identities=23%  Similarity=0.360  Sum_probs=200.0

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccC---cCccccEEEEEecCCeeEEEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---HINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      |...+.||+|+||.||+|.+ .+|+.||+|.++..........+.+|+.+++.++   |||++++++++.++...++|||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            45567899999999999975 5689999999876544455667889999999986   9999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++++|.+++..  ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++.........
T Consensus        83 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          83 YAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             cCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence            9999999999843  378999999999999999999999   99999999999999999999999999999866543321


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        .....|+..|+|||.+.+...++.++|+||||+++|+|++|..||........       .....         ....
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------~~~~~---------~~~~  219 (277)
T cd06917         158 --RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-------MMLIP---------KSKP  219 (277)
T ss_pred             --cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-------hhccc---------cCCC
Confidence              22346888999999987654678999999999999999999999853321100       00000         0000


Q ss_pred             Ccch-HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKD-KEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .... ...+.++.+++.+||+.||++||++.+++.
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         220 PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            1111 125678999999999999999999999987

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.1e-40  Score=337.75  Aligned_cols=264  Identities=22%  Similarity=0.315  Sum_probs=201.2

Q ss_pred             hHHHhhhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccc-cchhhHHHHHHHHHHhhccCcCccccEEEEEec--C
Q 015480           72 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--Q  147 (406)
Q Consensus        72 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~  147 (406)
                      ..+..-..|.+.+.||+|+||+||+|+.. ++..||+|++... ........+..|+.++.+++||||++++++|.+  .
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            34444456788899999999999999764 5788999998743 233445778999999999999999999998854  4


Q ss_pred             CeeEEEEEeccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhc----CCCeeecCCCCCcEEEcC------
Q 015480          148 HMTALVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEEC----QQRIIHYDIKPENVLLDA------  214 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~----~~~i~H~dlk~~Nill~~------  214 (406)
                      ..++|||||+++|+|.+++..   ....+++..++.|+.||+.||+|||+..    ..+|+||||||+||||+.      
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            578999999999999999853   2357999999999999999999999822    135999999999999964      


Q ss_pred             -----------CCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCC-CCCCcccceeecchhHHHHhhccccc
Q 015480          215 -----------NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNA  282 (406)
Q Consensus       215 -----------~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltg~~p~  282 (406)
                                 .+.+||+|||++........   .....||+.|+|||++.+. ..++.++||||||||||||++|..||
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             cccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                       23589999999976543321   1235689999999998643 35789999999999999999999998


Q ss_pred             ccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcc
Q 015480          283 IVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGV  354 (406)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~  354 (406)
                      ......      ..........         . .......+..+.+|+..||+.+|.+||++.+++.  .+..+
T Consensus       244 ~~~~~~------~qli~~lk~~---------p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        244 HKANNF------SQLISELKRG---------P-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             CcCCcH------HHHHHHHhcC---------C-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            532211      0011111110         0 1111234577999999999999999999999984  55433

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.6e-40  Score=299.48  Aligned_cols=252  Identities=27%  Similarity=0.406  Sum_probs=203.8

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      +.+.+.||+|+||.||++.+. +++.+|+|.+...........+.+|+++++.++||||+++++++......++++||++
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD   82 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence            456678999999999999775 5899999999876545566788999999999999999999999999999999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      +++|.+++......+++..+..++.|++.||.|||+  ..+++|+||||+||++++++.++|+|||.+.........   
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~---  157 (265)
T cd06605          83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---  157 (265)
T ss_pred             CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh---
Confidence            999999996555789999999999999999999997  379999999999999999999999999998755432211   


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                       ...++..|+|||.+.+. .++.++||||||+++|+|++|..|+.........     ..+.....      ........
T Consensus       158 -~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~~~------~~~~~~~~  224 (265)
T cd06605         158 -TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-----IFELLQYI------VNEPPPRL  224 (265)
T ss_pred             -cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-----HHHHHHHH------hcCCCCCC
Confidence             15578899999999876 7899999999999999999999998544321110     11111110      01111112


Q ss_pred             hHH-HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          319 DKE-KAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       319 ~~~-~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      +.. .+..+.+++..||..||.+|||+.+++.
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            222 6778999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.6e-39  Score=299.66  Aligned_cols=247  Identities=24%  Similarity=0.329  Sum_probs=200.7

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      |...+.||+|+||.||+|.+ .+++.||+|.+...........+.+|+.++..++||||+++++++.++...++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            45667899999999999965 46889999998754444455678899999999999999999999999999999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      +++|.+++.  ...+++..+..++.|++.++.|||+   .+++|+||+|+||+++.++.++|+|||++.........  .
T Consensus        86 ~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~--~  158 (277)
T cd06641          86 GGSALDLLE--PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--R  158 (277)
T ss_pred             CCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchhh--h
Confidence            999999884  3468999999999999999999999   99999999999999999999999999998765432211  1


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ....++..|+|||.+.+. ..+.++|+|||||++|+|++|..|+......       ......         ........
T Consensus       159 ~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~---------~~~~~~~~  221 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPM-------KVLFLI---------PKNNPPTL  221 (277)
T ss_pred             ccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchH-------HHHHHH---------hcCCCCCC
Confidence            234578899999998766 6889999999999999999999887432110       000000         11111223


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       319 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      ....+..+.+++.+||+.+|.+||++.++++.
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            33456779999999999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.3e-39  Score=303.29  Aligned_cols=249  Identities=20%  Similarity=0.289  Sum_probs=201.1

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      .+|.+.+.||+|+||.||+|.. .+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            4567788999999999999975 5799999999875432 3446788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +++++|.+++.  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++......... 
T Consensus        98 ~~~~~L~~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-  171 (297)
T cd06656          98 LAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  171 (297)
T ss_pred             cCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-
Confidence            99999999984  3468899999999999999999999   99999999999999999999999999998755433211 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                       .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||..........              ..........
T Consensus       172 -~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--------------~~~~~~~~~~  235 (297)
T cd06656         172 -RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------------LIATNGTPEL  235 (297)
T ss_pred             -cCcccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--------------eeccCCCCCC
Confidence             1234578899999998876 68899999999999999999999985432211000              0000001111


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..+...+..+.+++.+||+.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            223345677899999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.1e-39  Score=295.60  Aligned_cols=255  Identities=24%  Similarity=0.340  Sum_probs=204.1

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|++.+.||.|+||+||+|.. .++..+++|++...........+.+|+++++.++|+|++++++.+......++|||++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   81 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL   81 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence            456788899999999999975 4688999999975543346678999999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          158 ENGSLDGYLFGK--KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       158 ~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      ++++|.+++...  ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.........
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999543  3568999999999999999999999   99999999999999999999999999999766543322


Q ss_pred             E--EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          236 V--TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       236 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      .  ......|+..|+|||.+.....++.++|+||||+++|+|++|..||.......      ....... .      ...
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~-~------~~~  225 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQ-N------DPP  225 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhc-C------CCC
Confidence            1  12234588899999998765568999999999999999999999985332210      0001000 0      000


Q ss_pred             CCCcc--hHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          314 GIEEK--DKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       314 ~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .....  ....+..+.+++..||+.||++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            11111  1355678999999999999999999999886

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.5e-39  Score=309.96  Aligned_cols=261  Identities=19%  Similarity=0.221  Sum_probs=193.7

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecC------Ce
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------HM  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  149 (406)
                      .+|.+.+.||+|+||.||++.. ..++.||||++.... .......+.+|+.+++.++||||+++++++...      ..
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~  103 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  103 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence            4567788999999999999965 458899999987542 223456788999999999999999999987543      35


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+++ +|.+++.   ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  176 (364)
T cd07875         104 VYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  176 (364)
T ss_pred             EEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence            7899999965 7777663   347889999999999999999999   99999999999999999999999999999765


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc--------ccchhHHHHHH
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL--------DWFPKHVWEEY  301 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~~  301 (406)
                      .....   .....||..|+|||++.+. .++.++|||||||++|||++|+.||........        .......+...
T Consensus       177 ~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (364)
T cd07875         177 GTSFM---MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  252 (364)
T ss_pred             CCCCc---ccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            43221   2345689999999999876 789999999999999999999999854321100        00000000000


Q ss_pred             hhh---------hcchh----hcc----CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          302 EKC---------ELGAM----ILG----CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       302 ~~~---------~~~~~----~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...         .....    ...    .............+.+++.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000         00000    000    0000111123457899999999999999999999988

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.6e-39  Score=299.38  Aligned_cols=265  Identities=22%  Similarity=0.277  Sum_probs=201.8

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |.+.+.||+|+||.||+|.+ .+|..||+|++..... ......+.+|+.++++++||||+++++++.+....++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            56778899999999999976 4689999999875432 334567899999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                       +++|.+++......+++.++..++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||++........ ..
T Consensus        82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~  156 (286)
T cd07832          82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RL  156 (286)
T ss_pred             -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cc
Confidence             999999986666789999999999999999999999   9999999999999999999999999999986654322 11


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc-cc-------chhHHHHHHhhh-hcch
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL-DW-------FPKHVWEEYEKC-ELGA  308 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~-------~~~~~~~~~~~~-~~~~  308 (406)
                      .....|+..|+|||.+.+...++.++||||+|+++|||++|.+++........ ..       .....|...... ....
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK  236 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence            22356888999999987665678999999999999999999766643221100 00       000000000000 0000


Q ss_pred             hhccCC----CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 MILGCG----IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ......    ......+.+..+.+++.+||+.+|.+||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            000000    00111234578999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-39  Score=303.54  Aligned_cols=253  Identities=21%  Similarity=0.296  Sum_probs=202.4

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      +|.+.+.||.|+||.||+|.. .+|+.|++|.+..... ...+.+.+|+.+++.++|||++++++++.+....++|+||+
T Consensus        20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            466778899999999999965 5689999999875422 34567889999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++++|..++.  ...+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.........  
T Consensus        99 ~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--  171 (296)
T cd06655          99 AGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--  171 (296)
T ss_pred             CCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc--
Confidence            9999999884  3468999999999999999999999   99999999999999999999999999998755433221  


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      .....++..|+|||.+.+. .++.++|||||||++|+|++|..||........       .......       ......
T Consensus       172 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-------~~~~~~~-------~~~~~~  236 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYLIATN-------GTPELQ  236 (296)
T ss_pred             CCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhc-------CCcccC
Confidence            1234688899999998876 688999999999999999999998854322100       0000000       000111


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcc
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGV  354 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~  354 (406)
                      .+...+..+.+++.+||..||.+||++.+++.  .+...
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence            23345667899999999999999999999997  44443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.6e-39  Score=296.38  Aligned_cols=250  Identities=23%  Similarity=0.312  Sum_probs=193.8

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc----chhhHHHHHHHHHHhhccCcCccccEEEEEec--CCeeE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL----GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMTA  151 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  151 (406)
                      .|...+.||+|+||.||+|.. .+|..||+|.+....    .......+.+|+.++++++||||+++++++.+  ....+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            356678899999999999965 468999999886431    12234578899999999999999999999865  35778


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +++||+++++|.+++.. ...+++.....++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++.....
T Consensus        83 l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          83 IFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            99999999999999843 3468899999999999999999999   9999999999999999999999999999875532


Q ss_pred             CC-ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          232 NK-THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       232 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      .. .........++..|+|||.+.+. .++.++|||||||++|||++|+.||.....          ......     ..
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----------~~~~~~-----~~  222 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEA----------MAAIFK-----IA  222 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccch----------HHHHHH-----Hh
Confidence            11 11111234578899999999876 789999999999999999999998853211          011110     00


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ........+......+.+++ .||..+|++||++++|++
T Consensus       223 ~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         223 TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            11111223344556677777 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-39  Score=297.03  Aligned_cols=255  Identities=22%  Similarity=0.305  Sum_probs=198.0

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccc---------hhhHHHHHHHHHHhhccCcCccccEEEEEecCCe
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG---------RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM  149 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  149 (406)
                      |...+.||+|+||.||+|.. .+|+.||+|.++....         ....+.+..|+.+++.++|||++++++++.....
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            44567899999999999965 4689999998753211         1123567889999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+++++|.+++... ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++...
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            99999999999999998543 578999999999999999999999   99999999999999999999999999999765


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCC-CCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      .............|+..|+|||.+.... .++.++|+||||+++|+|++|..|+......      ....+... ...  
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~-~~~--  229 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGN-KRS--  229 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhc-ccc--
Confidence            4322222223456888999999987652 4789999999999999999999987432110      00000000 000  


Q ss_pred             hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        ............+..+.+++..||+.+|++||++.+|++
T Consensus       230 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         230 --APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             --CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence              000001122345688999999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2e-39  Score=296.28  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=201.6

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccc-cchhhHHHHHHHHHHhhccCcCccccEEEEEec--CCeeEEEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMTALVYE  155 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e  155 (406)
                      |++.+.||.|+||.||++.. .+|..||+|++... ......+.+..|+.+++.++||||+++++++..  ....+++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            45677899999999999965 56889999998743 233455678899999999999999999998754  456789999


Q ss_pred             eccCCChhhHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHHhc--CCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          156 YMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEEC--QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       156 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      |+++++|.+++...   ...+++..++.++.|++.||.|||..+  ..+++|+||+|+||+++.++.+||+|||++....
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~  161 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG  161 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence            99999999998542   567899999999999999999999211  1899999999999999999999999999998765


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      .....  .....++..|+|||.+.+. .++.++|+||||+++|+|++|..|+......       ...+.         .
T Consensus       162 ~~~~~--~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~---------~  222 (265)
T cd08217         162 HDSSF--AKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQL-------QLASK---------I  222 (265)
T ss_pred             CCccc--ccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHH-------HHHHH---------H
Confidence            44321  1234689999999999876 6889999999999999999999988543210       01111         1


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      ........+...+..+.+++.+||+.+|++||++.+|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         223 KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            1122233444567889999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-39  Score=295.41  Aligned_cols=248  Identities=25%  Similarity=0.333  Sum_probs=199.9

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEecccc----chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL----GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      |...+.||+|+||.||+|... ++..|++|.+....    .....+.+..|+.+++.++|+||+++++++.+....++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            455678999999999999765 78999999986432    1234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+++++|.+++.. ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++....... 
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-  156 (258)
T cd06632          82 ELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-  156 (258)
T ss_pred             EecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence            99999999999843 3568999999999999999999999   999999999999999999999999999987654332 


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                        ......|+..|+|||.+.....++.++|+||||+++|+|++|+.||......      ...... ..        ...
T Consensus       157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~-~~--------~~~  219 (258)
T cd06632         157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKI-GR--------SKE  219 (258)
T ss_pred             --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHH-Hh--------ccc
Confidence              1234568889999999876533889999999999999999999998543210      000110 00        011


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....+...+..+.+++.+||+.+|.+||++.+++.
T Consensus       220 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         220 LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            12223345677899999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9e-40  Score=312.04  Aligned_cols=259  Identities=21%  Similarity=0.266  Sum_probs=193.4

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecC------Ce
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------HM  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  149 (406)
                      .+|...+.||+|+||.||++.. ..++.||+|.+.... .......+.+|+.+++.++||||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   96 (355)
T cd07874          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD   96 (355)
T ss_pred             hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence            3566778999999999999965 458899999987542 223446788899999999999999999998643      35


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+++ +|.+.+.   ..+++..+..++.|+++||+|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus        97 ~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          97 VYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             eEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence            6899999975 6666663   358889999999999999999999   99999999999999999999999999999765


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccc---------hhHHHHH
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWF---------PKHVWEE  300 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~---------~~~~~~~  300 (406)
                      .....   .....||..|+|||++.+. .++.++|||||||++|+|++|+.||....... .+.         ....+..
T Consensus       170 ~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         170 GTSFM---MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             CCccc---cCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHh
Confidence            43221   2345689999999999876 78999999999999999999999985432100 000         0000000


Q ss_pred             Hhhhhcchhhc---------------cCCC---CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          301 YEKCELGAMIL---------------GCGI---EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       301 ~~~~~~~~~~~---------------~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ... .......               ....   .......+..+.+++.+||+.||++|||+.++++
T Consensus       245 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         245 LQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             hcH-HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence            000 0000000               0000   0111223567899999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.2e-39  Score=296.19  Aligned_cols=253  Identities=26%  Similarity=0.372  Sum_probs=199.4

Q ss_pred             hcccccccccceeEEEEEEeCC--CcEEEEEEeccc---------cchhhHHHHHHHHHHhhc-cCcCccccEEEEEecC
Q 015480           80 SNYSTRLGFGGFGEVYKGQFPN--GVKIAVKVLNRN---------LGRIAEEQFMAEVGTIGR-TYHINLVRLYGFCHDQ  147 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~~--g~~vavK~~~~~---------~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~  147 (406)
                      |.+.+.||+|+||.||+|.+..  ++.+|+|.+...         ........+..|+.++.+ ++||||+++++++.++
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            4566789999999999998754  788999987532         122234567788888865 7899999999999999


Q ss_pred             CeeEEEEEeccCCChhhHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccc
Q 015480          148 HMTALVYEYMENGSLDGYLF---GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  224 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfG  224 (406)
                      +..+++|||+++++|.+++.   .....+++..++.++.|++.||.|||+  ..+++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEeccc
Confidence            99999999999999998873   245678999999999999999999995  2689999999999999999999999999


Q ss_pred             cccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhh
Q 015480          225 LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC  304 (406)
Q Consensus       225 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (406)
                      ++.......   ......|+..|+|||.+.+. .++.++||||||+++|||++|..|+.......       ........
T Consensus       160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-------~~~~~~~~  228 (269)
T cd08528         160 LAKQKQPES---KLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-------LATKIVEA  228 (269)
T ss_pred             ceeeccccc---ccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHH-------HHHHHhhc
Confidence            997655433   22345688999999999876 68999999999999999999999875332110       00111111


Q ss_pred             hcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                      ..        .+......+..+.+++.+||+.||++||++.++..++++
T Consensus       229 ~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         229 VY--------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             cC--------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            00        011112345779999999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.5e-39  Score=300.38  Aligned_cols=263  Identities=23%  Similarity=0.301  Sum_probs=196.3

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|.+.+.||+|+||.||+|.. .+|..||+|++...........+.+|+.+++.++|+||+++++++.++...++||||+
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~   85 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM   85 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence            456678899999999999965 4688999999976543334456788999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      . ++|.+++......+.+..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++........  
T Consensus        86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--  159 (291)
T cd07870          86 H-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--  159 (291)
T ss_pred             c-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--
Confidence            6 67777775555678889999999999999999999   99999999999999999999999999998754322111  


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHH-----------HHhhh-h
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWE-----------EYEKC-E  305 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~-~  305 (406)
                      .....++..|+|||.+.+...++.++||||||+++|||++|..||.........  ....+.           ..... .
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ--LEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH--HHHHHHHcCCCChhhhhhhhhccc
Confidence            123456889999999876546788999999999999999999998643221000  000000           00000 0


Q ss_pred             cc-hhhcc---CCCCc--chHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          306 LG-AMILG---CGIEE--KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       306 ~~-~~~~~---~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .. .....   .....  .....+..+.+++.+|+..||.+|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00 00000   00000  00012467889999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3e-39  Score=298.52  Aligned_cols=250  Identities=23%  Similarity=0.322  Sum_probs=193.2

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHH-hhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      .|.+.+.||+|+||.||+|.+. +|+.||+|+++..........+..|+.. ++.++||||+++++++..+...+++|||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~   81 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV   81 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence            3566788999999999999764 6999999999765433344566667665 5567899999999999999999999999


Q ss_pred             ccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCC-CeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          157 MENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       157 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ++ |+|.+++..   ....+++..+..++.|++.||+|||+   + +++||||||+||+++.++.+||+|||++......
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            96 588887743   34578999999999999999999998   6 9999999999999999999999999999765432


Q ss_pred             CceEEecCCCCCCCccCccccCCC---CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGN---YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ..   .....|+..|+|||.+.+.   ..++.++|+|||||++|+|++|+.|+......         .+.....     
T Consensus       158 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~-----  220 (283)
T cd06617         158 VA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---------FQQLKQV-----  220 (283)
T ss_pred             cc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---------HHHHHHH-----
Confidence            11   1224578899999988652   24688999999999999999999987532211         0111100     


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .............+.++.+++..||+.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         221 VEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000001111235678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.5e-39  Score=298.79  Aligned_cols=262  Identities=24%  Similarity=0.297  Sum_probs=195.4

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecC--CeeEEEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQ--HMTALVYE  155 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  155 (406)
                      |.+.+.||+|+||.||+|.. .++..||+|.++............+|+.++.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            34567899999999999975 4689999999876433333344567888998885 99999999999887  88999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |++ ++|.+++......+++..+..++.|++.||+|||+   .+++||||+|+||+++. +.+||+|||++.........
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            997 58888886656689999999999999999999999   99999999999999999 99999999999765433221


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc-ccc-------hhHHHHHHhhhhcc
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL-DWF-------PKHVWEEYEKCELG  307 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~-------~~~~~~~~~~~~~~  307 (406)
                         ....++..|+|||.+.....++.++|||||||++|||++|..||........ ...       ..............
T Consensus       156 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         156 ---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             ---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence               2245788999999876544678999999999999999999988854322100 000       00000000000000


Q ss_pred             hhhccC----CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 AMILGC----GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ......    .+.......+..+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000000    001112245788999999999999999999999886

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.9e-39  Score=296.54  Aligned_cols=258  Identities=26%  Similarity=0.364  Sum_probs=199.8

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecC--CeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  155 (406)
                      ++...+.||.|++|.||++.. .+++.+|+|.+...........+.+|++++++++||||+++++++.+.  ...++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            355678899999999999976 458899999998654444567799999999999999999999998653  46899999


Q ss_pred             eccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          156 YMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       156 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |+++++|.+++..   ....++...+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999988742   34568999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ..    ....++..|+|||.+.+. .++.++||||||+++|+|++|..|+.........  ............... ...
T Consensus       159 ~~----~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~  230 (287)
T cd06621         159 LA----GTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG--PIELLSYIVNMPNPE-LKD  230 (287)
T ss_pred             cc----ccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC--hHHHHHHHhcCCchh-hcc
Confidence            21    124578899999998876 7899999999999999999999998654321111  000111111100000 000


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        ........+..+.+++.+||+.+|.+|||+.|+++
T Consensus       231 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         231 --EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             --CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence              01111234678999999999999999999999998

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-39  Score=302.81  Aligned_cols=258  Identities=22%  Similarity=0.262  Sum_probs=203.8

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEec-cccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCCee
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMT  150 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  150 (406)
                      +.+.+..|...++||+||.+.||++...+.+.||+|.+. .........-|..|+..|.+|+ |.+||++++|-..++.+
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            445666677888999999999999988777778877665 3344556688999999999996 99999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ||||||-+ .+|..+|..+...+..-.+..+..|++.++.++|.   +||||.||||.|+|+- .|.+||+|||+|....
T Consensus       436 YmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  436 YMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             EEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence            99999874 49999997665555533888999999999999999   9999999999999995 5699999999999888


Q ss_pred             CCCceEEecCCCCCCCccCccccCCC----------CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHH
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEE  300 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  300 (406)
                      .+.+.......+||+.||+||.+...          ...++++||||||||||+|+.|++||..-.         ..+..
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---------n~~aK  581 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---------NQIAK  581 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---------HHHHH
Confidence            77777766778999999999987422          136789999999999999999999984211         11222


Q ss_pred             HhhhhcchhhccCC-CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          301 YEKCELGAMILGCG-IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       301 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      +.     +..+... ++-.......++.++++.||+.||.+||++.++|+
T Consensus       582 l~-----aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  582 LH-----AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HH-----hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            11     1111111 11001111233999999999999999999999987

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.3e-39  Score=293.63  Aligned_cols=247  Identities=21%  Similarity=0.344  Sum_probs=199.1

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |.+.+.||+|+||.||++.. .+++.+|+|.+.... .......+..|+++++.++|||++++++.+..+...++||||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            56678899999999999965 468899999987532 3334577899999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC-CceEeccccccccCCCCce
Q 015480          158 ENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       158 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~DfGl~~~~~~~~~~  235 (406)
                      ++++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++ .+||+|||++.........
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~  158 (256)
T cd08220          82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA  158 (256)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence            999999999654 3458999999999999999999999   9999999999999998654 5899999999866443221


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                         ....|+..|+|||.+.+. .++.++||||||+++|+|++|..|+......      ... ...         .....
T Consensus       159 ---~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~-~~~---------~~~~~  218 (256)
T cd08220         159 ---YTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLP------ALV-LKI---------MSGTF  218 (256)
T ss_pred             ---cccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchH------HHH-HHH---------HhcCC
Confidence               234578899999999876 6889999999999999999999887433211      000 000         01111


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...+...+..+.+++.+||+.+|.+|||+.++++
T Consensus       219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1222345678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.1e-39  Score=301.22  Aligned_cols=265  Identities=19%  Similarity=0.214  Sum_probs=198.2

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecC--CeeEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTALVY  154 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  154 (406)
                      .|.+.+.||+|+||.||+|.+. +++.+|+|.++.... ......+.+|+.++.+++||||+++++++...  ...++||
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            4566788999999999999775 588999999975422 22334677899999999999999999999877  8999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+.+ +|.+++......+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        86 e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          86 EYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             hhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            99975 9999886656679999999999999999999999   9999999999999999999999999999986654321


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc--------cchhHHHHHHhhhhc
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD--------WFPKHVWEEYEKCEL  306 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~  306 (406)
                      .  .....++..|+|||.+.+...++.++|+||||+++|+|++|..||.........        ......|........
T Consensus       162 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
T cd07843         162 P--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG  239 (293)
T ss_pred             c--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence            1  123457889999999876645789999999999999999999988543211000        000000111100000


Q ss_pred             c------hhhccCCCCcchHH-HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          307 G------AMILGCGIEEKDKE-KAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       307 ~------~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .      ...........+.. .+..+.+++.+||+.||++|||+.|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0      00000000011111 3677899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.1e-39  Score=294.22  Aligned_cols=250  Identities=22%  Similarity=0.270  Sum_probs=195.6

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc----chhhHHHHHHHHHHhhccCcCccccEEEEEecC--CeeE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL----GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTA  151 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  151 (406)
                      .|.+.+.||+|+||.||+|.. .+|..||+|.+....    .....+.+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS   82 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence            355678899999999999976 458999999885321    122346788999999999999999999998763  4678


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      ++|||+++++|.+++.. ...+++.....++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          83 IFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence            99999999999999843 3568899999999999999999999   9999999999999999999999999999975542


Q ss_pred             CCce-EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          232 NKTH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       232 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      .... .......|+..|+|||.+.+. .++.++||||||+++|||++|+.||......          .....     ..
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------~~~~~-----~~  222 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----------AAIFK-----IA  222 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchH----------HHHHH-----Hh
Confidence            2111 112234588899999998876 6899999999999999999999987432110          01100     01


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ........+...+..+.+++.+|+. +|++||++++|++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         223 TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            1111223445666788899999995 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4e-39  Score=298.22  Aligned_cols=260  Identities=25%  Similarity=0.308  Sum_probs=199.0

Q ss_pred             eChHHHhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEe--
Q 015480           70 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCH--  145 (406)
Q Consensus        70 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~--  145 (406)
                      +..+.....+|.+.+.||+|+||.||++.. .+|+.+|+|++...  ......+..|+.++..+ +||||+++++++.  
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            344444556677888999999999999966 45889999988642  12345678899999999 6999999999884  


Q ss_pred             ---cCCeeEEEEEeccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCce
Q 015480          146 ---DQHMTALVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK  219 (406)
Q Consensus       146 ---~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k  219 (406)
                         ++...++||||+++++|.+++..   ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEE
Confidence               34578999999999999998742   34568899999999999999999999   9999999999999999999999


Q ss_pred             EeccccccccCCCCceEEecCCCCCCCccCccccCCC----CCCCcccceeecchhHHHHhhcccccccCCCcccccchh
Q 015480          220 VADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPK  295 (406)
Q Consensus       220 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~  295 (406)
                      |+|||++.........  .....|+..|+|||++...    ..++.++|||||||++|||++|+.|+......       
T Consensus       165 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-------  235 (286)
T cd06638         165 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-------  235 (286)
T ss_pred             EccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-------
Confidence            9999998765432221  1234589999999987532    24788999999999999999999987543211       


Q ss_pred             HHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          296 HVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                         ......  ...  .......+...+..+.+++.+||+.||++|||+.++++.
T Consensus       236 ---~~~~~~--~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         236 ---RALFKI--PRN--PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ---HHHhhc--ccc--CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence               000000  000  000001112245679999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=301.44  Aligned_cols=266  Identities=20%  Similarity=0.281  Sum_probs=200.3

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      +|++.+.||+|+||.||+|.+. +++.||+|.++... .....+.+.+|++++++++|+||+++++++.+++..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            4677889999999999999764 58899999987532 233457789999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      ++++.+..+. .....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++......... 
T Consensus        82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-  156 (288)
T cd07833          82 VERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-  156 (288)
T ss_pred             CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-
Confidence            9987776655 445668999999999999999999999   99999999999999999999999999999866544321 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhH--------HHHHHhh-hhcc
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKH--------VWEEYEK-CELG  307 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~-~~~~  307 (406)
                      ......++..|+|||++.+...++.++||||||+++|+|++|.+||.........+....        ....... ....
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            123356788999999988765688999999999999999999988753322110000000        0000000 0000


Q ss_pred             hhhc-cCCCC-----cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 AMIL-GCGIE-----EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~~~~-~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..-. .....     ..+...+.++.+++.+||+.+|++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0000 00000     011123688999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.3e-39  Score=319.91  Aligned_cols=263  Identities=17%  Similarity=0.228  Sum_probs=187.5

Q ss_pred             HhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccC------cCccccEEEEEecC
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY------HINLVRLYGFCHDQ  147 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~  147 (406)
                      ....+|.+.++||+|+||+||+|.+ .+++.||||+++...  .....+..|+.++..++      |.+++++++++...
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            3456678889999999999999965 458899999996431  22334555666666554      45688999988764


Q ss_pred             -CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC----------
Q 015480          148 -HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----------  216 (406)
Q Consensus       148 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----------  216 (406)
                       ...++|||++ +++|.+++. ....+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++          
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~-~~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIM-KHGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccc
Confidence             5788999998 678888884 34679999999999999999999997  14999999999999998765          


Q ss_pred             ------CceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc
Q 015480          217 ------SPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL  290 (406)
Q Consensus       217 ------~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  290 (406)
                            .+||+|||++......     .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~  353 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH  353 (467)
T ss_pred             cCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                  4999999988643222     1346789999999999877 789999999999999999999999864332100


Q ss_pred             --------ccchhHHHHHHhhhhcchhh------ccCC-----------CCcchHHHHHHHHHHHHHhcccCCCCCCChH
Q 015480          291 --------DWFPKHVWEEYEKCELGAMI------LGCG-----------IEEKDKEKAKRLCMVALWCVQDSPEDRPPMS  345 (406)
Q Consensus       291 --------~~~~~~~~~~~~~~~~~~~~------~~~~-----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  345 (406)
                              ..++................      ....           ...........+.+|+.+||+.||.+|||+.
T Consensus       354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~  433 (467)
T PTZ00284        354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR  433 (467)
T ss_pred             HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence                    00000000000000000000      0000           0000011235678999999999999999999


Q ss_pred             HHHH
Q 015480          346 AVIK  349 (406)
Q Consensus       346 ~vl~  349 (406)
                      |+++
T Consensus       434 e~L~  437 (467)
T PTZ00284        434 QMTT  437 (467)
T ss_pred             HHhc
Confidence            9997

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.2e-38  Score=304.35  Aligned_cols=197  Identities=27%  Similarity=0.388  Sum_probs=168.1

Q ss_pred             HHhhhhhcccccccccceeEEEEE-EeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-c-----CccccEEEEEec
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-H-----INLVRLYGFCHD  146 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~  146 (406)
                      +....+|.+.+.||+|+||.|-+| +..+++.||||+++.+.  .-..+...|+.+|..|+ |     -|+|+++++|..
T Consensus       182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f  259 (586)
T KOG0667|consen  182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF  259 (586)
T ss_pred             ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence            334446677889999999999999 45779999999998753  34456677999999887 4     389999999999


Q ss_pred             CCeeEEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC--CceEecc
Q 015480          147 QHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF--SPKVADF  223 (406)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~--~~kl~Df  223 (406)
                      .++.|||+|.+.. +|.+++..+ -..++...+..++.||+.||.+||.   .+|||+||||+||||.+-+  .+||+||
T Consensus       260 r~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDF  335 (586)
T KOG0667|consen  260 RNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDF  335 (586)
T ss_pred             ccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEec
Confidence            9999999999955 999999654 4579999999999999999999999   9999999999999997543  6999999


Q ss_pred             ccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhccccc
Q 015480          224 GLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNA  282 (406)
Q Consensus       224 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~  282 (406)
                      |.+........     .+.-+..|.|||++.+. +|+.+.||||||||+.||++|.+.|
T Consensus       336 GSSc~~~q~vy-----tYiQSRfYRAPEVILGl-pY~~~IDmWSLGCIlAEL~tG~PLf  388 (586)
T KOG0667|consen  336 GSSCFESQRVY-----TYIQSRFYRAPEVILGL-PYDTAIDMWSLGCILAELFTGEPLF  388 (586)
T ss_pred             ccccccCCcce-----eeeeccccccchhhccC-CCCCccceeehhhhHHhHhcCcccc
Confidence            99987654433     24457799999999998 8999999999999999999997554

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9.4e-39  Score=298.93  Aligned_cols=247  Identities=26%  Similarity=0.364  Sum_probs=196.8

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|...+.||+|+||+||+|.. .+|+.||+|.+....  .......+.+|+++++.++||||+++++++.+....++|||
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   95 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME   95 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence            356677899999999999976 468999999986432  22334678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+. |++.+++......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......   
T Consensus        96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---  168 (307)
T cd06607          96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---  168 (307)
T ss_pred             hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence            997 57777776556679999999999999999999999   99999999999999999999999999998755432   


Q ss_pred             EEecCCCCCCCccCccccCC--CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          236 VTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                         ....++..|+|||++.+  ...++.++||||||+++|||++|..|+.......      .... ..        ...
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~-~~--------~~~  230 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH-IA--------QND  230 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHH-Hh--------cCC
Confidence               23457889999998742  2357889999999999999999999875332110      0000 00        000


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      .........+..+.+++.+||+.+|++||++.+|+..
T Consensus       231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0111123456789999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.2e-39  Score=293.98  Aligned_cols=253  Identities=27%  Similarity=0.369  Sum_probs=200.4

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccc-----hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-----RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      |...+.||+|+||.||+|.. .+|+.||+|++.....     ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            44567899999999999965 5689999999874321     12346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC-CceEeccccccccCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRN  232 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~DfGl~~~~~~~  232 (406)
                      +||+++++|.+++. ....+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++ .+||+|||++......
T Consensus        82 ~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          82 VEWMAGGSVSHLLS-KYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EeccCCCcHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            99999999999984 34578999999999999999999999   9999999999999998776 5999999999766433


Q ss_pred             CceE--EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          233 KTHV--TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       233 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      ....  ......|+..|+|||.+.+. .++.++||||+|+++|+|++|..|+.........       ....     ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~-----~~~  224 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL-------ALIF-----KIA  224 (268)
T ss_pred             cccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH-------HHHH-----HHh
Confidence            2111  11234578899999998776 6899999999999999999999988533221100       0000     000


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ........+...+..+.+++.+||..+|++||++.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            111123344567788999999999999999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=9e-39  Score=296.60  Aligned_cols=244  Identities=24%  Similarity=0.285  Sum_probs=198.2

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||.||++.+. +++.||+|++....  .....+.+.+|++++++++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            3567788999999999999764 58999999987532  22345678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++......   
T Consensus        82 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---  154 (290)
T cd05580          82 YVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---  154 (290)
T ss_pred             cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence            9999999999843 4678999999999999999999999   99999999999999999999999999999866543   


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        .....|++.|+|||.+.+. ..+.++||||||+++|+|++|..||.....       ..........          .
T Consensus       155 --~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~----------~  214 (290)
T cd05580         155 --TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILEG----------K  214 (290)
T ss_pred             --CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcC----------C
Confidence              1234688999999998776 688999999999999999999998753321       1111111110          0


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                      ...+...+..+.+++.+||..||.+|+     ++.++++
T Consensus       215 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         215 VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            112233467889999999999999999     6666654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.7e-39  Score=300.69  Aligned_cols=256  Identities=21%  Similarity=0.263  Sum_probs=199.9

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||.||++... +++.|++|.+.....  ......+..|++++..++||||+++++.+.++...++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            3566788999999999999764 578999999875422  2234578899999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++++|.+++.. ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++........
T Consensus        82 ~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          82 YVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            9999999999943 4578999999999999999999999   99999999999999999999999999998642211000


Q ss_pred             -------------EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHh
Q 015480          236 -------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE  302 (406)
Q Consensus       236 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  302 (406)
                                   .......++..|+|||.+.+. .++.++|+||||+++|||++|..||......       .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-------~~~~~~~  229 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------ELFGQVI  229 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHH
Confidence                         011124578899999998876 6899999999999999999999988532111       1111111


Q ss_pred             hhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                      ....       .........+..+.+++.+||+.||++||+..++.+.|+.
T Consensus       230 ~~~~-------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         230 SDDI-------EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             hccc-------CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            1100       0111112456779999999999999999998777777765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-39  Score=300.89  Aligned_cols=252  Identities=21%  Similarity=0.250  Sum_probs=199.8

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccch--hhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR--IAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|+..+.||+|+||.||+|... +++.||+|.+......  .....+..|++++..++||||+++++.+.+....++|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            3566788999999999999764 4899999999764322  244678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          156 YMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       156 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      |+.+++|.+++... ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            99999999998543 4678999999999999999999999   9999999999999999999999999999875432211


Q ss_pred             e---------------------------EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCC
Q 015480          235 H---------------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGAT  287 (406)
Q Consensus       235 ~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~  287 (406)
                      .                           .......|+..|+|||++.+. .++.++||||||+++|+|++|..||.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            0                           011234678899999999876 689999999999999999999999853321


Q ss_pred             cccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCC----hHHHHH
Q 015480          288 ESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPP----MSAVIK  349 (406)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~~vl~  349 (406)
                      .       .......        ............+..+.+++.+||+.||++||+    +++++.
T Consensus       238 ~-------~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 D-------ETFSNIL--------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             H-------HHHHHHh--------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            1       0000000        000001111226788999999999999999999    777666

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.1e-39  Score=294.45  Aligned_cols=247  Identities=23%  Similarity=0.256  Sum_probs=201.2

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      |.+.+.||.|+||.||+|... ++..||+|++....  .....+.+.+|++++++++||||+++++++.+....++|+||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            567788999999999999764 58999999997542  223457889999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +.+++|.+++... ..+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++........  
T Consensus        82 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--  155 (258)
T cd05578          82 LLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--  155 (258)
T ss_pred             CCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc--
Confidence            9999999998443 688999999999999999999999   9999999999999999999999999999976544321  


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                       .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..|+........    ........         . ...
T Consensus       156 -~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~---------~-~~~  219 (258)
T cd05578         156 -TTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQE---------T-ADV  219 (258)
T ss_pred             -ccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhc---------c-ccc
Confidence             2235688899999998876 689999999999999999999999865433211    11111000         0 112


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCCh--HHHH
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPM--SAVI  348 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~~vl  348 (406)
                      ..+...+..+.+++.+||+.||.+||++  ++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            2333456889999999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-39  Score=294.28  Aligned_cols=251  Identities=25%  Similarity=0.358  Sum_probs=197.7

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCC------e
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQH------M  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------~  149 (406)
                      .+|.+.+.||+|+||.||+|... +++.+++|++....  ...+.+.+|+.+++++ .|+||+++++++.+..      .
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            45677889999999999999774 57899999987542  2456789999999999 6999999999997644      4


Q ss_pred             eEEEEEeccCCChhhHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccc
Q 015480          150 TALVYEYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  226 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~  226 (406)
                      .++||||+++++|.+++...   +..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccc
Confidence            89999999999999988532   4678999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCceEEecCCCCCCCccCccccCCC----CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHh
Q 015480          227 KLCDRNKTHVTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE  302 (406)
Q Consensus       227 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  302 (406)
                      .........  .....|+..|+|||.+...    ..++.++||||||+++|+|++|..||......      .. .....
T Consensus       161 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~-~~~~~  231 (275)
T cd06608         161 AQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RA-LFKIP  231 (275)
T ss_pred             eecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HH-HHHhh
Confidence            765432221  2235688899999987532    24678999999999999999999998532111      00 00000


Q ss_pred             hhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...       ..........+..+.+++.+||..||++|||+.++++
T Consensus       232 ~~~-------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 RNP-------PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ccC-------CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            000       0001122346678999999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.1e-39  Score=296.46  Aligned_cols=250  Identities=25%  Similarity=0.342  Sum_probs=195.1

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEec------CCe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHD------QHM  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~~  149 (406)
                      ..|.+.+.||+|+||.||+|.+ .+++.+|+|++...  ......+..|+.++.++ +||||+++++++..      ...
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            4566678899999999999976 56889999998653  23445688899999998 69999999999853      457


Q ss_pred             eEEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      .+++|||+++|+|.+++... ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++..
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            89999999999999998543 4568888999999999999999999   9999999999999999999999999999875


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCC----CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhh
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC  304 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (406)
                      ......  ......|+..|+|||.+..    ...++.++|||||||++|||++|..||.......          .... 
T Consensus       171 ~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~----------~~~~-  237 (282)
T cd06636         171 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR----------ALFL-  237 (282)
T ss_pred             hhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh----------hhhh-
Confidence            532211  1123568889999998753    2257889999999999999999999985322110          0000 


Q ss_pred             hcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       .   ............++..+.+++.+||+.||.+||++.++++
T Consensus       238 -~---~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 -I---PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -H---hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence             0   0011111122345678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.5e-38  Score=290.75  Aligned_cols=253  Identities=26%  Similarity=0.370  Sum_probs=200.1

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |...+.||+|+||.||+|.. .+++.|++|.++.... ......+..|+.+++.++|+||+++++++.+.+..++|+||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            56678899999999999975 4689999999875433 235678999999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++...........
T Consensus        82 ~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          82 SGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             CCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            99999999843 4568899999999999999999999   9999999999999999999999999999986654332211


Q ss_pred             --ecCCCCCCCccCccccCCCC--CCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          238 --ISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       238 --~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                        .....++..|+|||.+.+..  ..+.++||||||+++|+|++|+.||......         +........    ...
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---------~~~~~~~~~----~~~  224 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---------FQIMFHVGA----GHK  224 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---------HHHHHHHhc----CCC
Confidence              12346788999999987652  3789999999999999999999998532211         000000000    000


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .........+..+.+++.+||+.+|.+||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            001111223677889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.6e-39  Score=296.95  Aligned_cols=264  Identities=21%  Similarity=0.282  Sum_probs=196.7

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |+..+.||.|+||.||+|+.. +|+.||||.+..+.. ......+..|++++++++||||+++++++.+....++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            456778999999999999764 689999999875322 223457889999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          158 ENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       158 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      . ++|.+++... ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++......... 
T Consensus        82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~-  156 (284)
T cd07860          82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-  156 (284)
T ss_pred             c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-
Confidence            6 5888888543 4678999999999999999999999   99999999999999999999999999998755432211 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc--------chhHHHHHHhhhhcch
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW--------FPKHVWEEYEKCELGA  308 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~  308 (406)
                       .....++..|+|||.+.+...++.++||||||+++|||++|+.||..........        .....+..........
T Consensus       157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence             1233468899999988765457889999999999999999999885432110000        0000000000000000


Q ss_pred             hhc----cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 MIL----GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...    ...........+..+.+++.+||+.||++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000    00000111234567889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.5e-39  Score=296.93  Aligned_cols=264  Identities=23%  Similarity=0.311  Sum_probs=199.1

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      |...++||.|++|.||+|+.. +|..||+|+++..........+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD   81 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence            566788999999999999774 5899999999765443445677889999999999999999999999999999999998


Q ss_pred             CCChhhHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          159 NGSLDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       159 ~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      + +|.+++....  ..+++..+..++.|++.||+|||+   .+++||||+|+||++++++.++|+|||++......... 
T Consensus        82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~-  156 (284)
T cd07836          82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-  156 (284)
T ss_pred             c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc-
Confidence            5 8888875433  568999999999999999999999   99999999999999999999999999999755432211 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc--------chhHHHHHHhhhhcch
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW--------FPKHVWEEYEKCELGA  308 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~  308 (406)
                       .....++..|++||.+.+...++.++||||||+++|+|++|..||..........        .....++.........
T Consensus       157 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         157 -FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             -cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence             1234568899999998765567899999999999999999999886433211000        0000011111000000


Q ss_pred             hhccC----CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 MILGC----GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .....    .........+..+.+++..|++.||.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000    000111234677899999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.2e-38  Score=291.17  Aligned_cols=251  Identities=27%  Similarity=0.390  Sum_probs=204.3

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      +.+.+.||+|++|.||+|... +|+.|++|++...........+..|+..+..++|+|++++++++......++||||++
T Consensus         3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06623           3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD   82 (264)
T ss_pred             ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence            556788999999999999775 5999999998865443456789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      +++|.+++.. ...+++..+..++.|+++||+|||+  ..+++|+||+|+||+++.++.++|+|||++..........  
T Consensus        83 ~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~--  157 (264)
T cd06623          83 GGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--  157 (264)
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc--
Confidence            9999999943 3678999999999999999999996  2799999999999999999999999999998664333221  


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ....++..|+|||.+.+. .++.++|+||||+++|+|++|..|+......  .+     .+....      .........
T Consensus       158 ~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~-----~~~~~~------~~~~~~~~~  223 (264)
T cd06623         158 NTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQP--SF-----FELMQA------ICDGPPPSL  223 (264)
T ss_pred             cceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccccc--CH-----HHHHHH------HhcCCCCCC
Confidence            234578899999998876 7899999999999999999999998544321  00     011100      001111222


Q ss_pred             hHH-HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          319 DKE-KAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       319 ~~~-~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ... .+..+.+++..||+.+|++||++.++++
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             CcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            333 6788999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-39  Score=305.09  Aligned_cols=274  Identities=21%  Similarity=0.286  Sum_probs=200.3

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecC-----CeeE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-----HMTA  151 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  151 (406)
                      ..|.+.+.||+|+||.||+|.. .+|+.||+|++...........+.+|+.++++++||||+++++++...     ...+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            3567788999999999999965 568999999987533334556788999999999999999999987654     3578


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +++||+.+ +|.+++  ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        85 lv~e~~~~-~l~~~~--~~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          85 IVQELMET-DLYKLI--KTQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             EEehhccc-CHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            99999965 888777  34579999999999999999999999   9999999999999999999999999999976543


Q ss_pred             CCceE-EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc-----cch---hHHHHHHh
Q 015480          232 NKTHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD-----WFP---KHVWEEYE  302 (406)
Q Consensus       232 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-----~~~---~~~~~~~~  302 (406)
                      ..... ......|+..|+|||.+.+...++.++|||||||++|+|++|+.||.........     .+.   ...+....
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            22111 1123568899999998765546899999999999999999999988532210000     000   00000000


Q ss_pred             hhhcchhhc----cCCCC--cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH--hhccccC
Q 015480          303 KCELGAMIL----GCGIE--EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM--LEGVVEV  357 (406)
Q Consensus       303 ~~~~~~~~~----~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~--L~~~~~~  357 (406)
                      .........    ....+  ......+.++.+++.+||+.+|.+|||+.++++.  ++.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence            000000000    00000  0112345779999999999999999999999984  6665543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-38  Score=294.30  Aligned_cols=243  Identities=23%  Similarity=0.276  Sum_probs=188.2

Q ss_pred             cccccceeEEEEEEe-CCCcEEEEEEeccccch--hhHHHHHHHHHH---hhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           85 RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGR--IAEEQFMAEVGT---IGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~--~~~~~~~~e~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      .||+|+||.||++.. .+|+.+|+|.+.+....  .....+..|..+   +...+|||++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999976 45899999998754221  122333444433   334579999999999999999999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      +++|.+++. ....+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++........    
T Consensus        81 ~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~----  152 (279)
T cd05633          81 GGDLHYHLS-QHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----  152 (279)
T ss_pred             CCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc----
Confidence            999999884 44579999999999999999999999   9999999999999999999999999999875433221    


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ....|+..|+|||.+.+...++.++|||||||++|||++|..||.........        .......      ......
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--------~~~~~~~------~~~~~~  218 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------EIDRMTL------TVNVEL  218 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--------HHHHHhh------cCCcCC
Confidence            23468999999999865446889999999999999999999998643322111        0000000      001122


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          319 DKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       319 ~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                      +...+..+.+++.+||+.||++||     +++++++
T Consensus       219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            344667899999999999999999     5888877

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=299.65  Aligned_cols=266  Identities=20%  Similarity=0.247  Sum_probs=196.5

Q ss_pred             hcccccccccceeEEEEEEeC---CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecC--CeeEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP---NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTAL  152 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~---~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  152 (406)
                      |.+.+.||+|+||.||+|...   ++..||+|.+....  .......+.+|+.++..++||||+++++++.+.  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            566788999999999999764   47899999998632  122346678899999999999999999999988  88999


Q ss_pred             EEEeccCCChhhHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC----CCCceEeccc
Q 015480          153 VYEYMENGSLDGYLFGK----KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA----NFSPKVADFG  224 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~----~~~~kl~DfG  224 (406)
                      ||||+++ +|.+++...    ...+++..+..++.|++.||+|||+   .+++||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999975 676666321    2368999999999999999999999   99999999999999999    8999999999


Q ss_pred             cccccCCCCc-eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccch--hHHHHHH
Q 015480          225 LAKLCDRNKT-HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP--KHVWEEY  301 (406)
Q Consensus       225 l~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~--~~~~~~~  301 (406)
                      ++........ ........++..|+|||.+.+...++.++||||||+++|+|++|++||...........+  .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9986543322 112234567889999998876556899999999999999999999998644332210000  0000000


Q ss_pred             ---------------hhh-hcch---hhccCCCC--cchH------HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          302 ---------------EKC-ELGA---MILGCGIE--EKDK------EKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       302 ---------------~~~-~~~~---~~~~~~~~--~~~~------~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                                     ... ....   ........  ....      ..+..+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                           000 0000   00000000  0000      33457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.9e-38  Score=289.83  Aligned_cols=243  Identities=26%  Similarity=0.348  Sum_probs=195.6

Q ss_pred             ccccceeEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCCh
Q 015480           86 LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  162 (406)
Q Consensus        86 ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  162 (406)
                      ||.|+||.||++... +++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999774 489999999975432  23457799999999999999999999999999999999999999999


Q ss_pred             hhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCC
Q 015480          163 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK  242 (406)
Q Consensus       163 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~  242 (406)
                      .+++.. ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........   .....
T Consensus        81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~~~~  153 (262)
T cd05572          81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFC  153 (262)
T ss_pred             HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---ccccc
Confidence            999943 4568999999999999999999999   9999999999999999999999999999986654321   12345


Q ss_pred             CCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHH
Q 015480          243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK  322 (406)
Q Consensus       243 gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (406)
                      |+..|+|||.+.+. .++.++|+||||+++|+|++|..|+.....+.     ........        ........+...
T Consensus       154 ~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~--------~~~~~~~~~~~~  219 (262)
T cd05572         154 GTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-----MEIYNDIL--------KGNGKLEFPNYI  219 (262)
T ss_pred             CCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-----HHHHHHHh--------ccCCCCCCCccc
Confidence            78899999998766 68999999999999999999999986543211     00011100        001112222333


Q ss_pred             HHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 015480          323 AKRLCMVALWCVQDSPEDRPP-----MSAVIK  349 (406)
Q Consensus       323 ~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  349 (406)
                      +..+.+++.+||+.+|++||+     +.|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            678999999999999999999     666665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.2e-39  Score=299.82  Aligned_cols=245  Identities=21%  Similarity=0.330  Sum_probs=195.9

Q ss_pred             cccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCC
Q 015480           83 STRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  161 (406)
                      ...||+|+||.||++.. .+++.||+|++..... ...+.+.+|+.++..++|||++++++++..++..++|+||+++++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            34699999999999966 4689999999865422 345678899999999999999999999999999999999999999


Q ss_pred             hhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCC
Q 015480          162 LDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY  241 (406)
Q Consensus       162 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~  241 (406)
                      |..++.  ...+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.+||+|||++.........  ....
T Consensus       105 L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~  177 (297)
T cd06659         105 LTDIVS--QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSL  177 (297)
T ss_pred             HHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccce
Confidence            998773  3568999999999999999999999   99999999999999999999999999998755433221  1235


Q ss_pred             CCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHH
Q 015480          242 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKE  321 (406)
Q Consensus       242 ~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (406)
                      .|+..|+|||.+.+. .++.++|||||||++|||++|..||.......       .........       .........
T Consensus       178 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~-------~~~~~~~~~  242 (297)
T cd06659         178 VGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------AMKRLRDSP-------PPKLKNAHK  242 (297)
T ss_pred             ecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhccC-------CCCccccCC
Confidence            688999999999876 68999999999999999999999985332110       000110000       000111123


Q ss_pred             HHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          322 KAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       322 ~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      .+..+.+++.+||+.+|.+||++.++++.
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            45678999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=335.46  Aligned_cols=251  Identities=27%  Similarity=0.360  Sum_probs=205.6

Q ss_pred             hcccccccccceeEEEEEE-eCCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~-~~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      +.-...||.|.||.||-|. ..+|+..|+|-++-.. .......+.+|+.++..++|||+|+++|+-.+++..+|-||||
T Consensus      1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred             eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence            3445679999999999995 5679999999886322 2334467889999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce--
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH--  235 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~--  235 (406)
                      ++|+|.+.+ ...+..++.....+..|++.|+.|||.   +|||||||||+||+|+.+|.+|++|||.|.....+...  
T Consensus      1317 ~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1317 EGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             ccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence            999999998 455566777777888999999999999   99999999999999999999999999999877655311  


Q ss_pred             EEecCCCCCCCccCccccCCCC--CCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      .......||+.|||||++.+..  +...++||||+||++.||+||++||..-...         |.      +...+..+
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---------~a------IMy~V~~g 1457 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---------WA------IMYHVAAG 1457 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---------hH------HHhHHhcc
Confidence            1234567999999999997652  5678999999999999999999998532221         22      22223334


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..+..+...+.+-.+++.+||..||+.|+++.|+++
T Consensus      1458 h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1458 HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            446666678899999999999999999999988876

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.5e-38  Score=294.77  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=194.2

Q ss_pred             cccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEEEecc
Q 015480           81 NYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      ...+.||+|+||.||++.. .+|+.||+|.+...........+.+|+.++.++. ||||+++++++.++...+++|||+.
T Consensus         7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~   86 (288)
T cd06616           7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD   86 (288)
T ss_pred             HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence            3456799999999999965 4589999999876544445667889999999996 9999999999999999999999986


Q ss_pred             CCChhhHh---h-cCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          159 NGSLDGYL---F-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       159 ~g~L~~~l---~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      . ++.++.   . .....+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.+||+|||++........
T Consensus        87 ~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  163 (288)
T cd06616          87 I-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA  163 (288)
T ss_pred             C-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence            4 665543   2 234679999999999999999999997  25999999999999999999999999999976543322


Q ss_pred             eEEecCCCCCCCccCccccCCC--CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          235 HVTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      .   ....|+..|+|||.+.+.  ..++.++|||||||++|||++|+.||.....         ..+.........  ..
T Consensus       164 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------~~~~~~~~~~~~--~~  229 (288)
T cd06616         164 K---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---------VFDQLTQVVKGD--PP  229 (288)
T ss_pred             c---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---------HHHHHhhhcCCC--CC
Confidence            1   223578899999998765  3688999999999999999999999753320         011111000000  00


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..........+..+.+++.+||+.+|++|||+++|++
T Consensus       230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0001112346778999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.6e-38  Score=294.26  Aligned_cols=248  Identities=25%  Similarity=0.352  Sum_probs=200.0

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      |...+.||+|+||.||+|.+. ++..|++|++.....  ....+..|+++++.++|+|++++++++......++++||++
T Consensus        21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   98 (286)
T cd06614          21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD   98 (286)
T ss_pred             chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence            455677999999999999775 688999999976432  45678899999999999999999999999999999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      +++|.+++......+++..+..++.|++.||.|||+   .|++|+||+|+||+++.++.++|+|||++.........  .
T Consensus        99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~  173 (286)
T cd06614          99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--R  173 (286)
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh--h
Confidence            999999996554589999999999999999999999   99999999999999999999999999998755433211  1


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ....++..|+|||.+.+. .++.++|+||||+++|+|++|..|+.......       ........       .......
T Consensus       174 ~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-------~~~~~~~~-------~~~~~~~  238 (286)
T cd06614         174 NSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-------ALFLITTK-------GIPPLKN  238 (286)
T ss_pred             ccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhc-------CCCCCcc
Confidence            223478899999998876 68999999999999999999998875322110       00000000       0000111


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       319 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....+..+.+++.+||+.+|.+||++.++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            2235678999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.1e-39  Score=298.53  Aligned_cols=245  Identities=22%  Similarity=0.335  Sum_probs=195.1

Q ss_pred             cccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCC
Q 015480           83 STRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  161 (406)
                      ...||+|+||.||++.. .++..||||.+... .....+.+.+|+.+++.++||||+++++.+...+..++||||+++++
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecc-hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            35699999999999965 46889999998653 22345678899999999999999999999999999999999999999


Q ss_pred             hhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCC
Q 015480          162 LDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY  241 (406)
Q Consensus       162 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~  241 (406)
                      |.+++.  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.........  ....
T Consensus       106 L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~  178 (292)
T cd06658         106 LTDIVT--HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSL  178 (292)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--Ccee
Confidence            999883  3468999999999999999999999   99999999999999999999999999998754332211  1224


Q ss_pred             CCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHH
Q 015480          242 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKE  321 (406)
Q Consensus       242 ~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (406)
                      .|+..|+|||.+.+. .++.++||||||+++|||++|..||......       ........ .     .... ......
T Consensus       179 ~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~-~-----~~~~-~~~~~~  243 (292)
T cd06658         179 VGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-------QAMRRIRD-N-----LPPR-VKDSHK  243 (292)
T ss_pred             ecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh-c-----CCCc-cccccc
Confidence            578899999998766 6889999999999999999999987532211       00001000 0     0000 111123


Q ss_pred             HHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          322 KAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       322 ~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      .+..+.+++..||..||.+|||+.++++.
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            45678899999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-39  Score=295.75  Aligned_cols=265  Identities=22%  Similarity=0.249  Sum_probs=198.6

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecC--CeeEEEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTALVYE  155 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  155 (406)
                      |.+.+.||+|+||.||+|... +|+.+|+|++.... .......+.+|+++++.++|||++++++++.+.  ...++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            345678999999999999765 48899999998653 223446788999999999999999999999888  89999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++ +|.+++......+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            9975 8988886555689999999999999999999999   99999999999999999999999999999866544321


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccc--------hhHHHHHHhhhhcc
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWF--------PKHVWEEYEKCELG  307 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~  307 (406)
                       ......++..|+|||.+.+...++.++||||||+++|||++|..|+...........        ....|.........
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         157 -DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             -cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence             122345678899999877654689999999999999999999998854332100000        00000000000000


Q ss_pred             hhh-ccCC----CCcchHH-HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 AMI-LGCG----IEEKDKE-KAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~~~-~~~~----~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ... ....    ....... ++..+.+++.+||+.+|.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            000 0000    0001111 2678999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.2e-38  Score=294.41  Aligned_cols=249  Identities=21%  Similarity=0.307  Sum_probs=199.6

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      .+|.+.+.||+|+||.||++.. .++..||+|.+.... ....+.+..|+.+++.++|||++++++++...+..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            4567778899999999999965 468899999986432 23456788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +++++|.+++.  ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......... 
T Consensus        98 ~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-  171 (293)
T cd06647          98 LAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  171 (293)
T ss_pred             CCCCcHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-
Confidence            99999999984  3457899999999999999999999   99999999999999999999999999998755433221 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                       .....|++.|+|||.+... .++.++|+||||+++|++++|..||...........      ...        ......
T Consensus       172 -~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~--------~~~~~~  235 (293)
T cd06647         172 -RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IAT--------NGTPEL  235 (293)
T ss_pred             -cccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhc--------CCCCCC
Confidence             1234588899999998766 689999999999999999999999854322111000      000        000011


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ......+..+.+++.+||..+|++||++.+++.
T Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  268 (293)
T cd06647         236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  268 (293)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            122335567899999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.1e-38  Score=285.92  Aligned_cols=248  Identities=27%  Similarity=0.429  Sum_probs=201.7

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      |...+.||+|++|.||++... +|..+++|++..... .....+.+|+++++.++|+|++++++++..+...++++||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            455678999999999999774 688999999976533 355788999999999999999999999999999999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      +++|.+++......+++..+..++.|++.||.|||.   .+++|+||+|+||++++++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            999999986655689999999999999999999999   9999999999999999999999999999976654432   2


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ....++..|+|||.+.+. ..+.++|+||||+++|+|++|..|+.......       .......       ........
T Consensus       155 ~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~-------~~~~~~~~  219 (253)
T cd05122         155 NTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMK-------ALFKIAT-------NGPPGLRN  219 (253)
T ss_pred             cceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHHHh-------cCCCCcCc
Confidence            235578899999998876 58899999999999999999999875432110       0000000       00000111


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       319 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....+..+.+++.+||+.||++|||+.++++
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1223678999999999999999999999876

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=311.40  Aligned_cols=267  Identities=25%  Similarity=0.370  Sum_probs=205.4

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC------eeEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH------MTAL  152 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~l  152 (406)
                      +...+.||+|+||.||+|++ .+|+.||||.++........+...+|+++|++++|||||+++++-.+..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            34457799999999999985 5699999999998777777889999999999999999999999865543      5679


Q ss_pred             EEEeccCCChhhHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc--CCC--CceEeccccc
Q 015480          153 VYEYMENGSLDGYLFG--KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANF--SPKVADFGLA  226 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~--~~kl~DfGl~  226 (406)
                      |||||.||+|+..+..  +...+++...+.++.+++.||.|||.   ++|+||||||.||++-  ++|  ..||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999965  34679999999999999999999999   9999999999999993  334  4799999999


Q ss_pred             cccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhc
Q 015480          227 KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCEL  306 (406)
Q Consensus       227 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (406)
                      +..+.+.   ......||..|++||.......++..+|.|||||++|++.||..||.....+....  ...|........
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~--~~~~~~~tkkp~  246 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK--EIMWHIITKKPS  246 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc--hhhhhhhccCCC
Confidence            9887665   34568899999999999854489999999999999999999999997655442110  011111111100


Q ss_pred             c----hh-------hccCCCC---cchHHHHHHHHHHHHHhcccCCCCCC--ChHHHHHHhhcc
Q 015480          307 G----AM-------ILGCGIE---EKDKEKAKRLCMVALWCVQDSPEDRP--PMSAVIKMLEGV  354 (406)
Q Consensus       307 ~----~~-------~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RP--s~~~vl~~L~~~  354 (406)
                      .    ..       ......+   .........+-.++..+|..+|.+|.  ...+....+..+
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            0    00       0000111   12234455667788888999999998  666666655554

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-39  Score=324.30  Aligned_cols=266  Identities=28%  Similarity=0.385  Sum_probs=216.0

Q ss_pred             hHHHhhhhhcccccccccceeEEEEEEeC----C----CcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEE
Q 015480           72 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP----N----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYG  142 (406)
Q Consensus        72 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~  142 (406)
                      .+++......+.+.||+|.||.|++|...    .    ...||||.++........+.+..|+++|..+. |+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34555555566779999999999999642    1    45789999998776677889999999999995 999999999


Q ss_pred             EEecCCeeEEEEEeccCCChhhHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCC
Q 015480          143 FCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP  207 (406)
Q Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~  207 (406)
                      +|..+...++|+||+..|+|.+++..++               ..++...++.+++|||.|++||++   .+++||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhh
Confidence            9999999999999999999999996655               348999999999999999999999   9999999999


Q ss_pred             CcEEEcCCCCceEeccccccccCCCCceEEe-cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCC
Q 015480          208 ENVLLDANFSPKVADFGLAKLCDRNKTHVTI-SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGA  286 (406)
Q Consensus       208 ~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~  286 (406)
                      +|||+..+..+||+|||+++........... +...-+..|||||.+... .++.++||||||++||||+|...+...+.
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~-~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR-VFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC-cccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            9999999999999999999976655444321 111134579999999985 89999999999999999998554332221


Q ss_pred             CcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          287 TESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      ..     ...         +...+..+.+.+.+..++.++++++..||+.+|++||++.++.+.++...
T Consensus       526 ~~-----~~~---------l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  526 PP-----TEE---------LLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             Cc-----HHH---------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            10     111         11233444556677788999999999999999999999999999998853

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.6e-38  Score=296.31  Aligned_cols=250  Identities=26%  Similarity=0.351  Sum_probs=197.8

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      |...+.||+|+||.||+++. .+|..||+|.+....  .......+..|+++++.++|||++++++++.++...++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            44567799999999999976 468899999986432  223346788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +.+ +|.+.+......+++.++..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......    
T Consensus       107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----  178 (317)
T cd06635         107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----  178 (317)
T ss_pred             CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence            975 8878776666779999999999999999999999   99999999999999999999999999998654322    


Q ss_pred             EecCCCCCCCccCccccCC--CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          237 TISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                        ....|+..|+|||.+..  ...++.++|||||||++|||++|..|+......       ........        ...
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~--------~~~  241 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQ--------NES  241 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHh--------ccC
Confidence              23457889999998742  225789999999999999999999987532110       00011100        011


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      ........+..+.+++.+||+.+|.+||++.++++.+-..
T Consensus       242 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         242 PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence            1112234566799999999999999999999999865444

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.9e-38  Score=285.83  Aligned_cols=251  Identities=25%  Similarity=0.348  Sum_probs=203.9

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecC--CeeEEEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTALVYE  155 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  155 (406)
                      |...+.||+|++|.||+|... +|..|++|++..... ....+.+.+|++.+++++||||+++++.+.+.  ...++++|
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            445678999999999999775 689999999875432 23467889999999999999999999999988  89999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++++|.+++... ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        82 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          82 YVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            99999999998544 389999999999999999999999   99999999999999999999999999999876654331


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                      .......++..|+|||.+.+. ..+.++||||||+++|+|++|..|+......     ....+.         .......
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~---------~~~~~~~  222 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYK---------IGSSGEP  222 (260)
T ss_pred             ccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHh---------ccccCCC
Confidence            112335688899999998876 5899999999999999999999998544310     000000         0011112


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...+...+..+.+++.+|++.||++||++.+++.
T Consensus       223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            2333445788999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.4e-38  Score=296.83  Aligned_cols=265  Identities=22%  Similarity=0.247  Sum_probs=197.0

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCC------
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH------  148 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  148 (406)
                      ...|.+.+.||+|+||.||+|... +|+.||+|.++.... ......+.+|+.+++.++|||++++++++.+..      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            345667889999999999999774 589999999975422 233456788999999999999999999987654      


Q ss_pred             ----eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccc
Q 015480          149 ----MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  224 (406)
Q Consensus       149 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfG  224 (406)
                          ..++|+||+++ ++.+++......+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~dfg  161 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFG  161 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCccc
Confidence                78999999976 7777775555679999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHH----
Q 015480          225 LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEE----  300 (406)
Q Consensus       225 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~----  300 (406)
                      ++......... ......++..|+|||.+.+...++.++|||||||++|||++|++|+.......  .+ ......    
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~-~~~~~~~~~~  237 (302)
T cd07864         162 LARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QL-ELISRLCGSP  237 (302)
T ss_pred             ccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HH-HHHHHHhCCC
Confidence            99765433221 11223457789999988765467899999999999999999998885432110  00 000000    


Q ss_pred             -------Hhhhhcchhhc-c----CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          301 -------YEKCELGAMIL-G----CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       301 -------~~~~~~~~~~~-~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                             ........... .    ..........+..+.+++..||+.||.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   00000000000 0    0000111124677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=293.91  Aligned_cols=263  Identities=23%  Similarity=0.320  Sum_probs=197.0

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |.+.+.||+|+||+||+|... +++.|+||.+.............+|+..+.+++ |||++++++++.++...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            356778999999999999875 588999999876543333445567999999999 999999999999999999999999


Q ss_pred             cCCChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          158 ENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       158 ~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                       +|+|.+++.... ..+++..+..++.|++.+|.|||+   .+++|+||+|+||++++++.++|+|||++........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             779998885543 578999999999999999999999   9999999999999999999999999999976543322  


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc--------cchhHHHHH-Hhhhhcc
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD--------WFPKHVWEE-YEKCELG  307 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~-~~~~~~~  307 (406)
                       .....++..|+|||.+.+...++.++|+||||+++|||++|+.||.........        ......|.. .......
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence             123457889999998866556899999999999999999999887443221000        000000000 0000000


Q ss_pred             hhhccCCC----CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 AMILGCGI----EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ........    .......+..+.+++.+||+.||++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000000    0001122467999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.1e-38  Score=290.28  Aligned_cols=248  Identities=22%  Similarity=0.339  Sum_probs=198.2

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |.+.+.||+|+||.||+|... +|..+|+|.+.... .....+.+.+|+.+++.++|+||+++++.+.+....++|+||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            456788999999999999764 58899999986531 2234567889999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC-ceEeccccccccCCCCce
Q 015480          158 ENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS-PKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       158 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-~kl~DfGl~~~~~~~~~~  235 (406)
                      ++++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++. +||+|||.+.........
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~  158 (257)
T cd08225          82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL  158 (257)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence            999999998543 3458999999999999999999999   99999999999999998864 699999999766433221


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        .....|+..|+|||.+.+. .++.++|+||||+++|||++|..|+.....      ....... .         ....
T Consensus       159 --~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~---------~~~~  219 (257)
T cd08225         159 --AYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKI-C---------QGYF  219 (257)
T ss_pred             --ccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH-h---------cccC
Confidence              1234588899999998766 688999999999999999999988743211      0111110 0         1111


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .......+..+.+++.+||+.+|++|||+.++++
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            2223345567999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.2e-38  Score=294.49  Aligned_cols=264  Identities=21%  Similarity=0.245  Sum_probs=187.2

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeCC----CcEEEEEEeccccchhhH----------HHHHHHHHHhhccCcCcccc
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAE----------EQFMAEVGTIGRTYHINLVR  139 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~----------~~~~~e~~~l~~l~h~niv~  139 (406)
                      ++....|.+.++||+|+||+||+|.+.+    +..+|+|+..........          .....+...+..+.|+|+++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            3445678888999999999999997644    456677764422111111          11233445566778999999


Q ss_pred             EEEEEecCC----eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC
Q 015480          140 LYGFCHDQH----MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN  215 (406)
Q Consensus       140 ~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~  215 (406)
                      +++++....    ..+++++++.. ++.+.+. .....++..+..++.|++.||+|||+   .+++||||||+|||++.+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGN  162 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhcc-CHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCC
Confidence            999875543    34678888744 6666663 23346788899999999999999999   999999999999999999


Q ss_pred             CCceEeccccccccCCCCce-----EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc
Q 015480          216 FSPKVADFGLAKLCDRNKTH-----VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL  290 (406)
Q Consensus       216 ~~~kl~DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  290 (406)
                      +.++|+|||+++........     .......||+.|+|||++.+. .++.++|||||||++|||++|..||........
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            99999999999865432211     111234699999999999877 789999999999999999999999965422111


Q ss_pred             ccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          291 DWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                      . .... .     ......+....  .....+++.+.+++..|++.+|++||+++++++.|+
T Consensus       242 ~-~~~~-~-----~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 L-IHAA-K-----CDFIKRLHEGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             H-HHHh-H-----HHHHHHhhhhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            0 0000 0     00000011110  011234678999999999999999999999998774

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.1e-38  Score=298.68  Aligned_cols=266  Identities=23%  Similarity=0.266  Sum_probs=196.9

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecC--CeeEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTALV  153 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  153 (406)
                      ..|++.+.||+|+||.||+|.. .+|+.||+|.++.... ......+.+|+.++.+++|+||+++++++.+.  +..++|
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            3466778899999999999976 4689999999874322 12234567899999999999999999998765  568999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+.+ +|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999965 8888886656789999999999999999999999   999999999999999999999999999998665432


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc--------chhHHHHHHhhhh
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW--------FPKHVWEEYEKCE  305 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~  305 (406)
                      ..  .....++..|+|||.+.+...++.++|||||||++|||++|..||..........        .....|.......
T Consensus       163 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         163 KP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             CC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence            11  1223457789999998765568999999999999999999999885332110000        0000000000000


Q ss_pred             c-chhhcc-CCCC---cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          306 L-GAMILG-CGIE---EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       306 ~-~~~~~~-~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      . ...... ....   ......+..+.+++.+||+.||++|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0 000000 0000   001124677889999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.4e-38  Score=292.81  Aligned_cols=252  Identities=25%  Similarity=0.346  Sum_probs=195.6

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecC-----Ce
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQ-----HM  149 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----~~  149 (406)
                      ...|.+.+.||+|+||.||++.. .+|+.+|+|++....  .....+.+|+.++.++ +|||++++++++...     ..
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~   98 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ   98 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence            45567778999999999999976 468899999986532  2345678899999988 799999999998653     35


Q ss_pred             eEEEEEeccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccc
Q 015480          150 TALVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  226 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~  226 (406)
                      .++||||+++++|.+++..   ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++
T Consensus        99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~  175 (291)
T cd06639          99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVS  175 (291)
T ss_pred             eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence            7999999999999998843   34678999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCceEEecCCCCCCCccCccccCCCC----CCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHh
Q 015480          227 KLCDRNKTHVTISGYKGTPGYSAPEFLSGNY----PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE  302 (406)
Q Consensus       227 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  302 (406)
                      .........  .....|+..|+|||.+....    .++.++|||||||++|||++|+.|+......      .... ...
T Consensus       176 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------~~~~-~~~  246 (291)
T cd06639         176 AQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------KTLF-KIP  246 (291)
T ss_pred             hhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------HHHH-HHh
Confidence            765432211  12346788999999876432    3688999999999999999999987533211      0000 000


Q ss_pred             hhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .....      . ...+......+.+++.+||+.+|++||++.++++
T Consensus       247 ~~~~~------~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         247 RNPPP------T-LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             cCCCC------C-CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            00000      0 0112234567999999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-40  Score=308.96  Aligned_cols=249  Identities=23%  Similarity=0.378  Sum_probs=202.1

Q ss_pred             cccccccccceeEEEEEEeCC-CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           81 NYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      ++...||.|+||.||++..++ +-..|-|++... +....++|+-|+++|+.+.||+||++++.|..++.++++.|||.|
T Consensus        35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            334459999999999997754 445577888654 345678899999999999999999999999989999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |-.+..+-.-+..+++.++..+++|++.||.|||+   +.|||||||+.|||+.-+|.++|+|||.+.......  ....
T Consensus       114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~--qkRD  188 (1187)
T KOG0579|consen  114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR--QKRD  188 (1187)
T ss_pred             chHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHH--hhhc
Confidence            99999887788899999999999999999999999   999999999999999999999999999986443222  2234


Q ss_pred             CCCCCCCccCccccCC----CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          240 GYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                      .+.||+.|||||+...    ..+|+.++||||||++|.||..+.+|...-.       +..+.-.....       ..+.
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-------pMRVllKiaKS-------ePPT  254 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKS-------EPPT  254 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-------hHHHHHHHhhc-------CCCc
Confidence            5789999999998742    3479999999999999999999988753221       11111111111       1122


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .-.+...+..+.+++..||.+||..||++.++++
T Consensus       255 LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  255 LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            2345677888999999999999999999999887

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=296.23  Aligned_cols=247  Identities=27%  Similarity=0.325  Sum_probs=201.0

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      .++...+.||+|+||+||-++. .+|..||+|.+.+..-  ...+...+.|-.+|.+++.+.||.+-..|+..+.+|+|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            3344557899999999999965 5699999998875422  123345678999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          155 EYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       155 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      ..|+||+|.-.+... +..+++..+.-++.+|+.||++||.   .+||+||+||+|||+|++|+++|+|+|||..+....
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            999999998877443 4579999999999999999999999   999999999999999999999999999998776554


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      .   ..+.+||.+|||||++.+. .|+...|+|||||++|||+.|+.||....            +.....++...+...
T Consensus       342 ~---~~~rvGT~GYMAPEvl~ne-~Y~~s~Dwf~lGCllYemi~G~sPFr~~K------------eKvk~eEvdrr~~~~  405 (591)
T KOG0986|consen  342 P---IRGRVGTVGYMAPEVLQNE-VYDFSPDWFSLGCLLYEMIAGHSPFRQRK------------EKVKREEVDRRTLED  405 (591)
T ss_pred             c---cccccCcccccCHHHHcCC-cccCCccHHHHHhHHHHHHcccCchhhhh------------hhhhHHHHHHHHhcc
Confidence            3   3456899999999999988 59999999999999999999999984321            112222222222221


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCCh
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPM  344 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  344 (406)
                      . .+.+...++++.+++...|..||.+|.-.
T Consensus       406 ~-~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  406 P-EEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             h-hhcccccCHHHHHHHHHHHccCHHHhccC
Confidence            1 34446778889999999999999999643

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-40  Score=294.92  Aligned_cols=268  Identities=21%  Similarity=0.292  Sum_probs=227.8

Q ss_pred             eeeChHHHhhhhhcccccccccceeEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEE
Q 015480           68 VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY  141 (406)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~  141 (406)
                      .+...+++...+++....+-+|.||.||.|.|      .+.+.|.+|.++...++.+...+..|.-++..+.|||+.++.
T Consensus       274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence            34566777788888888899999999999954      345678899999888888889999999999999999999999


Q ss_pred             EEEecC-CeeEEEEEeccCCChhhHhh-----c--CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc
Q 015480          142 GFCHDQ-HMTALVYEYMENGSLDGYLF-----G--KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD  213 (406)
Q Consensus       142 ~~~~~~-~~~~lv~e~~~~g~L~~~l~-----~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~  213 (406)
                      +++.++ ..+++++.++.-|+|..|+.     .  ..+.++..+...++.|++.|++|||+   ++++|.||.++|++||
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVID  430 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceeh
Confidence            998654 57788999999999999995     1  23457888999999999999999999   9999999999999999


Q ss_pred             CCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCccccc
Q 015480          214 ANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDW  292 (406)
Q Consensus       214 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  292 (406)
                      +...+||+|=.+++..-..+...-..+...+..||+||.+.+. .++.++||||||++||||+| |+.|+          
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~Py----------  499 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPY----------  499 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCc----------
Confidence            9999999999999987766655544555678899999999987 89999999999999999987 44443          


Q ss_pred             chhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          293 FPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                            .+.+..++...+.++.+...+.+++++|..++.-||...|++||++++++..|.++.
T Consensus       500 ------aeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  500 ------AEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             ------cccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                  233344555566666677788999999999999999999999999999999998764

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-39  Score=305.28  Aligned_cols=246  Identities=26%  Similarity=0.407  Sum_probs=194.8

Q ss_pred             cccccccccceeEEEEEEe-CCCcEEEEEEe---ccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCe--eEEEE
Q 015480           81 NYSTRLGFGGFGEVYKGQF-PNGVKIAVKVL---NRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM--TALVY  154 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~---~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~  154 (406)
                      .|...||+|+|-+||+|-+ .+|..||--.+   .-.......++|..|+++|+.|+||||+++|++|.+...  .-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            3456799999999999954 45878874322   222344556899999999999999999999999987655  67899


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC-CCCceEeccccccccCCCC
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~DfGl~~~~~~~~  233 (406)
                      |.+..|+|..|+ .+.+.++...+..|+.||++||.|||+. .++|+|||||.+||+|+. .|.+||+|+|||.......
T Consensus       123 EL~TSGtLr~Y~-kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYR-KKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ecccCCcHHHHH-HHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            999999999999 4556788899999999999999999984 479999999999999975 4899999999999876554


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      ..    ...|||.|||||+...  .|++.+||||||++++||.|+..|+.--.      .+..++.....+.....+.  
T Consensus       201 ak----svIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~------n~AQIYKKV~SGiKP~sl~--  266 (632)
T KOG0584|consen  201 AK----SVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECT------NPAQIYKKVTSGIKPAALS--  266 (632)
T ss_pred             cc----eeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhC------CHHHHHHHHHcCCCHHHhh--
Confidence            43    2569999999999883  68999999999999999999998874221      1222223322222221111  


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                            .-..+++.++|..|+.. .++|||+.|+|.
T Consensus       267 ------kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  267 ------KVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ------ccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                  11236799999999999 999999999998

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=293.28  Aligned_cols=263  Identities=22%  Similarity=0.316  Sum_probs=196.0

Q ss_pred             cccccccccceeEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           81 NYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      +..+.||.|++|.||+|.. .+|..||+|++..+.. ......+.+|+++++.++|||++++++++.+....+++|||++
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~   81 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD   81 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence            4567899999999999976 4699999999875432 2234568889999999999999999999999999999999995


Q ss_pred             CCChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          159 NGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       159 ~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                       ++|.+++.... ..+++..+..++.|+++||+|||+   .+++||||+|+||+++.++.++|+|||++.........  
T Consensus        82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--  155 (283)
T cd07835          82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--  155 (283)
T ss_pred             -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--
Confidence             68999885433 468999999999999999999999   99999999999999999999999999999755432211  


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc--------chhHHHHHHhhh-hcch
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW--------FPKHVWEEYEKC-ELGA  308 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~-~~~~  308 (406)
                      .....++..|+|||++.+...++.++||||||+++|+|++|..||..........        .....|...... ....
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP  235 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence            1223468899999988765467899999999999999999999885432210000        000000000000 0000


Q ss_pred             hh---ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 MI---LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..   ............+..+.+++.+||+.||.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00   000001111234467899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.2e-38  Score=295.41  Aligned_cols=267  Identities=24%  Similarity=0.296  Sum_probs=193.9

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCC--------
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH--------  148 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  148 (406)
                      +|...+.||+|+||.||+|.. .+|+.||||.+.... .......+.+|+.++++++||||+++++++....        
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            466778899999999999976 468999999886432 2223345678999999999999999999987654        


Q ss_pred             eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          149 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      ..++||||+.+ +|.+++......+++.++..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++..
T Consensus        93 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          93 SFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             eEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence            44899999965 8888886666679999999999999999999999   9999999999999999999999999999976


Q ss_pred             cCCCCce--EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc--------cchhHHH
Q 015480          229 CDRNKTH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD--------WFPKHVW  298 (406)
Q Consensus       229 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~~  298 (406)
                      .......  .......++..|+|||.+.+...++.++||||||+++|||++|..|+.........        ..+...+
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW  248 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            5432211  11223457889999998876545788999999999999999999887543221000        0000000


Q ss_pred             HHHhhhhcch-hhccCCCCcc------hHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          299 EEYEKCELGA-MILGCGIEEK------DKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       299 ~~~~~~~~~~-~~~~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .......... ..........      .......+.+++.+||+.||.+|||++++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0000000000 0000000000      0012356789999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.8e-39  Score=316.89  Aligned_cols=264  Identities=18%  Similarity=0.272  Sum_probs=185.1

Q ss_pred             hhhcccccccccceeEEEEEEeCC--CcEEEEEEe--------------ccc--cchhhHHHHHHHHHHhhccCcCcccc
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPN--GVKIAVKVL--------------NRN--LGRIAEEQFMAEVGTIGRTYHINLVR  139 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~--g~~vavK~~--------------~~~--~~~~~~~~~~~e~~~l~~l~h~niv~  139 (406)
                      ..|.+.+.||+|+||+||++.+..  +...++|.+              .+.  ........+.+|+.++.+++||||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            467888999999999999986532  222222211              100  11223456889999999999999999


Q ss_pred             EEEEEecCCeeEEEEEeccCCChhhHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC
Q 015480          140 LYGFCHDQHMTALVYEYMENGSLDGYLFGK----KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN  215 (406)
Q Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~  215 (406)
                      +++++.+.+..++|++++. ++|.+++...    ........+..++.|++.||+|||+   ++|+||||||+|||++.+
T Consensus       228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCC
Confidence            9999999999999999995 4777776332    2234466788899999999999999   999999999999999999


Q ss_pred             CCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc-ccch
Q 015480          216 FSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL-DWFP  294 (406)
Q Consensus       216 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~  294 (406)
                      +.+||+|||+++......... .....||..|+|||++.+. .++.++|||||||++|||++|..++........ ..+.
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999999998665432211 2245789999999999877 789999999999999999998754432221110 0000


Q ss_pred             h-----------------HHHHHHhhhhcchhhccCCCCcch--HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          295 K-----------------HVWEEYEKCELGAMILGCGIEEKD--KEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       295 ~-----------------~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .                 ..++..........  ........  ...+..+.+++.+||+.||.+|||+.|++.
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHA--GHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccC--ccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0                 00000000000000  00000000  113456788899999999999999999987

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=285.77  Aligned_cols=240  Identities=26%  Similarity=0.316  Sum_probs=198.8

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .++|.+.||+|.||+|.+++- .+|+.||+|++++..-  ......-..|-++|...+||.+..+-..|+..+.+|+|||
T Consensus       169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe  248 (516)
T KOG0690|consen  169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME  248 (516)
T ss_pred             hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence            456788999999999999965 4699999999987632  2233445679999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |..||.|.-.| ...+.+++....-+...|+.||.|||+   ++|++||||.+|+|+|.+|++||+|||+++.--.  ..
T Consensus       249 yanGGeLf~HL-srer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--~g  322 (516)
T KOG0690|consen  249 YANGGELFFHL-SRERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--YG  322 (516)
T ss_pred             EccCceEeeeh-hhhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc--cc
Confidence            99999998887 456678999999999999999999999   9999999999999999999999999999974332  22


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                      .....++||+.|+|||++... .|..++|+|.+||++|||++|+.||.....+.+       .+         .+.... 
T Consensus       323 ~t~kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-------Fe---------LIl~ed-  384 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-------FE---------LILMED-  384 (516)
T ss_pred             ceeccccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchhHH-------HH---------HHHhhh-
Confidence            335679999999999999987 899999999999999999999999865433211       11         111110 


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCC
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRP  342 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  342 (406)
                      -..+...+++...|+...|.+||.+|.
T Consensus       385 ~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  385 LKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            234566677888999999999999995

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.5e-38  Score=301.52  Aligned_cols=266  Identities=23%  Similarity=0.259  Sum_probs=196.4

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhcc-CcCccccEEEEEecC--CeeEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQ--HMTAL  152 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~~l  152 (406)
                      ..|.+.+.||+|+||.||+|.+. +|+.+|+|++.... .......+.+|+.++.++ +||||+++++++...  ...++
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            34566788999999999999764 58899999886432 223345677899999999 999999999998653  46899


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ||||++ ++|..++...  .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        87 v~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~  160 (337)
T cd07852          87 VFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL  160 (337)
T ss_pred             Eecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence            999997 5998888433  78899999999999999999999   99999999999999999999999999999865433


Q ss_pred             Cce---EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc--------cchhHHHHHH
Q 015480          233 KTH---VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD--------WFPKHVWEEY  301 (406)
Q Consensus       233 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~~  301 (406)
                      ...   .......|+..|+|||.+.+...++.++||||||+++|+|++|+.||.........        ......+...
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07852         161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI  240 (337)
T ss_pred             cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence            221   12233568899999998876556889999999999999999999988532211000        0000000000


Q ss_pred             hhh---hcchhhc---cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          302 EKC---ELGAMIL---GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       302 ~~~---~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...   .......   ...........+.++.+++..||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence            000   0000000   00011111225678999999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.4e-38  Score=295.82  Aligned_cols=262  Identities=19%  Similarity=0.259  Sum_probs=193.5

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccC-cCccccEEEEEecCCe-----e
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHM-----T  150 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----~  150 (406)
                      .|...+.||+|+||.||+|.+ .+|+.||+|.++.... ......+.+|+.+++.+. ||||+++++++.....     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            356678899999999999976 4689999999875432 223457888999999995 6999999999977665     8


Q ss_pred             EEEEEeccCCChhhHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC-CCCceEecccc
Q 015480          151 ALVYEYMENGSLDGYLFGK----KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGL  225 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~DfGl  225 (406)
                      ++||||+++ +|.+++...    ...+++..+..++.|++.||.|||+   .+++||||+|+||+++. ++.+||+|||+
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeeccc
Confidence            999999986 888887432    3468999999999999999999999   99999999999999998 88999999999


Q ss_pred             ccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhh-
Q 015480          226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC-  304 (406)
Q Consensus       226 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  304 (406)
                      +.........  .....+++.|+|||.+.+...++.++||||||+++|+|++|..||.........  .. ........ 
T Consensus       158 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~-~~~~~~~~~  232 (295)
T cd07837         158 GRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LH-IFKLLGTPT  232 (295)
T ss_pred             ceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HH-HHHHhCCCC
Confidence            8755332211  122346788999998876546799999999999999999999888543221100  00 00000000 


Q ss_pred             --------hcchhh-ccC----CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          305 --------ELGAMI-LGC----GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       305 --------~~~~~~-~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                              ...... ...    .........+..+.+++.+||+.||.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                    000000 000    000111235677899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.8e-39  Score=323.81  Aligned_cols=246  Identities=28%  Similarity=0.409  Sum_probs=189.2

Q ss_pred             cccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec---------------
Q 015480           83 STRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD---------------  146 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------------  146 (406)
                      .+.||+||||.||+++++ +|+.||||++.-..+......+.+|+..+++|+|||||+++..+.+               
T Consensus       484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~  563 (1351)
T KOG1035|consen  484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS  563 (1351)
T ss_pred             HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence            456999999999999764 8999999999876555566789999999999999999999853200               


Q ss_pred             --------------------------------------------------------------------------------
Q 015480          147 --------------------------------------------------------------------------------  146 (406)
Q Consensus       147 --------------------------------------------------------------------------------  146 (406)
                                                                                                      
T Consensus       564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d  643 (1351)
T KOG1035|consen  564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD  643 (1351)
T ss_pred             hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence                                                                                            


Q ss_pred             ----------------C--------CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeee
Q 015480          147 ----------------Q--------HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH  202 (406)
Q Consensus       147 ----------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H  202 (406)
                                      +        ..+||-||||+..+|.+++..+...-.....++++.+|++||.|+|+   +|+||
T Consensus       644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~---~giIH  720 (1351)
T KOG1035|consen  644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD---QGIIH  720 (1351)
T ss_pred             cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh---Cceee
Confidence                            0        12468899999977877774433222567899999999999999999   99999


Q ss_pred             cCCCCCcEEEcCCCCceEeccccccccC----------------CCCceEEecCCCCCCCccCccccCCCC--CCCcccc
Q 015480          203 YDIKPENVLLDANFSPKVADFGLAKLCD----------------RNKTHVTISGYKGTPGYSAPEFLSGNY--PITHKCD  264 (406)
Q Consensus       203 ~dlk~~Nill~~~~~~kl~DfGl~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~D  264 (406)
                      |||||.||++++++.+||+|||++....                ........++..||.-|+|||++.+..  .|+.|+|
T Consensus       721 RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiD  800 (1351)
T KOG1035|consen  721 RDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKID  800 (1351)
T ss_pred             ccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhh
Confidence            9999999999999999999999998621                001112345678999999999998775  6999999


Q ss_pred             eeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc---hHHHHHHHHHHHHHhcccCCCCC
Q 015480          265 VYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK---DKEKAKRLCMVALWCVQDSPEDR  341 (406)
Q Consensus       265 vwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~R  341 (406)
                      +||||+|++||+.-   |.               ..+........+..+.++..   ..+....-..++.++++.||.+|
T Consensus       801 mYSLGIVlFEM~yP---F~---------------TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kR  862 (1351)
T KOG1035|consen  801 MYSLGIVLFEMLYP---FG---------------TSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKR  862 (1351)
T ss_pred             hHHHHHHHHHHhcc---CC---------------chHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccC
Confidence            99999999999852   21               11111112222223333333   44555566789999999999999


Q ss_pred             CChHHHHH
Q 015480          342 PPMSAVIK  349 (406)
Q Consensus       342 Ps~~~vl~  349 (406)
                      ||+.|+++
T Consensus       863 PtA~eLL~  870 (1351)
T KOG1035|consen  863 PTATELLN  870 (1351)
T ss_pred             CCHHHHhh
Confidence            99999986

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.5e-38  Score=290.64  Aligned_cols=244  Identities=29%  Similarity=0.352  Sum_probs=192.4

Q ss_pred             ccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCCh
Q 015480           86 LGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  162 (406)
Q Consensus        86 ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  162 (406)
                      ||+|+||+||++.. .+|+.||+|.+....  .......+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999965 468999999987532  122345677899999999999999999999999999999999999999


Q ss_pred             hhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCC
Q 015480          163 DGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY  241 (406)
Q Consensus       163 ~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~  241 (406)
                      .+++.... ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++........   ....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cccc
Confidence            99985433 468999999999999999999999   9999999999999999999999999999876543221   1234


Q ss_pred             CCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHH
Q 015480          242 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKE  321 (406)
Q Consensus       242 ~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (406)
                      .++..|+|||.+.+. .++.++||||||+++|+|++|+.||........       .......     ... .....+..
T Consensus       155 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~-----~~~-~~~~~~~~  220 (277)
T cd05577         155 AGTPGYMAPEVLQGE-VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-------KEELKRR-----TLE-MAVEYPDK  220 (277)
T ss_pred             cCCCCcCCHHHhcCC-CCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-------HHHHHhc-----ccc-ccccCCcc
Confidence            578899999998876 589999999999999999999999854322110       0111100     000 01122233


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          322 KAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       322 ~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                      .+..+.+++.+||+.||.+||     ++.+++.
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            467899999999999999999     5555654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.5e-38  Score=290.59  Aligned_cols=244  Identities=22%  Similarity=0.328  Sum_probs=195.9

Q ss_pred             cccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCC
Q 015480           83 STRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  161 (406)
                      .+.||+|++|.||++.. .+++.+++|.+... .....+.+.+|+.+++.++|||++++++++...+..++++||+++++
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~  102 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA  102 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence            46799999999999975 46889999988643 22344668899999999999999999999999999999999999999


Q ss_pred             hhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCC
Q 015480          162 LDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY  241 (406)
Q Consensus       162 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~  241 (406)
                      |.+++..  ..+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||++.........  ....
T Consensus       103 L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~  175 (285)
T cd06648         103 LTDIVTH--TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSL  175 (285)
T ss_pred             HHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--cccc
Confidence            9999854  568999999999999999999999   99999999999999999999999999988754432211  1234


Q ss_pred             CCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHH
Q 015480          242 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKE  321 (406)
Q Consensus       242 ~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (406)
                      .|+..|+|||.+.+. .++.++||||||+++|||++|..|+......       ..........       .........
T Consensus       176 ~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------~~~~~~~~~~-------~~~~~~~~~  240 (285)
T cd06648         176 VGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------QAMKRIRDNL-------PPKLKNLHK  240 (285)
T ss_pred             cCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHHHhcC-------CCCCccccc
Confidence            588999999998876 6899999999999999999999987542210       0011111100       000111223


Q ss_pred             HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          322 KAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       322 ~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .+..+.+++.+||+.+|++||++.++++
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         241 VSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            5578999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.9e-38  Score=285.81  Aligned_cols=248  Identities=24%  Similarity=0.382  Sum_probs=203.0

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |.+.+.||.|+||.||++.+. ++..|++|++..... ......+..|+++++.++|||++++++.+......++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            456778999999999999764 589999999875422 245567889999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          158 ENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       158 ~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ++++|.+++...   ...+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence            999999998654   4789999999999999999999999   8999999999999999999999999999986654431


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                        ......|++.|+|||.+.+. .++.++|+||+|+++|+|++|..|+......       ......         ....
T Consensus       159 --~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~---------~~~~  219 (258)
T cd08215         159 --LAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLL-------ELALKI---------LKGQ  219 (258)
T ss_pred             --eecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHH-------HHHHHH---------hcCC
Confidence              12234678899999998776 6899999999999999999999887543211       001111         1111


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....+...+..+.+++.+||..+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            12223355678999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.4e-38  Score=288.69  Aligned_cols=243  Identities=23%  Similarity=0.261  Sum_probs=188.5

Q ss_pred             cccccceeEEEEEEe-CCCcEEEEEEeccccch--hhHHHHHHHH---HHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           85 RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGR--IAEEQFMAEV---GTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~--~~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      .||+|+||.||++.. .+|+.||+|.+......  .....+..|.   ..++...||||+.+++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            389999999999965 45899999998754211  1122233443   34445679999999999999999999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      +|+|..++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........    
T Consensus        81 g~~L~~~l~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~----  152 (278)
T cd05606          81 GGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----  152 (278)
T ss_pred             CCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC----
Confidence            999998884 45679999999999999999999999   9999999999999999999999999999875543221    


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ....|+..|+|||.+.+...++.++||||+|+++|||++|+.||..........    .....         . ......
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~---------~-~~~~~~  218 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMT---------L-TMAVEL  218 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHh---------h-ccCCCC
Confidence            234689999999998765468899999999999999999999986442211100    00000         0 001122


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          319 DKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       319 ~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                      +...+..+.+++.+||..+|.+||     ++.++++
T Consensus       219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            233467899999999999999999     8889875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.9e-38  Score=292.54  Aligned_cols=254  Identities=24%  Similarity=0.356  Sum_probs=195.2

Q ss_pred             hhhcccccccccceeEEEEEEeCC-CcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ..+.+.+.||+|+||.||+|.+.+ |+.||||.++..........+..|+.++.+.. ||||+++++++.+....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            345677899999999999998754 89999999976433334456677887777665 9999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+. ++|.+++......+++..+..++.|++.||+|||+  ..+++||||+|+||++++++.+||+|||++.........
T Consensus        95 ~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~  171 (296)
T cd06618          95 LMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK  171 (296)
T ss_pred             ccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence            985 47887775556689999999999999999999996  258999999999999999999999999998765432221


Q ss_pred             EEecCCCCCCCccCccccCCC---CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          236 VTISGYKGTPGYSAPEFLSGN---YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                         ....++..|+|||.+.+.   ..++.++||||||+++|+|++|+.||......      ...........      .
T Consensus       172 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~------~  236 (296)
T cd06618         172 ---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLTKILQEE------P  236 (296)
T ss_pred             ---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------HHHHHHHhcCC------C
Confidence               223578899999998754   24788999999999999999999987532111      00000000000      0


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      .. ......++.++.+++.+||+.||.+||++.++++.
T Consensus       237 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 PS-LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CC-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00 01111356779999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-39  Score=274.16  Aligned_cols=250  Identities=23%  Similarity=0.321  Sum_probs=201.8

Q ss_pred             cccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEEEecc
Q 015480           81 NYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      .+...||.|+.|.||++++. +|...|||.++++......++++..++++..-+ .|.||+.+|+|..+...++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            34456999999999999764 488999999998777677788999999988876 8999999999999999999999985


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      . -++.++..-.+++.+.-+-++...+++||.||..  +++|+|||+||+|||+|+.|++||||||++-.+-.....   
T Consensus       175 ~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh---  248 (391)
T KOG0983|consen  175 T-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH---  248 (391)
T ss_pred             H-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc---
Confidence            4 6777777777889999999999999999999998  699999999999999999999999999999765443332   


Q ss_pred             cCCCCCCCccCccccCCC--CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          239 SGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                      +...|-+.|||||.+...  ..|+-++||||||+.++||.||+.|+.....+..      +.....+.       .....
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe------~ltkvln~-------ePP~L  315 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE------VLTKVLNE-------EPPLL  315 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH------HHHHHHhc-------CCCCC
Confidence            234578899999988643  4688899999999999999999999865433211      11111111       01111


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ......+..+++++..||.+|+.+||.+.++++
T Consensus       316 ~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  316 PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            122337888999999999999999999999887

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-38  Score=292.38  Aligned_cols=263  Identities=21%  Similarity=0.312  Sum_probs=200.7

Q ss_pred             cccccccccceeEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           81 NYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      ...+.||+|++|.||+|.. .+|+.+++|.+..... ......+..|+.++++++|+||+++++++.++...++|+||++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD   81 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence            4567899999999999976 4689999999875432 2345678899999999999999999999999999999999997


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      + +|.+++......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+.......  ...
T Consensus        82 ~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~  155 (283)
T cd05118          82 T-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPY  155 (283)
T ss_pred             C-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccc
Confidence            5 8888886656789999999999999999999999   999999999999999999999999999997665443  112


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc--------chhHHHHHHhh---hhcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW--------FPKHVWEEYEK---CELG  307 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~---~~~~  307 (406)
                      ....++..|+|||.+.+...++.++|+||||+++|+|++|+.||..........        .....+.....   ....
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            334578899999998766568999999999999999999998874432210000        00000000000   0000


Q ss_pred             hhh--ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 AMI--LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...  ............+..+.+++..||+.||.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            000  000111222346788999999999999999999999886

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.6e-38  Score=287.29  Aligned_cols=245  Identities=23%  Similarity=0.332  Sum_probs=195.5

Q ss_pred             ccccceeEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCCh
Q 015480           86 LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  162 (406)
Q Consensus        86 ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  162 (406)
                      ||+|+||.||++... +|+.+++|++.....  ......+.+|++++.+++||||+++++.+.+....+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999775 499999999875422  23456788999999999999999999999999999999999999999


Q ss_pred             hhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc------eE
Q 015480          163 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT------HV  236 (406)
Q Consensus       163 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~------~~  236 (406)
                      .+++... ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++........      ..
T Consensus        81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            9998543 378999999999999999999999   9999999999999999999999999999875443311      11


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                      ......++..|+|||..... ..+.++||||||+++|+|++|..|+......       ..........          .
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~----------~  218 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQ-GHSKTVDWWSLGCILYEFLVGIPPFHGETPE-------EIFQNILNGK----------I  218 (265)
T ss_pred             cccCcccCccccCHHHhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCC----------c
Confidence            22334578899999998876 5889999999999999999999988543211       0011111000          0


Q ss_pred             cchHH--HHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          317 EKDKE--KAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       317 ~~~~~--~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                      ..+..  .+..+.+++.+||+.+|.+||++..+.+.|+
T Consensus       219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            11111  3678999999999999999999966666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.4e-38  Score=286.17  Aligned_cols=246  Identities=26%  Similarity=0.354  Sum_probs=201.9

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |.+.+.||+|+||.||++.. .+|+.+++|.+.... .......+.+|+.+++.++|+||+++++++.+....++||||+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            55678899999999999965 468899999987532 2334567888999999999999999999999999999999999


Q ss_pred             cCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          158 ENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       158 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ++++|.+++..   ....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++....... 
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-  157 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-  157 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence            99999998843   24578999999999999999999999   999999999999999999999999999997665441 


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                         .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.|+......       .....         .....
T Consensus       158 ---~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~~~~~---------~~~~~  217 (256)
T cd08530         158 ---AKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-------DLRYK---------VQRGK  217 (256)
T ss_pred             ---cccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH---------HhcCC
Confidence               1224578899999998876 6889999999999999999999988533211       00011         11122


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....+...+.++.+++.+||+.+|++||++.++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            23344467788999999999999999999999886

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-38  Score=299.17  Aligned_cols=251  Identities=23%  Similarity=0.329  Sum_probs=207.3

Q ss_pred             HhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccch-hhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGR-IAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      .....|.+...||+|.|++|.+|++ .+|..||||.+.+..-. .....+.+|+++|..++|||||+++.+......+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            3344566778999999999999965 56999999999875432 334568999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ||||+.+|.+.+++... +...+..+..++.|+.++++|||+   +.|+|||||++||||+.+.++||+|||++..+...
T Consensus       133 V~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc
Confidence            99999999999999544 455558999999999999999999   99999999999999999999999999999887743


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ..   ...++|++.|.|||++.+.....+.+|+||+|+++|-|+.|..||+...-....       +....++       
T Consensus       209 ~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-------~rvl~gk-------  271 (596)
T KOG0586|consen  209 LM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-------PRVLRGK-------  271 (596)
T ss_pred             cc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-------chheeee-------
Confidence            32   346899999999999999878899999999999999999999999754332211       0000000       


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                         -..+.-.+.++.++++.+|-.+|.+|++++++.+
T Consensus       272 ---~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  272 ---YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ---ecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence               1122334456888999999999999999999887

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.2e-37  Score=295.26  Aligned_cols=262  Identities=21%  Similarity=0.249  Sum_probs=194.9

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecC------C
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------H  148 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  148 (406)
                      ...|...+.||+|+||.||+|.. .+|+.||+|.+.... .......+.+|+.+++.++||||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            35577788999999999999975 468999999986432 223445678899999999999999999998643      3


Q ss_pred             eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          149 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      ..++||||+.+ +|.+.+...   ++...+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  167 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  167 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence            56899999964 888877322   8899999999999999999999   9999999999999999999999999999986


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc--------ccchhHHHHH
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL--------DWFPKHVWEE  300 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~  300 (406)
                      ......   .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||........        ..........
T Consensus       168 ~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         168 AGTSFM---MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             CCCCCC---CCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            543321   2234578899999999876 789999999999999999999998854321100        0000000000


Q ss_pred             Hhhh--------h------cchh----hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          301 YEKC--------E------LGAM----ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       301 ~~~~--------~------~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....        .      ....    .............+..+.+++.+||+.||++|||+.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0000        0      0000    0000000112234667899999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.4e-37  Score=291.17  Aligned_cols=248  Identities=25%  Similarity=0.350  Sum_probs=195.5

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccc--cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      |...+.||+|+||.||+|... ++..+|+|.+...  .......++.+|+++++.++|+|++++++++.+....++||||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            444567999999999999764 5889999988642  2223446788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +. |+|.+++......+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......    
T Consensus        97 ~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----  168 (308)
T cd06634          97 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----  168 (308)
T ss_pred             cC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence            96 58888775556678999999999999999999999   99999999999999999999999999998755432    


Q ss_pred             EecCCCCCCCccCccccCC--CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          237 TISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                        ....++..|+|||.+.+  ...++.++|||||||++|+|++|..|+.......       .......        ...
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~--------~~~  231 (308)
T cd06634         169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQ--------NES  231 (308)
T ss_pred             --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-------HHHHHhh--------cCC
Confidence              23457889999998742  2257889999999999999999998874321100       0000000        000


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                      ........+..+.+++.+||+.+|.+||++.++++...
T Consensus       232 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence            11122345677999999999999999999999998543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=284.73  Aligned_cols=250  Identities=23%  Similarity=0.268  Sum_probs=196.8

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccc----cchhhHHHHHHHHHHhhccCcCccccEEEEEecC--CeeE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTA  151 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  151 (406)
                      .|.+.+.||+|+||.||+|.. .+|..||+|.+...    ........+.+|++++++++||||+++++++.+.  ...+
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            356778999999999999975 46899999987532    1223446788999999999999999999998764  4678


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +++||+++++|.+++. ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++....
T Consensus        83 ~v~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          83 IFVEYMPGGSIKDQLK-AYGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEEeCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            9999999999999984 33458899999999999999999999   9999999999999999999999999999976532


Q ss_pred             CCc-eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          232 NKT-HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       232 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      ... ........|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||.....          .....     ...
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------~~~~~-----~~~  222 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEA----------MAAIF-----KIA  222 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCH----------HHHHH-----HHH
Confidence            111 1111234588899999999876 689999999999999999999999753211          01111     011


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ........+...+..+.+++.+||. +|..||++.+++.
T Consensus       223 ~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1111233455677889999999999 5799999998775

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.4e-38  Score=297.86  Aligned_cols=267  Identities=20%  Similarity=0.270  Sum_probs=197.6

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEec----CCeeE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHD----QHMTA  151 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~  151 (406)
                      ..|.+.+.||+|+||.||+|.. .+|+.||+|++..... ......+.+|+.++..++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            3456678899999999999965 4699999999875432 2344667889999999999999999998753    35679


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +||||+. ++|.+++. ....+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++.....
T Consensus        85 lv~e~~~-~~l~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          85 VVMDLME-SDLHHIIH-SDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             EEEehhh-hhHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            9999995 58988884 34569999999999999999999999   9999999999999999999999999999976543


Q ss_pred             CCce--EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc--------cchhHHHHHH
Q 015480          232 NKTH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD--------WFPKHVWEEY  301 (406)
Q Consensus       232 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~~  301 (406)
                      ....  .......|+..|+|||.+.+...++.++||||||+++|||++|+.||.........        ..+...+...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence            2211  11123468889999999876546899999999999999999999998543211000        0000000000


Q ss_pred             hhhhcchhhc----cCCC--CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          302 EKCELGAMIL----GCGI--EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       302 ~~~~~~~~~~----~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..........    ....  .......+..+.+++.+||+.+|.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            0000000000    0000  0111335788999999999999999999999888

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.3e-38  Score=292.55  Aligned_cols=265  Identities=21%  Similarity=0.248  Sum_probs=194.1

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      .|.+.+.||+|++|+||+|... +|+.||+|.+..... ......+..|++++++++||||+++++++.+....++||||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY   82 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence            3566788999999999999764 689999999864322 23346788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC-CCCceEeccccccccCCCCc
Q 015480          157 MENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       157 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ++ ++|.+++... ...+++..+..++.|++.||+|||+   ++++|+||+|+||+++. ++.+||+|||++........
T Consensus        83 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         83 LD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             cc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            96 4787777433 3346888999999999999999999   99999999999999985 55799999999975543211


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccch--------hHHHHHHhhhhc
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP--------KHVWEEYEKCEL  306 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~  306 (406)
                      .  .....++..|+|||.+.+...++.++||||||+++|+|++|..||............        ...|........
T Consensus       159 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        159 T--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             c--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            1  123456889999999876546789999999999999999999988543221000000        000000000000


Q ss_pred             chhhccCCCC----cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          307 GAMILGCGIE----EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       307 ~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..........    ......+..+.+++.+|++.+|++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000000000    011234567899999999999999999999987

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=283.58  Aligned_cols=245  Identities=23%  Similarity=0.275  Sum_probs=189.6

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHh-hccCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTI-GRTYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|+||.||+|.. .+|+.||+|+++....  ......+..|..++ ...+|+|++++++++.+++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4699999999999966 4589999999875321  11223345555444 455899999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      ++|.+++. ....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++.....      ..
T Consensus        82 ~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIK-TLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999984 34578999999999999999999999   9999999999999999999999999999875432      12


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ...|+..|+|||.+.+. .++.++||||||+++|+|++|..|+.....       ...+.........      ......
T Consensus       152 ~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~------~~~~~~  217 (260)
T cd05611         152 KFVGTPDYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETP-------DAVFDNILSRRIN------WPEEVK  217 (260)
T ss_pred             cCCCCcCccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcccC------CCCccc
Confidence            34578899999998877 589999999999999999999999853221       1111111111100      011122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                      ..++..+.+++.+||+.||++||++.++.+.|.
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            245688999999999999999998876655543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.7e-38  Score=296.96  Aligned_cols=270  Identities=20%  Similarity=0.253  Sum_probs=198.9

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecC-----CeeE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-----HMTA  151 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  151 (406)
                      .|...+.||+|+||+||+|.. .+|..||||.+.... .......+.+|+.+++.++|+||+++++++...     ...+
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            466678899999999999965 568999999987532 223345677899999999999999999988654     3479


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +|+||+. ++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        86 lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          86 IVYELMD-TDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             EEEeCCC-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence            9999996 68988884 44679999999999999999999999   9999999999999999999999999999976543


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc--------ccchhHHHHHHhh
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL--------DWFPKHVWEEYEK  303 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~  303 (406)
                      ...  ......++..|+|||.+.....++.++|||||||++|+|++|+.||........        .......+.....
T Consensus       161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         161 KGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             Ccc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            321  123345788999999887543688999999999999999999998853211000        0000000000000


Q ss_pred             hhcchhhc---c---CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH--hhccc
Q 015480          304 CELGAMIL---G---CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM--LEGVV  355 (406)
Q Consensus       304 ~~~~~~~~---~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~--L~~~~  355 (406)
                      ........   .   ..........+..+.+++.+||+.+|++|||+.++++.  +..+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence            00000000   0   00011122456778999999999999999999999984  65543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.7e-37  Score=289.81  Aligned_cols=244  Identities=26%  Similarity=0.369  Sum_probs=192.8

Q ss_pred             cccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           81 NYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      ...+.||+|+||+||+|+. .+|..|++|.+....  .......+..|+++++.++|||++++++++.+....++||||+
T Consensus        24 ~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  103 (313)
T cd06633          24 VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC  103 (313)
T ss_pred             hcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecC
Confidence            3356799999999999976 468899999986432  2233457888999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      . |+|.+++......+++.++..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++......     
T Consensus       104 ~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-----  174 (313)
T cd06633         104 L-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-----  174 (313)
T ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC-----
Confidence            6 58888876666779999999999999999999999   99999999999999999999999999998643221     


Q ss_pred             ecCCCCCCCccCccccCC--CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          238 ISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                       ....|+..|+|||.+..  ...++.++||||||+++|+|++|..|+........      . ......        ...
T Consensus       175 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~-~~~~~~--------~~~  238 (313)
T cd06633         175 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------L-YHIAQN--------DSP  238 (313)
T ss_pred             -CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------H-HHHHhc--------CCC
Confidence             23567889999999742  23578899999999999999999998754321100      0 000000        000


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .......+..+.+++.+||+.+|.+||++.+++.
T Consensus       239 ~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1112234567899999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.5e-37  Score=289.15  Aligned_cols=257  Identities=16%  Similarity=0.149  Sum_probs=193.0

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEeccc-cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCC
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  161 (406)
                      .+.+|.|+++.||++.. +|+.||+|++... ........+..|+++++.++||||+++++++.+.+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455666666666655 6899999998754 334456789999999999999999999999999999999999999999


Q ss_pred             hhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc-----e
Q 015480          162 LDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT-----H  235 (406)
Q Consensus       162 L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~-----~  235 (406)
                      |.+++... ...+++..+..++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||.+........     .
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            99999643 4568899999999999999999999   9999999999999999999999999999865432211     0


Q ss_pred             EEecCCCCCCCccCccccCCC-CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHh------------
Q 015480          236 VTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE------------  302 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------  302 (406)
                      .......++..|+|||.+.+. ..++.++|+|||||++|||++|..||........      ..+...            
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM------LLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhccCccccccCch
Confidence            111234567789999998753 2578899999999999999999999864321100      000000            


Q ss_pred             ---hhhcch--------hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          303 ---KCELGA--------MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       303 ---~~~~~~--------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                         ......        ..............+..+.+++..||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence               000000        00000011122345678899999999999999999999988

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-37  Score=281.49  Aligned_cols=247  Identities=25%  Similarity=0.323  Sum_probs=201.0

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      |.+.+.||+|++|.||++... +++.|++|.+..... ......+.+|++++.+++|||++++++++.+....+++|||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            456788999999999999764 588999999976432 235578999999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++.........  
T Consensus        82 ~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  155 (254)
T cd06627          82 ENGSLRQIIKK-FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--  155 (254)
T ss_pred             CCCcHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence            99999999843 3679999999999999999999999   99999999999999999999999999999866543322  


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      .....++..|+|||...+. ..+.++||||+|+++|+|++|..|+......      ...+.. .         ......
T Consensus       156 ~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~-~---------~~~~~~  218 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRI-V---------QDDHPP  218 (254)
T ss_pred             ccccccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHH-h---------ccCCCC
Confidence            1234578899999998776 5889999999999999999999887532210      000110 0         011122


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .+...+..+.+++.+||..+|++||++.+++.
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            23345678999999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.7e-37  Score=288.30  Aligned_cols=243  Identities=23%  Similarity=0.324  Sum_probs=194.4

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCCh
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  162 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  162 (406)
                      .+||+|+||.||++.. .+|+.||+|.+... .......+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            5699999999999976 46899999988643 233456788999999999999999999999999999999999999999


Q ss_pred             hhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCC
Q 015480          163 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK  242 (406)
Q Consensus       163 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~  242 (406)
                      .+++.  ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.........  .....
T Consensus       105 ~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~  177 (292)
T cd06657         105 TDIVT--HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLV  177 (292)
T ss_pred             HHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccccc
Confidence            99873  3468999999999999999999999   99999999999999999999999999998755432211  12345


Q ss_pred             CCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHH
Q 015480          243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK  322 (406)
Q Consensus       243 gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (406)
                      |+..|+|||.+.+. .++.++|+||||+++|+|++|..|+.......       ........ .     ... .......
T Consensus       178 ~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-------~~~~~~~~-~-----~~~-~~~~~~~  242 (292)
T cd06657         178 GTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDN-L-----PPK-LKNLHKV  242 (292)
T ss_pred             cCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhh-C-----Ccc-cCCcccC
Confidence            78899999988765 67899999999999999999999875321110       00000000 0     000 1112234


Q ss_pred             HHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          323 AKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       323 ~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      +..+.+++.+||+.+|.+||++.++++
T Consensus       243 ~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         243 SPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            567889999999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.1e-37  Score=290.55  Aligned_cols=262  Identities=19%  Similarity=0.256  Sum_probs=192.2

Q ss_pred             ccccc--ceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCC
Q 015480           85 RLGFG--GFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        85 ~ig~G--~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      .||+|  +||+||++++ .+|+.||+|++.... .....+.+.+|+.+++.++||||++++++|......++|+||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  9999999976 479999999987532 2234477889999999999999999999999999999999999999


Q ss_pred             ChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE--E
Q 015480          161 SLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV--T  237 (406)
Q Consensus       161 ~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~--~  237 (406)
                      +|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++++||+.+..........  .
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            999998543 3468999999999999999999999   999999999999999999999999998654332211110  0


Q ss_pred             ---ecCCCCCCCccCccccCCC-CCCCcccceeecchhHHHHhhcccccccCCCccc-----------cc----chhHHH
Q 015480          238 ---ISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL-----------DW----FPKHVW  298 (406)
Q Consensus       238 ---~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-----------~~----~~~~~~  298 (406)
                         .....++..|+|||++.+. ..++.++|||||||++|||++|..||........           .+    .+....
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence               0112346679999998764 2478999999999999999999999854321100           00    000000


Q ss_pred             ------HHHhhh----hcc-----hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          299 ------EEYEKC----ELG-----AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       299 ------~~~~~~----~~~-----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                            ......    ...     ...............+..+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                  000000    000     000000111223456788999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-37  Score=284.10  Aligned_cols=259  Identities=24%  Similarity=0.322  Sum_probs=192.1

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHhhcc---CcCccccEEEEEecCCe-----
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRT---YHINLVRLYGFCHDQHM-----  149 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~-----  149 (406)
                      |++.+.||+|+||.||+|++. +|..||+|+++.... ......+.+|+.++.++   +|||++++++++.+.+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            345678999999999999875 489999999974322 12234566787776655   59999999999988776     


Q ss_pred             eEEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      .+++|||+.+ +|.+++... ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999975 898888543 3468999999999999999999999   9999999999999999999999999999976


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHh---hhh
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE---KCE  305 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~  305 (406)
                      .......   ....++..|+|||.+.+. .++.++|+|||||++|||++|.+|+.......  ..... .+...   ...
T Consensus       157 ~~~~~~~---~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~  229 (287)
T cd07838         157 YSFEMAL---TSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKI-FDVIGLPSEEE  229 (287)
T ss_pred             ccCCccc---ccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHH-HHHcCCCChHh
Confidence            6433221   223478899999999876 68999999999999999999988875332110  00000 00000   000


Q ss_pred             cc------hhhccC----CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          306 LG------AMILGC----GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       306 ~~------~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..      ......    .........+..+.+++.+||+.||++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00      000000    001112345677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.7e-37  Score=287.76  Aligned_cols=257  Identities=22%  Similarity=0.230  Sum_probs=200.1

Q ss_pred             hcccccccccceeEEEEEEe----CCCcEEEEEEecccc---chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeE
Q 015480           80 SNYSTRLGFGGFGEVYKGQF----PNGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~----~~g~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  151 (406)
                      |.+.+.||+|+||.||+++.    .+++.||||+++...   .....+.+..|+.++.++ +||||+++++.+..+...+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            45678899999999999964    357889999987431   122345688999999999 5999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +||||+++|+|.+++.. ...+++..+..++.|+++||.|||+   .+++||||+|+||+++.++.++|+|||++.....
T Consensus        82 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          82 LILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            99999999999999843 4568999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCceEEecCCCCCCCccCccccCCCC-CCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      ..... .....|+..|+|||.+.+.. ..+.++||||||+++|||++|..|+........       .........    
T Consensus       158 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~----  225 (288)
T cd05583         158 EEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-------QSEISRRIL----  225 (288)
T ss_pred             ccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-------HHHHHHHHH----
Confidence            32221 12345788999999986542 368899999999999999999999853221110       011111000    


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                       . .....+...+..+.+++.+||+.||++|||+.++.+.|+..
T Consensus       226 -~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         226 -K-SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             -c-cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence             0 01122333557789999999999999999999888877653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.8e-37  Score=286.55  Aligned_cols=252  Identities=23%  Similarity=0.269  Sum_probs=194.8

Q ss_pred             hcccccccccceeEEEEEEe----CCCcEEEEEEecccc---chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeE
Q 015480           80 SNYSTRLGFGGFGEVYKGQF----PNGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~----~~g~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  151 (406)
                      |.+.+.||+|+||.||+++.    .+|..||+|+++...   .....+.+..|+.++.++ +|+||+++++++..+...+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            45678899999999999975    368999999987532   122346788899999999 5999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +||||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||+|+|||++.++.+||+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          82 LILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            99999999999999843 4568899999999999999999999   9999999999999999999999999999976543


Q ss_pred             CCceEEecCCCCCCCccCccccCCC-CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      .... ......|+..|+|||.+... ..++.++||||||+++|+|++|..|+........   .    ......     .
T Consensus       158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~----~~~~~~-----~  224 (290)
T cd05613         158 DEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS---Q----AEISRR-----I  224 (290)
T ss_pred             cccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc---H----HHHHHH-----h
Confidence            2211 11234588899999998653 2467899999999999999999998853221100   0    000000     0


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                      ... ....+...+..+.+++.+||+.||++||     ++.+++.
T Consensus       225 ~~~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         225 LKS-EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             hcc-CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            000 1122334567789999999999999997     5555544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.2e-37  Score=292.15  Aligned_cols=269  Identities=20%  Similarity=0.251  Sum_probs=198.7

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCC------e
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH------M  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  149 (406)
                      .+|...+.||+|+||.||++.. .+|..||||++.... .......+.+|+.+++.++||||+++++++..+.      .
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            3566778899999999999964 569999999986432 2233456889999999999999999999987653      3


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+ +++|.+++.  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++...
T Consensus        95 ~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~  168 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQT  168 (343)
T ss_pred             EEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence            58999999 779988873  3578999999999999999999999   99999999999999999999999999999755


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc--------ccchhHHHHHH
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL--------DWFPKHVWEEY  301 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~~  301 (406)
                      ....     ....++..|+|||.+.+...++.++|+||||+++|+|++|..||........        ...+.......
T Consensus       169 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         169 DSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             ccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            4321     2345788999999987644688999999999999999999999854321100        00000000000


Q ss_pred             hhhhcchhhcc------CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--HhhccccC
Q 015480          302 EKCELGAMILG------CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVVEV  357 (406)
Q Consensus       302 ~~~~~~~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~~~  357 (406)
                      ...........      ..........+..+.+++.+|++.||++|||+.+++.  .++.....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence            00000000000      0000111234567899999999999999999999995  55555433

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.1e-38  Score=293.26  Aligned_cols=268  Identities=24%  Similarity=0.277  Sum_probs=194.2

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecC--------
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--------  147 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------  147 (406)
                      ..|.+.++||+|+||.||+|.+. +|+.||+|++..... ......+.+|+++++.++||||+++++++.+.        
T Consensus         8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   87 (311)
T cd07866           8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR   87 (311)
T ss_pred             ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence            45677889999999999999764 689999999865322 22234678899999999999999999987543        


Q ss_pred             CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          148 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ...++|+||+.+ +|...+......+++..+..++.|+++||.|||+   .+++|+||||+||++++++.++|+|||++.
T Consensus        88 ~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          88 GSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             ceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccch
Confidence            346899999965 7877776666789999999999999999999999   999999999999999999999999999997


Q ss_pred             ccCCCCceE---------EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc------
Q 015480          228 LCDRNKTHV---------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW------  292 (406)
Q Consensus       228 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~------  292 (406)
                      .........         ......++..|+|||.+.+...++.++||||||+++|||++|++||..........      
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~  243 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC  243 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            654322111         11233567889999988765468899999999999999999998875332210000      


Q ss_pred             --chhHHHHHHhhhhcch--hhccCC---CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          293 --FPKHVWEEYEKCELGA--MILGCG---IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       293 --~~~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        .....+..+.......  ......   ...........+.+++.+||+.||.+|||+.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence              0000000000000000  000000   00001123367889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.9e-37  Score=293.65  Aligned_cols=259  Identities=20%  Similarity=0.221  Sum_probs=193.3

Q ss_pred             cccccccceeEEEEEEeC-CCcEEEEEEeccccchh-------------hHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           83 STRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRI-------------AEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      .+.||+|+||+||+|... +|+.||+|.+.......             ....+.+|+++++.++||||+++++++....
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            467999999999999754 68999999986432111             0124778999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          149 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      ..++||||+. |+|.+++. ....+++.....++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++..
T Consensus        94 ~~~lv~e~~~-~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~~~~  168 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARR  168 (335)
T ss_pred             cEEEEEeccc-cCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccceee
Confidence            9999999996 58988884 45568999999999999999999999   9999999999999999999999999999976


Q ss_pred             cCCCC------------ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhH
Q 015480          229 CDRNK------------THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKH  296 (406)
Q Consensus       229 ~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  296 (406)
                      .....            .........++..|+|||.+.+...++.++|||||||++|||++|..||........  . ..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~-~~  245 (335)
T PTZ00024        169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ--L-GR  245 (335)
T ss_pred             cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HH
Confidence            54111            011112334678899999987654678999999999999999999998854432100  0 00


Q ss_pred             HHHHHh-----------hhhcchhh---ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          297 VWEEYE-----------KCELGAMI---LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       297 ~~~~~~-----------~~~~~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ......           ........   ............+..+.+++..||+.+|++||++++++.
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            000000           00000000   000000111234577899999999999999999999997

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.8e-37  Score=281.01  Aligned_cols=239  Identities=23%  Similarity=0.261  Sum_probs=185.0

Q ss_pred             ccccc--ccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEEEe
Q 015480           81 NYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        81 ~~~~~--ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      .+.+.  ||+|+||.||++.. .+|..+|+|.+.......      .|+.....+ +|||++++++++..++..++||||
T Consensus        17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~   90 (267)
T PHA03390         17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY   90 (267)
T ss_pred             ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence            34444  59999999999965 568899999987532111      122222222 699999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC-CceEeccccccccCCCCce
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~DfGl~~~~~~~~~~  235 (406)
                      +++++|.+++... ..+++..+..++.|+++||.|||+   .+++||||||+||+++.++ .++|+|||++.......  
T Consensus        91 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--  164 (267)
T PHA03390         91 IKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS--  164 (267)
T ss_pred             CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc--
Confidence            9999999999543 489999999999999999999999   9999999999999999998 99999999987554322  


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                          ...++..|+|||++.+. .++.++||||||+++|||++|..||.........      ...+....      . ..
T Consensus       165 ----~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~------~-~~  226 (267)
T PHA03390        165 ----CYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD------LESLLKRQ------Q-KK  226 (267)
T ss_pred             ----cCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh------HHHHHHhh------c-cc
Confidence                24578999999999876 6899999999999999999999998633222110      01111110      0 11


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCC-hHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPP-MSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~~vl~  349 (406)
                      .......+..+.+++.+||+.+|.+||+ ++++++
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        227 LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            1223356778999999999999999995 688874

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-37  Score=293.52  Aligned_cols=272  Identities=20%  Similarity=0.256  Sum_probs=203.4

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCC-----eeEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-----MTAL  152 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l  152 (406)
                      |.+.+.||+|+||.||+|... +|+.||+|.+..... ....+.+.+|+.+++.++||||+++++++....     ..++
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            567788999999999999764 489999999876432 334567899999999999999999999998775     7899


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      +|||+++ +|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++......
T Consensus        82 v~e~~~~-~l~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          82 VTELMET-DLHKVIK-SPQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             Eecchhh-hHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            9999974 8888884 34489999999999999999999999   99999999999999999999999999999866543


Q ss_pred             Cc-eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc--------cchhHHHHHHhh
Q 015480          233 KT-HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD--------WFPKHVWEEYEK  303 (406)
Q Consensus       233 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~  303 (406)
                      .. ........++..|+|||.+.+...++.++|+||||+++|+|++|..||.........        ......+.....
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence            21 011233457889999999887657899999999999999999999988543221000        000000000000


Q ss_pred             hhcchhhc------cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcccc
Q 015480          304 CELGAMIL------GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVVE  356 (406)
Q Consensus       304 ~~~~~~~~------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~~  356 (406)
                      ........      ...........+..+.+++.+||+.+|.+||++.+++.  .++.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            00000000      00000111234677899999999999999999999998  4655543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.4e-37  Score=282.26  Aligned_cols=247  Identities=23%  Similarity=0.327  Sum_probs=194.4

Q ss_pred             hcccccccccceeEEEEEEeCC-CcEEEEEEeccc----cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~~-g~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      |.+.+.||+|+||.||++.+.. +..+++|+++..    ........+..|+.+++.++||||+++++++.+....++||
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            5677889999999999997643 455666666532    12223456778999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          155 EYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       155 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||+   .+++|+||+|+||++++ +.++|+|||++.....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence            99999999988853   34679999999999999999999999   99999999999999975 5799999999876543


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ....  .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..|+.....          ......      ..
T Consensus       158 ~~~~--~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----------~~~~~~------~~  218 (260)
T cd08222         158 SCDL--ATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNF----------LSVVLR------IV  218 (260)
T ss_pred             Cccc--ccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHHH------HH
Confidence            3221  1235578899999998765 678899999999999999999988742211          011000      11


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .......+...+..+.+++.+||+.+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         219 EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            11223334566788999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-37  Score=284.67  Aligned_cols=263  Identities=24%  Similarity=0.294  Sum_probs=198.6

Q ss_pred             cccccccccceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           81 NYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      ...+.||+|+||.||+|+.. +++.||+|++.... .....+.+..|+.+++.++|+|++++++++.+....++||||++
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD   81 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence            44567999999999999765 59999999998643 22334678889999999999999999999999999999999997


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                       ++|.+++......+++..+..++.|++.||+|||+   .+++||||+|+||++++++.++|+|||++........  ..
T Consensus        82 -~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~  155 (282)
T cd07829          82 -MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TY  155 (282)
T ss_pred             -cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--cc
Confidence             59999996554679999999999999999999999   9999999999999999999999999999976543322  12


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc--------ccchhHHHHHHhhhhcchhh
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL--------DWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~  310 (406)
                      ....++..|+|||.+.+...++.++||||||+++|||++|.+||........        .......|............
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            2344577899999987655789999999999999999999888754321100        00000011111100000000


Q ss_pred             ccC----CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          311 LGC----GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       311 ~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...    .........+..+.+++..||+.||++||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000    000111223677999999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.5e-37  Score=283.29  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=199.7

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  154 (406)
                      .|.+.+.||+|+||.||+|... +|+.||+|++....  .......+..|.+++.+++ ||||+++++++.+....++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            3566788999999999999764 69999999987532  2233467888999999998 999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          82 EYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            99999999999943 4579999999999999999999999   9999999999999999999999999999976543321


Q ss_pred             e------------------EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhH
Q 015480          235 H------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKH  296 (406)
Q Consensus       235 ~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  296 (406)
                      .                  .......++..|+|||..... ..+.++|+||||++++++++|..|+.....         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------  227 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNE---------  227 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccH---------
Confidence            1                  112234578899999998766 689999999999999999999998754321         


Q ss_pred             HHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCCh----HHHHH
Q 015480          297 VWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPM----SAVIK  349 (406)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~~vl~  349 (406)
                       ........       ......+...+..+.+++.+||+.+|.+||++    .++++
T Consensus       228 -~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         228 -YLTFQKIL-------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -HHHHHHHH-------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence             01111000       00112223446789999999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-38  Score=311.55  Aligned_cols=259  Identities=25%  Similarity=0.260  Sum_probs=208.0

Q ss_pred             hHHHhhhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccc--cchhhHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           72 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        72 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      ...+....|.+.+.||+|+||+|..++.+ +++.||+|++.+-  ........|+.|-.+|..-+.+=|++++-.|.++.
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            45566777888899999999999999874 4888999999752  11223456888999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          149 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      ++|+||||++||+|..++.... .+++..+..++..|+-||..||+   .|+|||||||+|||||.+|++||+|||.+..
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHh
Confidence            9999999999999999995555 89999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCC----CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhh
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC  304 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (406)
                      +..+.. ......+|||.|.+||++..    ...|++.+|+||+||++|||+.|..||..+          ...+.+.+.
T Consensus       225 m~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad----------slveTY~KI  293 (1317)
T KOG0612|consen  225 MDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD----------SLVETYGKI  293 (1317)
T ss_pred             cCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH----------HHHHHHHHH
Confidence            765544 33467889999999999853    236899999999999999999999998532          233333322


Q ss_pred             hcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCC---hHHHHH
Q 015480          305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPP---MSAVIK  349 (406)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~~vl~  349 (406)
                      -..  -..-..+ .....+.+..+||.+.+. +|+.|..   ++++-.
T Consensus       294 m~h--k~~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  294 MNH--KESLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             hch--hhhcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            111  1111112 123477888888888764 6888887   888766

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-37  Score=290.45  Aligned_cols=267  Identities=20%  Similarity=0.260  Sum_probs=195.4

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCC------ee
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH------MT  150 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~  150 (406)
                      .|...+.||+|+||.||+|.. .+|+.||+|++.... .......+.+|+.+++.++||||+++++++....      ..
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   95 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF   95 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence            456678899999999999975 468999999987532 2223456889999999999999999999986543      45


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ++|+||+.. +|..+.   ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++...
T Consensus        96 ~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~  168 (342)
T cd07879          96 YLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHAD  168 (342)
T ss_pred             EEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence            899999964 776655   3468999999999999999999999   999999999999999999999999999987543


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc--------chhHHHHHHh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW--------FPKHVWEEYE  302 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~  302 (406)
                      ...     ....++..|+|||.+.+...++.++|||||||++|||++|+.||..........        ......+...
T Consensus       169 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (342)
T cd07879         169 AEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE  243 (342)
T ss_pred             CCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence            221     234578899999998765468899999999999999999999986432110000        0000000000


Q ss_pred             hhhcchhhccC---CCC---cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--HhhccccC
Q 015480          303 KCELGAMILGC---GIE---EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVVEV  357 (406)
Q Consensus       303 ~~~~~~~~~~~---~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~~~  357 (406)
                      ...........   ...   ......+..+.+++.+||+.||.+||++.+++.  .++.....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            00000000000   000   001124567889999999999999999999995  46666543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=8.4e-37  Score=288.20  Aligned_cols=264  Identities=21%  Similarity=0.260  Sum_probs=196.3

Q ss_pred             hhhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEec-CCeeEE
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-QHMTAL  152 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~l  152 (406)
                      .+..|.+.+.||.|+||.||++.. .+|..||+|++.... .......+..|++++..++||||+++++++.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            345577789999999999999965 478999999886432 22345678899999999999999999999865 567889


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ++||+ +++|.+++.  ...+++..+..++.|+++||.|||+   .+++||||+|+||++++++.++|+|||++......
T Consensus        88 v~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          88 VTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             Eeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence            99999 568988873  3467888899999999999999999   99999999999999999999999999999754322


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc--------ccchhHHHHHHhhh
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL--------DWFPKHVWEEYEKC  304 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~  304 (406)
                      .     ....++..|+|||.+.+...++.++||||||+++|+|++|..||........        ...+....+.....
T Consensus       162 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd07856         162 M-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE  236 (328)
T ss_pred             c-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence            1     2345788999999887644689999999999999999999988854321100        00000000000000


Q ss_pred             hcchhhccC-CCC-----cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          305 ELGAMILGC-GIE-----EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       305 ~~~~~~~~~-~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      ......... ...     ......+..+.+++.+||+.+|++||++.+++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000 000     1112245789999999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-37  Score=279.39  Aligned_cols=274  Identities=26%  Similarity=0.323  Sum_probs=209.3

Q ss_pred             cCCCceeeChHHHhhhhhcccccccccceeEEEEE-EeCCCcEEEEEEeccc--cc----hhhHHHHHHHHHHhhccCcC
Q 015480           63 GREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLNRN--LG----RIAEEQFMAEVGTIGRTYHI  135 (406)
Q Consensus        63 ~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~-~~~~g~~vavK~~~~~--~~----~~~~~~~~~e~~~l~~l~h~  135 (406)
                      ..+....|...-+.+.+|-+..+||+|||++||++ .+...+.||||+-.-+  ..    ....+...+|.++-+.|.||
T Consensus       448 ~NEdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHp  527 (775)
T KOG1151|consen  448 HNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHP  527 (775)
T ss_pred             cccchhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcc
Confidence            33444566666677788888899999999999999 5566889999986532  22    12235677899999999999


Q ss_pred             ccccEEEEEe-cCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc-
Q 015480          136 NLVRLYGFCH-DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-  213 (406)
Q Consensus       136 niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~-  213 (406)
                      .||++|++|. +.+.+|-|+|||+|.+|+-|| ...+.+++..+..|+.||+.||.||... +.+|+|-||||.|||+. 
T Consensus       528 RIVKlYDyfslDtdsFCTVLEYceGNDLDFYL-KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~  605 (775)
T KOG1151|consen  528 RIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYL-KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVN  605 (775)
T ss_pred             eeeeeeeeeeeccccceeeeeecCCCchhHHH-HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEec
Confidence            9999999985 667889999999999999888 5567899999999999999999999973 48999999999999994 


Q ss_pred             --CCCCceEeccccccccCCCCce-----EEecCCCCCCCccCccccCC---CCCCCcccceeecchhHHHHhhcccccc
Q 015480          214 --ANFSPKVADFGLAKLCDRNKTH-----VTISGYKGTPGYSAPEFLSG---NYPITHKCDVYSFGMVLFEIVGRRRNAI  283 (406)
Q Consensus       214 --~~~~~kl~DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~il~elltg~~p~~  283 (406)
                        ..|.+||+||||++.++.+...     .-.+...||.+|++||++.-   .+..+.++||||+|||+|..+.|++||.
T Consensus       606 GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG  685 (775)
T KOG1151|consen  606 GTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG  685 (775)
T ss_pred             CcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence              4578999999999988754332     22356789999999998742   2357889999999999999999999997


Q ss_pred             cCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          284 VGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ......         ..+....+.... .-..+ ..+..+.+..+++.+||+..-++|.+..++..
T Consensus       686 hnqsQQ---------dILqeNTIlkAt-EVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  686 HNQSQQ---------DILQENTILKAT-EVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             CchhHH---------HHHhhhchhcce-eccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            654321         111111111000 00011 11345567889999999999999988777643

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.2e-37  Score=288.95  Aligned_cols=265  Identities=20%  Similarity=0.248  Sum_probs=192.5

Q ss_pred             hcccccccccceeEEEEEEeC-C--CcEEEEEEeccccc-hhhHHHHHHHHHHhhcc-CcCccccEEEEEecC----Cee
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-N--GVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQ----HMT  150 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~--g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~~  150 (406)
                      |.+.+.||+|+||.||++... +  +..||+|.+..... ......+.+|+.++.++ +||||+++++.+...    ...
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            566788999999999999764 3  77899999875322 22346788899999999 599999999875432    456


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      +++++|+. ++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        82 ~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          82 YLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            88999985 58988883 45678999999999999999999999   999999999999999999999999999997654


Q ss_pred             CCCce--EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc--------ccchhHHHHH
Q 015480          231 RNKTH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL--------DWFPKHVWEE  300 (406)
Q Consensus       231 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~  300 (406)
                      .....  .......|+..|+|||.+.+...++.++||||||+++|+|++|..||........        .......+..
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            32211  1123356899999999877654689999999999999999999988754321100        0000000011


Q ss_pred             Hhhhhcchh---hccCC---CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          301 YEKCELGAM---ILGCG---IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       301 ~~~~~~~~~---~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .........   .....   ........+..+.+++.+||+.||.+|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000   00000   00111123567999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-36  Score=289.04  Aligned_cols=261  Identities=20%  Similarity=0.255  Sum_probs=192.6

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecC------Ce
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------HM  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  149 (406)
                      .+|...+.||+|+||.||+|.. .+|+.||+|++.... .....+.+.+|+.++.+++||||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            4466678899999999999965 568999999987532 223346788899999999999999999988543      34


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .+++++++ +++|.+++.  ...+++..+..++.|+++||+|||+   .+++||||||+||++++++.+||+|||++...
T Consensus        97 ~~lv~~~~-~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877          97 VYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             EEEEehhc-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence            67888887 779988873  3468999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc--------ccchhHHHHHH
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL--------DWFPKHVWEEY  301 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~~  301 (406)
                      ...     .....++..|+|||.+.+...++.++|||||||++|||++|+.||........        ...........
T Consensus       171 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T cd07877         171 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  245 (345)
T ss_pred             ccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            322     12346788999999887644688999999999999999999998843221100        00000000000


Q ss_pred             hhhhcchhhcc-CCCC-----cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          302 EKCELGAMILG-CGIE-----EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       302 ~~~~~~~~~~~-~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ........... ...+     ......+..+.+++.+|++.||.+||++.+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            00000000000 0000     001123567899999999999999999999987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.5e-37  Score=291.95  Aligned_cols=260  Identities=20%  Similarity=0.277  Sum_probs=195.2

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCe------e
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM------T  150 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------~  150 (406)
                      .|...+.||+|+||.||+|... +++.||+|++.... .......+.+|+.++++++|||++++++++.....      .
T Consensus        16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07851          16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV   95 (343)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence            4667788999999999999774 58899999987532 22334567789999999999999999998866554      8


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ++|+||+ +++|.+++.  ...+++..+..++.|++.||+|||+   .+++||||+|+||++++++.++|+|||++....
T Consensus        96 ~lv~e~~-~~~L~~~~~--~~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          96 YLVTHLM-GADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             EEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence            9999999 669999884  3569999999999999999999999   999999999999999999999999999997654


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc--------ccchhHHHHHHh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL--------DWFPKHVWEEYE  302 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~  302 (406)
                      ..     .....++..|+|||.+.+...++.++||||||+++|||++|+.||........        ...+...+....
T Consensus       170 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         170 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             cc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence            32     23356788999999987644678999999999999999999998854322100        000000011110


Q ss_pred             hhhcchhhcc---CCCC---cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          303 KCELGAMILG---CGIE---EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       303 ~~~~~~~~~~---~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..........   ....   ......+..+.+++.+||+.||++|||+.+|++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0000000000   0000   111123678999999999999999999999987

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.3e-37  Score=292.02  Aligned_cols=268  Identities=21%  Similarity=0.237  Sum_probs=194.0

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecC---------
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ---------  147 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---------  147 (406)
                      .+|...+.||.|+||.||+|.. .+|..||+|.+..... ...+.+.+|+++++.++||||+++++++...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            4566778999999999999965 5689999999865432 3456788999999999999999999876553         


Q ss_pred             -----CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc-CCCCceEe
Q 015480          148 -----HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVA  221 (406)
Q Consensus       148 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~  221 (406)
                           ...++||||++ ++|.+++.  ...+++..+..++.|++.||.|||+   .+++||||||+||+++ +++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999997 58988873  3468899999999999999999999   9999999999999997 45678999


Q ss_pred             ccccccccCCCCceE-EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc--------cc
Q 015480          222 DFGLAKLCDRNKTHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL--------DW  292 (406)
Q Consensus       222 DfGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~  292 (406)
                      |||++.......... ......++..|+|||.+.+...++.++|||||||++|+|++|+.||........        ..
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999997654321111 112235788999999876544688999999999999999999999854321100        00


Q ss_pred             chhHHHHHHhhhhcchhhc-cCCCC-----cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhc
Q 015480          293 FPKHVWEEYEKCELGAMIL-GCGIE-----EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEG  353 (406)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~  353 (406)
                      ........... ....... .....     ......+.++.+++.+||+.||.+|||+.+++.  .++.
T Consensus       238 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         238 VREEDRNELLN-VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             CChHHhhhhhh-hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence            00000000000 0000000 00000     111234577899999999999999999999986  4543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=270.68  Aligned_cols=267  Identities=21%  Similarity=0.295  Sum_probs=206.9

Q ss_pred             cccccccceeEEEEE-EeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEEEeccCC
Q 015480           83 STRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      .+.||+|+|+.|--+ ...+|..||||++.+. ......+..+|++++.+.+ |+||++++++|.++..+|||||-|.||
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG  161 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence            467999999999998 4678999999999876 4467788999999999996 999999999999999999999999999


Q ss_pred             ChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC---CceEeccccccccCC-----C
Q 015480          161 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKLCDR-----N  232 (406)
Q Consensus       161 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~DfGl~~~~~~-----~  232 (406)
                      +|...+ .++..+++..+.++..+|+.||.|||.   +||.|||+||+|||-....   -+|||||.|..-...     .
T Consensus       162 plLshI-~~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  162 PLLSHI-QKRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             hHHHHH-HHhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            999988 456789999999999999999999999   9999999999999996554   489999998753221     1


Q ss_pred             CceEEecCCCCCCCccCccccC----CCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          233 KTHVTISGYKGTPGYSAPEFLS----GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      .........+|+..|||||+..    ....|+.+.|.||||+|+|-||+|.+||-......-.|-.-.+ -..-...+..
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~-Cr~CQ~~LFe  316 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV-CRVCQNKLFE  316 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc-cHHHHHHHHH
Confidence            2222344578999999999753    2236889999999999999999999999655444333322111 0000111111


Q ss_pred             hhccCCCC---cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhccc
Q 015480          309 MILGCGIE---EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVV  355 (406)
Q Consensus       309 ~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~  355 (406)
                      .+..+..+   ......+.+..+++...+..|+.+|.++.++++  ....+.
T Consensus       317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~  368 (463)
T KOG0607|consen  317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA  368 (463)
T ss_pred             HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence            22222211   223467788899999999999999999999987  444443

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.3e-38  Score=273.93  Aligned_cols=268  Identities=20%  Similarity=0.259  Sum_probs=197.0

Q ss_pred             hhcccccccccceeEEEEEEeCC-----CcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEec-CCeeE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFPN-----GVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-QHMTA  151 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~~-----g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~  151 (406)
                      .|+....||+|.||.||+|.-.+     ...+|+|.++.... ........+|+.+++.++|||++.+..++.. +...+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~  104 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW  104 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence            35567789999999999994322     23689999875422 2234567789999999999999999999877 78899


Q ss_pred             EEEEeccCCChhhHhh----cCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC----CCceEecc
Q 015480          152 LVYEYMENGSLDGYLF----GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN----FSPKVADF  223 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~----~~~kl~Df  223 (406)
                      |++||.+. +|...++    ...+.++...+..|+.||+.|+.|||+   .=++||||||.||||..+    |.+||+||
T Consensus       105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999987 8888874    234578999999999999999999999   789999999999999877    89999999


Q ss_pred             ccccccCCCCce-EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc---cchhHH--
Q 015480          224 GLAKLCDRNKTH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD---WFPKHV--  297 (406)
Q Consensus       224 Gl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~---~~~~~~--  297 (406)
                      |+++.+.+.-.. ......+-|.+|.|||.+.+...|+.+.|||+.|||+.||++-.+.|.........   +.....  
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            999988654322 23344567889999999999889999999999999999999988777554332221   111111  


Q ss_pred             ------------HHHHhhhhcc-hhhcc---CCCCcc-h-------HHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          298 ------------WEEYEKCELG-AMILG---CGIEEK-D-------KEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       298 ------------~~~~~~~~~~-~~~~~---~~~~~~-~-------~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                                  |....+.... ..+..   ...... .       ...++...+|+..+|..||.+|.|+.+.++.
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence                        1111000000 00000   000000 0       0112337789999999999999999998874

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=275.77  Aligned_cols=237  Identities=29%  Similarity=0.341  Sum_probs=192.2

Q ss_pred             ccccceeEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCCh
Q 015480           86 LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  162 (406)
Q Consensus        86 ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  162 (406)
                      ||+|+||.||++... +++.+|+|++.....  ......+..|+.++++++||||+++++.+.++...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999764 589999999876432  22456788999999999999999999999999999999999999999


Q ss_pred             hhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCC
Q 015480          163 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK  242 (406)
Q Consensus       163 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~  242 (406)
                      .+++.. ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        81 ~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  154 (250)
T cd05123          81 FSHLSK-EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFC  154 (250)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCc
Confidence            999943 3468999999999999999999999   9999999999999999999999999999976544321  123456


Q ss_pred             CCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHH
Q 015480          243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK  322 (406)
Q Consensus       243 gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (406)
                      ++..|+|||.+.+. ..+.++|+||||+++|+|++|..||......       ........          .....+...
T Consensus       155 ~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~----------~~~~~~~~~  216 (250)
T cd05123         155 GTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK-------EIYEKILK----------DPLRFPEFL  216 (250)
T ss_pred             CCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHhc----------CCCCCCCCC
Confidence            78899999998876 6789999999999999999999988543210       00011100          011222233


Q ss_pred             HHHHHHHHHHhcccCCCCCCChHH
Q 015480          323 AKRLCMVALWCVQDSPEDRPPMSA  346 (406)
Q Consensus       323 ~~~l~~l~~~cl~~dP~~RPs~~~  346 (406)
                      +..+.+++.+||..||++||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            678899999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=269.70  Aligned_cols=247  Identities=27%  Similarity=0.363  Sum_probs=194.2

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEEEeccCCC
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~  161 (406)
                      ..||.|+||+|++-.+ +.|+..|||+++.+..+....+++.|.+...+- +.||||++||.+..++-.|+.||.|.- +
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-S  148 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-S  148 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-h
Confidence            4699999999999955 569999999999876667778899888876554 699999999999999999999999954 7


Q ss_pred             hhhHhh----cCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          162 LDGYLF----GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       162 L~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      |+.+..    ..+..+++.-+-.|+...+.||.||..  ...|+|||+||+|||++..|.+||||||.+-.+...-..  
T Consensus       149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk--  224 (361)
T KOG1006|consen  149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK--  224 (361)
T ss_pred             HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHh--
Confidence            766552    245678888888999999999999998  478999999999999999999999999999765433222  


Q ss_pred             ecCCCCCCCccCccccCCCC-CCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC-
Q 015480          238 ISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI-  315 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  315 (406)
                       +.-.|-..|||||.+.... .|+-+|||||||++|||+.||+-|+.....         +.+........    +.++ 
T Consensus       225 -T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---------vfeql~~Vv~g----dpp~l  290 (361)
T KOG1006|consen  225 -TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---------VFEQLCQVVIG----DPPIL  290 (361)
T ss_pred             -hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---------HHHHHHHHHcC----CCCee
Confidence             2345667899999987543 489999999999999999999977532111         11222211111    1111 


Q ss_pred             --CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 --EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 --~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        +....+.+..+..++..|+.+|-.+||.++++.+
T Consensus       291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence              1223457888999999999999999999999877

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-37  Score=265.79  Aligned_cols=254  Identities=22%  Similarity=0.254  Sum_probs=199.0

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEec----CCeeEEEEEec
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHD----QHMTALVYEYM  157 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~  157 (406)
                      ++||-|-.|.|-.+.. .+|+.+|+|++...      ...++|+++--.. .|||||+++++|.+    ...+.+|||.+
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m  141 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM  141 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence            6799999999999954 56999999998742      3456788776665 49999999999854    45777999999


Q ss_pred             cCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC---CCCceEeccccccccCCCC
Q 015480          158 ENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       158 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~DfGl~~~~~~~~  233 (406)
                      +||.|...+..+ ...+++.++..|+.||+.|++|||+   .+|+||||||+|+|...   |..+||+|||+|+......
T Consensus       142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~  218 (400)
T KOG0604|consen  142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG  218 (400)
T ss_pred             cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCCc
Confidence            999999998654 4679999999999999999999999   99999999999999964   5579999999998665432


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                         .....+-|+.|.|||++... .|+...|+||+||++|-|++|.+||.......   .+.........+...      
T Consensus       219 ---~L~TPc~TPyYvaPevlg~e-KydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gqy~------  285 (400)
T KOG0604|consen  219 ---DLMTPCFTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQYE------  285 (400)
T ss_pred             ---cccCCcccccccCHHHhCch-hcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccCcc------
Confidence               23456789999999999877 69999999999999999999999997544321   111111111111110      


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--HhhccccCCC
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVVEVLP  359 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~~~~~  359 (406)
                      ...+...+.++...++++.+|..+|.+|.|+.++++  .+........
T Consensus       286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~  333 (400)
T KOG0604|consen  286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQ  333 (400)
T ss_pred             CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCC
Confidence            012344567888999999999999999999999988  5554444433

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-38  Score=270.73  Aligned_cols=264  Identities=25%  Similarity=0.356  Sum_probs=199.2

Q ss_pred             cccccccceeEEEEEEeCC-CcEEEEEEec-cccchhhHHHHHHHHHHhhccCcCccccEEEEEec--------CCeeEE
Q 015480           83 STRLGFGGFGEVYKGQFPN-GVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--------QHMTAL  152 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~-g~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~~~~~l  152 (406)
                      ..+||+|.||+||+|+.++ |+.||+|..- .+..+.--....+|+++|..+.|+|++.++..|..        ...+|+
T Consensus        22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl  101 (376)
T KOG0669|consen   22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL  101 (376)
T ss_pred             HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence            4579999999999997654 7888887653 33233344567899999999999999999988843        235789


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ||++|+. +|..++......++..++.+++.++..||.|+|.   ..|+|||+||.|+||+.+|.+||+|||+++.+...
T Consensus       102 Vf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~  177 (376)
T KOG0669|consen  102 VFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAFSTS  177 (376)
T ss_pred             eHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence            9999987 9999996666889999999999999999999999   89999999999999999999999999999765433


Q ss_pred             C--ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcc-c-------ccchhHHHHHHh
Q 015480          233 K--THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES-L-------DWFPKHVWEEYE  302 (406)
Q Consensus       233 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-~-------~~~~~~~~~~~~  302 (406)
                      .  .....++.+-|.+|.+||.+.+...++++.|||..|||+.||++|.+.+....... .       ......+|...+
T Consensus       178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d  257 (376)
T KOG0669|consen  178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVD  257 (376)
T ss_pred             cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcc
Confidence            2  22234556679999999999998899999999999999999999987654322110 0       111222333333


Q ss_pred             hhhcchhhccCCCCc----chHHH------HHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          303 KCELGAMILGCGIEE----KDKEK------AKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       303 ~~~~~~~~~~~~~~~----~~~~~------~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      +-.+...+...++.+    ...+.      .++..+|+..++..||.+|+++++++..
T Consensus       258 ~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  258 NLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            332222221111111    11122      2367899999999999999999998874

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=281.01  Aligned_cols=245  Identities=25%  Similarity=0.308  Sum_probs=198.2

Q ss_pred             HHhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccC-cCccccEEEEEecCCe
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHM  149 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  149 (406)
                      .+....++|...||+|+||+|.++.- .+.+.+|||+++++.-  ....+--+.|-++|+... -|.+++++.+|+.-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            34556678899999999999999955 3467899999997642  122334456777887764 7789999999999999


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      +|+||||+.||+|.-.+ +.-+.+.+..+.-++..||-||-|||+   +||++||||.+|||+|.+|++||+|||+++.-
T Consensus       425 LyFVMEyvnGGDLMyhi-QQ~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHI-QQVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eeeEEEEecCchhhhHH-HHhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999999998777 445678888999999999999999999   99999999999999999999999999999743


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      -..  ......++||+.|+|||++..+ +|+..+|+|||||+||||+.|++||+....+.+       .....+.     
T Consensus       501 i~~--~~TTkTFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-------F~aI~eh-----  565 (683)
T KOG0696|consen  501 IFD--GVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------FQAIMEH-----  565 (683)
T ss_pred             ccC--CcceeeecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHHc-----
Confidence            322  2233468999999999999988 899999999999999999999999976543311       1111111     


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCC
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRP  342 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  342 (406)
                          . -..+...+.+...++...|.+.|.+|.
T Consensus       566 ----n-vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  566 ----N-VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ----c-CcCcccccHHHHHHHHHHhhcCCcccc
Confidence                1 234567788899999999999999994

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=280.96  Aligned_cols=244  Identities=24%  Similarity=0.321  Sum_probs=201.4

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEeccc-cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCC
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  161 (406)
                      +.||+|.||+||-|++ ++|+.||||++.+. .....+.+++.|+.+|.+++||.||.+..-|+..+..++|||-+.|.-
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            6799999999999965 67999999999754 344566889999999999999999999999999999999999997655


Q ss_pred             hhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC---CCceEeccccccccCCCCceEEe
Q 015480          162 LDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       162 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      |.-.|....+++++....-++.||+.||.|||.   ++|+|+||||+|||+.+.   -.+||||||+|+........   
T Consensus       650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR---  723 (888)
T KOG4236|consen  650 LEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR---  723 (888)
T ss_pred             HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhhh---
Confidence            665666677889999999999999999999999   999999999999999654   36999999999988765543   


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ...+||+.|+|||+++++ .|...-|+||.|||+|--++|.-||..+.....         ...+   ..++..   +..
T Consensus       724 rsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd---------QIQN---AaFMyP---p~P  787 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND---------QIQN---AAFMYP---PNP  787 (888)
T ss_pred             hhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhH---------Hhhc---cccccC---CCc
Confidence            347899999999999987 899999999999999999999999865543211         1111   111111   233


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       319 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..+.+.+..+|+...|+..-.+|-|.+.-+.
T Consensus       788 W~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            4567788999999999999999998876544

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.6e-36  Score=269.60  Aligned_cols=220  Identities=20%  Similarity=0.154  Sum_probs=175.5

Q ss_pred             cceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCChhhHhh
Q 015480           89 GGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF  167 (406)
Q Consensus        89 G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  167 (406)
                      |.||.||++.. .+|+.||+|.++...      .+..|...+....||||+++++++.+....++||||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            89999999966 568999999997642      22344455555679999999999999999999999999999999984


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCc
Q 015480          168 GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY  247 (406)
Q Consensus       168 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y  247 (406)
                      . ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++++|||.+.......     ....++..|
T Consensus        78 ~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y  148 (237)
T cd05576          78 K-FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY  148 (237)
T ss_pred             H-hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence            3 3468999999999999999999999   999999999999999999999999999886554321     234467789


Q ss_pred             cCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHH
Q 015480          248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLC  327 (406)
Q Consensus       248 ~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (406)
                      +|||.+.+. .++.++||||+|+++|||++|..|+........                     .......+...+..+.
T Consensus       149 ~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~  206 (237)
T cd05576         149 CAPEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------------THTTLNIPEWVSEEAR  206 (237)
T ss_pred             cCCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------------cccccCCcccCCHHHH
Confidence            999998766 678999999999999999999876532211000                     0000012233557789


Q ss_pred             HHHHHhcccCCCCCCChH
Q 015480          328 MVALWCVQDSPEDRPPMS  345 (406)
Q Consensus       328 ~l~~~cl~~dP~~RPs~~  345 (406)
                      +++.+||+.||++||++.
T Consensus       207 ~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         207 SLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHccCCHHHhcCCC
Confidence            999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=243.90  Aligned_cols=260  Identities=20%  Similarity=0.247  Sum_probs=197.4

Q ss_pred             cccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCC
Q 015480           83 STRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      -++||+|.||+||+|+. .+++.||+|.++-+. .+.......+|+-+++.+.|.|||+++++...+..+.+|+|||.. 
T Consensus         7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-   85 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-   85 (292)
T ss_pred             HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence            45799999999999965 558999999998543 333446788999999999999999999999999999999999965 


Q ss_pred             ChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecC
Q 015480          161 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG  240 (406)
Q Consensus       161 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~  240 (406)
                      +|..+...-++.++.+.+..++.|+++||.|+|+   +++.|||+||.|+||+.+|..||+|||+++.+.-...  ..+.
T Consensus        86 dlkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr--cysa  160 (292)
T KOG0662|consen   86 DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--CYSA  160 (292)
T ss_pred             HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--eeec
Confidence            9999998888999999999999999999999999   9999999999999999999999999999987764432  2334


Q ss_pred             CCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHH--hhhhcc---hhhccCCC
Q 015480          241 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEY--EKCELG---AMILGCGI  315 (406)
Q Consensus       241 ~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~  315 (406)
                      .+-|.+|.+|.++.+..-|+...|+||-|||+.|+.....|...+..-..+ +....+..-  .+....   ...+-...
T Consensus       161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq-lkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH-HHHHHHHhCCCccccCCccccCCCCccc
Confidence            567899999999998878999999999999999999766665444321110 000000000  000000   00010011


Q ss_pred             Ccch---------HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKD---------KEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~---------~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      +..+         +.....=.+++...+.-+|..|.+++..++
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            1111         122233467888889999999999998765

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-37  Score=283.16  Aligned_cols=243  Identities=24%  Similarity=0.320  Sum_probs=203.1

Q ss_pred             ccccccceeEEEEEEeCCCc-EEEEEEeccc--cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCC
Q 015480           84 TRLGFGGFGEVYKGQFPNGV-KIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~-~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      .-||-|+||.|=+++.++.. .+|+|++++.  ....+.+++..|-++|...+.|.||++|-.|.++...|++||-|-||
T Consensus       426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG  505 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG  505 (732)
T ss_pred             hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence            45999999999999875433 3899998764  34456788899999999999999999999999999999999999999


Q ss_pred             ChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecC
Q 015480          161 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG  240 (406)
Q Consensus       161 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~  240 (406)
                      .|...+ ..++.++..+..-++..+++|+.|||+   ++|++|||||+|+++|.+|-+||.|||+|+........++   
T Consensus       506 ElWTiL-rdRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwT---  578 (732)
T KOG0614|consen  506 ELWTIL-RDRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWT---  578 (732)
T ss_pred             hhhhhh-hhcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCCceee---
Confidence            999999 567789999999999999999999999   9999999999999999999999999999999887766654   


Q ss_pred             CCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchH
Q 015480          241 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK  320 (406)
Q Consensus       241 ~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (406)
                      ++||+.|.|||++.++ ..+.++|.||||+++|||++|.+||....+-       ..++..-.+        -..-..+.
T Consensus       579 FcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dpm-------ktYn~ILkG--------id~i~~Pr  642 (732)
T KOG0614|consen  579 FCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDPM-------KTYNLILKG--------IDKIEFPR  642 (732)
T ss_pred             ecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCchH-------HHHHHHHhh--------hhhhhccc
Confidence            8999999999999987 8999999999999999999999999543221       011111111        01123456


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 015480          321 EKAKRLCMVALWCVQDSPEDRPP-----MSAVIK  349 (406)
Q Consensus       321 ~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  349 (406)
                      ...+...+++++....+|.+|.-     +.+|-+
T Consensus       643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk  676 (732)
T KOG0614|consen  643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKK  676 (732)
T ss_pred             ccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence            66778899999999999999975     555554

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.5e-35  Score=301.30  Aligned_cols=145  Identities=30%  Similarity=0.365  Sum_probs=129.0

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.++||+|+||+||+|.+. +++.||||+++...  .......+..|+.++..++||||+++++++......++|||
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE   84 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME   84 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence            4567789999999999999764 68999999997532  22334678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      |+.+++|.+++.. ...+++..++.++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++
T Consensus        85 y~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          85 YLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999843 4568899999999999999999999   899999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-36  Score=284.54  Aligned_cols=237  Identities=23%  Similarity=0.271  Sum_probs=190.6

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      .|.+...+|.|+|+.|-.+.. .+++..++|++.+...     +-.+|+.++... +||||+++.+.+.+..+.|+|||+
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~  397 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL  397 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence            455667799999999999954 5688899999986422     233566555555 699999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEE-cCCCCceEeccccccccCCCCce
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL-DANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill-~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +.|+-+.+.+... .... ..+..|+.+|+.++.|||+   +|++||||||+|||+ ++.++++|+|||.++.....   
T Consensus       398 l~g~ell~ri~~~-~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---  469 (612)
T KOG0603|consen  398 LDGGELLRRIRSK-PEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---  469 (612)
T ss_pred             ccccHHHHHHHhc-chhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence            9999887776333 2233 7888899999999999999   999999999999999 68999999999999866554   


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        ....+-|..|.|||++... ++++++||||||++||+||+|+.|+.....+               .++...+..   
T Consensus       470 --~~tp~~t~~y~APEvl~~~-~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---------------~ei~~~i~~---  528 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLAIQ-EYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---------------IEIHTRIQM---  528 (612)
T ss_pred             --hcccchhhcccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCccccCCch---------------HHHHHhhcC---
Confidence              2234568899999999966 8999999999999999999999998655443               011111111   


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .......+....+|+.+||+.||.+||++.++..
T Consensus       529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            2223667888999999999999999999999877

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=282.75  Aligned_cols=252  Identities=24%  Similarity=0.321  Sum_probs=203.6

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEec-----CCe
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHD-----QHM  149 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-----~~~  149 (406)
                      +.++.+.+.||.|.+|.||+++. ++|+..|+|+...+..  ..+.+..|.++++.+ +|||++.++|++.-     ++.
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            44567788899999999999964 5799999999886533  445677788888877 59999999999843     578


Q ss_pred             eEEEEEeccCCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          150 TALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      +|||||||.+|+..|++.. .+..+.|..+..|++.++.||++||.   ..++|||||-.|||++.++.+||+|||++..
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeee
Confidence            9999999999999999853 36789999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCCC----CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhh
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC  304 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (406)
                      .+....  ..+.+.||+.|||||++...    ..|+.++|+||||++..||--|.+|+....+-.          .+...
T Consensus       173 ldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr----------aLF~I  240 (953)
T KOG0587|consen  173 LDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR----------ALFLI  240 (953)
T ss_pred             eecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh----------hhccC
Confidence            664332  23457899999999998643    246789999999999999999998875432211          10000


Q ss_pred             hcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                          ..........+...++++.++|..||.+|...||++.++++
T Consensus       241 ----pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  241 ----PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ----CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                00112222345678899999999999999999999998876

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.2e-34  Score=258.95  Aligned_cols=239  Identities=28%  Similarity=0.422  Sum_probs=191.4

Q ss_pred             ceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCChhhHhhc
Q 015480           90 GFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFG  168 (406)
Q Consensus        90 ~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  168 (406)
                      +||.||+|.+. +|+.+++|++.........+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999875 48999999998653322267899999999999999999999999999999999999999999999854


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCcc
Q 015480          169 KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYS  248 (406)
Q Consensus       169 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~  248 (406)
                      .. .+++..+..++.+++.++.|||+   .+++|+||+|+||+++.++.++|+|||.+.......   ......++..|+
T Consensus        81 ~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RG-RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             cc-CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            33 38999999999999999999999   899999999999999999999999999998665432   223456788999


Q ss_pred             CccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHH
Q 015480          249 APEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCM  328 (406)
Q Consensus       249 aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (406)
                      +||.+.+. .++.++||||||+++|+|++|..|+......      ....+.......       .........+..+.+
T Consensus       154 ~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~-------~~~~~~~~~~~~~~~  219 (244)
T smart00220      154 APEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKP-------PFPPPEWKISPEAKD  219 (244)
T ss_pred             CHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCC-------CCccccccCCHHHHH
Confidence            99998865 6788999999999999999999887542111      001111111000       000011115678999


Q ss_pred             HHHHhcccCCCCCCChHHHHH
Q 015480          329 VALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       329 l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ++.+||..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.6e-35  Score=274.61  Aligned_cols=219  Identities=25%  Similarity=0.356  Sum_probs=177.2

Q ss_pred             eeeChHHHhhhhhcccccccccceeEEEEE-EeCCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEE
Q 015480           68 VRFTSLQLNNFTSNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFC  144 (406)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  144 (406)
                      +++.........+--.+.||-|+||+|.++ +..+...||+|.+++..  ...+....+.|-.||+.-..+=||++|-.|
T Consensus       619 iRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF  698 (1034)
T KOG0608|consen  619 IRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF  698 (1034)
T ss_pred             HHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe
Confidence            334344444444444577999999999999 55667789999998642  223445678899999999999999999999


Q ss_pred             ecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccc
Q 015480          145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  224 (406)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfG  224 (406)
                      .+.+.+|+||+|++||++..+|. +.+.+.+..+..++.++.+|+++.|.   .|+|||||||+|||||.+|++||+|||
T Consensus       699 QDkdnLYFVMdYIPGGDmMSLLI-rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFG  774 (1034)
T KOG0608|consen  699 QDKDNLYFVMDYIPGGDMMSLLI-RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFG  774 (1034)
T ss_pred             ccCCceEEEEeccCCccHHHHHH-HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeecc
Confidence            99999999999999999999984 44678888888999999999999998   999999999999999999999999999


Q ss_pred             cccccC---C-----CCceEE--------------------------------ecCCCCCCCccCccccCCCCCCCcccc
Q 015480          225 LAKLCD---R-----NKTHVT--------------------------------ISGYKGTPGYSAPEFLSGNYPITHKCD  264 (406)
Q Consensus       225 l~~~~~---~-----~~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~D  264 (406)
                      |+.-+.   +     ......                                .-..+||+.|+|||++... .++..+|
T Consensus       775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cd  853 (1034)
T KOG0608|consen  775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCD  853 (1034)
T ss_pred             ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-Cccccch
Confidence            985221   0     000000                                0123599999999999977 8999999


Q ss_pred             eeecchhHHHHhhcccccccCCCcccc
Q 015480          265 VYSFGMVLFEIVGRRRNAIVGATESLD  291 (406)
Q Consensus       265 vwslG~il~elltg~~p~~~~~~~~~~  291 (406)
                      +||.|||||||+.|++||.........
T Consensus       854 wws~gvil~em~~g~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  854 WWSVGVILYEMLVGQPPFLADTPGETQ  880 (1034)
T ss_pred             hhHhhHHHHHHhhCCCCccCCCCCcce
Confidence            999999999999999999876665433

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=258.00  Aligned_cols=270  Identities=19%  Similarity=0.259  Sum_probs=202.7

Q ss_pred             eeeChHHHhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccC--cCc----cccE
Q 015480           68 VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY--HIN----LVRL  140 (406)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~n----iv~~  140 (406)
                      ..|...+....+|.+...+|+|+||.|-.+.+ ..+..||+|+++.-  ....+..+-|++++.++.  -|+    +|.+
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m  156 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQM  156 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence            55666777788888899999999999999954 45889999999852  235567788999999994  233    7888


Q ss_pred             EEEEecCCeeEEEEEeccCCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC-----
Q 015480          141 YGFCHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-----  214 (406)
Q Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~-----  214 (406)
                      .++|.-.++.|+|+|.+ |.|+.+++.. +..++....+..+++|++++++|||+   .+++|-||||+|||+.+     
T Consensus       157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEE
Confidence            89999999999999998 6699999965 34678999999999999999999999   99999999999999831     


Q ss_pred             ---------------CCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcc
Q 015480          215 ---------------NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR  279 (406)
Q Consensus       215 ---------------~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~  279 (406)
                                     +..++++|||.|+.-......     .+.|..|.|||++.+- +++.++||||+||||.|+.+|.
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~-----iVsTRHYRAPEViLgL-GwS~pCDvWSiGCIL~ElytG~  306 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHST-----IVSTRHYRAPEVILGL-GWSQPCDVWSIGCILVELYTGE  306 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccCcce-----eeeccccCCchheecc-CcCCccCceeeeeEEEEeeccc
Confidence                           345899999999876555432     4468899999999987 8999999999999999999999


Q ss_pred             cccccCCCc--------ccccchhHHHHHH-----hh------------hhcchhhccCCCC----cchHHHHHHHHHHH
Q 015480          280 RNAIVGATE--------SLDWFPKHVWEEY-----EK------------CELGAMILGCGIE----EKDKEKAKRLCMVA  330 (406)
Q Consensus       280 ~p~~~~~~~--------~~~~~~~~~~~~~-----~~------------~~~~~~~~~~~~~----~~~~~~~~~l~~l~  330 (406)
                      ..|..-..-        .....+.......     ..            ++.......+...    ........+|.+|+
T Consensus       307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl  386 (415)
T KOG0671|consen  307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL  386 (415)
T ss_pred             eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence            766332210        0111111111111     00            0000011111100    11234567799999


Q ss_pred             HHhcccCCCCCCChHHHHH
Q 015480          331 LWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       331 ~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..||..||.+|+|+.|++.
T Consensus       387 ~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHccCccccccHHHHhc
Confidence            9999999999999999886

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=254.01  Aligned_cols=248  Identities=23%  Similarity=0.283  Sum_probs=194.1

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchh--hHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRI--AEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ..+++.+.||+|+|.+|..+++ ++.+.||+|++++..-..  ..+=...|-.+..+- +||.+|-++.+|+.+..+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            3456678999999999999976 457889999998653211  222234455565554 699999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      .||++||+|.-.+ .....++++.+.-+...|.-||.|||+   +||++||||.+|||+|..|++||+|+|+++..-.+.
T Consensus       330 ieyv~ggdlmfhm-qrqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  330 IEYVNGGDLMFHM-QRQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEecCcceeeeh-hhhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence            9999999997666 455678899999999999999999999   999999999999999999999999999998544332


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccc-hhHHHHHHhhhhcchhhcc
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWF-PKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  312 (406)
                      .  ..+.++||+.|.|||++++. .|...+|+|+|||+++||+.|+.||+....+..+.. .....+......       
T Consensus       406 d--~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq-------  475 (593)
T KOG0695|consen  406 D--TTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ-------  475 (593)
T ss_pred             c--ccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-------
Confidence            2  23568999999999999998 899999999999999999999999986554432211 111122111111       


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCC
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRP  342 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  342 (406)
                         -..+...+.....+++.-|++||.+|.
T Consensus       476 ---iriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  476 ---IRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ---ccccceeehhhHHHHHHhhcCCcHHhc
Confidence               123445556677788888999999995

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.3e-33  Score=282.09  Aligned_cols=260  Identities=19%  Similarity=0.200  Sum_probs=164.7

Q ss_pred             hhhhcccccccccceeEEEEEEeC-C----CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEE------Ee
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-N----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF------CH  145 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~  145 (406)
                      ...|.+.+.||+|+||.||+|.+. +    +..||+|.+....   ..+.+..+  .+....+.++..++..      ..
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            345677889999999999999764 4    6899999876431   11112111  1112222222222211      24


Q ss_pred             cCCeeEEEEEeccCCChhhHhhcCCCCC-------------------CHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCC
Q 015480          146 DQHMTALVYEYMENGSLDGYLFGKKRAI-------------------EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIK  206 (406)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk  206 (406)
                      +....++||||+.+++|.+++.......                   ....+..++.|++.||+|||+   ++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence            5668899999999999999885432211                   223466799999999999999   999999999


Q ss_pred             CCcEEEcC-CCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCC---------------------CCCCcccc
Q 015480          207 PENVLLDA-NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN---------------------YPITHKCD  264 (406)
Q Consensus       207 ~~Nill~~-~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------~~~~~~~D  264 (406)
                      |+|||++. ++.+||+|||+++........ ......+++.|+|||.+...                     ..++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 579999999999765432221 12345789999999965322                     12345679


Q ss_pred             eeecchhHHHHhhcccccccCCCcccccchhHHHH-HHhhhhcchhhccCCCC------cchHHHHHHHHHHHHHhcccC
Q 015480          265 VYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWE-EYEKCELGAMILGCGIE------EKDKEKAKRLCMVALWCVQDS  337 (406)
Q Consensus       265 vwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~d  337 (406)
                      ||||||++|||+++..+......   .+ ...... .................      +..........+|+.+||+.|
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~---~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLI---QF-NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHH---HH-HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            99999999999987654321100   00 000000 00000000000000000      000111234568999999999


Q ss_pred             CCCCCChHHHHH
Q 015480          338 PEDRPPMSAVIK  349 (406)
Q Consensus       338 P~~RPs~~~vl~  349 (406)
                      |.+|||+.++++
T Consensus       438 P~kR~ta~e~L~  449 (566)
T PLN03225        438 GRQRISAKAALA  449 (566)
T ss_pred             cccCCCHHHHhC
Confidence            999999999998

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-34  Score=277.62  Aligned_cols=240  Identities=25%  Similarity=0.362  Sum_probs=183.5

Q ss_pred             ccccccceeE-EEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEEEeccCCC
Q 015480           84 TRLGFGGFGE-VYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        84 ~~ig~G~~g~-V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~  161 (406)
                      +.+|.|+-|+ ||+|.+ .|+.||||++-..    ......+|+..|+.- .|||||++++.-.++...||..|.|.. +
T Consensus       515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s  588 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S  588 (903)
T ss_pred             HHcccCCCCcEEEEEee-CCceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence            5689999986 899999 6889999988653    334567899999887 499999999999999999999999965 9


Q ss_pred             hhhHhhcCCC---CCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC---C--CCceEeccccccccCCCC
Q 015480          162 LDGYLFGKKR---AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---N--FSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       162 L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~--~~~kl~DfGl~~~~~~~~  233 (406)
                      |.+++.....   .......+.+..|+++||++||+   .+|+||||||.||||+.   +  ..++|+|||+++.+....
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            9999965311   11224567889999999999999   99999999999999975   3  468999999999876554


Q ss_pred             ce-EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhc-ccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          234 TH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR-RRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       234 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      .. ....+..||.+|+|||++... .-+.++||||+||++|+.++| ..||........        +. ..+.   ...
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NI-l~~~---~~L  732 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NI-LTGN---YTL  732 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhcc-ccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hh-hcCc---cce
Confidence            32 224567899999999999877 567799999999999999987 667753211100        00 0000   000


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      . .+... .++  +..+||.+|++++|..||++.+|+.
T Consensus       733 ~-~L~~~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  733 V-HLEPL-PDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             e-eeccC-chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            0 00111 111  7899999999999999999999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-34  Score=235.06  Aligned_cols=210  Identities=25%  Similarity=0.336  Sum_probs=173.1

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCee
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  150 (406)
                      +++......-...||+|++|.|-+-++ .+|...|+|.++.........+..+|+++..+. ..|.+|.+||...+....
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            344444444456799999999888855 579999999998776666777888999987765 699999999999999999


Q ss_pred             EEEEEeccCCChhhHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          151 ALVYEYMENGSLDGYLF---GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ++.||.|.- +|+.+..   ..+..+.+..+-+|+..+.+||.|||+  +..++|||+||+||||+.+|++|+||||.+-
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999965 8887763   467789999999999999999999999  5889999999999999999999999999997


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCCC---CCCCcccceeecchhHHHHhhcccccccCCCc
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSGN---YPITHKCDVYSFGMVLFEIVGRRRNAIVGATE  288 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~  288 (406)
                      .+.++-...   ...|-..|||||.+...   ..|+-++||||||+.+.||.+++.|+.....+
T Consensus       198 ~L~dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  198 YLVDSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             eehhhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence            665443221   13356689999988642   36899999999999999999999998765543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-32  Score=269.16  Aligned_cols=263  Identities=18%  Similarity=0.167  Sum_probs=177.1

Q ss_pred             hhhhhcccccccccceeEEEEEEe-----------------CCCcEEEEEEeccccchhhHH--------------HHHH
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQF-----------------PNGVKIAVKVLNRNLGRIAEE--------------QFMA  124 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~~  124 (406)
                      ....|.+.++||+|+||+||+|..                 .+++.||||.+..... ...+              ....
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchhHH
Confidence            455677789999999999999953                 2356899999864321 1122              2344


Q ss_pred             HHHHhhccCcCcc-----ccEEEEEec--------CCeeEEEEEeccCCChhhHhhcCC---------------------
Q 015480          125 EVGTIGRTYHINL-----VRLYGFCHD--------QHMTALVYEYMENGSLDGYLFGKK---------------------  170 (406)
Q Consensus       125 e~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~---------------------  170 (406)
                      |+.++.+++|.++     ++++++|..        ....+|||||+++++|.++++...                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6667777766544     677777753        356799999999999999885321                     


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCcc
Q 015480          171 --RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYS  248 (406)
Q Consensus       171 --~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~  248 (406)
                        ..+++..+..++.|++.+|.|||+   .+++||||||+|||++.++.+||+|||++.......... .....+++.|+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~  377 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYS  377 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCccee
Confidence              124677889999999999999999   999999999999999999999999999997543322111 11223578999


Q ss_pred             CccccCCCC---------------------CCCcccceeecchhHHHHhhccc-ccccCCCcccccc-hhHHHHHHhhhh
Q 015480          249 APEFLSGNY---------------------PITHKCDVYSFGMVLFEIVGRRR-NAIVGATESLDWF-PKHVWEEYEKCE  305 (406)
Q Consensus       249 aPE~~~~~~---------------------~~~~~~DvwslG~il~elltg~~-p~~~~~~~~~~~~-~~~~~~~~~~~~  305 (406)
                      |||.+....                     ....+.||||+||++++|++|.. |+.....-..... .....+.+..  
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--  455 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--  455 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--
Confidence            999875321                     11235799999999999999875 4321100000000 0000000100  


Q ss_pred             cchhhccCCC-CcchHHHHHHHHHHHHHhcccCC---CCCCChHHHHH
Q 015480          306 LGAMILGCGI-EEKDKEKAKRLCMVALWCVQDSP---EDRPPMSAVIK  349 (406)
Q Consensus       306 ~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~~vl~  349 (406)
                          ...... -......+....+++.++|..+|   .+|+|+.++++
T Consensus       456 ----~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        456 ----YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ----hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence                000000 01223456778999999999766   68999999986

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=6.1e-34  Score=238.68  Aligned_cols=258  Identities=19%  Similarity=0.290  Sum_probs=196.9

Q ss_pred             hhhcccccccccceeEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecC--CeeEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQ--HMTALV  153 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv  153 (406)
                      ..|++.+++|+|-+++||.|. ..+++.++||++++    ...+.+.+|+.+|..|. ||||++++++..+.  ..+.||
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            456678899999999999995 56789999999986    35577999999999997 99999999999775  467799


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC-CCceEeccccccccCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRN  232 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~DfGl~~~~~~~  232 (406)
                      +||+++.+...+.    ..++.-.+..+++++++||.|||+   .||.|||+||.|++||.. ..++|+|+|+|.++...
T Consensus       114 FE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            9999987776654    567788899999999999999999   999999999999999864 57999999999887655


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhH------HHHHH-hhh-
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKH------VWEEY-EKC-  304 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~------~~~~~-~~~-  304 (406)
                      ...   +..+.+..|--||.+-.-..++..-|+|||||++..|+..+.||..+.....+...-.      ....+ .+. 
T Consensus       187 ~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  187 KEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             cee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            433   2345566788999987665789999999999999999999999987765432211100      00000 000 


Q ss_pred             -----hcchhhccCC-------CC-cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          305 -----ELGAMILGCG-------IE-EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       305 -----~~~~~~~~~~-------~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                           +....+....       +. +...-..++..+++...|..|-++|||++|.+.
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                 0000000000       01 111123478899999999999999999999765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.4e-31  Score=234.98  Aligned_cols=212  Identities=37%  Similarity=0.616  Sum_probs=184.1

Q ss_pred             ccccceeEEEEEEeCC-CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCChhh
Q 015480           86 LGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDG  164 (406)
Q Consensus        86 ig~G~~g~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  164 (406)
                      ||+|++|.||++...+ |+.+++|++...........+.+|+..+..+.|++++++++++......++++||+.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998754 899999999865332245789999999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC-CCCceEeccccccccCCCCceEEecCCCC
Q 015480          165 YLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNKTHVTISGYKG  243 (406)
Q Consensus       165 ~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~DfGl~~~~~~~~~~~~~~~~~g  243 (406)
                      ++......+++..+..++.++++++++||+   .+++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            985544578999999999999999999999   89999999999999999 89999999999986654321  1223457


Q ss_pred             CCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHH
Q 015480          244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKA  323 (406)
Q Consensus       244 t~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (406)
                      ...|++||........+.++|+|++|+++++|                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            88999999987643578899999999999998                                                


Q ss_pred             HHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          324 KRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       324 ~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      ..+.+++..|++.||++||++.++++.
T Consensus       188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            458899999999999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-32  Score=235.67  Aligned_cols=251  Identities=19%  Similarity=0.290  Sum_probs=193.8

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEE-EecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGF-CHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e  155 (406)
                      .|++.+.+|+|.||.+-++.++ +.+.+++|.+.+.  .....+|.+|..---.| .|.||+.-|++ |+..+.+.+++|
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            4677788999999999999774 4778999998864  34567899998765566 49999998876 567778889999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc--CCCCceEeccccccccCCCC
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |++.|+|...+  ....+.+.....++.|+++||.|+|+   ++++|||||.+||||-  +..++||||||+.+..+...
T Consensus       103 ~aP~gdL~snv--~~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV  177 (378)
T KOG1345|consen  103 FAPRGDLRSNV--EAAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV  177 (378)
T ss_pred             cCccchhhhhc--CcccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence            99999999877  34568888899999999999999999   9999999999999993  33489999999997554322


Q ss_pred             ceEEecCCCCCCCccCccccC----CCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          234 THVTISGYKGTPGYSAPEFLS----GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      .     ...-+..|.+||...    +.....+.+|+|.||+++|.++||..||-....   ...+.+.|..+..+...+ 
T Consensus       178 ~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~---~d~~Y~~~~~w~~rk~~~-  248 (378)
T KOG1345|consen  178 K-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI---MDKPYWEWEQWLKRKNPA-  248 (378)
T ss_pred             h-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc---cCchHHHHHHHhcccCcc-
Confidence            1     122456799999754    233467889999999999999999999963322   334455566666655442 


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                           .+......+..+..+.++-+..+|++|-.+.++.++
T Consensus       249 -----~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  249 -----LPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             -----CchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence                 233445566778889999999999999555555443

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-33  Score=242.62  Aligned_cols=263  Identities=21%  Similarity=0.311  Sum_probs=192.5

Q ss_pred             cccccccceeEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCC-----eeEEEEE
Q 015480           83 STRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-----MTALVYE  155 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e  155 (406)
                      .+-||-|+||.||.+.+ .+|+.||+|.+..-.. -...+.+.+|++++.-++|.|++..+++..-..     .+|+++|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            45699999999999976 5699999998864322 234577899999999999999999998876543     4578899


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      .+.. +|.+.+ -....++...+.-+.+||++||.|||+   .+|.||||||.|+|++.|-.+||||||+++..+.+...
T Consensus       138 LmQS-DLHKII-VSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  138 LMQS-DLHKII-VSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHh-hhhhee-ccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            8854 888877 456788888999999999999999999   99999999999999999999999999999976654332


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcc-cc----cchhHHHHHHhh---hhcc
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES-LD----WFPKHVWEEYEK---CELG  307 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-~~----~~~~~~~~~~~~---~~~~  307 (406)
                       .++..+-|-.|.|||++.+...|+.+.||||.|||+.||+.++..|-...+-. ++    .+.....+.+..   +...
T Consensus       213 -hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  213 -NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             -hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence             23444567899999999998889999999999999999998876653222110 00    000001111111   1111


Q ss_pred             hhhccCCCC-c--------chHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 015480          308 AMILGCGIE-E--------KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML  351 (406)
Q Consensus       308 ~~~~~~~~~-~--------~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  351 (406)
                      .++...... .        .+...-.+...+...++..||..|.+..+.+..+
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            111111100 0        1112334566788889999999999999887643

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-32  Score=254.77  Aligned_cols=193  Identities=27%  Similarity=0.390  Sum_probs=166.1

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHH---------HHHHHHHhhccC---cCccccEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQ---------FMAEVGTIGRTY---HINLVRLYGFCHD  146 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~---------~~~e~~~l~~l~---h~niv~~~~~~~~  146 (406)
                      |...+.+|+|+||.|+.|.++ +...|+||.+.+..  .-.+.         .-.|+.+|+.++   |+||++++++|++
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeR--IL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKER--ILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhh--hhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            455678999999999999664 46789999998642  11122         335999999997   9999999999999


Q ss_pred             CCeeEEEEEec-cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccc
Q 015480          147 QHMTALVYEYM-ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  225 (406)
Q Consensus       147 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl  225 (406)
                      ++.+||+||-. ++.+|.+++ .....+++..+..|+.|++.|+++||+   .||+|||||-+||.++.+|-+||+|||.
T Consensus       641 dd~yyl~te~hg~gIDLFd~I-E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFI-EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhh-hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccc
Confidence            99999999986 455899998 566789999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhccccc
Q 015480          226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNA  282 (406)
Q Consensus       226 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~  282 (406)
                      +....+...    ..++||..|.|||++.+.......-|||++|++||-++....|+
T Consensus       717 aa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  717 AAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             hhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            976654432    34789999999999999977888999999999999999877765

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=1.7e-31  Score=247.47  Aligned_cols=274  Identities=21%  Similarity=0.273  Sum_probs=206.4

Q ss_pred             CCceeeChHHHhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccC------cCcc
Q 015480           65 EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY------HINL  137 (406)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni  137 (406)
                      +..+++...++.+.+|....-.|+|-|++|.+|.. ..|..||||+++.+  +.-.+.=+.|+++|.+|+      --|+
T Consensus       419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hc  496 (752)
T KOG0670|consen  419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHC  496 (752)
T ss_pred             cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHH
Confidence            34567778889999999888999999999999966 44889999999875  233445578999999996      2489


Q ss_pred             ccEEEEEecCCeeEEEEEeccCCChhhHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC
Q 015480          138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFG--KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN  215 (406)
Q Consensus       138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~  215 (406)
                      ++++-.|...+++|||+|-+. .+|.+.|..  .+-.+....+..++.|+.-||..|..   .+++|.||||.|||+++.
T Consensus       497 lrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  497 LRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNES  572 (752)
T ss_pred             HHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccC
Confidence            999999999999999999984 599999954  45568888999999999999999998   999999999999999875


Q ss_pred             -CCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcc-ccc-
Q 015480          216 -FSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES-LDW-  292 (406)
Q Consensus       216 -~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-~~~-  292 (406)
                       ..+||||||.|.....+..    +.+.-+..|.|||++.+- .|+...|+||.||+||||.||+..|-...... +.+ 
T Consensus       573 k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~-~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~  647 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGL-PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF  647 (752)
T ss_pred             cceeeeccCccccccccccc----cHHHHHHhccCcceeecC-cccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence             4689999999976655432    234445689999999988 89999999999999999999997653221100 000 


Q ss_pred             ---chhHHHHHHhhh------------------------h-------------cchhh-ccCCCCcchHHHHHHHHHHHH
Q 015480          293 ---FPKHVWEEYEKC------------------------E-------------LGAMI-LGCGIEEKDKEKAKRLCMVAL  331 (406)
Q Consensus       293 ---~~~~~~~~~~~~------------------------~-------------~~~~~-~~~~~~~~~~~~~~~l~~l~~  331 (406)
                         ....+...+..+                        +             +...+ .....+.........|.+|+.
T Consensus       648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd  727 (752)
T KOG0670|consen  648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD  727 (752)
T ss_pred             HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence               000000000000                        0             00000 011122333456678899999


Q ss_pred             HhcccCCCCCCChHHHHH
Q 015480          332 WCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       332 ~cl~~dP~~RPs~~~vl~  349 (406)
                      .||..||++|.|..+.|.
T Consensus       728 kml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  728 KMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHhccChhhcCCHHHHhc
Confidence            999999999999998875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-30  Score=237.81  Aligned_cols=149  Identities=24%  Similarity=0.314  Sum_probs=121.1

Q ss_pred             HHHhcCCCceeeChHHH-hhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccC---
Q 015480           59 LQEIGREKPVRFTSLQL-NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---  133 (406)
Q Consensus        59 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---  133 (406)
                      ..++..+..-.....+. .+.+|-..++||-|.|++||++.+ .+.+.||+|+.+.  .+...+..+.|+.+|++++   
T Consensus        58 ~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS--AqhYtEaAlDEIklL~~v~~~D  135 (590)
T KOG1290|consen   58 PEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS--AQHYTEAALDEIKLLQQVREGD  135 (590)
T ss_pred             hhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh--hhHHHHHHHHHHHHHHHHHhcC
Confidence            44455555444444444 448899999999999999999954 5678999999986  3456677889999999874   


Q ss_pred             --c---CccccEEEEEec----CCeeEEEEEeccCCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeec
Q 015480          134 --H---INLVRLYGFCHD----QHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY  203 (406)
Q Consensus       134 --h---~niv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~  203 (406)
                        |   .+||++++.|..    +.+.|||+|++ |-+|..++.. ..+.+....+.+|++||+.||.|||.  ..||||-
T Consensus       136 p~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHT  212 (590)
T KOG1290|consen  136 PNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHT  212 (590)
T ss_pred             CCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCcccc
Confidence              2   369999999965    46899999999 6688888854 45779999999999999999999999  4799999


Q ss_pred             CCCCCcEEE
Q 015480          204 DIKPENVLL  212 (406)
Q Consensus       204 dlk~~Nill  212 (406)
                      ||||+|||+
T Consensus       213 DlKPENvLl  221 (590)
T KOG1290|consen  213 DLKPENVLL  221 (590)
T ss_pred             CCCcceeee
Confidence            999999998

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=8.3e-30  Score=226.73  Aligned_cols=200  Identities=35%  Similarity=0.520  Sum_probs=170.0

Q ss_pred             cccccccccceeEEEEEEeCC-CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           81 NYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      .+.+.||+|++|.||++...+ ++.+++|.+.........+.+.+|++.+..++|+|++++++++......++++||+++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   81 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG   81 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence            456789999999999997754 8899999998653322567889999999999999999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      ++|.+++......+++..+..++.+++.++.+||+   .+++|+||+|+||+++.++.++|+|||.+......... ...
T Consensus        82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~  157 (225)
T smart00221       82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLK  157 (225)
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-ccc
Confidence            99999985443338999999999999999999999   89999999999999999999999999999876544211 112


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhccccccc
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIV  284 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~  284 (406)
                      ...++..|++||.+.+...++.++|+|+||+++++|++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            345778899999984333678899999999999999999999843

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=253.21  Aligned_cols=252  Identities=23%  Similarity=0.308  Sum_probs=198.0

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|.+.+++|+|++|.|||+++ ..++..|+|+++-... ....-+.+|+-+++..+||||+.++|.+..++.+++.||||
T Consensus        16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             chhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            455678899999999999976 4589999999986533 34455678999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      .+|+|.+.- .-.+++++.++..+++..++||.|||+   .|-+|||||-.|||+++.|.+|+.|||.+..+...-.  .
T Consensus        95 gggslQdiy-~~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~--K  168 (829)
T KOG0576|consen   95 GGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA--K  168 (829)
T ss_pred             CCCccccee-eecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhh--h
Confidence            999999876 456789999999999999999999999   9999999999999999999999999999875543222  2


Q ss_pred             ecCCCCCCCccCccccC--CCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          238 ISGYKGTPGYSAPEFLS--GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                      ...+.||+.|||||+..  ....|...+|||++|+...|+---++|...-.+       ......+.+.     ......
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-------mr~l~LmTkS-----~~qpp~  236 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-------MRALFLMTKS-----GFQPPT  236 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-------HHHHHHhhcc-----CCCCCc
Confidence            34578999999999753  333689999999999999999776665422111       1111111110     111122


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..........+.++++.|+-++|++||+++.++.
T Consensus       237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            2333456778999999999999999999987654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-31  Score=231.91  Aligned_cols=254  Identities=21%  Similarity=0.281  Sum_probs=186.2

Q ss_pred             cccccccceeEEEEE-EeCCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecC------CeeEEEE
Q 015480           83 STRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------HMTALVY  154 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~-~~~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv~  154 (406)
                      .+.+|.|.- .|.-+ ..-.++.||+|....... ....++..+|..++..++|+||++++.+|.-.      ...|+||
T Consensus        22 L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~  100 (369)
T KOG0665|consen   22 LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM  100 (369)
T ss_pred             ecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence            345888887 55555 334688999998764322 22346678899999999999999999998543      3568999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      |+|.. +|...+.   -.++-.++..|.+|++.|++|||+   .||+||||||+||++..+..+||.|||+++..+..  
T Consensus       101 e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--  171 (369)
T KOG0665|consen  101 ELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--  171 (369)
T ss_pred             Hhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc--
Confidence            99955 8888774   456778899999999999999999   99999999999999999999999999999855433  


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccch---------hHHHHHHhh--
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP---------KHVWEEYEK--  303 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~---------~~~~~~~~~--  303 (406)
                       ..++.+..|..|.|||++.+. .+.+.+||||+||++.||++|+..|... .....|..         ......+..  
T Consensus       172 -~~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf~g~-d~idQ~~ki~~~lgtpd~~F~~qL~~~~  248 (369)
T KOG0665|consen  172 -FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLFPGK-DHIDQWNKIIEQLGTPDPSFMKQLQPTV  248 (369)
T ss_pred             -cccCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEecCc-hHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence             345667889999999999988 5999999999999999999999766421 11111100         000000000  


Q ss_pred             ------------hhcchhhcc---CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          304 ------------CELGAMILG---CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       304 ------------~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                                  ....+..-+   ....+...-....+.+++.+||-.||++|.|++++++
T Consensus       249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                        000000000   0011112234566889999999999999999999998

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=9.3e-30  Score=231.33  Aligned_cols=260  Identities=24%  Similarity=0.333  Sum_probs=193.9

Q ss_pred             hcccccccccceeEEEEEEeC----CCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  154 (406)
                      +...++||+|+|++||++.+.    ..+.||+|.+....   ....+..|++.|..+. +.||+++.+++..++...+|+
T Consensus        38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts---~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl  114 (418)
T KOG1167|consen   38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS---SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL  114 (418)
T ss_pred             hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc---CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence            456788999999999999653    46789999998642   3456889999999995 999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC-CCCceEeccccccccCCCC
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~DfGl~~~~~~~~  233 (406)
                      ||++.....++.    ..++...+..+++.++.||.++|.   .||+||||||+|+|.+. .+.-.|+|||++...+...
T Consensus       115 p~~~H~~f~~l~----~~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  115 PYFEHDRFRDLY----RSLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             cccCccCHHHHH----hcCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            999998888887    346688999999999999999999   99999999999999975 4678999999987221000


Q ss_pred             -------------c-----------------------------eEEecCCCCCCCccCccccCCCCCCCcccceeecchh
Q 015480          234 -------------T-----------------------------HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMV  271 (406)
Q Consensus       234 -------------~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~i  271 (406)
                                   .                             .....+..||++|.|||++......+++.||||.|+|
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence                         0                             0001134599999999999988788999999999999


Q ss_pred             HHHHhhcccccccCCCcccccchh-----------------H--HHHH---------Hh-hhhc-chhhccC-----CCC
Q 015480          272 LFEIVGRRRNAIVGATESLDWFPK-----------------H--VWEE---------YE-KCEL-GAMILGC-----GIE  316 (406)
Q Consensus       272 l~elltg~~p~~~~~~~~~~~~~~-----------------~--~~~~---------~~-~~~~-~~~~~~~-----~~~  316 (406)
                      ++.+++++.||.....+.......                 .  .|+.         .. .... .+....+     ...
T Consensus       268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~  347 (418)
T KOG1167|consen  268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE  347 (418)
T ss_pred             eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence            999999999987544332110000                 0  0110         00 0000 0000110     011


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ......+..+.+++.+|+..||.+|.|+++.|+
T Consensus       348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            112234457899999999999999999999887

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-28  Score=214.49  Aligned_cols=279  Identities=20%  Similarity=0.212  Sum_probs=222.0

Q ss_pred             hhhhhcccccccccceeEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEE
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  153 (406)
                      ....|...++||+|+||.++.|+ +-+++.||||.....   ....++..|.+..+.|. .++|..++.+..++.+-.||
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            34456788999999999999995 578999999987754   23456788888888875 79999999999999899999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC-----CCceEeccccccc
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-----FSPKVADFGLAKL  228 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-----~~~kl~DfGl~~~  228 (406)
                      +|++ |.+|+|++.-.++.++..++..+|.|++.-++|+|+   +.+|+|||||+|+||..-     ..+.++|||+|+.
T Consensus       103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            9999 779999997788899999999999999999999999   999999999999999643     3588999999998


Q ss_pred             cCCCCceEE-----ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhh
Q 015480          229 CDRNKTHVT-----ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK  303 (406)
Q Consensus       229 ~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  303 (406)
                      +....+...     .....||.+||+-..+.++ +.+.+.|+-|||-++++.|-|..||-.-..+.       ..+.+  
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr-EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-------nK~kY--  248 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-------NKEKY--  248 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccc-hhhhhhhHHHhhhhhhhhccCCCccccccCcc-------hHHHH--
Confidence            766554432     2345699999999999998 78999999999999999999999884322211       11222  


Q ss_pred             hhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCCCCCccchhhhh
Q 015480          304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYLDLIK  371 (406)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~p~~~~~~~~~~  371 (406)
                      .++.+....-.+.......+.++..-+...-+.+..+-|+++-+...+.++.....-..-..|+|...
T Consensus       249 eKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~l  316 (449)
T KOG1165|consen  249 EKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGL  316 (449)
T ss_pred             HHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence            22222223333445556778889999999999999999999999998888877666555444444433

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=4.3e-29  Score=261.36  Aligned_cols=195  Identities=17%  Similarity=0.216  Sum_probs=138.8

Q ss_pred             cCc-CccccEEEEE-------ecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeec
Q 015480          132 TYH-INLVRLYGFC-------HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY  203 (406)
Q Consensus       132 l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~  203 (406)
                      ++| +||++++++|       .+...+++++||+ +++|.+++......+++..+..++.||++||.|||+   ++|+||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeeec
Confidence            345 5888888877       2334567788987 569999997666779999999999999999999999   999999


Q ss_pred             CCCCCcEEEcC-------------------CCCceEeccccccccCCCCc--------------eEEecCCCCCCCccCc
Q 015480          204 DIKPENVLLDA-------------------NFSPKVADFGLAKLCDRNKT--------------HVTISGYKGTPGYSAP  250 (406)
Q Consensus       204 dlk~~Nill~~-------------------~~~~kl~DfGl~~~~~~~~~--------------~~~~~~~~gt~~y~aP  250 (406)
                      ||||+||||+.                   ++.+|++|||+++.......              ........||+.||||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            99999999954                   44566667776653211000              0001123578899999


Q ss_pred             cccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHH
Q 015480          251 EFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVA  330 (406)
Q Consensus       251 E~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  330 (406)
                      |++.+. .++.++|||||||+||||++|.+|+.....         ........     .    .+............++
T Consensus       185 E~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------~~~~~~~~-----~----~~~~~~~~~~~~~~~~  245 (793)
T PLN00181        185 EEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKSR---------TMSSLRHR-----V----LPPQILLNWPKEASFC  245 (793)
T ss_pred             hhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHHH---------HHHHHHHh-----h----cChhhhhcCHHHHHHH
Confidence            999877 689999999999999999998876431100         00111000     0    0111111234456888


Q ss_pred             HHhcccCCCCCCChHHHHH
Q 015480          331 LWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       331 ~~cl~~dP~~RPs~~~vl~  349 (406)
                      .+||+.+|.+||++.++++
T Consensus       246 ~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHhCCCChhhCcChHHHhh
Confidence            9999999999999999986

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-28  Score=206.18  Aligned_cols=279  Identities=19%  Similarity=0.240  Sum_probs=216.5

Q ss_pred             HhhhhhcccccccccceeEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  152 (406)
                      +....|.+.++||+|+||.+|.|. ..+|+.||||+...+.   ...++..|..+...|+ -..|..+..+..+...-.+
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            344567788999999999999994 5789999999987653   2346778999999887 4678888888899999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC---CCceEecccccccc
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFGLAKLC  229 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~DfGl~~~~  229 (406)
                      ||+.+ |.+|.++++-....++..+++-++-|++.-++|+|.   ++++||||||+|+|..-+   ..+.|+|||+++.+
T Consensus        89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence            99999 789999997778889999999999999999999999   999999999999999643   46889999999876


Q ss_pred             CCCCceE-----EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhh
Q 015480          230 DRNKTHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC  304 (406)
Q Consensus       230 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (406)
                      ....+..     ...+..||.+|.+-..+.+. ..+.+.|+-|+|.+|.++..|..||-.-...       ...+.+  .
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~-------tk~QKy--E  234 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAA-------TKKQKY--E  234 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchh-------hHHHHH--H
Confidence            5443222     22345699999999988876 6799999999999999999999888432111       111111  1


Q ss_pred             hcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCCCCC--ccchhhh
Q 015480          305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKP--FRYLDLI  370 (406)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~p~~--~~~~~~~  370 (406)
                      .+.+....-.++......|.++.-.+..|-..-.++-|+..-+.+.+.-+...+..-.-  +.|....
T Consensus       235 kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lk  302 (341)
T KOG1163|consen  235 KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLK  302 (341)
T ss_pred             HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHH
Confidence            22222223333445566788999999999999999999999998888777666655433  3444443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=3.8e-27  Score=221.32  Aligned_cols=262  Identities=20%  Similarity=0.240  Sum_probs=198.2

Q ss_pred             hhcccccccccceeEEEEEEeCCC--cEEEEEEeccccchhhHHHHHHHHHHhhccCc----CccccEEEEE-ecCCeeE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFPNG--VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH----INLVRLYGFC-HDQHMTA  151 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~~g--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~  151 (406)
                      .|.+.++||+|+||.||.+...+.  ..+|+|+.......... .+..|..++..+..    +++..+++.. ......+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            677889999999999999976543  57899988764332222 67888888888863    6899999999 5778889


Q ss_pred             EEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC-----CCceEecccc
Q 015480          152 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-----FSPKVADFGL  225 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-----~~~kl~DfGl  225 (406)
                      +||+.+ |.+|.++.... .+.++..++..|+.|++.+|++||+   .|++||||||.|+++...     ..+.|.|||+
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            999998 77999988544 4789999999999999999999999   999999999999999765     3689999999


Q ss_pred             cc--ccCCCCce----E-E-ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHH
Q 015480          226 AK--LCDRNKTH----V-T-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHV  297 (406)
Q Consensus       226 ~~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  297 (406)
                      ++  ........    . . ...++||.+|+++.++.+. ..+.+.|+||++.++.|++.|..||........       
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-------  245 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-------  245 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccch-------
Confidence            98  33222211    1 1 1346699999999999987 899999999999999999999988843222111       


Q ss_pred             HHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          298 WEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                      ...........     .........+.++.++...+-..+..++|.+..+...|.......
T Consensus       246 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  246 KSKFEKDPRKL-----LTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             HHHHHHHhhhh-----ccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            01111100000     000022234566777777777899999999999999988876554

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.4e-27  Score=204.66  Aligned_cols=167  Identities=20%  Similarity=0.201  Sum_probs=126.3

Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |+|.+++...+..+++.++..++.|++.||+|||+   .+      ||+|||++.++.+|+  ||++.......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc------
Confidence            68999997667789999999999999999999998   66      999999999999999  99987654322      


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                       ..||+.|+|||++.+. .++.++|||||||++|||++|+.|+.......     .. ..........   .........
T Consensus        64 -~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-----~~-~~~~~~~~~~---~~~~~~~~~  132 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELS-----AI-LEILLNGMPA---DDPRDRSNL  132 (176)
T ss_pred             -CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhc-----HH-HHHHHHHhcc---CCccccccH
Confidence             2578999999999877 78999999999999999999999985332110     00 0111110000   000001122


Q ss_pred             HHHHH--HHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          320 KEKAK--RLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       320 ~~~~~--~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      .....  .+.+++.+||+.||.+||++.++++.+..+
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            33333  699999999999999999999999987654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.6e-26  Score=216.69  Aligned_cols=179  Identities=20%  Similarity=0.157  Sum_probs=134.5

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeC--CCcEEEEEEecccc----chhhHHHHHHHHHHhhccCcCccccEEEEEecC
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFP--NGVKIAVKVLNRNL----GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ  147 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~--~g~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  147 (406)
                      ......|.+.+.||+|+||+||+|.+.  +|+.||||++....    .......|.+|+++|.+++|+|++..+..+   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            344556788899999999999999764  57888999875331    223456789999999999999998533222   


Q ss_pred             CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCC-CCCcEEEcCCCCceEeccccc
Q 015480          148 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI-KPENVLLDANFSPKVADFGLA  226 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dl-k~~Nill~~~~~~kl~DfGl~  226 (406)
                      ...++||||++|++|.. + ....      ...++.|++++|.|||+   +||+|||| ||+|||++.++.+||+|||++
T Consensus        91 ~~~~LVmE~~~G~~L~~-~-~~~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-A-RPHG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             CCcEEEEEccCCCCHHH-h-Cccc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            45799999999999963 2 1111      14678899999999999   99999999 999999999999999999999


Q ss_pred             cccCCCCceEE------ecCCCCCCCccCccccCCCC-----CCCccccee
Q 015480          227 KLCDRNKTHVT------ISGYKGTPGYSAPEFLSGNY-----PITHKCDVY  266 (406)
Q Consensus       227 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~-----~~~~~~Dvw  266 (406)
                      +..........      ..+..+++.|+|||.+....     ..+..+|-|
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            87654332111      23456888999999986431     233446666

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-27  Score=204.54  Aligned_cols=250  Identities=20%  Similarity=0.349  Sum_probs=192.2

Q ss_pred             hcccccccccceeEEEEEEeCCCcEEEEEEecc-ccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      .++..+|.+...|+.|+|+|. |..+++|++.- ........+|..|.-.|+-+.||||+.++|.|.....+.++..||+
T Consensus       192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            355678999999999999994 55677787763 3333445789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEe--ccccccccCCCCce
Q 015480          159 NGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVA--DFGLAKLCDRNKTH  235 (406)
Q Consensus       159 ~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~--DfGl~~~~~~~~~~  235 (406)
                      .|+|...++... -.++..++.+++.++|+|++|||+.. .-|.---|....++||++.+++|+  |--++.        
T Consensus       271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--------  341 (448)
T KOG0195|consen  271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------  341 (448)
T ss_pred             chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--------
Confidence            999999997543 34677899999999999999999842 233344688999999999988874  221111        


Q ss_pred             EEecCCCCCCCccCccccCCCCC--CCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYP--ITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                       ...+..-.+.||+||.+.....  .-.++|+|||++++|||.|+..||..-.+-...               .+....+
T Consensus       342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialeg  405 (448)
T KOG0195|consen  342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEG  405 (448)
T ss_pred             -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhcc
Confidence             1112334678999999986533  245799999999999999999988543221100               0112333


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      .....++..+..+..|+.-|++.||.+||.++.|+-.|++..
T Consensus       406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            445567778889999999999999999999999999998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=3.2e-26  Score=228.42  Aligned_cols=255  Identities=19%  Similarity=0.186  Sum_probs=189.8

Q ss_pred             ccccccccceeEEEEEEe-CCCcEEEEEEec----cccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           82 YSTRLGFGGFGEVYKGQF-PNGVKIAVKVLN----RNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        82 ~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~----~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ....+|.|++|.|+.... ......+.|..+    .... ......+..|+-+-..+.|||++..+..+.+.....-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            356799999997777743 333334444332    2111 1112226667777888999999888877776665555699


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      ||++ +|..++. ....++...+..++.|+..|+.|+|+   .|+.|||+|++|+++..+|.+||+|||.+.........
T Consensus       402 ~~~~-Dlf~~~~-~~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  402 YCPY-DLFSLVM-SNGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             cccH-HHHHHHh-cccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            9999 9999883 33578889999999999999999999   99999999999999999999999999999766544333


Q ss_pred             --EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          236 --VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       236 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                        ....+.+|+..|+|||.+.+........||||.|+++..|++|+.||.........+        .........-...
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~~~~~~  548 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQRNIFE  548 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhcccccccccc
Confidence              445678899999999999988556778999999999999999999987654433221        0000000111111


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      +........+.+...++.+||+.||.+|.|+++|++
T Consensus       549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            223344567788899999999999999999999987

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=2.8e-23  Score=194.71  Aligned_cols=262  Identities=29%  Similarity=0.366  Sum_probs=197.5

Q ss_pred             hcccccccccceeEEEEEEeCCCcEEEEEEeccccchh--hHHHHHHHHHHhhccCcC-ccccEEEEEecCCeeEEEEEe
Q 015480           80 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRI--AEEQFMAEVGTIGRTYHI-NLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  156 (406)
                      |...+.||.|+||.||++...  ..+++|.+.......  ....+.+|+.++..+.|+ +++++++++......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            345678999999999999875  789999998654443  467899999999999988 799999999887778999999


Q ss_pred             ccCCChhhHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC-CceEeccccccccCCCC
Q 015480          157 MENGSLDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRNK  233 (406)
Q Consensus       157 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~DfGl~~~~~~~~  233 (406)
                      +.++++.+++....  ..+.......+..|++.++.|+|.   .+++|||+||+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997774333  378999999999999999999999   8999999999999999998 79999999998554433


Q ss_pred             ceE----EecCCCCCCCccCccccCCC--CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          234 THV----TISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       234 ~~~----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ...    ......|+..|+|||.+.+.  ...+...|+||+|++++++++|..|+......   ................
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence            221    23457799999999999873  37899999999999999999999885433221   0001111111111100


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      .. ...............+.+++..|+..+|..|.+..+....
T Consensus       234 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SL-ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cc-ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00 0000000002234578899999999999999998887764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=6.2e-24  Score=183.50  Aligned_cols=140  Identities=16%  Similarity=0.181  Sum_probs=109.7

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchh-h------------------------HHHHHHHHHHhhccCcCccc
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRI-A------------------------EEQFMAEVGTIGRTYHINLV  138 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~-~------------------------~~~~~~e~~~l~~l~h~niv  138 (406)
                      ..||+|+||.||+|...+|+.||||+++...... .                        ......|++.+.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            5699999999999988789999999997542110 0                        11224599999999888774


Q ss_pred             cEEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHH-HHhcCCCeeecCCCCCcEEEcCCCC
Q 015480          139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL-HEECQQRIIHYDIKPENVLLDANFS  217 (406)
Q Consensus       139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~i~H~dlk~~Nill~~~~~  217 (406)
                      ....+...  ..+|||||++++++..... ....++...+..++.|++.+|.++ |+   .|++||||||+|||++ ++.
T Consensus        83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          83 CPEPILLK--SHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCcEEEec--CCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CCc
Confidence            44333222  2389999999887765432 345789999999999999999999 67   8999999999999998 478


Q ss_pred             ceEeccccccccC
Q 015480          218 PKVADFGLAKLCD  230 (406)
Q Consensus       218 ~kl~DfGl~~~~~  230 (406)
                      ++|+|||++....
T Consensus       156 v~LiDFG~a~~~~  168 (190)
T cd05147         156 LYIIDVSQSVEHD  168 (190)
T ss_pred             EEEEEccccccCC
Confidence            9999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=2.5e-23  Score=181.90  Aligned_cols=173  Identities=14%  Similarity=0.111  Sum_probs=132.4

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchh--hHHH------HHHHHHHhhccCcCccccEEEEEec
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRI--AEEQ------FMAEVGTIGRTYHINLVRLYGFCHD  146 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~--~~~~------~~~e~~~l~~l~h~niv~~~~~~~~  146 (406)
                      +.+.+|...+.+|.|+||.||+... ++..+|+|+++......  ....      +.+|+..+.+++||+|..+.+++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4456777889999999999999866 57789999998543222  1122      5789999999999999999988654


Q ss_pred             C--------CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCc
Q 015480          147 Q--------HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP  218 (406)
Q Consensus       147 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  218 (406)
                      .        ...+|+|||++|.+|.++.     .++.    ....+++.+|..||.   .|++|||+||+||+++.+| +
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-E
Confidence            3        3578999999999998874     1222    345689999999999   9999999999999999998 9


Q ss_pred             eEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHh
Q 015480          219 KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV  276 (406)
Q Consensus       219 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ell  276 (406)
                      +|+|||............              ...... .+..++|+||||+++.-+.
T Consensus       174 ~liDfg~~~~~~e~~a~d--------------~~vler-~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAKD--------------RIDLER-HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhHH--------------HHHHHh-HhcccccccceeEeehHHH
Confidence            999999886443221110              022223 4567999999999987654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=3.6e-22  Score=173.11  Aligned_cols=142  Identities=18%  Similarity=0.211  Sum_probs=111.7

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEeccccch-------------------------hhHHHHHHHHHHhhccCcCcc
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGR-------------------------IAEEQFMAEVGTIGRTYHINL  137 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~l~~l~h~ni  137 (406)
                      ...||+|+||.||+|...+|+.||||+++.....                         .....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3569999999999998778999999999854211                         001234578999999999987


Q ss_pred             ccEEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC
Q 015480          138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  217 (406)
Q Consensus       138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  217 (406)
                      .....+....  .+|||||++|+++..... ....++......++.|++.++.++|+  ..|++||||||+||+++ ++.
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~~  155 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CCC
Confidence            5554444332  489999999876543321 33567888999999999999999997  37999999999999999 889


Q ss_pred             ceEeccccccccC
Q 015480          218 PKVADFGLAKLCD  230 (406)
Q Consensus       218 ~kl~DfGl~~~~~  230 (406)
                      ++|+|||++....
T Consensus       156 ~~liDFG~a~~~~  168 (190)
T cd05145         156 PYIIDVSQAVELD  168 (190)
T ss_pred             EEEEEcccceecC
Confidence            9999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=1e-22  Score=194.60  Aligned_cols=221  Identities=25%  Similarity=0.352  Sum_probs=166.3

Q ss_pred             hhccCcCccccEEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCC
Q 015480          129 IGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE  208 (406)
Q Consensus       129 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~  208 (406)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+......+++.....+..+++.||+|||+.  ....|+.+++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence            4578899999999999999999999999999999999977788899999999999999999999983  33399999999


Q ss_pred             cEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCC--C----CCcccceeecchhHHHHhhccccc
Q 015480          209 NVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY--P----ITHKCDVYSFGMVLFEIVGRRRNA  282 (406)
Q Consensus       209 Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~----~~~~~DvwslG~il~elltg~~p~  282 (406)
                      |+++|....+||+|||+.................-..-|.|||.+....  .    .+.+.||||||++++|+++...||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9999999999999999987664311111111122345799999987631  1    467899999999999999999999


Q ss_pred             ccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          283 IVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                      .........  ... ......  .........+... .+...++..++..||..+|.+||++++|-..++.+...
T Consensus       159 ~~~~~~~~~--~ei-i~~~~~--~~~~~~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  159 DLRNLVEDP--DEI-ILRVKK--GGSNPFRPSIELL-NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccccCCh--HHH-HHHHHh--cCCCCcCcchhhh-hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            765443222  111 111111  0000011111111 14455799999999999999999999999999887654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=8.1e-22  Score=168.72  Aligned_cols=188  Identities=17%  Similarity=0.056  Sum_probs=139.1

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEeccccc---hhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEEEecc
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG---RIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      ...|++|+||+||.+.. .+.+++.+.+....-   ......+.+|+++|.++. |+++++++++    ...+++|||+.
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            45799999999998866 678888777765322   112235789999999995 5889999886    34689999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCC-CCCcEEEcCCCCceEeccccccccCCCCce--
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI-KPENVLLDANFSPKVADFGLAKLCDRNKTH--  235 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dl-k~~Nill~~~~~~kl~DfGl~~~~~~~~~~--  235 (406)
                      |.+|...+..        ....++.|++.+|.++|+   .||+|||| ||+|||++.++.++|+|||++.........  
T Consensus        82 G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         82 GAAMYQRPPR--------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             CccHHhhhhh--------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            9898654311        123577899999999999   99999999 799999999999999999999855433210  


Q ss_pred             ----EEe-----cCCCCCCCccCccccCCCCCCC-cccceeecchhHHHHhhcccccccCC
Q 015480          236 ----VTI-----SGYKGTPGYSAPEFLSGNYPIT-HKCDVYSFGMVLFEIVGRRRNAIVGA  286 (406)
Q Consensus       236 ----~~~-----~~~~gt~~y~aPE~~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~  286 (406)
                          ...     .-...++.|++|+...--...+ ...++++-|+-+|.++|++.+...+.
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                000     0112567788887543221223 56788999999999999998765443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=2.8e-23  Score=198.44  Aligned_cols=225  Identities=25%  Similarity=0.223  Sum_probs=182.3

Q ss_pred             ccccceeEEEEEEe----CCCcEEEEEEeccccch-hhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEEEeccC
Q 015480           86 LGFGGFGEVYKGQF----PNGVKIAVKVLNRNLGR-IAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        86 ig~G~~g~V~~~~~----~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +|+|+||.|++++-    ..|..+|+|++++.... ........|..++...+ ||.++++...++.+...++++++..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            79999999998732    34778999998754221 12225566888888887 99999999999999999999999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |.|...+ .+...+++.....+...++-++.++|.   .+++|||+|++||+++.+|++++.|||+++..-....     
T Consensus        82 g~lft~l-~~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----  152 (612)
T KOG0603|consen   82 GDLFTRL-SKEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----  152 (612)
T ss_pred             chhhhcc-ccCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----
Confidence            9998877 455677888888888899999999999   9999999999999999999999999999986543332     


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                       .+||..|||||++.   .....+|.||||++++||++|..||...                    ....+.. .....+
T Consensus       153 -~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~~--------------------~~~~Il~-~~~~~p  207 (612)
T KOG0603|consen  153 -ACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGGD--------------------TMKRILK-AELEMP  207 (612)
T ss_pred             -cccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCchH--------------------HHHHHhh-hccCCc
Confidence             27999999999998   4588999999999999999999887430                    0001111 113456


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCh
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPM  344 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~  344 (406)
                      ......+.+++..++..+|..|.-.
T Consensus       208 ~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  208 RELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            7788889999999999999999755

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=1.8e-22  Score=202.47  Aligned_cols=251  Identities=21%  Similarity=0.215  Sum_probs=181.6

Q ss_pred             hcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHH--hhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           80 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT--IGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      +.+.+.||++.|=+|.+|++.+|. |+||++-+.........|.+.++-  ...++|||.+++.-+-..+...|||-+|+
T Consensus        25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv  103 (1431)
T KOG1240|consen   25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV  103 (1431)
T ss_pred             eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence            456778999999999999998887 899998765444455555554433  44568999999988888888889999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC-----
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN-----  232 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~-----  232 (406)
                      .+ +|.|.+ ..+..+...+..-|+.|++.||..+|.   .||+|||||.+||||+.-+=+.|+||.-.+...-.     
T Consensus       104 kh-nLyDRl-STRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  104 KH-NLYDRL-STRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             hh-hhhhhh-ccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            76 999988 455667778888899999999999999   99999999999999999988999999877543211     


Q ss_pred             CceEEecCCCCCCCccCccccCCC----------CCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHH
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEY  301 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  301 (406)
                      +........+.-..|.|||.+...          ...+++-||||+||++.||++ |+++|....-           -.+
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL-----------~aY  247 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL-----------LAY  247 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH-----------HhH
Confidence            111112222334589999976431          125788999999999999986 4666542110           011


Q ss_pred             hhh--hcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          302 EKC--ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       302 ~~~--~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      +.+  ...+.... .++      ...++.++..|++.||++|.++++.++.-.++
T Consensus       248 r~~~~~~~e~~Le-~Ie------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  248 RSGNADDPEQLLE-KIE------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             hccCccCHHHHHH-hCc------CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence            111  00000000 001      12488999999999999999999999975544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=2.5e-21  Score=174.30  Aligned_cols=231  Identities=20%  Similarity=0.240  Sum_probs=147.3

Q ss_pred             cccccccccceeEEEEEEe-CCCcEEEEEEeccc--cchhhHHHHHHHHHHhhccCc----------CccccEEEEEe--
Q 015480           81 NYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYH----------INLVRLYGFCH--  145 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h----------~niv~~~~~~~--  145 (406)
                      ...+.||.|+++.||.+++ .+|+.+|+|+....  ......+++++|.-....+.+          -.++-.++...  
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            3456799999999999976 45899999988632  223345667777655544322          12222222221  


Q ss_pred             -------cC---C-----eeEEEEEeccCCChhhHhh---cC---CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecC
Q 015480          146 -------DQ---H-----MTALVYEYMENGSLDGYLF---GK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD  204 (406)
Q Consensus       146 -------~~---~-----~~~lv~e~~~~g~L~~~l~---~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~d  204 (406)
                             ..   .     ..+++|+-+ .++|.+++.   ..   ...+....+..+..|+++.+++||+   .|++|+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecc
Confidence                   11   1     235788877 458888763   11   1234455667788999999999999   9999999


Q ss_pred             CCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCC-------CCCCCcccceeecchhHHHHhh
Q 015480          205 IKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG-------NYPITHKCDVYSFGMVLFEIVG  277 (406)
Q Consensus       205 lk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwslG~il~ellt  277 (406)
                      |+|+|++++.+|.++|+||+.....+.   ....  ...+..|.+||....       ...++.+.|.|+||+++|.|++
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGT---RYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTE---EEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCc---eeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            999999999999999999988764432   1111  234578999997532       1247889999999999999999


Q ss_pred             cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCC
Q 015480          278 RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDR  341 (406)
Q Consensus       278 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  341 (406)
                      +..|+...........                    ...... +.++.+..|+..+|+.||.+|
T Consensus       246 ~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999976544322211                    011222 778889999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=1.3e-21  Score=199.32  Aligned_cols=201  Identities=21%  Similarity=0.226  Sum_probs=158.3

Q ss_pred             ChHHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC---cCccccEEEEEecC
Q 015480           71 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---HINLVRLYGFCHDQ  147 (406)
Q Consensus        71 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~  147 (406)
                      ..+++.+..+.+.+.||+|+||+||+|...+|+.||+|+-+....    -+|.-=.+++.+|+   -+.|..+...+.-.
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP----WEFYICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc----eeeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence            446677777888899999999999999887899999999876422    11222222333333   23445555544555


Q ss_pred             CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc-------CCCCceE
Q 015480          148 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-------ANFSPKV  220 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~-------~~~~~kl  220 (406)
                      +.-+||+||.+.|+|.++++ ..+.++|..+.-++.|++..+..||.   .+|||+||||+|+||.       +...++|
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             CcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence            56679999999999999995 66789999999999999999999999   9999999999999993       2346899


Q ss_pred             eccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhccc
Q 015480          221 ADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR  280 (406)
Q Consensus       221 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~  280 (406)
                      +|||.+..+.--.........++|-.+--+|+..|+ .+++.+|.|.|+.+++-||.|+.
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHHH
Confidence            999999755432222334566788899999999998 89999999999999999999984

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=2.1e-20  Score=162.98  Aligned_cols=134  Identities=18%  Similarity=0.242  Sum_probs=104.1

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-----CcCccccEEEEEecCC---e-eEEE
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-----YHINLVRLYGFCHDQH---M-TALV  153 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~-~~lv  153 (406)
                      .+.||+|+||.||. .-.++.. +||++..... ...+.+.+|+.++..+     .||||++++|++.++.   . ..+|
T Consensus         7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cceecCCCceEEEE-CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            45799999999996 2234444 6998875322 2456789999999999     5799999999998874   3 3478


Q ss_pred             EEe--ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHH-HHHHHhcCCCeeecCCCCCcEEEcC----CCCceEeccccc
Q 015480          154 YEY--MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGL-VYLHEECQQRIIHYDIKPENVLLDA----NFSPKVADFGLA  226 (406)
Q Consensus       154 ~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~~~~i~H~dlk~~Nill~~----~~~~kl~DfGl~  226 (406)
                      +||  +.+|+|.+++..  ..+++.  ..++.|++.++ +|||+   ++|+||||||+|||++.    ++.++|+||+.+
T Consensus        84 ~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             ecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            999  557999999943  245555  35677888777 99999   99999999999999974    347999995544

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=4.5e-20  Score=164.81  Aligned_cols=142  Identities=18%  Similarity=0.179  Sum_probs=110.6

Q ss_pred             hcccccccccceeEEEEEE--eCCCcEEEEEEeccccch-----------------------hhHHHHHHHHHHhhccCc
Q 015480           80 SNYSTRLGFGGFGEVYKGQ--FPNGVKIAVKVLNRNLGR-----------------------IAEEQFMAEVGTIGRTYH  134 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~--~~~g~~vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~h  134 (406)
                      |.+.+.||+|+||.||+|.  ..+|+.||+|+++.....                       .....+..|+..+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            4567889999999999997  568999999998753210                       011345689999999975


Q ss_pred             C--ccccEEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCC-eeecCCCCCcEE
Q 015480          135 I--NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIHYDIKPENVL  211 (406)
Q Consensus       135 ~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-i~H~dlk~~Nil  211 (406)
                      .  .+.+++++    ...++||||+++++|..... ............++.|++.++++||+   .+ ++||||||+||+
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIl  181 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNIL  181 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEE
Confidence            3  34445543    23479999999988876542 33456667788999999999999999   89 999999999999


Q ss_pred             EcCCCCceEeccccccccC
Q 015480          212 LDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       212 l~~~~~~kl~DfGl~~~~~  230 (406)
                      ++ ++.++|+|||.+....
T Consensus       182 i~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      182 VH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EE-CCCEEEEEChhhhccC
Confidence            99 8899999999986433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.5e-19  Score=159.51  Aligned_cols=135  Identities=24%  Similarity=0.297  Sum_probs=113.8

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccch-------hhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGR-------IAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      +.||+|++|.||+|.+ +|..+++|+.......       .....+.+|++++..+.|+|+.....++.+....+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4699999999999987 6778999986543211       1224678899999999999998888777777888999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      ++|++|.+++....    . .+..++.+++.+|.++|+   .+++|+|++|.|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999884322    1 788999999999999999   9999999999999999 78999999998863

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=2.3e-19  Score=156.75  Aligned_cols=138  Identities=20%  Similarity=0.244  Sum_probs=109.2

Q ss_pred             hhcccccccccceeEEEEEEeCCCcEEEEEEeccccch---------------------hhHHHHHHHHHHhhccCcC--
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGR---------------------IAEEQFMAEVGTIGRTYHI--  135 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~~l~h~--  135 (406)
                      .+.+.+.||+|+||.||++...+|+.||||+++.....                     .....+..|..++..+.|+  
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            35667889999999999998888999999987643200                     1112367788889888877  


Q ss_pred             ccccEEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC
Q 015480          136 NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN  215 (406)
Q Consensus       136 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~  215 (406)
                      .++..++.    ...++||||++|++|.....       ......++.+++.++.++|+   .+++||||||+||+++++
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~  161 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCC
Confidence            44555442    34589999999999876542       13456788999999999999   999999999999999999


Q ss_pred             CCceEeccccccccC
Q 015480          216 FSPKVADFGLAKLCD  230 (406)
Q Consensus       216 ~~~kl~DfGl~~~~~  230 (406)
                      +.++|+|||++....
T Consensus       162 ~~~~liDfg~~~~~~  176 (198)
T cd05144         162 EKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcEEEEECCccccCC
Confidence            999999999996444

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=2.4e-19  Score=156.84  Aligned_cols=131  Identities=23%  Similarity=0.299  Sum_probs=107.2

Q ss_pred             cccccceeEEEEEEeCCCcEEEEEEeccccc-------hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           85 RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG-------RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .||+|+||.||+|.+ +|..+++|+......       ......+.+|++++..++|+++.....++.+....++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999986 678899998654211       112356788999999999887666555566666778999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      +|++|.+++.....        .++.+++.+|.+||+   .+++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999988743211        889999999999999   9999999999999999 88999999999863

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.4e-19  Score=163.96  Aligned_cols=199  Identities=22%  Similarity=0.275  Sum_probs=144.7

Q ss_pred             CcCccccEEEEEec---------------------------CCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHH
Q 015480          133 YHINLVRLYGFCHD---------------------------QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT  185 (406)
Q Consensus       133 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi  185 (406)
                      .|||||++.++|.+                           ...+|+||...+. +|..++.  ....+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~--~~~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW--TRHRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh--cCCCchHHHHHHHHHH
Confidence            59999999987743                           2356789998866 9999984  3456667788889999


Q ss_pred             HHHHHHHHHhcCCCeeecCCCCCcEEE--cCCC--CceEeccccccccCCCCce----EEecCCCCCCCccCccccCCCC
Q 015480          186 AKGLVYLHEECQQRIIHYDIKPENVLL--DANF--SPKVADFGLAKLCDRNKTH----VTISGYKGTPGYSAPEFLSGNY  257 (406)
Q Consensus       186 ~~~l~~LH~~~~~~i~H~dlk~~Nill--~~~~--~~kl~DfGl~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~  257 (406)
                      ++|+.|||.   +|+.|||+|++||||  |+|+  .+.++|||.+---+.....    .......|...-||||+.....
T Consensus       351 LEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999   999999999999999  4555  4678999988533321111    1112345788999999876542


Q ss_pred             C-----CCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHH
Q 015480          258 P-----ITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALW  332 (406)
Q Consensus       258 ~-----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  332 (406)
                      .     .-.++|.|+.|.+.||+++...||.....-.++.      ..+.         ....+..+..++..+.+++..
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~------r~Yq---------e~qLPalp~~vpp~~rqlV~~  492 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT------RTYQ---------ESQLPALPSRVPPVARQLVFD  492 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheech------hhhh---------hhhCCCCcccCChHHHHHHHH
Confidence            2     2358999999999999999999986533221111      0011         122345556677889999999


Q ss_pred             hcccCCCCCCChHHHHHHhh
Q 015480          333 CVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       333 cl~~dP~~RPs~~~vl~~L~  352 (406)
                      .|+.||++|++..-..+.|.
T Consensus       493 lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  493 LLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HhcCCccccCCccHHHhHHH
Confidence            99999999999776555443

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=1.2e-20  Score=177.18  Aligned_cols=173  Identities=22%  Similarity=0.335  Sum_probs=130.1

Q ss_pred             eeEEEEEeccCCChhhHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccc
Q 015480          149 MTALVYEYMENGSLDGYLFGK--KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  226 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~  226 (406)
                      ++++.|++|...+|.+++..+  ....++.....++.|++.|+.|      ++.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999533  3467888999999999999999      58999999999999999999999999999


Q ss_pred             cccCCCC----ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHh
Q 015480          227 KLCDRNK----THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE  302 (406)
Q Consensus       227 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  302 (406)
                      .......    .....+...||..||+||.+.+. .|+.++||||||+||+|++.--.                  ....
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~------------------T~~e  464 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFS------------------TQFE  464 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhc------------------cHHH
Confidence            7665444    22234567899999999999988 89999999999999999986110                  0111


Q ss_pred             hhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHH
Q 015480          303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSA  346 (406)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~  346 (406)
                      ......-+.++.+++.....-+.-..++.+++++.|.+||++.+
T Consensus       465 r~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  465 RIATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             HHHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHH
Confidence            11111112233333222222233457899999999999995444

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=1.2e-18  Score=174.58  Aligned_cols=134  Identities=20%  Similarity=0.262  Sum_probs=109.5

Q ss_pred             cccccccccceeEEEEEEeCCCcEEEEEEe-ccccc------hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           81 NYSTRLGFGGFGEVYKGQFPNGVKIAVKVL-NRNLG------RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~~~g~~vavK~~-~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ...+.||+|+||+||+|.+... .+++|+. .+...      ....+.+.+|++++..++|++++....++.+....++|
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             CccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            3467899999999999987544 3444432 22111      11235688999999999999999888888777778999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      |||+++++|.+++.         ....++.+++++|.+||+   .+++||||||+|||+ +++.++|+|||+++.
T Consensus       415 ~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        415 MEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999883         457899999999999999   999999999999999 677999999999964

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.75  E-value=4.5e-19  Score=178.03  Aligned_cols=209  Identities=22%  Similarity=0.284  Sum_probs=141.5

Q ss_pred             hhhhcccccccccceeEEEEEEeCC-CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ...++.++.|..|++|.||.++++. .+.+|+|+-+.+.       +.+-  ++.....|.+|                 
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-------ilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-------ILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccch-------hhhc--cccccCCccee-----------------
Confidence            3445667889999999999998753 6778885443321       1110  22222233332                 


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                          |+=...+ +.-+.+...        ++.+++|||+   .||+|||+||+|++|..-|++|++|||+++........
T Consensus       136 ----gDc~tll-k~~g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ----GDCATLL-KNIGPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ----chhhhhc-ccCCCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence                2333333 222233222        2778999999   99999999999999999999999999998754322111


Q ss_pred             E-------------EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHh
Q 015480          236 V-------------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE  302 (406)
Q Consensus       236 ~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  302 (406)
                      .             .....+||+.|.|||++..+ .|...+|+|++|+|+||.+-|..||+.+.++.+  +...+..   
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeel--fg~visd---  273 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVISD---  273 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHH--Hhhhhhh---
Confidence            1             01345899999999999876 799999999999999999999999976644321  1111000   


Q ss_pred             hhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCC
Q 015480          303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRP  342 (406)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  342 (406)
                               ...-.+.....+.++++++.+.|+.+|.+|-
T Consensus       274 ---------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  274 ---------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ---------hccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence                     0011223445667899999999999999995

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=3e-17  Score=142.04  Aligned_cols=139  Identities=18%  Similarity=0.213  Sum_probs=98.6

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEeccccchh-hHHH----------------------HHHHHHHhhccCcCc--c
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRI-AEEQ----------------------FMAEVGTIGRTYHIN--L  137 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~-~~~~----------------------~~~e~~~l~~l~h~n--i  137 (406)
                      .+.||+|+||+||+|...+|+.||||+++...... ....                      ...|...+..+.+.+  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            45799999999999988789999999987532111 1111                      134555666654432  4


Q ss_pred             ccEEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC
Q 015480          138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  217 (406)
Q Consensus       138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  217 (406)
                      .+.+++    ...++||||++++.+........ ... .....++.+++.++.++|.  ..+++|+||||+||+++ ++.
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CCc
Confidence            455543    23589999999854432110110 011 6678899999999999996  37899999999999999 899


Q ss_pred             ceEeccccccccC
Q 015480          218 PKVADFGLAKLCD  230 (406)
Q Consensus       218 ~kl~DfGl~~~~~  230 (406)
                      ++|+|||.+....
T Consensus       153 ~~liDfg~a~~~~  165 (187)
T cd05119         153 VYIIDVPQAVEID  165 (187)
T ss_pred             EEEEECccccccc
Confidence            9999999996443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=6.1e-17  Score=134.53  Aligned_cols=134  Identities=20%  Similarity=0.165  Sum_probs=113.9

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCc--CccccEEEEEecCCeeEEEEEeccCC
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH--INLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      .+.||+|.++.||++...+ ..+++|.......   ...+..|+..+..++|  .++++++++....+..+++|||++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            4579999999999998854 7899999876432   4678899999999976  58999999988888899999999987


Q ss_pred             ChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          161 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       161 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      .+..+        +......++.+++++++++|.....+++|+|++|+||+++.++.++++|||.+..
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77653        5567788899999999999984334799999999999999989999999999863

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=7.7e-19  Score=175.66  Aligned_cols=257  Identities=22%  Similarity=0.241  Sum_probs=194.9

Q ss_pred             hhhcccccccccceeEEEEEEeC--CCcEEEEEEecccc-chhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP--NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~--~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  153 (406)
                      ..+.+.+.||+|+|+.|-.....  ....+|+|.+.... ......+...|..+-..+. |+|++.+++...+.+..++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            34566677999999999888552  34556777665432 2333455566777777776 99999999999999999999


Q ss_pred             EEeccCCChhhHh-hcCCCCCCHHHHHHHHHHHHHHHHHHH-HhcCCCeeecCCCCCcEEEcCCC-CceEeccccccccC
Q 015480          154 YEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGLVYLH-EECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCD  230 (406)
Q Consensus       154 ~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~i~H~dlk~~Nill~~~~-~~kl~DfGl~~~~~  230 (406)
                      ++|..++++.+.+ .......+......++.|+..++.|+| .   .++.|+|+||+|.+++..+ ..++.|||+|..+.
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999888 333336777788899999999999999 7   9999999999999999999 99999999998776


Q ss_pred             C-CCceEEecCCCC-CCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          231 R-NKTHVTISGYKG-TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       231 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      . ..........+| ++.|+|||...+.....+..|+||.|+++.-+++|..|+.........+....   ...      
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~---~~~------  247 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK---SNK------  247 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec---ccc------
Confidence            6 444555556778 99999999988754678899999999999999999999865544332211100   000      


Q ss_pred             hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                         ................+++..++..+|..|.+..++..
T Consensus       248 ---~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 ---GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ---cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence               00001122334456778888899999999999887654

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=1.7e-16  Score=142.05  Aligned_cols=135  Identities=21%  Similarity=0.265  Sum_probs=104.6

Q ss_pred             cccc-ccceeEEEEEEeCCCcEEEEEEecccc------------chhhHHHHHHHHHHhhccCcCcc--ccEEEEEecCC
Q 015480           84 TRLG-FGGFGEVYKGQFPNGVKIAVKVLNRNL------------GRIAEEQFMAEVGTIGRTYHINL--VRLYGFCHDQH  148 (406)
Q Consensus        84 ~~ig-~G~~g~V~~~~~~~g~~vavK~~~~~~------------~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~  148 (406)
                      ..|| .|+.|+||+++.. +..+++|.+....            .......+.+|++++.+++|+++  +..+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4587 8999999999874 6789999885310            11233567889999999998875  67777654322


Q ss_pred             ----eeEEEEEeccC-CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecc
Q 015480          149 ----MTALVYEYMEN-GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF  223 (406)
Q Consensus       149 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (406)
                          ..++|||+++| .+|.+++..  ..++..    .+.+++.+|.+||+   .||+||||||.|||++.++.++|+||
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEEC
Confidence                23599999997 689888743  345543    35689999999999   99999999999999999999999999


Q ss_pred             ccccc
Q 015480          224 GLAKL  228 (406)
Q Consensus       224 Gl~~~  228 (406)
                      |.+..
T Consensus       187 g~~~~  191 (239)
T PRK01723        187 DRGEL  191 (239)
T ss_pred             CCccc
Confidence            98864

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.62  E-value=1.8e-15  Score=146.93  Aligned_cols=141  Identities=16%  Similarity=0.189  Sum_probs=98.6

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhhH---------------------------------------HHHHH
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAE---------------------------------------EQFMA  124 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~---------------------------------------~~~~~  124 (406)
                      +.||+|++|.||+|++.+|+.||||+.++.......                                       -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            469999999999999999999999998764211110                                       12444


Q ss_pred             HHHHhhccC----cCccccEEEEEe-cCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHH-HHHHHHHhcCC
Q 015480          125 EVGTIGRTY----HINLVRLYGFCH-DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK-GLVYLHEECQQ  198 (406)
Q Consensus       125 e~~~l~~l~----h~niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~-~l~~LH~~~~~  198 (406)
                      |...+.++.    |.+-+.+-.++. .....+|||||++|++|.++........+   ...++.+++. .+..+|.   .
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~---~  276 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR---D  276 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh---C
Confidence            555444442    222233322322 23456899999999999887643222222   3456666665 4678888   9


Q ss_pred             CeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       199 ~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      |++|+|+||.||+++.++.++++|||++....
T Consensus       277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            99999999999999999999999999986543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=2.7e-15  Score=143.92  Aligned_cols=255  Identities=22%  Similarity=0.236  Sum_probs=189.0

Q ss_pred             HHHhhhhhcccccccc--cceeEEEEEEe---CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccC-cCccccEEEEEe
Q 015480           73 LQLNNFTSNYSTRLGF--GGFGEVYKGQF---PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTY-HINLVRLYGFCH  145 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~--G~~g~V~~~~~---~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~  145 (406)
                      .......+...+.+|.  |.+|.||.+..   .++..+|+|.-+.... ......=.+|+.....++ |+|.++.+..+.
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence            4455566677888999  99999999976   4578899987432211 122233345666666664 999999999999


Q ss_pred             cCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHH----HHHHHHHhcCCCeeecCCCCCcEEEcCC-CCceE
Q 015480          146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK----GLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKV  220 (406)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~----~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl  220 (406)
                      ..+..++-+|+|. .+|..+.+.....+....++.+..+..+    ||.++|+   .+++|-|+||.||+...+ ..+++
T Consensus       189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  189 GSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             cCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecccccceeec
Confidence            9999999999995 6888888777777888888899988888    9999999   999999999999999999 88999


Q ss_pred             eccccccccCCCCceEE---ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHH
Q 015480          221 ADFGLAKLCDRNKTHVT---ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHV  297 (406)
Q Consensus       221 ~DfGl~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  297 (406)
                      +|||+...+........   .....|...|++||...+-  ++..+|+|++|.++.+..++......+....        
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------  334 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSS--------  334 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCC--------
Confidence            99999987765432111   1223578899999998864  6899999999999999988876654432211        


Q ss_pred             HHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          298 WEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      |...+...+.        .+........+...+.++++.+|-.|++.+.+..
T Consensus       335 W~~~r~~~ip--------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  335 WSQLRQGYIP--------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccccccccCc--------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1111111110        1222233445556889999999999998877665

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.49  E-value=7e-14  Score=137.51  Aligned_cols=137  Identities=16%  Similarity=0.213  Sum_probs=90.1

Q ss_pred             ccccccceeEEEEEEeCC-CcEEEEEEeccccchh---------------------------------hHH------HHH
Q 015480           84 TRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRI---------------------------------AEE------QFM  123 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~-g~~vavK~~~~~~~~~---------------------------------~~~------~~~  123 (406)
                      +.||+|++|.||+|++++ |+.||||+.+++..+.                                 ..+      ++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            469999999999999877 9999999998652111                                 011      233


Q ss_pred             HHHHHhhccC----cCccccEEEEEec-CCeeEEEEEeccCCChhhHhhcCCCC-----CCHHHHHHHHHHHHHHHHHHH
Q 015480          124 AEVGTIGRTY----HINLVRLYGFCHD-QHMTALVYEYMENGSLDGYLFGKKRA-----IEWEKLHEIAIGTAKGLVYLH  193 (406)
Q Consensus       124 ~e~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~i~~qi~~~l~~LH  193 (406)
                      +|+..+.+++    +.+.+.+-.++.+ ....+|||||++|+++.++-.-....     +....+..++.|       +.
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VF  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HH
Confidence            4444444432    3333443333332 34567999999999998753211222     222222233333       33


Q ss_pred             HhcCCCeeecCCCCCcEEEcCCC----CceEeccccccccC
Q 015480          194 EECQQRIIHYDIKPENVLLDANF----SPKVADFGLAKLCD  230 (406)
Q Consensus       194 ~~~~~~i~H~dlk~~Nill~~~~----~~kl~DfGl~~~~~  230 (406)
                      .   .|++|+|+||.||+++.+|    .++++|||++....
T Consensus       278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            4   8999999999999999888    99999999987554

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=1.7e-13  Score=116.48  Aligned_cols=129  Identities=22%  Similarity=0.130  Sum_probs=95.4

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCcc-ccEEEEEecCCeeEEEEEeccCCCh
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGFCHDQHMTALVYEYMENGSL  162 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L  162 (406)
                      +.|+.|.++.||+++.. |..|++|+......  ....+..|+..+..+.+.++ .+++++..  ...++||||++|.++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            46899999999999874 77899999765421  22356788999888865554 45555443  345799999999887


Q ss_pred             hhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhc--CCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          163 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC--QQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       163 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ....         .....++.+++++|+.||+..  ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            6431         112345678999999999821  12369999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.47  E-value=8e-13  Score=128.39  Aligned_cols=167  Identities=16%  Similarity=0.185  Sum_probs=128.2

Q ss_pred             EeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHH
Q 015480           98 QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK  177 (406)
Q Consensus        98 ~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~  177 (406)
                      +..++.+|.|...+.... .......+-++.|+.++||||+++++.+..+...|||+|-+.  .|..++...    ....
T Consensus        33 ~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~  105 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEE  105 (690)
T ss_pred             eeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHH
Confidence            345688899988876544 344567778889999999999999999999999999999984  677777322    2556


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCC
Q 015480          178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY  257 (406)
Q Consensus       178 ~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  257 (406)
                      ....+.||+.||.|||+  ..+++|++|.-+.|+|++.|..||++|.++........  ......---.|..|+.+... 
T Consensus       106 v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s-  180 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS-  180 (690)
T ss_pred             HHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc-
Confidence            66778999999999996  48899999999999999999999999998864433221  00111112246677765533 


Q ss_pred             CCCcccceeecchhHHHHhhc
Q 015480          258 PITHKCDVYSFGMVLFEIVGR  278 (406)
Q Consensus       258 ~~~~~~DvwslG~il~elltg  278 (406)
                        .-..|.|.|||+++|++.|
T Consensus       181 --~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 --EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --ccchhhhhHHHHHHHHhCc
Confidence              2467999999999999998

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=7.4e-14  Score=124.29  Aligned_cols=203  Identities=21%  Similarity=0.274  Sum_probs=135.9

Q ss_pred             HHHhhccCcCccccEEEEEecC-----CeeEEEEEeccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcC
Q 015480          126 VGTIGRTYHINLVRLYGFCHDQ-----HMTALVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQ  197 (406)
Q Consensus       126 ~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~  197 (406)
                      ..-+-++.|.|||+++.|+.+.     ....+++||+..|+|..+|++   ....+......+++-||..||.|||+. .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            3445566799999999998654     346789999999999999953   345678888999999999999999984 5


Q ss_pred             CCeeecCCCCCcEEEcCCCCceEeccccccccC--CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHH
Q 015480          198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCD--RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI  275 (406)
Q Consensus       198 ~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el  275 (406)
                      .+++|+++..+.|++..+|-+|+.--.-.....  ............+.++|.+||.=... ..+.++|||+||....||
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc-ccccchhhhhhhHHHHHH
Confidence            899999999999999999888874321111000  00000011223467899999975544 567899999999999999


Q ss_pred             hhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          276 VGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       276 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .-+......+.....       .+......+...  .          -..-..++..|++..|..||+|.+++.
T Consensus       276 ailEiq~tnseS~~~-------~ee~ia~~i~~l--e----------n~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  276 AILEIQSTNSESKVE-------VEENIANVIIGL--E----------NGLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHheeccCCCcceee-------hhhhhhhheeec--c----------CccccCcCcccccCCCCCCcchhhhhc
Confidence            876543211111000       000000000000  0          001234677899999999999998764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.42  E-value=4.6e-12  Score=108.63  Aligned_cols=139  Identities=14%  Similarity=0.107  Sum_probs=100.5

Q ss_pred             ccccccceeEEEEEEeCC-------CcEEEEEEecccc------------c---------hhhHHHHH----HHHHHhhc
Q 015480           84 TRLGFGGFGEVYKGQFPN-------GVKIAVKVLNRNL------------G---------RIAEEQFM----AEVGTIGR  131 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~-------g~~vavK~~~~~~------------~---------~~~~~~~~----~e~~~l~~  131 (406)
                      ..||.|--+.||.|...+       +..+|||+.+...            .         ......+.    +|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            358999999999996543       4789999985321            0         11122333    79999998


Q ss_pred             cCc--CccccEEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHH-HHhcCCCeeecCCCCC
Q 015480          132 TYH--INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL-HEECQQRIIHYDIKPE  208 (406)
Q Consensus       132 l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~i~H~dlk~~  208 (406)
                      +..  -++...+++    ...+|||||+.+..+.... -++..++..+...+..+++.+|..| |.   .+++|+||++.
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~-Lkd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~~  154 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK-LKDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSEY  154 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh-hhccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHH
Confidence            863  467777765    3457999999765442211 1223455566778889999999999 87   89999999999


Q ss_pred             cEEEcCCCCceEeccccccccCC
Q 015480          209 NVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       209 Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      |||++ ++.+.|+|||.+...+.
T Consensus       155 NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         155 NMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             HEEEE-CCcEEEEECCCceeCCC
Confidence            99997 46899999999875543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.38  E-value=4.7e-12  Score=112.41  Aligned_cols=143  Identities=19%  Similarity=0.196  Sum_probs=112.0

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCc--CccccEEEEEecCC---eeEEEEEecc
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH--INLVRLYGFCHDQH---MTALVYEYME  158 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~---~~~lv~e~~~  158 (406)
                      +.|+.|.++.||++...+|..+++|.............+..|.+++..+.+  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            458999999999998877789999998754322234578899999999875  44677888776643   5689999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC------------------------------------------  196 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------------------------------------  196 (406)
                      |.++.+.+..  ..++......++.+++++|..||+..                                          
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9888775521  45777888888999999999998521                                          


Q ss_pred             -----------CCCeeecCCCCCcEEEcC--CCCceEeccccccc
Q 015480          197 -----------QQRIIHYDIKPENVLLDA--NFSPKVADFGLAKL  228 (406)
Q Consensus       197 -----------~~~i~H~dlk~~Nill~~--~~~~kl~DfGl~~~  228 (406)
                                 ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                       256799999999999998  56789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=3.1e-13  Score=129.91  Aligned_cols=244  Identities=18%  Similarity=0.194  Sum_probs=174.9

Q ss_pred             hhcccccccccceeEEEEEEe--CCCcEEEEEEeccccchhhHHH-HHHHHHHhhcc-CcCccccEEEEEecCCeeEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF--PNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~--~~g~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ++..+..||.|.|+.|+....  .++..|++|.+.+.......+. -..|+-+...+ .|.|++.....+......++--
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~  345 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL  345 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence            345567899999999999853  4678899998876544333322 24565555555 4889999888888888888999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC-CCceEeccccccccCCCC
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+++++.... .-...++...++++..|++.++.++|+   +.++|+|+||+||++..+ +..++.|||....+.-. 
T Consensus       346 e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-  420 (524)
T KOG0601|consen  346 EFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-  420 (524)
T ss_pred             hhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccccee-
Confidence            999999887665 334456777889999999999999998   999999999999999886 78899999998632111 


Q ss_pred             ceEEecCCCCCCCcc-CccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          234 THVTISGYKGTPGYS-APEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                          .......-++. .+|.+.....+..+.|++|||.-+.|.+++......+..    |               ..+..
T Consensus       421 ----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~---------------~~i~~  477 (524)
T KOG0601|consen  421 ----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----S---------------LTIRS  477 (524)
T ss_pred             ----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc----c---------------eeeec
Confidence                11122344555 366666666889999999999999999988753211110    0               00111


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML  351 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  351 (406)
                      +. ..........+..+...+...++..||.+.++....
T Consensus       478 ~~-~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  478 GD-TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             cc-ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence            11 122233337788888889999999999988876544

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.37  E-value=8e-12  Score=103.08  Aligned_cols=141  Identities=20%  Similarity=0.289  Sum_probs=106.6

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEecccc-------chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-------GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ...|-+|+-+.|+++.+ .|+.+.||.-....       ......+.++|++++.+++--.|.--.=++.+...-.|+||
T Consensus        12 l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             ceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            34588999999999998 68888887654321       22334677889999999876566555556666667789999


Q ss_pred             eccC-CChhhHhhcCCCC-CCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC---ceEecccccc
Q 015480          156 YMEN-GSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---PKVADFGLAK  227 (406)
Q Consensus       156 ~~~~-g~L~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~DfGl~~  227 (406)
                      |++| .++.+++...... ........++..|-+.+.-||.   .+++|+||..+||++..++.   +.++|||++.
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence            9977 4788888544332 3333347888888999999999   99999999999999976653   5899999985

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.37  E-value=8.4e-12  Score=103.48  Aligned_cols=130  Identities=20%  Similarity=0.245  Sum_probs=98.6

Q ss_pred             cccccceeEEEEEEeCCCcEEEEEEeccc-c------chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           85 RLGFGGFGEVYKGQFPNGVKIAVKVLNRN-L------GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~~~g~~vavK~~~~~-~------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .+++|+-+.+|.+.+. |..+++|.-.++ .      ......+-.+|+.+++++.--.|..-+=+..+.....|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            4789999999999874 445666654322 1      1122355678999999987655555555556666778999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      +|..|.+++...        ...++..+-.-+.-||.   .||+|+||.++||++..++ +.++||||+.
T Consensus        82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          82 EGELLKDALEEA--------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             CChhHHHHHHhc--------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccc
Confidence            999999888544        25566667777888999   9999999999999998775 9999999986

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.18  E-value=2.4e-10  Score=108.20  Aligned_cols=213  Identities=15%  Similarity=0.195  Sum_probs=149.0

Q ss_pred             eEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEe----cCCeeEEEEEeccC-CChhhH
Q 015480           92 GEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH----DQHMTALVYEYMEN-GSLDGY  165 (406)
Q Consensus        92 g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-g~L~~~  165 (406)
                      .+.|++. ..+|..|++|++..+.. ........-+++++++.|+|+|++.+++.    .+..+++||+|.++ ++|.++
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccc-cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            4789994 56899999999953321 11122345678899999999999999886    35578899999886 467665


Q ss_pred             hhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          166 LFG--------------KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       166 l~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      ...              .+....++.+|.++.|+..||.++|+   .|+..+-|.+.+||++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            521              12346789999999999999999999   9999999999999999999999999988765554


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      +..                |.+.    --.+-|.=.||.+++.|.||........         .. ...          
T Consensus       446 d~~----------------~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d---------~~-~~s----------  485 (655)
T KOG3741|consen  446 DPT----------------EPLE----SQQQNDLRDLGLLLLALATGTENSNRTD---------ST-QSS----------  485 (655)
T ss_pred             CCC----------------cchh----HHhhhhHHHHHHHHHHHhhccccccccc---------ch-HHH----------
Confidence            431                1121    1235677789999999999964311000         00 000          


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML  351 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  351 (406)
                        ........++.++.+++......++.+ -++.+++.++
T Consensus       486 --~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  486 --HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             --HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence              011223456667777777777777776 5666666543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.17  E-value=3.5e-10  Score=96.73  Aligned_cols=127  Identities=24%  Similarity=0.337  Sum_probs=84.2

Q ss_pred             EEEEEEeCCCcEEEEEEecccc-------------------------chhhHHHHHHHHHHhhccCcC--ccccEEEEEe
Q 015480           93 EVYKGQFPNGVKIAVKVLNRNL-------------------------GRIAEEQFMAEVGTIGRTYHI--NLVRLYGFCH  145 (406)
Q Consensus        93 ~V~~~~~~~g~~vavK~~~~~~-------------------------~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~  145 (406)
                      .||.|...+|..+|+|+.+...                         .........+|.+.|.++..-  ++.+++++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899988899999999985320                         011224567799999999765  567777553 


Q ss_pred             cCCeeEEEEEecc--CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHH-HHHhcCCCeeecCCCCCcEEEcCCCCceEec
Q 015480          146 DQHMTALVYEYME--NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY-LHEECQQRIIHYDIKPENVLLDANFSPKVAD  222 (406)
Q Consensus       146 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~-LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (406)
                         ...|||||++  |..+..+....   ++......++.+++..+.. +|.   .|++|+||.+.|||++++ .+.++|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEe
Confidence               3369999998  65565444211   1134456677777775555 567   999999999999999988 999999


Q ss_pred             cccccccC
Q 015480          223 FGLAKLCD  230 (406)
Q Consensus       223 fGl~~~~~  230 (406)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99986544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.12  E-value=1.1e-09  Score=99.39  Aligned_cols=131  Identities=15%  Similarity=0.047  Sum_probs=95.5

Q ss_pred             EEEEEEeCCCcEEEEEEeccccchh----------hHHHHHHHHHHhhccCcCc--cccEEEEEec-----CCeeEEEEE
Q 015480           93 EVYKGQFPNGVKIAVKVLNRNLGRI----------AEEQFMAEVGTIGRTYHIN--LVRLYGFCHD-----QHMTALVYE  155 (406)
Q Consensus        93 ~V~~~~~~~g~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~-----~~~~~lv~e  155 (406)
                      .|.++.+ +|+.|.||......-..          ....+.+|...+..+...+  .+..+++...     ...-+||||
T Consensus        37 rvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         37 RTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             eEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            4667766 67889999774321111          1124778988888875433  3444555533     234679999


Q ss_pred             eccCC-ChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC-------CCCceEeccccc
Q 015480          156 YMENG-SLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-------NFSPKVADFGLA  226 (406)
Q Consensus       156 ~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~-------~~~~kl~DfGl~  226 (406)
                      ++++. +|.+++... ....+......++.+++..+.-||.   .|++|+|++++|||++.       ++.+.|+||+.+
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            99886 798887421 3455667788999999999999999   99999999999999975       467899999988


Q ss_pred             c
Q 015480          227 K  227 (406)
Q Consensus       227 ~  227 (406)
                      .
T Consensus       193 ~  193 (268)
T PRK15123        193 Q  193 (268)
T ss_pred             c
Confidence            5

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.06  E-value=3.1e-11  Score=122.47  Aligned_cols=244  Identities=18%  Similarity=0.193  Sum_probs=162.6

Q ss_pred             cccccccceeEEEEEEe-CCCcEEEEEEeccc--cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           83 STRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      .+-+-+|+++.++.++- ..|...++|+....  ......+....+-.++-..++|-++...--+......+|+++|..+
T Consensus       809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~  888 (1205)
T KOG0606|consen  809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG  888 (1205)
T ss_pred             cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence            34577899999888743 23444455544321  0111122233333333334456565554445556778899999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC------C-
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR------N-  232 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~------~-  232 (406)
                      ++|...++... ..+.+........+..+++|||+   ..+.|+|++|.|.++..+|+.++.|||.......      . 
T Consensus       889 ~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~s  964 (1205)
T KOG0606|consen  889 GDLPSKLHNSG-CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLS  964 (1205)
T ss_pred             CCchhhhhcCC-CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCCcc
Confidence            99999885443 45555566666778899999998   6699999999999999999999999984321110      0 


Q ss_pred             --------------C--------ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc
Q 015480          233 --------------K--------THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL  290 (406)
Q Consensus       233 --------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  290 (406)
                                    .        .........||+.|.+||...+. .....+|+|++|++++|.++|.+||....... 
T Consensus       965 g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~- 1042 (1205)
T KOG0606|consen  965 GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-RHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ- 1042 (1205)
T ss_pred             cccccCccccccccccccccccchhhccccccCCCcccCCcccccc-cCCCcchhhhhhhhhhhhhcCCCCCCCcchhh-
Confidence                          0        00011234689999999999987 78899999999999999999999986544321 


Q ss_pred             ccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChH
Q 015480          291 DWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMS  345 (406)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  345 (406)
                            ..+......       ..-...+...+.+..+++...+..+|.+|..+.
T Consensus      1043 ------~f~ni~~~~-------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 ------IFENILNRD-------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             ------hhhccccCC-------CCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence                  111111111       111233345566788888888999999998766

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.00  E-value=5.2e-09  Score=92.18  Aligned_cols=137  Identities=23%  Similarity=0.249  Sum_probs=99.9

Q ss_pred             cccccccccceeEEEEEEeCCCcEEEEEEecccc-------------------c--hhhHHHHHHHHHHhhccCcC--cc
Q 015480           81 NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-------------------G--RIAEEQFMAEVGTIGRTYHI--NL  137 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~-------------------~--~~~~~~~~~e~~~l~~l~h~--ni  137 (406)
                      .++..||-|--|.||.|..++|.++|||.-+-..                   +  ........+|.+.|.+|...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            4567899999999999999999999999764210                   0  12234567789999988644  66


Q ss_pred             ccEEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC
Q 015480          138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  217 (406)
Q Consensus       138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  217 (406)
                      .+.+++    +...+||||++|-.|...-      ++.+....++..|++-+.-+-.   .|++|+|+.+-||++++||.
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~  240 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCC
Confidence            666654    4557999999986664432      2344445555555555554445   89999999999999999999


Q ss_pred             ceEeccccccccC
Q 015480          218 PKVADFGLAKLCD  230 (406)
Q Consensus       218 ~kl~DfGl~~~~~  230 (406)
                      +.++||-.+...+
T Consensus       241 ~~vIDwPQ~v~~~  253 (304)
T COG0478         241 IVVIDWPQAVPIS  253 (304)
T ss_pred             EEEEeCcccccCC
Confidence            9999997765433

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.99  E-value=3.2e-10  Score=110.95  Aligned_cols=152  Identities=21%  Similarity=0.334  Sum_probs=104.6

Q ss_pred             HHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE------e-cCCCCCCCccCccccCC
Q 015480          183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT------I-SGYKGTPGYSAPEFLSG  255 (406)
Q Consensus       183 ~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~------~-~~~~gt~~y~aPE~~~~  255 (406)
                      .+++.|+.|+|.  ..++||++|.|++|.++.++.+||+.|+.+...........      . .-......|.|||++.+
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345599999998  48999999999999999999999999999875544221100      0 00123558999999988


Q ss_pred             CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcc
Q 015480          256 NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQ  335 (406)
Q Consensus       256 ~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  335 (406)
                      . ..+.++|+||+|+++|-+..|+.+..........            .......+.........+.+.++.+=+.+++.
T Consensus       184 ~-~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~------------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 T-TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS------------YSFSRNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             c-cccccccceeeeeEEEEEecCCcchhhccCCcch------------hhhhhcccccccccccccCcHHHHHHHHHHhc
Confidence            6 7899999999999999999665543322211110            00001111111122235667788888899999


Q ss_pred             cCCCCCCChHHHHH
Q 015480          336 DSPEDRPPMSAVIK  349 (406)
Q Consensus       336 ~dP~~RPs~~~vl~  349 (406)
                      .++.-||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998777654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.95  E-value=3.7e-09  Score=103.70  Aligned_cols=142  Identities=19%  Similarity=0.223  Sum_probs=92.4

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhh---------------------------------------HHHHHH
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIA---------------------------------------EEQFMA  124 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~---------------------------------------~~~~~~  124 (406)
                      +-|+.++-|.||+|++++|+.||||+.+++..+..                                       +-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            45899999999999999999999999976521111                                       012334


Q ss_pred             HHHHhhccC----cCccccEEEEE-ecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCC
Q 015480          125 EVGTIGRTY----HINLVRLYGFC-HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR  199 (406)
Q Consensus       125 e~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~  199 (406)
                      |..-+.+++    ...-+++=.++ .-.....|+|||++|-.+.+....+...++...+.....++.  +..+=.   .|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~---dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLR---DG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHh---cC
Confidence            444444432    11122222222 224455799999999999888533334555333333222211  222222   79


Q ss_pred             eeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          200 IIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       200 i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ++|.|.+|.||+++.+|.+.+.|||+.....
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            9999999999999999999999999987554

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.94  E-value=3.9e-08  Score=91.30  Aligned_cols=260  Identities=13%  Similarity=0.106  Sum_probs=158.2

Q ss_pred             ccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEE-------ecCCeeEEE
Q 015480           82 YSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFC-------HDQHMTALV  153 (406)
Q Consensus        82 ~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~-------~~~~~~~lv  153 (406)
                      .++-||+|+-+.+|-.-.-.+  .+-|++....... ..   +.+..|... .||-+-.-+.+=       .......++
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~-~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAA-QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchhhc--hhheeecCCCchH-HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            456799999999997632112  3447665432211 11   122233333 455433312111       112235678


Q ss_pred             EEeccCC-ChhhHhh-----cCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          154 YEYMENG-SLDGYLF-----GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       154 ~e~~~~g-~L~~~l~-----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      |..+++. .+..++.     .+.....|..+++.+..+|.+.+.||.   .|.+-+|+.++|+|+++++.+.|.|-..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEccccee
Confidence            8887764 2333332     223457899999999999999999999   999999999999999999999998855443


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccC-C---CCCCCcccceeecchhHHHHhhc-ccccccCCCcccccchhHHHH-HH
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLS-G---NYPITHKCDVYSFGMVLFEIVGR-RRNAIVGATESLDWFPKHVWE-EY  301 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~---~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~-~~  301 (406)
                      ...+..   .....+|...|.+||... +   ...-+...|-|.||+++++++.| +.|+..-........+   .+ ..
T Consensus       166 i~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p---~E~~I  239 (637)
T COG4248         166 INANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP---LETDI  239 (637)
T ss_pred             eccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc---chhhh
Confidence            332222   223467889999999754 1   12457789999999999999877 6676432111111000   01 11


Q ss_pred             hhhhcchh------hccCCCCcchHHHHHHHHHHHHHhccc--CCCCCCChHHHHHHhhcccc
Q 015480          302 EKCELGAM------ILGCGIEEKDKEKAKRLCMVALWCVQD--SPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       302 ~~~~~~~~------~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPs~~~vl~~L~~~~~  356 (406)
                      ..+.....      ......+....-.+..+..+..+|+..  ++.-|||++-.+..|..+.+
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence            11111100      011111222234567788899999864  47799999998887776543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.88  E-value=2.1e-08  Score=87.84  Aligned_cols=124  Identities=19%  Similarity=0.210  Sum_probs=90.5

Q ss_pred             CCcEEEEEEeccccch------hhHHHHHHHHHHhhccCcC--ccccEEEEEecC----CeeEEEEEeccCC-ChhhHhh
Q 015480          101 NGVKIAVKVLNRNLGR------IAEEQFMAEVGTIGRTYHI--NLVRLYGFCHDQ----HMTALVYEYMENG-SLDGYLF  167 (406)
Q Consensus       101 ~g~~vavK~~~~~~~~------~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~  167 (406)
                      .++.+.+|........      .......+|...+..+...  .++..+++....    ...+||+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            3556666654322111      2334677888887777533  355666665542    2347999999884 7999884


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC---CceEeccccccc
Q 015480          168 GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKL  228 (406)
Q Consensus       168 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~DfGl~~~  228 (406)
                      .... .+......++.+++..+.-||.   .|++|+|+++.|||++.++   .+.++||+-++.
T Consensus       111 ~~~~-~~~~~~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  111 QWEQ-LDPSQRRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hhcc-cchhhHHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            3222 6667788999999999999999   9999999999999999887   799999988764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.79  E-value=4.8e-08  Score=95.57  Aligned_cols=141  Identities=21%  Similarity=0.298  Sum_probs=94.6

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchh------------------------------------hHHHHHHHHH
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRI------------------------------------AEEQFMAEVG  127 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~------------------------------------~~~~~~~e~~  127 (406)
                      +-||.-+.|.||+|+.++|+.||||+-++.....                                    .+-+|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            4599999999999999999999999987542111                                    0113444444


Q ss_pred             Hhhc----cCcCc------cccEEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcC
Q 015480          128 TIGR----TYHIN------LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ  197 (406)
Q Consensus       128 ~l~~----l~h~n------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~  197 (406)
                      -..+    +.|-+      |.+++..+  .....|+||||+|..+.|.-.-....++...+..-+.+.     |++....
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~-----~~~qIf~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEA-----YLEQIFK  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHH-----HHHHHHh
Confidence            3333    33444      34444333  235579999999998887764455566666555544433     2222223


Q ss_pred             CCeeecCCCCCcEEEcC----CCCceEeccccccccCC
Q 015480          198 QRIIHYDIKPENVLLDA----NFSPKVADFGLAKLCDR  231 (406)
Q Consensus       198 ~~i~H~dlk~~Nill~~----~~~~kl~DfGl~~~~~~  231 (406)
                      .|++|+|-+|.||++..    ++.+.+.|||+......
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            68999999999999984    66899999999875543

>PRK09902 hypothetical protein; Provisional

Probab=98.79  E-value=1.2e-07  Score=81.69  Aligned_cols=137  Identities=16%  Similarity=0.105  Sum_probs=101.7

Q ss_pred             ccccceeEEEEEEeCCCcEEEEEEeccccc-----hhhHHHHHHHHHHhhccCcC--ccccEEEEEe-c----CCeeEEE
Q 015480           86 LGFGGFGEVYKGQFPNGVKIAVKVLNRNLG-----RIAEEQFMAEVGTIGRTYHI--NLVRLYGFCH-D----QHMTALV  153 (406)
Q Consensus        86 ig~G~~g~V~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~-~----~~~~~lv  153 (406)
                      -|+||-+-|++..+ +|..+-+|.-.....     ......|.+|...+.+|..-  ++.+.. ++. .    ...-+||
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            46799999999887 455788887642211     23457899999999988633  244444 322 1    1245699


Q ss_pred             EEeccC-CChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC--ceEecccccc
Q 015480          154 YEYMEN-GSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS--PKVADFGLAK  227 (406)
Q Consensus       154 ~e~~~~-g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--~kl~DfGl~~  227 (406)
                      +|-+.| -+|.+++... -.+.+......+..+++..+.-||+   .|+.|+|+.+.||+++.++.  ++++||--++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997753 4888887432 3456778888999999999999999   99999999999999987777  9999996654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.76  E-value=1.7e-07  Score=83.19  Aligned_cols=137  Identities=18%  Similarity=0.269  Sum_probs=85.8

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCc--cccEEEEEecCCeeEEEEEeccCCC
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN--LVRLYGFCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~  161 (406)
                      ..||+|..+.||+.   .|..+++|......   ......+|.+++..+..-+  +.+.+++..+.+...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            45899999999984   24467888876532   3345688999998886433  5778888888888889999999863


Q ss_pred             -hhhHh---------------------hcCC-CCCCHHHHHH-HHH----------HHHH-HHHHHHHh-cCCCeeecCC
Q 015480          162 -LDGYL---------------------FGKK-RAIEWEKLHE-IAI----------GTAK-GLVYLHEE-CQQRIIHYDI  205 (406)
Q Consensus       162 -L~~~l---------------------~~~~-~~~~~~~~~~-i~~----------qi~~-~l~~LH~~-~~~~i~H~dl  205 (406)
                       +...+                     +.-. .......... +..          .+.. ...+|... ....++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             21111                     1100 0111111000 000          0001 12222211 1346789999


Q ss_pred             CCCcEEEcCCCCceEecccccc
Q 015480          206 KPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       206 k~~Nill~~~~~~kl~DfGl~~  227 (406)
                      .|.||++++++ +.++||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999888 9999998874

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.56  E-value=7e-07  Score=79.64  Aligned_cols=140  Identities=21%  Similarity=0.182  Sum_probs=85.0

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcC--ccccEEEEEec---CCeeEEEEEecc
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI--NLVRLYGFCHD---QHMTALVYEYME  158 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~~  158 (406)
                      +.|+.|..+.||+....+ ..+++|.....   .....+..|..++..+...  .+.+++.+...   ....+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            458899999999999866 58999987653   3556778888888888633  35677765433   335689999999


Q ss_pred             CCChhh----------------Hh---hcC---CCCCCHHH---------HHHH------------HHHHHH-HHHHHHH
Q 015480          159 NGSLDG----------------YL---FGK---KRAIEWEK---------LHEI------------AIGTAK-GLVYLHE  194 (406)
Q Consensus       159 ~g~L~~----------------~l---~~~---~~~~~~~~---------~~~i------------~~qi~~-~l~~LH~  194 (406)
                      |.++..                .+   +..   ........         ....            ...+.. .++.++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988777                11   111   11111110         0000            111222 3444443


Q ss_pred             h----cCCCeeecCCCCCcEEEc-CCCCceEecccccc
Q 015480          195 E----CQQRIIHYDIKPENVLLD-ANFSPKVADFGLAK  227 (406)
Q Consensus       195 ~----~~~~i~H~dlk~~Nill~-~~~~~kl~DfGl~~  227 (406)
                      .    ....++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2    246799999999999999 56666899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.56  E-value=1.2e-06  Score=75.98  Aligned_cols=136  Identities=17%  Similarity=0.138  Sum_probs=84.1

Q ss_pred             hhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHH---------HHHHHHhhccCc---CccccEEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQF---------MAEVGTIGRTYH---INLVRLYGFC  144 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~---------~~e~~~l~~l~h---~niv~~~~~~  144 (406)
                      +..+...+.+-......|.+-.. +|..+++|..+.... ...+.|         .+.+..+..++.   .....++.+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            33344444555555555666665 678899998875422 122222         223333333322   2223322222


Q ss_pred             e-----cCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCce
Q 015480          145 H-----DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK  219 (406)
Q Consensus       145 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k  219 (406)
                      .     -....+|+|||++|..|.+...     ++.    .++..+++++.-||.   .|++|+|..|.|++++++ .++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~  174 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIR  174 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEE
Confidence            1     1234468999999988876541     222    344567788999999   999999999999999865 599


Q ss_pred             Eecccccc
Q 015480          220 VADFGLAK  227 (406)
Q Consensus       220 l~DfGl~~  227 (406)
                      ++||+..+
T Consensus       175 iID~~~k~  182 (229)
T PF06176_consen  175 IIDTQGKR  182 (229)
T ss_pred             EEECcccc
Confidence            99998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.49  E-value=3.7e-08  Score=95.87  Aligned_cols=182  Identities=16%  Similarity=0.106  Sum_probs=131.5

Q ss_pred             ccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCc-cccEEEEEecCCeeEEEEEeccCC
Q 015480           82 YSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        82 ~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      +.+..++|++++++|.+-...+....+.+...      ....-++++|.+++||| .+..++-+..+...+++++++.++
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~  319 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG  319 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence            34558899999999986533333445555432      34566899999999999 777777777788899999999887


Q ss_pred             -ChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          161 -SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       161 -~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                       +-........-.+..-+...+...-+++++++|+   ..-+|+|    ||+..+ +..+..||+....+....   ..+
T Consensus       320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~  388 (829)
T KOG0576|consen  320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPR  388 (829)
T ss_pred             ccccccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---ccc
Confidence             3322221222334444556667777889999998   4457888    777765 688999999987665443   234


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccc
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRN  281 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p  281 (406)
                      ...+++.|+|||+.... .+..+.|+|++|+-..+|--|.+|
T Consensus       389 t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             cCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCC
Confidence            46789999999988877 688999999999877777766654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.48  E-value=1.9e-06  Score=77.64  Aligned_cols=137  Identities=12%  Similarity=0.065  Sum_probs=84.6

Q ss_pred             ccccce-eEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEEEeccCCChh
Q 015480           86 LGFGGF-GEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYMENGSLD  163 (406)
Q Consensus        86 ig~G~~-g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  163 (406)
                      |-.|.. ..||+.... +..+.+|+.....    ...+.+|++++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444555 789999764 4688888876532    335677888888774 445667888887777789999999998776


Q ss_pred             hHh-------------------hcC---CCCCCH--HHHHHHHH--------------------HHHHHHHHHHH----h
Q 015480          164 GYL-------------------FGK---KRAIEW--EKLHEIAI--------------------GTAKGLVYLHE----E  195 (406)
Q Consensus       164 ~~l-------------------~~~---~~~~~~--~~~~~i~~--------------------qi~~~l~~LH~----~  195 (406)
                      ...                   +.-   ...+..  ........                    .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            431                   110   001110  00000000                    01111222211    0


Q ss_pred             cCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       196 ~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            12569999999999999998778899998774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.47  E-value=2.6e-06  Score=90.02  Aligned_cols=80  Identities=15%  Similarity=0.251  Sum_probs=58.4

Q ss_pred             cccccccceeEEEEEEeCCC---cEEEEEEeccccchhhHHHHHHHHHHhhccC-cCcc--ccEEEEEecC---CeeEEE
Q 015480           83 STRLGFGGFGEVYKGQFPNG---VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINL--VRLYGFCHDQ---HMTALV  153 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv  153 (406)
                      .+.++.|.+..+|+....++   ..+++|+............+.+|.++++.+. |+++  .+++.+|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45689999999999877554   3677777654322223456889999999985 6654  8888888764   467899


Q ss_pred             EEeccCCCh
Q 015480          154 YEYMENGSL  162 (406)
Q Consensus       154 ~e~~~~g~L  162 (406)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999988653

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.46  E-value=2.7e-06  Score=74.55  Aligned_cols=137  Identities=20%  Similarity=0.297  Sum_probs=90.5

Q ss_pred             cccccceeEEEEEEeCCCcEEEEEEeccccchh------------------hHH----H-HHHHHHHhhccC--cCcccc
Q 015480           85 RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRI------------------AEE----Q-FMAEVGTIGRTY--HINLVR  139 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~------------------~~~----~-~~~e~~~l~~l~--h~niv~  139 (406)
                      .|++|--+.||+|...++..+|+|+++......                  ...    . ..+|..-|.++.  +-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            477788889999988789999999996431100                  000    0 134555565553  334455


Q ss_pred             EEEEEecCCeeEEEEEeccCCCh-hhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCc
Q 015480          140 LYGFCHDQHMTALVYEYMENGSL-DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP  218 (406)
Q Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  218 (406)
                      -+++..    ..|||||+...-+ .-.|  +.-.+.......+..++++.+.-|-.  ..++||+||..-|||+. ++.+
T Consensus       135 Pi~~~~----nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         135 PIAFRN----NVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             ceeecC----CeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCeE
Confidence            555442    2599999855311 1111  22233444567777777777776664  37999999999999999 8899


Q ss_pred             eEeccccccccC
Q 015480          219 KVADFGLAKLCD  230 (406)
Q Consensus       219 kl~DfGl~~~~~  230 (406)
                      .++|||.+....
T Consensus       206 ~iID~~QaV~~~  217 (268)
T COG1718         206 YIIDVSQAVTID  217 (268)
T ss_pred             EEEECccccccC
Confidence            999999987554

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.26  E-value=7.4e-06  Score=73.38  Aligned_cols=73  Identities=15%  Similarity=0.127  Sum_probs=46.8

Q ss_pred             cccccccee-EEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcC---ccccEEEEEecC---CeeEEEEEe
Q 015480           84 TRLGFGGFG-EVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI---NLVRLYGFCHDQ---HMTALVYEY  156 (406)
Q Consensus        84 ~~ig~G~~g-~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~  156 (406)
                      +.|+.|+.. .||+.    +..+++|..+..   .....+..|.+++..+...   .+..+++.....   ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~---~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA---GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc---chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            347777776 48976    234677865542   2345788899998877532   345555544332   245789999


Q ss_pred             ccCCChh
Q 015480          157 MENGSLD  163 (406)
Q Consensus       157 ~~~g~L~  163 (406)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9997774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.26  E-value=1.2e-05  Score=66.78  Aligned_cols=126  Identities=21%  Similarity=0.303  Sum_probs=87.4

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccc-cEEEEEecCCeeEEEEEeccCCC
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV-RLYGFCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~  161 (406)
                      .+.||+|++|.||+|.+. |..+|+|+-+.+.   ....+..|++++..+.--++- +++.+..+    ++.|||..|-+
T Consensus        27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~   98 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP   98 (201)
T ss_pred             hhhhhcccccEEEEeecc-CceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence            456999999999999995 5589999887653   456788899999888765553 45554433    35699999988


Q ss_pred             hhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCC--CcEEEcCCCCceEeccccccc
Q 015480          162 LDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP--ENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       162 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~--~Nill~~~~~~kl~DfGl~~~  228 (406)
                      |.++....    +-.+    ...+++.---|-.   .||-|+.|.-  .||++. ++.+.|+||.-|+.
T Consensus        99 L~~~~~~~----~rk~----l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIGG----DRKH----LLRVLEKAYKLDR---LGIEHGELSRPWKNVLVN-DRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcc----cHHH----HHHHHHHHHHHHH---hccchhhhcCCceeEEec-CCcEEEEEccchhh
Confidence            87765221    2222    3344555444555   8899988864  455554 44999999988863

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.21  E-value=7.4e-06  Score=70.37  Aligned_cols=103  Identities=22%  Similarity=0.202  Sum_probs=81.8

Q ss_pred             HHHHHhhccCc-CccccEEEEEecCCeeEEEEEeccCCChhhHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCe
Q 015480          124 AEVGTIGRTYH-INLVRLYGFCHDQHMTALVYEYMENGSLDGYLF--GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI  200 (406)
Q Consensus       124 ~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i  200 (406)
                      .|.-++..+++ +++++++|+|-+    +++.||...+++...-.  ..-...+|..+.+|+.++++.+.+|+......+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47777888875 699999999943    67999998776642110  112357899999999999999999997555567


Q ss_pred             eecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          201 IHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       201 ~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      .-.|++++|+-++++|++|++|...+...+
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            789999999999999999999998875443

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=98.20  E-value=4.2e-05  Score=70.97  Aligned_cols=76  Identities=9%  Similarity=0.060  Sum_probs=56.8

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCc---CccccEEEEEecC---CeeEEEEEe
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH---INLVRLYGFCHDQ---HMTALVYEY  156 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~---~~~~lv~e~  156 (406)
                      .+.||.|..+.||+....+| .+.+|..+..   .....+..|.+.++.+..   -.+.++++++.+.   +..+||||+
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG-NPMPLMARSF---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeecCCccceeEEEEEcCCC-CEEEEEeccc---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            45699999999999987666 4667774431   133578899999988853   4688899888643   568999999


Q ss_pred             ccCCCh
Q 015480          157 MENGSL  162 (406)
Q Consensus       157 ~~~g~L  162 (406)
                      ++++++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998765

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.19  E-value=4.6e-05  Score=65.84  Aligned_cols=129  Identities=21%  Similarity=0.327  Sum_probs=88.4

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEecccc---------------chhhHHHHHHHHHHhhccC------cCccccEE
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL---------------GRIAEEQFMAEVGTIGRTY------HINLVRLY  141 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~---------------~~~~~~~~~~e~~~l~~l~------h~niv~~~  141 (406)
                      ...||+|+.-.||.--  +.....||+.....               ......+..+|+.-...+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~HP--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEECC--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            3469999999999853  33457888887653               1112345666665555544      88999999


Q ss_pred             EEEecCCeeEEEEEeccC------CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC
Q 015480          142 GFCHDQHMTALVYEYMEN------GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN  215 (406)
Q Consensus       142 ~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~  215 (406)
                      |+..++.-..+|+|.+.+      -+|.+++  ....++. ...+.+   -+-..||-.   .+|+.+|++|.||++..+
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l--~~~~~~~-~~~~~L---~~f~~~l~~---~~Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYL--KEGGLTE-ELRQAL---DEFKRYLLD---HHIVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHH--HcCCccH-HHHHHH---HHHHHHHHH---cCCeecCCCcccEEEEec
Confidence            999999999999998643      2577777  3334554 333333   344566776   889999999999999543


Q ss_pred             C----CceEec
Q 015480          216 F----SPKVAD  222 (406)
Q Consensus       216 ~----~~kl~D  222 (406)
                      .    .+.|+|
T Consensus       155 ~~~~~~lvlID  165 (199)
T PF10707_consen  155 DSGEFRLVLID  165 (199)
T ss_pred             CCCceEEEEEe
Confidence            2    466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.17  E-value=2.3e-05  Score=67.15  Aligned_cols=128  Identities=23%  Similarity=0.347  Sum_probs=90.9

Q ss_pred             hhhhhcccccccccce-eEEEEEEeCCCcEEEEEEecc---c--------cc--h-------hhHHHHHHHHHHhhccC-
Q 015480           76 NNFTSNYSTRLGFGGF-GEVYKGQFPNGVKIAVKVLNR---N--------LG--R-------IAEEQFMAEVGTIGRTY-  133 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~-g~V~~~~~~~g~~vavK~~~~---~--------~~--~-------~~~~~~~~e~~~l~~l~-  133 (406)
                      .+..+.+.+.||.|.- |.||+++. +|+.||+|+.+.   .        ..  .       .....|..|.+...+|+ 
T Consensus        35 h~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   35 HGDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CCCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            3367788899999999 99999999 688999999321   0        00  0       12245888988888775 


Q ss_pred             --cCcc--ccEEEEEecC------------------CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 015480          134 --HINL--VRLYGFCHDQ------------------HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY  191 (406)
Q Consensus       134 --h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~  191 (406)
                        +.++  |+++||..-.                  ....||.||++...          .++..    -+.++.+-+..
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~  179 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKI  179 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHH
Confidence              4466  9999997221                  12347888776533          22323    34556677888


Q ss_pred             HHHhcCCCeeecCCCCCcEEEcCCCCceEeccccc
Q 015480          192 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  226 (406)
Q Consensus       192 LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~  226 (406)
                      +|.   .||+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHH---CCeeeccCcccccc-----CCEEEecccC
Confidence            998   99999999999987     4689999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.04  E-value=5.1e-05  Score=67.90  Aligned_cols=138  Identities=16%  Similarity=0.168  Sum_probs=80.6

Q ss_pred             ccccccceeEEEEEEeCC--CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCc-cccEEEEEecCCeeEEEEEeccCC
Q 015480           84 TRLGFGGFGEVYKGQFPN--GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      +.|..|-...+|+....+  +..|++|+......  ...+..+|+.++..+...+ .+++++.+.    ..++|||++|.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            357778888999998764  67899997764321  1122346888888775333 445554432    24899999987


Q ss_pred             ChhhH-------h----------hcCCC----------CCC-HHHHHHHHH----------------------HHHHHHH
Q 015480          161 SLDGY-------L----------FGKKR----------AIE-WEKLHEIAI----------------------GTAKGLV  190 (406)
Q Consensus       161 ~L~~~-------l----------~~~~~----------~~~-~~~~~~i~~----------------------qi~~~l~  190 (406)
                      ++...       +          +....          ... +..+..+..                      .+...+.
T Consensus        78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  157 (235)
T cd05157          78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS  157 (235)
T ss_pred             cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence            76321       0          11111          111 122222211                      1111111


Q ss_pred             HH----HHh-cCCCeeecCCCCCcEEEcC-CCCceEecccccc
Q 015480          191 YL----HEE-CQQRIIHYDIKPENVLLDA-NFSPKVADFGLAK  227 (406)
Q Consensus       191 ~L----H~~-~~~~i~H~dlk~~Nill~~-~~~~kl~DfGl~~  227 (406)
                      .|    ... ....++|+|+.+.|||+++ ++.+.++||..+.
T Consensus       158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            22    110 1357999999999999998 5789999998774

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.98  E-value=0.00021  Score=68.42  Aligned_cols=76  Identities=14%  Similarity=0.211  Sum_probs=54.3

Q ss_pred             ccccccceeEEEEEEeCCC-cEEEEEEeccccc------hhhHHHHHHHHHHhhccC---cCccccEEEEEecCCeeEEE
Q 015480           84 TRLGFGGFGEVYKGQFPNG-VKIAVKVLNRNLG------RIAEEQFMAEVGTIGRTY---HINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g-~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  153 (406)
                      +.||.|.+..||++...+| +.++||.-.....      ....+++..|.+.|..+.   ..++++++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4699999999999988777 5899998542111      124466777888887763   3467777776  34556899


Q ss_pred             EEeccCCC
Q 015480          154 YEYMENGS  161 (406)
Q Consensus       154 ~e~~~~g~  161 (406)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.97  E-value=5.2e-05  Score=68.85  Aligned_cols=135  Identities=11%  Similarity=0.094  Sum_probs=78.4

Q ss_pred             ccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCcc-ccEEEEEecCCeeEEEEEeccCCChhh
Q 015480           86 LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGFCHDQHMTALVYEYMENGSLDG  164 (406)
Q Consensus        86 ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~~  164 (406)
                      +..|-.+.+|+... +|..+++|......... ..+..+|.++++.+...++ .+++..+.    .++||||++|..+..
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            56688889999974 56788888765432111 1135678888888764333 44554432    368999999876642


Q ss_pred             H-----------------hhcC---CCCCCHH-HHHHHHHHH---------HHHHHHHHHh-----cCCCeeecCCCCCc
Q 015480          165 Y-----------------LFGK---KRAIEWE-KLHEIAIGT---------AKGLVYLHEE-----CQQRIIHYDIKPEN  209 (406)
Q Consensus       165 ~-----------------l~~~---~~~~~~~-~~~~i~~qi---------~~~l~~LH~~-----~~~~i~H~dlk~~N  209 (406)
                      .                 ++..   ...++.. .+..+..++         ...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 1111   1112211 111111111         1112222111     12468999999999


Q ss_pred             EEEcCCCCceEecccccc
Q 015480          210 VLLDANFSPKVADFGLAK  227 (406)
Q Consensus       210 ill~~~~~~kl~DfGl~~  227 (406)
                      |++++++ +.|+||..+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999877 7899998875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.91  E-value=3.8e-05  Score=80.24  Aligned_cols=196  Identities=17%  Similarity=0.190  Sum_probs=133.0

Q ss_pred             HHHHHHhhccCcCccccEEEEEecCCee----EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCC
Q 015480          123 MAEVGTIGRTYHINLVRLYGFCHDQHMT----ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ  198 (406)
Q Consensus       123 ~~e~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~  198 (406)
                      .-|.+.+.+..|+|++.++.|-.+....    .+..++|..-++...+ ..-..++..+.+.+..++.+||.|+|+   .
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-q~v~~i~~~~~r~~~~~~~~GL~~~h~---~  305 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-QSVGSIPLETLRILHQKLLEGLAYLHS---L  305 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-hhccccCHHHHHHHHHHHhhhHHHHHH---h
Confidence            3466677788999999999987654332    3567788888888777 455678899999999999999999998   5


Q ss_pred             CeeecCCCCC---cEEEcCCCCceEe--ccccccccCCCCceEEecCCCCCCCccCccccCCCC-CCCcccceeecchhH
Q 015480          199 RIIHYDIKPE---NVLLDANFSPKVA--DFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVL  272 (406)
Q Consensus       199 ~i~H~dlk~~---Nill~~~~~~kl~--DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il  272 (406)
                      ...|.-+..+   +...+..+...++  ||+.+..........   ...-+..|.+||...... ......|+|.+|...
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            4444444444   4444556666666  888887655433221   122345677888766541 223447999999999


Q ss_pred             HHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 015480          273 FEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML  351 (406)
Q Consensus       273 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  351 (406)
                      ..+..|..+........                          .-.+......+.+....|+..++++|+++.+++...
T Consensus       383 ~~~~~~~~i~~~~~~~~--------------------------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAVPV--------------------------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhcCcccccccchh--------------------------hhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            99998875432221110                          000011112577888999999999999999998854

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.88  E-value=0.0001  Score=68.41  Aligned_cols=139  Identities=17%  Similarity=0.177  Sum_probs=83.4

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCc--cccEEEE------EecCCeeEEEEE
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN--LVRLYGF------CHDQHMTALVYE  155 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e  155 (406)
                      +.|..|....+|+....++ .+++|+...    .....+..|++++..+.+.+  +.+++..      ....+..++|++
T Consensus        20 ~~i~~G~~n~~y~v~~~~~-~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          20 EGISAGIENTNYFVTTDSG-RYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             ecccCccccceEEEEeCCC-cEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            3577788889999976444 688898764    23345667777777775332  4444432      123445689999


Q ss_pred             eccCCChhh----Hh----------hc--C--C------CCCCHHHHH----------HHHHHHHHHHHHHHH----hcC
Q 015480          156 YMENGSLDG----YL----------FG--K--K------RAIEWEKLH----------EIAIGTAKGLVYLHE----ECQ  197 (406)
Q Consensus       156 ~~~~g~L~~----~l----------~~--~--~------~~~~~~~~~----------~i~~qi~~~l~~LH~----~~~  197 (406)
                      |++|..+..    ..          +.  .  .      ....|....          .....+...+.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999877532    00          10  0  0      011121110          011112334444442    123


Q ss_pred             CCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          198 QRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       198 ~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      .+++|+|+.|.||++++++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            679999999999999998778899998774

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.79  E-value=0.00037  Score=65.08  Aligned_cols=141  Identities=18%  Similarity=0.204  Sum_probs=81.7

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCc--cccEEEE------EecCCeeEEEE
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN--LVRLYGF------CHDQHMTALVY  154 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~  154 (406)
                      .+.++.|....+|+.+..+| .+++|+.....   .......|.+++..|...+  +.+++..      ....+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~---~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV---KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC---CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            34577777789999876555 57788765421   1234455666666664222  3444432      12245678999


Q ss_pred             EeccCCChhh-----------H---hhc--CC--C-------CCCHHHHHH------------HHHHHHHHHHHHHH---
Q 015480          155 EYMENGSLDG-----------Y---LFG--KK--R-------AIEWEKLHE------------IAIGTAKGLVYLHE---  194 (406)
Q Consensus       155 e~~~~g~L~~-----------~---l~~--~~--~-------~~~~~~~~~------------i~~qi~~~l~~LH~---  194 (406)
                      +|++|..+..           .   ++.  ..  .       ...|.....            ....+.+.++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            9998865421           0   111  00  0       011111100            01122334555542   


Q ss_pred             -hcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          195 -ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       195 -~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                       ....+++|+|+++.||+++.++...|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             224789999999999999998877899998874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.72  E-value=2.5e-05  Score=71.04  Aligned_cols=138  Identities=14%  Similarity=0.105  Sum_probs=93.5

Q ss_pred             hcccccccccceeEEEEEEeCCCcEEEEEEecccc---------------------chhhHHHHHHHHHHhhccCc-C-c
Q 015480           80 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL---------------------GRIAEEQFMAEVGTIGRTYH-I-N  136 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~---------------------~~~~~~~~~~e~~~l~~l~h-~-n  136 (406)
                      +.+.++||-|--+.||.+-..+|++.++|.-+-..                     -..+.-...+|..-|+.|.. - -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            34678899999999999999899999998653110                     00111234567777777742 2 3


Q ss_pred             cccEEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC
Q 015480          137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF  216 (406)
Q Consensus       137 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~  216 (406)
                      +.+.+++    ...++|||++.|-+|...-+-    .+..+   +...+..-+--|-.   +|+||+|..-=||++++++
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~d~~~---ly~~lm~~Iv~la~---~GlIHgDFNEFNimv~dd~  239 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV----EDPPT---LYDDLMGLIVRLAN---HGLIHGDFNEFNIMVKDDD  239 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeeec----CChHH---HHHHHHHHHHHHHH---cCceecccchheeEEecCC
Confidence            4555554    355899999998887654321    22222   33333333445555   9999999999999999999


Q ss_pred             CceEeccccccccCC
Q 015480          217 SPKVADFGLAKLCDR  231 (406)
Q Consensus       217 ~~kl~DfGl~~~~~~  231 (406)
                      .++++||-.......
T Consensus       240 ~i~vIDFPQmvS~sh  254 (465)
T KOG2268|consen  240 KIVVIDFPQMVSTSH  254 (465)
T ss_pred             CEEEeechHhhccCC
Confidence            999999987654443

>PRK05231 homoserine kinase; Provisional

Probab=97.69  E-value=0.0009  Score=62.84  Aligned_cols=139  Identities=17%  Similarity=0.205  Sum_probs=75.8

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcC--ccccEEE------EEecCCeeEEEEE
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI--NLVRLYG------FCHDQHMTALVYE  155 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~------~~~~~~~~~lv~e  155 (406)
                      +.|+.|....+|+.+..+| .+++|+... .   ..+....|+.++..|...  .+.+.+.      +....+..+++++
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~-~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFER-L---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEecc-C---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            3477788889999987666 688888752 1   122333444555444321  1333332      1122456789999


Q ss_pred             eccCCChhh-----H------h---hcCCC----------CCCH-HHHHH------------HHHH-HHHHHHHHHHh--
Q 015480          156 YMENGSLDG-----Y------L---FGKKR----------AIEW-EKLHE------------IAIG-TAKGLVYLHEE--  195 (406)
Q Consensus       156 ~~~~g~L~~-----~------l---~~~~~----------~~~~-~~~~~------------i~~q-i~~~l~~LH~~--  195 (406)
                      |++|..+..     .      +   +....          .+.| .....            ...+ +...+..+...  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            999875421     1      1   11000          1111 11111            1111 11122222211  


Q ss_pred             --cCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          196 --CQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       196 --~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                        ...+++|+|+.|.||+++.+...-|+||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              24689999999999999977666899998874

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.65  E-value=0.00038  Score=64.81  Aligned_cols=137  Identities=22%  Similarity=0.257  Sum_probs=82.0

Q ss_pred             cccccceeEEEEEEeCC-------CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCc-cccEEEEEecCCeeEEEEEe
Q 015480           85 RLGFGGFGEVYKGQFPN-------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~  156 (406)
                      .+..|-...+|+....+       ++.+++|+......  ...+...|.+++..+...+ ..++++++..    .+|+||
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            45566677899997654       57899998765321  2234567877777775333 3456665542    368999


Q ss_pred             ccCCChhhH-------h----------hcCCCC--------C--CHHHHHH--------------------------HHH
Q 015480          157 MENGSLDGY-------L----------FGKKRA--------I--EWEKLHE--------------------------IAI  183 (406)
Q Consensus       157 ~~~g~L~~~-------l----------~~~~~~--------~--~~~~~~~--------------------------i~~  183 (406)
                      ++|..+...       +          +.....        .  -+..+..                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            988776431       0          111100        0  0111111                          111


Q ss_pred             HHHHHHHHHHH------hcCCCeeecCCCCCcEEEcCC----CCceEecccccc
Q 015480          184 GTAKGLVYLHE------ECQQRIIHYDIKPENVLLDAN----FSPKVADFGLAK  227 (406)
Q Consensus       184 qi~~~l~~LH~------~~~~~i~H~dlk~~Nill~~~----~~~kl~DfGl~~  227 (406)
                      .+...+.+|-.      .....++|+|+.+.|||++++    +.+.++||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22222334432      134679999999999999985    889999998874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.54  E-value=0.001  Score=61.07  Aligned_cols=73  Identities=19%  Similarity=0.268  Sum_probs=47.8

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC---cCccccEEEEEecCCeeEEEEEeccC
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---HINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      .+.++.|....+|+.+ .+++.+.||+-..    .....|..|.+-|+.|.   .-.+++++++....+..+|||||++.
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEEG----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecCh----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            4568889999999998 4678899998763    23346778888777773   44688899988877777999999987


Q ss_pred             C
Q 015480          160 G  160 (406)
Q Consensus       160 g  160 (406)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.49  E-value=0.0014  Score=60.67  Aligned_cols=136  Identities=21%  Similarity=0.267  Sum_probs=84.8

Q ss_pred             cccee-EEEEEEeCCCcEEEEEEecc-ccchhhHHHHHHHHHHhhccCc--CccccEEEEEecCC--eeEEEEEeccCCC
Q 015480           88 FGGFG-EVYKGQFPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYH--INLVRLYGFCHDQH--MTALVYEYMENGS  161 (406)
Q Consensus        88 ~G~~g-~V~~~~~~~g~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~g~  161 (406)
                      +||++ .+|..... ++.+++. ... ...........+|..+++.+.-  --+...+++|.++.  ..+.||+|++|..
T Consensus        34 ~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~  111 (321)
T COG3173          34 SGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEV  111 (321)
T ss_pred             cCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEeccee
Confidence            34443 34555443 7778887 332 2223345667788888887742  34555677777766  7789999998854


Q ss_pred             hhhHhhcCCCCCCHHHHHHHH-HHHHHHHHHHHHh---------------------------------------------
Q 015480          162 LDGYLFGKKRAIEWEKLHEIA-IGTAKGLVYLHEE---------------------------------------------  195 (406)
Q Consensus       162 L~~~l~~~~~~~~~~~~~~i~-~qi~~~l~~LH~~---------------------------------------------  195 (406)
                      +.+.+...    +..  .+.+ ..+++.|.-||+.                                             
T Consensus       112 ~~~~~~~~----~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~  185 (321)
T COG3173         112 VWSALPPE----SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK  185 (321)
T ss_pred             ccCcCCcc----cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence            43322100    000  1222 2444555555542                                             


Q ss_pred             ----------cCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          196 ----------CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       196 ----------~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                                ....++|+|+.+.|++++.++.+=+.||+++...+.
T Consensus       186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence                      135799999999999999998899999999975543

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.29  E-value=0.0048  Score=59.08  Aligned_cols=81  Identities=16%  Similarity=0.132  Sum_probs=53.2

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEeccccc---h---hhHHHHHHHHHHhhccC---cCccccEEEEEecCCeeEEE
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG---R---IAEEQFMAEVGTIGRTY---HINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~---~---~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  153 (406)
                      .+.||.|....||+.... +..++||.-.....   .   ....+-..|.+.|..+.   ..++.+++.++.+.  .+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEE
Confidence            456899999999999874 45688997652111   1   13344455566666553   35788899888744  5789


Q ss_pred             EEeccC--CChhhHh
Q 015480          154 YEYMEN--GSLDGYL  166 (406)
Q Consensus       154 ~e~~~~--g~L~~~l  166 (406)
                      |||+++  ..+.+.+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999977  3454443

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.19  E-value=0.0051  Score=57.35  Aligned_cols=143  Identities=15%  Similarity=0.129  Sum_probs=94.9

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccc--------------------cchhhHH---H--HHHHHHHhhccCcCccc
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRN--------------------LGRIAEE---Q--FMAEVGTIGRTYHINLV  138 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~--------------------~~~~~~~---~--~~~e~~~l~~l~h~niv  138 (406)
                      -.|..|--+.||-+.-.+|..+|||+++..                    .+.....   .  ...|++-|.+++...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            458888889999999989999999998532                    0111111   1  12366666666554443


Q ss_pred             cEEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCc
Q 015480          139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP  218 (406)
Q Consensus       139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  218 (406)
                      .---+...  ...|||+|+.. +-.-.=.-++..++...+..+-.|++.-+.-|-.  ..++||.||.--|+|+. +|.+
T Consensus       230 ~PePIlLk--~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyh-dG~l  303 (520)
T KOG2270|consen  230 CPEPILLK--NHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYH-DGKL  303 (520)
T ss_pred             CCCceeee--cceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEE-CCEE
Confidence            22222221  22589999953 2211111245567777788888888888888876  37899999999999985 5689


Q ss_pred             eEeccccccccCCC
Q 015480          219 KVADFGLAKLCDRN  232 (406)
Q Consensus       219 kl~DfGl~~~~~~~  232 (406)
                      .++|-+.+...+.+
T Consensus       304 yiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  304 YIIDVSQSVEHDHP  317 (520)
T ss_pred             EEEEccccccCCCh
Confidence            99999888655443

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.17  E-value=0.0057  Score=57.58  Aligned_cols=80  Identities=19%  Similarity=0.142  Sum_probs=50.3

Q ss_pred             cccccceeEEEEEEeCCC-cEEEEEEecccc------chhhHHHHHHHHHHhhccC--cC-ccccEEEEEecCCeeEEEE
Q 015480           85 RLGFGGFGEVYKGQFPNG-VKIAVKVLNRNL------GRIAEEQFMAEVGTIGRTY--HI-NLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~~~g-~~vavK~~~~~~------~~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~  154 (406)
                      .||.|....||++...+| +.|+||.-..-.      -....++...|.+.|....  -| .+++++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            489999999999987654 579998754211      1233455667777776653  34 45555543  344556899


Q ss_pred             EeccCC-ChhhHh
Q 015480          155 EYMENG-SLDGYL  166 (406)
Q Consensus       155 e~~~~g-~L~~~l  166 (406)
                      |+++.. .|.+.|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            998553 344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.14  E-value=0.0065  Score=55.68  Aligned_cols=70  Identities=16%  Similarity=0.055  Sum_probs=41.1

Q ss_pred             ccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-c-Cc-cccEEEEEecCCeeEEEEEeccCCCh
Q 015480           86 LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-H-IN-LVRLYGFCHDQHMTALVYEYMENGSL  162 (406)
Q Consensus        86 ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h-~n-iv~~~~~~~~~~~~~lv~e~~~~g~L  162 (406)
                      .++|-...|+.....+|..+++|.-+..   .....+.+|.++++.+. + |- +.+++.  .+.  .+++|++++|..+
T Consensus        19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~~---~~~~~l~rE~~vL~~L~~~l~vpvP~~~~--~~~--~~~~y~~i~G~p~   91 (276)
T cd05152          19 NESGLDFQVVFAKDTDGVPWVLRIPRRP---DVSERAAAEKRVLALVRKHLPVQVPDWRV--HTP--ELIAYPKLPGVPA   91 (276)
T ss_pred             cCCcceeEEEEEEcCCCCeEEEEecCCH---HHHHHHHHHHHHHHHHHhcCCCCCCceee--ecC--ceEEEeccCCCcc
Confidence            4555555677665556888888876532   23456788999988885 2 21 222222  122  2466777766544

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=97.13  E-value=0.006  Score=57.89  Aligned_cols=137  Identities=18%  Similarity=0.281  Sum_probs=80.5

Q ss_pred             cccccceeEEEEEEeCC-----CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCcc-ccEEEEEecCCeeEEEEEecc
Q 015480           85 RLGFGGFGEVYKGQFPN-----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~  158 (406)
                      .|-.|-.-.+|++.+.+     +..|++|+...... .. -+-..|..++..+..-++ .++++.+...    .|++|++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-ee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            45557788899987533     36789998765421 11 123668888877754443 4566665432    5899998


Q ss_pred             CCChhhH-----------------hhcCC----C-CCCHHHHHHHHHHH-----------------HHHHHHHHH-----
Q 015480          159 NGSLDGY-----------------LFGKK----R-AIEWEKLHEIAIGT-----------------AKGLVYLHE-----  194 (406)
Q Consensus       159 ~g~L~~~-----------------l~~~~----~-~~~~~~~~~i~~qi-----------------~~~l~~LH~-----  194 (406)
                      +.+|...                 +|...    . ..-+.++.++..++                 ...+..|..     
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7776421                 11111    0 11233333332211                 111222221     


Q ss_pred             hcCCCeeecCCCCCcEEEcC-CCCceEecccccc
Q 015480          195 ECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAK  227 (406)
Q Consensus       195 ~~~~~i~H~dlk~~Nill~~-~~~~kl~DfGl~~  227 (406)
                      .....++|+|+++.|||+++ ++.+.++||..+.
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            11357899999999999986 4689999998875

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.87  E-value=0.019  Score=53.65  Aligned_cols=31  Identities=16%  Similarity=0.225  Sum_probs=28.1

Q ss_pred             CCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          197 QQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       197 ~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ..+++|+|+.+.|+|+++++.+.++||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            4689999999999999999999999998774

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.83  E-value=0.014  Score=54.53  Aligned_cols=30  Identities=27%  Similarity=0.301  Sum_probs=25.9

Q ss_pred             CCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          197 QQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       197 ~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            368999999999999987 678999998663

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.80  E-value=0.024  Score=49.54  Aligned_cols=75  Identities=21%  Similarity=0.254  Sum_probs=54.3

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC---cCccccEEEEEecCCeeEEEEEeccCC
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---HINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      +.+.-|.--+.|...+ ....+.||+-..    .....|..|+.-|..+.   .-++.+++.+..+....|+|+||++-|
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~   96 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR----EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG   96 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecch----hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence            3455566666676665 456788887543    24456778877666654   456888899989999999999999987


Q ss_pred             Chh
Q 015480          161 SLD  163 (406)
Q Consensus       161 ~L~  163 (406)
                      .+.
T Consensus        97 ~~d   99 (286)
T COG3001          97 PLD   99 (286)
T ss_pred             CCC
Confidence            775

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.76  E-value=0.0065  Score=56.56  Aligned_cols=76  Identities=17%  Similarity=0.162  Sum_probs=61.0

Q ss_pred             cCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccc
Q 015480          146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  225 (406)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl  225 (406)
                      +....|++|++. |+++.     ......+.+...++.+.+..+.-+..  +-.+-|||+.-.||||+ +|++-|+||-+
T Consensus       297 e~~y~yl~~kdh-gt~is-----~ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         297 ETLYLYLHFKDH-GTPIS-----IIKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             CceEEEEEEecC-Cceee-----eeecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeee
Confidence            344667788876 55653     23456788999999999988888887  57899999999999999 99999999999


Q ss_pred             ccccC
Q 015480          226 AKLCD  230 (406)
Q Consensus       226 ~~~~~  230 (406)
                      ++.-.
T Consensus       368 sRl~~  372 (488)
T COG5072         368 SRLSY  372 (488)
T ss_pred             eeccc
Confidence            98433

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.73  E-value=0.011  Score=51.95  Aligned_cols=30  Identities=30%  Similarity=0.482  Sum_probs=21.6

Q ss_pred             CCeeecCCCCCcEEE-cCCCCceEecccccc
Q 015480          198 QRIIHYDIKPENVLL-DANFSPKVADFGLAK  227 (406)
Q Consensus       198 ~~i~H~dlk~~Nill-~~~~~~kl~DfGl~~  227 (406)
                      ..++|+|+.+.|||+ +.++.++++||..+.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            578999999999999 888999999998874

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.60  E-value=0.022  Score=53.75  Aligned_cols=137  Identities=15%  Similarity=0.195  Sum_probs=77.9

Q ss_pred             cccccceeEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCcc-ccEEEEEecCCeeEEEEEeccC
Q 015480           85 RLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      .|..|-...+|+....+    +..|++|+......  ..-+-.+|..++..+..-++ .++++++. ++   +|.+|+++
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            35457777899886533    23788998765322  11223567888877765444 45666653 22   58999987


Q ss_pred             CChhhH-------h----------hcCC----C-CCCHHHHHHHHHHH----------------------HHHHHHHHHh
Q 015480          160 GSLDGY-------L----------FGKK----R-AIEWEKLHEIAIGT----------------------AKGLVYLHEE  195 (406)
Q Consensus       160 g~L~~~-------l----------~~~~----~-~~~~~~~~~i~~qi----------------------~~~l~~LH~~  195 (406)
                      .+|..-       +          |...    . ..-+..+..+..++                      ..-+..+...
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            665321       1          1111    1 11233333322221                      1112222211


Q ss_pred             -----cCCCeeecCCCCCcEEEcC-CCCceEecccccc
Q 015480          196 -----CQQRIIHYDIKPENVLLDA-NFSPKVADFGLAK  227 (406)
Q Consensus       196 -----~~~~i~H~dlk~~Nill~~-~~~~kl~DfGl~~  227 (406)
                           ...-++|+|+.+.|||+++ ++.++++||..|.
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence                 1234899999999999975 5789999998874

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.42  E-value=0.019  Score=54.87  Aligned_cols=75  Identities=16%  Similarity=0.236  Sum_probs=49.3

Q ss_pred             cccccccceeEEEEEEeCC-CcEEEEEEecccc----c-hhhHHHHHHHHHHhhccC--cC-ccccEEEEEecCCeeEEE
Q 015480           83 STRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNL----G-RIAEEQFMAEVGTIGRTY--HI-NLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~-g~~vavK~~~~~~----~-~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv  153 (406)
                      .+.||.|.-..||++...+ +..|+||.-..-.    + ....++..-|.+.|+...  -| ++++++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            3468999999999998753 5679998753211    1 234566777878777653  34 45556543  34455689


Q ss_pred             EEeccC
Q 015480          154 YEYMEN  159 (406)
Q Consensus       154 ~e~~~~  159 (406)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999854

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.31  E-value=0.0053  Score=59.58  Aligned_cols=48  Identities=23%  Similarity=0.260  Sum_probs=38.2

Q ss_pred             HHHHHHHHHHhhccCcCccccEEEEEecCC-eeEEEEEeccCCChhhHhh
Q 015480          119 EEQFMAEVGTIGRTYHINLVRLYGFCHDQH-MTALVYEYMENGSLDGYLF  167 (406)
Q Consensus       119 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~  167 (406)
                      ..++......++.+.|+|+..++++-.... ...+|+|++ +.+|.+++.
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~   74 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK   74 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence            345667788889999999999999886543 466899999 559999884

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.25  E-value=0.00032  Score=75.50  Aligned_cols=160  Identities=12%  Similarity=0.035  Sum_probs=109.5

Q ss_pred             HHHHHHHHHhhccCcCccccEEEEEe--cCCeeEEEEEeccCCChhhHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHH
Q 015480          120 EQFMAEVGTIGRTYHINLVRLYGFCH--DQHMTALVYEYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHE  194 (406)
Q Consensus       120 ~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~  194 (406)
                      +....|.+.++...|+++.....-..  ++...+..++|+.+|.+.+.+.+.   ...+...-+...-.+...+..-+|+
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            33445666666678988877665443  344667899999999999988432   2233333333333333555555554


Q ss_pred             hc--CCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhH
Q 015480          195 EC--QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVL  272 (406)
Q Consensus       195 ~~--~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il  272 (406)
                      ..  ..-.+|+++|+.|.+|..+..+|+.++|+.+...+...  ......+++.|++|++...- .++.++|+|..|+.+
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~i-k~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEI-KFTKRSDILRRSLSL 1430 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHH-hhhhHHHHHHHHHHH
Confidence            22  24578999999999999999999999999983322211  12335577788999876644 678889999999999


Q ss_pred             HHHhhccccc
Q 015480          273 FEIVGRRRNA  282 (406)
Q Consensus       273 ~elltg~~p~  282 (406)
                      |+...|..++
T Consensus      1431 y~rs~~n~~f 1440 (2724)
T KOG1826|consen 1431 YLRSDGNAYF 1440 (2724)
T ss_pred             HHHhcccHHH
Confidence            9998877654

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.23  E-value=0.12  Score=48.60  Aligned_cols=72  Identities=13%  Similarity=0.092  Sum_probs=43.9

Q ss_pred             cceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCc--cccEE---E--EEecCCeeEEEEEeccCCC
Q 015480           89 GGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN--LVRLY---G--FCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        89 G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~---~--~~~~~~~~~lv~e~~~~g~  161 (406)
                      +.-..||+....+|..+++|+.+...  .....+..|.+.+..|....  ++...   |  +..-++..+.++++++|..
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            34457999988788889999886432  24455666777766653211  22211   1  1222456778999998764


Q ss_pred             h
Q 015480          162 L  162 (406)
Q Consensus       162 L  162 (406)
                      .
T Consensus       114 ~  114 (325)
T PRK11768        114 P  114 (325)
T ss_pred             C
Confidence            3

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.22  E-value=0.025  Score=49.18  Aligned_cols=118  Identities=19%  Similarity=0.202  Sum_probs=75.5

Q ss_pred             cceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCChhhHhhc
Q 015480           89 GGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFG  168 (406)
Q Consensus        89 G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  168 (406)
                      |+-++.-.++.+-| ...+|.++.-.......-|..+.+++++++  .|+++..  .+...+.++.|+|.....      
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc------
Confidence            44455555544334 345566654433334456788888888864  4666662  234455689999843211      


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccc
Q 015480          169 KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  226 (406)
Q Consensus       169 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~  226 (406)
                             ...-.|.. =+++|.-.|+. ..+.+|+|-.|+||+-|..|.+||.|-+..
T Consensus       142 -------~~~N~i~a-gi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 -------NFSNFITA-GIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             -------chhHHHHH-hHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence                   11112221 14667888863 378999999999999999999999997654

The function of this family is unknown.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.90  E-value=0.034  Score=52.77  Aligned_cols=60  Identities=22%  Similarity=0.217  Sum_probs=39.1

Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA  214 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~  214 (406)
                      .|+-+|..|-++..++....  ..+....+++.--+.|+--+--  -.+++|.|+.|.||++.-
T Consensus       321 vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             eeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEe
Confidence            36677888888888884333  2333444555444555443332  168999999999999953

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.87  E-value=0.18  Score=47.31  Aligned_cols=137  Identities=22%  Similarity=0.284  Sum_probs=81.3

Q ss_pred             ccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCc------cccEEE----EEecCCeeEEEEE
Q 015480           86 LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN------LVRLYG----FCHDQHMTALVYE  155 (406)
Q Consensus        86 ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~----~~~~~~~~~lv~e  155 (406)
                      |.+ .-..+|+.+..+|.. ++|+.+..   ....++..|+..+..|.-.+      +..+=|    ........+-+++
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~---~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG---WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC---CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            444 445789998877765 88988764   34455666777777664221      222212    1122236778999


Q ss_pred             eccCCChhh-H-----------h---hc--CC---------CCCCHHH-------------HHHHHHHHHHHHHHHHHh-
Q 015480          156 YMENGSLDG-Y-----------L---FG--KK---------RAIEWEK-------------LHEIAIGTAKGLVYLHEE-  195 (406)
Q Consensus       156 ~~~~g~L~~-~-----------l---~~--~~---------~~~~~~~-------------~~~i~~qi~~~l~~LH~~-  195 (406)
                      |++|..+.. .           +   +.  .+         ....|..             -.....++...+..+.+. 
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999988772 1           1   10  00         1122320             011233444455555542 


Q ss_pred             ---cCCC---eeecCCCCCcEEEcCCCC-ceEecccccc
Q 015480          196 ---CQQR---IIHYDIKPENVLLDANFS-PKVADFGLAK  227 (406)
Q Consensus       196 ---~~~~---i~H~dlk~~Nill~~~~~-~kl~DfGl~~  227 (406)
                         ....   +||+|+.|.||+++.+.. +-++|||-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               1233   999999999999999885 8899998764

>PRK06148 hypothetical protein; Provisional

Probab=95.85  E-value=0.14  Score=55.76  Aligned_cols=138  Identities=17%  Similarity=0.206  Sum_probs=76.5

Q ss_pred             cccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-------cCccccEE-----EEEec-CC--e
Q 015480           85 RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-------HINLVRLY-----GFCHD-QH--M  149 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-------h~niv~~~-----~~~~~-~~--~  149 (406)
                      .|+ |..-.+|+.+..+|..+++|+.+....   ......|...|..|.       -|.+++..     ....+ ++  .
T Consensus        32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~---~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         32 PLD-GERDLNFRLTTDDGADYILKIVNPSEP---RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             ecC-CcCCceEEEEeCCCCeEEEEEcCCccc---hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            354 445778999887888999999986422   223334445554442       22333221     11111 22  4


Q ss_pred             eEEEEEeccCCChhhH-------h----------h----c--C---CCCCCHHH-----------------HHHHHHHHH
Q 015480          150 TALVYEYMENGSLDGY-------L----------F----G--K---KRAIEWEK-----------------LHEIAIGTA  186 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~-------l----------~----~--~---~~~~~~~~-----------------~~~i~~qi~  186 (406)
                      .+-+++|++|..+.+.       +          +    .  .   ...+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            5678999999777541       0          0    0  0   11122211                 112222222


Q ss_pred             HHHH-----HHHHhcCCCeeecCCCCCcEEEcCCC--Cce-Eecccccc
Q 015480          187 KGLV-----YLHEECQQRIIHYDIKPENVLLDANF--SPK-VADFGLAK  227 (406)
Q Consensus       187 ~~l~-----~LH~~~~~~i~H~dlk~~Nill~~~~--~~k-l~DfGl~~  227 (406)
                      ....     .+.+ ...++||+|+.+.|||++.++  .+. |+|||-+.
T Consensus       188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            2221     1222 246899999999999999875  555 99999875

>PTZ00384 choline kinase; Provisional

Probab=95.42  E-value=0.18  Score=48.52  Aligned_cols=74  Identities=14%  Similarity=0.173  Sum_probs=44.4

Q ss_pred             ccccccceeEEEEEEeCCC--cE-----EEEEEeccccchhhHHHHHHHHHHhhccCcCcc-ccEEEEEecCCeeEEEEE
Q 015480           84 TRLGFGGFGEVYKGQFPNG--VK-----IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g--~~-----vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e  155 (406)
                      +.|..|-...+|++...++  ..     |.++..... . ...-+-.+|++++..+...++ .++++.+..    ++|+|
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e  129 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-N-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE  129 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-C-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence            3455688889999976433  22     444432211 1 111223568888888865544 556666543    59999


Q ss_pred             eccCCChh
Q 015480          156 YMENGSLD  163 (406)
Q Consensus       156 ~~~~g~L~  163 (406)
                      |++|.+|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99987764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	406
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-49
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-47
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-36
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-35
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-32
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-31
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-31
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-31
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-26
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-26
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-25
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-25
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-25
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-25
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-25
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-25
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-25
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-25
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-25
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-25
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-25
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-24
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-24
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-24
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-24
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-24
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-23
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-23
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-23
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-23
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-22
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-22
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-22
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-22
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-22
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-22
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-22
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-22
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-22
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-22
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-22
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-22
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-21
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-21
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-21
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-20
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-20
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-20
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-20
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-18
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-17
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-17
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-17
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-17
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-17
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-17
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-17
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-16
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-16
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-16
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-16
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-16
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-16
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-16
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-16
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-16
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-16
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-15
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-15
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-15
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-15
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-15
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-15
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-15
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-15
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-15
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-15
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-14
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		9e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-14
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		9e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-12
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		8e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-09
3soa_A	444	Full-Length Human Camkii Length = 444		1e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		8e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		9e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-07
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		6e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		9e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		9e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		8e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  191 bits (484), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 119/296 (40%), Positives = 165/296 (55%), Gaps = 17/296 (5%)
Query: 69  RFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEV 126
           RF+  +L   + N+S +  LG GGFG+VYKG+  +G  +AVK L     +  E QF  EV
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEV 86
Query: 127 GTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA---IEWEKLHEIAI 183
             I    H NL+RL GFC       LVY YM NGS+   L  +  +   ++W K   IA+
Sbjct: 87  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 146
Query: 184 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG 243
           G+A+GL YLH+ C  +IIH D+K  N+LLD  F   V DFGLAKL D    HV  +  +G
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VRG 205
Query: 244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV-GRR-----RNAIVGATESLDWFPKHV 297
           T G+ APE+LS     + K DV+ +G++L E++ G+R     R A       LDW    +
Sbjct: 206 TIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 264
Query: 298 WEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG 353
            E+  +  +   + G     KD E+ ++L  VAL C Q SP +RP MS V++MLEG
Sbjct: 265 KEKKLEALVDVDLQG---NYKD-EEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 117/296 (39%), Positives = 163/296 (55%), Gaps = 17/296 (5%)
Query: 69  RFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEV 126
           RF+  +L   + N+  +  LG GGFG+VYKG+  +G  +AVK L     +  E QF  EV
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEV 78
Query: 127 GTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA---IEWEKLHEIAI 183
             I    H NL+RL GFC       LVY YM NGS+   L  +  +   ++W K   IA+
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 184 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG 243
           G+A+GL YLH+ C  +IIH D+K  N+LLD  F   V DFGLAKL D    HV  +  +G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VRG 197
Query: 244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV-GRR-----RNAIVGATESLDWFPKHV 297
             G+ APE+LS     + K DV+ +G++L E++ G+R     R A       LDW    +
Sbjct: 198 XIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 298 WEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG 353
            E+  +  +   + G     KD E+ ++L  VAL C Q SP +RP MS V++MLEG
Sbjct: 257 KEKKLEALVDVDLQG---NYKD-EEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 104/291 (35%), Positives = 159/291 (54%), Gaps = 14/291 (4%)
Query: 69  RFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEV 126
           R   + L   T+N+  +  +G G FG+VYKG   +G K+A+K       +   E+F  E+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ-GIEEFETEI 86
Query: 127 GTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAI 183
            T+    H +LV L GFC +++   L+Y+YMENG+L  +L+G      ++ WE+  EI I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 184 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL-CDRNKTHVTISGYK 242
           G A+GL YLH    + IIH D+K  N+LLD NF PK+ DFG++K   + ++TH+     K
Sbjct: 147 GAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXV-VK 202
Query: 243 GTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEY 301
           GT GY  PE F+ G   +T K DVYSFG+VLFE++  R   +      +    +   E +
Sbjct: 203 GTLGYIDPEYFIKGR--LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 302 EKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
              +L  ++     ++   E  ++    A+ C+  S EDRP M  V+  LE
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 104/291 (35%), Positives = 158/291 (54%), Gaps = 14/291 (4%)
Query: 69  RFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEV 126
           R   + L   T+N+  +  +G G FG+VYKG   +G K+A+K       +   E+F  E+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ-GIEEFETEI 86
Query: 127 GTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAI 183
            T+    H +LV L GFC +++   L+Y+YMENG+L  +L+G      ++ WE+  EI I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 184 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL-CDRNKTHVTISGYK 242
           G A+GL YLH    + IIH D+K  N+LLD NF PK+ DFG++K   +  +TH+     K
Sbjct: 147 GAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXV-VK 202
Query: 243 GTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEY 301
           GT GY  PE F+ G   +T K DVYSFG+VLFE++  R   +      +    +   E +
Sbjct: 203 GTLGYIDPEYFIKGR--LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 302 EKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
              +L  ++     ++   E  ++    A+ C+  S EDRP M  V+  LE
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 90/220 (40%), Positives = 115/220 (52%), Gaps = 19/220 (8%)
Query: 70  FTSLQLNNFTSNYSTR--------LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEE- 120
           F+  +L N T+N+  R        +G GGFG VYKG + N   +AVK L   +    EE 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 121 --QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWE 176
             QF  E+  + +  H NLV L GF  D     LVY YM NGSL   L        + W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
              +IA G A G+ +LHE      IH DIK  N+LLD  F+ K++DFGLA+  ++    V
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
             S   GT  Y APE L G   IT K D+YSFG+VL EI+
Sbjct: 191 MXSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEII 228

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/220 (40%), Positives = 114/220 (51%), Gaps = 19/220 (8%)
Query: 70  FTSLQLNNFTSNYSTR--------LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEE- 120
           F+  +L N T+N+  R        +G GGFG VYKG + N   +AVK L   +    EE 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 67
Query: 121 --QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWE 176
             QF  E+  + +  H NLV L GF  D     LVY YM NGSL   L        + W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
              +IA G A G+ +LHE      IH DIK  N+LLD  F+ K++DFGLA+  ++    V
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
                 GT  Y APE L G   IT K D+YSFG+VL EI+
Sbjct: 185 MXXRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEII 222

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/220 (40%), Positives = 114/220 (51%), Gaps = 19/220 (8%)
Query: 70  FTSLQLNNFTSNYSTR--------LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEE- 120
           F+  +L N T+N+  R        +G GGFG VYKG + N   +AVK L   +    EE 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 121 --QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWE 176
             QF  E+  + +  H NLV L GF  D     LVY YM NGSL   L        + W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
              +IA G A G+ +LHE      IH DIK  N+LLD  F+ K++DFGLA+  ++    V
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
                 GT  Y APE L G   IT K D+YSFG+VL EI+
Sbjct: 191 MXXRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEII 228

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 89/220 (40%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 70  FTSLQLNNFTSNYSTR--------LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEE- 120
           F+  +L N T+N+  R         G GGFG VYKG + N   +AVK L   +    EE 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 121 --QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWE 176
             QF  E+    +  H NLV L GF  D     LVY Y  NGSL   L        + W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
              +IA G A G+ +LHE      IH DIK  N+LLD  F+ K++DFGLA+  ++    V
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
             S   GT  Y APE L G   IT K D+YSFG+VL EI+
Sbjct: 182 XXSRIVGTTAYXAPEALRGE--ITPKSDIYSFGVVLLEII 219

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 138/272 (50%), Gaps = 30/272 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 145 HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 84  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 137
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PIT 260
           H D++  N+L+    S K+ADFGLA+L + N+ +    G K    ++APE +  NY   T
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTFT 194
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++L EIV   R    G T           E  +  E G  ++      ++ 
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIPYPGMTNP---------EVIQNLERGYRMVRPDNCPEEL 245
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 246 YQLMRLC----W--KERPEDRPTFDYLRSVLE 271

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 138/272 (50%), Gaps = 30/272 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 145 HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 83  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 136
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PIT 260
           H D++  N+L+    S K+ADFGLA+L + N+ +    G K    ++APE +  NY   T
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTFT 193
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++L EIV   R    G T           E  +  E G  ++      ++ 
Sbjct: 194 IKSDVWSFGILLTEIVTHGRIPYPGMTNP---------EVIQNLERGYRMVRPDNCPEEL 244
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 245 YQLMRLC----W--KERPEDRPTFDYLRSVLE 270

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 138/272 (50%), Gaps = 30/272 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 145 HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 131
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PIT 260
           H D++  N+L+    S K+ADFGLA+L + N+ +    G K    ++APE +  NY   T
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTFT 188
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++L EIV   R    G T           E  +  E G  ++      ++ 
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNP---------EVIQNLERGYRMVRPDNCPEEL 239
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 240 YQLMRLC----W--KERPEDRPTFDYLRSVLE 265

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 138/272 (50%), Gaps = 30/272 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 145 HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 88  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 141
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PIT 260
           H D++  N+L+    S K+ADFGLA+L + N+ +    G K    ++APE +  NY   T
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTFT 198
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++L EIV   R    G T           E  +  E G  ++      ++ 
Sbjct: 199 IKSDVWSFGILLTEIVTHGRIPYPGMTNP---------EVIQNLERGYRMVRPDNCPEEL 249
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 250 YQLMRLC----W--KERPEDRPTFDYLRSVLE 275

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 137/272 (50%), Gaps = 30/272 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 145 HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 84  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 137
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PIT 260
           H D++  N+L+    S K+ADFGLA+L + N+      G K    ++APE +  NY   T
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAI--NYGTFT 194
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++L EIV   R    G T           E  +  E G  ++      ++ 
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIPYPGMTNP---------EVIQNLERGYRMVRPDNCPEEL 245
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 246 YQLMRLC----W--KERPEDRPTFDYLRSVLE 271

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 137/272 (50%), Gaps = 30/272 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 145 HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 80  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 133
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PIT 260
           H D++  N+L+    S K+ADFGLA+L + N+      G K    ++APE +  NY   T
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAI--NYGTFT 190
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++L EIV   R    G T           E  +  E G  ++      ++ 
Sbjct: 191 IKSDVWSFGILLTEIVTHGRIPYPGMTNP---------EVIQNLERGYRMVRPDNCPEEL 241
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 242 YQLMRLC----W--KERPEDRPTFDYLRSVLE 267

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 137/272 (50%), Gaps = 30/272 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 145 HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 87  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 140
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PIT 260
           H D++  N+L+    S K+ADFGLA+L + N+      G K    ++APE +  NY   T
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAI--NYGTFT 197
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++L EIV   R    G T           E  +  E G  ++      ++ 
Sbjct: 198 IKSDVWSFGILLTEIVTHGRIPYPGMTNP---------EVIQNLERGYRMVRPDNCPEEL 248
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 249 YQLMRLC----W--KERPEDRPTFDYLRSVLE 274

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 137/272 (50%), Gaps = 30/272 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 145 HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 79  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 132
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PIT 260
           H D++  N+L+    S K+ADFGLA+L + N+      G K    ++APE +  NY   T
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAI--NYGTFT 189
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++L EIV   R    G T           E  +  E G  ++      ++ 
Sbjct: 190 IKSDVWSFGILLTEIVTHGRIPYPGMTNP---------EVIQNLERGYRMVRPDNCPEEL 240
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 241 YQLMRLC----W--KERPEDRPTFDYLRSVLE 266

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 137/272 (50%), Gaps = 30/272 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 145 HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 131
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PIT 260
           H D++  N+L+    S K+ADFGLA+L + N+      G K    ++APE +  NY   T
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAI--NYGTFT 188
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++L EIV   R    G T           E  +  E G  ++      ++ 
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNP---------EVIQNLERGYRMVRPDNCPEEL 239
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 240 YQLMRLC----W--KERPEDRPTFDYLRSVLE 265

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 138/272 (50%), Gaps = 30/272 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 145 HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 73  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 126
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PIT 260
           H D++  N+L+    S K+ADFGLA+L + N+ +    G K    ++APE +  NY   T
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTFT 183
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++L EIV   R    G T           E  +  E G  ++      ++ 
Sbjct: 184 IKSDVWSFGILLTEIVTHGRIPYPGMTNP---------EVIQNLERGYRMVRPDNCPEEL 234
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 235 YQLMRLC----W--KERPEDRPTFDYLRSVLE 260

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 137/272 (50%), Gaps = 30/272 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 145 HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 86  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 139
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PIT 260
           H D++  N+L+    S K+ADFGLA+L + N+      G K    ++APE +  NY   T
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAI--NYGTFT 196
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++L EIV   R    G T           E  +  E G  ++      ++ 
Sbjct: 197 IKSDVWSFGILLTEIVTHGRIPYPGMTNP---------EVIQNLERGYRMVRPDNCPEEL 247
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 248 YQLMRLC----W--KERPEDRPTFDYLRSVLE 273

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 137/272 (50%), Gaps = 30/272 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 145 HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 131
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PIT 260
           H D++  N+L+    S K+ADFGLA+L + N+      G K    ++APE +  NY   T
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAI--NYGTFT 188
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++L EIV   R    G T           E  +  E G  ++      ++ 
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNP---------EVIQNLERGYRMVRPDNCPEEL 239
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 240 YQLMRLC----W--KERPEDRPTFDYLRSVLE 265

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 138/272 (50%), Gaps = 30/272 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 145 HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 74  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 127
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PIT 260
           H +++  N+L+    S K+ADFGLA+L + N+ +    G K    ++APE +  NY   T
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTFT 184
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++L EIV   R    G T           E  +  E G  ++      ++ 
Sbjct: 185 IKSDVWSFGILLTEIVTHGRIPYPGMTNP---------EVIQNLERGYRMVRPDNCPEEL 235
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 236 YQLMRLC----W--KERPEDRPTFDYLRSVLE 261

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 133/276 (48%), Gaps = 22/276 (7%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
            +   +G G FG V+ G + N  K+A+K +    G ++EE F+ E   + +  H  LV+L
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG C +Q    LV+E+ME+G L  YL  ++     E L  + +   +G+ YL E C   +
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+   N L+  N   KV+DFG+ +    +  + + +G K    +++PE  S +   +
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS-RYS 180
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++++E+    +      + S         E  E    G  +       K +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNS---------EVVEDISTGFRLY------KPR 225
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
             +  +  +   C ++ PEDRP  S +++ L  + E
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 133/276 (48%), Gaps = 22/276 (7%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
            +   +G G FG V+ G + N  K+A+K +    G ++EE F+ E   + +  H  LV+L
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQL 70
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG C +Q    LV+E+ME+G L  YL  ++     E L  + +   +G+ YL E C   +
Sbjct: 71  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 127
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+   N L+  N   KV+DFG+ +    +  + + +G K    +++PE  S +   +
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS-RYS 185
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++++E+    +      + S         E  E    G  +       K +
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYENRSNS---------EVVEDISTGFRLY------KPR 230
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
             +  +  +   C ++ PEDRP  S +++ L  + E
Sbjct: 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 133/276 (48%), Gaps = 22/276 (7%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
            +   +G G FG V+ G + N  K+A+K +    G ++EE F+ E   + +  H  LV+L
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQL 67
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG C +Q    LV+E+ME+G L  YL  ++     E L  + +   +G+ YL E C   +
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 124
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+   N L+  N   KV+DFG+ +    +  + + +G K    +++PE  S +   +
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS-RYS 182
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++++E+    +      + S         E  E    G  +       K +
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNS---------EVVEDISTGFRLY------KPR 227
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
             +  +  +   C ++ PEDRP  S +++ L  + E
Sbjct: 228 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 263

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 133/276 (48%), Gaps = 22/276 (7%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
            +   +G G FG V+ G + N  K+A+K +    G ++E+ F+ E   + +  H  LV+L
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKE--GSMSEDDFIEEAEVMMKLSHPKLVQL 87
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG C +Q    LV+E+ME+G L  YL  ++     E L  + +   +G+ YL E C   +
Sbjct: 88  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 144
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+   N L+  N   KV+DFG+ +    +  + + +G K    +++PE  S +   +
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSR-YS 202
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++++E+    +      + S         E  E    G  +       K +
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYENRSNS---------EVVEDISTGFRLY------KPR 247
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
             +  +  +   C ++ PEDRP  S +++ L  + E
Sbjct: 248 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 283

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 136/286 (47%), Gaps = 26/286 (9%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVKIAVKVL-NRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           N   ++G G FG V++ ++ +G  +AVK+L  ++       +F+ EV  + R  H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF--GKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
             G        ++V EY+  GSL   L   G +  ++  +   +A   AKG+ YLH    
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-N 157
Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY 257
             I+H ++K  N+L+D  ++ KV DFGL++L  +  T ++     GTP + APE L  + 
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLR-DE 214
Query: 258 PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI-LGCGIE 316
           P   K DVYSFG++L+E+                   +  W      ++ A +   C   
Sbjct: 215 PSNEKSDVYSFGVILWELATL----------------QQPWGNLNPAQVVAAVGFKCKRL 258
Query: 317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE-VLPPP 361
           E  +    ++  +   C  + P  RP  + ++ +L  +++  +PPP
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 132/276 (47%), Gaps = 22/276 (7%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
            +   +G G FG V+ G + N  K+A+K +    G ++EE F+ E   + +  H  LV+L
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQL 68
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG C +Q    LV E+ME+G L  YL  ++     E L  + +   +G+ YL E C   +
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 125
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+   N L+  N   KV+DFG+ +    +  + + +G K    +++PE  S +   +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSR-YS 183
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++++E+    +      + S         E  E    G  +       K +
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNS---------EVVEDISTGFRLY------KPR 228
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
             +  +  +   C ++ PEDRP  S +++ L  + E
Sbjct: 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 91/272 (33%), Positives = 135/272 (49%), Gaps = 30/272 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G  GEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 145 HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 131
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PIT 260
           H D++  N+L+    S K+ADFGLA+L + +       G K    ++APE +  NY   T
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIE-DAEXTAREGAKFPIKWTAPEAI--NYGTFT 188
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++L EIV   R    G T           E  +  E G  ++      ++ 
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNP---------EVIQNLERGYRMVRPDNCPEEL 239
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 240 YQLMRLC----W--KERPEDRPTFDYLRSVLE 265

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 134/286 (46%), Gaps = 26/286 (9%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVKIAVKVL-NRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           N   ++G G FG V++ ++ +G  +AVK+L  ++       +F+ EV  + R  H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF--GKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
             G        ++V EY+  GSL   L   G +  ++  +   +A   AKG+ YLH    
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-N 157
Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY 257
             I+H D+K  N+L+D  ++ KV DFGL++L  +    +      GTP + APE L  + 
Sbjct: 158 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLR-DE 214
Query: 258 PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI-LGCGIE 316
           P   K DVYSFG++L+E+                   +  W      ++ A +   C   
Sbjct: 215 PSNEKSDVYSFGVILWELATL----------------QQPWGNLNPAQVVAAVGFKCKRL 258
Query: 317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE-VLPPP 361
           E  +    ++  +   C  + P  RP  + ++ +L  +++  +PPP
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 140/283 (49%), Gaps = 26/283 (9%)
Query: 83  STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMA---EVGTIGRTYHINLVR 139
           STR+G G FG VYKG++   V  AVK+L   +     EQF A   EV  + +T H+N++ 
Sbjct: 41  STRIGSGSFGTVYKGKWHGDV--AVKILK--VVDPTPEQFQAFRNEVAVLRKTRHVNILL 96
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
             G+    ++ A+V ++ E  SL  +L  ++   +  +L +IA  TA+G+ YLH    + 
Sbjct: 97  FMGYMTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KN 152
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF--LSGNY 257
           IIH D+K  N+ L    + K+ DFGLA +  R      +    G+  + APE   +  N 
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212
Query: 258 PITHKCDVYSFGMVLFEIV-GRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE 316
           P + + DVYS+G+VL+E++ G    + +   + + +    V   Y   +L  +   C   
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM---VGRGYASPDLSKLYKNC--- 266
Query: 317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP 359
               +  KRL      CV+   E+RP    ++  +E +   LP
Sbjct: 267 ---PKAMKRLVAD---CVKKVKEERPLFPQILSSIELLQHSLP 303

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 107/195 (54%), Gaps = 9/195 (4%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 143
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 19  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                + A+V ++ E  SL  +L   +   E +KL +IA  TA+G+ YLH +    IIH 
Sbjct: 77  STKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 132
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF--LSGNYPITH 261
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE   +  + P + 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 262 KCDVYSFGMVLFEIV 276
           + DVY+FG+VL+E++
Sbjct: 193 QSDVYAFGIVLYELM 207

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 131/274 (47%), Gaps = 22/274 (8%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
            +   +G G FG V+ G + N  K+A+K +    G ++EE F+ E   + +  H  LV+L
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQL 67
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG C +Q    LV+E+ME+G L  YL  ++     E L  + +   +G+ YL E     +
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ASV 124
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+   N L+  N   KV+DFG+ +    +  + + +G K    +++PE  S +   +
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSR-YS 182
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
            K DV+SFG++++E+    +      + S         E  E    G  +       K +
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNS---------EVVEDISTGFRLY------KPR 227
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV 354
             +  +  +   C ++ PEDRP  S +++ L  +
Sbjct: 228 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 106/195 (54%), Gaps = 9/195 (4%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 143
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 31  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                + A+V ++ E  SL  +L   +   E +KL +IA  TA+G+ YLH +    IIH 
Sbjct: 89  STKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF--LSGNYPITH 261
           D+K  N+ L  + + K+ DFGLA    R           G+  + APE   +  + P + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 262 KCDVYSFGMVLFEIV 276
           + DVY+FG+VL+E++
Sbjct: 205 QSDVYAFGIVLYELM 219

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 106/195 (54%), Gaps = 9/195 (4%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 143
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 31  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                + A+V ++ E  SL  +L   +   E +KL +IA  TA+G+ YLH +    IIH 
Sbjct: 89  STAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF--LSGNYPITH 261
           D+K  N+ L  + + K+ DFGLA    R           G+  + APE   +  + P + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 262 KCDVYSFGMVLFEIV 276
           + DVY+FG+VL+E++
Sbjct: 205 QSDVYAFGIVLYELM 219

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/199 (36%), Positives = 111/199 (55%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           +G G FG V K ++     +A+K +     R A   F+ E+  + R  H N+V+LYG C 
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESERKA---FIVELRQLSRVNHPNIVKLYGACL 72
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA--IGTAKGLVYLHEECQQRIIHY 203
           +     LV EY E GSL   L G +    +   H ++  +  ++G+ YLH    + +IH 
Sbjct: 73  NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 130
Query: 204 DIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG-NYPITH 261
           D+KP N+LL A  +  K+ DFG A  CD  +TH+T    KG+  + APE   G NY  + 
Sbjct: 131 DLKPPNLLLVAGGTVLKICDFGTA--CDI-QTHMT--NNKGSAAWMAPEVFEGSNY--SE 183
Query: 262 KCDVYSFGMVLFEIVGRRR 280
           KCDV+S+G++L+E++ RR+
Sbjct: 184 KCDVFSWGIILWEVITRRK 202

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/199 (36%), Positives = 111/199 (55%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           +G G FG V K ++     +A+K +     R A   F+ E+  + R  H N+V+LYG C 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESERKA---FIVELRQLSRVNHPNIVKLYGACL 71
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA--IGTAKGLVYLHEECQQRIIHY 203
           +     LV EY E GSL   L G +    +   H ++  +  ++G+ YLH    + +IH 
Sbjct: 72  NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 204 DIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG-NYPITH 261
           D+KP N+LL A  +  K+ DFG A  CD  +TH+T    KG+  + APE   G NY  + 
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTA--CDI-QTHMT--NNKGSAAWMAPEVFEGSNY--SE 182
Query: 262 KCDVYSFGMVLFEIVGRRR 280
           KCDV+S+G++L+E++ RR+
Sbjct: 183 KCDVFSWGIILWEVITRRK 201

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 86  LGFGGFGEVYKGQFPNG-----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           +G G FGEVYKG          V +A+K L           F+ E G +G+  H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G         ++ EYMENG+LD +L  K       +L  +  G A G+ YL        
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNY 168
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           +H D+   N+L+++N   KV+DFGL++ L D  +   T SG K    ++APE +S     
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KF 227
Query: 260 THKCDVYSFGMVLFEIV 276
           T   DV+SFG+V++E++
Sbjct: 228 TSASDVWSFGIVMWEVM 244

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 131/270 (48%), Gaps = 26/270 (9%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G +    K+A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKP--GTMSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 145 HDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++ +  +V EYM  GSL  +L  G+ RA++   L ++A   A G+ Y+    +   IH 
Sbjct: 74  SEEPIY-IVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 129
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D++  N+L+      K+ADFGLA+L + N+      G K    ++APE  L G + I  K
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTAR-QGAKFPIKWTAPEAALYGRFTI--K 186
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV+SFG++L E+V + R    G         + V E+ E+         C I       
Sbjct: 187 SDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVERGYRMPCPQDCPIS------ 234
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
              L  + + C +  PE+RP    +   LE
Sbjct: 235 ---LHELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 136/279 (48%), Gaps = 22/279 (7%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 143
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 42  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 100 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 155
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF--LSGNYPITH 261
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE   +    P + 
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 262 KCDVYSFGMVLFEIV-GRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           + DVY+FG+VL+E++ G+   + +   + + +    V   Y   +L  +   C       
Sbjct: 216 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---VGRGYLSPDLSKVRSNC------- 265
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP 359
            KA +  M    C++   ++RP    ++  +E +   LP
Sbjct: 266 PKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 302

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 105/195 (53%), Gaps = 9/195 (4%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 143
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 43  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 156
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF--LSGNYPITH 261
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE   +    P + 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 262 KCDVYSFGMVLFEIV 276
           + DVY+FG+VL+E++
Sbjct: 217 QSDVYAFGIVLYELM 231

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 135/284 (47%), Gaps = 32/284 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 143
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 17  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 75  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 130
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF--LSGNYPITH 261
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE   +    P + 
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 262 KCDVYSFGMVLFEIV-GRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           + DVY+FG+VL+E++ G+   + +   + +                   ++G G    D 
Sbjct: 191 QSDVYAFGIVLYELMTGQLPYSNINNRDQI-----------------IFMVGRGYLSPDL 233
Query: 321 EKAKRLCMVALW-----CVQDSPEDRPPMSAVIKMLEGVVEVLP 359
            K +  C  A+      C++   ++RP    ++  +E +   LP
Sbjct: 234 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 277

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 135/284 (47%), Gaps = 32/284 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 143
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 20  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 78  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 133
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF--LSGNYPITH 261
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE   +    P + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 262 KCDVYSFGMVLFEIV-GRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           + DVY+FG+VL+E++ G+   + +   + +                   ++G G    D 
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINNRDQI-----------------IFMVGRGYLSPDL 236
Query: 321 EKAKRLCMVALW-----CVQDSPEDRPPMSAVIKMLEGVVEVLP 359
            K +  C  A+      C++   ++RP    ++  +E +   LP
Sbjct: 237 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 280

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 135/284 (47%), Gaps = 32/284 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 143
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 20  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 78  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 133
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF--LSGNYPITH 261
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE   +    P + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 262 KCDVYSFGMVLFEIV-GRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           + DVY+FG+VL+E++ G+   + +   + +                   ++G G    D 
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINNRDQI-----------------IFMVGRGYLSPDL 236
Query: 321 EKAKRLCMVALW-----CVQDSPEDRPPMSAVIKMLEGVVEVLP 359
            K +  C  A+      C++   ++RP    ++  +E +   LP
Sbjct: 237 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 280

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 135/284 (47%), Gaps = 32/284 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 143
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 15  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 73  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF--LSGNYPITH 261
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE   +    P + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 262 KCDVYSFGMVLFEIV-GRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           + DVY+FG+VL+E++ G+   + +   + +                   ++G G    D 
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQI-----------------IFMVGRGYLSPDL 231
Query: 321 EKAKRLCMVALW-----CVQDSPEDRPPMSAVIKMLEGVVEVLP 359
            K +  C  A+      C++   ++RP    ++  +E +   LP
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 135/284 (47%), Gaps = 32/284 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 143
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 15  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 73  STAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF--LSGNYPITH 261
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE   +    P + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 262 KCDVYSFGMVLFEIV-GRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           + DVY+FG+VL+E++ G+   + +   + +                   ++G G    D 
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQI-----------------IFMVGRGYLSPDL 231
Query: 321 EKAKRLCMVALW-----CVQDSPEDRPPMSAVIKMLEGVVEVLP 359
            K +  C  A+      C++   ++RP    ++  +E +   LP
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 107/194 (55%), Gaps = 10/194 (5%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G + N  K+AVK L    G ++ + F+ E   +    H  LVRLY   
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
             +    ++ EYM  GSL  +L   +   +   KL + +   A+G+ Y+    ++  IH 
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 134
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS-GNYPITHK 262
           D++  NVL+  +   K+ADFGLA++ + N+ +    G K    ++APE ++ G + I  K
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGCFTI--K 191
Query: 263 CDVYSFGMVLFEIV 276
            DV+SFG++L+EIV
Sbjct: 192 SDVWSFGILLYEIV 205

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 134/284 (47%), Gaps = 32/284 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 143
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 35  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 93  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 148
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF--LSGNYPITH 261
           D+K  N+ L  + + K+ DFGLA    R           G+  + APE   +    P + 
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 208
Query: 262 KCDVYSFGMVLFEIV-GRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           + DVY+FG+VL+E++ G+   + +   + +                   ++G G    D 
Sbjct: 209 QSDVYAFGIVLYELMTGQLPYSNINNRDQI-----------------IFMVGRGYLSPDL 251
Query: 321 EKAKRLCMVALW-----CVQDSPEDRPPMSAVIKMLEGVVEVLP 359
            K +  C  A+      C++   ++RP    ++  +E +   LP
Sbjct: 252 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 295

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 135/279 (48%), Gaps = 22/279 (7%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 143
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 43  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 156
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF--LSGNYPITH 261
           D+K  N+ L  + + K+ DFGLA    R           G+  + APE   +    P + 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 262 KCDVYSFGMVLFEIV-GRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           + DVY+FG+VL+E++ G+   + +   + + +    V   Y   +L  +   C       
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---VGRGYLSPDLSKVRSNC------- 266
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP 359
            KA +  M    C++   ++RP    ++  +E +   LP
Sbjct: 267 PKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 303

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 134/284 (47%), Gaps = 32/284 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 143
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 15  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 73  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF--LSGNYPITH 261
           D+K  N+ L  + + K+ DFGLA    R           G+  + APE   +    P + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 262 KCDVYSFGMVLFEIV-GRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           + DVY+FG+VL+E++ G+   + +   + +                   ++G G    D 
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQI-----------------IFMVGRGYLSPDL 231
Query: 321 EKAKRLCMVALW-----CVQDSPEDRPPMSAVIKMLEGVVEVLP 359
            K +  C  A+      C++   ++RP    ++  +E +   LP
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 101/190 (53%), Gaps = 7/190 (3%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           LG G FG V  G++     +AVK++    G ++E++F  E  T+ +  H  LV+ YG C 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKE--GSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 205
            ++   +V EY+ NG L  YL    + +E  +L E+     +G+ +L      + IH D+
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDL 130
Query: 206 KPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDV 265
              N L+D +   KV+DFG+ +    +  +V+  G K    +SAPE     +  + K DV
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPEVFH-YFKYSSKSDV 188
Query: 266 YSFGMVLFEI 275
           ++FG++++E+
Sbjct: 189 WAFGILMWEV 198

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 109/199 (54%), Gaps = 11/199 (5%)
Query: 84  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 17  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 74
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 75  VSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 130
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITH 261
            D++  N+L+  N   KVADFGLA+L + N+ +    G K    ++APE  L G + I  
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI-- 187
Query: 262 KCDVYSFGMVLFEIVGRRR 280
           K DV+SFG++L E+  + R
Sbjct: 188 KSDVWSFGILLTELTTKGR 206

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 84  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 14  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 71
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 72  VSEEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 127
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITH 261
            D++  N+L+  N   KVADFGLA+L + N+      G K    ++APE  L G + I  
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTAR-QGAKFPIKWTAPEAALYGRFTI-- 184
Query: 262 KCDVYSFGMVLFEIVGRRR 280
           K DV+SFG++L E+  + R
Sbjct: 185 KSDVWSFGILLTELTTKGR 203

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 109/198 (55%), Gaps = 11/198 (5%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D++  N+L+  N   KVADFGLA+L + N+ +    G K    ++APE  L G + I  K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI--K 361
Query: 263 CDVYSFGMVLFEIVGRRR 280
            DV+SFG++L E+  + R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 109/198 (55%), Gaps = 11/198 (5%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D++  N+L+  N   KVADFGLA+L + N+ +    G K    ++APE  L G + I  K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI--K 361
Query: 263 CDVYSFGMVLFEIVGRRR 280
            DV+SFG++L E+  + R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 109/199 (54%), Gaps = 11/199 (5%)
Query: 84  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 13  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 70
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 71  VSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 126
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITH 261
            D++  N+L+  N   KVADFGLA+L + N+ +    G K    ++APE  L G + I  
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI-- 183
Query: 262 KCDVYSFGMVLFEIVGRRR 280
           K DV+SFG++L E+  + R
Sbjct: 184 KSDVWSFGILLTELTTKGR 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 109/199 (54%), Gaps = 11/199 (5%)
Query: 84  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 15  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 72
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 73  VSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 128
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITH 261
            D++  N+L+  N   KVADFGLA+L + N+ +    G K    ++APE  L G + I  
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI-- 185
Query: 262 KCDVYSFGMVLFEIVGRRR 280
           K DV+SFG++L E+  + R
Sbjct: 186 KSDVWSFGILLTELTTKGR 204

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 109/199 (54%), Gaps = 11/199 (5%)
Query: 84  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKIRHEKLVQLYAV 81
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 82  VSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITH 261
            D++  N+L+  N   KVADFGLA+L + N+ +    G K    ++APE  L G + I  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI-- 194
Query: 262 KCDVYSFGMVLFEIVGRRR 280
           K DV+SFG++L E+  + R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K+LN   G  A  +FM E   +    H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C    +  LV + M +G L  Y+   K  I  + L    +  AKG++YL E   +R+
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRL 138
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H D+   NVL+ +    K+ DFGLA+L + ++      G K    + A E +      T
Sbjct: 139 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK-FT 197
Query: 261 HKCDVYSFGMVLFEIV 276
           H+ DV+S+G+ ++E++
Sbjct: 198 HQSDVWSYGVTIWELM 213

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K+LN   G  A  +FM E   +    H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C    +  LV + M +G L  Y+   K  I  + L    +  AKG++YL E   +R+
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRL 161
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H D+   NVL+ +    K+ DFGLA+L + ++      G K    + A E +      T
Sbjct: 162 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK-FT 220
Query: 261 HKCDVYSFGMVLFEIV 276
           H+ DV+S+G+ ++E++
Sbjct: 221 HQSDVWSYGVTIWELM 236

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 109/199 (54%), Gaps = 11/199 (5%)
Query: 84  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 82  VSEEPIY-IVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITH 261
            D++  N+L+  N   KVADFGLA+L + N+ +    G K    ++APE  L G + I  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI-- 194
Query: 262 KCDVYSFGMVLFEIVGRRR 280
           K DV+SFG++L E+  + R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 109/199 (54%), Gaps = 11/199 (5%)
Query: 84  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 82  VSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITH 261
            D++  N+L+  N   KVADFGLA+L + N+ +    G K    ++APE  L G + I  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI-- 194
Query: 262 KCDVYSFGMVLFEIVGRRR 280
           K DV+SFG++L E+  + R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 109/198 (55%), Gaps = 11/198 (5%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H 
Sbjct: 249 SEEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D++  N+L+  N   KVADFGLA+L + N+ +    G K    ++APE  L G + I  K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI--K 361
Query: 263 CDVYSFGMVLFEIVGRRR 280
            DV+SFG++L E+  + R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 109/199 (54%), Gaps = 11/199 (5%)
Query: 84  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 82  VSEEPIY-IVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITH 261
            D++  N+L+  N   KVADFGLA+L + N+ +    G K    ++APE  L G + I  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI-- 194
Query: 262 KCDVYSFGMVLFEIVGRRR 280
           K DV+SFG++L E+  + R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 107/194 (55%), Gaps = 10/194 (5%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV+ G + N  K+AVK L    G ++ + F+ E   +    H  LVRLY   
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
             +    ++ E+M  GSL  +L   +   +   KL + +   A+G+ Y+    ++  IH 
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 133
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS-GNYPITHK 262
           D++  NVL+  +   K+ADFGLA++ + N+ +    G K    ++APE ++ G + I  K
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGCFTI--K 190
Query: 263 CDVYSFGMVLFEIV 276
            +V+SFG++L+EIV
Sbjct: 191 SNVWSFGILLYEIV 204

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 109/198 (55%), Gaps = 11/198 (5%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H 
Sbjct: 332 SEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D++  N+L+  N   KVADFGLA+L + N+ +    G K    ++APE  L G + I  K
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI--K 444
Query: 263 CDVYSFGMVLFEIVGRRR 280
            DV+SFG++L E+  + R
Sbjct: 445 SDVWSFGILLTELTTKGR 462

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 84  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 82  VSEEPIY-IVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITH 261
            D++  N+L+  N   KVADFGLA+L + N+      G K    ++APE  L G + I  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTAR-QGAKFPIKWTAPEAALYGRFTI-- 194
Query: 262 KCDVYSFGMVLFEIVGRRR 280
           K DV+SFG++L E+  + R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 109/199 (54%), Gaps = 11/199 (5%)
Query: 84  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 21  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++ +  +V EYM  GSL  +L G+  + +   +L +++   A G+ Y+    +   +H
Sbjct: 79  VSEEPIY-IVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITH 261
            D++  N+L+  N   KVADFGLA+L + N+ +    G K    ++APE  L G + I  
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI-- 191
Query: 262 KCDVYSFGMVLFEIVGRRR 280
           K DV+SFG++L E+  + R
Sbjct: 192 KSDVWSFGILLTELTTKGR 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 84  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 82  VSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITH 261
            D+   N+L+  N   KVADFGLA+L + N+ +    G K    ++APE  L G + I  
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI-- 194
Query: 262 KCDVYSFGMVLFEIVGRRR 280
           K DV+SFG++L E+  + R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GNMSPEAFLQEAQVMKKLRHEKLVQLYAVV 249
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H 
Sbjct: 250 SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D++  N+L+  N   KVADFGL +L + N+ +    G K    ++APE  L G + I  K
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI--K 362
Query: 263 CDVYSFGMVLFEIVGRRR 280
            DV+SFG++L E+  + R
Sbjct: 363 SDVWSFGILLTELTTKGR 380

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 84  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++ +  +V EYM  G L  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 82  VSEEPIY-IVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITH 261
            D++  N+L+  N   KVADFGLA+L + N+ +    G K    ++APE  L G + I  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI-- 194
Query: 262 KCDVYSFGMVLFEIVGRRR 280
           K DV+SFG++L E+  + R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 84  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 21  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++ +  +V EYM  GSL  +L G+  + +   +L +++   A G+ Y+    +   +H
Sbjct: 79  VSEEPIY-IVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITH 261
            D++  N+L+  N   KVADFGLA+L + N+      G K    ++APE  L G + I  
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNE-WTARQGAKFPIKWTAPEAALYGRFTI-- 191
Query: 262 KCDVYSFGMVLFEIVGRRR 280
           K DV+SFG++L E+  + R
Sbjct: 192 KSDVWSFGILLTELTTKGR 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 84  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++ +  +V EYM  G L  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 82  VSEEPIY-IVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITH 261
            D++  N+L+  N   KVADFGLA+L + N+ +    G K    ++APE  L G + I  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI-- 194
Query: 262 KCDVYSFGMVLFEIVGRRR 280
           K DV+SFG++L E+  + R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 117/216 (54%), Gaps = 15/216 (6%)
Query: 65  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMA 124
           +KP    + ++   +     +LG G FGEV+   +    K+AVK +    G ++ E F+A
Sbjct: 2   QKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLA 59
Query: 125 EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF---GKKRAIEWEKLHEI 181
           E   +    H  LV+L+     + +  ++ E+M  GSL  +L    G K+ +   KL + 
Sbjct: 60  EANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLP--KLIDF 116
Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY 241
           +   A+G+ ++    Q+  IH D++  N+L+ A+   K+ADFGLA++ + N+ +    G 
Sbjct: 117 SAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGA 172
Query: 242 KGTPGYSAPEFLS-GNYPITHKCDVYSFGMVLFEIV 276
           K    ++APE ++ G++ I  K DV+SFG++L EIV
Sbjct: 173 KFPIKWTAPEAINFGSFTI--KSDVWSFGILLMEIV 206

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 117/216 (54%), Gaps = 15/216 (6%)
Query: 65  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMA 124
           +KP    + ++   +     +LG G FGEV+   +    K+AVK +    G ++ E F+A
Sbjct: 175 QKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLA 232
Query: 125 EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF---GKKRAIEWEKLHEI 181
           E   +    H  LV+L+     + +  ++ E+M  GSL  +L    G K+ +   KL + 
Sbjct: 233 EANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLP--KLIDF 289
Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY 241
           +   A+G+ ++    Q+  IH D++  N+L+ A+   K+ADFGLA++ + N+ +    G 
Sbjct: 290 SAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGA 345
Query: 242 KGTPGYSAPEFLS-GNYPITHKCDVYSFGMVLFEIV 276
           K    ++APE ++ G++ I  K DV+SFG++L EIV
Sbjct: 346 KFPIKWTAPEAINFGSFTI--KSDVWSFGILLMEIV 379

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 86  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 169
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFGLA+ L D  +   T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 261 HKCDVYSFGMVLFEIV 276
              DV+S+G+VL+E++
Sbjct: 229 SASDVWSYGIVLWEVM 244

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 86  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 84  GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 140
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFGL++ L D  +   T  G K    +++PE ++     T
Sbjct: 141 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 199
Query: 261 HKCDVYSFGMVLFEIV 276
              DV+S+G+VL+E++
Sbjct: 200 SASDVWSYGIVLWEVM 215

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 86  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGFV 169
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFGL++ L D  +   T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 261 HKCDVYSFGMVLFEIV 276
              DV+S+G+VL+E++
Sbjct: 229 SASDVWSYGIVLWEVM 244

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 86  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 100
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 101 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 157
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFGL++ L D  +   T  G K    +++PE ++     T
Sbjct: 158 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 216
Query: 261 HKCDVYSFGMVLFEIV 276
              DV+S+G+VL+E++
Sbjct: 217 SASDVWSYGIVLWEVM 232

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 86  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 110
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 111 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 167
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFGL++ L D  +   T  G K    +++PE ++     T
Sbjct: 168 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 226
Query: 261 HKCDVYSFGMVLFEIV 276
              DV+S+G+VL+E++
Sbjct: 227 SASDVWSYGIVLWEVM 242

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 11/198 (5%)
Query: 86  LGFGGFGEVYKGQFPNGVK----IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FGEV +G+     K    +A+K L          +F++E   +G+  H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G   +     ++ E+MENG+LD +L          +L  +  G A G+ YL E      +
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAE---MSYV 138
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNK---THVTISGYKGTPGYSAPEFLSGNYP 258
           H D+   N+L+++N   KV+DFGL++  + N    T+ +  G K    ++APE ++    
Sbjct: 139 HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR-K 197
Query: 259 ITHKCDVYSFGMVLFEIV 276
            T   D +S+G+V++E++
Sbjct: 198 FTSASDAWSYGIVMWEVM 215

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G FGEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 132
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T    +G K    ++APE L+ N   + K
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TXTAHAGAKFPIKWTAPESLAYN-KFSIK 190
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI      A  G +      P  V+E  EK        GC       EK
Sbjct: 191 SDVWAFGVLLWEI------ATYGMSPYPGIDPSQVYELLEKDYRMERPEGC------PEK 238
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 239 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 269

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 86  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 169
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFGL++ L D  +   T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 261 HKCDVYSFGMVLFEIV 276
              DV+S+G+VL+E++
Sbjct: 229 SASDVWSYGIVLWEVM 244

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 86  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 169
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFGL++ L D  +   T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 261 HKCDVYSFGMVLFEIV 276
              DV+S+G+VL+E++
Sbjct: 229 SASDVWSYGIVLWEVM 244

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 86  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 169
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFGL++ L D  +   T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 261 HKCDVYSFGMVLFEIV 276
              DV+S+G+VL+E++
Sbjct: 229 SASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 86  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 169
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFGL++ L D  +   T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 261 HKCDVYSFGMVLFEIV 276
              DV+S+G+VL+E++
Sbjct: 229 SASDVWSYGIVLWEVM 244

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 86  LGFGGFGEVYKGQF----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G  GEV  G+        V +A+K L           F++E   +G+  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G      +  +V EYMENGSLD +L          +L  +  G   G+ YL +      +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YV 173
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   NVL+D+N   KV+DFGL++ L D      T +G K    ++APE ++     +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFR-TFS 232
Query: 261 HKCDVYSFGMVLFEIVG 277
              DV+SFG+V++E++ 
Sbjct: 233 SASDVWSFGVVMWEVLA 249

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 86  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 169
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFGL + L D  +   T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 261 HKCDVYSFGMVLFEIV 276
              DV+S+G+VL+E++
Sbjct: 229 SASDVWSYGIVLWEVM 244

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 86  LGFGGFGEVYKGQFPNGVK----IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FGEV +G+     K    +A+K L          +F++E   +G+  H N++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G   +     ++ E+MENG+LD +L          +L  +  G A G+ YL E      +
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAE---MSYV 140
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNK---THVTISGYKGTPGYSAPEFLSGNYP 258
           H D+   N+L+++N   KV+DFGL++  + N    T  +  G K    ++APE ++    
Sbjct: 141 HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRK- 199
Query: 259 ITHKCDVYSFGMVLFEIV 276
            T   D +S+G+V++E++
Sbjct: 200 FTSASDAWSYGIVMWEVM 217

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 86  LGFGGFGEVYKGQF----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G  GEV  G+        V +A+K L           F++E   +G+  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G      +  +V EYMENGSLD +L          +L  +  G   G+ YL +      +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YV 173
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   NVL+D+N   KV+DFGL++ L D      T +G K    ++APE ++     +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFS 232
Query: 261 HKCDVYSFGMVLFEIVG 277
              DV+SFG+V++E++ 
Sbjct: 233 SASDVWSFGVVMWEVLA 249

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 132
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T    +G K    ++APE L+ N   + K
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TFTAHAGAKFPIKWTAPESLAYN-KFSIK 190
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI      A  G +      P  V+E  EK        GC       EK
Sbjct: 191 SDVWAFGVLLWEI------ATYGMSPYPGIDPSQVYELLEKDYRMERPEGC------PEK 238
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 239 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 269

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 132
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T    +G K    ++APE L+ N   + K
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TXTAHAGAKFPIKWTAPESLAYN-KFSIK 190
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI      A  G +      P  V+E  EK        GC       EK
Sbjct: 191 SDVWAFGVLLWEI------ATYGMSPYPGIDPSQVYELLEKDYRMERPEGC------PEK 238
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 239 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 269

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 100/194 (51%), Gaps = 10/194 (5%)
Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEE--QFMAEVGTIGRTYHINLVRLYG 142
           LG G FG+V  G+    G K+AVK+LNR   R  +   +   E+  +    H ++++LY 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
                    +V EY+  G L  Y+    R  E E    +      G+ Y H   +  ++H
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES-RRLFQQILSGVDYCH---RHMVVH 139
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+KPENVLLDA+ + K+ADFGL+ +    +    +    G+P Y+APE +SG      +
Sbjct: 140 RDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRXSCGSPNYAAPEVISGRLYAGPE 196
Query: 263 CDVYSFGMVLFEIV 276
            D++S G++L+ ++
Sbjct: 197 VDIWSSGVILYALL 210

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 197
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 245
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 246 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 86  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         +V E MENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 84  GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 140
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFGL++ L D  +   T  G K    +++PE ++     T
Sbjct: 141 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 199
Query: 261 HKCDVYSFGMVLFEIV 276
              DV+S+G+VL+E++
Sbjct: 200 SASDVWSYGIVLWEVM 215

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 135
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPESLAYN-KFSIK 193
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 194 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 241
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 242 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 272

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 197
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 245
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 246 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 124/280 (44%), Gaps = 34/280 (12%)
Query: 86  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G+        + +A+K L           F++E   +G+  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         ++ EYMENGSLD +L          +L  +  G   G+ YL +      +
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSAV 153
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFG+++ L D  +   T  G K    ++APE ++     T
Sbjct: 154 HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFT 212
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
              DV+S+G+V++E+              + +  +  W+   +  + A      IEE  +
Sbjct: 213 SASDVWSYGIVMWEV--------------MSYGERPYWDMSNQDVIKA------IEEGYR 252
Query: 321 EKAKRLCMVALW-----CVQDSPEDRPPMSAVIKMLEGVV 355
                 C +AL      C Q    DRP    ++ ML+ ++
Sbjct: 253 LPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 292

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPESLAYN-KFSIK 194
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 242
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 243 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 273

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 192
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 240
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 241 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 124/280 (44%), Gaps = 34/280 (12%)
Query: 86  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G+        + +A+K L           F+ E   +G+  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         +V EYMENGSLD +L          +L  +  G + G+ YL +      +
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSD---MGYV 146
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFGL++ L D  +   T  G K    ++APE ++     T
Sbjct: 147 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR-KFT 205
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
              DV+S+G+V++E+V               +  +  WE   +  + A      +EE  +
Sbjct: 206 SASDVWSYGIVMWEVVS--------------YGERPYWEMTNQDVIKA------VEEGYR 245
Query: 321 EKAKRLCMVALW-----CVQDSPEDRPPMSAVIKMLEGVV 355
             +   C  AL+     C Q     RP    ++ ML+ ++
Sbjct: 246 LPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLI 285

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 192
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 240
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 241 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 86  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         +V E MENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGAV 169
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFGL++ L D  +   T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 261 HKCDVYSFGMVLFEIV 276
              DV+S+G+VL+E++
Sbjct: 229 SASDVWSYGIVLWEVM 244

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 197
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 245
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 246 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 192
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 240
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 241 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 138
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 196
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 197 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 244
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 245 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 275

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 192
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 240
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 241 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 192
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 240
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 241 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 197
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 245
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 246 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 147
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 205
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 206 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 253
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 254 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 284

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 194
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 242
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 243 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 273

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 124/280 (44%), Gaps = 34/280 (12%)
Query: 86  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G+        + +A+K L           F++E   +G+  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         ++ EYMENGSLD +L          +L  +  G   G+ YL +      +
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSYV 138
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFG+++ L D  +   T  G K    ++APE ++     T
Sbjct: 139 HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFT 197
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
              DV+S+G+V++E+              + +  +  W+   +  + A      IEE  +
Sbjct: 198 SASDVWSYGIVMWEV--------------MSYGERPYWDMSNQDVIKA------IEEGYR 237
Query: 321 EKAKRLCMVALW-----CVQDSPEDRPPMSAVIKMLEGVV 355
                 C +AL      C Q    DRP    ++ ML+ ++
Sbjct: 238 LPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 277

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 86  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         +V E MENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 169
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFGL++ L D  +   T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 261 HKCDVYSFGMVLFEIV 276
              DV+S+G+VL+E++
Sbjct: 229 SASDVWSYGIVLWEVM 244

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 194
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 242
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 243 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 273

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 124/280 (44%), Gaps = 34/280 (12%)
Query: 86  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G+        + +A+K L           F++E   +G+  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         ++ EYMENGSLD +L          +L  +  G   G+ YL +      +
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSYV 132
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFG+++ L D  +   T  G K    ++APE ++     T
Sbjct: 133 HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFT 191
Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
              DV+S+G+V++E+              + +  +  W+   +  + A      IEE  +
Sbjct: 192 SASDVWSYGIVMWEV--------------MSYGERPYWDMSNQDVIKA------IEEGYR 231
Query: 321 EKAKRLCMVALW-----CVQDSPEDRPPMSAVIKMLEGVV 355
                 C +AL      C Q    DRP    ++ ML+ ++
Sbjct: 232 LPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 271

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 129/270 (47%), Gaps = 24/270 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 192
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 240
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
              L M A W  Q +P DRP  + + +  E
Sbjct: 241 VYEL-MRACW--QWNPSDRPSFAEIHQAFE 267

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 130/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 135
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T    +G K    ++APE L+ N   + K
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TXTAHAGAKFPIKWTAPESLAYN-KFSIK 193
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 194 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 241
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 242 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 272

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 130/274 (47%), Gaps = 24/274 (8%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 144 CHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T    +G K    ++APE L+ N   + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TXTAHAGAKFPIKWTAPESLAYN-KFSIK 197
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI     +   G   S       V+E  EK        GC       EK
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 245
Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
              L M A W  Q +P DRP  + + +  E + +
Sbjct: 246 VYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 276

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 106/196 (54%), Gaps = 25/196 (12%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV+   +    K+AVK +    G ++ E F+AE   +    H  LV+L+   
Sbjct: 189 KLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 246
Query: 145 HDQHMTALVYEYMENGSLDGYLF---GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
             + +  ++ E+M  GSL  +L    G K+ +   KL + +   A+G+ ++    Q+  I
Sbjct: 247 TKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE---QRNYI 300
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS-GNYPIT 260
           H D++  N+L+ A+   K+ADFGLA++           G K    ++APE ++ G++ I 
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLARV-----------GAKFPIKWTAPEAINFGSFTI- 348
Query: 261 HKCDVYSFGMVLFEIV 276
            K DV+SFG++L EIV
Sbjct: 349 -KSDVWSFGILLMEIV 363

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 31/289 (10%)
Query: 84  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 74  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 133
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 134 AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 190
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 191 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 244
Query: 262 KCDVYSFGMVLFEI-VGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           + D++S G+ L E+ VGR               P    +E E      ++ GC +E    
Sbjct: 245 QSDIWSMGLSLVEMAVGRYP------------IPPPDAKELE------LMFGCQVEGDAA 286
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYLDL 369
           E   R             + RPPM A+ ++L+ +V   PP  P     L
Sbjct: 287 ETPPRPRTPGRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLPSAVFSL 334

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 99/190 (52%), Gaps = 7/190 (3%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 205
            Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D+
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 130
Query: 206 KPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDV 265
              N L++     KV+DFGL++    +  + +  G K    +S PE L  +   + K D+
Sbjct: 131 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDI 188
Query: 266 YSFGMVLFEI 275
           ++FG++++EI
Sbjct: 189 WAFGVLMWEI 198

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 99/190 (52%), Gaps = 7/190 (3%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 205
            Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D+
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 206 KPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDV 265
              N L++     KV+DFGL++    +  + +  G K    +S PE L  +   + K D+
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSRGSKFPVRWSPPEVLMYS-KFSSKSDI 189
Query: 266 YSFGMVLFEI 275
           ++FG++++EI
Sbjct: 190 WAFGVLMWEI 199

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 144 CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            ++   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 399
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFP----KHVWEEYEKCELGAMILGCGIEEK 318
            DV++FG++L+EI          AT  +  +P      V+E  EK        GC     
Sbjct: 400 SDVWAFGVLLWEI----------ATYGMSPYPGIDLSQVYELLEKDYRMERPEGC----- 444
Query: 319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
             EK   L M A W  Q +P DRP  + + +  E + +
Sbjct: 445 -PEKVYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 478

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 133/283 (46%), Gaps = 31/283 (10%)
Query: 84  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 99  AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 155
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 209
Query: 262 KCDVYSFGMVLFEI-VGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           + D++S G+ L E+ VGR               P    +E E      ++ GC +E    
Sbjct: 210 QSDIWSMGLSLVEMAVGRYP------------IPPPDAKELE------LMFGCQVEGDAA 251
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKP 363
           E   R         +   + RPPM A+ ++L+ +V   PP  P
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPM-AIFELLDYIVNEPPPKLP 293

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 132/283 (46%), Gaps = 31/283 (10%)
Query: 84  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 128
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 182
Query: 262 KCDVYSFGMVLFEI-VGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           + D++S G+ L E+ VGR               P    +E E      ++ GC +E    
Sbjct: 183 QSDIWSMGLSLVEMAVGRYP------------IPPPDAKELE------LMFGCQVEGDAA 224
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKP 363
           E   R             + RPPM A+ ++L+ +V   PP  P
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLP 266

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 132/283 (46%), Gaps = 31/283 (10%)
Query: 84  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 128
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 182
Query: 262 KCDVYSFGMVLFEI-VGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           + D++S G+ L E+ VGR               P    +E E      ++ GC +E    
Sbjct: 183 QSDIWSMGLSLVEMAVGRYP------------IPPPDAKELE------LMFGCQVEGDAA 224
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKP 363
           E   R             + RPPM A+ ++L+ +V   PP  P
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLP 266

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 86  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G+        V +A+K L           F+ E   +G+  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         +V E+MENG+LD +L          +L  +  G A G+ YL +      +
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLAD---MGYV 167
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV-TISGYKGTPGYSAPEFLSGNYPIT 260
           H D+   N+L+++N   KV+DFGL+++ + +   V T +G K    ++APE +      T
Sbjct: 168 HRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR-KFT 226
Query: 261 HKCDVYSFGMVLFEIV 276
              DV+S+G+V++E++
Sbjct: 227 SASDVWSYGIVMWEVM 242

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 99/190 (52%), Gaps = 7/190 (3%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 205
            Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D+
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 126
Query: 206 KPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDV 265
              N L++     KV+DFGL++    +  + +  G K    +S PE L  +   + K D+
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDI 184
Query: 266 YSFGMVLFEI 275
           ++FG++++EI
Sbjct: 185 WAFGVLMWEI 194

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 104/199 (52%), Gaps = 15/199 (7%)
Query: 82  YSTRLGFGGFGEVY-KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           +  +LG G FG+V+   +  +G++  +K +N++  ++  EQ  AE+  +    H N++++
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLF---GKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
           +    D H   +V E  E G L   +     + +A+    + E+       L Y H    
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---S 142
Query: 198 QRIIHYDIKPENVLLD--ANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS 254
           Q ++H D+KPEN+L    +  SP K+ DFGLA+L  ++  H T +   GT  Y APE   
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF-KSDEHSTNAA--GTALYMAPEVFK 199
Query: 255 GNYPITHKCDVYSFGMVLF 273
            +  +T KCD++S G+V++
Sbjct: 200 RD--VTFKCDIWSAGVVMY 216

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 99/190 (52%), Gaps = 7/190 (3%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 205
            Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D+
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 206 KPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDV 265
              N L++     KV+DFGL++    +  + +  G K    +S PE L  +   + K D+
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDI 189
Query: 266 YSFGMVLFEI 275
           ++FG++++EI
Sbjct: 190 WAFGVLMWEI 199

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 132/283 (46%), Gaps = 31/283 (10%)
Query: 84  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 128
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 182
Query: 262 KCDVYSFGMVLFEI-VGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           + D++S G+ L E+ VGR               P    +E E      ++ GC +E    
Sbjct: 183 QSDIWSMGLSLVEMAVGRYP------------IPPPDAKELE------LMFGCQVEGDAA 224
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKP 363
           E   R             + RPPM A+ ++L+ +V   PP  P
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLP 266

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 132/283 (46%), Gaps = 31/283 (10%)
Query: 84  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 128
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 182
Query: 262 KCDVYSFGMVLFEI-VGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           + D++S G+ L E+ VGR               P    +E E      ++ GC +E    
Sbjct: 183 QSDIWSMGLSLVEMAVGRYP------------IPPPDAKELE------LMFGCQVEGDAA 224
Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKP 363
           E   R             + RPPM A+ ++L+ +V   PP  P
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLP 266

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 100/190 (52%), Gaps = 7/190 (3%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 205
            Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D+
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 206 KPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDV 265
              N L++     KV+DFGL++    ++   ++ G K    +S PE L  +   + K D+
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEETSSV-GSKFPVRWSPPEVLMYS-KFSSKSDI 204
Query: 266 YSFGMVLFEI 275
           ++FG++++EI
Sbjct: 205 WAFGVLMWEI 214

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 144 CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 380
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            ++   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 438
Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFP----KHVWEEYEKCELGAMILGCGIEEK 318
            DV++FG++L+EI          AT  +  +P      V+E  EK        GC     
Sbjct: 439 SDVWAFGVLLWEI----------ATYGMSPYPGIDLSQVYELLEKDYRMERPEGC----- 483
Query: 319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
             EK   L M A W  Q +P DRP  + + +  E + +
Sbjct: 484 -PEKVYEL-MRACW--QWNPSDRPSFAEIHQAFETMFQ 517

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 99/190 (52%), Gaps = 7/190 (3%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 205
            Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D+
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 137
Query: 206 KPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDV 265
              N L++     KV+DFGL++    +  + +  G K    +S PE L  +   + K D+
Sbjct: 138 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDI 195
Query: 266 YSFGMVLFEI 275
           ++FG++++EI
Sbjct: 196 WAFGVLMWEI 205

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 99/190 (52%), Gaps = 7/190 (3%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 205
            Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D+
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 206 KPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDV 265
              N L++     KV+DFGL++    +  + +  G K    +S PE L  +   + K D+
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDI 204
Query: 266 YSFGMVLFEI 275
           ++FG++++EI
Sbjct: 205 WAFGVLMWEI 214

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEE--QFMAEVGTIGRTYHINLVRLYG 142
           LG G FG+V  G+    G K+AVK+LNR   R  +   +   E+  +    H ++++LY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 143 FCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
                    +V EY+  G L  Y+   G+   +E  +L +  +       Y H   +  +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD---YCH---RHMV 132
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H D+KPENVLLDA+ + K+ADFGL+ +    +   T     G+P Y+APE +SG     
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLYAG 189
Query: 261 HKCDVYSFGMVLFEIV 276
            + D++S G++L+ ++
Sbjct: 190 PEVDIWSCGVILYALL 205

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 86  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G         + +A+K L           F++E   +G+  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         ++ E+MENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYV 157
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCD---RNKTHVTISGYKGTPGYSAPEFLSGNYP 258
           H D+   N+L+++N   KV+DFGL++  +    + T+ +  G K    ++APE +     
Sbjct: 158 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-K 216
Query: 259 ITHKCDVYSFGMVLFEIV 276
            T   DV+S+G+V++E++
Sbjct: 217 FTSASDVWSYGIVMWEVM 234

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYG 142
           LG G FG+V  G+    G K+AVK+LNR   R  +   +   E+  +    H ++++LY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 143 FCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
                    +V EY+  G L  Y+   G+   +E  +L +  +       Y H   +  +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD---YCH---RHMV 132
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H D+KPENVLLDA+ + K+ADFGL+ +    +    +    G+P Y+APE +SG     
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRDSCGSPNYAAPEVISGRLYAG 189
Query: 261 HKCDVYSFGMVLFEIV 276
            + D++S G++L+ ++
Sbjct: 190 PEVDIWSCGVILYALL 205

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 11/195 (5%)
Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G FG+VYK Q     V  A KV++        E +M E+  +    H N+V+L    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
           + ++   ++ E+   G++D  +   +R +   ++  +   T   L YLH+    +IIH D
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRD 160
Query: 205 IKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL----SGNYPIT 260
           +K  N+L   +   K+ADFG++      +T      + GTP + APE +    S + P  
Sbjct: 161 LKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 261 HKCDVYSFGMVLFEI 275
           +K DV+S G+ L E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 101/193 (52%), Gaps = 9/193 (4%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    +V EYM  G+L  YL    R  +    L  +A   +  + YL    ++  IH
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIH 153
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-TFSIK 211
Query: 263 CDVYSFGMVLFEI 275
            DV++FG++L+EI
Sbjct: 212 SDVWAFGVLLWEI 224

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 105/198 (53%), Gaps = 12/198 (6%)
Query: 84  TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           + LG G  G V K Q  P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 22  SELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 81
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             +     ++  E+M+ GSLD  L   KR I  E L +++I   +GL YL E+ Q  I+H
Sbjct: 82  AFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSIAVLRGLAYLREKHQ--IMH 138
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y APE L G +  + 
Sbjct: 139 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMAPERLQGTH-YSV 192
Query: 262 KCDVYSFGMVLFEI-VGR 278
           + D++S G+ L E+ VGR
Sbjct: 193 QSDIWSMGLSLVELAVGR 210

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G FG+VYK Q     V  A KV++        E +M E+  +    H N+V+L    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
           + ++   ++ E+   G++D  +   +R +   ++  +   T   L YLH+    +IIH D
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRD 160
Query: 205 IKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL----SGNYPIT 260
           +K  N+L   +   K+ADFG++    R         + GTP + APE +    S + P  
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSAKNTRXIQRR--DSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 261 HKCDVYSFGMVLFEI 275
           +K DV+S G+ L E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 89  GGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH 148
           G FG V+K Q  N   +AVK+      +  + ++  EV ++    H N+++  G   ++ 
Sbjct: 35  GRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIG--AEKR 89
Query: 149 MTA------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC------ 196
            T+      L+  + E GSL  +L  K   + W +L  IA   A+GL YLHE+       
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 197 -QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
            +  I H DIK +NVLL  N +  +ADFGLA   +  K+     G  GT  Y APE L G
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207
Query: 256 NYPITH----KCDVYSFGMVLFEIVGR 278
                     + D+Y+ G+VL+E+  R
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASR 234

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 92  GEVY-KGQFPNGVKIAVK-----VLNRNLGRIAEEQ---FMAEVGTIGRTYHINLVRLYG 142
           GEV  KG F   +K+  +     ++ + L R  EE    F+ EV  +    H N+++  G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             +       + EY++ G+L G +        W +    A   A G+ YLH      IIH
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIH 131
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLC----------------DRNKTHVTISGYKGTPG 246
            D+   N L+  N +  VADFGLA+L                 DR K +  +    G P 
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV----GNPY 187
Query: 247 YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
           + APE ++G      K DV+SFG+VL EI+GR
Sbjct: 188 WMAPEMINGR-SYDEKVDVFSFGIVLCEIIGR 218

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 67  PVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQ 121
           P  F       F+  Y  +  LG G FGEV   +    G + AVKV+++     +  +E 
Sbjct: 13  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 72
Query: 122 FMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI 181
            + EV  + +  H N+++LY F  D+    LV E    G L   +  +KR  E +    I
Sbjct: 73  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-I 131
Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNKTHV 236
                 G+ Y+H   + +I+H D+KPEN+LL     DAN   ++ DFGL+   + +K   
Sbjct: 132 IRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK--- 183
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
            +    GT  Y APE L G Y    KCDV+S G++L+
Sbjct: 184 KMKDKIGTAYYIAPEVLHGTYD--EKCDVWSTGVILY 218

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G FG+VYK Q     V  A KV++        E +M E+  +    H N+V+L    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
           + ++   ++ E+   G++D  +   +R +   ++  +   T   L YLH+    +IIH D
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRD 160
Query: 205 IKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL----SGNYPIT 260
           +K  N+L   +   K+ADFG++    R         + GTP + APE +    S + P  
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSAKNTRXIQRR--DXFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 261 HKCDVYSFGMVLFEI 275
           +K DV+S G+ L E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 23/200 (11%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G F +V   +    G ++A+K++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQRI 200
              +    L+ EY   G +  YL    R  E E   K  +I       + Y H   Q+RI
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCH---QKRI 132
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG----YKGTPGYSAPEFLSGN 256
           +H D+K EN+LLDA+ + K+ADFG +          T+ G    + G+P Y+APE   G 
Sbjct: 133 VHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLDTFCGSPPYAAPELFQGK 185
Query: 257 YPITHKCDVYSFGMVLFEIV 276
                + DV+S G++L+ +V
Sbjct: 186 KYDGPEVDVWSLGVILYTLV 205

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 86  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G         + +A+K L           F++E   +G+  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         ++ E+MENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYV 131
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCD---RNKTHVTISGYKGTPGYSAPEFLSGNYP 258
           H  +   N+L+++N   KV+DFGL++  +    + T+ +  G K    ++APE +     
Sbjct: 132 HRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-K 190
Query: 259 ITHKCDVYSFGMVLFEIV 276
            T   DV+S+G+V++E++
Sbjct: 191 FTSASDVWSYGIVMWEVM 208

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 12/213 (5%)
Query: 84  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 15  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 74
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 75  AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 131
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+L+++    K+ DFG++ +L D          + GT  Y +PE L G +  + 
Sbjct: 132 RDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE-----FVGTRSYMSPERLQGTH-YSV 185
Query: 262 KCDVYSFGMVLFEI-VGRRRNAIVGATESLDWF 293
           + D++S G+ L E+ VGR     +   E LD+ 
Sbjct: 186 QSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYI 218

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 122/284 (42%), Gaps = 36/284 (12%)
Query: 82  YSTRLGFGGFGEVYKGQF---PNGVKIAVKVLNRNLGRIAE----EQFMAEVGTIGRTYH 134
           Y  ++G GGFG V+KG+     + V I   +L  + G        ++F  EV  +    H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
            N+V+LYG  H+     +V E++  G L   L  K   I+W     + +  A G+ Y+  
Sbjct: 83  PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 195 ECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
           +    I+H D++  N+ L     +A    KVADFGL++       H ++SG  G   + A
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVH-SVSGLLGNFQWMA 194
Query: 250 PEFLSG-NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
           PE +       T K D YSF M+L+         I+      D +       Y K +   
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILY--------TILTGEGPFDEY------SYGKIKFIN 240
Query: 309 MILGCGIEEKDKEKA-KRLCMVALWCVQDSPEDRPPMSAVIKML 351
           MI   G+     E    RL  V   C    P+ RP  S ++K L
Sbjct: 241 MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 67  PVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQ 121
           P  F       F+  Y  +  LG G FGEV   +    G + AVKV+++     +  +E 
Sbjct: 36  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 95
Query: 122 FMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI 181
            + EV  + +  H N+++LY F  D+    LV E    G L   +  +KR  E +    I
Sbjct: 96  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-I 154
Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNKTHV 236
                 G+ Y+H   + +I+H D+KPEN+LL     DAN   ++ DFGL+   + +K   
Sbjct: 155 IRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK--- 206
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
            +    GT  Y APE L G Y    KCDV+S G++L+
Sbjct: 207 KMKDKIGTAYYIAPEVLHGTYD--EKCDVWSTGVILY 241

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 67  PVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQ 121
           P  F       F+  Y  +  LG G FGEV   +    G + AVKV+++     +  +E 
Sbjct: 37  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 96
Query: 122 FMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI 181
            + EV  + +  H N+++LY F  D+    LV E    G L   +  +KR  E +    I
Sbjct: 97  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-I 155
Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNKTHV 236
                 G+ Y+H   + +I+H D+KPEN+LL     DAN   ++ DFGL+   + +K   
Sbjct: 156 IRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK--- 207
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
            +    GT  Y APE L G Y    KCDV+S G++L+
Sbjct: 208 KMKDKIGTAYYIAPEVLHGTYD--EKCDVWSTGVILY 242

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 19/198 (9%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G F +V   +    G ++A+K++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQRI 200
              +    L+ EY   G +  YL    R  E E   K  +I       + Y H   Q+RI
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCH---QKRI 135
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV--TISGYKGTPGYSAPEFLSGNYP 258
           +H D+K EN+LLDA+ + K+ADFG +     N+  V   +  + G P Y+APE   G   
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFS-----NEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 259 ITHKCDVYSFGMVLFEIV 276
              + DV+S G++L+ +V
Sbjct: 191 DGPEVDVWSLGVILYTLV 208

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAE----EQFMAEVGTIGRTYHINLVRLY 141
           +G G FG VY G++ +  +  ++   ++L RI E    E F+ E   +    H N++ L 
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 142 GF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           G     + +  ++  YM +G L  ++   +R    + L    +  A+G+ YL E   Q+ 
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKF 145
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTP-GYSAPEFLSGNYP 258
           +H D+   N +LD +F+ KVADFGLA+ + DR    V    +   P  ++A E L   Y 
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ-TYR 204
Query: 259 ITHKCDVYSFGMVLFEIVGR 278
            T K DV+SFG++L+E++ R
Sbjct: 205 FTTKSDVWSFGVLLWELLTR 224

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 67  PVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQ 121
           P  F       F+  Y  +  LG G FGEV   +    G + AVKV+++     +  +E 
Sbjct: 19  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 78
Query: 122 FMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI 181
            + EV  + +  H N+++LY F  D+    LV E    G L   +  +KR  E +    I
Sbjct: 79  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-I 137
Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNKTHV 236
                 G+ Y+H   + +I+H D+KPEN+LL     DAN   ++ DFGL+   + +K   
Sbjct: 138 IRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK--- 189
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
            +    GT  Y APE L G Y    KCDV+S G++L+
Sbjct: 190 KMKDKIGTAYYIAPEVLHGTYD--EKCDVWSTGVILY 224

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 71  TSLQLNNFTSNYST--RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ--FMAE 125
           +SL       NY     LG G FG+V        G K+A+K++N+ +   ++ Q     E
Sbjct: 5   SSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIERE 64
Query: 126 VGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT 185
           +  +    H ++++LY     +    +V EY  N   D Y+  + +  E E     A   
Sbjct: 65  ISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQE-----ARRF 118
Query: 186 AKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKG 243
            + ++   E C + +I+H D+KPEN+LLD + + K+ADFGL+  + D N    +     G
Sbjct: 119 FQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----G 174
Query: 244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           +P Y+APE +SG      + DV+S G++L+ ++ RR
Sbjct: 175 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 13/195 (6%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G F +V   +    G ++AVK++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 202
              +    LV EY   G +  YL    R  E E     A    + +V   + C Q+ I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE-----ARAKFRQIVSAVQYCHQKFIVH 136
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+K EN+LLDA+ + K+ADFG + +    NK    +  + G P Y+APE   G      
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDAFCGAPPYAAPELFQGKKYDGP 192
Query: 262 KCDVYSFGMVLFEIV 276
           + DV+S G++L+ +V
Sbjct: 193 EVDVWSLGVILYTLV 207

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G F +V   +    G ++AVK++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 202
              +    LV EY   G +  YL    R  E E     A    + +V   + C Q+ I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE-----ARAKFRQIVSAVQYCHQKFIVH 136
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+K EN+LLDA+ + K+ADFG + +    NK    +  + G+P Y+APE   G      
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKKYDGP 192
Query: 262 KCDVYSFGMVLFEIV 276
           + DV+S G++L+ +V
Sbjct: 193 EVDVWSLGVILYTLV 207

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG V+KG + P G    + + +KV+    GR + +     +  IG   H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C    +  LV +Y+  GSL  ++   + A+  + L    +  AKG+ YL E     +
Sbjct: 99  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGM 154
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS-GNYPI 259
           +H ++   NVLL +    +VADFG+A L   +   +  S  K    + A E +  G Y  
Sbjct: 155 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY-- 212
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 213 THQSDVWSYGVTVWELM 229

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 71  TSLQLNNFTSNYST--RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ--FMAE 125
           +SL       NY     LG G FG+V        G K+A+K++N+ +   ++ Q     E
Sbjct: 4   SSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIERE 63
Query: 126 VGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT 185
           +  +    H ++++LY     +    +V EY  N   D Y+  + +  E E     A   
Sbjct: 64  ISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQE-----ARRF 117
Query: 186 AKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKG 243
            + ++   E C + +I+H D+KPEN+LLD + + K+ADFGL+  + D N    +     G
Sbjct: 118 FQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----G 173
Query: 244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           +P Y+APE +SG      + DV+S G++L+ ++ RR
Sbjct: 174 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 15/199 (7%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLYG 142
           LG G FG+V        G K+A+K++N+ +   ++ Q     E+  +    H ++++LY 
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RII 201
               +    +V EY  N   D Y+  + +  E E     A    + ++   E C + +I+
Sbjct: 72  VIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQE-----ARRFFQQIISAVEYCHRHKIV 125
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+KPEN+LLD + + K+ADFGL+  + D N    +     G+P Y+APE +SG     
Sbjct: 126 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKLYAG 181
Query: 261 HKCDVYSFGMVLFEIVGRR 279
            + DV+S G++L+ ++ RR
Sbjct: 182 PEVDVWSCGVILYVMLCRR 200

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G F +V   +    G ++AVK++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 202
              +    LV EY   G +  YL    R  E E     A    + +V   + C Q+ I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE-----ARAKFRQIVSAVQYCHQKFIVH 136
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+K EN+LLDA+ + K+ADFG + +    NK    +  + G+P Y+APE   G      
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKKYDGP 192
Query: 262 KCDVYSFGMVLFEIV 276
           + DV+S G++L+ +V
Sbjct: 193 EVDVWSLGVILYTLV 207

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 18/200 (9%)
Query: 86  LGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEEQFMAE--VGTIGRTYHINLVRLYG 142
           LG G FG+V     +    K+A+K ++R L + ++     E  +  +    H ++++LY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE--KLHEIAIGTAKGLVYLHEECQQRI 200
                    +V EY   G L  Y+  KKR  E E  +  +  I   +   Y H   + +I
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIE---YCH---RHKI 129
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           +H D+KPEN+LLD N + K+ADFGL+  + D N    +     G+P Y+APE ++G    
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVINGKLYA 185
Query: 260 THKCDVYSFGMVLF-EIVGR 278
             + DV+S G+VL+  +VGR
Sbjct: 186 GPEVDVWSCGIVLYVMLVGR 205

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 104/200 (52%), Gaps = 21/200 (10%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-----FMAEVGTIGRTYHINLVR 139
           ++G G +G VYK +   G  +A+K +  +    AE++      + E+  +   +H N+V 
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLD----AEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L    H +    LV+E+ME   L   L   K  ++  ++        +G+ + H   Q R
Sbjct: 84  LIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHR 139
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
           I+H D+KP+N+L++++ + K+ADFGLA+   +  R+ TH  ++ +     Y AP+ L G+
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW-----YRAPDVLMGS 194
Query: 257 YPITHKCDVYSFGMVLFEIV 276
              +   D++S G +  E++
Sbjct: 195 KKYSTSVDIWSIGCIFAEMI 214

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 15/199 (7%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLYG 142
           LG G FG+V        G K+A+K++N+ +   ++ Q     E+  +    H ++++LY 
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RII 201
               +    +V EY  N   D Y+  + +  E E     A    + ++   E C + +I+
Sbjct: 76  VIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQE-----ARRFFQQIISAVEYCHRHKIV 129
Query: 202 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           H D+KPEN+LLD + + K+ADFGL+  + D N    +     G+P Y+APE +SG     
Sbjct: 130 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKLYAG 185
Query: 261 HKCDVYSFGMVLFEIVGRR 279
            + DV+S G++L+ ++ RR
Sbjct: 186 PEVDVWSCGVILYVMLCRR 204

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 104/200 (52%), Gaps = 21/200 (10%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-----FMAEVGTIGRTYHINLVR 139
           ++G G +G VYK +   G  +A+K +  +    AE++      + E+  +   +H N+V 
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLD----AEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L    H +    LV+E+ME   L   L   K  ++  ++        +G+ + H   Q R
Sbjct: 84  LIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHR 139
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
           I+H D+KP+N+L++++ + K+ADFGLA+   +  R+ TH  ++ +     Y AP+ L G+
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW-----YRAPDVLMGS 194
Query: 257 YPITHKCDVYSFGMVLFEIV 276
              +   D++S G +  E++
Sbjct: 195 KKYSTSVDIWSIGCIFAEMI 214

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 84  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 128
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 182
Query: 262 KCDVYSFGMVLFEI-VGR 278
           + D++S G+ L E+ VGR
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 128/296 (43%), Gaps = 43/296 (14%)
Query: 86  LGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FG+V+  +  N       + +AVK L ++    A + F  E   +    H ++V+
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF-----------GKKRAIEWE----KLHEIAIG 184
            YG C D     +V+EYM++G L+ +L            G+ R  + E    ++  IA  
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT-HVTISGYKG 243
            A G+VYL     Q  +H D+   N L+ AN   K+ DFG+++  D   T +  + G+  
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGGHTM 196
Query: 244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK 303
            P    P         T + DV+SFG++L+EI                 + K  W +   
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---------------YGKQPWFQLSN 241
Query: 304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP 359
            E+   I    + E+ +   K +  V L C Q  P+ R  +  + K+L  + +  P
Sbjct: 242 TEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKATP 297

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG V+KG + P G    + + +KV+    GR + +     +  IG   H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C    +  LV +Y+  GSL  ++   + A+  + L    +  AKG+ YL E     +
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGM 136
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS-GNYPI 259
           +H ++   NVLL +    +VADFG+A L   +   +  S  K    + A E +  G Y  
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY-- 194
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 195 THQSDVWSYGVTVWELM 211

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 121/284 (42%), Gaps = 36/284 (12%)
Query: 82  YSTRLGFGGFGEVYKGQF---PNGVKIAVKVLNRNLGRIAE----EQFMAEVGTIGRTYH 134
           Y  ++G GGFG V+KG+     + V I   +L  + G        ++F  EV  +    H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
            N+V+LYG  H+     +V E++  G L   L  K   I+W     + +  A G+ Y+  
Sbjct: 83  PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 195 ECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
           +    I+H D++  N+ L     +A    KVADFG ++       H ++SG  G   + A
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVH-SVSGLLGNFQWMA 194
Query: 250 PEFLSG-NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
           PE +       T K D YSF M+L+         I+      D +       Y K +   
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILY--------TILTGEGPFDEY------SYGKIKFIN 240
Query: 309 MILGCGIEEKDKEKA-KRLCMVALWCVQDSPEDRPPMSAVIKML 351
           MI   G+     E    RL  V   C    P+ RP  S ++K L
Sbjct: 241 MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G F +V   +    G ++AV+++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 202
              +    LV EY   G +  YL    R  E E     A    + +V   + C Q+ I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE-----ARAKFRQIVSAVQYCHQKFIVH 136
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+K EN+LLDA+ + K+ADFG + +    NK    +  + G+P Y+APE   G      
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKKYDGP 192
Query: 262 KCDVYSFGMVLFEIV 276
           + DV+S G++L+ +V
Sbjct: 193 EVDVWSLGVILYTLV 207

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 85  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLV 138
           +LG G FG V +G++  P+G  V +AVK L  ++    E  + F+ EV  +    H NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---K 134
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNY 257
           R IH D+   N+LL      K+ DFGL +   +N  H  +  ++  P  + APE L    
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TR 193
Query: 258 PITHKCDVYSFGMVLFEI 275
             +H  D + FG+ L+E+
Sbjct: 194 TFSHASDTWMFGVTLWEM 211

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 121/284 (42%), Gaps = 36/284 (12%)
Query: 82  YSTRLGFGGFGEVYKGQF---PNGVKIAVKVLNRNLGRIAE----EQFMAEVGTIGRTYH 134
           Y  ++G GGFG V+KG+     + V I   +L  + G        ++F  EV  +    H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
            N+V+LYG  H+     +V E++  G L   L  K   I+W     + +  A G+ Y+  
Sbjct: 83  PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 195 ECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
           +    I+H D++  N+ L     +A    KVADF L++       H ++SG  G   + A
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVH-SVSGLLGNFQWMA 194
Query: 250 PEFLSG-NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
           PE +       T K D YSF M+L+         I+      D +       Y K +   
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILY--------TILTGEGPFDEY------SYGKIKFIN 240
Query: 309 MILGCGIEEKDKEKA-KRLCMVALWCVQDSPEDRPPMSAVIKML 351
           MI   G+     E    RL  V   C    P+ RP  S ++K L
Sbjct: 241 MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 85  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLV 138
           +LG G FG V +G++  P+G  V +AVK L  ++    E  + F+ EV  +    H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SK 140
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNY 257
           R IH D+   N+LL      K+ DFGL +   +N  H  +  ++  P  + APE L    
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK-TR 199
Query: 258 PITHKCDVYSFGMVLFEI 275
             +H  D + FG+ L+E+
Sbjct: 200 TFSHASDTWMFGVTLWEM 217

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 27  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 83
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 84  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 143
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 144 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPV 200
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 201 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 232

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 85  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLV 138
           +LG G FG V +G++  P+G  V +AVK L  ++    E  + F+ EV  +    H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SK 130
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNY 257
           R IH D+   N+LL      K+ DFGL +   +N  H  +  ++  P  + APE L    
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK-TR 189
Query: 258 PITHKCDVYSFGMVLFEI 275
             +H  D + FG+ L+E+
Sbjct: 190 TFSHASDTWMFGVTLWEM 207

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 84  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 31  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 90
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 91  AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 147
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 148 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 201
Query: 262 KCDVYSFGMVLFEI-VGR 278
           + D++S G+ L E+ VGR
Sbjct: 202 QSDIWSMGLSLVEMAVGR 219

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +  VYKG     GV +A+K +  +         + E+  +    H N+VRLY  
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 144 CHDQHMTALVYEYMENG---SLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
            H ++   LV+E+M+N     +D    G   R +E   +        +GL + HE    +
Sbjct: 72  IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NK 128
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I+H D+KP+N+L++     K+ DFGLA+         T S    T  Y AP+ L G+   
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTY 186
Query: 260 THKCDVYSFGMVLFEIV 276
           +   D++S G +L E++
Sbjct: 187 STSIDIWSCGCILAEMI 203

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G F +V   +    G ++AV+++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 202
              +    LV EY   G +  YL    R  E E     A    + +V   + C Q+ I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE-----ARAKFRQIVSAVQYCHQKFIVH 136
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+K EN+LLDA+ + K+ADFG + +    NK    +  + G+P Y+APE   G      
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDEFCGSPPYAAPELFQGKKYDGP 192
Query: 262 KCDVYSFGMVLFEIV 276
           + DV+S G++L+ +V
Sbjct: 193 EVDVWSLGVILYTLV 207

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 12/212 (5%)
Query: 85  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLV 138
           +LG G FG V +G++  P+G  V +AVK L  ++    E  + F+ EV  +    H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SK 130
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNY 257
           R IH D+   N+LL      K+ DFGL +   +N  H  +  ++  P  + APE L    
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TR 189
Query: 258 PITHKCDVYSFGMVLFEIVGRRRNAIVGATES 289
             +H  D + FG+ L+E+    +   +G   S
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGR-IAE--EQFMAEVGTIGRTYHINLVRLYG 142
           +G GGFG+VY+  F  G ++AVK    +    I++  E    E        H N++ L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
            C  +    LV E+   G L+  L GK+  I  + L   A+  A+G+ YLH+E    IIH
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 203 YDIKPENVLL--------DANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS 254
            D+K  N+L+         +N   K+ DFGLA+   R         Y     + APE + 
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAY----AWMAPEVIR 187
Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
            +   +   DV+S+G++L+E++
Sbjct: 188 ASM-FSKGSDVWSYGVLLWELL 208

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 85  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLV 138
           +LG G FG V +G++  P+G  V +AVK L  ++    E  + F+ EV  +    H NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---K 134
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNY 257
           R IH D+   N+LL      K+ DFGL +   +N  H  +  ++  P  + APE L    
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TR 193
Query: 258 PITHKCDVYSFGMVLFEI 275
             +H  D + FG+ L+E+
Sbjct: 194 TFSHASDTWMFGVTLWEM 211

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 103/221 (46%), Gaps = 29/221 (13%)
Query: 67  PVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQ 121
           P  F       F+  Y  +  LG G FGEV   +    G + AVKV+++     +  +E 
Sbjct: 13  PGXFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 72
Query: 122 FMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI 181
            + EV  + +  H N+ +LY F  D+    LV E    G L   +  +KR  E +    I
Sbjct: 73  LLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-I 131
Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNKTHV 236
                 G+ Y H   + +I+H D+KPEN+LL     DAN   ++ DFGL+       TH 
Sbjct: 132 IRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANI--RIIDFGLS-------THF 179
Query: 237 TISGYK----GTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
             S       GT  Y APE L G Y    KCDV+S G++L+
Sbjct: 180 EASKKXKDKIGTAYYIAPEVLHGTYD--EKCDVWSTGVILY 218

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 85  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLV 138
           +LG G FG V +G++  P+G  V +AVK L  ++    E  + F+ EV  +    H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SK 140
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNY 257
           R IH D+   N+LL      K+ DFGL +   +N  H  +  ++  P  + APE L    
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TR 199
Query: 258 PITHKCDVYSFGMVLFEI 275
             +H  D + FG+ L+E+
Sbjct: 200 TFSHASDTWMFGVTLWEM 217

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 81  NYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLV 138
           N    LG G FGEV K +      + AVKV+N+   +  +    + EV  + +  H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           +L+    D     +V E    G L   +  +KR  E +    I      G+ Y+H   + 
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR-IIKQVFSGITYMH---KH 140
Query: 199 RIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
            I+H D+KPEN+LL++   +   K+ DFGL+    +N     +    GT  Y APE L G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG 197
Query: 256 NYPITHKCDVYSFGMVLF 273
            Y    KCDV+S G++L+
Sbjct: 198 TYD--EKCDVWSAGVILY 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 85  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLV 138
           +LG G FG V +G++  P+G  V +AVK L  ++    E  + F+ EV  +    H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---K 130
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNY 257
           R IH D+   N+LL      K+ DFGL +   +N  H  +  ++  P  + APE L    
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TR 189
Query: 258 PITHKCDVYSFGMVLFEI 275
             +H  D + FG+ L+E+
Sbjct: 190 TFSHASDTWMFGVTLWEM 207

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P+G    + +A+KVL  N    A ++ + E   +       + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C    +  LV + M  G L  ++   +  +  + L    +  AKG+ YL +    R+
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLED---VRL 140
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H D+   NVL+ +    K+ DFGLA+L D ++T     G K    + A E +      T
Sbjct: 141 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRR-FT 199
Query: 261 HKCDVYSFGMVLFEIV 276
           H+ DV+S+G+ ++E++
Sbjct: 200 HQSDVWSYGVTVWELM 215

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 13/195 (6%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G F +V   +    G ++AVK++++  L   + ++   EV       H N+V+L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 202
              +    LV EY   G +  YL    R  E E     A    + +V   + C Q+ I+H
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKE-----ARAKFRQIVSAVQYCHQKFIVH 136
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+K EN+LLDA+ + K+ADFG + +    NK    +  + G P Y+APE   G      
Sbjct: 137 RDLKAENLLLDADXNIKIADFGFSNEFTFGNK----LDAFCGAPPYAAPELFQGKKYDGP 192
Query: 262 KCDVYSFGMVLFEIV 276
           + DV+S G++L+ +V
Sbjct: 193 EVDVWSLGVILYTLV 207

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 98/195 (50%), Gaps = 13/195 (6%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G F +V   +    G ++AVK++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 202
              +    LV EY   G +  YL    R  E E     A    + +V   + C Q+ I+H
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE-----ARAKFRQIVSAVQYCHQKYIVH 137
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+K EN+LLD + + K+ADFG + +    NK    +  + G+P Y+APE   G      
Sbjct: 138 RDLKAENLLLDGDMNIKIADFGFSNEFTVGNK----LDTFCGSPPYAAPELFQGKKYDGP 193
Query: 262 KCDVYSFGMVLFEIV 276
           + DV+S G++L+ +V
Sbjct: 194 EVDVWSLGVILYTLV 208

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 9/203 (4%)
Query: 75  LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 133
           LN+       ++G G FGEV+ G+   +   +AVK     L    + +F+ E   + +  
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS 170
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H N+VRL G C  +    +V E ++ G    +L  +   +  + L ++    A G+ YL 
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEF 252
            +C    IH D+   N L+      K++DFG+++  + +  +    G +  P  ++APE 
Sbjct: 231 SKC---CIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAPEA 286
Query: 253 LS-GNYPITHKCDVYSFGMVLFE 274
           L+ G Y  + + DV+SFG++L+E
Sbjct: 287 LNYGRY--SSESDVWSFGILLWE 307

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G F +V   +    G ++AVK++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 202
              +    LV EY   G +  YL     A  W K  E A    + +V   + C Q+ I+H
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLV----AHGWMKEKE-ARAKFRQIVSAVQYCHQKFIVH 129
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+K EN+LLDA+ + K+ADFG + +    NK    +  + G+P Y+APE   G      
Sbjct: 130 RDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKKYDGP 185
Query: 262 KCDVYSFGMVLFEIVG 277
           + DV+S G++L+ +V 
Sbjct: 186 EVDVWSLGVILYTLVS 201

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 29/222 (13%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           +G G FGEV++G++  G ++AVK+ +       EE+       I +T  +    + GF  
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIA 103
Query: 146 DQHMTA-------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-- 196
             +          LV +Y E+GSL  YL   +  +  E + ++A+ TA GL +LH E   
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 197 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK--GTPGYSAPE 251
              +  I H D+K +N+L+  N +  +AD GLA   D     + I+     GT  Y APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 252 FLSGNYPITH-----KCDVYSFGMVLFEIVGRRRNAIVGATE 288
            L  +  + H     + D+Y+ G+V +EI   RR +I G  E
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHE 261

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 29/222 (13%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           +G G FGEV++G++  G ++AVK+ +       EE+       I +T  +    + GF  
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIA 65
Query: 146 DQH-------MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-- 196
             +          LV +Y E+GSL  YL   +  +  E + ++A+ TA GL +LH E   
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 123
Query: 197 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK--GTPGYSAPE 251
              +  I H D+K +N+L+  N +  +AD GLA   D     + I+     GT  Y APE
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 183
Query: 252 FLSGNYPITH-----KCDVYSFGMVLFEIVGRRRNAIVGATE 288
            L  +  + H     + D+Y+ G+V +EI   RR +I G  E
Sbjct: 184 VLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHE 223

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 29/222 (13%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           +G G FGEV++G++  G ++AVK+ +       EE+       I +T  +    + GF  
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIA 64
Query: 146 DQH-------MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-- 196
             +          LV +Y E+GSL  YL   +  +  E + ++A+ TA GL +LH E   
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 197 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK--GTPGYSAPE 251
              +  I H D+K +N+L+  N +  +AD GLA   D     + I+     GT  Y APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 252 FLSGNYPITH-----KCDVYSFGMVLFEIVGRRRNAIVGATE 288
            L  +  + H     + D+Y+ G+V +EI   RR +I G  E
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHE 222

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 28  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 84
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 145 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 202 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 233

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 25  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 81
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 82  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 141
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 142 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 198
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 199 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 230

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 29/222 (13%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           +G G FGEV++G++  G ++AVK+ +       EE+       I +T  +    + GF  
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIA 90
Query: 146 DQHMTA-------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-- 196
             +          LV +Y E+GSL  YL   +  +  E + ++A+ TA GL +LH E   
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 148
Query: 197 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK--GTPGYSAPE 251
              +  I H D+K +N+L+  N +  +AD GLA   D     + I+     GT  Y APE
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 208
Query: 252 FLSGNYPITH-----KCDVYSFGMVLFEIVGRRRNAIVGATE 288
            L  +  + H     + D+Y+ G+V +EI   RR +I G  E
Sbjct: 209 VLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHE 248

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 47  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 103
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 104 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 163
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 164 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 220
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 221 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 252

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 29/222 (13%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           +G G FGEV++G++  G ++AVK+ +       EE+       I +T  +    + GF  
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIA 70
Query: 146 DQH-------MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-- 196
             +          LV +Y E+GSL  YL   +  +  E + ++A+ TA GL +LH E   
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 128
Query: 197 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK--GTPGYSAPE 251
              +  I H D+K +N+L+  N +  +AD GLA   D     + I+     GT  Y APE
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 188
Query: 252 FLSGNYPITH-----KCDVYSFGMVLFEIVGRRRNAIVGATE 288
            L  +  + H     + D+Y+ G+V +EI   RR +I G  E
Sbjct: 189 VLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHE 228

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 20  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 76
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 77  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 136
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 137 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 193
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 194 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 225

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 46  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 102
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 103 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 162
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 163 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 219
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 220 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 251

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 27  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 83
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 84  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 143
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 144 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 200
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 201 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 232

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 29/222 (13%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           +G G FGEV++G++  G ++AVK+ +       EE+       I +T  +    + GF  
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIA 67
Query: 146 DQHMTA-------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-- 196
             +          LV +Y E+GSL  YL   +  +  E + ++A+ TA GL +LH E   
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 125
Query: 197 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK--GTPGYSAPE 251
              +  I H D+K +N+L+  N +  +AD GLA   D     + I+     GT  Y APE
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 185
Query: 252 FLSGNYPITH-----KCDVYSFGMVLFEIVGRRRNAIVGATE 288
            L  +  + H     + D+Y+ G+V +EI   RR +I G  E
Sbjct: 186 VLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHE 225

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 28  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 84
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 145 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 202 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 233

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 26  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 82
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 83  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 142
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 143 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 199
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 200 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 231

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 23  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 79
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 140 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 197 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 228

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 81  NYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLV 138
           N    LG G FGEV K +      + AVKV+N+   +  +    + EV  + +  H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           +L+    D     +V E    G L   +  +KR  E +    I      G+ Y+H   + 
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR-IIKQVFSGITYMH---KH 140
Query: 199 RIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
            I+H D+KPEN+LL++   +   K+ DFGL+    +N     +    GT  Y APE L G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG 197
Query: 256 NYPITHKCDVYSFGMVLF 273
            Y    KCDV+S G++L+
Sbjct: 198 TYD--EKCDVWSAGVILY 213

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 81  NYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLV 138
           N    LG G FGEV K +      + AVKV+N+   +  +    + EV  + +  H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           +L+    D     +V E    G L   +  +KR  E +    I      G+ Y+H   + 
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-QVFSGITYMH---KH 140
Query: 199 RIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
            I+H D+KPEN+LL++   +   K+ DFGL+    +N     +    GT  Y APE L G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG 197
Query: 256 NYPITHKCDVYSFGMVLF 273
            Y    KCDV+S G++L+
Sbjct: 198 TYD--EKCDVWSAGVILY 213

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 9/203 (4%)
Query: 75  LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 133
           LN+       ++G G FGEV+ G+   +   +AVK     L    + +F+ E   + +  
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS 170
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H N+VRL G C  +    +V E ++ G    +L  +   +  + L ++    A G+ YL 
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEF 252
            +C    IH D+   N L+      K++DFG+++  + +       G +  P  ++APE 
Sbjct: 231 SKC---CIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVXAASGGLRQVPVKWTAPEA 286
Query: 253 LS-GNYPITHKCDVYSFGMVLFE 274
           L+ G Y  + + DV+SFG++L+E
Sbjct: 287 LNYGRY--SSESDVWSFGILLWE 307

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 86  LGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG+V    +       G  +AVK L  + G      +  E+  +   YH ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 141 YGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            G C DQ   +L  V EY+  GSL  YL   + +I   +L   A    +G+ YLH    Q
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---SQ 136
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFLSGNY 257
             IH ++   NVLLD +   K+ DFGLAK       +  +     +P +  APE L   Y
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK-EY 195
Query: 258 PITHKCDVYSFGMVLFEIV 276
              +  DV+SFG+ L+E++
Sbjct: 196 KFYYASDVWSFGVTLYELL 214

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 86  LGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG+V    +       G  +AVK L  + G      +  E+  +   YH ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 141 YGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            G C DQ   +L  V EY+  GSL  YL   + +I   +L   A    +G+ YLH    Q
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQ 136
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFLSGNY 257
             IH ++   NVLLD +   K+ DFGLAK       +  +     +P +  APE L   Y
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK-EY 195
Query: 258 PITHKCDVYSFGMVLFEIV 276
              +  DV+SFG+ L+E++
Sbjct: 196 KFYYASDVWSFGVTLYELL 214

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 29  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 85
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 86  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 145
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ +L     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 146 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV 202
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 203 KWMALESLQ-TQKFTTKSDVWSFGVLLWELMTR 234

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 85  RLGFGGFGEVYKGQFPNG-VKIAVKVL-------------NRNLGRIAEEQFMAEVGTIG 130
           +LG G +GEV   +  NG  + A+KV+             N+N+ +  EE +  E+  + 
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY-NEISLLK 101
Query: 131 RTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLV 190
              H N+++L+    D+    LV E+ E G L   +  + +  E +  + I      G+ 
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN-IMKQILSGIC 160
Query: 191 YLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
           YLH   +  I+H DIKPEN+LL+      + K+ DFGL+    ++     +    GT  Y
Sbjct: 161 YLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYY 214
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLF 273
            APE L   Y    KCDV+S G++++
Sbjct: 215 IAPEVLKKKY--NEKCDVWSCGVIMY 238

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 109/227 (48%), Gaps = 19/227 (8%)
Query: 62  IGREKPVRFTSLQLNNFTSNYSTR---LGFGGFGEV----YKGQFPN-GVKIAVKVLNRN 113
           +  +KP   T +   +F   +  R   LG G FG+V    Y  +  N G ++AVK L   
Sbjct: 4   VSEKKPA--TEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE 61
Query: 114 LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTALVYEYMENGSLDGYLFGKKR 171
            G         E+  +   YH N+V+  G C +   +   L+ E++ +GSL  YL   K 
Sbjct: 62  SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN 121
Query: 172 AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 231
            I  ++  + A+   KG+ YL     ++ +H D+   NVL+++    K+ DFGL K  + 
Sbjct: 122 KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178
Query: 232 NKTHVTISGYKGTPGY-SAPE-FLSGNYPITHKCDVYSFGMVLFEIV 276
           +K   T+   + +P +  APE  +   + I    DV+SFG+ L E++
Sbjct: 179 DKEXXTVKDDRDSPVFWYAPECLMQSKFYIAS--DVWSFGVTLHELL 223

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 89/196 (45%), Gaps = 16/196 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG--VEHQLRREVEIQSHLRHPNILRL 77
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L    R  E ++        A  L Y H    +R+
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE-QRTATYITELANALSYCH---SKRV 133
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +N   K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC----GTLDYLPPEMIEGRMH-D 188
Query: 261 HKCDVYSFGMVLFEIV 276
            K D++S G++ +E +
Sbjct: 189 EKVDLWSLGVLCYEFL 204

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 86  LGFGGFGEVYKGQF---PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G FG V +G +      + +A+KVL +   +   E+ M E   + +  +  +VRL G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
            C  + +  LV E    G L  +L GK+  I    + E+    + G+ YL E   +  +H
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 133
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI-SGYKGTPGYSAPEFLSGNYPITH 261
            D+   NVLL      K++DFGL+K    + ++ T  S  K    + APE ++     + 
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSS 192
Query: 262 KCDVYSFGMVLFEIV 276
           + DV+S+G+ ++E +
Sbjct: 193 RSDVWSYGVTMWEAL 207

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 74
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 130
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +  C    +  T     GT  Y  PE + G     
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTT--LSGTLDYLPPEMIEGRMH-D 185
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 186 EKVDLWSLGVLCYEFLVGK 204

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 26  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 82
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 83  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 142
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ +L     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 143 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 199
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 200 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 231

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG--VEHQLRREVEIQSHLRHPNILRL 77
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L    R  E ++        A  L Y H    +R+
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE-QRTATYITELANALSYCH---SKRV 133
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +N   K+ADFG +     ++     +   GT  Y  PE + G     
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMH-D 188
Query: 261 HKCDVYSFGMVLFEIV 276
            K D++S G++ +E +
Sbjct: 189 EKVDLWSLGVLCYEFL 204

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 193
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNKTHVTISGYKGTP-GYSA 249
           E      IH DI   N LL      +VA   DFG+A+   R  ++    G    P  +  
Sbjct: 159 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 214
Query: 250 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 215 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 257
Query: 309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +   G  +  K     +  +   C Q  PEDRP  + +++ +E
Sbjct: 258 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 28  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 84
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ +L     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 145 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 202 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 87  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 143
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ +L     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 204 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 261 KWMALESLQ-TQKFTTKSDVWSFGVLLWELMTR 292

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 193
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNKTHVTISGYKGTP-GYSA 249
           E      IH DI   N LL      +VA   DFG+A+   R  ++    G    P  +  
Sbjct: 185 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 240
Query: 250 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 241 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 283
Query: 309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +   G  +  K     +  +   C Q  PEDRP  + +++ +E
Sbjct: 284 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 327

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 29  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 85
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 86  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 145
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ +L     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 146 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 202
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 203 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 234

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 33  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 89
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 90  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 149
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ +L     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 150 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 206
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 207 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 238

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 86  LGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG+V    +       G  +AVK L  + G      +  E+  +   YH ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 141 YGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            G C D    +L  V EY+  GSL  YL   + +I   +L   A    +G+ YLH    Q
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFLSGNY 257
             IH D+   NVLLD +   K+ DFGLAK          +     +P +  APE L   Y
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLK-EY 212
Query: 258 PITHKCDVYSFGMVLFEIV 276
              +  DV+SFG+ L+E++
Sbjct: 213 KFYYASDVWSFGVTLYELL 231

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 76  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 129
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 28  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 84
Query: 130 GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHV-TISGYKGTP 245
           G+ +L     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 145 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 202 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 233

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 89  GGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF----C 144
           G FG V+K Q  N   +AVK+    L      Q   E+ +     H NL++         
Sbjct: 26  GRFGCVWKAQLMNDF-VAVKIFP--LQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGS 82
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-------- 196
           + +    L+  + + GSL  YL G    I W +L  +A   ++GL YLHE+         
Sbjct: 83  NLEVELWLITAFHDKGSLTDYLKGN--IITWNELCHVAETMSRGLSYLHEDVPWCRGEGH 140
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
           +  I H D K +NVLL ++ +  +ADFGLA   +  K      G  GT  Y APE L G 
Sbjct: 141 KPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGA 200
Query: 257 YPITH----KCDVYSFGMVLFEIVGRRRNA 282
                    + D+Y+ G+VL+E+V R + A
Sbjct: 201 INFQRDAFLRIDMYAMGLVLWELVSRCKAA 230

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 193
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNKTHVTISGYKGTP-GYSA 249
           E      IH DI   N LL      +VA   DFG+A+   R  ++    G    P  +  
Sbjct: 159 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 214
Query: 250 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 215 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 257
Query: 309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +   G  +  K     +  +   C Q  PEDRP  + +++ +E
Sbjct: 258 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 86  LGFGGFGEV----YKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG+V    Y  +  N G ++AVK L    G         E+  +   YH N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 141 YGFCHDQ--HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            G C +   +   L+ E++ +GSL  YL   K  I  ++  + A+   KG+ YL     +
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPE-FLSGN 256
           + +H D+   NVL+++    K+ DFGL K  + +K   T+   + +P +  APE  +   
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 193
Query: 257 YPITHKCDVYSFGMVLFEIV 276
           + I    DV+SFG+ L E++
Sbjct: 194 FYIAS--DVWSFGVTLHELL 211

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 193
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNKTHVTISGYKGTP-GYSA 249
           E      IH DI   N LL      +VA   DFG+A+   R  ++    G    P  +  
Sbjct: 175 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 230
Query: 250 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 231 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 273
Query: 309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +   G  +  K     +  +   C Q  PEDRP  + +++ +E
Sbjct: 274 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 317

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 81  NYSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI 135
            Y ++LG G FG V   ++       G  +AVK L  + G   +  F  E+  +   +  
Sbjct: 13  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSD 71
Query: 136 NLVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
            +V+  G  +   +    LV EY+ +G L  +L   +  ++  +L   +    KG+ YL 
Sbjct: 72  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 131
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEF 252
               +R +H D+   N+L+++    K+ADFGLAKL   +K +  +     +P +  APE 
Sbjct: 132 S---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 188
Query: 253 LSGNYPITHKCDVYSFGMVLFEI 275
           LS N   + + DV+SFG+VL+E+
Sbjct: 189 LSDNI-FSRQSDVWSFGVVLYEL 210

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 193
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNKTHVTISGYKGTP-GYSA 249
           E      IH DI   N LL      +VA   DFG+A+   R  ++    G    P  +  
Sbjct: 165 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 220
Query: 250 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 221 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 263
Query: 309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +   G  +  K     +  +   C Q  PEDRP  + +++ +E
Sbjct: 264 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 307

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 193
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNKTHVTISGYKGTP-GYSA 249
           E      IH DI   N LL      +VA   DFG+A+   R  ++    G    P  +  
Sbjct: 173 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 228
Query: 250 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 229 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 271
Query: 309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +   G  +  K     +  +   C Q  PEDRP  + +++ +E
Sbjct: 272 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 63  GREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRI 117
           G + P  F    L      Y ++LG G FG V   ++       G  +AVK L  + G  
Sbjct: 1   GPQDPTIFEERHLK-----YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPD 54
Query: 118 AEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEW 175
            +  F  E+  +   +   +V+  G  +   +    LV EY+ +G L  +L   +  ++ 
Sbjct: 55  QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA 114
Query: 176 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH 235
            +L   +    KG+ YL     +R +H D+   N+L+++    K+ADFGLAKL   +K +
Sbjct: 115 SRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 171
Query: 236 VTISGYKGTPGY-SAPEFLSGNYPITHKCDVYSFGMVLFEI 275
             +     +P +  APE LS N   + + DV+SFG+VL+E+
Sbjct: 172 YVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYEL 211

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 81  NYSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI 135
            Y ++LG G FG V   ++       G  +AVK L  + G   +  F  E+  +   +  
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSD 84
Query: 136 NLVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
            +V+  G  +   +    LV EY+ +G L  +L   +  ++  +L   +    KG+ YL 
Sbjct: 85  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEF 252
               +R +H D+   N+L+++    K+ADFGLAKL   +K +  +     +P +  APE 
Sbjct: 145 S---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 253 LSGNYPITHKCDVYSFGMVLFEI 275
           LS N   + + DV+SFG+VL+E+
Sbjct: 202 LSDNI-FSRQSDVWSFGVVLYEL 223

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 193
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNKTHVTISGYKGTP-GYSA 249
           E      IH DI   N LL      +VA   DFG+A+   R  ++    G    P  +  
Sbjct: 158 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 213
Query: 250 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 214 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 256
Query: 309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +   G  +  K     +  +   C Q  PEDRP  + +++ +E
Sbjct: 257 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 193
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNKTHVTISGYKGTP-GYSA 249
           E      IH DI   N LL      +VA   DFG+A+   R  ++    G    P  +  
Sbjct: 159 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYR-ASYYRKGGCAMLPVKWMP 214
Query: 250 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 215 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 257
Query: 309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +   G  +  K     +  +   C Q  PEDRP  + +++ +E
Sbjct: 258 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 78
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G +   L  K    + ++        A  L Y H    +R+
Sbjct: 79  YGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYITELANALSYCH---SKRV 134
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 189
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 190 EKVDLWSLGVLCYEFLVGK 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 78
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G +   L  K    + ++        A  L Y H    +R+
Sbjct: 79  YGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYITELANALSYCH---SKRV 134
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGTLDYLPPEMIEGRMH-D 189
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 190 EKVDLWSLGVLCYEFLVGK 208

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 14/194 (7%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           +LG G +GEV   +     V+ A+K++ + ++   +  + + EV  +    H N+++LY 
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           F  D+    LV E  + G L   +  + +  E +    I      G+ YLH   +  I+H
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA-AVIIKQVLSGVTYLH---KHNIVH 159
Query: 203 YDIKPENVLLDANFSP---KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KPEN+LL++       K+ DFGL+ + +  K    +    GT  Y APE L   Y  
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLRKKYD- 215
Query: 260 THKCDVYSFGMVLF 273
             KCDV+S G++LF
Sbjct: 216 -EKCDVWSIGVILF 228

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 193
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNKTHVTISGYKGTP-GYSA 249
           E      IH DI   N LL      +VA   DFG+A+   R  ++    G    P  +  
Sbjct: 173 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 228
Query: 250 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 229 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 271
Query: 309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +   G  +  K     +  +   C Q  PEDRP  + +++ +E
Sbjct: 272 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 193
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNKTHVTISGYKGTP-GYSA 249
           E      IH DI   N LL      +VA   DFG+A+   R  ++    G    P  +  
Sbjct: 158 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 213
Query: 250 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 214 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 256
Query: 309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +   G  +  K     +  +   C Q  PEDRP  + +++ +E
Sbjct: 257 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 193
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNKTHVTISGYKGTP-GYSA 249
           E      IH DI   N LL      +VA   DFG+A+   R  ++    G    P  +  
Sbjct: 150 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 205
Query: 250 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 206 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 248
Query: 309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +   G  +  K     +  +   C Q  PEDRP  + +++ +E
Sbjct: 249 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 292

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 90
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 91  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 146
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 147 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 201
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 202 EKVDLWSLGVLCYEFLVGK 220

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 193
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNKTHVTISGYKGTP-GYSA 249
           E      IH DI   N LL      +VA   DFG+A+   R  ++    G    P  +  
Sbjct: 173 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 228
Query: 250 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 229 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 271
Query: 309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +   G  +  K     +  +   C Q  PEDRP  + +++ +E
Sbjct: 272 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 99
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 100 YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 155
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 156 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRM-HD 210
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 211 EKVDLWSLGVLCYEFLVGK 229

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 76
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 132
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 187
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 188 EKVDLWSLGVLCYEFLVGK 206

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 74
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 130
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC----GTLDYLPPEMIEGRMH-D 185
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 186 EKVDLWSLGVLCYEFLVGK 204

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 73
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 129
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++     +   GT  Y  PE + G     
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEGRMH-D 184
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 76
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 132
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++     +   GT  Y  PE + G     
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEGRMH-D 187
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 188 EKVDLWSLGVLCYEFLVGK 206

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 78
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 134
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 189
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 190 EKVDLWSLGVLCYEFLVGK 208

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 73
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 129
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++     +   GT  Y  PE + G     
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMH-D 184
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 115/283 (40%), Gaps = 36/283 (12%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 193
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNKTHVTISGYKGTPGYSAP 250
           E      IH DI   N LL      +VA   DFG+A+   R   +           +  P
Sbjct: 199 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 251 E-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM 309
           E F+ G +  T K D +SFG++L+EI             SL + P   +      E+   
Sbjct: 256 EAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLEF 298
Query: 310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
           +   G  +  K     +  +   C Q  PEDRP  + +++ +E
Sbjct: 299 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 75
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 76  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 131
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 132 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMH-D 186
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 187 EKVDLWSLGVLCYEFLVGK 205

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 74
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 130
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++     +   GT  Y  PE + G     
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMH-D 185
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 186 EKVDLWSLGVLCYEFLVGK 204

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 13/203 (6%)
Query: 81  NYSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI 135
            Y ++LG G FG V   ++       G  +AVK L  + G   +  F  E+  +   +  
Sbjct: 10  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSD 68
Query: 136 NLVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
            +V+  G  +   +    LV EY+ +G L  +L   +  ++  +L   +    KG+ YL 
Sbjct: 69  FIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 128
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEF 252
               +R +H D+   N+L+++    K+ADFGLAKL   +K    +     +P +  APE 
Sbjct: 129 S---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPES 185
Query: 253 LSGNYPITHKCDVYSFGMVLFEI 275
           LS N   + + DV+SFG+VL+E+
Sbjct: 186 LSDNI-FSRQSDVWSFGVVLYEL 207

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 73
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 129
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++     +   GT  Y  PE + G     
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMH-D 184
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 115/283 (40%), Gaps = 36/283 (12%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 193
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNKTHVTISGYKGTPGYSAP 250
           E      IH DI   N LL      +VA   DFG+A+   R   +           +  P
Sbjct: 176 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 251 E-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM 309
           E F+ G +  T K D +SFG++L+EI             SL + P   +      E+   
Sbjct: 233 EAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLEF 275
Query: 310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
           +   G  +  K     +  +   C Q  PEDRP  + +++ +E
Sbjct: 276 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 76
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 132
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 187
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 188 EKVDLWSLGVLCYEFLVGK 206

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 73
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 129
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 184
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 78
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 134
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++     +   GT  Y  PE + G     
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMH-D 189
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 190 EKVDLWSLGVLCYEFLVGK 208

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 72
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 73  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 128
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 129 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 183
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 184 EKVDLWSLGVLCYEFLVGK 202

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 99
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 100 YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 155
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 156 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DDLCGTLDYLPPEMIEGRM-HD 210
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 211 EKVDLWSLGVLCYEFLVGK 229

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 86  LGFGGFGEVYKGQF---PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G FG V +G +      + +A+KVL +   +   E+ M E   + +  +  +VRL G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
            C  + +  LV E    G L  +L GK+  I    + E+    + G+ YL E   +  +H
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 459
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI-SGYKGTPGYSAPEFLSGNYPITH 261
            ++   NVLL      K++DFGL+K    + ++ T  S  K    + APE ++     + 
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSS 518
Query: 262 KCDVYSFGMVLFEIV 276
           + DV+S+G+ ++E +
Sbjct: 519 RSDVWSYGVTMWEAL 533

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 76
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 132
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMH-D 187
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 188 EKVDLWSLGVLCYEFLVGK 206

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIA--EEQFMAEVGTIGRTYHINLVRLYG 142
           LG G FG VY  +  N   I A+KVL +     A  E Q   EV       H N++RLYG
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           + HD     L+ EY   G++   L  K    + ++        A  L Y H    +++IH
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKKVIH 131
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            DIKPEN+LL +    K+ADFG +     ++     +   GT  Y  PE + G      K
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEGRMH-DEK 186
Query: 263 CDVYSFGMVLFE-IVGR 278
            D++S G++ +E +VG+
Sbjct: 187 VDLWSLGVLCYEFLVGK 203

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 125/285 (43%), Gaps = 40/285 (14%)
Query: 86  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 138
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 189
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG--TPGY 247
            YL+    ++ +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG     +
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLLPVRW 198
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG 307
            APE L      T   D++SFG+VL+EI         G +                 ++ 
Sbjct: 199 MAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---------------QVL 242
Query: 308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
             ++  G  ++     +R+  +   C Q +P+ RP    ++ +L+
Sbjct: 243 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 125/285 (43%), Gaps = 40/285 (14%)
Query: 86  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 138
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 80
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 189
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG--TPGY 247
            YL+    ++ +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG     +
Sbjct: 141 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLLPVRW 195
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG 307
            APE L      T   D++SFG+VL+EI         G +                 ++ 
Sbjct: 196 MAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---------------QVL 239
Query: 308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
             ++  G  ++     +R+  +   C Q +P+ RP    ++ +L+
Sbjct: 240 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 23/201 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHINLV 138
           ++G G +G VYK Q   G   A+K +     R+ +E        + E+  +    H N+V
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           +LY   H +    LV+E+++   L   L   +  +E        +    G+ Y H+   +
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---R 119
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSG 255
           R++H D+KP+N+L++     K+ADFGLA+   +  R  TH  ++ +     Y AP+ L G
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLW-----YRAPDVLMG 174
Query: 256 NYPITHKCDVYSFGMVLFEIV 276
           +   +   D++S G +  E+V
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMV 195

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 73
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 129
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++     +   GT  Y  PE + G     
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELCGTLDYLPPEMIEGRMH-D 184
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 77
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 133
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 134 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 188
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 189 EKVDLWSLGVLCYEFLVGK 207

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 73
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 129
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++     +   GT  Y  PE + G     
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLCGTLDYLPPEMIEGRMH-D 184
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 23/201 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHINLV 138
           ++G G +G VYK Q   G   A+K +     R+ +E        + E+  +    H N+V
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           +LY   H +    LV+E+++   L   L   +  +E        +    G+ Y H+   +
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---R 119
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSG 255
           R++H D+KP+N+L++     K+ADFGLA+   +  R  TH  ++ +     Y AP+ L G
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLW-----YRAPDVLMG 174
Query: 256 NYPITHKCDVYSFGMVLFEIV 276
           +   +   D++S G +  E+V
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMV 195

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 78
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 134
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEXIEGRXH-D 189
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 190 EKVDLWSLGVLCYEFLVGK 208

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 124/285 (43%), Gaps = 40/285 (14%)
Query: 86  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 138
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 189
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG--TPGY 247
            YL+    ++ +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG     +
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLLPVRW 198
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG 307
            APE L      T   D++SFG+VL+EI         G +                 ++ 
Sbjct: 199 MAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---------------QVL 242
Query: 308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
             ++  G  ++     +R+  +   C Q +P  RP    ++ +L+
Sbjct: 243 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 23/201 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHINLV 138
           ++G G +G VYK Q   G   A+K +     R+ +E        + E+  +    H N+V
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           +LY   H +    LV+E+++   L   L   +  +E        +    G+ Y H+   +
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---R 119
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSG 255
           R++H D+KP+N+L++     K+ADFGLA+   +  R  TH  ++ +     Y AP+ L G
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW-----YRAPDVLMG 174
Query: 256 NYPITHKCDVYSFGMVLFEIV 276
           +   +   D++S G +  E+V
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMV 195

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 73
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 129
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMH-D 184
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 84  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 139
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 140 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 197
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 198 THQSDVWSYGVTVWELM 214

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 78  FTSNYSTRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +T + +  LG G FG+V+K  +   G+K+A K++ +  G   +E+   E+  + +  H N
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKII-KTRGMKDKEEVKNEISVMNQLDHAN 147
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
           L++LY     ++   LV EY++ G L   +  +   +             +G+ ++H   
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH--- 204
Query: 197 QQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
           Q  I+H D+KPEN+L    DA    K+ DFGLA+   R K    +    GTP + APE +
Sbjct: 205 QMYILHLDLKPENILCVNRDAK-QIKIIDFGLAR---RYKPREKLKVNFGTPEFLAPEVV 260
Query: 254 SGNYPITHKCDVYSFGMVLFEIVG 277
           + ++ ++   D++S G++ + ++ 
Sbjct: 261 NYDF-VSFPTDMWSVGVIAYMLLS 283

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 93  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 148
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 149 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 206
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 207 THQSDVWSYGVTVWELM 223

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 84  LGICLTS-TVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 139
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 140 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 197
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 198 THQSDVWSYGVTVWELM 214

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 83  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 138
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 196
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 197 THQSDVWSYGVTVWELM 213

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 14/216 (6%)
Query: 85  RLGFGGFGEVYKGQFPNGVK--IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           R+G G FGEVYKG   N  K  +A+K+++        E    E+  + +     + R +G
Sbjct: 26  RIGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
                    ++ EY+  GS    L  K   +E   +  I     KGL YLH E   R IH
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE---RKIH 139
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            DIK  NVLL      K+ADFG+A +L D   T +  + + GTP + APE +  +     
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAPEVIKQS-AYDF 195
Query: 262 KCDVYSFGMVLFEIV-GRRRNAIVGATESLDWFPKH 296
           K D++S G+   E+  G   N+ +     L   PK+
Sbjct: 196 KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN 231

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 87  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 142
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 143 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 200
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 201 THQSDVWSYGVTVWELM 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 85  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 140
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 198
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 199 THQSDVWSYGVTVWELM 215

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 15/192 (7%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-FC 144
           +G G FG+V  G +  G K+AVK +  +      + F+AE   + +  H NLV+L G   
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAI-EWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++    +V EYM  GSL  YL  + R++   + L + ++   + + YL        +H 
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 132
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKC 263
           D+   NVL+  +   KV+DFGL K     +   T    K    ++APE L      + K 
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR-EAAFSTKS 186
Query: 264 DVYSFGMVLFEI 275
           DV+SFG++L+EI
Sbjct: 187 DVWSFGILLWEI 198

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 83  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 138
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 196
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 197 THQSDVWSYGVTVWELM 213

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 15/192 (7%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-FC 144
           +G G FG+V  G +  G K+AVK +  +      + F+AE   + +  H NLV+L G   
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAI-EWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++    +V EYM  GSL  YL  + R++   + L + ++   + + YL        +H 
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 126
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKC 263
           D+   NVL+  +   KV+DFGL K     +   T    K    ++APE L      + K 
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR-EKKFSTKS 180
Query: 264 DVYSFGMVLFEI 275
           DV+SFG++L+EI
Sbjct: 181 DVWSFGILLWEI 192

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 86  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 141
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 142 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 199
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 200 THQSDVWSYGVTVWELM 216

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 86  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 141
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 142 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 199
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 200 THQSDVWSYGVTVWELM 216

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 83  LGICLTS-TVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 138
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 196
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 197 THQSDVWSYGVTVWELM 213

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 83  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 138
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 196
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 197 THQSDVWSYGVTVWELM 213

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 70
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 71  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 126
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++     +   GT  Y  PE + G     
Sbjct: 127 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMH-D 181
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 182 EKVDLWSLGVLCYEFLVGK 200

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 85  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 140
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 198
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 199 THQSDVWSYGVTVWELM 215

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 77  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 132
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 190
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 191 THQSDVWSYGVTVWELM 207

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF- 143
           ++G G +GEV+ G++  G K+AVKV         EE        I +T  +    + GF 
Sbjct: 44  QIGKGRYGEVWMGKW-RGEKVAVKVFF-----TTEEASWFRETEIYQTVLMRHENILGFI 97
Query: 144 CHDQHMTA------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC- 196
             D   T       L+ +Y ENGSL  YL  K   ++ + + ++A  +  GL +LH E  
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 197 ----QQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYSAP 250
               +  I H D+K +N+L+  N +  +AD GLA   + D N+  +  +   GT  Y  P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 251 EFLSGNYPITH-----KCDVYSFGMVLFEIVGR 278
           E L  +    H       D+YSFG++L+E+  R
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 31/217 (14%)
Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG GGFG V++ +   +    A+K +      +A E+ M EV  + +  H  +VR +   
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 145 HDQHMT-------ALVYEYME-----NGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGL 189
            +++ T         VY Y++       +L  ++ G+    E E+   LH I +  A+ +
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH-IFLQIAEAV 131
Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI----------S 239
            +LH    + ++H D+KP N+    +   KV DFGL    D+++   T+          +
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
           G  GT  Y +PE + GN   +HK D++S G++LFE++
Sbjct: 189 GQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELL 224

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 76
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 132
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G     
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DDLCGTLDYLPPEMIEGRMH-D 187
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 188 EKVDLWSLGVLCYEFLVGK 206

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 86  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 141
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 142 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 199
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 200 THQSDVWSYGVTVWELM 216

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-FC 144
           LG G FG+VYK +      +A   +         E ++ E+  +    H  +V+L G + 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
           HD  +  ++ E+   G++D  +    R +   ++  +     + L +LH    +RIIH D
Sbjct: 87  HDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRD 142
Query: 205 IKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL----SGNYPIT 260
           +K  NVL+      ++ADFG++      KT      + GTP + APE +      + P  
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 200
Query: 261 HKCDVYSFGMVLFEI 275
           +K D++S G+ L E+
Sbjct: 201 YKADIWSLGITLIEM 215

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 15/192 (7%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-FC 144
           +G G FG+V  G +  G K+AVK +  +      + F+AE   + +  H NLV+L G   
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAI-EWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++    +V EYM  GSL  YL  + R++   + L + ++   + + YL        +H 
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 141
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKC 263
           D+   NVL+  +   KV+DFGL K     +   T    K    ++APE L      + K 
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR-EKKFSTKS 195
Query: 264 DVYSFGMVLFEI 275
           DV+SFG++L+EI
Sbjct: 196 DVWSFGILLWEI 207

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 15/192 (7%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-FC 144
           +G G FG+V  G +  G K+AVK +  +      + F+AE   + +  H NLV+L G   
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAI-EWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++    +V EYM  GSL  YL  + R++   + L + ++   + + YL        +H 
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 313
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKC 263
           D+   NVL+  +   KV+DFGL K     +   T    K    ++APE L      + K 
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR-EKKFSTKS 367
Query: 264 DVYSFGMVLFEI 275
           DV+SFG++L+EI
Sbjct: 368 DVWSFGILLWEI 379

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 86  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 141
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 142 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 199
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 200 THQSDVWSYGVTVWELM 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 90  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 145
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 146 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 203
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 204 THQSDVWSYGVTVWELM 220

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 75
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 76  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 131
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+A+FG +     ++         GT  Y  PE + G     
Sbjct: 132 IHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 186
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 187 EKVDLWSLGVLCYEFLVGK 205

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 89  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 144
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 145 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 202
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 203 THQSDVWSYGVTVWELM 219

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 25/201 (12%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-------GRIAEEQFMAEVGTIGRTYHINL 137
           LG G FG V+  +   NG   A+KVL + +           +E+ M  + T     H  +
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-----HPFI 68
Query: 138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE-WEKLHEIAIGTAKGLVYLHEEC 196
           +R++G   D     ++ +Y+E G L   L   +R      K +   +  A  L YLH   
Sbjct: 69  IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA--LEYLH--- 123
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
            + II+ D+KPEN+LLD N   K+ DFG AK        +      GTP Y APE +S  
Sbjct: 124 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDYIAPEVVSTK 178
Query: 257 YPITHKCDVYSFGMVLFEIVG 277
            P     D +SFG++++E++ 
Sbjct: 179 -PYNKSIDWWSFGILIYEMLA 198

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-FC 144
           LG G FG+VYK +      +A   +         E ++ E+  +    H  +V+L G + 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
           HD  +  ++ E+   G++D  +    R +   ++  +     + L +LH    +RIIH D
Sbjct: 79  HDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRD 134
Query: 205 IKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL----SGNYPIT 260
           +K  NVL+      ++ADFG++      KT      + GTP + APE +      + P  
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 192
Query: 261 HKCDVYSFGMVLFEI 275
           +K D++S G+ L E+
Sbjct: 193 YKADIWSLGITLIEM 207

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAV-KVLNRNLGRIAEEQFM-AEVGTIGRTYHINLVRLYGF 143
           +G G +G   K +  +  KI V K L+      AE+Q + +EV  +    H N+VR Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 144 CHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-- 199
             D+  T L  V EY E G L   +    +  ++    E  +     L    +EC +R  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD-EEFVLRVMTQLTLALKECHRRSD 132
Query: 200 ----IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
               ++H D+KP NV LD   + K+ DFGLA++ + + +      + GTP Y +PE ++ 
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYMSPEQMN- 189
Query: 256 NYPITHKCDVYSFGMVLFEIVG 277
                 K D++S G +L+E+  
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCA 211

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 10/196 (5%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 108 LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 163
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E +      T
Sbjct: 164 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 222
Query: 261 HKCDVYSFGMVLFEIV 276
           H+ DV+S+G+ ++E++
Sbjct: 223 HQSDVWSYGVTVWELM 238

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 125/285 (43%), Gaps = 40/285 (14%)
Query: 86  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 138
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 189
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG--TPGY 247
            YL+    ++ +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG     +
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 198
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG 307
            APE L      T   D++SFG+VL+EI         G +                 ++ 
Sbjct: 199 MAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---------------QVL 242
Query: 308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
             ++  G  ++     +R+  +   C Q +P+ RP    ++ +L+
Sbjct: 243 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 108/246 (43%), Gaps = 30/246 (12%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYG 142
           LGFGG  EV+  +   +   +AVKVL  +L R      +F  E        H  +V +Y 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 143 FCHDQH----MTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLH 193
               +     +  +V EY++  +L   +        KRAIE      +     + L + H
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNFSH 133
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEF 252
              Q  IIH D+KP N+++ A  + KV DFG+A+ + D   +    +   GT  Y +PE 
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 253 LSGNYPITHKCDVYSFGMVLFEIV-------GRRRNAIVGATESLDWFPKHVWEEYEKCE 305
             G+  +  + DVYS G VL+E++       G   +++       D  P     E    +
Sbjct: 191 ARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARHEGLSAD 249
Query: 306 LGAMIL 311
           L A++L
Sbjct: 250 LDAVVL 255

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 125/285 (43%), Gaps = 40/285 (14%)
Query: 86  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 138
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 189
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG--TPGY 247
            YL+    ++ +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG     +
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETAYYRKGGKGLLPVRW 198
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG 307
            APE L      T   D++SFG+VL+EI         G +                 ++ 
Sbjct: 199 MAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---------------QVL 242
Query: 308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
             ++  G  ++     +R+  +   C Q +P+ RP    ++ +L+
Sbjct: 243 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 76
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 132
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH DIKPEN+LL +    K+A+FG +     ++         GT  Y  PE + G     
Sbjct: 133 IHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 187
Query: 261 HKCDVYSFGMVLFE-IVGR 278
            K D++S G++ +E +VG+
Sbjct: 188 EKVDLWSLGVLCYEFLVGK 206

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYG 142
           LGFGG  EV+  +   +   +AVKVL  +L R      +F  E        H  +V +Y 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 143 FCHDQH----MTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLH 193
               +     +  +V EY++  +L   +        KRAIE      +     + L + H
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNFSH 133
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEF 252
              Q  IIH D+KP N+L+ A  + KV DFG+A+ + D   +    +   GT  Y +PE 
Sbjct: 134 ---QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQ 190
Query: 253 LSGNYPITHKCDVYSFGMVLFEIV 276
             G+  +  + DVYS G VL+E++
Sbjct: 191 ARGDS-VDARSDVYSLGCVLYEVL 213

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 86  LGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG+V    +       G  +AVK L    G      +  E+  +   YH ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 141 YGFCHDQ--HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            G C DQ      LV EY+  GSL  YL   +  +   +L   A    +G+ YLH    Q
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQICEGMAYLH---AQ 130
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFLSGNY 257
             IH  +   NVLLD +   K+ DFGLAK       +  +     +P +  APE L    
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK-EC 189
Query: 258 PITHKCDVYSFGMVLFEIV 276
              +  DV+SFG+ L+E++
Sbjct: 190 KFYYASDVWSFGVTLYELL 208

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 82  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 76
Query: 137 LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 134
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFL 253
              +R IH D+   N+L++     K+ DFGL K+  ++K    +     +P +  APE L
Sbjct: 135 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 254 SGNYPITHKCDVYSFGMVLFEI 275
           + +   +   DV+SFG+VL+E+
Sbjct: 194 TES-KFSVASDVWSFGVVLYEL 214

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKV----LNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G K+ + V    L       A ++ + E   +    + ++ RL
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 117 LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 172
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 173 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 230
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 231 THQSDVWSYGVTVWELM 247

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 86  LGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG+V    +       G  +AVK L    G      +  E+  +   YH ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 141 YGFCHDQ--HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            G C DQ      LV EY+  GSL  YL   +  +   +L   A    +G+ YLH    Q
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQICEGMAYLH---AQ 131
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFLSGNY 257
             IH  +   NVLLD +   K+ DFGLAK       +  +     +P +  APE L    
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK-EC 190
Query: 258 PITHKCDVYSFGMVLFEIV 276
              +  DV+SFG+ L+E++
Sbjct: 191 KFYYASDVWSFGVTLYELL 209

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 82  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 71
Query: 137 LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 129
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFL 253
              +R IH D+   N+L++     K+ DFGL K+  ++K    +     +P +  APE L
Sbjct: 130 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 254 SGNYPITHKCDVYSFGMVLFEI 275
           + +   +   DV+SFG+VL+E+
Sbjct: 189 TES-KFSVASDVWSFGVVLYEL 209

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 82  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 70
Query: 137 LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 128
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFL 253
              +R IH D+   N+L++     K+ DFGL K+  ++K    +     +P +  APE L
Sbjct: 129 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 254 SGNYPITHKCDVYSFGMVLFEI 275
           + +   +   DV+SFG+VL+E+
Sbjct: 188 TES-KFSVASDVWSFGVVLYEL 208

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 82  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 75
Query: 137 LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 133
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFL 253
              +R IH D+   N+L++     K+ DFGL K+  ++K    +     +P +  APE L
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 254 SGNYPITHKCDVYSFGMVLFEI 275
           + +   +   DV+SFG+VL+E+
Sbjct: 193 TES-KFSVASDVWSFGVVLYEL 213

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAV-KVLNRNLGRIAEEQFM-AEVGTIGRTYHINLVRLYGF 143
           +G G +G   K +  +  KI V K L+      AE+Q + +EV  +    H N+VR Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 144 CHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-- 199
             D+  T L  V EY E G L   +    +  ++    E  +     L    +EC +R  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD-EEFVLRVMTQLTLALKECHRRSD 132
Query: 200 ----IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
               ++H D+KP NV LD   + K+ DFGLA++ + + +      + GTP Y +PE ++ 
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KTFVGTPYYMSPEQMN- 189
Query: 256 NYPITHKCDVYSFGMVLFEIVG 277
                 K D++S G +L+E+  
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCA 211

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 82  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 72
Query: 137 LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFL 253
              +R IH D+   N+L++     K+ DFGL K+  ++K    +     +P +  APE L
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 254 SGNYPITHKCDVYSFGMVLFEI 275
           + +   +   DV+SFG+VL+E+
Sbjct: 190 TES-KFSVASDVWSFGVVLYEL 210

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 63  GREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRI 117
           G   P +F    L      +  +LG G FG V   ++       G  +AVK L  +    
Sbjct: 1   GSRDPTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH 55
Query: 118 AEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEW 175
             + F  E+  +    H N+V+  G C+   +    L+ EY+  GSL  YL   K  I+ 
Sbjct: 56  LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 114
Query: 176 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH 235
            KL +      KG+ YL     +R IH ++   N+L++     K+ DFGL K+  ++K +
Sbjct: 115 IKLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEY 171
Query: 236 VTISGYKGTPGY-SAPEFLSGNYPITHKCDVYSFGMVLFEI 275
             +     +P +  APE L+ +   +   DV+SFG+VL+E+
Sbjct: 172 YKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYEL 211

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 82  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 78
Query: 137 LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 136
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFL 253
              +R IH D+   N+L++     K+ DFGL K+  ++K    +     +P +  APE L
Sbjct: 137 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 254 SGNYPITHKCDVYSFGMVLFEI 275
           + +   +   DV+SFG+VL+E+
Sbjct: 196 TES-KFSVASDVWSFGVVLYEL 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 82  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 72
Query: 137 LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFL 253
              +R IH D+   N+L++     K+ DFGL K+  ++K    +     +P +  APE L
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 254 SGNYPITHKCDVYSFGMVLFEI 275
           + +   +   DV+SFG+VL+E+
Sbjct: 190 TES-KFSVASDVWSFGVVLYEL 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 82  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 77
Query: 137 LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 135
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFL 253
              +R IH D+   N+L++     K+ DFGL K+  ++K    +     +P +  APE L
Sbjct: 136 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 254 SGNYPITHKCDVYSFGMVLFEI 275
           + +   +   DV+SFG+VL+E+
Sbjct: 195 TES-KFSVASDVWSFGVVLYEL 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 82  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 79
Query: 137 LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 137
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFL 253
              +R IH D+   N+L++     K+ DFGL K+  ++K    +     +P +  APE L
Sbjct: 138 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 254 SGNYPITHKCDVYSFGMVLFEI 275
           + +   +   DV+SFG+VL+E+
Sbjct: 197 TES-KFSVASDVWSFGVVLYEL 217

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYG 142
           LGFGG  EV+  +   +   +AVKVL  +L R      +F  E        H  +V +Y 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 143 FCHDQH----MTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLH 193
               +     +  +V EY++  +L   +        KRAIE      +     + L + H
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNFSH 133
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEF 252
              Q  IIH D+KP N+++ A  + KV DFG+A+ + D   +    +   GT  Y +PE 
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 253 LSGNYPITHKCDVYSFGMVLFEIV 276
             G+  +  + DVYS G VL+E++
Sbjct: 191 ARGDS-VDARSDVYSLGCVLYEVL 213

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 82  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 103
Query: 137 LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFL 253
              +R IH D+   N+L++     K+ DFGL K+  ++K    +     +P +  APE L
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 254 SGNYPITHKCDVYSFGMVLFEI 275
           + +   +   DV+SFG+VL+E+
Sbjct: 221 TES-KFSVASDVWSFGVVLYEL 241

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 83  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 15  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 74
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 187
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 75  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 134
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT--P 245
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG    
Sbjct: 135 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXRKGGKGLLPV 189
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 190 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 218

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 125/285 (43%), Gaps = 40/285 (14%)
Query: 86  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 138
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 82
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 189
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG--TPGY 247
            YL+    ++ +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG     +
Sbjct: 143 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 197
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG 307
            APE L      T   D++SFG+VL+EI         G +                 ++ 
Sbjct: 198 MAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---------------QVL 241
Query: 308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
             ++  G  ++     +R+  +   C Q +P+ RP    ++ +L+
Sbjct: 242 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 82  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 72
Query: 137 LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFL 253
              +R IH D+   N+L++     K+ DFGL K+  ++K    +     +P +  APE L
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 254 SGNYPITHKCDVYSFGMVLFEI 275
           + +   +   DV+SFG+VL+E+
Sbjct: 190 TES-KFSVASDVWSFGVVLYEL 210

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 82  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 90
Query: 137 LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 148
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFL 253
              +R IH D+   N+L++     K+ DFGL K+  ++K    +     +P +  APE L
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 254 SGNYPITHKCDVYSFGMVLFEI 275
           + +   +   DV+SFG+VL+E+
Sbjct: 208 TES-KFSVASDVWSFGVVLYEL 228

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIA--EEQFMAEVGTIGRTYHINLVRLYG 142
           LG G F  VY+ +    G+++A+K++++     A   ++   EV    +  H +++ LY 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           +  D +   LV E   NG ++ YL  + +     +          G++YLH      I+H
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILH 135
Query: 203 YDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+   N+LL  N + K+ADFGLA +L   ++ H T+    GTP Y +PE  + +    H
Sbjct: 136 RDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYISPEIATRS---AH 189
Query: 262 --KCDVYSFGMVLFE-IVGR 278
             + DV+S G + +  ++GR
Sbjct: 190 GLESDVWSLGCMFYTLLIGR 209

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  A+G+ YL +   +R+
Sbjct: 80  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLED---RRL 135
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 136 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 193
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 194 THQSDVWSYGVTVWELM 210

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 82  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 90
Query: 137 LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 148
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFL 253
              +R IH D+   N+L++     K+ DFGL K+  ++K    +     +P +  APE L
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 254 SGNYPITHKCDVYSFGMVLFEI 275
           + +   +   DV+SFG+VL+E+
Sbjct: 208 TES-KFSVASDVWSFGVVLYEL 228

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 83  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 24  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 83
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 187
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 84  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT--P 245
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG    
Sbjct: 144 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXRKGGKGLLPV 198
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 199 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 227

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 133/314 (42%), Gaps = 53/314 (16%)
Query: 67  PVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKI--AVKVLNRNLGRIAEEQFM 123
           P  +  L  N+    +   +G G FG+V K +   +G+++  A+K +     +     F 
Sbjct: 6   PTIYPVLDWNDI--KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 63
Query: 124 AEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
            E+  + +  +H N++ L G C  +    L  EY  +G+L  +L  K R +E +    IA
Sbjct: 64  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIA 122
Query: 183 IGTA----------------KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 226
             TA                +G+ YL    Q++ IH D+   N+L+  N+  K+ADFGL+
Sbjct: 123 NSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS 179
Query: 227 KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI-THKCDVYSFGMVLFEIVGRRRNAIVG 285
           +        V +    G          S NY + T   DV+S+G++L+EIV        G
Sbjct: 180 R-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 234
Query: 286 ATESLDWFPKHVWEEYEKCELGAMI---LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRP 342
            T +         E YEK   G  +   L C  E  D  +          C ++ P +RP
Sbjct: 235 MTCA---------ELYEKLPQGYRLEKPLNCDDEVYDLMRQ---------CWREKPYERP 276
Query: 343 PMSAVIKMLEGVVE 356
             + ++  L  ++E
Sbjct: 277 SFAQILVSLNRMLE 290

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAV-KVLNRNLGRIAEEQFM-AEVGTIGRTYHINLVRLYGF 143
           +G G +G   K +  +  KI V K L+      AE+Q + +EV  +    H N+VR Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 144 CHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-- 199
             D+  T L  V EY E G L   +    +  ++    E  +     L    +EC +R  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD-EEFVLRVMTQLTLALKECHRRSD 132
Query: 200 ----IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
               ++H D+KP NV LD   + K+ DFGLA++ + ++       + GTP Y +PE ++ 
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA--KEFVGTPYYMSPEQMN- 189
Query: 256 NYPITHKCDVYSFGMVLFEIVG 277
                 K D++S G +L+E+  
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCA 211

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 117/269 (43%), Gaps = 38/269 (14%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FG+V K              +AVK+L  N         ++E   + +  H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYL-----------------------FGKKRAIEWE 176
           LYG C       L+ EY + GSL G+L                          +RA+   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
            L   A   ++G+ YL E    +++H D+   N+L+      K++DFGL++      ++V
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG-ATESLDWFPK 295
             S  +    + A E L  ++  T + DV+SFG++L+EIV    N   G   E L    K
Sbjct: 208 KRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266
Query: 296 --HVWEEYEKC--ELGAMILGCGIEEKDK 320
             H  E  + C  E+  ++L C  +E DK
Sbjct: 267 TGHRMERPDNCSEEMYRLMLQCWKQEPDK 295

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 87  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 142
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFG AKL    +      G K    + A E  L   Y  
Sbjct: 143 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 200
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 201 THQSDVWSYGVTVWELM 217

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           L  G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 83  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 138
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 196
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 197 THQSDVWSYGVTVWELM 213

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 136/336 (40%), Gaps = 58/336 (17%)
Query: 54  TMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN------GVKIAV 107
            M+ F+Q I R   V                 LG G FG+V+  +  N       + +AV
Sbjct: 2   AMDTFVQHIKRHNIV-------------LKRELGEGAFGKVFLAECYNLCPEQDKILVAV 48
Query: 108 KVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL- 166
           K L ++    A + F  E   +    H ++V+ YG C +     +V+EYM++G L+ +L 
Sbjct: 49  KTL-KDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLR 107
Query: 167 -FGKKRAIEWE----------KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN 215
             G    +  E          ++  IA   A G+VYL     Q  +H D+   N L+  N
Sbjct: 108 AHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGEN 164
Query: 216 FSPKVADFGLAKLCDRNKT-HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 274
              K+ DFG+++  D   T +  + G+   P    P         T + DV+S G+VL+E
Sbjct: 165 LLVKIGDFGMSR--DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 222
Query: 275 IVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCV 334
           I                 + K  W +    E+   I    + ++ +   + +  + L C 
Sbjct: 223 IFT---------------YGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCW 267
Query: 335 QDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYLDLI 370
           Q  P  R  +  +  +L+ + +  P      YLD++
Sbjct: 268 QREPHMRKNIKGIHTLLQNLAKASPV-----YLDIL 298

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           L  G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 90  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 145
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 146 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 203
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 204 THQSDVWSYGVTVWELM 220

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 104/225 (46%), Gaps = 35/225 (15%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           +G G +GEV++G + +G  +AVK+ +       +EQ       I  T  +    + GF  
Sbjct: 16  VGKGRYGEVWRGLW-HGESVAVKIFSSR-----DEQSWFRETEIYNTVLLRHDNILGFIA 69
Query: 146 DQHMTA--------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC- 196
              MT+        L+  Y E+GSL  Y F +++ +E      +A+  A GL +LH E  
Sbjct: 70  SD-MTSRNSSTQLWLITHYHEHGSL--YDFLQRQTLEPHLALRLAVSAACGLAHLHVEIF 126
Query: 197 ----QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK--GTPGYSAP 250
               +  I H D K  NVL+ +N    +AD GLA +  +   ++ I      GT  Y AP
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 251 EFLSGNYPITHKC-------DVYSFGMVLFEIVGRRRNAIVGATE 288
           E L     I   C       D+++FG+VL+EI   RR  + G  E
Sbjct: 187 EVLDEQ--IRTDCFESYKWTDIWAFGLVLWEIA--RRTIVNGIVE 227

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 19/222 (8%)
Query: 60  QEIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLG 115
           Q++GR     F       F+ NY  +  LG G F  V +      G++ A K++N + L 
Sbjct: 11  QQMGRGS--EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS 68
Query: 116 RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEW 175
               ++   E     +  H N+VRL+    ++    LV++ +  G L   +  ++   E 
Sbjct: 69  ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA 128
Query: 176 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLA-KLCDR 231
           +  H I     + + Y H      I+H ++KPEN+LL +     + K+ADFGLA ++ D 
Sbjct: 129 DASHCIQ-QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
              H    G+ GTPGY +PE L  + P +   D+++ G++L+
Sbjct: 185 EAWH----GFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILY 221

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 76  NNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGR 131
             F+ NY  +  LG G F  V +      G++ A K++N + L     ++   E     +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 132 TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY 191
             H N+VRL+    ++    LV++ +  G L   +  ++   E +  H I     + + Y
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIAY 120
Query: 192 LHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLA-KLCDRNKTHVTISGYKGTPGY 247
            H      I+H ++KPEN+LL +     + K+ADFGLA ++ D    H    G+ GTPGY
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----GFAGTPGY 173
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLF 273
            +PE L  + P +   D+++ G++L+
Sbjct: 174 LSPEVLKKD-PYSKPVDIWACGVILY 198

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 133/314 (42%), Gaps = 53/314 (16%)
Query: 67  PVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKI--AVKVLNRNLGRIAEEQFM 123
           P  +  L  N+    +   +G G FG+V K +   +G+++  A+K +     +     F 
Sbjct: 16  PTIYPVLDWNDI--KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 73
Query: 124 AEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
            E+  + +  +H N++ L G C  +    L  EY  +G+L  +L  K R +E +    IA
Sbjct: 74  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIA 132
Query: 183 IGTA----------------KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 226
             TA                +G+ YL    Q++ IH D+   N+L+  N+  K+ADFGL+
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS 189
Query: 227 KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI-THKCDVYSFGMVLFEIVGRRRNAIVG 285
           +        V +    G          S NY + T   DV+S+G++L+EIV        G
Sbjct: 190 R-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244
Query: 286 ATESLDWFPKHVWEEYEKCELGAMI---LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRP 342
            T +         E YEK   G  +   L C  E  D  +          C ++ P +RP
Sbjct: 245 MTCA---------ELYEKLPQGYRLEKPLNCDDEVYDLMRQ---------CWREKPYERP 286
Query: 343 PMSAVIKMLEGVVE 356
             + ++  L  ++E
Sbjct: 287 SFAQILVSLNRMLE 300

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 76  NNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGR 131
             F+ NY  +  LG G F  V +      G++ A K++N + L     ++   E     +
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 60
Query: 132 TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY 191
             H N+VRL+    ++    LV++ +  G L   +  ++   E +  H I     + + Y
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIAY 119
Query: 192 LHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLA-KLCDRNKTHVTISGYKGTPGY 247
            H      I+H ++KPEN+LL +     + K+ADFGLA ++ D    H    G+ GTPGY
Sbjct: 120 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----GFAGTPGY 172
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLF 273
            +PE L  + P +   D+++ G++L+
Sbjct: 173 LSPEVLKKD-PYSKPVDIWACGVILY 197

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           L  G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 90  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 145
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E  L   Y  
Sbjct: 146 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 203
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 204 THQSDVWSYGVTVWELM 220

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 85  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 140
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H D+   NVL+      K+ DFG AKL    +      G K    + A E +      T
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 199
Query: 261 HKCDVYSFGMVLFEIV 276
           H+ DV+S+G+ ++E++
Sbjct: 200 HQSDVWSYGVTVWELM 215

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 39/210 (18%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVL-------NRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +LG GG   VY  +     +K+A+K +          L R     F  EV    +  H N
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-----FEREVHNSSQLSHQN 72
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA--------KG 188
           +V +     +     LV EY+E  +L  Y+         E    +++ TA         G
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---------ESHGPLSVDTAINFTNQILDG 123
Query: 189 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK-GTPGY 247
           + + H+    RI+H DIKP+N+L+D+N + K+ DFG+AK    ++T +T + +  GT  Y
Sbjct: 124 IKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQY 178
Query: 248 SAPEFLSGNYPITHKC-DVYSFGMVLFEIV 276
            +PE   G    T +C D+YS G+VL+E++
Sbjct: 179 FSPEQAKGEA--TDECTDIYSIGIVLYEML 206

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 23/199 (11%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 141
           +LG G +GEV   +    G + A+K++ ++           + EV  + +  H N+++LY
Sbjct: 11  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
            F  D+    LV E    G L   +  +++  E +    I      G  YLH   +  I+
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDA-AVIMKQVLSGTTYLH---KHNIV 126
Query: 202 HYDIKPENVLLDANFSP---KVADFGLAKLCDRNKTHVTISGYK----GTPGYSAPEFLS 254
           H D+KPEN+LL++       K+ DFGL+        H  + G      GT  Y APE L 
Sbjct: 127 HRDLKPENLLLESKSRDALIKIVDFGLS-------AHFEVGGKMKERLGTAYYIAPEVLR 179
Query: 255 GNYPITHKCDVYSFGMVLF 273
             Y    KCDV+S G++L+
Sbjct: 180 KKYD--EKCDVWSCGVILY 196

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 85  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 140
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFG AKL    +      G K    + A E  L   Y  
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 198
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 199 THQSDVWSYGVTVWELM 215

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 85  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 140
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFG AKL    +      G K    + A E  L   Y  
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 198
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 199 THQSDVWSYGVTVWELM 215

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 83  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 138
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFG AKL    +      G K    + A E  L   Y  
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 196
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 197 THQSDVWSYGVTVWELM 213

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 17/204 (8%)
Query: 78  FTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTY 133
           F+ NY  +  LG G F  V +      G++ A K++N + L     ++   E     +  
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H N+VRL+    ++    LV++ +  G L   +  ++   E +  H I     + + Y H
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIAYCH 122
Query: 194 EECQQRIIHYDIKPENVLLDANF---SPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSA 249
                 I+H ++KPEN+LL +     + K+ADFGLA ++ D    H    G+ GTPGY +
Sbjct: 123 ---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----GFAGTPGYLS 175
Query: 250 PEFLSGNYPITHKCDVYSFGMVLF 273
           PE L  + P +   D+++ G++L+
Sbjct: 176 PEVLKKD-PYSKPVDIWACGVILY 198

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 86  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 75  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DI   NVL+ +N   K+ DFGL++  + + T+   S  K    + APE ++     T 
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 188
Query: 262 KCDVYSFGMVLFEIV--------GRRRNAIVGATESLDWFP 294
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 229

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           RLG GGFG V +    + G ++A+K   + L     E++  E+  + +  H N+V     
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 144 CHDQHMTA------LVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
                  A      L  EY E G L  YL  F     ++   +  +    +  L YLHE 
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 196 CQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF 252
              RIIH D+KPEN++L         K+ D G AK  D+ +     + + GT  Y APE 
Sbjct: 142 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPEL 195
Query: 253 L-SGNYPITHKCDVYSFGMVLFEIV 276
           L    Y +T   D +SFG + FE +
Sbjct: 196 LEQKKYTVT--VDYWSFGTLAFECI 218

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 86  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DI   NVL+ +N   K+ DFGL++  + + T+   S  K    + APE ++     T 
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 191
Query: 262 KCDVYSFGMVLFEIV--------GRRRNAIVGATESLDWFP 294
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 232

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 86  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 80  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 135
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DI   NVL+ +N   K+ DFGL++  + + T+   S  K    + APE ++     T 
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 193
Query: 262 KCDVYSFGMVLFEIV--------GRRRNAIVGATESLDWFP 294
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 194 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 234

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           RLG GGFG V +    + G ++A+K   + L     E++  E+  + +  H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 144 CHDQHMTA------LVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
                  A      L  EY E G L  YL  F     ++   +  +    +  L YLHE 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139
Query: 196 CQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF 252
              RIIH D+KPEN++L         K+ D G AK  D+ +     + + GT  Y APE 
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPEL 194
Query: 253 L-SGNYPITHKCDVYSFGMVLFEIV 276
           L    Y +T   D +SFG + FE +
Sbjct: 195 LEQKKYTVT--VDYWSFGTLAFECI 217

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 82  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 75
Query: 137 LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           +V+  G C+   +    L+ EY+  GSL  YL      I+  KL +      KG+ YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL-- 133
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFL 253
              +R IH D+   N+L++     K+ DFGL K+  ++K    +     +P +  APE L
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 254 SGNYPITHKCDVYSFGMVLFEI 275
           + +   +   DV+SFG+VL+E+
Sbjct: 193 TES-KFSVASDVWSFGVVLYEL 213

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 90  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 145
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPI 259
           +H D+   NVL+      K+ DFG AKL    +      G K    + A E  L   Y  
Sbjct: 146 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-- 203
Query: 260 THKCDVYSFGMVLFEIV 276
           TH+ DV+S+G+ ++E++
Sbjct: 204 THQSDVWSYGVTVWELM 220

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 86  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DI   NVL+ +N   K+ DFGL++  + + T+   S  K    + APE ++     T 
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 191
Query: 262 KCDVYSFGMVLFEIV--------GRRRNAIVGATESLDWFP 294
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 232

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 15  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 86  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 81  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 136
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DI   NVL+ +N   K+ DFGL++  + + T+   S  K    + APE ++     T 
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 194
Query: 262 KCDVYSFGMVLFEIV--------GRRRNAIVGATESLDWFP 294
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 195 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 235

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 25/200 (12%)
Query: 85  RLGFGGFGEVY--KGQFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRL 140
           +LG G +GEV   K +   G + A+K++ ++           + EV  + +  H N+++L
Sbjct: 28  KLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y F  D+    LV E    G L   +  +++  E +    I      G  YLH   +  I
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDA-AVIMKQVLSGTTYLH---KHNI 142
Query: 201 IHYDIKPENVLLDANFSP---KVADFGLAKLCDRNKTHVTISGYK----GTPGYSAPEFL 253
           +H D+KPEN+LL++       K+ DFGL+        H  + G      GT  Y APE L
Sbjct: 143 VHRDLKPENLLLESKSRDALIKIVDFGLS-------AHFEVGGKMKERLGTAYYIAPEVL 195
Query: 254 SGNYPITHKCDVYSFGMVLF 273
              Y    KCDV+S G++L+
Sbjct: 196 RKKY--DEKCDVWSCGVILY 213

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 116/269 (43%), Gaps = 38/269 (14%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FG+V K              +AVK+L  N         ++E   + +  H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYL-----------------------FGKKRAIEWE 176
           LYG C       L+ EY + GSL G+L                          +RA+   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
            L   A   ++G+ YL E    +++H D+   N+L+      K++DFGL++      + V
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG-ATESLDWFPK 295
             S  +    + A E L  ++  T + DV+SFG++L+EIV    N   G   E L    K
Sbjct: 208 KRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266
Query: 296 --HVWEEYEKC--ELGAMILGCGIEEKDK 320
             H  E  + C  E+  ++L C  +E DK
Sbjct: 267 TGHRMERPDNCSEEMYRLMLQCWKQEPDK 295

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 124/285 (43%), Gaps = 40/285 (14%)
Query: 86  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 138
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 189
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG--TPGY 247
            YL+    ++ +H ++   N ++  +F+ K+ DFG+ +  D  +T     G KG     +
Sbjct: 144 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 198
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG 307
            APE L      T   D++SFG+VL+EI         G +                 ++ 
Sbjct: 199 MAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---------------QVL 242
Query: 308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
             ++  G  ++     +R+  +   C Q +P  RP    ++ +L+
Sbjct: 243 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 86  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 83  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DI   NVL+ +N   K+ DFGL++  + + T+   S  K    + APE ++     T 
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 196
Query: 262 KCDVYSFGMVLFEIV--------GRRRNAIVGATESLDWFP 294
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 197 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 237

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 124/285 (43%), Gaps = 40/285 (14%)
Query: 86  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 138
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 84
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 189
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG--TPGY 247
            YL+    ++ +H ++   N ++  +F+ K+ DFG+ +  D  +T     G KG     +
Sbjct: 145 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 199
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG 307
            APE L      T   D++SFG+VL+EI         G +                 ++ 
Sbjct: 200 MAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---------------QVL 243
Query: 308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
             ++  G  ++     +R+  +   C Q +P  RP    ++ +L+
Sbjct: 244 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 86  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 106 GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 161
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DI   NVL+ +N   K+ DFGL++  + + T+   S  K    + APE ++     T 
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 219
Query: 262 KCDVYSFGMVLFEIV--------GRRRNAIVGATESLDWFP 294
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 220 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 260

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYG 142
           LGFGG  EV+  +       +AVKVL  +L R      +F  E        H  +V +Y 
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 143 FCHDQH----MTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLH 193
               +     +  +V EY++  +L   +        KRAIE      +     + L + H
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNFSH 133
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEF 252
              Q  IIH D+KP N+++ A  + KV DFG+A+ + D   +    +   GT  Y +PE 
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 253 LSGNYPITHKCDVYSFGMVLFEIV 276
             G+  +  + DVYS G VL+E++
Sbjct: 191 ARGDS-VDARSDVYSLGCVLYEVL 213

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 85  RLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N+V+
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 78
Query: 140 LYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
             G C+   +    L+ E++  GSL  YL   K  I+  KL +      KG+ YL     
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 135
Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-SAPEFLSGN 256
           +R IH D+   N+L++     K+ DFGL K+  ++K    +     +P +  APE L+ +
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 257 YPITHKCDVYSFGMVLFEI 275
              +   DV+SFG+VL+E+
Sbjct: 196 -KFSVASDVWSFGVVLYEL 213

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 26/263 (9%)
Query: 100 PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN 159
           P   K+A+K +N    + + ++ + E+  + + +H N+V  Y     +    LV + +  
Sbjct: 38  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97
Query: 160 GSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL 212
           GS+   +         K   ++   +  I     +GL YLH+  Q   IH D+K  N+LL
Sbjct: 98  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 154
Query: 213 DANFSPKVADFGLAKL------CDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVY 266
             + S ++ADFG++          RNK   T   + GTP + APE +        K D++
Sbjct: 155 GEDGSVQIADFGVSAFLATGGDITRNKVRKT---FVGTPCWMAPEVMEQVRGYDFKADIW 211
Query: 267 SFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRL 326
           SFG+   E+         GA     + P  V     + +  ++  G   +E  K+  K  
Sbjct: 212 SFGITAIELA-------TGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSF 264
Query: 327 CMVALWCVQDSPEDRPPMSAVIK 349
             +   C+Q  PE RP  + +++
Sbjct: 265 RKMISLCLQKDPEKRPTAAELLR 287

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 15  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 88/190 (46%), Gaps = 20/190 (10%)
Query: 101 NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI--------NLVRLYGFCHDQHMTAL 152
            G + AVK++     R++ EQ         R  HI        +++ L           L
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177
Query: 153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL 212
           V++ M  G L  YL  +K A+  ++   I     + + +LH      I+H D+KPEN+LL
Sbjct: 178 VFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILL 233
Query: 213 DANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH-----KCDVYS 267
           D N   +++DFG +   +  +    +    GTPGY APE L  +   TH     + D+++
Sbjct: 234 DDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWA 290
Query: 268 FGMVLFEIVG 277
            G++LF ++ 
Sbjct: 291 CGVILFTLLA 300

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 18/221 (8%)
Query: 82  YSTRLGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YH 134
           +   LG G FG+V +      G+    +K+AVK+L        +E  M+E+  +     H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
            N+V L G C       ++ EY   G L  +L  K R +E +    IA  TA     LH 
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 195 ECQ----------QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
             Q          +  IH D+   NVLL      K+ DFGLA+    +  ++     +  
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG 285
             + APE +  +   T + DV+S+G++L+EI     N   G
Sbjct: 230 VKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 83  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 20  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 79
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAI---------EWEKLHEIAIGTAK 187
           +VRL G       T ++ E M  G L  YL   + A+            K+ ++A   A 
Sbjct: 80  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 139
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT--P 245
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG    
Sbjct: 140 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 194
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 195 RWMSPESLKDGVFTTYS-DVWSFGVVLWEI 223

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 86  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 132
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 99
Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 177
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKN 215
Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 83  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAI---------EWEKLHEIAIGTAK 187
           +VRL G       T ++ E M  G L  YL   + A+            K+ ++A   A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG--TP 245
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG    
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 204
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 205 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 233

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 13/220 (5%)
Query: 61  EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE 119
           E+ +E+P     L++ +F  +    LG G FG+V+  +F    +  A+K L +++  + +
Sbjct: 2   ELNKERPSLQIKLKIEDFILH--KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD 59
Query: 120 --EQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE 176
             E  M E   +   + H  L  ++     +     V EY+  G L  Y        +  
Sbjct: 60  DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL-MYHIQSCHKFDLS 118
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
           +    A     GL +LH    + I++ D+K +N+LLD +   K+ADFG+ K  +      
Sbjct: 119 RATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDA 173
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
             + + GTP Y APE L G     H  D +SFG++L+E++
Sbjct: 174 KTNXFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEML 212

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 83  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 21  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 80
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 187
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 81  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 140
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT--P 245
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG    
Sbjct: 141 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 195
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 196 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 224

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 83  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 23  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 82
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 187
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 83  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT--P 245
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG    
Sbjct: 143 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 197
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 198 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 83  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 17  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 76
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 187
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 77  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT--P 245
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG    
Sbjct: 137 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 191
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 192 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 220

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 83  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 23  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 82
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 187
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 83  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT--P 245
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG    
Sbjct: 143 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 197
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 198 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 226

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 86  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DI   NVL+ +N   K+ DFGL++  + + T+   S  K    + APE ++     T 
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 571
Query: 262 KCDVYSFGMVLFEIV--------GRRRNAIVGATESLDWFP 294
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 612

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 83  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 187
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 149
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG--TP 245
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG    
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 204
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 205 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 233

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 86  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DI   NVL+ +N   K+ DFGL++  + + T    S  K    + APE ++     T 
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWMAPESINFRR-FTS 191
Query: 262 KCDVYSFGMVLFEIV--------GRRRNAIVGATESLDWFP 294
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 232

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 86  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 132
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 99
Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 177
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +       
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 26/263 (9%)
Query: 100 PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN 159
           P   K+A+K +N    + + ++ + E+  + + +H N+V  Y     +    LV + +  
Sbjct: 33  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 92
Query: 160 GSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL 212
           GS+   +         K   ++   +  I     +GL YLH+  Q   IH D+K  N+LL
Sbjct: 93  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 149
Query: 213 DANFSPKVADFGLAKL------CDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVY 266
             + S ++ADFG++          RNK   T   + GTP + APE +        K D++
Sbjct: 150 GEDGSVQIADFGVSAFLATGGDITRNKVRKT---FVGTPCWMAPEVMEQVRGYDFKADIW 206
Query: 267 SFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRL 326
           SFG+   E+         GA     + P  V     + +  ++  G   +E  K+  K  
Sbjct: 207 SFGITAIELA-------TGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSF 259
Query: 327 CMVALWCVQDSPEDRPPMSAVIK 349
             +   C+Q  PE RP  + +++
Sbjct: 260 RKMISLCLQKDPEKRPTAAELLR 282

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 86  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 132
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 99
Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 177
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 100 -HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 13  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 123
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 184 AEPVDVWSCGIVLTAMLA 201

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 83  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 24  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 83
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 187
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 84  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT--P 245
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG    
Sbjct: 144 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 198
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 199 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 227

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 86  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 132
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 99
Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 177
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 100 -HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYG 142
           LGFGG  EV+  +       +AVKVL  +L R      +F  E        H  +V +Y 
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 143 FCHDQH----MTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLH 193
               +     +  +V EY++  +L   +        KRAIE      +     + L + H
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNFSH 133
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEF 252
              Q  IIH D+KP N+++ A  + KV DFG+A+ + D   +    +   GT  Y +PE 
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 253 LSGNYPITHKCDVYSFGMVLFEIV 276
             G+  +  + DVYS G VL+E++
Sbjct: 191 ARGDS-VDARSDVYSLGCVLYEVL 213

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 86  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 132
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 99
Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 177
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +       
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 15  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 15  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 15/221 (6%)
Query: 61  EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE 119
           E+ +E+P     L++ +F  +    LG G FG+V+  +F    +  A+K L +++  + +
Sbjct: 3   ELNKERPSLQIKLKIEDFELH--KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD 60
Query: 120 --EQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE 176
             E  M E   +   + H  L  ++     +     V EY+  G L  Y        +  
Sbjct: 61  DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL-MYHIQSCHKFDLS 119
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT-H 235
           +    A     GL +LH    + I++ D+K +N+LLD +   K+ADFG   +C  N    
Sbjct: 120 RATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFG---MCKENMLGD 173
Query: 236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
              + + GTP Y APE L G     H  D +SFG++L+E++
Sbjct: 174 AKTNEFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEML 213

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 133/314 (42%), Gaps = 53/314 (16%)
Query: 67  PVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKI--AVKVLNRNLGRIAEEQFM 123
           P  +  L  N+    +   +G G FG+V K +   +G+++  A+K +     +     F 
Sbjct: 13  PTIYPVLDWNDI--KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 70
Query: 124 AEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
            E+  + +  +H N++ L G C  +    L  EY  +G+L  +L  K R +E +    IA
Sbjct: 71  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIA 129
Query: 183 IGTA----------------KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 226
             TA                +G+ YL    Q++ IH ++   N+L+  N+  K+ADFGL+
Sbjct: 130 NSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLS 186
Query: 227 KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI-THKCDVYSFGMVLFEIVGRRRNAIVG 285
           +        V +    G          S NY + T   DV+S+G++L+EIV        G
Sbjct: 187 R-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 241
Query: 286 ATESLDWFPKHVWEEYEKCELGAMI---LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRP 342
            T +         E YEK   G  +   L C  E  D  +          C ++ P +RP
Sbjct: 242 MTCA---------ELYEKLPQGYRLEKPLNCDDEVYDLMRQ---------CWREKPYERP 283
Query: 343 PMSAVIKMLEGVVE 356
             + ++  L  ++E
Sbjct: 284 SFAQILVSLNRMLE 297

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 115/269 (42%), Gaps = 38/269 (14%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FG+V K              +AVK+L  N         ++E   + +  H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYL-----------------------FGKKRAIEWE 176
           LYG C       L+ EY + GSL G+L                          +RA+   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
            L   A   ++G+ YL E     ++H D+   N+L+      K++DFGL++      + V
Sbjct: 151 DLISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG-ATESLDWFPK 295
             S  +    + A E L  ++  T + DV+SFG++L+EIV    N   G   E L    K
Sbjct: 208 KRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266
Query: 296 --HVWEEYEKC--ELGAMILGCGIEEKDK 320
             H  E  + C  E+  ++L C  +E DK
Sbjct: 267 TGHRMERPDNCSEEMYRLMLQCWKQEPDK 295

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 7/196 (3%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +  VYKG+       +A+K +       A    + EV  +    H N+V L+  
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            H +    LV+EY++   L  YL      I    +        +GL Y H   +Q+++H 
Sbjct: 69  IHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHR 124
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKC 263
           D+KP+N+L++     K+ADFGLA+   ++    T      T  Y  P+ L G+   + + 
Sbjct: 125 DLKPQNLLINERGELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQI 182
Query: 264 DVYSFGMVLFEIVGRR 279
           D++  G + +E+   R
Sbjct: 183 DMWGVGCIFYEMATGR 198

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 15  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 15  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 15  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 86  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 132
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 145
Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 177
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 146 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 205 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 262 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 298

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 15  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++     D         I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KPEN+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 127 RDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 181
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 86  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DI   NVL+ A    K+ DFGL++  + + T+   S  K    + APE ++     T 
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 191
Query: 262 KCDVYSFGMVLFEIV--------GRRRNAIVGATESLDWFP 294
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 232

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 83  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 52  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 111
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 187
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 112 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 171
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT--P 245
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D  +T     G KG    
Sbjct: 172 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 226
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 227 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 255

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 38/219 (17%)
Query: 86  LGFGGFGEVY--------KGQFPNGVKIAVKVLNRNLGR------IAEEQFMAEVGTIGR 131
           LG G FG+V         K +    V +AVK+L  +         ++E + M  +G    
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK--- 99
Query: 132 TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 176
             H N++ L G C       ++ EY   G+L  YL  ++                 + ++
Sbjct: 100 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
            L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    + 
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
             +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 215 KTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 86  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 132
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 99
Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 177
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
           L       A+G+ YL     Q+ IH D+   NVL+  N   ++ADFGLA+  +    +  
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKK 215
Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHINLVR 139
           LG G F  VYK +  N  +I V +    LG  +E +       + E+  +    H N++ 
Sbjct: 18  LGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 140 LY-GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           L   F H  +++ LV+++ME   L+  +      +    +    + T +GL YLH   Q 
Sbjct: 77  LLDAFGHKSNIS-LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 131
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNKTHVTISGYKGTPGYSAPEFLSG 255
            I+H D+KP N+LLD N   K+ADFGLAK     +R   H  ++ +     Y APE L G
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRW-----YRAPELLFG 186
Query: 256 NYPITHKCDVYSFGMVLFEIVGR 278
                   D+++ G +L E++ R
Sbjct: 187 ARMYGVGVDMWAVGCILAELLLR 209

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 86  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 132
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 91
Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 177
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 92  -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 151 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 207
Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 208 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 244

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 86  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DI   NVL+ A    K+ DFGL++  + + T+   S  K    + APE ++     T 
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 571
Query: 262 KCDVYSFGMVLFEIV--------GRRRNAIVGATESLDWFP 294
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 612

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 86  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 132
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 88
Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 177
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 89  -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 148 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 204
Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 205 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 241

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 86  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 132
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 86
Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 177
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 87  -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 146 LVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKK 202
Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 203 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 239

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 83  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 136
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 17  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 76
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 187
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 77  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT--P 245
           G+ YL+     + +H D+   N  +  +F+ K+ DFG+ +  D  +T     G KG    
Sbjct: 137 GMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 191
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 192 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 220

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 20/199 (10%)
Query: 86  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVR 139
           LG G F  V K  +   G++ A K + +   R     +  E+   EV  + +  H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L+    ++    L+ E +  G L  +L  +K ++  E+          G+ YLH    ++
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 200 IIHYDIKPENV-LLDANF---SPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
           I H+D+KPEN+ LLD N      K+ DFGLA   +     V      GTP + APE +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIV-- 190
Query: 256 NY-PITHKCDVYSFGMVLF 273
           NY P+  + D++S G++ +
Sbjct: 191 NYEPLGLEADMWSIGVITY 209

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 119/292 (40%), Gaps = 40/292 (13%)
Query: 86  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRL 140
           LG G FG V +G         +K+AVK +  +     E E+F++E   +    H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 141 YGFCHDQHMTAL-----VYEYMENGSLDGYLFGKK-----RAIEWEKLHEIAIGTAKGLV 190
            G C +     +     +  +M+ G L  YL   +     + I  + L +  +  A G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 191 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAP 250
           YL     +  +H D+   N +L  + +  VADFGL+K       +      K    + A 
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 251 EFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGAT--ESLDWFPK-HVWEEYEKCELG 307
           E L+     T K DV++FG+ ++EI  R      G    E  D+    H  ++ E C   
Sbjct: 219 ESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDC--- 274
Query: 308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP 359
                             L  +   C +  P DRP  S +   LE ++E LP
Sbjct: 275 ---------------LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYG 142
           LGFGG  EV+  +       +AVKVL  +L R      +F  E        H  +V +Y 
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 96
Query: 143 FCHDQH----MTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLH 193
               +     +  +V EY++  +L   +        KRAIE      +     + L + H
Sbjct: 97  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNFSH 150
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEF 252
              Q  IIH D+KP N+++ A  + KV DFG+A+ + D   +    +   GT  Y +PE 
Sbjct: 151 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 207
Query: 253 LSGNYPITHKCDVYSFGMVLFEIV 276
             G+  +  + DVYS G VL+E++
Sbjct: 208 ARGDS-VDARSDVYSLGCVLYEVL 230

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 86  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 131
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 77
Query: 132 TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 176
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 78  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA+       + 
Sbjct: 136 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
             +  +    + APE L      TH+ DV+SFG++L+EI
Sbjct: 193 KTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 230

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 86  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 131
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 84
Query: 132 TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 176
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 85  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA+       + 
Sbjct: 143 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 199
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
             +  +    + APE L      TH+ DV+SFG++L+EI
Sbjct: 200 KTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 237

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 86  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 131
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 85
Query: 132 TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 176
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 86  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA+       + 
Sbjct: 144 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 200
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
             +  +    + APE L      TH+ DV+SFG++L+EI
Sbjct: 201 KTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 238

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 86  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 131
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 92
Query: 132 TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 176
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 93  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA+       + 
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
             +  +    + APE L      TH+ DV+SFG++L+EI
Sbjct: 208 KTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 86  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 131
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 81
Query: 132 TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 176
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 82  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA+       + 
Sbjct: 140 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 196
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
             +  +    + APE L      TH+ DV+SFG++L+EI
Sbjct: 197 KTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 234

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 71  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 122
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNKTHVTI 238
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 239 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 273
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPAFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 18/221 (8%)
Query: 82  YSTRLGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YH 134
           +   LG G FG+V +      G+    +K+AVK+L        +E  M+E+  +     H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
            N+V L G C       ++ EY   G L  +L  K R +E +    IA  T      LH 
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHF 169
Query: 195 ECQ----------QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
             Q          +  IH D+   NVLL      K+ DFGLA+    +  ++     +  
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG 285
             + APE +  +   T + DV+S+G++L+EI     N   G
Sbjct: 230 VKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 86/198 (43%), Gaps = 15/198 (7%)
Query: 86  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G  GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAAGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 38/219 (17%)
Query: 86  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 131
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 92
Query: 132 TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 176
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 93  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA+         
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXK 207
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
             +  +    + APE L      TH+ DV+SFG++L+EI
Sbjct: 208 KTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 86  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 131
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 92
Query: 132 TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 176
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 93  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA+       + 
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
             +  +    + APE L      TH+ DV+SFG++L+EI
Sbjct: 208 KTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 78  FTSNYST--RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTY 133
           F  N+    ++G G +G VYK +    G  +A+K +  +          + E+  +    
Sbjct: 8   FMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 67
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H N+V+L    H ++   LV+E++               I    +        +GL + H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAP 250
                R++H D+KP+N+L++   + K+ADFGLA+   +  R  TH  ++ +     Y AP
Sbjct: 128 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAP 179
Query: 251 EFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           E L G    +   D++S G +  E+V RR
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA---IGTAKGLVYLHEECQQR 199
             H ++   LV+E++   S+D   F    A+    L  I        +GL + H     R
Sbjct: 73  VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHR 126
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
           ++H D+KPEN+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G 
Sbjct: 127 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGC 181
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
              +   D++S G +  E+V RR
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R  TH  ++ +     Y APE L G    
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGXKYY 181
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 86  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVR 139
           LG G F  V K  +   G++ A K + +   R     ++ E+   EV  + +  H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L+    ++    L+ E +  G L  +L  +K ++  E+          G+ YLH    ++
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 200 IIHYDIKPENV-LLDANF---SPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
           I H+D+KPEN+ LLD N      K+ DFGLA   +     V      GTP + APE +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIV-- 190
Query: 256 NY-PITHKCDVYSFGMVLF 273
           NY P+  + D++S G++ +
Sbjct: 191 NYEPLGLEADMWSIGVITY 209

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 89/206 (43%), Gaps = 24/206 (11%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRLYG 142
           LG GGFGEV+  Q     K+              + +   M E   + + +   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 143 FCHDQHMTALVYEYMENGSL---------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
               +    LV   M  G +         D   F + RAI +            GL +LH
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY------TAQIVSGLEHLH 306
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
              Q+ II+ D+KPENVLLD + + +++D GLA      +T     GY GTPG+ APE L
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT--KGYAGTPGFMAPELL 361
Query: 254 SGNYPITHKCDVYSFGMVLFEIVGRR 279
            G        D ++ G+ L+E++  R
Sbjct: 362 LGE-EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 89/206 (43%), Gaps = 24/206 (11%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRLYG 142
           LG GGFGEV+  Q     K+              + +   M E   + + +   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 143 FCHDQHMTALVYEYMENGSL---------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
               +    LV   M  G +         D   F + RAI +            GL +LH
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY------TAQIVSGLEHLH 306
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
              Q+ II+ D+KPENVLLD + + +++D GLA      +T     GY GTPG+ APE L
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT--KGYAGTPGFMAPELL 361
Query: 254 SGNYPITHKCDVYSFGMVLFEIVGRR 279
            G        D ++ G+ L+E++  R
Sbjct: 362 LGE-EYDFSVDYFALGVTLYEMIAAR 386

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 86  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVR 139
           LG G F  V K  +   G++ A K + +   R     ++ E+   EV  + +  H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L+    ++    L+ E +  G L  +L  +K ++  E+          G+ YLH    ++
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 200 IIHYDIKPENV-LLDANF---SPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
           I H+D+KPEN+ LLD N      K+ DFGLA   +     V      GTP + APE +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIV-- 190
Query: 256 NY-PITHKCDVYSFGMVLF 273
           NY P+  + D++S G++ +
Sbjct: 191 NYEPLGLEADMWSIGVITY 209

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 86  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 132
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 99
Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 177
            H N++ L G C       ++  Y   G+L  YL  ++                 + ++ 
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G FGEV+KG      K+ A+K+++        E    E+  + +     + + YG 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 144 CHDQHMTALVYEYMENGS-LDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQ 197
                   ++ EY+  GS LD         +E   L E  I T      KGL YLH E  
Sbjct: 89  YLKDTKLWIIMEYLGGGSALD--------LLEPGPLDETQIATILREILKGLDYLHSE-- 138
Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
            + IH DIK  NVLL  +   K+ADFG+A +L D   T +  + + GTP + APE +  +
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAPEVIKQS 194
Query: 257 YPITHKCDVYSFGMVLFEIV 276
                K D++S G+   E+ 
Sbjct: 195 -AYDSKADIWSLGITAIELA 213

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 89/206 (43%), Gaps = 24/206 (11%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRLYG 142
           LG GGFGEV+  Q     K+              + +   M E   + + +   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 143 FCHDQHMTALVYEYMENGSL---------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
               +    LV   M  G +         D   F + RAI +            GL +LH
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY------TAQIVSGLEHLH 306
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
              Q+ II+ D+KPENVLLD + + +++D GLA      +T     GY GTPG+ APE L
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT--KGYAGTPGFMAPELL 361
Query: 254 SGNYPITHKCDVYSFGMVLFEIVGRR 279
            G        D ++ G+ L+E++  R
Sbjct: 362 LGE-EYDFSVDYFALGVTLYEMIAAR 386

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 86  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVR 139
           LG G F  V K  +   G++ A K + +   R     ++ E+   EV  + +  H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L+    ++    L+ E +  G L  +L  +K ++  E+          G+ YLH    ++
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 200 IIHYDIKPENV-LLDANF---SPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
           I H+D+KPEN+ LLD N      K+ DFGLA   +     V      GTP + APE +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIV-- 190
Query: 256 NY-PITHKCDVYSFGMVLF 273
           NY P+  + D++S G++ +
Sbjct: 191 NYEPLGLEADMWSIGVITY 209

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA---IGTAKGLVYLHEECQQR 199
             H ++   LV+E++   S+D   F    A+    L  I        +GL + H     R
Sbjct: 71  VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHR 124
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
           ++H D+KPEN+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G 
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGC 179
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
              +   D++S G +  E+V RR
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 89/206 (43%), Gaps = 24/206 (11%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRLYG 142
           LG GGFGEV+  Q     K+              + +   M E   + + +   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 143 FCHDQHMTALVYEYMENGSL---------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
               +    LV   M  G +         D   F + RAI +            GL +LH
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY------TAQIVSGLEHLH 306
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
              Q+ II+ D+KPENVLLD + + +++D GLA      +T     GY GTPG+ APE L
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT--KGYAGTPGFMAPELL 361
Query: 254 SGNYPITHKCDVYSFGMVLFEIVGRR 279
            G        D ++ G+ L+E++  R
Sbjct: 362 LGE-EYDFSVDYFALGVTLYEMIAAR 386

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 86  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVR 139
           LG G F  V K  +   G++ A K + +   R     ++ E+   EV  + +  H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L+    ++    L+ E +  G L  +L  +K ++  E+          G+ YLH    ++
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 200 IIHYDIKPENV-LLDANF---SPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
           I H+D+KPEN+ LLD N      K+ DFGLA   +     V      GTP + APE +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIV-- 190
Query: 256 NY-PITHKCDVYSFGMVLF 273
           NY P+  + D++S G++ +
Sbjct: 191 NYEPLGLEADMWSIGVITY 209

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G FGEV+KG      K+ A+K+++        E    E+  + +     + + YG 
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 73
Query: 144 CHDQHMTALVYEYMENGS-LDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQ 197
                   ++ EY+  GS LD         +E   L E  I T      KGL YLH E  
Sbjct: 74  YLKDTKLWIIMEYLGGGSALD--------LLEPGPLDETQIATILREILKGLDYLHSE-- 123
Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
            + IH DIK  NVLL  +   K+ADFG+A +L D   T +  + + GTP + APE +  +
Sbjct: 124 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVIKQS 179
Query: 257 YPITHKCDVYSFGMVLFEIV 276
                K D++S G+   E+ 
Sbjct: 180 -AYDSKADIWSLGITAIELA 198

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 78  FTSNYST--RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTY 133
           F  N+    ++G G +G VYK +    G  +A+K +  +          + E+  +    
Sbjct: 8   FMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 67
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H N+V+L    H ++   LV+E++               I    +        +GL + H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAP 250
                R++H D+KP+N+L++   + K+ADFGLA+   +  R  TH  ++ +     Y AP
Sbjct: 128 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAP 179
Query: 251 EFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           E L G    +   D++S G +  E+V RR
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 25/199 (12%)
Query: 84  TRLGFGGFGEVYK-----GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
           + LG G    VY+      Q P  +K+  K +++ + R        E+G + R  H N++
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR-------TEIGVLLRLSHPNII 111
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           +L          +LV E +  G L   +  K    E +    +     + + YLHE    
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK-QILEAVAYLHE---N 167
Query: 199 RIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS 254
            I+H D+KPEN LL A  +P    K+ADFGL+K+ +      T+ G   TPGY APE L 
Sbjct: 168 GIVHRDLKPEN-LLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG---TPGYCAPEILR 223
Query: 255 GNYPITHKCDVYSFGMVLF 273
           G      + D++S G++ +
Sbjct: 224 GC-AYGPEVDMWSVGIITY 241

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G FGEV+KG      K+ A+K+++        E    E+  + +     + + YG 
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 73
Query: 144 CHDQHMTALVYEYMENGS-LDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQ 197
                   ++ EY+  GS LD         +E   L E  I T      KGL YLH E  
Sbjct: 74  YLKDTKLWIIMEYLGGGSALD--------LLEPGPLDETQIATILREILKGLDYLHSE-- 123
Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
            + IH DIK  NVLL  +   K+ADFG+A +L D   T +  + + GTP + APE +  +
Sbjct: 124 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAPEVIKQS 179
Query: 257 YPITHKCDVYSFGMVLFEIV 276
                K D++S G+   E+ 
Sbjct: 180 -AYDSKADIWSLGITAIELA 198

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 125
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R  TH  ++ +     Y APE L G    
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGCKYY 180
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 86  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 131
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 92
Query: 132 TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 176
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 93  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA+       + 
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
             +  +    + APE L      TH+ DV+SFG++L+EI
Sbjct: 208 KTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++     D         I    +        +GL + H     R++H
Sbjct: 73  VIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 129
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 184
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 130
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R  TH  ++ +     Y APE L G    
Sbjct: 131 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGCKYY 185
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 186 STAVDIWSLGCIFAEMVTRR 205

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 127
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R  TH  ++ +     Y APE L G    
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGCKYY 182
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 86  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVR 139
           LG G F  V K  +   G++ A K + +   R     ++ E+   EV  + +  H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L+    ++    L+ E +  G L  +L  +K ++  E+          G+ YLH    ++
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 200 IIHYDIKPENV-LLDANF---SPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
           I H+D+KPEN+ LLD N      K+ DFGLA   +     V      GTP + APE +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIV-- 190
Query: 256 NY-PITHKCDVYSFGMVLF 273
           NY P+  + D++S G++ +
Sbjct: 191 NYEPLGLEADMWSIGVITY 209

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R  TH  ++ +     Y APE L G    
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGCKYY 181
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 125
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R  TH  ++ +     Y APE L G    
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGCKYY 180
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R  TH  ++ +     Y APE L G    
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGCKYY 181
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 24/221 (10%)
Query: 85  RLGFGGFGEVYKGQFPNGVK--IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           R+G G FGEV+KG   N  +  +A+K+++        E    E+  + +     + + YG
Sbjct: 30  RIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQ 197
                    ++ EY+  GS    L    RA  ++   E  I T      KGL YLH E  
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLL----RAGPFD---EFQIATMLKEILKGLDYLHSE-- 139
Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
            + IH DIK  NVLL      K+ADFG+A +L D   T +  + + GTP + APE +  +
Sbjct: 140 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVIQQS 195
Query: 257 YPITHKCDVYSFGMVLFEIV-GRRRNAIVGATESLDWFPKH 296
                K D++S G+   E+  G   N+ +     L   PK+
Sbjct: 196 -AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN 235

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++     D         I    +        +GL + H     R++H
Sbjct: 72  VIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 128
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 183
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 184 STAVDIWSLGCIFAEMVTRR 203

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 71  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 122
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNKTHVTI 238
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 239 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 273
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 71  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 122
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNKTHVTI 238
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 239 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 273
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 86  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 131
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 133
Query: 132 TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 176
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 134 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA+       + 
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
             +  +    + APE L      TH+ DV+SFG++L+EI
Sbjct: 249 KTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 286

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 71  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 122
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 1   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60
Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 119
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNKTHVTI 238
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 120 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 239 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 273
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 177 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 207

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 85  RLGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
           ++G G +G VYK      G+     KI +      +   A    + E+  +    H N+V
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTA----IREISLLKELNHPNIV 65
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           +L    H ++   LV+E++               I    +        +GL + H     
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SH 122
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSG 255
           R++H D+KP+N+L++   + K+ADFGLA+   +  R  TH  ++ +     Y APE L G
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLG 177
Query: 256 NYPITHKCDVYSFGMVLFEIVGRR 279
               +   D++S G +  E+V RR
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 85  RLGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
           ++G G +G VYK      G+     KI +      +   A    + E+  +    H N+V
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTA----IREISLLKELNHPNIV 64
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           +L    H ++   LV+E++               I    +        +GL + H     
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SH 121
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSG 255
           R++H D+KP+N+L++   + K+ADFGLA+   +  R  TH  ++ +     Y APE L G
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLG 176
Query: 256 NYPITHKCDVYSFGMVLFEIVGRR 279
               +   D++S G +  E+V RR
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 71  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 122
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNKTHVTI 238
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 239 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 273
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH---SHRVLH 126
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R  TH  ++ +     Y APE L G    
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGCKYY 181
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 85  RLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G FGEV+KG      K+ A+K+++        E    E+  + +     + + YG 
Sbjct: 34  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 93
Query: 144 CHDQHMTALVYEYMENGS-LDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQ 197
                   ++ EY+  GS LD         +E   L E  I T      KGL YLH E  
Sbjct: 94  YLKDTKLWIIMEYLGGGSALD--------LLEPGPLDETQIATILREILKGLDYLHSE-- 143
Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
            + IH DIK  NVLL  +   K+ADFG+A +L D   T +  + + GTP + APE +  +
Sbjct: 144 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVIKQS 199
Query: 257 YPITHKCDVYSFGMVLFEIV 276
                K D++S G+   E+ 
Sbjct: 200 -AYDSKADIWSLGITAIELA 218

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 86  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 132
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 99
Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 177
            H N++ L G C       ++  Y   G+L  YL  ++                 + ++ 
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 71  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 122
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 1   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60
Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 119
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNKTHVTI 238
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 120 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 239 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 273
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 177 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 207

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 143 FCHDQHMTALVYE--------YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             H ++   LV+E        +M+  +L G      ++  ++ L        +GL + H 
Sbjct: 69  VIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLL--------QGLAFCH- 119
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPE 251
               R++H D+KP+N+L++   + K+ADFGLA+   +  R  TH  ++ +     Y APE
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPE 172
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            L G    +   D++S G +  E+V RR
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 71  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 122
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNKTHVTI 238
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 239 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 273
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 71  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 122
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNKTHVTI 238
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 239 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 273
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 128
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KPEN+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 129 RDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 183
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 184 STAVDIWSLGCIFAEMVTRR 203

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 39/221 (17%)
Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G FG+V K +   +    A+K +     +++    ++EV  +    H  +VR Y   
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS--TILSEVMLLASLNHQYVVRYYAAW 71
Query: 145 HDQH-----MTA--------LVYEYMENGSLDGYL----FGKKRAIEWEKLHEIAIGTAK 187
            ++      MTA        +  EY ENG+L   +      ++R   W    +I     +
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL----E 127
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN------------KTH 235
            L Y+H    Q IIH D+KP N+ +D + + K+ DFGLAK   R+             + 
Sbjct: 128 ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
             ++   GT  Y A E L G      K D+YS G++ FE++
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYGF 143
           +G G +G+VYKG+    G   A+KV++  +    EE+   E+  + + ++H N+   YG 
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 144 CHDQHMTA------LVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEEC 196
              ++         LV E+   GS+   +   K   ++ E +  I     +GL +LH   
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 146
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS-- 254
           Q ++IH DIK +NVLL  N   K+ DFG++   DR  T    + + GTP + APE ++  
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIACD 204
Query: 255 GNYPITH--KCDVYSFGMVLFEIV 276
            N   T+  K D++S G+   E+ 
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMA 228

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 71  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 122
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNKTHVTI 238
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 239 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 273
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 71  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 122
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNKTHVTI 238
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 239 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 273
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 22/224 (9%)
Query: 79  TSNYS--TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR----IAEEQFMAEVGTIGR 131
           TS Y     +G G +G VYK + P +G  +A+K +    G     I+  + +A +  +  
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 132 TYHINLVRLYGFCHDQHM-----TALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGT 185
             H N+VRL   C            LV+E+++   L  YL       +  E + ++    
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
            +GL +LH  C   I+H D+KPEN+L+ +  + K+ADFGLA++       + ++    T 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPVVVTL 175
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES 289
            Y APE L  +   T   D++S G +  E+  RR+    G +E+
Sbjct: 176 WYRAPEVLLQSTYAT-PVDMWSVGCIFAEMF-RRKPLFCGNSEA 217

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 127
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KPEN+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 128 RDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 182
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 71  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 122
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNKTHVTI 238
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 239 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 273
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 71  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 122
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNKTHVTI 238
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 239 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 273
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 71  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 122
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNKTHVTI 238
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 239 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 273
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 129/307 (42%), Gaps = 60/307 (19%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRLY 141
           +G G FG VY  +   N   +A+K ++ + G+ + E++   + EV  + +  H N ++  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G    +H   LV EY   GS    L   K+ ++  ++  +  G  +GL YLH      +I
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMI 137
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL----SGNY 257
           H D+K  N+LL      K+ DFG A +          + + GTP + APE +     G Y
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEGQY 191
Query: 258 PITHKCDVYSFGMVLFEIVGRR-----RNAI-----VGATESLDWFPKHVWEEYEKCELG 307
               K DV+S G+   E+  R+      NA+     +   ES      H W EY +  + 
Sbjct: 192 --DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH-WSEYFRNFVD 248
Query: 308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYL 367
           +                        C+Q  P+DRP    ++K       VL    P   +
Sbjct: 249 S------------------------CLQKIPQDRPTSEVLLKHR----FVLRERPPTVIM 280
Query: 368 DLIKMTR 374
           DLI+ T+
Sbjct: 281 DLIQRTK 287

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 147
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV-TISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 89/198 (44%), Gaps = 20/198 (10%)
Query: 86  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VY     K  F   +K+  K      G   E Q   E+      +H N++RL
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEG--VEHQLRREIEIQAHLHHPNILRL 88
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y + +D+    L+ EY   G L   L  K    + ++   I    A  L+Y H    +++
Sbjct: 89  YNYFYDRRRIYLILEYAPRGELYKEL-QKSCTFDEQRTATIMEELADALMYCH---GKKV 144
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCD--RNKTHVTISGYKGTPGYSAPEFLSGNYP 258
           IH DIKPEN+LL      K+ADFG +      R KT        GT  Y  PE + G   
Sbjct: 145 IHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC------GTLDYLPPEMIEGRMH 198
Query: 259 ITHKCDVYSFGMVLFEIV 276
              K D++  G++ +E++
Sbjct: 199 -NEKVDLWCIGVLCYELL 215

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 79  TSNYS--TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR----IAEEQFMAEVGTIGR 131
           TS Y     +G G +G VYK + P +G  +A+K +    G     I+  + +A +  +  
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 132 TYHINLVRLYGFCHDQHM-----TALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGT 185
             H N+VRL   C            LV+E+++   L  YL       +  E + ++    
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
            +GL +LH  C   I+H D+KPEN+L+ +  + K+ADFGLA++       + +     T 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALDPVVVTL 175
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES 289
            Y APE L  +   T   D++S G +  E+  RR+    G +E+
Sbjct: 176 WYRAPEVLLQSTYAT-PVDMWSVGCIFAEMF-RRKPLFCGNSEA 217

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 147
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV-TISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 20/220 (9%)
Query: 82  YSTRLGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YH 134
           +   LG G FG+V +      G+    +K+AVK+L        +E  M+E+  +     H
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 101
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------RAIEWEKLHEIAIGT 185
            N+V L G C       ++ EY   G L  +L  K          R +E   L   +   
Sbjct: 102 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 161
Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
           A+G+ +L     +  IH D+   NVLL      K+ DFGLA+    +  ++     +   
Sbjct: 162 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 218
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG 285
            + APE +  +   T + DV+S+G++L+EI     N   G
Sbjct: 219 KWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 20/220 (9%)
Query: 82  YSTRLGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YH 134
           +   LG G FG+V +      G+    +K+AVK+L        +E  M+E+  +     H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------RAIEWEKLHEIAIGT 185
            N+V L G C       ++ EY   G L  +L  K          R +E   L   +   
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 169
Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
           A+G+ +L     +  IH D+   NVLL      K+ DFGLA+    +  ++     +   
Sbjct: 170 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 226
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG 285
            + APE +  +   T + DV+S+G++L+EI     N   G
Sbjct: 227 KWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 155
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 215
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 216 SIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 147
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 147
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV-TISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 71  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 122
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 182
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNKTHVTI 238
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 239 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 273
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 85  RLGFGGFGE-VYKGQFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G FG+ +      +G +  +K +N   +     E+   EV  +    H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 143 FCHDQHMTALVYEYMENGSL-------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
              +     +V +Y E G L        G LF + + ++W       +     L ++H+ 
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVHD- 143
Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
             ++I+H DIK +N+ L  + + ++ DFG+A++   N T        GTP Y +PE +  
Sbjct: 144 --RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPE-ICE 198
Query: 256 NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL 290
           N P  +K D+++ G VL+E+   +     G+ ++L
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           ++G G F EVY+     +GV +A+K +     +   A    + E+  + +  H N+++ Y
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 142 G-FCHDQHMTALVYEYMENGSLD---GYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
             F  D  +  +V E  + G L     +   +KR I    + +  +     L ++H    
Sbjct: 99  ASFIEDNELN-IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--- 154
Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY 257
           +R++H DIKP NV + A    K+ D GL +      T        GTP Y +PE +  N 
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN- 211
Query: 258 PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE 317
               K D++S G +L+E+    ++   G   +L    K +    E+C+   +        
Sbjct: 212 GYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKI----EQCDYPPL-------- 258
Query: 318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAV 347
                ++ L  +   C+   PE RP ++ V
Sbjct: 259 PSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 145
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 206 SIDIWSVGCILAEMLSNR 223

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 129/307 (42%), Gaps = 60/307 (19%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRLY 141
           +G G FG VY  +   N   +A+K ++ + G+ + E++   + EV  + +  H N ++  
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G    +H   LV EY   GS    L   K+ ++  ++  +  G  +GL YLH      +I
Sbjct: 121 GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMI 176
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL----SGNY 257
           H D+K  N+LL      K+ DFG A +          + + GTP + APE +     G Y
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEGQY 230
Query: 258 PITHKCDVYSFGMVLFEIVGRR-----RNAI-----VGATESLDWFPKHVWEEYEKCELG 307
               K DV+S G+   E+  R+      NA+     +   ES      H W EY +  + 
Sbjct: 231 --DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH-WSEYFRNFVD 287
Query: 308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYL 367
           +                        C+Q  P+DRP    ++K       VL    P   +
Sbjct: 288 S------------------------CLQKIPQDRPTSEVLLKHR----FVLRERPPTVIM 319
Query: 368 DLIKMTR 374
           DLI+ T+
Sbjct: 320 DLIQRTK 326

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 149
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 210 SIDIWSVGCILAEMLSNR 227

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 30/208 (14%)
Query: 84  TRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHIN 136
           T+LG G +GEVYK         +A+K +     R+  E+       + EV  +    H N
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRI-----RLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
           ++ L    H  H   L++EY EN  L  Y+  K   +    +         G+ + H   
Sbjct: 95  IIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH--- 149
Query: 197 QQRIIHYDIKPENVLL---DANFSP--KVADFGLAK---LCDRNKTHVTISGYKGTPGYS 248
            +R +H D+KP+N+LL   DA+ +P  K+ DFGLA+   +  R  TH  I+ +     Y 
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW-----YR 204
Query: 249 APEFLSGNYPITHKCDVYSFGMVLFEIV 276
            PE L G+   +   D++S   +  E++
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 128
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 183
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 184 STAVDIWSLGCIFAEMVTRR 203

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 152
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 213 SIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 153
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 214 SIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 144
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 205 SIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 181
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 20/218 (9%)
Query: 86  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G FG V++  +   G   A K +        +E    E+ T+    H  LV L+   
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 117
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
            D +   ++YE+M  G L   +  +   +  ++  E      KGL ++HE      +H D
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLD 174
Query: 205 IKPENVLLDANFSP--KVADFGL-AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           +KPEN++     S   K+ DFGL A L  +    VT     GT  ++APE   G  P+ +
Sbjct: 175 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEGK-PVGY 229
Query: 262 KCDVYSFGMVLFEIV-------GRRRNAIVGATESLDW 292
             D++S G++ + ++       G   +  +   +S DW
Sbjct: 230 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 267

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 181
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 125
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 180
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 127
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 182
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 145
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 206 SIDIWSVGCILAEMLSNR 223

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 117/283 (41%), Gaps = 41/283 (14%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHINLVRLYG 142
           +G G FG+VY G++   V I +  + R+     E+Q   F  EV    +T H N+V   G
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERD----NEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
            C      A++    +  +L   +   K  ++  K  +IA    KG+ YLH +    I+H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILH 153
Query: 203 YDIKPENVLLDANFSPKVADFGLAKL-----CDRNKTHVTISGYKGTPGYSAPEFL---- 253
            D+K +NV  D N    + DFGL  +       R +  + I    G   + APE +    
Sbjct: 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN--GWLCHLAPEIIRQLS 210
Query: 254 ----SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM 309
                   P +   DV++ G + +E+  R         E++      +W+     +    
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI------IWQMGTGMKPNLS 264
Query: 310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +G G E  D         + L+C     E+RP  + ++ MLE
Sbjct: 265 QIGMGKEISD---------ILLFCWAFEQEERPTFTKLMDMLE 298

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTY-HINLVRLY 141
           +G G FG+V   +     V  AVKVL +   L +  E+  M+E   + +   H  LV L+
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
                      V +Y+  G L  Y   ++R     +    A   A  L YLH      I+
Sbjct: 106 FSFQTADKLYFVLDYINGGEL-FYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIV 161
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH-VTISGYKGTPGYSAPEFLSGNYPIT 260
           + D+KPEN+LLD+     + DFG   LC  N  H  T S + GTP Y APE L    P  
Sbjct: 162 YRDLKPENILLDSQGHIVLTDFG---LCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYD 217
Query: 261 HKCDVYSFGMVLFEIV 276
              D +  G VL+E++
Sbjct: 218 RTVDWWCLGAVLYEML 233

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 147
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV-TISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 129
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 184
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 128
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 183
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 184 STAVDIWSLGCIFAEMVTRR 203

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE-------EQFMA 124
           L +N+F+ +    +G GGFGEVY  +  +  K+ A+K L++   ++ +       E+ M 
Sbjct: 186 LTMNDFSVHRI--IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 125 EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG 184
            + + G    I  +  Y F H     + + + M  G L  Y   +        +   A  
Sbjct: 244 SLVSTGDCPFIVCMS-YAF-HTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFYAAE 300
Query: 185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
              GL ++H    + +++ D+KP N+LLD +   +++D GLA    + K H ++    GT
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 353
Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            GY APE L          D +S G +LF+++
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE-------EQFMA 124
           L +N+F+ +    +G GGFGEVY  +  +  K+ A+K L++   ++ +       E+ M 
Sbjct: 186 LTMNDFSVHRI--IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 125 EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG 184
            + + G    I  +  Y F H     + + + M  G L  Y   +        +   A  
Sbjct: 244 SLVSTGDCPFIVCMS-YAF-HTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFYAAE 300
Query: 185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
              GL ++H    + +++ D+KP N+LLD +   +++D GLA    + K H ++    GT
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 353
Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            GY APE L          D +S G +LF+++
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 181
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 181
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 20/218 (9%)
Query: 86  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G FG V++  +   G   A K +        +E    E+ T+    H  LV L+   
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
            D +   ++YE+M  G L   +  +   +  ++  E      KGL ++HE      +H D
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLD 280
Query: 205 IKPENVLLDANFSP--KVADFGL-AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           +KPEN++     S   K+ DFGL A L  +    VT     GT  ++APE   G  P+ +
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEGK-PVGY 335
Query: 262 KCDVYSFGMVLFEIV-------GRRRNAIVGATESLDW 292
             D++S G++ + ++       G   +  +   +S DW
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 373

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 12/214 (5%)
Query: 69  RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAE 125
           +   LQ+     +    +G G FGEV   +     K+ A+K+L++   + R     F  E
Sbjct: 66  KIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEE 125
Query: 126 VGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT 185
              +       +V+L+    D     +V EYM  G L   +       +W K +     T
Sbjct: 126 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFY-----T 180
Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
           A+ ++ L       +IH D+KP+N+LLD +   K+ADFG     D     V      GTP
Sbjct: 181 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VHCDTAVGTP 239
Query: 246 GYSAPEFL---SGNYPITHKCDVYSFGMVLFEIV 276
            Y +PE L    G+     +CD +S G+ LFE++
Sbjct: 240 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 273

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 86  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           LG G FGEVY+G + N     + +AVK   ++     +E+FM+E   +    H ++V+L 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G   ++  T ++ E    G L  YL   K +++   L   ++   K + YL        +
Sbjct: 76  GIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCV 131
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DI   N+L+ +    K+ DFGL++  + ++ +   S  +    + +PE ++     T 
Sbjct: 132 HRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRR-FTT 189
Query: 262 KCDVYSFGMVLFEIVGRRRNA--------IVGATESLDWFPK 295
             DV+ F + ++EI+   +          ++G  E  D  PK
Sbjct: 190 ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK 231

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 125
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 180
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 86  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           LG G FGEVY+G + N     + +AVK   ++     +E+FM+E   +    H ++V+L 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G   ++  T ++ E    G L  YL   K +++   L   ++   K + YL        +
Sbjct: 92  GIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCV 147
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DI   N+L+ +    K+ DFGL++  + ++ +   S  +    + +PE ++     T 
Sbjct: 148 HRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRR-FTT 205
Query: 262 KCDVYSFGMVLFEIVGRRRNA--------IVGATESLDWFPK 295
             DV+ F + ++EI+   +          ++G  E  D  PK
Sbjct: 206 ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK 247

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 167
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 228 SIDIWSVGCILAEMLSNR 245

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 73  VIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 129
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 184
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 130
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 131 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 185
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 186 STAVDIWSLGCIFAEMVTRR 205

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE-------EQFMA 124
           L +N+F+ +    +G GGFGEVY  +  +  K+ A+K L++   ++ +       E+ M 
Sbjct: 185 LTMNDFSVHRI--IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 125 EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG 184
            + + G    I +   Y F H     + + + M  G L  Y   +        +   A  
Sbjct: 243 SLVSTGDCPFI-VCMSYAF-HTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFYAAE 299
Query: 185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
              GL ++H    + +++ D+KP N+LLD +   +++D GLA    + K H ++    GT
Sbjct: 300 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 352
Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            GY APE L          D +S G +LF+++
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 127
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 182
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE-------EQFMA 124
           L +N+F+ +    +G GGFGEVY  +  +  K+ A+K L++   ++ +       E+ M 
Sbjct: 186 LTMNDFSVHRI--IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 125 EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG 184
            + + G    I +   Y F H     + + + M  G L  Y   +        +   A  
Sbjct: 244 SLVSTGDCPFI-VCMSYAF-HTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFYAAE 300
Query: 185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
              GL ++H    + +++ D+KP N+LLD +   +++D GLA    + K H ++    GT
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 353
Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            GY APE L          D +S G +LF+++
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 129
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 184
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC- 144
           +G G +GEV++G +  G  +AVK+ +       +E+       +  T  +    + GF  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIA 69
Query: 145 ------HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-- 196
                 H      L+  Y E GSL  YL  +   ++      I +  A GL +LH E   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 197 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK--GTPGYSAPE 251
              +  I H D+K +N+L+  N    +AD GLA +  ++   + +      GT  Y APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 252 FLSGNYPIT-----HKCDVYSFGMVLFEIVGRR-RNAIV 284
            L     +       + D+++FG+VL+E+  R   N IV
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E+++              I    +        +GL + H     R++H
Sbjct: 73  VIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 129
Query: 203 YDIKPENVLLDANFSPKVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 184
Query: 260 THKCDVYSFGMVLFEIVGRR 279
           +   D++S G +  E+V RR
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC- 144
           +G G +GEV++G +  G  +AVK+ +       +E+       +  T  +    + GF  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIA 69
Query: 145 ------HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-- 196
                 H      L+  Y E GSL  YL  +   ++      I +  A GL +LH E   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 197 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK--GTPGYSAPE 251
              +  I H D+K +N+L+  N    +AD GLA +  ++   + +      GT  Y APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 252 FLSGNYPIT-----HKCDVYSFGMVLFEIVGRR-RNAIV 284
            L     +       + D+++FG+VL+E+  R   N IV
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 86  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           LG G FGEVY+G + N     + +AVK   ++     +E+FM+E   +    H ++V+L 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G   ++  T ++ E    G L  YL   K +++   L   ++   K + YL        +
Sbjct: 80  GIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCV 135
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DI   N+L+ +    K+ DFGL++  + ++ +   S  +    + +PE ++     T 
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRR-FTT 193
Query: 262 KCDVYSFGMVLFEIVGRRRNA--------IVGATESLDWFPK 295
             DV+ F + ++EI+   +          ++G  E  D  PK
Sbjct: 194 ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK 235

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 79  TSNYS--TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR----IAEEQFMAEVGTIGR 131
           TS Y     +G G +G VYK + P +G  +A+K +    G     I+  + +A +  +  
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 132 TYHINLVRLYGFCHDQHM-----TALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGT 185
             H N+VRL   C            LV+E+++   L  YL       +  E + ++    
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
            +GL +LH  C   I+H D+KPEN+L+ +  + K+ADFGLA++       + +     T 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVVVTL 175
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES 289
            Y APE L  +   T   D++S G +  E+  RR+    G +E+
Sbjct: 176 WYRAPEVLLQSTYAT-PVDMWSVGCIFAEMF-RRKPLFCGNSEA 217

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR---LYG 142
           +G G +GEV++G +  G  +AVK+ +       E+ +  E       Y+  ++R   + G
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRET----ELYNTVMLRHENILG 95
Query: 143 FC-------HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
           F        H      L+  Y E GSL  YL  +   ++      I +  A GL +LH E
Sbjct: 96  FIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIE 153
Query: 196 C-----QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK--GTPGYS 248
                 +  I H D+K +N+L+  N    +AD GLA +  ++   + +      GT  Y 
Sbjct: 154 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 213
Query: 249 APEFLSGNYPIT-----HKCDVYSFGMVLFEIVGRR-RNAIV 284
           APE L     +       + D+++FG+VL+E+  R   N IV
Sbjct: 214 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 255

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +G VYK      G  +A+K +         ++ + E+  + +    ++V+ YG 
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL---QEIIKEISIMQQCDSPHVVKYYGS 92
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                   +V EY   GS+   +  + + +  +++  I   T KGL YLH     R IH 
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHR 149
Query: 204 DIKPENVLLDANFSPKVADFGLA-KLCDR-NKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           DIK  N+LL+     K+ADFG+A +L D   K +  I    GTP + APE +     I +
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVI----GTPFWMAPEVIQ---EIGY 202
Query: 262 KC--DVYSFGMVLFEIV-GRRRNAIVGATESLDWFPKHVWEEYEKCEL 306
            C  D++S G+   E+  G+   A +    ++   P +    + K EL
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL 250

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A++ ++    +   ++ + E+  + R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY        D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 167
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 168 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 228 SIDIWSVGCILAEMLSNR 245

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 86  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 141
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 149
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNYPIT 260
           H D+   NVLL      K++DFGL+K    ++ +     +   P  + APE ++  Y  +
Sbjct: 150 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 208
Query: 261 HKCDVYSFGMVLFE 274
            K DV+SFG++++E
Sbjct: 209 SKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 86  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 141
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 149
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNYPIT 260
           H D+   NVLL      K++DFGL+K    ++ +     +   P  + APE ++  Y  +
Sbjct: 150 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 208
Query: 261 HKCDVYSFGMVLFE 274
            K DV+SFG++++E
Sbjct: 209 SKSDVWSFGVLMWE 222

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 16/196 (8%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G FG VY   +  N   +A+KVL ++       E Q   E+       H N++R+Y 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           + HD+    L+ E+   G L   L    R  E ++        A  L Y HE   +++IH
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDE-QRSATFMEELADALHYCHE---RKVIH 137
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH- 261
            DIKPEN+L+      K+ADFG +      +         GT  Y  PE + G    TH 
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGK---THD 190
Query: 262 -KCDVYSFGMVLFEIV 276
            K D++  G++ +E +
Sbjct: 191 EKVDLWCAGVLCYEFL 206

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 86  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 141
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 93  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 147
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNYPIT 260
           H D+   NVLL      K++DFGL+K    ++ +     +   P  + APE ++  Y  +
Sbjct: 148 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 206
Query: 261 HKCDVYSFGMVLFE 274
            K DV+SFG++++E
Sbjct: 207 SKSDVWSFGVLMWE 220

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 86  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 141
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 139
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNYPIT 260
           H D+   NVLL      K++DFGL+K    ++ +     +   P  + APE ++  Y  +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 198
Query: 261 HKCDVYSFGMVLFE 274
            K DV+SFG++++E
Sbjct: 199 SKSDVWSFGVLMWE 212

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 16/196 (8%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G FG VY   +  N   +A+KVL ++       E Q   E+       H N++R+Y 
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           + HD+    L+ E+   G L   L    R  E ++        A  L Y HE   +++IH
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDE-QRSATFMEELADALHYCHE---RKVIH 138
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH- 261
            DIKPEN+L+      K+ADFG +      +         GT  Y  PE + G    TH 
Sbjct: 139 RDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGK---THD 191
Query: 262 -KCDVYSFGMVLFEIV 276
            K D++  G++ +E +
Sbjct: 192 EKVDLWCAGVLCYEFL 207

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 105/260 (40%), Gaps = 52/260 (20%)
Query: 72  SLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR 131
           SL L+N        +G G +G VYKG   +   +AVKV +      A  Q       I R
Sbjct: 9   SLDLDNL--KLLELIGRGRYGAVYKGSL-DERPVAVKVFS-----FANRQNFINEKNIYR 60
Query: 132 T---YHINLVRLYGFCHDQHMTA-------LVYEYMENGSLDGYLFGKKRAIEWEKLHEI 181
                H N+ R      D+ +TA       LV EY  NGSL  YL       +W     +
Sbjct: 61  VPLMEHDNIARF--IVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRL 116
Query: 182 AIGTAKGLVYLHEEC------QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK-- 233
           A    +GL YLH E       +  I H D+   NVL+  + +  ++DFGL+     N+  
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 234 -----THVTISGYKGTPGYSAPEFLSGNYPI------THKCDVYSFGMVLFEIVGRRRNA 282
                 +  IS   GT  Y APE L G   +        + D+Y+ G++ +EI  R    
Sbjct: 177 RPGEEDNAAISEV-GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR---- 231
Query: 283 IVGATESLDWFPKHVWEEYE 302
                   D FP     EY+
Sbjct: 232 ------CTDLFPGESVPEYQ 245

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 86  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 141
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 129
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNYPIT 260
           H D+   NVLL      K++DFGL+K    ++ +     +   P  + APE ++  Y  +
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 188
Query: 261 HKCDVYSFGMVLFE 274
            K DV+SFG++++E
Sbjct: 189 SKSDVWSFGVLMWE 202

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 86  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 141
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 73  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 127
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNYPIT 260
           H D+   NVLL      K++DFGL+K    ++ +     +   P  + APE ++  Y  +
Sbjct: 128 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 186
Query: 261 HKCDVYSFGMVLFE 274
            K DV+SFG++++E
Sbjct: 187 SKSDVWSFGVLMWE 200

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 14/194 (7%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF 143
           LG G F  V +  + P G + A K++N       + Q +     I R   H N+VRL+  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 202
             ++    LV++ +  G L   +  ++   E +  H I     + ++     C    I+H
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI-----QQILESVNHCHLNGIVH 126
Query: 203 YDIKPENVLLDAN---FSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KPEN+LL +     + K+ADFGLA   +         G+ GTPGY +PE L  + P 
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLRKD-PY 183
Query: 260 THKCDVYSFGMVLF 273
               D+++ G++L+
Sbjct: 184 GKPVDMWACGVILY 197

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 96/195 (49%), Gaps = 13/195 (6%)
Query: 86  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 141
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 133
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKL--CDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           H D+   NVLL      K++DFGL+K    D N       G K    + APE ++  Y  
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG-KWPVKWYAPECIN-YYKF 191
Query: 260 THKCDVYSFGMVLFE 274
           + K DV+SFG++++E
Sbjct: 192 SSKSDVWSFGVLMWE 206

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 39/221 (17%)
Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G FG+V K +   +    A+K +     +++    ++EV  +    H  +VR Y   
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS--TILSEVMLLASLNHQYVVRYYAAW 71
Query: 145 HDQH-----MTA--------LVYEYMENGSLDGYL----FGKKRAIEWEKLHEIAIGTAK 187
            ++      MTA        +  EY EN +L   +      ++R   W    +I     +
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL----E 127
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN------------KTH 235
            L Y+H    Q IIH D+KP N+ +D + + K+ DFGLAK   R+             + 
Sbjct: 128 ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
             ++   GT  Y A E L G      K D+YS G++ FE++
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 86  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 141
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 133
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNYPIT 260
           H D+   NVLL      K++DFGL+K    ++ +     +   P  + APE ++  Y  +
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 192
Query: 261 HKCDVYSFGMVLFE 274
            K DV+SFG++++E
Sbjct: 193 SKSDVWSFGVLMWE 206

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 121/308 (39%), Gaps = 56/308 (18%)
Query: 82  YSTRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI 135
           Y   +G G FG V++ + P  +       +AVK+L        +  F  E   +    + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 136 NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--------------- 180
           N+V+L G C       L++EYM  G L+ +L            H                
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 181 --------IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
                   IA   A G+ YL E   ++ +H D+   N L+  N   K+ADFGL++    +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNI-YS 226
Query: 233 KTHVTISGYKGTP-GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG-ATESL 290
             +    G    P  +  PE +  N   T + DV+++G+VL+EI         G A E +
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285
Query: 291 DWFPK--HVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVI 348
            ++ +  ++    E C L            +     RLC   L      P DRP   ++ 
Sbjct: 286 IYYVRDGNILACPENCPL------------ELYNLMRLCWSKL------PADRPSFCSIH 327
Query: 349 KMLEGVVE 356
           ++L+ + E
Sbjct: 328 RILQRMCE 335

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 83  STRLGFGGFGEVYKGQFPNGV--KIAVKVLNRNLGRIAEEQ-------FMAEVGTIGRTY 133
           S  LG G  GEV K  F      K+A+K++++    I   +          E+  + +  
Sbjct: 15  SKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE-KLHEIAIGTAKGLVYL 192
           H  ++++  F  D     +V E ME G L   + G KR  E   KL+   +  A  + YL
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYL 130
Query: 193 HEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
           HE     IIH D+KPENVLL +   +   K+ DFG +K+        T+    GTP Y A
Sbjct: 131 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPTYLA 184
Query: 250 PEFL--SGNYPITHKCDVYSFGMVLF 273
           PE L   G        D +S G++LF
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 83  STRLGFGGFGEVYKGQFPNGV--KIAVKVLNRNLGRIAEEQ-------FMAEVGTIGRTY 133
           S  LG G  GEV K  F      K+A+K++++    I   +          E+  + +  
Sbjct: 15  SKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE-KLHEIAIGTAKGLVYL 192
           H  ++++  F  D     +V E ME G L   + G KR  E   KL+   +  A  + YL
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYL 130
Query: 193 HEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
           HE     IIH D+KPENVLL +   +   K+ DFG +K+        T+    GTP Y A
Sbjct: 131 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPTYLA 184
Query: 250 PEFL--SGNYPITHKCDVYSFGMVLF 273
           PE L   G        D +S G++LF
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 83  STRLGFGGFGEVYKGQFPNGV--KIAVKVLNRNLGRIAEEQ-------FMAEVGTIGRTY 133
           S  LG G  GEV K  F      K+A+K++++    I   +          E+  + +  
Sbjct: 14  SKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 72
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE-KLHEIAIGTAKGLVYL 192
           H  ++++  F  D     +V E ME G L   + G KR  E   KL+   +  A  + YL
Sbjct: 73  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYL 129
Query: 193 HEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
           HE     IIH D+KPENVLL +   +   K+ DFG +K+        T+    GTP Y A
Sbjct: 130 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPTYLA 183
Query: 250 PEFL--SGNYPITHKCDVYSFGMVLF 273
           PE L   G        D +S G++LF
Sbjct: 184 PEVLVSVGTAGYNRAVDCWSLGVILF 209

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 25/227 (11%)
Query: 79  TSNYS--TRLGFGGFGEVYKGQFPNGVKI----AVKVLNRNLGR----IAEEQFMAEVGT 128
           TS Y     +G G +G VYK + P+        +V+V N   G     I+  + +A +  
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 129 IGRTYHINLVRLYGFCHDQHM-----TALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIA 182
           +    H N+VRL   C            LV+E+++   L  YL       +  E + ++ 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK 242
               +GL +LH  C   I+H D+KPEN+L+ +  + K+ADFGLA++       + ++   
Sbjct: 127 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALTPVV 180
Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES 289
            T  Y APE L  +   T   D++S G +  E+  RR+    G +E+
Sbjct: 181 VTLWYRAPEVLLQSTYAT-PVDMWSVGCIFAEMF-RRKPLFCGNSEA 225

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 83  STRLGFGGFGEVYKGQFPNGV--KIAVKVLNRNLGRIAEEQ-------FMAEVGTIGRTY 133
           S  LG G  GEV K  F      K+A+K++++    I   +          E+  + +  
Sbjct: 15  SKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE-KLHEIAIGTAKGLVYL 192
           H  ++++  F  D     +V E ME G L   + G KR  E   KL+   +  A  + YL
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYL 130
Query: 193 HEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
           HE     IIH D+KPENVLL +   +   K+ DFG +K+        T+    GTP Y A
Sbjct: 131 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPTYLA 184
Query: 250 PEFL--SGNYPITHKCDVYSFGMVLF 273
           PE L   G        D +S G++LF
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 94/189 (49%), Gaps = 19/189 (10%)
Query: 90  GFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM 149
           G G+ Y  +F     I  + L+ +   ++ E+   EV  +    H N++ L+    ++  
Sbjct: 28  GTGKEYAAKF-----IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82
Query: 150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN 209
             L+ E +  G L  +L  +K ++  ++  +       G+ YLH    +RI H+D+KPEN
Sbjct: 83  VVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPEN 138
Query: 210 V-LLDANF-SP--KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PITHKCD 264
           + LLD N  +P  K+ DFG+A   +       I    GTP + APE +  NY P+  + D
Sbjct: 139 IMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAPEIV--NYEPLGLEAD 193
Query: 265 VYSFGMVLF 273
           ++S G++ +
Sbjct: 194 MWSIGVITY 202

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 94/189 (49%), Gaps = 19/189 (10%)
Query: 90  GFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM 149
           G G+ Y  +F     I  + L+ +   ++ E+   EV  +    H N++ L+    ++  
Sbjct: 35  GTGKEYAAKF-----IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 89
Query: 150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN 209
             L+ E +  G L  +L  +K ++  ++  +       G+ YLH    +RI H+D+KPEN
Sbjct: 90  VVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPEN 145
Query: 210 V-LLDANF-SP--KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PITHKCD 264
           + LLD N  +P  K+ DFG+A   +       I    GTP + APE +  NY P+  + D
Sbjct: 146 IMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAPEIV--NYEPLGLEAD 200
Query: 265 VYSFGMVLF 273
           ++S G++ +
Sbjct: 201 MWSIGVITY 209

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 14/194 (7%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF 143
           LG G F  V +  + P G + A K++N       + Q +     I R   H N+VRL+  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 202
             ++    LV++ +  G L   +  ++   E +  H I     + ++     C    I+H
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI-----QQILESVNHCHLNGIVH 126
Query: 203 YDIKPENVLLDAN---FSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            D+KPEN+LL +     + K+ADFGLA   +         G+ GTPGY +PE L  + P 
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLRKD-PY 183
Query: 260 THKCDVYSFGMVLF 273
               D+++ G++L+
Sbjct: 184 GKPVDMWACGVILY 197

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 83  STRLGFGGFGEVYKGQFPNGV--KIAVKVLNRNLGRIAEEQ-------FMAEVGTIGRTY 133
           S  LG G  GEV K  F      K+A+K++++    I   +          E+  + +  
Sbjct: 21  SKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 79
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE-KLHEIAIGTAKGLVYL 192
           H  ++++  F  D     +V E ME G L   + G KR  E   KL+   +  A  + YL
Sbjct: 80  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYL 136
Query: 193 HEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
           HE     IIH D+KPENVLL +   +   K+ DFG +K+        T+    GTP Y A
Sbjct: 137 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPTYLA 190
Query: 250 PEFL--SGNYPITHKCDVYSFGMVLF 273
           PE L   G        D +S G++LF
Sbjct: 191 PEVLVSVGTAGYNRAVDCWSLGVILF 216

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 86  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 141
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 437 GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 491
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNYPIT 260
           H D+   NVLL      K++DFGL+K    ++ +     +   P  + APE ++  Y  +
Sbjct: 492 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 550
Query: 261 HKCDVYSFGMVLFE 274
            K DV+SFG++++E
Sbjct: 551 SKSDVWSFGVLMWE 564

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 86  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 141
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 438 GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 492
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNYPIT 260
           H D+   NVLL      K++DFGL+K    ++ +     +   P  + APE ++  Y  +
Sbjct: 493 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 551
Query: 261 HKCDVYSFGMVLFE 274
            K DV+SFG++++E
Sbjct: 552 SKSDVWSFGVLMWE 565

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 86/201 (42%), Gaps = 15/201 (7%)
Query: 81  NYSTRLGFGGFGEVYKG-QFPNGVKIA-VKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
            +   +G G F  VYKG      V++A  ++ +R L +   ++F  E   +    H N+V
Sbjct: 29  KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIV 88
Query: 139 RLY----GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
           R Y         +    LV E   +G+L  YL  + +  + + L        KGL +LH 
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELXTSGTLKTYL-KRFKVXKIKVLRSWCRQILKGLQFLHT 147
Query: 195 ECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
                IIH D+K +N+ +     S K+ D GLA L   +     I    GTP + APE  
Sbjct: 148 RTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFXAPEXY 202
Query: 254 SGNYPITHKCDVYSFGMVLFE 274
              Y      DVY+FG    E
Sbjct: 203 EEKYD--ESVDVYAFGXCXLE 221

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 116/236 (49%), Gaps = 20/236 (8%)
Query: 64  REKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQF 122
           RE     +SL L +F  +    +G G + +V   +     +I A+KV+ + L  + +++ 
Sbjct: 8   RESGKASSSLGLQDF--DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKEL--VNDDED 63
Query: 123 MAEVGTIGRTY-----HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK 177
           +  V T    +     H  LV L+     +     V EY+  G L  +   ++R +  E 
Sbjct: 64  IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEH 122
Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
               +   +  L YLHE   + II+ D+K +NVLLD+    K+ D+G+ K   R     T
Sbjct: 123 ARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T 177
Query: 238 ISGYKGTPGYSAPEFLSG-NYPITHKCDVYSFGMVLFEIV-GRRRNAIVGATESLD 291
            S + GTP Y APE L G +Y  +   D ++ G+++FE++ GR    IVG++++ D
Sbjct: 178 TSXFCGTPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPD 231

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 91/198 (45%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  +    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 149
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 210 SIDIWSVGCILAEMLSNR 227

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 91/198 (45%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  +    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 149
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 210 SIDIWSVGCILAEMLSNR 227

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 93/189 (49%), Gaps = 19/189 (10%)
Query: 90  GFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM 149
           G G+ Y  +F     I  + L  +   ++ E+   EV  +    H N++ L+    ++  
Sbjct: 49  GTGKEYAAKF-----IKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 103
Query: 150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN 209
             L+ E +  G L  +L  +K ++  ++  +       G+ YLH    +RI H+D+KPEN
Sbjct: 104 VVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPEN 159
Query: 210 V-LLDANF-SP--KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY-PITHKCD 264
           + LLD N  +P  K+ DFG+A   +       I    GTP + APE +  NY P+  + D
Sbjct: 160 IMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAPEIV--NYEPLGLEAD 214
Query: 265 VYSFGMVLF 273
           ++S G++ +
Sbjct: 215 MWSIGVITY 223

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 96/230 (41%), Gaps = 35/230 (15%)
Query: 86  LGFGGFGEVYK----GQFPNGVKI--AVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLV 138
           LG G FG+V      G    GV I  AVK+L         E  M+E+  + +   H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKR----------------------AIEWE 176
            L G C       L++EY   G L  YL  K+                        + +E
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
            L   A   AKG+ +L     +  +H D+   NVL+      K+ DFGLA+    +  +V
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 237 TISGYKGTPGYSAPEFL-SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG 285
                +    + APE L  G Y I  K DV+S+G++L+EI     N   G
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTI--KSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGF 143
           LG G +G V K +  P+G  +AVK +   +    +++ + ++    RT      V  YG 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 144 CHDQHMTALVYEYMENGSLDGY---LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
              +    +  E M+  SLD +   +  K + I  + L +IA+   K L +LH +    +
Sbjct: 119 LFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 175
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG--TPGYSAPEFLSGNYP 258
           IH D+KP NVL++A    K+ DFG++     +      +G K    P    PE     Y 
Sbjct: 176 IHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYS 235
Query: 259 ITHKCDVYSFGMVLFEIVGRR 279
           +  K D++S G+ + E+   R
Sbjct: 236 V--KSDIWSLGITMIELAILR 254

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 78  FTSNYSTR--LGFGGFGEVYKGQFPNGVK-IAVKVLNR------------NLGRIAEEQF 122
           ++  YST   LG G FG V+        K + VK + +             LG++     
Sbjct: 22  YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT---- 77
Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI- 181
             E+  + R  H N++++     +Q    LV E   +G LD + F  +     E L    
Sbjct: 78  -LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYI 135
Query: 182 --AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS 239
              + +A G + L +     IIH DIK EN+++  +F+ K+ DFG A   +R K   T  
Sbjct: 136 FRQLVSAVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-- 188
Query: 240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            + GT  Y APE L GN     + +++S G+ L+ +V
Sbjct: 189 -FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 120/279 (43%), Gaps = 32/279 (11%)
Query: 86  LGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FG+V+  +  N       + +AVK L +     A + F  E   +    H ++VR
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVR 84
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF-----------GKKRA---IEWEKLHEIAIGT 185
            +G C +     +V+EYM +G L+ +L            G+  A   +   +L  +A   
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT-HVTISGYKGT 244
           A G+VYL        +H D+   N L+      K+ DFG+++  D   T +  + G    
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRTML 199
Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV--GRRRNAIVGATESLDWFPK-HVWEEY 301
           P    P         T + DV+SFG+VL+EI   G++    +  TE++D   +    E  
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERP 259
Query: 302 EKC--ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSP 338
             C  E+ A++ GC   E  +  + +     L  +  +P
Sbjct: 260 RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 298

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 13/176 (7%)
Query: 105 IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDG 164
            AVK++++ +    +++  A     G   H N+V+L+   HDQ  T LV E +  G L  
Sbjct: 39  FAVKIISKRMEANTQKEITALKLCEG---HPNIVKLHEVFHDQLHTFLVMELLNGGELFE 95
Query: 165 YLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVA 221
            +  KK   E E  + I       + ++H+     ++H D+KPEN+L    + N   K+ 
Sbjct: 96  RIKKKKHFSETEASY-IMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKII 151
Query: 222 DFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 277
           DFG A+L   +   +    +  T  Y+APE L+ N      CD++S G++L+ ++ 
Sbjct: 152 DFGFARLKPPDNQPLKTPCF--TLHYAAPELLNQN-GYDESCDLWSLGVILYTMLS 204

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 12/194 (6%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAV--KVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V K +  +  +I    K L  +  ++ ++  M E+  + +  H NLV L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 144 CHDQHMTALVYEYMENGSLDGY-LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    LV+E++++  LD   LF     ++++ + +       G+ + H      IIH
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCH---SHNIIH 147
Query: 203 YDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            DIKPEN+L+  +   K+ DFG A+ L    + +        T  Y APE L G+     
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY---DDEVATRWYRAPELLVGDVKYGK 204
Query: 262 KCDVYSFGMVLFEI 275
             DV++ G ++ E+
Sbjct: 205 AVDVWAIGCLVTEM 218

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 120/279 (43%), Gaps = 32/279 (11%)
Query: 86  LGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FG+V+  +  N       + +AVK L +     A + F  E   +    H ++VR
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVR 78
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLF-----------GKKRA---IEWEKLHEIAIGT 185
            +G C +     +V+EYM +G L+ +L            G+  A   +   +L  +A   
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT-HVTISGYKGT 244
           A G+VYL        +H D+   N L+      K+ DFG+++  D   T +  + G    
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRTML 193
Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV--GRRRNAIVGATESLDWFPK-HVWEEY 301
           P    P         T + DV+SFG+VL+EI   G++    +  TE++D   +    E  
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERP 253
Query: 302 EKC--ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSP 338
             C  E+ A++ GC   E  +  + +     L  +  +P
Sbjct: 254 RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 292

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 128/285 (44%), Gaps = 53/285 (18%)
Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-- 142
           +G GGFG+V+K +   +G    +K +  N      E+   EV  + +  H+N+V   G  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYN-----NEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 143 --FCHDQHMTA------------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI--GTA 186
             F +D   ++            +  E+ + G+L+ ++  K+R  + +K+  + +     
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQIT 132
Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG 246
           KG+ Y+H    +++I+ D+KP N+ L      K+ DFGL      +         KGT  
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXR---SKGTLR 186
Query: 247 YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCEL 306
           Y +PE +S       + D+Y+ G++L E++    +    A E+  +F           +L
Sbjct: 187 YMSPEQISSQ-DYGKEVDLYALGLILAELL----HVCDTAFETSKFF----------TDL 231
Query: 307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML 351
              I+    ++K+K   ++L       +   PEDRP  S +++ L
Sbjct: 232 RDGIISDIFDKKEKTLLQKL-------LSKKPEDRPNTSEILRTL 269

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 120/279 (43%), Gaps = 32/279 (11%)
Query: 86  LGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG G FG+V+  +  N       + +AVK L +     A + F  E   +    H ++VR
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVR 107
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYL-----------FGKKRA---IEWEKLHEIAIGT 185
            +G C +     +V+EYM +G L+ +L            G+  A   +   +L  +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT-HVTISGYKGT 244
           A G+VYL        +H D+   N L+      K+ DFG+++  D   T +  + G    
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRTML 222
Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV--GRRRNAIVGATESLDWFPK-HVWEEY 301
           P    P         T + DV+SFG+VL+EI   G++    +  TE++D   +    E  
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERP 282
Query: 302 EKC--ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSP 338
             C  E+ A++ GC   E  +  + +     L  +  +P
Sbjct: 283 RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 78  FTSNYST--RLGFGGFGEVYK--GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 133
           FT +Y     LG G F  V +   + P   + A K++N       + Q +     I R  
Sbjct: 29  FTDDYQLFEELGKGAFSVVRRCVKKTPTQ-EYAAKIINTKKLSARDHQKLEREARICRLL 87
Query: 134 -HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 192
            H N+VRL+    ++    LV++ +  G L   +  ++   E +  H I     + + ++
Sbjct: 88  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH-QILESVNHI 146
Query: 193 HEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
           H   Q  I+H D+KPEN+LL +     + K+ADFGLA   +         G+ GTPGY +
Sbjct: 147 H---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGTPGYLS 201
Query: 250 PEFLSGNYPITHKCDVYSFGMVLF 273
           PE L  + P     D+++ G++L+
Sbjct: 202 PEVLRKD-PYGKPVDIWACGVILY 224

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H  LV L+     +     V EY+  G L  +   ++R +  E     +   +  L YLH
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
           E   + II+ D+K +NVLLD+    K+ D+G+ K   R     T S + GTP Y APE L
Sbjct: 171 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEIL 225
Query: 254 SG-NYPITHKCDVYSFGMVLFEIV-GRRRNAIVGATESLD 291
            G +Y  +   D ++ G+++FE++ GR    IVG++++ D
Sbjct: 226 RGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVK-IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           ++   LG G F EV   +     K +A+K + +      E     E+  + +  H N+V 
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L           L+ + +  G L   +  K    E +    +       + YLH+     
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA-SRLIFQVLDAVKYLHD---LG 136
Query: 200 IIHYDIKPENVL---LDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
           I+H D+KPEN+L   LD +    ++DFGL+K+ D       +S   GTPGY APE L+  
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQK 193
Query: 257 YPITHKCDVYSFGMVLF 273
            P +   D +S G++ +
Sbjct: 194 -PYSKAVDCWSIGVIAY 209

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 83  STRLGFGGFGEVYKGQFPNGV--KIAVKVLNRNLGRIAEEQ-------FMAEVGTIGRTY 133
           S  LG G  GEV K  F      K+A++++++    I   +          E+  + +  
Sbjct: 140 SKTLGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE-KLHEIAIGTAKGLVYL 192
           H  ++++  F  D     +V E ME G L   + G KR  E   KL+   +  A  + YL
Sbjct: 199 HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYL 255
Query: 193 HEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
           HE     IIH D+KPENVLL +   +   K+ DFG +K+        T+    GTP Y A
Sbjct: 256 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPTYLA 309
Query: 250 PEFL--SGNYPITHKCDVYSFGMVLF 273
           PE L   G        D +S G++LF
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILF 335

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVK-IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           ++   LG G F EV   +     K +A+K + +      E     E+  + +  H N+V 
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L           L+ + +  G L   +  K    E +    +       + YLH+     
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA-SRLIFQVLDAVKYLHD---LG 136
Query: 200 IIHYDIKPENVL---LDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
           I+H D+KPEN+L   LD +    ++DFGL+K+ D       +S   GTPGY APE L+  
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQK 193
Query: 257 YPITHKCDVYSFGMVLF 273
            P +   D +S G++ +
Sbjct: 194 -PYSKAVDCWSIGVIAY 209

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 83  STRLGFGGFGEVYKGQFPNGV--KIAVKVLNRNLGRIAEEQ-------FMAEVGTIGRTY 133
           S  LG G  GEV K  F      K+A++++++    I   +          E+  + +  
Sbjct: 154 SKTLGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 212
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE-KLHEIAIGTAKGLVYL 192
           H  ++++  F  D     +V E ME G L   + G KR  E   KL+   +  A  + YL
Sbjct: 213 HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYL 269
Query: 193 HEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
           HE     IIH D+KPENVLL +   +   K+ DFG +K+        T+    GTP Y A
Sbjct: 270 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPTYLA 323
Query: 250 PEFL--SGNYPITHKCDVYSFGMVLF 273
           PE L   G        D +S G++LF
Sbjct: 324 PEVLVSVGTAGYNRAVDCWSLGVILF 349

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 78  FTSNYST--RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY- 133
           F S Y     LG G F  V +  +   G + A K++N       + Q +     I R   
Sbjct: 20  FQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLK 79
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H N+VRL+    ++    L+++ +  G L   +  ++   E +  H I     + +++ H
Sbjct: 80  HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QILEAVLHCH 138
Query: 194 EECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAP 250
              Q  ++H D+KPEN+LL +     + K+ADFGLA   +  +      G+ GTPGY +P
Sbjct: 139 ---QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSP 193
Query: 251 EFLSGNYPITHKCDVYSFGMVLF 273
           E L  + P     D+++ G++L+
Sbjct: 194 EVLRKD-PYGKPVDLWACGVILY 215

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVK-IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           ++   LG G F EV   +     K +A+K + +      E     E+  + +  H N+V 
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L           L+ + +  G L   +  K    E +    +       + YLH+     
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA-SRLIFQVLDAVKYLHD---LG 136
Query: 200 IIHYDIKPENVL---LDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
           I+H D+KPEN+L   LD +    ++DFGL+K+ D       +S   GTPGY APE L+  
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQK 193
Query: 257 YPITHKCDVYSFGMVLF 273
            P +   D +S G++ +
Sbjct: 194 -PYSKAVDCWSIGVIAY 209

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 90/198 (45%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   +     T  Y APE +  +   T 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 90/198 (45%), Gaps = 7/198 (3%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 145 HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 152
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL+     K+ DFGLA++ D +  H   +     T  Y APE +  +   T 
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 262 KCDVYSFGMVLFEIVGRR 279
             D++S G +L E++  R
Sbjct: 213 SIDIWSVGCILAEMLSNR 230

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H  LV L+     +     V EY+  G L  +   ++R +  E     +   +  L YLH
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
           E   + II+ D+K +NVLLD+    K+ D+G+ K   R     T S + GTP Y APE L
Sbjct: 128 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEIL 182
Query: 254 SG-NYPITHKCDVYSFGMVLFEIV-GRRRNAIVGATESLD 291
            G +Y  +   D ++ G+++FE++ GR    IVG++++ D
Sbjct: 183 RGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H  LV L+     +     V EY+  G L  +   ++R +  E     +   +  L YLH
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
           E   + II+ D+K +NVLLD+    K+ D+G+ K   R     T S + GTP Y APE L
Sbjct: 124 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEIL 178
Query: 254 SG-NYPITHKCDVYSFGMVLFEIV-GRRRNAIVGATESLD 291
            G +Y  +   D ++ G+++FE++ GR    IVG++++ D
Sbjct: 179 RGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPD 216

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           +G G FGEV   +  +  K+ A+K+L++   + R     F  E   +       +V+L+ 
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
              D     +V EYM  G L   +       +W + +     TA+ ++ L        IH
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIH 196
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS---GNYPI 259
            D+KP+N+LLD +   K+ADFG     ++ +  V      GTP Y +PE L    G+   
Sbjct: 197 RDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVLKSQGGDGYY 255
Query: 260 THKCDVYSFGMVLFEIV 276
             +CD +S G+ L+E++
Sbjct: 256 GRECDWWSVGVFLYEML 272

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           +G G FGEV   +  +  K+ A+K+L++   + R     F  E   +       +V+L+ 
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
              D     +V EYM  G L   +       +W + +     TA+ ++ L        IH
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIH 191
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS---GNYPI 259
            D+KP+N+LLD +   K+ADFG     ++ +  V      GTP Y +PE L    G+   
Sbjct: 192 RDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVLKSQGGDGYY 250
Query: 260 THKCDVYSFGMVLFEIV 276
             +CD +S G+ L+E++
Sbjct: 251 GRECDWWSVGVFLYEML 267

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVK-IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           ++   LG G F EV   +     K +A+K + +      E     E+  + +  H N+V 
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L           L+ + +  G L   +  K    E +    +       + YLH+     
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA-SRLIFQVLDAVKYLHD---LG 136
Query: 200 IIHYDIKPENVL---LDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
           I+H D+KPEN+L   LD +    ++DFGL+K+ D       +S   GTPGY APE L+  
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQK 193
Query: 257 YPITHKCDVYSFGMVLF 273
            P +   D +S G++ +
Sbjct: 194 -PYSKAVDCWSIGVIAY 209

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYGF 143
           +G G +G V K    P+G  +AVK +   +    ++Q + ++  + R+     +V+ YG 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 144 CHDQHMTALVYEYMENGSLDG---YLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
              +    +  E M   S D    Y++      I  E L +I + T K L +L E    +
Sbjct: 90  LFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--K 146
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGN-- 256
           IIH DIKP N+LLD + + K+ DFG++ +L D     +  +   G   Y APE +  +  
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----SIAKTRDAGCRPYMAPERIDPSAS 202
Query: 257 ---YPITHKCDVYSFGMVLFEIVGRR 279
              Y +  + DV+S G+ L+E+   R
Sbjct: 203 RQGYDV--RSDVWSLGITLYELATGR 226

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 94/215 (43%), Gaps = 17/215 (7%)
Query: 69  RFTSLQLNNFTSNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVG 127
           R+T LQ           +G G +G V          ++A+K ++    +   ++ + E+ 
Sbjct: 44  RYTQLQY----------IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQ 93
Query: 128 TIGRTYHINLVRLYGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT 185
            + R  H N++ +        + A+  VY   +    D Y   K + +  + +       
Sbjct: 94  ILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQI 153
Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGT 244
            +GL Y+H      ++H D+KP N+L++     K+ DFGLA++ D    H   ++    T
Sbjct: 154 LRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVAT 210
Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
             Y APE +  +   T   D++S G +L E++  R
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 72  SLQLNNF--TSNYSTRLGFGGFGEVY-KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT 128
           S+Q  N   T  +   LG G F EV+   Q   G   A+K + ++     +     E+  
Sbjct: 1   SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAV 59
Query: 129 IGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKG 188
           + +  H N+V L           LV + +  G L   +   +R +  EK   + I     
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL--ERGVYTEKDASLVIQQVLS 117
Query: 189 LV-YLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
            V YLHE     I+H D+KPEN+L    + N    + DFGL+K+    + +  +S   GT
Sbjct: 118 AVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGT 170
Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
           PGY APE L+   P +   D +S G++ +
Sbjct: 171 PGYVAPEVLAQK-PYSKAVDCWSIGVITY 198

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           +G G FGEV   +  +  K+ A+K+L++   + R     F  E   +       +V+L+ 
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
              D     +V EYM  G L   +       +W + +     TA+ ++ L        IH
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIH 196
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS---GNYPI 259
            D+KP+N+LLD +   K+ADFG     ++ +  V      GTP Y +PE L    G+   
Sbjct: 197 RDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVLKSQGGDGYY 255
Query: 260 THKCDVYSFGMVLFEIV 276
             +CD +S G+ L+E++
Sbjct: 256 GRECDWWSVGVFLYEML 272

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 23/214 (10%)
Query: 81  NYSTRLGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTY 133
           N    LG G FG+V +       +      +AVK+L            M+E+   I   +
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 134 HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGK-----------KRAIEWEKLHEI 181
           H+N+V L G C       +V  E+ + G+L  YL  K           K  +  E L   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY 241
           +   AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 242 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
           +    + APE +      T + DV+SFG++L+EI
Sbjct: 207 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 239

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 129
           + +N F   Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 145 VTMNEF--EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 202
Query: 130 GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
             + H  L  L Y F  HD+     V EY   G L  +L  ++R    ++          
Sbjct: 203 QNSRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVS 259
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
            L YLH E  + +++ D+K EN++LD +   K+ DFGL K  +  K   T+  + GTP Y
Sbjct: 260 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEY 315
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            APE L  N       D +  G+V++E++  R
Sbjct: 316 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 129
           + +N F   Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 148 VTMNEF--EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 205
Query: 130 GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
             + H  L  L Y F  HD+     V EY   G L  +L  ++R    ++          
Sbjct: 206 QNSRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVS 262
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
            L YLH E  + +++ D+K EN++LD +   K+ DFGL K  +  K   T+  + GTP Y
Sbjct: 263 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEY 318
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            APE L  N       D +  G+V++E++  R
Sbjct: 319 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGF 143
           LG G +G V K +  P+G  +AVK +   +    +++ + ++    RT      V  YG 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 144 CHDQHMTALVYEYMENGSLDGY---LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
              +    +  E M+  SLD +   +  K + I  + L +IA+   K L +LH +    +
Sbjct: 75  LFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG--TPGYSAPEFLSGNYP 258
           IH D+KP NVL++A    K+ DFG++     +      +G K    P    PE     Y 
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYS 191
Query: 259 ITHKCDVYSFGMVLFEIVGRR 279
           +  K D++S G+ + E+   R
Sbjct: 192 V--KSDIWSLGITMIELAILR 210

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRT-Y 133
           ++   LG G FG+V +      +K      +AVK+L  +      E  M+E+  +     
Sbjct: 42  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 101
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH-------------- 179
           H+N+V L G C     T ++ EY   G L  +L  K+ +    K                
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 180 ---EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
                +   AKG+ +L     +  IH D+   N+LL      K+ DFGLA+    +  +V
Sbjct: 162 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 218
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
                +    + APE +  N   T + DV+S+G+ L+E+
Sbjct: 219 VKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWEL 256

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 129
           + +N+F  +Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 7   VTMNDF--DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 64
Query: 130 GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
             T H  L  L Y F  HD+     V EY   G L  +L  ++R    E+          
Sbjct: 65  QNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVS 121
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
            L YLH    + +++ DIK EN++LD +   K+ DFGL K  +      T+  + GTP Y
Sbjct: 122 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEY 176
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            APE L  N       D +  G+V++E++  R
Sbjct: 177 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 129
           + +N+F  +Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 2   VTMNDF--DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 130 GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
             T H  L  L Y F  HD+     V EY   G L  +L  ++R    E+          
Sbjct: 60  QNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVS 116
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
            L YLH    + +++ DIK EN++LD +   K+ DFGL K  +      T+  + GTP Y
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEY 171
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            APE L  N       D +  G+V++E++  R
Sbjct: 172 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 96/233 (41%), Gaps = 33/233 (14%)
Query: 82  YSTRLGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YH 134
           +   LG G FG+V +      G+    +K+AVK+L        +E  M+E+  +     H
Sbjct: 35  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 94
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK----------------------RA 172
            N+V L G C       ++ EY   G L  +L  K                       R 
Sbjct: 95  ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP 154
Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           +E   L   +   A+G+ +L     +  IH D+   NVLL      K+ DFGLA+    +
Sbjct: 155 LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG 285
             ++     +    + APE +  +   T + DV+S+G++L+EI     N   G
Sbjct: 212 SNYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 15/214 (7%)
Query: 71  TSLQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVG 127
           + + +N F   Y   LG G FG+V    +   G   A+K+L + +    +E    + E  
Sbjct: 3   SRVTMNEF--EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 60
Query: 128 TIGRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT 185
            +  + H  L  L Y F  HD+     V EY   G L  +L  ++R    ++        
Sbjct: 61  VLQNSRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEI 117
Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
              L YLH E  + +++ D+K EN++LD +   K+ DFGL K  +  K   T+  + GTP
Sbjct: 118 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTP 173
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            Y APE L  N       D +  G+V++E++  R
Sbjct: 174 EYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 206

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRT-Y 133
           ++   LG G FG+V +      +K      +AVK+L  +      E  M+E+  +     
Sbjct: 44  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 103
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH-------------- 179
           H+N+V L G C     T ++ EY   G L  +L  K+ +    K                
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 180 ---EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
                +   AKG+ +L     +  IH D+   N+LL      K+ DFGLA+    +  +V
Sbjct: 164 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 220
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
                +    + APE +  N   T + DV+S+G+ L+E+
Sbjct: 221 VKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWEL 258

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRT-Y 133
           ++   LG G FG+V +      +K      +AVK+L  +      E  M+E+  +     
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH-------------- 179
           H+N+V L G C     T ++ EY   G L  +L  K+ +    K                
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 180 ---EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
                +   AKG+ +L     +  IH D+   N+LL      K+ DFGLA+    +  +V
Sbjct: 169 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYV 225
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
                +    + APE +  N   T + DV+S+G+ L+E+
Sbjct: 226 VKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWEL 263

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 129
           + +N+F  +Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 5   VTMNDF--DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 62
Query: 130 GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
             T H  L  L Y F  HD+     V EY   G L  +L  ++R    E+          
Sbjct: 63  QNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVS 119
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
            L YLH    + +++ DIK EN++LD +   K+ DFGL K  +      T+  + GTP Y
Sbjct: 120 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEY 174
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            APE L  N       D +  G+V++E++  R
Sbjct: 175 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 129
           + +N+F  +Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 2   VTMNDF--DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 130 GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
             T H  L  L Y F  HD+     V EY   G L  +L  ++R    E+          
Sbjct: 60  QNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVS 116
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
            L YLH    + +++ DIK EN++LD +   K+ DFGL K  +      T+  + GTP Y
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEY 171
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            APE L  N       D +  G+V++E++  R
Sbjct: 172 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 86  LGFGGFGEVYKGQ-FPNGVK-IAVKVLNRNLGR----IAEEQFMAEVGTIGRTYHINLVR 139
           +G G +G+V+K +   NG + +A+K +    G     ++  + +A +  +    H N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 140 LYGFC-----HDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLH 193
           L+  C       +    LV+E+++   L  YL    +  +  E + ++     +GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
                R++H D+KP+N+L+ ++   K+ADFGLA++       + ++    T  Y APE L
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVL 191
Query: 254 SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATE 288
             +   T   D++S G +  E+  RR+    G+++
Sbjct: 192 LQSSYAT-PVDLWSVGCIFAEMF-RRKPLFRGSSD 224

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 86  LGFGGFGEVYKGQ-FPNGVK-IAVKVLNRNLGR----IAEEQFMAEVGTIGRTYHINLVR 139
           +G G +G+V+K +   NG + +A+K +    G     ++  + +A +  +    H N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 140 LYGFC-----HDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLH 193
           L+  C       +    LV+E+++   L  YL    +  +  E + ++     +GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
                R++H D+KP+N+L+ ++   K+ADFGLA++       + ++    T  Y APE L
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVL 191
Query: 254 SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATE 288
             +   T   D++S G +  E+  RR+    G+++
Sbjct: 192 LQSSYAT-PVDLWSVGCIFAEMF-RRKPLFRGSSD 224

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 23/214 (10%)
Query: 81  NYSTRLGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTY 133
           N    LG G FG+V +       +      +AVK+L            M+E+   I   +
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 134 HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGK-----------KRAIEWEKLHEI 181
           H+N+V L G C       +V  E+ + G+L  YL  K           K  +  E L   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY 241
           +   AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 242 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
           +    + APE +      T + DV+SFG++L+EI
Sbjct: 207 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 239

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 109/259 (42%), Gaps = 31/259 (11%)
Query: 63  GREKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVK-IAVKVLNRNLGRIAE 119
           GRE  + F  ++  +   NY  +  +G G +G VY     N  K +A+K +NR    + +
Sbjct: 10  GREN-LYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID 68
Query: 120 -EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL--VYEYMENGSLD-GYLFGKKRAIEW 175
            ++ + E+  + R     ++RLY       +     +Y  +E    D   LF     +  
Sbjct: 69  CKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTE 128
Query: 176 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK-T 234
           E +  I      G  ++HE     IIH D+KP N LL+ + S KV DFGLA+  +  K T
Sbjct: 129 EHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 235 HVT-------------------ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
           ++                    ++ +  T  Y APE +      T   D++S G +  E+
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 276 VGRRRNAIVGATESLDWFP 294
           +   ++ I   T     FP
Sbjct: 246 LNMLQSHINDPTNRFPLFP 264

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 129
           + +N+F  +Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 2   VTMNDF--DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 130 GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
             T H  L  L Y F  HD+     V EY   G L  +L  ++R    E+          
Sbjct: 60  QNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVS 116
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
            L YLH    + +++ DIK EN++LD +   K+ DFGL K  +      T+  + GTP Y
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEY 171
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            APE L  N       D +  G+V++E++  R
Sbjct: 172 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 129
           + +N+F  +Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 2   VTMNDF--DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 130 GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
             T H  L  L Y F  HD+     V EY   G L  +L  ++R    E+          
Sbjct: 60  QNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVS 116
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
            L YLH    + +++ DIK EN++LD +   K+ DFGL K  +      T+  + GTP Y
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEY 171
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            APE L  N       D +  G+V++E++  R
Sbjct: 172 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 129
           + +N F   Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 6   VTMNEF--EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 63
Query: 130 GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
             + H  L  L Y F  HD+     V EY   G L  +L  ++R    ++          
Sbjct: 64  QNSRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVS 120
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
            L YLH E  + +++ D+K EN++LD +   K+ DFGL K  +  K   T+  + GTP Y
Sbjct: 121 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEY 176
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            APE L  N       D +  G+V++E++  R
Sbjct: 177 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRT-Y 133
           ++   LG G FG+V +      +K      +AVK+L  +      E  M+E+  +     
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH-------------- 179
           H+N+V L G C     T ++ EY   G L  +L  K+ +    K                
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 180 ---EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
                +   AKG+ +L     +  IH D+   N+LL      K+ DFGLA+    +  +V
Sbjct: 169 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 225
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
                +    + APE +  N   T + DV+S+G+ L+E+
Sbjct: 226 VKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWEL 263

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 129
           + +N F   Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 7   VTMNEF--EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 64
Query: 130 GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
             + H  L  L Y F  HD+     V EY   G L  +L  ++R    ++          
Sbjct: 65  QNSRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVS 121
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
            L YLH E  + +++ D+K EN++LD +   K+ DFGL K  +  K   T+  + GTP Y
Sbjct: 122 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEY 177
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            APE L  N       D +  G+V++E++  R
Sbjct: 178 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 208

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 81  NYSTRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRT-Y 133
           ++   LG G FG+V +      +K      +AVK+L  +      E  M+E+  +     
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH-------------- 179
           H+N+V L G C     T ++ EY   G L  +L  K+ +    K                
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 180 ---EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
                +   AKG+ +L     +  IH D+   N+LL      K+ DFGLA+    +  +V
Sbjct: 146 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
                +    + APE +  N   T + DV+S+G+ L+E+
Sbjct: 203 VKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWEL 240

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 130/298 (43%), Gaps = 66/298 (22%)
Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-- 142
           +G GGFG+V+K +   +G    ++ +  N      E+   EV  + +  H+N+V   G  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYN-----NEKAEREVKALAKLDHVNIVHYNGCW 74
Query: 143 --FCHDQHMTA-------------------------LVYEYMENGSLDGYLFGKKRAIEW 175
             F +D   +                          +  E+ + G+L+ ++  K+R  + 
Sbjct: 75  DGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKL 133
Query: 176 EKLHEIAI--GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK 233
           +K+  + +     KG+ Y+H    +++IH D+KP N+ L      K+ DFGL     +N 
Sbjct: 134 DKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL-KND 189
Query: 234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWF 293
              T S  KGT  Y +PE +S       + D+Y+ G++L E++    +    A E+  +F
Sbjct: 190 GKRTRS--KGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELL----HVCDTAFETSKFF 242
Query: 294 PKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML 351
                      +L   I+    ++K+K   ++L       +   PEDRP  S +++ L
Sbjct: 243 ----------TDLRDGIISDIFDKKEKTLLQKL-------LSKKPEDRPNTSEILRTL 283

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 129
           + +N+F  +Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 2   VTMNDF--DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 130 GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
             T H  L  L Y F  HD+     V EY   G L  +L  ++R    E+          
Sbjct: 60  QNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVS 116
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
            L YLH    + +++ DIK EN++LD +   K+ DFGL K  +      T+  + GTP Y
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEY 171
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            APE L  N       D +  G+V++E++  R
Sbjct: 172 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 86  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 138
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 139 RLYGFCHDQHMTALV-YEYMENGSLDGYLFGK-------------KRAIEWEKLHEIAIG 184
            L G C       +V  E+ + G+L  YL  K             K  +  E L   +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
            AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++   V     +  
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
             + APE +      T + DV+SFG++L+EI
Sbjct: 214 LKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 243

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIA----VKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           ++G G +G V+K +     +I     V++ + + G       + E+  +    H N+VRL
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG--VPSSALREICLLKELKHKNIVRL 66
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           +   H      LV+E+ +   L  Y       ++ E +        KGL + H    + +
Sbjct: 67  HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG---TPGYSAPEFLSGNY 257
           +H D+KP+N+L++ N   K+ADFGLA+        + +  Y     T  Y  P+ L G  
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLAR-----AFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 258 PITHKCDVYSFGMVLFEIVGRRRNAIVG 285
             +   D++S G +  E+    R    G
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPG 205

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 12/196 (6%)
Query: 82  YSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           +   LG G F EV   +    G   AVK + +   +  E     E+  + +  H N+V L
Sbjct: 26  FKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVAL 85
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
                  +   LV + +  G L   +  K    E +    +       + YLH   +  I
Sbjct: 86  EDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTE-KDASTLIRQVLDAVYYLH---RMGI 141
Query: 201 IHYDIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY 257
           +H D+KPEN+L    D      ++DFGL+K+  +     T     GTPGY APE L+   
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTAC---GTPGYVAPEVLAQK- 197
Query: 258 PITHKCDVYSFGMVLF 273
           P +   D +S G++ +
Sbjct: 198 PYSKAVDCWSIGVIAY 213

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 90/215 (41%), Gaps = 51/215 (23%)
Query: 106 AVKVLNRNLGRIAE----EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGS 161
           A+K++N+N  R       E+   EV  + + +H N+ RLY    D+    LV E    G 
Sbjct: 55  AIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGH 114
Query: 162 L-----------------------------------DGYLFGKKRAIEW---EKL-HEIA 182
           L                                   +G + G + ++++   EKL   I 
Sbjct: 115 LLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN--FSPKVADFGLAKLCDR--NKTHVTI 238
                 L YLH    Q I H DIKPEN L   N  F  K+ DFGL+K   +  N  +  +
Sbjct: 175 RQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM 231
Query: 239 SGYKGTPGYSAPEFL-SGNYPITHKCDVYSFGMVL 272
           +   GTP + APE L + N     KCD +S G++L
Sbjct: 232 TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 13/210 (6%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           +G G FG+V   Q  +  K+ A+K +N+   + R        E+  +    H  LV L+ 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
              D+    +V + +  G L  Y   +    + E +          L YL     QRIIH
Sbjct: 83  SFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKLFICELVMALDYLQ---NQRIIH 138
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI--T 260
            D+KP+N+LLD +    + DF +A +  R      I+   GT  Y APE  S       +
Sbjct: 139 RDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITTMAGTKPYMAPEMFSSRKGAGYS 195
Query: 261 HKCDVYSFGMVLFEIV-GRRRNAIVGATES 289
              D +S G+  +E++ GRR   I  +T S
Sbjct: 196 FAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 86  LGFGGFGEVYKGQ-FPNGVK-IAVKVLNRNLGR----IAEEQFMAEVGTIGRTYHINLVR 139
           +G G +G+V+K +   NG + +A+K +    G     ++  + +A +  +    H N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 140 LYGFC-----HDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLH 193
           L+  C       +    LV+E+++   L  YL    +  +  E + ++     +GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
                R++H D+KP+N+L+ ++   K+ADFGLA++       + ++    T  Y APE L
Sbjct: 138 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVL 191
Query: 254 SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATE 288
             +   T   D++S G +  E+  RR+    G+++
Sbjct: 192 LQSSYAT-PVDLWSVGCIFAEMF-RRKPLFRGSSD 224

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 103/245 (42%), Gaps = 33/245 (13%)
Query: 80  SNYSTR--LGFGGFGEVYKGQFPNGVK-IAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHI 135
            NY  +  +G G +G VY     N  K +A+K +NR    + + ++ + E+  + R    
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 136 NLVRLYGFCHDQHMTAL--VYEYMENGSLD-GYLFGKKRAIEWEKLHEIAIGTAKGLVYL 192
            ++RL+     + +     +Y  +E    D   LF     +  + +  I      G  ++
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFI 147
Query: 193 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK-THVT-------------- 237
           HE     IIH D+KP N LL+ + S K+ DFGLA+  + +K  H+               
Sbjct: 148 HESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGP 204
Query: 238 --------ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES 289
                   ++ +  T  Y APE +      T+  D++S G +  E++   ++ I   T  
Sbjct: 205 HNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNR 264
Query: 290 LDWFP 294
              FP
Sbjct: 265 FPLFP 269

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 81  NYSTRLGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTY 133
           N    LG G FG+V +       +      +AVK+L            M+E+   I   +
Sbjct: 31  NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 134 HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGK--------------KRAIEWEKL 178
           H+N+V L G C       +V  E+ + G+L  YL  K              K  +  E L
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 179 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI 238
              +   AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++   V  
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
              +    + APE +      T + DV+SFG++L+EI
Sbjct: 208 GDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 243

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 70  FTSLQLNNFTSNYST--RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEV 126
             ++    FT  Y     LG G F  V +  +   G + A  ++N       + Q +   
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 127 GTIGRTY-HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT 185
             I R   H N+VRL+    ++    L+++ +  G L   +  ++   E +  H I    
Sbjct: 61  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QI 119
Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKLCDRNKTHVTISGYK 242
            + +++ H   Q  ++H ++KPEN+LL +     + K+ADFGLA   +  +      G+ 
Sbjct: 120 LEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFA 174
Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
           GTPGY +PE L  + P     D+++ G++L+
Sbjct: 175 GTPGYLSPEVLRKD-PYGKPVDLWACGVILY 204

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 93/216 (43%), Gaps = 16/216 (7%)
Query: 77  NFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 133
           N +S++  +  LG G +G V      P G  +A+K +      +   + + E+  +    
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 134 HINLVRLYGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY 191
           H N++ ++             VY   E    D +     + +  + +      T + +  
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 192 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT--------ISGYKG 243
           LH      +IH D+KP N+L+++N   KV DFGLA++ D +    +        ++ Y  
Sbjct: 128 LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           T  Y APE +  +   +   DV+S G +L E+  RR
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 26/226 (11%)
Query: 82  YSTRLGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YH 134
           +   LG G FG+V +      G+    +K+AVK+L        +E  M+E+  +     H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEKLH 179
            N+V L G C       ++ EY   G L  +L  K+                 +    L 
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLL 169
Query: 180 EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS 239
             +   A+G+ +L     +  IH D+   NVLL      K+ DFGLA+    +  ++   
Sbjct: 170 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG 285
             +    + APE +  +   T + DV+S+G++L+EI     N   G
Sbjct: 227 NARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 86  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRL 140
           LG G FG V + Q      + VK+AVK+L  ++   ++ E+F+ E   +    H ++ +L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 141 YGFCHDQH------MTALVYEYMENGSLDGYLFGKKRA-----IEWEKLHEIAIGTAKGL 189
            G            +  ++  +M++G L  +L   +       +  + L    +  A G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
            YL     +  IH D+   N +L  + +  VADFGL++       +      K    + A
Sbjct: 151 EYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG 285
            E L+ N    H  DV++FG+ ++EI+ R +    G
Sbjct: 208 LESLADNLYTVHS-DVWAFGVTMWEIMTRGQTPYAG 242

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V       +G+KIAVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 116
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 117 --DVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 171
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 172 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 226
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 227 MHYNMTVDIWSVGCIMAELLTGR 249

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTH-VTISGYKGT 244
           +GL Y+H     ++IH D+KP N+L++ N   K+ DFG+A+ LC     H   ++ Y  T
Sbjct: 169 RGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR 280
             Y APE +   +  T   D++S G +  E++ RR+
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTH-VTISGYKGT 244
           +GL Y+H     ++IH D+KP N+L++ N   K+ DFG+A+ LC     H   ++ Y  T
Sbjct: 170 RGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR 280
             Y APE +   +  T   D++S G +  E++ RR+
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           +G G FGEV   +  N  K+ A+K+LN+   L R     F  E   +       +  L+ 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 143 FCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
              D +   LV +Y   G L   L  F  +   E  + +      A+ ++ +    Q   
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY-----LAEMVIAIDSVHQLHY 196
Query: 201 IHYDIKPENVLLDANFSPKVADFG-LAKLCDRNKTHVTISGYKGTPGYSAPEFLS----G 255
           +H DIKP+N+L+D N   ++ADFG   KL +      +++   GTP Y +PE L     G
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEGG 254
Query: 256 NYPITHKCDVYSFGMVLFEIV 276
                 +CD +S G+ ++E++
Sbjct: 255 KGRYGPECDWWSLGVCMYEML 275

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGCLLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 153
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+     +
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SAS 212
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 213 KSSDLWALGCIIYQLVA 229

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTI--GRTYHINLVRL 140
           +G G FGEV   +  N  +I A+K+LN+   L R     F  E   +  G    I  +  
Sbjct: 82  IGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH- 140
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y F  + H+  LV +Y   G L   L   +  +  E +    IG  + ++ +    Q   
Sbjct: 141 YAFQDENHLY-LVMDYYVGGDLLTLLSKFEDKLP-EDMARFYIG--EMVLAIDSIHQLHY 196
Query: 201 IHYDIKPENVLLDANFSPKVADFG-LAKLCDRNKTHVTISGYKGTPGYSAPEFL----SG 255
           +H DIKP+NVLLD N   ++ADFG   K+ D      +++   GTP Y +PE L     G
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA--VGTPDYISPEILQAMEDG 254
Query: 256 NYPITHKCDVYSFGMVLFEIV 276
                 +CD +S G+ ++E++
Sbjct: 255 MGKYGPECDWWSLGVCMYEML 275

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 91/193 (47%), Gaps = 12/193 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF 143
           +G G F  V +  +   G + A K++N       + Q +     I R   H N+VRL+  
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
             ++    LV++ +  G L   +  ++   E +  H I     + +++ H   Q  ++H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ-QILEAVLHCH---QMGVVHR 127
Query: 204 DIKPENVLLDANF---SPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           D+KPEN+LL +     + K+ADFGLA   +         G+ GTPGY +PE L       
Sbjct: 128 DLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLRKE-AYG 184
Query: 261 HKCDVYSFGMVLF 273
              D+++ G++L+
Sbjct: 185 KPVDIWACGVILY 197

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 19/205 (9%)
Query: 83  STRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRL 140
           S  LG G + +V       NG + AVK++ +  G  +  +   EV T+ +   + N++ L
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGH-SRSRVFREVETLYQCQGNKNILEL 76
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
             F  D     LV+E ++ GS+  ++  +K   E E    +    A  L +LH    + I
Sbjct: 77  IEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREA-SRVVRDVAAALDFLH---TKGI 132
Query: 201 IHYDIKPENVLLDA--NFSP-KVADFGLAKLCDRNKTHVTISGYK-----GTPGYSAPE- 251
            H D+KPEN+L ++    SP K+ DF L      N +   I+  +     G+  Y APE 
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEV 192
Query: 252 ---FLSGNYPITHKCDVYSFGMVLF 273
              F         +CD++S G+VL+
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLY 217

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 81  NYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
            +  RLG G FGEV++ +    G + AVK +   + R+  E+ +A  G         +V 
Sbjct: 75  THQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--EELVACAGL----SSPRIVP 128
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           LYG   +     +  E +E GSL G L  +   +  ++         +GL YLH    +R
Sbjct: 129 LYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRR 184
Query: 200 IIHYDIKPENVLLDANFS-PKVADFGLAKLCDR----NKTHVTISGYKGTPGYSAPEFLS 254
           I+H D+K +NVLL ++ S   + DFG A LC +     K+ +T     GT  + APE + 
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 243
Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
           G  P   K D++S   ++  ++
Sbjct: 244 GK-PCDAKVDIWSSCCMMLHML 264

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 39/221 (17%)
Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF- 143
           LG G FG+V K +   +    A+K +     +++    ++EV  +    H  +VR Y   
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS--TILSEVXLLASLNHQYVVRYYAAW 71
Query: 144 ------------CHDQHMTALVYEYMENGSLDGYL----FGKKRAIEWEKLHEIAIGTAK 187
                          +    +  EY EN +L   +      ++R   W    +I     +
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL----E 127
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN------------KTH 235
            L Y+H    Q IIH ++KP N+ +D + + K+ DFGLAK   R+             + 
Sbjct: 128 ALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
             ++   GT  Y A E L G      K D YS G++ FE +
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 86  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 138
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 139 RLYGFCHDQHMTALV-YEYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 182
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK 242
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++   V     +
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
               + APE +      T + DV+SFG++L+EI
Sbjct: 212 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 243

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTI--GRTYHINLVRL 140
           +G G FGEV   +  N  +I A+K+LN+   L R     F  E   +  G    I  +  
Sbjct: 98  IGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH- 156
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y F  + H+  LV +Y   G L   L   +  +  E +    IG    ++ +    Q   
Sbjct: 157 YAFQDENHLY-LVMDYYVGGDLLTLLSKFEDKLP-EDMARFYIGEM--VLAIDSIHQLHY 212
Query: 201 IHYDIKPENVLLDANFSPKVADFG-LAKLCDRNKTHVTISGYKGTPGYSAPEFL----SG 255
           +H DIKP+NVLLD N   ++ADFG   K+ D      +++   GTP Y +PE L     G
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA--VGTPDYISPEILQAMEDG 270
Query: 256 NYPITHKCDVYSFGMVLFEIV 276
                 +CD +S G+ ++E++
Sbjct: 271 MGKYGPECDWWSLGVCMYEML 291

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 86  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 138
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 139 RLYGFCHDQHMTALV-YEYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 182
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK 242
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     +
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
               + APE +      T + DV+SFG++L+EI
Sbjct: 212 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 243

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 151
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK-SAC 210
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 211 KSSDLWALGCIIYQLVA 227

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 58/109 (53%), Gaps = 15/109 (13%)
Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
           LH I I  A+ + +LH    + ++H D+KP N+    +   KV DFGL    D+++   T
Sbjct: 167 LH-IFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 238 I----------SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
           +           G  GT  Y +PE + GN   +HK D++S G++LFE++
Sbjct: 223 VLTPMPAYATHXGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELL 270

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 91/181 (50%), Gaps = 19/181 (10%)
Query: 101 NGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN 159
            G ++AVK ++ R   R   E    EV  +   +H N+V +Y          +V E++E 
Sbjct: 69  TGKQVAVKKMDLRKQQR--RELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEG 126
Query: 160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK 219
           G+L   +   +  +  E++  + +   + L YLH    Q +IH DIK +++LL ++   K
Sbjct: 127 GALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIK 181
Query: 220 VADFG----LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
           ++DFG    ++K   + K  V      GTP + APE +S   P   + D++S G+++ E+
Sbjct: 182 LSDFGFCAQVSKEVPKRKXLV------GTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEM 234
Query: 276 V 276
           +
Sbjct: 235 I 235

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 86  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 138
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 139 RLYGFCHDQHMTALV-YEYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 182
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK 242
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++   V     +
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
               + APE +      T + DV+SFG++L+EI
Sbjct: 203 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 234

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 65/131 (49%), Gaps = 16/131 (12%)
Query: 152 LVYEYMENGSL---DGYLFGKKRA----IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
           ++YEYMEN S+   D Y F   +     I  + +  I         Y+H E  + I H D
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRD 177
Query: 205 IKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT-HK 262
           +KP N+L+D N   K++DFG ++ + D+      I G +GT  +  PEF S        K
Sbjct: 178 VKPSNILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAK 232
Query: 263 CDVYSFGMVLF 273
            D++S G+ L+
Sbjct: 233 VDIWSLGICLY 243

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 86  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 138
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 139 RLYGFCHDQHMTALVY-EYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 182
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK 242
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     +
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
               + APE +      T + DV+SFG++L+EI
Sbjct: 203 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 234

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 86  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 138
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 139 RLYGFCHDQHMTALVY-EYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 182
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK 242
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++   V     +
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
               + APE +      T + DV+SFG++L+EI
Sbjct: 203 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 234

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 86  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 138
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 139 RLYGFCHDQHMTALVY-EYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 182
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK 242
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     +
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
               + APE +      T + DV+SFG++L+EI
Sbjct: 203 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 234

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 76  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 131
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 132 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 190
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 191 KSSDLWALGCIIYQLVA 207

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 73  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 128
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 129 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 187
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 188 KSSDLWALGCIIYQLVA 204

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 86  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 138
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 139 RLYGFCHDQHMTALV-YEYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 182
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK 242
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     +
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
               + APE +      T + DV+SFG++L+EI
Sbjct: 214 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 245

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 75  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 130
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 131 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 189
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 190 KSSDLWALGCIIYQLVA 206

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 129
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 188
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 189 KSSDLWALGCIIYQLVA 205

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 150
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SAC 209
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 210 KSSDLWALGCIIYQLVA 226

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 104/236 (44%), Gaps = 39/236 (16%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMA--EVGTIGRTYHINLVRLYG 142
           LG GGFGEV   Q    G   A K L +   +  + + MA  E   + +     +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 143 FCHDQHMTALVYEYMENGSLDGYL-------FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
               +    LV   M  G L  ++       F + RA+ +      A     GL  LH E
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY------AAEICCGLEDLHRE 305
Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV----TISGYKGTPGYSAPE 251
              RI++ D+KPEN+LLD +   +++D GLA        HV    TI G  GT GY APE
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLA-------VHVPEGQTIKGRVGTVGYMAPE 355
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIVG------RRRNAIVGATESLDWFPKHVWEEY 301
            +  N   T   D ++ G +L+E++       +R+  I    E ++   K V EEY
Sbjct: 356 VVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEVPEEY 408

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 154
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SAC 213
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 214 KSSDLWALGCIIYQLVA 230

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 86  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 138
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 139 RLYGFCHDQHMTALV-YEYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 182
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK 242
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     +
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
               + APE +      T + DV+SFG++L+EI
Sbjct: 249 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 280

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 77/149 (51%), Gaps = 12/149 (8%)
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H N+++L           LV++ M+ G L  YL  +K  +  ++  +I     + +  LH
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALH 141
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF- 252
              +  I+H D+KPEN+LLD + + K+ DFG +   D  +   ++    GTP Y APE  
Sbjct: 142 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVC---GTPSYLAPEII 195
Query: 253 ---LSGNYPITHK-CDVYSFGMVLFEIVG 277
              ++ N+P   K  D++S G++++ ++ 
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 104/236 (44%), Gaps = 39/236 (16%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMA--EVGTIGRTYHINLVRLYG 142
           LG GGFGEV   Q    G   A K L +   +  + + MA  E   + +     +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 143 FCHDQHMTALVYEYMENGSLDGYL-------FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
               +    LV   M  G L  ++       F + RA+ +      A     GL  LH E
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY------AAEICCGLEDLHRE 305
Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV----TISGYKGTPGYSAPE 251
              RI++ D+KPEN+LLD +   +++D GLA        HV    TI G  GT GY APE
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLA-------VHVPEGQTIKGRVGTVGYMAPE 355
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIVG------RRRNAIVGATESLDWFPKHVWEEY 301
            +  N   T   D ++ G +L+E++       +R+  I    E ++   K V EEY
Sbjct: 356 VVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEVPEEY 408

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 81  NYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
            +  R+G G FGEV++ +    G + AVK +   + R+  E+ +A  G         +V 
Sbjct: 77  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--EELVACAGL----SSPRIVP 130
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           LYG   +     +  E +E GSL G L  +   +  ++         +GL YLH    +R
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRR 186
Query: 200 IIHYDIKPENVLLDANFS-PKVADFGLAKLCDR----NKTHVTISGYKGTPGYSAPEFLS 254
           I+H D+K +NVLL ++ S   + DFG A LC +     K+ +T     GT  + APE + 
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 245
Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
           G  P   K D++S   ++  ++
Sbjct: 246 GK-PCDAKVDIWSSCCMMLHML 266

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 81  NYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
            +  R+G G FGEV++ +    G + AVK +   + R+  E+ +A  G         +V 
Sbjct: 61  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--EELVACAGL----SSPRIVP 114
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           LYG   +     +  E +E GSL G L  +   +  ++         +GL YLH    +R
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRR 170
Query: 200 IIHYDIKPENVLLDANFS-PKVADFGLAKLCDR----NKTHVTISGYKGTPGYSAPEFLS 254
           I+H D+K +NVLL ++ S   + DFG A LC +     K+ +T     GT  + APE + 
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
           G  P   K D++S   ++  ++
Sbjct: 230 GK-PCDAKVDIWSSCCMMLHML 250

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 153
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 212
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 213 KSSDLWALGCIIYQLVA 229

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 151
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 210
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 211 KSSDLWALGCIIYQLVA 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 80  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 135
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 136 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 194
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 195 KSSDLWALGCIIYQLVA 211

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 153
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 212
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 213 KSSDLWALGCIIYQLVA 229

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 86  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 138
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 139 RLYGFCHDQHMTALV-YEYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 182
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK 242
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++   V     +
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
               + APE +      T + DV+SFG++L+EI
Sbjct: 212 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 243

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--------GRIAEEQFM 123
           ++L +F  N+   LG G FG+V   +     ++ AVK+L +++          + E++ +
Sbjct: 338 MKLTDF--NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL 395
Query: 124 AEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI-- 181
           A  G         L +L+           V EY+  G L   ++  ++   +++ H +  
Sbjct: 396 ALPGKPPF-----LTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFY 447
Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY 241
           A   A GL +L     + II+ D+K +NV+LD+    K+ADFG+ K  +     VT   +
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXF 502
Query: 242 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 277
            GTP Y APE ++   P     D ++FG++L+E++ 
Sbjct: 503 CGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLA 537

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 103 YFCFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 158
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 159 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 217
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 218 KSSDLWALGCIIYQLVA 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 154
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 213
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 214 KSSDLWALGCIIYQLVA 230

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 151
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 210
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 211 KSSDLWALGCIIYQLVA 227

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNA 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 153
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 212
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 213 KSSDLWALGCIIYQLVA 229

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIAV--KVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G V+K +  +  +I    K L      + ++  + E+  + +  H NLV L  
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 143 FCHDQHMTALVYEYMENG---SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
               +    LV+EY ++     LD Y    +R +    +  I   T + + + H   +  
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCH---KHN 122
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
            IH D+KPEN+L+  +   K+ DFG A+L      +        T  Y +PE L G+   
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQY 180
Query: 260 THKCDVYSFGMVLFEIVG 277
               DV++ G V  E++ 
Sbjct: 181 GPPVDVWAIGCVFAELLS 198

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 23/202 (11%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G +G VY G+   N V+IA+K +     R ++     E+       H N+V+  G  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGSF 88
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKL--HEIAIG-----TAKGLVYLHEECQ 197
            +     +  E +  GSL   L  K     W  L  +E  IG       +GL YLH+   
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSK-----WGPLKDNEQTIGFYTKQILEGLKYLHD--- 140
Query: 198 QRIIHYDIKPENVLLDA-NFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLS- 254
            +I+H DIK +NVL++  +   K++DFG +K L   N    T   + GT  Y APE +  
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET---FTGTLQYMAPEIIDK 197
Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
           G        D++S G  + E+ 
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMA 219

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 150
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 209
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 210 KSSDLWALGCIIYQLVA 226

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 153
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 212
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 213 KSSDLWALGCIIYQLVA 229

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 85  RLGFGGFGEVYKGQFPNGVKIA----VKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           ++G G +G V+K +     +I     V++ + + G       + E+  +    H N+VRL
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG--VPSSALREICLLKELKHKNIVRL 66
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           +   H      LV+E+ +   L  Y       ++ E +        KGL + H    + +
Sbjct: 67  HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG---TPGYSAPEFLSGNY 257
           +H D+KP+N+L++ N   K+A+FGLA+        + +  Y     T  Y  P+ L G  
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLAR-----AFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 258 PITHKCDVYSFGMVLFEIVGRRRNAIVG 285
             +   D++S G +  E+    R    G
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPG 205

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGE-VYKGQFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F   V   +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 151
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 210
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 211 KSSDLWALGCIIYQLVA 227

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 153
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAX 212
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 213 KSSDLWALGCIIYQLVA 229

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 76/149 (51%), Gaps = 12/149 (8%)
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H N+++L           LV++ M+ G L  YL  +K  +  ++  +I     + +  LH
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALH 128
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF- 252
              +  I+H D+KPEN+LLD + + K+ DFG +   D  +    +    GTP Y APE  
Sbjct: 129 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYLAPEII 182
Query: 253 ---LSGNYPITHK-CDVYSFGMVLFEIVG 277
              ++ N+P   K  D++S G++++ ++ 
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLA 211

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 80  SNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
           + +  RLG G FGEV++ +    G + AVK +   + R   E+ MA  G         +V
Sbjct: 95  ATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA--EELMACAGLTSP----RIV 148
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            LYG   +     +  E +E GSL G L  ++  +  ++         +GL YLH    +
Sbjct: 149 PLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYYLGQALEGLEYLH---SR 204
Query: 199 RIIHYDIKPENVLLDANFS-PKVADFGLAKLCDRN---KTHVTISGYKGTPGYSAPEFLS 254
           RI+H D+K +NVLL ++ S   + DFG A     +   K+ +T     GT  + APE + 
Sbjct: 205 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVL 264
Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
           G      K DV+S   ++  ++
Sbjct: 265 GRS-CDAKVDVWSSCCMMLHML 285

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 105/243 (43%), Gaps = 37/243 (15%)
Query: 52  GQTMER---FLQEIGR---EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKG-QFPNGVK 104
           G + ER   + QE+ +   E P R+ +L          + +G G +G V        G++
Sbjct: 11  GMSQERPTFYRQELNKTIWEVPERYQNL----------SPVGSGAYGSVCAAFDTKTGLR 60
Query: 105 IAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLD 163
           +AVK L+R    I   ++   E+  +    H N++ L     D    A   E   +  L 
Sbjct: 61  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLV 116
Query: 164 GYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF 216
            +L G      ++ +KL +     +     +GL Y+H      IIH D+KP N+ ++ + 
Sbjct: 117 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDX 173
Query: 217 SPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
             K+ DFGLA+  D   T     GY  T  Y APE +          D++S G ++ E++
Sbjct: 174 ELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 228
Query: 277 GRR 279
             R
Sbjct: 229 TGR 231

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG GGF + Y+    +  ++ A KV+ ++  L    +E+   E+       + ++V  +G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           F  D     +V E     SL   L  +++A+   +       T +G+ YLH     R+IH
Sbjct: 94  FFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTIQGVQYLH---NNRVIH 149
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK-----GTPGYSAPEFL--SG 255
            D+K  N+ L+ +   K+ DFGLA       T +   G +     GTP Y APE L   G
Sbjct: 150 RDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 256 NYPITHKCDVYSFGMVLFEIV 276
           +   + + D++S G +L+ ++
Sbjct: 203 H---SFEVDIWSLGCILYTLL 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 92
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 93  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 147
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 148 SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 202
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG GGF + Y+    +  ++ A KV+ ++  L    +E+   E+       + ++V  +G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           F  D     +V E     SL   L  +++A+   +       T +G+ YLH     R+IH
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTIQGVQYLH---NNRVIH 165
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK-----GTPGYSAPEFL--SG 255
            D+K  N+ L+ +   K+ DFGLA       T +   G +     GTP Y APE L   G
Sbjct: 166 RDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 256 NYPITHKCDVYSFGMVLFEIV 276
           +   + + D++S G +L+ ++
Sbjct: 219 H---SFEVDIWSLGCILYTLL 236

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G       K + +  + +  +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 140
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 100
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 101 YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 156
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 157 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 215
Query: 261 HKCDVYSFGMVLFEIVG 277
              D+++ G +++++V 
Sbjct: 216 KSSDLWALGCIIYQLVA 232

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--------GRIAEEQFM 123
           ++L +F  N+   LG G FG+V   +     ++ AVK+L +++          + E++ +
Sbjct: 17  MKLTDF--NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL 74
Query: 124 AEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI-- 181
           A  G         L +L+           V EY+  G L   ++  ++   +++ H +  
Sbjct: 75  ALPGKPPF-----LTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFY 126
Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK-THVTISG 240
           A   A GL +L     + II+ D+K +NV+LD+    K+ADFG   +C  N    VT   
Sbjct: 127 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFG---MCKENIWDGVTTKX 180
Query: 241 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 277
           + GTP Y APE ++   P     D ++FG++L+E++ 
Sbjct: 181 FCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLA 216

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 105/243 (43%), Gaps = 37/243 (15%)
Query: 52  GQTMER---FLQEIGR---EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKG-QFPNGVK 104
           G + ER   + QE+ +   E P R+ +L          + +G G +G V        G++
Sbjct: 11  GMSQERPTFYRQELNKTIWEVPERYQNL----------SPVGSGAYGSVCAAFDTKTGLR 60
Query: 105 IAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLD 163
           +AVK L+R    I   ++   E+  +    H N++ L     D    A   E   +  L 
Sbjct: 61  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLV 116
Query: 164 GYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF 216
            +L G      ++ +KL +     +     +GL Y+H      IIH D+KP N+ ++ + 
Sbjct: 117 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 173
Query: 217 SPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
             K+ DFGLA+  D   T     GY  T  Y APE +          D++S G ++ E++
Sbjct: 174 ELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 228
Query: 277 GRR 279
             R
Sbjct: 229 TGR 231

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG GGF + Y+    +  ++ A KV+ ++  L    +E+   E+       + ++V  +G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           F  D     +V E     SL   L  +++A+   +       T +G+ YLH     R+IH
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTIQGVQYLH---NNRVIH 165
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK-----GTPGYSAPEFL--SG 255
            D+K  N+ L+ +   K+ DFGLA       T +   G +     GTP Y APE L   G
Sbjct: 166 RDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 256 NYPITHKCDVYSFGMVLFEIV 276
           +   + + D++S G +L+ ++
Sbjct: 219 H---SFEVDIWSLGCILYTLL 236

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG GGF + Y+    +  ++ A KV+ ++  L    +E+   E+       + ++V  +G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           F  D     +V E     SL   L  +++A+   +       T +G+ YLH     R+IH
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTIQGVQYLH---NNRVIH 165
Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK-----GTPGYSAPEFL--SG 255
            D+K  N+ L+ +   K+ DFGLA       T +   G +     GTP Y APE L   G
Sbjct: 166 RDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKTLCGTPNYIAPEVLCKKG 218
Query: 256 NYPITHKCDVYSFGMVLFEIV 276
           +   + + D++S G +L+ ++
Sbjct: 219 H---SFEVDIWSLGCILYTLL 236

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 100/234 (42%), Gaps = 28/234 (11%)
Query: 61  EIGREKPVRFTSLQLNNFTSNYSTR------LGFGGFGEVYKG-QFPNGVKIAVKVLNRN 113
           E+ +E+P  F   +LN        R      +G G +G V        G+++AVK L+R 
Sbjct: 6   EMSQERPT-FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 64
Query: 114 LGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK--K 170
              I   ++   E+  +    H N++ L     D    A   E   +  L  +L G    
Sbjct: 65  FQSIIHAKRTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLN 120
Query: 171 RAIEWEKLHE-----IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 225
             ++ +KL +     +     +GL Y+H      IIH D+KP N+ ++ +   K+ DFGL
Sbjct: 121 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 177
Query: 226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           A+  D   T     GY  T  Y APE +          D++S G ++ E++  R
Sbjct: 178 ARHTDDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 76/149 (51%), Gaps = 12/149 (8%)
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H N+++L           LV++ M+ G L  YL  +K  +  ++  +I     + +  LH
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALH 141
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF- 252
              +  I+H D+KPEN+LLD + + K+ DFG +   D  +    +    GTP Y APE  
Sbjct: 142 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYLAPEII 195
Query: 253 ---LSGNYPITHK-CDVYSFGMVLFEIVG 277
              ++ N+P   K  D++S G++++ ++ 
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G       K + +  + +  +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 29/205 (14%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 86
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 87  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 143
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE 251
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   Y  +  Y APE
Sbjct: 144 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 197
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIV 276
            + G    T   DV+S G VL E++
Sbjct: 198 LIFGATDYTSSIDVWSAGCVLAELL 222

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 29/205 (14%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 94
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 95  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 151
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE 251
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   Y  +  Y APE
Sbjct: 152 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 205
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIV 276
            + G    T   DV+S G VL E++
Sbjct: 206 LIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 29/205 (14%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 115
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE 251
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   Y  +  Y APE
Sbjct: 173 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 226
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIV 276
            + G    T   DV+S G VL E++
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN--LGRIAEEQFMAE--VG 127
           L ++NF   +   LG G FG+V   +    G   AVKVL ++  L     E  M E  + 
Sbjct: 20  LGIDNF--EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRIL 77
Query: 128 TIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
           ++ R  H  L +L+           V E++  G L  +   K R  +  +    A     
Sbjct: 78  SLARN-HPFLTQLFCCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARARFYAAEIIS 135
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTP 245
            L++LH+   + II+ D+K +NVLLD     K+ADFG+ K  +C+     VT + + GTP
Sbjct: 136 ALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN----GVTTATFCGTP 188
Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            Y APE L          D ++ G++L+E++
Sbjct: 189 DYIAPEILQ-EMLYGPAVDWWAMGVLLYEML 218

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 100/234 (42%), Gaps = 28/234 (11%)
Query: 61  EIGREKPVRFTSLQLNNFTSNYSTR------LGFGGFGEVYKG-QFPNGVKIAVKVLNRN 113
           E+ +E+P  F   +LN        R      +G G +G V        G+++AVK L+R 
Sbjct: 6   EMSQERPT-FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 64
Query: 114 LGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK--K 170
              I   ++   E+  +    H N++ L     D    A   E   +  L  +L G    
Sbjct: 65  FQSIIHAKRTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLN 120
Query: 171 RAIEWEKLHE-----IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 225
             ++ +KL +     +     +GL Y+H      IIH D+KP N+ ++ +   K+ DFGL
Sbjct: 121 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGL 177
Query: 226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           A+  D   T     GY  T  Y APE +          D++S G ++ E++  R
Sbjct: 178 ARHTDDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 100/234 (42%), Gaps = 28/234 (11%)
Query: 61  EIGREKPVRFTSLQLNNFTSNYSTR------LGFGGFGEVYKG-QFPNGVKIAVKVLNRN 113
           E+ +E+P  F   +LN        R      +G G +G V        G+++AVK L+R 
Sbjct: 23  EMSQERPT-FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 81
Query: 114 LGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK--K 170
              I   ++   E+  +    H N++ L     D    A   E   +  L  +L G    
Sbjct: 82  FQSIIHAKRTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLN 137
Query: 171 RAIEWEKLHE-----IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 225
             ++ +KL +     +     +GL Y+H      IIH D+KP N+ ++ +   K+ DFGL
Sbjct: 138 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 194
Query: 226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           A+  D   T     GY  T  Y APE +          D++S G ++ E++  R
Sbjct: 195 ARHTDDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 92
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 93  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 147
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 148 SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 202
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 29/205 (14%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 109
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 110 FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 166
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE 251
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   Y  +  Y APE
Sbjct: 167 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 220
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIV 276
            + G    T   DV+S G VL E++
Sbjct: 221 LIFGATDYTSSIDVWSAGCVLAELL 245

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 75  LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY- 133
           L+NF      ++G G  G V      +  K+ V V   +L +    + +     I R Y 
Sbjct: 153 LDNFI-----KIGEGSTGIVCIATVRSSGKL-VAVKKMDLRKQQRRELLFNEVVIMRDYQ 206
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H N+V +Y          +V E++E G+L   +   +  +  E++  + +   + L  LH
Sbjct: 207 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH 264
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNKTHVTISGYKGTPGYSA 249
               Q +IH DIK +++LL  +   K++DFG    ++K   R K  V      GTP + A
Sbjct: 265 A---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMA 315
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE +S   P   + D++S G+++ E+V
Sbjct: 316 PELIS-RLPYGPEVDIWSLGIMVIEMV 341

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 11/161 (6%)
Query: 120 EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEK 177
           EQ   E+  + +  H N+V+L     D +   L  V+E +  G +      K  + +  +
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
            +   +   KG+ YLH    Q+IIH DIKP N+L+  +   K+ADFG++   +   +   
Sbjct: 141 FYFQDL--IKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN--EFKGSDAL 193
Query: 238 ISGYKGTPGYSAPEFLSGNYPI--THKCDVYSFGMVLFEIV 276
           +S   GTP + APE LS    I      DV++ G+ L+  V
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 75  LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY- 133
           L+NF      ++G G  G V      +  K+ V V   +L +    + +     I R Y 
Sbjct: 31  LDNFI-----KIGEGSTGIVCIATVRSSGKL-VAVKKMDLRKQQRRELLFNEVVIMRDYQ 84
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H N+V +Y          +V E++E G+L   +   +  +  E++  + +   + L  LH
Sbjct: 85  HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH 142
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNKTHVTISGYKGTPGYSA 249
               Q +IH DIK +++LL  +   K++DFG    ++K   R K  V      GTP + A
Sbjct: 143 A---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMA 193
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE +S   P   + D++S G+++ E+V
Sbjct: 194 PELIS-RLPYGPEVDIWSLGIMVIEMV 219

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 29/205 (14%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 117
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 118 FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 174
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE 251
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   Y  +  Y APE
Sbjct: 175 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 228
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIV 276
            + G    T   DV+S G VL E++
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAELL 253

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 100/234 (42%), Gaps = 28/234 (11%)
Query: 61  EIGREKPVRFTSLQLNNFTSNYSTR------LGFGGFGEVYKG-QFPNGVKIAVKVLNRN 113
           E+ +E+P  F   +LN        R      +G G +G V        G+++AVK L+R 
Sbjct: 5   EMSQERPT-FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 63
Query: 114 LGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK--K 170
              I   ++   E+  +    H N++ L     D    A   E   +  L  +L G    
Sbjct: 64  FQSIIHAKRTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLN 119
Query: 171 RAIEWEKLHE-----IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 225
             ++ +KL +     +     +GL Y+H      IIH D+KP N+ ++ +   K+ DFGL
Sbjct: 120 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 176
Query: 226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           A+  D   T     GY  T  Y APE +          D++S G ++ E++  R
Sbjct: 177 ARHTDDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 12/201 (5%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGF 143
           LG G +G V K +  P+G   AVK +   +    +++ + ++    RT      V  YG 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 144 CHDQHMTALVYEYMENGSLDGY---LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
              +    +  E + + SLD +   +  K + I  + L +IA+   K L +LH +    +
Sbjct: 102 LFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 158
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK--GTPGYSAPEFLSGNYP 258
           IH D+KP NVL++A    K  DFG++     +      +G K    P    PE     Y 
Sbjct: 159 IHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYS 218
Query: 259 ITHKCDVYSFGMVLFEIVGRR 279
           +  K D++S G+   E+   R
Sbjct: 219 V--KSDIWSLGITXIELAILR 237

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 29/205 (14%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 119
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 120 FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 176
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE 251
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   Y  +  Y APE
Sbjct: 177 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 230
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIV 276
            + G    T   DV+S G VL E++
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELL 255

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 92
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 93  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 147
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 148 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 202
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 86
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 87  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 141
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 142 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 196
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 94
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 95  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 149
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 204
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 16/216 (7%)
Query: 77  NFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 133
           N +S++  +  LG G +G V      P G  +A+K +      +   + + E+  +    
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 134 HINLVRLYGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY 191
           H N++ ++             VY   E    D +     + +  + +      T + +  
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 192 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT--------ISGYKG 243
           LH      +IH D+KP N+L+++N   KV DFGLA++ D +    +        +  +  
Sbjct: 128 LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           T  Y APE +  +   +   DV+S G +L E+  RR
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 89
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 90  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 144
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 145 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 199
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 75  LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY- 133
           L+NF      ++G G  G V      +  K+ V V   +L +    + +     I R Y 
Sbjct: 33  LDNFI-----KIGEGSTGIVCIATVRSSGKL-VAVKKMDLRKQQRRELLFNEVVIMRDYQ 86
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H N+V +Y          +V E++E G+L   +   +  +  E++  + +   + L  LH
Sbjct: 87  HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH 144
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNKTHVTISGYKGTPGYSA 249
               Q +IH DIK +++LL  +   K++DFG    ++K   R K  V      GTP + A
Sbjct: 145 A---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMA 195
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE +S   P   + D++S G+++ E+V
Sbjct: 196 PELIS-RLPYGPEVDIWSLGIMVIEMV 221

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 89
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 90  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 144
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 145 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 199
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 99
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 100 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 154
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 155 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 209
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 89
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 90  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 144
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 145 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 199
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 99
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 100 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 154
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 155 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 209
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 29/205 (14%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 160
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 161 FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 217
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE 251
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   Y  +  Y APE
Sbjct: 218 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 271
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIV 276
            + G    T   DV+S G VL E++
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELL 296

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 75  LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY- 133
           L+NF      ++G G  G V      +  K+ V V   +L +    + +     I R Y 
Sbjct: 22  LDNFI-----KIGEGSTGIVCIATVRSSGKL-VAVKKMDLRKQQRRELLFNEVVIMRDYQ 75
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H N+V +Y          +V E++E G+L   +   +  +  E++  + +   + L  LH
Sbjct: 76  HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH 133
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNKTHVTISGYKGTPGYSA 249
               Q +IH DIK +++LL  +   K++DFG    ++K   R K  V      GTP + A
Sbjct: 134 A---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMA 184
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE +S   P   + D++S G+++ E+V
Sbjct: 185 PELIS-RLPYGPEVDIWSLGIMVIEMV 210

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 29/205 (14%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 81
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE 251
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   Y  +  Y APE
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 192
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIV 276
            + G    T   DV+S G VL E++
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 23/215 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 93
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 94  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 148
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 149 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 203
Query: 257 YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD 291
                  D++S G ++ E++  R   +   T+ +D
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHID 236

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 23/202 (11%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G +G VY G+   N V+IA+K +     R ++     E+       H N+V+  G  
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-LHEEIALHKHLKHKNIVQYLGSF 74
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKL--HEIAIG-----TAKGLVYLHEECQ 197
            +     +  E +  GSL   L  K     W  L  +E  IG       +GL YLH+   
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSK-----WGPLKDNEQTIGFYTKQILEGLKYLHD--- 126
Query: 198 QRIIHYDIKPENVLLDA-NFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLS- 254
            +I+H DIK +NVL++  +   K++DFG +K L   N    T   + GT  Y APE +  
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET---FTGTLQYMAPEIIDK 183
Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
           G        D++S G  + E+ 
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMA 205

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 29/205 (14%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLD------HCNIVRLRYF 81
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE 251
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   Y  +  Y APE
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 192
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIV 276
            + G    T   DV+S G VL E++
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 106
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 107 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 161
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 162 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 216
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 38/220 (17%)
Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVL-----NRNLGRIAEEQFMAEVGTIGRTYHINLV 138
           +LG G +G V+K      G  +AVK +     N    +    + M      G    +NL+
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEEC 196
            +    +D+ +  LV++YME       L    RA   E +H+  +     K + YLH   
Sbjct: 76  NVLRADNDRDV-YLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT------------------- 237
              ++H D+KP N+LL+A    KVADFGL++    N   VT                   
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSR-SFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 238 -ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            ++ Y  T  Y APE L G+   T   D++S G +L EI+
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 84
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 85  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 139
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 140 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 194
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 89
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 90  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 144
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 145 SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 199
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 84
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 85  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 139
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 140 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 194
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 107
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 108 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 162
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 163 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 217
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 16/216 (7%)
Query: 77  NFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 133
           N +S++  +  LG G +G V      P G  +A+K +      +   + + E+  +    
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 134 HINLVRLYGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY 191
           H N++ ++             VY   E    D +     + +  + +      T + +  
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 192 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT--------ISGYKG 243
           LH      +IH D+KP N+L+++N   KV DFGLA++ D +    +        ++    
Sbjct: 128 LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           T  Y APE +  +   +   DV+S G +L E+  RR
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 80  SNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
           + +  RLG G FGEV++ +    G + AVK +   + R   E+ MA  G         +V
Sbjct: 76  ATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA--EELMACAGLTSP----RIV 129
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            LYG   +     +  E +E GSL G L  ++  +  ++         +GL YLH    +
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYYLGQALEGLEYLH---SR 185
Query: 199 RIIHYDIKPENVLLDANFS-PKVADFGLAKLCDRN---KTHVTISGYKGTPGYSAPEFLS 254
           RI+H D+K +NVLL ++ S   + DFG A     +   K  +T     GT  + APE + 
Sbjct: 186 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVL 245
Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
           G      K DV+S   ++  ++
Sbjct: 246 GRS-CDAKVDVWSSCCMMLHML 266

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 83
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 84  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 193
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 85
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 86  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 140
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 141 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 195
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 29/205 (14%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLD------HCNIVRLRYF 81
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE 251
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   Y  +  Y APE
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 192
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIV 276
            + G    T   DV+S G VL E++
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 75  LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY- 133
           L+NF      ++G G  G V      +  K+ V V   +L +    + +     I R Y 
Sbjct: 26  LDNFI-----KIGEGSTGIVCIATVRSSGKL-VAVKKMDLRKQQRRELLFNEVVIMRDYQ 79
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H N+V +Y          +V E++E G+L   +   +  +  E++  + +   + L  LH
Sbjct: 80  HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH 137
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNKTHVTISGYKGTPGYSA 249
               Q +IH DIK +++LL  +   K++DFG    ++K   R K  V      GTP + A
Sbjct: 138 A---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMA 188
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE +S   P   + D++S G+++ E+V
Sbjct: 189 PELIS-RLPYGPEVDIWSLGIMVIEMV 214

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 75  LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY- 133
           L+NF      ++G G  G V      +  K+ V V   +L +    + +     I R Y 
Sbjct: 76  LDNFI-----KIGEGSTGIVCIATVRSSGKL-VAVKKMDLRKQQRRELLFNEVVIMRDYQ 129
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H N+V +Y          +V E++E G+L   +   +  +  E++  + +   + L  LH
Sbjct: 130 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH 187
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNKTHVTISGYKGTPGYSA 249
               Q +IH DIK +++LL  +   K++DFG    ++K   R K  V      GTP + A
Sbjct: 188 A---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMA 238
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE +S   P   + D++S G+++ E+V
Sbjct: 239 PELIS-RLPYGPEVDIWSLGIMVIEMV 264

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 93/236 (39%), Gaps = 29/236 (12%)
Query: 62  IGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLG 115
           I + K  +   + L+     +   LG   FG+VYKG             +A+K L     
Sbjct: 12  INQHKQAKLKEISLS--AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE 69
Query: 116 RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK------ 169
               E+F  E     R  H N+V L G        ++++ Y  +G L  +L  +      
Sbjct: 70  GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV 129
Query: 170 ---------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV 220
                    K A+E      +    A G+ YL       ++H D+   NVL+    + K+
Sbjct: 130 GSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKI 186
Query: 221 ADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEI 275
           +D GL +       +  +        + APE  + G + I    D++S+G+VL+E+
Sbjct: 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSI--DSDIWSYGVVLWEV 240

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG GGF + ++    +  ++ A K++ ++L       E+   E+       H ++V  +G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEECQQR 199
           F  D     +V E     SL      +K   E E    L +I +G      YLH   + R
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLH---RNR 141
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK-----GTPGYSAPEFLS 254
           +IH D+K  N+ L+ +   K+ DFGLA       T V   G +     GTP Y APE LS
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKTLCGTPNYIAPEVLS 194
Query: 255 --GNYPITHKCDVYSFGMVLFEIV 276
             G+   + + DV+S G +++ ++
Sbjct: 195 KKGH---SFEVDVWSIGCIMYTLL 215

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG GGF + ++    +  ++ A K++ ++L       E+   E+       H ++V  +G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEECQQR 199
           F  D     +V E     SL      +K   E E    L +I +G      YLH   + R
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLH---RNR 159
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK-----GTPGYSAPEFLS 254
           +IH D+K  N+ L+ +   K+ DFGLA       T V   G +     GTP Y APE LS
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIAPEVLS 212
Query: 255 --GNYPITHKCDVYSFGMVLFEIV 276
             G+   + + DV+S G +++ ++
Sbjct: 213 KKGH---SFEVDVWSIGCIMYTLL 233

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 92/181 (50%), Gaps = 19/181 (10%)
Query: 101 NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYMEN 159
           +G ++AVK+++  L +    + +     I R Y H N+V +Y          ++ E+++ 
Sbjct: 69  SGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126
Query: 160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK 219
           G+L   +   +  +  E++  +     + L YLH    Q +IH DIK +++LL  +   K
Sbjct: 127 GALTDIV--SQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVK 181
Query: 220 VADFG----LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
           ++DFG    ++K   + K  V      GTP + APE +S +   T + D++S G+++ E+
Sbjct: 182 LSDFGFCAQISKDVPKRKXLV------GTPYWMAPEVISRSLYAT-EVDIWSLGIMVIEM 234
Query: 276 V 276
           V
Sbjct: 235 V 235

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG GGF + ++    +  ++ A K++ ++L       E+   E+       H ++V  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEECQQR 199
           F  D     +V E     SL      +K   E E    L +I +G      YLH   + R
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLH---RNR 137
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK-----GTPGYSAPEFLS 254
           +IH D+K  N+ L+ +   K+ DFGLA       T V   G +     GTP Y APE LS
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKTLCGTPNYIAPEVLS 190
Query: 255 --GNYPITHKCDVYSFGMVLFEIV 276
             G+   + + DV+S G +++ ++
Sbjct: 191 KKGH---SFEVDVWSIGCIMYTLL 211

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 86  LGFGGFGEVY---KGQFPN-GVKIAVKVLNRNLGRIAEE-QFMAEVGTIGRTYHINLVRL 140
           LG G FG+V+   K   P+ G   A+KVL +   ++ +  +   E   +    H  +V+L
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           +     +    L+ +++  G L   L  K+     E +       A GL +LH      I
Sbjct: 96  HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALGLDHLHSLG---I 151
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I+ D+KPEN+LLD     K+ DFGL+K   D  K   +   + GT  Y APE ++     
Sbjct: 152 IYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS---FCGTVEYMAPEVVN-RQGH 207
Query: 260 THKCDVYSFGMVLFEIV 276
           +H  D +S+G+++FE++
Sbjct: 208 SHSADWWSYGVLMFEML 224

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 30/203 (14%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKV---LNRNLGRIAE------EQFMAEVGTIGRTYHIN 136
           +G G +GEV         KIAV+    + R   +I +      ++F  E+  +    H N
Sbjct: 17  IGRGSWGEV---------KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
           ++RLY    D     LV E    G L   +   KR         I       + Y H   
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLSAVAYCH--- 123
Query: 197 QQRIIHYDIKPENVLL--DANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
           +  + H D+KPEN L   D+  SP K+ DFGLA    R K    +    GTP Y +P+ L
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL 180
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
            G Y    +CD +S G++++ ++
Sbjct: 181 EGLY--GPECDEWSAGVMMYVLL 201

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG GGF + ++    +  ++ A K++ ++L       E+   E+       H ++V  +G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEECQQR 199
           F  D     +V E     SL      +K   E E    L +I +G      YLH   + R
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLH---RNR 161
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK-----GTPGYSAPEFLS 254
           +IH D+K  N+ L+ +   K+ DFGLA       T V   G +     GTP Y APE LS
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIAPEVLS 214
Query: 255 --GNYPITHKCDVYSFGMVLFEIV 276
             G+   + + DV+S G +++ ++
Sbjct: 215 KKGH---SFEVDVWSIGCIMYTLL 235

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 30/203 (14%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVKV---LNRNLGRIAE------EQFMAEVGTIGRTYHIN 136
           +G G +GEV         KIAV+    + R   +I +      ++F  E+  +    H N
Sbjct: 34  IGRGSWGEV---------KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 84
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
           ++RLY    D     LV E    G L   +   KR         I       + Y H   
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLSAVAYCH--- 140
Query: 197 QQRIIHYDIKPENVLL--DANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
           +  + H D+KPEN L   D+  SP K+ DFGLA    R K    +    GTP Y +P+ L
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL 197
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
            G Y    +CD +S G++++ ++
Sbjct: 198 EGLY--GPECDEWSAGVMMYVLL 218

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 85/202 (42%), Gaps = 25/202 (12%)
Query: 86  LGFGGFGEV---YKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G +G V   Y  +     K+AVK L+R     I   +   E+  +    H N++ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHE 194
               D    A   E      L   L G       K +A+  E +  +     +GL Y+H 
Sbjct: 94  ----DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS 254
                IIH D+KP NV ++ +   ++ DFGLA+  D   T     GY  T  Y APE + 
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT-----GYVATRWYRAPEIML 201
Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
                    D++S G ++ E++
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELL 223

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 115
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVT--ISGYKGTPGYSA 249
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   S Y     Y A
Sbjct: 173 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 224
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE + G    T   DV+S G VL E++
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 26/202 (12%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG GGF + ++    +  ++ A K++ ++L       E+   E+       H ++V  +G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEECQQR 199
           F  D     +V E     SL      +K   E E    L +I +G      YLH   + R
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLH---RNR 135
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK-----GTPGYSAPEFLS 254
           +IH D+K  N+ L+ +   K+ DFGLA       T V   G +     GTP Y APE LS
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIAPEVLS 188
Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
                + + DV+S G +++ ++
Sbjct: 189 KKGH-SFEVDVWSIGCIMYTLL 209

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 20/226 (8%)
Query: 61  EIGREKPVRFTSLQ-LNNFTSNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRI 117
           ++G E  + F S++  NNF    S  LG G F  V +      G + A K L  R  G+ 
Sbjct: 12  DLGTEN-LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD 70
Query: 118 AEEQFMAEVGTIGRTYHI-NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK-KRAIEW 175
              + + E+  +        ++ L+    +     L+ EY   G +      +    +  
Sbjct: 71  CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE 130
Query: 176 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKLCDRN 232
             +  +     +G+ YLH   Q  I+H D+KP+N+LL + +     K+ DFG++    R 
Sbjct: 131 NDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS----RK 183
Query: 233 KTHVT-ISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIV 276
             H   +    GTP Y APE L  NY PIT   D+++ G++ + ++
Sbjct: 184 IGHACELREIMGTPEYLAPEIL--NYDPITTATDMWNIGIIAYMLL 227

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G       K + +  + +  +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGL +  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG GGF + ++    +  ++ A K++ ++L       E+   E+       H ++V  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEECQQR 199
           F  D     +V E     SL      +K   E E    L +I +G      YLH   + R
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLH---RNR 137
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK-----GTPGYSAPEFLS 254
           +IH D+K  N+ L+ +   K+ DFGLA       T V   G +     GTP Y APE LS
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKTLCGTPNYIAPEVLS 190
Query: 255 --GNYPITHKCDVYSFGMVLFEIV 276
             G+   + + DV+S G +++ ++
Sbjct: 191 KKGH---SFEVDVWSIGCIMYTLL 211

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 94
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 95  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 149
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+      T   ++GY  T  Y APE +   
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWYRAPEIMLNW 204
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 93
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVT--ISGYKGTPGYSA 249
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   S Y     Y A
Sbjct: 151 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 202
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE + G    T   DV+S G VL E++
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ D+GLA+  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 100
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 157
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVT--ISGYKGTPGYSA 249
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   S Y     Y A
Sbjct: 158 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 209
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE + G    T   DV+S G VL E++
Sbjct: 210 PELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 110
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 111 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 165
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D       + GY  T  Y APE +   
Sbjct: 166 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGYVATRWYRAPEIMLNW 220
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 89
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 146
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVT--ISGYKGTPGYSA 249
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   S Y     Y A
Sbjct: 147 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 198
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE + G    T   DV+S G VL E++
Sbjct: 199 PELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 94
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 95  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 149
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+      T   ++GY  T  Y APE +   
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWYRAPEIMLNW 204
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L++    I   ++   E+  +    H N++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 99
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 100 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 154
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 155 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 209
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 93
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVT--ISGYKGTPGYSA 249
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   S Y     Y A
Sbjct: 151 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 202
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE + G    T   DV+S G VL E++
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 109/228 (47%), Gaps = 51/228 (22%)
Query: 73  LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRN-----------------L 114
           ++L +F  N+   LG G FG+V         ++ A+K+L ++                 L
Sbjct: 16  VKLTDF--NFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVL 73
Query: 115 GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL-----FGK 169
             + +  F+ ++ +  +T    + RLY           V EY+  G L  ++     F +
Sbjct: 74  ALLDKPPFLTQLHSCFQT----VDRLY----------FVMEYVNGGDLMYHIQQVGKFKE 119
Query: 170 KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 229
            +A+ +    EI+IG    L +LH   ++ II+ D+K +NV+LD+    K+ADFG+ K  
Sbjct: 120 PQAVFYAA--EISIG----LFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-- 168
Query: 230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 277
           +     VT   + GTP Y APE ++   P     D +++G++L+E++ 
Sbjct: 169 EHMMDGVTTREFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLA 215

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 94
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 95  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 149
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+      T   ++GY  T  Y APE +   
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWYRAPEIMLNW 204
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 81
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVT--ISGYKGTPGYSA 249
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   S Y     Y A
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 190
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE + G    T   DV+S G VL E++
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 82
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 83  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 139
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVT--ISGYKGTPGYSA 249
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   S Y     Y A
Sbjct: 140 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 191
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE + G    T   DV+S G VL E++
Sbjct: 192 PELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G FG V++  +   G     K +N     + +     E+  + + +H  L+ L+   
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
            D++   L+ E++  G L   +  +   +   ++        +GL ++HE     I+H D
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLD 174
Query: 205 IKPENVLLDAN--FSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           IKPEN++ +     S K+ DFGLA KL       VT +    T  ++APE +    P+  
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA----TAEFAAPEIVDRE-PVGF 229
Query: 262 KCDVYSFGMV 271
             D+++ G++
Sbjct: 230 YTDMWAIGVL 239

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 27/212 (12%)
Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           LG   FG+VYKG             +A+K L         E+F  E     R  H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIG 184
           L G        ++++ Y  +G L  +L  +               K A+E      +   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
            A G+ YL       ++H D+   NVL+    + K++D GL +       +  +      
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 245 PGYSAPE-FLSGNYPITHKCDVYSFGMVLFEI 275
             + APE  + G + I    D++S+G+VL+E+
Sbjct: 194 IRWMAPEAIMYGKFSI--DSDIWSYGVVLWEV 223

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 85/202 (42%), Gaps = 25/202 (12%)
Query: 86  LGFGGFGEV---YKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G +G V   Y  +     K+AVK L+R     I   +   E+  +    H N++ L 
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHE 194
               D    A   E      L   L G       K +A+  E +  +     +GL Y+H 
Sbjct: 86  ----DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS 254
                IIH D+KP NV ++ +   ++ DFGLA+  D   T     GY  T  Y APE + 
Sbjct: 142 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT-----GYVATRWYRAPEIML 193
Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
                    D++S G ++ E++
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELL 215

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 81
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVT--ISGYKGTPGYSA 249
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   S Y     Y A
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 190
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE + G    T   DV+S G VL E++
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 85
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 142
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVT--ISGYKGTPGYSA 249
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   S Y     Y A
Sbjct: 143 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 194
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE + G    T   DV+S G VL E++
Sbjct: 195 PELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 97
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 98  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 152
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 153 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 207
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 208 MHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 23/215 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 93
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 94  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 148
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 149 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 203
Query: 257 YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD 291
                  D++S G ++ E++  R   +   T+ +D
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHID 236

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 85/202 (42%), Gaps = 25/202 (12%)
Query: 86  LGFGGFGEV---YKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G +G V   Y  +     K+AVK L+R     I   +   E+  +    H N++ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHE 194
               D    A   E      L   L G       K +A+  E +  +     +GL Y+H 
Sbjct: 94  ----DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS 254
                IIH D+KP NV ++ +   ++ DFGLA+  D   T     GY  T  Y APE + 
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT-----GYVATRWYRAPEIML 201
Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
                    D++S G ++ E++
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELL 223

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 23/215 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 107
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 108 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 162
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 163 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 217
Query: 257 YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD 291
                  D++S G ++ E++  R   +   T+ +D
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHID 250

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 106
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 107 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 161
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 162 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 216
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 107/258 (41%), Gaps = 19/258 (7%)
Query: 82  YSTRLGFGGFGEVYKG---------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT 132
           ++  LG G F +++KG         Q  +  ++ +KVL++   R   E F      + + 
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQL-HETEVLLKVLDK-AHRNYSESFFEAASMMSKL 69
Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 192
            H +LV  YG C       LV E+++ GSLD YL   K  I      E+A   A  + +L
Sbjct: 70  SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129
Query: 193 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG--YKGTPGYSAP 250
            E     +IH ++  +N+LL      K  +    KL D   +   +     +    +  P
Sbjct: 130 EE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPP 186
Query: 251 EFLSGNYPITHKCDVYSFGMVLFEIV--GRRRNAIVGATESLDWF-PKHVWEEYEKCELG 307
           E +     +    D +SFG  L+EI   G +  + + +   L ++  +H     +  EL 
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELA 246
Query: 308 AMILGCGIEEKDKEKAKR 325
            +I  C   E D   + R
Sbjct: 247 NLINNCMDYEPDHRPSFR 264

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 23/215 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 83
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 84  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 193
Query: 257 YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD 291
                  D++S G ++ E++  R   +   T+ +D
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHID 226

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 107/258 (41%), Gaps = 19/258 (7%)
Query: 82  YSTRLGFGGFGEVYKG---------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT 132
           ++  LG G F +++KG         Q  +  ++ +KVL++   R   E F      + + 
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQL-HETEVLLKVLDK-AHRNYSESFFEAASMMSKL 69
Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 192
            H +LV  YG C       LV E+++ GSLD YL   K  I      E+A   A  + +L
Sbjct: 70  SHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFL 129
Query: 193 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG--YKGTPGYSAP 250
            E     +IH ++  +N+LL      K  +    KL D   +   +     +    +  P
Sbjct: 130 EE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPP 186
Query: 251 EFLSGNYPITHKCDVYSFGMVLFEIV--GRRRNAIVGATESLDWF-PKHVWEEYEKCELG 307
           E +     +    D +SFG  L+EI   G +  + + +   L ++  +H     +  EL 
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELA 246
Query: 308 AMILGCGIEEKDKEKAKR 325
            +I  C   E D   + R
Sbjct: 247 NLINNCMDYEPDHRPSFR 264

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 28/234 (11%)
Query: 65  EKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVKIAVK-VLN-----RNLGR 116
           E  +R    +L+   S Y+ +  +  G +G V  G    G+ +A+K V N     R +  
Sbjct: 7   EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI 66
Query: 117 IAE----EQFMAEVGTIGRTYHINLVRLYG-FCHDQ----HMTALVYEYMENGSLDGYLF 167
           +++    ++ + E+  +   +H N++ L   F H +    H   LV E M    L   + 
Sbjct: 67  LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH 125
Query: 168 GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 227
            ++  I  + +         GL  LHE     ++H D+ P N+LL  N    + DF LA+
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 228 --LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
               D NKTH     Y     Y APE +      T   D++S G V+ E+  R+
Sbjct: 183 EDTADANKTH-----YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLD------HCNIVRLRYF 81
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVT--ISGYKGTPGYSA 249
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   S Y     Y A
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 190
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE + G    T   DV+S G VL E++
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 86  LGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF 143
           LG+G  G V ++G F  G  +AVK +  +   IA    + E+  +  +  H N++R Y  
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIRYY-- 93
Query: 144 CHDQHMTALVYEYME--NGSLDGYLFGKKRAIEWEKLHE------IAIGTAKGLVYLHEE 195
           C +      +Y  +E  N +L   +  K  + E  KL +      +    A G+ +LH  
Sbjct: 94  CSET-TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 150
Query: 196 CQQRIIHYDIKPENVLLDA-------------NFSPKVADFGLAKLCDRNKT--HVTISG 240
              +IIH D+KP+N+L+               N    ++DFGL K  D  +      ++ 
Sbjct: 151 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 241 YKGTPGYSAPEFL--SGNYPITHKCDVYSFGMVLFEIVGR 278
             GT G+ APE L  S    +T   D++S G V + I+ +
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSK 249

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 28/234 (11%)
Query: 65  EKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVKIAVK-VLN-----RNLGR 116
           E  +R    +L+   S Y+ +  +  G +G V  G    G+ +A+K V N     R +  
Sbjct: 7   EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI 66
Query: 117 IAE----EQFMAEVGTIGRTYHINLVRLYG-FCHDQ----HMTALVYEYMENGSLDGYLF 167
           +++    ++ + E+  +   +H N++ L   F H +    H   LV E M    L   + 
Sbjct: 67  LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH 125
Query: 168 GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 227
            ++  I  + +         GL  LHE     ++H D+ P N+LL  N    + DF LA+
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 228 --LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
               D NKTH     Y     Y APE +      T   D++S G V+ E+  R+
Sbjct: 183 EDTADANKTH-----YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 108/266 (40%), Gaps = 33/266 (12%)
Query: 84  TRLGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
            ++G G FGEV+K +    G K+A+K VL  N         + E+  +    H N+V L 
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 142 GFCHDQHM--------TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
             C  +            LV+++ E+  L G L          ++  +      GL Y+H
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD--RNKTHVTISGYKGTPGYSAPE 251
              + +I+H D+K  NVL+  +   K+ADFGLA+     +N           T  Y  PE
Sbjct: 143 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIVGRRR--------------NAIVGATESLDWFPKHV 297
            L G        D++  G ++ E+  R                + + G+     W     
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 259
Query: 298 WEEYEKCELGAMILGCGIEEKDKEKA 323
           +E YEK EL   + G   + KD+ KA
Sbjct: 260 YELYEKLEL---VKGQKRKVKDRLKA 282

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 86  LGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF 143
           LG+G  G V ++G F  G  +AVK +  +   IA    + E+  +  +  H N++R Y  
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIRYY-- 93
Query: 144 CHDQHMTALVYEYME--NGSLDGYLFGKKRAIEWEKLHE------IAIGTAKGLVYLHEE 195
           C +      +Y  +E  N +L   +  K  + E  KL +      +    A G+ +LH  
Sbjct: 94  CSET-TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 150
Query: 196 CQQRIIHYDIKPENVLLDA-------------NFSPKVADFGLAKLCDRNKT--HVTISG 240
              +IIH D+KP+N+L+               N    ++DFGL K  D  +      ++ 
Sbjct: 151 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 241 YKGTPGYSAPEFL--SGNYPITHKCDVYSFGMVLFEIVGR 278
             GT G+ APE L  S    +T   D++S G V + I+ +
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSK 249

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYGF 143
           +G G  G+V+K +F   G  IAVK + R+  +   ++ + ++  + +++    +V+ +G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKR---AIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
                   +  E M  G+    L  KKR    I    L ++ +   K L YL E  +  +
Sbjct: 93  FITNTDVFIAMELM--GTCAEKL--KKRMQGPIPERILGKMTVAIVKALYYLKE--KHGV 146
Query: 201 IHYDIKPENVLLDANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           IH D+KP N+LLD     K+ DFG++ +L D      +     G   Y APE +    P 
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS----AGCAAYMAPERIDPPDPT 202
Query: 260 TH----KCDVYSFGMVLFEIV 276
                 + DV+S G+ L E+ 
Sbjct: 203 KPDYDIRADVWSLGISLVELA 223

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 114/275 (41%), Gaps = 34/275 (12%)
Query: 86  LGFGGFGE-VYKGQFPNGVKIAVKVLNRNLGRIA--EEQFMAEVGTIGRTYHINLVRLYG 142
           LG G  G  VY+G F N   +AVK +       A  E Q + E        H N++R + 
Sbjct: 32  LGHGAEGTIVYRGMFDNR-DVAVKRILPECFSFADREVQLLRESDE-----HPNVIRYFC 85
Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
              D+    +  E +   +L  Y+  K  A    +   +   T  GL +LH      I+H
Sbjct: 86  TEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVH 141
Query: 203 YDIKPENVLLD-----ANFSPKVADFGLA-KLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
            D+KP N+L+            ++DFGL  KL     +    SG  GT G+ APE LS +
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 257 YP--ITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG 314
                T+  D++S G V + ++          +E    F K +  +     LGA  L C 
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVI----------SEGSHPFGKSLQRQ-ANILLGACSLDCL 250
Query: 315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK 349
             EK ++   R  +  +  +   P+ RP    V+K
Sbjct: 251 HPEKHEDVIARELIEKMIAM--DPQKRPSAKHVLK 283

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 16/207 (7%)
Query: 84  TRLGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
            ++G G FGEV+K +    G K+A+K VL  N         + E+  +    H N+V L 
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 142 GFCHDQHM--------TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
             C  +            LV+++ E+  L G L          ++  +      GL Y+H
Sbjct: 84  EICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL--CDRNKTHVTISGYKGTPGYSAPE 251
              + +I+H D+K  NVL+  +   K+ADFGLA+     +N           T  Y  PE
Sbjct: 143 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIVGR 278
            L G        D++  G ++ E+  R
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 108/266 (40%), Gaps = 33/266 (12%)
Query: 84  TRLGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
            ++G G FGEV+K +    G K+A+K VL  N         + E+  +    H N+V L 
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 142 GFCHDQHM--------TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
             C  +            LV+++ E+  L G L          ++  +      GL Y+H
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD--RNKTHVTISGYKGTPGYSAPE 251
              + +I+H D+K  NVL+  +   K+ADFGLA+     +N           T  Y  PE
Sbjct: 142 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 198
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIVGRRR--------------NAIVGATESLDWFPKHV 297
            L G        D++  G ++ E+  R                + + G+     W     
Sbjct: 199 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 258
Query: 298 WEEYEKCELGAMILGCGIEEKDKEKA 323
           +E YEK EL   + G   + KD+ KA
Sbjct: 259 YELYEKLEL---VKGQKRKVKDRLKA 281

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 16/207 (7%)
Query: 84  TRLGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
            ++G G FGEV+K +    G K+A+K VL  N         + E+  +    H N+V L 
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 142 GFCHDQHM--------TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
             C  +            LV+++ E+  L G L          ++  +      GL Y+H
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD--RNKTHVTISGYKGTPGYSAPE 251
              + +I+H D+K  NVL+  +   K+ADFGLA+     +N           T  Y  PE
Sbjct: 143 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIVGR 278
            L G        D++  G ++ E+  R
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     G   T  Y APE +   
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GXVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 33/207 (15%)
Query: 86  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 81
Query: 144 CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 192
            +      D     LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 82  FYSSGEKKDVVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 193 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVT--ISGYKGTPGYSA 249
           H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   S Y     Y A
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 190
Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIV 276
           PE + G    T   DV+S G VL E++
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 83
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++  KL +     +     +GL Y+H   
Sbjct: 84  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIH--- 138
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +   
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 193
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 12/197 (6%)
Query: 84  TRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLY 141
           T +G G +G V       +G K+A+K L+R     I  ++   E+  +    H N++ L 
Sbjct: 48  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEW--EKLHEIAIGTAKGLVYLHEECQQR 199
                       Y++            K   +E+  EK+  +     KGL Y+H      
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG--- 164
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           ++H D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +      
Sbjct: 165 VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----GYVVTRWYRAPEVILSWMHY 219
Query: 260 THKCDVYSFGMVLFEIV 276
               D++S G ++ E++
Sbjct: 220 NQTVDIWSVGCIMAEML 236

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ D GLA+  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+  FGLA+  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 42/224 (18%)
Query: 86  LGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF 143
           LG+G  G V ++G F  G  +AVK +  +   IA    + E+  +  +  H N++R Y  
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIRYY-- 75
Query: 144 CHDQHMTALVYEYME--NGSLDGYLFGKKRAIEWEKLHE------IAIGTAKGLVYLHEE 195
           C +      +Y  +E  N +L   +  K  + E  KL +      +    A G+ +LH  
Sbjct: 76  CSET-TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 132
Query: 196 CQQRIIHYDIKPENVLLDA-------------NFSPKVADFGLAKLCDRNKT--HVTISG 240
              +IIH D+KP+N+L+               N    ++DFGL K  D  ++     ++ 
Sbjct: 133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 241 YKGTPGYSAPEFL--SGNYP----ITHKCDVYSFGMVLFEIVGR 278
             GT G+ APE L  S N      +T   D++S G V + I+ +
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ D GLA+  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++G+  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++G+  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ D GLA+  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 24/203 (11%)
Query: 84  TRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLY 141
           T +G G +G V       +G K+A+K L+R     I  ++   E+  +    H N++ L 
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 142 GF------CHDQHMTALVYEYMENG--SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
                     + +   LV  +M+     + G  F +      EK+  +     KGL Y+H
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSE------EKIQYLVYQMLKGLKYIH 143
Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
                 ++H D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +
Sbjct: 144 SAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----GYVVTRWYRAPEVI 195
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
                     D++S G ++ E++
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEML 218

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 83
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 84  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++G+  T  Y APE +   
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIMLNW 193
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 19/199 (9%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG- 142
           +G G +G V        G K+A+K L R     +  ++   E+  +    H N++ L   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 143 FCHDQHMTA-----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
           F  D+ +       LV  +M  G+  G L   ++  E +++  +     KGL Y+H    
Sbjct: 93  FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGE-DRIQFLVYQMLKGLRYIHAAG- 148
Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY 257
             IIH D+KP N+ ++ +   K+ DFGLA+  D       + G   T  Y APE +    
Sbjct: 149 --IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MXGXVVTRWYRAPEVILNWM 201
Query: 258 PITHKCDVYSFGMVLFEIV 276
             T   D++S G ++ E++
Sbjct: 202 RYTQTVDIWSVGCIMAEMI 220

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 78  FTSNYSTR--LGFGGFGE----VYKGQFPNGVKIAVKVLNRNLGRIAEE-QFMAEVGTIG 130
           F+  Y  +  +G G + E    V+K      ++ AVKV++++    +EE + +   G   
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKA---TNMEYAVKVIDKSKRDPSEEIEILLRYGQ-- 79
Query: 131 RTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAK 187
              H N++ L     D     LV E M  G L   +  +K   E E    LH I     K
Sbjct: 80  ---HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG----K 132
Query: 188 GLVYLHEECQQRIIHYDIKPENVL-LDANFSP---KVADFGLAKLCDRNKTHVTISGYKG 243
            + YLH    Q ++H D+KP N+L +D + +P   ++ DFG AK        +    Y  
Sbjct: 133 TVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-- 187
Query: 244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 277
           T  + APE L         CD++S G++L+ ++ 
Sbjct: 188 TANFVAPEVLK-RQGYDEGCDIWSLGILLYTMLA 220

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 81/197 (41%), Gaps = 14/197 (7%)
Query: 81  NYSTRLGFGGFG--EVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
           ++   +G G FG   + + +    + +AVK + R  G   +E    E+       H N+V
Sbjct: 23  DFVKDIGSGNFGVARLMRDKLTKEL-VAVKYIER--GAAIDENVQREIINHRSLRHPNIV 79
Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           R           A++ EY   G L   +    R  E E           G+ Y H     
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ-QLLSGVSYCH---SM 135
Query: 199 RIIHYDIKPENVLLDANFSP--KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
           +I H D+K EN LLD + +P  K+ DFG +K    +  H       GTP Y APE L   
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRQ 192
Query: 257 YPITHKCDVYSFGMVLF 273
                  DV+S G+ L+
Sbjct: 193 EYDGKIADVWSCGVTLY 209

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 78  FTSNYSTR--LGFGGFGE----VYKGQFPNGVKIAVKVLNRNLGRIAEE-QFMAEVGTIG 130
           F+  Y  +  +G G + E    V+K      ++ AVKV++++    +EE + +   G   
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKA---TNMEYAVKVIDKSKRDPSEEIEILLRYGQ-- 79
Query: 131 RTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAK 187
              H N++ L     D     LV E M  G L   +  +K   E E    LH I     K
Sbjct: 80  ---HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG----K 132
Query: 188 GLVYLHEECQQRIIHYDIKPENVL-LDANFSP---KVADFGLAKLCDRNKTHVTISGYKG 243
            + YLH    Q ++H D+KP N+L +D + +P   ++ DFG AK        +    Y  
Sbjct: 133 TVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-- 187
Query: 244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 277
           T  + APE L         CD++S G++L+ ++ 
Sbjct: 188 TANFVAPEVLK-RQGYDEGCDIWSLGILLYTMLA 220

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 81/192 (42%), Gaps = 14/192 (7%)
Query: 86  LGFGGFG--EVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG   + + +  N + +AVK + R  G   +E    E+       H N+VR    
Sbjct: 27  IGAGNFGVARLMRDKQANEL-VAVKYIER--GEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                  A+V EY   G L   +    R  E E           G+ Y H     ++ H 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ-QLISGVSYAH---AMQVAHR 139
Query: 204 DIKPENVLLDANFSP--KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           D+K EN LLD + +P  K+ADFG +K    +  H       GTP Y APE L        
Sbjct: 140 DLKLENTLLDGSPAPRLKIADFGYSKA---SVLHSQPKSAVGTPAYIAPEVLLKKEYDGK 196
Query: 262 KCDVYSFGMVLF 273
             DV+S G+ L+
Sbjct: 197 VADVWSCGVTLY 208

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 112/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       +G G 
Sbjct: 2   NAAAAKKGXEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTIGTGS 53
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EYM  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYMPGGDMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     KVADFG AK        +      GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 114/255 (44%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       +G G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTIGTGS 53
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EYM  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYMPGGDMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     KVADFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIKVADFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 84  TRLGFGGFGEVYKGQFP-NGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRL 140
           +RLG G +GEV+K +   +G   AVK  ++   G     + +AEVG+  +   H   VRL
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
                +  +  L  E +   SL  +      ++   ++      T   L +LH    Q +
Sbjct: 123 EQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGL 178
Query: 201 IHYDIKPENVLLDANFSPKVADFG-LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           +H D+KP N+ L      K+ DFG L +L       V     +G P Y APE L G+Y  
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ----EGDPRYMAPELLQGSYGT 234
Query: 260 THKCDVYSFGMVLFEIV 276
               DV+S G+ + E+ 
Sbjct: 235 A--ADVFSLGLTILEVA 249

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 29/205 (14%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLN----RNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           +G G F  V +      G + AVK+++     +   ++ E    E        H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 141 YGFCHDQHMTALVYEYMENGSL---------DGYLFGKKRAIEWEKLHEIAIGTAKGLVY 191
                   M  +V+E+M+   L          G+++ +  A  + +         + L Y
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR------QILEALRY 145
Query: 192 LHEECQQRIIHYDIKPENVLLDA--NFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYS 248
            H+     IIH D+KPENVLL +  N +P K+ DFG+A      ++ +   G  GTP + 
Sbjct: 146 CHD---NNIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVGTPHFM 200
Query: 249 APEFLSGNYPITHKCDVYSFGMVLF 273
           APE +    P     DV+  G++LF
Sbjct: 201 APEVVKRE-PYGKPVDVWGCGVILF 224

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 42/224 (18%)
Query: 86  LGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF 143
           LG+G  G V ++G F  G  +AVK +  +   IA    + E+  +  +  H N++R Y  
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIRYY-- 75
Query: 144 CHDQHMTALVYEYME--NGSLDGYLFGKKRAIEWEKLHE------IAIGTAKGLVYLHEE 195
           C +      +Y  +E  N +L   +  K  + E  KL +      +    A G+ +LH  
Sbjct: 76  CSET-TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 132
Query: 196 CQQRIIHYDIKPENVLLDA-------------NFSPKVADFGLAKLCDRNKT--HVTISG 240
              +IIH D+KP+N+L+               N    ++DFGL K  D  +      ++ 
Sbjct: 133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 191
Query: 241 YKGTPGYSAPEFL--SGNYP----ITHKCDVYSFGMVLFEIVGR 278
             GT G+ APE L  S N      +T   D++S G V + I+ +
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 86  LGFGGFGEVYK----GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY--HIN--- 136
           LG G +G+V+          G   A+KVL +    I ++    E     R    HI    
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKK--ATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 137 -LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
            LV L+     +    L+ +Y+  G L  +L  ++R  E    HE+ I   + ++ L   
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIVLALEHL 175
Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
            +  II+ DIK EN+LLD+N    + DFGL+K    ++T      + GT  Y AP+ + G
Sbjct: 176 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIVRG 234
Query: 256 NYPITHKC-DVYSFGMVLFEIV 276
                 K  D +S G++++E++
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELL 256

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 86  LGFGGFGEVYKGQFPNGVKI----AVKVLNRNLGRIAEE-QFMAEVGTIGRTYHINLVRL 140
           LG G FG+V+  +  +G       A+KVL +   ++ +  +   E   +    H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           +     +    L+ +++  G L   L  K+     E +       A  L +LH      I
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLG---I 147
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I+ D+KPEN+LLD     K+ DFGL+K   D  K   +   + GT  Y APE ++     
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS---FCGTVEYMAPEVVN-RRGH 203
Query: 260 THKCDVYSFGMVLFEIV 276
           T   D +SFG+++FE++
Sbjct: 204 TQSADWWSFGVLMFEML 220

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 86  LGFGGFGEVYKGQFPNGVKI----AVKVLNRNLGRIAEE-QFMAEVGTIGRTYHINLVRL 140
           LG G FG+V+  +  +G       A+KVL +   ++ +  +   E   +    H  +V+L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           +     +    L+ +++  G L   L  K+     E +       A  L +LH      I
Sbjct: 93  HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLG---I 148
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I+ D+KPEN+LLD     K+ DFGL+K   D  K   +   + GT  Y APE ++     
Sbjct: 149 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS---FCGTVEYMAPEVVN-RRGH 204
Query: 260 THKCDVYSFGMVLFEIV 276
           T   D +SFG+++FE++
Sbjct: 205 TQSADWWSFGVLMFEML 221

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 86  LGFGGFGEVYKGQFPNGVKI----AVKVLNRNLGRIAEE-QFMAEVGTIGRTYHINLVRL 140
           LG G FG+V+  +  +G       A+KVL +   ++ +  +   E   +    H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           +     +    L+ +++  G L   L  K+     E +       A  L +LH      I
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLG---I 147
Query: 201 IHYDIKPENVLLDANFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           I+ D+KPEN+LLD     K+ DFGL+K   D  K   +   + GT  Y APE ++     
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS---FCGTVEYMAPEVVN-RRGH 203
Query: 260 THKCDVYSFGMVLFEIV 276
           T   D +SFG+++FE++
Sbjct: 204 TQSADWWSFGVLMFEML 220

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DF LA+  D   T     GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMT-----GYVATRWYRAPEIMLNW 197
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 93/198 (46%), Gaps = 20/198 (10%)
Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G  G VY       G ++A++ +N    +  +E  + E+  +    + N+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL-- 83
Query: 144 CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
             D ++      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 84  --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 200 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
           +IH DIK +N+LL  + S K+ DFG  A++        T+    GTP + APE ++    
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVT-RKA 192
Query: 259 ITHKCDVYSFGMVLFEIV 276
              K D++S G++  E++
Sbjct: 193 YGPKVDIWSLGIMAIEMI 210

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 36/209 (17%)
Query: 86  LGFGGFGEVYKGQFPNGVK----IAVKVLN-----RNLGRIAEEQFMAEVGTIGRTYHIN 136
           LG GG+G+V++ +   G       A+KVL      RN    A  +  AE   +    H  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK--AERNILEEVKHPF 82
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK-----LHEIAIGTAKGLVY 191
           +V L           L+ EY+  G L  ++  ++  I  E      L EI++     L +
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMA----LGH 136
Query: 192 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYSA 249
           LH   Q+ II+ D+KPEN++L+     K+ DFGL K  + D   TH     + GT  Y A
Sbjct: 137 LH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT----FCGTIEYMA 189
Query: 250 PEFL--SGNYPITHKCDVYSFGMVLFEIV 276
           PE L  SG+       D +S G ++++++
Sbjct: 190 PEILMRSGH---NRAVDWWSLGALMYDML 215

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 80/192 (41%), Gaps = 14/192 (7%)
Query: 86  LGFGGFG--EVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG   + + +  N + +AVK + R  G   +E    E+       H N+VR    
Sbjct: 26  IGSGNFGVARLMRDKQSNEL-VAVKYIER--GEKIDENVKREIINHRSLRHPNIVRFKEV 82
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                  A+V EY   G L   +    R  E E           G+ Y H     ++ H 
Sbjct: 83  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ-QLISGVSYCH---AMQVCHR 138
Query: 204 DIKPENVLLDANFSP--KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           D+K EN LLD + +P  K+ DFG +K    +  H       GTP Y APE L        
Sbjct: 139 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 195
Query: 262 KCDVYSFGMVLF 273
             DV+S G+ L+
Sbjct: 196 VADVWSCGVTLY 207

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G  G VY       G ++A++ +N    +  +E  + E+  +    + N+V     
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL-- 84
Query: 144 CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
             D ++      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 85  --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 137
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           +IH DIK +N+LL  + S K+ DFG        ++    S   GTP + APE ++     
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVT-RKAY 194
Query: 260 THKCDVYSFGMVLFEIV 276
             K D++S G++  E++
Sbjct: 195 GPKVDIWSLGIMAIEMI 211

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL-GRIAEEQFMAEV---GTIGRTYHINLVR 139
           ++G G FG V+K  +  +G   A+K   + L G + E+  + EV     +G+  H+  VR
Sbjct: 14  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV--VR 71
Query: 140 LY-GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEE 195
            +  +  D HM  +  EY   GSL   +    R + + K   L ++ +   +GL Y+H  
Sbjct: 72  YFSAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 128
Query: 196 CQQRIIHYDIKPENVLLDANFSPKVA-------DFGLAKLCDR--NKTHVT-ISGYK--- 242
               ++H DIKP N+ +     P  A       D+   K+  +  +  HVT IS  +   
Sbjct: 129 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 187
Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 277
           G   + A E L  NY    K D+++  + +    G
Sbjct: 188 GDSRFLANEVLQENYTHLPKADIFALALTVVXAAG 222

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 24/205 (11%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRN--LGRIA---------EEQFMAEVGTIGRTY 133
           LG GGFG V+ G +  + +++A+KV+ RN  LG            E   + +VG  G   
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG-- 96
Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           H  ++RL  +   Q    LV E       D + +  ++    E       G     +   
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQ-DLFDYITEKGPLGEGPSRCFFGQVVAAI--- 152
Query: 194 EECQQR-IIHYDIKPENVLLDANFS-PKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE 251
           + C  R ++H DIK EN+L+D      K+ DFG   L          + + GT  YS PE
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPE 208
Query: 252 FLSGNYPITHKCDVYSFGMVLFEIV 276
           ++S +        V+S G++L+++V
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMV 233

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 36/209 (17%)
Query: 86  LGFGGFGEVYKGQFPNGVK----IAVKVLN-----RNLGRIAEEQFMAEVGTIGRTYHIN 136
           LG GG+G+V++ +   G       A+KVL      RN    A  +  AE   +    H  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK--AERNILEEVKHPF 82
Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK-----LHEIAIGTAKGLVY 191
           +V L           L+ EY+  G L  ++  ++  I  E      L EI++     L +
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMA----LGH 136
Query: 192 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYSA 249
           LH   Q+ II+ D+KPEN++L+     K+ DFGL K  + D   TH     + GT  Y A
Sbjct: 137 LH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHX----FCGTIEYMA 189
Query: 250 PEFL--SGNYPITHKCDVYSFGMVLFEIV 276
           PE L  SG+       D +S G ++++++
Sbjct: 190 PEILMRSGH---NRAVDWWSLGALMYDML 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G  G VY       G ++A++ +N    +  +E  + E+  +    + N+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL-- 83
Query: 144 CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
             D ++      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 84  --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           +IH DIK +N+LL  + S K+ DFG        ++    S   GTP + APE ++     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVT-RKAY 193
Query: 260 THKCDVYSFGMVLFEIV 276
             K D++S G++  E++
Sbjct: 194 GPKVDIWSLGIMAIEMI 210

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 143
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 107
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 196
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 108 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 162
Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
              IIH D+KP N+ ++ +   K+ DFGLA+  D       + G   T  Y APE +   
Sbjct: 163 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXVATRWYRAPEIMLNW 217
Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E++  R
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G  G VY       G ++A++ +N    +  +E  + E+  +    + N+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL-- 83
Query: 144 CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
             D ++      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 84  --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           +IH DIK +N+LL  + S K+ DFG        ++    S   GTP + APE ++     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTPYWMAPEVVT-RKAY 193
Query: 260 THKCDVYSFGMVLFEIV 276
             K D++S G++  E++
Sbjct: 194 GPKVDIWSLGIMAIEMI 210

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 65/134 (48%), Gaps = 11/134 (8%)
Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           GF  D+ ++    +  E    DG+    K  I  E L   +   A+G+ +L     ++ I
Sbjct: 172 GFQEDKSLS----DVEEEEDSDGFY---KEPITMEDLISYSFQVARGMEFLS---SRKCI 221
Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H D+   N+LL  N   K+ DFGLA+   +N  +V     +    + APE +      T 
Sbjct: 222 HRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYST- 280
Query: 262 KCDVYSFGMVLFEI 275
           K DV+S+G++L+EI
Sbjct: 281 KSDVWSYGVLLWEI 294

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 112/253 (44%), Gaps = 29/253 (11%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 53
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN-LGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQ 147
           FG V        G   A+K+L++  + ++ E E  + E   +       LV+L     D 
Sbjct: 54  FGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 148 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHYDI 205
               +V EY   G +  +L   +R   + + H    A        YLH      +I+ D+
Sbjct: 114 SNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDL 167
Query: 206 KPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHKCD 264
           KPEN+++D     KV DFGLAK        +      GTP Y APE  LS  Y      D
Sbjct: 168 KPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKAVD 220
Query: 265 VYSFGMVLFEIVG 277
            ++ G++++E+  
Sbjct: 221 WWALGVLIYEMAA 233

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 112/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       +G G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTIGTGS 53
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     KVADFG AK        +      GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 115/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA-----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKA---KEDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL-GRIAEEQFMAEV---GTIGRTYHINLVR 139
           ++G G FG V+K  +  +G   A+K   + L G + E+  + EV     +G+  H+  VR
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV--VR 73
Query: 140 LY-GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEE 195
            +  +  D HM  +  EY   GSL   +    R + + K   L ++ +   +GL Y+H  
Sbjct: 74  YFSAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 130
Query: 196 CQQRIIHYDIKPENVLLDANFSPKVA-------DFGLAKLCDR--NKTHVT-ISGYK--- 242
               ++H DIKP N+ +     P  A       D+   K+  +  +  HVT IS  +   
Sbjct: 131 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 189
Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 277
           G   + A E L  NY    K D+++  + +    G
Sbjct: 190 GDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 224

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXL----XGTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 54
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 55  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 113 DNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 166
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 219
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 220 VDWWALGVLIYEMAA 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 2   NAAAAKKGXEQESVKEFLAKAK---EDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 2   NAAAAKKGXEQESVKEFLAKAK---EDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL-GRIAEEQFMAEV---GTIGRTYHINLVR 139
           ++G G FG V+K  +  +G   A+K   + L G + E+  + EV     +G+  H+  VR
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV--VR 73
Query: 140 LY-GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEE 195
            +  +  D HM  +  EY   GSL   +    R + + K   L ++ +   +GL Y+H  
Sbjct: 74  YFSAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 130
Query: 196 CQQRIIHYDIKPENVLLDANFSPKVA-------DFGLAKLCDR--NKTHVT-ISGYK--- 242
               ++H DIKP N+ +     P  A       D+   K+  +  +  HVT IS  +   
Sbjct: 131 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 189
Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 277
           G   + A E L  NY    K D+++  + +    G
Sbjct: 190 GDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 224

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 2   NAAAAKKGXEQESVKEFLAKAK---EDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 6/162 (3%)
Query: 118 AEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEW 175
            E     E+  + R  H N+++L    +++    +  V EY   G  +      ++    
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV 108
Query: 176 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH 235
            + H        GL YLH    Q I+H DIKP N+LL    + K++  G+A+        
Sbjct: 109 CQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165
Query: 236 VTISGYKGTPGYSAPEFLSGNYPIT-HKCDVYSFGMVLFEIV 276
            T    +G+P +  PE  +G    +  K D++S G+ L+ I 
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNIT 207

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 20/226 (8%)
Query: 59  LQEIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLG 115
           +Q +G    V+        FT  Y  +  +G G +    +       ++ AVK+++++  
Sbjct: 1   MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60
Query: 116 RIAEE-QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 174
              EE + +   G      H N++ L     D     +V E M+ G L   +  +K   E
Sbjct: 61  DPTEEIEILLRYGQ-----HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE 115
Query: 175 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVL-LDANFSP---KVADFGLAKLCD 230
            E    +     K + YLH    Q ++H D+KP N+L +D + +P   ++ DFG AK   
Sbjct: 116 REA-SAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171
Query: 231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
                +    Y  T  + APE L         CD++S G++L+ ++
Sbjct: 172 AENGLLMTPCY--TANFVAPEVLE-RQGYDAACDIWSLGVLLYTML 214

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 2   NAAAAKKGXEQESVKEFLAKAK---EDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL---RRIGRFAEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL-GRIAEEQFMAEV---GTIGRTYHINLVR 139
           ++G G FG V+K  +  +G   A+K   + L G + E+  + EV     +G+  H+  VR
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV--VR 75
Query: 140 LY-GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEE 195
            +  +  D HM  +  EY   GSL   +    R + + K   L ++ +   +GL Y+H  
Sbjct: 76  YFSAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 132
Query: 196 CQQRIIHYDIKPENVLLDANFSPKVA-------DFGLAKLCDR--NKTHVT-ISGYK--- 242
               ++H DIKP N+ +     P  A       D+   K+  +  +  HVT IS  +   
Sbjct: 133 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191
Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 277
           G   + A E L  NY    K D+++  + +    G
Sbjct: 192 GDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 93/198 (46%), Gaps = 20/198 (10%)
Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G  G VY       G ++A++ +N    +  +E  + E+  +    + N+V     
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL-- 84
Query: 144 CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
             D ++      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 85  --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 137
Query: 200 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
           +IH +IK +N+LL  + S K+ DFG  A++        T+    GTP + APE ++    
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVT-RKA 193
Query: 259 ITHKCDVYSFGMVLFEIV 276
              K D++S G++  E++
Sbjct: 194 YGPKVDIWSLGIMAIEMI 211

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 115/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 23  NAAAAKKGSEQESVKEFLAKA---KEDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 74
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 75  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 132
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 133 DNSNLYMVMEYVAGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLH---SLDLIYR 186
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 187 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 239
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 240 VDWWALGVLIYEMAA 254

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 152 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 210
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENL 192
Query: 211 LLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 267
           L  +   N   K+ DFG AK      +H +++    TP Y APE L G       CD++S
Sbjct: 193 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 248
Query: 268 FGMVLF 273
            G++++
Sbjct: 249 LGVIMY 254

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 152 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 210
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 142 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENL 198
Query: 211 LLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 267
           L  +   N   K+ DFG AK      +H +++    TP Y APE L G       CD++S
Sbjct: 199 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 254
Query: 268 FGMVLF 273
            G++++
Sbjct: 255 LGVIMY 260

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 152 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 210
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 96  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENL 152
Query: 211 LLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 267
           L  +   N   K+ DFG AK      +H +++    TP Y APE L G       CD++S
Sbjct: 153 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 208
Query: 268 FGMVLF 273
            G++++
Sbjct: 209 LGVIMY 214

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 152 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 210
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 97  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENL 153
Query: 211 LLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 267
           L  +   N   K+ DFG AK      +H +++    TP Y APE L G       CD++S
Sbjct: 154 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 209
Query: 268 FGMVLF 273
            G++++
Sbjct: 210 LGVIMY 215

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 112/253 (44%), Gaps = 29/253 (11%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 53
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN-LGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQ 147
           FG V        G   A+K+L++  + ++ E E  + E   +       LV+L     D 
Sbjct: 54  FGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 148 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHYDI 205
               +V EY   G +  +L   +R   + + H    A        YLH      +I+ D+
Sbjct: 114 SNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDL 167
Query: 206 KPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHKCD 264
           KPEN+++D     +V DFGLAK        +      GTP Y APE  LS  Y      D
Sbjct: 168 KPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKAVD 220
Query: 265 VYSFGMVLFEIVG 277
            ++ G++++E+  
Sbjct: 221 WWALGVLIYEMAA 233

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 152 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 210
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 90  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENL 146
Query: 211 LLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 267
           L  +   N   K+ DFG AK      +H +++    TP Y APE L G       CD++S
Sbjct: 147 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 202
Query: 268 FGMVLF 273
            G++++
Sbjct: 203 LGVIMY 208

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 86  LGFGGFGEVYKGQFPNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G FG V++ +     ++A+K VL     +  E Q M  V       H N+V L  F 
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK------HPNVVDLKAFF 101
Query: 145 H------DQHMTALVYEYM-ENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEEC 196
           +      D+    LV EY+ E        + K K+ +    +        + L Y+H   
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG 161
Query: 197 QQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTI--SGYKGTPGYSAPEFL 253
              I H DIKP+N+LLD      K+ DFG AK+    + +V+   S Y     Y APE +
Sbjct: 162 ---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-----YRAPELI 213
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
            G    T   D++S G V+ E++
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELM 236

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 152 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 210
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 98  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENL 154
Query: 211 LLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 267
           L  +   N   K+ DFG AK      +H +++    TP Y APE L G       CD++S
Sbjct: 155 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 210
Query: 268 FGMVLF 273
            G++++
Sbjct: 211 LGVIMY 216

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 115/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 23  NAAAAKKGSEQESVKEFLAKA---KEDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 74
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 75  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 132
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 133 DNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 186
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 187 DLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC-----GTPEYLAPEIILSKGY--NKA 239
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 240 VDWWALGVLIYEMAA 254

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 152 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 210
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 91  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENL 147
Query: 211 LLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 267
           L  +   N   K+ DFG AK      +H +++    TP Y APE L G       CD++S
Sbjct: 148 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 203
Query: 268 FGMVLF 273
            G++++
Sbjct: 204 LGVIMY 209

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 152 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 210
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 92  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENL 148
Query: 211 LLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 267
           L  +   N   K+ DFG AK      +H +++    TP Y APE L G       CD++S
Sbjct: 149 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 204
Query: 268 FGMVLF 273
            G++++
Sbjct: 205 LGVIMY 210

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 152 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 210
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 92  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENL 148
Query: 211 LLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 267
           L  +   N   K+ DFG AK      +H +++    TP Y APE L G       CD++S
Sbjct: 149 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 204
Query: 268 FGMVLF 273
            G++++
Sbjct: 205 LGVIMY 210

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 113/255 (44%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 54
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 55  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 166
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWTLC----GTPEYLAPEIILSKGY--NKA 219
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 220 VDWWALGVLIYEMAA 234

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 152 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 210
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 106 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENL 162
Query: 211 LLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 267
           L  +   N   K+ DFG AK      +H +++    TP Y APE L G       CD++S
Sbjct: 163 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 218
Query: 268 FGMVLF 273
            G++++
Sbjct: 219 LGVIMY 224

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 152 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 210
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 90  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENL 146
Query: 211 LLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 267
           L  +   N   K+ DFG AK      +H +++    TP Y APE L G       CD++S
Sbjct: 147 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTEPCYTPYYVAPEVL-GPEKYDKSCDMWS 202
Query: 268 FGMVLF 273
            G++++
Sbjct: 203 LGVIMY 208

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 117/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++++  
Sbjct: 219 VDWWALGVLIYQMAA 233

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 2   NAAAACKGSEQESVKEFLAKAK---EDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 113/255 (44%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 53
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 114/253 (45%), Gaps = 29/253 (11%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F    +  LG G 
Sbjct: 3   NAAAAKKGXEQESVKEFLAKAK---EDFLKKW--ESPAQNTA-HLDQFERIRT--LGTGS 54
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHIN-LVRLYGFCHDQ 147
           FG V   +    G   A+K+L++  + ++ + +       I +  +   LV+L     D 
Sbjct: 55  FGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDN 114
Query: 148 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHYDI 205
               +V EY   G +  +L   +R   + + H    A        YLH      +I+ D+
Sbjct: 115 SNLYMVLEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDL 168
Query: 206 KPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHKCD 264
           KPEN+L+D     KVADFG AK        +      GTP Y APE  LS  Y      D
Sbjct: 169 KPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKAVD 221
Query: 265 VYSFGMVLFEIVG 277
            ++ G++++E+  
Sbjct: 222 WWALGVLIYEMAA 234

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 73
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E ME    D + F  +R    E+L           V    
Sbjct: 74  -GVIRLLDWFERPDSFVLILERMEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 131
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 132 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 185
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMV 208

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 113/255 (44%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 53
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 46/229 (20%)
Query: 85  RLGFGGFGEVY--KGQFPNGV--KIAVKVL--NRNLGRIAEE-QFMAEVGTIGRTYHINL 137
           ++G G F  VY    Q   G   KIA+K L    +  RIA E Q +   G       +  
Sbjct: 28  KIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVK- 86
Query: 138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
              Y F  + H+  +   Y+E+ S    L     ++ ++++ E  +   K L  +H   Q
Sbjct: 87  ---YCFRKNDHVV-IAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIH---Q 135
Query: 198 QRIIHYDIKPENVLLDANFSP-KVADFGLAK--------------------LCDRNKTHV 236
             I+H D+KP N L +       + DFGLA+                     C +NK  +
Sbjct: 136 FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSI 195
Query: 237 TISGYK------GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            +S  +      GTPG+ APE L+     T   D++S G++   ++  R
Sbjct: 196 CLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 92/197 (46%), Gaps = 12/197 (6%)
Query: 102 GVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG-FCHDQHMTALVYEYMEN 159
           G+ +AVK L+R    +   ++   E+  +    H N++ L   F   + +      Y+  
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 106
Query: 160 GSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP 218
             +D  L       ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + 
Sbjct: 107 ELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 163
Query: 219 KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
           K+ DFGLA+      T+  ++ Y  T  Y APE + G        D++S G ++ E+V  
Sbjct: 164 KILDFGLARTA---STNFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELV-- 217
Query: 279 RRNAIVGATESLDWFPK 295
           + + I   T+ +D + K
Sbjct: 218 KGSVIFQGTDHIDQWNK 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 111/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 2   NAAAAKKGXEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 53
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 111/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 53
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 111/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 54
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 55  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 166
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 219
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 220 VDWWALGVLIYEMAA 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 114/255 (44%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKETGNHFAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEYSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 114/255 (44%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKETGNHFAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEYSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 110/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 53
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY   G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+++D     KV DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 55/112 (49%), Gaps = 14/112 (12%)
Query: 171 RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP------KVADFG 224
           R I    + +I+     GL Y+H  C   IIH DIKPENVL++   SP      K+AD G
Sbjct: 126 RGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG 183
Query: 225 LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            A   D + T+        T  Y +PE L G  P     D++S   ++FE++
Sbjct: 184 NACWYDEHYTNSI-----QTREYRSPEVLLGA-PWGCGADIWSTACLIFELI 229

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 111/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 53
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 111/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 54
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 55  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLH---SLDLIYR 166
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 219
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 220 VDWWALGVLIYEMAA 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 112/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKETGNHFAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEYSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 55/112 (49%), Gaps = 14/112 (12%)
Query: 171 RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP------KVADFG 224
           R I    + +I+     GL Y+H  C   IIH DIKPENVL++   SP      K+AD G
Sbjct: 126 RGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG 183
Query: 225 LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            A   D + T+        T  Y +PE L G  P     D++S   ++FE++
Sbjct: 184 NACWYDEHYTNSI-----QTREYRSPEVLLGA-PWGCGADIWSTACLIFELI 229

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 111/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 2   NAAAAKKGXEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 53
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 79/192 (41%), Gaps = 14/192 (7%)
Query: 86  LGFGGFG--EVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG   + + +  N + +AVK + R  G   +E    E+       H N+VR    
Sbjct: 27  IGSGNFGVARLMRDKQSNEL-VAVKYIER--GEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                  A+V EY   G L   +    R  E E           G+ Y H     ++ H 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ-QLISGVSYCH---AMQVCHR 139
Query: 204 DIKPENVLLDANFSP--KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           D+K EN LLD + +P  K+  FG +K    +  H       GTP Y APE L        
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 262 KCDVYSFGMVLF 273
             DV+S G+ L+
Sbjct: 197 VADVWSCGVTLY 208

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 110/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 53
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY   G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+++D     KV DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 78/192 (40%), Gaps = 14/192 (7%)
Query: 86  LGFGGFG--EVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG   + + +  N + +AVK + R  G         E+       H N+VR    
Sbjct: 27  IGSGNFGVARLMRDKQSNEL-VAVKYIER--GEKIAANVKREIINHRSLRHPNIVRFKEV 83
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                  A+V EY   G L   +    R  E E           G+ Y H     ++ H 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ-QLISGVSYCH---AMQVCHR 139
Query: 204 DIKPENVLLDANFSP--KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           D+K EN LLD + +P  K+ DFG +K    +  H       GTP Y APE L        
Sbjct: 140 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 262 KCDVYSFGMVLF 273
             DV+S G+ L+
Sbjct: 197 VADVWSCGVTLY 208

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 117/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKA---KEDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+++D     +V DFG AK   + +T        GTP Y APE  +S  Y     
Sbjct: 166 DLKPENLIIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIIISKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 112/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ESPAQNTA-HLDQFER--IKTLGTGS 54
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 55  FGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 166
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 219
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 220 VDWWALGVLIYEMAA 234

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 79/192 (41%), Gaps = 14/192 (7%)
Query: 86  LGFGGFG--EVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG   + + +  N + +AVK + R  G   +E    E+       H N+VR    
Sbjct: 27  IGSGNFGVARLMRDKQSNEL-VAVKYIER--GEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                  A+V EY   G L   +    R  E E           G+ Y H     ++ H 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ-QLISGVSYCH---AMQVCHR 139
Query: 204 DIKPENVLLDANFSP--KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           D+K EN LLD + +P  K+  FG +K    +  H       GTP Y APE L        
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAYIAPEVLLKKEYDGK 196
Query: 262 KCDVYSFGMVLF 273
             DV+S G+ L+
Sbjct: 197 VADVWSCGVTLY 208

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 112/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ESPAQNTA-HLDQFER--IKTLGTGS 54
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 55  FGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 166
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 219
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 220 VDWWALGVLIYEMAA 234

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 116/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP Y AP   LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPAIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 112/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 3   NAAAAKKGXEQESVKEFLAKAK---EDFLKKW--ESPAQNTA-HLDQFER--IKTLGTGS 54
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 55  FGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 166
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 219
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 220 VDWWALGVLIYEMAA 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 113/255 (44%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F    +  LG G 
Sbjct: 23  NAAAAKKGSEQESVKEFLAKA---KEDFLKKW--ESPAQNTA-HLDQFERIKT--LGTGS 74
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 75  FGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 132
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 133 DNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 186
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 187 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 239
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 240 VDWWALGVLIYEMAA 254

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 111/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ESPAQNTA-HLDQFER--IKTLGTGS 54
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 55  FGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY   G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 166
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+++D     KV DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 167 DLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 219
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 220 VDWWALGVLIYEMAA 234

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 59/126 (46%), Gaps = 11/126 (8%)
Query: 152 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 210
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 136 IVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLH---SINIAHRDVKPENL 192
Query: 211 LLDA---NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 267
           L  +   N   K+ DFG AK      +H +++    TP Y APE L G       CD +S
Sbjct: 193 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDXWS 248
Query: 268 FGMVLF 273
            G++ +
Sbjct: 249 LGVIXY 254

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVL 211
           LV+E M  GS+  ++  ++   E E    +    A  L +LH    + I H D+KPEN+L
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEA-SVVVQDVASALDFLH---NKGIAHRDLKPENIL 143
Query: 212 LD--ANFSP-KVADFGLAKLCDRNKTHVTISGYK-----GTPGYSAPEFL---SGNYPIT 260
            +     SP K+ DFGL      N     IS  +     G+  Y APE +   S    I 
Sbjct: 144 CEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY 203
Query: 261 HK-CDVYSFGMVLF 273
            K CD++S G++L+
Sbjct: 204 DKRCDLWSLGVILY 217

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 110/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 53
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY   G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+++D     +V DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 166 DLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 102 GVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG-FCHDQHMTALVYEYMEN 159
           G+ +AVK L+R    +   ++   E+  +    H N++ L   F   + +      Y+  
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 160 GSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP 218
             +D  L       ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + 
Sbjct: 109 ELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 165
Query: 219 KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 278
           K+ DFGLA+      T+  ++ Y  T  Y APE + G        D++S G ++ E+V  
Sbjct: 166 KILDFGLARTA---CTNFMMTPYVVTRYYRAPEVILG-MGYAANVDIWSVGCIMGELV-- 219
Query: 279 RRNAIVGATESLDWFPK 295
           +   I   T+ +D + K
Sbjct: 220 KGCVIFQGTDHIDQWNK 236

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 111/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 3   NAAAAKKGXEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 54
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       L +L     
Sbjct: 55  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLTKLEFSFK 112
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY   G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 166
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+++D     KV DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 167 DLKPENLMIDQQGYIKVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 219
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 220 VDWWALGVLIYEMAA 234

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 59/133 (44%), Gaps = 12/133 (9%)
Query: 145 HDQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
           H +    ++ E ME G L   +  +  +A    +  EI       + +LH      I H 
Sbjct: 77  HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHR 133
Query: 204 DIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           D+KPEN+L    + +   K+ DFG AK   +N           TP Y APE L G     
Sbjct: 134 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY----TPYYVAPEVL-GPEKYD 188
Query: 261 HKCDVYSFGMVLF 273
             CD++S G++++
Sbjct: 189 KSCDMWSLGVIMY 201

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 59/133 (44%), Gaps = 12/133 (9%)
Query: 145 HDQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
           H +    ++ E ME G L   +  +  +A    +  EI       + +LH      I H 
Sbjct: 96  HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHR 152
Query: 204 DIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           D+KPEN+L    + +   K+ DFG AK   +N           TP Y APE L G     
Sbjct: 153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY----TPYYVAPEVL-GPEKYD 207
Query: 261 HKCDVYSFGMVLF 273
             CD++S G++++
Sbjct: 208 KSCDMWSLGVIMY 220

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 109/255 (42%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 54
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       L +L     
Sbjct: 55  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLTKLEFSFK 112
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY   G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 166
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+++D     KV DFG AK        +      GTP Y APE  LS  Y     
Sbjct: 167 DLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY--NKA 219
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 220 VDWWALGVLIYEMAA 234

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 111/255 (43%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+  L+ F       LG G 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ENPAQNTA-HLDQFER--IKTLGTGS 54
Query: 91  FGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V        G   A+K+L++     L +I  E  + E   +       L +L     
Sbjct: 55  FGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLTKLEFSFK 112
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY   G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLH---SLDLIYR 166
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+++D     KV DFG AK   + +T        GTP Y APE  LS  Y     
Sbjct: 167 DLKPENLMIDQQGYIKVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKA 219
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 220 VDWWALGVLIYEMAA 234

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG-- 177
Query: 233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            T   ++ Y  T  Y APE + G        D++S G+++ E++
Sbjct: 178 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGVIMGEMI 219

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 116/255 (45%), Gaps = 33/255 (12%)
Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK---EDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGS 53
Query: 91  FGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +   +G   A+K+L++     L +I  E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 146 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHY 203
           D     +V EY+  G +  +L   +R   + + H    A        YLH      +I+ 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHK 262
           D+KPEN+L+D     +V DFG AK   + +T        GTP   APE  LS  Y     
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEALAPEIILSKGY--NKA 218
Query: 263 CDVYSFGMVLFEIVG 277
            D ++ G++++E+  
Sbjct: 219 VDWWALGVLIYEMAA 233

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG-- 177
Query: 233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            T   ++ Y  T  Y APE + G        D++S G ++ E+V  +
Sbjct: 178 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 57/233 (24%)
Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVL-----NRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           L  GGF  VY+ Q   +G + A+K L      +N   I E  FM ++     + H N+V+
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKL-----SGHPNIVQ 90
Query: 140 LYGFCHDQHMTA----------LVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAK 187
              FC    +            L+   +  G L  +L     +  +  + + +I   T +
Sbjct: 91  ---FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY------ 241
            + ++H + +  IIH D+K EN+LL    + K+ DFG A          TIS Y      
Sbjct: 148 AVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA---------TTISHYPDYSWS 197
Query: 242 -------------KGTPGYSAPEF--LSGNYPITHKCDVYSFGMVLFEIVGRR 279
                          TP Y  PE   L  N+PI  K D+++ G +L+ +  R+
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG-- 177
Query: 233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            T   ++ Y  T  Y APE + G        D++S G ++ E+V  +
Sbjct: 178 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 116 LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG-- 170
Query: 233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            T   ++ Y  T  Y APE + G        D++S G ++ E+V  +
Sbjct: 171 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG-- 177
Query: 233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            T   ++ Y  T  Y APE + G        D++S G+++ E++
Sbjct: 178 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGVIMGEMI 219

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 21/221 (9%)
Query: 68  VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNR--NLGRIAEEQFMA 124
           VR   ++L          +G G F EV   +    G   A+K++N+   L R     F  
Sbjct: 51  VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 125 EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIA 182
           E   +       + +L+    D++   LV EY   G L   L  FG++   E  + +   
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY- 241
           I  A   V+     +   +H DIKP+N+LLD     ++ADFG    C + +   T+    
Sbjct: 171 IVMAIDSVH-----RLGYVHRDIKPDNILLDRCGHIRLADFG---SCLKLRADGTVRSLV 222
Query: 242 -KGTPGYSAPEFLSG------NYPITHKCDVYSFGMVLFEI 275
             GTP Y +PE L              +CD ++ G+  +E+
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 86  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 92
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 198
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 93  EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 146
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNY 257
            +I+ D+KPEN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y
Sbjct: 147 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWTLC----GTPEYLAPEIILSKGY 201
Query: 258 PITHKCDVYSFGMVLFEIVG 277
                 D ++ G++++E+  
Sbjct: 202 --NKAVDWWALGVLIYEMAA 219

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 112/251 (44%), Gaps = 31/251 (12%)
Query: 35  ASANKPEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEV 94
           A     +E V E + +A    E FL++   E P + T+ QL+ F  +    LG G FG V
Sbjct: 1   AKKGXEQESVKEFLAKAK---EDFLKKW--ETPSQNTA-QLDQF--DRIKTLGTGSFGRV 52
Query: 95  YKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM 149
              +   +G   A+K+L++     L +I  E  + E   +       LV+L     D   
Sbjct: 53  MLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFKDNSN 110
Query: 150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRIIHYDIKP 207
             +V EY+  G +  +L   +R   + + H    A        YLH      +I+ D+KP
Sbjct: 111 LYMVMEYVAGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKP 164
Query: 208 ENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHKCDVY 266
           EN+L+D     +V DFG AK   + +T        GTP Y APE  LS  Y      D +
Sbjct: 165 ENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY--NKAVDWW 217
Query: 267 SFGMVLFEIVG 277
           + G++++E+  
Sbjct: 218 ALGVLIYEMAA 228

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 65  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 119
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 18  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 72
Query: 120 EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 179
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 73  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH 129
Query: 180 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK        + 
Sbjct: 130 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC 186
Query: 238 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 277
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 187 -----GTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 220

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 74
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 75  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 132
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 133 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 186
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 7/92 (7%)
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      T   ++ Y  T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            APE + G        D++S G ++ E+V  +
Sbjct: 192 RAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 7/92 (7%)
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      T   ++ Y  T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            APE + G        D++S G ++ E+V  +
Sbjct: 192 RAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 73
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 74  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 131
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 132 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 185
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMV 208

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 74
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 75  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 132
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 133 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 186
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMV 209

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 88
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 89  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 146
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 147 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 200
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMV 223

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG-- 177
Query: 233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            T   ++ Y  T  Y APE + G        D++S G ++ E++
Sbjct: 178 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMI 219

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 72
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 73  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 130
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 131 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 184
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMV 207

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 88
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 89  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 146
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 147 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 200
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMV 223

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 74
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 75  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 132
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 133 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 186
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMV 209

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 101
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 102 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 160 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 213
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMV 236

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 89
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 90  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 148 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 201
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMV 224

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 69
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 70  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 128 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMV 204

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 102
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 103 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 161 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 214
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 116
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 117 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 174
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 175 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 228
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMV 251

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 89
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 90  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 148 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 201
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 89
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 90  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 148 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 201
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 20/205 (9%)
Query: 77  NFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEE-QFMAEVGTIGRT 132
            FT  Y  +  +G G +    +        + AVK+++++     EE + +   G     
Sbjct: 19  QFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQ---- 74
Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 192
            H N++ L     D     +V E  + G L   +  +K   E E    +     K + YL
Sbjct: 75  -HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREA-SAVLFTITKTVEYL 132
Query: 193 HEECQQRIIHYDIKPENVL-LDANFSP---KVADFGLAKLCDRNKTHVTISGYKGTPGYS 248
           H    Q ++H D+KP N+L +D + +P   ++ DFG AK        +    Y  T  + 
Sbjct: 133 HA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY--TANFV 187
Query: 249 APEFLSGNYPITHKCDVYSFGMVLF 273
           APE L         CD++S G++L+
Sbjct: 188 APEVLE-RQGYDAACDIWSLGVLLY 211

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 102
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 103 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 161 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 214
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 101
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 102 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 160 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 213
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMV 236

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 116
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 117 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 174
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 175 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 228
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMV 251

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 101
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 102 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 160 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 213
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 102
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 103 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 161 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 214
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      T   ++ Y  T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            APE + G        D++S G ++ E++
Sbjct: 192 RAPEVILG-MGYKENVDIWSVGCIMGEMI 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 178
Query: 233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            T   ++ Y  T  Y APE + G        D++S G ++ E+V  +
Sbjct: 179 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 101
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 102 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 160 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 213
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMV 236

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 23/200 (11%)
Query: 86  LGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 99
Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 198
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 153
Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNY 257
            +I+ D+KPEN+L+D     +V DFG AK        +      GTP Y APE  LS  Y
Sbjct: 154 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY 208
Query: 258 PITHKCDVYSFGMVLFEIVG 277
                 D ++ G++++E+  
Sbjct: 209 --NKAVDWWALGVLIYEMAA 226

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 102
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 103 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 161 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 214
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 177
Query: 233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            T   ++ Y  T  Y APE + G        D++S G ++ E+V  +
Sbjct: 178 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      T   ++ Y  T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            APE + G        D++S G ++ E++
Sbjct: 192 RAPEVILG-MGYKENVDIWSVGCIMGEMI 219

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 121
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 122 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 179
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 180 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 233
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 234 RYHRYHGRSAAVWSLGILLYDMV 256

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 178
Query: 233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            T   ++ Y  T  Y APE + G        D++S G ++ E+V  +
Sbjct: 179 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 171
Query: 233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            T   ++ Y  T  Y APE + G        D++S G ++ E+V  +
Sbjct: 172 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 216

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 96
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 97  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 154
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 155 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 208
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 209 RYHRYHGRSAAVWSLGILLYDMV 231

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 108
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 109 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 167 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 220
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMV 243

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 215
Query: 233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            T   ++ Y  T  Y APE + G        D++S G ++ E+V  +
Sbjct: 216 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 260

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 86  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 134
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 69
Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 70  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 195 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 128 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 254 SGNYPITHKCDVYSFGMVLFEIV 276
             +        V+S G++L+++V
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMV 204

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 170
Query: 233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            T   ++ Y  T  Y APE + G        D++S G ++ E+V  +
Sbjct: 171 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      T   ++ Y  T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            APE + G        D++S G ++ E++
Sbjct: 192 RAPEVILG-MGYKENVDIWSVGCIMGEMI 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 171
Query: 233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            T   ++ Y  T  Y APE + G        D++S G ++ E+V  +
Sbjct: 172 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 122 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 176
Query: 233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            T   ++ Y  T  Y APE + G        D++S G ++ E+V  +
Sbjct: 177 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 44/78 (56%), Gaps = 4/78 (5%)
Query: 200 IIHYDIKPENVLLD-ANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
           + H DIKP NVL++ A+ + K+ DFG AK    ++ +V    Y  +  Y APE + GN  
Sbjct: 152 VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV---AYICSRYYRAPELIFGNQH 208
Query: 259 ITHKCDVYSFGMVLFEIV 276
            T   D++S G +  E++
Sbjct: 209 YTTAVDIWSVGCIFAEMM 226

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 173 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 177
Query: 233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            T   ++ Y  T  Y APE + G        D++S G ++ E+V  +
Sbjct: 178 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 56/108 (51%), Gaps = 9/108 (8%)
Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      T   ++ Y  T  Y
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 192
Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPK 295
            APE + G        D++S G ++ E++  +   +   T+ +D + K
Sbjct: 193 RAPEVILG-MGYKENVDIWSVGCIMGEMI--KGGVLFPGTDHIDQWNK 237
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	406
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-111
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-96
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-74
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-61
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-61
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-60
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-59
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-58
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-56
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-56
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-54
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-54
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-50
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-42
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-41
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-40
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-39
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-39
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-39
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-39
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-39
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-38
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-38
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-38
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-37
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-37
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-37
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-36
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-35
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-34
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-34
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-34
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-34
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-34
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-34
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-33
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-33
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-33
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-33
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-32
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-32
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-32
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-32
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-31
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-31
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-31
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-30
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-30
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-30
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-30
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-29
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-29
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-29
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-29
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-29
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-29
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-29
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-28
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-28
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-28
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-28
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-28
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-28
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-28
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-27
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-27
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-27
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-27
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-27
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-26
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-26
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-25
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-25
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-25
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-24
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-24
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-24
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-23
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-23
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-22
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-17
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-17
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-17
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-12
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-12
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-12
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-07
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-06

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  328 bits (844), Expect = e-111
 Identities = 119/307 (38%), Positives = 169/307 (55%), Gaps = 23/307 (7%)

Query: 61  EIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIA 118
           E+   +  RF+  +L   + N+S +  LG GGFG+VYKG+  +G  +AVK L     +  
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70

Query: 119 EEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA---IEW 175
           E QF  EV  I    H NL+RL GFC       LVY YM NGS+   L  +  +   ++W
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW 130

Query: 176 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH 235
            K   IA+G+A+GL YLH+ C  +IIH D+K  N+LLD  F   V DFGLAKL D   TH
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190

Query: 236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES------ 289
           VT +  +GT G+ APE+LS     + K DV+ +G++L E++  +R   +    +      
Sbjct: 191 VT-TAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248

Query: 290 LDWFPKHVWEEYEKCELGAMI---LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSA 346
           LDW    V    ++ +L A++   L         E+ ++L  VAL C Q SP +RP MS 
Sbjct: 249 LDW----VKGLLKEKKLEALVDVDLQ---GNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301

Query: 347 VIKMLEG 353
           V++MLEG
Sbjct: 302 VVRMLEG 308

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  292 bits (749), Expect = 3e-97
 Identities = 108/304 (35%), Positives = 160/304 (52%), Gaps = 30/304 (9%)

Query: 69  RFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEV 126
           R   + L   T+N+  +  +G G FG+VYKG   +G K+A+K           E+F  E+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEI 86

Query: 127 GTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---WEKLHEIAI 183
            T+    H +LV L GFC +++   L+Y+YMENG+L  +L+G         WE+  EI I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 184 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC-DRNKTHVTISGYK 242
           G A+GL YLH      IIH D+K  N+LLD NF PK+ DFG++K   + ++TH++ +  K
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS-TVVK 202

Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV-GRRRNAIVGATES-----LDWFPKH 296
           GT GY  PE+      +T K DVYSFG+VLFE++  R   AIV +         +W    
Sbjct: 203 GTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARS--AIVQSLPREMVNLAEW---- 255

Query: 297 VWEEYEKCELGAMI---LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG 353
             E +   +L  ++   L   I     E  ++    A+ C+  S EDRP M  V+  LE 
Sbjct: 256 AVESHNNGQLEQIVDPNLADKI---RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312

Query: 354 VVEV 357
            + +
Sbjct: 313 ALRL 316

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  288 bits (740), Expect = 6e-96
 Identities = 102/305 (33%), Positives = 146/305 (47%), Gaps = 31/305 (10%)

Query: 69  RFTSLQLNNFTSNYSTR--------LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIA-- 118
            F+  +L N T+N+  R        +G GGFG VYKG   N   +AVK L   +      
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72

Query: 119 -EEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKR--AIEW 175
            ++QF  E+  + +  H NLV L GF  D     LVY YM NGSL   L        + W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132

Query: 176 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN-KT 234
               +IA G A G+ +LHE      IH DIK  N+LLD  F+ K++DFGLA+  ++  +T
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189

Query: 235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES----L 290
            +T S   GT  Y APE L G   IT K D+YSFG+VL EI+       V         L
Sbjct: 190 VMT-SRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPA--VDEHREPQLLL 244

Query: 291 DWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM 350
           D   + + +E +  E     +   + + D    + +  VA  C+ +    RP +  V ++
Sbjct: 245 DIK-EEIEDEEKTIE---DYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300

Query: 351 LEGVV 355
           L+ + 
Sbjct: 301 LQEMT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  234 bits (599), Expect = 1e-74
 Identities = 75/292 (25%), Positives = 114/292 (39%), Gaps = 26/292 (8%)

Query: 82  YSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
                  G FG V+K Q      +AVK+           Q   EV ++    H N+++  
Sbjct: 28  LLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFI 84

Query: 142 GFCHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE-- 195
           G             L+  + E GSL  +L  K   + W +L  IA   A+GL YLHE+  
Sbjct: 85  GAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLAYLHEDIP 142

Query: 196 -----CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAP 250
                 +  I H DIK +NVLL  N +  +ADFGLA   +  K+     G  GT  Y AP
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202

Query: 251 EFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCEL 306
           E L G          + D+Y+ G+VL+E+  R   A     E +  F + + +     ++
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDM 262

Query: 307 GAMILGCGI------EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
             +++            +       LC     C     E R     V + + 
Sbjct: 263 QEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  200 bits (511), Expect = 2e-61
 Identities = 73/325 (22%), Positives = 115/325 (35%), Gaps = 43/325 (13%)

Query: 72  SLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAE--VGTI 129
           SL L+N        +G G +G VYKG   +   +AVKV +        + F+ E  +  +
Sbjct: 9   SLDLDNLK--LLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRV 61

Query: 130 GRTYHINLVRLYGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG 184
               H N+ R                 LV EY  NGSL  YL       +W     +A  
Sbjct: 62  PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHS 119

Query: 185 TAKGLVYLHEE------CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN------ 232
             +GL YLH E       +  I H D+   NVL+  + +  ++DFGL+     N      
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179

Query: 233 KTHVTISGYKGTPGYSAPEFLSGNY------PITHKCDVYSFGMVLFEIVGRRRNAIVG- 285
           +         GT  Y APE L G            + D+Y+ G++ +EI  R  +   G 
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239

Query: 286 -ATESLDWFPKHVWEEYEKCELGAMILGCG----IEE---KDKEKAKRLCMVALWCVQDS 337
              E    F   V       ++  ++          E   ++    + L      C    
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299

Query: 338 PEDRPPMSAVIKMLEGVVEVLPPPK 362
            E R       + +  ++ +    K
Sbjct: 300 AEARLTAQXAEERMAELMMIWERNK 324

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  197 bits (503), Expect = 2e-60
 Identities = 78/292 (26%), Positives = 137/292 (46%), Gaps = 46/292 (15%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G FG V++ ++ +G  +AVK+L   +       +F+ EV  + R  H N+V   G 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
                  ++V EY+  GSL   L     +  ++  +   +A   AKG+ YLH      I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H ++K  N+L+D  ++ KV DFGL++L  +  T ++     GTP + APE L    P   
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE-PSNE 218

Query: 262 KCDVYSFGMVLFEIVGRRR-----------NAIVGATESLDWFPKHVWEEYEKCELGAMI 310
           K DVYSFG++L+E+   ++            A+    + L+  P+++       ++ A+I
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE-IPRNLNP-----QVAAII 272

Query: 311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV-EVLPPP 361
            GC                  W   + P  RP  + ++ +L  ++   +PPP
Sbjct: 273 EGC------------------W--TNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  192 bits (491), Expect = 6e-59
 Identities = 78/279 (27%), Positives = 130/279 (46%), Gaps = 36/279 (12%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           R+G G FG VYKG++   V  AVK+LN         + F  EVG + +T H+N++   G+
Sbjct: 31  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                + A+V ++ E  SL  +L   +   E +KL +IA  TA+G+ YLH    + IIH 
Sbjct: 89  STAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG--NYPITH 261
           D+K  N+ L  + + K+ DFGLA    R           G+  + APE +    + P + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204

Query: 262 KCDVYSFGMVLFEIVGRR--------RNAIVGATESLDWFPKHVWEEYEKCELGAMILGC 313
           + DVY+FG+VL+E++  +        R+ I+            V       +L  +   C
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM----------VGRGSLSPDLSKVRSNC 254

Query: 314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
                     KR+  +   C++   ++RP    ++  +E
Sbjct: 255 P---------KRMKRLMAECLKKKRDERPSFPRILAEIE 284

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  190 bits (486), Expect = 3e-58
 Identities = 72/290 (24%), Positives = 118/290 (40%), Gaps = 52/290 (17%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVL------NRNLGRIAEEQFMAEVGTIGRTYHINL 137
           ++G GGFG V+KG+   +   +A+K L               ++F  EV  +    H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85

Query: 138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
           V+LYG  H+     +V E++  G L   L  K   I+W     + +  A G+ Y+     
Sbjct: 86  VKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQN 142

Query: 198 QRIIHYDIKPENVLLD-----ANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF 252
             I+H D++  N+ L      A    KVADFGL+    +   H ++SG  G   + APE 
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVH-SVSGLLGNFQWMAPET 197

Query: 253 LSG-NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL 311
           +       T K D YSF M+L+ I+                 P      +++   G +  
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEG-------------P------FDEYSYGKIKF 238

Query: 312 GCGIEEKDK---------EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
              I E+            + + + +   W     P+ RP  S ++K L 
Sbjct: 239 INMIREEGLRPTIPEDCPPRLRNV-IELCW--SGDPKKRPHFSYIVKELS 285

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  191 bits (487), Expect = 4e-58
 Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 54/298 (18%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
            +G G FG V K ++     +A+K +         + F+ E+  + R  H N+V+LYG C
Sbjct: 15  VVGRGAFGVVCKAKW-RAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIE--WEKLHEIAIGTAKGLVYLHEECQQRIIH 202
            +     LV EY E GSL   L G +              +  ++G+ YLH    + +IH
Sbjct: 71  LNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128

Query: 203 YDIKPENVLLDANFS-PKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            D+KP N+LL A  +  K+ DFG A     + T       KG+  + APE   G+   + 
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT-----NNKGSAAWMAPEVFEGS-NYSE 182

Query: 262 KCDVYSFGMVLFEIVGRRR------------NAIVGATESLDWFPKHVWEEYEKCELGAM 309
           KCDV+S+G++L+E++ RR+               V          K++ +  E      +
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP-LIKNLPKPIES-----L 236

Query: 310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP-PPKPFRY 366
           +  C                  W     P  RP M  ++K++  ++   P   +P +Y
Sbjct: 237 MTRC------------------W--SKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  186 bits (474), Expect = 3e-56
 Identities = 79/321 (24%), Positives = 114/321 (35%), Gaps = 52/321 (16%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            LG G FG+  K      G  + +K L        +  F+ EV  +    H N+++  G 
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            +       + EY++ G+L G +        W +    A   A G+ YLH      IIH 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK------------GTPGYSAPE 251
           D+   N L+  N +  VADFGLA+L    KT                    G P + APE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192

Query: 252 FLSGNYPITHKCDVYSFGMVLFEIVGRR--------RNAIVGATESLDWFPKHVWEEYEK 303
            ++G      K DV+SFG+VL EI+GR         R    G          +V    ++
Sbjct: 193 MINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---------LNVRGFLDR 242

Query: 304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL----P 359
                    C               + + C    PE RP    +   LE +   L    P
Sbjct: 243 Y----CPPNC---------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289

Query: 360 PPKPFRYLDLIKMTRLKSLES 380
                  LD       +  ES
Sbjct: 290 LGPQLEQLDRGFWETYRRGES 310

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  185 bits (471), Expect = 4e-56
 Identities = 70/290 (24%), Positives = 110/290 (37%), Gaps = 56/290 (19%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNR---NLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
            +G GGFG+VY+  +  G ++AVK              E    E        H N++ L 
Sbjct: 14  IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G C  +    LV E+   G L+  L GK+  I  + L   A+  A+G+ YLH+E    II
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPII 130

Query: 202 HYDIKPENVLLDANFSP--------KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
           H D+K  N+L+              K+ DFGLA    R     T     G   + APE +
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEVI 186

Query: 254 SGNYPITHKCDVYSFGMVLFEIVGRRR-----------NAIVGATESLDWFPKHVWEEYE 302
             +   +   DV+S+G++L+E++                 +     +L   P    E + 
Sbjct: 187 RAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP-IPSTCPEPFA 244

Query: 303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
           K     ++  C                  W     P  RP  + ++  L 
Sbjct: 245 K-----LMEDC------------------W--NPDPHSRPSFTNILDQLT 269

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  184 bits (470), Expect = 3e-55
 Identities = 71/291 (24%), Positives = 118/291 (40%), Gaps = 30/291 (10%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           ++G G +GEV+ G++  G K+AVKV        A      E+       H N++      
Sbjct: 44  QIGKGRYGEVWMGKW-RGEKVAVKVFFTT--EEASWFRETEIYQTVLMRHENILGFIAAD 100

Query: 145 HDQHMT----ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR- 199
                +     L+ +Y ENGSL  YL  K   ++ + + ++A  +  GL +LH E     
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158

Query: 200 ----IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS--GYKGTPGYSAPEFL 253
               I H D+K +N+L+  N +  +AD GLA     +   V I      GT  Y  PE L
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218

Query: 254 SG-----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW-FPKHVWEEYEKCELG 307
                  ++      D+YSFG++L+E+   RR    G  E     +   V  +    ++ 
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVA--RRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276

Query: 308 AMILGCGI------EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            ++    +           E  +++  +   C   +P  R     V K L 
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  180 bits (458), Expect = 9e-54
 Identities = 63/286 (22%), Positives = 112/286 (39%), Gaps = 45/286 (15%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            +G G FG+VY G++   V  A+++++         + F  EV    +T H N+V   G 
Sbjct: 40  LIGKGRFGQVYHGRWHGEV--AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
           C      A++    +  +L   +   K  ++  K  +IA    KG+ YLH    + I+H 
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHK 154

Query: 204 DIKPENVLLDANFSPKVADFGLAKL---CDRNKTHVTISGYKGTPGYSAPEFLSGNYPI- 259
           D+K +NV  D N    + DFGL  +       +    +    G   + APE +    P  
Sbjct: 155 DLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213

Query: 260 -------THKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG 312
                  +   DV++ G + +E+  R              +P      ++     A+I  
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHARE-------------WP------FKTQPAEAIIWQ 254

Query: 313 CG------IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            G      + +    K     ++  W      E+RP  + ++ MLE
Sbjct: 255 MGTGMKPNLSQIGMGKEISDILLFCW--AFEQEERPTFTKLMDMLE 298

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  178 bits (453), Expect = 2e-53
 Identities = 61/301 (20%), Positives = 113/301 (37%), Gaps = 45/301 (14%)

Query: 62  IGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLN-RNLGRIAEE 120
           + +   + F  L          T+L     GE++KG++  G  I VKVL  R+       
Sbjct: 1   MNKHSGIDFKQLNF-------LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSR 52

Query: 121 QFMAEVGTIGRTYHINLVRLYGFCHDQHMT--ALVYEYMENGSLDGYLF-GKKRAIEWEK 177
            F  E   +    H N++ + G C         L+  +M  GSL   L  G    ++  +
Sbjct: 53  DFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQ 112

Query: 178 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT 237
             + A+  A+G+ +LH   +  I  + +   +V++D + + +++   +            
Sbjct: 113 AVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFS-------FQ 164

Query: 238 ISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPK 295
             G    P + APE L            D++SF ++L+E+V R               P 
Sbjct: 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV-------------P- 210

Query: 296 HVWEEYEKCELGAMILGCG----IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML 351
             + +    E+G  +   G    I         +L      C+ + P  RP    ++ +L
Sbjct: 211 --FADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMK---ICMNEDPAKRPKFDMIVPIL 265

Query: 352 E 352
           E
Sbjct: 266 E 266

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  179 bits (457), Expect = 2e-53
 Identities = 70/290 (24%), Positives = 122/290 (42%), Gaps = 28/290 (9%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
            +G G FGEV++G++  G ++AVK+ +            AE+       H N++      
Sbjct: 49  SIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAAD 105

Query: 145 HDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR- 199
           +  + T     LV +Y E+GSL  YL   +  +  E + ++A+ TA GL +LH E     
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163

Query: 200 ----IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS--GYKGTPGYSAPEFL 253
               I H D+K +N+L+  N +  +AD GLA   D     + I+     GT  Y APE L
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223

Query: 254 SG-----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
                  ++    + D+Y+ G+V +EI  RR +      +    +   V  +    E+  
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIA-RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282

Query: 309 MILGCGI------EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
           ++    +        +  E  + +  +   C   +   R     + K L 
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  171 bits (435), Expect = 1e-50
 Identities = 64/295 (21%), Positives = 111/295 (37%), Gaps = 38/295 (12%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
            +G G +GEV++G +  G  +AVK+ +             E+       H N++      
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASD 71

Query: 145 HDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE----- 195
                ++    L+  Y E GSL  YL  +   ++      I +  A GL +LH E     
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS--GYKGTPGYSAPEFL 253
            +  I H D+K +N+L+  N    +AD GLA +  ++   + +      GT  Y APE L
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189

Query: 254 SG-----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
                   +    + D+++FG+VL+E+   RR    G  E      K  + +    +   
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNGIVEDY----KPPFYDVVPNDPSF 243

Query: 309 MILGCGIEEKD------KEKAKRLCMVALW-----CVQDSPEDRPPMSAVIKMLE 352
             +   +                  + +L      C   +P  R     + K L 
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  151 bits (383), Expect = 3e-42
 Identities = 65/278 (23%), Positives = 115/278 (41%), Gaps = 30/278 (10%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G FGEV+ G+   +   +AVK     L    + +F+ E   + +  H N+VRL G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
           C  +    +V E ++ G    +L  +   +  + L ++    A G+ YL     +  IH 
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHR 237

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPE-FLSGNYPITH 261
           D+   N L+      K++DFG+++       +    G +  P  ++APE    G Y  + 
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADG-VYAASGGLRQVPVKWTAPEALNYGRY--SS 294

Query: 262 KCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP---KHVWEEYEKCELGAMILGCGIEEK 318
           + DV+SFG++L+E              SL   P       +  E  E G      G    
Sbjct: 295 ESDVWSFGILLWETF------------SLGASPYPNLSNQQTREFVEKG------GRLPC 336

Query: 319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
            +     +  +   C    P  RP  S + + L+ + +
Sbjct: 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  146 bits (371), Expect = 6e-41
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 14/199 (7%)

Query: 85  RLGFGGFGEVYKGQFPNG-----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
            LG G FG VYKG +        + +A+K L       A ++ + E   +    + ++ R
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L G C    +  L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R
Sbjct: 82  LLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RR 137

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPE-FLSGNY 257
           ++H D+   NVL+      K+ DFGLAKL    +      G K  P  + A E  L   Y
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK-VPIKWMALESILHRIY 196

Query: 258 PITHKCDVYSFGMVLFEIV 276
             TH+ DV+S+G+ ++E++
Sbjct: 197 --THQSDVWSYGVTVWELM 213

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  143 bits (362), Expect = 6e-40
 Identities = 66/298 (22%), Positives = 116/298 (38%), Gaps = 49/298 (16%)

Query: 85  RLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
            LG G FG+V   ++       G ++AVK L    G         E+  +   YH N+V+
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 140 LYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
             G C +       L+ E++ +GSL  YL   K  I  ++  + A+   KG+ YL     
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS--- 144

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG------YSAPE 251
           ++ +H D+   NVL+++    K+ DFGL K  + +K +     Y           + APE
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY-----YTVKDDRDSPVFWYAPE 199

Query: 252 FLSGNYPI-THKCDVYSFGMVLFEIV--GRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
                        DV+SFG+ L E++      ++ +     +               L  
Sbjct: 200 --CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM---TVTRLVN 254

Query: 309 MILGCGIEEKDKEKAKRL-----C-----MVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
            +          ++ KRL     C      +   C +  P +R     +I+  E +++
Sbjct: 255 TL----------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  142 bits (361), Expect = 1e-39
 Identities = 76/304 (25%), Positives = 116/304 (38%), Gaps = 49/304 (16%)

Query: 85  RLGFGGFGEVYKGQFPN-----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
            LG G FG+V    +       G  +AVK L  + G      +  E+  +   YH ++++
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 140 LYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
             G C D    +  LV EY+  GSL  YL   + +I   +L   A    +G+ YLH    
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLHA--- 152

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYS-----APEF 252
           Q  IH D+   NVLLD +   K+ DFGLAK       +          G S     APE 
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAPE- 207

Query: 253 LSGNYPI-THKCDVYSFGMVLFEIV--GRRRNAIVGATESLDWFPKHVWEEYEKCELGAM 309
                    +  DV+SFG+ L+E++       +       L         +     L  +
Sbjct: 208 -CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA---QGQMTVLRLTEL 263

Query: 310 ILGCGIEEKDKEKAKRL-----CMVALW-----CVQDSPEDRPPMSAVIKMLEGVVEVLP 359
           +          E+ +RL     C   ++     C +     RP    +I +L+ V E   
Sbjct: 264 L----------ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313

Query: 360 PPKP 363
              P
Sbjct: 314 GQAP 317

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  146 bits (371), Expect = 2e-39
 Identities = 82/301 (27%), Positives = 134/301 (44%), Gaps = 37/301 (12%)

Query: 53  QTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNR 112
           Q + +   EI RE      SL+L         +LG G FGEV+ G +    ++A+K L  
Sbjct: 255 QGLAKDAWEIPRE------SLRLEV-------KLGQGCFGEVWMGTWNGTTRVAIKTLKP 301

Query: 113 NLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL-FGKKR 171
             G ++ E F+ E   + +  H  LV+LY    ++ +  +V EYM  GSL  +L     +
Sbjct: 302 --GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGK 358

Query: 172 AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 231
            +   +L ++A   A G+ Y+        +H D++  N+L+  N   KVADFGLA+L + 
Sbjct: 359 YLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 415

Query: 232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD 291
           N+ +    G K    ++APE        T K DV+SFG++L E+  +      G      
Sbjct: 416 NE-YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTK------GRVPYPG 467

Query: 292 WFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML 351
              + V ++ E+         C          + L  +   C +  PE+RP    +   L
Sbjct: 468 MVNREVLDQVERGYRMPCPPEC---------PESLHDLMCQCWRKEPEERPTFEYLQAFL 518

Query: 352 E 352
           E
Sbjct: 519 E 519

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  145 bits (367), Expect = 2e-39
 Identities = 82/301 (27%), Positives = 134/301 (44%), Gaps = 37/301 (12%)

Query: 53  QTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNR 112
           Q + +   EI RE      SL+L         +LG G FGEV+ G +    ++A+K L  
Sbjct: 172 QGLAKDAWEIPRE------SLRLEV-------KLGQGCFGEVWMGTWNGTTRVAIKTLKP 218

Query: 113 NLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL-FGKKR 171
             G ++ E F+ E   + +  H  LV+LY    ++ +  +V EYM  GSL  +L     +
Sbjct: 219 --GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGK 275

Query: 172 AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 231
            +   +L ++A   A G+ Y+        +H D++  N+L+  N   KVADFGLA+L + 
Sbjct: 276 YLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 332

Query: 232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD 291
           N+ +    G K    ++APE        T K DV+SFG++L E+  +      G      
Sbjct: 333 NE-YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTK------GRVPYPG 384

Query: 292 WFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML 351
              + V ++ E+         C          + L  +   C +  PE+RP    +   L
Sbjct: 385 MVNREVLDQVERGYRMPCPPEC---------PESLHDLMCQCWRKEPEERPTFEYLQAFL 435

Query: 352 E 352
           E
Sbjct: 436 E 436

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  141 bits (357), Expect = 7e-39
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 12/198 (6%)

Query: 85  RLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
            LG G FG VYKG +        + +A+K L       A ++ + E   +    + ++ R
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L G C    +  L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R
Sbjct: 82  LLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RR 137

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           ++H D+   NVL+      K+ DFGLAKL    +      G K    + A E  S  + I
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE--SILHRI 195

Query: 260 -THKCDVYSFGMVLFEIV 276
            TH+ DV+S+G+ ++E++
Sbjct: 196 YTHQSDVWSYGVTVWELM 213

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  140 bits (356), Expect = 8e-39
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 85  RLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
            LG G FG V+KG +        + + +KV+    GR + +     +  IG   H ++VR
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L G C    +  LV +Y+  GSL  ++   + A+  + L    +  AKG+ YL E     
Sbjct: 80  LLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HG 135

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           ++H ++   NVLL +    +VADFG+A L   +   +  S  K    + A E  S ++  
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE--SIHFGK 193

Query: 260 -THKCDVYSFGMVLFEIV 276
            TH+ DV+S+G+ ++E++
Sbjct: 194 YTHQSDVWSYGVTVWELM 211

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  140 bits (354), Expect = 8e-39
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 25/209 (11%)

Query: 84  TRLGFGGFGEVYKGQFPNG---VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
             LG G FG V +G +      + +A+KVL +   +   E+ M E   + +  +  +VRL
Sbjct: 16  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 141 YGFC-HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
            G C  +  M  LV E    G L  +L GK+  I    + E+    + G+ YL E   + 
Sbjct: 76  IGVCQAEALM--LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KN 130

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG------YSAPE-F 252
            +H D+   NVLL      K++DFGL+K    + ++     Y           + APE  
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-----YTARSAGKWPLKWYAPECI 185

Query: 253 LSGNYPITHKCDVYSFGMVLFEIV--GRR 279
               +  + + DV+S+G+ ++E +  G++
Sbjct: 186 NFRKF--SSRSDVWSYGVTMWEALSYGQK 212

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  144 bits (364), Expect = 1e-38
 Identities = 74/271 (27%), Positives = 128/271 (47%), Gaps = 26/271 (9%)

Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L      +  E+F+ E   +    H NLV+L G 
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 144 CHDQHMTALVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL +   +  IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 341

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            ++   N L+  N   KVADFGL++L   + T+   +G K    ++APE L+ N   + K
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 399

Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEE-YEKCELGAMILGCGIEEKDKE 321
            DV++FG++L+EI           T  +  +P     + YE  E           E+ + 
Sbjct: 400 SDVWAFGVLLWEIA----------TYGMSPYPGIDLSQVYELLEKD------YRMERPEG 443

Query: 322 KAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
             +++  +   C Q +P DRP  + + +  E
Sbjct: 444 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  139 bits (352), Expect = 2e-38
 Identities = 69/294 (23%), Positives = 112/294 (38%), Gaps = 49/294 (16%)

Query: 85  RLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N+V+
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 75

Query: 140 LYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
             G C+        L+ EY+  GSL  YL   K  I+  KL +      KG+ YL     
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT--- 132

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG------YSAPE 251
           +R IH D+   N+L++     K+ DFGL K+  ++K       +K          + APE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF-----FKVKEPGESPIFWYAPE 187

Query: 252 FLSGNYPI-THKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI 310
             S      +   DV+SFG+VL+E+      +     E +         +     L  ++
Sbjct: 188 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 311 LGCGIEEKDKEKAKRL-----C-------MVALWCVQDSPEDRPPMSAVIKMLE 352
                     +   RL     C       M   W   ++   RP    +   ++
Sbjct: 246 ----------KNNGRLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 287

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  142 bits (361), Expect = 2e-38
 Identities = 60/193 (31%), Positives = 103/193 (53%), Gaps = 9/193 (4%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV+   +    K+AVK +    G ++ E F+AE   +    H  LV+L+   
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 145 HDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
             + +  ++ E+M  GSL  +L   +       KL + +   A+G+ ++ +   +  IH 
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHR 308

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKC 263
           D++  N+L+ A+   K+ADFGLA++ + N  +    G K    ++APE ++     T K 
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDN-EYTAREGAKFPIKWTAPEAINFG-SFTIKS 366

Query: 264 DVYSFGMVLFEIV 276
           DV+SFG++L EIV
Sbjct: 367 DVWSFGILLMEIV 379

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  137 bits (348), Expect = 3e-38
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 21/199 (10%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
            LG G FG V  G++     +AVK++    G ++E++F  E  T+ +  H  LV+ YG C
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKE--GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
             ++   +V EY+ NG L  YL    + +E  +L E+     +G+ +L      + IH D
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRD 129

Query: 205 IKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG------YSAPE-FLSGNY 257
           +   N L+D +   KV+DFG+ +    ++       Y  + G      +SAPE F    Y
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQ-------YVSSVGTKFPVKWSAPEVFHYFKY 182

Query: 258 PITHKCDVYSFGMVLFEIV 276
             + K DV++FG++++E+ 
Sbjct: 183 --SSKSDVWAFGILMWEVF 199

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  139 bits (351), Expect = 4e-38
 Identities = 69/289 (23%), Positives = 114/289 (39%), Gaps = 39/289 (13%)

Query: 85  RLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N+V+
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 106

Query: 140 LYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
             G C+        L+ EY+  GSL  YL   K  I+  KL +      KG+ YL     
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT--- 163

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGN 256
           +R IH D+   N+L++     K+ DFGL K+  ++K +  +     +P  + APE  S  
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE--SLT 221

Query: 257 YPI-THKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI 315
               +   DV+SFG+VL+E+      +     E +         +     L  ++     
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL----- 276

Query: 316 EEKDKEKAKRL-----C-------MVALWCVQDSPEDRPPMSAVIKMLE 352
                +   RL     C       M   W   ++   RP    +   ++
Sbjct: 277 -----KNNGRLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 318

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  136 bits (346), Expect = 8e-38
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 23/204 (11%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
            +G G FG V+ G + N  K+A+K +    G ++EE F+ E   + +  H  LV+LYG C
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
            +Q    LV E+ME+G L  YL  ++     E L  + +   +G+ YL E     +IH D
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRD 129

Query: 205 IKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG------YSAPE-FLSGNY 257
           +   N L+  N   KV+DFG+ +    ++       Y  + G      +++PE F    Y
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQ-------YTSSTGTKFPVKWASPEVFSFSRY 182

Query: 258 PITHKCDVYSFGMVLFEIV--GRR 279
             + K DV+SFG++++E+   G+ 
Sbjct: 183 --SSKSDVWSFGVLMWEVFSEGKI 204

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  138 bits (349), Expect = 9e-38
 Identities = 75/289 (25%), Positives = 127/289 (43%), Gaps = 40/289 (13%)

Query: 85  RLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           +LG G FG V   ++       G  +AVK L ++ G   +  F  E+  +   +   +V+
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 140 LYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
             G  +     +  LV EY+ +G L  +L   +  ++  +L   +    KG+ YL     
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS--- 145

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGN 256
           +R +H D+   N+L+++    K+ADFGLAKL   +K +  +     +P  + APE  S +
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE--SLS 203

Query: 257 YPI-THKCDVYSFGMVLFEIV--GRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC 313
             I + + DV+SFG+VL+E+     +              P   +     CE     L  
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKS-----------CSPSAEFLRMMGCERDVPALSR 252

Query: 314 GIEEKDKEKAKRL-----C-----MVALWCVQDSPEDRPPMSAVIKMLE 352
            +E    E+ +RL     C      +   C   SP+DRP  SA+   L+
Sbjct: 253 LLEL--LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  136 bits (345), Expect = 1e-37
 Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 23/204 (11%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
            LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
             Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRD 145

Query: 205 IKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG------YSAPE-FLSGNY 257
           +   N L++     KV+DFGL++    ++       Y  + G      +S PE  +   +
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDE-------YTSSVGSKFPVRWSPPEVLMYSKF 198

Query: 258 PITHKCDVYSFGMVLFEIV--GRR 279
             + K D+++FG++++EI   G+ 
Sbjct: 199 --SSKSDIWAFGVLMWEIYSLGKM 220

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  135 bits (343), Expect = 2e-37
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 22/202 (10%)

Query: 85  RLGFGGFGEVYKGQF--PNGVKI--AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
            LG G FGEVY+G +    G KI  AVK   ++     +E+FM+E   +    H ++V+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G   ++  T ++ E    G L  YL   K +++   L   ++   K + YL        
Sbjct: 79  IGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INC 134

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG-----YSAPEFLSG 255
           +H DI   N+L+ +    K+ DFGL++  +          YK +       + +PE  S 
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY------YKASVTRLPIKWMSPE--SI 186

Query: 256 NYPI-THKCDVYSFGMVLFEIV 276
           N+   T   DV+ F + ++EI+
Sbjct: 187 NFRRFTTASDVWMFAVCMWEIL 208

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  136 bits (344), Expect = 5e-37
 Identities = 73/236 (30%), Positives = 111/236 (47%), Gaps = 27/236 (11%)

Query: 53  QTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF--PNG---VKIAV 107
           Q + +F  EI          +            +G G FGEVYKG     +G   V +A+
Sbjct: 32  QAVLKFTTEIHPS------CVTRQK-------VIGAGEFGEVYKGMLKTSSGKKEVPVAI 78

Query: 108 KVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF 167
           K L           F+ E G +G+  H N++RL G         ++ EYMENG+LD +L 
Sbjct: 79  KTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR 138

Query: 168 GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 227
            K       +L  +  G A G+ YL        +H D+   N+L+++N   KV+DFGL++
Sbjct: 139 EKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 195

Query: 228 -LCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV--GRR 279
            L D  +   T SG K    ++APE      +  T   DV+SFG+V++E++  G R
Sbjct: 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKF--TSASDVWSFGIVMWEVMTYGER 249

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  135 bits (341), Expect = 7e-37
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 26/210 (12%)

Query: 85  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLV 138
           +LG G FG V +G++  P+G  V +AVK L  ++     A + F+ EV  +    H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 85  RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---K 140

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG------YSAPE- 251
           R IH D+   N+LL      K+ DFGL +   +N  H     Y           + APE 
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH-----YVMQEHRKVPFAWCAPES 195

Query: 252 FLSGNYPITHKCDVYSFGMVLFEIV--GRR 279
             +  +  +H  D + FG+ L+E+   G+ 
Sbjct: 196 LKTRTF--SHASDTWMFGVTLWEMFTYGQE 223

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  135 bits (342), Expect = 1e-36
 Identities = 69/239 (28%), Positives = 108/239 (45%), Gaps = 26/239 (10%)

Query: 49  WEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP----NGVK 104
            E G+    F +EI          + +          +G G  GEV  G+        V 
Sbjct: 33  EEPGRAGRSFTREIEAS------RIHIEK-------IIGSGDSGEVCYGRLRVPGQRDVP 79

Query: 105 IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDG 164
           +A+K L           F++E   +G+  H N++RL G      +  +V EYMENGSLD 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139

Query: 165 YLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG 224
           +L          +L  +  G   G+ YL +      +H D+   NVL+D+N   KV+DFG
Sbjct: 140 FLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFG 196

Query: 225 LAK-LCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV--GRR 279
           L++ L D      T +G K    ++APE      +  +   DV+SFG+V++E++  G R
Sbjct: 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF--SSASDVWSFGVVMWEVLAYGER 253

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  133 bits (338), Expect = 1e-36
 Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 22/202 (10%)

Query: 85  RLGFGGFGEVYKGQFPNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
            +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G   +  +  ++ E    G L  +L  +K +++   L   A   +  L YL     +R 
Sbjct: 82  IGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 137

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG-----YSAPE-FLS 254
           +H DI   NVL+ +N   K+ DFGL++  + +        YK + G     + APE    
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESINF 191

Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
             +  T   DV+ FG+ ++EI+
Sbjct: 192 RRF--TSASDVWMFGVCMWEIL 211

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  133 bits (337), Expect = 2e-36
 Identities = 71/200 (35%), Positives = 110/200 (55%), Gaps = 23/200 (11%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 145 HDQHMTALVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
             + +  ++ EYMENGSL  +L       +   KL ++A   A+G+ ++ E   +  IH 
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG------YSAPEFLS-GN 256
           D++  N+L+    S K+ADFGLA+L + N+       Y    G      ++APE ++ G 
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNE-------YTAREGAKFPIKWTAPEAINYGT 186

Query: 257 YPITHKCDVYSFGMVLFEIV 276
           +  T K DV+SFG++L EIV
Sbjct: 187 F--TIKSDVWSFGILLTEIV 204

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  135 bits (341), Expect = 4e-36
 Identities = 68/235 (28%), Positives = 110/235 (46%), Gaps = 26/235 (11%)

Query: 53  QTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNG----VKIAVK 108
           QT+  F +E+         ++ ++         +G G FGEV  G+        + +A+K
Sbjct: 33  QTVHEFAKELDAT------NISIDK-------VVGAGEFGEVCSGRLKLPSKKEISVAIK 79

Query: 109 VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFG 168
            L           F+ E   +G+  H N++RL G         +V EYMENGSLD +L  
Sbjct: 80  TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK 139

Query: 169 KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK- 227
                   +L  +  G A G+ YL +      +H D+   N+L+++N   KV+DFGL + 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRV 196

Query: 228 LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI-THKCDVYSFGMVLFEIV--GRR 279
           L D  +   T  G K    +++PE  +  Y   T   DV+S+G+VL+E++  G R
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPE--AIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  138 bits (349), Expect = 4e-36
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 13/203 (6%)

Query: 84  TRLGFGGFGEVYKGQFPNG---VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
             LG G FG V +G +      + +A+KVL +   +   E+ M E   + +  +  +VRL
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C  + +  LV E    G L  +L GK+  I    + E+    + G+ YL E   +  
Sbjct: 402 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNF 457

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP-GYSAPEFLSGNYPI 259
           +H ++   NVLL      K++DFGL+K    + ++ T       P  + APE    N+  
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE--CINFRK 515

Query: 260 -THKCDVYSFGMVLFEIV--GRR 279
            + + DV+S+G+ ++E +  G++
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQK 538

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  135 bits (343), Expect = 5e-36
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 29/201 (14%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
            +G G FG+V  G +  G K+AVK +  +      + F+AE   + +  H NLV+L G  
Sbjct: 200 TIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 145 -HDQHMTALVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++    +V EYM  GSL  YL  + R  +  + L + ++   + + YL        +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 312

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG------YSAPEFLSGN 256
            D+   NVL+  +   KV+DFGL K                         ++APE L   
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEAL--R 359

Query: 257 YPI-THKCDVYSFGMVLFEIV 276
               + K DV+SFG++L+EI 
Sbjct: 360 EKKFSTKSDVWSFGILLWEIY 380

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  131 bits (331), Expect = 2e-35
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 33/225 (14%)

Query: 78  FTSNYST--RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH 134
           + S++     LG G FG+V K +   +    A+K +            ++EV  +    H
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNH 61

Query: 135 INLVRLYG-FCHDQHMTA------------LVYEYMENGSLDGYLFGKKRAIEWEKLHEI 181
             +VR Y  +   ++               +  EY ENG+L   +  +    + ++   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY 241
                + L Y+H    Q IIH D+KP N+ +D + + K+ DFGLAK   R+   + +   
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 242 K------------GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 274
                        GT  Y A E L G      K D+YS G++ FE
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  130 bits (328), Expect = 6e-35
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 19/202 (9%)

Query: 86  LGFGGFGEVYKGQFPNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FG VY G   +     +  AVK LNR        QF+ E   +    H N++ L 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92

Query: 142 GFCHDQHMTAL-VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           G C     + L V  YM++G L  ++  +      + L    +  AKG+ YL     ++ 
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKF 149

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG-----YSAPE-FLS 254
           +H D+   N +LD  F+ KVADFGLA+     + +   S +  T       + A E   +
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMALESLQT 206

Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
             +  T K DV+SFG++L+E++
Sbjct: 207 QKF--TTKSDVWSFGVLLWELM 226

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  129 bits (327), Expect = 6e-35
 Identities = 73/299 (24%), Positives = 122/299 (40%), Gaps = 43/299 (14%)

Query: 85  RLGFGGFGEVYKGQFPNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
            +G G FG VY G++ +     ++ A+K L+R       E F+ E   +    H N++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 141 YGFCHDQHMTAL-VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
            G           +  YM +G L  ++   +R    + L    +  A+G+ YL E   Q+
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QK 144

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG-----YSAPEFLS 254
            +H D+   N +LD +F+ KVADFGLA+     + +   S  +         ++A E  S
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYY---SVQQHRHARLPVKWTALE--S 199

Query: 255 GNYPI-THKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP---KHVWEEYEKCELGAMI 310
                 T K DV+SFG++L+E++ R      GA       P      ++       G   
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTR------GAP------PYRHIDPFDLTHFLAQG--- 244

Query: 311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYLDL 369
                  + +     L  V   C +  P  RP    ++  +E +V  L       Y+ L
Sbjct: 245 ---RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH---YVQL 297

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  131 bits (331), Expect = 7e-35
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 19/202 (9%)

Query: 86  LGFGGFGEVYKGQFPNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FG VY G   +     +  AVK LNR        QF+ E   +    H N++ L 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156

Query: 142 GFCHDQHMTAL-VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           G C     + L V  YM++G L  ++  +      + L    +  AKG+ +L     ++ 
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKF 213

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG-----YSAPEFLSG 255
           +H D+   N +LD  F+ KVADFGLA+     +       +  T       + A E  S 
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKWMALE--SL 268

Query: 256 NYPI-THKCDVYSFGMVLFEIV 276
                T K DV+SFG++L+E++
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELM 290

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  129 bits (326), Expect = 9e-35
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 25/208 (12%)

Query: 85  RLGFGGFGEVYKGQFPNG---VKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRL 140
            LG G FG V KG +        +AVK+L         +++ +AE   + +  +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      
Sbjct: 84  IGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 138

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG------YSAPEFLS 254
           +H D+   NVLL      K++DFGL+K    ++ +     YK          + APE   
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-----YKAQTHGKWPVKWYAPE--C 191

Query: 255 GNYPI-THKCDVYSFGMVLFEIV--GRR 279
            NY   + K DV+SFG++++E    G++
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  129 bits (327), Expect = 9e-35
 Identities = 53/235 (22%), Positives = 92/235 (39%), Gaps = 30/235 (12%)

Query: 63  GREKPVRFTSLQLNNFTSNYST--RLGFGGFGEVYKGQFPNGVKIAVKVLNR-NLGRIAE 119
              + + F S+ +      YS   ++G GG  +V++         A+K +N         
Sbjct: 13  LGTENLYFQSMSVKG--RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 70

Query: 120 EQFMAEVGTIGRTYHINL--VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE- 176
           + +  E+  + +    +   +RLY +        +V E   N  L+ +L  KK    WE 
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWER 129

Query: 177 --KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT 234
                 +     + +  +H   Q  I+H D+KP N L+  +   K+ DFG+A     + T
Sbjct: 130 KSYWKNML----EAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181

Query: 235 HVTISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGMVLFE-IVGR 278
            V      GT  Y  PE +               I+ K DV+S G +L+    G+
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  128 bits (324), Expect = 1e-34
 Identities = 55/234 (23%), Positives = 87/234 (37%), Gaps = 39/234 (16%)

Query: 59  LQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF--------PNGVKIAVKVL 110
             +I  E       L  N         LG G F +++KG           +  ++ +KVL
Sbjct: 2   FHKIRNE------DLIFNE-------SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL 48

Query: 111 NRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK 170
                R   E F      + +  H +LV  YG C       LV E+++ GSLD YL   K
Sbjct: 49  -DKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK 107

Query: 171 RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP--------KVAD 222
             I      E+A   A  + +L E     +IH ++  +N+LL              K++D
Sbjct: 108 NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164

Query: 223 FGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            G++               +    +  PE +     +    D +SFG  L+EI 
Sbjct: 165 PGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  128 bits (323), Expect = 2e-34
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 23/201 (11%)

Query: 85  RLGFGGFGEVYKGQFPNG-VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L      +  E+F+ E   +    H NLV+L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 144 CHDQHMTALVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL +   +  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 134

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG------YSAPEFLS-G 255
            D+   N L+  N   KVADFGL++L       +T   Y    G      ++APE L+  
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL-------MTGDTYTAHAGAKFPIKWTAPESLAYN 187

Query: 256 NYPITHKCDVYSFGMVLFEIV 276
            +  + K DV++FG++L+EI 
Sbjct: 188 KF--SIKSDVWAFGVLLWEIA 206

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  133 bits (336), Expect = 3e-34
 Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 22/202 (10%)

Query: 85  RLGFGGFGEVYKGQFPNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
            +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G   +  +  ++ E    G L  +L  +K +++   L   A   +  L YL     +R 
Sbjct: 457 IGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRF 512

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG-----YSAPEFLS- 254
           +H DI   NVL+ +N   K+ DFGL++  + +        YK + G     + APE ++ 
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESINF 566

Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
             +  T   DV+ FG+ ++EI+
Sbjct: 567 RRF--TSASDVWMFGVCMWEIL 586

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  126 bits (320), Expect = 5e-34
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 29/201 (14%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
            +G G FG+V  G +  G K+AVK +  +      + F+AE   + +  H NLV+L G  
Sbjct: 28  TIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 145 -HDQHMTALVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++    +V EYM  GSL  YL    +  +  + L + ++   + + YL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 140

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG------YSAPEFLSGN 256
            D+   NVL+  +   KV+DFGL K                         ++APE L   
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEAL--R 187

Query: 257 YPI-THKCDVYSFGMVLFEIV 276
               + K DV+SFG++L+EI 
Sbjct: 188 EKKFSTKSDVWSFGILLWEIY 208

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  128 bits (324), Expect = 5e-34
 Identities = 48/207 (23%), Positives = 82/207 (39%), Gaps = 25/207 (12%)

Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINL--VRLYG 142
           +G GG  +V++         A+K +N         + +  E+  + +    +   +RLY 
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQR 199
           +        +V E   N  L+ +L  KK    WE       +     + +  +H   Q  
Sbjct: 77  YEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNML----EAVHTIH---QHG 128

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG---- 255
           I+H D+KP N L+  +   K+ DFG+A     + T V      GT  Y  PE +      
Sbjct: 129 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187

Query: 256 ------NYPITHKCDVYSFGMVLFEIV 276
                    I+ K DV+S G +L+ + 
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMT 214

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  126 bits (319), Expect = 8e-34
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 19/200 (9%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G FG VY  +   N   +A+KVL ++       E Q   E+       H N++R+Y 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQR 199
           + HD+    L+ E+   G L   L    R  E      + E+A      L Y H   +++
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA----DALHYCH---ERK 134

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           +IH DIKPEN+L+      K+ADFG +      +         GT  Y  PE + G    
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIEGK-TH 189

Query: 260 THKCDVYSFGMVLFE-IVGR 278
             K D++  G++ +E +VG 
Sbjct: 190 DEKVDLWCAGVLCYEFLVGM 209

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  127 bits (322), Expect = 8e-34
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 21/202 (10%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG GGF + ++          A K++ ++  L     E+   E+       H ++V  +G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQR 199
           F  D     +V E     SL      +K   E E    L +I      G  YLH   + R
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYLH---RNR 161

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDR-NKTHVTISGYKGTPGYSAPEFLSGN-Y 257
           +IH D+K  N+ L+ +   K+ DFGLA   +   +    +    GTP Y APE LS   +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGH 218

Query: 258 PITHKCDVYSFGMVLFE-IVGR 278
             + + DV+S G +++  +VG+
Sbjct: 219 --SFEVDVWSIGCIMYTLLVGK 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  126 bits (319), Expect = 8e-34
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 21/202 (10%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG GGF + ++          A K++ ++  L     E+   E+       H ++V  +G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQR 199
           F  D     +V E     SL      +K   E E    L +I      G  YLH   + R
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYLH---RNR 135

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDR-NKTHVTISGYKGTPGYSAPEFLSGN-Y 257
           +IH D+K  N+ L+ +   K+ DFGLA   +   +    +    GTP Y APE LS   +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGH 192

Query: 258 PITHKCDVYSFGMVLFE-IVGR 278
             + + DV+S G +++  +VG+
Sbjct: 193 --SFEVDVWSIGCIMYTLLVGK 212

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  126 bits (318), Expect = 9e-34
 Identities = 63/197 (31%), Positives = 91/197 (46%), Gaps = 13/197 (6%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G FG VY  +   +   +A+KVL +        E Q   EV       H N++RLYG
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           + HD     L+ EY   G++   L    +  E      I    A  L Y H    +R+IH
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCH---SKRVIH 132

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G      K
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGR-MHDEK 187

Query: 263 CDVYSFGMVLFE-IVGR 278
            D++S G++ +E +VG+
Sbjct: 188 VDLWSLGVLCYEFLVGK 204

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  131 bits (331), Expect = 2e-33
 Identities = 65/208 (31%), Positives = 89/208 (42%), Gaps = 27/208 (12%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY-- 141
           RLG GGFG V +      G ++A+K   + L     E++  E+  + +  H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 142 ----GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT-----AKGLVYL 192
                      +  L  EY E G L  YL   +       L E  I T     +  L YL
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC---CGLKEGPIRTLLSDISSALRYL 137

Query: 193 HEECQQRIIHYDIKPENVLLDANFSP---KVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
           HE    RIIH D+KPEN++L         K+ D G AK  D+ +       + GT  Y A
Sbjct: 138 HE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE---FVGTLQYLA 191

Query: 250 PEFLSG-NYPITHKCDVYSFGMVLFEIV 276
           PE L    Y  T   D +SFG + FE +
Sbjct: 192 PELLEQKKY--TVTVDYWSFGTLAFECI 217

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  128 bits (322), Expect = 2e-33
 Identities = 47/207 (22%), Positives = 81/207 (39%), Gaps = 25/207 (12%)

Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINL--VRLYG 142
           +G GG  +V++         A+K +N         + +  E+  + +    +   +RLY 
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQR 199
           +        +V E   N  L+ +L  KK    WE       +     + +  +H   Q  
Sbjct: 124 YEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNML----EAVHTIH---QHG 175

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG---- 255
           I+H D+KP N L+  +   K+ DFG+A     + T V      G   Y  PE +      
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 256 ------NYPITHKCDVYSFGMVLFEIV 276
                    I+ K DV+S G +L+ + 
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMT 261

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  126 bits (319), Expect = 2e-33
 Identities = 81/308 (26%), Positives = 118/308 (38%), Gaps = 53/308 (17%)

Query: 85  RLGFGGFGEVYKGQFPNG------VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
            LG G FGEVY+GQ          +++AVK L        E  F+ E   I +  H N+V
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYL------FGKKRAIEWEKLHEIAIGTAKGLVYL 192
           R  G         ++ E M  G L  +L        +  ++    L  +A   A G  YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 193 HEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNKTHVTISGY--KGTPGY 247
            E      IH DI   N LL         K+ DFG+A+   R         Y  KG    
Sbjct: 157 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-------SYYRKGGCAM 206

Query: 248 S-----APE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEY 301
                  PE F+ G +  T K D +SFG++L+EI             SL + P   +   
Sbjct: 207 LPVKWMPPEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSK 249

Query: 302 EKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV---EVL 358
              E+   +   G  +  K     +  +   C Q  PEDRP  + +++ +E      +V+
Sbjct: 250 SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309

Query: 359 PPPKPFRY 366
               P  Y
Sbjct: 310 NTALPIEY 317

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  127 bits (320), Expect = 2e-33
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 33/283 (11%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG 
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            +     ++  E+M+ GSLD  +  K   I  + L +++I   KGL YL E+   +I+H 
Sbjct: 100 FYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHR 156

Query: 204 DIKPENVLLDANFSPKVADFGLA-KLCD-RNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           D+KP N+L+++    K+ DFG++ +L D    + V      GT  Y +PE L G    + 
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGT-HYSV 209

Query: 262 KCDVYSFGMVLFEI-VGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           + D++S G+ L E+ VGR              +P    +  E   +          E D 
Sbjct: 210 QSDIWSMGLSLVEMAVGR--------------YPIPPPDAKELELMFG-----CQVEGDA 250

Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKP 363
            +           +     D  P  A+ ++L+ +V   PP  P
Sbjct: 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  125 bits (315), Expect = 3e-33
 Identities = 60/202 (29%), Positives = 87/202 (43%), Gaps = 15/202 (7%)

Query: 82  YSTRLGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           +   +G G F  VYKG      V++A   L  R L +   ++F  E   +    H N+VR
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 140 LYGFCHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
            Y              LV E M +G+L  YL  + + ++ + L        KGL +LH  
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHT- 147

Query: 196 CQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS 254
               IIH D+K +N+ +     S K+ D GLA L   +          GTP + APE   
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEMYE 203

Query: 255 GNYPITHKCDVYSFGMVLFEIV 276
             Y      DVY+FGM + E+ 
Sbjct: 204 EKY--DESVDVYAFGMCMLEMA 223

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  123 bits (311), Expect = 1e-32
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 29/216 (13%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            LG GGFG V++ +   +    A+K +      +A E+ M EV  + +  H  +VR +  
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 144 CHD---------QHMTALVY---EYMENGSLDGYLFGKKRA--IEWEKLHEIAIGTAKGL 189
             +               +Y   +     +L  ++ G+      E      I +  A+ +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI----------S 239
            +LH    + ++H D+KP N+    +   KV DFGL    D+++   T+          +
Sbjct: 132 EFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188

Query: 240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
           G  GT  Y +PE + GN   +HK D++S G++LFE+
Sbjct: 189 GQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFEL 223

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  124 bits (312), Expect = 2e-32
 Identities = 48/211 (22%), Positives = 78/211 (36%), Gaps = 28/211 (13%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            LG G    V++G+    G   A+KV N        +  M E   + +  H N+V+L+  
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 144 --CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT-----AKGLVYLHEEC 196
                     L+ E+   GSL   L     A     L E            G+ +L E  
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRE-- 130

Query: 197 QQRIIHYDIKPENVLL----DANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEF 252
              I+H +IKP N++     D     K+ DFG A+  + ++  V++    GT  Y  P+ 
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDM 186

Query: 253 LSGNYPI-------THKCDVYSFGMVLFEIV 276
                             D++S G+  +   
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  126 bits (317), Expect = 2e-32
 Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 19/200 (9%)

Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIA--EEQFMAEVGTIGRTYHINLVRLYGF 143
           LG G  G +      +   +AVK +       A  E Q + E        H N++R +  
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRES-----DEHPNVIRYFCT 86

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
             D+    +  E     +L  Y+  K  A    +   +   T  GL +LH      I+H 
Sbjct: 87  EKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHR 142

Query: 204 DIKPENVLL-----DANFSPKVADFGLAKLCDRNKTHVTI-SGYKGTPGYSAPEFLSGNY 257
           D+KP N+L+            ++DFGL K     +   +  SG  GT G+ APE LS + 
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC 202

Query: 258 --PITHKCDVYSFGMVLFEI 275
               T+  D++S G V + +
Sbjct: 203 KENPTYTVDIFSAGCVFYYV 222

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  122 bits (308), Expect = 3e-32
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 24/204 (11%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G F  VY+ +    G+++A+K++++         ++   EV    +  H +++ LY 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAI-EWE---KLHEIAIGTAKGLVYLHEECQQ 198
           +  D +   LV E   NG ++ YL  + +   E E    +H+I      G++YLH     
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLYLH---SH 131

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDR-NKTHVTISGYKGTPGYSAPEFLSGNY 257
            I+H D+   N+LL  N + K+ADFGLA      ++ H T+    GTP Y +PE  + + 
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYISPEIATRSA 188

Query: 258 PITH--KCDVYSFGMVLFE-IVGR 278
              H  + DV+S G + +  ++GR
Sbjct: 189 ---HGLESDVWSLGCMFYTLLIGR 209

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  122 bits (308), Expect = 3e-32
 Identities = 51/237 (21%), Positives = 82/237 (34%), Gaps = 46/237 (19%)

Query: 77  NFTSNYSTR------LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGT 128
              S Y+T       +G G FG V+K     +G   A+K   +   G + E+  + EV  
Sbjct: 4   GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63

Query: 129 IGRTY-HINLVRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT- 185
                 H ++VR +  +  D HM  +  EY   GSL   +   +         E  +   
Sbjct: 64  HAVLGQHSHVVRYFSAWAEDDHML-IQNEYCNGGSLADAI--SENYRIMSYFKEAELKDL 120

Query: 186 ----AKGLVYLHEECQQRIIHYDIKPENVLLDANFSP-------------------KVAD 222
                +GL Y+H      ++H DIKP N+ +     P                   K+ D
Sbjct: 121 LLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177

Query: 223 FGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            G        +         G   + A E L  NY    K D+++  + +    G  
Sbjct: 178 LGHVTRISSPQVEE------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  126 bits (318), Expect = 3e-32
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 16/215 (7%)

Query: 66  KPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLN-RNLGRIAEEQ 121
            P  F + +  + +  Y     LG G +GEV   +     V+ A+K++   ++   +  +
Sbjct: 23  TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82

Query: 122 FMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI 181
            + EV  +    H N+++LY F  D+    LV E  + G L   +  + +  E      I
Sbjct: 83  LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE-VDAAVI 141

Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVTI 238
                 G+ YLH   +  I+H D+KPEN+LL   + +   K+ DFGL+ + +  K     
Sbjct: 142 IKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER 198

Query: 239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
               GT  Y APE L   Y    KCDV+S G++LF
Sbjct: 199 L---GTAYYIAPEVLRKKY--DEKCDVWSIGVILF 228

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  122 bits (309), Expect = 4e-32
 Identities = 55/197 (27%), Positives = 82/197 (41%), Gaps = 18/197 (9%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTY-HINLVRLY 141
           RLG G +GEV+K +   +G   AVK       G     + +AEVG+  +   H   VRL 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 142 G-FCHDQHMTALVYEYME--NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
             +     +    Y   E    SL  +      ++   ++      T   L +LH    Q
Sbjct: 124 QAWEEGGIL----YLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---Q 176

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
            ++H D+KP N+ L      K+ DFGL                +G P Y APE L G+Y 
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPELLQGSY- 232

Query: 259 ITHKCDVYSFGMVLFEI 275
                DV+S G+ + E+
Sbjct: 233 -GTAADVFSLGLTILEV 248

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  124 bits (312), Expect = 5e-32
 Identities = 48/210 (22%), Positives = 78/210 (37%), Gaps = 28/210 (13%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF- 143
           LG G    V++G+    G   A+KV N        +  M E   + +  H N+V+L+   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76

Query: 144 -CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT-----AKGLVYLHEECQ 197
                    L+ E+   GSL   L     A     L E            G+ +L E   
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRE--- 130

Query: 198 QRIIHYDIKPENVLL----DANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
             I+H +IKP N++     D     K+ DFG A+  + ++  V++    GT  Y  P+  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDMY 187

Query: 254 SGNYPI-------THKCDVYSFGMVLFEIV 276
                            D++S G+  +   
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  123 bits (311), Expect = 5e-32
 Identities = 81/308 (26%), Positives = 120/308 (38%), Gaps = 53/308 (17%)

Query: 85  RLGFGGFGEVYKGQFPNG------VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
            LG G FGEVY+GQ          +++AVK L        E  F+ E   I +  H N+V
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYL------FGKKRAIEWEKLHEIAIGTAKGLVYL 192
           R  G         ++ E M  G L  +L        +  ++    L  +A   A G  YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 193 HEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNKTHVTISGY--KGTPGY 247
            E      IH DI   N LL         K+ DFG+A+        +  +GY  KG    
Sbjct: 198 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD-------IYRAGYYRKGGCAM 247

Query: 248 S-----APE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEY 301
                  PE F+ G +  T K D +SFG++L+EI             SL + P   +   
Sbjct: 248 LPVKWMPPEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSK 290

Query: 302 EKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV---EVL 358
              E+   +   G  +  K     +  +   C Q  PEDRP  + +++ +E      +V+
Sbjct: 291 SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350

Query: 359 PPPKPFRY 366
               P  Y
Sbjct: 351 NTALPIEY 358

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  121 bits (306), Expect = 5e-32
 Identities = 48/219 (21%), Positives = 93/219 (42%), Gaps = 32/219 (14%)

Query: 77  NFTSNYST--RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 133
            F  ++     +G GGFG+V+K +   +G    +K +     +   E+   EV  + +  
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKALAKLD 62

Query: 134 HINLVRLYGFCHDQHMTA----------------LVYEYMENGSLDGYLFGKK-RAIEWE 176
           H+N+V   G                         +  E+ + G+L+ ++  ++   ++  
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 177 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV 236
              E+     KG+ Y+H    +++I+ D+KP N+ L      K+ DFGL      +    
Sbjct: 123 LALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179

Query: 237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 275
                KGT  Y +PE +S       + D+Y+ G++L E+
Sbjct: 180 RS---KGTLRYMSPEQISSQ-DYGKEVDLYALGLILAEL 214

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  124 bits (314), Expect = 8e-32
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 17/216 (7%)

Query: 66  KPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEE 120
            P  F       F+  Y  +  LG G FGEV   +    G + AVKV+++     +  +E
Sbjct: 12  TPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE 71

Query: 121 QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE 180
             + EV  + +  H N+++LY F  D+    LV E    G L   +  +KR  E      
Sbjct: 72  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE-VDAAR 130

Query: 181 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVT 237
           I      G+ Y+H   + +I+H D+KPEN+LL     + + ++ DFGL+   + +K    
Sbjct: 131 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187

Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
                GT  Y APE L G Y    KCDV+S G++L+
Sbjct: 188 KI---GTAYYIAPEVLHGTY--DEKCDVWSTGVILY 218

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  121 bits (306), Expect = 2e-31
 Identities = 45/198 (22%), Positives = 95/198 (47%), Gaps = 9/198 (4%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G FG+    +   +G +  +K +N   +     E+   EV  +    H N+V+    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             +     +V +Y E G L   +  +K    + +++ +  +     L ++H+   ++I+H
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILH 148

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            DIK +N+ L  + + ++ DFG+A++ + +   +  +   GTP Y +PE      P  +K
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARA-CIGTPYYLSPEICENK-PYNNK 205

Query: 263 CDVYSFGMVLFEIVGRRR 280
            D+++ G VL+E+   + 
Sbjct: 206 SDIWALGCVLYELCTLKH 223

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  120 bits (304), Expect = 2e-31
 Identities = 72/316 (22%), Positives = 124/316 (39%), Gaps = 46/316 (14%)

Query: 85  RLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
            LG G FG VY+G     VK      +A+K +N         +F+ E   +      ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYL---------FGKKRAIEWEKLHEIAIGTAKGL 189
           RL G       T ++ E M  G L  YL                   K+ ++A   A G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY-- 247
            YL+     + +H D+   N ++  +F+ K+ DFG+ +       +      KG  G   
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLP 203

Query: 248 ---SAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK 303
               +PE    G +  T   DV+SFG+VL+EI             +L   P   ++    
Sbjct: 204 VRWMSPESLKDGVF--TTYSDVWSFGVVLWEIA------------TLAEQP---YQGLSN 246

Query: 304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKP 363
            ++   ++  G+ +K       L  +   C Q +P+ RP    +I  ++  +E       
Sbjct: 247 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306

Query: 364 FRYLDLIKMTRLKSLE 379
           F Y +  K+   + L+
Sbjct: 307 FYYSEENKLPEPEELD 322

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  120 bits (302), Expect = 3e-31
 Identities = 48/200 (24%), Positives = 82/200 (41%), Gaps = 12/200 (6%)

Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLY 141
            +G GG G+VY+ +       +A+K+++  L        +   E  T GR    ++V ++
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
            F        +    +    L   L  ++  +   +   I       L   H        
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAGAT 156

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK-GTPGYSAPEFLSGNYPIT 260
           H D+KPEN+L+ A+    + DFG+A         +T  G   GT  Y APE  S +   T
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSES-HAT 213

Query: 261 HKCDVYSFGMVLFEIV-GRR 279
           ++ D+Y+   VL+E + G  
Sbjct: 214 YRADIYALTCVLYECLTGSP 233

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  122 bits (308), Expect = 3e-31
 Identities = 55/219 (25%), Positives = 87/219 (39%), Gaps = 38/219 (17%)

Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIA--EEQFMAEVGTIGRTYHINLVRLYGF 143
           LG+G  G V       G  +AVK +  +   IA  E + + E        H N++R Y  
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTES-----DDHPNVIRYYCS 77

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH------EIAIGTAKGLVYLHEECQ 197
                   +  E     +L   +  K  + E  KL        +    A G+ +LH    
Sbjct: 78  ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133

Query: 198 QRIIHYDIKPENVLLD-------------ANFSPKVADFGLAKLCDRNKT--HVTISGYK 242
            +IIH D+KP+N+L+               N    ++DFGL K  D  ++     ++   
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193

Query: 243 GTPGYSAPEFLSGNY------PITHKCDVYSFGMVLFEI 275
           GT G+ APE L  +        +T   D++S G V + I
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  120 bits (302), Expect = 3e-31
 Identities = 58/297 (19%), Positives = 112/297 (37%), Gaps = 43/297 (14%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG GGF  V   +   +G   A+K +  +  +   E+   E        H N++RL  +
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 144 CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHE-----IAIGTAKGLVYLHE 194
           C  +        L+  + + G+L   +  ++   +   L E     + +G  +GL  +H 
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFLTEDQILWLLLGICRGLEAIH- 151

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG-------YKGTPGY 247
              +   H D+KP N+LL     P + D G       +      +         + T  Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 248 SAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWE-EYEKC 304
            APE  S   +  I  + DV+S G VL+ ++                F +  ++  ++K 
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMM----------------FGEGPYDMVFQKG 253

Query: 305 ELGAMILGCGIEEKDKEK-AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPP 360
           +  A+ +   +      + +  L  +    +   P  RP +  ++  LE +    P 
Sbjct: 254 DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  120 bits (302), Expect = 4e-31
 Identities = 63/316 (19%), Positives = 116/316 (36%), Gaps = 62/316 (19%)

Query: 85  RLGFGGFGEVYKGQFPNG----VKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVR 139
            LG G FG V + Q        VK+AVK+L  ++   ++ E+F+ E   +    H ++ +
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89

Query: 140 LYGFCHDQHMTA------LVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKG 188
           L G               ++  +M++G L  +L           +  + L    +  A G
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 189 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG-- 246
           + YL     +  IH D+   N +L  + +  VADFGL++       +      +G     
Sbjct: 150 MEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-----RQGCASKL 201

Query: 247 ---YSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP---KHVWE 299
              + A E      Y  T   DV++FG+ ++EI+            +    P       E
Sbjct: 202 PVKWLALESLADNLY--TVHSDVWAFGVTMWEIM------------TRGQTPYAGIENAE 247

Query: 300 EYEKCELGAMI---LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
            Y     G  +     C          + +  +   C    P+ RP  + +   LE ++ 
Sbjct: 248 IYNYLIGGNRLKQPPEC---------MEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298

Query: 357 VLPPPKPFR---YLDL 369
            L      +   Y+++
Sbjct: 299 HLSVLSTSQDPLYINI 314

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  119 bits (300), Expect = 4e-31
 Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 29/232 (12%)

Query: 55  MERFLQEIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLN 111
           M          + + F           +  +  LG G FG+V+  +   +G++  +K +N
Sbjct: 1   MHHHHHHSSGRENLYFQG----TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTIN 56

Query: 112 RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK-- 169
           ++  ++  EQ  AE+  +    H N+++++    D H   +V E  E G L      +  
Sbjct: 57  KDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL----LERIV 112

Query: 170 KRAIEWEKLHEIAIGT-----AKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVA 221
                 + L E  +          L Y H    Q ++H D+KPEN+L      +   K+ 
Sbjct: 113 SAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKII 169

Query: 222 DFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
           DFGLA+L   ++     +   GT  Y APE    +   T KCD++S G+V++
Sbjct: 170 DFGLAELFKSDEHSTNAA---GTALYMAPEVFKRDV--TFKCDIWSAGVVMY 216

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  119 bits (301), Expect = 4e-31
 Identities = 72/302 (23%), Positives = 116/302 (38%), Gaps = 58/302 (19%)

Query: 85  RLGFGGFGEVYKGQFPNG----VKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVR 139
            LG G FG V +G         +K+AVK +  +     E E+F++E   +    H N++R
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100

Query: 140 LYGFCHDQHMTA-----LVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGL 189
           L G C +          ++  +M+ G L  YL         + I  + L +  +  A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG--- 246
            YL     +  +H D+   N +L  + +  VADFGL+K       +      +G      
Sbjct: 161 EYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY-----RQGRIAKMP 212

Query: 247 --YSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP---KHVWEE 300
             + A E      Y  T K DV++FG+ ++EI             +    P       E 
Sbjct: 213 VKWIAIESLADRVY--TSKSDVWAFGVTMWEIA------------TRGMTPYPGVQNHEM 258

Query: 301 YEKCELGAMI---LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV 357
           Y+    G  +     C            L  +   C +  P DRP  S +   LE ++E 
Sbjct: 259 YDYLLHGHRLKQPEDC---------LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309

Query: 358 LP 359
           LP
Sbjct: 310 LP 311

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  118 bits (299), Expect = 5e-31
 Identities = 52/220 (23%), Positives = 84/220 (38%), Gaps = 39/220 (17%)

Query: 85  RLGFGGFGEVYKGQFPNG------VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
            LG   FG+VYKG             +A+K L         E+F  E     R  H N+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRAIEWEKLHEIAI 183
            L G        ++++ Y  +G L  +L                  K A+E      +  
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135

Query: 184 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG 243
             A G+ YL       ++H D+   NVL+    + K++D GL +             YK 
Sbjct: 136 QIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY------YKL 186

Query: 244 TPG------YSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 276
                    + APE  + G +  +   D++S+G+VL+E+ 
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKF--SIDSDIWSYGVVLWEVF 224

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  119 bits (301), Expect = 6e-31
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 44/220 (20%)

Query: 85  RLGFGGFGEVYKGQFPNG---VKIAVKVLNRNLGRIAEEQFMAEV---GTIGRTYHINLV 138
            +G G FG+V K +       +  A+K +     +     F  E+     +G   H N++
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNII 89

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRAIEWEKLHEIAI 183
            L G C  +    L  EY  +G+L  +L                     +  ++L   A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 184 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG 243
             A+G+ YL +   ++ IH D+   N+L+  N+  K+ADFGL++  +          Y  
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE---------VYVK 197

Query: 244 TPG------YSAPEFLSGNYPI-THKCDVYSFGMVLFEIV 276
                    + A E L  NY + T   DV+S+G++L+EIV
Sbjct: 198 KTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV 235

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  119 bits (300), Expect = 1e-30
 Identities = 45/218 (20%), Positives = 80/218 (36%), Gaps = 32/218 (14%)

Query: 86  LGFGGFGEVYKGQFPNGVKIAVKVLNRN----------------LGRIAEEQFMAEVGTI 129
           L  G F ++   +  +    A+K   ++                  +   + F  E+  I
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 130 GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHE-----IA 182
               +   +   G   +     ++YEYMEN S+  +   F          +       I 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK 242
                   Y+H   ++ I H D+KP N+L+D N   K++DFG ++     K   +    +
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS----R 211

Query: 243 GTPGYSAPEFLSGNYPI-THKCDVYSFGMVLFE-IVGR 278
           GT  +  PEF S        K D++S G+ L+      
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  118 bits (298), Expect = 1e-30
 Identities = 73/302 (24%), Positives = 122/302 (40%), Gaps = 53/302 (17%)

Query: 85  RLGFGGFGEVYKGQFPNG------VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
            LG G FG+V+  +  N       + +AVK L       A + F  E   +    H ++V
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA-ARKDFQREAELLTNLQHEHIV 80

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRAIEWEKLHEIAI 183
           + YG C D     +V+EYM++G L+ +L                  K  +   ++  IA 
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 184 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG 243
             A G+VYL     Q  +H D+   N L+ AN   K+ DFG+++       +       G
Sbjct: 141 QIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-----VG 192

Query: 244 TPG-----YSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHV 297
                   +  PE  +   +  T + DV+SFG++L+EI             +    P   
Sbjct: 193 GHTMLPIRWMPPESIMYRKF--TTESDVWSFGVILWEIF------------TYGKQP--- 235

Query: 298 WEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV 357
           W +    E+   I    + E+ +   K +  V L C Q  P+ R  +  + K+L  + + 
Sbjct: 236 WFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295

Query: 358 LP 359
            P
Sbjct: 296 TP 297

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  118 bits (298), Expect = 2e-30
 Identities = 71/313 (22%), Positives = 117/313 (37%), Gaps = 59/313 (18%)

Query: 85  RLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
            LG G FG+V+  +  N +       +AVK L       A + F  E   +    H ++V
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES-ARQDFQREAELLTMLQHQHIV 106

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYL--------------FGKKRAIEWEKLHEIAIG 184
           R +G C +     +V+EYM +G L+ +L                    +   +L  +A  
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY-KG 243
            A G+VYL        +H D+   N L+      K+ DFG+++             Y  G
Sbjct: 167 VAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY------YRVG 217

Query: 244 TPG-----YSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHV 297
                   +  PE  L   +  T + DV+SFG+VL+EI             +    P   
Sbjct: 218 GRTMLPIRWMPPESILYRKF--TTESDVWSFGVVLWEIF------------TYGKQP--- 260

Query: 298 WEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV 357
           W +    E    I      E+ +     +  +   C Q  P+ R  +  V   L+ + + 
Sbjct: 261 WYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320

Query: 358 LPPPKPFRYLDLI 370
            P      YLD++
Sbjct: 321 PPV-----YLDVL 328

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  117 bits (296), Expect = 2e-30
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLY 141
           +LG GG   VY  +     +K+A+K +        E  ++F  EV    +  H N+V + 
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
               +     LV EY+E  +L  Y+      +  +           G+ + H     RI+
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMRIV 133

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK-GTPGYSAPEFLSGNYPIT 260
           H DIKP+N+L+D+N + K+ DFG+AK    ++T +T + +  GT  Y +PE   G     
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPEQAKGE-ATD 190

Query: 261 HKCDVYSFGMVLFEIV-GRR 279
              D+YS G+VL+E++ G  
Sbjct: 191 ECTDIYSIGIVLYEMLVGEP 210

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  121 bits (305), Expect = 2e-30
 Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 16/204 (7%)

Query: 77  NFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRT 132
            F   Y+    LG G FGEV K +      + AVKV+N  +         + EV  + + 
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78

Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 192
            H N+++L+    D     +V E    G L   +  +KR  E      I      G+ Y+
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYM 137

Query: 193 HEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
           H   +  I+H D+KPEN+LL   + +   K+ DFGL+    +N          GT  Y A
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYYIA 191

Query: 250 PEFLSGNYPITHKCDVYSFGMVLF 273
           PE L G Y    KCDV+S G++L+
Sbjct: 192 PEVLRGTY--DEKCDVWSAGVILY 213

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  117 bits (295), Expect = 2e-30
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 26/209 (12%)

Query: 77  NFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRT 132
            F   Y+    LG G FGEV K +      + AVKV+N  +         + EV  + + 
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78

Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT-----AK 187
            H N+++L+    D     +V E    G     LF     I+ ++  E            
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGE----LF--DEIIKRKRFSEHDAARIIKQVFS 132

Query: 188 GLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
           G+ Y+H   +  I+H D+KPEN+LL   + +   K+ DFGL+    +N          GT
Sbjct: 133 GITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GT 186

Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
             Y APE L G Y    KCDV+S G++L+
Sbjct: 187 AYYIAPEVLRGTY--DEKCDVWSAGVILY 213

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  117 bits (295), Expect = 4e-30
 Identities = 73/298 (24%), Positives = 123/298 (41%), Gaps = 37/298 (12%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLY 141
            LGFGG  EV+  +   +   +AVKVL  +L R      +F  E        H  +V +Y
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 142 GFCHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
                +        +V EY++  +L   +   +  +  ++  E+     + L + H+   
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSHQ--- 134

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK-GTPGYSAPEFLSGN 256
             IIH D+KP N+++ A  + KV DFG+A+    +   VT +    GT  Y +PE   G+
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194

Query: 257 YPITHKCDVYSFGMVLFEIV-GRR----RNAIVGATESLDWFPKHVWEEYEKCELGAMIL 311
             +  + DVYS G VL+E++ G       + +  A        +HV E+           
Sbjct: 195 -SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-------QHVREDPIP-------- 238

Query: 312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPP-MSAVIKMLEGVVEVLPPPKPFRYLD 368
                 + +  +  L  V L  +  +PE+R    + +   L  V    PP  P    D
Sbjct: 239 ---PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTD 293

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  116 bits (292), Expect = 5e-30
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 12/205 (5%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
            +G G +G   K +   +G  +  K L+  ++    ++  ++EV  +    H N+VR Y 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 143 FCHDQHMTAL--VYEYMENGSLDGYLFGKKRA---IEWEKLHEIAIGTAKGLVYLHE--E 195
              D+  T L  V EY E G L   +    +    ++ E +  +       L   H   +
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
               ++H D+KP NV LD   + K+ DFGLA++ + + +      + GTP Y +PE ++ 
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFVGTPYYMSPEQMNR 190

Query: 256 NYPITHKCDVYSFGMVLFEIVGRRR 280
                 K D++S G +L+E+     
Sbjct: 191 M-SYNEKSDIWSLGCLLYELCALMP 214

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  115 bits (289), Expect = 1e-29
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 18/201 (8%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYG 142
            LG G +G V K +  P+G  +AVK +   +    +++ + ++    RT      V  YG
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 143 FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
               +    +  E M + SLD +      K + I  + L +IA+   K L +LH +    
Sbjct: 74  ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LS 130

Query: 200 IIHYDIKPENVLLDANFSPKVADFGL-AKLCD-RNKTHVTISGYKGTPGYSAPEFLSGNY 257
           +IH D+KP NVL++A    K+ DFG+   L D   K         G   Y APE ++   
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-----GCKPYMAPERINPEL 185

Query: 258 PI---THKCDVYSFGMVLFEI 275
                + K D++S G+ + E+
Sbjct: 186 NQKGYSVKSDIWSLGITMIEL 206

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  115 bits (291), Expect = 1e-29
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 15/200 (7%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYG 142
            +G G +G V K    P+G  +AVK +   +    ++Q + ++  + R+     +V+ YG
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
               +    +  E M       Y +        I  E L +I + T K L +L E    +
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LK 146

Query: 200 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
           IIH DIKP N+LLD + + K+ DFG+  +L D            G   Y APE +  +  
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA----GCRPYMAPERIDPSAS 202

Query: 259 I---THKCDVYSFGMVLFEI 275
                 + DV+S G+ L+E+
Sbjct: 203 RQGYDVRSDVWSLGITLYEL 222

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  114 bits (288), Expect = 2e-29
 Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 26/208 (12%)

Query: 77  NFTSNYST--RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 133
           +    Y+    +G G +GEV         ++ A K + +       ++F  E+  +    
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLD 64

Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT-----AKG 188
           H N++RLY    D     LV E    G L    F  +R +      E             
Sbjct: 65  HPNIIRLYETFEDNTDIYLVMELCTGGEL----F--ERVVHKRVFRESDAARIMKDVLSA 118

Query: 189 LVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
           + Y H   +  + H D+KPEN L      +   K+ DFGLA      K   T  G   TP
Sbjct: 119 VAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG---TP 172

Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLF 273
            Y +P+ L G Y    +CD +S G++++
Sbjct: 173 YYVSPQVLEGLY--GPECDEWSAGVMMY 198

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  115 bits (289), Expect = 2e-29
 Identities = 58/225 (25%), Positives = 91/225 (40%), Gaps = 46/225 (20%)

Query: 85  RLGFGGFGEVYKGQ------FPNGVKIAVKVLNRNLGRIAEEQFMAEVG---TIGRTYHI 135
            LG G FG+V +            + +AVK+L  +      E  M+E+     +G   H+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--HM 87

Query: 136 NLVRLYGFCHDQHMTALVYEYMENGSLDGYL-----------------FGKKRAIEWEKL 178
           N+V L G C     T ++ EY   G L  +L                    + A++ E L
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 179 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI 238
              +   AKG+ +L     +  IH D+   N+LL      K+ DFGLA+  D        
Sbjct: 148 LSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR--DIKNDSN-- 200

Query: 239 SGYKGTPG------YSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 276
             Y           + APE   +  Y  T + DV+S+G+ L+E+ 
Sbjct: 201 --YVVKGNARLPVKWMAPESIFNCVY--TFESDVWSYGIFLWELF 241

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  115 bits (289), Expect = 3e-29
 Identities = 78/319 (24%), Positives = 125/319 (39%), Gaps = 66/319 (20%)

Query: 85  RLGFGGFGEVYKG--------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVG---TIGRTY 133
            LG G FG+V           +    V +AVK+L  +         ++E+     IG+  
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-- 99

Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRAIEWEKL 178
           H N++ L G C       ++ EY   G+L  YL                  +  + ++ L
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 179 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI 238
                  A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+        +  
Sbjct: 160 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARD-------INN 209

Query: 239 SGY--KGTPG-----YSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL 290
             Y  K T G     + APE      Y  TH+ DV+SFG++++EI             +L
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIF------------TL 255

Query: 291 DWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM 350
              P   +      EL  ++      +K       L M+   C    P  RP    +++ 
Sbjct: 256 GGSP---YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

Query: 351 LEGVVEVLPPPKPFRYLDL 369
           L+ ++ +    +   YLDL
Sbjct: 313 LDRILTLTTNEE---YLDL 328

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  114 bits (288), Expect = 3e-29
 Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 14/198 (7%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYG 142
            +G G  G+V+K +F   G  IAVK + R+  +   ++ + ++  + ++     +V+ +G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
                    +  E M   +       +    E   L ++ +   K L YL E+    +IH
Sbjct: 92  TFITNTDVFIAMELMGTCAEKLKKRMQGPIPE-RILGKMTVAIVKALYYLKEK--HGVIH 148

Query: 203 YDIKPENVLLDANFSPKVADFGL-AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI-- 259
            D+KP N+LLD     K+ DFG+  +L D      +     G   Y APE +    P   
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA----GCAAYMAPERIDPPDPTKP 204

Query: 260 --THKCDVYSFGMVLFEI 275
               + DV+S G+ L E+
Sbjct: 205 DYDIRADVWSLGISLVEL 222

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  117 bits (296), Expect = 3e-29
 Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 37/231 (16%)

Query: 66  KPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRN--------- 113
            P  +   +      +Y     LG G +GEV   +      + A+KV+ ++         
Sbjct: 22  NPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSD 81

Query: 114 ---LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK 170
                    E+   E+  +    H N+++L+    D+    LV E+ E G L    F  +
Sbjct: 82  DNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----F--E 135

Query: 171 RAIEWEKLHEIAIGT-----AKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVAD 222
           + I   K  E            G+ YLH   +  I+H DIKPEN+LL   ++  + K+ D
Sbjct: 136 QIINRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVD 192

Query: 223 FGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
           FGL+    ++          GT  Y APE L   Y    KCDV+S G++++
Sbjct: 193 FGLSSFFSKDYKLRDRL---GTAYYIAPEVLKKKY--NEKCDVWSCGVIMY 238

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  114 bits (287), Expect = 4e-29
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 16/197 (8%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           +G G F EVY+     +GV +A+K +     +   A    + E+  + +  H N+++ Y 
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT-----AKGLVYLHEECQ 197
              + +   +V E  + G L   +  K    +   + E  +          L ++H    
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTVWKYFVQLCSALEHMHS--- 154

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY 257
           +R++H DIKP NV + A    K+ D GL +      T        GTP Y +PE +  N 
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHEN- 211

Query: 258 PITHKCDVYSFGMVLFE 274
               K D++S G +L+E
Sbjct: 212 GYNFKSDIWSLGCLLYE 228

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  114 bits (287), Expect = 6e-29
 Identities = 64/245 (26%), Positives = 96/245 (39%), Gaps = 55/245 (22%)

Query: 61  EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKG------QFPNGVKIAVKVLNRNL 114
           E  R        LQ           LG G FG+V +       +    +K+AVK+L    
Sbjct: 42  EFPRNN------LQFGK-------TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88

Query: 115 GRIAEEQFMAEVG---TIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKR 171
               +E  M+E+     +G+  H N+V L G C       ++ EY   G L  +L  K R
Sbjct: 89  HADEKEALMSELKIMSHLGQ--HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR 146

Query: 172 AIEWEK-------------LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP 218
            +E +              L   +   A+G+ +L     +  IH D+   NVLL      
Sbjct: 147 VLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVA 203

Query: 219 KVADFGLAKLCDRNKTHVTISGYKGTPG------YSAPE-FLSGNYPITHKCDVYSFGMV 271
           K+ DFGLA+  D          Y           + APE      Y  T + DV+S+G++
Sbjct: 204 KIGDFGLAR--DIMNDSN----YIVKGNARLPVKWMAPESIFDCVY--TVQSDVWSYGIL 255

Query: 272 LFEIV 276
           L+EI 
Sbjct: 256 LWEIF 260

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  115 bits (288), Expect = 6e-29
 Identities = 45/267 (16%), Positives = 87/267 (32%), Gaps = 36/267 (13%)

Query: 86  LGFGGFGEVYKGQF------PNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLV 138
           LG G F +VY+          N  K  +KV    N         + E   +  +     +
Sbjct: 73  LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMER--LKPSMQHMFM 130

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE-----IAIGTAKGLVYLH 193
           + Y     Q+ + LV E    G+L   +    +    + + +      A+     +  +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAI-NLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189

Query: 194 EECQQRIIHYDIKPENVLL-----------DANFSPKVADFGLAKLCDRNKTHVTISGYK 242
           +     IIH DIKP+N +L           D +    + D G +            +   
Sbjct: 190 D---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246

Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE-IVGRRRNAIVGATESLDWFPKHVWEEY 301
            T G+   E LS   P  ++ D +     ++  + G     +    E  +  P+ ++   
Sbjct: 247 ETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGT---YMKVKNEGGECKPEGLFRRL 302

Query: 302 EKCELGAMILGC--GIEEKDKEKAKRL 326
              ++          I +     +  L
Sbjct: 303 PHLDMWNEFFHVMLNIPDCHHLPSLDL 329

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  113 bits (286), Expect = 8e-29
 Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 15/196 (7%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +G G F +V   +    G ++A+K++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQRI 200
              +    L+ EY   G +  YL    R  E E   K  +I       + Y H   Q+RI
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCH---QKRI 135

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H D+K EN+LLDA+ + K+ADFG +           +  + G P Y+APE   G     
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDG 192

Query: 261 HKCDVYSFGMVLFEIV 276
            + DV+S G++L+ +V
Sbjct: 193 PEVDVWSLGVILYTLV 208

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  114 bits (287), Expect = 9e-29
 Identities = 30/250 (12%), Positives = 62/250 (24%), Gaps = 46/250 (18%)

Query: 64  REKPVRFTSLQLNNFTSNYST--RLGFGGFGEVYKG-QFPNGVKIAVKVLNRN--LGRIA 118
           +       SL L+           L  G    V+           A+KV        R  
Sbjct: 47  QNAETTVDSL-LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSE 105

Query: 119 EEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA--------------------------L 152
            E+         R    +             +                           L
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165

Query: 153 VYEYM-----ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 207
           +            S   +++  +       LH +     +    L     + ++H    P
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTP 222

Query: 208 ENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVY 266
           +N+ +  +    + D        +  T    S       Y+  EFL+ +    TH  + +
Sbjct: 223 DNLFIMPDGRLMLGDVSALW---KVGTRGPASS--VPVTYAPREFLNASTATFTHALNAW 277

Query: 267 SFGMVLFEIV 276
             G+ ++ + 
Sbjct: 278 QLGLSIYRVW 287

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  114 bits (288), Expect = 9e-29
 Identities = 73/305 (23%), Positives = 118/305 (38%), Gaps = 61/305 (20%)

Query: 85  RLGFGGFGEVYKG--------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVG---TIGRTY 133
            LG G FG+V           +    V +AVK+L  +         ++E+     IG+  
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-- 145

Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRAIEWEKL 178
           H N++ L G C       ++ EY   G+L  YL                  +  + ++ L
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 179 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI 238
                  A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +        
Sbjct: 206 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY---- 258

Query: 239 SGYKGTPG------YSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD 291
             YK T        + APE      Y  TH+ DV+SFG++++EI             +L 
Sbjct: 259 --YKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIF------------TLG 302

Query: 292 WFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKML 351
             P   +      EL  ++      +K       L M+   C    P  RP    +++ L
Sbjct: 303 GSP---YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359

Query: 352 EGVVE 356
           + ++ 
Sbjct: 360 DRILT 364

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  117 bits (294), Expect = 1e-28
 Identities = 48/204 (23%), Positives = 81/204 (39%), Gaps = 24/204 (11%)

Query: 85  RLGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY- 141
            +  GG G +Y    +  NG  + +K L  +    A+   MAE   +    H ++V+++ 
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 142 -GFCHDQHMTALVY---EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
                D+H   + Y   EY+   SL        + +   +     +     L YLH    
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHS--- 200

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK-GTPGYSAPEFLSGN 256
             +++ D+KPEN++L      K+ D G           +   GY  GTPG+ APE +   
Sbjct: 201 IGLVYNDLKPENIMLTEE-QLKLIDLGAVS-------RINSFGYLYGTPGFQAPEIVRTG 252

Query: 257 YPITHKCDVYSFGMVLFEIVGRRR 280
              T   D+Y+ G  L  +     
Sbjct: 253 --PTVATDIYTVGRTLAALTLDLP 274

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  112 bits (283), Expect = 1e-28
 Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 19/198 (9%)

Query: 86  LGFGGFGEVYKG-QFPNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           LG G +G VY G    N V+IA+K +  R+      +    E+       H N+V+  G 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS--QPLHEEIALHKHLKHKNIVQYLGS 87

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEW-EKLHEIAIGTA---KGLVYLHEECQQR 199
             +     +  E +  GSL   L  K   ++  E+   I   T    +GL YLH+    +
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT--IGFYTKQILEGLKYLHD---NQ 142

Query: 200 IIHYDIKPENVLLDA-NFSPKVADFGLAK-LCDRNKTHVTISGYKGTPGYSAPEFLSGNY 257
           I+H DIK +NVL++  +   K++DFG +K L   N    T     GT  Y APE +    
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF---TGTLQYMAPEIIDKGP 199

Query: 258 P-ITHKCDVYSFGMVLFE 274
                  D++S G  + E
Sbjct: 200 RGYGKAADIWSLGCTIIE 217

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  113 bits (284), Expect = 2e-28
 Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 22/198 (11%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           R+G G FGEV++ +    G + AVK +        E   + E+          +V LYG 
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGA 118

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA---KGLVYLHEECQQRI 200
             +     +  E +E GSL   +  K+     E             +GL YLH    +RI
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDR--ALYYLGQALEGLEYLHT---RRI 171

Query: 201 IHYDIKPENVLLDANFSP-KVADFGLAK---LCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
           +H D+K +NVLL ++ S   + DFG A         K+ +T     GT  + APE + G 
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231

Query: 257 YPITHKCDVYSFGMVLFE 274
            P   K D++S   ++  
Sbjct: 232 -PCDAKVDIWSSCCMMLH 248

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  111 bits (279), Expect = 4e-28
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)

Query: 76  NNFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIA--------EEQFMA 124
           + F  NY  +  LG G    V +    P   + AVK+++   G            E  + 
Sbjct: 13  HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72

Query: 125 EVGTIGR-TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI 183
           EV  + + + H N+++L           LV++ M+ G L  YL  K    E ++  +I  
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE-KETRKIMR 131

Query: 184 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKG 243
              + +  LH+     I+H D+KPEN+LLD + + K+ DFG +   D  +    +    G
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---G 185

Query: 244 TPGYSAPEFLSGNYPITHK-----CDVYSFGMVLF 273
           TP Y APE +  +    H       D++S G++++
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 220

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  112 bits (283), Expect = 5e-28
 Identities = 65/248 (26%), Positives = 101/248 (40%), Gaps = 57/248 (22%)

Query: 61  EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN--------GVKIAVKVLNR 112
           E+ R++      L L          LG G FG+V   +             K+AVK+L  
Sbjct: 65  ELPRDR------LVLGK-------PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS 111

Query: 113 NLGRIAEEQFMAEVG---TIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL--- 166
           +         ++E+     IG+  H N++ L G C       ++ EY   G+L  YL   
Sbjct: 112 DATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR 169

Query: 167 ------------FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA 214
                          +  +  + L   A   A+G+ YL     ++ IH D+   NVL+  
Sbjct: 170 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTE 226

Query: 215 NFSPKVADFGLAKLCDRNKTHVTISGYKGTPG-----YSAPE-FLSGNYPITHKCDVYSF 268
           +   K+ADFGLA+       +      K T G     + APE      Y  TH+ DV+SF
Sbjct: 227 DNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIY--THQSDVWSF 279

Query: 269 GMVLFEIV 276
           G++L+EI 
Sbjct: 280 GVLLWEIF 287

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  112 bits (281), Expect = 5e-28
 Identities = 65/320 (20%), Positives = 112/320 (35%), Gaps = 65/320 (20%)

Query: 85  RLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
            +G G FG V++ + P  +       +AVK+L        +  F  E   +    + N+V
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYL-----------------------FGKKRAIEW 175
           +L G C       L++EYM  G L+ +L                             +  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 176 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH 235
            +   IA   A G+ YL E   ++ +H D+   N L+  N   K+ADFGL++       +
Sbjct: 174 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230

Query: 236 VTISGYKGTPGY-----SAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES 289
                              PE      Y  T + DV+++G+VL+EI             S
Sbjct: 231 K-----ADGNDAIPIRWMPPESIFYNRY--TTESDVWAYGVVLWEIF------------S 271

Query: 290 LDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK 349
               P   +      E+   +    I    +     L  +   C    P DRP   ++ +
Sbjct: 272 YGLQP---YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328

Query: 350 MLEGVVEVLPPPKPFRYLDL 369
           +L+ + E          + +
Sbjct: 329 ILQRMCERAEG-----TVGV 343

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  112 bits (282), Expect = 5e-28
 Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 23/214 (10%)

Query: 76  NNFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR- 131
             F   Y  +  +G G    V +      G + AVK++     R++ EQ         R 
Sbjct: 90  KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149

Query: 132 -------TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG 184
                    H +++ L           LV++ M  G L  YL  K    E ++   I   
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE-KETRSIMRS 208

Query: 185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
             + + +LH      I+H D+KPEN+LLD N   +++DFG +   +  +    +    GT
Sbjct: 209 LLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC---GT 262

Query: 245 PGYSAPEFLSGNYPITHK-----CDVYSFGMVLF 273
           PGY APE L  +   TH       D+++ G++LF
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  110 bits (277), Expect = 1e-27
 Identities = 60/224 (26%), Positives = 89/224 (39%), Gaps = 45/224 (20%)

Query: 85  RLGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVG---TIGRTYHI 135
            LG G FG+V +              +AVK+L            M+E+     IG   H+
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HL 91

Query: 136 NLVRLYGFCHDQHM-TALVYEYMENGSLDGYL---------------FGKKRAIEWEKLH 179
           N+V L G C        ++ E+ + G+L  YL                  K  +  E L 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 180 EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS 239
             +   AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+  D  K      
Sbjct: 152 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPD--- 203

Query: 240 GYKGTPG------YSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 276
            Y           + APE      Y  T + DV+SFG++L+EI 
Sbjct: 204 -YVRKGDARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIF 244

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  109 bits (275), Expect = 1e-27
 Identities = 58/192 (30%), Positives = 82/192 (42%), Gaps = 11/192 (5%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G +GEV           +AVK+++        E    E+       H N+V+ YG  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQRII 201
            + ++  L  EY   G L   +       E +     H++  G      YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GIGIT 127

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L        
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187

Query: 262 KCDVYSFGMVLF 273
             DV+S G+VL 
Sbjct: 188 PVDVWSCGIVLT 199

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  110 bits (276), Expect = 2e-27
 Identities = 61/270 (22%), Positives = 93/270 (34%), Gaps = 54/270 (20%)

Query: 55  MERFLQEIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN 111
           M          + + F    L      Y  +  +G G +G V    +       A+K++N
Sbjct: 1   MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60

Query: 112 R----NLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF 167
           +     +     E+   EV  + + +H N+ RLY    D+    LV E    G L   L 
Sbjct: 61  KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120

Query: 168 GKKRAIEWEKLHEIAIGTAK---------------------------------------G 188
                   +   ++                                              
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180

Query: 189 LVYLHEECQQRIIHYDIKPENVLL--DANFSPKVADFGLAKLCDRNKTH--VTISGYKGT 244
           L YLH    Q I H DIKPEN L   + +F  K+ DFGL+K   +        ++   GT
Sbjct: 181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237

Query: 245 PGYSAPEFLSG-NYPITHKCDVYSFGMVLF 273
           P + APE L+  N     KCD +S G++L 
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  110 bits (277), Expect = 2e-27
 Identities = 28/237 (11%), Positives = 66/237 (27%), Gaps = 54/237 (22%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRN-------LGRIAEE---------------- 120
            LG        +      G    V V           + ++ EE                
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 121 ----QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM----ENGSLDGYLFG---K 169
               +F+     +       ++R+     D  + +  + Y        +    L      
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 170 KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 229
            +++      ++ +   + L  LH      ++H  ++P +++LD      +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 230 DRNKTHVTISGYKGTPGYSAPEFLS----------GNYPITHKCDVYSFGMVLFEIV 276
                         + G+  PE  +              +T   D ++ G+V++ I 
Sbjct: 257 GARVVSS------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  108 bits (273), Expect = 3e-27
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 25/209 (11%)

Query: 77  NFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRT 132
            F+ NY  +  LG G F  V +      G++ A K++N + L     ++   E     + 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62

Query: 133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE-----IAIGTAK 187
            H N+VRL+    ++    LV++ +  G L    F  +  +  E   E           +
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGEL----F--EDIVAREFYSEADASHCIQQILE 116

Query: 188 GLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
            + Y H      I+H ++KPEN+LL       + K+ADFGLA   + ++     +   GT
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GT 170

Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
           PGY +PE L  + P +   D+++ G++L+
Sbjct: 171 PGYLSPEVLKKD-PYSKPVDIWACGVILY 198

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (276), Expect = 4e-27
 Identities = 39/300 (13%), Positives = 86/300 (28%), Gaps = 55/300 (18%)

Query: 16  IIRYFWEKLNRTETETRNAASANKPEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQL 75
           +I   + ++ +    T +    +  +  V   +W  GQ   R   E+G E+P        
Sbjct: 28  VIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPF-RVESELG-ERPRTLVR--- 82

Query: 76  NNFTSNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLN-------RNLGRIAEE------- 120
                   T LG        +      G    V V           + ++ EE       
Sbjct: 83  -------GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135

Query: 121 -------------QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV----YEYMENGSLD 163
                        +F+     +       ++R+     D  + +             +  
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195

Query: 164 GYLFGKKR---AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV 220
             L        ++      ++ +   + L  LH      ++H  ++P +++LD      +
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFL 252

Query: 221 ADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP----ITHKCDVYSFGMVLFEIV 276
             F        +       G+   P  +A   L         +T   D ++ G+ ++ I 
Sbjct: 253 TGFEHLVRDGASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  108 bits (273), Expect = 5e-27
 Identities = 58/192 (30%), Positives = 82/192 (42%), Gaps = 11/192 (5%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           LG G +GEV           +AVK+++        E    E+       H N+V+ YG  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQRII 201
            + ++  L  EY   G L   +       E +     H++  G      YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GIGIT 127

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L        
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187

Query: 262 KCDVYSFGMVLF 273
             DV+S G+VL 
Sbjct: 188 PVDVWSCGIVLT 199

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  108 bits (273), Expect = 5e-27
 Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 47/228 (20%)

Query: 85  RLGFGGFGEVYKGQ------FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
            LG G FG+V K              +AVK+L  N         ++E   + +  H +++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYL-----------------------FGKKRAIEW 175
           +LYG C       L+ EY + GSL G+L                          +RA+  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 176 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH 235
             L   A   ++G+ YL E    +++H D+   N+L+      K++DFGL++  D  +  
Sbjct: 150 GDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSR--DVYEED 204

Query: 236 VTISGY-KGTPG-----YSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 276
                Y K + G     + A E      Y  T + DV+SFG++L+EIV
Sbjct: 205 S----YVKRSQGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLWEIV 246

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  109 bits (274), Expect = 6e-27
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 25/220 (11%)

Query: 66  KPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRIAEEQ 121
           +   F       F+ NY  +  LG G F  V +      G++ A K++N + L     ++
Sbjct: 15  RGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK 74

Query: 122 FMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE- 180
              E     +  H N+VRL+    ++    LV++ +  G L    F  +  +  E   E 
Sbjct: 75  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----F--EDIVAREFYSEA 128

Query: 181 ----IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSP-KVADFGLAKLCDRNK 233
                     + + Y H      I+H ++KPEN+LL   A  +  K+ADFGLA   + ++
Sbjct: 129 DASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185

Query: 234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
                +   GTPGY +PE L  + P +   D+++ G++L+
Sbjct: 186 AWHGFA---GTPGYLSPEVLKKD-PYSKPVDIWACGVILY 221

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  108 bits (272), Expect = 9e-27
 Identities = 61/230 (26%), Positives = 88/230 (38%), Gaps = 51/230 (22%)

Query: 85  RLGFGGFGEVYKGQ------FPNGVKIAVKVLNRNLGRIAEEQFMAEVG---TIGRTYHI 135
            LG G FG+V              +++AVK+L         E  M+E+     +G   H 
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--HE 109

Query: 136 NLVRLYGFCHDQHMTALVYEYMENGSLDGYL----------------------FGKKRAI 173
           N+V L G C       L++EY   G L  YL                            +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 174 EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK 233
            +E L   A   AKG+ +L     +  +H D+   NVL+      K+ DFGLA+  D   
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR--DIMS 224

Query: 234 THVTISGYKGTPG------YSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 276
                  Y           + APE    G Y  T K DV+S+G++L+EI 
Sbjct: 225 DSN----YVVRGNARLPVKWMAPESLFEGIY--TIKSDVWSYGILLWEIF 268

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  107 bits (270), Expect = 9e-27
 Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 30/208 (14%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-----------TY 133
           LG GGFG V+ G    + +++A+KV+ RN  R+     +++  T                
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRN--RVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGS-LDGYLFGKKRAIEWE---KLHEIAIGTAKGL 189
           H  ++RL  +   Q    LV E       L  Y+  K    E        ++       +
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV----AAI 152

Query: 190 VYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYS 248
            + H    + ++H DIK EN+L+D      K+ DFG   L              GT  YS
Sbjct: 153 QHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----GTRVYS 205

Query: 249 APEFLSGNYPITHKCDVYSFGMVLFEIV 276
            PE++S +        V+S G++L+++V
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMV 233

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  109 bits (273), Expect = 1e-26
 Identities = 47/230 (20%), Positives = 101/230 (43%), Gaps = 27/230 (11%)

Query: 56  ERFLQEIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN- 111
           ++F ++I ++   +   ++  +    Y     LG G FG V++  +   G     K +N 
Sbjct: 27  DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 86

Query: 112 RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL------DGY 165
                        E+  + + +H  L+ L+    D++   L+ E++  G L      + Y
Sbjct: 87  PYPLDK--YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY 144

Query: 166 LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP--KVADF 223
              +   I +  + +      +GL ++H   +  I+H DIKPEN++ +   +   K+ DF
Sbjct: 145 KMSEAEVINY--MRQAC----EGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDF 195

Query: 224 GLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
           GLA   + ++     +    T  ++APE +    P+    D+++ G++ +
Sbjct: 196 GLATKLNPDEIVKVTT---ATAEFAAPEIVDRE-PVGFYTDMWAIGVLGY 241

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  109 bits (273), Expect = 2e-26
 Identities = 55/218 (25%), Positives = 87/218 (39%), Gaps = 33/218 (15%)

Query: 76  NNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLNRN-------LGRIAEEQFMAE 125
                 Y     LG G  GEV    +     K+A++++++                   E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190

Query: 126 VGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE----- 180
           +  + +  H  ++++  F   +    +V E ME G L    F   + +  ++L E     
Sbjct: 191 IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL----F--DKVVGNKRLKEATCKL 243

Query: 181 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVT 237
                   + YLHE     IIH D+KPENVLL   + +   K+ DFG +K+        T
Sbjct: 244 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 300

Query: 238 ISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLF 273
           +    GTP Y APE L            D +S G++LF
Sbjct: 301 LC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  107 bits (268), Expect = 4e-26
 Identities = 56/197 (28%), Positives = 80/197 (40%), Gaps = 24/197 (12%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G FG     +       +AVK + R  G   +E    E+       H N+VR     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQRII 201
                 A++ EY   G L   +    R  E E      ++  G +    Y H     +I 
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS----YCH---SMQIC 138

Query: 202 HYDIKPENVLLDANFSP--KVADFGLAKLCDRN---KTHVTISGYKGTPGYSAPEFLSGN 256
           H D+K EN LLD + +P  K+ DFG +K    +   K+ V      GTP Y APE L   
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLRQ 192

Query: 257 YPITHKCDVYSFGMVLF 273
                  DV+S G+ L+
Sbjct: 193 EYDGKIADVWSCGVTLY 209

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  107 bits (268), Expect = 5e-26
 Identities = 57/220 (25%), Positives = 106/220 (48%), Gaps = 27/220 (12%)

Query: 67  PVRFTSLQLNNFTSNYS----TRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ 121
             R  + +     S Y+      LG G FG+V+K  +   G+K+A K++    G   +E+
Sbjct: 74  DHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR-GMKDKEE 132

Query: 122 FMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL------DGYLFGKKRAIEW 175
              E+  + +  H NL++LY     ++   LV EY++ G L      + Y   +   I +
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192

Query: 176 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP--KVADFGLAKLCDRNK 233
             + +I     +G+ ++H   Q  I+H D+KPEN+L     +   K+ DFGLA+     +
Sbjct: 193 --MKQIC----EGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243

Query: 234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
                    GTP + APE ++ ++ ++   D++S G++ +
Sbjct: 244 KLKVNF---GTPEFLAPEVVNYDF-VSFPTDMWSVGVIAY 279

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  105 bits (265), Expect = 6e-26
 Identities = 46/206 (22%), Positives = 84/206 (40%), Gaps = 28/206 (13%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI--------- 135
           LG GGFG VY G    + + +A+K + ++  RI++   +     +     +         
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKD--RISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 136 NLVRLYGFCHDQHMTALVYEYMEN-GSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVY 191
            ++RL  +        L+ E  E    L  ++  +    E        ++     + + +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL----EAVRH 164

Query: 192 LHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAP 250
            H      ++H DIK EN+L+D N    K+ DFG   L              GT  YS P
Sbjct: 165 CH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPP 217

Query: 251 EFLSGNYPITHKCDVYSFGMVLFEIV 276
           E++  +        V+S G++L+++V
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMV 243

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  105 bits (264), Expect = 6e-26
 Identities = 57/214 (26%), Positives = 87/214 (40%), Gaps = 28/214 (13%)

Query: 72  SLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT 128
           S+Q  N    +     LG G F EV+   Q   G   A+K + ++     +     E+  
Sbjct: 1   SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAV 59

Query: 129 IGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL-DGYLFGKKRAIEWEKLHE-----IA 182
           + +  H N+V L           LV + +  G L D       R +E     E     + 
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFD-------RILERGVYTEKDASLVI 112

Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVTIS 239
                 + YLHE     I+H D+KPEN+L    + N    + DFGL+K+           
Sbjct: 113 QQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC- 168

Query: 240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
              GTPGY APE L+   P +   D +S G++ +
Sbjct: 169 ---GTPGYVAPEVLAQK-PYSKAVDCWSIGVITY 198

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  105 bits (265), Expect = 6e-26
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 25/211 (11%)

Query: 77  NFTSNYSTR---LGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGR 131
           NF + Y      LG G F  V +      G + A K L  R  G+    + + E+  +  
Sbjct: 25  NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84

Query: 132 TYHI-NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE-IAIGTAK-- 187
                 ++ L+    +     L+ EY   G +    F        E + E   I   K  
Sbjct: 85  AKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQI 140

Query: 188 --GLVYLHEECQQRIIHYDIKPENVLLDANFSP---KVADFGLAKLCDRNKTHVTISGYK 242
             G+ YLH+     I+H D+KP+N+LL + +     K+ DFG+++          I    
Sbjct: 141 LEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--- 194

Query: 243 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
           GTP Y APE L+ + PIT   D+++ G++ +
Sbjct: 195 GTPEYLAPEILNYD-PITTATDMWNIGIIAY 224

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (266), Expect = 9e-26
 Identities = 55/362 (15%), Positives = 102/362 (28%), Gaps = 66/362 (18%)

Query: 87  GFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRLYG 142
           GF     V   ++ P G  + V+ +N  L   + E       E+       H N+V    
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRIN--LEACSNEMVTFLQGELHVSKLFNHPNIVPYRA 93

Query: 143 -FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG-----TAKGLVYLHEEC 196
            F  D  +  +V  +M  GS    +         + ++E+AI        K L Y+H   
Sbjct: 94  TFIADNEL-WVVTSFMAYGSAKDLI----CTHFMDGMNELAIAYILQGVLKALDYIH--- 145

Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFG-LAKLCD----RNKTHVTISGYKGTPGYSAPE 251
               +H  +K  ++L+  +    ++       +      +   H           + +PE
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205

Query: 252 FLSGN-YPITHKCDVYSFG------------------M-VLFEIVGRRRNAIVGATESLD 291
            L  N      K D+YS G                    +L E +      ++  +    
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPA 265

Query: 292 WFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALW----------CVQDSPEDR 341
                           +  L           +        +          C+Q +P+ R
Sbjct: 266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDAR 325

Query: 342 PPMS----------AVIKMLEGVVEVLPPPKPFRYLDLIKMTRLKSL-ESSDGLNSSNQS 390
           P  S             +  E + E+L P  P    +  +      +      L      
Sbjct: 326 PSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNLEELEVD 385

Query: 391 RW 392
            W
Sbjct: 386 DW 387

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  105 bits (263), Expect = 1e-25
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 30/214 (14%)

Query: 77  NFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-----EQFMAEVGT 128
                Y     LG G F  V K  +   G++ A K + +   R +      E+   EV  
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68

Query: 129 IGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI-AIGTAK 187
           + +  H N++ L+    ++    L+ E +  G     LF      + E L E  A    K
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGE----LF--DFLAQKESLSEEEATSFIK 122

Query: 188 ----GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNKTHVTIS 239
               G+ YLH    ++I H+D+KPEN++L     P    K+ DFGLA   +       I 
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179

Query: 240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
              GTP + APE ++   P+  + D++S G++ +
Sbjct: 180 ---GTPEFVAPEIVNYE-PLGLEADMWSIGVITY 209

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  105 bits (265), Expect = 1e-25
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 30/220 (13%)

Query: 71  TSLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLNR-----NLGRIAEEQF 122
            + +       Y     LG G F  V K  +   G++ A K + +     +   +  E+ 
Sbjct: 3   ETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEI 62

Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI- 181
             EV  + +  H N++ L+    ++    L+ E +  G     LF      + E L E  
Sbjct: 63  EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGE----LF--DFLAQKESLSEEE 116

Query: 182 AIGTAK----GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNK 233
           A    K    G+ YLH    ++I H+D+KPEN++L     P    K+ DFGLA   +   
Sbjct: 117 ATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173

Query: 234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
               I    GTP + APE ++   P+  + D++S G++ +
Sbjct: 174 EFKNIF---GTPEFVAPEIVNYE-PLGLEADMWSIGVITY 209

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  104 bits (262), Expect = 1e-25
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG- 142
            +G G    V      P   K+A+K +N    + + ++ + E+  + + +H N+V  Y  
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 143 FCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIG-----TAKGLVYLHEE 195
           F     +  LV + +  GS+   +     K   +   L E  I        +GL YLH+ 
Sbjct: 82  FVVKDEL-WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK- 139

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGL-AKLCD-----RNKTHVTISGYKGTPGYSA 249
                IH D+K  N+LL  + S ++ADFG+ A L       RNK   T     GTP + A
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV---GTPCWMA 194

Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEI 275
           PE +        K D++SFG+   E+
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIEL 220

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  103 bits (260), Expect = 2e-25
 Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 32/215 (14%)

Query: 77  NFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKV-----LNRNLGRIAEEQFMAEVGT 128
               +Y     LG G F  V K  Q   G + A K      L+ +   ++ E+   EV  
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 129 IGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL-DGYLFGKKRAIEWEKLHEI-AIGTA 186
           +    H N++ L+    ++    L+ E +  G L D          E E L E  A    
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFD-------FLAEKESLTEDEATQFL 114

Query: 187 K----GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNKTHVTI 238
           K    G+ YLH    +RI H+D+KPEN++L     P    K+ DFG+A   +       I
Sbjct: 115 KQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171

Query: 239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
               GTP + APE ++   P+  + D++S G++ +
Sbjct: 172 F---GTPEFVAPEIVNYE-PLGLEADMWSIGVITY 202

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  103 bits (259), Expect = 2e-25
 Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 20/199 (10%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMA----EVGTIGRTYHINLVRL 140
           LG G FG+V  G+    G K+AVK+LNR   +I     +     E+  +    H ++++L
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQ--KIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQ 197
           Y          +V EY+  G L  Y+    R  E E      +I         Y H   +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCH---R 129

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY 257
             ++H D+KPENVLLDA+ + K+ADFGL+ +    +   T     G+P Y+APE +SG  
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRL 186

Query: 258 PITHKCDVYSFGMVLFEIV 276
               + D++S G++L+ ++
Sbjct: 187 YAGPEVDIWSCGVILYALL 205

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  104 bits (261), Expect = 2e-25
 Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 31/217 (14%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYGF 143
           L  GGF  VY+ Q   +G + A+K L  N         + EV  + + + H N+V+    
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 144 CH--DQHMTALVYEY---ME--NGSLDGYLFGKKRAIEWEKLHE-----IAIGTAKGLVY 191
                +       E+    E   G L  +L   K+      L       I   T + + +
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFL---KKMESRGPLSCDTVLKIFYQTCRAVQH 151

Query: 192 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYK--------- 242
           +H   +  IIH D+K EN+LL    + K+ DFG A        +   +  +         
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 243 -GTPGYSAPEF--LSGNYPITHKCDVYSFGMVLFEIV 276
             TP Y  PE   L  N+PI  K D+++ G +L+ + 
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  104 bits (260), Expect = 3e-25
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 28/206 (13%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMA---------EVGTIGRTYHI 135
           LG G FG V+         ++ VK + +   ++ E+ ++          E+  + R  H 
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKE--KVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 136 NLVRLYGFCHDQHMTALVYEYMENGS-LDGYLFGKKRAIEWE---KLHEIAIGTAKGLVY 191
           N++++     +Q    LV E   +G  L  ++    R  E        ++         Y
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG----Y 145

Query: 192 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNKTHVTISGYKGTPGYSAP 250
           L     + IIH DIK EN+++  +F+ K+ DFG  A L      +       GT  Y AP
Sbjct: 146 LR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC----GTIEYCAP 198

Query: 251 EFLSGNYPITHKCDVYSFGMVLFEIV 276
           E L GN     + +++S G+ L+ +V
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLV 224

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  103 bits (260), Expect = 4e-25
 Identities = 58/228 (25%), Positives = 94/228 (41%), Gaps = 30/228 (13%)

Query: 59  LQEIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLG 115
           +Q +G    V+        FT  Y  +  +G G +    +       ++ AVK+++++  
Sbjct: 1   MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60

Query: 116 RIAEE-QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 174
              EE + +   G      H N++ L     D     +V E M+ G L   +  +K   E
Sbjct: 61  DPTEEIEILLRYGQ-----HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE 115

Query: 175 WE---KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSP-KVADFGLAK 227
            E    L  I     K + YLH    Q ++H D+KP N+L      N    ++ DFG AK
Sbjct: 116 REASAVLFTIT----KTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

Query: 228 LCDR-NKTHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLF 273
                N   +T      T  + APE L    Y     CD++S G++L+
Sbjct: 169 QLRAENGLLMTPC---YTANFVAPEVLERQGY--DAACDIWSLGVLLY 211

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  102 bits (257), Expect = 5e-25
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 21/198 (10%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG- 142
           ++G G FGEV+KG        +A+K+++        E    E+  + +     + + YG 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI---GTAKGLVYLHEECQQR 199
           +  D  +  ++ EY+  GS    L  +   ++ E   +IA       KGL YLH    ++
Sbjct: 89  YLKDTKL-WIIMEYLGGGSALDLL--EPGPLD-ET--QIATILREILKGLDYLHS---EK 139

Query: 200 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNKTHVTISGYKGTPGYSAPEFLS-GNY 257
            IH DIK  NVLL  +   K+ADFG+  +L D      T   + GTP + APE +    Y
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPEVIKQSAY 196

Query: 258 PITHKCDVYSFGMVLFEI 275
               K D++S G+   E+
Sbjct: 197 --DSKADIWSLGITAIEL 212

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  103 bits (258), Expect = 5e-25
 Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 28/217 (12%)

Query: 77  NFTSNYSTR---LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR- 131
            F   Y  +   LG G    V          + AVK++ +  G     +   EV  + + 
Sbjct: 9   RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFREVEMLYQC 67

Query: 132 TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKG 188
             H N++ L  F  ++    LV+E M  GS+  ++  ++   E E    + ++    A  
Sbjct: 68  QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDV----ASA 123

Query: 189 LVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVTISGYK--- 242
           L +LH    + I H D+KPEN+L    +     K+ DF L      N     IS  +   
Sbjct: 124 LDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180

Query: 243 --GTPGYSAPEFLSGNYPITH----KCDVYSFGMVLF 273
             G+  Y APE +            +CD++S G++L+
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  103 bits (258), Expect = 5e-25
 Identities = 58/221 (26%), Positives = 88/221 (39%), Gaps = 41/221 (18%)

Query: 77  NFTSNYST--RLGFGGFGEVYKG-QFPNGVKIAVKVLNRN-------LGRIAEEQFMAEV 126
                Y     LG G  GEV    +     K+A+K++++                   E+
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66

Query: 127 GTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL-DGYLFGKKRAIEWEKLHEIAIGT 185
             + +  H  ++++  F   +    +V E ME G L D       + +  ++L E    T
Sbjct: 67  EILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFD-------KVVGNKRLKE---AT 115

Query: 186 AKGLV--------YLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNKT 234
            K           YLHE     IIH D+KPENVLL   + +   K+ DFG +K+      
Sbjct: 116 CKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172

Query: 235 HVTISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLF 273
             T+    GTP Y APE L            D +S G++LF
Sbjct: 173 MRTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  102 bits (257), Expect = 5e-25
 Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 22/204 (10%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN-LGRIA--EEQFMAEVGTIGRTYHINLVRLY 141
           LG G +G+V +        + AVK+L +  L RI   E     E+  + R  H N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 142 GFCHDQHMTA--LVYEYMENGSLDGYLFG---KKRAIEWE---KLHEIAIGTAKGLVYLH 193
              +++      +V EY   G  +  +     +KR    +      ++  G      YLH
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126

Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
               Q I+H DIKP N+LL    + K++  G+A+         T    +G+P +  PE  
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183

Query: 254 SGNYPIT-HKCDVYSFGMVLFEIV 276
           +G    +  K D++S G+ L+ I 
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNIT 207

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (258), Expect = 7e-25
 Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 30/220 (13%)

Query: 71  TSLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKV-----LNRNLGRIAEEQF 122
           T  +  N    Y T   LG G F  V K  +   G++ A K         +   ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61

Query: 123 MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI- 181
             EV  +    H N++ L+    ++    L+ E +  G L    F      E E L E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL----F--DFLAEKESLTEEE 115

Query: 182 AIGTAK----GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNK 233
           A    K    G+ YLH     +I H+D+KPEN++L     P    K+ DFGLA   D   
Sbjct: 116 ATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

Query: 234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
               I    GTP + APE ++   P+  + D++S G++ +
Sbjct: 173 EFKNIF---GTPEFVAPEIVNYE-PLGLEADMWSIGVITY 208

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  103 bits (259), Expect = 7e-25
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 27/208 (12%)

Query: 77  NFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 133
             +  +     LG G    VY+ +        A+KVL +    + ++    E+G + R  
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK---TVDKKIVRTEIGVLLRLS 106

Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE-----IAIGTAKG 188
           H N+++L          +LV E +  G L    F   R +E     E           + 
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGEL----F--DRIVEKGYYSERDAADAVKQILEA 160

Query: 189 LVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
           + YLHE     I+H D+KPEN+L      +   K+ADFGL+K+ +      T+    GTP
Sbjct: 161 VAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTP 214

Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLF 273
           GY APE L G      + D++S G++ +
Sbjct: 215 GYCAPEILRGC-AYGPEVDMWSVGIITY 241

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  104 bits (262), Expect = 8e-25
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 24/215 (11%)

Query: 71  TSLQLNNFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLN-RNLGRIAEEQFMAEV 126
            ++    FT  Y     LG G F  V +      G + A  ++N + L     ++   E 
Sbjct: 2   ATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREA 61

Query: 127 GTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE-----I 181
                  H N+VRL+    ++    L+++ +  G L    F  +  +  E   E      
Sbjct: 62  RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----F--EDIVAREYYSEADASHC 115

Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVTI 238
                + +++ H+     ++H ++KPEN+LL       + K+ADFGLA   +  +     
Sbjct: 116 IQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AW 170

Query: 239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
            G+ GTPGY +PE L  + P     D+++ G++L+
Sbjct: 171 FGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILY 204

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  105 bits (263), Expect = 8e-25
 Identities = 56/259 (21%), Positives = 106/259 (40%), Gaps = 25/259 (9%)

Query: 26  RTETETRNAASANKPEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYST- 84
             +   R        +  +V          + ++ +I ++   +   ++ ++   +Y   
Sbjct: 103 PGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIH 162

Query: 85  -RLGFGGFGEVYKGQF-PNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
             LG G FG V++      G   A K +   +      E    E+ T+    H  LV L+
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLRHPTLVNLH 220

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI-AIGTAK----GLVYLHEEC 196
               D +   ++YE+M  G L   +  +       K+ E  A+   +    GL ++HE  
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHE-- 273

Query: 197 QQRIIHYDIKPENVLLDANFSP--KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS 254
               +H D+KPEN++     S   K+ DFGL    D  ++    +   GT  ++APE   
Sbjct: 274 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE 329

Query: 255 GNYPITHKCDVYSFGMVLF 273
           G  P+ +  D++S G++ +
Sbjct: 330 GK-PVGYYTDMWSVGVLSY 347

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  101 bits (254), Expect = 1e-24
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 31/205 (15%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG- 142
            LG G FG+VYK +    G   A KV+         E ++ E+  +    H  +V+L G 
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYIVEIEILATCDHPYIVKLLGA 84

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI---GTAKGLVYLHEECQQR 199
           + HD  +  ++ E+   G++D  +    R +  E   +I +      + L +LH    +R
Sbjct: 85  YYHDGKLW-IMIEFCPGGAVDAIMLELDRGLT-EP--QIQVVCRQMLEALNFLH---SKR 137

Query: 200 IIHYDIKPENVLLDANFSPKVADFGL-AKLCD---RNKTHVTISGYKGTPGYSAPE---- 251
           IIH D+K  NVL+      ++ADFG+ AK      +  + +      GTP + APE    
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMC 191

Query: 252 --FLSGNYPITHKCDVYSFGMVLFE 274
                  Y   +K D++S G+ L E
Sbjct: 192 ETMKDTPY--DYKADIWSLGITLIE 214

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  101 bits (255), Expect = 2e-24
 Identities = 37/208 (17%), Positives = 80/208 (38%), Gaps = 26/208 (12%)

Query: 77  NFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 133
                Y     LG G FG V++  +  +      K +        +     E+  +    
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIAR 59

Query: 134 HINLVRLYGFCHDQHMTALVYEYMENGSL------DGYLFGKKRAIEWEKLHEIAIGTAK 187
           H N++ L+          +++E++    +        +   ++  + +  +H++     +
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY--VHQVC----E 113

Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSP--KVADFGLAKLCDRNKTHVTISGYKGTP 245
            L +LH      I H+DI+PEN++     S   K+ +FG A+          +      P
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAP 167

Query: 246 GYSAPEFLSGNYPITHKCDVYSFGMVLF 273
            Y APE    +  ++   D++S G +++
Sbjct: 168 EYYAPEVHQHD-VVSTATDMWSLGTLVY 194

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  104 bits (261), Expect = 2e-24
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 27/243 (11%)

Query: 48  IWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-A 106
           +++     ++F +    +       L +N+F  +    +G GGFGEVY  +  +  K+ A
Sbjct: 161 VFQKFIESDKFTRFCQWKNVELNIHLTMNDF--SVHRIIGRGGFGEVYGCRKADTGKMYA 218

Query: 107 VKVLN--RNLGRIAEEQFMAE---VGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGS 161
           +K L+  R   +  E   + E   +  +       +V +    H     + + + M  G 
Sbjct: 219 MKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD 278

Query: 162 LDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF 216
           L  +L     F +     +    EI +G    L ++H    + +++ D+KP N+LLD + 
Sbjct: 279 LHYHLSQHGVFSEADMRFY--AAEIILG----LEHMH---NRFVVYRDLKPANILLDEHG 329

Query: 217 SPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE-I 275
             +++D GLA    + K H       GT GY APE L          D +S G +LF+ +
Sbjct: 330 HVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

Query: 276 VGR 278
            G 
Sbjct: 386 RGH 388

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  103 bits (258), Expect = 2e-24
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 20/199 (10%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMA----EVGTIGRTYHINLVRL 140
           LG G FG+V  G+    G K+AVK+LNR   +I     +     E+  +    H ++++L
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQ--KIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQ 197
           Y          +V EY+  G L  Y+    R  E E      +I  G      Y H   +
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCH---R 134

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY 257
             ++H D+KPENVLLDA+ + K+ADFGL+ +    +   T     G+P Y+APE +SG  
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRL 191

Query: 258 PITHKCDVYSFGMVLFEIV 276
               + D++S G++L+ ++
Sbjct: 192 YAGPEVDIWSSGVILYALL 210

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  101 bits (254), Expect = 3e-24
 Identities = 54/214 (25%), Positives = 85/214 (39%), Gaps = 27/214 (12%)

Query: 77  NFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN----RNLGRIAEEQFMAEVGTI 129
            F   Y     +G G F  V +      G + AVK+++     +   ++ E    E    
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80

Query: 130 GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEW--EK-----LHEIA 182
               H ++V L        M  +V+E+M+   L   +  +  A     E      + +I 
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140

Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSP-KVADFGLAKLCDRNKTHVTIS 239
               + L Y H+     IIH D+KP  VLL    N +P K+  FG+A     +       
Sbjct: 141 ----EALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAG 191

Query: 240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
           G  GTP + APE +    P     DV+  G++LF
Sbjct: 192 GRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILF 224

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  101 bits (252), Expect = 3e-24
 Identities = 44/208 (21%), Positives = 83/208 (39%), Gaps = 34/208 (16%)

Query: 155 EYMENGSLDGYLFGKKRA--IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL 212
           +     +L  ++  +      E      I I  A+ + +LH    + ++H D+KP N+  
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFF 197

Query: 213 DANFSPKVADFGLAKLCDRNKTHVTIS----------GYKGTPGYSAPEFLSGNYPITHK 262
             +   KV DFGL    D+++   T+           G  GT  Y +PE + GN   +HK
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN-NYSHK 256

Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            D++S G++LFE+                 +      + E+  +   +          +K
Sbjct: 257 VDIFSLGLILFEL----------------LYSFS--TQMERVRIITDVRNLKFPLLFTQK 298

Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKM 350
             +  M+    +  SP +RP  + +I+ 
Sbjct: 299 YPQEHMMVQDMLSPSPTERPEATDIIEN 326

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  101 bits (253), Expect = 3e-24
 Identities = 59/203 (29%), Positives = 88/203 (43%), Gaps = 29/203 (14%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTIGRTYHINLVRLY 141
            +G G FG VY  +   N   +A+K ++ +  +  E+    + EV  + +  H N ++  
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120

Query: 142 G-FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI---GTAKGLVYLHEECQ 197
           G +  +     LV EY    + D     KK   E     EIA    G  +GL YLH    
Sbjct: 121 GCYLREHTA-WLVMEYCLGSASDLLEVHKKPLQE----VEIAAVTHGALQGLAYLHS--- 172

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNKTHVTISGYKGTPGYSAPE----F 252
             +IH D+K  N+LL      K+ DFG  + +   N + V      GTP + APE     
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-SFV------GTPYWMAPEVILAM 225

Query: 253 LSGNYPITHKCDVYSFGMVLFEI 275
             G Y    K DV+S G+   E+
Sbjct: 226 DEGQY--DGKVDVWSLGITCIEL 246

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 98.6 bits (246), Expect = 3e-23
 Identities = 50/200 (25%), Positives = 97/200 (48%), Gaps = 24/200 (12%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG- 142
           ++G G  G V   +   +G ++AVK+++    +   E    EV  +    H N+V +Y  
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQHFNVVEMYKS 110

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG-----TAKGLVYLHEECQ 197
           +   + +  ++ E+++ G+L          +   +L+E  I        + L YLH    
Sbjct: 111 YLVGEELW-VLMEFLQGGALTD-------IVSQVRLNEEQIATVCEAVLQALAYLH---A 159

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
           Q +IH DIK +++LL  +   K++DFG  A++        ++    GTP + APE +S +
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV---GTPYWMAPEVISRS 216

Query: 257 YPITHKCDVYSFGMVLFEIV 276
                + D++S G+++ E+V
Sbjct: 217 -LYATEVDIWSLGIMVIEMV 235

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 97.8 bits (244), Expect = 3e-23
 Identities = 47/195 (24%), Positives = 92/195 (47%), Gaps = 14/195 (7%)

Query: 85  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG- 142
           ++G G  G VY       G ++A++ +N    +  +E  + E+  +    + N+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           +     +  +V EY+  GSL   +   +  ++  ++  +     + L +LH     ++IH
Sbjct: 86  YLVGDELW-VVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIH 139

Query: 203 YDIKPENVLLDANFSPKVADFGL-AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
            DIK +N+LL  + S K+ DFG  A++        T+    GTP + APE ++       
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRK-AYGP 195

Query: 262 KCDVYSFGMVLFEIV 276
           K D++S G++  E++
Sbjct: 196 KVDIWSLGIMAIEMI 210

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 23/200 (11%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMA----EVGTIGRTYHINLVRL 140
           LG G FG+V     +    K+A+K ++R    + +         E+  +    H ++++L
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQ--LLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQ 197
           Y          +V EY   G L  Y+  KKR  E E      +I         Y H   +
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH---R 126

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKL-CDRNKTHVTISGYKGTPGYSAPEFLSGN 256
            +I+H D+KPEN+LLD N + K+ADFGL+ +  D N    +     G+P Y+APE ++G 
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVINGK 182

Query: 257 YPITHKCDVYSFGMVLFEIV 276
                + DV+S G+VL+ ++
Sbjct: 183 LYAGPEVDVWSCGIVLYVML 202

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 97.4 bits (243), Expect = 6e-23
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 24/199 (12%)

Query: 84  TRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
            +LG G +G VYK      G  +A+K +         ++ + E+  + +    ++V+ YG
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYG 91

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI---GTAKGLVYLHEECQQR 199
                    +V EY   GS+   +  + + +  E   EIA     T KGL YLH     R
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT-ED--EIATILQSTLKGLEYLH---FMR 145

Query: 200 IIHYDIKPENVLLDANFSPKVADFGL-AKLCD---RNKTHVTISGYKGTPGYSAPEFLSG 255
            IH DIK  N+LL+     K+ADFG+  +L D   +  T +      GTP + APE +  
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------GTPFWMAPEVIQE 199

Query: 256 NYPITHKCDVYSFGMVLFE 274
                   D++S G+   E
Sbjct: 200 I-GYNCVADIWSLGITAIE 217

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 52/217 (23%), Positives = 85/217 (39%), Gaps = 39/217 (17%)

Query: 76  NNFTSNY---STRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR 131
              T +Y      LG G  G+V +      G K A+K+L  +     E     +      
Sbjct: 24  YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASG--- 80

Query: 132 TYHINLVRLYGFCHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEK-----LHEIA 182
               ++V +     + H       ++ E ME G L   +  +      E+     + +I 
Sbjct: 81  --GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138

Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRN--KTHVT 237
                 + +LH      I H D+KPEN+L    + +   K+ DFG AK   +N  +T   
Sbjct: 139 ----TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC- 190

Query: 238 ISGYKGTPGYSAPEFLSG-NYPITHKCDVYSFGMVLF 273
                 TP Y APE L    Y     CD++S G++++
Sbjct: 191 -----YTPYYVAPEVLGPEKY--DKSCDMWSLGVIMY 220

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 29/215 (13%)

Query: 73  LQLNNFTSNYSTR-----LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEV 126
           ++ + F  +Y        LG G F    K     +    AVK++++      E     E+
Sbjct: 1   MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEI 56

Query: 127 GTIGR-TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIA 182
             +     H N+V+L+   HDQ  T LV E +  G L   +  KK   E E    + ++ 
Sbjct: 57  TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL- 115

Query: 183 IGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAK-LCDRNKTHVTI 238
                 + ++H+     ++H D+KPEN+L    + N   K+ DFG A+     N+   T 
Sbjct: 116 ---VSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169

Query: 239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
                T  Y+APE L+ N      CD++S G++L+
Sbjct: 170 C---FTLHYAAPELLNQN-GYDESCDLWSLGVILY 200

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 95.0 bits (237), Expect = 3e-22
 Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 43/221 (19%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN---------------LGRIAEEQFMAEVGTI 129
           +G G +G V       +    A+KVL++                  R A    +   G I
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 130 GRTY----------HINLVRLYGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWE- 176
            + Y          H N+V+L     D +   L  V+E +  G +       K   E + 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQA 139

Query: 177 --KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT 234
                ++     KG+ YLH    Q+IIH DIKP N+L+  +   K+ADFG++     +  
Sbjct: 140 RFYFQDLI----KGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192

Query: 235 HVTISGYKGTPGYSAPEFLSGNYPITH--KCDVYSFGMVLF 273
            ++ +   GTP + APE LS    I      DV++ G+ L+
Sbjct: 193 LLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 95.1 bits (237), Expect = 4e-22
 Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 44/216 (20%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGR----IAEEQFMAEVGTIGRTYHINLVR 139
            +G G +G+VYKG+    G   A+KV++           E   + +        H N+  
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH-----HRNIAT 85

Query: 140 LYG-FCHDQHMTA-----LVYEYMENGSL-DGYLFGKKRAIEWEKLHEIAI---GTAKGL 189
            YG F             LV E+   GS+ D     K   ++ E+   IA       +GL
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK-EE--WIAYICREILRGL 142

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL-AKLCD---RNKTHVTISGYKGTP 245
            +LH+    ++IH DIK +NVLL  N   K+ DFG+ A+L     R  T +      GTP
Sbjct: 143 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTP 193

Query: 246 GYSAPE------FLSGNYPITHKCDVYSFGMVLFEI 275
            + APE           Y    K D++S G+   E+
Sbjct: 194 YWMAPEVIACDENPDATY--DFKSDLWSLGITAIEM 227

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 95.1 bits (237), Expect = 9e-22
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 25/206 (12%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRL-Y 141
           +G G FG+V   Q  +  K+ A+K +N+   + R        E+  +    H  LV L Y
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82

Query: 142 GFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
            F  ++ M  +V + +  G L  +L     F ++    +  + E+ +     L YL    
Sbjct: 83  SFQDEEDMF-MVVDLLLGGDLRYHLQQNVHFKEETVKLF--ICELVMA----LDYLQN-- 133

Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
            QRIIH D+KP+N+LLD +    + DF +A +  R     T++   GT  Y APE  S  
Sbjct: 134 -QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMFSSR 189

Query: 257 YPITHKCDV--YSFGMVLFE-IVGRR 279
               +   V  +S G+  +E + GRR
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRR 215

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 93.8 bits (234), Expect = 9e-22
 Identities = 50/199 (25%), Positives = 82/199 (41%), Gaps = 22/199 (11%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G F  V   +     +  A+K+L +   +          E   + R  H   V+LY 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 143 FCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLH--EIAIGTAKGLVYLHEE 195
              D         Y +NG L  Y+     F +       + +  EI       L YLH  
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT----RFYTAEIVSA----LEYLHG- 148

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
             + IIH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+ 
Sbjct: 149 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206

Query: 256 NYPITHKCDVYSFGMVLFE 274
                   D+++ G ++++
Sbjct: 207 K-SACKSSDLWALGCIIYQ 224

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 95.2 bits (237), Expect = 2e-21
 Identities = 72/242 (29%), Positives = 101/242 (41%), Gaps = 32/242 (13%)

Query: 49  WEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AV 107
           +       RFLQ     K +    +  N F       LG GGFGEV   Q     K+ A 
Sbjct: 161 YLDSIYFNRFLQW----KWLERQPVTKNTF--RQYRVLGKGGFGEVCACQVRATGKMYAC 214

Query: 108 KVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRL-YGFCHDQHMTALVYEYMENGSL-- 162
           K L   R   R  E   + E   + +     +V L Y +     +  LV   M  G L  
Sbjct: 215 KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL-CLVLTLMNGGDLKF 273

Query: 163 -----DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS 217
                    F + RA+ +    EI  G    L  LH    +RI++ D+KPEN+LLD +  
Sbjct: 274 HIYHMGQAGFPEARAVFY--AAEICCG----LEDLHR---ERIVYRDLKPENILLDDHGH 324

Query: 218 PKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE-IV 276
            +++D GLA      +   TI G  GT GY APE +      T   D ++ G +L+E I 
Sbjct: 325 IRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIA 380

Query: 277 GR 278
           G+
Sbjct: 381 GQ 382

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 94.5 bits (235), Expect = 4e-21
 Identities = 76/246 (30%), Positives = 108/246 (43%), Gaps = 37/246 (15%)

Query: 49  WEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AV 107
           +       RFLQ     K +    +  + F       LG GGFGEV+  Q     K+ A 
Sbjct: 162 FLDSLYFLRFLQW----KWLEAQPMGEDWF--LDFRVLGRGGFGEVFACQMKATGKLYAC 215

Query: 108 KVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRL-YGFCHDQHMTAL--VYEYMENGSL 162
           K LN  R   R   +  M E   + + +   +V L Y F   +  T L  V   M  G +
Sbjct: 216 KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF---ETKTDLCLVMTIMNGGDI 272

Query: 163 ---------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD 213
                    D   F + RAI +    +I  G    L +LH+   + II+ D+KPENVLLD
Sbjct: 273 RYHIYNVDEDNPGFQEPRAIFY--TAQIVSG----LEHLHQ---RNIIYRDLKPENVLLD 323

Query: 214 ANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
            + + +++D GLA      +T     GY GTPG+ APE L G        D ++ G+ L+
Sbjct: 324 DDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLY 380

Query: 274 E-IVGR 278
           E I  R
Sbjct: 381 EMIAAR 386

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 54/233 (23%), Positives = 88/233 (37%), Gaps = 38/233 (16%)

Query: 60  QEIGREKPVRFTSLQLNNFTSNYSTR---LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG 115
           Q+  +        ++ N    +Y      LG G  G+V +        K A+K+L     
Sbjct: 41  QQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK 100

Query: 116 RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA----LVYEYMENGSL-------DG 164
              E +              ++VR+     + +       +V E ++ G L         
Sbjct: 101 ARREVELHWRASQ-----CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD 155

Query: 165 YLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVA 221
             F ++ A E   +  I     + + YLH      I H D+KPEN+L      N   K+ 
Sbjct: 156 QAFTEREASEI--MKSIG----EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 206

Query: 222 DFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS-GNYPITHKCDVYSFGMVLF 273
           DFG AK    + +  T      TP Y APE L    Y     CD++S G++++
Sbjct: 207 DFGFAKETTSHNSLTTPC---YTPYYVAPEVLGPEKY--DKSCDMWSLGVIMY 254

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 87.1 bits (216), Expect = 1e-19
 Identities = 34/287 (11%), Positives = 73/287 (25%), Gaps = 60/287 (20%)

Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 141
             G     + ++        ++A+  ++       +     ++    + R     + R+ 
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
              H +    +V E++  GSL            AI            A      H   + 
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR------AMQSLAAAADAAH---RA 148

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
            +      P  V         V+  G   L                P             
Sbjct: 149 GVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA------- 179

Query: 259 ITHKCDVYSFGMVLFEIV-GRRRNAIVGATESLDWFPKHVWEEYEK-CELGAMILGCGIE 316
              + D+   G  L+ ++  R      G    L    +    +  +  ++   I      
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI------ 232

Query: 317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKP 363
                   ++  VA   VQ     R   S ++ +++    V    + 
Sbjct: 233 ------PFQISAVAARSVQGDGGIRSA-STLLNLMQQATAVADRTEV 272

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 19/200 (9%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           +G G FGEV   +  N  K+ A+K+LN+   L R     F  E   +       +  L+ 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAI--EWEK--LHEIAIGTAKGLVYLHEECQQ 198
              D +   LV +Y   G L   L   +  +  E  +  L E+ I     +  +H   Q 
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA----IDSVH---QL 194

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
             +H DIKP+N+L+D N   ++ADFG       + T  +     GTP Y +PE L     
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAMEG 253

Query: 259 ITHK----CDVYSFGMVLFE 274
              +    CD +S G+ ++E
Sbjct: 254 GKGRYGPECDWWSLGVCMYE 273

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           +G G FGEV   +  +  K+ A+K+L++   + R     F  E   +       +V+L+ 
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK--LHEIAIGTAKGLVYLHEECQQRI 200
              D     +V EYM  G L   +       +W +    E+ +     L  +H       
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA----LDAIH---SMGF 189

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS---GNY 257
           IH D+KP+N+LLD +   K+ADFG     ++       +   GTP Y +PE L    G+ 
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDG 248

Query: 258 PITHKCDVYSFGMVLFE 274
               +CD +S G+ L+E
Sbjct: 249 YYGRECDWWSVGVFLYE 265

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 86.3 bits (214), Expect = 9e-19
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 23/203 (11%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRL-Y 141
           +G G F EV   +     ++ A+K++N+   L R     F  E   +       + +L +
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128

Query: 142 GFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEK--LHEIAIGTAKGLVYLHEECQ 197
            F  D++   LV EY   G L   L  FG++   E  +  L EI +     +  +H   +
Sbjct: 129 AF-QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA----IDSVH---R 180

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL---- 253
              +H DIKP+N+LLD     ++ADFG       + T  ++    GTP Y +PE L    
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPEILQAVG 239

Query: 254 --SGNYPITHKCDVYSFGMVLFE 274
              G      +CD ++ G+  +E
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYE 262

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 63/256 (24%), Positives = 108/256 (42%), Gaps = 41/256 (16%)

Query: 33  NAASANK--PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGG 90
           NAA+A K   +E V E + +A +   +  +   +         QL+ F  +    LG G 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNT------AQLDQF--DRIKTLGTGS 53

Query: 91  FGEVYKGQFPNGVKI-AVKVLNRNLGRIAE----EQFMAEVGTIGRTYHINLVRLYGFCH 145
           FG V   +        A+K+L++   ++ +    E  + E   +       LV+L     
Sbjct: 54  FGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111

Query: 146 DQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLH--EIAIGTAKGLVYLHEECQQ 198
           D     +V EY+  G +  +L     F +  A    + +  +I +       YLH     
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA----RFYAAQIVLT----FEYLHS---L 160

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
            +I+ D+KPEN+L+D     +V DFG AK     +T  T+    GTP   APE +     
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTW-TLC---GTPEALAPEIILSK-G 214

Query: 259 ITHKCDVYSFGMVLFE 274
                D ++ G++++E
Sbjct: 215 YNKAVDWWALGVLIYE 230

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 36/207 (17%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR--------TYHIN 136
           +G G FG+V K         +A+K++ RN  R    Q   E+  +          T ++ 
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHR-QAAEEIRILEHLRKQDKDNTMNV- 161

Query: 137 LVRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVYL 192
            + +   F    H+  + +E +   S++ Y   KK   +      + + A    + L  L
Sbjct: 162 -IHMLENFTFRNHI-CMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216

Query: 193 HEECQQRIIHYDIKPENVLLDANFSP--KVADFGLAKLCDRNKTHVTI--SGYKGTPGYS 248
           H   + RIIH D+KPEN+LL        KV DFG +  C  ++   T   S +     Y 
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQSRF-----YR 266

Query: 249 APEFLSGNYPITHKCDVYSFGMVLFEI 275
           APE + G        D++S G +L E+
Sbjct: 267 APEVILG-ARYGMPIDMWSLGCILAEL 292

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 81.8 bits (203), Expect = 1e-17
 Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 23/204 (11%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ----FMA--EVGTIGRTYHINLV 138
           ++G G +G VYK +   G  +A+K +     R+  E       A  E+  +   +H N+V
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRI-----RLDAEDEGIPSTAIREISLLKELHHPNIV 82

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            L    H +    LV+E+ME   L   L   K  ++  ++        +G+ + H   Q 
Sbjct: 83  SLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QH 138

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNKTHVTISGYKGTPGYSAPEFLSG 255
           RI+H D+KP+N+L++++ + K+ADFGLA+      R+ TH  +     T  Y AP+ L G
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-----TLWYRAPDVLMG 193

Query: 256 NYPITHKCDVYSFGMVLFEIVGRR 279
           +   +   D++S G +  E++  +
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK 217

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 40/217 (18%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTI-----------GRTY 133
           LG+G F  V+  +   N   +A+K++ R      E     E+  +               
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 84

Query: 134 HINLVRLYG-FCH----DQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGT 185
             ++++L   F H      H+  +V+E +     +     KK   R I    + +I+   
Sbjct: 85  ANHILKLLDHFNHKGPNGVHV-VMVFEVL---GENLLALIKKYEHRGIPLIYVKQISKQL 140

Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSP------KVADFGLAKLCDRNKTHVTIS 239
             GL Y+H  C   IIH DIKPENVL++   SP      K+AD G A  C  ++ +    
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTN-- 194

Query: 240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
               T  Y +PE L G  P     D++S   ++FE++
Sbjct: 195 -SIQTREYRSPEVLLG-APWGCGADIWSTACLIFELI 229

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 40/213 (18%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ------FMA--EVGTIGRTYHI 135
           ++G G +G V+K +    G  +A+K       +  E +       +A  E+  + +  H 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIK-------KFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 136 NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
           NLV L      +    LV+EY ++ ++   L   +R +    +  I   T + + + H  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-- 119

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNKTH--VTISGYKGTPGYSAP 250
            +   IH D+KPEN+L+  +   K+ DFG A+L             T         Y +P
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-------WYRSP 171

Query: 251 EFLSG--NY--PITHKCDVYSFGMVLFEIVGRR 279
           E L G   Y  P+    DV++ G V  E++   
Sbjct: 172 ELLVGDTQYGPPV----DVWAIGCVFAELLSGV 200

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 74/278 (26%), Positives = 115/278 (41%), Gaps = 58/278 (20%)

Query: 22  EKLNRTETETRNAASANKPEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSN 81
           + + +         S +K    V  V+   GQ  +R        + V +T  +       
Sbjct: 15  KPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDR-------PQEVSYTDTK------- 60

Query: 82  YSTRLGFGGFGEVYKGQF-PNGVKIAVK-VLN--RNLGRIAEEQFMAEVGTIGRTYHINL 137
               +G G FG VY+ +   +G  +A+K VL   R   R  E Q M ++       H N+
Sbjct: 61  ---VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--ELQIMRKLD------HCNI 109

Query: 138 VRLYGFCHDQHMTA------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG-----TA 186
           VRL  F +            LV +Y+       Y   +  +   + L  I +        
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVT--ISGYKG 243
           + L Y+H      I H DIKP+N+LLD + +  K+ DFG AK   R + +V+   S Y  
Sbjct: 167 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221

Query: 244 TPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRR 279
              Y APE + G  +Y  T   DV+S G VL E++  +
Sbjct: 222 ---YRAPELIFGATDY--TSSIDVWSAGCVLAELLLGQ 254

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 54/204 (26%), Positives = 83/204 (40%), Gaps = 30/204 (14%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR--------TYHIN 136
           +G G FG+V K         +A+K++ +N       Q   EV  +           Y+I 
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLN-QAQIEVRLLELMNKHDTEMKYYI- 118

Query: 137 LVRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVYL 192
            V L   F    H+  LV+E +   S + Y   +    R +      + A      L++L
Sbjct: 119 -VHLKRHFMFRNHL-CLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173

Query: 193 HEECQQRIIHYDIKPENVLLDANFSP--KVADFGLAKLCDRNKTHVTISGYKGTPGYSAP 250
               +  IIH D+KPEN+LL        K+ DFG +  C   +       Y  +  Y +P
Sbjct: 174 ATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQ---YIQSRFYRSP 227

Query: 251 EFLSGNYPITHKCDVYSFGMVLFE 274
           E L G  P     D++S G +L E
Sbjct: 228 EVLLG-MPYDLAIDMWSLGCILVE 250

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 80.2 bits (199), Expect = 4e-17
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 23/204 (11%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ----FMA--EVGTIGRTYHINLV 138
           ++G G +G VYK Q   G   A+K +     R+ +E          E+  +    H N+V
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           +LY   H +    LV+E+++   L   L   +  +E        +    G+ Y H    +
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DR 119

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNKTHVTISGYKGTPGYSAPEFLSG 255
           R++H D+KP+N+L++     K+ADFGLA+      R  TH  +     T  Y AP+ L G
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-----TLWYRAPDVLMG 174

Query: 256 NYPITHKCDVYSFGMVLFEIVGRR 279
           +   +   D++S G +  E+V   
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 79.1 bits (196), Expect = 8e-17
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 24/206 (11%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ----FMA--EVGTIGRTYHINL 137
           ++G G +G V+K +       +A+K +     R+ ++       A  E+  +    H N+
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
           VRL+   H      LV+E+ +   L  Y       ++ E +        KGL + H    
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---S 119

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNKTHVTISGYKGTPGYSAPEFLS 254
           + ++H D+KP+N+L++ N   K+A+FGLA+      R  +   +     T  Y  P+ L 
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-----TLWYRPPDVLF 174

Query: 255 GNYPITHKCDVYSFGMVLFEIVGRRR 280
           G    +   D++S G +  E+    R
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 63/238 (26%), Positives = 98/238 (41%), Gaps = 50/238 (21%)

Query: 61  EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVK-VLN--RNLGRI 117
           + G ++ + +T+ +           +G G FG V++ +     ++A+K VL   R   R 
Sbjct: 33  KTGEQREIAYTNCK----------VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR- 81

Query: 118 AEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA------LVYEYMENGSLDGYLFGKKR 171
            E Q M  V       H N+V L  F +            LV EY+       Y   +  
Sbjct: 82  -ELQIMRIVK------HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVYRASRHY 131

Query: 172 AIEWEKLHEIAIG-----TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP-KVADFGL 225
           A   + +  + I        + L Y+H      I H DIKP+N+LLD      K+ DFG 
Sbjct: 132 AKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188

Query: 226 AKLCDRNK--THVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRR 279
           AK+    +       S Y     Y APE + G  NY  T   D++S G V+ E++  +
Sbjct: 189 AKILIAGEPNVSYICSRY-----YRAPELIFGATNY--TTNIDIWSTGCVMAELMQGQ 239

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 79.1 bits (196), Expect = 1e-16
 Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 31/201 (15%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE----EQFMAEVGTIGRTYHINLVRL 140
           LG G FG V+  +  +  +  A+KVL +    +      E    E   +    H  ++R+
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKE--IVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLH--EIAIGTAKGLVYLH 193
           +G   D     ++ +Y+E G L   L     F    A    K +  E+ +     L YLH
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA----KFYAAEVCLA----LEYLH 123

Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
               + II+ D+KPEN+LLD N   K+ DFG AK    + T+ T+    GTP Y APE +
Sbjct: 124 S---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTY-TLC---GTPDYIAPEVV 175

Query: 254 SGNYPITHKCDVYSFGMVLFE 274
           S   P     D +SFG++++E
Sbjct: 176 STK-PYNKSIDWWSFGILIYE 195

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 57/237 (24%), Positives = 95/237 (40%), Gaps = 39/237 (16%)

Query: 60  QEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRI 117
            E  R++  RF   +            G G FG V  G+    G+ +A+K V+     R 
Sbjct: 15  DERSRKEMDRFQVER----------MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN 64

Query: 118 AEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA-------LVYEYMENGSLDGYLFGKK 170
            E Q M +   +   +H N+V+L  + +             +V EY+       +   + 
Sbjct: 65  RELQIMQD---LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRN 118

Query: 171 RAIEWEKLHEIAIG-----TAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVADFG 224
                     I I        + +  LH      + H DIKP NVL++ A+ + K+ DFG
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFG 177

Query: 225 LAKLCDRNKTHVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRR 279
            AK    ++ +V    Y  +  Y APE + G  +Y  T   D++S G +  E++   
Sbjct: 178 SAKKLSPSEPNV---AYICSRYYRAPELIFGNQHY--TTAVDIWSVGCIFAEMMLGE 229

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 40/213 (18%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQ------FMA--EVGTIGRTYHI 135
            +G G +G V K +    G  +A+K       +  E         +A  E+  + +  H 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIK-------KFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 136 NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
           NLV L   C  +    LV+E++++ ++   L      ++++ + +       G+ + H  
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH-- 141

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNKTH--VTISGYKGTPGYSAP 250
               IIH DIKPEN+L+  +   K+ DFG A+              T         Y AP
Sbjct: 142 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-------WYRAP 193

Query: 251 EFLSG--NY--PITHKCDVYSFGMVLFEIVGRR 279
           E L G   Y   +    DV++ G ++ E+    
Sbjct: 194 ELLVGDVKYGKAV----DVWAIGCLVTEMFMGE 222

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 27/206 (13%)

Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRI---AEEQF----MAEVGTIGRTYHIN 136
           +LG G +  VYKG+       +A+K        I    EE      + EV  +    H N
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALK-------EIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
           +V L+   H +    LV+EY++   L  YL      I    +        +GL Y H   
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--- 117

Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNKTHVTISGYKGTPGYSAPEFL 253
           +Q+++H D+KP+N+L++     K+ADFGLA+      +   +  +     T  Y  P+ L
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-----TLWYRPPDIL 172

Query: 254 SGNYPITHKCDVYSFGMVLFEIVGRR 279
            G+   + + D++  G + +E+   R
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 65/257 (25%), Positives = 101/257 (39%), Gaps = 27/257 (10%)

Query: 29  TETRNAASANKPEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGF 88
           T  +  A   K +            +     +E+          + +N F   Y   LG 
Sbjct: 101 TAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEF--EYLKLLGK 158

Query: 89  GGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRL-YGFC 144
           G FG+V   +     +  A+K+L +   + +      + E   +  + H  L  L Y F 
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218

Query: 145 HDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
               +   V EY   G L  +L     F + RA  +    EI       L YLH E  + 
Sbjct: 219 THDRL-CFVMEYANGGELFFHLSRERVFSEDRARFY--GAEIVSA----LDYLHSE--KN 269

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYSAPEFLSGNY 257
           +++ D+K EN++LD +   K+ DFGL K  + D      T     GTP Y APE L  N 
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-TFC---GTPEYLAPEVLEDN- 324

Query: 258 PITHKCDVYSFGMVLFE 274
                 D +  G+V++E
Sbjct: 325 DYGRAVDWWGLGVVMYE 341

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 77.6 bits (192), Expect = 5e-16
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 25/207 (12%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQF--MA--EVGTIGRTYHINLVR 139
            LG G F  VYK +       +A+K +       A++     A  E+  +    H N++ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
           L      +   +LV+++ME   L+  +      +    +    + T +GL YLH   Q  
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHW 132

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNKTH--VTISGYKGTPGYSAPEFLS 254
           I+H D+KP N+LLD N   K+ADFGLAK     +R  TH  VT         Y APE L 
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-------WYRAPELLF 185

Query: 255 G--NYPITHKCDVYSFGMVLFEIVGRR 279
           G   Y      D+++ G +L E++ R 
Sbjct: 186 GARMY--GVGVDMWAVGCILAELLLRV 210

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 76.9 bits (190), Expect = 7e-16
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 38/214 (17%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQF----MAEVGTIGRTYHINLVR 139
           +LG G +  VYKG     GV +A+K +  +    +EE      + E+  +    H N+VR
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLD----SEEGTPSTAIREISLMKELKHENIVR 67

Query: 140 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT-----AKGLVYLHE 194
           LY   H ++   LV+E+M+N  L  Y+  +        L    +        +GL + H 
Sbjct: 68  LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH- 125

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNKTH--VTISGYKGTPGYSA 249
             + +I+H D+KP+N+L++     K+ DFGLA+         +   VT+        Y A
Sbjct: 126 --ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL-------WYRA 176

Query: 250 PEFLSG--NY--PITHKCDVYSFGMVLFEIVGRR 279
           P+ L G   Y   I    D++S G +L E++  +
Sbjct: 177 PDVLMGSRTYSTSI----DIWSCGCILAEMITGK 206

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 77.3 bits (191), Expect = 7e-16
 Identities = 66/271 (24%), Positives = 108/271 (39%), Gaps = 45/271 (16%)

Query: 25  NRTETETRNAASANKPEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYST 84
           +  E  +   A+    +           +   R     G  + V      + NF      
Sbjct: 8   HEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVG-----IENF--ELLK 60

Query: 85  RLGFGGFGEVY---KGQFPNGVKI-AVKVLNRNLGRIAE-----EQFMAEVGTIGRTYHI 135
            LG G +G+V+   K    +  K+ A+KVL +    I +     E    E   +      
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA--TIVQKAKTTEHTRTERQVLEHIRQS 118

Query: 136 N-LVRL-YGFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRAIEWEKLH--EIAIG 184
             LV L Y F   Q  T L  + +Y+  G L  +L     F +       +++  EI + 
Sbjct: 119 PFLVTLHYAF---QTETKLHLILDYINGGELFTHLSQRERFTEHEV----QIYVGEIVLA 171

Query: 185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
               L +LH+     II+ DIK EN+LLD+N    + DFGL+K    ++T      + GT
Sbjct: 172 ----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGT 223

Query: 245 PGYSAPEFLSGN-YPITHKCDVYSFGMVLFE 274
             Y AP+ + G         D +S G++++E
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 74/286 (25%), Positives = 125/286 (43%), Gaps = 44/286 (15%)

Query: 18  RYFWEKLNRTETETRNAASANKPEEDVVEVIWEAGQTMERFLQEIGREKPVRFTS----- 72
             +++ L++ E E  N     +  E   E+  +  +       +   EK     S     
Sbjct: 273 DGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNN 332

Query: 73  -----LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMA 124
                ++L +F  N+   LG G FG+V   +     ++ AVK+L ++  +     E  M 
Sbjct: 333 GNRDRMKLTDF--NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV 390

Query: 125 E---VGTIGRTYHINLVRL-YGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEW 175
           E   +   G+     L +L   F     +   V EY+  G L  ++     F +  A+ +
Sbjct: 391 EKRVLALPGK--PPFLTQLHSCFQTMDRLY-FVMEYVNGGDLMYHIQQVGRFKEPHAVFY 447

Query: 176 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNK 233
               EIAIG    L +L     + II+ D+K +NV+LD+    K+ADFG+ K  + D   
Sbjct: 448 --AAEIAIG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498

Query: 234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE-IVGR 278
           T  T     GTP Y APE ++   P     D ++FG++L+E + G+
Sbjct: 499 TK-TFC---GTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQ 539

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 45/216 (20%), Positives = 73/216 (33%), Gaps = 57/216 (26%)

Query: 76  NNFTSNYSTR---LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR 131
           N    +Y      LG G  G+V +        K A+K+L        E +          
Sbjct: 13  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ--- 69

Query: 132 TYHINLVRLYGFCHDQHMTA----LVYEYMENGSL-------DGYLFGKKRAIEWEKLHE 180
               ++VR+     + +       +V E ++ G L           F ++ A E   +  
Sbjct: 70  --CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI--MKS 125

Query: 181 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNKTHVT 237
           I     + + YLH      I H D+KPEN+L      N   K+ DFG             
Sbjct: 126 IG----EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF------------ 166

Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 273
                      A E     Y     CD++S G++++
Sbjct: 167 -----------AKETTGEKY--DKSCDMWSLGVIMY 189

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 36/206 (17%)

Query: 86  LGFGGFGEVY---KGQFPNGVKI-AVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG+V+   K    +  ++ A+KVL    L      +   E   +    H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 141 -YGFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRAIEWEKLH--EIAIGTAKGLV 190
            Y F   Q    L  + +++  G L   L     F ++      K +  E+A+     L 
Sbjct: 92  HYAF---QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV----KFYLAELALA----LD 140

Query: 191 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYS 248
           +LH      II+ D+KPEN+LLD     K+ DFGL+K  +    K + +     GT  Y 
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY-SFC---GTVEYM 193

Query: 249 APEFLSGNYPITHKCDVYSFGMVLFE 274
           APE ++     T   D +SFG+++FE
Sbjct: 194 APEVVNRR-GHTQSADWWSFGVLMFE 218

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 69/233 (29%), Positives = 112/233 (48%), Gaps = 34/233 (14%)

Query: 61  EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRI 117
           E+ +E+P     L++ +F       LG G FG+V+  +F    +  A+K L ++  L   
Sbjct: 2   ELNKERPSLQIKLKIEDF--ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD 59

Query: 118 AEEQFMAE---VGTIGRTYHINLVRL-YGFCHDQHMTALVYEYMENGSLDGYL-----FG 168
             E  M E   +       H  L  +   F   +++   V EY+  G L  ++     F 
Sbjct: 60  DVECTMVEKRVLSLAWE--HPFLTHMFCTFQTKENLF-FVMEYLNGGDLMYHIQSCHKFD 116

Query: 169 KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK- 227
             RA  +    EI +G    L +LH    + I++ D+K +N+LLD +   K+ADFG+ K 
Sbjct: 117 LSRATFY--AAEIILG----LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167

Query: 228 -LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE-IVGR 278
            +    KT+ T   + GTP Y APE L G     H  D +SFG++L+E ++G+
Sbjct: 168 NMLGDAKTN-T---FCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQ 215

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 38/208 (18%)

Query: 86  LGFGGFGEVY---KGQFPNGVKI-AVKVLNRN--LGRIAE-EQFMAEVGTIGRTYHINLV 138
           LG GG+G+V+   K    N  KI A+KVL +   +    +     AE   +    H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 139 RL-YGFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRAIEWEKLH--EIAIGTAKG 188
            L Y F   Q    L  + EY+  G L   L     F +  A      +  EI++     
Sbjct: 85  DLIYAF---QTGGKLYLILEYLSGGELFMQLEREGIFMEDTA----CFYLAEISMA---- 133

Query: 189 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPG 246
           L +LH+   + II+ D+KPEN++L+     K+ DFGL K  + D   TH T     GT  
Sbjct: 134 LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH-TFC---GTIE 186

Query: 247 YSAPEFLSGNYPITHKCDVYSFGMVLFE 274
           Y APE L  +       D +S G ++++
Sbjct: 187 YMAPEILMRS-GHNRAVDWWSLGALMYD 213

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 74.9 bits (185), Expect = 3e-15
 Identities = 58/221 (26%), Positives = 91/221 (41%), Gaps = 46/221 (20%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQF----MAEVGT---IGRTYHIN 136
            +G G +G VYK +   +G  +A+K +    G           + EV     +    H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 137 LVRLYGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA----- 186
           +VRL   C            LV+E+++   L  YL         +K     +        
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL---------DKAPPPGLPAETIKDL 125

Query: 187 -----KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK--THVTIS 239
                +GL +LH      I+H D+KPEN+L+ +  + K+ADFGLA++       T V + 
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV- 181

Query: 240 GYKGTPGYSAPEFLSG-NYPITHKCDVYSFGMVLFEIVGRR 279
               T  Y APE L    Y      D++S G +  E+  R+
Sbjct: 182 ----TLWYRAPEVLLQSTY--ATPVDMWSVGCIFAEMFRRK 216

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 50/220 (22%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ----FMA--EVGTIGRTYHINL 137
           +LG G +GEVYK         +A+K +     R+  E+      A  EV  +    H N+
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRI-----RLEHEEEGVPGTAIREVSLLKELQHRNI 95

Query: 138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK--------GL 189
           + L    H  H   L++EY EN  L  Y+         +K  ++++   K        G+
Sbjct: 96  IELKSVIHHNHRLHLIFEYAEN-DLKKYM---------DKNPDVSMRVIKSFLYQLINGV 145

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSP-----KVADFGLAKLC---DRNKTH--VTIS 239
            + H    +R +H D+KP+N+LL  + +      K+ DFGLA+      R  TH  +T+ 
Sbjct: 146 NFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL- 201

Query: 240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
                  Y  PE L G+   +   D++S   +  E++ + 
Sbjct: 202 ------WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 48/224 (21%), Positives = 84/224 (37%), Gaps = 47/224 (20%)

Query: 85  RLGFGGFGEVYKGQ---FPNGVKIAVKVLNRNLGRIAEEQF----MAEVGTIGRTYHINL 137
           ++G G +G VYK +     +    A+K       +I           E+  +    H N+
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALK-------QIEGTGISMSACREIALLRELKHPNV 80

Query: 138 VRLYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK-------- 187
           + L             L+++Y E+  L   +   + +   +K  ++  G  K        
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLC---DRNKTH----- 235
           G+ YLH      ++H D+KP N+L+          K+AD G A+L     +         
Sbjct: 140 GIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           VT         Y APE L G    T   D+++ G +  E++   
Sbjct: 197 VTF-------WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 61/202 (30%), Positives = 88/202 (43%), Gaps = 30/202 (14%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRL-Y 141
           LG G FG+V   +     +  A+K+L +   + +      + E   +  T H  L  L Y
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72

Query: 142 GFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
            F   Q    L  V EY   G L  +L     F ++RA  +    EI       L YLH 
Sbjct: 73  AF---QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSA----LEYLHS 123

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYSAPEF 252
              + +++ DIK EN++LD +   K+ DFGL K  + D      T     GTP Y APE 
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFC---GTPEYLAPEV 176

Query: 253 LSGNYPITHKCDVYSFGMVLFE 274
           L  N       D +  G+V++E
Sbjct: 177 LEDN-DYGRAVDWWGLGVVMYE 197

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 50/238 (21%), Positives = 83/238 (34%), Gaps = 28/238 (11%)

Query: 63  GREKPVRFTSLQLNN----FTSNYS--TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGR 116
           G +         L        S Y+    +  G +G V  G    G+ +A+K +   +  
Sbjct: 1   GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSD 60

Query: 117 IAEEQFMAEVGTIGRTY----------HINLVRLYGFCHDQHMTA-----LVYEYMENGS 161
                 +++     R            H N++ L          A     LV E M    
Sbjct: 61  GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-D 119

Query: 162 LDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVA 221
           L   +  ++  I  + +         GL  LHE     ++H D+ P N+LL  N    + 
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITIC 176

Query: 222 DFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           DF LA+    +      + Y     Y APE +      T   D++S G V+ E+  R+
Sbjct: 177 DFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 62/249 (24%), Positives = 101/249 (40%), Gaps = 33/249 (13%)

Query: 40  PEEDVVEVIWEAGQTMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF 99
             E++           E       RE     +SL L +F  +    +G G + +V   + 
Sbjct: 16  TTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDF--DLLRVIGRGSYAKVLLVRL 73

Query: 100 PNGVKI-AVKVLNRN--LGRIAEEQFMAE---VGTIGRTYHINLVRL-YGFCHDQHMTAL 152
               +I A++V+ +         +    E           H  LV L   F  +  +   
Sbjct: 74  KKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN--HPFLVGLHSCFQTESRLF-F 130

Query: 153 VYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 207
           V EY+  G L  ++       ++ A  +    EI++     L YLHE   + II+ D+K 
Sbjct: 131 VIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEISLA----LNYLHE---RGIIYRDLKL 181

Query: 208 ENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDV 265
           +NVLLD+    K+ D+G+ K  L   + T  T     GTP Y APE L G        D 
Sbjct: 182 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-TFC---GTPNYIAPEILRGE-DYGFSVDW 236

Query: 266 YSFGMVLFE 274
           ++ G+++FE
Sbjct: 237 WALGVLMFE 245

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 54/224 (24%)

Query: 85  RLGFGGFGEVYKGQ--FPNGVKIAVKVLNRNLGR-------IAEEQFMAEVGTIGRTYHI 135
            +G G +G+V+K +     G  +A+K +    G        I E   +     +    H 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH---LETFEHP 74

Query: 136 NLVRLYGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA---- 186
           N+VRL+  C            LV+E+++   L  YL         +K+ E  + T     
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---------DKVPEPGVPTETIKD 124

Query: 187 ------KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK--THVTI 238
                 +GL +LH     R++H D+KP+N+L+ ++   K+ADFGLA++       T V +
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181

Query: 239 SGYKGTPGYSAPEFLSG-NY--PITHKCDVYSFGMVLFEIVGRR 279
                T  Y APE L   +Y  P+    D++S G +  E+  R+
Sbjct: 182 -----TLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 31/203 (15%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAE---VGTIGRTYHINLVR 139
           LG G FG+V   +     ++ AVK+L ++  +     E  M E   +   G+     L +
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK--PPFLTQ 85

Query: 140 L-YGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           L   F     +   V EY+  G L  ++     F +  A+ +    EIAIG    L +L 
Sbjct: 86  LHSCFQTMDRLY-FVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIG----LFFLQ 138

Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYSAPE 251
               + II+ D+K +NV+LD+    K+ADFG+ K  + D   T  T     GTP Y APE
Sbjct: 139 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-TFC---GTPDYIAPE 191

Query: 252 FLSGNYPITHKCDVYSFGMVLFE 274
            ++   P     D ++FG++L+E
Sbjct: 192 IIAYQ-PYGKSVDWWAFGVLLYE 213

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 48/223 (21%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ----FMA--EVGTIGRTYHINL 137
           ++G G FGEV+K +    G K+A+K +      +  E+      A  E+  +    H N+
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKV-----LMENEKEGFPITALREIKILQLLKHENV 78

Query: 138 VRLYGFCHDQHMTA--------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGL 189
           V L   C  +            LV+++ E+  L G L          ++  +      GL
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK-------TH--VTISG 240
            Y+H   + +I+H D+K  NVL+  +   K+ADFGLA+     K       T+  VT+  
Sbjct: 138 YYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL-- 192

Query: 241 YKGTPGYSAPEFLSG--NY--PITHKCDVYSFGMVLFEIVGRR 279
                 Y  PE L G  +Y  PI    D++  G ++ E+  R 
Sbjct: 193 -----WYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.5 bits (176), Expect = 7e-14
 Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 32/208 (15%)

Query: 86  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAE---VGTIGRTYHINLVR 139
           LG G FG+V   +      + AVKVL ++  L     E  M E   +       H  L +
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFLTQ 88

Query: 140 L-YGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           L   F     +   V E++  G L  ++     F + RA  +    EI       L++LH
Sbjct: 89  LFCCFQTPDRLF-FVMEFVNGGDLMFHIQKSRRFDEARARFY--AAEIISA----LMFLH 141

Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVTISGYKGTPGYSAPE 251
           +   + II+ D+K +NVLLD     K+ADFG+ K  +C+   T  T     GTP Y APE
Sbjct: 142 D---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA-TFC---GTPDYIAPE 194

Query: 252 FLSGNYPITHKCDVYSFGMVLFE-IVGR 278
            L          D ++ G++L+E + G 
Sbjct: 195 ILQEM-LYGPAVDWWAMGVLLYEMLCGH 221

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 70.8 bits (174), Expect = 8e-14
 Identities = 47/214 (21%), Positives = 85/214 (39%), Gaps = 45/214 (21%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEE----QFMAEVGTIGRTYHINLV 138
           +LG G + EV++     N  K+ VK+L      +I  E    + +            N++
Sbjct: 43  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG--------GPNII 94

Query: 139 RLYGFCHDQH--MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI-----GTAKGLVY 191
            L     D      ALV+E++ N                + L +  I        K L Y
Sbjct: 95  TLADIVKDPVSRTPALVFEHVNNTDFKQLY---------QTLTDYDIRFYMYEILKALDY 145

Query: 192 LHEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAP 250
            H      I+H D+KP NV++D  +   ++ D+GLA+     + +   +    +  +  P
Sbjct: 146 CH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGP 199

Query: 251 EFLSG----NYPITHKCDVYSFGMVLFEIVGRRR 280
           E L      +Y +    D++S G +L  ++ R+ 
Sbjct: 200 ELLVDYQMYDYSL----DMWSLGCMLASMIFRKE 229

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 37/97 (38%), Positives = 47/97 (48%), Gaps = 14/97 (14%)

Query: 180 EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVT 237
           EIA      L YLH      I++ D+KPEN+LLD+     + DFGL K  +   + T  T
Sbjct: 147 EIASA----LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS-T 198

Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 274
                GTP Y APE L    P     D +  G VL+E
Sbjct: 199 FC---GTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYE 231

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 55/234 (23%), Positives = 89/234 (38%), Gaps = 44/234 (18%)

Query: 69  RFTSLQLNN----FTSNYS--TRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ 121
            F    +N         Y   T +G G +G V       +G K+A+K     L R  + +
Sbjct: 9   GFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK----KLSRPFQSE 64

Query: 122 FMAEVGTIGRTY----------HINLVRLYGFCHDQHMTA------LVYEYMENGSLDGY 165
             A+     R Y          H N++ L                 LV  +M+   L   
Sbjct: 65  IFAK-----RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKI 118

Query: 166 LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 225
           +         EK+  +     KGL Y+H      ++H D+KP N+ ++ +   K+ DFGL
Sbjct: 119 M---GLKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 172

Query: 226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           A+  D   T     GY  T  Y APE +          D++S G ++ E++  +
Sbjct: 173 ARHADAEMT-----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 36/97 (37%), Positives = 52/97 (53%), Gaps = 14/97 (14%)

Query: 180 EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNKTHVT 237
           EI++     L YLHE   + II+ D+K +NVLLD+    K+ D+G+ K  L   + T  T
Sbjct: 118 EISLA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-T 169

Query: 238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 274
                GTP Y APE L G        D ++ G+++FE
Sbjct: 170 FC---GTPNYIAPEILRGE-DYGFSVDWWALGVLMFE 202

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 53/212 (25%), Positives = 84/212 (39%), Gaps = 37/212 (17%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---------- 133
            +G G +G V        G K+A+K     L R  + +  A+     R Y          
Sbjct: 32  PVGSGAYGAVCSAVDGRTGAKVAIK----KLYRPFQSELFAK-----RAYRELRLLKHMR 82

Query: 134 HINLVRLYGFCHDQHMTA------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 187
           H N++ L                 LV  +M     D     K   +  +++  +     K
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---DLGKLMKHEKLGEDRIQFLVYQMLK 139

Query: 188 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
           GL Y+H      IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y
Sbjct: 140 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-----GYVVTRWY 191

Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
            APE +      T   D++S G ++ E++  +
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 43/216 (19%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY----------H 134
           +G G +G V       N V++A+K ++       E Q   +     RT           H
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISP-----FEHQTYCQ-----RTLREIKILLRFRH 84

Query: 135 INLVRLYGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG----- 184
            N++ +        +       +V + ME    D Y     + ++ + L    I      
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET---DLY-----KLLKTQHLSNDHICYFLYQ 136

Query: 185 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI-SGYKG 243
             +GL Y+H      ++H D+KP N+LL+     K+ DFGLA++ D +  H    + Y  
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 244 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           T  Y APE +  +   T   D++S G +L E++  R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 9/94 (9%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG 246
            G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      T   ++ Y  T  
Sbjct: 138 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRY 191

Query: 247 YSAPEF-LSGNYPITHKCDVYSFGMVLFEIVGRR 279
           Y APE  L   Y      D++S G ++ E++   
Sbjct: 192 YRAPEVILGMGY--KENVDIWSVGCIMGEMIKGG 223

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 11/96 (11%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNKTHVTISGYKGTP 245
           + + ++H      I H DIKP+N+L+++  +  K+ DFG AK    ++  V    Y  + 
Sbjct: 152 RAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV---AYICSR 205

Query: 246 GYSAPEFL--SGNYPITHKCDVYSFGMVLFEIVGRR 279
            Y APE +  +  Y  T   D++S G V  E++  +
Sbjct: 206 FYRAPELMLGATEY--TPSIDLWSIGCVFGELILGK 239

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 60/253 (23%), Positives = 94/253 (37%), Gaps = 54/253 (21%)

Query: 55  MERFLQEIGREKPVRFTSLQLNN----FTSNYS--TRLGFGGFGEVYKGQ-FPNGVKIAV 107
           M        +E+P  F   +LN         Y   + +G G +G V        G+++AV
Sbjct: 1   MAHHHHHHSQERPT-FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAV 59

Query: 108 KVLNRNLGRIAEEQFMAEVGTIGRTY----------HINLVRLYGFCHDQHMTA------ 151
           K     L R  +    A+     RTY          H N++ L                 
Sbjct: 60  K----KLSRPFQSIIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110

Query: 152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG-----TAKGLVYLHEECQQRIIHYDIK 206
           LV   M     D         ++ +KL +  +        +GL Y+H      IIH D+K
Sbjct: 111 LVTHLMGA---DLN-----NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLK 159

Query: 207 PENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVY 266
           P N+ ++ +   K+ DFGLA+      T     GY  T  Y APE +          D++
Sbjct: 160 PSNLAVNEDCELKILDFGLARHTADEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIW 214

Query: 267 SFGMVLFEIVGRR 279
           S G ++ E++  R
Sbjct: 215 SVGCIMAELLTGR 227

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 52/224 (23%), Positives = 89/224 (39%), Gaps = 54/224 (24%)

Query: 86  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR--------TYHI 135
           LG G FG+V +         ++A+K++ RN+G+  E     E+  + +         +  
Sbjct: 27  LGEGTFGKVVECLDHARGKSQVALKII-RNVGKYRE-AARLEINVLKKIKEKDKENKFLC 84

Query: 136 NLVRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVY 191
             V +   F    HM  + +E +     + + F K+   +      +  +A      L +
Sbjct: 85  --VLMSDWFNFHGHM-CIAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138

Query: 192 LHEECQQRIIHYDIKPENVLLDANFSP-------------------KVADFGLAKLCDRN 232
           LHE    ++ H D+KPEN+L   +                      +VADFG A     +
Sbjct: 139 LHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDH 193

Query: 233 KTHVTI--SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 274
           + H TI  + +     Y  PE +         CDV+S G +LFE
Sbjct: 194 EHHTTIVATRH-----YRPPEVILE-LGWAQPCDVWSIGCILFE 231

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 54/224 (24%)

Query: 86  LGFGGFGEVYKGQ--FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR--------TYHI 135
           LG G FG+V +       G  +AVK++ +N+ R  E    +E+  +          T+  
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCE-AARSEIQVLEHLNTTDPNSTFRC 79

Query: 136 NLVRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVY 191
             V++   F H  H+  +V+E +    L  Y F K+        + + ++A    K + +
Sbjct: 80  --VQMLEWFEHHGHI-CIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133

Query: 192 LHEECQQRIIHYDIKPENVLLDANFSP-------------------KVADFGLAKLCDRN 232
           LH     ++ H D+KPEN+L   +                      KV DFG A     +
Sbjct: 134 LHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDD 188

Query: 233 KTHVTI--SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 274
           + H T+  + +     Y APE +      +  CDV+S G +L E
Sbjct: 189 EHHSTLVSTRH-----YRAPEVILA-LGWSQPCDVWSIGCILIE 226

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 55/235 (23%), Positives = 95/235 (40%), Gaps = 45/235 (19%)

Query: 69  RFTSLQLNN----FTSNYS--TRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ 121
           +F S+++ +        Y     +G G  G V           +A+K     L R  + Q
Sbjct: 47  QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK----KLSRPFQNQ 102

Query: 122 FMAEVGTIGRTY----------HINLVRLYGFCHDQHMTA------LVYEYMENGSLDGY 165
             A+     R Y          H N++ L      Q          LV E M+  +L   
Sbjct: 103 THAK-----RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQV 156

Query: 166 LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 225
           +   +  ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGL
Sbjct: 157 I---QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 210

Query: 226 AKLCDRNKTHVTISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRR 279
           A+      T   ++ Y  T  Y APE  L   Y      D++S G ++ E+V  +
Sbjct: 211 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGY--KENVDIWSVGCIMGEMVRHK 260

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 57/228 (25%), Positives = 83/228 (36%), Gaps = 58/228 (25%)

Query: 86  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVG---TIGRT----YHINL 137
           +G G FG V   Q   N    AVKV+ RN+ +        E      I        +I  
Sbjct: 43  MGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTR-SAKIEADILKKIQNDDINNNNI-- 98

Query: 138 VRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVYLH 193
           V+ +G F +  HM  L++E +       Y    +        E +    I   K L YL 
Sbjct: 99  VKYHGKFMYYDHM-CLIFEPL---GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154

Query: 194 EECQQRIIHYDIKPENVLLDANFSP-------------------------KVADFGLAKL 228
           +     + H D+KPEN+LLD  +                           K+ DFG A  
Sbjct: 155 KM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA-- 209

Query: 229 CDRNKTHVTI--SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 274
             ++  H +I  +       Y APE +          D++SFG VL E
Sbjct: 210 TFKSDYHGSIINTRQ-----YRAPEVILN-LGWDVSSDMWSFGCVLAE 251

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 26/95 (27%), Positives = 48/95 (50%), Gaps = 5/95 (5%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNKTHVTI-SGYKGT 244
           +GL Y+H      ++H D+KP N+ ++  +   K+ DFGLA++ D + +H    S    T
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187

Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 279
             Y +P  L      T   D+++ G +  E++  +
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 6/108 (5%)

Query: 170 KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 229
           K  +  E L   +   AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+  
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDI 243

Query: 230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPI-THKCDVYSFGMVLFEIV 276
            ++  +V     +    + APE  +    + T + DV+SFG++L+EI 
Sbjct: 244 YKDPDYVRKGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIF 289

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 34/151 (22%), Positives = 57/151 (37%), Gaps = 16/151 (10%)

Query: 85  RLGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINL 137
            LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+
Sbjct: 29  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 138 VRLYGFC-HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
           V L G C        ++ E+ + G+L  YL          K +E      KG  +   + 
Sbjct: 89  VNLLGACTKPGGPLMVIVEFCKFGNLSTYL--------RSKRNEFVPYKTKGARFRQGKD 140

Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAK 227
               I  D+K     + ++ S   + F   K
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 15/103 (14%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT--------I 238
           + +  LH      +IH D+KP N+L+++N   KV DFGLA++ D +    +        +
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 239 SGYKGTPGYSAPEFL--SGNYPITHKCDVYSFGMVLFEIVGRR 279
             +  T  Y APE +  S  Y  +   DV+S G +L E+  RR
Sbjct: 180 VEFVATRWYRAPEVMLTSAKY--SRAMDVWSCGCILAELFLRR 220

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 54/276 (19%), Positives = 88/276 (31%), Gaps = 90/276 (32%)

Query: 77  NFTSNYS--TRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRN-------------LGRIAEE 120
            F   Y    +LG+G F  V+          +A+KV+                L  +   
Sbjct: 34  LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRN- 92

Query: 121 QFMAEVGTIGRTYHINLVRLYG-FCHD----QHMTALVYEYMENG-SLDGYLFG-KKRAI 173
              ++     R     +V+L   F        H+  +V+E +  G  L  ++     + +
Sbjct: 93  ---SDPNDPNREM---VVQLLDDFKISGVNGTHI-CMVFEVL--GHHLLKWIIKSNYQGL 143

Query: 174 EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL--------------------- 212
               + +I     +GL YLH +C+  IIH DIKPEN+LL                     
Sbjct: 144 PLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG 201

Query: 213 ----------------------------DANFSPKVADFGLAKLCDRNKTHVTISGYKGT 244
                                             K+AD G A    ++ T   I     T
Sbjct: 202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTED-IQ----T 256

Query: 245 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR 280
             Y + E L G+       D++S   + FE+     
Sbjct: 257 RQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDY 291

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 33/114 (28%), Positives = 47/114 (41%), Gaps = 26/114 (22%)

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG 246
           K + YLH      ++H D+KP N+LL+A    KVADFGL++     +             
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 247 -------------------YSAPEFL--SGNYPITHKCDVYSFGMVLFEIVGRR 279
                              Y APE L  S  Y  T   D++S G +L EI+  +
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKY--TKGIDMWSLGCILGEILCGK 228

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 46/263 (17%), Positives = 83/263 (31%), Gaps = 91/263 (34%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---------- 133
            +G G +G V +         +A+K     + R+ E+    +     R            
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIK----KILRVFEDLIDCK-----RILREIAILNRLN 110

Query: 134 HINLVRLYGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-- 186
           H ++V++      + +       +V E  +    D                ++   T   
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIAD---SD--------------FKKL-FRTPVY 152

Query: 187 --------------KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
                          G+ Y+H      I+H D+KP N L++ + S KV DFGLA+  D  
Sbjct: 153 LTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209

Query: 233 KTHVTISGYKGTPG-------------------------YSAPEFL--SGNYPITHKCDV 265
           +   +                                  Y APE +    NY  T   DV
Sbjct: 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY--TEAIDV 267

Query: 266 YSFGMVLFEIVGRRRNAIVGATE 288
           +S G +  E++   +  +    +
Sbjct: 268 WSIGCIFAELLNMIKENVAYHAD 290

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.9 bits (135), Expect = 7e-09
 Identities = 39/201 (19%), Positives = 70/201 (34%), Gaps = 31/201 (15%)

Query: 85  RLGFGGFGEVYKGQ---------FPNGVKIAVKVLNRN---------LGRIAEEQFMAEV 126
                  G +Y+            P   K ++K+  ++           R A+   + + 
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 127 GTIGRTYHINLVRLYGF-CHDQHMTALVYEYMENG-SLDGYLFGKKRAIEWEKL-HEIAI 183
             +  T  + +    GF  H      LV   +  G SL   L    + +  E+   ++A 
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVAC 166

Query: 184 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV--ADFGLAKLCDRNKTHVTISGY 241
                L +LHE      +H ++  EN+ +D     +V  A +G A     +  HV     
Sbjct: 167 RLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223

Query: 242 KGTPGYSAPEFLSGNYPITHK 262
             +P     EF+S +    HK
Sbjct: 224 SRSPHEGDLEFISMD---LHK 241

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 55.3 bits (132), Expect = 1e-08
 Identities = 31/215 (14%), Positives = 55/215 (25%), Gaps = 52/215 (24%)

Query: 59  LQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIA 118
           + E  ++ PV F+   L         ++G G FGEV++    +   +A+K++      + 
Sbjct: 2   MGECSQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIADHT-PVAIKIIAIEGPDLV 59

Query: 119 E-------EQFMAEV---------GTIGRTYHINLVRLYGFCHDQ--------------- 147
                   E+ + E+                    + L      Q               
Sbjct: 60  NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119

Query: 148 ---------------HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 192
                              +V E+   G     +  K           I       L   
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLS--SLATAKSILHQLTASLAVA 177

Query: 193 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 227
               +    H D+   NVLL      K+      K
Sbjct: 178 EASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 52/262 (19%), Positives = 86/262 (32%), Gaps = 82/262 (31%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---------- 133
            +G G +G VY          +A+K     + R+ E+    +     R            
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIK----KVNRMFEDLIDCK-----RILREITILNRLK 83

Query: 134 HINLVRLYGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-- 186
              ++RLY       +       +V E  ++   D              L ++   T   
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIADS---D--------------LKKL-FKTPIF 125

Query: 187 --------------KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
                          G  ++HE     IIH D+KP N LL+ + S KV DFGLA+  +  
Sbjct: 126 LTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182

Query: 233 KTHVTISGYKGTPG--------------------YSAPEFLSGNYPITHKCDVYSFGMVL 272
           K    ++  +                        Y APE +      T   D++S G + 
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242

Query: 273 FEIVGRRRNAIVGATESLDWFP 294
            E++   ++ I   T     FP
Sbjct: 243 AELLNMLQSHINDPTNRFPLFP 264

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 44/189 (23%), Positives = 70/189 (37%), Gaps = 32/189 (16%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIA---VKVLNRNLGRIAEE----QFMAEVGTIGRTYHIN 136
           ++G GGFG +Y         K A   VKV  +  G +  E    Q +A+   I +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 137 LVRLYGFCH----------DQHMTALVYEYMENG-SLDGYLFGKKRAIEWEKLHEIAIGT 185
            +   G              +    +V E +  G  L   + G+    +   + ++ I  
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ-KISGQNGTFKKSTVLQLGIRM 160

Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV--ADFGLAKLCDRNKTHVTI----- 238
              L Y+HE      +H DIK  N+LL      +V  AD+GL+     N  H        
Sbjct: 161 LDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR 217

Query: 239 SGYKGTPGY 247
            G+ GT  +
Sbjct: 218 KGHNGTIEF 226

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 52.8 bits (127), Expect = 9e-08
 Identities = 38/201 (18%), Positives = 66/201 (32%), Gaps = 31/201 (15%)

Query: 85  RLGFGGFGEVYKGQFPNG------VKIAVKVLNRNLGRIAEE----QFMAEVGTIGRTYH 134
            +G GGFG +Y     +           VKV   + G +  E    Q  A+   I +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 135 INLVRLYGFCH----------DQHMTALVYEYMENG-SLDGYLFGKKRAIEWEKLHEIAI 183
              ++  G              +    ++ +    G  L        +    + + ++++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 184 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV--ADFGLAKLCDRNKTHVTISGY 241
                L Y+HE      +H DIK  N+LL+     +V   D+GLA        H   +  
Sbjct: 160 RILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216

Query: 242 KGTPGYSAPEFLSGNYPITHK 262
                    EF S +    H 
Sbjct: 217 PKRCHDGTIEFTSID---AHN 234

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 43/180 (23%), Positives = 68/180 (37%), Gaps = 29/180 (16%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI-----NLV 138
           ++G G FGE+  G+       +A+K+           Q   E     R Y        + 
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEY----RFYKQLGSGDGIP 68

Query: 139 RLYGFCHDQHMTALVYEYMENG-SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
           ++Y F       A+V E +  G SL+       R    + +  IAI     + Y+H +  
Sbjct: 69  QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN- 125

Query: 198 QRIIHYDIKPENVLLDANFSPK-----VADFGLAKLCDRNKTHVTIS-----GYKGTPGY 247
             +I+ D+KPEN L+    +       + DF LAK     +T   I         GT  Y
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 42/178 (23%), Positives = 69/178 (38%), Gaps = 27/178 (15%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI-----NLV 138
           ++G G FGE+Y G       ++A+K+ N         Q + E     + Y I      + 
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLLYES----KIYRILQGGTGIP 66

Query: 139 RLYGFCHDQHMTALVYEYMENG-SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
            +  F  +     LV + +  G SL+       R +  + +  +A      + ++H +  
Sbjct: 67  NVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS- 123

Query: 198 QRIIHYDIKPENVLLDANFSPK---VADFGLAKLCDRNKTHVTIS-----GYKGTPGY 247
              +H DIKP+N L+          + DFGLAK      TH  I         GT  Y
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 42/179 (23%), Positives = 68/179 (37%), Gaps = 27/179 (15%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGR---IAEEQFMAEV-GTIGRTYHINLVR 139
           R+G G FG +++G    N  ++A+K   R         E +    + G  G      +  
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG------IPN 70

Query: 140 LYGFCHDQHMTALVYEYMENG-SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           +Y F  +     LV + +  G SL+  L    R    + +   A      +  +HE   +
Sbjct: 71  VYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---K 125

Query: 199 RIIHYDIKPENVLLDANFSPK-----VADFGLAKLCDRNKTHVTIS-----GYKGTPGY 247
            +++ DIKP+N L+    S       V DFG+ K      T   I         GT  Y
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 40/178 (22%), Positives = 67/178 (37%), Gaps = 27/178 (15%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI-----NLV 138
           ++G G FG++Y G     G ++A+K+           Q   E     + Y +      + 
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIES----KIYKMMQGGVGIP 68

Query: 139 RLYGFCHDQHMTALVYEYMENG-SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
            +     +     +V E +  G SL+       R    + +  +A      + Y+H    
Sbjct: 69  TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS--- 123

Query: 198 QRIIHYDIKPENVLLDANFSPK---VADFGLAKLCDRNKTHVTI-----SGYKGTPGY 247
           +  IH D+KP+N L+          + DFGLAK     +TH  I         GT  Y
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.5 bits (112), Expect = 6e-06
 Identities = 37/315 (11%), Positives = 81/315 (25%), Gaps = 87/315 (27%)

Query: 2   SVIFGLIVIIVVFYIIRYFWEKLNRTETETRNAASANKPEED-----------VVEVIWE 50
            V   L         + +    L   E ++      +   +D            + +I E
Sbjct: 276 QVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAE 335

Query: 51  AGQ----TMERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYK--GQFPNGVK 104
           + +    T + +   +  +K        LN              + +++     FP    
Sbjct: 336 SIRDGLATWDNWKH-VNCDKLTTIIESSLNVLEPAE--------YRKMFDRLSVFPPSAH 386

Query: 105 IAVKVLNR---NLGRIAEEQFMAEVGTIG--------RTYHINLVRLYGFCHDQHMTAL- 152
           I   +L+    ++ +      + ++             T  I  + L      ++  AL 
Sbjct: 387 IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446

Query: 153 -----VYE----YMENG----SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH-EECQQ 198
                 Y     +  +      LD Y +           H         + + H +  + 
Sbjct: 447 RSIVDHYNIPKTFDSDDLIPPYLDQYFY----------SH---------IGH-HLKNIEH 486

Query: 199 RIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRNKTHV--TISGYKGTPGYSAPEFLSG 255
                      V LD  F   K+     A     +  +    +  YK         ++  
Sbjct: 487 --PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYK--------PYICD 536

Query: 256 NYPITHK--CDVYSF 268
           N P   +    +  F
Sbjct: 537 NDPKYERLVNAILDF 551

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	406
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.39
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.3
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.06
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.88
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.71
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.69
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.66
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.59
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.57
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.39
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.32
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.22
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.09
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.0
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.77
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.75
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.69
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.68
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.67
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.66
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.64
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.53
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.45
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.34
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.99
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.35
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.84
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	93.77
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	93.69
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	91.0
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.33
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.2
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	84.74

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.3e-61  Score=449.16  Aligned_cols=261  Identities=22%  Similarity=0.328  Sum_probs=216.5

Q ss_pred             HhhhhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      +.-.+++|.++||+|+||+||+|.+.      +++.||||+++........+.|.+|+.++++++|||||+++|+|.++.
T Consensus        23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence            34455678899999999999999862      468899999986655556688999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc
Q 015480          149 MTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD  213 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~  213 (406)
                      ..+||||||++|+|.++|...               ...+++..+..|+.|||+||+|||+   ++|+||||||+||||+
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEEC
Confidence            999999999999999999532               2468999999999999999999999   9999999999999999


Q ss_pred             CCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCccccc
Q 015480          214 ANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDW  292 (406)
Q Consensus       214 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  292 (406)
                      +++.+||+|||+++...............||+.|||||++.+. .++.++|||||||++|||+| |..||.....     
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-----  253 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----  253 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-----
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCH-----
Confidence            9999999999999876544333334456799999999999877 79999999999999999998 7888743221     


Q ss_pred             chhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          293 FPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                        ..+...         +..+...+.+..++..+.+|+.+||+.||++|||+.+|++.|+...
T Consensus       254 --~~~~~~---------i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          254 --QDVVEM---------IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             --HHHHHH---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             --HHHHHH---------HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence              111111         2222333445667888999999999999999999999999998653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.5e-61  Score=446.89  Aligned_cols=260  Identities=23%  Similarity=0.379  Sum_probs=215.2

Q ss_pred             hhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      ..+.+.++||+|+||+||+|++.      +|..||||+++.. .....+.|.+|+++|++++|||||+++|+|.+++..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            45567889999999999999763      4788999999754 3455678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCce
Q 015480          152 LVYEYMENGSLDGYLFGK------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK  219 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k  219 (406)
                      ||||||++|+|.+++...            ...++|.++..++.|||+||+|||+   ++|+||||||+||||++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEE
Confidence            999999999999999643            3579999999999999999999999   9999999999999999999999


Q ss_pred             EeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHH
Q 015480          220 VADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVW  298 (406)
Q Consensus       220 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  298 (406)
                      |+|||+++...............||+.|||||++.+. .++.++|||||||++|||+| |+.||.....       ....
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~~  240 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEVI  240 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHH
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHH
Confidence            9999999876554444333445689999999999877 79999999999999999998 8988853221       1111


Q ss_pred             HHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          299 EEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                      ....         .+.....+..++.++.+|+.+||+.||++|||+.+|++.|+++.+..
T Consensus       241 ~~i~---------~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          241 ECIT---------QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             HHHH---------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHHH---------cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            1111         12223445567788999999999999999999999999999886543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-60  Score=439.70  Aligned_cols=270  Identities=27%  Similarity=0.424  Sum_probs=212.2

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccc-cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      +++....+.+.++||+|+||+||+|++.+  .||||+++.. ......+.|.+|+.++++++|||||+++|++.+ +.++
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~  107 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA  107 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence            34555566788999999999999998853  5999999743 234456789999999999999999999999865 4679


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      ||||||++|+|.+++......+++.++..|+.|||+||+|||+   ++|+||||||+||||++++.+||+|||+|+....
T Consensus       108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            9999999999999997777889999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCceEEecCCCCCCCccCccccCCC--CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ..........+||+.|||||++.+.  ..++.++|||||||++|||+||+.||......      ..........     
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~-----  253 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRG-----  253 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTT-----
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcC-----
Confidence            4433344567899999999998643  25899999999999999999999998533211      0111111111     


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCC
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP  359 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~  359 (406)
                      .........+..++..+.+|+.+||+.||++|||+.+|++.|+.+....|
T Consensus       254 ~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          254 YASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             CCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             CCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            01111223445677889999999999999999999999999988765443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-60  Score=446.85  Aligned_cols=259  Identities=23%  Similarity=0.355  Sum_probs=207.6

Q ss_pred             hhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      ..+.+.++||+|+||+||+|++.      +++.||||+++.. .....+.|.+|+++|++++|||||+++|+|.+....+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            44566789999999999999864      4788999999754 3455678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC
Q 015480          152 LVYEYMENGSLDGYLFGK--------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  217 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  217 (406)
                      ||||||++|+|.++++..              ..+++|.++..|+.|||+||+|||+   ++|+||||||+||||++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCc
Confidence            999999999999999543              2469999999999999999999999   99999999999999999999


Q ss_pred             ceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhH
Q 015480          218 PKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKH  296 (406)
Q Consensus       218 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  296 (406)
                      +||+|||+++...............||+.|||||++.+. .++.++|||||||++|||+| |+.||.....       ..
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------~~  268 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------TE  268 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------HH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCH-------HH
Confidence            999999999876554443334456799999999999987 79999999999999999998 8988853221       11


Q ss_pred             HHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          297 VWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                      ......         .+...+.+..++.++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       269 ~~~~i~---------~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          269 AIDCIT---------QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHHH---------HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHH---------cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            111111         1122334456778899999999999999999999999999998764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.3e-58  Score=434.66  Aligned_cols=266  Identities=24%  Similarity=0.351  Sum_probs=220.2

Q ss_pred             hHHHhhhhhcccccccccceeEEEEEEeCC------CcEEEEEEeccccchhhHHHHHHHHHHhhccCc-CccccEEEEE
Q 015480           72 SLQLNNFTSNYSTRLGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH-INLVRLYGFC  144 (406)
Q Consensus        72 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~  144 (406)
                      .+++....+.+.+.||+|+||+||+|.+..      ++.||||++.........+.|.+|+++|.+++| ||||+++|+|
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~  137 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC  137 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence            456667788889999999999999997632      467999999876665667789999999999965 9999999999


Q ss_pred             ecC-CeeEEEEEeccCCChhhHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCC
Q 015480          145 HDQ-HMTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE  208 (406)
Q Consensus       145 ~~~-~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~  208 (406)
                      .+. ..++||||||++|+|.++|+..               ...+++..+..++.|||+||+|||+   ++|+||||||+
T Consensus       138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~  214 (353)
T 4ase_A          138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAAR  214 (353)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred             EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCcc
Confidence            764 5789999999999999999543               2458999999999999999999999   99999999999


Q ss_pred             cEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCC
Q 015480          209 NVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGAT  287 (406)
Q Consensus       209 Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~  287 (406)
                      |||+++++.+||+|||+|+..............+||+.|||||++.+. .++.++|||||||++|||+| |+.||.....
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999977665555555667799999999999877 79999999999999999998 8988853321


Q ss_pred             cccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          288 ESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      .      .........         +.....+..++.++.+++..||+.||++|||+.+|++.|+.+++
T Consensus       294 ~------~~~~~~i~~---------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          294 D------EEFCRRLKE---------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             S------HHHHHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H------HHHHHHHHc---------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            1      111111111         12233344567889999999999999999999999999988764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.5e-58  Score=429.75  Aligned_cols=249  Identities=20%  Similarity=0.335  Sum_probs=202.5

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      +|.+.+.||+|+||+||+|++ .+|+.||||++.... .....+.+.+|+++|++++|||||++++++.+++.+||||||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy  104 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY  104 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            577889999999999999976 569999999997542 334567899999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          157 MENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       157 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+||+|.+++... ...+++..+..++.||+.||+|||+   ++|+||||||+||||+.+|.+||+|||+|+....... 
T Consensus       105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  180 (350)
T 4b9d_A          105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-  180 (350)
T ss_dssp             CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH-
T ss_pred             CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc-
Confidence            9999999999644 4567999999999999999999999   9999999999999999999999999999986643211 


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                       .....+||+.|||||++.+. .++.++|||||||++|||++|+.||......       ........         ...
T Consensus       181 -~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~---------~~~  242 (350)
T 4b9d_A          181 -LARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMK-------NLVLKIIS---------GSF  242 (350)
T ss_dssp             -HHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHH---------TCC
T ss_pred             -cccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHc---------CCC
Confidence             12345799999999999987 7999999999999999999999999643211       11111111         112


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      +..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2333456778999999999999999999999987

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.1e-57  Score=423.34  Aligned_cols=253  Identities=22%  Similarity=0.246  Sum_probs=205.0

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .+.+.++||+|+||+||+|++ .+|+.||||+++....      ..+|+.+++.++|||||++++++.+++.+|||||||
T Consensus        59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            345667899999999999976 4699999999975422      246999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC-CceEeccccccccCCCCce-
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRNKTH-  235 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~DfGl~~~~~~~~~~-  235 (406)
                      +||+|.+++. ..+.+++..+..++.||+.||+|||+   ++|+||||||+||||+.+| .+||+|||+|+........ 
T Consensus       133 ~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          133 EGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             TTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             CCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            9999999994 44579999999999999999999999   9999999999999999988 6999999999876543221 


Q ss_pred             --EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          236 --VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       236 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                        ......+||+.|||||++.+. .++.++|||||||++|||++|+.||........  .     .......       .
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~-----~~i~~~~-------~  273 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--C-----LKIASEP-------P  273 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--H-----HHHHHSC-------C
T ss_pred             ceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--H-----HHHHcCC-------C
Confidence              122346799999999999987 799999999999999999999999964432211  0     1111110       0


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      .....+..++..+.+++.+||+.||.+|||+.|+++.|.....
T Consensus       274 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          274 PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            0112334567889999999999999999999999998877654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.3e-57  Score=420.24  Aligned_cols=272  Identities=26%  Similarity=0.338  Sum_probs=202.6

Q ss_pred             hhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC----eeEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH----MTALVY  154 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  154 (406)
                      ++.+.++||+|+||+||+|++ +|+.||||+++...  .....+..|+..+.+++|||||+++|+|.+++    .++|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            456678999999999999998 68999999997532  22223345666677899999999999997653    579999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhc-----CCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-----QQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      |||++|+|.++++.  ..+++..+.+++.|+++||+|||+.+     ..+|+||||||+||||+.++.+||+|||+++..
T Consensus        81 Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            99999999999953  46999999999999999999999721     139999999999999999999999999999876


Q ss_pred             CCCCceE--EecCCCCCCCccCccccCCCC-----CCCcccceeecchhHHHHhhcccccccCCCcccccchhH----HH
Q 015480          230 DRNKTHV--TISGYKGTPGYSAPEFLSGNY-----PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKH----VW  298 (406)
Q Consensus       230 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~----~~  298 (406)
                      .......  .....+||+.|||||++.+..     .++.++|||||||++|||+||.+|+........++....    ..
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            5543322  123457999999999987542     367899999999999999999988754433222221110    01


Q ss_pred             HHHhhhhcchhhccCCCCc--chHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          299 EEYEKCELGAMILGCGIEE--KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      +.......... ....++.  ...+.+..+.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus       239 ~~~~~~~~~~~-~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          239 EEMRKVVCEQK-LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHTTSC-CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccc-CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            11111111000 0111121  123567889999999999999999999999999988753

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.5e-57  Score=417.92  Aligned_cols=249  Identities=21%  Similarity=0.299  Sum_probs=209.2

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ..|.+.+.||+|+||+||+|+. .+|+.||||++.+..  .....+.+.+|+++|++++|||||++++++.+++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            3578889999999999999975 569999999997532  2234577999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      |||+||+|.+++. ..+.+++..+..++.||+.||+|||+   ++|+||||||+||||+.+|.+||+|||+|+.......
T Consensus       112 Ey~~gG~L~~~i~-~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            9999999999994 44679999999999999999999999   9999999999999999999999999999998765444


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                      .......+||+.|||||++.+. .++.++||||+||++|||++|+.||......       ..........         
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~~---------  250 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEG-------LIFAKIIKLE---------  250 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTC---------
T ss_pred             cccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCC---------
Confidence            4444567899999999999887 7899999999999999999999999543211       1111111111         


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVI  348 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl  348 (406)
                       ...+...+.++.+|+.+||+.||++|||++|++
T Consensus       251 -~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence             112234567899999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.9e-57  Score=423.58  Aligned_cols=248  Identities=21%  Similarity=0.288  Sum_probs=206.5

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|++.++||+|+||+||+|.+ .+|+.||||++..... ...+.+.+|+++|++++|||||+++++|.+++.+|||||||
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            467788999999999999976 4699999999975422 23456889999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      +||+|.+++..  ..+++..+..++.||+.||+|||+   ++|+||||||+||||+.+|.+||+|||+|+........  
T Consensus       154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--  226 (346)
T 4fih_A          154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--  226 (346)
T ss_dssp             TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--
T ss_pred             CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--
Confidence            99999999853  569999999999999999999999   99999999999999999999999999999876544322  


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      ....+||+.|||||++.+. .|+.++|||||||++|||++|..||......       .........       ......
T Consensus       227 ~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~-------~~~~~~  291 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDN-------LPPRLK  291 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHS-------SCCCCS
T ss_pred             ccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHcC-------CCCCCC
Confidence            2457899999999999877 7999999999999999999999998543211       111111111       001122


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .....+.++.+|+.+||+.||++|||+.|+++
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            33456788999999999999999999999887

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.2e-56  Score=408.51  Aligned_cols=245  Identities=25%  Similarity=0.406  Sum_probs=198.0

Q ss_pred             cccccccccceeEEEEEEe-CCCcEEEEEEeccc-cchhhHHHHHHHHHHhhccCcCccccEEEEEec----CCeeEEEE
Q 015480           81 NYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD----QHMTALVY  154 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  154 (406)
                      .+.++||+|+||+||+|.+ .+|+.||+|++... ......+.|.+|++++++++|||||+++++|.+    +..++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            5667899999999999976 46899999999753 234456789999999999999999999999865    35689999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCC--eeecCCCCCcEEEc-CCCCceEeccccccccCC
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLD-ANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--i~H~dlk~~Nill~-~~~~~kl~DfGl~~~~~~  231 (406)
                      |||+||+|.+++. ....+++..+..++.||+.||+|||+   ++  |+||||||+||||+ .+|.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999994 45679999999999999999999998   77  99999999999997 489999999999986544


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ...    ...+||+.|||||++.+  .++.++|||||||++|||+||+.||......      ...........      
T Consensus       185 ~~~----~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~------  246 (290)
T 3fpq_A          185 SFA----KAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGV------  246 (290)
T ss_dssp             TSB----EESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTC------
T ss_pred             Ccc----CCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCC------
Confidence            322    23679999999999875  4899999999999999999999998533211      11111111110      


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        .....+...++++.+|+.+||+.||++|||+.++++
T Consensus       247 --~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          247 --KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             --CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              001122334567999999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.1e-56  Score=403.20  Aligned_cols=246  Identities=23%  Similarity=0.388  Sum_probs=192.2

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||+||+|.. .+|+.||||++++..  .......+.+|++++++++|||||++++++.+++..|+|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            577889999999999999976 569999999997542  22345679999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      || +|+|.+++. .++.+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|+....... 
T Consensus        94 y~-~g~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~-  167 (275)
T 3hyh_A           94 YA-GNELFDYIV-QRDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF-  167 (275)
T ss_dssp             CC-CEEHHHHHH-HSCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred             CC-CCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc-
Confidence            99 679999984 45679999999999999999999999   9999999999999999999999999999986543322 


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        ....+||+.|||||++.+...++.++||||+||++|||++|+.||.....       ...........          
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-------~~~~~~i~~~~----------  228 (275)
T 3hyh_A          168 --LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-------PVLFKNISNGV----------  228 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTC----------
T ss_pred             --cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCC----------
Confidence              23467999999999999874557899999999999999999999954321       11111111111          


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...+...+.++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1122345678999999999999999999999987

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.8e-56  Score=424.79  Aligned_cols=248  Identities=21%  Similarity=0.293  Sum_probs=205.8

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|.+.++||+|+||+||+|.+ .+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            467788999999999999976 4699999999975422 33456889999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      +||+|.+++.  ...+++..+..++.||+.||+|||+   ++|+||||||+||||+.+|.+||+|||+|+........  
T Consensus       231 ~gG~L~~~i~--~~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~--  303 (423)
T 4fie_A          231 EGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--  303 (423)
T ss_dssp             TTEEHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC--
T ss_pred             CCCcHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc--
Confidence            9999999984  3469999999999999999999999   99999999999999999999999999999876544322  


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      ....+||+.|||||++.+. .|+.++|||||||++|||++|..||......       ..........       .....
T Consensus       304 ~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~~-------~~~~~  368 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDNL-------PPRLK  368 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSC-------CCCCS
T ss_pred             ccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHcCC-------CCCCc
Confidence            2457899999999999877 7999999999999999999999998543211       1111111110       01112


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .....+.++.+|+.+||+.||++|||+.|+++
T Consensus       369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            22345678999999999999999999999987

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-54  Score=401.66  Aligned_cols=248  Identities=23%  Similarity=0.368  Sum_probs=190.4

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC----------
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH----------  148 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----------  148 (406)
                      |.+.+.||+|+||+||+|++ .+|+.||||+++........+.+.+|+++|++++|||||++++++.+.+          
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            67788999999999999976 4699999999986555556678999999999999999999999986543          


Q ss_pred             --eeEEEEEeccCCChhhHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccc
Q 015480          149 --MTALVYEYMENGSLDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  224 (406)
Q Consensus       149 --~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfG  224 (406)
                        ..|+|||||++|+|.+++....  ....+..+..++.|+++||+|||+   ++|+||||||+||||+.++.+||+|||
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccCc
Confidence              3689999999999999996443  235677789999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCce----------EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccch
Q 015480          225 LAKLCDRNKTH----------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP  294 (406)
Q Consensus       225 l~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~  294 (406)
                      +|+........          ...+..+||+.|||||++.+. .++.++|||||||++|||++   ||....        
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~--------  231 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQM--------  231 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHH--------
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCcc--------
Confidence            99876543221          112346799999999999987 79999999999999999996   442110        


Q ss_pred             hHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          295 KHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       .......      .......+......++.+.+|+.+||+.||++|||+.++++
T Consensus       232 -~~~~~~~------~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          232 -ERVRTLT------DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -HHHHHHH------HHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHH------HHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             0001110      11122233444556677889999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.8e-56  Score=410.02  Aligned_cols=248  Identities=23%  Similarity=0.232  Sum_probs=196.4

Q ss_pred             hhhcccccccccceeEEEEEEe----CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF----PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~----~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      ..|.+.+.||+|+||+||+|+.    .+++.||||++++.. .......+.+|+++|++++|||||++++++.+++.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4678899999999999999965    247899999997532 22233468899999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |||||+||+|.+++. +.+.+++..+..++.|++.||+|||+   ++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999994 45679999999999999999999999   99999999999999999999999999999865433


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ...  ....+||+.|||||++.+. .++.++|||||||++|||++|+.||......       ..........       
T Consensus       180 ~~~--~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~~~-------  242 (304)
T 3ubd_A          180 EKK--AYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-------ETMTMILKAK-------  242 (304)
T ss_dssp             -CC--CCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC-------
T ss_pred             Ccc--ccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHH-------HHHHHHHcCC-------
Confidence            221  2357899999999999887 7999999999999999999999999543211       1111111111       


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCCh-----HHHHH
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPM-----SAVIK  349 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~~vl~  349 (406)
                         ...+...+.++.+|+.+||+.||++|||+     +|+++
T Consensus       243 ---~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          243 ---LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ---CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence               12233456789999999999999999985     56654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-52  Score=398.44  Aligned_cols=272  Identities=19%  Similarity=0.250  Sum_probs=204.3

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEec------CCe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD------QHM  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  149 (406)
                      .+|.+.+.||+|+||+||+|.+ .+|+.||||+++... .....+.+.+|+++|+.++|||||++++++..      ...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            3577889999999999999976 569999999997543 23345678899999999999999999999764      357


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .|||||||+ |+|.+++ ...+.+++..+..++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+++..
T Consensus       134 ~~ivmE~~~-g~L~~~i-~~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQII-HSSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHH-TSSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999996 6899998 456789999999999999999999999   99999999999999999999999999999866


Q ss_pred             CCCC--ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccc--------hhHHHH
Q 015480          230 DRNK--THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWF--------PKHVWE  299 (406)
Q Consensus       230 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--------~~~~~~  299 (406)
                      ....  ........+||+.|||||++.+...++.++||||+||++|||++|++||...........        ....+.
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            4321  122234578999999999988765789999999999999999999999954321100000        000000


Q ss_pred             HHhhhhcchhhc--cCCCC----cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcc
Q 015480          300 EYEKCELGAMIL--GCGIE----EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGV  354 (406)
Q Consensus       300 ~~~~~~~~~~~~--~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~  354 (406)
                      ............  .....    ......+.++.+|+.+||..||.+|||+.|+++  .+.+.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence            000000000000  00000    011123567899999999999999999999987  56554

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.3e-51  Score=388.22  Aligned_cols=200  Identities=24%  Similarity=0.340  Sum_probs=170.8

Q ss_pred             hhhcccccccccceeEEEEEEeC----CCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  152 (406)
                      ..|.+.++||+|+||+||+|+.+    +++.||+|.+....   ....+.+|+++|..+ +||||+++++++.+.+..++
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            45788899999999999999652    47889999987542   345688999999988 69999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC-CCceEeccccccccCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDR  231 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~DfGl~~~~~~  231 (406)
                      |||||++|+|.+++    +.+++.++..++.|++.||+|||+   +||+||||||+|||++.+ +.+||+|||+|+....
T Consensus        98 vmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           98 AMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             EEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            99999999999998    358999999999999999999999   999999999999999877 7999999999975543


Q ss_pred             CCc--------------------------eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccC
Q 015480          232 NKT--------------------------HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG  285 (406)
Q Consensus       232 ~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  285 (406)
                      ...                          .......+||+.|+|||++.+...++.++||||+||++|||++|+.||..+
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            211                          111234679999999999987757899999999999999999999999655


Q ss_pred             CC
Q 015480          286 AT  287 (406)
Q Consensus       286 ~~  287 (406)
                      ..
T Consensus       251 ~~  252 (361)
T 4f9c_A          251 SD  252 (361)
T ss_dssp             SS
T ss_pred             CC
Confidence            43

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.6e-50  Score=402.60  Aligned_cols=249  Identities=22%  Similarity=0.242  Sum_probs=200.2

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHH---HHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQF---MAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      .|.+.+.||+|+||+||+|+. .+|+.||||++.+...  ......+   ..++.+++.++|||||+++++|.+.+.+||
T Consensus       190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl  269 (689)
T 3v5w_A          190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF  269 (689)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence            467789999999999999976 4699999999975311  1122223   344677788899999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |||||+||+|.+++. ..+.+++..+..++.||+.||+|||+   ++|+||||||+||||+.+|++||+|||+|+.....
T Consensus       270 VmEy~~GGdL~~~l~-~~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          270 ILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EECCCCSCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            999999999999994 45679999999999999999999999   99999999999999999999999999999876544


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ..    ...+||+.|||||++.+...|+.++|||||||++|||++|.+||.........    .........        
T Consensus       346 ~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~----~i~~~i~~~--------  409 (689)
T 3v5w_A          346 KP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLTM--------  409 (689)
T ss_dssp             CC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH----HHHHHHHHC--------
T ss_pred             CC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHhhcCC--------
Confidence            32    34689999999999975547999999999999999999999999643322110    011111110        


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPP-----MSAVIK  349 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  349 (406)
                        ....+...+.++.+|+.+||+.||.+|++     ++||++
T Consensus       410 --~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 --AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             --CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence              01223446778999999999999999998     577766

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.9e-50  Score=401.57  Aligned_cols=250  Identities=21%  Similarity=0.306  Sum_probs=208.7

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|.+.+.||+|+||+||+|.. .+|+.||+|++... .....+.+.+|+.+|+.++|||||+++++|.++..++||||||
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            577889999999999999976 56999999999754 2345577899999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC--CCceEeccccccccCCCCce
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN--FSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~--~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +||+|.+++......+++..+..++.||+.||+|||+   ++|+||||||+|||++.+  +.+||+|||+++........
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~  313 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV  313 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence            9999999997667789999999999999999999999   999999999999999854  89999999999987655433


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                      .   ..+||+.|||||++.+. .++.++|||||||++|||++|..||......       ...........      ...
T Consensus       314 ~---~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-------~~~~~i~~~~~------~~~  376 (573)
T 3uto_A          314 K---VTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCDW------NMD  376 (573)
T ss_dssp             E---EECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTCC------CCC
T ss_pred             e---eeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHhCCC------CCC
Confidence            2   35799999999999987 7999999999999999999999998543221       11111111100      011


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .......+.++.+|+.+||+.||.+|||+.|+++
T Consensus       377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1223345678999999999999999999999988

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.7e-49  Score=369.57  Aligned_cols=277  Identities=35%  Similarity=0.565  Sum_probs=225.8

Q ss_pred             hhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ....|.+.+.||+|+||+||+|.+.+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  115 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK  115 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence            345667788999999999999998889999999987643 2456789999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          156 YMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |+++|+|.+++....   ..+++..+..++.|++.||+|||+   ++++||||||+||+++.++.+||+|||++......
T Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTEL  192 (321)
T ss_dssp             CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred             cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999985432   368999999999999999999999   99999999999999999999999999999865433


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ..........||+.|+|||++.+. .++.++||||||+++|||++|+.||.............+................
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (321)
T 2qkw_B          193 DQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP  271 (321)
T ss_dssp             SCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred             cccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence            222222345689999999998776 6899999999999999999999998765444332222222222233333333333


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                      ..........+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            333455678899999999999999999999999999999987643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.3e-49  Score=369.90  Aligned_cols=285  Identities=39%  Similarity=0.608  Sum_probs=224.2

Q ss_pred             eeChHHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           69 RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        69 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      .+...++....|...+.||+|+||+||+|+..+|+.||||++...........+.+|++++..++||||+++++++.+..
T Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  100 (326)
T 3uim_A           21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT  100 (326)
T ss_dssp             CTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred             cHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence            44556666777888899999999999999988899999999986543333447899999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccc
Q 015480          149 MTALVYEYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  225 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl  225 (406)
                      ..++||||+++|+|.+++...   ...+++..+..++.|++.||+|||+.+..+++||||||+|||++.++.+||+|||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  180 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL  180 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence            999999999999999999643   33599999999999999999999992112999999999999999999999999999


Q ss_pred             ccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCc--ccccchhHHHHHHhh
Q 015480          226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATE--SLDWFPKHVWEEYEK  303 (406)
Q Consensus       226 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~  303 (406)
                      +.......... .....||+.|+|||++.+. .++.++||||||+++|||++|..||......  .......+.......
T Consensus       181 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (326)
T 3uim_A          181 AKLMDYKDTHV-TTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE  258 (326)
T ss_dssp             CEECCSSSSCE-ECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred             ccccCcccccc-cccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence            98765443332 3456699999999999776 6899999999999999999999998532111  111111111111112


Q ss_pred             hhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      ...................+..+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            2222223333334556788899999999999999999999999999998753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6e-49  Score=375.87  Aligned_cols=263  Identities=25%  Similarity=0.377  Sum_probs=215.9

Q ss_pred             HHhhhhhcccccccccceeEEEEEEe--------CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEE
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQF--------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFC  144 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  144 (406)
                      ++....|.+.+.||+|+||+||+|.+        .++..||||+++........+.+.+|+.++..+ +||||+++++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            34456677889999999999999975        245679999998765555667899999999999 899999999999


Q ss_pred             ecCCeeEEEEEeccCCChhhHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCc
Q 015480          145 HDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN  209 (406)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~N  209 (406)
                      .+.+..++||||+++|+|.+++....               ..+++..+..++.|++.||+|||+   ++|+||||||+|
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~N  233 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARN  233 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGG
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhh
Confidence            99999999999999999999996432               358999999999999999999999   999999999999


Q ss_pred             EEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCc
Q 015480          210 VLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATE  288 (406)
Q Consensus       210 ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~  288 (406)
                      ||++.++.+||+|||+++...............+|+.|+|||++.+. .++.++|||||||++|||++ |..||......
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999999866544332223345678899999999876 78999999999999999999 88887532211


Q ss_pred             ccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          289 SLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                             ......         ........+..++..+.+++..||+.||.+||++.++++.|+.+..
T Consensus       313 -------~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          313 -------ELFKLL---------KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             -------GHHHHH---------HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------HHHHHH---------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                   111111         1111223344566789999999999999999999999999998764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.2e-49  Score=369.89  Aligned_cols=266  Identities=26%  Similarity=0.418  Sum_probs=217.5

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeC----CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCe
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM  149 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  149 (406)
                      ++...+|.+.+.||+|+||+||+|.+.    .+..||||+++........+.+.+|+.++.+++||||+++++++.+...
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            455677888899999999999999773    3456999999876566667889999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+++|+|.+++......+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            999999999999999997777789999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCc-eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          230 DRNKT-HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       230 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ..... ........+|+.|+|||++.+. .++.++||||||+++|||++ |..||......       .......     
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-------~~~~~~~-----  268 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-------DVISSVE-----  268 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HHHHHHH-----
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHH-----
Confidence            54322 2223344568899999999876 78999999999999999999 88887432211       1111111     


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCC
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP  359 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~  359 (406)
                          .......+..++..+.+++..||+.||.+|||+.+|++.|+.+.....
T Consensus       269 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          269 ----EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             ----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             ----cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence                111122334566789999999999999999999999999999875543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-49  Score=381.88  Aligned_cols=265  Identities=22%  Similarity=0.321  Sum_probs=216.2

Q ss_pred             ChHHHhhhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCe
Q 015480           71 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM  149 (406)
Q Consensus        71 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  149 (406)
                      ..+++....+.+.+.||+|+||+||+|.+. +|+.||||+++..........|.+|++++++++||||+++++++.+...
T Consensus       107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  186 (377)
T 3cbl_A          107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP  186 (377)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence            345566677888899999999999999875 6899999999865554555678999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+++|+|.+++......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            999999999999999997666679999999999999999999999   99999999999999999999999999999865


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      .............++..|+|||++.+. .++.++|||||||++|||++ |..|+.....       ....+..       
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~-------~~~~~~~-------  328 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSN-------QQTREFV-------  328 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-------HHHHHHH-------
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHH-------
Confidence            432211111122356789999999866 68999999999999999998 8887743211       1111111       


Q ss_pred             hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                        ........+..++..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       329 --~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          329 --EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             --HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence              111122233445678999999999999999999999999998774

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.9e-49  Score=365.31  Aligned_cols=267  Identities=27%  Similarity=0.466  Sum_probs=206.9

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      .++....|.+.+.||+|+||+||+|++ +|+.||||++.... .....+.+.+|++++++++||||+++++++.+....+
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            344556778889999999999999987 68899999997543 3344577999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHhcCCC--eeecCCCCCcEEEcCCCCceEecccccc
Q 015480          152 LVYEYMENGSLDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      +||||+++|+|.+++....  ..+++..+..++.|++.||+|||+   .+  ++||||||+|||++.++.+||+|||+++
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            9999999999999996443  249999999999999999999999   88  9999999999999999999999999997


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      .......  ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......       ......      
T Consensus       188 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~-------~~~~~~------  251 (309)
T 3p86_A          188 LKASTFL--SSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPA-------QVVAAV------  251 (309)
T ss_dssp             ----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHH------
T ss_pred             ccccccc--ccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHH------
Confidence            5443321  12345789999999999877 6899999999999999999999998533211       000110      


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCCC
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPP  361 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~p  361 (406)
                        .........+...+..+.+++.+||+.||.+|||+.++++.|+.+.....+|
T Consensus       252 --~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~  303 (309)
T 3p86_A          252 --GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP  303 (309)
T ss_dssp             --HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred             --HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence              0111122334456678999999999999999999999999999998765554

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.1e-48  Score=367.11  Aligned_cols=274  Identities=27%  Similarity=0.367  Sum_probs=211.8

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC----e
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH----M  149 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~  149 (406)
                      .+....|.+.+.||+|+||+||+|++. |+.||||++...  ......+..|+.++.+++||||+++++++.+..    .
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           20 YFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             EETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             ccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence            345567788899999999999999884 789999999753  234455667999999999999999999998744    4


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCC----------CeeecCCCCCcEEEcCCCCce
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ----------RIIHYDIKPENVLLDANFSPK  219 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~----------~i~H~dlk~~Nill~~~~~~k  219 (406)
                      .++||||+++|+|.+++..  ..+++..+..++.|++.||+|||+   .          +++||||||+|||++.++.+|
T Consensus        97 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             EEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence            6999999999999999954  459999999999999999999998   7          999999999999999999999


Q ss_pred             EeccccccccCCCCceEEecCCCCCCCccCccccCCC----CCCCcccceeecchhHHHHhhcccccccCCCcccccchh
Q 015480          220 VADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPK  295 (406)
Q Consensus       220 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~  295 (406)
                      |+|||+++...............||+.|+|||++.+.    ..++.++|||||||++|||++|+.||..........+..
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            9999999876654443334456799999999998763    245678999999999999999999986543332211111


Q ss_pred             HH-----HHHHhhhhcchhhccCCCCc--chHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          296 HV-----WEEYEKCELGAMILGCGIEE--KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       296 ~~-----~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      ..     ............ .......  .....+..+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKK-KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSC-CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhccCCchhhhhhhhhccc-CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            00     011110000000 0011111  123567789999999999999999999999999988753

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.5e-49  Score=376.44  Aligned_cols=264  Identities=26%  Similarity=0.444  Sum_probs=204.8

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeC----CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCe
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM  149 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  149 (406)
                      ++....|.+.+.||+|+||+||+|++.    ++..||||+++........+.|.+|+.++.+++||||+++++++.+...
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            345567788899999999999999764    5778999999876555667789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+++|+|.+++......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            999999999999999997777789999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCce-EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          230 DRNKTH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       230 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ...... .......++..|+|||++.+. .++.++||||||+++|||++ |..||.....       ..........   
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-------~~~~~~i~~~---  266 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSN-------QDVIKAVDEG---  266 (373)
T ss_dssp             ----------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-------HHHHHHHHTT---
T ss_pred             ccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcC---
Confidence            543221 112233467789999999876 78999999999999999997 8888753321       1111111111   


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                            .....+..++..+.+++..||+.||.+||++.+|++.|+.+...
T Consensus       267 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          267 ------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             ------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence                  11122334567899999999999999999999999999988643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.2e-48  Score=363.34  Aligned_cols=253  Identities=24%  Similarity=0.302  Sum_probs=204.6

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|.+.+.||+|+||+||+|.+. +|+.||+|++.........+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   87 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   87 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence            4677889999999999999764 789999999975444344567899999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++|+|.+++ .....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...........
T Consensus        88 ~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           88 SGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             TTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             CCCcHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence            999999998 445679999999999999999999999   9999999999999999999999999999986654433333


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      .....||+.|+|||++.+...++.++|||||||++|+|++|..||.........      ...+...        .....
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~--------~~~~~  229 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEK--------KTYLN  229 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH------HHHHHTT--------CTTST
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHhcc--------cccCC
Confidence            445789999999999987644588999999999999999999998643322111      1111110        11111


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .....+..+.+++.+||+.||.+|||+.|+++
T Consensus       230 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          230 PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            22345677899999999999999999999987

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.8e-48  Score=360.31  Aligned_cols=264  Identities=27%  Similarity=0.398  Sum_probs=214.2

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ..+|.+.+.||+|+||+||+|.+ .+|+.||+|++... .....+.+.+|++++.+++||||+++++++.++...++|||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            45667788999999999999976 46899999988653 34566789999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++|+|.+++......+++..+..++.|+++||+|||+   .+++||||||+|||++.++.+||+|||++.........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            999999999997777889999999999999999999999   99999999999999999999999999999866443221


Q ss_pred             E------------EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhh
Q 015480          236 V------------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK  303 (406)
Q Consensus       236 ~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  303 (406)
                      .            ......||+.|+|||++.+. .++.++||||||+++|||++|..|+..............  .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~--~~~~~  241 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV--RGFLD  241 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH--HHHHH
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh--hcccc
Confidence            1            11145799999999999876 789999999999999999999988754433222111100  00000


Q ss_pred             hhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCC
Q 015480          304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP  359 (406)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~  359 (406)
                      .            ..+..++..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       242 ~------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          242 R------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             H------------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             c------------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence            0            0112334568999999999999999999999999999865543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.4e-49  Score=365.22  Aligned_cols=279  Identities=24%  Similarity=0.363  Sum_probs=212.7

Q ss_pred             HHhhhhhcccccccccceeEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecC-
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-  147 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-  147 (406)
                      ++...+|.+.+.||+|+||+||+|++     .+|+.||||++... .....+.+.+|+.++.+++||||+++++++... 
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            44567788899999999999999974     36899999999754 334557899999999999999999999998653 


Q ss_pred             -CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccc
Q 015480          148 -HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  226 (406)
Q Consensus       148 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~  226 (406)
                       ...++||||+++|+|.+++......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence             56899999999999999997777779999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCce-EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhh
Q 015480          227 KLCDRNKTH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCE  305 (406)
Q Consensus       227 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (406)
                      ......... .......++..|+|||.+.+. .++.++||||||+++|||++|..|+.......................
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            876543322 122334577789999999876 789999999999999999999987643211100000000000000001


Q ss_pred             cchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          306 LGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                      .............+..++..+.+++..||+.||++|||+.++++.|+.+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            1111222223334456678899999999999999999999999999988654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.9e-48  Score=353.10  Aligned_cols=261  Identities=25%  Similarity=0.432  Sum_probs=216.2

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ++...+|.+.+.||+|+||.||+|++.++..||+|++....  ...+.+.+|++++.+++||||+++++++.+....++|
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV   81 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence            34566788889999999999999999888899999998643  2456799999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+++++|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999997666679999999999999999999999   999999999999999999999999999998765543


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      .. ......+|+.|+|||.+.+. .++.++||||||+++|||++ |..||......       ........         
T Consensus       159 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~---------  220 (268)
T 3sxs_A          159 YV-SSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-------EVVLKVSQ---------  220 (268)
T ss_dssp             EE-ECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHT---------
T ss_pred             hh-cccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChH-------HHHHHHHc---------
Confidence            32 23455677889999999876 68999999999999999999 88887533211       11111111         


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                      ......+...+..+.+++..||+.||.+|||+.++++.|+.+.+.
T Consensus       221 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          221 GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            111122233456799999999999999999999999999988643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-48  Score=371.68  Aligned_cols=271  Identities=24%  Similarity=0.358  Sum_probs=222.1

Q ss_pred             ChHHHhhhhhcccccccccceeEEEEEEe--------CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEE
Q 015480           71 TSLQLNNFTSNYSTRLGFGGFGEVYKGQF--------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLY  141 (406)
Q Consensus        71 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~  141 (406)
                      ...++...+|.+.+.||+|+||+||+|.+        .++..||+|++...........+.+|++++.++ +||||++++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~  141 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL  141 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence            34566777888899999999999999975        234679999998766666668899999999999 899999999


Q ss_pred             EEEecCCeeEEEEEeccCCChhhHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCC
Q 015480          142 GFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIK  206 (406)
Q Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk  206 (406)
                      +++.+....++||||+++|+|.+++....               ..+++..+..++.|++.||+|||+   .+++|||||
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlk  218 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLA  218 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCC
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCC
Confidence            99999999999999999999999996433               459999999999999999999999   999999999


Q ss_pred             CCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccC
Q 015480          207 PENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVG  285 (406)
Q Consensus       207 ~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~  285 (406)
                      |+|||++.++.+||+|||+++...............+|+.|+|||++.+. .++.++|||||||++|||++ |..||...
T Consensus       219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999876554333333455678899999999876 78999999999999999999 88887432


Q ss_pred             CCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCCC
Q 015480          286 ATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPP  361 (406)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~p  361 (406)
                      ..       ........         .......+..++.++.+++.+||+.||++|||+.+|++.|+.+.......
T Consensus       298 ~~-------~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          298 PV-------EELFKLLK---------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             CH-------HHHHHHHH---------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             CH-------HHHHHHHH---------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence            11       11111111         11112233445678999999999999999999999999999997655443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.7e-48  Score=355.13  Aligned_cols=259  Identities=28%  Similarity=0.479  Sum_probs=214.4

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      +....|.+.+.||+|+||+||+|.+.+++.||+|++....  ...+.+.+|++++.+++||||+++++++.+....++||
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            4456678889999999999999998889999999998643  24567999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+++++|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            9999999999997777789999999999999999999999   9999999999999999999999999999986543321


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      . ......+|+.|+|||.+.+. .++.++||||||+++|+|++ |..||......       ........         .
T Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-------~~~~~~~~---------~  223 (269)
T 4hcu_A          162 T-SSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDIST---------G  223 (269)
T ss_dssp             H-STTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHT---------T
T ss_pred             c-cccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHhc---------C
Confidence            1 12345577889999999876 78999999999999999999 88887532211       11111111         1


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      .....+...+..+.+++..||+.||.+|||+.++++.|+++.+
T Consensus       224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          224 FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            1122233346779999999999999999999999999988753

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.4e-48  Score=370.24  Aligned_cols=268  Identities=23%  Similarity=0.355  Sum_probs=216.9

Q ss_pred             eChHHHhhhhhcccccccccceeEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEE
Q 015480           70 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYG  142 (406)
Q Consensus        70 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~  142 (406)
                      ...+++...+|.+.+.||+|+||.||+|++      .+++.||||+++........+.+.+|++++.++ +||||+++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            344566677888899999999999999963      346899999998765555667899999999999 7999999999


Q ss_pred             EEecCC-eeEEEEEeccCCChhhHhhcCCC--------------------------------------------------
Q 015480          143 FCHDQH-MTALVYEYMENGSLDGYLFGKKR--------------------------------------------------  171 (406)
Q Consensus       143 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------  171 (406)
                      ++.+.+ ..++||||+++|+|.+++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            998754 48999999999999999964422                                                  


Q ss_pred             ---------------CCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          172 ---------------AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       172 ---------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                                     .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++..........
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence                           28999999999999999999999   999999999999999999999999999998765544444


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                      ......||+.|+|||++.+. .++.++||||||+++|||++ |..||......      ..........         ..
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~~~~---------~~  314 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEG---------TR  314 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS------HHHHHHHHHT---------CC
T ss_pred             hccccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchh------HHHHHHHHcC---------CC
Confidence            44556789999999999876 78999999999999999998 99888543221      1111111111         11


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      ...+...+.++.+++..||+.||.+|||+.++++.|+.+..
T Consensus       315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            22233456779999999999999999999999999998753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-48  Score=366.06  Aligned_cols=265  Identities=25%  Similarity=0.372  Sum_probs=215.7

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD  146 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  146 (406)
                      .++....|.+.+.||+|+||.||+|++.      +++.||+|+++........+.+.+|+.++.+++||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3445567788899999999999999763      3588999999876555566789999999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChhhHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeec
Q 015480          147 QHMTALVYEYMENGSLDGYLFGKK-----------------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY  203 (406)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~  203 (406)
                      ....++||||+++|+|.+++....                       ..+++..++.++.|+++||.|||+   ++++||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence            999999999999999999996432                       578999999999999999999999   999999


Q ss_pred             CCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-ccccc
Q 015480          204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNA  282 (406)
Q Consensus       204 dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~  282 (406)
                      ||||+|||++.++.+||+|||++................+|+.|+|||++.+. .++.++||||||+++|||++ |..||
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCcC
Confidence            99999999999999999999999866433222223345678999999998876 68999999999999999999 88887


Q ss_pred             ccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          283 IVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                      ......       .......         .......+..++..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       278 ~~~~~~-------~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          278 YGMAHE-------EVIYYVR---------DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             TTSCHH-------HHHHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CCCChH-------HHHHHHh---------CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            532211       1111111         1112223345667899999999999999999999999999998653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.1e-46  Score=347.16  Aligned_cols=280  Identities=35%  Similarity=0.541  Sum_probs=224.0

Q ss_pred             eeeChHHHhhhhhccc--------ccccccceeEEEEEEeCCCcEEEEEEecccc---chhhHHHHHHHHHHhhccCcCc
Q 015480           68 VRFTSLQLNNFTSNYS--------TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRTYHIN  136 (406)
Q Consensus        68 ~~~~~~~~~~~~~~~~--------~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~n  136 (406)
                      ..|...++...+.+|.        +.||+|+||.||+|.+ +++.||+|++....   .....+.+.+|+.++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            3566666666666654        5699999999999987 68899999987532   2334678999999999999999


Q ss_pred             cccEEEEEecCCeeEEEEEeccCCChhhHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC
Q 015480          137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA  214 (406)
Q Consensus       137 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~  214 (406)
                      |+++++++.+....++||||+++++|.+++...  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcC
Confidence            999999999999999999999999999998532  4569999999999999999999999   99999999999999999


Q ss_pred             CCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccch
Q 015480          215 NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP  294 (406)
Q Consensus       215 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~  294 (406)
                      ++.+||+|||++................||+.|+|||.+.+  .++.++||||||+++|+|++|..||.........  .
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~  244 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--L  244 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--T
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--H
Confidence            99999999999987665444444445679999999999875  4789999999999999999999998654433211  1


Q ss_pred             hHHHHHHhh-hhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          295 KHVWEEYEK-CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       295 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      . ....... ...................+..+.+++.+||+.||.+|||+.+|++.|+++.+
T Consensus       245 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          245 D-IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             H-HHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             H-HHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            1 1111111 11111112223345567888999999999999999999999999999988753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6e-48  Score=363.00  Aligned_cols=261  Identities=24%  Similarity=0.343  Sum_probs=206.0

Q ss_pred             HhhhhhcccccccccceeEEEEEEeC-CCc----EEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCe
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGV----KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM  149 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  149 (406)
                      +....|.+.+.||+|+||+||+|.+. +|+    +||+|.+.........+.+.+|+.++++++||||++++++|.+.. 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            34566788899999999999999763 444    358888875544456678999999999999999999999998865 


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++|+||+.+|+|.+++......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            679999999999999998777889999999999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      .............+|..|+|||++.+. .++.++|||||||++|||++ |..||.......       .....       
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~-------  232 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSIL-------  232 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHH-------
T ss_pred             cCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-------HHHHH-------
Confidence            655444444456678899999999876 78999999999999999999 998885432211       11111       


Q ss_pred             hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                        ........+..++..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus       233 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          233 --EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             --HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             --HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence              1111122334456789999999999999999999999999988754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.5e-48  Score=359.87  Aligned_cols=265  Identities=26%  Similarity=0.393  Sum_probs=219.0

Q ss_pred             hHHHhhhhhcccccccccceeEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEe
Q 015480           72 SLQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH  145 (406)
Q Consensus        72 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  145 (406)
                      .+++....|.+.+.||+|+||.||+|.+      .++..||+|++.........+.+.+|+++++.++||||+++++++.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            4455667788889999999999999975      3458899999987655566688999999999999999999999999


Q ss_pred             cCCeeEEEEEeccCCChhhHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeee
Q 015480          146 DQHMTALVYEYMENGSLDGYLFGKK-----------------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH  202 (406)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H  202 (406)
                      +....++||||+++++|.+++....                       ..+++..+..++.|++.||+|||+   .+++|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH  173 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVH  173 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEEC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcc
Confidence            9999999999999999999996432                       248999999999999999999999   99999


Q ss_pred             cCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccc
Q 015480          203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRN  281 (406)
Q Consensus       203 ~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p  281 (406)
                      |||||+||+++.++.+||+|||++................+|+.|+|||.+.+. .++.++||||||+++|||++ |..|
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999877655444444455678899999999876 68999999999999999999 8888


Q ss_pred             cccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          282 AIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      |......       ........         ......+...+..+.+++.+||+.||.+||++.++++.|+++..
T Consensus       253 ~~~~~~~-------~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          253 YPGIPPE-------RLFNLLKT---------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             STTCCGG-------GHHHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHH-------HHHHHhhc---------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            7543221       11111111         11122334566789999999999999999999999999988754

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-47  Score=362.78  Aligned_cols=267  Identities=24%  Similarity=0.334  Sum_probs=213.6

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEe
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCH  145 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  145 (406)
                      +++....|.+.+.||+|+||+||+|.+      .++..||+|++.........+.+.+|+.++.++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            455567788889999999999999975      246789999998654444557899999999999 8999999999999


Q ss_pred             cCCeeEEEEEeccCCChhhHhhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHHHhcCCCeeec
Q 015480          146 DQHMTALVYEYMENGSLDGYLFGKKR----------------------AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY  203 (406)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~  203 (406)
                      +.+..++||||+++|+|.+++.....                      .+++..+..++.|++.||+|||+   .+++||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccC
Confidence            99999999999999999999965432                      37999999999999999999999   999999


Q ss_pred             CCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-ccccc
Q 015480          204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNA  282 (406)
Q Consensus       204 dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~  282 (406)
                      ||||+|||++.++.+||+|||++................||+.|+|||++.+. .++.++||||||+++|||++ |..||
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            99999999999999999999999876554444444455678899999998776 68999999999999999998 88888


Q ss_pred             ccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          283 IVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                      ......      .........         ......+...+..+.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus       276 ~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          276 PGIPVD------ANFYKLIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             TTCCCS------HHHHHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             ccCCcH------HHHHHHHhc---------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            543221      111111111         1112223345678999999999999999999999999999886543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=9e-48  Score=354.18  Aligned_cols=263  Identities=23%  Similarity=0.410  Sum_probs=214.2

Q ss_pred             eChHHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCe
Q 015480           70 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM  149 (406)
Q Consensus        70 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  149 (406)
                      +..+++...+|.+.+.||+|+||+||+|++.++..||+|++....  ...+.+.+|++++.+++||||+++++++.+...
T Consensus        16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence            345566777888899999999999999999888899999998643  245678999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+++++|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccc
Confidence            999999999999999997667789999999999999999999999   99999999999999999999999999999866


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      ...... ......+|+.|+|||.+.+. .++.++||||||+++|||++ |+.||......       ........     
T Consensus       171 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~-----  236 (283)
T 3gen_A          171 LDDEYT-SSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQ-----  236 (283)
T ss_dssp             CCHHHH-STTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHT-----
T ss_pred             cccccc-cccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChh-------HHHHHHhc-----
Confidence            433211 12334567889999999876 68999999999999999998 88887532211       11111111     


Q ss_pred             hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                          ......+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       237 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          237 ----GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence                1111222334577999999999999999999999999998875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.1e-47  Score=356.37  Aligned_cols=248  Identities=22%  Similarity=0.348  Sum_probs=206.1

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ..|.+.+.||+|+||.||+|.+ .+|+.||||++.... .....+.+.+|+++++.++||||+++++++.+....++|||
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   94 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME   94 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence            3567788999999999999976 679999999997543 33455778999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++|+|.+++.. ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++........ 
T Consensus        95 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  169 (328)
T 3fe3_A           95 YASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-  169 (328)
T ss_dssp             CCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG-
T ss_pred             CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc-
Confidence            9999999999843 4579999999999999999999999   9999999999999999999999999999986654332 


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        ....+||+.|+|||++.+....+.++|||||||++|||++|+.||......       ..........          
T Consensus       170 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~----------  230 (328)
T 3fe3_A          170 --LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-------ELRERVLRGK----------  230 (328)
T ss_dssp             --GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC----------
T ss_pred             --cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC----------
Confidence              245679999999999988744568999999999999999999998543211       1111111111          


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...+...+..+.+++.+||+.||.+|||+.++++
T Consensus       231 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          231 YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1122335677899999999999999999999987

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-48  Score=370.57  Aligned_cols=262  Identities=27%  Similarity=0.365  Sum_probs=211.1

Q ss_pred             HhhhhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      +....|.+.+.||+|+||+||+|.+.      +++.||||+++..........+.+|+.++.+++||||+++++++.+..
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            44566778899999999999999842      467899999986655566678999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhcCC------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC---Cce
Q 015480          149 MTALVYEYMENGSLDGYLFGKK------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPK  219 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~k  219 (406)
                      ..++||||+++|+|.+++....      ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999995432      468999999999999999999999   9999999999999999555   599


Q ss_pred             EeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHH
Q 015480          220 VADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVW  298 (406)
Q Consensus       220 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  298 (406)
                      |+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++ |..||......       ...
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-------~~~  296 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVL  296 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHH
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHH
Confidence            9999999754322211112234578899999999876 78999999999999999998 88887533211       111


Q ss_pred             HHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          299 EEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      ..         +........+..++..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       297 ~~---------i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          297 EF---------VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             HH---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH---------HHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            11         11111222334556779999999999999999999999999988754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.5e-47  Score=352.16  Aligned_cols=250  Identities=20%  Similarity=0.294  Sum_probs=206.2

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ..+|...+.||+|+||+||+|.. .+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            34677889999999999999975 5699999999875432 345678999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++|+|.+++..  ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.........
T Consensus        98 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (297)
T 3fxz_A           98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (297)
T ss_dssp             CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence            9999999999954  368999999999999999999999   99999999999999999999999999999866544332


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        .....||+.|+|||++.+. .++.++|||||||++|||++|..||......       .........       ....
T Consensus       173 --~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~~~~-------~~~~  235 (297)
T 3fxz_A          173 --RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATN-------GTPE  235 (297)
T ss_dssp             --BCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHH-------CSCC
T ss_pred             --cCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhC-------CCCC
Confidence              2346799999999999877 7899999999999999999999998543211       000000000       0111


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...+...+..+.+++.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            2233456678999999999999999999999987

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.6e-47  Score=361.07  Aligned_cols=268  Identities=24%  Similarity=0.375  Sum_probs=218.9

Q ss_pred             hHHHhhhhhcccccccccceeEEEEEEeC--------CCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEE
Q 015480           72 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP--------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYG  142 (406)
Q Consensus        72 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~  142 (406)
                      .+++...+|.+.+.||+|+||+||+|.+.        ++..||+|+++..........+.+|+.++.++ +||||+++++
T Consensus        29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            34566678888999999999999999763        46789999998765556667899999999999 8999999999


Q ss_pred             EEecCCeeEEEEEeccCCChhhHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCC
Q 015480          143 FCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP  207 (406)
Q Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~  207 (406)
                      ++.+.+..++||||+++|+|.+++....               ..+++..+..++.|++.||.|||+   .+++||||||
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp  185 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAA  185 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSG
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCcc
Confidence            9999999999999999999999996443               248999999999999999999999   9999999999


Q ss_pred             CcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCC
Q 015480          208 ENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGA  286 (406)
Q Consensus       208 ~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~  286 (406)
                      +||+++.++.+||+|||++................+|+.|+|||++.+. .++.++||||||+++|||++ |..||....
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            9999999999999999999877655443334455678899999998776 68999999999999999999 888874321


Q ss_pred             CcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCC
Q 015480          287 TESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP  359 (406)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~  359 (406)
                      .       ..........         .....+..++..+.+++.+||+.||.+|||+.++++.|+.+....+
T Consensus       265 ~-------~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          265 V-------EELFKLLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             H-------HHHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             H-------HHHHHHHhcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            1       1111111111         1122334456789999999999999999999999999999865443

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.9e-47  Score=356.96  Aligned_cols=266  Identities=23%  Similarity=0.368  Sum_probs=218.6

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEe
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCH  145 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  145 (406)
                      +++...+|.+.+.||+|+||+||+|.+      .+++.||+|++.........+.+.+|+.++.++ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            455566788889999999999999974      357899999998765555668899999999999 8999999999999


Q ss_pred             cCCeeEEEEEeccCCChhhHhhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCC
Q 015480          146 DQHMTALVYEYMENGSLDGYLFGKKR-----------------AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE  208 (406)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~  208 (406)
                      +.+..++||||+++|+|.+++.....                 .+++..+..++.|++.||+|||+   .+++||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccc
Confidence            99999999999999999999965432                 48999999999999999999999   99999999999


Q ss_pred             cEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCC
Q 015480          209 NVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGAT  287 (406)
Q Consensus       209 Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~  287 (406)
                      ||+++.++.+||+|||++................||+.|+|||.+.+. .++.++||||||+++|||++ |..||.....
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            999999999999999999877655444444455678899999998876 78999999999999999998 8888754322


Q ss_pred             cccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          288 ESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                      ..      .........         .....+...+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       254 ~~------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          254 DS------KFYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             SH------HHHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hh------HHHHHhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            11      111111111         11122234567899999999999999999999999999987643

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.8e-47  Score=357.94  Aligned_cols=268  Identities=18%  Similarity=0.183  Sum_probs=212.6

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ...|.+.+.||+|+||+||+|.. .+|+.||||++....   ..+.+.+|+.++..+ +||||+++++++.+....++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC---SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            34577789999999999999975 579999999987542   224588999999999 8999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC-----ceEecccccccc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS-----PKVADFGLAKLC  229 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-----~kl~DfGl~~~~  229 (406)
                      ||+ +++|.+++......+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.     +||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999 899999997667789999999999999999999999   99999999999999998887     999999999876


Q ss_pred             CCCCceE-----EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhh
Q 015480          230 DRNKTHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC  304 (406)
Q Consensus       230 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (406)
                      .......     ......||+.|+|||++.+. .++.++|||||||++|||++|..||.........    .........
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~----~~~~~i~~~  235 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK----ERYQKIGDT  235 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH----HHHHHHHHH
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHH----HHHHHHHhh
Confidence            5433211     12356799999999999886 7899999999999999999999999654322111    001111111


Q ss_pred             hcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCCCC
Q 015480          305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPK  362 (406)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~p~  362 (406)
                      ....     .........+ ++.+++..||+.||.+||++++|++.|+++......+.
T Consensus       236 ~~~~-----~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~  287 (330)
T 2izr_A          236 KRAT-----PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMF  287 (330)
T ss_dssp             HHHS-----CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred             hccC-----CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCC
Confidence            0000     0000011133 89999999999999999999999999998876554443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.1e-47  Score=356.88  Aligned_cols=276  Identities=22%  Similarity=0.323  Sum_probs=215.8

Q ss_pred             ChHHHhhhhhcccccccccceeEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEe
Q 015480           71 TSLQLNNFTSNYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH  145 (406)
Q Consensus        71 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  145 (406)
                      ....+....|...+.||+|+||.||+|.+     .+|+.||+|++...........+.+|+.++..++||||+++++++.
T Consensus        14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (302)
T 4e5w_A           14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT   93 (302)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence            34445566678889999999999999983     4689999999986554455678999999999999999999999998


Q ss_pred             cC--CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecc
Q 015480          146 DQ--HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF  223 (406)
Q Consensus       146 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (406)
                      +.  ...++||||+++|+|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+||
T Consensus        94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Df  170 (302)
T 4e5w_A           94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDF  170 (302)
T ss_dssp             C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcc
Confidence            76  66899999999999999997667789999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCceE-EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcc----cccchhHHH
Q 015480          224 GLAKLCDRNKTHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES----LDWFPKHVW  298 (406)
Q Consensus       224 Gl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~----~~~~~~~~~  298 (406)
                      |++.......... ......||..|+|||++.+. .++.++||||||+++|||++|..|+.......    .......  
T Consensus       171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--  247 (302)
T 4e5w_A          171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM--  247 (302)
T ss_dssp             TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGG--
T ss_pred             cccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccccc--
Confidence            9998776544332 23345688899999999876 68899999999999999999998753221100    0000000  


Q ss_pred             HHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          299 EEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                         .................+...+..+.+++.+||+.||.+|||+.++++.|+.++
T Consensus       248 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          248 ---TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             ---HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence               001111111222223344456788999999999999999999999999998764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.4e-47  Score=376.30  Aligned_cols=264  Identities=26%  Similarity=0.424  Sum_probs=215.3

Q ss_pred             ChHHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           71 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        71 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      ...++....+.+.+.||+|+||+||+|.+.++..||||+++...  ...+.|.+|+.++++++||||+++++++. ....
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            33566667788889999999999999999888999999998643  35678999999999999999999999987 5678


Q ss_pred             EEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          151 ALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      ++||||+++|+|.+++... ...+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||+++..
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            9999999999999999643 2478999999999999999999999   99999999999999999999999999999866


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      ...... ......+|..|+|||++... .++.++|||||||++|||++ |+.||.....       .........     
T Consensus       335 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~-----  400 (454)
T 1qcf_A          335 EDNEYT-AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------PEVIRALER-----  400 (454)
T ss_dssp             CCHHHH-TTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHH-----
T ss_pred             CCCcee-ccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHc-----
Confidence            432111 11234567899999999866 68999999999999999999 8888743211       111111111     


Q ss_pred             hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                          ......+..++..+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus       401 ----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          401 ----GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             ----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence                1112233456788999999999999999999999999999987543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.8e-47  Score=351.91  Aligned_cols=260  Identities=23%  Similarity=0.322  Sum_probs=202.2

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCe
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM  149 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  149 (406)
                      ++...+|.+.+.||+|+||+||+|.+..    +..||+|++.........+.+.+|+.++++++||||+++++++.+ +.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~   89 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP   89 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SS
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-Cc
Confidence            4556678889999999999999997642    557999998865555566789999999999999999999999854 56


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence            789999999999999997677789999999999999999999999   99999999999999999999999999999866


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      ...... ......+|+.|+|||++.+. .++.++||||||+++|||++ |..||.......       .......     
T Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-------~~~~i~~-----  232 (281)
T 1mp8_A          167 EDSTYY-KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIEN-----  232 (281)
T ss_dssp             -------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHT-----
T ss_pred             Cccccc-ccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-------HHHHHHc-----
Confidence            543221 12234567899999999866 78999999999999999996 888875432211       1111111     


Q ss_pred             hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                          ......+..++..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       233 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          233 ----GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                1112233456678999999999999999999999999998875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.7e-46  Score=350.51  Aligned_cols=263  Identities=21%  Similarity=0.251  Sum_probs=204.1

Q ss_pred             hhhcccccccccceeEEEEEEeCCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      .+|.+.++||+|+||+||+|++.+|+.||+|++..... ......+.+|++++++++||||+++++++.++...++||||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  100 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF  100 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred             hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence            45677889999999999999988899999999975432 22346788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +++ +|.+++......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++......... 
T Consensus       101 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-  175 (311)
T 3niz_A          101 MEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS-  175 (311)
T ss_dssp             CSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred             CCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc-
Confidence            975 8888887777789999999999999999999999   99999999999999999999999999999876533222 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhh---h------c-
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC---E------L-  306 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~------~-  306 (406)
                       .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.........   ..........   .      . 
T Consensus       176 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          176 -YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTTSGGGTTSH
T ss_pred             -ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHHhhhhhccc
Confidence             234568999999999987557899999999999999999999998643322110   0000000000   0      0 


Q ss_pred             ------chhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          307 ------GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       307 ------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                            ................+.++.+|+.+||+.||.+|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                  0000000000111234567899999999999999999999987

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.9e-47  Score=349.10  Aligned_cols=270  Identities=27%  Similarity=0.452  Sum_probs=203.1

Q ss_pred             eChHHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           70 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        70 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      +...++...+|.+.++||+|+||+||+|++.+  .||+|+++... .....+.+.+|+.++++++||||+++++++. ..
T Consensus        16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~   92 (289)
T 3og7_A           16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-AP   92 (289)
T ss_dssp             --CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             CCCCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CC
Confidence            34456777888999999999999999998743  59999997543 3345578999999999999999999999664 45


Q ss_pred             eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          149 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      ..++||||+++++|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE  169 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred             ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccc
Confidence            6799999999999999997777889999999999999999999999   9999999999999999999999999999986


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCC--CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhc
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCEL  306 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (406)
                      ..............||+.|+|||.+..  ...++.++||||||+++|||++|+.||......      ....+.......
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~  243 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSL  243 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSC
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhccccc
Confidence            554333333345679999999999862  236788999999999999999999998543221      111111111111


Q ss_pred             chhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                           ..........++..+.+++..||+.||.+|||+.++++.|+++..
T Consensus       244 -----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          244 -----SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             -----CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -----CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                 111122334566889999999999999999999999999998753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.9e-47  Score=356.98  Aligned_cols=274  Identities=26%  Similarity=0.354  Sum_probs=215.1

Q ss_pred             hcccccccccceeEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec--CCeeEE
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMTAL  152 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l  152 (406)
                      +.+.+.||+|+||+||++.+     .+|+.||||++.........+.+.+|++++++++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            37789999999999998864     26889999999876555667889999999999999999999999987  467899


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ||||+++|+|.+++..  ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus       113 v~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            9999999999999943  359999999999999999999999   99999999999999999999999999999877654


Q ss_pred             CceE-EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          233 KTHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       233 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      .... ......||..|+|||++.+. .++.++||||||+++|||++|..||............ ................
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG-IAQGQMTVLRLTELLE  265 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC-SCCHHHHHHHHHHHHH
T ss_pred             ccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhc-ccccchhHHHHHHHHh
Confidence            3322 22345688899999999876 6889999999999999999999887532211000000 0000111111222222


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCC
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPP  360 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~  360 (406)
                      .......+..++..+.+++.+||+.||.+|||+.++++.|+.+.+....
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  314 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG  314 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence            3333344556678899999999999999999999999999988654433

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.7e-47  Score=358.96  Aligned_cols=266  Identities=24%  Similarity=0.355  Sum_probs=217.1

Q ss_pred             ChHHHhhhhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEE
Q 015480           71 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC  144 (406)
Q Consensus        71 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  144 (406)
                      ..+++....|.+.+.||+|+||.||+|.+.      +++.||+|++...........+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            345666778888999999999999999753      37889999998665555667899999999999999999999999


Q ss_pred             ecCCeeEEEEEeccCCChhhHhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC
Q 015480          145 HDQHMTALVYEYMENGSLDGYLFGK---------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN  215 (406)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~  215 (406)
                      .+....++||||+++|+|.+++...         ...+++..+..++.|++.||+|||+   ++++||||||+||+++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCC
Confidence            9999999999999999999998532         1467999999999999999999999   999999999999999999


Q ss_pred             CCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccch
Q 015480          216 FSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFP  294 (406)
Q Consensus       216 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~  294 (406)
                      +.+||+|||++................+|+.|+|||++.+. .++.++||||||+++|||++ |..||......      
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------  247 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------  247 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHH------
Confidence            99999999999866543332223344578899999998876 68999999999999999999 77776432111      


Q ss_pred             hHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          295 KHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                       ......         ........+...+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       248 -~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          248 -QVLRFV---------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -HHHHHH---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -HHHHHH---------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence             111111         1111223334566789999999999999999999999999998865

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4e-47  Score=376.56  Aligned_cols=264  Identities=27%  Similarity=0.418  Sum_probs=217.5

Q ss_pred             ChHHHhhhhhcccccccccceeEEEEEEeCC-CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCe
Q 015480           71 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM  149 (406)
Q Consensus        71 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  149 (406)
                      ..+++....+.+.+.||+|+||+||+|.+.. +..||||+++...  ...+.|.+|+.+|++++||||++++++|.+...
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  290 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP  290 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            3456666778888999999999999998754 8899999998643  346789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          150 TALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      .++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  367 (495)
T 1opk_A          291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRL  367 (495)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred             EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeeccccee
Confidence            9999999999999999965 34569999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ...... .......++..|+|||++.+. .++.++|||||||++|||++ |..||......       ...+...     
T Consensus       368 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-------~~~~~~~-----  433 (495)
T 1opk_A          368 MTGDTY-TAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLE-----  433 (495)
T ss_dssp             CTTCCE-ECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------GHHHHHH-----
T ss_pred             ccCCce-eecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHH-----
Confidence            654322 222345577899999999876 68999999999999999999 88777432211       1111111     


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                          .......+..++..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       434 ----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          434 ----KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             ----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             ----cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence                1111223345677899999999999999999999999999988643

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-47  Score=356.66  Aligned_cols=264  Identities=27%  Similarity=0.451  Sum_probs=208.4

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeCC-----CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFPN-----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      ++....+...+.||+|+||+||+|.+..     +..||+|+++..........+.+|+.++.+++||||+++++++.+..
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            3445566777899999999999997642     24599999987655556678999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          149 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      ..++||||+++|+|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            9999999999999999997777789999999999999999999999   9999999999999999999999999999986


Q ss_pred             cCCCCce-EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhc
Q 015480          229 CDRNKTH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCEL  306 (406)
Q Consensus       229 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (406)
                      ....... .......+|..|+|||++.+. .++.++||||||+++|||++ |..||.....       ........    
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~~~~----  264 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAIN----  264 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHH----
T ss_pred             hccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHH----
Confidence            6543221 122234567899999999876 78999999999999999998 9888743221       11111111    


Q ss_pred             chhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                           .......+..++..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus       265 -----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          265 -----DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             -----TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -----CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                 1111222345567899999999999999999999999999988643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.9e-46  Score=349.07  Aligned_cols=249  Identities=24%  Similarity=0.370  Sum_probs=200.2

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC---------
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH---------  148 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---------  148 (406)
                      .|.+.+.||+|+||.||+|++. +|+.||||+++........+.+.+|+.++++++||||+++++++.+..         
T Consensus         7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~   86 (332)
T 3qd2_B            7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD   86 (332)
T ss_dssp             HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred             cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence            4677889999999999999875 799999999986545556788999999999999999999999986543         


Q ss_pred             ------------------------------------------------eeEEEEEeccCCChhhHhhcCC--CCCCHHHH
Q 015480          149 ------------------------------------------------MTALVYEYMENGSLDGYLFGKK--RAIEWEKL  178 (406)
Q Consensus       149 ------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~  178 (406)
                                                                      ..++|||||++++|.+++....  ...++..+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~  166 (332)
T 3qd2_B           87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC  166 (332)
T ss_dssp             C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred             hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence                                                            3789999999999999996432  34677789


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce----------EEecCCCCCCCcc
Q 015480          179 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH----------VTISGYKGTPGYS  248 (406)
Q Consensus       179 ~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~----------~~~~~~~gt~~y~  248 (406)
                      ..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++........          .......||+.|+
T Consensus       167 ~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          167 LHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            9999999999999999   99999999999999999999999999999876544221          1123457999999


Q ss_pred             CccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHH
Q 015480          249 APEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCM  328 (406)
Q Consensus       249 aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  328 (406)
                      |||++.+. .++.++|||||||++|||++|..|+...            ..      ..........+......+..+.+
T Consensus       244 aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~~------------~~------~~~~~~~~~~~~~~~~~~~~~~~  304 (332)
T 3qd2_B          244 SPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQMER------------VR------IITDVRNLKFPLLFTQKYPQEHM  304 (332)
T ss_dssp             CHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHHH------------HH------HHHHHHTTCCCHHHHHHCHHHHH
T ss_pred             ChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhHH------------HH------HHHHhhccCCCcccccCChhHHH
Confidence            99999876 7899999999999999999987553110            00      00111122234445566778899


Q ss_pred             HHHHhcccCCCCCCChHHHHH
Q 015480          329 VALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       329 l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ++.+||+.||.+|||+.++++
T Consensus       305 li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          305 MVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCCCcCCCHHHHhh
Confidence            999999999999999999987

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.7e-46  Score=344.54  Aligned_cols=269  Identities=19%  Similarity=0.202  Sum_probs=214.9

Q ss_pred             hhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEE
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ....|.+.+.||+|+||.||+|.. .+|+.||+|++....   ....+.+|+.++..+ +|+|++++++++.+....++|
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            345677889999999999999975 579999999986532   234578899999999 799999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC-----ceEeccccccc
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS-----PKVADFGLAKL  228 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-----~kl~DfGl~~~  228 (406)
                      |||+ +++|.+++......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.     +||+|||++..
T Consensus        85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999 999999997767789999999999999999999999   99999999999999987776     99999999987


Q ss_pred             cCCCCce-----EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhh
Q 015480          229 CDRNKTH-----VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK  303 (406)
Q Consensus       229 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  303 (406)
                      .......     .......||+.|+|||++.+. .++.++||||||+++|||++|+.||.........    ........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~  235 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----QKYERIGE  235 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH----HHHHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccH----HHHHHHHh
Confidence            6544321     112346799999999999876 6899999999999999999999998654322111    11111111


Q ss_pred             hhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCCC
Q 015480          304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPP  361 (406)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~p  361 (406)
                      ...     ..........++..+.+++..||+.||++||++.+|++.|+++.......
T Consensus       236 ~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          236 KKQ-----STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             HHH-----HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             hcc-----CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence            100     00001111234678999999999999999999999999999997655443

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.8e-46  Score=343.74  Aligned_cols=261  Identities=24%  Similarity=0.345  Sum_probs=201.4

Q ss_pred             hhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhc--cCcCccccEEEEEec----CCee
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR--TYHINLVRLYGFCHD----QHMT  150 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~  150 (406)
                      ...|.+.+.||+|+||+||+|++ +|+.||||++...    ....+..|.+++..  ++||||+++++++.+    ....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            45677889999999999999988 7899999998753    34456666666665  789999999998654    3568


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HhcCCCeeecCCCCCcEEEcCCCCceEec
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH--------EECQQRIIHYDIKPENVLLDANFSPKVAD  222 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (406)
                      ++||||+++|+|.+++  ....+++..+..++.|++.||+|||        +   ++++||||||+|||++.++.+||+|
T Consensus        82 ~lv~e~~~~g~L~~~l--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             EEEECCCTTCBHHHHH--TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEehhhccCCCHHHHH--hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEee
Confidence            8999999999999999  4457999999999999999999999        7   9999999999999999999999999


Q ss_pred             cccccccCCCCceEE--ecCCCCCCCccCccccCCCC-----CCCcccceeecchhHHHHhhc----------ccccccC
Q 015480          223 FGLAKLCDRNKTHVT--ISGYKGTPGYSAPEFLSGNY-----PITHKCDVYSFGMVLFEIVGR----------RRNAIVG  285 (406)
Q Consensus       223 fGl~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslG~il~elltg----------~~p~~~~  285 (406)
                      ||+++..........  .....||+.|+|||++.+..     .++.++|||||||++|||++|          ..||...
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            999987655443322  23357999999999987653     234799999999999999999          5555332


Q ss_pred             CCcccccchhHHHHHHhhhhcchhhccCCCC--cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          286 ATESLDWFPKHVWEEYEKCELGAMILGCGIE--EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      ......      ............ .....+  ......+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus       237 ~~~~~~------~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          237 VPNDPS------FEDMRKVVCVDQ-QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SCSSCC------HHHHHHHHTTSC-CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcc------hhhhhHHHhccC-CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            221111      111111100000 011111  12345788999999999999999999999999999865

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.1e-46  Score=347.22  Aligned_cols=266  Identities=24%  Similarity=0.326  Sum_probs=208.1

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ..+|.+.+.||+|+||.||+|.. .+|+.||+|++....  .....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            45678889999999999999975 468999999986432  234457899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+++++|.+++. ....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.......
T Consensus        90 ~e~~~g~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999994 34579999999999999999999999   999999999999999999999999999998664332


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      .. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||.......      ........ .....    
T Consensus       166 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~-~~~~~----  232 (294)
T 4eqm_A          166 LT-QTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQD-SVPNV----  232 (294)
T ss_dssp             ----------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSS-CCCCH----
T ss_pred             cc-ccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhc-cCCCc----
Confidence            21 12345689999999999877 68999999999999999999999985432110      00000000 00000    


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCC-ChHHHHHHhhccccCCCC
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRP-PMSAVIKMLEGVVEVLPP  360 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~~vl~~L~~~~~~~~~  360 (406)
                       ........+..+.+++.+||+.||.+|| +++++.+.|+.+......
T Consensus       233 -~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~  279 (294)
T 4eqm_A          233 -TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA  279 (294)
T ss_dssp             -HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred             -chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence             0011223567899999999999999999 999999999988655433

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.4e-47  Score=360.09  Aligned_cols=261  Identities=25%  Similarity=0.332  Sum_probs=207.3

Q ss_pred             hhhhhcccccccccceeEEEEEEeC-CCcE----EEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVK----IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      ....|.+.+.||+|+||+||+|.+. +|+.    ||+|.+...........+.+|+.++.+++||||+++++++.+ ...
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~   89 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSL   89 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSE
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Ccc
Confidence            3456777889999999999999763 4544    788887654333344567889999999999999999999864 567


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ++||||+++|+|.+++......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++...
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            89999999999999997767789999999999999999999999   999999999999999999999999999998776


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ............||..|+|||++.+. .++.++||||||+++|||++ |..||.......       ........     
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~-----  233 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKG-----  233 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-------HHHHHHTT-----
T ss_pred             cccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-------HHHHHHcC-----
Confidence            55443334456788899999999876 68999999999999999999 999886432211       11111111     


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                          .....+..++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       234 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          234 ----ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             ----CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             ----CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                11122223455688999999999999999999999999988643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.9e-47  Score=356.72  Aligned_cols=262  Identities=24%  Similarity=0.338  Sum_probs=205.7

Q ss_pred             HhhhhhcccccccccceeEEEEEEeC-CCcE----EEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCe
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVK----IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM  149 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  149 (406)
                      +....|.+.+.||+|+||+||+|.+. +|+.    ||+|.+...........+.+|+.++.+++||||+++++++.+.. 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            34556788899999999999999753 4544    57777765545556788999999999999999999999998765 


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++|++|+.+|+|.+++......+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            789999999999999997777889999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      .............+|+.|+|||.+.+. .++.++|||||||++|||++ |..||.......       .....       
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~-------  232 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSIL-------  232 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHH-------
T ss_pred             cCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHH-------
Confidence            554444334445678899999999876 78999999999999999999 998885432211       11111       


Q ss_pred             hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                        ........+..++..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus       233 --~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          233 --EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             --HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             --HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence              11112223344567799999999999999999999999999998643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=346.06  Aligned_cols=270  Identities=19%  Similarity=0.190  Sum_probs=212.2

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC--eeEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH--MTALV  153 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv  153 (406)
                      +.+|.+.+.||+|+||+||+|.+. +|+.||||++.........+.+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            456778899999999999999764 489999999986544445677889999999999999999999998765  77999


Q ss_pred             EEeccCCChhhHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEE----cCCCCceEecccccc
Q 015480          154 YEYMENGSLDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL----DANFSPKVADFGLAK  227 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~DfGl~~  227 (406)
                      |||+++++|.+++....  ..+++..+..++.|++.||+|||+   .+++||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999996433  349999999999999999999999   999999999999999    788889999999998


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCC-------CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHH
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSG-------NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEE  300 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  300 (406)
                      ........   ....||+.|+|||++..       ...++.++|||||||++|||++|..||.........  ... ...
T Consensus       165 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~-~~~  238 (319)
T 4euu_A          165 ELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEV-MYK  238 (319)
T ss_dssp             ECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHH-HHH
T ss_pred             ecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHH-HHH
Confidence            76544322   34568999999998752       236899999999999999999999998643322111  111 111


Q ss_pred             Hhhhhcchh-----------h----ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          301 YEKCELGAM-----------I----LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       301 ~~~~~~~~~-----------~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      .........           .    ............+..+.+++..||+.||++|||++|+++...+..
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            111100000           0    001112345678889999999999999999999999999887553

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1e-46  Score=369.60  Aligned_cols=252  Identities=28%  Similarity=0.397  Sum_probs=206.9

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC-eeEEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-MTALV  153 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv  153 (406)
                      +....+.+.+.||+|+||+||+|.+ +|+.||||+++...   ..+.|.+|+.+|++++||||+++++++.+.. ..++|
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            4455677788999999999999988 47899999998642   4567999999999999999999999987665 78999


Q ss_pred             EEeccCCChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          154 YEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |||+++|+|.+++.... ..+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||+++.....
T Consensus       266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            99999999999996543 347999999999999999999999   99999999999999999999999999999854322


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      .     ....++..|+|||++.+. .++.++||||||+++|||++ |..||.......       .......        
T Consensus       343 ~-----~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~--------  401 (450)
T 1k9a_A          343 Q-----DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEK--------  401 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-------HHHHHHT--------
T ss_pred             c-----cCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc--------
Confidence            1     123578899999999876 78999999999999999998 988875332211       1111111        


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                       ......+..++..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus       402 -~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          402 -GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence             1112334456788999999999999999999999999998875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.6e-46  Score=353.49  Aligned_cols=251  Identities=22%  Similarity=0.334  Sum_probs=204.9

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccch-----hhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      ..|.+.+.||+|+||+||+|... +|+.||+|++......     ...+.+.+|+.++.+++||||+++++++.+....+
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            45778899999999999999764 6999999999754321     13577999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC----CceEecccccc
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----SPKVADFGLAK  227 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~DfGl~~  227 (406)
                      +||||+++|+|.+++. ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++    .+||+|||++.
T Consensus        92 lv~e~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           92 LILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             EEEECCCSCBHHHHHT-TCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             EEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            9999999999999994 45679999999999999999999999   9999999999999998877    79999999998


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      .......   .....||+.|+|||++.+. .++.++|||||||++|+|++|..||......       ........... 
T Consensus       168 ~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~-  235 (361)
T 2yab_A          168 EIEDGVE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANITAVSY-  235 (361)
T ss_dssp             ECCTTCC---CCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTCC-
T ss_pred             EcCCCCc---cccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCC-
Confidence            7654322   2346799999999999876 7899999999999999999999998543211       11111111100 


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                           ..........+..+.+++..||..||.+|||+.++++
T Consensus       236 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          236 -----DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -----CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -----CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 0001112234677999999999999999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.8e-47  Score=356.08  Aligned_cols=267  Identities=22%  Similarity=0.356  Sum_probs=198.5

Q ss_pred             ChHHHhhhhhcccccccccceeEEEEEEeCC-C---cEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEe
Q 015480           71 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN-G---VKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCH  145 (406)
Q Consensus        71 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-g---~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  145 (406)
                      ....+...+|.+.+.||+|+||+||+|.+.. +   ..||||+++... .....+.+.+|++++++++||||+++++++.
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            3444556678888999999999999997654 3   279999997542 2345678999999999999999999999998


Q ss_pred             cCCee------EEEEEeccCCChhhHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC
Q 015480          146 DQHMT------ALVYEYMENGSLDGYLFGK-----KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA  214 (406)
Q Consensus       146 ~~~~~------~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~  214 (406)
                      +....      ++||||+++|+|.+++...     ...+++..+..++.|++.||+|||+   .+++||||||+|||++.
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~  172 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAE  172 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECT
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcC
Confidence            87655      8999999999999998432     2368999999999999999999999   99999999999999999


Q ss_pred             CCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccc
Q 015480          215 NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWF  293 (406)
Q Consensus       215 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~  293 (406)
                      ++.+||+|||+++...............+++.|+|||.+.+. .++.++|||||||++|||++ |..||.......    
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----  247 (323)
T 3qup_A          173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----  247 (323)
T ss_dssp             TSCEEECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----
T ss_pred             CCCEEEeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHH----
Confidence            999999999999876544433333345578899999999876 78999999999999999999 888875432211    


Q ss_pred             hhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          294 PKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                         .....         ........+...+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       248 ---~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          248 ---IYNYL---------IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             ---HHHHH---------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ---HHHHH---------hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence               11111         11111223345567899999999999999999999999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.5e-47  Score=371.67  Aligned_cols=264  Identities=28%  Similarity=0.434  Sum_probs=210.4

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      +++....+.+.++||+|+||+||+|.+.++..||||+++...  ...+.|.+|+.+|++++||||+++++++.+ ...++
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            455667778889999999999999999888889999998643  245689999999999999999999999977 67899


Q ss_pred             EEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          153 VYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      ||||+++|+|.+++... ...+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||+++....
T Consensus       256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            99999999999999543 3569999999999999999999999   9999999999999999999999999999986653


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      .... ......++..|+|||++.+. .++.++||||||+++|||++ |..||.....       ........        
T Consensus       333 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~--------  395 (452)
T 1fmk_A          333 NEYT-ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVE--------  395 (452)
T ss_dssp             -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHH--------
T ss_pred             Ccee-cccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH--------
Confidence            3221 12334578899999998876 78999999999999999999 8888743211       11111111        


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCC
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPP  360 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~  360 (406)
                       .......+..++..+.+++.+||+.||++|||+.+|++.|+.+.....+
T Consensus       396 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          396 -RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             -TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             -cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence             1111223345677899999999999999999999999999999765544

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.3e-47  Score=353.95  Aligned_cols=267  Identities=23%  Similarity=0.359  Sum_probs=216.6

Q ss_pred             ChHHHhhhhhcccccccccceeEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEE
Q 015480           71 TSLQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGF  143 (406)
Q Consensus        71 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  143 (406)
                      ..+++....|.+.+.||+|+||+||+|.+      .+++.||||++...........+.+|+.++.++ +||||++++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            34556667888899999999999999964      357899999998765555667899999999999 69999999999


Q ss_pred             EecCC-eeEEEEEeccCCChhhHhhcCCC---------------CCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCC
Q 015480          144 CHDQH-MTALVYEYMENGSLDGYLFGKKR---------------AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP  207 (406)
Q Consensus       144 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~  207 (406)
                      +.+.+ ..++||||+++|+|.+++.....               .+++..+..++.|++.||.|||+   .+++||||||
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp  176 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAA  176 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCcc
Confidence            87754 58999999999999999965432               28999999999999999999999   9999999999


Q ss_pred             CcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCC
Q 015480          208 ENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGA  286 (406)
Q Consensus       208 ~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~  286 (406)
                      +||+++.++.+||+|||++................||+.|+|||++.+. .++.++||||||+++|||++ |..||....
T Consensus       177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            9999999999999999999876655444444556678899999999876 78999999999999999998 888875432


Q ss_pred             CcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          287 TESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      ..      ..........         .....+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       256 ~~------~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          256 ID------EEFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             CS------HHHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hh------HHHHHHhccC---------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            11      1111111111         1112223356779999999999999999999999999998753

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.8e-46  Score=346.80  Aligned_cols=263  Identities=26%  Similarity=0.378  Sum_probs=208.4

Q ss_pred             hhhhcccccccccceeEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEe-cCCeeE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH-DQHMTA  151 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~  151 (406)
                      ..+|.+.+.||+|+||+||+|.+.+    +..||+|.+.........+.+.+|+.++++++||||+++++++. .+...+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3456778999999999999997632    23589999987655566688999999999999999999999864 456889


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||+   ++++||||||+||+++.++.+||+|||++.....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            9999999999999997777789999999999999999999999   9999999999999999999999999999986643


Q ss_pred             CCc--eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          232 NKT--HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       232 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ...  ........||+.|+|||.+.+. .++.++||||||+++|+|++|..|+........      ......       
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~------~~~~~~-------  246 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLL-------  246 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT------HHHHHH-------
T ss_pred             cchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH------HHHHHh-------
Confidence            321  1222345678899999999876 789999999999999999996554432222110      001111       


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                        .......+...+..+.+++..||+.||.+|||+.++++.|+.+....
T Consensus       247 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          247 --QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             --TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             --cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence              11112223334577999999999999999999999999999987544

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-46  Score=349.90  Aligned_cols=255  Identities=17%  Similarity=0.223  Sum_probs=208.3

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      ..|.+.+.||+|+||+||+|... +|+.||+|++...  ......+.+|+.++..++||||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            35677889999999999999764 5889999998753  23456788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC--CCCceEeccccccccCCCCc
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA--NFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~--~~~~kl~DfGl~~~~~~~~~  234 (406)
                      +++|+|.+++......+++..+..++.|++.||.|||+   .+++||||||+|||++.  ++.+||+|||++........
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            99999999996666789999999999999999999999   99999999999999987  78999999999987765433


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                      ..   ...||+.|+|||++.+. .++.++|||||||++|+|++|..||......       ............      .
T Consensus       160 ~~---~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~------~  222 (321)
T 1tki_A          160 FR---LLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEYT------F  222 (321)
T ss_dssp             EE---EEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCCC------C
T ss_pred             cc---cccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHHHcCCCC------C
Confidence            22   34589999999999876 6899999999999999999999998543211       111111111100      0


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcc
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGV  354 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~  354 (406)
                      ........+.++.+++.+||+.||.+|||+.++++  .+...
T Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            00111245678999999999999999999999998  55444

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.4e-47  Score=345.83  Aligned_cols=259  Identities=28%  Similarity=0.463  Sum_probs=213.5

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      +....|.+.+.||+|+||.||+|.+.+++.||+|++.....  ..+.+.+|++++.+++||||+++++++.+....++||
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            34556788899999999999999988889999999986432  3467999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+++++|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            9999999999997777789999999999999999999999   9999999999999999999999999999986543211


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                       .......++..|+|||++.+. .++.++||||||+++|+|++ |..||......       .........         
T Consensus       160 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~i~~~---------  221 (267)
T 3t9t_A          160 -TSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTG---------  221 (267)
T ss_dssp             -HSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTT---------
T ss_pred             -cccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHH-------HHHHHHhcC---------
Confidence             112335577899999999866 68999999999999999999 78887532211       111111111         


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      .....+...+..+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus       222 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          222 FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1112223446779999999999999999999999999988753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.1e-47  Score=355.25  Aligned_cols=278  Identities=25%  Similarity=0.341  Sum_probs=216.0

Q ss_pred             HhhhhhcccccccccceeEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEe--cC
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH--DQ  147 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~  147 (406)
                      ++...|.+.+.||+|+||.||+|.+     .+|+.||||++... .....+.+.+|++++.+++||||+++++++.  +.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            3456778889999999999999984     46889999999764 3345577999999999999999999999986  45


Q ss_pred             CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          148 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ...++||||+++++|.+++......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccce
Confidence            67899999999999999997656679999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCceE-EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhc
Q 015480          228 LCDRNKTHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCEL  306 (406)
Q Consensus       228 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (406)
                      ......... ......||..|+|||++.+. .++.++||||||+++|+|++|..|+.............. .........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~  253 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE-RDVPALSRL  253 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc-cccccHHHH
Confidence            775544332 22345688889999999876 689999999999999999999998754322100000000 000000111


Q ss_pred             chhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                      ............+..++..+.+++..||+.||.+|||+.++++.|+.+....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            1112222223344566788999999999999999999999999999986544

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.7e-46  Score=351.61  Aligned_cols=248  Identities=25%  Similarity=0.306  Sum_probs=204.4

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ..|.+.+.||+|+||+||+|+.. +|+.||+|++++..  .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            45677899999999999999764 69999999997542  2234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+++|+|.+++. ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.+|.+||+|||+++.......
T Consensus        85 E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           85 EYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             ECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             eCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            9999999999884 34679999999999999999999999   9999999999999999999999999999985433222


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                      .  ....+||+.|+|||++.+. .++.++|||||||++|||++|..||......       ..........         
T Consensus       161 ~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~---------  221 (337)
T 1o6l_A          161 T--MKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEE---------  221 (337)
T ss_dssp             C--BCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC---------
T ss_pred             c--ccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC---------
Confidence            1  2346799999999999877 7899999999999999999999998543211       1111111110         


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                       ...+...+.++.+++.+||+.||.+||     ++.++++
T Consensus       222 -~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          222 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence             112234567899999999999999999     8999887

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.1e-46  Score=346.08  Aligned_cols=262  Identities=21%  Similarity=0.262  Sum_probs=201.4

Q ss_pred             hhcccccccccceeEEEEEEeCCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      +|.+.+.||+|+||+||+|+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence            4667889999999999999888899999999975422 223467889999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++ +|.+++......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.........  
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  156 (288)
T 1ob3_A           83 DQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--  156 (288)
T ss_dssp             SE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             CC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc--
Confidence            76 9999987667789999999999999999999999   99999999999999999999999999999866533221  


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhh---hcchh-----
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC---ELGAM-----  309 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----  309 (406)
                      .....||+.|+|||++.+...++.++|||||||++|||++|..||........   ...........   .....     
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCChhhchhhhcccc
Confidence            23456899999999998765689999999999999999999999854321100   00000000000   00000     


Q ss_pred             h-------ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          310 I-------LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       310 ~-------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .       ............+..+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0       000000111235677899999999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.2e-45  Score=346.34  Aligned_cols=247  Identities=20%  Similarity=0.324  Sum_probs=203.2

Q ss_pred             hcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      +...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++......++||||++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            455678999999999999875 69999999997543 2345678999999999999999999999999999999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      +++|.+++.  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.........  .
T Consensus       126 ~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~  198 (321)
T 2c30_A          126 GGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--R  198 (321)
T ss_dssp             SCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--B
T ss_pred             CCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--c
Confidence            999999984  4579999999999999999999999   99999999999999999999999999999866543222  2


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ....||+.|+|||++.+. .++.++||||||+++|||++|+.||......       ..........       ......
T Consensus       199 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~-------~~~~~~  263 (321)
T 2c30_A          199 KSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-------QAMKRLRDSP-------PPKLKN  263 (321)
T ss_dssp             CCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSS-------CCCCTT
T ss_pred             ccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCC-------CCCcCc
Confidence            346799999999999876 7899999999999999999999998543211       1111111110       000112


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       319 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....+..+.+++.+||+.||++|||+.++++
T Consensus       264 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          264 SHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2345677999999999999999999999987

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-46  Score=347.66  Aligned_cols=262  Identities=25%  Similarity=0.344  Sum_probs=210.2

Q ss_pred             hhcccccccccceeEEEEEEeC-C---CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCee-EEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-N---GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT-ALV  153 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv  153 (406)
                      .+...+.||+|+||+||+|.+. +   +..||+|.+.........+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4455688999999999999753 2   3379999998755555668899999999999999999999999876554 899


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+.+|+|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            99999999999997777889999999999999999999999   999999999999999999999999999997554322


Q ss_pred             c--eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          234 T--HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       234 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      .  ........+|+.|+|||.+.+. .++.++||||||+++|+|++|..|+.......      .......         
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~------~~~~~~~---------  242 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF------DLTHFLA---------  242 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG------GHHHHHH---------
T ss_pred             ccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHH------HHHHHhh---------
Confidence            1  1122345678899999999876 78999999999999999999776654332211      0111111         


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCC
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP  359 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~  359 (406)
                      .......+...+..+.+++.+||+.||.+|||+.++++.|+++.....
T Consensus       243 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          243 QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            111122233456789999999999999999999999999999876543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=348.46  Aligned_cols=277  Identities=25%  Similarity=0.332  Sum_probs=205.0

Q ss_pred             eChHHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhcc--CcCccccEEEEEecC
Q 015480           70 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT--YHINLVRLYGFCHDQ  147 (406)
Q Consensus        70 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~  147 (406)
                      ..........|.+.+.||+|+||.||+|++. |+.||||++...    ....+..|.+++...  +||||+++++++.+.
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            3344455567888999999999999999884 899999998653    234455566666554  899999999999877


Q ss_pred             ----CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCC--------CeeecCCCCCcEEEcCC
Q 015480          148 ----HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ--------RIIHYDIKPENVLLDAN  215 (406)
Q Consensus       148 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~--------~i~H~dlk~~Nill~~~  215 (406)
                          ...++||||+++|+|.+++..  ..+++..+..++.|++.||+|||+   .        +++||||||+|||++.+
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~  178 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKN  178 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCC
Confidence                788999999999999999943  469999999999999999999998   6        99999999999999999


Q ss_pred             CCceEeccccccccCCCCceE--EecCCCCCCCccCccccCCCCCCCc------ccceeecchhHHHHhhcccccccCCC
Q 015480          216 FSPKVADFGLAKLCDRNKTHV--TISGYKGTPGYSAPEFLSGNYPITH------KCDVYSFGMVLFEIVGRRRNAIVGAT  287 (406)
Q Consensus       216 ~~~kl~DfGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~~DvwslG~il~elltg~~p~~~~~~  287 (406)
                      +.+||+|||++..........  ......||+.|+|||++.+. ....      ++|||||||++|||++|..|+.....
T Consensus       179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~  257 (337)
T 3mdy_A          179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE  257 (337)
T ss_dssp             SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence            999999999997665433221  12345799999999999866 3333      49999999999999999655432222


Q ss_pred             cccccchh----HHHHHHhhhhcchhhccCCCC--cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          288 ESLDWFPK----HVWEEYEKCELGAMILGCGIE--EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       288 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                      ...++...    .............. .....+  .....++..+.+++.+||+.||++|||+.+|++.|+.+.+..
T Consensus       258 ~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          258 YQLPYHDLVPSDPSYEDMREIVCIKK-LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHHTTSC-CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ccccHhhhcCCCCchhhhHHHHhhhc-cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            11111110    00111111100000 011111  112478889999999999999999999999999999886543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.9e-46  Score=356.74  Aligned_cols=276  Identities=14%  Similarity=0.192  Sum_probs=208.4

Q ss_pred             hhhhhcccccccccceeEEEEEEeCC------CcEEEEEEeccccchh----------hHHHHHHHHHHhhccCcCcccc
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRI----------AEEQFMAEVGTIGRTYHINLVR  139 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~~------g~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~  139 (406)
                      ....|.+.+.||+|+||+||+|.+.+      ++.||||++.......          ....+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34577888999999999999997754      4789999987542111          1123445666778889999999


Q ss_pred             EEEEEecC----CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc--
Q 015480          140 LYGFCHDQ----HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--  213 (406)
Q Consensus       140 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~--  213 (406)
                      +++++.+.    ...++||||+ +++|.+++......+++..+..++.|++.||+|||+   .+|+||||||+|||++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence            99998764    5589999999 999999997777889999999999999999999999   9999999999999999  


Q ss_pred             CCCCceEeccccccccCCCCceE-----EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCc
Q 015480          214 ANFSPKVADFGLAKLCDRNKTHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATE  288 (406)
Q Consensus       214 ~~~~~kl~DfGl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~  288 (406)
                      .++.+||+|||+++.........     ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            88999999999997654322111     11235599999999999877 6899999999999999999999999743222


Q ss_pred             ccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCCCC
Q 015480          289 SLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPK  362 (406)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~p~  362 (406)
                      ..  ......... ..........+.   ....++.++.+++..||+.||.+||++.+|++.|+.+......+.
T Consensus       268 ~~--~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~  335 (364)
T 3op5_A          268 PK--YVRDSKIRY-RENIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD  335 (364)
T ss_dssp             HH--HHHHHHHHH-HHCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred             HH--HHHHHHHHh-hhhHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence            10  000000110 011111111100   002235789999999999999999999999999999876655543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-46  Score=346.01  Aligned_cols=261  Identities=26%  Similarity=0.363  Sum_probs=213.1

Q ss_pred             hhhhcccc-cccccceeEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           77 NFTSNYST-RLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        77 ~~~~~~~~-~ig~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      ..++.+.+ .||+|+||.||+|.+.   ++..||+|+++........+.+.+|++++.+++||||+++++++. .+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEE
Confidence            34455555 8999999999999753   578899999987655566788999999999999999999999994 456899


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ||||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            999999999999997677789999999999999999999999   99999999999999999999999999999876544


Q ss_pred             CceE-EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          233 KTHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       233 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      .... ......+|+.|+|||++.+. .++.++||||||+++|||++ |..||......       .......        
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~i~--------  227 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIE--------  227 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHH--------
T ss_pred             cceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHh--------
Confidence            3322 12334578899999999766 68999999999999999998 99888543221       1111111        


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                       .......+..++..+.+++..||+.||.+||++.++++.|+.+....
T Consensus       228 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          228 -QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             -TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -cCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence             11122334456788999999999999999999999999999886443

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-47  Score=360.58  Aligned_cols=261  Identities=26%  Similarity=0.363  Sum_probs=199.6

Q ss_pred             hhcccccccccceeEEEEEEeC--C--CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec-CCeeEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP--N--GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-QHMTALV  153 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~--~--g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv  153 (406)
                      .|.+.+.||+|+||+||+|.+.  +  +..||+|.++........+.+.+|+.++++++||||+++++++.+ +...++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4556788999999999999753  2  246899999765555567889999999999999999999998754 5678999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+++|+|.+++......+++..+..++.|+++||+|||+   .+++||||||+|||++.++.+||+|||+++......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            99999999999997777789999999999999999999999   999999999999999999999999999998654332


Q ss_pred             ce--EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          234 TH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       234 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      ..  .......+|+.|+|||++.+. .++.++|||||||++|||++ |.+||.......       .......       
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-------~~~~~~~-------  311 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQ-------  311 (373)
T ss_dssp             -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-------HHHHHHT-------
T ss_pred             cccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-------HHHHHHc-------
Confidence            11  112335578899999999876 78999999999999999999 555553322111       0011111       


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCC
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP  359 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~  359 (406)
                        ......+..++..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus       312 --~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          312 --GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             --CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence              11122233456789999999999999999999999999999875544

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=347.26  Aligned_cols=251  Identities=22%  Similarity=0.334  Sum_probs=204.7

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccch-----hhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      ..|.+.+.||+|+||.||+|... +|+.||+|++......     ...+.+.+|+.++..++||||+++++++.+....+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45778899999999999999764 6899999999754221     24578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC----CceEecccccc
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----SPKVADFGLAK  227 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~DfGl~~  227 (406)
                      +||||+++++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+|||++.++    .+||+|||++.
T Consensus        91 lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           91 LILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEECCCSCBHHHHHT-TSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCCHHHHHH-hcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            9999999999999994 45679999999999999999999999   9999999999999999887    79999999998


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      .......   .....||+.|+|||++.+. .++.++|||||||++|+|++|..||......       ........... 
T Consensus       167 ~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~~-  234 (326)
T 2y0a_A          167 KIDFGNE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANVSAVNY-  234 (326)
T ss_dssp             ECCTTSC---CCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHTCC-
T ss_pred             ECCCCCc---cccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-------HHHHHHHhcCC-
Confidence            7654322   2345799999999999876 7899999999999999999999998543211       01111111100 


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                           ..........+..+.+++.+||+.||.+|||+.++++
T Consensus       235 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          235 -----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -----CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 0001112234577899999999999999999999998

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.5e-45  Score=340.07  Aligned_cols=257  Identities=28%  Similarity=0.435  Sum_probs=207.2

Q ss_pred             HhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhh------HHHHHHHHHHhhccCcCccccEEEEEecC
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIA------EEQFMAEVGTIGRTYHINLVRLYGFCHDQ  147 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~  147 (406)
                      +...+|.+.+.||+|+||+||+|.+ .+++.||+|++........      .+.+.+|+.++.+++||||+++++++.+.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            4456778889999999999999976 5789999999865322111      16789999999999999999999999776


Q ss_pred             CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCC--eeecCCCCCcEEEcCCCC-----ceE
Q 015480          148 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLDANFS-----PKV  220 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--i~H~dlk~~Nill~~~~~-----~kl  220 (406)
                      .  ++||||+++|+|.+++......+++..+..++.|++.||+|||+   .+  ++||||||+|||++.++.     +||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            5  69999999999999997777889999999999999999999999   88  999999999999988776     999


Q ss_pred             eccccccccCCCCceEEecCCCCCCCccCccccCC-CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHH
Q 015480          221 ADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG-NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWE  299 (406)
Q Consensus       221 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  299 (406)
                      +|||+++.....     .....||+.|+|||++.. ...++.++||||||+++|||++|..||.........     ...
T Consensus       171 ~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~  240 (287)
T 4f0f_A          171 ADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-----FIN  240 (287)
T ss_dssp             CCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-----HHH
T ss_pred             CCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-----HHH
Confidence            999999744332     234678999999999843 235789999999999999999999998643322111     011


Q ss_pred             HHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          300 EYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      ....        .......+..++..+.+++..||+.||.+|||+.++++.|+++
T Consensus       241 ~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          241 MIRE--------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHH--------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHhc--------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            1111        1111233345567899999999999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.8e-46  Score=355.50  Aligned_cols=256  Identities=22%  Similarity=0.265  Sum_probs=202.2

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  152 (406)
                      -..|.+.+.||+|+||+||+|+.. +|+.||+|++++...  ......+..|..++.++ +||||+++++++.+....++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            345778899999999999999764 588999999986432  12234578899999887 79999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ||||+++|+|..++. ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.+|.+||+|||+++.....
T Consensus       131 V~E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            999999999999984 34579999999999999999999999   99999999999999999999999999999853322


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc--chhHHHHHHhhhhcchhh
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW--FPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  310 (406)
                      ..  .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..........  ......+.....      
T Consensus       207 ~~--~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------  277 (396)
T 4dc2_A          207 GD--TTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------  277 (396)
T ss_dssp             TC--CBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC------
T ss_pred             CC--ccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc------
Confidence            22  13457899999999999887 78999999999999999999999996432221110  011111111111      


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCCh------HHHHH
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPM------SAVIK  349 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~~vl~  349 (406)
                          ....+...+.++.+|+.+||+.||.+||++      .+|++
T Consensus       278 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          278 ----QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             ----ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence                112233456789999999999999999996      56665

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.9e-45  Score=337.29  Aligned_cols=254  Identities=24%  Similarity=0.296  Sum_probs=207.8

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      ..|.+.+.||+|+||.||+|... +|+.||+|++.........+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            45677889999999999999764 68999999997654445567899999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +++++|.+++ .....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++..........
T Consensus        87 ~~~~~L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           87 CSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             CTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCcHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            9999999998 445679999999999999999999999   999999999999999999999999999998654433322


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                      ......||+.|+|||.+.+....+.++||||||+++|||++|..||.........      ...+...        ....
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~--------~~~~  228 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEK--------KTYL  228 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH------HHHHHTT--------CTTS
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHhhhc--------cccc
Confidence            2345678999999999987644578999999999999999999998654322111      1111110        0011


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ......+..+.+++.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            112345677899999999999999999999876

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.9e-46  Score=353.48  Aligned_cols=265  Identities=23%  Similarity=0.336  Sum_probs=214.5

Q ss_pred             hHHHhhhhhcccccccccceeEEEEEEeCC-C-----cEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEE
Q 015480           72 SLQLNNFTSNYSTRLGFGGFGEVYKGQFPN-G-----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFC  144 (406)
Q Consensus        72 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-g-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  144 (406)
                      ..++....|.+.+.||+|+||+||+|.+.. |     ..||+|++.........+.+.+|+.++..+ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            345556677888999999999999997632 2     479999998765555667899999999999 899999999999


Q ss_pred             ecCCeeEEEEEeccCCChhhHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEE
Q 015480          145 HDQHMTALVYEYMENGSLDGYLFGK-------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVL  211 (406)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nil  211 (406)
                      .+....++||||+++|+|.+++...             ...+++..+..++.|++.||+|||+   .+++||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEE
Confidence            9999999999999999999998532             3468999999999999999999999   99999999999999


Q ss_pred             EcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCccc
Q 015480          212 LDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESL  290 (406)
Q Consensus       212 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~  290 (406)
                      ++.++.+||+|||++................||+.|+|||++.+. .++.++||||||+++|||++ |..||......  
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--  273 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--  273 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchh--
Confidence            999999999999999866544443334455678899999998876 68999999999999999998 88887533221  


Q ss_pred             ccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          291 DWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                          ..........         .....+...+..+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus       274 ----~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          274 ----SKFYKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             ----HHHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence                1111111111         111122334577999999999999999999999999998764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=351.08  Aligned_cols=269  Identities=22%  Similarity=0.275  Sum_probs=199.5

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      +|.+.+.||+|+||+||+|... +|+.||+|++...........+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   82 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence            4667889999999999999764 689999999975433222234567999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      + |+|.+++......+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++.........  
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--  156 (324)
T 3mtl_A           83 D-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--  156 (324)
T ss_dssp             S-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc--
Confidence            7 49999987777789999999999999999999999   99999999999999999999999999999755433221  


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHh------------hhh
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE------------KCE  305 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------~~~  305 (406)
                      .....||+.|+|||++.+...++.++|||||||++|||++|+.||........   .........            ...
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHhchhhhcchh
Confidence            23456899999999998755789999999999999999999999854322110   000000000            000


Q ss_pred             cchhhccCCC----CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcccc
Q 015480          306 LGAMILGCGI----EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVVE  356 (406)
Q Consensus       306 ~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~~  356 (406)
                      ..........    .......+..+.+|+.+||+.||.+|||+.|+++  .+..+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            0000000000    0111234577899999999999999999999998  5555543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.7e-46  Score=350.60  Aligned_cols=247  Identities=23%  Similarity=0.333  Sum_probs=202.8

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ..|.+.+.||+|+||+||+|.+ .+|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            3567788999999999999976 6789999999975321  122357889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+ +|+|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++........
T Consensus        89 E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~  163 (336)
T 3h4j_B           89 EYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF  163 (336)
T ss_dssp             CCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred             ECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence            999 6799888843 4579999999999999999999999   8999999999999999999999999999986654322


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                         ....+||+.|+|||++.+....++++|||||||++|+|++|..||.........                ..+. ..
T Consensus       164 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~-~~  223 (336)
T 3h4j_B          164 ---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVN-SC  223 (336)
T ss_dssp             ---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCC-SS
T ss_pred             ---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHH-cC
Confidence               234679999999999988744588999999999999999999998654322111                0000 01


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....+...+..+.+++.+||+.||.+|||+.++++
T Consensus       224 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          224 VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            11223345677999999999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.3e-46  Score=344.00  Aligned_cols=262  Identities=31%  Similarity=0.471  Sum_probs=212.5

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      +++...+|.+.+.||+|+||.||+|.+.++..||+|++....  ...+.+.+|++++.+++||||+++++++.+ +..++
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence            445567788899999999999999998888899999997643  245679999999999999999999999875 45789


Q ss_pred             EEEeccCCChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          153 VYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      ||||+++++|.+++.... ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            999999999999995432 379999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      .... ......++..|+|||.+.+. .++.++||||||+++|||++ |..||......       ........       
T Consensus       162 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~-------  225 (279)
T 1qpc_A          162 NEYT-AREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-------EVIQNLER-------  225 (279)
T ss_dssp             SCEE-CCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHT-------
T ss_pred             cccc-cccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-------HHHHHHhc-------
Confidence            3322 22345578899999999766 68999999999999999999 88887432111       11111111       


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                        ......+...+..+.+++..||+.||.+|||+.++++.|+.+....
T Consensus       226 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          226 --GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence              1111223345678999999999999999999999999999886443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.4e-45  Score=341.16  Aligned_cols=263  Identities=20%  Similarity=0.261  Sum_probs=204.2

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      +|.+.+.||+|+||+||+|.+ .+|+.||+|++.... .......+.+|+.++++++||||+++++++.++...++||||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   82 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence            467788999999999999976 468999999997543 233457788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +++ +|.+++......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++......... 
T Consensus        83 ~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  157 (292)
T 3o0g_A           83 CDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-  157 (292)
T ss_dssp             CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC-
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc-
Confidence            976 6666665667789999999999999999999999   99999999999999999999999999999866533222 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhh---hc---chh-
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC---EL---GAM-  309 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~---~~~-  309 (406)
                       .....||+.|+|||++.+...++.++|||||||++|||++|..|+..+......  ...........   ..   ... 
T Consensus       158 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGGGST
T ss_pred             -ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHHhCCCChhhhhhhcccc
Confidence             234578999999999987755899999999999999999998886543321100  00000000000   00   000 


Q ss_pred             --------hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          310 --------ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       310 --------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                              .............+..+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                    0000111222345678899999999999999999999987

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2e-46  Score=345.93  Aligned_cols=264  Identities=27%  Similarity=0.427  Sum_probs=218.2

Q ss_pred             eChHHHhhhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           70 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        70 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      +..+++....|.+.+.||+|+||.||+|.+. ++..||+|++....  ...+.+.+|+.++++++||||+++++++.+..
T Consensus         5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A            5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            4556677788899999999999999999775 48899999997642  35678999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          149 MTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ..++||||+++++|.+++.. ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSR  159 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccce
Confidence            99999999999999999965 34669999999999999999999999   899999999999999999999999999998


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhc
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCEL  306 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (406)
                      ........ ......+|+.|+|||.+.+. .++.++||||||+++|+|++ |..||......       ...+...    
T Consensus       160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-------~~~~~~~----  226 (288)
T 3kfa_A          160 LMTGDTYT-AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLE----  226 (288)
T ss_dssp             TSCSSSSE-EETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------GHHHHHH----
T ss_pred             eccCCccc-cccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHh----
Confidence            76544332 23445578899999999876 78999999999999999999 88877533211       1111111    


Q ss_pred             chhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                           .......+...+..+.+++..||+.||.+|||+.++++.|+.+..
T Consensus       227 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          227 -----KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             -----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence                 111122334456789999999999999999999999999988753

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9e-46  Score=345.06  Aligned_cols=258  Identities=28%  Similarity=0.494  Sum_probs=202.4

Q ss_pred             hhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      ...|.+.+.||+|+||+||+|++ .++.||+|++...   ...+.+.+|++++++++||||+++++++.+  ..++||||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            34567788999999999999988 4788999998753   345789999999999999999999998874  47899999


Q ss_pred             ccCCChhhHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC-ceEeccccccccCCCC
Q 015480          157 MENGSLDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS-PKVADFGLAKLCDRNK  233 (406)
Q Consensus       157 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-~kl~DfGl~~~~~~~~  233 (406)
                      +++|+|.+++....  ..+++..+..++.|+++||+|||+...++++||||||+|||++.++. +||+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~  160 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM  160 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc
Confidence            99999999996543  25789999999999999999999744368999999999999998887 7999999997554321


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                           ....||+.|+|||++.+. .++.++||||||+++|||++|+.||........    ...+ ..         ...
T Consensus       161 -----~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~-~~---------~~~  220 (307)
T 2eva_A          161 -----TNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMW-AV---------HNG  220 (307)
T ss_dssp             ---------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHH-HH---------HTT
T ss_pred             -----ccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHH-HH---------hcC
Confidence                 234589999999999876 789999999999999999999999864322110    0000 00         111


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCC
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPP  360 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~  360 (406)
                      .........+..+.+++.+||+.||.+|||+.++++.|+.+....+.
T Consensus       221 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence            12223344567899999999999999999999999999998765544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.6e-46  Score=354.05  Aligned_cols=253  Identities=24%  Similarity=0.319  Sum_probs=205.4

Q ss_pred             hhhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      .-..|.+.+.||+|+||.||+|.. .+|+.||+|++....  .......+.+|+.++..++||||+++++++.+....++
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            345677889999999999999976 458999999997532  22345678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ||||+.+|+|.+++. ....+++..+..++.|++.||.|||+   .||+||||||+|||++.+|.+||+|||++......
T Consensus        93 v~e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQ-QNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EECCCTTEEHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            999999999999994 45679999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CceEEecCCCCCCCccCccccCCC--CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      ..   .....||+.|+|||++.+.  ..++.++|||||||++|||++|..||.........    .........      
T Consensus       169 ~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~----~~~~~~~~~------  235 (384)
T 4fr4_A          169 TQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK----EIVHTFETT------  235 (384)
T ss_dssp             CC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH----HHHHHHHHC------
T ss_pred             Cc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH----HHHHHHhhc------
Confidence            32   2456799999999998742  25899999999999999999999999643322111    111111110      


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCC-hHHHHH
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPP-MSAVIK  349 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~~vl~  349 (406)
                          ....+...+..+.+++.+||+.||.+||+ ++++++
T Consensus       236 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 ----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                11223345678999999999999999998 667665

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.6e-46  Score=340.47  Aligned_cols=252  Identities=25%  Similarity=0.377  Sum_probs=195.0

Q ss_pred             hhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccc---hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG---RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ...|.+.+.||+|+||.||+|.+ +|+.||+|+++....   ....+.+.+|+++++.++||||+++++++.+....++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            34567788999999999999988 488999999875422   22346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCC---eeecCCCCCcEEEcC--------CCCceEec
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR---IIHYDIKPENVLLDA--------NFSPKVAD  222 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~---i~H~dlk~~Nill~~--------~~~~kl~D  222 (406)
                      |||+++++|.+++  ....+++..+..++.|++.||+|||+   .+   ++||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999998  35679999999999999999999999   77   999999999999986        77899999


Q ss_pred             cccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHh
Q 015480          223 FGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE  302 (406)
Q Consensus       223 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  302 (406)
                      ||++........    ....||+.|+|||.+.+. .++.++||||||+++|+|++|+.||......       ...... 
T Consensus       160 fg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~-  226 (271)
T 3dtc_A          160 FGLAREWHRTTK----MSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-------AVAYGV-  226 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHH-
T ss_pred             CCcccccccccc----cCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHhh-
Confidence            999976543322    235689999999999876 7899999999999999999999998532211       000000 


Q ss_pred             hhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                             .........+..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       227 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          227 -------AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -------HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -------hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                   011111223344567899999999999999999999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=342.11  Aligned_cols=250  Identities=24%  Similarity=0.295  Sum_probs=196.7

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccch-------------------------hhHHHHHHHHHHhhc
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGR-------------------------IAEEQFMAEVGTIGR  131 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~l~~  131 (406)
                      ..|.+.+.||+|+||.||+|.. .+|+.||||++......                         ...+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            4577788999999999999976 46899999998753211                         123568899999999


Q ss_pred             cCcCccccEEEEEec--CCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCc
Q 015480          132 TYHINLVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN  209 (406)
Q Consensus       132 l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~N  209 (406)
                      ++||||+++++++.+  ....++||||+++++|.+++  ....+++..+..++.|++.||+|||+   .+++||||||+|
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N  167 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSN  167 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHH
Confidence            999999999999986  56889999999999998875  45679999999999999999999999   999999999999


Q ss_pred             EEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCC--CCcccceeecchhHHHHhhcccccccCCC
Q 015480          210 VLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP--ITHKCDVYSFGMVLFEIVGRRRNAIVGAT  287 (406)
Q Consensus       210 ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~  287 (406)
                      ||++.++.+||+|||++.........  .....||+.|+|||++.+...  ++.++|||||||++|||++|..||.....
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            99999999999999999876543322  245679999999999976532  47889999999999999999999854321


Q ss_pred             cccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          288 ESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .       ...........        ........+..+.+++.+||+.||.+|||+.++++
T Consensus       246 ~-------~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          246 M-------CLHSKIKSQAL--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             H-------HHHHHHHHCCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             H-------HHHHHHhcccC--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            0       11111111100        01111234577999999999999999999999875

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2e-45  Score=350.26  Aligned_cols=252  Identities=21%  Similarity=0.323  Sum_probs=205.6

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ...|.+.+.||+|+||.||+|.. .+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            45678889999999999999976 468999999997542 3344577899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC---CceEeccccccccCC
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKLCDR  231 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~DfGl~~~~~~  231 (406)
                      ||+++|+|.+++. ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++   .+||+|||++.....
T Consensus       108 e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          108 DLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CCCCSCBHHHHHT-TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             ecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            9999999999984 45679999999999999999999999   9999999999999998654   599999999986654


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ...   .....||+.|+|||++.+. .++.++|||||||++|+|++|..||......       ............    
T Consensus       184 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~~----  248 (362)
T 2bdw_A          184 SEA---WHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGAYD----  248 (362)
T ss_dssp             CCS---CCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC----
T ss_pred             Ccc---cccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCCC----
Confidence            322   2346799999999999876 7899999999999999999999998543211       111111111100    


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        .........+..+.+++.+||+.||.+||++.++++
T Consensus       249 --~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          249 --YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             --CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              001122345678999999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.9e-46  Score=348.34  Aligned_cols=270  Identities=24%  Similarity=0.368  Sum_probs=204.3

Q ss_pred             eChHHHhhhhhcccccccccceeEEEEEEeC----CCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEE
Q 015480           70 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFC  144 (406)
Q Consensus        70 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~----~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  144 (406)
                      +....+....|.+.+.||+|+||.||+|.+.    ++..||+|++.... .....+.+.+|+.++.+++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            4455566777888999999999999999653    35589999997542 334457799999999999999999999999


Q ss_pred             ecCC-----eeEEEEEeccCCChhhHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC
Q 015480          145 HDQH-----MTALVYEYMENGSLDGYLFG-----KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA  214 (406)
Q Consensus       145 ~~~~-----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~  214 (406)
                      .+..     ..++||||+++|+|.+++..     ....+++..++.++.|+++||.|||+   .+++||||||+||+++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~  182 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRD  182 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcC
Confidence            8755     35899999999999999842     34679999999999999999999999   99999999999999999


Q ss_pred             CCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccc
Q 015480          215 NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWF  293 (406)
Q Consensus       215 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~  293 (406)
                      ++.+||+|||++................+++.|+|||.+.+. .++.++||||||+++|||++ |..||.......    
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  257 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE----  257 (313)
T ss_dssp             TSCEEECSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----
T ss_pred             CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHH----
Confidence            999999999999866544332223345678899999999876 78999999999999999999 777774332210    


Q ss_pred             hhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCC
Q 015480          294 PKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP  359 (406)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~  359 (406)
                         ......         .......+..++..+.+++.+||+.||.+|||+.++++.|+.+....|
T Consensus       258 ---~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          258 ---MYDYLL---------HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             ---HHHHHH---------TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             ---HHHHHH---------cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence               111111         111123334566789999999999999999999999999998875543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-45  Score=351.65  Aligned_cols=251  Identities=20%  Similarity=0.285  Sum_probs=206.0

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      ..|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++..++||||+++++++.+....++||||
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            4577889999999999999976 468999999997542 23456789999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC--CCCceEeccccccccCCCCc
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA--NFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~--~~~~kl~DfGl~~~~~~~~~  234 (406)
                      +++|+|.+++......+++..+..++.|++.||+|||+   .+|+||||||+|||++.  ++.+||+|||++........
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            99999999996666689999999999999999999999   99999999999999974  57899999999987655433


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                      ..   ...||+.|+|||++.+. .++.++|||||||++|||++|..||......       ...........      ..
T Consensus       207 ~~---~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~i~~~~~------~~  269 (387)
T 1kob_A          207 VK---VTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKRCDW------EF  269 (387)
T ss_dssp             EE---EECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHCCC------CC
T ss_pred             ee---eeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC------CC
Confidence            22   24689999999999876 7899999999999999999999998543211       11111111110      00


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ........+.++.+++.+||+.||.+|||+.++++
T Consensus       270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            11222345678999999999999999999999998

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=342.95  Aligned_cols=248  Identities=25%  Similarity=0.318  Sum_probs=197.8

Q ss_pred             HhhhhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  151 (406)
                      +....|...++||+|+||+||+|.+. +|+.||||++.... .......+..|+..+..+ +||||++++++|.+....+
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            34466888899999999999999775 69999999986532 223344556666666655 8999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +||||+ +++|.+++......+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.....
T Consensus       134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999999 669999987667789999999999999999999999   9999999999999999999999999999976654


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ...   .....||+.|+|||++.+  .++.++|||||||++|||++|..++...          ..+........     
T Consensus       210 ~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~-----  269 (311)
T 3p1a_A          210 AGA---GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYL-----  269 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCC-----
T ss_pred             CCC---CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCC-----
Confidence            322   234569999999999876  5899999999999999999997665321          11122111110     


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                         ........+..+.+++.+||+.||++|||+.++++
T Consensus       270 ---~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 ---PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence               01122345678999999999999999999999986

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=357.91  Aligned_cols=253  Identities=19%  Similarity=0.260  Sum_probs=204.6

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ...|.+.+.||+|+||+||+|.. .+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            45678889999999999999965 579999999997543 2334567899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc---CCCCceEeccccccccCC
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~DfGl~~~~~~  231 (406)
                      |||++|+|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++   .++.+||+|||++.....
T Consensus        90 E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~  165 (444)
T 3soa_A           90 DLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG  165 (444)
T ss_dssp             CCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred             EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence            99999999999854 4579999999999999999999999   9999999999999998   567899999999986654


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ....  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||......       ............    
T Consensus       166 ~~~~--~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~----  231 (444)
T 3soa_A          166 EQQA--WFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQH-------RLYQQIKAGAYD----  231 (444)
T ss_dssp             TCCB--CCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCCC----
T ss_pred             CCce--eecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHhCCCC----
Confidence            4322  2346799999999999876 7899999999999999999999998543211       111221111110    


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        .........+..+.+++..||+.||.+|||+.++++
T Consensus       232 --~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          232 --FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             --CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence              001112345678999999999999999999999998

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.6e-46  Score=343.20  Aligned_cols=259  Identities=24%  Similarity=0.343  Sum_probs=207.8

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      +....|.+.+.||+|+||+||+|.+.+    +..||+|++.........+.+.+|+.+++.++||||+++++++.++ ..
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~   87 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence            345567788999999999999997532    3469999998765555678899999999999999999999998764 56


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ++||||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            89999999999999997666779999999999999999999999   999999999999999999999999999998665


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ..... ......+++.|+|||++.+. .++.++||||||+++|||++ |+.||.......       ........     
T Consensus       165 ~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-------~~~~~~~~-----  230 (281)
T 3cc6_A          165 DEDYY-KASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-------VIGVLEKG-----  230 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-------HHHHHHHT-----
T ss_pred             ccccc-ccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHH-------HHHHHhcC-----
Confidence            43221 12345578899999999766 78999999999999999998 999885432211       11111111     


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                          .....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       231 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          231 ----DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence                111222345677999999999999999999999999998874

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.5e-46  Score=347.57  Aligned_cols=262  Identities=24%  Similarity=0.345  Sum_probs=190.9

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|.+.+.||+|+||+||+|.. .+|+.||+|+++..........+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   85 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM   85 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence            466778899999999999976 4689999999976544444567889999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          158 ENGSLDGYLFGK-----KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       158 ~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      + |+|.+++...     ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++......
T Consensus        86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            8 5999988432     2468999999999999999999999   99999999999999999999999999999866533


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhh--------
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC--------  304 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------  304 (406)
                      ...  .....||+.|+|||++.+...++.++|||||||++|||++|+.||........   ...........        
T Consensus       162 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          162 VNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             CCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGGG
T ss_pred             ccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhhh
Confidence            221  23456899999999998755689999999999999999999999864322110   00000000000        


Q ss_pred             -hcchh---hccCCCC--------cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          305 -ELGAM---ILGCGIE--------EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       305 -~~~~~---~~~~~~~--------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       .....   .......        ......+..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence             00000   0000000        001124567999999999999999999999886

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=351.55  Aligned_cols=277  Identities=24%  Similarity=0.361  Sum_probs=214.1

Q ss_pred             HHhhhhhcccccccccceeEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      .+....|.+.+.||+|+||.||+|++     .+|+.||+|++... .....+.+.+|+.++++++||||+++++++....
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            34456678889999999999999973     46899999999764 3345678999999999999999999999987654


Q ss_pred             --eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccc
Q 015480          149 --MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  226 (406)
Q Consensus       149 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~  226 (406)
                        ..++||||+++++|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcch
Confidence              7899999999999999997777789999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCceEE-ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhh
Q 015480          227 KLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCE  305 (406)
Q Consensus       227 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (406)
                      ........... .....++..|+|||.+.+. .++.++||||||+++|||++|..|+.......................
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            87765443322 2334577889999998876 689999999999999999999988643211000000000000000001


Q ss_pred             cchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          306 LGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      +...+........+..++..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11111122222334456788999999999999999999999999998874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.7e-46  Score=376.31  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=203.3

Q ss_pred             cccccceeEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCC
Q 015480           85 RLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  161 (406)
                      .||+|+||.||+|.+.   ++..||||+++........+.+.+|+++|++++||||+++++++.+ +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999999763   4677999999876555567889999999999999999999999987 56899999999999


Q ss_pred             hhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE-EecC
Q 015480          162 LDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV-TISG  240 (406)
Q Consensus       162 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~  240 (406)
                      |.+++......+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++......... ....
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            999997777789999999999999999999999   999999999999999999999999999998765332211 1123


Q ss_pred             CCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          241 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       241 ~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ..+++.|+|||++.+. .++.++|||||||++|||++ |+.||......       .......         .......+
T Consensus       499 ~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~---------~~~~~~~p  561 (613)
T 2ozo_A          499 GKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIE---------QGKRMECP  561 (613)
T ss_dssp             ---CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-------HHHHHHH---------TTCCCCCC
T ss_pred             CCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHH---------cCCCCCCC
Confidence            3467899999999876 78999999999999999998 99888543221       1111111         11222334


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      ..++..+.+++..||+.||.+||++.+|++.|+.+.
T Consensus       562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            456788999999999999999999999999999874

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.5e-45  Score=346.27  Aligned_cols=255  Identities=22%  Similarity=0.275  Sum_probs=202.9

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ..|.+.+.||+|+||.||+|+.. +|+.||+|++.+..  .......+.+|..++.++ +||||+++++++.+....++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            35677889999999999999764 58999999997643  233456788999999887 899999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+++|+|.+++. ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.+|.+||+|||+++......
T Consensus        89 ~e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             ECCCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            99999999999984 34579999999999999999999999   999999999999999999999999999998543222


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc--chhHHHHHHhhhhcchhhc
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW--FPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  311 (406)
                      .  .....+||+.|+|||++.+. .++.++|||||||++|||++|..||..........  ............       
T Consensus       165 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-------  234 (345)
T 3a8x_A          165 D--TTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------  234 (345)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-------
T ss_pred             C--cccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-------
Confidence            1  12456799999999999876 78999999999999999999999996432221110  011111111111       


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCCh------HHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPM------SAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~~vl~  349 (406)
                         ....+...+..+.+++.+||+.||.+||++      .++++
T Consensus       235 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          235 ---QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             ---CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence               012233456789999999999999999996      56655

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.5e-45  Score=336.75  Aligned_cols=254  Identities=21%  Similarity=0.333  Sum_probs=206.0

Q ss_pred             hhhhcccccccccceeEEEEEEeCCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecC--CeeEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTALV  153 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  153 (406)
                      -.+|.+.+.||+|+||+||+|++ +|+.||+|++.... .....+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            34567788999999999999998 48899999997543 334557799999999999999999999999887  788999


Q ss_pred             EEeccCCChhhHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHHhcCCC--eeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          154 YEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~--i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      |||+++|+|.+++..... .+++..+..++.|++.||+|||+   .+  ++||||||+||+++.++.++|+|||+.....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999965443 69999999999999999999998   88  9999999999999999999999998875433


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCC--CCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      .       ....||+.|+|||.+.+..  .++.++||||||+++|||++|..||......       ......       
T Consensus       165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~-------  223 (271)
T 3kmu_A          165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------EIGMKV-------  223 (271)
T ss_dssp             C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------HHHHHH-------
T ss_pred             c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------HHHHHH-------
Confidence            2       2346899999999987652  2334899999999999999999998532211       000111       


Q ss_pred             hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                       .........+...+..+.+++..||+.||.+|||+.++++.|+.+.+
T Consensus       224 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          224 -ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence             11111223334566789999999999999999999999999988753

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2e-46  Score=346.08  Aligned_cols=257  Identities=25%  Similarity=0.373  Sum_probs=206.0

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCC-C-------cEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPN-G-------VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD  146 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  146 (406)
                      +...+|.+.+.||+|+||+||+|.+.. +       ..||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            345667888999999999999996543 3       47999999754 23456789999999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC--------c
Q 015480          147 QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS--------P  218 (406)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--------~  218 (406)
                      ....++||||+++|+|.+++......+++..+..++.|++.||+|||+   ++++||||||+|||++.++.        +
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence            999999999999999999997766679999999999999999999999   99999999999999998887        9


Q ss_pred             eEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHH
Q 015480          219 KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVW  298 (406)
Q Consensus       219 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  298 (406)
                      ||+|||++.......      ...||+.|+|||++.+...++.++||||||+++|||++|..|+.......      ...
T Consensus       161 kl~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~------~~~  228 (289)
T 4fvq_A          161 KLSDPGISITVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ------RKL  228 (289)
T ss_dssp             EECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHH
T ss_pred             eeccCcccccccCcc------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH------HHH
Confidence            999999997543321      23478899999999874478999999999999999999765543322110      000


Q ss_pred             HHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          299 EEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                      .....        .   ...+...+..+.+++..||+.||.+|||+.++++.|+.+....
T Consensus       229 ~~~~~--------~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          229 QFYED--------R---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             HHHHT--------T---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             HHhhc--------c---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            11100        0   1111122456899999999999999999999999999997543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.6e-46  Score=350.08  Aligned_cols=263  Identities=27%  Similarity=0.377  Sum_probs=208.2

Q ss_pred             HHhhhhhcccccccccceeEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecC
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ  147 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  147 (406)
                      ++...+|.+.+.||+|+||.||+|.+      .+++.||||++...........+.+|+.++.+++||||+++++++.+.
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            34556778889999999999999974      347789999997655556667899999999999999999999999999


Q ss_pred             CeeEEEEEeccCCChhhHhhcCC------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC---CCCc
Q 015480          148 HMTALVYEYMENGSLDGYLFGKK------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSP  218 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~  218 (406)
                      ...++||||+++++|.+++....      ..+++..++.++.|++.||.|||+   .+++||||||+|||++.   +..+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceE
Confidence            99999999999999999996443      458999999999999999999999   99999999999999984   4469


Q ss_pred             eEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHH
Q 015480          219 KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHV  297 (406)
Q Consensus       219 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  297 (406)
                      ||+|||++................||+.|+|||++.+. .++.++||||||+++|||++ |..||......       ..
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~  254 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EV  254 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HH
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-------HH
Confidence            99999999865443333223345678899999998776 68999999999999999998 88877432211       11


Q ss_pred             HHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          298 WEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      .....         .......+..++..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus       255 ~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          255 LEFVT---------SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHh---------cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            11111         111122334456789999999999999999999999999988754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=9.2e-46  Score=351.10  Aligned_cols=250  Identities=25%  Similarity=0.294  Sum_probs=199.3

Q ss_pred             hhhhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeE
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  151 (406)
                      .-..|.+.+.||+|+||+||+|+.. +|+.||||++++..  .....+.+..|..++..+ +||||+++++++.+....+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3445778899999999999999764 58999999997542  223456788899999988 6999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +||||+++|+|.+++. ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.+|.+||+|||+++....
T Consensus       101 lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQ-KSRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            9999999999999984 34679999999999999999999999   9999999999999999999999999999975433


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ...  .....+||+.|+|||++.+. .++.++|||||||++|||++|..||......       ..........      
T Consensus       177 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~~------  240 (353)
T 3txo_A          177 NGV--TTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAILNDE------  240 (353)
T ss_dssp             -----------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC------
T ss_pred             CCc--cccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCC------
Confidence            222  22346799999999999876 7899999999999999999999998543221       1111111111      


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCCh------HHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPM------SAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~~vl~  349 (406)
                          ...+...+..+.+++.+||+.||.+||++      .++++
T Consensus       241 ----~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 ----VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                11223356778999999999999999998      67766

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.5e-45  Score=344.69  Aligned_cols=249  Identities=23%  Similarity=0.286  Sum_probs=180.9

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEEEeccCCC
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~  161 (406)
                      +.||+|+||+||+|.+ .+|+.||||++...    ....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            6799999999999976 46899999999753    4566788999999997 9999999999999999999999999999


Q ss_pred             hhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC---CceEeccccccccCCCCceEEe
Q 015480          162 LDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       162 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      |.+++.. ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++   .+||+|||+++........  .
T Consensus        93 L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--~  166 (325)
T 3kn6_A           93 LFERIKK-KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--L  166 (325)
T ss_dssp             HHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--c
Confidence            9999954 4679999999999999999999999   9999999999999998766   7999999999865443222  2


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK  318 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (406)
                      ....||+.|+|||++.+. .++.++|||||||++|+|++|..||........................      ......
T Consensus       167 ~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~  239 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEA  239 (325)
T ss_dssp             -----------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHH
T ss_pred             cccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCccc
Confidence            345689999999999876 7899999999999999999999998654332111111111111111100      001122


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       319 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....+.++.+++..||+.||.+|||+.++++
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            2346788999999999999999999999875

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.1e-45  Score=345.73  Aligned_cols=257  Identities=20%  Similarity=0.244  Sum_probs=205.5

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc----chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL----GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      ...|.+.+.||+|+||+||+|.. .+|+.||||++....    .....+.+.+|+.++..++||||+++++++.++...+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45678889999999999999976 468999999986421    1124577999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC---ceEecccc
Q 015480          152 LVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---PKVADFGL  225 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~DfGl  225 (406)
                      +|||||++++|.+++..   ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            99999999999888743   24468999999999999999999999   99999999999999987654   99999999


Q ss_pred             ccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhh
Q 015480          226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCE  305 (406)
Q Consensus       226 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (406)
                      +.........  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.....        ..........
T Consensus       180 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~i~~~~  248 (351)
T 3c0i_A          180 AIQLGESGLV--AGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RLFEGIIKGK  248 (351)
T ss_dssp             CEECCTTSCB--CCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HHHHHHHHTC
T ss_pred             eeEecCCCee--ecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HHHHHHHcCC
Confidence            9876543321  2346799999999999876 689999999999999999999999854211        1111111111


Q ss_pred             cchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhc
Q 015480          306 LGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEG  353 (406)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~  353 (406)
                      ..      .........+..+.+++.+||+.||++|||+.++++  .+..
T Consensus       249 ~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          249 YK------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             CC------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             CC------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            00      000111234678999999999999999999999987  4443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=349.03  Aligned_cols=255  Identities=21%  Similarity=0.284  Sum_probs=197.6

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCc--CccccEEEEEecCCeeE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYH--INLVRLYGFCHDQHMTA  151 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~  151 (406)
                      +....|.+.+.||+|+||.||++...+++.||||++.... .....+.+.+|+.++..++|  |||+++++++.++...+
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            3455678889999999999999988889999999987542 33445788999999999976  99999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +|||+ .+++|.+++.. ...+++..+..++.|++.||+|||+   .+|+||||||+|||++ ++.+||+|||+++....
T Consensus        86 lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           86 MVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             EEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99994 57899999954 5679999999999999999999999   9999999999999997 67899999999987655


Q ss_pred             CCceEEecCCCCCCCccCccccCC----------CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHH
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSG----------NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEY  301 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  301 (406)
                      ...........||+.|+|||++.+          ...++.++|||||||++|||++|+.||.......         ...
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---------~~~  230 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---------SKL  230 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---------HHH
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH---------HHH
Confidence            443333345679999999999853          1368999999999999999999999985322110         000


Q ss_pred             hhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          302 EKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                           ............+...+..+.+++..||+.||.+|||+.++++
T Consensus       231 -----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          231 -----HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             -----HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence                 0011111111222233467899999999999999999999987

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.2e-45  Score=337.76  Aligned_cols=267  Identities=19%  Similarity=0.216  Sum_probs=210.0

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEE-ecCCeeEEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC-HDQHMTALVYE  155 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e  155 (406)
                      .+|.+.+.||+|+||.||+|.. .+|+.||+|++.....   ...+.+|+.++..++|++++..+.++ .+....++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            4577788999999999999975 6799999999875422   24588999999999988866666555 66778899999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEE---cCCCCceEeccccccccCCC
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |+ +++|.+++......+++..+..++.|++.||+|||+   ++++||||||+|||+   +.++.+||+|||++......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 899999997667789999999999999999999999   999999999999999   48889999999999876544


Q ss_pred             CceE-----EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          233 KTHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       233 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ....     ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......................   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  237 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST---  237 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS---
T ss_pred             ccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC---
Confidence            3211     12345799999999999887 68999999999999999999999996543322111111111110000   


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCCC
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPP  361 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~p  361 (406)
                            .........+..+.+++.+||+.||.+|||+.+|++.|+.+......+
T Consensus       238 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  285 (296)
T 3uzp_A          238 ------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             ------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             ------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence                  001111234577999999999999999999999999999987665443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.8e-45  Score=349.54  Aligned_cols=276  Identities=15%  Similarity=0.150  Sum_probs=207.3

Q ss_pred             Hhhhhhccccccccc--ceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           75 LNNFTSNYSTRLGFG--GFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G--~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      ....+|.+.+.||+|  +||+||+|+.. +|+.||||++.... .....+.+.+|+.+++.++||||+++++++.++...
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            345678888999999  99999999775 69999999997543 233456788899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          151 ALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      ++|||||++|+|.+++... ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||.+...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            9999999999999999543 4679999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCce-----EEecCCCCCCCccCccccCCC-CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHh-
Q 015480          230 DRNKTH-----VTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE-  302 (406)
Q Consensus       230 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-  302 (406)
                      ......     .......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.........  ......... 
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~  256 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPC  256 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC-------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCc
Confidence            322111     111234689999999999873 36899999999999999999999998543221110  000000000 


Q ss_pred             ---------------------hhhcchhh---------ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--H
Q 015480          303 ---------------------KCELGAMI---------LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--M  350 (406)
Q Consensus       303 ---------------------~~~~~~~~---------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~  350 (406)
                                           ........         ............+..+.+|+.+||+.||.+|||+.++++  .
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~  336 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  336 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence                                 00000000         000001123345678999999999999999999999987  3


Q ss_pred             hhccc
Q 015480          351 LEGVV  355 (406)
Q Consensus       351 L~~~~  355 (406)
                      ++.+.
T Consensus       337 f~~~~  341 (389)
T 3gni_B          337 FKQIK  341 (389)
T ss_dssp             GGGC-
T ss_pred             HHHHh
Confidence            55543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.1e-46  Score=360.64  Aligned_cols=264  Identities=20%  Similarity=0.230  Sum_probs=209.0

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      .+....|.+.++||+|+||+||+|++. +|+.||+|++.+..  .......+..|..++..++||||++++++|.+....
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            344556778899999999999999875 48899999997531  111223488999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ++|||||++|+|.+++......+++..+..++.|++.||.|||+   .+|+||||||+||||+.++.+||+|||+++...
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~  226 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  226 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence            99999999999999997667789999999999999999999999   999999999999999999999999999997665


Q ss_pred             CCCceEEecCCCCCCCccCccccC----CCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhc
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLS----GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCEL  306 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (406)
                      ..... .....+||+.|+|||++.    +...++.++|||||||++|||++|+.||......       .......... 
T Consensus       227 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~-  297 (437)
T 4aw2_A          227 EDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHK-  297 (437)
T ss_dssp             TTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHH-
T ss_pred             cCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-------HHHHhhhhcc-
Confidence            44332 234568999999999986    2336899999999999999999999998643211       0111111000 


Q ss_pred             chhhccCCCCcchHHHHHHHHHHHHHhcccCCCC--CCChHHHHH--Hhhc
Q 015480          307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPED--RPPMSAVIK--MLEG  353 (406)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~vl~--~L~~  353 (406)
                          .....+......+..+.+|+.+||..+|++  ||+++++++  .+..
T Consensus       298 ----~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          298 ----ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             ----HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             ----ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence                000112222235677999999999888888  999999988  4443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-45  Score=340.91  Aligned_cols=245  Identities=26%  Similarity=0.317  Sum_probs=203.2

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ..|.+.+.||+|+||+||+|+.. +|+.||+|++++..  .....+.+.+|..+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            35677889999999999999764 69999999997542  1234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+++|+|.+++.. ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.+|.+||+|||+++.....  
T Consensus        86 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           86 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence            99999999999953 4579999999999999999999999   99999999999999999999999999999865432  


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                         .....||+.|+|||++.+. .++.++|||||||++|||++|..||......       ..........         
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~---------  219 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEKILNAE---------  219 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHCC---------
T ss_pred             ---cccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC---------
Confidence               1346799999999999876 7899999999999999999999998543211       1111111111         


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                       ...+...+.++.+++.+||+.||.+||     +++++++
T Consensus       220 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          220 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence             112234567899999999999999999     8899886

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.7e-45  Score=349.08  Aligned_cols=250  Identities=22%  Similarity=0.311  Sum_probs=199.6

Q ss_pred             cccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCC
Q 015480           83 STRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  161 (406)
                      .+.||+|+||.||+|.. .+|+.||+|+++... ....+.+.+|+.++.+++||||+++++++.+....++||||+++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            46799999999999976 569999999997642 2456789999999999999999999999999999999999999999


Q ss_pred             hhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEE--cCCCCceEeccccccccCCCCceEEec
Q 015480          162 LDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL--DANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       162 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill--~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      |.+++......+++..+..++.|++.||+|||+   .+|+||||||+|||+  +.++.+||+|||+++........   .
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~---~  246 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---K  246 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---C
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---c
Confidence            999997666789999999999999999999999   999999999999999  56789999999999876544322   2


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcch
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD  319 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (406)
                      ...||+.|+|||++.+. .++.++|||||||++|||++|..||......       ...........      .......
T Consensus       247 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~------~~~~~~~  312 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------ETLNNILACRW------DLEDEEF  312 (373)
T ss_dssp             CCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCC------CSCSGGG
T ss_pred             cccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccC------CCChhhh
Confidence            35689999999999876 7899999999999999999999998543211       11111111100      0011222


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhc
Q 015480          320 KEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEG  353 (406)
Q Consensus       320 ~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~  353 (406)
                      ...+.++.+++.+||+.||.+|||+.++++  .+..
T Consensus       313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          313 QDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence            345678999999999999999999999998  4443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.7e-46  Score=373.90  Aligned_cols=265  Identities=28%  Similarity=0.439  Sum_probs=214.8

Q ss_pred             hHHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           72 SLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        72 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      .+++....+.+.++||+|+||+||+|.+.++..||||+++...  ...+.|.+|+++|++++||||+++++++.+ ...+
T Consensus       261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            3456667778889999999999999999888889999998643  245679999999999999999999999977 6789


Q ss_pred             EEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          152 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      +||||+++|+|.+++... ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            999999999999999543 3569999999999999999999999   999999999999999999999999999998654


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ..... ......++..|+|||++.+. .++.++|||||||++|||++ |..||.....       .........      
T Consensus       415 ~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~~~~~i~~------  479 (535)
T 2h8h_A          415 DNEYT-ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVER------  479 (535)
T ss_dssp             CHHHH-TTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HHHHHHHHT------
T ss_pred             CCcee-cccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHc------
Confidence            32111 11234567899999998876 78999999999999999999 8888743211       111111111      


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCC
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPP  360 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~  360 (406)
                         ......+..++..+.+|+.+||+.||++|||+.+|++.|+.+.....+
T Consensus       480 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  527 (535)
T 2h8h_A          480 ---GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  527 (535)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence               111223345677899999999999999999999999999998765443

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2e-45  Score=350.24  Aligned_cols=254  Identities=21%  Similarity=0.235  Sum_probs=193.1

Q ss_pred             hhhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ...+|.+.+.||+|+||+||+++.. +|+.||+|++....  ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            3456888899999999999999764 68999999997542  23456889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC--ceEeccccccccCCC
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS--PKVADFGLAKLCDRN  232 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--~kl~DfGl~~~~~~~  232 (406)
                      ||+++|+|.+++.. ...+++..+..++.|++.||+|||+   ++++||||||+|||++.++.  +||+|||+++.....
T Consensus        96 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           96 EYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            99999999999843 4579999999999999999999999   99999999999999987765  999999999743322


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ..   .....||+.|+|||++.+....+.++|||||||++|+|++|+.||........  .... .......        
T Consensus       172 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~-~~~~~~~--------  237 (361)
T 3uc3_A          172 SQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKT-IQRILSV--------  237 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHH-HHHHHTT--------
T ss_pred             CC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHH-HHHHhcC--------
Confidence            21   23356999999999998763334559999999999999999999864332211  1111 0111000        


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..........+..+.+|+.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            0001111234577899999999999999999999998

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.5e-45  Score=336.11  Aligned_cols=250  Identities=25%  Similarity=0.391  Sum_probs=199.1

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      ..|.+.+.||+|+||+||++.. .+|..||+|++.........+.+.+|++++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            4678889999999999999976 468999999998765555678899999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEE---cCCCCceEeccccccccC
Q 015480          157 MENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCD  230 (406)
Q Consensus       157 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~DfGl~~~~~  230 (406)
                      +++|+|.+++..   ....+++..+..++.|++.||+|||+   .+++||||||+||++   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999999998843   34679999999999999999999999   999999999999999   456789999999997654


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      ....   .....||+.|+|||++.+  .++.++||||||+++|||++|..||......       .........      
T Consensus       179 ~~~~---~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~------  240 (285)
T 3is5_A          179 SDEH---STNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-------EVQQKATYK------  240 (285)
T ss_dssp             -----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC------
T ss_pred             Cccc---CcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHH-------HHHhhhccC------
Confidence            4322   234568999999999864  5799999999999999999999998543211       011111110      


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       ...........+..+.+++.+||+.||.+|||+.++++
T Consensus       241 -~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          241 -EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00111111124567899999999999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.1e-45  Score=347.37  Aligned_cols=252  Identities=24%  Similarity=0.310  Sum_probs=203.2

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCe
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHM  149 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  149 (406)
                      .+....|.+.+.||+|+||+||+|++. +|+.||+|++++..  .......+..|..++..+ +||||+++++++.+...
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            344456778899999999999999774 68999999997542  123456678899999877 89999999999999999


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.+|.+||+|||+++..
T Consensus        93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            9999999999999999843 4579999999999999999999999   99999999999999999999999999999754


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ......  ....+||+.|+|||++.+. .++.++|||||||++|||++|..||......       ..........    
T Consensus       169 ~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~----  234 (345)
T 1xjd_A          169 MLGDAK--TNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMDN----  234 (345)
T ss_dssp             CCTTCC--BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC----
T ss_pred             ccCCCc--ccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHhCC----
Confidence            322221  2456799999999999877 7899999999999999999999998543211       1111111110    


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChH-HHHH
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMS-AVIK  349 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-~vl~  349 (406)
                            ...+...+..+.+++.+||+.||.+||++. ++++
T Consensus       235 ------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          235 ------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                  112233567899999999999999999997 6654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2e-45  Score=345.72  Aligned_cols=258  Identities=24%  Similarity=0.395  Sum_probs=204.4

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEE--EEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKI--AVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~v--avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ..|.+.+.||+|+||.||+|.+ .+|..+  |+|.+.........+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            4567789999999999999976 356644  999987654445567799999999999 899999999999999999999


Q ss_pred             EEeccCCChhhHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCc
Q 015480          154 YEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP  218 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  218 (406)
                      |||+++|+|.+++....               ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence            99999999999995443               479999999999999999999999   999999999999999999999


Q ss_pred             eEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHH
Q 015480          219 KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHV  297 (406)
Q Consensus       219 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  297 (406)
                      ||+|||++.......   ......+++.|+|||++.+. .++.++||||||+++|||++ |..||......       ..
T Consensus       182 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~  250 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------EL  250 (327)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HH
T ss_pred             EEcccCcCccccccc---cccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-------HH
Confidence            999999997432211   11234578899999998766 68999999999999999998 99888533211       11


Q ss_pred             HHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          298 WEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                      ......         ......+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       251 ~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          251 YEKLPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             HHHGGG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHhhc---------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            111111         1112223345678999999999999999999999999999887543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6e-45  Score=345.22  Aligned_cols=245  Identities=21%  Similarity=0.225  Sum_probs=203.9

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ..|.+.+.||+|+||.||+|+.. +|+.||+|++....  .....+.+.+|+.++..++||||+++++++.+....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            45677889999999999999764 69999999997532  1234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+++|+|.+++.. ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.+|.+||+|||+++...... 
T Consensus       121 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-  195 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-  195 (350)
T ss_dssp             ECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCCc-
Confidence            99999999999953 3569999999999999999999999   999999999999999999999999999998665432 


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                          ....||+.|+|||++.+. .++.++|||||||++|||++|..||.....       ...........         
T Consensus       196 ----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~---------  254 (350)
T 1rdq_E          196 ----WTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSGK---------  254 (350)
T ss_dssp             ----CCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC---------
T ss_pred             ----ccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCH-------HHHHHHHHcCC---------
Confidence                235689999999999877 789999999999999999999999854321       11111111111         


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPP-----MSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  349 (406)
                       ...+...+..+.+++.+||+.||.+||+     +.+|++
T Consensus       255 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence             1122345678999999999999999998     888876

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.5e-45  Score=343.33  Aligned_cols=272  Identities=26%  Similarity=0.345  Sum_probs=211.1

Q ss_pred             eeeChHHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhc--cCcCccccEEEEEe
Q 015480           68 VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR--TYHINLVRLYGFCH  145 (406)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~  145 (406)
                      .++...+....+|.+.+.||+|+||.||+|++ +|+.||||++...    ....+.+|.+++..  ++||||+++++++.
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            34445566677889999999999999999988 5899999999753    34567888888877  78999999999998


Q ss_pred             cCC----eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HhcCCCeeecCCCCCcEEEc
Q 015480          146 DQH----MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH--------EECQQRIIHYDIKPENVLLD  213 (406)
Q Consensus       146 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~~i~H~dlk~~Nill~  213 (406)
                      +..    ..++||||+++|+|.+++..  ..+++..++.++.|++.||+|||        +   .+++||||||+|||++
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~  181 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVK  181 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEEC
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEEC
Confidence            876    78999999999999999953  46899999999999999999999        6   8999999999999999


Q ss_pred             CCCCceEeccccccccCCCCceE--EecCCCCCCCccCccccCCCCC-----CCcccceeecchhHHHHhhcc-------
Q 015480          214 ANFSPKVADFGLAKLCDRNKTHV--TISGYKGTPGYSAPEFLSGNYP-----ITHKCDVYSFGMVLFEIVGRR-------  279 (406)
Q Consensus       214 ~~~~~kl~DfGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwslG~il~elltg~-------  279 (406)
                      .++.+||+|||++..........  ......||+.|+|||++.+...     ++.++||||||+++|||++|.       
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  261 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  261 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence            99999999999998765544332  2244579999999999876522     237899999999999999994       


Q ss_pred             ---cccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc--chHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          280 ---RNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE--KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       280 ---~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                         .||.........      ............ .....+.  .....+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       262 ~~~~p~~~~~~~~~~------~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          262 DYQLPYYDLVPSDPS------VEEMRKVVCEQK-LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CCCCTTTTTSCSSCC------HHHHHHHHTTSC-CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCccccCcCccc------HHHHHHHHHHHH-hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence               444322111100      011111100000 0111111  1246778899999999999999999999999999988


Q ss_pred             cc
Q 015480          355 VE  356 (406)
Q Consensus       355 ~~  356 (406)
                      ..
T Consensus       335 ~~  336 (342)
T 1b6c_B          335 SQ  336 (342)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-45  Score=341.14  Aligned_cols=260  Identities=25%  Similarity=0.344  Sum_probs=206.6

Q ss_pred             Hhhhhhcccc-cccccceeEEEEEEe---CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCe
Q 015480           75 LNNFTSNYST-RLGFGGFGEVYKGQF---PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM  149 (406)
Q Consensus        75 ~~~~~~~~~~-~ig~G~~g~V~~~~~---~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  149 (406)
                      +...+|.+.+ .||+|+||+||+|.+   .+++.||||+++.... ....+.+.+|+.++..++||||+++++++ +...
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence            3445667766 899999999999954   3478899999975432 23457899999999999999999999999 5567


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+++++|.+++.. ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        92 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             cEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            8899999999999999954 4569999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCceEE-ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          230 DRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       230 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ........ .....+++.|+|||.+.+. .++.++||||||+++|||++ |..||......       .......     
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~-----  234 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLE-----  234 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHH-----
T ss_pred             ccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHH-----
Confidence            55433222 2234567899999999776 68999999999999999999 99887543211       1111111     


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                          .......+..++..+.+++..||+.||.+||++.++++.|+.+..
T Consensus       235 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          235 ----KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             ----TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                111223334567789999999999999999999999999998853

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.3e-44  Score=334.97  Aligned_cols=266  Identities=20%  Similarity=0.218  Sum_probs=207.4

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEE-ecCCeeEEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC-HDQHMTALVYE  155 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e  155 (406)
                      .+|.+.+.||+|+||+||+|.. .+|+.||+|++....   ....+.+|+.++..++|+|++..++.+ .+....++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            4577889999999999999975 578999999876432   223578899999999988777666655 66778899999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEE---cCCCCceEeccccccccCCC
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |+ +++|.+++......+++..+..++.|++.||+|||+   .+++||||||+|||+   +.++.+||+|||++......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            99 899999997667789999999999999999999999   999999999999999   78899999999999876544


Q ss_pred             CceE-----EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          233 KTHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       233 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ....     ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......................   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  237 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST---  237 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS---
T ss_pred             ccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc---
Confidence            3211     12346789999999999887 68999999999999999999999996543322211111111110000   


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCC
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPP  360 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~  360 (406)
                            .........+..+.+++..||+.||++|||+.++++.|+++......
T Consensus       238 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          238 ------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             ------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             ------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence                  00011123357899999999999999999999999999999765543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.1e-45  Score=345.08  Aligned_cols=269  Identities=25%  Similarity=0.358  Sum_probs=200.5

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCe----
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM----  149 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  149 (406)
                      ..+|.+.+.||+|+||.||+|.+ .+|+.||||++....  .......+.+|+.++.+++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            34677889999999999999975 578999999997643  22344678999999999999999999999876543    


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+++++|.+++.. ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...
T Consensus        91 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            4999999999999999943 4579999999999999999999999   99999999999999999999999999999866


Q ss_pred             CCCCce-EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          230 DRNKTH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       230 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      ...... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||.......      ............ 
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~-  238 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIP-  238 (311)
T ss_dssp             ---------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCC-
T ss_pred             cccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCCC-
Confidence            543221 122345689999999999877 78999999999999999999999985432210      001111110000 


Q ss_pred             hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHH-HHhhccccCCCCCCC
Q 015480          309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVI-KMLEGVVEVLPPPKP  363 (406)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl-~~L~~~~~~~~~p~~  363 (406)
                            ........+..+.+++.+||+.||.+||+..+++ +.+..+....+++.|
T Consensus       239 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~  288 (311)
T 3ork_A          239 ------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP  288 (311)
T ss_dssp             ------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSC
T ss_pred             ------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCC
Confidence                  0011123567899999999999999999666554 566665554444333

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.2e-45  Score=357.56  Aligned_cols=252  Identities=24%  Similarity=0.372  Sum_probs=207.3

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ..|.+.+.||+|+||.||+|.+. +|+.||||++.....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            45677889999999999999764 799999999975321  123467899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+++|+|.+++. ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        96 E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           96 EYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             ECCSSEEHHHHTT-SSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             eCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            9999999999994 45679999999999999999999999   9999999999999999999999999999987654322


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                         ....+||+.|+|||++.+....+.++|||||||++|||++|..||......       ..........         
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~---------  232 (476)
T 2y94_A          172 ---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-------TLFKKICDGI---------  232 (476)
T ss_dssp             ---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-------HHHHHHHTTC---------
T ss_pred             ---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHhcCC---------
Confidence               234679999999999988745588999999999999999999998643221       1111111111         


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhc
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEG  353 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~  353 (406)
                       ...+...+..+.+++.+||+.||.+|||+.++++  .+..
T Consensus       233 -~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          233 -FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             -cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence             1122234567999999999999999999999997  4543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.1e-45  Score=350.96  Aligned_cols=254  Identities=20%  Similarity=0.275  Sum_probs=197.8

Q ss_pred             hhhhhcccccccccceeEEEEEEeCCCcEEEEEEecccc-chhhHHHHHHHHHHhhccC--cCccccEEEEEecCCeeEE
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTY--HINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~l  152 (406)
                      ....|.+.+.||+|+||+||+|...+|+.||||++.... .....+.+.+|+.++.+++  ||||+++++++......++
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            344578889999999999999988889999999997542 3345578999999999996  5999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ||| +.+++|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++ ++.+||+|||+++.....
T Consensus       134 v~E-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEE-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             EEe-cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            999 568899999954 3578999999999999999999999   9999999999999995 589999999999876544


Q ss_pred             CceEEecCCCCCCCccCccccCC----------CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHh
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSG----------NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE  302 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  302 (406)
                      ..........||+.|+|||++.+          ...++.++|||||||++|||++|..||.......     .. ...  
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~-~~~--  279 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SK-LHA--  279 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HH-HHH--
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HH-HHH--
Confidence            43333345679999999999864          1258899999999999999999999985322110     00 000  


Q ss_pred             hhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                            ..........+...+..+.+++.+||+.||.+|||+.++++
T Consensus       280 ------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          280 ------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             ------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence                  01111111112222567899999999999999999999987

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.4e-45  Score=355.06  Aligned_cols=273  Identities=23%  Similarity=0.289  Sum_probs=202.1

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecC-----Cee
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-----HMT  150 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  150 (406)
                      .+|.+.+.||+|+||.||+|.+ .+|+.||||++.... .....+.+.+|+.+++.++||||+++++++...     ...
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            4577889999999999999976 458899999997542 234457899999999999999999999999766     578


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ++||||+. ++|.+++. ....+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       106 ~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             EEEEECCS-EEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             EEEEecCC-cCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence            99999996 59999984 45679999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCce--------------------EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc
Q 015480          231 RNKTH--------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL  290 (406)
Q Consensus       231 ~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  290 (406)
                      .....                    .......||+.|+|||++.....++.++|||||||++|||++|..|+........
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~  260 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF  260 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence            43221                    1235678999999999876555799999999999999999987666543322211


Q ss_pred             ccchhH------------------HHHHH------------------hhhhcchhhccCC-CC-----cchHHHHHHHHH
Q 015480          291 DWFPKH------------------VWEEY------------------EKCELGAMILGCG-IE-----EKDKEKAKRLCM  328 (406)
Q Consensus       291 ~~~~~~------------------~~~~~------------------~~~~~~~~~~~~~-~~-----~~~~~~~~~l~~  328 (406)
                      ++++..                  .....                  ........+.... ..     ......+..+.+
T Consensus       261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  340 (432)
T 3n9x_A          261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN  340 (432)
T ss_dssp             CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred             ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence            111000                  00000                  0000000000000 00     011235678999


Q ss_pred             HHHHhcccCCCCCCChHHHHH--Hhhccc
Q 015480          329 VALWCVQDSPEDRPPMSAVIK--MLEGVV  355 (406)
Q Consensus       329 l~~~cl~~dP~~RPs~~~vl~--~L~~~~  355 (406)
                      |+.+||+.||.+|||+.++++  .+..+.
T Consensus       341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          341 LLESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             HHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence            999999999999999999998  566553

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-45  Score=352.06  Aligned_cols=272  Identities=18%  Similarity=0.187  Sum_probs=213.3

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC--eeEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH--MTALV  153 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv  153 (406)
                      +.+|.+.+.||+|+||+||+|.+. +|+.||||++.........+.+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            456788899999999999999764 589999999986544445677889999999999999999999998755  77999


Q ss_pred             EEeccCCChhhHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEE----cCCCCceEecccccc
Q 015480          154 YEYMENGSLDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL----DANFSPKVADFGLAK  227 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~DfGl~~  227 (406)
                      |||+++|+|.+++....  ..+++..+..++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999995432  349999999999999999999999   999999999999999    777889999999998


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCCC-------CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHH
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSGN-------YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEE  300 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  300 (406)
                      .......   .....||+.|+|||++.+.       ..++.++|||||||++|||++|+.||.........  ... ...
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~-~~~  238 (396)
T 4eut_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEV-MYK  238 (396)
T ss_dssp             ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHH-HHH
T ss_pred             EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHH-HHH
Confidence            7654332   2345689999999987641       25788999999999999999999999643322111  111 111


Q ss_pred             Hhhhhcchhh---------------ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          301 YEKCELGAMI---------------LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       301 ~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                      .....-....               ............+..+.+++..||+.||++||+++++++.++.+...
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            1111000000               00111233467888999999999999999999999999999887653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.8e-45  Score=346.13  Aligned_cols=250  Identities=24%  Similarity=0.339  Sum_probs=189.2

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ...|.+.+.||+|+||.||+|++. +++.||||++....   ..+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            455777899999999999999775 58899999997542   34568899999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC---CCCceEeccccccccCCC
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~DfGl~~~~~~~  232 (406)
                      |+++|+|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+|||++.   ++.+||+|||+++.....
T Consensus       129 ~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          129 LVTGGELFDRIV-EKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCCSCBHHHHHT-TCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             eCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999999999984 45679999999999999999999999   99999999999999975   889999999999865433


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ..   .....||+.|+|||++.+. .++.++|||||||++|||++|..||.......      ...........      
T Consensus       205 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~------  268 (349)
T 2w4o_A          205 VL---MKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEY------  268 (349)
T ss_dssp             -----------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCC------
T ss_pred             cc---cccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCC------
Confidence            21   2345689999999999876 78999999999999999999999985433211      01111111110      


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..........+..+.+++.+||+.||++|||+.++++
T Consensus       269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          269 YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0011222345678999999999999999999999988

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.3e-45  Score=342.33  Aligned_cols=251  Identities=22%  Similarity=0.243  Sum_probs=195.3

Q ss_pred             HhhhhhcccccccccceeEEEEEEe----CCCcEEEEEEeccccc---hhhHHHHHHHHHHhhccCcCccccEEEEEecC
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF----PNGVKIAVKVLNRNLG---RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ  147 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  147 (406)
                      +....|.+.+.||+|+||.||+++.    .+|+.||+|+++....   ......+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            3445678889999999999999976    4789999999976421   22345678899999999999999999999999


Q ss_pred             CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          148 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      +..++||||+++++|.+++. ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             CEEEEEEeCCCCCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999999984 34578999999999999999999999   999999999999999999999999999997


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      .......  ......||+.|+|||++.+. .++.++||||||+++|||++|..||......       ..........  
T Consensus       170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~~--  237 (327)
T 3a62_A          170 ESIHDGT--VTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRK-------KTIDKILKCK--  237 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTC--
T ss_pred             ccccCCc--cccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCC--
Confidence            5433221  22356799999999999876 7899999999999999999999998543211       1111111110  


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                              ...+...+..+.+++.+||+.||.+||     ++.++++
T Consensus       238 --------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 --------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                    112234567899999999999999999     7778876

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.7e-45  Score=344.25  Aligned_cols=250  Identities=23%  Similarity=0.283  Sum_probs=202.6

Q ss_pred             hhhhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeE
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  151 (406)
                      .-..|.+.+.||+|+||+||+|+.. +|+.||+|++++..  .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3345777899999999999999775 48899999997542  123456788999999988 7999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +||||++||+|.+++.. ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.+|.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            99999999999999843 3569999999999999999999999   9999999999999999999999999999985432


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ...  .....+||+.|+|||++.+. .++.++|||||||++|||++|..||......       ..........      
T Consensus       174 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~~------  237 (353)
T 2i0e_A          174 DGV--TTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIMEHN------  237 (353)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC------
T ss_pred             CCc--ccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHH-------HHHHHHHhCC------
Confidence            221  12356799999999999877 7899999999999999999999998543211       1111111110      


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPP-----MSAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  349 (406)
                          ...+...+.++.+++.+||+.||.+||+     +.++++
T Consensus       238 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                1122345678999999999999999996     466665

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-44  Score=355.63  Aligned_cols=198  Identities=23%  Similarity=0.327  Sum_probs=155.7

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEec-----CCee
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-----QHMT  150 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~  150 (406)
                      .+|.+.+.||+|+||+||+|.+ .+|+.||||++.... .....+.+.+|+.++..++||||+++++++..     ....
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            4678889999999999999965 468999999987542 23445789999999999999999999999943     3578


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      |+||||+ +++|.+++. ....+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++...
T Consensus       133 ~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             EEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             EEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            9999998 469999884 45679999999999999999999999   999999999999999999999999999998664


Q ss_pred             CCCce-------------------------EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhccc
Q 015480          231 RNKTH-------------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR  280 (406)
Q Consensus       231 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~  280 (406)
                      .....                         ......+||+.|+|||++.....++.++|||||||++|||++|..
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            32110                         123456789999999987555479999999999999999999543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.8e-45  Score=346.95  Aligned_cols=257  Identities=17%  Similarity=0.165  Sum_probs=208.1

Q ss_pred             hHHHhhhhhcccccccccceeEEEEEE------eCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC---cCccccEEE
Q 015480           72 SLQLNNFTSNYSTRLGFGGFGEVYKGQ------FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---HINLVRLYG  142 (406)
Q Consensus        72 ~~~~~~~~~~~~~~ig~G~~g~V~~~~------~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~  142 (406)
                      ..++....|.+.+.||+|+||+||+|.      ..+++.||+|++...    ....+..|++++..++   |+||+++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            345566778888999999999999993      456899999999764    3445677777777665   999999999


Q ss_pred             EEecCCeeEEEEEeccCCChhhHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC----
Q 015480          143 FCHDQHMTALVYEYMENGSLDGYLFG----KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA----  214 (406)
Q Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~----  214 (406)
                      ++...+..++||||+++|+|.+++..    ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.    
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccC
Confidence            99999999999999999999999953    45679999999999999999999999   99999999999999998    


Q ss_pred             -------CCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCC
Q 015480          215 -------NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGAT  287 (406)
Q Consensus       215 -------~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~  287 (406)
                             ++.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                   899999999999765533333445667899999999999887 689999999999999999999999854332


Q ss_pred             cccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCC-CChHHHHHHhhccccC
Q 015480          288 ESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDR-PPMSAVIKMLEGVVEV  357 (406)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~~vl~~L~~~~~~  357 (406)
                      ....              .     .......  .....+.+++..|++.+|.+| |++.++.+.|++....
T Consensus       291 ~~~~--------------~-----~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          291 GECK--------------P-----EGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             TEEE--------------E-----CSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             Ccee--------------e-----chhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            1100              0     0000000  124567889999999999999 5788888888887654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.8e-45  Score=343.26  Aligned_cols=270  Identities=24%  Similarity=0.333  Sum_probs=198.6

Q ss_pred             hhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHH--hhccCcCccccEEEEEec-----CCe
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT--IGRTYHINLVRLYGFCHD-----QHM  149 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~-----~~~  149 (406)
                      -..|.+.+.||+|+||.||+|++ +|+.||||++...    ....+..|.++  +..++||||+++++.+..     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            34567788999999999999987 6899999999753    23344444444  556899999999986532     336


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCC---------CeeecCCCCCcEEEcCCCCceE
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ---------RIIHYDIKPENVLLDANFSPKV  220 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~---------~i~H~dlk~~Nill~~~~~~kl  220 (406)
                      .++||||+++|+|.+++...  ..++..+..++.|+++||+|||+   .         +|+||||||+|||++.++.+||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEE
Confidence            78999999999999999443  45899999999999999999998   7         9999999999999999999999


Q ss_pred             eccccccccCCCCc------eEEecCCCCCCCccCccccCCC------CCCCcccceeecchhHHHHhhcccccccCCCc
Q 015480          221 ADFGLAKLCDRNKT------HVTISGYKGTPGYSAPEFLSGN------YPITHKCDVYSFGMVLFEIVGRRRNAIVGATE  288 (406)
Q Consensus       221 ~DfGl~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwslG~il~elltg~~p~~~~~~~  288 (406)
                      +|||++........      ........||+.|+|||++.+.      ..++.++|||||||++|||++|..|+..+...
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            99999986653321      1222345799999999998762      24667899999999999999998887554332


Q ss_pred             ccccchhH-------HHHHHhhhhcchhhccCCCC---cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          289 SLDWFPKH-------VWEEYEKCELGAMILGCGIE---EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       289 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                      ........       ........ ..........+   ......+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVL-VSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHH-HTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hHHHHhhhcccCCCchHHHHHhh-hcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            11100000       00000000 00000001111   12235778899999999999999999999999999998643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.6e-45  Score=340.86  Aligned_cols=265  Identities=20%  Similarity=0.242  Sum_probs=196.7

Q ss_pred             hhcc-cccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNY-STRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~-~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+ .+.||+|+||+||+|.. .+|+.||||++.... ......+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            3455 36799999999999975 468999999997642 23467789999999885 79999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC---ceEeccccccccCCC
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---PKVADFGLAKLCDRN  232 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~DfGl~~~~~~~  232 (406)
                      |+++|+|.+++.. ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.   +||+|||++......
T Consensus        92 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           92 KMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             CCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             cCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            9999999999954 4578999999999999999999999   99999999999999998776   999999999765422


Q ss_pred             Cc-----eEEecCCCCCCCccCccccCCC----CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhh
Q 015480          233 KT-----HVTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK  303 (406)
Q Consensus       233 ~~-----~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  303 (406)
                      ..     ........||+.|+|||++.+.    ..++.++|||||||++|||++|..||.........|...........
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence            11     1112235699999999998641    24788999999999999999999999755433322221110000000


Q ss_pred             hhcchhhccCCCCc---chHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          304 CELGAMILGCGIEE---KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       304 ~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       .....+.......   .....+..+.+++.+||+.||.+|||+.++++
T Consensus       248 -~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          248 -MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             -HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence             0000011111110   11234678999999999999999999999998

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.3e-45  Score=345.44  Aligned_cols=270  Identities=18%  Similarity=0.211  Sum_probs=201.0

Q ss_pred             HhhhhhcccccccccceeEEEEEEeC----CCcEEEEEEeccccchh----------hHHHHHHHHHHhhccCcCccccE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRI----------AEEQFMAEVGTIGRTYHINLVRL  140 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~----~g~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~  140 (406)
                      +....|.+.+.||+|+||+||+|.+.    ++..||+|+........          ....+.+|+..+..++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            34567888899999999999999875    57889999987543211          12346778899999999999999


Q ss_pred             EEEEec----CCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC
Q 015480          141 YGFCHD----QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF  216 (406)
Q Consensus       141 ~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~  216 (406)
                      ++++.+    ....++||||+ +++|.+++... ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSS
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCC
Confidence            999987    78899999999 99999998443 489999999999999999999999   9999999999999999887


Q ss_pred             --CceEeccccccccCCCCce-----EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcc
Q 015480          217 --SPKVADFGLAKLCDRNKTH-----VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATES  289 (406)
Q Consensus       217 --~~kl~DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~  289 (406)
                        .+||+|||+++........     .......||+.|+|||++.+. .++.++|||||||++|||++|..||.......
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence              9999999999866432111     111345799999999999876 78999999999999999999999985432211


Q ss_pred             cccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          290 LDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      ...  ........ ...........   .....+..+.+++..||+.||++|||+.+|++.|+....
T Consensus       268 ~~~--~~~~~~~~-~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          268 VAV--QTAKTNLL-DELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHH--HHHHHHHH-HTTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHH--HHHHHhhc-ccccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            100  00000000 00000000000   001345689999999999999999999999999998754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=355.11  Aligned_cols=259  Identities=21%  Similarity=0.207  Sum_probs=205.5

Q ss_pred             HHhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      .+....|.+.+.||+|+||+||+|+. .+|+.||+|++++..  .......+..|..++..++||||+++++++.+....
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            34456678889999999999999977 469999999997531  112234588999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ++||||+++|+|.+++......+++..+..++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+++...
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR  213 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence            99999999999999996656689999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCceEEecCCCCCCCccCccccCC------CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSG------NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC  304 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (406)
                      ..... .....+||+.|+|||++..      ...++.++|||||||++|||++|+.||......       .........
T Consensus       214 ~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~  285 (412)
T 2vd5_A          214 ADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-------ETYGKIVHY  285 (412)
T ss_dssp             TTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTH
T ss_pred             CCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhc
Confidence            44322 2234689999999999862      236899999999999999999999998543221       011111110


Q ss_pred             hcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCC---CChHHHHH
Q 015480          305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDR---PPMSAVIK  349 (406)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~~vl~  349 (406)
                      .     .....+......+.++.+++.+||. +|.+|   |+++++++
T Consensus       286 ~-----~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          286 K-----EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             H-----HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             c-----cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            0     0001122223456789999999999 99998   58999887

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.5e-44  Score=337.13  Aligned_cols=265  Identities=23%  Similarity=0.388  Sum_probs=201.3

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccc--cchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ..|.+.+.||+|+||.||+|.. .+|+.||+|++...  ........+.+|+.++..++||||+++++++.+....++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            4577889999999999999975 57999999999742  23345678899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          155 EYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       155 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999853   45679999999999999999999999   9999999999999999999999999999976543


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ....  .....|++.|+|||.+.+. .++.++||||||+++|+|++|..||.......     ............     
T Consensus       189 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~-----  255 (310)
T 2wqm_A          189 KTTA--AHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSLCKKIEQCDY-----  255 (310)
T ss_dssp             ------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-----HHHHHHHHTTCS-----
T ss_pred             CCcc--ccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhH-----HHHHHHhhcccC-----
Confidence            3221  2235689999999999876 78999999999999999999999985432110     011111111110     


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCCC
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPP  361 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~p  361 (406)
                         ........+..+.+++.+||+.||.+|||+.+|++.|+++.+..+.|
T Consensus       256 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          256 ---PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             ---CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             ---CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence               01112345678999999999999999999999999999997655544

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.7e-45  Score=341.56  Aligned_cols=269  Identities=21%  Similarity=0.260  Sum_probs=208.3

Q ss_pred             HHhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEe----cCC
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH----DQH  148 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~  148 (406)
                      .+...+|.+.+.||+|+||.||++.. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.    ...
T Consensus        25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            34566788899999999999999976 57999999998653 3345678899999999999999999999986    345


Q ss_pred             eeEEEEEeccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccc
Q 015480          149 MTALVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  225 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl  225 (406)
                      ..++||||+++|+|.+++..   ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence            78899999999999999854   46779999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCce-------EEecCCCCCCCccCccccCCCC--CCCcccceeecchhHHHHhhcccccccCCCcccccchhH
Q 015480          226 AKLCDRNKTH-------VTISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKH  296 (406)
Q Consensus       226 ~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  296 (406)
                      +.........       .......||+.|+|||++.+..  .++.++||||||+++|||++|..||.........     
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----  255 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-----  255 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-----
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-----
Confidence            8754321100       0001234799999999987542  2688999999999999999999988432111000     


Q ss_pred             HHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCC
Q 015480          297 VWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPP  360 (406)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~  360 (406)
                      ......         ...........+..+.+++.+||+.||.+|||+.++++.|+.+....+.
T Consensus       256 ~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          256 VALAVQ---------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             HHHHHH---------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             hhHHhh---------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence            000000         0001112234567899999999999999999999999999988644443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=331.59  Aligned_cols=248  Identities=23%  Similarity=0.364  Sum_probs=184.6

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||.||+|.. .+|+.||+|++.....  ....+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus        12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (278)
T 3cok_A           12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE   91 (278)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence            466788999999999999976 5799999999975321  1234678999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  168 (278)
T 3cok_A           92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK  168 (278)
T ss_dssp             CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence            999999999997766789999999999999999999999   99999999999999999999999999999866533221


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||.........       ..   ....    .   
T Consensus       169 --~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~---~~~~----~---  228 (278)
T 3cok_A          169 --HYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NK---VVLA----D---  228 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCSS----C---
T ss_pred             --ceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HH---Hhhc----c---
Confidence              1235689999999999876 6899999999999999999999998643321100       00   0000    0   


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...+...+.++.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          229 YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            1122334567899999999999999999999886

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.8e-45  Score=340.01  Aligned_cols=265  Identities=20%  Similarity=0.263  Sum_probs=199.2

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      +|.+.+.||+|+||+||+|.+. +|+.||+|++..... ....+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY   83 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence            4677889999999999999774 589999999865433 23456788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +++++|.+++ .....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++......... 
T Consensus        84 ~~~~~l~~~~-~~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  158 (311)
T 4agu_A           84 CDHTVLHELD-RYQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-  158 (311)
T ss_dssp             CSEEHHHHHH-HTSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CCCchHHHHH-hhhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc-
Confidence            9999998887 445679999999999999999999999   99999999999999999999999999999876533222 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccch--------hHHHHHHhhhhcch
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP--------KHVWEEYEKCELGA  308 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~  308 (406)
                       .....||+.|+|||++.+...++.++||||||+++|+|++|..||............        ..............
T Consensus       159 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          159 -YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             -cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence             234568999999999987557899999999999999999999998543321110000        00000000000000


Q ss_pred             hh---ccCCCC---cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 MI---LGCGIE---EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~~---~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..   ......   ......+..+.+++..||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00   000000   011235677999999999999999999999987

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.4e-45  Score=344.47  Aligned_cols=242  Identities=23%  Similarity=0.306  Sum_probs=200.6

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc-------hhhHHHHHHHHHHhhccCcCccccEEEEEecCCe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-------RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  149 (406)
                      ..|.+.+.||+|+||+||+|.+ .+|+.||||++.....       ......+.+|+.++.+++||||+++++++.+...
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            4677889999999999999975 5689999999975421       1123457789999999999999999999999999


Q ss_pred             eEEEEEeccCC-ChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          150 TALVYEYMENG-SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       150 ~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      .++||||+.+| +|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++..
T Consensus       104 ~~lv~e~~~~g~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFID-RHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAY  179 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHH-TCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence            99999999777 9999884 45579999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      ........   ...||+.|+|||++.+....+.++|||||||++|||++|..||.......                   
T Consensus       180 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------------  237 (335)
T 3dls_A          180 LERGKLFY---TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------------  237 (335)
T ss_dssp             CCTTCCBC---EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------------------
T ss_pred             CCCCCcee---ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------------------
Confidence            65543322   24689999999999877445899999999999999999999985311100                   


Q ss_pred             hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        ..  ....+...+..+.+++..||+.||.+|||+.++++
T Consensus       238 --~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          238 --EA--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             --TT--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --hh--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              00  01111224567999999999999999999999998

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.5e-45  Score=345.44  Aligned_cols=248  Identities=25%  Similarity=0.344  Sum_probs=201.2

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ..|...+.||+|+||+||+|.. .+|+.||||++....  .....+.+.+|++++.+++||||+++++++.++...++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            3467778999999999999975 579999999997532  2233467899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+. |+|.+++......+++..+..++.|+++||+|||+   .+++||||||+|||++.++.+||+|||++......  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9997 58888886666789999999999999999999999   99999999999999999999999999999765432  


Q ss_pred             eEEecCCCCCCCccCccccCC--CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          235 HVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                          ....||+.|+|||++.+  ...++.++|||||||++|||++|+.||......      .. .......        
T Consensus       208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~-~~~~~~~--------  268 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SA-LYHIAQN--------  268 (348)
T ss_dssp             ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HH-HHHHHHS--------
T ss_pred             ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HH-HHHHHhc--------
Confidence                23568999999999852  236899999999999999999999998543211      00 0111111        


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                      ..........+..+.+++.+||+.||.+|||+.++++.
T Consensus       269 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          269 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            01111123446778999999999999999999999873

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2e-44  Score=338.03  Aligned_cols=252  Identities=21%  Similarity=0.333  Sum_probs=205.1

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccch-----hhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      ...|.+.+.||+|+||.||+|... +|+.||+|++......     ...+.+.+|+.++.+++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            456788899999999999999764 6899999999754321     1357899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC----CceEeccccc
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----SPKVADFGLA  226 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~DfGl~  226 (406)
                      ++||||+++++|.+++. ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHH-TCSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            99999999999999994 45678999999999999999999999   9999999999999999888    7999999999


Q ss_pred             cccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhc
Q 015480          227 KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCEL  306 (406)
Q Consensus       227 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (406)
                      ........   .....||+.|+|||++.+. .++.++||||||+++|+|++|..||......       ...........
T Consensus       167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~  235 (321)
T 2a2a_A          167 HEIEDGVE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANITSVSY  235 (321)
T ss_dssp             EECCTTCC---CCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTCC
T ss_pred             eecCcccc---ccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhccc
Confidence            87654322   2345689999999999876 7899999999999999999999998543211       11111111000


Q ss_pred             chhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                            ..........+..+.+++.+||+.||.+|||+.++++
T Consensus       236 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          236 ------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             ------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             ------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  0001111234577999999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.5e-45  Score=338.60  Aligned_cols=252  Identities=27%  Similarity=0.388  Sum_probs=199.5

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecC-CeeEEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-HMTALV  153 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv  153 (406)
                      +....|.+.+.||+|+||+||+|++ +|+.||+|+++..   ...+.+.+|+.++.+++||||+++++++.+. ...++|
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             CChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            4456678889999999999999988 5889999999754   2456789999999999999999999997654 478999


Q ss_pred             EEeccCCChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          154 YEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |||+++++|.+++.... ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            99999999999995432 248999999999999999999999   99999999999999999999999999999755432


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      .     ....+++.|+|||.+.+. .++.++||||||+++|||++ |..||......       .......         
T Consensus       171 ~-----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------~~~~~~~---------  228 (278)
T 1byg_A          171 Q-----DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRVE---------  228 (278)
T ss_dssp             ----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-------GHHHHHT---------
T ss_pred             c-----cCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHh---------
Confidence            2     123578899999999876 78999999999999999998 88887533211       1111111         


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      .......+...+..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence            11112233455678999999999999999999999999998874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.9e-44  Score=336.34  Aligned_cols=264  Identities=19%  Similarity=0.220  Sum_probs=200.6

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ..|.+.+.||+|+||.||+|... +|+.||+|++.....  ....+.+.+|+.++.+++||||+++++++.++...++||
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            35677889999999999999764 689999999975432  233477899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus       114 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  189 (309)
T 2h34_A          114 RLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL  189 (309)
T ss_dssp             ECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence            99999999999953 4579999999999999999999999   9999999999999999999999999999976544322


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                      . ......|++.|+|||.+.+. .++.++||||||+++|||++|..||......       ........ ..      ..
T Consensus       190 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~-~~------~~  253 (309)
T 2h34_A          190 T-QLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQ-AI------PR  253 (309)
T ss_dssp             --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHS-CC------CC
T ss_pred             c-cccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhcc-CC------CC
Confidence            1 12345689999999999876 7899999999999999999999998543211       00111110 00      00


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCC-ChHHHHHHhhccccCCCCC
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRP-PMSAVIKMLEGVVEVLPPP  361 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~~vl~~L~~~~~~~~~p  361 (406)
                      ........+..+.+++.+||+.||.+|| +++++++.|+........+
T Consensus       254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~  301 (309)
T 2h34_A          254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD  301 (309)
T ss_dssp             GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred             ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence            0122234566799999999999999999 9999999999887665543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.2e-44  Score=336.65  Aligned_cols=248  Identities=25%  Similarity=0.331  Sum_probs=205.8

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      ..|...+.||+|+||.||+|.. .+|+.||+|++.........+.+.+|+.++..++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            3467788999999999999975 568999999998654445668899999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +++++|.+++.  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++......... 
T Consensus       102 ~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  175 (303)
T 3a7i_A          102 LGGGSALDLLE--PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-  175 (303)
T ss_dssp             CTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC-
T ss_pred             CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccccc-
Confidence            99999999983  4579999999999999999999999   99999999999999999999999999999766543221 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                       .....||+.|+|||.+.+. .++.++||||||+++|+|++|..||......       ........         ....
T Consensus       176 -~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~---------~~~~  237 (303)
T 3a7i_A          176 -RNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPM-------KVLFLIPK---------NNPP  237 (303)
T ss_dssp             -BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHH---------SCCC
T ss_pred             -cCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHH-------HHHHHhhc---------CCCC
Confidence             2346789999999999876 7899999999999999999999988532211       00111111         1112


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ......+..+.+++..||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            222345677999999999999999999999987

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.9e-44  Score=352.50  Aligned_cols=264  Identities=19%  Similarity=0.253  Sum_probs=209.0

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCc-CccccEEEEEecCCeeEEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH-INLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ..|.+.++||+|+||.||+|.+ .+|+.||||++.....   ...+..|++++..++| +++..+..++.+....+||||
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            4577889999999999999976 5699999998875422   2357889999999986 566677777788889999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEE---cCCCCceEeccccccccCCC
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |+ +++|.+++......+++..++.++.||+.||+|||+   ++|+||||||+||||   +.++.+||+|||+++.....
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 899999997667789999999999999999999999   999999999999999   68899999999999876544


Q ss_pred             CceE-----EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          233 KTHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       233 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ....     ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.........    ............
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~----~~~~~i~~~~~~  234 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK----QKYEKISEKKVA  234 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH----HHHHHHHHHHHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHH----HHHHHHhhcccc
Confidence            3221     12256799999999999887 7899999999999999999999998653322111    111111111110


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                           .........++.++.+++..||+.||.+||++.+|++.|+.+....
T Consensus       235 -----~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          235 -----TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             -----SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -----ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence                 0011122334678999999999999999999999999999885443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.9e-45  Score=352.80  Aligned_cols=258  Identities=22%  Similarity=0.271  Sum_probs=205.2

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCe
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM  149 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  149 (406)
                      ..+....|.+.+.||+|+||+||+|+.. +|+.||+|++.+..  .......+.+|+.++..++||||+++++++.+...
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3344566788899999999999999764 58999999997531  11123457899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++|||||+||+|.+++..  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.+|.+||+|||+++..
T Consensus       144 ~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~  218 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  218 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence            9999999999999999853  468999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCC---CCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhc
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNY---PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCEL  306 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (406)
                      ..... ......+||+.|+|||++.+..   .++.++|||||||++|||++|..||......       ...........
T Consensus       219 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~  290 (410)
T 3v8s_A          219 NKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMNHKN  290 (410)
T ss_dssp             CTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHHH
T ss_pred             ccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-------hHHHHHHhccc
Confidence            54432 2334678999999999987652   1788999999999999999999998643211       11111111100


Q ss_pred             chhhccCCCCcchHHHHHHHHHHHHHhcccCCCC--CCChHHHHH
Q 015480          307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPED--RPPMSAVIK  349 (406)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~vl~  349 (406)
                      .   .  . .......+.++.+|+.+||..+|.+  ||++++|++
T Consensus       291 ~---~--~-~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          291 S---L--T-FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             H---C--C-CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             c---c--c-CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            0   0  0 0111234577999999999999988  999999998

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.4e-44  Score=330.36  Aligned_cols=251  Identities=21%  Similarity=0.322  Sum_probs=203.8

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ..|.+.+.||+|+||.||+|.+ .+|+.||+|++.... .....+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            4577788999999999999976 458999999997543 33445778899999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC---ceEeccccccccCCC
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---PKVADFGLAKLCDRN  232 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~DfGl~~~~~~~  232 (406)
                      |+++++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.   +||+|||++......
T Consensus        86 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           86 LVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             CCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             cCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            999999998884 34579999999999999999999999   99999999999999987655   999999999766543


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ..   .....||+.|+|||++.+. .++.++||||||+++|+|++|..||......       ............     
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~-----  225 (284)
T 3kk8_A          162 EA---WHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGAYD-----  225 (284)
T ss_dssp             CB---CCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC-----
T ss_pred             cc---ccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchh-------HHHHHHHhcccc-----
Confidence            32   2346789999999999877 7899999999999999999999998543211       111111111110     


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       .........+..+.+++..||+.||.+|||+.++++
T Consensus       226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          226 -YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             001112345677999999999999999999999987

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.8e-44  Score=332.36  Aligned_cols=244  Identities=22%  Similarity=0.373  Sum_probs=200.2

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ..|.+.+.||+|+||+||+|.+. +|+.||+|++.... .......+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            45777889999999999999774 79999999997542 234557788999999998 8999999999999999999999


Q ss_pred             EeccCCChhhHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC----------------
Q 015480          155 EYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN----------------  215 (406)
Q Consensus       155 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~----------------  215 (406)
                      ||+++++|.+++...   ...+++..+..++.|++.||+|||+   ++++||||||+|||++.+                
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC------------------
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            999999999999543   2679999999999999999999999   999999999999999844                


Q ss_pred             ---CCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc
Q 015480          216 ---FSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW  292 (406)
Q Consensus       216 ---~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~  292 (406)
                         ..+||+|||++.......      ...||+.|+|||++.+...++.++||||||+++|+|++|.+++....      
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------  235 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------  235 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred             CCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence               479999999998765432      23589999999999876567789999999999999999987653211      


Q ss_pred             chhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          293 FPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                          .+......         .....+...+..+.+++.+||+.||.+|||+.++++
T Consensus       236 ----~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 ----QWHEIRQG---------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ----HHHHHHTT---------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HHHHHHcC---------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                11111111         112233345678999999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6e-45  Score=370.29  Aligned_cols=250  Identities=25%  Similarity=0.354  Sum_probs=199.9

Q ss_pred             ccccccceeEEEEEEe---CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQF---PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~---~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      +.||+|+||+||+|.+   .+++.||||+++.... ....+.+.+|++++.+++||||+++++++.++ ..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCC
Confidence            4799999999999955   3467899999986432 33467899999999999999999999999754 57899999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce-EEe
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH-VTI  238 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~-~~~  238 (406)
                      |+|.+++. ....+++..+..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+++........ ...
T Consensus       454 g~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999994 44679999999999999999999999   99999999999999999999999999999876543321 222


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      ....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||......       ......         .......
T Consensus       530 ~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i---------~~~~~~~  592 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAML---------EKGERMG  592 (635)
T ss_dssp             -----CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHH---------HTTCCCC
T ss_pred             cCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHH---------HcCCCCC
Confidence            334578899999999876 78999999999999999998 99888533211       111111         1112223


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      .+..++.++.+++..||+.||++||++.+|++.|+++.
T Consensus       593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            34456788999999999999999999999999998764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.8e-44  Score=337.06  Aligned_cols=263  Identities=21%  Similarity=0.319  Sum_probs=207.8

Q ss_pred             ceeeChHHHhhhhhccc-ccccccceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhccC-cCccccEEE
Q 015480           67 PVRFTSLQLNNFTSNYS-TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTY-HINLVRLYG  142 (406)
Q Consensus        67 ~~~~~~~~~~~~~~~~~-~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~  142 (406)
                      .+.|...+.-+..|.+. +.||+|+||.||+|... +|+.||+|++.... .......+.+|+.++..+. ||||+++++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            35566666666777776 88999999999999764 69999999987542 2234577899999999985 799999999


Q ss_pred             EEecCCeeEEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC---CCCc
Q 015480          143 FCHDQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSP  218 (406)
Q Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~  218 (406)
                      ++.+....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+|||++.   ++.+
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCE
T ss_pred             EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcE
Confidence            999999999999999999999998543 4679999999999999999999999   99999999999999988   7899


Q ss_pred             eEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHH
Q 015480          219 KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVW  298 (406)
Q Consensus       219 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  298 (406)
                      ||+|||++........   .....||+.|+|||++.+. .++.++||||||+++|||++|..||......       ...
T Consensus       174 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~  242 (327)
T 3lm5_A          174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------ETY  242 (327)
T ss_dssp             EECCGGGCEEC------------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHH
T ss_pred             EEeeCccccccCCccc---cccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHH
Confidence            9999999986654322   2335789999999999876 7899999999999999999999998543211       001


Q ss_pred             HHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          299 EEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ......      ............+..+.+++..||+.||.+|||+.++++
T Consensus       243 ~~i~~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          243 LNISQV------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHHT------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHhc------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            111111      011112223345677999999999999999999999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.7e-45  Score=347.80  Aligned_cols=267  Identities=23%  Similarity=0.338  Sum_probs=206.9

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      ++....|.+.+.||+|+||+||+|.+. +|+.||+|++.........+.+.+|+.++..++||||+++++++.++...++
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence            345567888899999999999999764 6899999999876555667889999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCC-CeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      ||||+++++|.+++.. ...+++..+..++.|++.||.|||+   . +++||||||+|||++.++.+||+|||++.....
T Consensus       109 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             EECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            9999999999999943 4569999999999999999999998   5 899999999999999999999999999975532


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccch---------hHHH----
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP---------KHVW----  298 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~---------~~~~----  298 (406)
                      ..    .....||+.|+|||++.+. .++.++|||||||++|||++|+.||............         ....    
T Consensus       185 ~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          185 SM----ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             HC--------CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred             cc----ccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence            21    1235689999999999877 7899999999999999999999998643221100000         0000    


Q ss_pred             -----HHH--------hhhhc-chhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          299 -----EEY--------EKCEL-GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       299 -----~~~--------~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                           ...        ..... ................+..+.+++.+||+.||.+|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                 000        00000 0000011111111234667999999999999999999999987

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.2e-44  Score=329.41  Aligned_cols=249  Identities=22%  Similarity=0.302  Sum_probs=202.6

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ...|.+.+.||+|+||+||+|... ++..||+|++..... ...+.+.+|++++.+++||||+++++++.+....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            345778899999999999999764 478999999876432 345789999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEE---cCCCCceEeccccccccCCC
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |+++++|.+++.. ...+++..+..++.|++.||+|||+   .+++||||||+||++   +.++.+||+|||++......
T Consensus        87 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           87 LCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            9999999998843 4569999999999999999999999   999999999999999   78899999999999866543


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ..   .....||+.|+|||.+.+.  ++.++||||||+++|||++|..||......       ...........      
T Consensus       163 ~~---~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~------  224 (277)
T 3f3z_A          163 KM---MRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-------EVMLKIREGTF------  224 (277)
T ss_dssp             SC---BCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC------
T ss_pred             cc---hhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCC------
Confidence            32   2345689999999998754  799999999999999999999998543211       11111111100      


Q ss_pred             CCCC-cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          313 CGIE-EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       313 ~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       ... ......+..+.+++.+||+.||.+|||+.++++
T Consensus       225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          225 -TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             000 011135678999999999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.7e-44  Score=344.56  Aligned_cols=249  Identities=25%  Similarity=0.297  Sum_probs=192.9

Q ss_pred             hhhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHH-hhccCcCccccEEEEEecCCeeE
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGT-IGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      ....|.+.+.||+|+||+||+|+.. +++.||+|++.+...  ......+..|..+ ++.++||||+++++++.+.+..+
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            3456788899999999999999764 588999999976432  2234566777776 56789999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +||||+++|+|.+++. ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.+|.+||+|||+++....
T Consensus       116 lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            9999999999999984 34578999999999999999999999   9999999999999999999999999999986433


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ...  .....+||+.|+|||++.+. .++.++|||||||++|||++|..||......       ..........      
T Consensus       192 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~~------  255 (373)
T 2r5t_A          192 HNS--TTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNKP------  255 (373)
T ss_dssp             CCC--CCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-------HHHHHHHHSC------
T ss_pred             CCC--ccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHhcc------
Confidence            221  12346799999999999877 7899999999999999999999998543211       1111111110      


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVI  348 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl  348 (406)
                          ...+...+..+.+++.+||+.||.+||++.+.+
T Consensus       256 ----~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          256 ----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             ----CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             ----cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence                111223557799999999999999999985433

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.1e-45  Score=339.45  Aligned_cols=267  Identities=22%  Similarity=0.323  Sum_probs=187.3

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      +.+....|.+.+.||+|+||.||+|.. .+|+.||||++.........+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            455666788889999999999999976 4689999999976544445677889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccc
Q 015480          152 LVYEYMENGSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  224 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfG  224 (406)
                      +||||+++++|.+++..       ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999999853       34569999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCc---eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHH
Q 015480          225 LAKLCDRNKT---HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEY  301 (406)
Q Consensus       225 l~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  301 (406)
                      ++........   ........||+.|+|||++.+...++.++||||||+++|||++|..||........      .....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~  240 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------LMLTL  240 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHH
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------HHHHh
Confidence            9976643221   11123456899999999987633689999999999999999999999864322110      00000


Q ss_pred             hhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          302 EKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      . ...................+..+.+++.+||+.||.+|||+.++++
T Consensus       241 ~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          241 Q-NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             T-SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             c-cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0 0000000000001112234567999999999999999999999987

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.7e-44  Score=333.22  Aligned_cols=254  Identities=22%  Similarity=0.290  Sum_probs=189.3

Q ss_pred             HhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHH-HHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEE-QFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      +....|.+.+.||+|+||+||+|.. .+|+.||+|++.......... .+..+...++.++||||+++++++.+....++
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            4456778889999999999999976 578999999998654333333 34455556888899999999999999999999


Q ss_pred             EEEeccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCC-CeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          153 VYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      ||||+++ +|.+++..   ....+++..+..++.|++.||+|||+   . +++||||||+||+++.++.+||+|||++..
T Consensus        84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            9999975 88777743   56789999999999999999999999   7 999999999999999999999999999986


Q ss_pred             cCCCCceEEecCCCCCCCccCccccC---CCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhh
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLS---GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCE  305 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (406)
                      .......   ....||+.|+|||++.   ....++.++||||||+++|||++|..||.......      ......    
T Consensus       160 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~----  226 (290)
T 3fme_A          160 LVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF------QQLKQV----  226 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH------HHHHHH----
T ss_pred             ccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH------HHHHHH----
Confidence            6543222   2346899999999972   33368999999999999999999999985422210      000111    


Q ss_pred             cchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          306 LGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                          .............+..+.+++.+||+.||.+|||+.++++
T Consensus       227 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          227 ----VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ----HHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----hccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                1111111122345678999999999999999999999987

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3e-44  Score=340.05  Aligned_cols=263  Identities=23%  Similarity=0.248  Sum_probs=201.5

Q ss_pred             hhhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc----chhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL----GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      ...+|.+.+.||+|+||+||+|.. .++..||+|++....    .....+.+.+|+.++++++||||+++++++.+....
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  103 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI  103 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence            345678889999999999999976 568899999987532    234557899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcC---------------------------------------CCCCCHHHHHHHHHHHHHHHHH
Q 015480          151 ALVYEYMENGSLDGYLFGK---------------------------------------KRAIEWEKLHEIAIGTAKGLVY  191 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~qi~~~l~~  191 (406)
                      ++||||+++|+|.+++...                                       ...+++..+..++.|++.||+|
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  183 (345)
T 3hko_A          104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY  183 (345)
T ss_dssp             EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence            9999999999999988410                                       1123577888999999999999


Q ss_pred             HHHhcCCCeeecCCCCCcEEEcCCC--CceEeccccccccCCCC--ceEEecCCCCCCCccCccccCCC-CCCCccccee
Q 015480          192 LHEECQQRIIHYDIKPENVLLDANF--SPKVADFGLAKLCDRNK--THVTISGYKGTPGYSAPEFLSGN-YPITHKCDVY  266 (406)
Q Consensus       192 LH~~~~~~i~H~dlk~~Nill~~~~--~~kl~DfGl~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dvw  266 (406)
                      ||+   .+++||||||+|||++.++  .+||+|||++.......  .........||+.|+|||++.+. ..++.++|||
T Consensus       184 LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw  260 (345)
T 3hko_A          184 LHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW  260 (345)
T ss_dssp             HHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred             HHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence            999   9999999999999998776  89999999998654322  11123456799999999998752 3688999999


Q ss_pred             ecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHH
Q 015480          267 SFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSA  346 (406)
Q Consensus       267 slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~  346 (406)
                      |||+++|||++|+.||......       ...........      ..........+..+.+++..||+.||.+||++.+
T Consensus       261 slG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  327 (345)
T 3hko_A          261 SAGVLLHLLLMGAVPFPGVNDA-------DTISQVLNKKL------CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMR  327 (345)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhccc------ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence            9999999999999998533211       00111111100      0011222345678999999999999999999999


Q ss_pred             HHH--Hhhcc
Q 015480          347 VIK--MLEGV  354 (406)
Q Consensus       347 vl~--~L~~~  354 (406)
                      +++  .++.+
T Consensus       328 ~l~hp~~~~~  337 (345)
T 3hko_A          328 ALQHPWISQF  337 (345)
T ss_dssp             HHHSHHHHTT
T ss_pred             HhcChhhccC
Confidence            988  45444

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=347.66  Aligned_cols=266  Identities=17%  Similarity=0.175  Sum_probs=205.8

Q ss_pred             hhhhcccccccccceeEEEEEEeCC---------CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCcccc--------
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPN---------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR--------  139 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------  139 (406)
                      ...|.+.+.||+|+||+||+|.+..         ++.||+|++...      ..+.+|++++.+++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            4578888999999999999998753         789999998753      35789999999999999887        


Q ss_pred             -------EEEEEec-CCeeEEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcE
Q 015480          140 -------LYGFCHD-QHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV  210 (406)
Q Consensus       140 -------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Ni  210 (406)
                             +++++.. +...++||||+ +++|.+++... ...+++..+..++.|++.||+|||+   ++++||||||+||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NI  190 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENI  190 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHE
Confidence                   6777765 77889999999 99999999654 4789999999999999999999999   9999999999999


Q ss_pred             EEcCCC--CceEeccccccccCCCCceE-----EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccc
Q 015480          211 LLDANF--SPKVADFGLAKLCDRNKTHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAI  283 (406)
Q Consensus       211 ll~~~~--~~kl~DfGl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~  283 (406)
                      |++.++  .+||+|||+++.........     ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            999998  89999999997654322111     11335799999999999876 78999999999999999999999986


Q ss_pred             cCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCC
Q 015480          284 VGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP  359 (406)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~  359 (406)
                      ........ ... ...... .........   .......+..+.+++.+||+.||.+|||+.+|++.|+.+.....
T Consensus       270 ~~~~~~~~-~~~-~~~~~~-~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          270 NCLPNTED-IMK-QKQKFV-DKPGPFVGP---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             GGTTCHHH-HHH-HHHHHH-HSCCCEECT---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cCCcCHHH-HHH-HHHhcc-CChhhhhhh---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            54321110 000 000000 000000000   00011335789999999999999999999999999999875543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.6e-44  Score=341.62  Aligned_cols=270  Identities=24%  Similarity=0.243  Sum_probs=207.4

Q ss_pred             eeeChHHHhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-----cCccccEE
Q 015480           68 VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-----HINLVRLY  141 (406)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~  141 (406)
                      ..+...++....|.+.++||+|+||+||+|++ .+|+.||||++...  ......+..|+.++..+.     ||||++++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            45566667778899999999999999999976 56899999999752  234566788999998886     99999999


Q ss_pred             EEEecCCeeEEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC------
Q 015480          142 GFCHDQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA------  214 (406)
Q Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~------  214 (406)
                      +++...+..++||||+ +++|.+++... ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.      
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEE
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccccc
Confidence            9999999999999999 88999999654 3469999999999999999999999   99999999999999975      


Q ss_pred             -------------------CCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHH
Q 015480          215 -------------------NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI  275 (406)
Q Consensus       215 -------------------~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el  275 (406)
                                         ++.+||+|||++.......     ....||+.|+|||++.+. .++.++|||||||++|||
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHH
Confidence                               7899999999998654332     245689999999999877 789999999999999999


Q ss_pred             hhcccccccCCCccc--------ccchhHHHHHHhhhhcchhhcc---------------------CCCCcchHHHHHHH
Q 015480          276 VGRRRNAIVGATESL--------DWFPKHVWEEYEKCELGAMILG---------------------CGIEEKDKEKAKRL  326 (406)
Q Consensus       276 ltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l  326 (406)
                      ++|+.||........        ...+..................                     ...+.........+
T Consensus       253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            999999864322100        0000111111000000000000                     00001111122678


Q ss_pred             HHHHHHhcccCCCCCCChHHHHH
Q 015480          327 CMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       327 ~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .+|+.+||+.||++|||+.++++
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhcCChhhCCCHHHHhc
Confidence            89999999999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.9e-44  Score=329.15  Aligned_cols=252  Identities=21%  Similarity=0.326  Sum_probs=201.6

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-----hhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-----RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      ...|.+.+.||+|+||.||+|... +|+.||+|++.....     ....+.+.+|+.++.+++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            346788899999999999999775 689999999875421     12367899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC----CceEeccccc
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----SPKVADFGLA  226 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~DfGl~  226 (406)
                      ++||||+++++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++    .+||+|||++
T Consensus        84 ~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           84 VLILELVSGGELFDFLA-EKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            99999999999999994 34579999999999999999999999   9999999999999998877    7999999999


Q ss_pred             cccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhc
Q 015480          227 KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCEL  306 (406)
Q Consensus       227 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (406)
                      ........   .....|++.|+|||++.+. .++.++||||||+++|+|++|..||......       .......... 
T Consensus       160 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~-  227 (283)
T 3bhy_A          160 HKIEAGNE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQ-------ETLTNISAVN-  227 (283)
T ss_dssp             EECC-----------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTC-
T ss_pred             eeccCCCc---ccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchH-------HHHHHhHhcc-
Confidence            86644322   2335689999999999876 7899999999999999999999998543211       1111111100 


Q ss_pred             chhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                           ...........+..+.+++.+||+.||.+|||+.++++
T Consensus       228 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          228 -----YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             -----CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence                 00001112234577999999999999999999999998

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.4e-44  Score=328.31  Aligned_cols=246  Identities=26%  Similarity=0.369  Sum_probs=199.0

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ..|.+.+.||+|+||+||+|.+ .+++.||+|++.....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            4567788999999999999966 4578999999865321  123467889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....... 
T Consensus        89 e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-  163 (279)
T 3fdn_A           89 EYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  163 (279)
T ss_dssp             CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence            99999999999843 3569999999999999999999999   999999999999999999999999999986543322 


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                         .....|++.|+|||.+.+. .++.++||||||+++|+|++|..||......       ..........         
T Consensus       164 ---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~---------  223 (279)
T 3fdn_A          164 ---RTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------ETYKRISRVE---------  223 (279)
T ss_dssp             -------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTC---------
T ss_pred             ---ccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHH-------HHHHHHHhCC---------
Confidence               2335689999999999876 7899999999999999999999998533211       1111111110         


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       ...+...+..+.+++.+||+.||.+|||+.++++
T Consensus       224 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          224 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             -CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence             1122335577899999999999999999999998

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-44  Score=348.48  Aligned_cols=264  Identities=25%  Similarity=0.296  Sum_probs=190.1

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccC-cCccccEEEEEecCC--eeEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQH--MTAL  152 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~~l  152 (406)
                      .+|.+.+.||+|+||.||+|.+ .+|+.||||++.... .......+.+|+.++..+. ||||+++++++...+  ..++
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            4577889999999999999975 569999999986532 3345567889999999997 999999999997544  7899


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |||||+ ++|.+++..  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 v~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             EEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred             EecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence            999997 589988843  479999999999999999999999   99999999999999999999999999999865321


Q ss_pred             -------------------CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc--
Q 015480          233 -------------------KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD--  291 (406)
Q Consensus       233 -------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--  291 (406)
                                         ..........||+.|+|||++.+...++.++|||||||++|||++|++||.........  
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  242 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER  242 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence                               11122345679999999999987557899999999999999999999998543211000  


Q ss_pred             ------------------cchhHHHHHHhhhhcchhhccCCCCcchH-------------HHHHHHHHHHHHhcccCCCC
Q 015480          292 ------------------WFPKHVWEEYEKCELGAMILGCGIEEKDK-------------EKAKRLCMVALWCVQDSPED  340 (406)
Q Consensus       292 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~l~~l~~~cl~~dP~~  340 (406)
                                        .......+.......   ...........             ..+..+.+|+.+||+.||.+
T Consensus       243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~  319 (388)
T 3oz6_A          243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVE---IRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK  319 (388)
T ss_dssp             HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC--------CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHhcCCCCHHHHHhccCHHHHHHHHhCccccc---ccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence                              000000000000000   00000000000             23567899999999999999


Q ss_pred             CCChHHHHHH
Q 015480          341 RPPMSAVIKM  350 (406)
Q Consensus       341 RPs~~~vl~~  350 (406)
                      |||+.++++.
T Consensus       320 R~t~~e~l~H  329 (388)
T 3oz6_A          320 RISANDALKH  329 (388)
T ss_dssp             SCCHHHHTTS
T ss_pred             CCCHHHHhCC
Confidence            9999999873

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.3e-44  Score=357.49  Aligned_cols=253  Identities=25%  Similarity=0.291  Sum_probs=206.5

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ...|.+.+.||+|+||.||+|+. .+|+.||+|++....  .......+.+|+.++..++||||+++++++.+....++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            45567778999999999999976 469999999997532  123446788999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          154 YEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |||++||+|.+++... ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.+|.+||+|||++......
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            9999999999998654 3459999999999999999999999   99999999999999999999999999999876544


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ...   ....||+.|+|||++.+. .++.++|||||||++|||++|..||........   ...........        
T Consensus       340 ~~~---~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~---~~~i~~~i~~~--------  404 (576)
T 2acx_A          340 QTI---KGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLVKEV--------  404 (576)
T ss_dssp             CCE---ECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC---HHHHHHHHHHC--------
T ss_pred             ccc---cccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchh---HHHHHHHhhcc--------
Confidence            322   345799999999999876 789999999999999999999999965432211   11111111110        


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                        ....+...+..+.+|+.+||+.||.+||     ++.+|++
T Consensus       405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence              0122234567899999999999999999     7788876

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.4e-45  Score=355.46  Aligned_cols=250  Identities=23%  Similarity=0.303  Sum_probs=194.9

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ...|.+.+.||+|+||.||+|.. .+|+.||||++....  .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            35677889999999999999975 568999999997541  223446678899999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+++|+|.+++. ....+++..+..++.|++.||+|||+  ..+|+||||||+|||++.++.+||+|||+++......
T Consensus       227 ~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          227 MEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             ECCCSSCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EeeCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            99999999999984 34579999999999999999999995  2789999999999999999999999999997543322


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      .  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......       ..........        
T Consensus       304 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~--------  365 (446)
T 4ejn_A          304 A--TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEE--------  365 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC--------
T ss_pred             c--ccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCC--------
Confidence            2  23457899999999999876 7899999999999999999999998543211       1111111110        


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                        ...+...+..+.+++.+||+.||.+||     ++.++++
T Consensus       366 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 --IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence              112234567899999999999999999     9999987

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=340.53  Aligned_cols=265  Identities=24%  Similarity=0.317  Sum_probs=192.8

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEe-----
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCH-----  145 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~-----  145 (406)
                      .++...+|.+.+.||+|+||.||+|.+ .+|+.||+|++... .......+.+|+.++.++. ||||+++++++.     
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~  101 (337)
T 3ll6_A           23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE  101 (337)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred             eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence            445566788899999999999999976 46899999998654 3345567899999999996 999999999993     


Q ss_pred             ---cCCeeEEEEEeccCCChhhHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCC--eeecCCCCCcEEEcCCCCc
Q 015480          146 ---DQHMTALVYEYMENGSLDGYLFG--KKRAIEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLDANFSP  218 (406)
Q Consensus       146 ---~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--i~H~dlk~~Nill~~~~~~  218 (406)
                         .....++||||+. |+|.+++..  ....+++..+..++.|++.||+|||+   .+  ++||||||+|||++.++.+
T Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A          102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCE
T ss_pred             cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCE
Confidence               3456789999996 699888853  45679999999999999999999998   88  9999999999999999999


Q ss_pred             eEeccccccccCCCCceE----------EecCCCCCCCccCccccC--CCCCCCcccceeecchhHHHHhhcccccccCC
Q 015480          219 KVADFGLAKLCDRNKTHV----------TISGYKGTPGYSAPEFLS--GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGA  286 (406)
Q Consensus       219 kl~DfGl~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~il~elltg~~p~~~~~  286 (406)
                      ||+|||++..........          ......||+.|+|||++.  ....++.++||||||+++|||++|..||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999998765432211          111345899999999983  23368899999999999999999999985432


Q ss_pred             CcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCCC
Q 015480          287 TESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPP  361 (406)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~p  361 (406)
                      ....           ....        .........+..+.+++..||+.||.+|||+.++++.|+.+....+.+
T Consensus       258 ~~~~-----------~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~  313 (337)
T 3ll6_A          258 KLRI-----------VNGK--------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN  313 (337)
T ss_dssp             ---------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHHh-----------hcCc--------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence            2100           0000        000111222345889999999999999999999999999987654443

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.1e-44  Score=341.43  Aligned_cols=266  Identities=22%  Similarity=0.297  Sum_probs=200.1

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .+|.+.+.||+|+||.||+|... +|+.||+|++.... .....+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            35677889999999999999764 58999999986543 23345678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++++|.+++ .....+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++.........
T Consensus       105 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          105 FVDHTILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             CCSEEHHHHHH-HSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             cCCcchHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            99999988876 345579999999999999999999999   99999999999999999999999999999765433221


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc--------chhHHHHHHhhhhcc
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW--------FPKHVWEEYEKCELG  307 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~  307 (406)
                        .....||+.|+|||++.+...++.++|||||||++|+|++|+.||..........        ........+......
T Consensus       181 --~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          181 --YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             --cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence              2345689999999999876578999999999999999999999986543211000        000000011110000


Q ss_pred             h-hhccCCC-----CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 A-MILGCGI-----EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~-~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      . .......     .......+..+.+++.+||+.||.+|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0 0000000     0111235678999999999999999999999887

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.7e-44  Score=338.64  Aligned_cols=268  Identities=22%  Similarity=0.276  Sum_probs=201.7

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEec--------C
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--------Q  147 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~  147 (406)
                      .+|.+.+.||+|+||+||+|.. .+|+.||+|++..... ......+.+|+.++..++||||+++++++.+        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            4677889999999999999976 5799999999865432 2234578899999999999999999999977        3


Q ss_pred             CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          148 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ...++||||+++ +|.+.+......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence            468999999975 8888886667789999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCC--ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccc--------hhHH
Q 015480          228 LCDRNK--THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWF--------PKHV  297 (406)
Q Consensus       228 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--------~~~~  297 (406)
                      ......  .........||+.|+|||++.+...++.++|||||||++|||++|..||...........        +...
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  252 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            664322  112224467899999999998765789999999999999999999999864322110000        0000


Q ss_pred             HHHHhhhhcchhhc--cCCCCcchH-----HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          298 WEEYEKCELGAMIL--GCGIEEKDK-----EKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       298 ~~~~~~~~~~~~~~--~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      +.............  .........     ..+..+.+|+.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            00000000000000  000000111     11456889999999999999999999998

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.9e-44  Score=348.03  Aligned_cols=253  Identities=23%  Similarity=0.269  Sum_probs=191.4

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc-------hhhHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-------RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      ...|.+.+.||+|+||+||+|.. .+++.||||++.....       ......+.+|+.++++++||||+++++++..+ 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            45677889999999999999965 5689999999875321       11223578999999999999999999998654 


Q ss_pred             eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC---CceEecccc
Q 015480          149 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGL  225 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~DfGl  225 (406)
                      ..++||||+++|+|.+++. ....+++..+..++.|++.||+|||+   .+++||||||+|||++.++   .+||+|||+
T Consensus       213 ~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             ceEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeeccc
Confidence            5789999999999999883 45679999999999999999999999   9999999999999997544   599999999


Q ss_pred             ccccCCCCceEEecCCCCCCCccCccccCC--CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhh
Q 015480          226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK  303 (406)
Q Consensus       226 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  303 (406)
                      ++.......   .....||+.|+|||++.+  ...++.++|||||||++|+|++|..||........      .......
T Consensus       289 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~------~~~~i~~  359 (419)
T 3i6u_A          289 SKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQITS  359 (419)
T ss_dssp             TTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC------HHHHHHT
T ss_pred             ceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH------HHHHHhc
Confidence            987653322   234679999999999863  33678999999999999999999999864322211      0111111


Q ss_pred             hhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....      ..+......+..+.+++.+||+.||.+|||+.++++
T Consensus       360 ~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          360 GKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             TCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCC------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1000      001112235678999999999999999999999987

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.9e-45  Score=343.07  Aligned_cols=250  Identities=20%  Similarity=0.312  Sum_probs=199.0

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ..|.+.+.||+|+||.||+|... +|+.||+|++.....     ...+|++++.++ +||||+++++++.+....++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            45777899999999999999764 689999999976432     235688888887 79999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC-C---CceEeccccccccCC
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-F---SPKVADFGLAKLCDR  231 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~---~~kl~DfGl~~~~~~  231 (406)
                      |+++|+|.+++. ....+++..+..++.|++.||+|||+   .+|+||||||+|||+.++ +   .+||+|||++.....
T Consensus        97 ~~~gg~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           97 LMKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             CCCSCBHHHHHH-TCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             CCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            999999999984 44679999999999999999999999   999999999999998543 3   499999999986654


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ....  .....||+.|+|||++.+. .++.++|||||||++|||++|..||.......    ..............   .
T Consensus       173 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~i~~~~~~---~  242 (342)
T 2qr7_A          173 ENGL--LMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDT----PEEILARIGSGKFS---L  242 (342)
T ss_dssp             TTCC--BCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC----HHHHHHHHHHCCCC---C
T ss_pred             CCCc--eeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC----HHHHHHHHccCCcc---c
Confidence            3322  2346789999999999865 68899999999999999999999986432211    11111222111110   0


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                         ........+..+.+++.+||+.||.+||++.++++
T Consensus       243 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          243 ---SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ---CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               01122345678999999999999999999999987

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.6e-44  Score=332.41  Aligned_cols=249  Identities=23%  Similarity=0.372  Sum_probs=203.4

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec---------
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD---------  146 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------  146 (406)
                      ...|...+.||+|+||.||+|.+. +|+.||+|++....     +.+.+|++++.+++||||+++++++..         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            455777889999999999999775 79999999997542     346789999999999999999999854         


Q ss_pred             -------CCeeEEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCc
Q 015480          147 -------QHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP  218 (406)
Q Consensus       147 -------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  218 (406)
                             ....++||||+++++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCE
Confidence                   44578999999999999999643 4679999999999999999999999   999999999999999999999


Q ss_pred             eEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHH
Q 015480          219 KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVW  298 (406)
Q Consensus       219 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  298 (406)
                      ||+|||++........   .....||+.|+|||.+.+. .++.++||||||+++|||++|..|+...         ....
T Consensus       162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~  228 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFET---------SKFF  228 (284)
T ss_dssp             EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHH
T ss_pred             EECcchhheecccccc---ccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHH
Confidence            9999999987654332   1235689999999999876 7899999999999999999998775321         0011


Q ss_pred             HHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          299 EEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                      ......         .   .+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       229 ~~~~~~---------~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          229 TDLRDG---------I---ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             HHHHTT---------C---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             HHhhcc---------c---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            111111         1   11224566889999999999999999999999998876443

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=8.5e-45  Score=335.48  Aligned_cols=262  Identities=27%  Similarity=0.395  Sum_probs=201.6

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeC--CCc--EEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecC
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFP--NGV--KIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ  147 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~--~g~--~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  147 (406)
                      .+....|.+.+.||+|+||+||+|.+.  ++.  .||+|+++...  .....+.+.+|+.++.+++||||+++++++.+.
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            345567888899999999999999752  333  68999987542  234557899999999999999999999999876


Q ss_pred             CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          148 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      . .++||||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccc
Confidence            5 789999999999999997666779999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCceEE-ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhh
Q 015480          228 LCDRNKTHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCE  305 (406)
Q Consensus       228 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (406)
                      .......... .....+|..|+|||++.+. .++.++||||||+++|+|++ |..||......       ........  
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~--  239 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILHKIDK--  239 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHT--
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-------HHHHHHHc--
Confidence            7655433222 2335578899999999876 68999999999999999999 89887533211       11111111  


Q ss_pred             cchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          306 LGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                            .......+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       240 ------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          240 ------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             ------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ------cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence                  11112223355678999999999999999999999999998875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1e-43  Score=335.28  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=206.6

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ..+|...+.||+|+||.||++.+. +++.||+|++....  .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            355777889999999999999764 58899999987542  234567789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+++++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++.......
T Consensus       120 ~e~~~~~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHK-RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999884 34579999999999999999999999   999999999999999999999999999998665332


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      ..  .....||..|+|||++.+. .++.++||||||+++|||++|..||......       ..........        
T Consensus       196 ~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~--------  257 (335)
T 2owb_A          196 ER--KKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRIKKNE--------  257 (335)
T ss_dssp             CC--BCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTC--------
T ss_pred             cc--ccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-------HHHHHHhcCC--------
Confidence            22  2345689999999999876 6899999999999999999999998543211       1111111110        


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhc
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEG  353 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~  353 (406)
                        ...+...+..+.+++.+||+.||.+|||+.++++  .+..
T Consensus       258 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          258 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence              1112234567899999999999999999999997  4443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.8e-44  Score=343.73  Aligned_cols=244  Identities=22%  Similarity=0.303  Sum_probs=187.6

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhc-cCcCccccEEEEEec----CCeeEEEEEec
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYGFCHD----QHMTALVYEYM  157 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~~lv~e~~  157 (406)
                      +.||+|+||+||+|.+ .+|+.||||++...      ..+.+|+.++.+ .+||||+++++++..    ....++|||||
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~  141 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL  141 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence            6799999999999976 46899999998642      346678887754 479999999999865    56789999999


Q ss_pred             cCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC---CCCceEeccccccccCCCC
Q 015480          158 ENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       158 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~DfGl~~~~~~~~  233 (406)
                      ++|+|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.   ++.+||+|||+++......
T Consensus       142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~  218 (400)
T 1nxk_A          142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  218 (400)
T ss_dssp             CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred             CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence            999999999654 3469999999999999999999999   99999999999999987   7899999999998654332


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      .   ....+||+.|+|||++.+. .++.++|||||||++|||++|..||..........   ............   .  
T Consensus       219 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~i~~~~~~---~--  286 (400)
T 1nxk_A          219 S---LTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQYE---F--  286 (400)
T ss_dssp             -----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC---SHHHHHHHTCCC---C--
T ss_pred             c---cccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH---HHHHHHHcCccc---C--
Confidence            2   2346789999999999876 78999999999999999999999996543322110   011111111110   0  


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       ........+.++.+|+.+||+.||.+|||+.++++
T Consensus       287 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          287 -PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             -CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             01111345678999999999999999999999998

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.2e-44  Score=340.81  Aligned_cols=260  Identities=20%  Similarity=0.253  Sum_probs=192.6

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      -.+|.+.+.||+|+||+||+|.. .+|+.||||+++.... ......+.+|+.++++++||||+++++++.++...++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            34677889999999999999965 5689999999975432 223456789999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc-----CCCCceEecccccccc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-----ANFSPKVADFGLAKLC  229 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~-----~~~~~kl~DfGl~~~~  229 (406)
                      ||+++ +|.+++.. ...+++..+..++.|++.||+|||+   .+|+||||||+|||++     .++.+||+|||++...
T Consensus       113 e~~~~-~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          113 EYAEN-DLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             ECCSE-EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             ecCCC-CHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            99975 99999843 4569999999999999999999999   9999999999999994     4556999999999876


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhh----
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCE----  305 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  305 (406)
                      ......  .....||+.|+|||++.+...++.++|||||||++|||++|..||.......      ..........    
T Consensus       188 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~~~~~  259 (329)
T 3gbz_A          188 GIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID------QLFKIFEVLGLPDD  259 (329)
T ss_dssp             C-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHHHCCCCT
T ss_pred             CCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH------HHHHHHHHhCCCch
Confidence            533222  2345689999999999876568999999999999999999999985432210      0000000000    


Q ss_pred             --cchh--------hccCCCCc-----chHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          306 --LGAM--------ILGCGIEE-----KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       306 --~~~~--------~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        ....        ........     .....+.++.+|+.+||+.||.+|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence              0000        00000000     01114577899999999999999999999987

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2e-43  Score=326.37  Aligned_cols=249  Identities=24%  Similarity=0.385  Sum_probs=199.0

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEec----CCee
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD----QHMT  150 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  150 (406)
                      ...|.+.+.||+|+||+||+|.+ .++..||+|.+.... .....+.+.+|+.++++++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            33466778899999999999976 568899999987542 34456789999999999999999999999865    4568


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCC--eeecCCCCCcEEEc-CCCCceEecccccc
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLD-ANFSPKVADFGLAK  227 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--i~H~dlk~~Nill~-~~~~~kl~DfGl~~  227 (406)
                      ++||||+++++|.+++. ....+++..+..++.|++.||.|||+   .+  ++||||||+|||++ .++.+||+|||++.
T Consensus       105 ~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEecCCCCHHHHHH-HccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            99999999999999994 34678999999999999999999998   77  99999999999997 78999999999997


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ........    ...||+.|+|||++.+  .++.++||||||+++|+|++|+.||......      ..........   
T Consensus       181 ~~~~~~~~----~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~---  245 (290)
T 1t4h_A          181 LKRASFAK----AVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSG---  245 (290)
T ss_dssp             GCCTTSBE----ESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTT---
T ss_pred             cccccccc----cccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhcc---
Confidence            65443322    2468999999998874  4899999999999999999999998543221      0111111111   


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                           ..........+..+.+++..||+.||.+|||+.++++
T Consensus       246 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          246 -----VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                 0011122233467999999999999999999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=336.62  Aligned_cols=264  Identities=23%  Similarity=0.296  Sum_probs=196.3

Q ss_pred             HhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc----hhhHHHHHHHHHHhhccC---cCccccEEEEEec
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG----RIAEEQFMAEVGTIGRTY---HINLVRLYGFCHD  146 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~  146 (406)
                      +...+|.+.+.||+|+||+||+|.+ .+|+.||+|++.....    ......+.+|+.+++.+.   ||||+++++++.+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            4456788889999999999999976 5689999999874321    112345667777776664   9999999999977


Q ss_pred             CC-----eeEEEEEeccCCChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceE
Q 015480          147 QH-----MTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV  220 (406)
Q Consensus       147 ~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl  220 (406)
                      ..     ..++||||+. ++|.+++.... ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEE
Confidence            55     5789999997 59999986543 349999999999999999999999   99999999999999999999999


Q ss_pred             eccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHH
Q 015480          221 ADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEE  300 (406)
Q Consensus       221 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  300 (406)
                      +|||++........   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........   .....+.
T Consensus       162 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~  234 (308)
T 3g33_A          162 ADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDL  234 (308)
T ss_dssp             CSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHHHH
T ss_pred             eeCccccccCCCcc---cCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHH
Confidence            99999986653322   2345789999999999876 689999999999999999999999854322110   0000000


Q ss_pred             Hhhhh---c------chhhccCCC----CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          301 YEKCE---L------GAMILGCGI----EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       301 ~~~~~---~------~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .....   .      .........    .......+..+.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            00000   0      000000000    0111234577899999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.4e-44  Score=368.92  Aligned_cols=261  Identities=23%  Similarity=0.318  Sum_probs=209.5

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      .++...+|.+.+.||+|+||+||+|.+..    +..||+|.+.........+.+.+|+.++++++||||+++++++.+ +
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~  463 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N  463 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C
Confidence            44555677888999999999999997632    567999998865555566789999999999999999999999854 5


Q ss_pred             eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          149 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      ..++||||+++|+|.+++......+++..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++.
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence            6899999999999999997666789999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ....... ......+|+.|+|||++.+. .++.++||||||+++|||++ |..||......       ........    
T Consensus       541 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-------~~~~~i~~----  607 (656)
T 2j0j_A          541 MEDSTYY-KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIEN----  607 (656)
T ss_dssp             CCC-----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHH----
T ss_pred             cCCCcce-eccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHc----
Confidence            6543222 12334578899999999876 78999999999999999997 88887532211       11111111    


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                           ......+..++..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       608 -----~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          608 -----GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                 1112233456678999999999999999999999999998875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.4e-44  Score=329.20  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=204.2

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      .+|...+.||+|+||.||++... +++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            45677889999999999999764 58899999987542  2345577899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+++++|.+++. ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        95 e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           95 ELCRRRSLLELHK-RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             ECCTTCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             ecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            9999999999884 34579999999999999999999999   9999999999999999999999999999986653322


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                      .  .....||+.|+|||.+.+. .++.++||||||+++|+|++|..||......       ..........         
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~---------  231 (294)
T 2rku_A          171 R--KKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRIKKNE---------  231 (294)
T ss_dssp             C--BCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTC---------
T ss_pred             c--cccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhhcc---------
Confidence            2  2345689999999999876 6899999999999999999999998543211       1111111110         


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       232 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          232 -YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence             1122344567899999999999999999999998

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.1e-44  Score=327.30  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=196.2

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ..+|.+.+.||+|+||.||+|.+. +|+.||+|++....  .......+.+|+.+++.++||||+++++++.+....++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            346777889999999999999775 69999999997532  122346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            999999999999943 3568999999999999999999999   899999999999999999999999999998665432


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      .   .....|++.|+|||.+.+....+.++||||||+++|+|++|..||......       ..........        
T Consensus       166 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~--------  227 (276)
T 2h6d_A          166 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-------TLFKKIRGGV--------  227 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC--------
T ss_pred             c---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhcCc--------
Confidence            2   223568999999999987744578999999999999999999998543211       1111111110        


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        ...+...+..+.+++.+||+.||.+|||+.++++
T Consensus       228 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          228 --FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence              1122234567899999999999999999999998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-44  Score=339.61  Aligned_cols=264  Identities=23%  Similarity=0.255  Sum_probs=199.4

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchh----hHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRI----AEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      .+|.+.+.||+|+||.||+|.+. +|+.||+|++.......    ....+.+|+.++..++||||+++++++.+....++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            45677889999999999999774 58999999997532211    12467899999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ||||+++ +|.+++......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.....
T Consensus        90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            9999986 8988887666789999999999999999999999   99999999999999999999999999999866433


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhh--------
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC--------  304 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------  304 (406)
                      ...  .....||+.|+|||++.+...++.++|||||||++|||++|.+||........   .....+.....        
T Consensus       166 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~~~~~~~~  240 (346)
T 1ua2_A          166 NRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDM  240 (346)
T ss_dssp             CCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSST
T ss_pred             ccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCChhhhhhh
Confidence            221  23457899999999997665689999999999999999999988754321100   00000100000        


Q ss_pred             -hcchhhccCCCCcc-----hHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 015480          305 -ELGAMILGCGIEEK-----DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM  350 (406)
Q Consensus       305 -~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  350 (406)
                       ..............     ....+..+.+++.+||+.||.+|||+.++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence             00000000000111     12345789999999999999999999999983

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.1e-43  Score=332.24  Aligned_cols=257  Identities=19%  Similarity=0.236  Sum_probs=201.5

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEec--CCeeEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHD--QHMTAL  152 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~l  152 (406)
                      ...|.+.+.||+|+||+||+|.. .+|+.||+|++...    ..+.+.+|+.++.+++ ||||+++++++.+  ....++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            35677889999999999999965 57899999999753    3467899999999997 9999999999987  667899


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC-CceEeccccccccCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDR  231 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~DfGl~~~~~~  231 (406)
                      ||||+++++|.+++.    .+++..+..++.|++.||+|||+   .+++||||||+|||++.++ .+||+|||+++....
T Consensus       111 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            999999999999883    48999999999999999999999   9999999999999999777 899999999986654


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ...   .....|+..|+|||++.+...++.++|||||||++|||++|+.||..+.........  .............+.
T Consensus       184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~--~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR--IAKVLGTEDLYDYID  258 (330)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH--HHHHHCHHHHHHHHH
T ss_pred             CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHH--HHHhcCCchhhhHHH
Confidence            332   234568999999999987557899999999999999999999998654332111000  000000000000000


Q ss_pred             -----------------------cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          312 -----------------------GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       312 -----------------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                                             ...........+..+.+++.+||+.||.+|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                                   00001112235688999999999999999999999987

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.2e-44  Score=349.73  Aligned_cols=258  Identities=21%  Similarity=0.255  Sum_probs=193.1

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecC------Ce
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------HM  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  149 (406)
                      .+|.+.+.||+|+||+||+|.. .+|+.||||++.... .....+.+.+|+.+++.++||||+++++++...      ..
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            4577788999999999999965 568999999997542 334457789999999999999999999999655      35


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+++ +|.+.+.   ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       142 ~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          142 VYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             EEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            6999999976 5666662   348999999999999999999999   99999999999999999999999999999866


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhH----------HHH
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKH----------VWE  299 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~----------~~~  299 (406)
                      .....   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........  +...          .+.
T Consensus       215 ~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~--~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          215 GTSFM---MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             --CCC---C----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHHHT
T ss_pred             CCCcc---cCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHH
Confidence            54322   2346799999999999887 799999999999999999999999854321100  0000          000


Q ss_pred             HHhhhhcchhhcc------------------CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          300 EYEKCELGAMILG------------------CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       300 ~~~~~~~~~~~~~------------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .... ........                  ..........+..+.+|+.+||+.||++|||++|+++
T Consensus       289 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          289 KLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             TSCH-HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Hcch-hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000 00000000                  0001112234678999999999999999999999998

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1e-43  Score=352.88  Aligned_cols=253  Identities=25%  Similarity=0.306  Sum_probs=204.7

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ..|...+.||+|+||+||+|+.. +|+.||+|++.+...  ......+..|+.++.+++||||+++++++.+....++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            45666788999999999999774 699999999975421  123467889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          155 EYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       155 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      ||++||+|.+++...   ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.+|.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999998543   3579999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ....  ....+||+.|+|||++.+. .++.++|||||||++|||++|..||........   ...........       
T Consensus       342 ~~~~--~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~---~~~~~~~i~~~-------  408 (543)
T 3c4z_A          342 GQTK--TKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRVLEQ-------  408 (543)
T ss_dssp             TCCC--BCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC---HHHHHHHHHHC-------
T ss_pred             CCcc--cccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchh---HHHHHHHHhhc-------
Confidence            3322  2345799999999999886 789999999999999999999999965432111   01111111111       


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCCh-----HHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPM-----SAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~~vl~  349 (406)
                         ....+...+..+.+++.+||+.||.+||++     ++|++
T Consensus       409 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          409 ---AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ---ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence               012233456789999999999999999975     56654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.8e-45  Score=334.61  Aligned_cols=254  Identities=21%  Similarity=0.308  Sum_probs=202.7

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEe--cCCeeEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCH--DQHMTALV  153 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv  153 (406)
                      ..|.+.+.||+|+||.||+|... +|+.||+|++.... .....+.+.+|+.++++++||||+++++++.  .....++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            35677889999999999999764 68999999997543 3345678999999999999999999999884  45688999


Q ss_pred             EEeccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCC-----eeecCCCCCcEEEcCCCCceEecccc
Q 015480          154 YEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-----IIHYDIKPENVLLDANFSPKVADFGL  225 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-----i~H~dlk~~Nill~~~~~~kl~DfGl  225 (406)
                      |||+++++|.+++..   ....+++..++.++.|++.||+|||+   .+     ++||||||+||+++.++.+||+|||+
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            999999999999953   24569999999999999999999999   77     99999999999999999999999999


Q ss_pred             ccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhh
Q 015480          226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCE  305 (406)
Q Consensus       226 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (406)
                      +.........  .....|++.|+|||.+.+. .++.++||||||+++|+|++|..||.....       .......... 
T Consensus       163 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~-  231 (279)
T 2w5a_A          163 ARILNHDTSF--AKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREG-  231 (279)
T ss_dssp             HHHC---CHH--HHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHT-
T ss_pred             heeecccccc--ccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCH-------HHHHHHHhhc-
Confidence            9866543221  1224589999999999876 789999999999999999999998854321       1111111111 


Q ss_pred             cchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 015480          306 LGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEG  353 (406)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  353 (406)
                              .....+...+..+.+++.+||+.||.+|||+.++++.+..
T Consensus       232 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          232 --------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             --------ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                    1122333456789999999999999999999999986643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-44  Score=343.08  Aligned_cols=256  Identities=21%  Similarity=0.233  Sum_probs=202.3

Q ss_pred             hhhhcccccccccceeEEEEEEe----CCCcEEEEEEecccc---chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCC
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF----PNGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQH  148 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~----~~g~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  148 (406)
                      -..|.+.+.||+|+||+||+|+.    .+|+.||||+++...   .....+.+.+|+.++..+ +||||+++++++.+..
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            35678889999999999999976    468999999997532   112345677899999999 6999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          149 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      ..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999953 4579999999999999999999999   9999999999999999999999999999976


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCCC-CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ........ .....||+.|+|||++.+. ..++.++|||||||++|||++|..||.........   .........    
T Consensus       209 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~----  280 (355)
T 1vzo_A          209 FVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRILK----  280 (355)
T ss_dssp             CCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHHH----
T ss_pred             cccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH---HHHHHHHhc----
Confidence            54322211 1235689999999999853 35789999999999999999999998644322111   111111100    


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHHH
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIKM  350 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~~  350 (406)
                            .....+...+..+.+++.+||+.||.+||     +++++++.
T Consensus       281 ------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          281 ------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                  01222334567789999999999999999     89998873

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-44  Score=339.43  Aligned_cols=268  Identities=20%  Similarity=0.266  Sum_probs=199.0

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCC------e
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH------M  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  149 (406)
                      ..|...+.||+|+||.||+|.+ .+|+.||||++.... .....+.+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            4567788999999999999976 569999999996532 3344577899999999999999999999997753      4


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+ +++|.+++..  ..+++..+..++.|+++||+|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus       105 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA  178 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence            59999999 7899999854  568999999999999999999999   99999999999999999999999999999865


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc--------cchhHHHHHH
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD--------WFPKHVWEEY  301 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~~  301 (406)
                      ...     .....||+.|+|||++.+...++.++|||||||++|||++|+.||.........        ..+...+...
T Consensus       179 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  253 (367)
T 1cm8_A          179 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  253 (367)
T ss_dssp             CSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             ccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            433     234678999999999887557899999999999999999999998643221000        0000000000


Q ss_pred             hhhhcchhh------ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcccc
Q 015480          302 EKCELGAMI------LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVVE  356 (406)
Q Consensus       302 ~~~~~~~~~------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~~  356 (406)
                      .........      ............+..+.+|+.+||+.||.+|||+.++++  .++.+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence            000000000      000111122344678999999999999999999999998  5665543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.6e-43  Score=350.41  Aligned_cols=257  Identities=24%  Similarity=0.327  Sum_probs=205.7

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ..+|.+.+.||+|+||+||+|... +|+.||||++.... .......+.+|++++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            356788899999999999999764 68999999986432 2234577899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc---CCCCceEeccccccccCC
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~DfGl~~~~~~  231 (406)
                      |||.+|+|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++   .++.+||+|||++.....
T Consensus       101 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          101 ELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            99999999998843 4579999999999999999999999   9999999999999995   456799999999986654


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ...   .....||+.|+|||++.+  .++.++|||||||++|+|++|..||......       ............    
T Consensus       177 ~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~----  240 (486)
T 3mwu_A          177 NTK---MKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------DILKRVETGKYA----  240 (486)
T ss_dssp             C-------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC----
T ss_pred             CCc---cCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC----
Confidence            322   234679999999999976  4899999999999999999999998543211       111111111110    


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhccc
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVV  355 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~  355 (406)
                        ...+.....+..+.+++.+||+.||.+|||+.++++  .+....
T Consensus       241 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          241 --FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             --SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             --CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence              001222345678999999999999999999999998  455443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.1e-43  Score=327.03  Aligned_cols=253  Identities=23%  Similarity=0.309  Sum_probs=205.8

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      -..|.+.+.||+|+||.||+|... +++.||+|++....  .......+.+|++++..++||||+++++++.+....++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            345777889999999999999764 58899999987532  112346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        93 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           93 LEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             ECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            999999999999843 3568999999999999999999999   999999999999999999999999999997554322


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      .    ....|++.|+|||.+.+. .++.++||||||+++|+|++|..||......       ..........        
T Consensus       169 ~----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~--------  228 (284)
T 2vgo_A          169 R----RTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-------ETHRRIVNVD--------  228 (284)
T ss_dssp             B----CCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTC--------
T ss_pred             c----ccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHh-------HHHHHHhccc--------
Confidence            1    345689999999999876 7899999999999999999999998543211       0111111100        


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhccc
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVV  355 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~  355 (406)
                        ...+...+..+.+++.+||+.||.+||++.++++  .+....
T Consensus       229 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          229 --LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             --cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence              1122335677899999999999999999999987  555443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=331.36  Aligned_cols=250  Identities=23%  Similarity=0.310  Sum_probs=200.4

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ...|.+.+.||+|+||.||+|.+. +|+.||+|++....   ..+.+.+|+.++..++||||+++++++.+....++|||
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            445677889999999999999764 58999999997542   34578899999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++++|.+++......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.........
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK  181 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence            999999999996566789999999999999999999999   99999999999999999999999999999766543221


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        .....|++.|+|||.+.+. .++.++||||||+++|+|++|..||......       .........       ....
T Consensus       182 --~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~-------~~~~  244 (314)
T 3com_A          182 --RNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPM-------RAIFMIPTN-------PPPT  244 (314)
T ss_dssp             --BCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHS-------CCCC
T ss_pred             --cCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcC-------CCcc
Confidence              2345689999999999876 7899999999999999999999998532211       000000000       0011


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...+...+..+.+++.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            1123345678999999999999999999999987

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.2e-43  Score=342.23  Aligned_cols=268  Identities=22%  Similarity=0.243  Sum_probs=204.8

Q ss_pred             eChHHHhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccC--------cCccccE
Q 015480           70 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY--------HINLVRL  140 (406)
Q Consensus        70 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~  140 (406)
                      +...++...+|.+.++||+|+||+||+|.. .+|+.||||++...  ....+.+.+|+.++..++        |+||+++
T Consensus        29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~  106 (397)
T 1wak_A           29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL  106 (397)
T ss_dssp             SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred             EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence            344445567788999999999999999965 56899999999753  345577889999999885        7889999


Q ss_pred             EEEEe----cCCeeEEEEEeccCCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCC-CeeecCCCCCcEEEcC
Q 015480          141 YGFCH----DQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDA  214 (406)
Q Consensus       141 ~~~~~----~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~i~H~dlk~~Nill~~  214 (406)
                      ++++.    +....++||||+ +++|.+++.. ....+++..+..++.|++.||+|||+   + +|+||||||+|||++.
T Consensus       107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~  182 (397)
T 1wak_A          107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSV  182 (397)
T ss_dssp             EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECC
T ss_pred             ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEec
Confidence            99997    567889999999 5566666543 44679999999999999999999999   8 9999999999999997


Q ss_pred             CC-------------------------------------------------CceEeccccccccCCCCceEEecCCCCCC
Q 015480          215 NF-------------------------------------------------SPKVADFGLAKLCDRNKTHVTISGYKGTP  245 (406)
Q Consensus       215 ~~-------------------------------------------------~~kl~DfGl~~~~~~~~~~~~~~~~~gt~  245 (406)
                      ++                                                 .+||+|||++......     .....||+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~  257 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTR  257 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCG
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCC
Confidence            75                                                 7999999999866433     23456899


Q ss_pred             CccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHH-----------hhhhcch-hhcc-
Q 015480          246 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEY-----------EKCELGA-MILG-  312 (406)
Q Consensus       246 ~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~-~~~~-  312 (406)
                      .|+|||++.+. .++.++|||||||++|||++|+.||...................           ....... .... 
T Consensus       258 ~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  336 (397)
T 1wak_A          258 QYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK  336 (397)
T ss_dssp             GGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred             cccCChhhcCC-CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence            99999999877 68999999999999999999999996543322111000000000           0000000 0000 


Q ss_pred             ---------C---------CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          313 ---------C---------GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       313 ---------~---------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                               .         .........+..+.+|+.+||+.||++|||+.++++
T Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                     0         001234677889999999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.2e-43  Score=326.44  Aligned_cols=252  Identities=25%  Similarity=0.350  Sum_probs=194.0

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec----------
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD----------  146 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----------  146 (406)
                      ..|.+.+.||+|+||.||+|.. .+|+.||||++...  ....+.+.+|+.++.+++||||+++++++.+          
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            3567788999999999999976 47999999999653  3455778999999999999999999998865          


Q ss_pred             ---CCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecc
Q 015480          147 ---QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF  223 (406)
Q Consensus       147 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (406)
                         ....++||||+++|+|.+++......+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeC
Confidence               457789999999999999997666778999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCc------------eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc
Q 015480          224 GLAKLCDRNKT------------HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD  291 (406)
Q Consensus       224 Gl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~  291 (406)
                      |++........            ........||+.|+|||++.+...++.++|||||||++|||++   |+.....    
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~----  233 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME----  233 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH----
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh----
Confidence            99976543211            1112345689999999999866568999999999999999998   3211100    


Q ss_pred             cchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          292 WFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        ...........      ............+..+.+++.+||+.||.+|||+.++++
T Consensus       234 --~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 --RVNILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             --HHHHHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --HHHHHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence              00011111110      001112233455677899999999999999999999987

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.6e-44  Score=351.98  Aligned_cols=256  Identities=25%  Similarity=0.343  Sum_probs=207.8

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ...|.+.+.||+|+||.||+|... +|+.||||++....  .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            456788899999999999999764 79999999986532  233567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEE---cCCCCceEeccccccccC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCD  230 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~DfGl~~~~~  230 (406)
                      |||+.+|+|.+++. ....+++..+..++.|++.||.|||+   .+|+||||||+|||+   +.++.+||+|||++....
T Consensus       105 ~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHH-TCSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999884 45679999999999999999999999   999999999999999   567899999999998765


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      .....   ....||+.|+|||++.+  .++.++|||||||++|+|++|..||......       ............   
T Consensus       181 ~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~---  245 (484)
T 3nyv_A          181 ASKKM---KDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEY-------DILKKVEKGKYT---  245 (484)
T ss_dssp             CCCSH---HHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC---
T ss_pred             ccccc---ccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCC---
Confidence            44322   23568999999999876  4799999999999999999999998543211       111111111100   


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcc
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGV  354 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~  354 (406)
                         .........+..+.+++.+||+.||.+|||+.++++  .+...
T Consensus       246 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          246 ---FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             ---CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             ---CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence               001222345678999999999999999999999997  45443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.3e-43  Score=336.65  Aligned_cols=252  Identities=21%  Similarity=0.308  Sum_probs=201.7

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-------hhhHHHHHHHHHHhhcc-CcCccccEEEEEecCC
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-------RIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQH  148 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  148 (406)
                      ..|.+.+.||+|+||.||+|.+. +|+.||||+++....       ....+.+.+|+.++.++ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            45677789999999999999874 699999999875431       11245688999999999 7999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          149 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      ..++||||+++++|.+++. ....+++..+..++.|++.||.|||+   .|++||||||+|||++.++.+||+|||++..
T Consensus       174 ~~~lv~e~~~g~~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~  249 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLT-EKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCH  249 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEEeCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence            9999999999999999984 34579999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCC-----CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhh
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSG-----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK  303 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  303 (406)
                      ......   .....||+.|+|||++.+     ...++.++|||||||++|||++|..||......       ........
T Consensus       250 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-------~~~~~i~~  319 (365)
T 2y7j_A          250 LEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-------LMLRMIME  319 (365)
T ss_dssp             CCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHH
T ss_pred             cCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHh
Confidence            654332   234679999999998853     225788999999999999999999998543211       01111111


Q ss_pred             hhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....      .........+..+.+++.+||+.||.+|||+.++++
T Consensus       320 ~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          320 GQYQ------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             TCCC------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCC------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1000      000011134567999999999999999999999987

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.5e-43  Score=349.68  Aligned_cols=251  Identities=25%  Similarity=0.354  Sum_probs=199.1

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ...|.+.+.||+|+||+||+|... +|..||+|++.... .......+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            346788899999999999999764 68999999997542 2233567899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC---CCceEeccccccccCC
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFGLAKLCDR  231 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~DfGl~~~~~~  231 (406)
                      |||++|+|.+++. ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.+   +.+||+|||++.....
T Consensus       116 e~~~~g~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          116 ECYKGGELFDEII-HRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             ECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999999884 34579999999999999999999999   999999999999999764   4599999999987654


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ...   .....||+.|+|||++.+  .++.++|||||||++|+|++|..||......       ............    
T Consensus       192 ~~~---~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~----  255 (494)
T 3lij_A          192 QKK---MKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-------EILRKVEKGKYT----  255 (494)
T ss_dssp             TBC---BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC----
T ss_pred             Ccc---ccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC----
Confidence            322   234679999999999874  5899999999999999999999998543221       111111111110    


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        .........+..+.+++.+||+.||.+|||+.++++
T Consensus       256 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          256 --FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             --CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence              001122345678999999999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.9e-43  Score=328.73  Aligned_cols=254  Identities=22%  Similarity=0.326  Sum_probs=202.5

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ..+|.+.+.||+|+||+||+|+.. +|+.||+|++.... ......+.+|+.++.+++||||+++++++.+....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            346778899999999999999764 69999999997542 2234678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEE---cCCCCceEeccccccccCCC
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||++   +.++.+||+|||++......
T Consensus        87 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           87 LVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             cCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            9999999998843 4578999999999999999999999   999999999999999   78899999999999754332


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ..    ....||+.|+|||++.+. .++.++||||||+++|||++|..||......       ...........      
T Consensus       163 ~~----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~------  224 (304)
T 2jam_A          163 IM----STACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETES-------KLFEKIKEGYY------  224 (304)
T ss_dssp             TT----HHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHCCC------
T ss_pred             cc----ccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCC------
Confidence            11    223589999999999876 7899999999999999999999998543211       11111111110      


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhc
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEG  353 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~  353 (406)
                      ..........+..+.+++.+||+.||.+|||+.++++  .+..
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (304)
T 2jam_A          225 EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG  267 (304)
T ss_dssp             CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred             CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence            0011222345678999999999999999999999987  4544

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.7e-45  Score=339.94  Aligned_cols=269  Identities=22%  Similarity=0.338  Sum_probs=204.1

Q ss_pred             ChHHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCe
Q 015480           71 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM  149 (406)
Q Consensus        71 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  149 (406)
                      ...++....|.+.+.||+|+||.||+|.+.+  .+|+|++.... .....+.+.+|+.++.+++||||+++++++.+...
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            4455566677888999999999999998743  49999987532 22233567889999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+++++|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++ ++.+||+|||++...
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            999999999999999997666689999999999999999999999   9999999999999998 679999999998754


Q ss_pred             CCCCce---EEecCCCCCCCccCccccCC--------CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHH
Q 015480          230 DRNKTH---VTISGYKGTPGYSAPEFLSG--------NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVW  298 (406)
Q Consensus       230 ~~~~~~---~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  298 (406)
                      ......   .......|++.|+|||++.+        ...++.++||||||+++|||++|..||......       ...
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~  252 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-------AII  252 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-------HHH
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHH
Confidence            322111   11223458899999999874        225789999999999999999999998543211       111


Q ss_pred             HHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCC
Q 015480          299 EEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPP  360 (406)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~  360 (406)
                      ........        ........+..+.+++..||+.||.+|||+.++++.|+.+......
T Consensus       253 ~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~  306 (319)
T 2y4i_B          253 WQMGTGMK--------PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR  306 (319)
T ss_dssp             HHHHTTCC--------CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred             HHhccCCC--------CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            11111100        0111113456699999999999999999999999999999765433

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3e-43  Score=349.99  Aligned_cols=256  Identities=23%  Similarity=0.317  Sum_probs=202.7

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccch------------hhHHHHHHHHHHhhccCcCccccEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR------------IAEEQFMAEVGTIGRTYHINLVRLYGF  143 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~~~~~  143 (406)
                      ...|.+.++||+|+||+||+|... +++.||+|++......            ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            456778899999999999999764 5889999999754211            235678999999999999999999999


Q ss_pred             EecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC---CceE
Q 015480          144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKV  220 (406)
Q Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl  220 (406)
                      +.+....++|||||++|+|.+++.. ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++   .+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEE
Confidence            9999999999999999999998843 4679999999999999999999999   9999999999999998776   6999


Q ss_pred             eccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHH
Q 015480          221 ADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEE  300 (406)
Q Consensus       221 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  300 (406)
                      +|||++........   .....||+.|+|||++.+  .++.++|||||||++|+|++|..||......       .....
T Consensus       191 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~  258 (504)
T 3q5i_A          191 VDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-------DIIKK  258 (504)
T ss_dssp             CCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHH
T ss_pred             EECCCCEEcCCCCc---cccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH
Confidence            99999987654432   234679999999999874  5899999999999999999999998543211       11111


Q ss_pred             HhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcc
Q 015480          301 YEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGV  354 (406)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~  354 (406)
                      .......      .........+..+.+++.+||+.||.+|||+.++++  .+.+.
T Consensus       259 i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          259 VEKGKYY------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             HHHCCCC------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred             HHcCCCC------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence            1111100      000111234678999999999999999999999987  45444

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.2e-44  Score=344.54  Aligned_cols=255  Identities=11%  Similarity=0.001  Sum_probs=182.9

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhcc--CcCccccEE-------EEEe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRT--YHINLVRLY-------GFCH  145 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l--~h~niv~~~-------~~~~  145 (406)
                      ..|.+.+.||+|+||+||+|.+ .+|+.||||++.....  ....+.+.+|+.++..+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            3467788999999999999976 4789999999986532  23456677885444444  699987755       5554


Q ss_pred             cC-----------------CeeEEEEEeccCCChhhHhhcCCCCCCHHHH------HHHHHHHHHHHHHHHHhcCCCeee
Q 015480          146 DQ-----------------HMTALVYEYMENGSLDGYLFGKKRAIEWEKL------HEIAIGTAKGLVYLHEECQQRIIH  202 (406)
Q Consensus       146 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~qi~~~l~~LH~~~~~~i~H  202 (406)
                      ..                 ...++||||++ |+|.+++...+..+.+..+      ..++.|++.||+|||+   ++|+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCcc
Confidence            33                 33799999998 7999999655555566666      7888999999999999   99999


Q ss_pred             cCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCC-CCCCcccceeecchhHHHHhhcccc
Q 015480          203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRN  281 (406)
Q Consensus       203 ~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltg~~p  281 (406)
                      |||||+|||++.++.+||+|||+++......     ....+|+.|+|||++.+. ..++.++|||||||++|||++|+.|
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998654221     134567999999999761 2689999999999999999999999


Q ss_pred             cccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          282 AIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      |.............        ...................+..+.+++.+||+.||++|||+.++++
T Consensus       293 f~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          293 FGLVTPGIKGSWKR--------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TTBCCTTCTTCCCB--------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCcCcccccchhh--------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            86553321110000        0000000000111112345678999999999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=8.9e-44  Score=332.41  Aligned_cols=262  Identities=21%  Similarity=0.284  Sum_probs=201.5

Q ss_pred             eeeChHHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEecccc-chhhHHHHHHHHHHhhccC--cCccccEEEEE
Q 015480           68 VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTY--HINLVRLYGFC  144 (406)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~  144 (406)
                      +.+....+....|.+.+.||+|+||.||++...+|+.||+|++.... .....+.+.+|+.++.+++  ||||+++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            34566677778889999999999999999998889999999997532 3345578999999999997  59999999999


Q ss_pred             ecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccc
Q 015480          145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  224 (406)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfG  224 (406)
                      .+....++||| +.+++|.+++.. ...+++..+..++.|+++||.|||+   .+++||||||+|||+++ +.+||+|||
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecc
Confidence            99999999999 557899999954 4578999999999999999999999   99999999999999964 899999999


Q ss_pred             cccccCCCCceEEecCCCCCCCccCccccCCC----------CCCCcccceeecchhHHHHhhcccccccCCCcccccch
Q 015480          225 LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP  294 (406)
Q Consensus       225 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~  294 (406)
                      ++................||+.|+|||.+.+.          ..++.++||||||+++|||++|+.||.......     
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----  246 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----  246 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----
Confidence            99876544333333345789999999998651          257889999999999999999999985332110     


Q ss_pred             hHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          295 KHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                          ....     ...........+...+..+.+++.+||+.||.+||++.++++
T Consensus       247 ----~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          247 ----SKLH-----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             ----HHHH-----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----HHHH-----HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                0000     001111111122223567999999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.9e-44  Score=345.75  Aligned_cols=242  Identities=15%  Similarity=0.123  Sum_probs=188.7

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccc--cchhhHHHHHHHH---HHhhccCcCccccEE-------EE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEV---GTIGRTYHINLVRLY-------GF  143 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~  143 (406)
                      ...|.+.+.||+|+||+||+|.+ .+|+.||||++...  ......+.+.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            34566788999999999999986 56999999999743  2334557889999   556666899999998       77


Q ss_pred             EecCC-----------------eeEEEEEeccCCChhhHhhcCC------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCe
Q 015480          144 CHDQH-----------------MTALVYEYMENGSLDGYLFGKK------RAIEWEKLHEIAIGTAKGLVYLHEECQQRI  200 (406)
Q Consensus       144 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i  200 (406)
                      +.+.+                 ..++||||+ +|+|.+++....      ..+++..+..++.|++.||+|||+   .+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence            66553                 378999999 679999995432      223468889999999999999999   999


Q ss_pred             eecCCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCC----------CCCCcccceeecch
Q 015480          201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGM  270 (406)
Q Consensus       201 ~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslG~  270 (406)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.          ..++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985332     2234567 999999998754          25899999999999


Q ss_pred             hHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          271 VLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       271 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ++|||++|+.||.........                ..+...     ....+..+.+++.+||+.||.+|||+.++++
T Consensus       302 il~elltg~~Pf~~~~~~~~~----------------~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGS----------------EWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CCS----------------GGGGSS-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccch----------------hhhhhh-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999999998543221110                000000     1233567999999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.6e-43  Score=337.66  Aligned_cols=271  Identities=20%  Similarity=0.254  Sum_probs=204.7

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecC-----CeeE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-----HMTA  151 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  151 (406)
                      .+|.+.+.||+|+||.||+|.. .+|+.||||++...........+.+|++++.+++||||+++++++...     ...+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            4677889999999999999975 468899999998654555567899999999999999999999999764     3689


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +||||+.+ +|.+++..  ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.....
T Consensus       107 iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          107 IVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             EEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence            99999974 99998843  469999999999999999999999   9999999999999999999999999999986653


Q ss_pred             CCceE-EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccc--------hhHHHHHHh
Q 015480          232 NKTHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWF--------PKHVWEEYE  302 (406)
Q Consensus       232 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--------~~~~~~~~~  302 (406)
                      ..... ......||+.|+|||++.+...++.++|||||||++|||++|+.||...........        ....+....
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            32211 123457999999999877665689999999999999999999999854332110000        000000000


Q ss_pred             hhhcchhhc----cCCC--CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcc
Q 015480          303 KCELGAMIL----GCGI--EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGV  354 (406)
Q Consensus       303 ~~~~~~~~~----~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~  354 (406)
                      .........    ....  .......+..+.+|+.+||+.||.+|||+.++++  .++..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            000000000    0000  0111234577999999999999999999999998  45544

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.7e-44  Score=341.12  Aligned_cols=266  Identities=18%  Similarity=0.215  Sum_probs=196.7

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccc----------hhhHHHHHHHHHHhhccCcCccccEEEE
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG----------RIAEEQFMAEVGTIGRTYHINLVRLYGF  143 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~~~~~  143 (406)
                      ......|.+.+.||+|+||.||+|...+|+.||||++.....          ....+.+.+|++++.+++||||++++++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            344556778899999999999999888899999999865322          1223789999999999999999999999


Q ss_pred             Eec-----CCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCc
Q 015480          144 CHD-----QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP  218 (406)
Q Consensus       144 ~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  218 (406)
                      +..     ....++||||+. |+|.+++......+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~  173 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDI  173 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCE
T ss_pred             EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCE
Confidence            843     346899999997 58888887777789999999999999999999999   999999999999999999999


Q ss_pred             eEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHH
Q 015480          219 KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVW  298 (406)
Q Consensus       219 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  298 (406)
                      ||+|||++........   .....||+.|+|||++.+...++.++|||||||++|+|++|+.||........   .....
T Consensus       174 kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~  247 (362)
T 3pg1_A          174 TICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ---LNKIV  247 (362)
T ss_dssp             EECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHH
T ss_pred             EEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence            9999999975443322   23356899999999988755789999999999999999999999864321100   00000


Q ss_pred             HHH-----------hhhhcchhh----ccCC---CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          299 EEY-----------EKCELGAMI----LGCG---IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       299 ~~~-----------~~~~~~~~~----~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      +..           .........    ....   ........+..+.+++.+||+.||.+|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            000           000000000    0000   00111234577999999999999999999999987

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=323.10  Aligned_cols=255  Identities=22%  Similarity=0.262  Sum_probs=201.8

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc---hhhHHHHHHHHHHhhccCcCccccEEEEEe--cCCeeEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG---RIAEEQFMAEVGTIGRTYHINLVRLYGFCH--DQHMTAL  152 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l  152 (406)
                      +|.+.+.||+|+||.||++.. .+|+.||+|++.....   ......+.+|+.++.+++||||+++++++.  +....++
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM   85 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence            577889999999999999976 4689999999975421   234577999999999999999999999984  4568899


Q ss_pred             EEEeccCCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          153 VYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      ||||++++ |.+++.. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            99999876 6666643 45679999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCceEEecCCCCCCCccCccccCCCC-CCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      ...........||+.|+|||++.+.. ..+.++||||||+++|||++|..||.....       ...........     
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~-----  229 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------YKLFENIGKGS-----  229 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCC-----
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------HHHHHHHhcCC-----
Confidence            43333345567999999999987642 347899999999999999999999854321       11111111111     


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcc
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGV  354 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~  354 (406)
                           ...+..++..+.+++.+||+.||.+|||+.++++  .+.+.
T Consensus       230 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          230 -----YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             -----CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             -----CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence                 1122345677899999999999999999999997  45544

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-43  Score=329.99  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=199.3

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      ...|.+.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|+.++..++||||+++++++.+....++|||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            355778889999999999999875 58999999987542 2345788999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  173 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK  173 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence            999999999987666789999999999999999999999   99999999999999999999999999997543211111


Q ss_pred             EEecCCCCCCCccCccccC----CCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          236 VTISGYKGTPGYSAPEFLS----GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                        .....||+.|+|||++.    ....++.++||||||+++|+|++|..|+......       .........       
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~-------  237 (302)
T 2j7t_A          174 --RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKS-------  237 (302)
T ss_dssp             -------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHS-------
T ss_pred             --cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHHHHHhcc-------
Confidence              12346899999999883    2336889999999999999999999988543211       001111111       


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .......+...+..+.+++.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          238 DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            01111223445678999999999999999999999876

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=341.91  Aligned_cols=263  Identities=18%  Similarity=0.238  Sum_probs=181.6

Q ss_pred             hcc-cccccccceeEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEe--cCCeeEEE
Q 015480           80 SNY-STRLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH--DQHMTALV  153 (406)
Q Consensus        80 ~~~-~~~ig~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv  153 (406)
                      |.+ .++||+|+||+||+|++.   +++.||||++....   ....+.+|+.++++++||||+++++++.  .....++|
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            444 468999999999999864   57899999997542   2346889999999999999999999994  46789999


Q ss_pred             EEeccCCChhhHhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEE----cCCCCceEe
Q 015480          154 YEYMENGSLDGYLFG--------KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL----DANFSPKVA  221 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~--------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~  221 (406)
                      |||+.+ +|.+++..        ....+++..+..++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+
T Consensus        99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999975 88777731        12359999999999999999999999   999999999999999    778899999


Q ss_pred             ccccccccCCCCc-eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc---cchhHH
Q 015480          222 DFGLAKLCDRNKT-HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD---WFPKHV  297 (406)
Q Consensus       222 DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~---~~~~~~  297 (406)
                      |||+++....... ........||+.|+|||++.+...++.++|||||||++|||++|..||.........   +.....
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            9999987654321 122344678999999999987656899999999999999999999999654332110   000000


Q ss_pred             HHHHhhhh------cc------------hhhccCCCCc-ch--------HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          298 WEEYEKCE------LG------------AMILGCGIEE-KD--------KEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       298 ~~~~~~~~------~~------------~~~~~~~~~~-~~--------~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ........      ..            .......... ..        ...+..+.+|+.+||+.||.+|||+.++++
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000      00            0000000000 00        011456889999999999999999999998

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.2e-43  Score=324.10  Aligned_cols=247  Identities=23%  Similarity=0.310  Sum_probs=196.4

Q ss_pred             cccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccCCC
Q 015480           83 STRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  161 (406)
                      ...||+|+||.||+|.+ .+++.||+|.+.... ....+.+.+|+.++..++||||+++++++.+....++||||+++++
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  105 (295)
T 2clq_A           27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS  105 (295)
T ss_dssp             BCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred             cEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence            34799999999999975 568899999987642 3445779999999999999999999999999999999999999999


Q ss_pred             hhhHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC-CCCceEeccccccccCCCCceEEe
Q 015480          162 LDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       162 L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      |.+++....  ..+++..+..++.|++.||.|||+   .+++|+||||+||+++. ++.+||+|||++........  ..
T Consensus       106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~  180 (295)
T 2clq_A          106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CT  180 (295)
T ss_dssp             HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------
T ss_pred             HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cc
Confidence            999996543  356789999999999999999999   99999999999999987 89999999999986653322  12


Q ss_pred             cCCCCCCCccCccccCCC-CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          239 SGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      ....|++.|+|||++.+. ..++.++||||||+++|+|++|+.||........     .....   .      .......
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~---~------~~~~~~~  246 (295)
T 2clq_A          181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-----AMFKV---G------MFKVHPE  246 (295)
T ss_dssp             CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-----HHHHH---H------HHCCCCC
T ss_pred             cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-----HHHhh---c------ccccccc
Confidence            345789999999998654 2378999999999999999999999853322110     00000   0      0011122


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .+...+..+.+++.+||+.||++||++.++++
T Consensus       247 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          247 IPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            33445678999999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.3e-43  Score=333.35  Aligned_cols=260  Identities=20%  Similarity=0.263  Sum_probs=204.4

Q ss_pred             hhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchh----------------hHHHHHHHHHHhhccCcCccccE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRI----------------AEEQFMAEVGTIGRTYHINLVRL  140 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~----------------~~~~~~~e~~~l~~l~h~niv~~  140 (406)
                      ...|.+.+.||+|+||.||+|.. +|+.||+|++.......                ..+.+.+|+.++.+++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            45677889999999999999988 89999999997532111                11789999999999999999999


Q ss_pred             EEEEecCCeeEEEEEeccCCChhhH------hhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc
Q 015480          141 YGFCHDQHMTALVYEYMENGSLDGY------LFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD  213 (406)
Q Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~  213 (406)
                      ++++.+.+..++||||+++|+|.++      +... ...+++..+..++.|++.||.|||+  ..+++||||||+||+++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD  186 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence            9999999999999999999999998      5332 5789999999999999999999996  37999999999999999


Q ss_pred             CCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCc-ccceeecchhHHHHhhcccccccCCCccccc
Q 015480          214 ANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH-KCDVYSFGMVLFEIVGRRRNAIVGATESLDW  292 (406)
Q Consensus       214 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DvwslG~il~elltg~~p~~~~~~~~~~~  292 (406)
                      .++.+||+|||++......    ......|+..|+|||++.+...++. ++||||||+++|||++|..||......    
T Consensus       187 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----  258 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL----  258 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred             CCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence            9999999999999866443    2345679999999999987644555 999999999999999999998654331    


Q ss_pred             chhHHHHHHhhhhcchhh---------ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          293 FPKHVWEEYEKCELGAMI---------LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        ................         ............+..+.+++.+||+.||.+|||+.++++
T Consensus       259 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 --VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             --HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              1111111111100000         000000111345678999999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.9e-43  Score=337.20  Aligned_cols=266  Identities=19%  Similarity=0.244  Sum_probs=185.4

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecC------Ce
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------HM  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  149 (406)
                      .+|...+.||+|+||.||+|.. .+|+.||||++.... .......+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            4577788999999999999965 568999999997542 334557788999999999999999999999654      56


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++|+||+ +++|.+++.  ...+++..+..++.|+++||.|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus       109 ~~lv~e~~-~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             EEEEeccc-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence            79999999 679999884  3579999999999999999999999   99999999999999999999999999999865


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc-c-------hhHHHHHH
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW-F-------PKHVWEEY  301 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-~-------~~~~~~~~  301 (406)
                      ...     .....||+.|+|||++.+...++.++|||||||++|||++|+.||.......... .       ....+...
T Consensus       183 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  257 (367)
T 2fst_X          183 ADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  257 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             ccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            432     2346789999999999875578999999999999999999999985432110000 0       00000000


Q ss_pred             hhhhcchhhcc-CCCC-----cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcc
Q 015480          302 EKCELGAMILG-CGIE-----EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGV  354 (406)
Q Consensus       302 ~~~~~~~~~~~-~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~  354 (406)
                      ........... ....     ......+..+.+|+.+||+.||.+|||+.++++  .+...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence            00000000000 0000     011123567899999999999999999999998  45544

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.1e-43  Score=361.34  Aligned_cols=250  Identities=23%  Similarity=0.279  Sum_probs=203.9

Q ss_pred             hhhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeE
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  151 (406)
                      .-..|.+.+.||+|+||+||+|+. .+|+.||||++++..  .....+.+..|..++..+ +||||+++++++.+.+.++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            345577788999999999999976 458899999997532  223446788899999987 6999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      |||||+++|+|.+++.. ...+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++....
T Consensus       419 lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            99999999999999953 3579999999999999999999999   9999999999999999999999999999985433


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ....  .....||+.|+|||++.+. .++.++|||||||++|||++|..||......       .........       
T Consensus       495 ~~~~--~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~-------  557 (674)
T 3pfq_A          495 DGVT--TKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIMEH-------  557 (674)
T ss_dssp             TTCC--BCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHSS-------
T ss_pred             CCcc--cccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHH-------HHHHHHHhC-------
Confidence            2221  3457899999999999877 7899999999999999999999998543211       111111111       


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCCh-----HHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPM-----SAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~~vl~  349 (406)
                        . ...+...+.++.+|+..||+.||.+||++     .+|++
T Consensus       558 --~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          558 --N-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --C-CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --C-CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence              1 12234566789999999999999999998     67765

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.5e-43  Score=330.74  Aligned_cols=253  Identities=23%  Similarity=0.285  Sum_probs=196.3

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc-------hhhHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-------RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      ...|.+.+.||+|+||.||+|.. .+|+.||||++.....       ......+.+|++++.+++||||+++++++..+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            35678889999999999999976 4589999999875321       112345889999999999999999999997765


Q ss_pred             eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC---ceEecccc
Q 015480          149 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---PKVADFGL  225 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~DfGl  225 (406)
                       .++||||+++++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+|||++.++.   +||+|||+
T Consensus        89 -~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             -EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             -eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence             799999999999999884 45679999999999999999999999   99999999999999987664   99999999


Q ss_pred             ccccCCCCceEEecCCCCCCCccCccccC--CCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhh
Q 015480          226 AKLCDRNKTHVTISGYKGTPGYSAPEFLS--GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK  303 (406)
Q Consensus       226 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  303 (406)
                      +........   .....||+.|+|||++.  +...++.++|||||||++|+|++|..||........      .......
T Consensus       164 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~  234 (322)
T 2ycf_A          164 SKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQITS  234 (322)
T ss_dssp             CEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC------HHHHHHH
T ss_pred             ceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH------HHHHHHh
Confidence            986643321   12245899999999873  233688999999999999999999999864332211      0111111


Q ss_pred             hhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....      ..+......+..+.+++.+||+.||.+||++.++++
T Consensus       235 ~~~~------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          235 GKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             TCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Cccc------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1100      001112234678999999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3e-43  Score=334.25  Aligned_cols=269  Identities=19%  Similarity=0.242  Sum_probs=202.6

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecC-----CeeE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-----HMTA  151 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  151 (406)
                      ..|.+.+.||+|+||.||+|.+. +|+.||||++...........+.+|+.+++.++||||+++++++...     ...+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            45677889999999999999764 68999999997654445567788999999999999999999998654     6789


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +||||+. ++|.+++..  ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.....
T Consensus        91 lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             EEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            9999997 589998843  579999999999999999999999   9999999999999999999999999999986653


Q ss_pred             CCceE--------EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhh
Q 015480          232 NKTHV--------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK  303 (406)
Q Consensus       232 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  303 (406)
                      .....        ......||+.|+|||++.+...++.++|||||||++|||++|..||.........   .........
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~  241 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL---LLIFGIIGT  241 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCC
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHHhCC
Confidence            22111        1233578999999998866447899999999999999999999998643211000   000000000


Q ss_pred             ------------hhcchhhcc------CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhccc
Q 015480          304 ------------CELGAMILG------CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVV  355 (406)
Q Consensus       304 ------------~~~~~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~  355 (406)
                                  .........      ..........+..+.+++.+||+.||++|||+.++++  .+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence                        000000000      0000111245678899999999999999999999998  555443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.1e-42  Score=330.87  Aligned_cols=265  Identities=20%  Similarity=0.210  Sum_probs=193.2

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCC------e
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH------M  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  149 (406)
                      ..|.+.+.||+|+||.||+|.. .+|+.||||++.... .......+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            4577788999999999999965 468999999997542 3344577889999999999999999999997664      7


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+++ +|.+++.   ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus       105 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             eEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            8999999975 7888774   358999999999999999999999   99999999999999999999999999999865


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc--------cchhHHHHH-
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD--------WFPKHVWEE-  300 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~-  300 (406)
                      ....   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.........        ......+.. 
T Consensus       178 ~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          178 GTSF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ---------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             cccc---ccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            4332   12345789999999999876 7899999999999999999999998543221000        000000000 


Q ss_pred             -------Hhhhh------cchh---hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhc
Q 015480          301 -------YEKCE------LGAM---ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEG  353 (406)
Q Consensus       301 -------~~~~~------~~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~  353 (406)
                             .....      ....   .............+..+.+|+.+||+.||.+|||+.++++  .+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence                   00000      0000   0000111122345788999999999999999999999998  5544

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-43  Score=338.55  Aligned_cols=261  Identities=19%  Similarity=0.217  Sum_probs=195.4

Q ss_pred             HhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec-------
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-------  146 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------  146 (406)
                      ....+|.+.+.||+|+||+||+|.. .+|+.||||++..+..     ...+|+.+++.++||||+++++++..       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            3445678889999999999999965 5799999999875422     12379999999999999999999843       


Q ss_pred             -------------------------------CCeeEEEEEeccCCChhhHhh---cCCCCCCHHHHHHHHHHHHHHHHHH
Q 015480          147 -------------------------------QHMTALVYEYMENGSLDGYLF---GKKRAIEWEKLHEIAIGTAKGLVYL  192 (406)
Q Consensus       147 -------------------------------~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~L  192 (406)
                                                     ....++||||+++ +|.+.+.   .....+++..+..++.|+++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           3448899999985 8777764   3567899999999999999999999


Q ss_pred             HHhcCCCeeecCCCCCcEEEc-CCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchh
Q 015480          193 HEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMV  271 (406)
Q Consensus       193 H~~~~~~i~H~dlk~~Nill~-~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~i  271 (406)
                      |+   .+|+||||||+|||++ .++.+||+|||+++........   ....||+.|+|||++.+...++.++|||||||+
T Consensus       158 H~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            99   9999999999999998 6889999999999866543322   345689999999998876568999999999999


Q ss_pred             HHHHhhcccccccCCCcccccchhHH-------HHHHhhh--hcchhhccCCCC-----cchHHHHHHHHHHHHHhcccC
Q 015480          272 LFEIVGRRRNAIVGATESLDWFPKHV-------WEEYEKC--ELGAMILGCGIE-----EKDKEKAKRLCMVALWCVQDS  337 (406)
Q Consensus       272 l~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~--~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~d  337 (406)
                      +|||++|+.||........  .....       .+.+...  ............     ..+...+..+.+|+.+||+.|
T Consensus       232 l~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            9999999999864322110  00000       0000000  000000000000     012235677999999999999


Q ss_pred             CCCCCChHHHHH
Q 015480          338 PEDRPPMSAVIK  349 (406)
Q Consensus       338 P~~RPs~~~vl~  349 (406)
                      |.+|||+.|+++
T Consensus       310 P~~R~t~~e~l~  321 (383)
T 3eb0_A          310 PDLRINPYEAMA  321 (383)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1e-42  Score=322.76  Aligned_cols=252  Identities=21%  Similarity=0.271  Sum_probs=202.3

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc--------hhhHHHHHHHHHHhhccC-cCccccEEEEEecC
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--------RIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQ  147 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  147 (406)
                      ..|.+.+.||+|+||.||+|.+. +|+.||||++.....        ....+.+.+|+.++.++. ||||+++++++.+.
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (298)
T 1phk_A           17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   96 (298)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence            45677889999999999999764 689999999864321        123467889999999996 99999999999999


Q ss_pred             CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          148 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ...++||||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.
T Consensus        97 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           97 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchh
Confidence            999999999999999999943 4579999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccC-----CCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHh
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLS-----GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE  302 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  302 (406)
                      .......   .....|++.|+|||++.     ....++.++||||||+++|+|++|..||......       .......
T Consensus       173 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~  242 (298)
T 1phk_A          173 QLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMIM  242 (298)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHH
T ss_pred             hcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-------HHHHHHh
Confidence            7654332   23456899999999875     2336789999999999999999999998543211       1111111


Q ss_pred             hhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....      ..........+..+.+++.+||+.||.+|||+.++++
T Consensus       243 ~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          243 SGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cCCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1110      0011122345678999999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-43  Score=328.45  Aligned_cols=253  Identities=25%  Similarity=0.340  Sum_probs=195.7

Q ss_pred             HhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEec------
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHD------  146 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------  146 (406)
                      .....|.+.+.||+|+||.||+|.+ .+|+.||+|++....  .....+.+|+.++.++ +||||+++++++..      
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            3455677889999999999999976 568999999987542  2446788999999999 79999999999976      


Q ss_pred             CCeeEEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccc
Q 015480          147 QHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  225 (406)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl  225 (406)
                      ....++||||+++|+|.+++... ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  175 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV  175 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence            46789999999999999999654 3679999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCceEEecCCCCCCCccCccccCC----CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHH
Q 015480          226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEY  301 (406)
Q Consensus       226 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  301 (406)
                      +.........  .....||+.|+|||++..    ...++.++|||||||++|+|++|..||......       ......
T Consensus       176 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~  246 (326)
T 2x7f_A          176 SAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RALFLI  246 (326)
T ss_dssp             TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHH
T ss_pred             ceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHh
Confidence            9765432211  233568999999999862    236889999999999999999999988532211       000000


Q ss_pred             hhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          302 EKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...        ..........+..+.+++.+||+.||.+||++.++++
T Consensus       247 ~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          247 PRN--------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHS--------CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hcC--------ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            000        0011112234578999999999999999999999988

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.7e-43  Score=339.56  Aligned_cols=268  Identities=19%  Similarity=0.206  Sum_probs=197.8

Q ss_pred             hhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC------e
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH------M  149 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  149 (406)
                      ...+|.+.+.||+|+||+||+|++.++..||+|.+.....     ...+|+++++.++||||+++++++....      .
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            3456788899999999999999987777799998865322     1236999999999999999999995433      4


Q ss_pred             eEEEEEeccCCChhhHh--hcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc-CCCCceEeccccc
Q 015480          150 TALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLA  226 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~DfGl~  226 (406)
                      .++||||++++.+....  ......+++..+..++.|+++||+|||+   .+|+||||||+|||++ .++.+||+|||++
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            78999999875443333  2346789999999999999999999999   9999999999999999 7999999999999


Q ss_pred             cccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccc--------hhHHH
Q 015480          227 KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWF--------PKHVW  298 (406)
Q Consensus       227 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--------~~~~~  298 (406)
                      +........   ....||+.|+|||++.+...++.++|||||||++|||++|+.||...........        ....+
T Consensus       190 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          190 KILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             EECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            876443322   3456899999999998765789999999999999999999999864322100000        00000


Q ss_pred             HHHhhhhcchhhccCCCCc-----chHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhccc
Q 015480          299 EEYEKCELGAMILGCGIEE-----KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVV  355 (406)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~  355 (406)
                      ..... .............     .....+.++.+|+.+||+.||.+|||+.++++  .++.+.
T Consensus       267 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          267 KTMNP-NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             HHHCG-GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             HhhCh-hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence            00000 0000000000000     11125578999999999999999999999998  455553

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.1e-42  Score=324.91  Aligned_cols=264  Identities=22%  Similarity=0.274  Sum_probs=202.7

Q ss_pred             HHhhhhhcccccccccceeEEEEEEe--CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCc------cccEEEEEe
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQF--PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN------LVRLYGFCH  145 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~  145 (406)
                      ++...+|.+.+.||+|+||+||+|..  .+|+.||+|+++..  ....+.+.+|+.++..++|+|      ++++++++.
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            34456788899999999999999975  36889999999753  334567889999999887665      999999999


Q ss_pred             cCCeeEEEEEeccCCChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC----------
Q 015480          146 DQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA----------  214 (406)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~----------  214 (406)
                      +.+..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+   ++++||||||+|||++.          
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCc
Confidence            999999999999 889999986543 478999999999999999999999   99999999999999987          


Q ss_pred             ---------CCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccC
Q 015480          215 ---------NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG  285 (406)
Q Consensus       215 ---------~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  285 (406)
                               ++.+||+|||++.......     ....||+.|+|||++.+. .++.++|||||||++|||++|..||...
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                     6789999999998654332     235689999999999876 7899999999999999999999998643


Q ss_pred             CCcccc--------cchhHHHHHHhhhhcc------------------h-hhccCCCCcchHHHHHHHHHHHHHhcccCC
Q 015480          286 ATESLD--------WFPKHVWEEYEKCELG------------------A-MILGCGIEEKDKEKAKRLCMVALWCVQDSP  338 (406)
Q Consensus       286 ~~~~~~--------~~~~~~~~~~~~~~~~------------------~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP  338 (406)
                      ......        ..+...+.........                  . ..............+..+.+++.+||+.||
T Consensus       238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            221100        0000000000000000                  0 000000011223567889999999999999


Q ss_pred             CCCCChHHHHH
Q 015480          339 EDRPPMSAVIK  349 (406)
Q Consensus       339 ~~RPs~~~vl~  349 (406)
                      .+|||+.++++
T Consensus       318 ~~Rpt~~ell~  328 (339)
T 1z57_A          318 AKRITLREALK  328 (339)
T ss_dssp             TTSCCHHHHTT
T ss_pred             ccccCHHHHhc
Confidence            99999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.6e-43  Score=339.09  Aligned_cols=264  Identities=22%  Similarity=0.257  Sum_probs=195.7

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec------CCe
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD------QHM  149 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  149 (406)
                      ...|...+.||+|+||.||+|++. +|+.||||++.....     .+.+|+++++.++||||+++++++..      ...
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            345777889999999999999874 599999999875422     23479999999999999999999843      224


Q ss_pred             eEEEEEeccCCChhhHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC-CCceEecccc
Q 015480          150 TALVYEYMENGSLDGYLF---GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGL  225 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~DfGl  225 (406)
                      .++||||+++ +|.+.+.   .....+++..+..++.|+++||+|||+   .+|+||||||+|||++.+ +.+||+|||+
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchh
Confidence            6799999986 6665553   346789999999999999999999999   999999999999999965 5689999999


Q ss_pred             ccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHH-------
Q 015480          226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVW-------  298 (406)
Q Consensus       226 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-------  298 (406)
                      ++........   ....||+.|+|||++.+...++.++|||||||++|||++|+.||........  +.....       
T Consensus       204 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~  278 (420)
T 1j1b_A          204 AKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTR  278 (420)
T ss_dssp             CEECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCH
T ss_pred             hhhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCH
Confidence            9866443221   3467899999999997765789999999999999999999999864322100  000000       


Q ss_pred             HHHhhh--hcchhhccCCCCc-----chHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcc
Q 015480          299 EEYEKC--ELGAMILGCGIEE-----KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGV  354 (406)
Q Consensus       299 ~~~~~~--~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~  354 (406)
                      +.+...  .............     .....+.++.+|+.+||+.||.+||++.++++  .++.+
T Consensus       279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence            000000  0000000000000     11234578999999999999999999999987  55554

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.7e-42  Score=325.72  Aligned_cols=257  Identities=23%  Similarity=0.299  Sum_probs=181.3

Q ss_pred             HhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHH-HhhccCcCccccEEEEEecCCeeEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVG-TIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      +....|...+.||+|+||.||+|.. .+|+.||||++...........+..|+. +++.++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            3445667788999999999999977 4689999999986544445556666666 7778899999999999999999999


Q ss_pred             EEEeccCCChhhHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHHhcCC-CeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          153 VYEYMENGSLDGYLFG----KKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ||||+++ +|.+++..    ....+++..+..++.|++.||.|||+   . +++||||||+||+++.++.+||+|||++.
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999986 88777742    35789999999999999999999999   7 99999999999999999999999999997


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccC---CCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhh
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLS---GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKC  304 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (406)
                      .......   .....||+.|+|||++.   ....++.++||||||+++|||++|..||........         .... 
T Consensus       175 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~~~~-  241 (327)
T 3aln_A          175 QLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------QLTQ-  241 (327)
T ss_dssp             C---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------CC-
T ss_pred             ecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------HHHH-
Confidence            6543322   12346899999999984   223689999999999999999999999854221100         0000 


Q ss_pred             hcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       .................+..+.+++.+||+.||.+|||+.++++
T Consensus       242 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          242 -VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence             00000000001111235678999999999999999999999976

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.8e-42  Score=331.21  Aligned_cols=260  Identities=20%  Similarity=0.251  Sum_probs=195.6

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCee-----
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT-----  150 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-----  150 (406)
                      .+|.+.+.||+|+||+||+|.+ .+|+.||||++.... .......+.+|+.+++.++||||+++++++......     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            4677788999999999999975 468999999997543 333457889999999999999999999999887655     


Q ss_pred             -EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          151 -ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       151 -~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                       ++||||+. ++|.+++   ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus       122 ~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             CEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             EEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence             99999997 5888777   3349999999999999999999999   99999999999999999999999999999755


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc--------chhHHHHHH
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW--------FPKHVWEEY  301 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~~~~~  301 (406)
                      ...     .....||+.|+|||++.+...++.++|||||||++|+|++|+.||..........        .........
T Consensus       195 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (371)
T 4exu_A          195 DAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  269 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             ccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence            432     2346789999999999875578999999999999999999999986432110000        000000000


Q ss_pred             hhhh---cchhhccCCCC---cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          302 EKCE---LGAMILGCGIE---EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       302 ~~~~---~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....   ...........   ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            0000   00000000000   111234678999999999999999999999987

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.5e-42  Score=335.18  Aligned_cols=198  Identities=23%  Similarity=0.297  Sum_probs=169.8

Q ss_pred             hhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc------CcCccccEEEEEecCC
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT------YHINLVRLYGFCHDQH  148 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~  148 (406)
                      ...+|.+.+.||+|+||+||+|.. .+|+.||||+++..  ......+..|+.++..+      +|+||+++++++....
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            345678889999999999999965 45899999999753  23446677788877776      5779999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC--ceEecccc
Q 015480          149 MTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS--PKVADFGL  225 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--~kl~DfGl  225 (406)
                      ..++||||+. ++|.+++.... ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.  +||+|||+
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            9999999996 58998886543 569999999999999999999999   89999999999999999987  99999999


Q ss_pred             ccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccC
Q 015480          226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG  285 (406)
Q Consensus       226 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  285 (406)
                      +.......     ....||+.|+|||++.+. .++.++|||||||++|||++|.+||...
T Consensus       249 a~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          249 SCYEHQRV-----YTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             CEETTCCC-----CSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceecCCcc-----cccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            97654332     245789999999999877 6899999999999999999999988543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.2e-42  Score=320.93  Aligned_cols=269  Identities=20%  Similarity=0.235  Sum_probs=193.6

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEe-----------
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH-----------  145 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-----------  145 (406)
                      .+|...+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.++++++||||+++++++.           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            45677889999999999999775 4899999998754 3345678899999999999999999999884           


Q ss_pred             ---cCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc-CCCCceEe
Q 015480          146 ---DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVA  221 (406)
Q Consensus       146 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~  221 (406)
                         +....++||||++ |+|.+++.  ...+++..+..++.|++.||+|||+   .+++||||||+||+++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEc
Confidence               3467899999997 59999983  4578999999999999999999999   9999999999999997 56799999


Q ss_pred             ccccccccCCCCce-EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccc--------c
Q 015480          222 DFGLAKLCDRNKTH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLD--------W  292 (406)
Q Consensus       222 DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~  292 (406)
                      |||++......... .......+|..|+|||.+.+...++.++||||||+++|||++|+.||.........        .
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999866432211 11223457889999998876447899999999999999999999998644321000        0


Q ss_pred             chhHHHHHHhhhh---cchhhccCC--CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhc
Q 015480          293 FPKHVWEEYEKCE---LGAMILGCG--IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEG  353 (406)
Q Consensus       293 ~~~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~  353 (406)
                      .....+.......   .........  ........+..+.+++.+||+.||.+|||+.++++  .+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI  311 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence            0000000000000   000000000  00111235678999999999999999999999987  4543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.6e-42  Score=328.70  Aligned_cols=270  Identities=20%  Similarity=0.232  Sum_probs=189.4

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC-------
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-------  148 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  148 (406)
                      -.+|.+.+.||+|+||+||+|.+ .+|+.||||++..+.  .....+.+++..+..++||||+++++++....       
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   99 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI   99 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence            34577788999999999999976 468999999986532  22345677888888999999999999996533       


Q ss_pred             eeEEEEEeccCCChhhHhh---cCCCCCCHHHHHHHHHHHHHHHHHHH--HhcCCCeeecCCCCCcEEEcC-CCCceEec
Q 015480          149 MTALVYEYMENGSLDGYLF---GKKRAIEWEKLHEIAIGTAKGLVYLH--EECQQRIIHYDIKPENVLLDA-NFSPKVAD  222 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~~~i~H~dlk~~Nill~~-~~~~kl~D  222 (406)
                      ..++||||+++ +|...+.   .....+++..+..++.|++.||.|||  +   .+|+||||||+|||++. ++.+||+|
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~D  175 (360)
T 3e3p_A          100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCD  175 (360)
T ss_dssp             EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred             eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEee
Confidence            37899999986 5544442   35677899999999999999999999  7   99999999999999996 89999999


Q ss_pred             cccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc--------ch
Q 015480          223 FGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW--------FP  294 (406)
Q Consensus       223 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~  294 (406)
                      ||++.........   ....||+.|+|||++.+...++.++|||||||++|||++|..||..........        ..
T Consensus       176 fg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          176 FGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             CTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             CCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            9999876544322   345689999999999776568999999999999999999999986533211000        00


Q ss_pred             hHHHHHHhhhhcc-hhhccCC------CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhccc
Q 015480          295 KHVWEEYEKCELG-AMILGCG------IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVV  355 (406)
Q Consensus       295 ~~~~~~~~~~~~~-~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~  355 (406)
                      ...+......... .......      ........+..+.+|+.+||+.||.+|||+.++++  .++++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence            0000000000000 0000000      01111225678999999999999999999999997  455543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.7e-42  Score=318.33  Aligned_cols=251  Identities=24%  Similarity=0.330  Sum_probs=201.6

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ..+|.+.+.||+|+||+||+|... +|+.||+|++.... .......+.+|++++++++||||+++++++.+....++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            356788899999999999999774 68999999987542 2335678999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC---CCceEeccccccccCC
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFGLAKLCDR  231 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~DfGl~~~~~~  231 (406)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.+   +.+||+|||++.....
T Consensus       101 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A          101 ELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            99999999998843 3578999999999999999999999   999999999999999764   4699999999986654


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ....   ....||+.|+|||.+.+.  ++.++||||||+++|+|++|..||......       ............    
T Consensus       177 ~~~~---~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~----  240 (287)
T 2wei_A          177 NTKM---KDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEY-------DILKRVETGKYA----  240 (287)
T ss_dssp             CSSC---SCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC----
T ss_pred             CCcc---ccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCC----
Confidence            3221   223478899999998764  789999999999999999999998543211       111111111110    


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        .........+..+.+++.+||+.||.+|||+.++++
T Consensus       241 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          241 --FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             --CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence              001112345678999999999999999999999998

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.3e-42  Score=326.20  Aligned_cols=262  Identities=23%  Similarity=0.336  Sum_probs=198.0

Q ss_pred             hhhhcccccccccceeEEEEEEe--CCCcEEEEEEeccccch-hhHHHHHHHHHHhhcc---CcCccccEEEEEe-----
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF--PNGVKIAVKVLNRNLGR-IAEEQFMAEVGTIGRT---YHINLVRLYGFCH-----  145 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~--~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----  145 (406)
                      ...|.+.+.||+|+||.||+|.+  .+|+.||+|++...... .....+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            35677889999999999999987  46889999998754221 1223566777777666   8999999999987     


Q ss_pred             cCCeeEEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccc
Q 015480          146 DQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  224 (406)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfG  224 (406)
                      .....++||||+. |+|.+++... ...+++..+..++.|++.||.|||+   .|++||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCc
Confidence            5678899999997 5999998654 3459999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhh-
Q 015480          225 LAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK-  303 (406)
Q Consensus       225 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  303 (406)
                      ++........   .....||..|+|||++.+. .++.++||||||+++|||++|+.||........  . ......... 
T Consensus       166 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~-~~i~~~~~~~  238 (326)
T 1blx_A          166 LARIYSFQMA---LTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--L-GKILDVIGLP  238 (326)
T ss_dssp             SCCCCCGGGG---GCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCCC
T ss_pred             ccccccCCCC---ccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH--H-HHHHHHcCCC
Confidence            9976543221   2345689999999999876 689999999999999999999999864322100  0 000000000 


Q ss_pred             --hhc------chhh----ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          304 --CEL------GAMI----LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       304 --~~~------~~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        ...      ....    ............+..+.+++.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              000      0000    000111122345678999999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.4e-42  Score=325.28  Aligned_cols=258  Identities=20%  Similarity=0.271  Sum_probs=196.2

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCe------
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM------  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------  149 (406)
                      .+|.+.+.||+|+||.||+|.+ .+|+.||||++.... .......+.+|+.+++.++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            4567788999999999999976 469999999997543 33345778999999999999999999999987654      


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||+. ++|.+++.   ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus       104 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             EEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence            499999997 58888773   359999999999999999999999   99999999999999999999999999999765


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhH----------HHH
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKH----------VWE  299 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~----------~~~  299 (406)
                      ...     .....||+.|+|||++.+...++.++|||||||++|||++|..||........  ....          .+.
T Consensus       177 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          177 DAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCCHHHHT
T ss_pred             CCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHH
Confidence            432     23456899999999988755789999999999999999999999864321100  0000          000


Q ss_pred             HHhhhhcchh---h---ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          300 EYEKCELGAM---I---LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       300 ~~~~~~~~~~---~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..........   .   ............+..+.+++.+||+.||.+|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000000000   0   001111222355788999999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=7.1e-42  Score=322.74  Aligned_cols=259  Identities=20%  Similarity=0.250  Sum_probs=175.4

Q ss_pred             hhhccc-ccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec----CCeeE
Q 015480           78 FTSNYS-TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD----QHMTA  151 (406)
Q Consensus        78 ~~~~~~-~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~  151 (406)
                      ..|.+. +.||+|+||+||+|.+. +|+.||||++....  ..   .......+..+.||||+++++++..    ....+
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            445664 46999999999999765 69999999987531  11   1222233556689999999999876    45689


Q ss_pred             EEEEeccCCChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC---CCCceEecccccc
Q 015480          152 LVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAK  227 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~DfGl~~  227 (406)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||.|||+   .+++||||||+|||++.   ++.+||+|||++.
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999999996543 479999999999999999999999   99999999999999976   4559999999997


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ......    .....||+.|+|||++.+. .++.++||||||+++|+|++|..||..........   ..........  
T Consensus       180 ~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~--  249 (336)
T 3fhr_A          180 ETTQNA----LQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQ--  249 (336)
T ss_dssp             EC--------------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             eccccc----cccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhccc--
Confidence            654322    2235689999999999766 78999999999999999999999985433221100   0000000000  


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--HhhccccCC
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVVEVL  358 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~~~~  358 (406)
                          ...........+..+.+++..||+.||.+|||+.++++  .+.......
T Consensus       250 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  298 (336)
T 3fhr_A          250 ----YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP  298 (336)
T ss_dssp             -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred             ----cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence                00001112345678999999999999999999999998  666554333

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.1e-42  Score=327.64  Aligned_cols=268  Identities=23%  Similarity=0.305  Sum_probs=202.1

Q ss_pred             HhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-----------cCccccEEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-----------HINLVRLYG  142 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~  142 (406)
                      +...+|.+.+.||+|+||+||+|.. .+|+.||||++...  ......+.+|+.++.+++           ||||+++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            3456788899999999999999976 56899999999753  334567888999988876           899999999


Q ss_pred             EEecCC----eeEEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCC-CeeecCCCCCcEEEc---
Q 015480          143 FCHDQH----MTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLD---  213 (406)
Q Consensus       143 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~i~H~dlk~~Nill~---  213 (406)
                      ++....    ..++||||+ +++|.+++... ...+++..+..++.|++.||+|||+   + +|+||||||+|||++   
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEE
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccC
Confidence            997654    789999999 88999998653 4569999999999999999999999   8 999999999999994   


Q ss_pred             ---CCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccc
Q 015480          214 ---ANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESL  290 (406)
Q Consensus       214 ---~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  290 (406)
                         .++.+||+|||++.......     ....||+.|+|||++.+. .++.++|||||||++|||++|..||........
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  243 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSY  243 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence               44479999999998665332     335689999999999877 689999999999999999999999965432211


Q ss_pred             ccchhHHHHHHh-----------hhhcc----------hhhcc----------CCCCcchHHHHHHHHHHHHHhcccCCC
Q 015480          291 DWFPKHVWEEYE-----------KCELG----------AMILG----------CGIEEKDKEKAKRLCMVALWCVQDSPE  339 (406)
Q Consensus       291 ~~~~~~~~~~~~-----------~~~~~----------~~~~~----------~~~~~~~~~~~~~l~~l~~~cl~~dP~  339 (406)
                      ............           .....          .....          ......+...+..+.+|+.+||+.||.
T Consensus       244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  323 (373)
T 1q8y_A          244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  323 (373)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence            100000000000           00000          00000          001123467788999999999999999


Q ss_pred             CCCChHHHHH--Hhhcc
Q 015480          340 DRPPMSAVIK--MLEGV  354 (406)
Q Consensus       340 ~RPs~~~vl~--~L~~~  354 (406)
                      +|||+.++++  .+.+.
T Consensus       324 ~Rpt~~ell~hp~f~~~  340 (373)
T 1q8y_A          324 KRADAGGLVNHPWLKDT  340 (373)
T ss_dssp             TCBCHHHHHTCGGGTTC
T ss_pred             ccCCHHHHhhChhhhcc
Confidence            9999999988  44443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7.1e-42  Score=319.93  Aligned_cols=254  Identities=22%  Similarity=0.262  Sum_probs=182.6

Q ss_pred             hhhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhH-HHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           76 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        76 ~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      .-..|.+.+.||+|+||.||+|.+. +|+.||||++......... ..+..+..++..++||||+++++++.+....++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3455677889999999999999774 6899999999765433333 3344455678888999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCC-CeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |||+ ++.+..+.......+++..+..++.|++.||.|||+   . +++||||||+||+++.++.+||+|||++......
T Consensus       103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999 556666664446789999999999999999999998   6 9999999999999999999999999999765433


Q ss_pred             CceEEecCCCCCCCccCccccCC----CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      ..   .....||+.|+|||++..    ...++.++||||||+++|||++|..||......      ............  
T Consensus       179 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~--  247 (318)
T 2dyl_A          179 KA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD------FEVLTKVLQEEP--  247 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHHHSCC--
T ss_pred             cc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc------HHHHHHHhccCC--
Confidence            22   123568999999999852    336789999999999999999999998643221      011111111100  


Q ss_pred             hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                           .........+..+.+++.+||+.||.+||++.++++
T Consensus       248 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          248 -----PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -----CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -----CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                 001111234577999999999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.7e-41  Score=322.70  Aligned_cols=199  Identities=25%  Similarity=0.304  Sum_probs=168.2

Q ss_pred             hhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cC-----ccccEEEEEecCCe
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HI-----NLVRLYGFCHDQHM  149 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~  149 (406)
                      ..+|.+.+.||+|+||+||+|... +|+.||||+++..  ......+..|+.++..++ |+     +|+++++++.....
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            456778899999999999999764 6889999999753  234566778888888775 44     49999999999999


Q ss_pred             eEEEEEeccCCChhhHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc--CCCCceEeccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSPKVADFGLA  226 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~~~kl~DfGl~  226 (406)
                      .++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+. ..+|+||||||+|||++  .++.+||+|||++
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            999999996 59999986543 5799999999999999999999941 17899999999999994  5778999999999


Q ss_pred             cccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccC
Q 015480          227 KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG  285 (406)
Q Consensus       227 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  285 (406)
                      +......     ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       209 ~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          209 CQLGQRI-----YQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             EETTCCC-----CSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eeccccc-----ccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            8764332     346789999999999887 7899999999999999999999998643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.5e-43  Score=328.76  Aligned_cols=246  Identities=22%  Similarity=0.314  Sum_probs=199.4

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccch-----hhHHHHHHHHHHhhccC--cCccccEEEEE
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTY--HINLVRLYGFC  144 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~--h~niv~~~~~~  144 (406)
                      .+....+|.+.+.||+|+||.||+|.. .+|+.||||++......     .....+.+|+.++.+++  ||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            344556788889999999999999965 56899999999754221     12245678999999996  59999999999


Q ss_pred             ecCCeeEEEEEeccC-CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc-CCCCceEec
Q 015480          145 HDQHMTALVYEYMEN-GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVAD  222 (406)
Q Consensus       145 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~D  222 (406)
                      .+....++|||++.+ ++|.+++.. ...+++..+..++.|++.||+|||+   .+++||||||+|||++ +++.+||+|
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            999999999999976 899999843 4678999999999999999999999   9999999999999999 788999999


Q ss_pred             cccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHh
Q 015480          223 FGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE  302 (406)
Q Consensus       223 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  302 (406)
                      ||++.......    .....||+.|+|||++.+....+.++||||||+++|||++|+.||....             ...
T Consensus       194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------------~~~  256 (320)
T 3a99_A          194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EII  256 (320)
T ss_dssp             CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHH
T ss_pred             Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------------hhh
Confidence            99998765432    2345689999999998776445789999999999999999999884321             000


Q ss_pred             hhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          303 KCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...          .......+..+.+++.+||+.||.+|||+.++++
T Consensus       257 ~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          257 RGQ----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HCC----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccc----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000          0111234567899999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.3e-41  Score=331.77  Aligned_cols=248  Identities=22%  Similarity=0.296  Sum_probs=184.9

Q ss_pred             ccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEEEEeccCC
Q 015480           82 YSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        82 ~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      ..+.||+|+||+||.+...+|+.||||++...    ..+.+.+|+.++.++ +||||+++++++.+....++|||||. |
T Consensus        19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g   93 (434)
T 2rio_A           19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L   93 (434)
T ss_dssp             EEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred             ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence            35779999999998776668999999998753    235678899999876 89999999999999999999999996 5


Q ss_pred             ChhhHhhcCCCC------CCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC-------------CCceEe
Q 015480          161 SLDGYLFGKKRA------IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-------------FSPKVA  221 (406)
Q Consensus       161 ~L~~~l~~~~~~------~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-------------~~~kl~  221 (406)
                      +|.+++......      .++..+..++.|++.||+|||+   .+|+||||||+|||++.+             +.+||+
T Consensus        94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~  170 (434)
T 2rio_A           94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS  170 (434)
T ss_dssp             EHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred             CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence            999999543321      1333467899999999999999   999999999999999754             479999


Q ss_pred             ccccccccCCCCceE--EecCCCCCCCccCccccCC------CCCCCcccceeecchhHHHHhh-cccccccCCCccccc
Q 015480          222 DFGLAKLCDRNKTHV--TISGYKGTPGYSAPEFLSG------NYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDW  292 (406)
Q Consensus       222 DfGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  292 (406)
                      |||++..........  ......||+.|+|||++.+      ...++.++|||||||++|||++ |..||.......   
T Consensus       171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---  247 (434)
T 2rio_A          171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---  247 (434)
T ss_dssp             CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---
T ss_pred             ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---
Confidence            999998765433211  1234579999999999865      2368999999999999999998 888874322110   


Q ss_pred             chhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          293 FPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                            ........   .............+.++.+++.+||+.||.+|||+.+|++
T Consensus       248 ------~~i~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ------SNIIRGIF---SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ------HHHHHTCC---CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------HHHhcCCC---CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                  00101100   0011111224567889999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=330.85  Aligned_cols=253  Identities=23%  Similarity=0.275  Sum_probs=189.0

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  153 (406)
                      +...+|...+.||+|+||+||.....+|+.||||++.....    ..+.+|+.++..+ +||||+++++++.+....++|
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            34455677789999999996655555899999999975422    2356799999998 799999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC---C--CCceEeccccccc
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---N--FSPKVADFGLAKL  228 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~--~~~kl~DfGl~~~  228 (406)
                      ||||. |+|.+++........+..+..++.|++.||+|||+   .+|+||||||+|||++.   +  ..+||+|||+++.
T Consensus        97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            99996 59999997666666666778999999999999999   99999999999999953   2  3578999999986


Q ss_pred             cCCCCc-eEEecCCCCCCCccCccccCC--CCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhh
Q 015480          229 CDRNKT-HVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKC  304 (406)
Q Consensus       229 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (406)
                      ...... ........||+.|+|||++.+  ...++.++|||||||++|||++ |..||......       . .....  
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~-~~~~~--  242 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------Q-ANILL--  242 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------H-HHHHT--
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------H-HHHHh--
Confidence            653321 122345679999999999874  2357889999999999999999 88777432111       0 00000  


Q ss_pred             hcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          305 ELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                        ...  ...........+..+.+|+.+||+.||.+|||+.++++
T Consensus       243 --~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          243 --GAC--SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             --TCC--CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --ccC--CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence              000  00011122345667889999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.3e-41  Score=320.01  Aligned_cols=265  Identities=20%  Similarity=0.231  Sum_probs=200.0

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeC-CC-cEEEEEEeccccchhhHHHHHHHHHHhhccCcCc------cccEEEEE
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NG-VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN------LVRLYGFC  144 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~g-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~  144 (406)
                      .+....+|.+.+.||+|+||+||+|... ++ +.||+|+++..  ....+.+.+|+.++..++|+|      ++.+++++
T Consensus        14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            3344567888999999999999999763 34 78999999753  345567889999999988766      99999999


Q ss_pred             ecCCeeEEEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEE-----------
Q 015480          145 HDQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL-----------  212 (406)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill-----------  212 (406)
                      ......++||||+ +++|.+++... ...+++..+..++.|++.||+|||+   .+|+||||||+|||+           
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccc
Confidence            9999999999999 55776766444 3679999999999999999999999   999999999999999           


Q ss_pred             --------cCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhccccccc
Q 015480          213 --------DANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIV  284 (406)
Q Consensus       213 --------~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~  284 (406)
                              +.++.+||+|||++.......     ....||+.|+|||++.+. .++.++|||||||++|||++|..||..
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCC
Confidence                    567899999999998654332     235689999999999876 789999999999999999999999864


Q ss_pred             CCCcccc--------cchhHHHHHHhhhhcc------------------hh-hccCCCCcchHHHHHHHHHHHHHhcccC
Q 015480          285 GATESLD--------WFPKHVWEEYEKCELG------------------AM-ILGCGIEEKDKEKAKRLCMVALWCVQDS  337 (406)
Q Consensus       285 ~~~~~~~--------~~~~~~~~~~~~~~~~------------------~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~d  337 (406)
                      .......        ..+...+.........                  .. .............+..+.+|+.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence            3321100        0000000000000000                  00 0000000112345678999999999999


Q ss_pred             CCCCCChHHHHH
Q 015480          338 PEDRPPMSAVIK  349 (406)
Q Consensus       338 P~~RPs~~~vl~  349 (406)
                      |++|||+.++++
T Consensus       322 P~~Rpt~~e~l~  333 (355)
T 2eu9_A          322 PAQRITLAEALL  333 (355)
T ss_dssp             TTTSCCHHHHTT
T ss_pred             hhhCcCHHHHhc
Confidence            999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=323.77  Aligned_cols=245  Identities=24%  Similarity=0.342  Sum_probs=191.5

Q ss_pred             HHhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccch-----hhHHHHHHHHHHhhcc----CcCccccEEEE
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRT----YHINLVRLYGF  143 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l----~h~niv~~~~~  143 (406)
                      +.....|.+.+.||+|+||.||+|.. .+|+.||+|++......     .....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34456688889999999999999976 56899999999754221     1223456788888888    89999999999


Q ss_pred             EecCCeeEEEEEe-ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc-CCCCceEe
Q 015480          144 CHDQHMTALVYEY-MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVA  221 (406)
Q Consensus       144 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~  221 (406)
                      +.+.+..++|||| +.+++|.+++.. ...+++..+..++.|++.||+|||+   .+++||||||+||+++ .++.+||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEE
Confidence            9999999999999 789999999954 4569999999999999999999999   8999999999999999 88999999


Q ss_pred             ccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHH
Q 015480          222 DFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEY  301 (406)
Q Consensus       222 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  301 (406)
                      |||++.......    .....|+..|+|||++.+....+.++||||||+++|||++|+.||....             ..
T Consensus       183 dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------------~~  245 (312)
T 2iwi_A          183 DFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------------EI  245 (312)
T ss_dssp             CCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HH
T ss_pred             EcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------------HH
Confidence            999998765432    2345689999999998766444669999999999999999999874211             00


Q ss_pred             hhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          302 EKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ....          ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          246 LEAE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHTC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhhc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000          1122334567899999999999999999999998

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=9.4e-42  Score=343.22  Aligned_cols=270  Identities=26%  Similarity=0.344  Sum_probs=203.7

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec------CCee
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD------QHMT  150 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~  150 (406)
                      .+|.+.+.||+|+||+||+|.+ .+|+.||||+++........+.+.+|++++.+++||||+++++++..      ....
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            4678889999999999999976 56899999999876555667889999999999999999999999765      6778


Q ss_pred             EEEEEeccCCChhhHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC---ceEecccc
Q 015480          151 ALVYEYMENGSLDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---PKVADFGL  225 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~DfGl  225 (406)
                      ++||||+++|+|.+++....  ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999999996533  368999999999999999999999   99999999999999997765   89999999


Q ss_pred             ccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhh
Q 015480          226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCE  305 (406)
Q Consensus       226 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (406)
                      +........   .....||+.|+|||.+.+. .++.++||||||+++|+|++|..||....... .|.............
T Consensus       171 a~~~~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          171 AKELDQGEL---CTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-QWHGKVREKSNEHIV  245 (676)
T ss_dssp             CCBTTSCCC---CCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-HSSTTCC------CC
T ss_pred             ccccccccc---cccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchh-hhhhhhhcccchhhh
Confidence            987654432   2346789999999999876 78999999999999999999999986432110 000000000000000


Q ss_pred             ----cchhh-cc---CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHH-----HHHHhhccc
Q 015480          306 ----LGAMI-LG---CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSA-----VIKMLEGVV  355 (406)
Q Consensus       306 ----~~~~~-~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~-----vl~~L~~~~  355 (406)
                          ..... ..   ..........+..+.+++..||+.||.+|||+.+     ..+.++.+.
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence                00000 00   0111233457889999999999999999999987     445555543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.4e-41  Score=344.60  Aligned_cols=243  Identities=21%  Similarity=0.271  Sum_probs=196.8

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeC--CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCe--
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFP--NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM--  149 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--  149 (406)
                      ++...+|.+.+.||+|+||+||+|.+.  +|+.||||++...........+.+|+.++.+++||||+++++++.+.+.  
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            444567888999999999999999774  6899999998765444556788999999999999999999999987655  


Q ss_pred             ---eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccc
Q 015480          150 ---TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  226 (406)
Q Consensus       150 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~  226 (406)
                         .||||||+++++|.+++..   .+++..+..++.|++.||.|||+   ++|+||||||+|||++.+ .+||+|||++
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             CceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccc
Confidence               6999999999999987733   79999999999999999999999   999999999999999886 9999999999


Q ss_pred             cccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhc
Q 015480          227 KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCEL  306 (406)
Q Consensus       227 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (406)
                      ......      ....||+.|+|||++.+.  .+.++|||||||++|+|++|.+|+.........               
T Consensus       229 ~~~~~~------~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---------------  285 (681)
T 2pzi_A          229 SRINSF------GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---------------  285 (681)
T ss_dssp             EETTCC------SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC---------------
T ss_pred             hhcccC------CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccccc---------------
Confidence            866543      345699999999998765  489999999999999999998876432111000               


Q ss_pred             chhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCC-hHHHHHHhhcc
Q 015480          307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPP-MSAVIKMLEGV  354 (406)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~~vl~~L~~~  354 (406)
                              ........+..+.+++.+||+.||.+||+ ++++.+.|..+
T Consensus       286 --------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          286 --------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             --------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             --------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                    01112234567899999999999999995 56666666554

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.2e-40  Score=303.47  Aligned_cols=235  Identities=13%  Similarity=0.033  Sum_probs=187.2

Q ss_pred             HhhhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeE
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA  151 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  151 (406)
                      +...+|.+.+.||+|+||.||+|.+. +|+.||||++.....  ....+.+.+|+.++.+++||||+++++++.+++..+
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            55667888999999999999999774 489999999986533  334578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +||||++|++|.+++..  + .....+..++.|++.||+|||+   +||+||||||+|||++.+|.+||+++|       
T Consensus       108 lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence            99999999999999932  2 4666789999999999999999   999999999999999999999998543       


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                                     |++        .++.++|||||||++|||++|+.||.............            ....
T Consensus       175 ---------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~------------~~~~  219 (286)
T 3uqc_A          175 ---------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE------------RDTA  219 (286)
T ss_dssp             ---------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC------------BCTT
T ss_pred             ---------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH------------HHhc
Confidence                           222        36889999999999999999999986543321100000            0000


Q ss_pred             cCCC--CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCC
Q 015480          312 GCGI--EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVL  358 (406)
Q Consensus       312 ~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~  358 (406)
                      ....  .......+..+.+++.+||+.||.+| |+.++++.|+.+....
T Consensus       220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            0000  01112356779999999999999999 9999999999886543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.4e-39  Score=297.13  Aligned_cols=232  Identities=21%  Similarity=0.287  Sum_probs=179.6

Q ss_pred             hccc-ccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHh-hccCcCccccEEEEEec----CCeeEE
Q 015480           80 SNYS-TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLVRLYGFCHD----QHMTAL  152 (406)
Q Consensus        80 ~~~~-~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~l  152 (406)
                      |.+. +.||+|+||.||+|.. .+|+.||+|++...      ..+.+|+.++ +..+||||+++++++.+    ....++
T Consensus        19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l   92 (299)
T 3m2w_A           19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   92 (299)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence            3444 6799999999999976 56899999998642      3466788887 55689999999999876    678899


Q ss_pred             EEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC---CCCceEeccccccc
Q 015480          153 VYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKL  228 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~DfGl~~~  228 (406)
                      ||||+++|+|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+|||++.   ++.+||+|||++..
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            99999999999999654 3579999999999999999999999   99999999999999998   78999999999863


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      ...                        . .++.++|||||||++|||++|..||.........            .....
T Consensus       170 ~~~------------------------~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~~~~~  212 (299)
T 3m2w_A          170 TTG------------------------E-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKT  212 (299)
T ss_dssp             CTT------------------------C-GGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSCC
T ss_pred             ccc------------------------c-cCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------HHHHH
Confidence            321                        2 5788999999999999999999998543221100            00000


Q ss_pred             hhccCCCC---cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--HhhccccC
Q 015480          309 MILGCGIE---EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVVEV  357 (406)
Q Consensus       309 ~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~~~  357 (406)
                      ........   ......+..+.+++.+||+.||.+|||+.++++  .+......
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~  266 (299)
T 3m2w_A          213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV  266 (299)
T ss_dssp             SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred             HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence            00000001   011235678999999999999999999999998  55554433

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5e-40  Score=310.14  Aligned_cols=243  Identities=14%  Similarity=0.110  Sum_probs=186.7

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCCCcEEEEEEecccc-------chhhHHHHHHHHHHhhccC---------cCccc
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-------GRIAEEQFMAEVGTIGRTY---------HINLV  138 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~---------h~niv  138 (406)
                      +....|.+.+.||+|+||+||+|++ +|+.||||++....       .....+.+.+|+.+++.++         ||||+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            3446678889999999999999988 78999999998542       2223467888998888875         77777


Q ss_pred             cEEEEEe------------------------------cCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHH
Q 015480          139 RLYGFCH------------------------------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKG  188 (406)
Q Consensus       139 ~~~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~  188 (406)
                      ++.+++.                              +....++|||||++|++.+.+.  +..+++..+..++.|++.|
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHH
Confidence            7777642                              2678999999999997766662  3678999999999999999


Q ss_pred             HHHHH-HhcCCCeeecCCCCCcEEEcCCC--------------------CceEeccccccccCCCCceEEecCCCCCCCc
Q 015480          189 LVYLH-EECQQRIIHYDIKPENVLLDANF--------------------SPKVADFGLAKLCDRNKTHVTISGYKGTPGY  247 (406)
Q Consensus       189 l~~LH-~~~~~~i~H~dlk~~Nill~~~~--------------------~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y  247 (406)
                      |+||| +   .+|+||||||+|||++.++                    .+||+|||+++.....       ...||+.|
T Consensus       174 L~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred             HHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence            99999 8   8999999999999999887                    8999999999866532       23589999


Q ss_pred             cCccccCCCCCCCcccceeecchh-HHHHhhcccccccCCCcccccchhHHHHHHhhhhcch--hhccCCCCcchHHHHH
Q 015480          248 SAPEFLSGNYPITHKCDVYSFGMV-LFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA--MILGCGIEEKDKEKAK  324 (406)
Q Consensus       248 ~aPE~~~~~~~~~~~~DvwslG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  324 (406)
                      +|||++.+. . +.++||||||++ .+++++|..||..           ..|.......+..  ..............+.
T Consensus       244 ~aPE~~~g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  310 (336)
T 2vuw_A          244 MDEDLFTGD-G-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYLTDKMLKQMTFKTKCNTPAMKQIKR  310 (336)
T ss_dssp             TCSGGGCCC-S-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHHHHHHHHTCCCSSCCCSHHHHHHHH
T ss_pred             cChhhhcCC-C-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHHHHhhhhhhccCcccchhhhhhcCH
Confidence            999999876 3 889999998777 7778888877621           1111111111110  0111122334567889


Q ss_pred             HHHHHHHHhcccCCCCCCChHHHH
Q 015480          325 RLCMVALWCVQDSPEDRPPMSAVI  348 (406)
Q Consensus       325 ~l~~l~~~cl~~dP~~RPs~~~vl  348 (406)
                      ++.+|+.+||+.|     |+.+++
T Consensus       311 ~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          311 KIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHHhccC-----CHHHHH
Confidence            9999999999976     899888

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.4e-40  Score=318.29  Aligned_cols=239  Identities=15%  Similarity=0.110  Sum_probs=177.3

Q ss_pred             hcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCc-Ccc---------cc-------
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYH-INL---------VR-------  139 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h-~ni---------v~-------  139 (406)
                      +...+.||+|+||+||+|.+ .+|+.||||++.....  ....+.+.+|+.++..++| +|.         +.       
T Consensus        80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  159 (413)
T 3dzo_A           80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  159 (413)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred             EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence            45567899999999999975 5699999999884322  2235779999999999976 221         11       


Q ss_pred             -----EEEEEec-----CCeeEEEEEeccCCChhhHhh------cCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeec
Q 015480          140 -----LYGFCHD-----QHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY  203 (406)
Q Consensus       140 -----~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~  203 (406)
                           +..++..     ....+++|+++ +++|.+++.      .....+++..+..++.|+++||+|||+   ++|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHr  235 (413)
T 3dzo_A          160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHT  235 (413)
T ss_dssp             CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred             CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccC
Confidence                 1111111     12456777766 679999883      235568888999999999999999999   999999


Q ss_pred             CCCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccC---------CCCCCCcccceeecchhHHH
Q 015480          204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS---------GNYPITHKCDVYSFGMVLFE  274 (406)
Q Consensus       204 dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DvwslG~il~e  274 (406)
                      ||||+||||+.++.+||+|||+++.....     .....| +.|+|||++.         ....++.++|||||||++||
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            99999999999999999999998754422     344667 9999999983         22368899999999999999


Q ss_pred             HhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          275 IVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       275 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      |++|+.||.........                .......     ...+..+.+|+.+||+.||.+||++.++++
T Consensus       310 lltg~~Pf~~~~~~~~~----------------~~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGS----------------EWIFRSC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHSSCCCCTTGGGSCS----------------GGGGSSC-----CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHCCCCCCCcchhhhH----------------HHHHhhc-----ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999998543321110                0011100     123467999999999999999999877754

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=3e-34  Score=287.67  Aligned_cols=187  Identities=16%  Similarity=0.123  Sum_probs=132.7

Q ss_pred             cccccceeEEEEE-EeCCCcEEEEEEecccc---------chhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEE
Q 015480           85 RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL---------GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        85 ~ig~G~~g~V~~~-~~~~g~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ..+.|++|.+..+ +.-.|+.||+|++....         .+...+.|.+|+++|+++ .|+||+++++++.++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            3566777766665 33458899999997531         233456799999999999 699999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |||++|++|.+++. ..+.++..   +|+.||+.||+|||+   +||+||||||+||||+++|.+||+|||+++......
T Consensus       321 MEyv~G~~L~d~i~-~~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLA-AGEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EECCCSEEHHHHHH-TTCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EecCCCCcHHHHHH-hCCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            99999999999994 44566654   588999999999999   999999999999999999999999999998665432


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhccccc
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNA  282 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~  282 (406)
                      ..  ....+||+.|||||++.+.  +..++|+||+|++++++.++..++
T Consensus       394 ~~--~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          394 SW--PTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             CC--SHHHHHHHHHHHHHHC-------------------CCCCTTHHHH
T ss_pred             cc--ccCceechhhccHHHhCCC--CCCcccccccccchhhhccccchh
Confidence            21  2335699999999999865  577899999999999998876554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.4e-29  Score=252.48  Aligned_cols=184  Identities=16%  Similarity=0.190  Sum_probs=141.9

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEeccccc-------hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG-------RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .+.||+|+||+||+|.. .+..+++|.......       ....+.+.+|++++++++||||+++..++.+.+..+||||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            45799999999999965 578899998653211       1123568999999999999999966666667777899999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      |+++++|.+++..         +..++.|+++||+|||+   ++|+||||||+|||++.  .+||+|||+++........
T Consensus       420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            9999999999843         56899999999999999   99999999999999998  9999999999877543221


Q ss_pred             E-----EecCCCCCCCccCccccCCC-CCCCcccceeecchhHHHHhhcccc
Q 015480          236 V-----TISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRN  281 (406)
Q Consensus       236 ~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltg~~p  281 (406)
                      .     ......||+.|||||++... ..|+...|+||..+-..+.+.++.+
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r  537 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR  537 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence            1     11245689999999998751 1577889999988887777765543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=2.4e-25  Score=203.97  Aligned_cols=143  Identities=15%  Similarity=0.069  Sum_probs=116.0

Q ss_pred             cccccccccceeEEEEEEeCCCcEEEEEEeccccch-----------------hhHHHHHHHHHHhhccCcCccccEEEE
Q 015480           81 NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGR-----------------IAEEQFMAEVGTIGRTYHINLVRLYGF  143 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~h~niv~~~~~  143 (406)
                      .+.+.||+|+||.||+|.+.+|+.||+|+++.....                 .....+.+|+.++.+++  | +++.++
T Consensus        93 ~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~  169 (282)
T 1zar_A           93 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV  169 (282)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred             EecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence            345899999999999998877999999999643211                 13567899999999998  5 666665


Q ss_pred             EecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecc
Q 015480          144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF  223 (406)
Q Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (406)
                      +.. +..++||||++|++|.+ +..       .....++.|++.||.|||+   .|++||||||+|||++ ++.+||+||
T Consensus       170 ~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          170 YAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             EEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred             Eec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence            544 55699999999999988 411       2345799999999999999   9999999999999999 999999999


Q ss_pred             ccccccCCCCceEEecCCCCCCCccCccccC
Q 015480          224 GLAKLCDRNKTHVTISGYKGTPGYSAPEFLS  254 (406)
Q Consensus       224 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  254 (406)
                      |+++.               +..++|||.+.
T Consensus       237 G~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          237 PQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             TTCEE---------------TTSTTHHHHHH
T ss_pred             CCCeE---------------CCCCCHHHHHH
Confidence            99862               34578899875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=4.1e-22  Score=180.24  Aligned_cols=137  Identities=15%  Similarity=0.146  Sum_probs=106.6

Q ss_pred             hcccccccccceeEEEEEEe-CCCcE--EEEEEeccccch-----------------------hhHHHHHHHHHHhhccC
Q 015480           80 SNYSTRLGFGGFGEVYKGQF-PNGVK--IAVKVLNRNLGR-----------------------IAEEQFMAEVGTIGRTY  133 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~-~~g~~--vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~  133 (406)
                      +.+.+.||+|+||.||+|.+ .+|+.  ||||+++.....                       .....+.+|+..+..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45668899999999999987 68989  999997543110                       11246788999999999


Q ss_pred             cCcc--ccEEEEEecCCeeEEEEEeccC-C----ChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-HhcCCCeeecCC
Q 015480          134 HINL--VRLYGFCHDQHMTALVYEYMEN-G----SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH-EECQQRIIHYDI  205 (406)
Q Consensus       134 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~i~H~dl  205 (406)
                      |+|+  +.++++    ...+|||||+.+ |    +|.++...    .++..+..++.|++.+|.||| +   .|++||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~givHrDl  197 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQE---AELVHADL  197 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCC
Confidence            8864  445543    356899999942 4    66665421    234567899999999999999 8   99999999


Q ss_pred             CCCcEEEcCCCCceEecccccccc
Q 015480          206 KPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       206 k~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      ||+|||++.  .++|+|||++...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999998  9999999999644

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=1.4e-19  Score=170.44  Aligned_cols=139  Identities=12%  Similarity=0.105  Sum_probs=100.0

Q ss_pred             hcccccccccceeEEEEEEeCCCcEEEEEEeccccc-------------hhhHHH--------HHHHHHHhhccCcCccc
Q 015480           80 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG-------------RIAEEQ--------FMAEVGTIGRTYHINLV  138 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~-------------~~~~~~--------~~~e~~~l~~l~h~niv  138 (406)
                      |.+...||+|+||.||+|...+|+.||||+++....             ......        ..+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            567789999999999999988999999999763210             001111        23456666666544432


Q ss_pred             cEEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC-
Q 015480          139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS-  217 (406)
Q Consensus       139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-  217 (406)
                      -..-+...  ..+|||||++|++|..+...       .....++.|++.+|.+||.   .|++||||||.|||+++++. 
T Consensus       177 vp~p~~~~--~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          177 VPEPIAQS--RHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             CCCEEEEE--TTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEECS
T ss_pred             CCeeeecc--CceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCCc
Confidence            22111112  23799999999888765421       2345788999999999999   99999999999999988763 


Q ss_pred             ---------ceEeccccccccC
Q 015480          218 ---------PKVADFGLAKLCD  230 (406)
Q Consensus       218 ---------~kl~DfGl~~~~~  230 (406)
                               +.|+||+.+....
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEETT
T ss_pred             ccccccccceEEEEeCCcccCC
Confidence                     8899999886544

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.39  E-value=1e-12  Score=118.66  Aligned_cols=140  Identities=11%  Similarity=0.006  Sum_probs=109.1

Q ss_pred             hcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEEEecc
Q 015480           80 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        80 ~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      +.+...++.|+.+.||++... |+.+++|+...... .....+.+|++++..+. +.++.++++++.+.+..++||||++
T Consensus        16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~   93 (263)
T 3tm0_A           16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD   93 (263)
T ss_dssp             SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred             ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence            445567888888999999864 67899999875321 12235888999999885 6788899999998889999999999


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC------------------------------------------  196 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------------------------------------  196 (406)
                      |.+|.+.+.      +......++.+++++|..||+..                                          
T Consensus        94 G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T 3tm0_A           94 GVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             SEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred             CeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence            999877531      11234578889999999999811                                          


Q ss_pred             --------------CCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          197 --------------QQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       197 --------------~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                                    ...++|+|++|.|||+++++.+.|+||+.+.
T Consensus       168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                          1459999999999999876667799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.34  E-value=2.1e-12  Score=116.19  Aligned_cols=128  Identities=13%  Similarity=-0.002  Sum_probs=97.6

Q ss_pred             cccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCc--cccEEEEEecCCeeEEEEEeccCCChhh
Q 015480           87 GFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN--LVRLYGFCHDQHMTALVYEYMENGSLDG  164 (406)
Q Consensus        87 g~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~  164 (406)
                      +.|..+.||++...+|..+++|+....    ....+..|+.++..+.+.+  +.+++++..+.+..++||||++|.+|. 
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            456669999998877888999997653    2245778999988886444  566899888888889999999998884 


Q ss_pred             HhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhc------------------------------------------------
Q 015480          165 YLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC------------------------------------------------  196 (406)
Q Consensus       165 ~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------------------------------------------  196 (406)
                       .. .   .+   ...++.++++.|..||+..                                                
T Consensus       104 -~~-~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (264)
T 1nd4_A          104 -SS-H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK  175 (264)
T ss_dssp             -TS-C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred             -cC-c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence             21 1   11   2367778888888888731                                                


Q ss_pred             -------CCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          197 -------QQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       197 -------~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                             ...++|+|++|.||++++++.+.|+|||.+.
T Consensus       176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                   1129999999999999887667799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.30  E-value=1.8e-11  Score=115.70  Aligned_cols=142  Identities=13%  Similarity=0.170  Sum_probs=107.3

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEec--cccchhhHHHHHHHHHHhhccC--cCccccEEEEEecC---CeeEEEEE
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTY--HINLVRLYGFCHDQ---HMTALVYE  155 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~--~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e  155 (406)
                      .+.|+.|.++.||+....+ ..+++|+..  ..........+.+|..+++.+.  +.++++++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            3568999999999998754 578888876  3322123456888999999887  45688999998776   45889999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC---------------------------------------  196 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---------------------------------------  196 (406)
                      |++|..+.+..   ...++......++.++++.|..||+..                                       
T Consensus       122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            99998875422   234678888999999999999999731                                       


Q ss_pred             ----------------CCCeeecCCCCCcEEEcCCCC--ceEeccccccc
Q 015480          197 ----------------QQRIIHYDIKPENVLLDANFS--PKVADFGLAKL  228 (406)
Q Consensus       197 ----------------~~~i~H~dlk~~Nill~~~~~--~kl~DfGl~~~  228 (406)
                                      ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                            257999999999999997754  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.06  E-value=4e-11  Score=110.61  Aligned_cols=186  Identities=17%  Similarity=0.171  Sum_probs=123.3

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCc--cccEEEEEecCC---eeEEEEEec
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HIN--LVRLYGFCHDQH---MTALVYEYM  157 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~  157 (406)
                      +.++.|....||+..    ..+++|+....   .....+.+|.+++..+. +..  +.+++.......   ..|+||+++
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            458999999999874    45888886532   34567889999998873 332  455555544433   457999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-----------------------------------------  196 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----------------------------------------  196 (406)
                      +|.+|.+...   ..++..+...++.++++.|..||+..                                         
T Consensus        99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            9988875432   34677788889999999999999611                                         


Q ss_pred             --------------CCCeeecCCCCCcEEEcC--CCCceEeccccccccCCCCceEEecCCCCCCCccCccccC------
Q 015480          197 --------------QQRIIHYDIKPENVLLDA--NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS------  254 (406)
Q Consensus       197 --------------~~~i~H~dlk~~Nill~~--~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------  254 (406)
                                    ...++|+|++|.||++++  ++.+.|+||+.+...+.......   ......-..|+...      
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~---~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS---LMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT---TCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH---HHhhccccCHHHHHHHHHHc
Confidence                          135899999999999998  45688999999875432211100   00000001222111      


Q ss_pred             CCC-------CCCcccceeecchhHHHHhhccccc
Q 015480          255 GNY-------PITHKCDVYSFGMVLFEIVGRRRNA  282 (406)
Q Consensus       255 ~~~-------~~~~~~DvwslG~il~elltg~~p~  282 (406)
                      +..       ......+.|++|.++|.+.+|..++
T Consensus       253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            000       0122368899999999999998654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.69  E-value=8.2e-08  Score=86.56  Aligned_cols=133  Identities=16%  Similarity=0.071  Sum_probs=97.3

Q ss_pred             cccccee-EEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEEEeccCCCh
Q 015480           86 LGFGGFG-EVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYMENGSL  162 (406)
Q Consensus        86 ig~G~~g-~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L  162 (406)
                      +..|..| .||+.... ++..+++|+-...    ....+.+|...|+.+. +-.+.++++++.+.+..++|||+++|.++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            4445554 68988664 4667899986542    4456888999888774 33478899999999999999999999888


Q ss_pred             hhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 015480          163 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC----------------------------------------------  196 (406)
Q Consensus       163 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------------  196 (406)
                      .+.....     ......+..+++..|..||+..                                              
T Consensus       108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            7655221     1233456667777777777520                                              


Q ss_pred             ---------CCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          197 ---------QQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       197 ---------~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                               ...++|+|+.+.|||+++++.+-|+||+.+.
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                     1238999999999999988777899998874

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.66  E-value=2.2e-07  Score=85.42  Aligned_cols=134  Identities=15%  Similarity=0.119  Sum_probs=95.8

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcC---ccccEEEEEe-cCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI---NLVRLYGFCH-DQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~  159 (406)
                      +.++.|....||+.    |..+++|+-..   ......+..|.++|..+.+.   .+.+++.++. ..+..++||||++|
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            45788888899998    56788888532   23456789999999998642   3667777774 45567899999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE--------------------------------------------  195 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------------------------------------------  195 (406)
                      .++.+...   ..++......++.++++.|..||+.                                            
T Consensus        98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            88866321   1234555566666666666666642                                            


Q ss_pred             -------------cCCCeeecCCCCCcEEEcC---CCC-ceEecccccc
Q 015480          196 -------------CQQRIIHYDIKPENVLLDA---NFS-PKVADFGLAK  227 (406)
Q Consensus       196 -------------~~~~i~H~dlk~~Nill~~---~~~-~kl~DfGl~~  227 (406)
                                   ....++|+|+++.||+++.   ++. +.|+||+.+.
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                         1235799999999999987   455 4899999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.57  E-value=1.1e-07  Score=89.37  Aligned_cols=81  Identities=10%  Similarity=-0.015  Sum_probs=56.6

Q ss_pred             ccc-cccceeEEEEEEeC-------CCcEEEEEEeccccc--hhhHHHHHHHHHHhhccC-c--CccccEEEEEecC---
Q 015480           84 TRL-GFGGFGEVYKGQFP-------NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTY-H--INLVRLYGFCHDQ---  147 (406)
Q Consensus        84 ~~i-g~G~~g~V~~~~~~-------~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~---  147 (406)
                      +.| +.|....+|+....       +|..+++|+......  ......+..|..++..+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 88989999998764       267888998754320  001245678888888875 3  3577888888665   


Q ss_pred             CeeEEEEEeccCCChhh
Q 015480          148 HMTALVYEYMENGSLDG  164 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~  164 (406)
                      ...++||||++|.++.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.39  E-value=1.2e-06  Score=83.58  Aligned_cols=75  Identities=13%  Similarity=0.065  Sum_probs=49.1

Q ss_pred             ccccccceeEEEEEEeC-CCcEEEEEEeccccc------hhhHHHHHHHHHHhhccCc--C-ccccEEEEEecCCeeEEE
Q 015480           84 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG------RIAEEQFMAEVGTIGRTYH--I-NLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~lv  153 (406)
                      +.||.|.++.||++... +++.+++|.......      ......+..|.+++..+..  + .+.+++.+.  ....++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEEE
Confidence            46999999999999754 468899998653211      0123456778888887642  3 445666543  3456899


Q ss_pred             EEeccCC
Q 015480          154 YEYMENG  160 (406)
Q Consensus       154 ~e~~~~g  160 (406)
                      ||++++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.32  E-value=4.3e-06  Score=77.77  Aligned_cols=138  Identities=14%  Similarity=0.174  Sum_probs=78.9

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCc--CccccEEE------EEecCCeeEEEEE
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH--INLVRLYG------FCHDQHMTALVYE  155 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~------~~~~~~~~~lv~e  155 (406)
                      +.|+.|..+.||+....+| .+++|+....     ...+..|..++..+..  -++.+++.      +....+..+++|+
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            3466678899999987655 4889988752     1223344555544431  12333332      1234567789999


Q ss_pred             eccCCChh-----------hH---hhc--CC-----------CCCCHHHH------------------------------
Q 015480          156 YMENGSLD-----------GY---LFG--KK-----------RAIEWEKL------------------------------  178 (406)
Q Consensus       156 ~~~~g~L~-----------~~---l~~--~~-----------~~~~~~~~------------------------------  178 (406)
                      |++|.++.           ..   ++.  ..           ....|...                              
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542           01   111  00           01123211                              


Q ss_pred             -HHHHHHHHHHHHHHHH----------hcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          179 -HEIAIGTAKGLVYLHE----------ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       179 -~~i~~qi~~~l~~LH~----------~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                       ..+...+..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             1111223345666653          124789999999999999888899999998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.22  E-value=1.1e-05  Score=74.07  Aligned_cols=135  Identities=19%  Similarity=0.195  Sum_probs=91.4

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC---cCccccEEEEEecCCeeEEEEEeccCC
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---HINLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      +.|+.|....+|+... ++..+++|+....    ....+..|.+.|+.+.   ...++++++++...+..++||||+++.
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            4689999999999987 4678889987642    3567888999888874   356889999988888899999999987


Q ss_pred             Chhh--------H---hhcCCC---------------------CCCHHHHH---HHHHH----------------HHHH-
Q 015480          161 SLDG--------Y---LFGKKR---------------------AIEWEKLH---EIAIG----------------TAKG-  188 (406)
Q Consensus       161 ~L~~--------~---l~~~~~---------------------~~~~~~~~---~i~~q----------------i~~~-  188 (406)
                      .+..        .   ++....                     .-+|....   ++..+                ++.. 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6521        1   121110                     11454322   11111                1111 


Q ss_pred             HHHHHH-hcCCCeeecCCCCCcEEEcCCCCceEeccc
Q 015480          189 LVYLHE-ECQQRIIHYDIKPENVLLDANFSPKVADFG  224 (406)
Q Consensus       189 l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~DfG  224 (406)
                      ...|.. .....++|+|+.+.|++++.++ +.|+|++
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            123321 1247899999999999999887 8888873

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.09  E-value=1.3e-05  Score=72.86  Aligned_cols=75  Identities=16%  Similarity=0.200  Sum_probs=54.6

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCc---CccccEEEEEecCCeeEEEEEeccC
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH---INLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      .+.+|.|..+.||+.+..+|+.|.+|+...... .....|..|...|+.+..   -.+++++++.    ..++||||+++
T Consensus        20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~   94 (288)
T 3f7w_A           20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDE   94 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCC
T ss_pred             EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecc
Confidence            456899999999999999999999998764322 223457889988887742   2355666543    23789999987


Q ss_pred             CCh
Q 015480          160 GSL  162 (406)
Q Consensus       160 g~L  162 (406)
                      +..
T Consensus        95 ~~~   97 (288)
T 3f7w_A           95 RPP   97 (288)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.00  E-value=3.7e-05  Score=73.79  Aligned_cols=80  Identities=13%  Similarity=0.044  Sum_probs=47.4

Q ss_pred             CCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE-ecCCCCCCCccCccccCCCC--CCCcccceeecchhHH
Q 015480          197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-ISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLF  273 (406)
Q Consensus       197 ~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~  273 (406)
                      ...++|+|++|.|||++.++ ++++||+.+........... ...  -...|++|+......  ......++......+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGN--LILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHH--HHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHH--HHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            47899999999999998876 99999998864331110000 000  012356665443110  1122345557777778


Q ss_pred             HHhhcc
Q 015480          274 EIVGRR  279 (406)
Q Consensus       274 elltg~  279 (406)
                      +.+++.
T Consensus       308 ~~y~~~  313 (420)
T 2pyw_A          308 NLFNKR  313 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            777654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.77  E-value=4.9e-05  Score=64.75  Aligned_cols=99  Identities=13%  Similarity=0.074  Sum_probs=67.7

Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEec
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS  239 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~  239 (406)
                      -+|.+.|...+.+++++++|.+++|.+.+|.-+-..  ..-..+=+.|..|++..+|.+.+.+ +.+.            
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            379999988899999999999999999998776210  1111333467999999999988764 1110            


Q ss_pred             CCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh
Q 015480          240 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG  277 (406)
Q Consensus       240 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt  277 (406)
                        .....+.|||...  ...+.+.=|||||+++|.-+-
T Consensus        98 --~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 --AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             -----------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred             --ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence              1123567888764  256788999999999999874

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.75  E-value=6e-05  Score=69.40  Aligned_cols=140  Identities=13%  Similarity=0.120  Sum_probs=78.9

Q ss_pred             ccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCc--cccEEEE------EecCCeeEEEEE
Q 015480           84 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN--LVRLYGF------CHDQHMTALVYE  155 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e  155 (406)
                      +.|+.|....+|+....+| .+++|+.....   ....+..|..++..+...+  +.+++..      ....+..+++++
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            4577888899999987666 68889887521   1234556777766664222  2333321      122356789999


Q ss_pred             eccCCChhh-----H---------hhc--CC--C----CC---CHHHHHH------------HHHHHHHHHHHHHHh---
Q 015480          156 YMENGSLDG-----Y---------LFG--KK--R----AI---EWEKLHE------------IAIGTAKGLVYLHEE---  195 (406)
Q Consensus       156 ~~~~g~L~~-----~---------l~~--~~--~----~~---~~~~~~~------------i~~qi~~~l~~LH~~---  195 (406)
                      |++|..+..     +         ++.  ..  .    ..   .|.....            +...+...+++++..   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            998865421     0         111  00  0    01   1222110            011234455666542   


Q ss_pred             -cCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          196 -CQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       196 -~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                       ...+++|+|+++.|||+++++.+.|+||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             13579999999999999987666899998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.69  E-value=0.0001  Score=68.25  Aligned_cols=140  Identities=18%  Similarity=0.130  Sum_probs=73.3

Q ss_pred             ccccccceeE-EEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCc--CccccEEEEEecCCeeEEEEEeccCC
Q 015480           84 TRLGFGGFGE-VYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH--INLVRLYGFCHDQHMTALVYEYMENG  160 (406)
Q Consensus        84 ~~ig~G~~g~-V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g  160 (406)
                      +.|+.|+... +|+....+|..+++|.......    ..+..|+.++..+..  -.+.+++.+..+.+  +++||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            3465554444 6787764467777776544210    223456666666542  23566777644433  7899999776


Q ss_pred             ChhhHhhcC-------------------------CCCCCHHHHH-------HH-------------HHHHHHHHHHHHH-
Q 015480          161 SLDGYLFGK-------------------------KRAIEWEKLH-------EI-------------AIGTAKGLVYLHE-  194 (406)
Q Consensus       161 ~L~~~l~~~-------------------------~~~~~~~~~~-------~i-------------~~qi~~~l~~LH~-  194 (406)
                      .+.+++...                         -..++.....       .+             ...+...+..+.. 
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            664433110                         0112211110       00             0011122222211 


Q ss_pred             --hcCCCeeecCCCCCcEEEcCC----CCceEecccccccc
Q 015480          195 --ECQQRIIHYDIKPENVLLDAN----FSPKVADFGLAKLC  229 (406)
Q Consensus       195 --~~~~~i~H~dlk~~Nill~~~----~~~kl~DfGl~~~~  229 (406)
                        .....++|||+.+.|||++.+    +.+.|+||+.+...
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence              123689999999999999875    67899999988643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.68  E-value=0.00013  Score=70.05  Aligned_cols=72  Identities=19%  Similarity=0.253  Sum_probs=50.1

Q ss_pred             ccccccceeEEEEEEeCC--------CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCcc-ccEEEEEecCCeeEEEE
Q 015480           84 TRLGFGGFGEVYKGQFPN--------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGFCHDQHMTALVY  154 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  154 (406)
                      +.|+.|....+|++...+        +..+++|+....   .....+..|..++..+...++ .++++.+.+    .+|+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            568888889999998753        578999988432   112445678888888864444 667776543    3899


Q ss_pred             EeccCCCh
Q 015480          155 EYMENGSL  162 (406)
Q Consensus       155 e~~~~g~L  162 (406)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.67  E-value=0.00014  Score=67.10  Aligned_cols=138  Identities=14%  Similarity=0.162  Sum_probs=80.4

Q ss_pred             cccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCc--cccEEEE-----EecCCeeEEEEEec
Q 015480           85 RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN--LVRLYGF-----CHDQHMTALVYEYM  157 (406)
Q Consensus        85 ~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~-----~~~~~~~~lv~e~~  157 (406)
                      .++ |....||+....+|+.+++|+.....  .....+..|..++..+....  +++++..     ....+..+++|+|+
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            366 77789999987778789999987431  13445667777777664222  3444432     12244567899999


Q ss_pred             cCCChhh-----H---------hhc--C------CCCCCHHHH----HHH---------------HHHHHHHHHHHHHh-
Q 015480          158 ENGSLDG-----Y---------LFG--K------KRAIEWEKL----HEI---------------AIGTAKGLVYLHEE-  195 (406)
Q Consensus       158 ~~g~L~~-----~---------l~~--~------~~~~~~~~~----~~i---------------~~qi~~~l~~LH~~-  195 (406)
                      +|..+..     +         ++.  .      ....++...    ..+               ...+...+..+... 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8754421     1         110  0      111222211    001               01111223333321 


Q ss_pred             ---cCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          196 ---CQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       196 ---~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                         ....++|+|+++.|||++ + .+.++||+.+.
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence               236789999999999999 4 89999998775

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.66  E-value=0.0002  Score=67.42  Aligned_cols=138  Identities=14%  Similarity=0.180  Sum_probs=84.2

Q ss_pred             ccccccceeEEEEEEeC--------CCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEE
Q 015480           84 TRLGFGGFGEVYKGQFP--------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  154 (406)
                      +.|..|-...+|++...        ++..+++|+.....  .....+.+|..+++.+. +.-..++++++.+    .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            45777888889999874        24789999864321  23455678999888875 3334667776654    2899


Q ss_pred             EeccCCChhhH-----------------hhcC----CCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 015480          155 EYMENGSLDGY-----------------LFGK----KRAIE--WEKLHEIAIGTAK-------------------GLVYL  192 (406)
Q Consensus       155 e~~~~g~L~~~-----------------l~~~----~~~~~--~~~~~~i~~qi~~-------------------~l~~L  192 (406)
                      ||++|.+|..-                 ++..    .+...  +.++.++..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998665311                 1111    11222  4555555544422                   23344


Q ss_pred             HHh-----cCCCeeecCCCCCcEEEcCC----CCceEecccccc
Q 015480          193 HEE-----CQQRIIHYDIKPENVLLDAN----FSPKVADFGLAK  227 (406)
Q Consensus       193 H~~-----~~~~i~H~dlk~~Nill~~~----~~~kl~DfGl~~  227 (406)
                      ...     ....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            321     13579999999999999876    789999998774

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.64  E-value=0.00015  Score=66.06  Aligned_cols=136  Identities=11%  Similarity=0.075  Sum_probs=74.5

Q ss_pred             cccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCcc-ccEEEEEecCCeeEEEEEec-cCC
Q 015480           83 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGFCHDQHMTALVYEYM-ENG  160 (406)
Q Consensus        83 ~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~g  160 (406)
                      .+.|+.|....+|+.     ..+++|+.......  ......|..++..+...++ .++++++  .+..++++||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            456888999999998     45888887643111  1123457777766643233 4666543  33457899999 665


Q ss_pred             ChhhH------------------hhcCCCC----CC-HHHHHHHHHH--------------HHHHHHHHHH-----hcCC
Q 015480          161 SLDGY------------------LFGKKRA----IE-WEKLHEIAIG--------------TAKGLVYLHE-----ECQQ  198 (406)
Q Consensus       161 ~L~~~------------------l~~~~~~----~~-~~~~~~i~~q--------------i~~~l~~LH~-----~~~~  198 (406)
                      ++...                  ++.....    .. +..+..+...              +...+..+..     ....
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~  173 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL  173 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence            54320                  0111110    11 1111111110              1111111111     1134


Q ss_pred             CeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          199 RIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       199 ~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      .++|+|+.+.||+ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            5899999999999 5667789999988753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.53  E-value=0.00047  Score=66.65  Aligned_cols=73  Identities=16%  Similarity=0.141  Sum_probs=47.4

Q ss_pred             ccccccceeEEEEEEeCC-CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCcc-ccEEEEEecCCeeEEEEEeccCCC
Q 015480           84 TRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGFCHDQHMTALVYEYMENGS  161 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~  161 (406)
                      +.|+.|-...+|++...+ +..+++|+........  .+...|..++..+...++ .++++++. +   .+||||++|.+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~--idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~  187 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI--INREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYA  187 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC--SCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh--cCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCcc
Confidence            468888889999998765 4788899875432111  112578888888764444 57777763 2   35999998755


Q ss_pred             h
Q 015480          162 L  162 (406)
Q Consensus       162 L  162 (406)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.45  E-value=0.00043  Score=65.06  Aligned_cols=73  Identities=7%  Similarity=0.129  Sum_probs=44.6

Q ss_pred             ccccccceeEEEEEEeCC---------CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCc-cccEEEEEecCCeeEEE
Q 015480           84 TRLGFGGFGEVYKGQFPN---------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYGFCHDQHMTALV  153 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv  153 (406)
                      +.|+.|....+|+....+         +..+++|+......  .......|..++..+...+ ..++++..  .  .++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            457888888999997754         26888898764321  1112356777877775334 44677654  2  3689


Q ss_pred             EEeccCCCh
Q 015480          154 YEYMENGSL  162 (406)
Q Consensus       154 ~e~~~~g~L  162 (406)
                      |||++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.34  E-value=0.0013  Score=61.05  Aligned_cols=30  Identities=27%  Similarity=0.279  Sum_probs=27.4

Q ss_pred             CCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          198 QRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       198 ~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ..++|+|+.+.||++++++.+.|+||+.+.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            679999999999999988889999998775

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.35  E-value=0.013  Score=55.87  Aligned_cols=137  Identities=12%  Similarity=0.135  Sum_probs=83.1

Q ss_pred             ccccccceeEEEEEEeCC--------CcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEE
Q 015480           84 TRLGFGGFGEVYKGQFPN--------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  154 (406)
                      +.+..|-...+|+....+        +..+++++......  ...+..+|..+++.+. +.-..++++.+.    .++||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~--~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG--KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc--hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            457778888999998753        57899998654321  1112356777777775 323456665442    27899


Q ss_pred             EeccCCChhh-------H-------h---hc------------CCCCCCHHHHHHHHHHH-------------------H
Q 015480          155 EYMENGSLDG-------Y-------L---FG------------KKRAIEWEKLHEIAIGT-------------------A  186 (406)
Q Consensus       155 e~~~~g~L~~-------~-------l---~~------------~~~~~~~~~~~~i~~qi-------------------~  186 (406)
                      ||++|.+|..       .       +   +.            ...+.-+.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            9999866421       0       0   10            01111244444443322                   2


Q ss_pred             HHHHHHHH---------------------hcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          187 KGLVYLHE---------------------ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       187 ~~l~~LH~---------------------~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ..+.+|..                     .....++|+|+.+.||+ +.++.+.++||..+.
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence            22333332                     11356899999999999 788899999998875

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.84  E-value=0.0057  Score=58.06  Aligned_cols=29  Identities=24%  Similarity=0.339  Sum_probs=24.7

Q ss_pred             CeeecCCCCCcEEE------cCCCCceEecccccc
Q 015480          199 RIIHYDIKPENVLL------DANFSPKVADFGLAK  227 (406)
Q Consensus       199 ~i~H~dlk~~Nill------~~~~~~kl~DfGl~~  227 (406)
                      .++|+|+.+.|||+      +++..++++||-+|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            46899999999999      456779999998875

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=93.77  E-value=0.037  Score=33.71  Aligned_cols=26  Identities=19%  Similarity=0.326  Sum_probs=14.2

Q ss_pred             chhhHHHHHHHHHHhhhhhhhhcccc
Q 015480            2 SVIFGLIVIIVVFYIIRYFWEKLNRT   27 (406)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~   27 (406)
                      ||+.|+++++++.+.+.+++|+++++
T Consensus        15 gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           15 GVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             eehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            34555665555556656666554443

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=93.69  E-value=0.04  Score=33.65  Aligned_cols=25  Identities=20%  Similarity=0.312  Sum_probs=13.7

Q ss_pred             chhhHHHHHHHHHHhhhhhhhhccc
Q 015480            2 SVIFGLIVIIVVFYIIRYFWEKLNR   26 (406)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~   26 (406)
                      ||+.|+++++++.+.+.+++|++++
T Consensus        16 gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           16 GMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             ehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            3455566555555565666555443

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=91.00  E-value=0.024  Score=54.78  Aligned_cols=63  Identities=3%  Similarity=0.019  Sum_probs=19.5

Q ss_pred             cccccccccceeEEEEEEeCC-CcEEEE------EEeccc-cchhhHHHHHHHHHHhhccCcCccccEEEEEec
Q 015480           81 NYSTRLGFGGFGEVYKGQFPN-GVKIAV------KVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD  146 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~~~-g~~vav------K~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  146 (406)
                      .+.++||   ||+||+|.+.. ..+||+      |..+.. ........|.+|..++..++|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            4567787   99999998754 367888      766542 222334568889999999999999999887643

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.33  E-value=1.1  Score=38.15  Aligned_cols=83  Identities=11%  Similarity=0.056  Sum_probs=58.4

Q ss_pred             CcCccccEEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHH-HHHHhcCCCeeecCCCCCcEE
Q 015480          133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLV-YLHEECQQRIIHYDIKPENVL  211 (406)
Q Consensus       133 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~-~LH~~~~~~i~H~dlk~~Nil  211 (406)
                      .||++  -..+-.+++.+.+.++.-+++.=...+    ...+....++++.+++.... ++++     -+|--++|+|++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence            47888  444446667766666654333222222    45778889999988887666 5554     577789999999


Q ss_pred             EcCCCCceEeccccc
Q 015480          212 LDANFSPKVADFGLA  226 (406)
Q Consensus       212 l~~~~~~kl~DfGl~  226 (406)
                      ++.++.+++.-.|+-
T Consensus       117 f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          117 FNRALEPFFLHVGVK  131 (219)
T ss_dssp             ECTTCCEEESCCEET
T ss_pred             EeCCCcEEEEEcCCc
Confidence            999999999877764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.20  E-value=0.83  Score=38.71  Aligned_cols=84  Identities=6%  Similarity=0.046  Sum_probs=60.0

Q ss_pred             CcCccccEEEEEecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEE
Q 015480          133 YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL  212 (406)
Q Consensus       133 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill  212 (406)
                      .||+.+.. .+-.+++...+.++.-  .+...+-  .-...+....++++.+|+....++++     -+|--|+|+|+++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~--~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFD--NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGG--GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcC--cccCCHH--HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence            58888877 5566666655555543  3333332  23457788899999999887766654     4677899999999


Q ss_pred             cCCCCceEeccccc
Q 015480          213 DANFSPKVADFGLA  226 (406)
Q Consensus       213 ~~~~~~kl~DfGl~  226 (406)
                      +.++.+++.-.|+-
T Consensus       113 ~~~~~p~i~~RGik  126 (215)
T 4ann_A          113 TRDGLPIAKTRGLQ  126 (215)
T ss_dssp             CTTSCEEESCCEET
T ss_pred             cCCCCEEEEEccCc
Confidence            99999999877764

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=84.74  E-value=0.57  Score=28.42  Aligned_cols=19  Identities=11%  Similarity=0.459  Sum_probs=7.3

Q ss_pred             hhHHHHHHHHHHhhhhhhh
Q 015480            4 IFGLIVIIVVFYIIRYFWE   22 (406)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~   22 (406)
                      ++|+++++++.+++.+++|
T Consensus        18 vVGvll~vi~~l~~~~~~R   36 (44)
T 2jwa_A           18 VVGILLVVVLGVVFGILIK   36 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhhee
Confidence            4444433333333333333

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	406
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-70
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-63
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-61
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-61
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-59
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-57
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-56
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-56
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-56
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-56
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-55
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-54
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-54
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-54
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-53
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-47
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-45
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-43
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-39
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-38
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-38
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-38
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-37
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-34
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-26
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-20

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (565), Expect = 1e-70
 Identities = 79/278 (28%), Positives = 129/278 (46%), Gaps = 20/278 (7%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           R+G G FG VYKG++   V  AVK+LN         + F  EVG + +T H+N++   G+
Sbjct: 15  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH    + IIH 
Sbjct: 73  STAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG--NYPITH 261
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE +      P + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188

Query: 262 KCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKE 321
           + DVY+FG+VL+E++  +         + D     V   Y   +L  +   C    K   
Sbjct: 189 QSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR-- 244

Query: 322 KAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP 359
                  +   C++   ++RP    ++  +E +   LP
Sbjct: 245 -------LMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 4e-63
 Identities = 72/272 (26%), Positives = 127/272 (46%), Gaps = 22/272 (8%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
            +G G FG V+ G + N  K+A+K +    G ++EE F+ E   + +  H  LV+LYG C
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
            +Q    LV+E+ME+G L  YL  ++     E L  + +   +G   +    +  +IH D
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG---MAYLEEACVIHRD 126

Query: 205 IKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCD 264
           +   N L+  N   KV+DFG+ +    ++   +  G K    +++PE  S +   + K D
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSFS-RYSSKSD 184

Query: 265 VYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAK 324
           V+SFG++++E+                   K  +E     E+   I       K +  + 
Sbjct: 185 VWSFGVLMWEVFSEG---------------KIPYENRSNSEVVEDISTGFRLYKPRLAST 229

Query: 325 RLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
            +  +   C ++ PEDRP  S +++ L  + E
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 9e-63
 Identities = 61/268 (22%), Positives = 120/268 (44%), Gaps = 22/268 (8%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
            LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
             Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 125

Query: 205 IKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCD 264
           +   N L++     KV+DFGL++    ++   +  G K    +S PE L  +   + K D
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLMYS-KFSSKSD 183

Query: 265 VYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAK 324
           +++FG++++EI    +                 +E +   E    I       +    ++
Sbjct: 184 IWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLYRPHLASE 228

Query: 325 RLCMVALWCVQDSPEDRPPMSAVIKMLE 352
           ++  +   C  +  ++RP    ++  + 
Sbjct: 229 KVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 5e-61
 Identities = 70/294 (23%), Positives = 124/294 (42%), Gaps = 28/294 (9%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
            +G G FGEV++G++  G ++AVK+ +    R       AE+       H N++      
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAAD 66

Query: 145 HDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC---- 196
           +  + T     LV +Y E+GSL  YL   +  +  E + ++A+ TA GL +LH E     
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 197 -QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI--SGYKGTPGYSAPEFL 253
            +  I H D+K +N+L+  N +  +AD GLA   D     + I  +   GT  Y APE L
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184

Query: 254 SG-----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
                  ++    + D+Y+ G+V +EI  R         +    +   V  +    E+  
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 309 MILGCGI------EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
           ++    +        +  E  + +  +   C   +   R     + K L  + +
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 7e-61
 Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 24/279 (8%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +LG G FGEV+ G +    ++A+K L      ++ E F+ E   + +  H  LV+LY   
Sbjct: 24  KLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H 
Sbjct: 82  SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 137

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKC 263
           D++  N+L+  N   KVADFGLA+L + N+      G K    ++APE        T K 
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYG-RFTIKS 195

Query: 264 DVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKA 323
           DV+SFG++L E+  + R                 +      E+   +          E  
Sbjct: 196 DVWSFGILLTELTTKGR---------------VPYPGMVNREVLDQVERGYRMPCPPECP 240

Query: 324 KRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPK 362
           + L  +   C +  PE+RP    +   LE       P  
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 3e-60
 Identities = 81/269 (30%), Positives = 128/269 (47%), Gaps = 24/269 (8%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
             + +  ++ EYMENGSL  +L       +   KL ++A   A+G+ ++ E      IH 
Sbjct: 78  TQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKC 263
           D++  N+L+    S K+ADFGLA+L + N+      G K    ++APE ++     T K 
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYG-TFTIKS 191

Query: 264 DVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKA 323
           DV+SFG++L EIV   R                 +      E+   +       +     
Sbjct: 192 DVWSFGILLTEIVTHGRIP---------------YPGMTNPEVIQNLERGYRMVRPDNCP 236

Query: 324 KRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
           + L  +   C ++ PEDRP    +  +LE
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 1e-59
 Identities = 67/271 (24%), Positives = 117/271 (43%), Gaps = 24/271 (8%)

Query: 86  LGFGGFGEVYKGQF---PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           LG G FG V +G +      + +A+KVL +   +   E+ M E   + +  +  +VRL G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
            C  + +  LV E    G L  +L GK+  I    + E+    + G+ YL    ++  +H
Sbjct: 77  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVH 132

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI-SGYKGTPGYSAPEFLSGNYPITH 261
            D+   NVLL      K++DFGL+K    + ++ T  S  K    + APE ++     + 
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSS 191

Query: 262 KCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKE 321
           + DV+S+G+ ++E +   +                 +++ +  E+ A I      E   E
Sbjct: 192 RSDVWSYGVTMWEALSYGQ---------------KPYKKMKGPEVMAFIEQGKRMECPPE 236

Query: 322 KAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
               L  +   C     EDRP    V + + 
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (491), Expect = 2e-59
 Identities = 64/278 (23%), Positives = 116/278 (41%), Gaps = 26/278 (9%)

Query: 86  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 141
           +G G FGEV  G         + +A+K L           F++E   +G+  H N++ L 
Sbjct: 34  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 93

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G         ++ E+MENGSLD +L          +L  +  G A G+ YL        +
Sbjct: 94  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYV 150

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS---GYKGTPGYSAPEFLSGNYP 258
           H D+   N+L+++N   KV+DFGL++  + + +  T +   G K    ++APE +     
Sbjct: 151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-K 209

Query: 259 ITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK 318
            T   DV+S+G+V++E++                  +  + +    ++   I        
Sbjct: 210 FTSASDVWSYGIVMWEVMSYG---------------ERPYWDMTNQDVINAIEQDYRLPP 254

Query: 319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
             +    L  + L C Q     RP    ++  L+ ++ 
Sbjct: 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 2e-57
 Identities = 69/298 (23%), Positives = 122/298 (40%), Gaps = 26/298 (8%)

Query: 66  KPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQ 121
           + V+   +  ++   +++  +G G FG VY G   +     +  AVK LNR        Q
Sbjct: 15  QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 74

Query: 122 FMAEVGTIGRTYHINLVRLYGFC-HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE 180
           F+ E   +    H N++ L G C   +    +V  YM++G L  ++  +      + L  
Sbjct: 75  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134

Query: 181 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK--THVTI 238
             +  AKG+        ++ +H D+   N +LD  F+ KVADFGLA+     +  +    
Sbjct: 135 FGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191

Query: 239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVW 298
           +G K    + A E L      T K DV+SFG++L+E++ R                   +
Sbjct: 192 TGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGA---------------PPY 235

Query: 299 EEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
            +    ++   +L      + +     L  V L C     E RP  S ++  +  +  
Sbjct: 236 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 6e-57
 Identities = 74/307 (24%), Positives = 131/307 (42%), Gaps = 36/307 (11%)

Query: 73  LQLNNFTSNYST--RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTI 129
           ++L +   ++     LG G  G V+K    P+G+ +A K+++  +      Q + E+  +
Sbjct: 1   MELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58

Query: 130 GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGL 189
                  +V  YG  +     ++  E+M+ GSLD  L    R I  + L +++I   KGL
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
            YL E+   +I+H D+KP N+L+++    K+ DFG++     +  +     + GT  Y +
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMS 171

Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM 309
           PE L G    + + D++S G+ L E+                  P    E         +
Sbjct: 172 PERLQGT-HYSVQSDIWSMGLSLVEMA----------VGRYPIPPPDAKEL-------EL 213

Query: 310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYL-- 367
           + GC +E    E   R             + RPPM A+ ++L+ +V   PP  P      
Sbjct: 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLPSGVFSL 272

Query: 368 ---DLIK 371
              D + 
Sbjct: 273 EFQDFVN 279

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-56
 Identities = 66/306 (21%), Positives = 121/306 (39%), Gaps = 28/306 (9%)

Query: 86  LGFGGFGEVYKGQFPN-----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G FG VYKG +        + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C    +  L+ + M  G L  Y+   K  I  + L    +  AKG+ YL     +R+
Sbjct: 77  LGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRL 132

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H D+   NVL+      K+ DFGLAKL    +      G K    + A E +      T
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYT 191

Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           H+ DV+S+G+ ++E++                     ++     E+ +++       +  
Sbjct: 192 HQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSILEKGERLPQPP 236

Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYLDLIKMTRLKSLES 380
                + M+ + C     + RP    +I       ++   P+ +  +   +   L S   
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFS---KMARDPQRYLVIQGDERMHLPSPTD 293

Query: 381 SDGLNS 386
           S+   +
Sbjct: 294 SNFYRA 299

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 3e-56
 Identities = 67/297 (22%), Positives = 109/297 (36%), Gaps = 47/297 (15%)

Query: 85  RLGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINL 137
            LG G FG+V              +++AVK+L         E  M+E+  + +   H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKR----------------------AIEW 175
           V L G C       L++EY   G L  YL  K+                        + +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 176 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH 235
           E L   A   AKG+ +L     +  +H D+   NVL+      K+ DFGLA+    +  +
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPK 295
           V     +    + APE L      T K DV+S+G++L+EI     N   G       F K
Sbjct: 221 VVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVD-ANFYK 278

Query: 296 HVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            +   ++              ++     + + ++   C       RP    +   L 
Sbjct: 279 LIQNGFK-------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (469), Expect = 4e-56
 Identities = 62/301 (20%), Positives = 108/301 (35%), Gaps = 48/301 (15%)

Query: 85  RLGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
            +G G FG V++ + P          +AVK+L        +  F  E   +    + N+V
Sbjct: 20  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKR-----------------------AIEW 175
           +L G C       L++EYM  G L+ +L                             +  
Sbjct: 80  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139

Query: 176 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH 235
            +   IA   A G+ YL E   ++ +H D+   N L+  N   K+ADFGL++       +
Sbjct: 140 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196

Query: 236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPK 295
                      +  PE +      T + DV+++G+VL+EI                    
Sbjct: 197 KADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGL--------------- 240

Query: 296 HVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV 355
             +      E+   +    I    +     L  +   C    P DRP   ++ ++L+ + 
Sbjct: 241 QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300

Query: 356 E 356
           E
Sbjct: 301 E 301

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 5e-56
 Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 25/285 (8%)

Query: 86  LGFGGFGEVYKGQFPNG-----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
           +G G FGEVYKG          V +A+K L           F+ E G +G+  H N++RL
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G         ++ EYMENG+LD +L  K       +L  +  G A G+ YL        
Sbjct: 75  EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNY 131

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV-TISGYKGTPGYSAPEFLSGNYPI 259
           +H D+   N+L+++N   KV+DFGL+++ + +     T SG K    ++APE +S     
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KF 190

Query: 260 THKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD 319
           T   DV+SFG+V++E++                     + E    E+   I         
Sbjct: 191 TSASDVWSFGIVMWEVMTYGE---------------RPYWELSNHEVMKAINDGFRLPTP 235

Query: 320 KEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKPF 364
            +    +  + + C Q     RP  + ++ +L+ ++      K  
Sbjct: 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 280

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 4e-55
 Identities = 65/296 (21%), Positives = 113/296 (38%), Gaps = 42/296 (14%)

Query: 85  RLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINL 137
            LG G FG+V +            + +AVK+L  +      E  M+E+  +     H+N+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 138 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKR-----------------AIEWEKLHE 180
           V L G C     T ++ EY   G L  +L  K+                  A++ E L  
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 181 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG 240
            +   AKG+ +L     +  IH D+   N+LL      K+ DFGLA+    +  +V    
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 241 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEE 300
            +    + APE +      T + DV+S+G+ L+E+     +   G       F K + E 
Sbjct: 207 ARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFYKMIKEG 264

Query: 301 YEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
           +                  +     +  +   C    P  RP    +++++E  + 
Sbjct: 265 FR-------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 9e-55
 Identities = 70/274 (25%), Positives = 109/274 (39%), Gaps = 24/274 (8%)

Query: 85  RLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLV 138
           +LG G FG V +G++       V +AVK L  ++    E  + F+ EV  +    H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 75  RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---K 130

Query: 199 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYP 258
           R IH D+   N+LL      K+ DFGL +   +N  H  +  ++  P             
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190

Query: 259 ITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEK 318
            +H  D + FG+ L+E+    +   +G   S     K   E                  +
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGER-------------LPR 236

Query: 319 DKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
            ++  + +  V + C    PEDRP   A+   L 
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 1e-54
 Identities = 66/272 (24%), Positives = 110/272 (40%), Gaps = 30/272 (11%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
            +G G FG+V  G +  G K+AVK +  +      + F+AE   + +  H NLV+L G  
Sbjct: 14  TIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 145 -HDQHMTALVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             ++    +V EYM  GSL  YL  + R  +  + L + ++   + + YL        +H
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   NVL+  +   KV+DFGL K     +        K    ++APE L      + K
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALREK-KFSTK 180

Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV+SFG++L+EI    R                 +      ++   +      +     
Sbjct: 181 SDVWSFGILLWEIYSFGR---------------VPYPRIPLKDVVPRVEKGYKMDAPDGC 225

Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV 354
              +  V   C       RP    + + LE +
Sbjct: 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-54
 Identities = 58/274 (21%), Positives = 109/274 (39%), Gaps = 28/274 (10%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
            +G G +G   K +   +G  +  K L+  ++    ++  ++EV  +    H N+VR Y 
Sbjct: 11  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70

Query: 143 FCHDQHMTAL--VYEYMENGSLDGYLFGKKR---AIEWEKLHEIAIGTAKGLVYLHE--E 195
              D+  T L  V EY E G L   +    +    ++ E +  +       L   H   +
Sbjct: 71  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130

Query: 196 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
               ++H D+KP NV LD   + K+ DFGLA++ + + +      + GTP Y +PE ++ 
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--AFVGTPYYMSPEQMNR 188

Query: 256 NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI 315
                 K D++S G +L+E+                      +  + + EL   I     
Sbjct: 189 M-SYNEKSDIWSLGCLLYEL----------------CALMPPFTAFSQKELAGKIREGKF 231

Query: 316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK 349
                  +  L  +    +      RP +  +++
Sbjct: 232 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  180 bits (458), Expect = 2e-54
 Identities = 72/314 (22%), Positives = 125/314 (39%), Gaps = 38/314 (12%)

Query: 76  NNFTSNYST--RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIG 130
           ++    +S    +G G FG VY  +   N   +A+K ++ +  +  E  +  + EV  + 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 131 RTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLV 190
           +  H N ++  G    +H   LV EY    + D     KK  ++  ++  +  G  +GL 
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLA 129

Query: 191 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAP 250
           YLH      +IH D+K  N+LL      K+ DFG A +     + V      GTP + AP
Sbjct: 130 YLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAP 180

Query: 251 EFLSGNY--PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGA 308
           E +          K DV+S G+   E+  R+             F  +            
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPP----------LFNMNAMSALYH----- 225

Query: 309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPPKPFRYLD 368
           +        +    ++        C+Q  P+DRP    ++K       VL    P   +D
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH----RFVLRERPPTVIMD 281

Query: 369 LIKMTR--LKSLES 380
           LI+ T+  ++ L++
Sbjct: 282 LIQRTKDAVRELDN 295

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  179 bits (454), Expect = 5e-54
 Identities = 70/274 (25%), Positives = 126/274 (45%), Gaps = 24/274 (8%)

Query: 85  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +    ++ E+M  G+L  YL    R  +    L  +A   +  + YL    ++  IH
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 138

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+   N L+  N   KVADFGL++L   +      +G K    ++APE L+ N   + K
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYN-KFSIK 196

Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK 322
            DV++FG++L+EI                      +   +  ++  ++      E+ +  
Sbjct: 197 SDVWAFGVLLWEIATYG---------------MSPYPGIDLSQVYELLEKDYRMERPEGC 241

Query: 323 AKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
            +++  +   C Q +P DRP  + + +  E + +
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 8e-54
 Identities = 65/309 (21%), Positives = 121/309 (39%), Gaps = 43/309 (13%)

Query: 67  PVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNG---VKIAVKVLNRNLGRIAEEQFM 123
           P  +  L  N+    +   +G G FG+V K +       +  A+K +     +     F 
Sbjct: 1   PTIYPVLDWNDIK--FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58

Query: 124 AEVGTIGR-TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK------------- 169
            E+  + +  +H N++ L G C  +    L  EY  +G+L  +L                
Sbjct: 59  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118

Query: 170 --KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 227
                +  ++L   A   A+G+ YL    Q++ IH D+   N+L+  N+  K+ADFGL++
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 175

Query: 228 LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGAT 287
             +           +    + A E L+ +   T   DV+S+G++L+EIV           
Sbjct: 176 GQEVYVKKTMG---RLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGG------- 224

Query: 288 ESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAV 347
                     +      EL   +      EK       +  +   C ++ P +RP  + +
Sbjct: 225 --------TPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 276

Query: 348 IKMLEGVVE 356
           +  L  ++E
Sbjct: 277 LVSLNRMLE 285

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-53
 Identities = 64/273 (23%), Positives = 114/273 (41%), Gaps = 26/273 (9%)

Query: 85  RLGFGGFGEVYKGQFPN---GVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRL 140
            LG G FG V KG +        +AVK+L         +++ +AE   + +  +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL    +   
Sbjct: 74  IGICEAESW-MLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE---ESNF 128

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTIS-GYKGTPGYSAPEFLSGNYPI 259
           +H D+   NVLL      K++DFGL+K    ++ +       K    + APE ++     
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KF 187

Query: 260 THKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD 319
           + K DV+SFG++++E     +                 +   +  E+ AM+         
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERMGCP 232

Query: 320 KEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
               + +  +   C     E+RP  +AV   L 
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-53
 Identities = 66/275 (24%), Positives = 108/275 (39%), Gaps = 29/275 (10%)

Query: 82  YSTRLGFGGFGEVYKGQFP-NGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVR 139
           +   +G G F  VYKG      V++A   L  R L +   ++F  E   +    H N+VR
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 140 LYGFCHD----QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 195
            Y         +    LV E M +G+L  YL  + + ++ + L        KGL +LH  
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 196 CQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS 254
               IIH D+K +N+ +     S K+ D GLA L   +     I    GTP + APE   
Sbjct: 132 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEMYE 186

Query: 255 GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG 314
             Y      DVY+FGM + E+            ++     + V    +            
Sbjct: 187 EKY--DESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPASF-------- 234

Query: 315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK 349
               DK     +  +   C++ + ++R  +  ++ 
Sbjct: 235 ----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 2e-52
 Identities = 62/270 (22%), Positives = 108/270 (40%), Gaps = 25/270 (9%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            LG G FG+VYK Q     V  A KV++        E +M E+  +    H N+V+L   
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            + ++   ++ E+   G++D  +   +R +   ++  +   T   L YLH+    +IIH 
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHR 134

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNY----PI 259
           D+K  N+L   +   K+ADFG++    R         + GTP + APE +        P 
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD--SFIGTPYWMAPEVVMCETSKDRPY 192

Query: 260 THKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKD 319
            +K DV+S G+ L E+              +    K    E                 + 
Sbjct: 193 DYKADVWSLGITLIEMAEIEP--PHHELNPMRVLLKIAKSEPPTLA---------QPSRW 241

Query: 320 KEKAKRLCMVALWCVQDSPEDRPPMSAVIK 349
               K        C++ + + R   S +++
Sbjct: 242 SSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 3e-52
 Identities = 64/275 (23%), Positives = 100/275 (36%), Gaps = 21/275 (7%)

Query: 78  FTSNYS--TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH 134
           F  ++     LG G +GEV           +AVK+++        E    E+       H
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62

Query: 135 INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
            N+V+ YG   + ++  L  EY   G L   +      +              G+VYLH 
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS 254
                I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L 
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 255 GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG 314
                    DV+S G+VL  ++                + +      E  +         
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGEL-----------PWDQPSDSCQEYSDWKEKKTYLN 227

Query: 315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK 349
             +K       L       + ++P  R  +  + K
Sbjct: 228 PWKKIDSAPLALLH---KILVENPSARITIPDIKK 259

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 8e-52
 Identities = 59/276 (21%), Positives = 113/276 (40%), Gaps = 25/276 (9%)

Query: 85  RLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 140
            +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
            G   +  +  ++ E    G L  +L  +K +++   L   A   +  L YL     +R 
Sbjct: 74  IGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 129

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H DI   NVL+ +N   K+ DFGL++  + +  +    G K    + APE ++     T
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMAPESINFR-RFT 187

Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
              DV+ FG+ ++EI+                     ++  +  ++   I          
Sbjct: 188 SASDVWMFGVCMWEIL---------------MHGVKPFQGVKNNDVIGRIENGERLPMPP 232

Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
                L  +   C    P  RP  + +   L  ++E
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 3e-51
 Identities = 68/268 (25%), Positives = 111/268 (41%), Gaps = 29/268 (10%)

Query: 85  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLY 141
            LG G FG VY  +   +   +A+KVL +        E Q   EV       H N++RLY
Sbjct: 13  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G+ HD     L+ EY   G++   L    +  + ++        A  L Y H    +R+I
Sbjct: 73  GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHS---KRVI 128

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H DIKPEN+LL +    K+ADFG +     ++         GT  Y  PE + G      
Sbjct: 129 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPPEMIEGR-MHDE 183

Query: 262 KCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKE 321
           K D++S G++ +E +  +      A    + + +    E+               +   E
Sbjct: 184 KVDLWSLGVLCYEFLVGKP--PFEANTYQETYKRISRVEFT------------FPDFVTE 229

Query: 322 KAKRLCMVALWCVQDSPEDRPPMSAVIK 349
            A+ L       ++ +P  RP +  V++
Sbjct: 230 GARDLIS---RLLKHNPSQRPMLREVLE 254

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 5e-51
 Identities = 62/287 (21%), Positives = 113/287 (39%), Gaps = 34/287 (11%)

Query: 85  RLGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 138
            LG G FG VY+G      +     ++A+K +N         +F+ E   +      ++V
Sbjct: 27  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 189
           RL G       T ++ E M  G L  YL   + A+            K+ ++A   A G+
Sbjct: 87  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
            YL      + +H D+   N ++  +F+ K+ DFG+ +       +           + +
Sbjct: 147 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203

Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM 309
           PE L      T   DV+SFG+VL+EI                   +  ++     ++   
Sbjct: 204 PESLKDG-VFTTYSDVWSFGVVLWEIA---------------TLAEQPYQGLSNEQVLRF 247

Query: 310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
           ++  G+ +K       L  +   C Q +P+ RP    +I  ++  +E
Sbjct: 248 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 6e-50
 Identities = 67/297 (22%), Positives = 114/297 (38%), Gaps = 43/297 (14%)

Query: 85  RLGFGGFGEVYKGQFP--------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHI 135
            LG G FG+V   +             K+AVK+L  +         ++E+  +     H 
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 136 NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEKLHE 180
           N++ L G C       ++ EY   G+L  YL  ++                 +  + L  
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 181 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG 240
            A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA+       +   + 
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 241 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEE 300
            +    + APE L      TH+ DV+SFG++L+EI                      +  
Sbjct: 197 GRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGG---------------SPYPG 240

Query: 301 YEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV 357
               EL  ++      +K       L M+   C    P  RP    +++ L+ +V +
Sbjct: 241 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 6e-47
 Identities = 66/295 (22%), Positives = 114/295 (38%), Gaps = 41/295 (13%)

Query: 85  RLGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINL 137
            LG G FG+V +       +      +AVK+L            M+E+  +    +H+N+
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 138 VRLYGFC-HDQHMTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEI 181
           V L G C        ++ E+ + G+L  YL  K               K  +  E L   
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 182 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGY 241
           +   AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 242 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEY 301
           +    + APE +      T + DV+SFG++L+EI     +   G     + F + + E  
Sbjct: 197 RLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGT 254

Query: 302 EKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE 356
                                   +    L C    P  RP  S +++ L  +++
Sbjct: 255 R-------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  161 bits (409), Expect = 8e-47
 Identities = 64/324 (19%), Positives = 115/324 (35%), Gaps = 31/324 (9%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            LG G FG V++      G   A K +        +E    E+ T+    H  LV L+  
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
             D +   ++YE+M  G L   +  +   +  ++  E      KGL ++HE      +H 
Sbjct: 92  FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHL 148

Query: 204 DIKPENVLLDANFSP--KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           D+KPEN++     S   K+ DFGL    D  ++        GT  ++APE   G  P+ +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGK-PVGY 204

Query: 262 KCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKE 321
             D++S G++ + ++               +  ++  E     +     +         E
Sbjct: 205 YTDMWSVGVLSYILLSGLSP----------FGGENDDETLRNVKSCDWNMDDSAFSGISE 254

Query: 322 KAKRLCMVALWCVQDSPEDRPPMSAVIKM-------LEGVVEVLPPPKPFRYLDLIKMTR 374
             K         +   P  R  +   ++          G    +P  +  +  D IK   
Sbjct: 255 DGKDFIR---KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKY 311

Query: 375 LKSLESSDGLNSSNQSRWYKETTP 398
               E    L   +     ++  P
Sbjct: 312 DAWPEPLPPLGRISNYSSLRKHRP 335

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 3e-45
 Identities = 51/268 (19%), Positives = 102/268 (38%), Gaps = 28/268 (10%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G  G VY       G ++A++ +N    +  +E  + E+  +    + N+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                   +V EY+  GSL   +   +  ++  ++  +     + L +LH     ++IH 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLH---SNQVIHR 140

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKC 263
           DIK +N+LL  + S K+ DFG        ++  +     GTP + APE ++       K 
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPEVVTRK-AYGPKV 197

Query: 264 DVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEK- 322
           D++S G++  E++                     +          +I   G  E    + 
Sbjct: 198 DIWSLGIMAIEMIEGE----------------PPYLNENPLRALYLIATNGTPELQNPEK 241

Query: 323 -AKRLCMVALWCVQDSPEDRPPMSAVIK 349
            +         C+    E R     +++
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 4e-44
 Identities = 52/227 (22%), Positives = 89/227 (39%), Gaps = 16/227 (7%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLY 141
            LG G F  V   +      + A+K+L +   +          E   + R  H   V+LY
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
               D         Y +NG L  Y+       E          TA+ +  L     + II
Sbjct: 75  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTAEIVSALEYLHGKGII 130

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           H D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+       
Sbjct: 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACK 189

Query: 262 KCDVYSFGMVLFEIV-------GRRRNAIVGATESLDW-FPKHVWEE 300
             D+++ G +++++V             I      L++ FP+  + +
Sbjct: 190 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 236

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 9e-44
 Identities = 48/317 (15%), Positives = 106/317 (33%), Gaps = 32/317 (10%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            LG G FG V++     +      K +        +     E+  +    H N++ L+  
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHES 69

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                   +++E++    +   +      +   ++        + L +LH      I H+
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHF 126

Query: 204 DIKPENVLLDANFSP--KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           DI+PEN++     S   K+ +FG A+                 P Y APE    +  ++ 
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDV-VST 182

Query: 262 KCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKE 321
             D++S G +++ ++          +    +  +   +  E              ++   
Sbjct: 183 ATDMWSLGTLVYVLL----------SGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232

Query: 322 KAKRLCMVALWCVQDSPEDRPPMSAVI------KMLEGV-VEVLPPPKPFRYLDLIKMTR 374
           +A          +    + R   S  +      + +E V  +V+   K  RY   +    
Sbjct: 233 EAMDFVD---RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKD 289

Query: 375 LKSLESSDGLNSSNQSR 391
           L  + S+  ++     R
Sbjct: 290 LNMVVSAARISCGGAIR 306

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  153 bits (388), Expect = 1e-43
 Identities = 59/276 (21%), Positives = 110/276 (39%), Gaps = 30/276 (10%)

Query: 73  LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTI 129
           L +N+F+      +G GGFGEVY  +    G   A+K L++     +  E   + E   +
Sbjct: 1   LTMNDFS--VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 58

Query: 130 ---GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA 186
                     +V +    H     + + + M  G L  +L       E + +   A    
Sbjct: 59  SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD-MRFYAAEII 117

Query: 187 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPG 246
            GL ++H    + +++ D+KP N+LLD +   +++D GLA    + K H ++    GT G
Sbjct: 118 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHG 170

Query: 247 YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCEL 306
           Y APE L          D +S G +LF+++                F +H  ++  + + 
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS-----------PFRQHKTKDKHEIDR 219

Query: 307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRP 342
             + +   + +    + + L       +Q     R 
Sbjct: 220 MTLTMAVELPDSFSPELRSLLE---GLLQRDVNRRL 252

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  149 bits (378), Expect = 3e-42
 Identities = 54/292 (18%), Positives = 111/292 (38%), Gaps = 26/292 (8%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            LG G FG V++      G     K +N     + +     E+  + + +H  L+ L+  
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDA 94

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
             D++   L+ E++  G L   +  +   +   ++        +GL ++HE     I+H 
Sbjct: 95  FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHL 151

Query: 204 DIKPENVLLDANFSP--KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           DIKPEN++ +   +   K+ DFGLA   + ++          T  ++APE +    P+  
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDRE-PVGF 207

Query: 262 KCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKE 321
             D+++ G++ + ++               +  +   E  +  +                
Sbjct: 208 YTDMWAIGVLGYVLLSGLSP----------FAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257

Query: 322 KAKRLCMVALWCVQDSPEDRPPMSAVIKM--LEGVVEVLPPPKPFRYLDLIK 371
           +AK         +Q  P  R  +   ++   L+G    L    P    + I+
Sbjct: 258 EAKDFIK---NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIR 306

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  146 bits (370), Expect = 7e-42
 Identities = 60/289 (20%), Positives = 110/289 (38%), Gaps = 37/289 (12%)

Query: 78  FTSNYST--RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--------RIAEEQFMAEV 126
           F  NY     LG G    V +    P   + AVK+++   G        +   E  + EV
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 127 GTIGRT-YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT 185
             + +   H N+++L           LV++ M+ G L  YL  +K  +  ++  +I    
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRAL 119

Query: 186 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTP 245
            + +  LH+     I+H D+KPEN+LLD + + K+ DFG +   D  +         GTP
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTP 173

Query: 246 GYSAPEFLSGNY-----PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEE 300
            Y APE +  +          + D++S G++++ ++               ++ +     
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS----------PPFWHRKQMLM 223

Query: 301 YEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK 349
                 G    G    +   +  K L       +   P+ R      + 
Sbjct: 224 LRMIMSGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALA 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  145 bits (366), Expect = 5e-41
 Identities = 49/266 (18%), Positives = 91/266 (34%), Gaps = 19/266 (7%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
            LG G F EV   +       +A+K + +      E     E+  + +  H N+V L   
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
                   L+ + +  G L   +  K           +       + YLH+         
Sbjct: 76  YESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDLK 134

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKC 263
                   LD +    ++DFGL+K+ D      T     GTPGY APE L+   P +   
Sbjct: 135 PENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST---ACGTPGYVAPEVLAQK-PYSKAV 190

Query: 264 DVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKA 323
           D +S G++ + ++               ++ ++  + +E+             +   + A
Sbjct: 191 DCWSIGVIAYILL----------CGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240

Query: 324 KRLCMVALWCVQDSPEDRPPMSAVIK 349
           K         ++  PE R      ++
Sbjct: 241 KDFIR---HLMEKDPEKRFTCEQALQ 263

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-40
 Identities = 57/299 (19%), Positives = 115/299 (38%), Gaps = 29/299 (9%)

Query: 74  QLNNFTSNYST--RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIG 130
           Q+ +    Y+    +G G +G V       N V++A+K ++    +   ++ + E+  + 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 131 RTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFG--KKRAIEWEKLHEIAIGTAKG 188
           R  H N++ +        +  +   Y+    +   L+   K + +  + +        +G
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121

Query: 189 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV-TISGYKGTPGY 247
           L Y+H      ++H D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR--------RNAIVGATESLDWFPKHVWE 299
            APE +  +   T   D++S G +L E++  R         + +      L    +    
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 300 EYEKCELGAMILGCGIEEKDK---------EKAKRLCMVALWCVQDSPEDRPPMSAVIK 349
                +    +L    + K            KA  L       +  +P  R  +   + 
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALA 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  142 bits (358), Expect = 3e-40
 Identities = 67/279 (24%), Positives = 115/279 (41%), Gaps = 27/279 (9%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLY 141
            LGFGG  EV+  +       +AVKVL  +L R      +F  E        H  +V +Y
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 142 GFCHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 197
                +        +V EY++  +L   +  +   +  ++  E+     + L + H+   
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQ--- 129

Query: 198 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISG-YKGTPGYSAPEFLSGN 256
             IIH D+KP N+++ A  + KV DFG+A+    +   VT +    GT  Y +PE   G+
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189

Query: 257 YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE 316
             +  + DVYS G VL+E++             +    +HV E+                
Sbjct: 190 -SVDARSDVYSLGCVLYEVLTGEP--PFTGDSPVSVAYQHVREDPIP-----------PS 235

Query: 317 EKDKEKAKRLCMVALWCVQDSPEDRPP-MSAVIKMLEGV 354
            + +  +  L  V L  +  +PE+R    + +   L  V
Sbjct: 236 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 3e-39
 Identities = 65/284 (22%), Positives = 102/284 (35%), Gaps = 28/284 (9%)

Query: 86  LGFGGFGEVYKGQFPN-GVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 140
           LG G F  VYK +  N    +A+K +                + E+  +    H N++ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
                 +   +LV+++ME       +      +    +    + T +GL YLH+     I
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---I 121

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           +H D+KP N+LLD N   K+ADFGLAK         T      T  Y APE L G     
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH--QVVTRWYRAPELLFGARMYG 179

Query: 261 HKCDVYSFGMVLFEIVGRRR--------------NAIVGATESLDWFPKHVWEEYEKCEL 306
              D+++ G +L E++ R                   +G      W       +Y   + 
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM 350
              I    I     +    L          +P  R   +  +KM
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM 280

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 4e-39
 Identities = 63/269 (23%), Positives = 110/269 (40%), Gaps = 28/269 (10%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTY-HINLVRL 140
            LG G FG+V+  +F       A+K L +++  + +  E  M E   +   + H  L  +
Sbjct: 9   MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68

Query: 141 YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
           +     +     V EY+  G L  ++    +  +  +    A     GL +LH    + I
Sbjct: 69  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHS---KGI 124

Query: 201 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPIT 260
           ++ D+K +N+LLD +   K+ADFG+ K             + GTP Y APE L G     
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN--TFCGTPDYIAPEILLGQ-KYN 181

Query: 261 HKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDK 320
           H  D +SFG++L+E++               +  +   E +    +        +E    
Sbjct: 182 HSVDWWSFGVLLYEML----------IGQSPFHGQDEEELFHSIRMDNPFYPRWLE---- 227

Query: 321 EKAKRLCMVALWCVQDSPEDRPPMSAVIK 349
           ++AK L +         PE R  +   I+
Sbjct: 228 KEAKDLLV---KLFVREPEKRLGVRGDIR 253

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  138 bits (347), Expect = 2e-38
 Identities = 50/280 (17%), Positives = 92/280 (32%), Gaps = 29/280 (10%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYG 142
           R+G G FG +++G    N  ++A+K   R   R    Q   E  T         +  +Y 
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPR---RSDAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           F  +     LV + +     D  L    R    + +   A      +  +H   ++ +++
Sbjct: 69  FGQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124

Query: 203 YDIKPENVLLDANFSP-----KVADFGLAKLCDRNKTHVTI-----SGYKGTPGYSAPEF 252
            DIKP+N L+    S       V DFG+ K      T   I         GT  Y +   
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 253 LSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG 312
             G    + + D+ + G V           + G+            ++YE+  +G     
Sbjct: 185 HLGR-EQSRRDDLEALGHVFMYF-------LRGSLPWQGLKAATNKQKYER--IGEKKQS 234

Query: 313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
             + E      +       +    + +  P    +  +  
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  137 bits (345), Expect = 3e-38
 Identities = 55/278 (19%), Positives = 103/278 (37%), Gaps = 19/278 (6%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G +G VYK Q   G   A+K +             + E+  +    H N+V+LY  
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 203
            H +    LV+E+++          +   +E        +    G+ Y H+   +R++H 
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHD---RRVLHR 124

Query: 204 DIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKC 263
           D+KP+N+L++     K+ADFGLA+           +    T  Y AP+ L G+   +   
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTI 182

Query: 264 DVYSFGMVLFEIVGRR--------RNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI 315
           D++S G +  E+V            + ++     L       W    +            
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242

Query: 316 EEKDKEKAKRLCMVAL----WCVQDSPEDRPPMSAVIK 349
               +   K L    +      ++  P  R      ++
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 3e-38
 Identities = 57/274 (20%), Positives = 103/274 (37%), Gaps = 39/274 (14%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEE-----QFMAEVGTIGR--TYHIN 136
            LG GGFG VY G    + + +A+K + ++      E     +   EV  + +  +    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
           ++RL  +        L+ E  E          ++ A++ E          + + + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-- 128

Query: 197 QQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
              ++H DIK EN+L+D N    K+ DFG   L            + GT  YS PE++  
Sbjct: 129 -CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWIRY 183

Query: 256 NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI 315
           +        V+S G++L+++V                 P    EE  + ++         
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGD-------------IPFEHDEEIIRGQV-------FF 223

Query: 316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK 349
            ++   + + L     WC+   P DRP    +  
Sbjct: 224 RQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 5e-38
 Identities = 59/291 (20%), Positives = 106/291 (36%), Gaps = 21/291 (7%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H ++   LV+E++               I    +        +GL + H      ++H
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLH 125

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+KP+N+L++   + K+ADFGLA+         T      T  Y APE L G    +  
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVTLWYRAPEILLGCKYYSTA 183

Query: 263 CDVYSFGMVLFEIVGRRR--------NAIVGATESLDWFPKHVWEEYEKCELGAMILGCG 314
            D++S G +  E+V RR         + +     +L    + VW                
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243

Query: 315 IEEKDKEKAKRLCMVAL----WCVQDSPEDRPPMSAVIKM--LEGVVEVLP 359
             +   +    L           +   P  R    A +     + V + +P
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (343), Expect = 7e-38
 Identities = 54/278 (19%), Positives = 98/278 (35%), Gaps = 27/278 (9%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           ++G G FG++Y G     G ++A+K+      +    Q   E            +    +
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECV---KTKHPQLHIESKIYKMMQGGVGIPTIRW 70

Query: 144 C-HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
           C  +     +V E +     D + F  ++    + +  +A      + Y+H    +  IH
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIHS---KNFIH 126

Query: 203 YDIKPENVL---LDANFSPKVADFGLAKLCDRNKTHVTI-----SGYKGTPGYSAPEFLS 254
            D+KP+N L           + DFGLAK     +TH  I         GT  Y++     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 255 GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG 314
           G    + + D+ S G VL           +G+            ++YE+       +   
Sbjct: 187 GI-EQSRRDDLESLGYVLMYF-------NLGSLPWQGLKAATKRQKYERIS--EKKMSTP 236

Query: 315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE 352
           IE   K           +C     +D+P  S + ++  
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 2e-37
 Identities = 64/292 (21%), Positives = 108/292 (36%), Gaps = 31/292 (10%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G FGEV+K +    G K+A+K +   N         + E+  +    H N+V L  
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76

Query: 143 FCHDQ--------HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 194
            C  +            LV+++ E+    G L          ++  +      GL   + 
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQMLLNGL---YY 132

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT--HVTISGYKGTPGYSAPEF 252
             + +I+H D+K  NVL+  +   K+ADFGLA+     K       +    T  Y  PE 
Sbjct: 133 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192

Query: 253 LSGNYPITHKCDVYSFGMVLFEIVGRRR--------NAIVGATESLDWFPKHVWEE---Y 301
           L G        D++  G ++ E+  R          + +   ++        VW     Y
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252

Query: 302 EKCELGAMILGCGIEEKDKEKAKRLCMVAL----WCVQDSPEDRPPMSAVIK 349
           E  E   ++ G   + KD+ KA      AL      +   P  R      + 
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  135 bits (342), Expect = 2e-37
 Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 13/199 (6%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLY 141
            LG G FG V+  +   NG   A+KVL + +    +  E    E   +    H  ++R++
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 142 GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 201
           G   D     ++ +Y+E G L   L   +R          A       + L     + II
Sbjct: 71  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV----CLALEYLHSKDII 126

Query: 202 HYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITH 261
           + D+KPEN+LLD N   K+ DFG AK               GTP Y APE +S   P   
Sbjct: 127 YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEVVSTK-PYNK 180

Query: 262 KCDVYSFGMVLFEIVGRRR 280
             D +SFG++++E++    
Sbjct: 181 SIDWWSFGILIYEMLAGYT 199

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 4e-37
 Identities = 64/286 (22%), Positives = 108/286 (37%), Gaps = 33/286 (11%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 144
           +G G FG VY+ +   +G  +A+K + ++     +     E+  + +  H N+VRL  F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82

Query: 145 H------DQHMTALVYEYMENGSLDGYLFG--KKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
           +      D+    LV +Y+              K+ +    +        + L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--- 139

Query: 197 QQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
              I H DIKP+N+LLD +    K+ DFG AK   R + +V+   Y  +  Y APE + G
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPELIFG 196

Query: 256 NYPITHKCDVYSFGMVLFEIVGRRR--------NAIVGATESLDWFPKHVWEEYEKCELG 307
               T   DV+S G VL E++  +         + +V   + L    +    E       
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256

Query: 308 AMILGCGIEEKDKEKAKRLCMVAL----WCVQDSPEDRPPMSAVIK 349
                       K    R    A+      ++ +P  R        
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 1e-36
 Identities = 60/290 (20%), Positives = 115/290 (39%), Gaps = 36/290 (12%)

Query: 85  RLGFGGFGEVYKGQF--PNGVKIAVKVLNRNLG----RIAEEQFMAEVGTIGRTYHINLV 138
            +G G +G+V+K +     G  +A+K +    G     ++  + +A +  +    H N+V
Sbjct: 14  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73

Query: 139 RLYGFCHDQH-----MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 193
           RL+  C            LV+E+++           +  +  E + ++     +GL +LH
Sbjct: 74  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133

Query: 194 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFL 253
                R++H D+KP+N+L+ ++   K+ADFGLA++        +      T  Y APE L
Sbjct: 134 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVVTLWYRAPEVL 187

Query: 254 SGNYPITHKCDVYSFGMVLFEIVGRRR--------------NAIVGATESLDWFPKHVWE 299
             +       D++S G +  E+  R+                 ++G     DW P+ V  
Sbjct: 188 LQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW-PRDVAL 245

Query: 300 EYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK 349
             +     +            E  K L +    C+  +P  R    + + 
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSALS 292

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 8e-35
 Identities = 58/274 (21%), Positives = 102/274 (37%), Gaps = 32/274 (11%)

Query: 86  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYGF 143
           LG G  G+V +        K A+K+L          +   EV    R +   ++VR+   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDV 73

Query: 144 CHDQHMTA----LVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
             + +       +V E ++ G L   +  +  +A    +  EI     + + YLH     
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 130

Query: 199 RIIHYDIKPENVLLDANFSP---KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSG 255
            I H D+KPEN+L  +       K+ DFG AK    + +  T      TP Y APE L  
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGP 187

Query: 256 NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI 315
                  CD++S G++++ ++         +   L   P        +  +G        
Sbjct: 188 E-KYDKSCDMWSLGVIMYILLCGYP--PFYSNHGLAISPGM----KTRIRMGQYEFPNPE 240

Query: 316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK 349
             +  E+ K L       ++  P  R  ++  + 
Sbjct: 241 WSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 2e-34
 Identities = 58/281 (20%), Positives = 107/281 (38%), Gaps = 43/281 (15%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-----GRIAEEQFMAEVGTIGRTYHINLV 138
            LG G F  V K +    G++ A K + +         ++ E    EV  +    H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 139 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 198
            L+    ++    L+ E +  G L  +   +K ++  E+  E       G   ++     
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNG---VYYLHSL 132

Query: 199 RIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLS 254
           +I H+D+KPEN++L     P    K+ DFGLA   D            GTP + APE ++
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVN 189

Query: 255 GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG 314
              P+  + D++S G++ + ++                     +    K E  A +    
Sbjct: 190 YE-PLGLEADMWSIGVITYILL----------------SGASPFLGDTKQETLANVSAVN 232

Query: 315 IEEKDK------EKAKRLCMVALWCVQDSPEDRPPMSAVIK 349
            E +D+        AK         +   P+ R  +   ++
Sbjct: 233 YEFEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 4e-34
 Identities = 49/280 (17%), Positives = 94/280 (33%), Gaps = 21/280 (7%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 142
           ++G G +G V+K +       +A+K +   +         + E+  +    H N+VRL+ 
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 143 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 202
             H      LV+E+ +      +               +     + L  L     + ++H
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF----QLLKGLGFCHSRNVLH 124

Query: 203 YDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHK 262
            D+KP+N+L++ N   K+A+FGLA+         +      T  Y  P+ L G    +  
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTS 182

Query: 263 CDVYSFGMVLFEIVGRRRNAIVGATES---------LDWFPKHVWEEYEKCELGAMILGC 313
            D++S G +  E+    R    G             L    +  W    K          
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242

Query: 314 GIEEKDKEKAKRLCMVAL----WCVQDSPEDRPPMSAVIK 349
                      +L           ++ +P  R      ++
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-33
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 12/211 (5%)

Query: 73  LQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEVGTI 129
           + +N+F   Y   LG G FG+V   +    G   A+K+L +   + +      + E   +
Sbjct: 2   VTMNDFD--YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59

Query: 130 GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGL 189
             T H  L  L            V EY   G L  +L  ++   E           A+ +
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER----ARFYGAEIV 115

Query: 190 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSA 249
             L     + +++ DIK EN++LD +   K+ DFGL K    +    T+  + GTP Y A
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLA 173

Query: 250 PEFLSGNYPITHKCDVYSFGMVLFEIVGRRR 280
           PE L  N       D +  G+V++E++  R 
Sbjct: 174 PEVLEDN-DYGRAVDWWGLGVVMYEMMCGRL 203

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (312), Expect = 6e-33
 Identities = 59/256 (23%), Positives = 99/256 (38%), Gaps = 29/256 (11%)

Query: 33  NAASANKPEEDVVEVIWEAGQTMERFLQEIGREKPVRFTS-----LQLNNFTSNYSTRLG 87
           NAA+A K  E          ++++ FL +   +   ++ +      QL+ F       LG
Sbjct: 2   NAAAAKKGSEQ---------ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFD--RIKTLG 50

Query: 88  FGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYGFC 144
            G FG V   +   +G   A+K+L++      +  E  + E   +       LV+L    
Sbjct: 51  TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110

Query: 145 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 204
            D     +V EY+  G +  +L  +            A        YLH      +I+ D
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRD 166

Query: 205 IKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCD 264
           +KPEN+L+D     +V DFG AK               GTP   APE +          D
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSK-GYNKAVD 220

Query: 265 VYSFGMVLFEIVGRRR 280
            ++ G++++E+     
Sbjct: 221 WWALGVLIYEMAAGYP 236

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 6e-31
 Identities = 62/308 (20%), Positives = 108/308 (35%), Gaps = 35/308 (11%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
            +G G +G V        G K+A+K L R     +  ++   E+  +    H N++ L  
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 143 FCHDQHMTALVYEY---MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
                       ++   M     D     K   +  +++  +     KGL Y+H      
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AG 141

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           IIH D+KP N+ ++ +   K+ DFGLA+  D   T     GY  T  Y APE +      
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-----GYVVTRWYRAPEVILNWMRY 196

Query: 260 THKCDVYSFGMVLFEIVGRRR--------NAIVGATESLDWFPKHVWEEYEKCELGAMIL 311
           T   D++S G ++ E++  +         + +    +     P    +  +  E    + 
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256

Query: 312 GCGIEEKDK---------EKAKRLCMVALWCVQDSPEDRPPMSAVIKM--LEGVVEVLPP 360
           G    EK             A  L       +    E R      +     E + +    
Sbjct: 257 GLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEALAHPYFESLHDTEDE 313

Query: 361 PKPFRYLD 368
           P+  +Y D
Sbjct: 314 PQVQKYDD 321

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  117 bits (294), Expect = 2e-30
 Identities = 43/201 (21%), Positives = 84/201 (41%), Gaps = 19/201 (9%)

Query: 85  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYG 142
           +LG G + EV++     N  K+ VK+L      + +++   E+  +       N++ L  
Sbjct: 42  KLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLAD 97

Query: 143 FCHDQ--HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 200
              D      ALV+E++ N           + +    +        K L Y H      I
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGI 150

Query: 201 IHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           +H D+KP NV++D  +   ++ D+GLA+     + +   +    +  +  PE L      
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMY 207

Query: 260 THKCDVYSFGMVLFEIVGRRR 280
            +  D++S G +L  ++ R+ 
Sbjct: 208 DYSLDMWSLGCMLASMIFRKE 228

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 2e-30
 Identities = 47/204 (23%), Positives = 83/204 (40%), Gaps = 12/204 (5%)

Query: 85  RLGFGGFGEVYKGQ----FPNGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRTYHI-N 136
            LG G +G+V+  +       G   A+KVL +          E    E   +        
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90

Query: 137 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
           LV L+     +    L+ +Y+  G L  +L  ++R  E E    + I   + ++ L    
Sbjct: 91  LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE----VQIYVGEIVLALEHLH 146

Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
           +  II+ DIK EN+LLD+N    + DFGL+K    ++T             +      G+
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 206

Query: 257 YPITHKCDVYSFGMVLFEIVGRRR 280
                  D +S G++++E++    
Sbjct: 207 SGHDKAVDWWSLGVLMYELLTGAS 230

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 1e-26
 Identities = 45/203 (22%), Positives = 83/203 (40%), Gaps = 19/203 (9%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
            +G G  G V           +A+K L+R    +   ++   E+  +    H N++ L  
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 143 FCHDQHMT------ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 196
               Q          LV E M+           +  ++ E++  +      G+ +LH   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAG 139

Query: 197 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGN 256
               IH D+KP N+++ ++ + K+ DFGLA+    +      + Y  T  Y APE + G 
Sbjct: 140 I---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILG- 192

Query: 257 YPITHKCDVYSFGMVLFEIVGRR 279
                  D++S G ++ E+V  +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 1e-26
 Identities = 49/200 (24%), Positives = 82/200 (41%), Gaps = 13/200 (6%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 142
            +G G +G V        G+++AVK L+R     I  ++   E+  +    H N++ L  
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84

Query: 143 FCHDQHMTA---LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 199
                        VY        D     K + +  + +  +     +GL Y+H      
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 141

Query: 200 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPI 259
           IIH D+KP N+ ++ +   K+ DFGLA+  D   T      Y  T  Y APE +      
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-----YVATRWYRAPEIMLNWMHY 196

Query: 260 THKCDVYSFGMVLFEIVGRR 279
               D++S G ++ E++  R
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  104 bits (259), Expect = 1e-25
 Identities = 45/209 (21%), Positives = 83/209 (39%), Gaps = 22/209 (10%)

Query: 85  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 143
           +LG+G F  V+  +   N   +A+K++  +  ++  E    E+  + R    +  +    
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 144 CH---------------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKG 188
                            +     +V+E +    L      + R I    + +I+     G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 189 LVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNKTHVTISGYKGTPGY 247
           L Y+H   +  IIH DIKPENVL++       +    +A L +        +    T  Y
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 248 SAPEFLSGNYPITHKCDVYSFGMVLFEIV 276
            +PE L G  P     D++S   ++FE++
Sbjct: 196 RSPEVLLGA-PWGCGADIWSTACLIFELI 223

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 85.6 bits (211), Expect = 3e-20
 Identities = 23/158 (14%), Positives = 42/158 (26%), Gaps = 19/158 (12%)

Query: 85  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG---------RIAEEQFMAEVGTIGRTYHI 135
            +G G    V+        +  VK                   +  F        R    
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 136 NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH-EIAIGTAKGLVYLHE 194
            L +L G    +      Y +  N  L   +  K+      +   E+     + +   + 
Sbjct: 67  ALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121

Query: 195 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 232
                I+H D+   NVL+       + DF  +      
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEE 155

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	406
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.62
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.4
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.92
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.74
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.11
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.51

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-58  Score=420.45  Aligned_cols=269  Identities=28%  Similarity=0.441  Sum_probs=211.1

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      ++....|.+.+.||+|+||+||+|++.+  .||||+++... .....+.|.+|+.++++++|||||++++++.+ ...++
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence            3445567788999999999999998743  59999997542 34456789999999999999999999998865 46799


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |||||++|+|.+++...+..+++..+..++.|+++||+|||+   ++|+||||||+||||+.++.+||+|||+++.....
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            999999999999997777789999999999999999999999   99999999999999999999999999999876654


Q ss_pred             CceEEecCCCCCCCccCccccCCC--CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhh
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMI  310 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (406)
                      ..........||+.|||||++.+.  ..++.++|||||||++|||+||+.||......      ...........     
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~-----  226 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIFMVGRGY-----  226 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHHTS-----
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCC-----
Confidence            444444567899999999998643  24799999999999999999999998543211      01111111111     


Q ss_pred             ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCC
Q 015480          311 LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLP  359 (406)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~  359 (406)
                      ...........+++.+.+|+.+||+.||++|||+.+|++.|+.+.+..|
T Consensus       227 ~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         227 LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             CCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            0111122334567889999999999999999999999999998876544

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-58  Score=416.95  Aligned_cols=256  Identities=28%  Similarity=0.481  Sum_probs=204.2

Q ss_pred             hhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      ..|.+.+.||+|+||+||+|.+.+++.||||+++.+.  ...++|.+|++++++++||||++++|+|.+++..++|||||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            3467788999999999999999889999999998643  34578999999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++|+|.+++......+++..+..++.|+|+||+|||+   ++|+||||||+|||+++++.+||+|||+++......... 
T Consensus        83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-  158 (263)
T d1sm2a_          83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-  158 (263)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCcee-
Confidence            9999999997777889999999999999999999999   999999999999999999999999999998765443222 


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      .....||+.|+|||++.+. .++.++|||||||++|||+|+..|+......      .........         .....
T Consensus       159 ~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~~~~~i~~---------~~~~~  222 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDIST---------GFRLY  222 (263)
T ss_dssp             ------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HHHHHHHHH---------TCCCC
T ss_pred             ecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCH------HHHHHHHHh---------cCCCC
Confidence            2345789999999999877 7999999999999999999966554332211      111111111         11122


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      .+..++.++.+++.+||+.||++|||+++|++.|+++.
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            33445678999999999999999999999999999875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-57  Score=413.59  Aligned_cols=253  Identities=24%  Similarity=0.303  Sum_probs=205.9

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|.+.+.||+|+||+||+|.+ .+|+.||||++.........+.+.+|++++++++||||+++++++.+++..++|||||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~   85 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   85 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence            467789999999999999976 4699999999976544444567899999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++|+|.+++ .....+++..+..++.|+++||+|||+   ++|+||||||+|||+++++.+||+|||+|+..........
T Consensus        86 ~gg~L~~~l-~~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          86 SGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             TTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             CCCcHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            999999998 455689999999999999999999999   9999999999999999999999999999987755444434


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      ....+||+.|||||++.+...++.++|||||||++|||++|+.||.........      ......        ......
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~------~~~~~~--------~~~~~~  227 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKE--------KKTYLN  227 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH------HHHHHT--------TCTTST
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH------HHHHhc--------CCCCCC
Confidence            456789999999999987744578899999999999999999999644322111      011110        111112


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .....+.++.+|+.+||+.||++|||++|+++
T Consensus       228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         228 PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            22345678899999999999999999999865

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-57  Score=419.22  Aligned_cols=259  Identities=25%  Similarity=0.416  Sum_probs=204.6

Q ss_pred             hhhcccccccccceeEEEEEEeCC-C---cEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPN-G---VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ..+.+.+.||+|+||+||+|.+.. |   ..||||.+.........+.|.+|+++|++++|||||+++|+|.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            456777899999999999997642 3   368999988766666678899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      ||||++|+|.+++......+++.++..++.||++||+|||+   ++++||||||+||||+.++.+||+|||+++......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            99999999999997777789999999999999999999999   999999999999999999999999999998765433


Q ss_pred             ceE---EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          234 THV---TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       234 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ...   ......||+.|||||.+.+. .++.++|||||||++|||+| |..||......       ......        
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-------~~~~~i--------  246 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-------DVINAI--------  246 (299)
T ss_dssp             -------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHH--------
T ss_pred             CcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHH-------HHHHHH--------
Confidence            222   12235689999999999876 78999999999999999998 78887432211       111111        


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                       ........+..++..+.+|+.+||+.||.+|||+.+|++.|+++++
T Consensus       247 -~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         247 -EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             -HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -HcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence             1122233445567889999999999999999999999999998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.8e-57  Score=414.36  Aligned_cols=265  Identities=27%  Similarity=0.436  Sum_probs=220.7

Q ss_pred             eChHHHhhhhhcccccccccceeEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC
Q 015480           70 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH  148 (406)
Q Consensus        70 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  148 (406)
                      +..+++....+.+.+.||+|+||+||+|.+. +|+.||||+++.+.  ...++|.+|+++|++++|||||+++++|.+++
T Consensus         9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (287)
T d1opja_           9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   86 (287)
T ss_dssp             CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence            4556677778888999999999999999774 58899999997643  34567999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          149 MTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ..++|||||++|+|.+++.. ....+++..+..++.|+++||+|||+   ++|+||||||+||||++++.+||+|||+++
T Consensus        87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~  163 (287)
T d1opja_          87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSR  163 (287)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred             eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEcccccee
Confidence            99999999999999999864 45689999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ........ ......|++.|+|||++.+. .++.++|||||||++|||++|..|+..+...      ....+..      
T Consensus       164 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------~~~~~~i------  229 (287)
T d1opja_         164 LMTGDTYT-AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELL------  229 (287)
T ss_dssp             TCCSSSSE-EETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHH------
T ss_pred             ecCCCCce-eeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchH------HHHHHHH------
Confidence            76554333 23445688999999999877 7899999999999999999988776433221      1111111      


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                         ........+..++.++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       230 ---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         230 ---EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ---hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence               1122233445567889999999999999999999999999988754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-57  Score=410.96  Aligned_cols=260  Identities=32%  Similarity=0.494  Sum_probs=212.7

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      +++....|.+.+.||+|+||+||+|.+++++.||||+++...  ...+.|.+|++++++++|||||+++|++.+ +..++
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            445556778889999999999999999888999999997643  345679999999999999999999998865 45789


Q ss_pred             EEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          153 VYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      |||||++|+|.+++... ...+++..+..++.||++||+|||+   ++|+||||||+||||++++.+||+|||+++....
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccC
Confidence            99999999999987433 3469999999999999999999999   9999999999999999999999999999987764


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ... .......||+.|+|||++.+. .++.++|||||||++|||+||..|+......      ........         
T Consensus       162 ~~~-~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~------~~~~~~i~---------  224 (272)
T d1qpca_         162 NEY-TAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLE---------  224 (272)
T ss_dssp             SCE-ECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHH---------
T ss_pred             Ccc-ccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCH------HHHHHHHH---------
Confidence            432 223456789999999999876 6899999999999999999977665433221      11111111         


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      .......+..++.++.+|+.+||+.||++|||+++|++.|+.+.
T Consensus       225 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            11222334456778999999999999999999999999998753

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-56  Score=410.86  Aligned_cols=261  Identities=28%  Similarity=0.454  Sum_probs=208.9

Q ss_pred             hhhcccccccccceeEEEEEEeCCC-----cEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPNG-----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      ..+...+.||+|+||+||+|.+.++     ..||||+++..........|.+|++++++++|||||+++|++.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            3456778899999999999976432     46999999876666666789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |||||.+|++.+++......+++..+..++.|++.||+|||+   ++|+||||||+||||+.++.+||+|||+++.....
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            999999999999887777889999999999999999999999   99999999999999999999999999999876543


Q ss_pred             Cc-eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          233 KT-HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       233 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      .. ........||+.|+|||++.+. .++.++|||||||++|||++|..|+......      ......         +.
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~------~~~~~~---------i~  227 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKA---------IN  227 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHH---------HH
T ss_pred             CccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCH------HHHHHH---------Hh
Confidence            22 2223345789999999999877 7999999999999999999977665433221      111111         12


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                      .+...+.+..++..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            2222344455678899999999999999999999999999988653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-56  Score=404.45  Aligned_cols=254  Identities=23%  Similarity=0.403  Sum_probs=214.0

Q ss_pred             hhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      ..+.+.++||+|+||+||+|++++++.||||+++...  ...++|.+|+.++++++||||++++|+|.+++..++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            3567889999999999999999888899999998643  34578999999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++|+|..++......+++..+.+++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++........ .
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~  157 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-S  157 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-C
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-e
Confidence            9999999987778889999999999999999999999   99999999999999999999999999999866544332 2


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCC
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIE  316 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (406)
                      .....||+.|+|||.+.+. .++.++|||||||++|||+| |+.||......       ......         ......
T Consensus       158 ~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-------~~~~~i---------~~~~~~  220 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHI---------AQGLRL  220 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HHHHHH---------HTTCCC
T ss_pred             ecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHH-------HHHHHH---------HhCCCC
Confidence            3346789999999999876 78999999999999999998 78777433211       111111         111222


Q ss_pred             cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          317 EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      ..+...+.++.+|+.+||+.||++|||+++|++.|.++
T Consensus       221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            33445667899999999999999999999999998654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=410.35  Aligned_cols=256  Identities=25%  Similarity=0.369  Sum_probs=211.9

Q ss_pred             hhcccc-cccccceeEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           79 TSNYST-RLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        79 ~~~~~~-~ig~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      .+.+.+ +||+|+||+||+|.+.   ++..||||+++........+.|.+|+++|++++|||||+++|++.++ ..++||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvm   87 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVM   87 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEE
Confidence            344455 4999999999999763   35679999998766666678899999999999999999999999764 578999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      |||++|+|.+++...+..+++..+..++.|+++||+|||+   ++|+||||||+||||+.++.+||+|||+++.......
T Consensus        88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence            9999999999987777889999999999999999999999   9999999999999999999999999999987765433


Q ss_pred             eE-EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          235 HV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       235 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      .. ......||+.|+|||++.+. .++.++|||||||++|||+| |..||......       ......         ..
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-------~~~~~i---------~~  227 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFI---------EQ  227 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHH---------HT
T ss_pred             ccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHH-------HHHHHH---------Hc
Confidence            22 22345689999999999876 78999999999999999998 89888533211       111111         12


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      +...+.+..++.++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       228 ~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            2223444567788999999999999999999999999998663

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-56  Score=414.78  Aligned_cols=260  Identities=24%  Similarity=0.352  Sum_probs=210.3

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeCC-C-----cEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEec
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFPN-G-----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHD  146 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~-g-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  146 (406)
                      ++....+.+.+.||+|+||+||+|++.. +     ..||+|.+...........+.+|+.++.++ +|||||++++++.+
T Consensus        33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            3444567888999999999999997632 2     369999997655545567899999999998 89999999999999


Q ss_pred             CCeeEEEEEeccCCChhhHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecC
Q 015480          147 QHMTALVYEYMENGSLDGYLFGKK----------------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD  204 (406)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~d  204 (406)
                      .+..++|||||++|+|.+++....                      ..+++..++.++.|+++||+|||+   ++|+|||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRD  189 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD  189 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecc
Confidence            999999999999999999996543                      358999999999999999999999   9999999


Q ss_pred             CCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccc
Q 015480          205 IKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAI  283 (406)
Q Consensus       205 lk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~  283 (406)
                      |||+|||++.++.+||+|||+|+...............||+.|||||++.+. .++.++|||||||++|||+| |..||.
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCC
Confidence            9999999999999999999999877665555555566789999999999877 78999999999999999998 888875


Q ss_pred             cCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 015480          284 VGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLE  352 (406)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  352 (406)
                      .....      ........         .......+..++.++.+|+.+||+.||++|||+++|++.|.
T Consensus       269 ~~~~~------~~~~~~~~---------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         269 GIPVD------ANFYKLIQ---------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TCCCS------HHHHHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHH------HHHHHHHh---------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            33221      11111111         11122334456788999999999999999999999999985

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-55  Score=403.82  Aligned_cols=265  Identities=29%  Similarity=0.457  Sum_probs=210.6

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ++...++.+.+.||+|+||+||+|.+.+++.||||+++...  ...+.|.+|+.++++++|||||+++|+|.+ +..++|
T Consensus        13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv   89 (285)
T d1fmka3          13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   89 (285)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             EcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence            34456788899999999999999999888899999997543  345789999999999999999999999965 457899


Q ss_pred             EEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          154 YEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      ||||++|+|..++... ...+++.+++.++.||+.||+|||+   .+++||||||+||||+.++.+||+|||+++.....
T Consensus        90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            9999999999888543 4579999999999999999999999   99999999999999999999999999999866543


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ... ......||+.|+|||++... .++.++|||||||++|||++|..|+......      ........         .
T Consensus       167 ~~~-~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------~~~~~~i~---------~  229 (285)
T d1fmka3         167 EYT-ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVE---------R  229 (285)
T ss_dssp             ----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHH---------T
T ss_pred             Cce-eeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCH------HHHHHHHH---------h
Confidence            322 22346789999999999876 7899999999999999999987766443221      11111111         1


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCCC
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPPP  361 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~p  361 (406)
                      ....+.+..++.++.+++.+||+.||++|||+++|+++|+......+|+
T Consensus       230 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~  278 (285)
T d1fmka3         230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  278 (285)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence            1122334456778999999999999999999999999999987665543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-55  Score=401.79  Aligned_cols=248  Identities=20%  Similarity=0.310  Sum_probs=206.1

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      +|.+.++||+|+||+||+|.. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..++|||||
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            578889999999999999976 5699999999875432 34577999999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++|+|.+++..  ..+++..+..++.|++.||+|||+   +||+||||||+|||++.+|.+||+|||+++........  
T Consensus       100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~--  172 (293)
T d1yhwa1         100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--  172 (293)
T ss_dssp             TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--
T ss_pred             CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccccc--
Confidence            99999998743  469999999999999999999999   99999999999999999999999999999876543322  


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      .....||+.|+|||++.+. .++.++|||||||++|||++|..||......      .........        ......
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~--------~~~~~~  237 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATN--------GTPELQ  237 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHH--------CSCCCS
T ss_pred             ccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhC--------CCCCCC
Confidence            2456799999999999887 7899999999999999999999998532211      001111110        011112


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            33456788999999999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-56  Score=401.45  Aligned_cols=252  Identities=21%  Similarity=0.339  Sum_probs=193.9

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEec--CCeeEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMTALVY  154 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  154 (406)
                      .|++.+.||+|+||+||+|+. .+|+.||+|++.... .+...+.+.+|++++++++|||||++++++.+  +..+++||
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm   84 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   84 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence            467789999999999999976 569999999997543 34455779999999999999999999999865  45689999


Q ss_pred             EeccCCChhhHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHhc--CCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          155 EYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEEC--QQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       155 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      |||++|+|.+++..   .+..+++..++.++.|++.||+|||+..  ..+|+||||||+||||+.++.+||+|||+++..
T Consensus        85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~  164 (269)
T d2java1          85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  164 (269)
T ss_dssp             ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred             ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence            99999999999853   3567999999999999999999999821  124999999999999999999999999999876


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ......  .....||+.|||||++.+. .++.++|||||||++|||++|+.||.....       ..........     
T Consensus       165 ~~~~~~--~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------~~~~~~i~~~-----  229 (269)
T d2java1         165 NHDTSF--AKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREG-----  229 (269)
T ss_dssp             -------------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHT-----
T ss_pred             ccCCCc--cccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCH-------HHHHHHHHcC-----
Confidence            543322  2346799999999999876 789999999999999999999999853221       1111111111     


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                          .....+..+++++.+|+.+||+.||.+|||++|+++
T Consensus       230 ----~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         230 ----KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                122333456778999999999999999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=402.67  Aligned_cols=249  Identities=25%  Similarity=0.357  Sum_probs=201.0

Q ss_pred             ccccccceeEEEEEEeC---CCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEeccC
Q 015480           84 TRLGFGGFGEVYKGQFP---NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  159 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~---~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  159 (406)
                      ++||+|+||+||+|.+.   .++.||||+++... .....+.|.+|+++|++++|||||+++|+|.++ ..+||||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            46999999999999763   35689999997542 233457899999999999999999999999764 56899999999


Q ss_pred             CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE-e
Q 015480          160 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT-I  238 (406)
Q Consensus       160 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~-~  238 (406)
                      |+|.+++. ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.......... .
T Consensus        92 g~L~~~l~-~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHh-hccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999984 45679999999999999999999999   9999999999999999999999999999987765443332 3


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccCCCCc
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGIEE  317 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (406)
                      ....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.....       .......         ..+....
T Consensus       168 ~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------~~~~~~i---------~~~~~~~  230 (277)
T d1xbba_         168 THGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAML---------EKGERMG  230 (277)
T ss_dssp             ---CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHH---------HTTCCCC
T ss_pred             cccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCH-------HHHHHHH---------HcCCCCC
Confidence            346789999999999876 78999999999999999998 8888753211       1111111         1222234


Q ss_pred             chHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          318 KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                      .+..++.++.+|+.+||+.||++|||+.+|++.|+..
T Consensus       231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            4456678899999999999999999999999988764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-55  Score=395.45  Aligned_cols=245  Identities=27%  Similarity=0.387  Sum_probs=205.2

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||+||+|++ .+|+.||+|++.+..  .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            467788999999999999977 468999999987532  22345678999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      ||++|+|.+++. ....+++..+..++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||++........ 
T Consensus        87 y~~~g~L~~~l~-~~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~-  161 (263)
T d2j4za1          87 YAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-  161 (263)
T ss_dssp             CCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC-
T ss_pred             ecCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCcc-
Confidence            999999999994 44579999999999999999999999   9999999999999999999999999999986654332 


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                         ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.....       ...........          
T Consensus       162 ---~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~----------  220 (263)
T d2j4za1         162 ---TTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVE----------  220 (263)
T ss_dssp             ---EETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTC----------
T ss_pred             ---cccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC----------
Confidence               235799999999999987 789999999999999999999999853321       11111111111          


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...+...+.++.+|+.+||+.||++|||++|+++
T Consensus       221 ~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            1122345678999999999999999999999986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=411.48  Aligned_cols=268  Identities=24%  Similarity=0.345  Sum_probs=208.1

Q ss_pred             HHhhhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      ++.+..|.+.++||+|+||+||+|.+ .+|+.||+|+++..........+.+|+.+|++++|||||+++++|.++...++
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            34566788889999999999999976 56899999999866555566789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |||||++|+|.+++. +.+.+++..+..++.|++.||.|||+  .++|+||||||+||||+.+|.+||+|||+|+.....
T Consensus        82 VmEy~~gg~L~~~l~-~~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             EEECCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEEcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            999999999999995 34579999999999999999999997  148999999999999999999999999999865432


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccch-hHHH--------H-HHh
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP-KHVW--------E-EYE  302 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-~~~~--------~-~~~  302 (406)
                      ..    ...+||+.|+|||++.+. .++.++||||+||++|||++|+.||............ ....        . ...
T Consensus       159 ~~----~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         159 MA----NSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             TC-------CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             cc----ccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            21    246799999999999987 7999999999999999999999999654322110000 0000        0 000


Q ss_pred             hh----------------hcch-hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          303 KC----------------ELGA-MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       303 ~~----------------~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..                .... ..............+.++.+++.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            00                0000 00000000011123567999999999999999999999987

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-55  Score=400.40  Aligned_cols=250  Identities=21%  Similarity=0.297  Sum_probs=203.7

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ..|.+.+.||+|+||+||+|++ .+|+.||||++.+..  .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            3578889999999999999976 569999999997532  2234567999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      |||++|+|.+++. ..+.+++..+..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+++.......
T Consensus        88 Ey~~gg~L~~~~~-~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhh-ccCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999884 45679999999999999999999999   9999999999999999999999999999987765444


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                      ........||+.|+|||++.+. .++.++|||||||++|||++|..||.....       ...........         
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~---------  226 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YLIFQKIIKLE---------  226 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTTC---------
T ss_pred             ccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCH-------HHHHHHHHcCC---------
Confidence            4444557899999999999887 789999999999999999999999864321       11111111111         


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       ...+...+.++.+|+.+||+.||.+|||++|+++
T Consensus       227 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         227 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence             1122345678999999999999999999999754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-55  Score=400.55  Aligned_cols=251  Identities=25%  Similarity=0.350  Sum_probs=206.0

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|.+.+.||+|+||+||+|.+ .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            467788999999999999976 468999999997642 344567899999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      ++|+|.+++......+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--H
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc--c
Confidence            9999999986667789999999999999999999999   9999999999999999999999999999975432211  1


Q ss_pred             ecCCCCCCCccCccccCC----CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          238 ISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      .....||+.|+|||++..    ...++.++|||||||++|||++|+.||.......       .........       .
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-------~~~~i~~~~-------~  232 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSE-------P  232 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHHSC-------C
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCC-------C
Confidence            234679999999999842    2357899999999999999999999985432211       111111111       1


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         233 PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            112233456788999999999999999999999876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-55  Score=404.81  Aligned_cols=262  Identities=24%  Similarity=0.362  Sum_probs=213.9

Q ss_pred             HHhhhhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecC
Q 015480           74 QLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ  147 (406)
Q Consensus        74 ~~~~~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  147 (406)
                      ++....+.+.+.||+|+||+||+|++.      +++.||||+++........++|.+|+.++++++||||++++++|.+.
T Consensus         9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~   88 (301)
T d1lufa_           9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG   88 (301)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence            334456788899999999999999763      45789999998765555678899999999999999999999999999


Q ss_pred             CeeEEEEEeccCCChhhHhhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecC
Q 015480          148 HMTALVYEYMENGSLDGYLFGK-----------------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD  204 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~d  204 (406)
                      ...+++|||+++|+|.+++...                       ...+++..+..++.|++.||+|||+   ++++|||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrD  165 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRD  165 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeE
Confidence            9999999999999999998532                       1348899999999999999999999   9999999


Q ss_pred             CCCCcEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhccc-ccc
Q 015480          205 IKPENVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR-NAI  283 (406)
Q Consensus       205 lk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~-p~~  283 (406)
                      |||+||||+.++.+||+|||+++...............||+.|+|||.+.+. .++.++|||||||++|||++|.. |+.
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCCC
Confidence            9999999999999999999999866544333334456789999999999877 79999999999999999999965 443


Q ss_pred             cCCCcccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          284 VGATESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      .. ..      ......         +........+..++.++.+|+.+||+.||++||||.+|++.|+++.
T Consensus       245 ~~-~~------~e~~~~---------v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GM-AH------EEVIYY---------VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TS-CH------HHHHHH---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CC-CH------HHHHHH---------HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            22 11      111111         1222233444566778999999999999999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-54  Score=390.09  Aligned_cols=245  Identities=25%  Similarity=0.400  Sum_probs=197.6

Q ss_pred             cccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEec----CCeeEEEE
Q 015480           81 NYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD----QHMTALVY  154 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  154 (406)
                      .+.++||+|+||+||+|.+ .+|+.||+|++.... .....+.+.+|+++|++++|||||++++++.+    +..+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            5667899999999999976 468899999987543 34455789999999999999999999999865    45689999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCC--eeecCCCCCcEEEc-CCCCceEeccccccccCC
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLD-ANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--i~H~dlk~~Nill~-~~~~~kl~DfGl~~~~~~  231 (406)
                      |||++|+|.+++. ....+++..+..++.||++||+|||+   ++  |+||||||+|||++ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHh-ccccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999994 44679999999999999999999998   77  99999999999996 578999999999986554


Q ss_pred             CCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhc
Q 015480          232 NKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMIL  311 (406)
Q Consensus       232 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (406)
                      ...    ....||+.|||||++.+  .++.++|||||||++|||++|+.||......      ..........       
T Consensus       168 ~~~----~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~-------  228 (270)
T d1t4ha_         168 SFA----KAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSG-------  228 (270)
T ss_dssp             TSB----EESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTT-------
T ss_pred             Ccc----CCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcC-------
Confidence            332    23579999999999875  4899999999999999999999998532211      1111111111       


Q ss_pred             cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          312 GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                       ..........++++.+|+.+||+.||++|||++|+++
T Consensus       229 -~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         229 -VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence             0111222334567999999999999999999999976

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-55  Score=398.82  Aligned_cols=259  Identities=23%  Similarity=0.318  Sum_probs=203.4

Q ss_pred             HhhhhhcccccccccceeEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           75 LNNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        75 ~~~~~~~~~~~ig~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      +....|.+.+.||+|+||+||+|.+..    +..||||.++........+.|.+|++++++++||||++++|++.+ +..
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~   82 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV   82 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeE
Confidence            344567888999999999999997632    456899998766555667889999999999999999999999964 578


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ++||||+++|+|.+++......+++..+..++.|+++||+|||+   ++++||||||+||+++.++.+||+|||+++...
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheecc
Confidence            99999999999999987778889999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ...... .....||+.|+|||++.+. .++.++|||||||++|||++ |.+|+......       .......       
T Consensus       160 ~~~~~~-~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-------~~~~~i~-------  223 (273)
T d1mp8a_         160 DSTYYK-ASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIE-------  223 (273)
T ss_dssp             ------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------GHHHHHH-------
T ss_pred             CCccee-ccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHH-------HHHHHHH-------
Confidence            433222 2345689999999999876 78999999999999999998 77777543221       1111111       


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                        .....+.+..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       224 --~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         224 --NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             --TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence              11223344566788999999999999999999999999998774

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-54  Score=399.76  Aligned_cols=251  Identities=22%  Similarity=0.303  Sum_probs=190.5

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      ..|.+.+.||+|+||+||+|++ .+|+.||||++...........+.+|+.+|++++|||||++++++.+++..++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            4578889999999999999976 468999999998654444456788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc---CCCCceEeccccccccCCCC
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~DfGl~~~~~~~~  233 (406)
                      |+||+|.+++. ..+.+++..+..++.|++.||+|||+   ++|+||||||+|||+.   +++.+||+|||+++......
T Consensus        89 ~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          89 VSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             CCSCBHHHHHH-TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             cCCCcHHHhhh-cccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            99999999994 45689999999999999999999999   9999999999999994   57899999999998665432


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                      .   ....+||+.|||||++.+. .++.++|||||||++|||++|..||......       ...........      .
T Consensus       165 ~---~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~~------~  227 (307)
T d1a06a_         165 V---LSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDA-------KLFEQILKAEY------E  227 (307)
T ss_dssp             -----------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHTTCC------C
T ss_pred             e---eeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHhccCC------C
Confidence            2   2346799999999999887 7899999999999999999999998543211       11111111110      0


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .........+.++.+|+.+||+.||++|||+.|+++
T Consensus       228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            011223355678999999999999999999999988

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.3e-53  Score=401.07  Aligned_cols=262  Identities=20%  Similarity=0.287  Sum_probs=213.8

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      .|.+.+.||+|+||+||+|.. .+|+.||||+++... ......+.+|+.+|++++|||||++++++.+++..+||||||
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            578889999999999999976 579999999997643 234567889999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc--CCCCceEeccccccccCCCCce
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +||+|.+++......+++..+..++.||+.||+|||+   +||+||||||+||||+  .++.+||+|||++.........
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~  185 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV  185 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence            9999999886667789999999999999999999999   9999999999999998  6789999999999877655433


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                      .   ...||+.|+|||++.+. .++.++|||||||++|||++|..||......       ...........      ...
T Consensus       186 ~---~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~------~~~  248 (352)
T d1koba_         186 K---VTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKRCDW------EFD  248 (352)
T ss_dssp             E---EECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHCCC------CCC
T ss_pred             e---eccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC------CCC
Confidence            2   25689999999999887 7999999999999999999999998533211       11111111110      011


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--HhhccccCCCCC
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVVEVLPPP  361 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~~~~~~p  361 (406)
                      .......+.++.+|+.+||+.||.+|||+.|+++  .++......+.+
T Consensus       249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~~~~~  296 (352)
T d1koba_         249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR  296 (352)
T ss_dssp             SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTCCCC
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcchhccc
Confidence            1223456678999999999999999999999988  465544443333

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-54  Score=399.68  Aligned_cols=246  Identities=24%  Similarity=0.333  Sum_probs=201.7

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|...+.||+|+||+||+|.+ .+|+.||||++.....  ....+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            467788999999999999975 5689999999975432  2344678999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      ||++|+|..++ ..+..+++..+..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||++......   
T Consensus        96 ~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---  168 (309)
T d1u5ra_          96 YCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (309)
T ss_dssp             CCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             ecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence            99999997666 445679999999999999999999999   99999999999999999999999999999865432   


Q ss_pred             EEecCCCCCCCccCccccCCC--CCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          236 VTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                         ....||+.|||||++.+.  ..++.++|||||||++|||++|..||......       .........        .
T Consensus       169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-------~~~~~i~~~--------~  230 (309)
T d1u5ra_         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQN--------E  230 (309)
T ss_dssp             ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHS--------C
T ss_pred             ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhC--------C
Confidence               245799999999998642  35899999999999999999999998532110       001111111        1


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .........+..+.+|+.+||+.||.+|||++++++
T Consensus       231 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            111122345678999999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=402.01  Aligned_cols=256  Identities=25%  Similarity=0.353  Sum_probs=204.9

Q ss_pred             hhcccccccccceeEEEEEEeC-CCc----EEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGV----KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  153 (406)
                      .|++.+.||+|+||+||+|.+. +|+    +||+|.++........+.|.+|+.++++++|||||+++|+|.++ ..+++
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v   88 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI   88 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence            4777899999999999999763 444    58999887655555678899999999999999999999999875 45788


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      +||+.+|+|.+++......+++..+..++.|||.||+|||+   ++|+||||||+||||+.++.+||+|||+++......
T Consensus        89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            99999999999998888899999999999999999999999   999999999999999999999999999999876655


Q ss_pred             ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          234 THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       234 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      .........||+.|+|||++.+. .++.++|||||||++|||+| |.+||......       .......         .
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-------~~~~~i~---------~  228 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EISSILE---------K  228 (317)
T ss_dssp             C--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-------GHHHHHH---------H
T ss_pred             ccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHH---------c
Confidence            44444556789999999999877 79999999999999999998 66666432211       1111111         1


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      +.....+..++..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus       229 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence            1223334456778999999999999999999999999988764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=395.04  Aligned_cols=262  Identities=26%  Similarity=0.385  Sum_probs=212.4

Q ss_pred             hhhhcccccccccceeEEEEEEeCCC----cEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec-CCeeE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-QHMTA  151 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~g----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~  151 (406)
                      ..+++|.++||+|+||+||+|.+.++    ..||||+++........++|.+|+++|++++||||++++|++.+ +...+
T Consensus        26 ~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~  105 (311)
T d1r0pa_          26 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  105 (311)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred             HceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence            34456678899999999999986432    35899999865566667889999999999999999999999865 56889


Q ss_pred             EEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCC
Q 015480          152 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  231 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~  231 (406)
                      +|||||++|+|.+++......+++..+..++.|+++||.|||+   .+|+||||||+||||++++.+||+|||+++....
T Consensus       106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred             EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence            9999999999999998777889999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCce--EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          232 NKTH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       232 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ....  .......||+.|+|||.+.+. .++.++||||||+++|||++|+.|+........      .....        
T Consensus       183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~------~~~~i--------  247 (311)
T d1r0pa_         183 KEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYL--------  247 (311)
T ss_dssp             TTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHH--------
T ss_pred             cccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH------HHHHH--------
Confidence            3222  122345689999999998876 789999999999999999998887754332110      01111        


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                       ..+.....+..++..+.+|+.+||+.||++||++.||++.|+++...
T Consensus       248 -~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         248 -LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             -HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -HcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence             11112233345567899999999999999999999999999988643

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.1e-53  Score=398.24  Aligned_cols=255  Identities=21%  Similarity=0.295  Sum_probs=210.7

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      +|.+.+.||+|+||+||+|++ .+|+.||||++... .....+.+.+|+.+|++++|||||++++++.+++..++|||||
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            578889999999999999976 56999999999764 3345678899999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc--CCCCceEeccccccccCCCCce
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +||+|.+++......+++..+..++.||+.||+|||+   ++|+||||||+|||++  .++.+||+|||+++........
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~  182 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV  182 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence            9999999997667789999999999999999999999   9999999999999995  4678999999999877655443


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                      .   ...||+.|||||++.+. .++.++|||||||++|||++|+.||......       ...........      ...
T Consensus       183 ~---~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~------~~~  245 (350)
T d1koaa2         183 K---VTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCDW------NMD  245 (350)
T ss_dssp             E---EECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCC------CSC
T ss_pred             c---eecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC------CCC
Confidence            2   35689999999999887 7899999999999999999999998533211       11111111110      011


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH--hhcc
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM--LEGV  354 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~--L~~~  354 (406)
                      .......+.++.+|+.+||+.||++|||++|+++.  +...
T Consensus       246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            22234456789999999999999999999999983  5443

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=398.90  Aligned_cols=265  Identities=24%  Similarity=0.352  Sum_probs=204.2

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEe
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCH  145 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  145 (406)
                      +++....|.+.++||+|+||+||+|.+.      +++.||||+++........+.+..|...+.++ +|+||+.+++++.
T Consensus         8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1           8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence            4455567888999999999999999752      35689999998765556667888898888887 6899999999986


Q ss_pred             cC-CeeEEEEEeccCCChhhHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCc
Q 015480          146 DQ-HMTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN  209 (406)
Q Consensus       146 ~~-~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~N  209 (406)
                      +. ...++|||||++|+|.+++...               ...+++..+..++.||++||+|||+   ++|+||||||+|
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~N  164 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARN  164 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccc
Confidence            64 5689999999999999999543               2358999999999999999999999   999999999999


Q ss_pred             EEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhccc-ccccCCCc
Q 015480          210 VLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR-NAIVGATE  288 (406)
Q Consensus       210 ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~-p~~~~~~~  288 (406)
                      |||++++.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|.. ||......
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999876655444444556799999999999876 78999999999999999999765 44322111


Q ss_pred             ccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          289 SLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                            .........+         .....+...++++.+++.+||+.||++|||+.+|++.|+++++
T Consensus       244 ------~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         244 ------EEFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             ------HHHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------HHHHHHHhcC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                  1111111111         1223334456789999999999999999999999999998753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=390.22  Aligned_cols=250  Identities=26%  Similarity=0.382  Sum_probs=198.6

Q ss_pred             hhhhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec-CCeeEEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-QHMTALVYE  155 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  155 (406)
                      -..+.+.+.||+|+||.||+|++ +|..||||+++.+   ...+.|.+|++++++++||||++++|+|.+ ++.+++|||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            34567788999999999999998 5789999999754   345679999999999999999999999865 466899999


Q ss_pred             eccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          156 YMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       156 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      |+++|+|.+++... ...+++..++.++.||+.||.|||+   .+++||||||+|||++.++.+||+|||+++...... 
T Consensus        82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-  157 (262)
T d1byga_          82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  157 (262)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence            99999999999543 3468999999999999999999999   999999999999999999999999999998654332 


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcchhhccC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGC  313 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (406)
                          ....+|..|+|||++.+. .++.++|||||||++|||+| |++|+......       .....         +...
T Consensus       158 ----~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-------~~~~~---------i~~~  216 (262)
T d1byga_         158 ----DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPR---------VEKG  216 (262)
T ss_dssp             --------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-------GHHHH---------HTTT
T ss_pred             ----ccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-------HHHHH---------HHcC
Confidence                234578999999999876 78999999999999999998 56655432111       01111         1122


Q ss_pred             CCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          314 GIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      ...+.+...+.++.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus       217 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            233445556788999999999999999999999999998764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-53  Score=388.77  Aligned_cols=252  Identities=22%  Similarity=0.330  Sum_probs=206.0

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-----chhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-----GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      +..|.+.+.||+|+||+||+|.+ .+|+.||||++.+..     .....+.+.+|+.+|++++|||||++++++.+....
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            34678889999999999999976 569999999986432     122457899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC----CceEeccccc
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----SPKVADFGLA  226 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~DfGl~  226 (406)
                      +||||||++|+|.+++.. .+.+++..+..++.|++.||+|||+   .+|+||||||+|||++.++    .+||+|||++
T Consensus        89 ~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999999999943 4579999999999999999999999   9999999999999998876    4999999999


Q ss_pred             cccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhc
Q 015480          227 KLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCEL  306 (406)
Q Consensus       227 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (406)
                      ........   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......       ...........
T Consensus       165 ~~~~~~~~---~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~~  233 (293)
T d1jksa_         165 HKIDFGNE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANVSAVNY  233 (293)
T ss_dssp             EECTTSCB---CSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHTTCC
T ss_pred             hhcCCCcc---ccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHH-------HHHHHHHhcCC
Confidence            87654432   2346789999999999876 7899999999999999999999998643211       11111111100


Q ss_pred             chhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          307 GAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                            ..........+..+.+|+.+||+.||++|||++++++
T Consensus       234 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 ------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  0001122345678999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-54  Score=395.14  Aligned_cols=264  Identities=25%  Similarity=0.366  Sum_probs=213.0

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeCC--------CcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEE
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFPN--------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGF  143 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  143 (406)
                      +++....|.+.+.||+|+||.||+|+...        +..||||+++.+........+.+|...+.++ +|||||+++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            44555677888999999999999997522        3479999998876666778899999999888 79999999999


Q ss_pred             EecCCeeEEEEEeccCCChhhHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCC
Q 015480          144 CHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE  208 (406)
Q Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~  208 (406)
                      |.++...++|||||++|+|.+++....               ..+++.+++.++.|++.||+|||+   ++|+||||||+
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~  164 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAAR  164 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeeccc
Confidence            999999999999999999999995432               458999999999999999999999   99999999999


Q ss_pred             cEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCC
Q 015480          209 NVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGAT  287 (406)
Q Consensus       209 Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~  287 (406)
                      |||++.++.+||+|||+++...............||+.|+|||.+.+. .++.++|||||||++|||++ |.+||.....
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            999999999999999999877655444444556789999999999876 79999999999999999998 5666542211


Q ss_pred             cccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          288 ESLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                             ........         .+.....+...+.++.+|+.+||+.||.+|||+.||++.|+++.+
T Consensus       244 -------~~~~~~i~---------~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         244 -------EELFKLLK---------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             -------HHHHHHHH---------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------HHHHHHHH---------cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                   11122211         222233344566789999999999999999999999999998864

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-54  Score=395.98  Aligned_cols=265  Identities=24%  Similarity=0.376  Sum_probs=218.0

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD  146 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  146 (406)
                      +++....+.+.++||+|+||+||+|.+.      +++.||||+++..........|.+|+.++++++||||++++|+|..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            4555667788899999999999999763      3578999999876565666789999999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChhhHhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC
Q 015480          147 QHMTALVYEYMENGSLDGYLFGK---------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  217 (406)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  217 (406)
                      +...++|||||++|+|.+++...         ...+++..+..++.|+|+||.|||+   ++|+||||||+|||++.+++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCce
Confidence            99999999999999999998422         2457999999999999999999999   99999999999999999999


Q ss_pred             ceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHH
Q 015480          218 PKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHV  297 (406)
Q Consensus       218 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  297 (406)
                      +||+|||+++...............||+.|+|||.+.+. .++.++||||||+++|||+||..++..+...      ...
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~  244 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQV  244 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHH
Confidence            999999999877655444444556789999999999877 7899999999999999999986443322111      111


Q ss_pred             HHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          298 WEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      ...         +..+.....+..++..+.+++.+||+.||.+|||+.+|++.|++..+
T Consensus       245 ~~~---------i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         245 LRF---------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHH---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHH---------HHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            111         11222333445567789999999999999999999999999988754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=394.53  Aligned_cols=266  Identities=23%  Similarity=0.376  Sum_probs=220.0

Q ss_pred             HHHhhhhhcccccccccceeEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEe
Q 015480           73 LQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCH  145 (406)
Q Consensus        73 ~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  145 (406)
                      +++....+.+.++||+|+||.||+|++      .+++.||||+++..........|.+|+.+++++ +|||||+++++|.
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            455566788899999999999999975      346789999998766656677899999999999 6999999999999


Q ss_pred             cCCeeEEEEEeccCCChhhHhhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCC
Q 015480          146 DQHMTALVYEYMENGSLDGYLFGKK-----------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE  208 (406)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~  208 (406)
                      +....++|||||++|+|.+++....                 ..+++..+..++.||++||+|||+   ++++||||||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~  174 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAAR  174 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccc
Confidence            9999999999999999999985432                 358999999999999999999999   99999999999


Q ss_pred             cEEEcCCCCceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCc
Q 015480          209 NVLLDANFSPKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATE  288 (406)
Q Consensus       209 Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~  288 (406)
                      |||++.++.+||+|||+++...............||+.|+|||.+.+. .++.++|||||||++|||+|++.|+......
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987766555555667899999999999876 7899999999999999999966555433222


Q ss_pred             ccccchhHHHHHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc
Q 015480          289 SLDWFPKHVWEEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE  356 (406)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~  356 (406)
                      .     ........         .......+...+..+.+|+.+||+.||.+|||+.+|+++|+++++
T Consensus       254 ~-----~~~~~~i~---------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         254 D-----SKFYKMIK---------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             S-----HHHHHHHH---------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H-----HHHHHHHh---------cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            1     11111111         111223334456789999999999999999999999999987653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=393.13  Aligned_cols=258  Identities=24%  Similarity=0.406  Sum_probs=204.6

Q ss_pred             hhhcccccccccceeEEEEEEeC-CCc--EEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEecCCeeEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQFP-NGV--KIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  153 (406)
                      ..+++.+.||+|+||+||+|.+. +|.  .||||.++........+.|.+|+++|+++ +|||||+++|+|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            34566789999999999999774 344  47888876544444567899999999998 799999999999999999999


Q ss_pred             EEeccCCChhhHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCc
Q 015480          154 YEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP  218 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  218 (406)
                      |||+++|+|.++++..               ...+++..+..++.|||.||.|||+   ++++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence            9999999999999543               3679999999999999999999999   999999999999999999999


Q ss_pred             eEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHH
Q 015480          219 KVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVW  298 (406)
Q Consensus       219 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  298 (406)
                      ||+|||+++........   ....||..|+|||.+.+. .++.++|||||||++|||++|..|+..+...      ....
T Consensus       167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~------~~~~  236 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELY  236 (309)
T ss_dssp             EECCTTCEESSCEECCC-------CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHH
T ss_pred             EEccccccccccccccc---cceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCH------HHHH
Confidence            99999999755432221   235689999999999877 7899999999999999999987543322111      1111


Q ss_pred             HHHhhhhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccC
Q 015480          299 EEYEKCELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEV  357 (406)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~  357 (406)
                      ..         +..+.....+..++.++.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus       237 ~~---------i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         237 EK---------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             HH---------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HH---------HHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            11         111222334455678899999999999999999999999999998754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=388.77  Aligned_cols=247  Identities=25%  Similarity=0.311  Sum_probs=205.8

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|.+.+.||+|+||+||+|+. .+|+.||||++++..  .....+.+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e   85 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence            467789999999999999976 579999999997542  22345778999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      ||+||+|.+++. ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.+|.+||+|||+++........
T Consensus        86 y~~gg~L~~~~~-~~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          86 YANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             CCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             ccCCCchhhhhh-cccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            999999999984 45678999999999999999999999   99999999999999999999999999999865443322


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                        ....+||+.|+|||++.+. .++.++|||||||++|||++|++||......       ..........          
T Consensus       162 --~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-------~~~~~i~~~~----------  221 (337)
T d1o6la_         162 --MKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEE----------  221 (337)
T ss_dssp             --BCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC----------
T ss_pred             --cccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHH-------HHHHHHhcCC----------
Confidence              2356799999999999987 7899999999999999999999998643221       1111111111          


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRPP-----MSAVIK  349 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  349 (406)
                      ...+...+.++.+|+.+||+.||.+||+     +.++++
T Consensus       222 ~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            1223446678999999999999999995     778876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-53  Score=385.61  Aligned_cols=258  Identities=28%  Similarity=0.391  Sum_probs=199.5

Q ss_pred             hhhhcccccccccceeEEEEEEeC--CC--cEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCee
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQFP--NG--VKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT  150 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~~--~g--~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  150 (406)
                      ...|++.+.||+|+||+||+|++.  ++  ..||||++.+..  .....+.|.+|+.++++++||||++++|+|.++ ..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence            345788899999999999999752  23  468999987542  233457899999999999999999999999764 67


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      ++|||||++|++.+++......+++..+..++.|+++||+|||+   ++|+||||||+||||+.++.+||+|||+++...
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            89999999999999987777789999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCceEE-ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhh-cccccccCCCcccccchhHHHHHHhhhhcch
Q 015480          231 RNKTHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGATESLDWFPKHVWEEYEKCELGA  308 (406)
Q Consensus       231 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (406)
                      ....... .....|+..|+|||++.+. .++.++|||||||++|||+| |..||......       ......       
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-------~~~~~i-------  227 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILHKI-------  227 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHH-------
T ss_pred             cCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-------HHHHHH-------
Confidence            5544332 2345678899999999887 78999999999999999998 78887422111       001111       


Q ss_pred             hhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcc
Q 015480          309 MILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGV  354 (406)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~  354 (406)
                       .......+.+...+..+.+|+.+||+.||++|||+.+|++.|++.
T Consensus       228 -~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         228 -DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence             111122233445667899999999999999999999999998753

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=385.86  Aligned_cols=271  Identities=26%  Similarity=0.336  Sum_probs=201.7

Q ss_pred             hhcccccccccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC----eeEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH----MTALVY  154 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  154 (406)
                      ++.+.++||+|+||+||+|++ +|+.||||+++...  ........|+..+.+++||||+++++++.+.+    ..++||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            456678899999999999997 68999999997532  12222334555566789999999999997643    678999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhc-----CCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-----QQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      |||++|+|.++++.  ..+++..+..++.|+|.||+|||+..     .++|+||||||+||||+.++.+||+|||+++..
T Consensus        81 Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          81 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            99999999999954  46999999999999999999999621     269999999999999999999999999999877


Q ss_pred             CCCCceE--EecCCCCCCCccCccccCCCC-----CCCcccceeecchhHHHHhhcccccccCCCcccccchh----HHH
Q 015480          230 DRNKTHV--TISGYKGTPGYSAPEFLSGNY-----PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPK----HVW  298 (406)
Q Consensus       230 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~----~~~  298 (406)
                      .......  ......||+.|+|||++.+..     .++.++|||||||++|||+||..|+.........+...    ...
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            5443322  234567999999999987542     25778999999999999999998875543322221110    001


Q ss_pred             HHHhhhhcchhhccCCCCc--chHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccc
Q 015480          299 EEYEKCELGAMILGCGIEE--KDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVV  355 (406)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~  355 (406)
                      ............ ...++.  ...+.+..+.+|+.+||+.||++|||+.||++.|+++.
T Consensus       239 ~~~~~~~~~~~~-~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         239 EEMRKVVCEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             HHHHHHHTTSCC-CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhcccc-CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            111111111111 111111  23456678999999999999999999999999998875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-51  Score=382.18  Aligned_cols=249  Identities=27%  Similarity=0.332  Sum_probs=206.0

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .|++.+.||+|+||+||+|++ .+|+.||||++++..  .....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   84 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   84 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence            367789999999999999976 569999999997542  22345778999999999999999999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCce
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  235 (406)
                      ||+||+|..++ .....+++..+..++.||+.||+|||+   ++|+||||||+||||+.+|.+||+|||+++......  
T Consensus        85 ~~~gg~l~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~--  158 (316)
T d1fota_          85 YIEGGELFSLL-RKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--  158 (316)
T ss_dssp             CCCSCBHHHHH-HHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred             ecCCccccccc-cccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence            99999999888 455678899999999999999999999   999999999999999999999999999998765432  


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                         ...+||+.|||||++.+. .++.++|||||||++|||++|+.||......       ..........          
T Consensus       159 ---~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~i~~~~----------  217 (316)
T d1fota_         159 ---YTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEKILNAE----------  217 (316)
T ss_dssp             ---CCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHCC----------
T ss_pred             ---ccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHH-------HHHHHHHcCC----------
Confidence               346799999999999877 7899999999999999999999998543211       1111111111          


Q ss_pred             CcchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH--Hhhcc
Q 015480          316 EEKDKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK--MLEGV  354 (406)
Q Consensus       316 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~--~L~~~  354 (406)
                      ...+...+.++.+++.+||+.||.+||     |++++++  .++++
T Consensus       218 ~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         218 LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            122234567799999999999999996     8999987  34443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=382.15  Aligned_cols=252  Identities=17%  Similarity=0.240  Sum_probs=206.6

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      +|.+.+.||+|+||+||+|.+ .+|+.||||+++...  .....+.+|+++|+.++|||||++++++.+++.+|||||||
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            467788999999999999976 468999999998642  34456889999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC--CCceEeccccccccCCCCce
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN--FSPKVADFGLAKLCDRNKTH  235 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~--~~~kl~DfGl~~~~~~~~~~  235 (406)
                      +||+|.+++......+++.++..++.||+.||+|||+   ++|+||||||+|||++.+  +.+||+|||+++........
T Consensus        84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~  160 (321)
T d1tkia_          84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence            9999999996666689999999999999999999999   999999999999999854  47999999999876554433


Q ss_pred             EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCCC
Q 015480          236 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCGI  315 (406)
Q Consensus       236 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (406)
                      .   ...||+.|+|||.+.+. .++.++|||||||++|+|++|..||......       ...........       ..
T Consensus       161 ~---~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-------~~~~~i~~~~~-------~~  222 (321)
T d1tkia_         161 R---LLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEY-------TF  222 (321)
T ss_dssp             E---EEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCC-------CC
T ss_pred             c---ccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC-------CC
Confidence            2   24589999999999877 7899999999999999999999998643221       11111111100       00


Q ss_pred             C-cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhc
Q 015480          316 E-EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEG  353 (406)
Q Consensus       316 ~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~  353 (406)
                      + ......+.++.+|+.+||..||.+|||++|+++  .+.+
T Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            1 111235678999999999999999999999998  4544

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.6e-51  Score=388.78  Aligned_cols=249  Identities=22%  Similarity=0.256  Sum_probs=200.0

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHH---HHHHHhhccCcCccccEEEEEecCCeeEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFM---AEVGTIGRTYHINLVRLYGFCHDQHMTAL  152 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~l  152 (406)
                      .|.+.+.||+|+||+||+|++ .+|+.||||++.+...  ......+.   .++.+++.++|||||++++++.+.+..|+
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i   84 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   84 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence            467788999999999999976 4699999999864311  11222333   45777888899999999999999999999


Q ss_pred             EEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCC
Q 015480          153 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  232 (406)
                      |||||++|+|.+++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+++.....
T Consensus        85 vmE~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          85 ILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EECCCCSCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEecCCCcHHHHHH-hcccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            999999999999994 44678999999999999999999999   99999999999999999999999999999876544


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhcc
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILG  312 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (406)
                      ..    ....||+.|+|||++.....++.++|||||||++|||++|+.||.........       .... .     .. 
T Consensus       161 ~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------~~~~-~-----~~-  222 (364)
T d1omwa3         161 KP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-------EIDR-M-----TL-  222 (364)
T ss_dssp             CC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-------HHHH-H-----SS-
T ss_pred             cc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHH-h-----cc-
Confidence            32    34679999999999976557899999999999999999999999654332110       0000 0     00 


Q ss_pred             CCCCcchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 015480          313 CGIEEKDKEKAKRLCMVALWCVQDSPEDRPP-----MSAVIK  349 (406)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  349 (406)
                      ......+...+.++.+|+.+||+.||.+|||     ++++++
T Consensus       223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         223 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            1112223345678999999999999999999     688876

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.2e-51  Score=373.68  Aligned_cols=251  Identities=21%  Similarity=0.288  Sum_probs=204.9

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--------hhhHHHHHHHHHHhhccC-cCccccEEEEEecCC
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--------RIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQH  148 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  148 (406)
                      +|.+.+.||+|+||+||+|+. .+|+.||||+++....        ....+.+.+|+.++++++ ||||+++++++.+++
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~   83 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   83 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence            567789999999999999976 5799999999875321        123356889999999997 999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccc
Q 015480          149 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  228 (406)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~  228 (406)
                      ..|||||||++|+|.+++. ....+++..+..++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~~ivmE~~~~g~L~~~l~-~~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          84 FFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             EEEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             ceEEEEEcCCCchHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchheeE
Confidence            9999999999999999995 35579999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCceEEecCCCCCCCccCccccCC-----CCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhh
Q 015480          229 CDRNKTHVTISGYKGTPGYSAPEFLSG-----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK  303 (406)
Q Consensus       229 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  303 (406)
                      ......   .....||+.|+|||.+.+     ...++.++||||+||++|||++|+.||......       ........
T Consensus       160 ~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-------~~~~~i~~  229 (277)
T d1phka_         160 LDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMIMS  229 (277)
T ss_dssp             CCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHH
T ss_pred             ccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-------HHHHHHHh
Confidence            654332   234679999999998752     335788999999999999999999998643211       11111111


Q ss_pred             hhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          304 CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ...      ..........++++.+++.+||+.||++|||++||++
T Consensus       230 ~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         230 GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            111      0112233456788999999999999999999999876

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.2e-51  Score=376.57  Aligned_cols=260  Identities=23%  Similarity=0.342  Sum_probs=201.2

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHhhccCcCccccEEEEEecCC----ee
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH----MT  150 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~  150 (406)
                      .+|.+.+.||+|+||+||+|.+ .+|+.||||+++.+..  ......+.+|+++++.++||||+++++++.+.+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            4578889999999999999975 5799999999976432  334567999999999999999999999987643    47


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      |+|||||+|++|.+++. ..+.+++.++..++.|++.||+|||+   ++|+||||||+|||++.++..+|+|||.+....
T Consensus        87 ~lvmE~~~g~~L~~~~~-~~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             EEEEECCCEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             EEEEECCCCCEehhhhc-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhc
Confidence            89999999999999884 44579999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCC-ceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          231 RNK-THVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       231 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||......      ............   
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~---  232 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI---  232 (277)
T ss_dssp             ----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC---
T ss_pred             cccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCC---
Confidence            332 22223456799999999999877 7899999999999999999999998543211      111111111100   


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCC-ChHHHHHHhhccc
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRP-PMSAVIKMLEGVV  355 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~~vl~~L~~~~  355 (406)
                          .........+.++.+++.+||+.||.+|| |++++++.|.++.
T Consensus       233 ----~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 ----PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             ----CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ----CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                00112234567899999999999999999 8999999887653

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=380.99  Aligned_cols=262  Identities=23%  Similarity=0.259  Sum_probs=197.6

Q ss_pred             ccccccceeEEEEEEe-CCCcEEEEEEeccccchh----hHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEecc
Q 015480           84 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRI----AEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  158 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  158 (406)
                      ++||+|+||+||+|.+ .+|+.||||+++......    ..+.+.+|+.++++++|||||++++++.+++..++||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            5799999999999976 469999999997542211    12468899999999999999999999999999999999998


Q ss_pred             CCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEEe
Q 015480          159 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVTI  238 (406)
Q Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~  238 (406)
                      ++++..+. ..+..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++........  .
T Consensus        84 ~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~  157 (299)
T d1ua2a_          84 TDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--Y  157 (299)
T ss_dssp             EEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--C
T ss_pred             chHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc--c
Confidence            87766555 566779999999999999999999999   99999999999999999999999999999866543322  2


Q ss_pred             cCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhh---------hhcchh
Q 015480          239 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK---------CELGAM  309 (406)
Q Consensus       239 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~  309 (406)
                      ....||+.|+|||++.....++.++|||||||++|||++|.+||........   .....+....         ......
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhhccchhccchh
Confidence            3467999999999987665789999999999999999999988854321100   0000000000         000000


Q ss_pred             hccCCCCcc-----hHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcc
Q 015480          310 ILGCGIEEK-----DKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGV  354 (406)
Q Consensus       310 ~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~  354 (406)
                      .........     ....+.++.+|+.+||+.||++|||++|+++  .+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence            000000111     1134577999999999999999999999987  45443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-50  Score=380.64  Aligned_cols=245  Identities=21%  Similarity=0.230  Sum_probs=204.6

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      ..|.+.+.||+|+||+||+|.+ .+|+.||||++.+..  .....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            3578889999999999999976 469999999987532  2234567899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      ||+.+|+|..++. ..+.+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+++...... 
T Consensus       121 e~~~~g~l~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-  195 (350)
T d1rdqe_         121 EYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-  195 (350)
T ss_dssp             ECCTTCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred             ccccccchhhhHh-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence            9999999999984 44579999999999999999999999   999999999999999999999999999998765432 


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                          ....||+.|||||++.+. .++.++|||||||++|||++|..||.....       ...........         
T Consensus       196 ----~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~---------  254 (350)
T d1rdqe_         196 ----WTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSGK---------  254 (350)
T ss_dssp             ----CCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC---------
T ss_pred             ----ccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCH-------HHHHHHHhcCC---------
Confidence                235699999999999987 789999999999999999999999853321       11111111111         


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRP-----PMSAVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  349 (406)
                       ...+...+.++.+++.+||+.||.+|+     |++++++
T Consensus       255 -~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence             122334567899999999999999994     8999987

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-51  Score=375.79  Aligned_cols=269  Identities=20%  Similarity=0.276  Sum_probs=203.0

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      .|...++||+|+||+||+|.+ .+|+.||||+++.... +...+.+.+|++++++++|||||++++++.++...++||||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~   82 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   82 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence            466778999999999999976 5799999999975432 22346789999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +.++.+..........+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++........ 
T Consensus        83 ~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~-  158 (298)
T d1gz8a_          83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-  158 (298)
T ss_dssp             CSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC-
T ss_pred             cCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCccc-
Confidence            97654444444556789999999999999999999999   99999999999999999999999999999876543322 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHH----------HHHHhhh-h
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHV----------WEEYEKC-E  305 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~~-~  305 (406)
                       .....||+.|+|||.+.....++.++|||||||++|+|++|+.||........  .....          +...... .
T Consensus       159 -~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         159 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             -TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             -ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhccccccccc
Confidence             23457999999999988775678999999999999999999999854321100  00000          0000000 0


Q ss_pred             cchhhccCCCC---cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcc
Q 015480          306 LGAMILGCGIE---EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGV  354 (406)
Q Consensus       306 ~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~  354 (406)
                      ...........   ......+.++.+|+.+||+.||++|||++|+++  .++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            00000000000   011234578899999999999999999999998  36555

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-50  Score=376.78  Aligned_cols=246  Identities=22%  Similarity=0.304  Sum_probs=196.8

Q ss_pred             hhccc-ccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhcc-CcCccccEEEEEec----CCeeE
Q 015480           79 TSNYS-TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHD----QHMTA  151 (406)
Q Consensus        79 ~~~~~-~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~  151 (406)
                      .|.+. +.||+|+||+||+|++ .+|+.||||+++..      ..+.+|+.++.++ +|||||+++++|.+    +..+|
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            35555 4599999999999976 56999999998642      3467899887655 79999999999865    46789


Q ss_pred             EEEEeccCCChhhHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC---CCCceEecccccc
Q 015480          152 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAK  227 (406)
Q Consensus       152 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~DfGl~~  227 (406)
                      +|||||+||+|.+++... ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceee
Confidence            999999999999999654 3579999999999999999999999   99999999999999985   5679999999998


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      .......   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.........       ...     .
T Consensus       163 ~~~~~~~---~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-------~~~-----~  226 (335)
T d2ozaa1         163 ETTSHNS---LTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGM-----K  226 (335)
T ss_dssp             ECCCCCC---CCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred             eccCCCc---cccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-------HHH-----H
Confidence            7654432   2346799999999999877 7999999999999999999999999654322110       000     0


Q ss_pred             hhhccCC--C-CcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 AMILGCG--I-EEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~~~~~~~--~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .......  . .......+.++.+|+.+||+.||++|||+.++++
T Consensus       227 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         227 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            0000000  1 1223456788999999999999999999999988

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-51  Score=378.42  Aligned_cols=247  Identities=24%  Similarity=0.308  Sum_probs=202.1

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHhh-ccCcCccccEEEEEecCCeeEEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIG-RTYHINLVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv~  154 (406)
                      .|.+.+.||+|+||+||+|++ .+|+.||||+++++.  .....+.+..|..++. .++||||+++++++.+++..|+||
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence            467789999999999999976 469999999997542  1233456777777765 689999999999999999999999


Q ss_pred             EeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCc
Q 015480          155 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKT  234 (406)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  234 (406)
                      |||++|+|.+++. ....+++..+..++.||+.||+|||+   ++++||||||+|||+++++.+||+|||+++.......
T Consensus        83 Ey~~~g~L~~~i~-~~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          83 EYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             ECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             eecCCCcHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            9999999999994 45678999999999999999999999   9999999999999999999999999999986554332


Q ss_pred             eEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchhhccCC
Q 015480          235 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAMILGCG  314 (406)
Q Consensus       235 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (406)
                      .  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......       .........          
T Consensus       159 ~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~~----------  218 (320)
T d1xjda_         159 K--TNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMD----------  218 (320)
T ss_dssp             C--BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC----------
T ss_pred             c--ccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHcC----------
Confidence            2  2346799999999999987 7899999999999999999999999543211       111111111          


Q ss_pred             CCcchHHHHHHHHHHHHHhcccCCCCCCChH-HHHH
Q 015480          315 IEEKDKEKAKRLCMVALWCVQDSPEDRPPMS-AVIK  349 (406)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-~vl~  349 (406)
                      ....+...+.++.+|+.+||+.||++||++. ++++
T Consensus       219 ~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            1122334567899999999999999999995 6764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.8e-50  Score=370.65  Aligned_cols=262  Identities=21%  Similarity=0.258  Sum_probs=201.8

Q ss_pred             hhcccccccccceeEEEEEEeCCCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEec
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  157 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  157 (406)
                      +|...++||+|+||+||+|++++|+.||||+++.... ....+.+.+|+.+|++++||||+++++++.+++..+++|||+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~   82 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence            5677889999999999999998999999999975432 233578999999999999999999999999999999999999


Q ss_pred             cCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceEE
Q 015480          158 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHVT  237 (406)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~  237 (406)
                      .++.+..+. ...+.+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.........  
T Consensus        83 ~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--  156 (286)
T d1ob3a_          83 DQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--  156 (286)
T ss_dssp             SEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             hhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc--
Confidence            876665554 566889999999999999999999999   99999999999999999999999999999876543322  


Q ss_pred             ecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhh---------hhcch
Q 015480          238 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK---------CELGA  308 (406)
Q Consensus       238 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~  308 (406)
                      .....|++.|+|||.+.+...++.++|||||||++|||++|+.||........  . .........         .....
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~-~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--L-MRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--H-HHHHHhhCCCChhhccchhhhhh
Confidence            23356899999999998776789999999999999999999999854321100  0 000000000         00000


Q ss_pred             h------hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          309 M------ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       309 ~------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      .      .............+..+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0      0000011122334578899999999999999999999975

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-51  Score=370.24  Aligned_cols=241  Identities=22%  Similarity=0.334  Sum_probs=196.5

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccch-----hhHHHHHHHHHHhhccC--cCccccEEEEEecCCe
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTY--HINLVRLYGFCHDQHM  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~  149 (406)
                      .+|.+.+.||+|+||+||+|.+ .+|+.||||++.+....     .....+.+|+.++++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            4678889999999999999976 57999999998753211     11234678999999986  8999999999999999


Q ss_pred             eEEEEEeccC-CChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCC-CCceEecccccc
Q 015480          150 TALVYEYMEN-GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAK  227 (406)
Q Consensus       150 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~DfGl~~  227 (406)
                      .++||||+.+ +++.+++. .+..+++..+..++.|++.||+|||+   ++|+||||||+|||++.+ +.+||+|||+++
T Consensus        84 ~~lv~e~~~~~~~l~~~~~-~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEeccCcchHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccce
Confidence            9999999976 57777773 45679999999999999999999999   999999999999999854 799999999998


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ......    .....||+.|+|||++.+...++.++|||||||++|||++|+.||....             ......  
T Consensus       160 ~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~--  220 (273)
T d1xwsa_         160 LLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQ--  220 (273)
T ss_dssp             ECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCC--
T ss_pred             eccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HHhhcc--
Confidence            654432    2346799999999999876456788999999999999999999984321             111110  


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                              ...+...+.++.+|+.+||+.||++|||++|+++
T Consensus       221 --------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 --------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             --------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                    0111234577999999999999999999999987

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=368.70  Aligned_cols=263  Identities=22%  Similarity=0.311  Sum_probs=198.1

Q ss_pred             hhhhcccccccccceeEEEEEEe-CC-CcEEEEEEeccccch-hhHHHHHHHHHHhhcc---CcCccccEEEEEec----
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PN-GVKIAVKVLNRNLGR-IAEEQFMAEVGTIGRT---YHINLVRLYGFCHD----  146 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~-g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----  146 (406)
                      +.+|.+.++||+|+||+||+|.+ .+ ++.||||+++..... .....+.+|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            45788889999999999999976 34 677999998754221 2233466777776665   79999999999853    


Q ss_pred             -CCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccc
Q 015480          147 -QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  225 (406)
Q Consensus       147 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl  225 (406)
                       ....+++|||+.++++..........+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhh
Confidence             357889999999887766666677789999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhh--
Q 015480          226 AKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK--  303 (406)
Q Consensus       226 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  303 (406)
                      +........   .....||+.|+|||++.+. .++.++||||+||++|||++|+.||........  + .........  
T Consensus       163 ~~~~~~~~~---~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~-~~i~~~~~~~~  235 (305)
T d1blxa_         163 ARIYSFQMA---LTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--L-GKILDVIGLPG  235 (305)
T ss_dssp             CCCCCGGGG---GCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCCCC
T ss_pred             hhhhccccc---CCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--H-HHHHHhhCCCc
Confidence            875543322   2456799999999999877 799999999999999999999999864321100  0 000000000  


Q ss_pred             -------hhcchhh----ccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          304 -------CELGAMI----LGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       304 -------~~~~~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                             .......    ............+..+.+|+.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                   0000000    000111122344567899999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.2e-48  Score=356.41  Aligned_cols=266  Identities=18%  Similarity=0.198  Sum_probs=209.8

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCc-CccccEEEEEecCCeeEEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH-INLVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  155 (406)
                      .+|.+.+.||+|+||+||+|++ .+|+.||||++....   ....+.+|++.+..+.| +|++.+++++.++...++|||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc---CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            4678889999999999999976 468999999986542   22346788888888865 899999999999999999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcC-----CCCceEeccccccccC
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-----NFSPKVADFGLAKLCD  230 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~-----~~~~kl~DfGl~~~~~  230 (406)
                      |+ +++|.+++......+++.++..++.|++.||+|||+   +||+||||||+|||++.     ++.+||+|||+++...
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99 679999997777889999999999999999999999   99999999999999974     5789999999998765


Q ss_pred             CCCce-----EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhh
Q 015480          231 RNKTH-----VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCE  305 (406)
Q Consensus       231 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (406)
                      .....     .......||+.|||||++.+. .++.++|||||||++|||++|..||...........    ........
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~----~~~i~~~~  232 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK----YERIGEKK  232 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH----HHHHHHHH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH----HHHHHhcc
Confidence            43221     122346799999999999987 799999999999999999999999964433221111    11111110


Q ss_pred             cchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhccccCCCC
Q 015480          306 LGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVEVLPP  360 (406)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~~~~~  360 (406)
                      .     ..........+++++.+++..|++.+|++||+++.+.+.|+++......
T Consensus       233 ~-----~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~  282 (293)
T d1csna_         233 Q-----STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  282 (293)
T ss_dssp             H-----HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             C-----CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence            0     0000111223457799999999999999999999999999887654433

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6e-48  Score=356.06  Aligned_cols=273  Identities=19%  Similarity=0.203  Sum_probs=206.9

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCc-cccEEEEEecCCeeEEEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYGFCHDQHMTALVYE  155 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e  155 (406)
                      .+|.+.+.||+|+||+||+|.+ .+|+.||||++....   ....+..|+++++.++|+| |+.+.+++.+....++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT---TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc---cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            3578889999999999999976 568999999987542   2235788999999998666 5555666678889999999


Q ss_pred             eccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEc---CCCCceEeccccccccCCC
Q 015480          156 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCDRN  232 (406)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~DfGl~~~~~~~  232 (406)
                      |+ +++|.+.+......+++..+..++.|++.||+|||+   ++|+||||||+|||++   .+..+||+|||+++.....
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            99 557777776777889999999999999999999999   9999999999999985   3557999999999876543


Q ss_pred             Cce-----EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcc
Q 015480          233 KTH-----VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELG  307 (406)
Q Consensus       233 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (406)
                      ...     .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....................    
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~----  234 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS----  234 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH----
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC----
Confidence            322     122456799999999999987 7899999999999999999999998654433222111111010000    


Q ss_pred             hhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcccc--CCCCCCCccch
Q 015480          308 AMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKMLEGVVE--VLPPPKPFRYL  367 (406)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~~~~--~~~~p~~~~~~  367 (406)
                           ...+.....++.++.+++..||+.||++||++.++.+.|+.+..  ......++.|.
T Consensus       235 -----~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~  291 (299)
T d1ckia_         235 -----TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  291 (299)
T ss_dssp             -----SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHH
T ss_pred             -----CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCch
Confidence                 00111223456789999999999999999999999999988743  33444555554

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=367.85  Aligned_cols=271  Identities=19%  Similarity=0.245  Sum_probs=199.5

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEecCC----eeEEE
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH----MTALV  153 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv  153 (406)
                      +|...++||+|+||+||+|.. .+|+.||||+++........+.+.+|+.+|++++||||+++++++....    ..+++
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence            477789999999999999965 6799999999986545556678999999999999999999999997653    23455


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNK  233 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  233 (406)
                      ++|+.+|+|.+++..  ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        89 ~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          89 VTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             EEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence            566779999999943  469999999999999999999999   999999999999999999999999999998654332


Q ss_pred             ce-EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHH-----HHH---hhh
Q 015480          234 TH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVW-----EEY---EKC  304 (406)
Q Consensus       234 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-----~~~---~~~  304 (406)
                      .. .......||+.|+|||++.....++.++||||+||++|||++|+.||................     ...   ...
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  243 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence            21 112446799999999998766578999999999999999999999985443211100000000     000   000


Q ss_pred             hcchhh--c--cCCCC--cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH--hhcc
Q 015480          305 ELGAMI--L--GCGIE--EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIKM--LEGV  354 (406)
Q Consensus       305 ~~~~~~--~--~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~--L~~~  354 (406)
                      ......  .  ....+  ......+.++.+|+.+||+.||.+|||+.++++.  |+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            000000  0  00000  0112334678999999999999999999999973  5444

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=367.33  Aligned_cols=268  Identities=20%  Similarity=0.259  Sum_probs=198.4

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCC------e
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH------M  149 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  149 (406)
                      .+|...++||+|+||+||+|.+ .+|+.||||+++... .....+.+.+|+++|++++|||||+++++|...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            4577788999999999999976 569999999997543 3344578899999999999999999999997654      5


Q ss_pred             eEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccccc
Q 015480          150 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  229 (406)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~  229 (406)
                      .++||||| +.+|..+..  ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus        98 ~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             CEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceecc
Confidence            69999999 557777763  4579999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc--------chhHHHHHH
Q 015480          230 DRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW--------FPKHVWEEY  301 (406)
Q Consensus       230 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~~~~~  301 (406)
                      ....     +...||+.|+|||++.+...++.++||||+||++|||++|+.||..........        .+...++..
T Consensus       172 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         172 DSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             CSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             CCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            5432     346799999999998876578999999999999999999999985432110000        000000000


Q ss_pred             hhhh---cchh---hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcccc
Q 015480          302 EKCE---LGAM---ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVVE  356 (406)
Q Consensus       302 ~~~~---~~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~~  356 (406)
                      ....   ....   .............+..+.+|+.+||..||++|||+.|+++  .++.+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence            0000   0000   0000111122334567889999999999999999999998  4666543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=366.71  Aligned_cols=266  Identities=21%  Similarity=0.233  Sum_probs=197.6

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccccEEEEEec------CCee
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD------QHMT  150 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~  150 (406)
                      .+|+..++||+|+||+||+|++ .+|+.||||++..+..     ...+|+++|++++||||++++++|..      ..+.
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            3577788999999999999976 4699999999976432     23479999999999999999999853      3357


Q ss_pred             EEEEEeccCCChhhHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC-CceEecccccc
Q 015480          151 ALVYEYMENGSLDGYLF--GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAK  227 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~DfGl~~  227 (406)
                      +||||||+++.+..+..  .....+++..+..++.|++.||+|||+   +||+||||||+|||++.++ .+||+|||++.
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchh
Confidence            89999998765444332  356689999999999999999999999   9999999999999999875 89999999998


Q ss_pred             ccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccc--------hhHHHH
Q 015480          228 LCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWF--------PKHVWE  299 (406)
Q Consensus       228 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--------~~~~~~  299 (406)
                      ........   ....||+.|+|||.+.+...++.++||||+||++|||++|..||...........        ....+.
T Consensus       172 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         172 QLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             ECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             hccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            76544322   3467899999999988766799999999999999999999999854332110000        000000


Q ss_pred             HHhhhhcchhhccCC-----CCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhccc
Q 015480          300 EYEKCELGAMILGCG-----IEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVV  355 (406)
Q Consensus       300 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~  355 (406)
                      ..... .........     ........+.++.+|+.+||+.||++|||+.|+++  .++++.
T Consensus       249 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         249 EMNPN-YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHCC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhccc-hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            00000 000000000     00111234667999999999999999999999997  455553

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-48  Score=358.43  Aligned_cols=265  Identities=21%  Similarity=0.230  Sum_probs=195.4

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEec--------C
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--------Q  147 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~  147 (406)
                      .+|.+.++||+|+||+||+|.+ .+|+.||||++.... ......++.+|+.+|++++||||+++++++..        +
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            4577889999999999999976 579999999986432 23345678999999999999999999999855        3


Q ss_pred             CeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          148 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ...++||||+.++.+..+. .....++...+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus        90 ~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceee
Confidence            4678999999876665443 566789999999999999999999999   999999999999999999999999999997


Q ss_pred             ccCCCCce--EEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHh---
Q 015480          228 LCDRNKTH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYE---  302 (406)
Q Consensus       228 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  302 (406)
                      ........  .......||+.|+|||++.+...++.++|||||||++|||++|+.||........   .........   
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~  242 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCGSIT  242 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH---HHHHHHhcCCCC
Confidence            66533221  1223457999999999998776789999999999999999999999853221100   000000000   


Q ss_pred             --------hhhcchhhcc-CCCCcch------HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          303 --------KCELGAMILG-CGIEEKD------KEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       303 --------~~~~~~~~~~-~~~~~~~------~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                              .......... .......      ......+.+|+.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence                    0000000000 0001111      112456789999999999999999999997

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=353.00  Aligned_cols=267  Identities=18%  Similarity=0.235  Sum_probs=208.3

Q ss_pred             hhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecCCeeEEEEEe
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  156 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  156 (406)
                      +|+..++||+|+||+||+|++ .+|+.||||+++... .......+.+|+.+++.++||||+++++++.+....++|+++
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~   82 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence            567788999999999999976 578999999997543 334567899999999999999999999999999999999999


Q ss_pred             ccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccCCCCceE
Q 015480          157 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNKTHV  236 (406)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  236 (406)
                      +.+++|..++ ...+.+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||.++........ 
T Consensus        83 ~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~-  157 (292)
T d1unla_          83 CDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-  157 (292)
T ss_dssp             CSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-
T ss_pred             cccccccccc-ccccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCcc-
Confidence            9998888776 466788999999999999999999999   99999999999999999999999999999876544322 


Q ss_pred             EecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhh-------------
Q 015480          237 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEK-------------  303 (406)
Q Consensus       237 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------  303 (406)
                       .....+++.|+|||.+.+...++.++|||||||++|||++|+.||..+...... .. ........             
T Consensus       158 -~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LK-RIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-HH-HHHHHHCCCCTTTCTTGGGST
T ss_pred             -ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH-HH-HHHhhcCCCChhhhhhhhhcc
Confidence             223457889999999887756899999999999999999999997544322110 00 00000000             


Q ss_pred             --hhcchhhccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhc
Q 015480          304 --CELGAMILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEG  353 (406)
Q Consensus       304 --~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~  353 (406)
                        ...................+..+.+|+.+||+.||.+|||++|+++  .+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence              0000000011112223345677899999999999999999999987  4443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.8e-47  Score=357.49  Aligned_cols=258  Identities=18%  Similarity=0.263  Sum_probs=199.6

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEec--CCeeEEE
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHD--QHMTALV  153 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv  153 (406)
                      ..|.+.++||+|+||+||+|++ .+|+.||||+++..    ..+++.+|+.+|.+++ ||||+++++++..  ....++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            4688889999999999999976 56999999999753    3467889999999995 9999999999974  4568999


Q ss_pred             EEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCC-CceEeccccccccCCC
Q 015480          154 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRN  232 (406)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~DfGl~~~~~~~  232 (406)
                      ||||.+++|..+.    +.+++..+..++.||+.||+|||+   +||+||||||+|||++.++ .+||+|||+++.....
T Consensus       111 ~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         111 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             EeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            9999999997654    469999999999999999999999   9999999999999998655 5899999999876544


Q ss_pred             CceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccch-------hHHHHHHhhhh
Q 015480          233 KTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP-------KHVWEEYEKCE  305 (406)
Q Consensus       233 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~~  305 (406)
                      ..   .....||+.|+|||.+.+...++.++||||+||++|||++|+.||..+.........       ...........
T Consensus       184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         184 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             Cc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            32   234678999999999887757899999999999999999999998655432111000       00000000000


Q ss_pred             cc------hhhc--------cCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          306 LG------AMIL--------GCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       306 ~~------~~~~--------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                      ..      ....        ...........+.++.+|+.+||+.||.+|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00      0000        00011122345678999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=355.87  Aligned_cols=253  Identities=22%  Similarity=0.249  Sum_probs=200.9

Q ss_pred             hhcccccccccceeEEEEEEe----CCCcEEEEEEecccc---chhhHHHHHHHHHHhhccCc-CccccEEEEEecCCee
Q 015480           79 TSNYSTRLGFGGFGEVYKGQF----PNGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRTYH-INLVRLYGFCHDQHMT  150 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~----~~g~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~  150 (406)
                      .|++.+.||+|+||+||+|+.    .+|+.||||++++..   .....+.+.+|++++++++| |||+++++++.+....
T Consensus        25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~  104 (322)
T d1vzoa_          25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  104 (322)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence            477889999999999999964    248899999987532   12234568899999999976 8999999999999999


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      +++|||+.+|+|.+++. ..+.+.+..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++...
T Consensus       105 ~~v~e~~~~~~L~~~i~-~~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         105 HLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEECCCCSCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeeeecccccHHHHHHH-hcccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            99999999999999984 44567889999999999999999999   999999999999999999999999999998664


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCC-CCCcccceeecchhHHHHhhcccccccCCCcccccchhHHHHHHhhhhcchh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFPKHVWEEYEKCELGAM  309 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (406)
                      ...... .....|++.|+|||.+.+.. .++.++|||||||+||||++|+.||.........   ..........     
T Consensus       181 ~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~~~~~~~-----  251 (322)
T d1vzoa_         181 ADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKS-----  251 (322)
T ss_dssp             GGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHHHC-----
T ss_pred             cccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcccC-----
Confidence            332221 23356899999999987542 4788999999999999999999998655433211   1111111110     


Q ss_pred             hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 015480          310 ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPP-----MSAVIK  349 (406)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  349 (406)
                           ....+...+.++.+++.+||+.||++|||     ++|+++
T Consensus       252 -----~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 -----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -----CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                 12233456788999999999999999995     788876

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-47  Score=355.67  Aligned_cols=269  Identities=17%  Similarity=0.224  Sum_probs=198.9

Q ss_pred             hhhcccccccccceeEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHhhccCcCccccEEEEEecC-----Cee
Q 015480           78 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-----HMT  150 (406)
Q Consensus        78 ~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  150 (406)
                      .+|...++||+|+||+||+|++ .+|+.||||+++... .....+.+.+|+++|++++|||||++++++...     ...
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            4577789999999999999975 579999999997543 233456789999999999999999999999643     344


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      +++++|+.+|+|.+++.  .+.+++..+..++.||+.||+|||+   +||+||||||+|||++.++.+|++|||++....
T Consensus        98 ~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             CEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             EEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccC
Confidence            67778888999999983  4579999999999999999999999   999999999999999999999999999997554


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccc--------hhHHHHHHh
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWF--------PKHVWEEYE  302 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--------~~~~~~~~~  302 (406)
                      ..     .....||+.|+|||.+.+...++.++|||||||++|+|++|+.||...........        .........
T Consensus       173 ~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         173 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             GG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             cc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            32     23456889999999988765679999999999999999999999854321100000        000000000


Q ss_pred             hh---hcchhhccCCCC---cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH--Hhhcccc
Q 015480          303 KC---ELGAMILGCGIE---EKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK--MLEGVVE  356 (406)
Q Consensus       303 ~~---~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~~~~  356 (406)
                      ..   ............   ......+.++.+|+.+||+.||.+|||+.|+++  .+.+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence            00   000000000000   011234567899999999999999999999998  6666543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-45  Score=345.99  Aligned_cols=260  Identities=20%  Similarity=0.225  Sum_probs=189.1

Q ss_pred             hhcccccccccceeEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHhhccCcCccccEEEEEec------CCee
Q 015480           79 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHD------QHMT  150 (406)
Q Consensus        79 ~~~~~~~ig~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~  150 (406)
                      +|...++||+|+||+||+|.+. +|+.||||++..... ......+.+|+.++++++||||++++++|..      ....
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~   97 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV   97 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence            4677889999999999999764 699999999975432 3345678999999999999999999999964      3678


Q ss_pred             EEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEeccccccccC
Q 015480          151 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  230 (406)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~~~~  230 (406)
                      |+|||||.++.+. .+   ...+++..+..++.|++.||.|||+   .||+||||||+|||++.++.+|++|||+++...
T Consensus        98 ~iv~Ey~~~~l~~-~~---~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          98 YLVMELMDANLCQ-VI---QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EEEEECCSEEHHH-HH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEEeccchHHHH-hh---hcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhccc
Confidence            9999999775544 44   2468999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCccccc--------chhHHH----
Q 015480          231 RNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDW--------FPKHVW----  298 (406)
Q Consensus       231 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~~----  298 (406)
                      ....   .....||+.|+|||++.+. .+++++||||+||++|||++|+.||..........        .....+    
T Consensus       171 ~~~~---~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         171 TSFM---MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             -------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             cccc---cccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            4322   2345789999999999887 78999999999999999999999985332110000        000000    


Q ss_pred             ---HHHhhhhc-------chh---hccCCCCcchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 015480          299 ---EEYEKCEL-------GAM---ILGCGIEEKDKEKAKRLCMVALWCVQDSPEDRPPMSAVIK  349 (406)
Q Consensus       299 ---~~~~~~~~-------~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  349 (406)
                         ........       ...   .............+..+.+|+.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence               00000000       000   0011112234457788999999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-40  Score=315.62  Aligned_cols=269  Identities=22%  Similarity=0.253  Sum_probs=192.5

Q ss_pred             hhhhcccccccccceeEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-----------cCccccEEEEE
Q 015480           77 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-----------HINLVRLYGFC  144 (406)
Q Consensus        77 ~~~~~~~~~ig~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~  144 (406)
                      +.+|.+.++||+|+||+||+|+. .+|+.||||+++.+  ....+.+.+|+.+++.++           |+||+++++++
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            34588899999999999999976 57999999999864  234466788888887765           57899999988


Q ss_pred             ec--CCeeEEEEEeccCCChhhH--hhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCC---
Q 015480          145 HD--QHMTALVYEYMENGSLDGY--LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---  217 (406)
Q Consensus       145 ~~--~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---  217 (406)
                      ..  ....+++++++..+.....  .......+++..+..++.|++.||+|||+  ..||+||||||+||||+.++.   
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTT
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccc
Confidence            54  3456677777655443222  23456788999999999999999999997  378999999999999986654   


Q ss_pred             ---ceEeccccccccCCCCceEEecCCCCCCCccCccccCCCCCCCcccceeecchhHHHHhhcccccccCCCcccccch
Q 015480          218 ---PKVADFGLAKLCDRNKTHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGATESLDWFP  294 (406)
Q Consensus       218 ---~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~  294 (406)
                         ++++|||.+.......     ....||+.|+|||++.+. .++.++||||+||++++|++|+.||............
T Consensus       168 ~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             EEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cceeeEeeccccccccccc-----ccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence               8999999997554322     346799999999999876 7899999999999999999999998643322111000


Q ss_pred             hHHHH-----------HHhhhhc----------chhhccC----------CCCcchHHHHHHHHHHHHHhcccCCCCCCC
Q 015480          295 KHVWE-----------EYEKCEL----------GAMILGC----------GIEEKDKEKAKRLCMVALWCVQDSPEDRPP  343 (406)
Q Consensus       295 ~~~~~-----------~~~~~~~----------~~~~~~~----------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs  343 (406)
                      .....           .......          .......          .........+.++.+|+.+||..||.+|||
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence            00000           0000000          0000000          011223567889999999999999999999


Q ss_pred             hHHHHH--Hhhccc
Q 015480          344 MSAVIK--MLEGVV  355 (406)
Q Consensus       344 ~~~vl~--~L~~~~  355 (406)
                      ++|+++  .+++..
T Consensus       322 a~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         322 AGGLVNHPWLKDTL  335 (362)
T ss_dssp             HHHHHTCGGGTTCT
T ss_pred             HHHHhcCcccCCCC
Confidence            999987  355443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.2e-24  Score=185.73  Aligned_cols=163  Identities=15%  Similarity=0.113  Sum_probs=119.9

Q ss_pred             cccccccccceeEEEEEEeCCCcEEEEEEeccccc-----------------hhhHHHHHHHHHHhhccCcCccccEEEE
Q 015480           81 NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG-----------------RIAEEQFMAEVGTIGRTYHINLVRLYGF  143 (406)
Q Consensus        81 ~~~~~ig~G~~g~V~~~~~~~g~~vavK~~~~~~~-----------------~~~~~~~~~e~~~l~~l~h~niv~~~~~  143 (406)
                      .+.++||+|+||+||+|...+|+.||||+++....                 .........|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35678999999999999888999999998753210                 1112345568888999999999998876


Q ss_pred             EecCCeeEEEEEeccCCChhhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCcEEEcCCCCceEecc
Q 015480          144 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF  223 (406)
Q Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (406)
                      ..    .+++|||+++..+.+        ++......++.|++.+|+|||+   +||+||||||+|||++++ .++|+||
T Consensus        83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEEC
Confidence            42    379999998865543        3334467899999999999999   999999999999999966 4899999


Q ss_pred             ccccccCCCCceEEecCCCCCCCccCc------cccCCCCCCCcccceeecchh
Q 015480          224 GLAKLCDRNKTHVTISGYKGTPGYSAP------EFLSGNYPITHKCDVYSFGMV  271 (406)
Q Consensus       224 Gl~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~~DvwslG~i  271 (406)
                      |++.....+...          .|...      +.+.  ..++.++|+||+.--
T Consensus       147 G~a~~~~~~~~~----------~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~  188 (191)
T d1zara2         147 PQSVEVGEEGWR----------EILERDVRNIITYFS--RTYRTEKDINSAIDR  188 (191)
T ss_dssp             TTCEETTSTTHH----------HHHHHHHHHHHHHHH--HHHCCCCCHHHHHHH
T ss_pred             CCcccCCCCCcH----------HHHHHHHHHHHHHHc--CCCCCcccHHHHHHH
Confidence            999765433221          11111      1111  256888999986543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.62  E-value=6e-08  Score=84.83  Aligned_cols=132  Identities=11%  Similarity=0.030  Sum_probs=90.8

Q ss_pred             ccceeEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC-cCccccEEEEEecCCeeEEEEEeccCCChhhHh
Q 015480           88 FGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYMENGSLDGYL  166 (406)
Q Consensus        88 ~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l  166 (406)
                      -++.+.||+... ++..+.+|+...... .....+.+|...+..+. +--+.+++.++.+++..++||++++|.++.+..
T Consensus        24 G~s~~~v~rv~~-~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~  101 (263)
T d1j7la_          24 GMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY  101 (263)
T ss_dssp             CCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred             CCCCCcEEEEEe-CCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence            344568999876 455677887764321 22334677888777664 434678888888888999999999998886544


Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHHhc--------------------------------------------------
Q 015480          167 FGKKRAIEWEKLHEIAIGTAKGLVYLHEEC--------------------------------------------------  196 (406)
Q Consensus       167 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------------------  196 (406)
                      ...      .....++.++++.+..||+..                                                  
T Consensus       102 ~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (263)
T d1j7la_         102 EDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK  175 (263)
T ss_dssp             TTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred             ccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence            111      112334556666666666420                                                  


Q ss_pred             ------CCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          197 ------QQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       197 ------~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                            ...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                  1248999999999999987767799998774

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.40  E-value=2.6e-07  Score=80.23  Aligned_cols=129  Identities=12%  Similarity=0.029  Sum_probs=86.2

Q ss_pred             ccccce-eEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccC--cCccccEEEEEecCCeeEEEEEeccCCCh
Q 015480           86 LGFGGF-GEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY--HINLVRLYGFCHDQHMTALVYEYMENGSL  162 (406)
Q Consensus        86 ig~G~~-g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L  162 (406)
                      +..|.. +.||+....+|..+++|......    ...+..|...++.+.  .-.+.+++++..+++..++||++++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            444543 67999988788888999876532    224667777776664  23467788888888889999999988666


Q ss_pred             hhHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 015480          163 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE-----------------------------------------------  195 (406)
Q Consensus       163 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------------------------------------------  195 (406)
                      .+..      ...   ...+.++++.|.-||+.                                               
T Consensus        94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            4311      111   11222333344444421                                               


Q ss_pred             --------cCCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          196 --------CQQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       196 --------~~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                              ....++|+|+.|.|||++++..+-|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                    01348999999999999987777899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.92  E-value=1e-05  Score=74.69  Aligned_cols=76  Identities=13%  Similarity=0.045  Sum_probs=48.2

Q ss_pred             ccccccceeEEEEEEeCC-CcEEEEEEecccc------chhhHHHHHHHHHHhhccC---cCccccEEEEEecCCeeEEE
Q 015480           84 TRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNL------GRIAEEQFMAEVGTIGRTY---HINLVRLYGFCHDQHMTALV  153 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~-g~~vavK~~~~~~------~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  153 (406)
                      +.||.|....||++...+ |+.+++|.-....      -.....+...|.+.|..+.   ...+++++.+.  ....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence            458999999999998654 6788999654211      1112334566777776653   23466676653  4455799


Q ss_pred             EEeccCCC
Q 015480          154 YEYMENGS  161 (406)
Q Consensus       154 ~e~~~~g~  161 (406)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.74  E-value=4.2e-05  Score=68.52  Aligned_cols=132  Identities=14%  Similarity=0.129  Sum_probs=77.0

Q ss_pred             eEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHhhccCcCccc--cEE-----EEEecCCeeEEEEEeccCCChh-
Q 015480           92 GEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV--RLY-----GFCHDQHMTALVYEYMENGSLD-  163 (406)
Q Consensus        92 g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv--~~~-----~~~~~~~~~~lv~e~~~~g~L~-  163 (406)
                      -.||+++..+|+.|++|+.+...  ...+++..|...+..|...++.  ..+     ..+......+.++++++|..+. 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            47999999999999999987642  2456677788887776532221  111     1223456678899999764432 


Q ss_pred             ----hH------h---h----c----CCCCCCHHH-------------------HHHHHHHHHHHHHHHHHh----cCCC
Q 015480          164 ----GY------L---F----G----KKRAIEWEK-------------------LHEIAIGTAKGLVYLHEE----CQQR  199 (406)
Q Consensus       164 ----~~------l---~----~----~~~~~~~~~-------------------~~~i~~qi~~~l~~LH~~----~~~~  199 (406)
                          .+      +   +    .    .+...++..                   ...+...+...++.+...    ...+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                11      0   0    0    011122111                   111122222333333321    2467


Q ss_pred             eeecCCCCCcEEEcCCCCceEecccccc
Q 015480          200 IIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       200 i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ++|+|+.+.|||++++  ..++||+-+.
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             eecCCCCcccEEEeCC--ceEEechhcc
Confidence            9999999999999743  4589998775

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.11  E-value=0.0013  Score=60.07  Aligned_cols=72  Identities=18%  Similarity=0.215  Sum_probs=48.6

Q ss_pred             ccccccceeEEEEEEeCCC--------cEEEEEEeccccchhhHHHHHHHHHHhhccCcCc-cccEEEEEecCCeeEEEE
Q 015480           84 TRLGFGGFGEVYKGQFPNG--------VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYGFCHDQHMTALVY  154 (406)
Q Consensus        84 ~~ig~G~~g~V~~~~~~~g--------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  154 (406)
                      +.|+.|-.-.+|++...++        ..|.+++.-.. .  ......+|..+++.+.-.+ ..++++++.+    .+|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            4677788889999986543        45677766532 1  2234567888888875334 4578887753    5899


Q ss_pred             EeccCCCh
Q 015480          155 EYMENGSL  162 (406)
Q Consensus       155 e~~~~g~L  162 (406)
                      ||++|.+|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.51  E-value=0.0085  Score=52.45  Aligned_cols=31  Identities=26%  Similarity=0.321  Sum_probs=27.7

Q ss_pred             CCCeeecCCCCCcEEEcCCCCceEecccccc
Q 015480          197 QQRIIHYDIKPENVLLDANFSPKVADFGLAK  227 (406)
Q Consensus       197 ~~~i~H~dlk~~Nill~~~~~~kl~DfGl~~  227 (406)
                      ..|++|+|+.++||+++.+...-++||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4789999999999999988777899998874